<SEC-DOCUMENT>0001275187-18-000011.txt : 20180723
<SEC-HEADER>0001275187-18-000011.hdr.sgml : 20180723
<ACCEPTANCE-DATETIME>20180723170434
ACCESSION NUMBER:		0001275187-18-000011
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		127
CONFORMED PERIOD OF REPORT:	20180531
FILED AS OF DATE:		20180723
DATE AS OF CHANGE:		20180723

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ANGIODYNAMICS INC
		CENTRAL INDEX KEY:			0001275187
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				113146460
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50761
		FILM NUMBER:		18965022

	BUSINESS ADDRESS:	
		STREET 1:		14 PLAZA DRIVE
		CITY:			LATHAM
		STATE:			NY
		ZIP:			12110
		BUSINESS PHONE:		5187981215

	MAIL ADDRESS:	
		STREET 1:		14 PLAZA DRIVE
		CITY:			LATHAM
		STATE:			NY
		ZIP:			12110
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>ango-053118x10k.htm
<DESCRIPTION>10-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s873F0C826871545281840CA31316648C"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">&#32;UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Washington, D.C. 20549</font></div><div style="line-height:120%;padding-bottom:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:240px;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:240px;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM 10-K</font></div><div style="line-height:120%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:240px;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:240px;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Wingdings;font-size:12pt;">x</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">For the fiscal year ended May&#160;31, 2018</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">OR</font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:6%;"></td><td style="width:94%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Wingdings;font-size:12pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commission file number 0-50761</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:240px;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:240px;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:24pt;"><font style="font-family:inherit;font-size:24pt;font-weight:bold;">AngioDynamics, Inc.</font></div><div style="line-height:120%;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Exact name of registrant as specified in its charter)</font></div><div style="line-height:120%;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-align:center;"><img src="angologoa15.gif" alt="angologoa15.gif" style="height:64px;width:422px;"></div><div style="line-height:120%;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:49%;"></td><td style="width:4%;"></td><td style="width:47%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Delaware</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">11-3146460</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(State or other jurisdiction of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">incorporation or organization)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(I.R.S. Employer</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Identification No.)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">14 Plaza Drive Latham, New York</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">12110</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Address of principal executive offices)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Zip Code)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Registrant&#8217;s telephone number, including area code (518)&#160;795-1400</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:44.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Securities registered pursuant to Section&#160;12(b) of the Act:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:49%;"></td><td style="width:4%;"></td><td style="width:47%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Title of each class</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Name of each exchange on which registered</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Common Stock, par value $.01 per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">NASDAQ Global Select Market</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Securities registered pursuant to Section&#160;12(g) of the Act:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">None</font></div><div style="line-height:120%;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Title of Class)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:240px;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:240px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;</font><font style="font-family:Wingdings;font-size:8pt;">&#168;</font><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;No&#160;&#160;</font><font style="font-family:Wingdings;font-size:8pt;">x</font></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or 15(d) of the Act.&#160;&#160;&#160;&#160;Yes&#160;&#160;</font><font style="font-family:Wingdings;font-size:8pt;">&#168;</font><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;No&#160;&#160;</font><font style="font-family:Wingdings;font-size:8pt;">x</font></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;&#160;&#160;Yes&#160;&#160;</font><font style="font-family:Wingdings;font-size:8pt;">x</font><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;No&#160;&#160;</font><font style="font-family:Wingdings;font-size:8pt;">&#168;</font></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;&#160;&#160;&#160;Yes&#160;&#160;</font><font style="font-family:Wingdings;font-size:8pt;">x</font><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;No&#160;&#160;</font><font style="font-family:Wingdings;font-size:8pt;">&#168;</font></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Indicate by check mark if disclosure of delinquent filers pursuant to Item&#160;405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant&#8217;s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.&#160;&#160;</font><font style="font-family:Wingdings;font-size:8pt;">x</font></div><div style="line-height:120%;padding-top:4px;text-align:left;padding-left:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See definitions of &#8220;large accelerated filer&#8221;, &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):</font></div><div><br></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-left:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.49122807017544%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:1%;"></td><td style="width:47%;"></td><td style="width:4%;"></td><td style="width:48%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Large&#160;accelerated&#160;filer&#160;&#160;</font><font style="font-family:Wingdings;font-size:8pt;">&#168;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accelerated&#160;filer&#160;&#160;</font><font style="font-family:Wingdings;font-size:8pt;">x</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-accelerated filer&#160;&#160;</font><font style="font-family:Wingdings;font-size:8pt;">&#168;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Smaller reporting company&#160;&#160;</font><font style="font-family:Wingdings;font-size:8pt;">&#168;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Emerging growth company&#160;&#160;</font><font style="font-family:Wingdings;font-size:8pt;">&#168;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;padding-left:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</font><font style="font-family:Wingdings;font-size:8pt;">&#168;</font><font style="font-family:inherit;font-size:8pt;">&#160;&#160;&#160;&#160;No&#160;&#160;</font><font style="font-family:Wingdings;font-size:8pt;">x</font></div><div style="line-height:120%;padding-top:4px;padding-left:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of November&#160;30, </font><font style="font-family:inherit;font-size:8pt;">2017</font><font style="font-family:inherit;font-size:8pt;">, the last business day of the registrant&#8217;s most recently completed second fiscal quarter, the aggregate market value of the registrant&#8217;s common stock held by non-affiliates was approximately $631,826,627 computed by reference to the last sale price of the common stock on that date as reported by The NASDAQ Global Select Market.</font></div><div style="line-height:120%;padding-top:4px;padding-left:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of July 20, 2018 there were 36,885,765 shares of the registrant&#8217;s common stock outstanding.</font></div><div style="line-height:120%;padding-top:4px;padding-left:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">DOCUMENTS INCORPORATED BY REFERENCE</font></div><div style="line-height:120%;padding-top:4px;padding-left:24px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">The information required for Part III of this Annual Report on Form 10-K is incorporated by reference to the registrant&#8217;s Proxy Statement for its </font><font style="font-family:inherit;font-size:8pt;">2018</font><font style="font-family:inherit;font-size:8pt;">&#32;Annual Meeting of Stockholders to be filed within 120 days of the registrant's fiscal year ended </font><font style="font-family:inherit;font-size:8pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:8pt;">. </font></div><div><br></div><hr style="page-break-after:always"><div><a name="s8DF55EE8CBD25E45A8E4E03651B2DED2"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">AngioDynamics, Inc. and Subsidiaries</font></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INDEX</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:13%;"></td><td style="width:82%;"></td><td style="width:5%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Page</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Part I:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;1.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sF44F67C9D6A9556EA158EFB54567F1FD"><font style="font-family:inherit;font-size:10pt;">Business</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sF44F67C9D6A9556EA158EFB54567F1FD">2</a></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;1A.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s45E0D44983255BA5918E1FB36A4CE359"><font style="font-family:inherit;font-size:10pt;">Risk Factors</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s45E0D44983255BA5918E1FB36A4CE359">15</a></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;1B.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sEB99CEE38E4C587BB968A8B10FFEABC2"><font style="font-family:inherit;font-size:10pt;">Unresolved Staff Comments</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sEB99CEE38E4C587BB968A8B10FFEABC2">32</a></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;2.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s4437426EA4B950B59DA355755740DED0"><font style="font-family:inherit;font-size:10pt;">Properties</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s4437426EA4B950B59DA355755740DED0">33</a></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;3.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sE5439C4C59BC5CB8820AAB04F194198B"><font style="font-family:inherit;font-size:10pt;">Legal Proceedings</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sE5439C4C59BC5CB8820AAB04F194198B">34</a></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item 4.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s77FDB34027475A61BF5909EA86BA33FA"><font style="font-family:inherit;font-size:10pt;">Mine Safety Disclosures</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s77FDB34027475A61BF5909EA86BA33FA">35</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Part II:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;5.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s068F2576656F50D1ACCF709E46DA21E5"><font style="font-family:inherit;font-size:10pt;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s068F2576656F50D1ACCF709E46DA21E5">35</a></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;6.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s3F5D762E7D035880B2758F79B82D1B9A"><font style="font-family:inherit;font-size:10pt;">Selected Financial Data</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s3F5D762E7D035880B2758F79B82D1B9A">37</a></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;7.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s0AA65678B779586CA9B070000872B023"><font style="font-family:inherit;font-size:10pt;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s0AA65678B779586CA9B070000872B023">38</a></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;7A.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sD1D18B5D1D9F5D46847727E9FC2A6561"><font style="font-family:inherit;font-size:10pt;">Quantitative and Qualitative Disclosures About Market Risk</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sD1D18B5D1D9F5D46847727E9FC2A6561">52</a></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;8.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sF191F5D89E185DCB87A027FC7019EF13"><font style="font-family:inherit;font-size:10pt;">Financial Statements and Supplementary Data</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sF191F5D89E185DCB87A027FC7019EF13">52</a></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;9.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s55441BFDF328508CB3A497CDE8416321"><font style="font-family:inherit;font-size:10pt;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s55441BFDF328508CB3A497CDE8416321">52</a></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;9A.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s2C16A94A9C1B53C297FF619C7007FDB8"><font style="font-family:inherit;font-size:10pt;">Controls and Procedures</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s2C16A94A9C1B53C297FF619C7007FDB8">52</a></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;9B.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s0829957ACF945163A9F21A521FCFF9E0"><font style="font-family:inherit;font-size:10pt;">Other Information</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s0829957ACF945163A9F21A521FCFF9E0">55</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Part III:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;10.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s291B895F6D8A5269BB80C0F93EF38561"><font style="font-family:inherit;font-size:10pt;">Directors, Executive Officers and Corporate Governance</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s291B895F6D8A5269BB80C0F93EF38561">56</a></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;11.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s5D1117B14BF25D4998B5549A0455EC0D"><font style="font-family:inherit;font-size:10pt;">Executive Compensation</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s5D1117B14BF25D4998B5549A0455EC0D">56</a></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;12.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sB10B3B80A7B65E77B78F63A5D1A28420"><font style="font-family:inherit;font-size:10pt;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sB10B3B80A7B65E77B78F63A5D1A28420">56</a></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;13.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s38B1B8739A1E5FA6B3D65865EB526D6F"><font style="font-family:inherit;font-size:10pt;">Certain Relationships and Related Transactions, and Director Independence</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s38B1B8739A1E5FA6B3D65865EB526D6F">56</a></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;14.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sA0967F23374356C388FB8C7E6794F6FF"><font style="font-family:inherit;font-size:10pt;">Principal Accounting Fees and Services</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sA0967F23374356C388FB8C7E6794F6FF">56</a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Part IV:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;15.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sD44898CFA615568392EEF9631BB9F4BE"><font style="font-family:inherit;font-size:10pt;">Exhibits, Financial Statement Schedules</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sD44898CFA615568392EEF9631BB9F4BE">57</a></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></div><hr style="page-break-after:always"><div><a name="s92056BEC05125FF0A9DE8CAEAF04B306"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Part I</font></div><div><a name="sF44F67C9D6A9556EA158EFB54567F1FD"></a></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:74px;"></td><td style="width:608px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;1.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Business.</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">OVERVIEW</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngioDynamics, Inc. (together with its subsidiaries, "AngioDynamics," the "Company," "we," "our" or "us") designs, manufactures and sells a wide range of medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease, vascular access and for use in oncology and surgical settings. Our devices are generally used in minimally invasive, image-guided procedures.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">HISTORY</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngioDynamics was founded in Queensbury, N.Y., U.S., in 1988. Queensbury was chosen due to its location in the heart of  "Catheter Valley," an area in New York's Adirondack Region named for its long history of catheter and other medical device manufacturing. Initially dedicated to the research and development of products used in interventional radiology, AngioDynamics began manufacturing and shipping product in the early 1990s. The Company soon became well established as a producer of diagnostic catheters for non-coronary angiography and thrombolytic delivery systems.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company grew over the following years as a result of acquisitions of companies including RITA Medical Systems in January 2007, Oncobionic in May 2008, Vortex Medical, Inc. in October 2012, Clinical Devices in August 2013 and the assets of Diomed in June 2008 and the assets of Microsulis Medical Limited in January 2013. These acquisitions added product lines including market-leading ablation and NanoKnife systems, vascular access products, angiographic products and accessories, dialysis products, drainage products, thrombolytic products, embolization products, venous products and targeted renal therapy products. More recently in May 2012, AngioDynamics acquired Navilyst Medical, bringing market-leading fluid management systems into our portfolio. The acquisition significantly expanded the Company's scale, doubling its share of the vascular access market while building critical mass in the peripheral vascular market.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Headquartered in Latham, N.Y., AngioDynamics is publicly traded on the NASDAQ stock exchange under the symbol ANGO.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PRODUCTS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our product offerings fall within three Global Business Units (GBUs): Peripheral Vascular ("PV"), Oncology/Surgery ("OS") and Vascular Access ("VA"). All products discussed below have been cleared for sale in the United States by the Food and Drug Administration (FDA). International regulatory clearances vary by product and jurisdiction.  Effective June 1, 2018 PV is now Vascular Interventions &amp; Therapies and OS is now Oncology.</font></div><div style="line-height:120%;text-align:left;text-indent:144px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Peripheral Vascular Products</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngioDynamics&#8217; Peripheral Vascular product offerings support the medical areas of Venous Insufficiency, Thrombus Management, Fluid Management and Peripheral Products (Core).</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Thrombus Management</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Thrombus Management portfolio includes the proprietary AngioVac venous drainage cannula and circuit, as well as catheter directed thrombolytic devices and Uni-Fuse infusion catheters. AngioDynamics offers a range of options when treating thrombus and removing fresh, soft thromboli or emboli.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">AngioVac</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our AngioVac venous drainage system includes a Venous Drainage Cannula and Extracorporeal Circuit. The cannula is indicated for use as a venous drainage cannula and for removal of fresh, soft thrombi or emboli during extracorporeal bypass. The cardiopulmonary bypass circuit is indicated for use in procedures requiring extracorporeal circulatory support for periods of up to six hours. AngioVac devices are for use with other manufacturers&#8217; off-the-shelf pump, filter and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. </font></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;text-align:left;text-indent:24px;"><img src="angiovacpicturea04.jpg" alt="angiovacpicturea04.jpg" style="height:126px;width:257px;"></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The AngioVac venous drainage cannula is a 22 French coil-reinforced cannula designed with a balloon actuated, expandable funnel shaped distal tip. The proprietary funnel shaped tip enhances venous drainage flow when the balloon is inflated, prevents clogging of the cannula with commonly encountered undesirable intravascular material, and facilitates en bloc removal of such extraneous material.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Thrombolytic Catheters</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thrombolytic catheters are used to deliver thrombolytic agents, which are drugs that dissolve blood clots in hemodialysis access grafts, arteries, veins and surgical bypass grafts. AngioDynamics&#8217; Uni-Fuse infusion catheter features pressure response outlets, a patented, time-tested slit technology that provides a consistent, even distribution of fluid volume along the entire length of the infusion pattern, resulting in a 12-fold advantage over standard side-hole catheters.&#185;</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We also offer the Pulse-Spray infusion system for high pressure, pulsed delivery of lytic agent to shorten treatment time, and the Speed Lyser infusion system built for dialysis grafts and fistulas.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Peripheral Products (Core)</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We offer a comprehensive portfolio for minimally invasive peripheral products.  Product categories include an extensive line of angiographic catheters and diagnostic and interventional guidewires, percutaneous drainage catheters and coaxial micro-introducer kits.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Angiographic Products and Accessories</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Angiographic products and accessories are used during peripheral diagnostic and interventional procedures. These products permit physicians to reach targeted locations to deliver contrast media for visualization purposes and therapeutic agents and devices, such as percutaneous transluminal angioplasty (PTA) balloons. Angiographic products consist of angiographic catheters and guidewires.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#185; </font><font style="font-family:inherit;font-size:9pt;">Yusuf SW, et al. Immediate and Early Follow-up Results of Pulse Spray Thrombolysis in Patients with Peripheral Ischaemia. British Journal of Surgery 1995; 82:338-340.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our angiographic catheter line includes the following brands, all with radiopaque tips to assure excellent visibility under fluoroscopy:</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soft-Vu flush catheters are available in flush and selective varieties. Flush Catheters are used in procedures where a high flow of contrast is required for &#8220;big picture&#8221; diagnostics. Anomalies discovered through a flush angiogram may require further investigation into a vessel of interest. Soft-Vu selective catheters are used to gain access to smaller or more distal vessels and advance the catheter or wire into the diseased section.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accu-Vu sizing catheters feature radiopaque marker bands at the distal (farthest away) portion of the catheter to provide a highly accurate measurement of the patient&#8217;s anatomy. This enables precise measurement for interventional devices (stents, filters, etc.)</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngiOptic catheters have total catheter radiopacity, ensuring tip-to-hub visibility. This catheter is also constructed with a firm tip material that enhances stability during high-flow injections, providing excellent pushability. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mariner catheters have a hydrophilic coating that, when combined with water, reduces friction. This makes insertion potentially easier and more comfortable for the patient, and can also be used for advancing through tortuous anatomy.</font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngioDynamics guidewires include Nit-Vu (featuring a kink-resistant NiTi alloy core facilitating smooth navigation through tortuous vasculature and accurate wire control) and PTFE Coated (fixed core and movable core) diagnostic guidewires.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngioDynamics catheters and guidewires are available in more than 500 tip configurations and lengths.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Drainage Products</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Drainage products percutaneously drain abscesses and other fluid pockets. An abscess is a tender inflamed mass that typically must be drained by a physician. AngioDynamics offers two brands of drainage catheters for multi-purpose/general, nephrostomy and biliary drainage: Total Abscession and Exodus. Each offer features and benefits depending on case presentation and physician preferences.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Micro Access Kits</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Micro Access sets provide interventional physicians a smaller introducer system for minimally-invasive procedures. Our Micro Access product line provides physicians with the means to choose from the wide selection of configurations, including guidewire, needle and introducer options. Two lines are available in stiff/standard, 10cm or 15cm and echogenic for visibility under ultrasound guidance: Micro Introducer Kit and Ministick Max.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Fluid Management </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Fluid Management product offerings include the NAMIC</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;Fluid Management portfolio.&#160;Since 1969, the NAMIC product line has been a leader in providing clinicians high quality, dependable devices that help in the diagnosis and treatment of cardiovascular and peripheral vascular disease. The NAMIC product line includes an extensive offering of manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers and interventional accessories.&#160;These devices are utilized together and allow clinicians to aspirate or inject contrast, saline, remove waste and monitor invasive blood pressures throughout the procedure.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Venous Insufficiency</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">VenaCure EVLT laser system</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;text-align:left;text-indent:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our VenaCure EVLT (endovenous laser treatment) system products are used in endovascular laser procedures to treat superficial venous disease (varicose veins). Superficial venous disease is a malfunction of one or more valves in the leg&#160;veins whereby blood refluxes or does not return to the heart, thereby pooling in the legs and leading to symptoms such as pain, swelling and ulcerations. VenaCure EVLT uses laser energy to stop the reflux by ablating (collapsing and destroying) the affected vein. Blood is then re-routed to other healthy veins.</font></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;text-align:left;text-indent:12px;"><img src="venacureevltpicturea06.jpg" alt="venacureevltpicturea06.jpg" style="height:158px;width:322px;"></div></div></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The procedure is minimally invasive and generally takes less than an hour, allowing the patient to quickly return to normal activities with minimal post-operative pain. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">VenaCure EVLT is sold as a system that includes diode laser hardware and procedure kits which include disposable laser fiber components, an access sheath, access wires and needles. Our VenaCure EVLT 1470 nanometer wavelength laser allows physicians to more efficiently heat the vein wall using lower power settings thereby reducing the risk of collateral&#160;damage. The NeverTouch tip fiber eliminates laser tip contact with the vein wall, which in turn minimizes perforations of the vein wall that typically result in less pain and bruising as compared to traditional bare-tip fibers. The NeverTouch tip also maximizes ultrasonic visibility, making it easier for physicians to use. Procedure kits are available in a variety of lengths and configurations to accommodate varied patient anatomies.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The VenaCure EVLT system comes with a comprehensive physician training program and extensive marketing support.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Asclera (polidocanol) Injection</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asclera (polidocanol) injection is the only FDA-approved sclerosant with an indication to treat uncomplicated spider veins and uncomplicated reticular veins in the lower extremity. AngioDynamics distributes Asclera through a global agreement with the manufacturer and their distributor. In a multicenter, randomized, double-blind, placebo and comparator-controlled trial in patients with spider or reticular varicose veins, 95% of patients treated with Asclera showed good improvement or complete treatment success as rated by physicians and 87% of patients were satisfied or very satisfied with their Asclera treatment. </font><font style="font-family:inherit;font-size:9pt;">&#178;</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Oncology/Surgery Products</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngioDynamics offers a range of comprehensive ablation technologies, including thermal tissue ablation systems (microwave energy and radiofrequency energy), surgical resection and the NanoKnife System, an innovative alternative to thermal ablation.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">IRE Ablation </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">NanoKnife</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup>&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The NanoKnife</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;System is an alternative to traditional thermal ablation that has received 510(k) clearance from the Food and Drug Administration for the surgical ablation of soft tissue. The NanoKnife Ablation System utilizes low energy direct current electrical pulses to permanently open pores in target cell membranes.&#160;These permanent pores or nano-scale defects in the cell membranes result in cell death.&#160;The treated tissue is then removed by the body&#8217;s natural processes in a matter of weeks, mimicking natural cell death.&#160;Unlike other ablation technologies, NanoKnife Ablation System does not achieve tissue ablation using thermal energy.</font></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div><div style="line-height:120%;text-align:left;"><img src="nanoknifepicturea05.jpg" alt="nanoknifepicturea05.jpg" style="height:164px;width:329px;"></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#178; Weiss, Voigts, Howell (2011) Absence of Concentration Congruity in Six Compounded Polidocanol Samples Obtained for Leg Sclerotherapy. American Society for Dermatologic Surgery, Inc., Volume 37: 1-4</font></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The NanoKnife Ablation System consists of two major components: a Low Energy Direct Current, or LEDC Generator and needle-like electrode probes.&#160;Up to six (6)&#160;electrode probes can be placed into or around the targeted soft tissue.&#160;Once the probes are in place, the user enters the appropriate parameters for voltage, number of pulses, interval between pulses, and the pulse length into the generator user interface.&#160;The generator then delivers a series of short electric pulses between each electrode probe. The energy delivery is hyperechoic and can be monitored under real-time ultrasound.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Microwave Ablation </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Solero Microwave Tissue Ablation (MTA) System</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Solero MTA System features the Solero Microwave (MW) Generator and the specially designed Solero MW Applicators. The solid state Solero MW Generator with a 2.45 GHz operating frequency can power up to 140W for optimized power delivery and fast ablations. The Solero MW Applicator&#8217;s optimized ceramic tip diffuses MW energy nearly spherically, and its patented cooling channel with thermocouple provides real-time monitoring to help protect non-targeted tissue during the ablation. In addition, the Solero MTA System offers physicians scalability with a single applicator designed for multiple, predictable ablation volumes by varying time and wattage. Solero is a single applicator system able to complete up to a 5 cm ablation in six (6) minutes at maximum power.  </font></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;text-align:left;text-indent:30px;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:30px;"><img src="solerowhitea04.jpg" alt="solerowhitea04.jpg" style="height:164px;width:329px;"></div></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Solero MTA System and Accessories are indicated in the U.S. for the ablation of soft tissue during open procedures. The Solero MTA System is not intended for cardiac use.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Radiofrequency Ablation </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">StarBurst Radiofrequency Ablation Devices</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Radiofrequency Ablation (RFA) products use radiofrequency energy to provide a minimally invasive approach to ablating solid cancerous or benign tumors. Our StarBurst Radiofrequency Ablation devices deliver radiofrequency energy to raise the temperature of cells above 45-50&#176;C, causing cellular death. The physician inserts the disposable needle electrode device into the targeted body tissue, typically under ultrasound, CT or Magnetic Resonance Imaging (MRI) guidance. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the procedure, our system automatically adjusts the amount of energy delivered in order to maintain the temperature necessary to ablate the targeted tissue. For a typical 5 cm ablation using our StarBurst </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;Xli-enhanced disposable device, the ablation process takes approximately ten minutes. The RFA system consists of a radiofrequency generator and a family of disposable devices.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to thermal ablation systems and NanoKnife, AngioDynamics also offers Habib 4X Surgical Resection devices that are used in minimally invasive laparoscopic surgery procedures in surgical specialties such as Hepato-Biliary, GI, Surgical Oncology, Transplant Surgery and Urology (Partial Nephrectomy Resections). It is clinically indicated to assist in coagulation of tissue during intraoperative and laparoscopic procedures.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Vascular Access Products</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our portfolio of Vascular Access products includes a broad offering of peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies. These products are used to deliver, primarily, short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system. Delivery to the circulatory system allows drugs to mix with a large volume of blood as compared to intravenous drug delivery into a superficial vessel. Our Vascular Access product family also includes the proprietary BioFlo catheter.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">BioFlo</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup>&#160;</font></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngioDynamics offers BioFlo, the only catheter on the market with Endexo Technology, a material more resistant to thrombus accumulation, in vitro (based on platelet count). Endexo Technology is a permanent and non-eluting polymer that is &#8220;blended&#8221; into the polyurethane from which the catheter is made. It is present throughout the catheter, including the extraluminal, intraluminal and cut catheter surface of the tip. Endexo Technology remains present for the life of the catheter. BioFlo&#8217;s long-term durability and efficacy is intended to provide clinicians a high degree of safety and confidence in providing better patient care and improved patient outcomes. BioFlo catheters are available across the Vascular Access family of products, including PICCs, midlines, ports and dialysis catheters.</font></div></div><div style='width:2%; float:left;'>&#160;</div><div style='float:right; width:49%;'><div style="line-height:120%;text-align:left;text-indent:24px;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;</font><img src="bioflopicturea04.jpg" alt="bioflopicturea04.jpg" style="height:164px;width:329px;"></div></div></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">PICCs</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A peripherally inserted central catheter, or PICC, is a long thin catheter that is inserted into a peripheral vein, typically in the upper arm, and advanced until the catheter tip terminates in a large vein in the chest near the heart to obtain intravenous access. PICCs can typically be used for prolonged periods of time and provide an alternative to central venous catheters. Our PICC product offerings include:</font></div><div style="line-height:120%;text-align:left;padding-left:72px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">BioFlo</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;PICC</font><font style="font-family:inherit;font-size:10pt;">: Our BioFlo line is the only power injectable PICC available that incorporates Endexo Technology into the manufacturing and design of the catheter. Advanced features such as large lumen diameters allow the BioFlo</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;PICC to deliver the power injection flow rates required for contrast-enhanced Computed Tomography (CT) scans compatible with up to 325 psi CT injections.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">BioFlo</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;Midline: </font><font style="font-family:inherit;font-size:10pt;">The BioFlo Midline Catheter is an effective solution to preserving a patient&#8217;s peripheral access. It provides a cost-effective alternative to multiple IV site rotations for patients who need short-term venous access.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Xcela PICC</font><font style="font-family:inherit;font-size:10pt;">: The Xcela</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;PICC line is designed to provide a high degree of safety, ease and confidence in patient care. Advanced features such as large lumen diameters allow the Xcela</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;PICC to deliver the power injection flow rates required for contrast-enhanced CTs compatible with up to 325 psi CT injections.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">PASV</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;Valve Technology: </font><font style="font-family:inherit;font-size:10pt;">The PASV</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;Valve Technology is available in both BioFlo and Xcela lines and is designed to automatically resist backflow and reduce blood reflux that could lead to catheter-related complications.</font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Ports </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Ports are implantable devices utilized for the central venous administration of a variety of medical therapies and for blood sampling and diagnostic purposes. Central venous access facilitates a more systemic delivery of treatment agents, while mitigating certain harsh side effects of certain treatment protocols and eliminating the need for repeated access to peripheral veins. Depending upon needle gauge size and the port size, a port can be utilized for up to approximately 2,000 accesses once implanted in the body. Our ports are used primarily in systemic or regional short- and long-term cancer treatment protocols that require frequent infusions of highly concentrated or toxic medications (such as chemotherapy agents, antibiotics or analgesics) and frequent blood samplings. Our port products and accessories include:</font></div><div style="line-height:120%;text-align:left;padding-left:72px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">BioFlo</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;Port</font><font style="font-family:inherit;font-size:10pt;">: Our BioFlo Port is the only port available that features a catheter with Endexo Technology. Advanced features of the BioFlo Port include multiple profile and catheter options, a large septum area for ease of access and the ability to administer contrast through a CT injection for purposes of imaging.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">SmartPort</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">: The Smart Port power-injectable port with Vortex technology offers the ability for a clinician to access a vein for both the delivery of medications or fluids and for administering power-injected contrast to perform a (CT) scan. The ability to access a port for power-injected contrast studies eliminates the need for additional needle sticks in the patient&#8217;s arm and wrist veins. Once implanted, repeated access to the bloodstream can be accomplished with greater ease and less discomfort. Our Smart Port is available in mini and low-profiles to accommodate more patient anatomies.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Vortex</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">:</font><font style="font-family:inherit;font-size:10pt;">&#32;Our Vortex port technology line of ports is a clear-flow port technology that, we believe, revolutionized port design. With its rounded chamber, the Vortex port is designed to have no sludge-harboring corners or dead spaces. This product line consists of titanium, plastic and dual-lumen offerings.</font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">PASV</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;Valve Technology: </font><font style="font-family:inherit;font-size:10pt;">The PASV</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;Valve Technology is designed to automatically resist backflow and reduce blood reflux that could lead to catheter-related complications.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">LifeGuard</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">:</font><font style="font-family:inherit;font-size:10pt;">&#32;The LifeGuard Safety Infusion Set and The LifeGuard Vision are used to infuse our ports and complement our port and vascular access catheters. The needles&#8217; low profile design is intended to allow clinicians to easily dress the site.</font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Dialysis Products</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We market a complete line of dialysis products that provide short and long-term vascular access for dialysis patients. Dialysis, or cleaning of the blood, is necessary in conditions such as acute renal failure, chronic renal failure and end-stage renal disease (ESRD). We currently offer a variety of dialysis catheters, including:</font></div><div style="line-height:120%;text-align:left;padding-left:72px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">BioFlo</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174; </sup></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">DuraMax</font><font style="font-family:inherit;font-size:10pt;">: Our BioFlo DuraMax is the only dialysis catheter with Endexo Technology. Advanced features of the BioFlo DuraMax dialysis catheter include large inner diameter lumens designed for long term patency, a proprietary guidewire lumen to facilitate catheter exchanges and Curved Tip Technology that allows the catheter to self-center in the Superior Vena Cava (SVC).</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">DuraMax</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">:</font><font style="font-family:inherit;font-size:10pt;">&#32;The DuraMax catheter is a stepped-tip catheter designed to improve ease of use, dialysis efficiency and overall patient outcomes.</font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, AngioDynamics also offers other renal therapies, including </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">DuraFlow&#8482; Chronic Hemodialysis Catheter, </font><font style="font-family:inherit;font-size:10pt;">Schon Chronic Hemodialysis Catheter, EVENMORE Chronic Hemodialysis Catheter, EMBOSAFE&#8482; Valved, Splitable Sheath Dilator and Perchik&#8482; Button Suture Retention Device.</font></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RESEARCH &amp; DEVELOPMENT </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our growth depends in large part on the continuous introduction of new and innovative products, together with ongoing enhancements to our existing products. This happens through internal product development, technology licensing and strategic alliances. We recognize the importance of, and intend to continue to make investments in, research and development (R&amp;D).</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our R&amp;D teams work closely with our marketing teams, sales force and regulatory and compliance teams to incorporate customer feedback into our development and design process. We believe that we have a reputation among interventional physicians as a strong partner for developing high quality products because of our tradition of close physician collaboration, dedicated market focus, responsiveness and execution capabilities for product development and commercialization.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">COMPETITION</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We encounter significant competition across our product lines and in each market in which our products are sold. These markets are characterized by rapid change resulting from technological advances, scientific discoveries and changing customer needs and expectations. We face competitors ranging from large manufacturers with multiple business lines to small manufacturers that offer a limited selection of products.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our primary device competitors include: Boston Scientific Corporation; Cook Medical; Medical Components, Inc. (Medcomp); TeleFlex Medical; BD Medical Technology; Smiths Medical, a subsidiary of Smiths Group plc; Medtronic; Merit Medical; Terumo Medical Corporation; Johnson and Johnson and Total Vein Systems.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We believe our products compete primarily based on their quality, clinical outcomes, ease of use, reliability, physician familiarity and cost-effectiveness. In the current environment of managed care, which is characterized by economically motivated buyers, consolidation among health care providers, increased competition and declining reimbursement rates, we have been increasingly required to compete on the basis of price. We believe that our continued competitive success will depend upon our ability to develop or acquire scientifically advanced technology, apply our technology cost-effectively across product lines and markets, attract and retain skilled personnel, obtain patent or other protection for our products, obtain required regulatory and reimbursement approvals, manufacture and successfully market our products either directly or through outside parties, and maintain sufficient inventory to meet customer demand.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SALES AND MARKETING</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We sell our broad line of quality devices in the United States primarily through a direct sales force and internationally through a combination of direct sales and distributor relationships. We support our customers and sales organization with a marketing staff that includes product managers, customer service representatives and other marketing specialists. </font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We focus our sales and marketing efforts on interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists and critical care nurses. </font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MANUFACTURING</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We manufacture certain proprietary components and products and assemble, inspect, test and package our finished products. By designing and manufacturing many of our products from raw materials, and assembling and testing our subassemblies and products, we believe that we are able to maintain better quality control, ensure compliance with applicable regulatory standards and our internal specifications, and limit outside access to our proprietary technology. We have custom-designed proprietary manufacturing and processing equipment and have developed proprietary enhancements for existing production machinery.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We own two primary manufacturing properties providing capabilities which include manufacturing, service, engineering and research, distribution warehouses and offices. These facilities are registered with the FDA and have been certified to ISO 13485 standards, as well as the CMD/CAS Canadian Medical Device Regulations. ISO 13485 is a quality system standard that satisfies European Union regulatory requirements, thus allowing us to market and sell our products in European Union countries. Our manufacturing facilities are subject to periodic inspections by regulatory authorities to ensure compliance with domestic and non-U.S. regulatory requirements. See &#8220;Government Regulation&#8221; section of this report for additional information. See Item 2 "Properties" for details on each manufacturing location.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2017, we announced the consolidation of our global operations into two facilities located in New York State. Operations being done in the Denmead, U.K. and Manchester, GA. manufacturing facilities were consolidated into the Glens Falls and Queensbury, N.Y. facilities during fiscal year 2018. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BACKLOG</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Historically, we ship the majority of products within 24-48 hours of receiving an order, and accordingly our backlog is not significant. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INTELLECTUAL PROPERTY</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patents, trademarks and other proprietary rights are very important to our business. We also rely upon trade secrets, manufacturing know-how, technological innovations and licensing opportunities to maintain and improve our competitive position. We regularly monitor and review third-party proprietary rights, including patents and patent applications, as available, to aid in the development of our intellectual property strategy, avoid infringement of third-party proprietary rights, and identify licensing opportunities.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company owns an extensive portfolio of patents and patent applications in the United States and in certain foreign countries. The portfolio also includes exclusive licenses to third party patents and applications.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Most of our products are sold under the AngioDynamics trade name or trademark. Additionally, products are also sold under product trademarks and/or registered product trademarks owned by AngioDynamics, Inc., or an affiliate or subsidiary. Some products contain trademarks of companies other than AngioDynamics.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Part I. Item&#160;3 of this report for additional details on litigation regarding proprietary technology.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LITIGATION</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We operate in an industry characterized by extensive patent litigation. Patent litigation can result in significant damage awards and injunctions that could prevent the manufacture and sale of affected products or result in significant royalty payments in order to continue selling the products. While it is not possible to predict the outcome of patent litigation incidents to our business, we believe the costs associated with this type of litigation could have a material adverse impact on our consolidated results of operations, financial position, or cash flows. The medical device industry is also susceptible to significant product liability claims. These claims may be brought by individuals seeking relief on their own behalf or purporting to represent a class. In addition, product liability claims may be asserted against us in the future based on events we are not aware of at the present time. At any given time, we are involved in a number of product liability actions. For additional information, see both Part I. Item&#160;3 of this report and Note 15 to the consolidated financial statements in this Annual Report on Form 10-K.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">GOVERNMENT REGULATION</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The products we manufacture and market are subject to regulation by the Food and Drug Administration (FDA) under the Federal Food, Drug, and Cosmetic Act, or FDCA, and international regulations to our specific target markets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">United States FDA Regulation</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Before a new medical device can be introduced into the market, a manufacturer generally must obtain marketing clearance or approval from the FDA through either a 510(k) submission (a premarket notification) or a premarket approval application (PMA).</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 510(k) procedure is available only in particular circumstances. The 510(k) clearance procedure is available only if a manufacturer can establish that its device is &#8220;substantially equivalent&#8221; in intended use and in safety and effectiveness to a &#8220;predicate device,&#8221; which is a legally marketed device with 510(k) clearance in class I or II or preamendment status based upon products commercially distributed on or before May&#160;28, 1976. After a device receives 510(k) clearance, any modification that could significantly affect its safety or effectiveness, or that would constitute a major change in its intended use, requires a new 510(k) clearance. The 510(k) clearance procedure including questions and responses may take up to 12 months. In some cases, supporting clinical data may be required. The FDA may determine that a new or modified device is not substantially equivalent to a predicate device or may require that additional information, including clinical data, be submitted before a determination is made, either of which could significantly delay the introduction of new or modified device products. If a device cannot demonstrate substantial equivalence, it may be subject to either a de novo submission or a PMA.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The PMA application procedure is more comprehensive than the 510(k) procedure and typically takes more time to complete. The PMA application must be supported by scientific evidence providing pre-clinical and clinical data relating to the safety and efficacy of the device and must include other information about the device and its components, design, manufacturing and labeling. The FDA will approve a PMA application only if a reasonable assurance that the device is safe and effective for its intended use can be provided. As part of the PMA application review, the FDA will inspect the manufacturer&#8217;s facilities for compliance with its Quality System Regulation, or QSR. As part of the PMA approval the FDA may place restrictions on the device, such as requiring additional patient follow-up for an indefinite period of time. If the FDA&#8217;s evaluation of the PMA application or the manufacturing facility is not favorable, the FDA may deny approval of the PMA application or issue a &#8220;not approvable&#8221; letter. The FDA may also require additional clinical trials, which can delay the PMA approval process by several years. After the PMA is approved, if significant changes are made to a device, its manufacturing or labeling, a PMA supplement containing additional information must be filed for prior FDA approval.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Historically, our products have been introduced into the market using the 510(k) procedure.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The process of FDA submissions requires extensive and expensive validations and testing. The financial outlay for this is large and requires a significant amount of time. Recent changes in both regulations and FDA perspectives have increased both time and testing requirements, which have caused significant delays and increased costs for approvals. The parameters for increased testing have and will continue to cause severe delays. The increased focus by the FDA on such issues as chemical identification of all colorants, non-acceptance of certain colorants (certain forms of carbon black) and other concerns, continue to cause problems and delays. In addition, changes to existing products call into question previously approved devices and result in additional costs for testing and material analysis.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The devices manufactured by us also are subject to the QSR, which imposes elaborate testing, control, documentation and other quality assurance procedures. Every phase of production, including raw materials, components and subassembly, manufacturing, testing, quality control, labeling, tracing of consignees after distribution and follow-up and reporting of complaint information is governed by the FDA&#8217;s QSR. Device manufacturers are required to register their facilities and list their products with the FDA and certain state agencies. The FDA periodically inspects manufacturing facilities and, if there are alleged violations, the operator of a facility must correct them or satisfactorily demonstrate the absence of the violations or face regulatory action. Penalties for failure to maintain compliance to the QSR include warning letters and potentially consent decrees. Failure to maintain the QSR appropriately could result in the development of further warning letters. In addition, non-compliance with applicable FDA requirements can result in, among other things, fines, injunctions, civil penalties, recall or seizure of products, total or partial suspension of production, failure of the FDA to grant marketing approvals, withdrawal of marketing approvals, a recommendation by the FDA to disallow us to enter into government contracts, and criminal prosecutions. The FDA also has the authority to request repair, replacement or refund of the cost of any device manufactured or distributed by us.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Other U.S. Regulatory Bodies</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We and our products are also subject to a variety of state and local laws in those jurisdictions where our products are, or will be, marketed, and federal, state and local laws relating to matters such as safe working conditions, manufacturing practices, environmental protection, fire hazard control and disposal of hazardous or potentially hazardous substances. In addition, we are subject to various federal and state laws governing our relationships with the physicians and others who purchase or make referrals for our products. For instance, federal law prohibits payments of any form that are intended to induce a referral for any item payable under Medicare, Medicaid or any other federal healthcare program. Many states have similar laws. There can be no assurance that we will not be required to incur significant costs to comply with such laws and regulations now or in the future, or that such laws or regulations will not have a material adverse effect upon our ability to do business.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">International Regulation</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Internationally, all of our current products are considered medical devices under applicable regulatory regimes, and we anticipate that this will be true for all of our future products. Sales of medical devices are subject to regulatory requirements in many countries. The regulatory review process may vary greatly from country to country. For example, the European Union has a dedicated set of regulations regarding medical devices, specifically regulating their design, manufacturing, clinical trials, labeling and adverse event reporting. Devices that comply with those requirements are entitled to bear a Conformit&#233; Europ&#233;enne, or CE Mark, indicating that the device conforms to the essential requirements of the applicable directives and can be commercially distributed in countries that are members of the European Union. Similar regulations are in place for Canada, Japan, China and most other countries.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In some cases, we rely on our international distributors to obtain regulatory approvals, complete product registrations, comply with clinical trial requirements and complete those steps that are customarily taken in the applicable jurisdictions.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International sales of medical devices manufactured in the United States that are not approved or cleared by the FDA for use in the United States, or are banned or deviate from lawful performance standards, are subject to FDA export requirements. Before exporting such products to a foreign country, we must first comply with the FDA&#8217;s regulatory procedures for exporting unapproved devices.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The process of obtaining approval to distribute medical products is costly and time-consuming in virtually all the major markets where we sell medical devices. We cannot assure that any new medical devices we develop will be approved in a timely or cost-effective manner or approved at all. There can be no assurance that new laws or regulations regarding the release or sale of medical devices will not delay or prevent sale of our current or future products.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">THIRD-PARTY REIMBURSEMENT AND ANTI-FRAUD AND CORRUPT PRACTICES REGULATION</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">United States</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The delivery of our devices is subject to regulation by the Department of Health and Human Services (HHS) and comparable state and non-U.S. agencies responsible for reimbursement and regulation of health care items and services. U.S. laws and regulations are imposed primarily in connection with the Medicare and Medicaid programs, as well as the government&#8217;s interest in regulating the quality and cost of health care. Foreign governments also impose regulations in connection with their health care reimbursement programs and the delivery of health care items and services.</font></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. federal health care laws apply when we or customers submit claims for items or services that are reimbursed under Medicare, Medicaid, or other federally-funded health care programs. The principal U.S. federal laws include: (1) the Anti-kickback Statute which prohibits offers to pay or receive remuneration of any kind for the purpose of including or rewarding referrals of items or services reimbursable by a federal health care program; (2) the False Claims Act which prohibits the submission of false or otherwise improper claims for payment to a federally-funded health care program, including claims resulting from a violation of the Anti-kickback Statute; (3) the Stark law which prohibits physicians from referring Medicare or Medicaid patients to a provider that bills these programs for the provision of certain designated health services if the physician (or a member of the physician&#8217;s immediate family) has a financial relationship with that provider; and (4) health care fraud statutes that prohibit false statements and improper claims to any third-party payer. There are often similar state false claims, anti-kickback, and anti-self-referral and insurance laws that apply to state-funded Medicaid and other health care programs and private third-party payers. In addition, the U.S. Foreign Corrupt Practices Act (FCPA) can be used to prosecute companies in the U.S. for arrangements with physicians or other parties outside the U.S. if the physician or party is a government official of another country and the arrangement violates the law of that country.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">International</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our success in international markets will depend largely upon the availability of reimbursement from the third-party payors through which healthcare providers are paid in those markets. Reimbursement and healthcare payment systems vary significantly by country. The main types of healthcare payment systems are government sponsored healthcare and private insurance. Reimbursement approval must be obtained individually in each country in which our products are marketed. Outside the U.S., we generally rely on our distributors to obtain reimbursement approval in the countries in which they will sell our products. There can be no assurance that reimbursement approvals will be received.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INSURANCE</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our product liability insurance coverage is limited to a maximum of $10 million per product liability claim and an annual aggregate policy limit of $10 million, subject to a self-insured retention of $500,000 per occurrence and $2 million in the aggregate. The policy covers, subject to policy conditions and exclusions, claims of bodily injury and property damage from any product sold or manufactured by us.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There is no assurance that this level of coverage is adequate. We may not be able to sustain or maintain this level of coverage and cannot assure you that adequate insurance coverage will continue to be available on commercially reasonable terms, or at all. A successful product liability claim or other claim with respect to uninsured or underinsured liabilities could have a material adverse effect on our business.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ENVIRONMENTAL, HEALTH AND SAFETY</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are subject to federal, state and local laws, rules, regulations and policies governing the use, generation, manufacture, storage, air emission, effluent discharge, handling and disposal of certain hazardous and potentially hazardous substances used in connection with our operations. Our operations are also subject to laws and regulations related to occupational health and safety. We maintain safety, training and maintenance programs as part of our ongoing efforts to ensure compliance with applicable laws and regulations. </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Although we believe that we have complied with environmental, health and safety laws and regulations in all material respects and, to date, have not been required to take any action to correct any noncompliance, there can be no assurance that we will not be required to incur significant costs to comply with environmental regulations in the future.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EMPLOYEES</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, we had approximately 1,145 full time employees. None of our employees are represented by a labor union and we have never experienced a work stoppage.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Executive Officers of the Company</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth certain information with respect to our executive officers.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:27%;"></td><td style="width:6%;"></td><td style="width:7%;"></td><td style="width:3%;"></td><td style="width:57%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Name</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Age</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Position</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">James C. Clemmer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">President and Chief Executive Officer</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Michael C. Greiner</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Executive Vice President and Chief Financial Officer</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stephen A. Trowbridge</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Vice President and General Counsel</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">David D. Helsel</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Vice President Global Operations</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Warren G. Nighan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Vice President Quality &amp; Regulatory Affairs</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Heather J. Daniels-Cariveau</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Vice President Human Resources</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benjamin H. Davis</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Vice President Business Development</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chad T. Campbell</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Vice President and General Manager, Vascular Access</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Brent J. Boucher </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Vice President and General Manager, Oncology/Surgery</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Robert A. Simpson</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Vice President and General Manager, Peripheral Vascular</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Kim L. Seabury </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Vice President, Information Technology</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">James C. Clemmer</font><font style="font-family:inherit;font-size:10pt;">&#32;became our President and Chief Executive Officer in April 2016. Prior to joining AngioDynamics, Mr.&#160;Clemmer served as President of the $1.8 billion medical supplies segment at Covidien plc. where he directed the strategic </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">and day-to-day operations for global business divisions that collectively manufactured 23 different product categories. In addition, he managed global manufacturing, research and development, operational excellence, business development and all other functions associated with the medical supplies business. Prior to his role at Covidien, Mr. Clemmer served as Group President at Kendall Healthcare, where he managed the U.S. business across five divisions and built the strategic plan for the medical supplies segment before it was spun off from Tyco. Mr. Clemmer began his career at Sage Products, Inc. Mr. Clemmer currently serves on the Board of Directors for AngioDynamics and Lantheus Medical Imaging. Mr. Clemmer is a graduate of the Massachusetts College of Liberal Arts, where he served as interim president from August 2015 until March 1, 2016.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Michael C. Greiner </font><font style="font-family:inherit;font-size:10pt;">joined AngioDynamics as the Executive Vice President and Chief Financial Officer in August 2016. Mr. Greiner most recently served as the Chief Financial Officer at Extreme Reach. Prior to Extreme Reach, Mr. Greiner served as Senior Vice President Corporate Finance and Chief Accounting Officer at Cimpress N.V. (Vistaprint N.V.), Global Controller for GE&#8217;s Water and Processing Technologies division and in leadership roles at Bausch &amp; Lomb and Wyeth. Mr. Greiner is also an advisor for Mirah, Inc., a measurement-based behavioral health Company, and serves as the President of the Foundation for Faces of Children. Mr. Greiner received a Bachelor and Master of Science in Accounting from Fairleigh Dickinson University and Master of Business Administration from the Columbia Business School. Mr. Greiner is also a Certified Public Accountant (inactive).</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Stephen A. Trowbridge</font><font style="font-family:inherit;font-size:10pt;">&#32;joined AngioDynamics as corporate counsel in June 2008, becoming our Vice President and General Counsel in June 2010 and Senior Vice President and General Counsel in August 2013. Mr. Trowbridge manages AngioDynamics&#8217; legal matters, including corporate governance, mergers and acquisitions, finance, securities regulation, litigation, regulatory matters, intellectual property and compliance. Mr. Trowbridge also oversees the Company&#8217;s clinical affairs, medical affairs and healthcare economics departments. Prior to AngioDynamics, Mr. Trowbridge served as Corporate Counsel at Philips Healthcare and Intermagnetics General Corporation. Mr. Trowbridge began his career with Cadwalader, Wickersham &amp; Taft LLP in the firm&#8217;s Mergers and Acquisitions and Securities Group. Mr. Trowbridge received a Bachelor of Science in Science and Technology Studies from Rensselaer Polytechnic Institute, a Juris Doctor from the University of Pennsylvania Law School, and a Master of Business Administration from Duke University&#8217;s Fuqua School of Business. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">David D. Helsel </font><font style="font-family:inherit;font-size:10pt;">currently services as Senior Vice President of Global Operations and R&amp;D and has been with AngioDynamics since December 2017.  Prior to joining AngioDynamics he was Senior Vice President, Global Supply Chain, at Hill-Rom Holdings for almost three years.  Before that, Mr. Helsel worked at Haemontiecs for three years where he served as Executive Vice President for Global Manufacturing and also spent almost nineteen years in various positions with increasing responsibility at Covidien, including Vice President of Operations for the Surgical Solutions Division and Medical Supplies Division.  An expert in Lean and Six Sigma, Mr. Helsel also served as Global Director of Operational Excellence, supporting sixty-three manufacturing facilities.  Mr. Helsel holds a Bachelor of Science in Mechanical Engineering from LeTourneau University.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Warren G. Nighan </font><font style="font-family:inherit;font-size:10pt;">joined AngioDynamics as the Senior Vice President of Quality and Regulatory Affairs in April 2017. Before joining AngioDynamics, Mr. Nighan was as a quality and regulatory consultant to clients in FDA-regulated industries, specializing in execution and management of quality systems implementation and remediation. Previously, Mr. Nighan served as the Executive Vice President of Global Clinical, Quality Affairs and Regulatory Affairs at Haemonetics Corporation, Vice President of Quality/Regulatory/Clinical/Technical Services at St. Jude Medical&#8217;s Atrial Fibrillation Division, and Corporate Vice President of Quality/Compliance at Tyco Healthcare/Covidien (Medtronic). Mr. Nighan earned a Bachelor and Master of Science in Nursing from Northeastern University&#8217;s Bouv&#233; College of Health Sciences.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Heather J. Daniels Cariveau </font><font style="font-family:inherit;font-size:10pt;">joined AngioDynamics in October 2016 as the Senior Vice President of Human Resources. Prior to joining AngioDynamics, Ms. Daniels Cariveau served as Human Resources Global Vice President at Zimmer Biomet, leading tactical and strategic HR initiatives for the Spine, Dental, Market Access/Healthcare Economics and Craniomaxillofacial/Thoracic businesses. Before Zimmer Biomet, Ms. Daniels Cariveau served in senior HR roles at GE, Datacard, Honeywell International, Inc. and Cigna Corporation. Ms. Daniels Cariveau holds a Bachelor of Arts in Broadcast Journalism and Spanish from the University of St. Thomas in St. Paul, Minn. and a Master of Arts in Human Resources and Industrial Relations from the University of Minnesota Carlson School of Management in Minneapolis, Minn.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Benjamin H. Davis</font><font style="font-family:inherit;font-size:10pt;">&#32;joined AngioDynamics as Senior Vice President of Business Development in March 2015. Prior to joining AngioDynamics, Mr. Davis most recently was the Vice President of Business Integration at C.R. Bard, Inc. where he also served as the Divisional Head of Business Development from 2004-2013. Before joining C.R. Bard, Inc., Mr. Davis held the position of Chief Financial Officer and Treasurer at Axya Medical Inc. He holds a Bachelor of Science in Business Administration from Bryant College and Master in Business Administration in Finance from Bentley University Graduate School of Business.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Chad T. Campbell</font><font style="font-family:inherit;font-size:10pt;">&#32;joined AngioDynamics in May 2016 as the Senior Vice President and General Manager for the Vascular Access Global Business Unit. In his role, Mr. Campbell oversees research and development and global commercialization of </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the Global Business Unit&#8217;s portfolio. Mr. Campbell joined AngioDynamics from Medtronic where he served as the Vice President of Marketing for the Patient Care and Safety business after serving as the Vice President of Marketing for the SharpSafety business at Covidien (Medtronic). During his tenure at Covidien, Mr. Campbell also held roles including Director of Marketing, Area Vice President of Sales, Region Manager, Product Manager and Account Manager. Mr. Campbell received a Bachelor of Arts from the University of Kentucky.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Brent J. Boucher</font><font style="font-family:inherit;font-size:10pt;">&#32;is our Senior Vice President and General Manager of our Oncology business.  Prior to joining AngioDynamics in November 2017, Mr. Boucher served as Executive in Residence for PDI's Infection Prevention business.  Prior to that, he spent 20 years at Covidien where he served as General Manager for several global businesses, including Lung Solutions, Surgical Solutions and Respiratory Care.  Mr. Boucher is a graduate of North Dakota State University.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Robert A. Simpson</font><font style="font-family:inherit;font-size:10pt;">&#32;joined AngioDynamics in February 2017 as the Senior Vice President and General Manager for the Peripheral Vascular Global Business Unit. In his role, Mr. Simpson oversees research and development and global commercialization of the Global Business Unit&#8217;s portfolio. Prior to AngioDynamics, Mr. Simpson served as the Vice President and General Manager of the Patient Care Global Business at Medtronic. He was responsible for leading the business strategy and operations while ensuring global execution. Prior to his role within the Patient Care business, Mr. Simpson led strategy and business development for Medtronic&#8217;s Patient Monitoring &amp; Recovery business. Mr. Simpson also held various leadership roles in Sales and Marketing during his time at Covidien (Medtronic) and Alcon (Novartis). Mr. Simpson received a Bachelor of Science in Management Science - Finance from the State University of New York at Geneseo and has completed a comprehensive, executive leadership development program at Babson College.</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Kim L. Seabury</font><font style="font-family:inherit;font-size:10pt;">&#160;became the head of the AngioDynamics IT group in September, 2011. Prior to joining AngioDynamics, Mrs. Seabury served as Vice President of Emerging Technologies and Product Development for Pitney Bowes Software, managing global software development teams for both core products and emerging SaaS solutions. Prior to her role at Pitney Bowes, Mrs. Seabury held several key leadership positions at MapInfo Corporation, including Global Managing Director of IT, IT Business Applications Director and Director of Web Operations. Mrs. Seabury is certified in PSI, Operational Excellence, ITIL and is a Six-Sigma Green Belt. In addition, Mrs. Seabury has extensive experience in project management and has participated in a variety of leadership development programs. Mrs. Seabury holds a Bachelor of Science degree in Applied Arts and Science from Rochester Institute of Technology.</font></div><div style='display:inline-block; width:100%;'><div style='float:left; width:49%;'><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">AVAILABLE INFORMATION</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our corporate headquarters is located at 14 Plaza Drive, Latham, New&#160;York 12110. Our phone number is (518)&#160;795-1400. Our website is </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">www.angiodynamics.com</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We make available, free-of-charge through our website, our Annual Reports on Form&#160;10-K, quarterly reports on Form&#160;10-Q, current reports on Form&#160;8-K and amendments to those reports filed or furnished pursuant to Section&#160;13(a) of the Securities Exchange Act of 1934, as amended, as soon as reasonably practicable after we electronically file or furnish such materials to the Securities and Exchange Commission, or SEC. In addition, our website includes, among other things, charters of the various committees of our Board of Directors and our code of business conduct and ethics applicable to all employees, officers and directors. Any stockholder also may obtain copies of these documents, free of charge, by sending a request in writing to our investor relations department: AngioDynamics, 14 Plaza Drive, Latham, N.Y. 12210, Attention: Saleem Cheeks. Information on our website or connected to our website is not incorporated by reference into this Annual Report on Form&#160;10-K.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></div><hr style="page-break-after:always"><div><a name="s45E0D44983255BA5918E1FB36A4CE359"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:74px;"></td><td style="width:608px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;1A.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Risk Factors.</font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to the other information contained in this Annual Report on Form 10-K, the following risk factors should be considered carefully in evaluating the Company's business.  Our financial and operating results are subject to a number of factors, many of which are not within our control. These factors include those set forth below.  Our business, financial condition or results of operations could be materially and adversely affected by any of these risks.  Additional risks not presently known to us or that we currently deem immaterial may also adversely affect our business, financial condition or results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RISKS RELATED TO OUR BUSINESS</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Consolidation in the healthcare industry could have an adverse effect on our revenues and results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Many healthcare industry companies, including medical device companies, are consolidating to create new companies with greater market power. As the healthcare industry consolidates, competition to provide goods and services to industry participants will become more intense. These industry participants may try to use their market power to negotiate price concessions or reductions for medical devices that incorporate components produced by us. If we are forced to reduce our prices because of consolidation in the healthcare industry, our revenues would decrease and our consolidated earnings, financial condition, or cash flow would suffer.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We face intense competition in the medical device industry. We may be unable to compete effectively with respect to technological innovation and price which may have an adverse effect on our revenues, financial condition or results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The markets for our products are highly competitive, and we expect competition to continue to intensify. We may not be able to compete effectively, and we may lose market share to our competitors. Our primary device competitors include: Boston Scientific Corporation; Cook Medical; Medical Components, Inc. (Medcomp); TeleFlex Medical; BD Medical Technology; Smiths Medical, a subsidiary of Smiths Group plc; Medtronic; Merit Medical; Terumo Medical Corporation; Johnson and Johnson and Total Vein Systems.  Many of our competitors have substantially greater:</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">financial and other resources to devote to product acquisitions, research and development, marketing and manufacturing;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">variety of products;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">technical capabilities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">history of developing and introducing new products;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">patent portfolios that may present an obstacle to our conduct of business;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">name recognition; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">distribution networks and in-house sales forces.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our competitors may succeed in developing technologies and products earlier, in obtaining patent protection or regulatory clearance earlier, or in commercializing new products or technologies more rapidly than us. Our competitors may also develop products and technologies that are superior to those we are developing or that otherwise could render our products obsolete or noncompetitive. In addition, we may face competition from providers of other medical therapies, such as pharmaceutical companies, that may offer non-surgical therapies for conditions that are currently, or in the future, may be treated using our products. Our products are generally sold at higher prices than those of our competitors. However, in the current environment of managed care, which is characterized by economically motivated buyers, consolidation among healthcare providers, increased competition and declining reimbursement rates, we are increasingly being required to compete on the basis of price. If we are not able to compete effectively, our market share and revenues may decline.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We face intense competition from other companies, and our inability to continue to effectively develop, acquire and/or market new products and technologies could have a material adverse effect on our business, results of operations and/or financial condition.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The medical device business is intensely competitive and is characterized by rapid technological change, frequent product introductions and evolving customer requirements. Our customers consider many factors when choosing among products, including features and reliability, quality, technology, clinical or economic outcomes, availability, price and services provided by the manufacturer. We face competition globally from a wide range of companies, some of which may have greater resources than us, which may enable them to adapt faster than us to customer needs or changes in customer requirements. Product introductions, alternative products or enhancements by competitors that provide better features, clinical outcomes or economic </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">value and/or offer lower pricing may make our products or proposed products obsolete or less competitive. In addition, the trend of consolidation in the medical device industry and among our customers could result in greater competition and pricing pressures.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a result, we engage in product development and improvement programs to maintain and improve our competitive position. These development and improvement programs involve significant investment in research and development, clinical trials and regulatory approvals and may require more time than anticipated to bring such products to market. We may not, however, be successful in enhancing existing products or developing new products or technologies that will achieve regulatory approval, be developed or manufactured in a cost effective manner, obtain appropriate intellectual property protection or receive market acceptance and we may be unable to recover all or a meaningful part of our investment in such products or technologies. Additionally, there can be no assurance that the size of the markets in which we compete will increase above existing levels or not decline, that we will be able to maintain, gain or regain market share or that we can compete effectively on the basis of price or that the number of procedures in which our products are used will increase above existing levels or not decline.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of our business strategy, we also pursue the acquisition of complementary businesses, technologies and products. We may not be able to identify appropriate acquisition candidates, consummate transactions or obtain agreements with favorable terms. Further, once a business is acquired, any inability to successfully integrate the business, decreases in customer loyalty or product orders, failure to retain and develop its workforce, failure to establish and maintain appropriate controls or unknown or contingent liabilities could adversely affect our ability to realize the anticipated benefits of any acquisition. The integration of an acquired business, whether or not successful, requires significant efforts which may result in additional expenses and divert the attention of our management and technical personnel from other projects. These transactions are inherently risky, and there can be no assurance that any past or future transaction will be successful. If we fail to develop and successfully manufacture and launch new products, generate satisfactory clinical results, provide sufficient economic value, enhance existing products, or identify, acquire and integrate complementary businesses, technologies and products or if we experience a decrease in market size or market share or declines in average selling price or procedural volumes, or otherwise fail to compete effectively, our business, results of operations and/or financial condition could be adversely affected.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">If we do not maintain our reputation with interventional physicians, interventional and surgical oncologists and critical care nurses our growth will be limited and our business could be harmed.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Physicians typically influence the medical device purchasing decisions of the hospitals and other healthcare institutions in which they practice. Consequently, our reputation with interventional physicians, interventional and surgical oncologists and critical care nursers is crucial to our continued growth. We believe that we have built a positive reputation based on the quality of our products, our physician-driven product development efforts, our marketing and training efforts and our presence at medical society meetings. Any actual or perceived diminution in the quality of our products, or our failure or inability to maintain these other efforts, could damage our reputation with interventional physicians and cause our growth to be limited and our business to be harmed.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">If we fail to develop or market new products and enhance existing products, we could lose market share to our competitors and our results of operations could suffer.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The market for interventional devices is characterized by rapid technological change, new product introductions, technological improvements, changes in physician requirements and evolving industry standards. To be successful, we must continue to develop and commercialize new products and to enhance versions of our existing products. Our products are technologically complex and require significant research, planning, design, development and testing before they may be marketed. This process generally takes at least 12 to 18 months from initial concept and may take up to several years. In addition, product life cycles are relatively short because medical device manufacturers continually develop smaller, more effective and less expensive versions of existing devices in response to physician demand.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our success in developing and commercializing new and enhanced versions of our products is affected by our ability to:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">recruit engineers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">timely and accurately identify new market trends;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">accurately assess customer needs;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">minimize the time and costs required to obtain regulatory clearance or approval;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">adopt competitive pricing;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">timely manufacture and deliver products;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">accurately predict and control costs associated with the development, manufacturing and support of our products; and</font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">anticipate and compete effectively with our competitors&#8217; efforts.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Market acceptance of our products depends in part on our ability to demonstrate that our products are cost-effective and easier to use, as well as offer technological advantages. Additionally, we may experience design, manufacturing, marketing or other difficulties that could delay or prevent our development, introduction or marketing of new products or new versions of our existing products. As a result of such difficulties and delays, our development expenses may increase and, as a consequence, our results of operations could suffer.</font></div><div style="line-height:120%;text-align:justify;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Development and sales of our products are dependent on a number of factors beyond our control, and our inability to make and complete research and development investments, enhance the product development process and be innovative to solve customer needs with respect to the respective products may adversely affect our business, financial condition and results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A significant aspect of our growth strategy is the continued market development of products including NanoKnife, AngioVac, Venacure EVLT and BioFlo products.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There can be no guarantee that we will be able to develop and manufacture additional next generation or updated products on commercially favorable terms, or at all. NanoKnife and AngioVac are developing technologies and the inability of either of them to achieve clinical acceptance, as well as our inability to generate meaningful clinical data to convince providers of the clinical and economic benefits of our BioFlo platform, could severely limit our ability to drive revenue growth.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We currently have FDA 510(k) clearance to market NanoKnife products for soft tissue ablation.  If we are not able to secure FDA approval to conduct investigational device exemption (IDE) trials or marketing approval for additional or more specific indications, through 510(k) clearance, pre-market approval or otherwise, our ability to market our NanoKnife products will be restricted which may have an adverse effect on our business, financial condition and results of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Undetected defects may increase our costs and impair the market acceptance of our products.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our products have occasionally contained, and may in the future contain, undetected defects. When these problems occur, we must divert the attention of our engineering personnel to address them. There is no assurance that we will not incur warranty or repair costs, be subject to liability claims for damages related to product defects, or experience manufacturing, shipping or other delays or interruptions as a result of these defects in the future. Our insurance policies may not provide sufficient protection should a claim be asserted. In addition, the occurrence of defects may result in significant customer relations problems and injury to our reputation, and may impair market acceptance of our products.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We, our competitors or other third parties, may engage in clinical trials with respect to our products.  The results of these trials may be unfavorable, or perceived as unfavorable by the market, and could have a material adverse effect on our business, financial condition or results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our products may be the subject of clinical trials conducted by us, our competitors or third parties for the purposes of obtaining regulatory clearances or to gather market data. Unfavorable or inconsistent clinical data from existing or future clinical trials conducted by us, by our competitors or by third parties, or the FDA's or the market's perception of this clinical data, may adversely impact our ability to obtain product approvals, our position in, and share of, the markets in which we participate and our business, financial condition, results of operations or future prospects.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">If we are unable to convince customers that our products can improve the cost structure of their business, our revenue growth and profitability may be materially adversely impacted.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Worldwide initiatives to contain healthcare costs have led government and the private sector to enact cost containment efforts as a means of managing the growth of health care utilization.  Common techniques include policies on price regulation, competitive pricing, bidding and tender mechanics, coverage and payment, comparative effectiveness of therapies, technology assessments, and managed-care arrangements.  These changes are causing the marketplace to put increased emphasis on the delivery of more cost-effective medical devices and therapies. Government programs, including Medicare and Medicaid, private health care insurance, and managed-care plans have attempted to control costs by limiting the amount of reimbursement they will pay for particular procedures or treatments, tying reimbursement to outcomes, shifting to population health management, and other mechanisms designed to constrain utilization and contain costs. Simultaneously, hospitals are redefining their role in health care delivery as many assume much more risk and control of the total cost of patient care.  To successfully make this transformation health systems are consolidating, purchasing or partnering with physicians, post-acute care providers, while also narrowing networks thus allowing greater control over outcomes.  Today, many systems are </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">becoming &#8216;mini&#8217; payer/provider organizations.   These newly redesigned health systems are creating mechanisms such as value analysis and centralized purchasing functions that set pricing and in some cases limit the number of vendors that can participate in the purchasing program. Hospitals are also aligning interests with physicians through employment and other arrangements, such as gainsharing, where a hospital agrees with physicians to share any realized cost savings resulting from the physicians&#8217; collective change in practice patterns such as standardization of devices where medically appropriate. This has created an increasing level of price sensitivity among customers for our products. Some third-party payers must also approve coverage and set reimbursement levels for new or innovative devices or therapies before they will reimburse health care providers who use the medical devices or therapies. Even though a new medical device may have been cleared for commercial distribution, we may find limited demand for the device until coverage and sufficient reimbursement levels have been obtained from governmental and private third-party payers. In addition, some private third-party payers require that certain procedures or that the use of certain products be authorized in advance as a condition of reimbursement. International examples of cost containment initiatives and health care reforms advancing clinical outcomes as the key to market access are emerging in France, Germany, the Netherlands and the UK.  This new criteria can severely restrict coverage, reduce reimbursement and delay access to key markets with requirements for incremental clinical benefit and coverage with evidence development.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cost-containment efforts of group purchasing organizations could adversely affect our selling prices, financial position and results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Many of our existing and potential customers have become members of group purchasing organizations, or GPOs, and integrated delivery network, or IDNs, in an effort to reduce costs. GPOs and IDNs negotiate pricing arrangements with healthcare product manufacturers and distributors and offer the negotiated prices to affiliated hospitals and other members. GPOs and IDNs typically award contracts on a category-by-category basis through a competitive bidding process. Bids are generally solicited from multiple manufacturers with the intention of driving down pricing. Due to the highly competitive nature of the GPO and IDN contracting processes, we may not be able to obtain market prices for our products or obtain or maintain contract positions with major GPOs and IDNs, which could adversely impact our profitability.  Also, sales through a GPO or IDN can be significant to our business and if we are unable to retain contracts with our customers, or acquire additional contracts, our financial results may be negatively impacted.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We are dependent on single and limited source suppliers which subjects our business and results of operations to risks of supplier business interruptions.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We currently purchase significant amounts of several key products and product components from single and limited source suppliers and anticipate that we will do so for future products as well. Any delays in delivery of or shortages in those or other products and components could interrupt and delay manufacturing of our products and result in the cancellation of orders for our products. Any or all of these suppliers could discontinue the manufacture or supply of these products and components at any time. Due to FDA and other business considerations, we may not be able to identify and integrate alternative sources of supply in a timely fashion or at all. Any transition to alternate suppliers may result in production delays and increased costs and may limit our ability to deliver products to our customers. Furthermore, if we are unable to identify alternative sources of supply, we would have to modify our products to use substitute components, which may cause delays in shipments, increased design and manufacturing costs and increased prices for our products.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, we purchase certain products as a distributor for the manufacturer of those products, including Asclera.  Operational, quality or regulatory issues of the manufacturers of the products we distribute could constrain or interrupt the availability of those products or services.&#160; Any constraint or interruption in the supply of finished products that we distribute could have a material adverse effect on our ability to sell products, our financial condition and our results of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We are heavily dependent on third-party distributors to generate a substantial portion of international revenues and are at the risk of these distributors also selling for our competitors along with being financially viable to be able to effectively distribute our products and make timely payment.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;">Outside of North America we rely heavily on third party distributors, either on a</font><font style="font-family:inherit;font-size:12pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">country-by-country</font><font style="font-family:inherit;font-size:12pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">basis or on a multi-country, regional basis, to market, sell and distribute our products.  International distributors accounted for approximately 81% of international revenues for the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">.  In certain circumstances, distributors may also sell competing products to our own or products for competing diagnostic modalities and may have incentives to shift sales towards those competing products. As a result, we cannot assure you that our international distributors will increase or maintain our current levels of unit sales or increase or maintain our current unit pricing, which, in turn, could have a material adverse effect on our business, results of operations, financial condition and cash flows.  In addition, there is a risk that our distributors will not be financially viable due to current economic and/or regulatory events in their respective countries.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Failure to secure adequate reimbursement for our products could materially impair our ability to grow revenue and drive profitability.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our products are used in medical procedures generally covered by government or private health plans.</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In general, a third-party payor only covers a medical product or procedure when the plan administrator is satisfied that the product or procedure improves health outcomes, including quality of life or functional ability, in a safe and cost-effective manner. Even if a device has received clearance or approval for marketing by the FDA, there is no assurance that third-party payors will cover the cost of the device and related procedures.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In many instances, third-party payors use price schedules that do not vary to reflect the cost of the products and equipment used in performing those procedures. In other instances, payment or reimbursement is separately available for the products and equipment used, in addition to payment or reimbursement for the procedure itself. Even if coverage is available, third-party payors may place restrictions on the circumstances where they provide coverage or may offer reimbursement that is not sufficient to cover the cost of our products.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Third-party payors who cover the cost of medical products or equipment, in addition to allowing a general charge for the procedure, often maintain lists of exclusive suppliers or approved lists of products deemed to be cost-effective. Authorization from those third-party payors is required prior to using products that are not on these lists as a condition of reimbursement. If our products are not on the approved lists, healthcare providers must determine if the additional cost and effort required in obtaining prior authorization, and the uncertainty of actually obtaining coverage, is justified by any perceived clinical benefits from using our products.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finally, the advent of contracted fixed rates per procedure has made it difficult to receive reimbursement for disposable products, even if the use of these products improves clinical outcomes. In addition, many third-party payors are moving to managed care systems in which providers contract to provide comprehensive healthcare for a fixed cost per person. Managed care providers often attempt to control the cost of healthcare by authorizing fewer elective surgical procedures. Under current prospective payment systems, such as the diagnosis related group system and the hospital out-patient prospective payment system, both of which are used by Medicare and in many managed care systems used by private third-party payors, the cost of our products will be incorporated into the overall cost of a procedure and not be separately reimbursed. As a result, we cannot be certain that hospital administrators and physicians will purchase our products, despite the clinical benefits and opportunity for cost savings that we believe can be derived from their use. If hospitals and physicians cannot obtain adequate reimbursement for our products or the procedures in which they are used, our business, financial condition, results of operations, and cash flows could suffer a material adverse impact.</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our success in international markets will depend largely upon the availability of reimbursement from the third-party payors through which healthcare providers are paid in those markets. Reimbursement and healthcare payment systems vary significantly by country. The main types of healthcare payment systems are government sponsored healthcare and private insurance. Reimbursement approval must be obtained individually in each country in which our products are marketed. Outside the United States, we generally rely on our distributors to obtain reimbursement approval in the countries in which they will sell our products. There can be no assurance that reimbursement approvals will be received.  The failure to secure reimbursement approvals in international markets could materially impact our financial position and results of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">If a product liability claim is brought against us or our product liability insurance coverage is inadequate, our business could be harmed.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The design, manufacture and marketing of the types of medical devices we sell entail an inherent risk of product liability. Our products are used by physicians to treat seriously ill patients. We are periodically subject to product liability claims, and patients or customers may in the future bring claims against us in a number of circumstances and for a number of reasons, including if our products were misused, if a component of our product fails, if our manufacture or design was flawed, if the product produced unsatisfactory results or if the instructions for use and operating manuals and disclosure of product related risks for our products were found to be inadequate. In addition, individuals or groups seeking to represent a class may file suit against us. The outcome of litigation, particularly class action lawsuits, is difficult to assess or quantify. Plaintiffs in these types of lawsuits often seek recovery of very large or indeterminate amounts, including not only actual damages, but also punitive damages. The magnitude of the potential losses relating to these lawsuits may remain unknown for substantial periods of time.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We carry a product liability policy with a limit of $10,000,000 per product liability claim and an aggregate policy limit of $10,000,000, subject to a self-insured retention of $500,000 per occurrence and $2,000,000 in the aggregate. We believe, based on claims made against us in the past, our existing product liability insurance coverage is reasonably adequate to protect us </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">from any liabilities we might incur. However, there is no assurance that this coverage will be sufficient to satisfy any claim made against us. In addition, we may not be able to continue to maintain adequate coverage at a reasonable cost and on reasonable terms, if at all. Any product liability claim brought against us, with or without merit, could increase our product liability insurance rates or prevent us from securing any coverage in the future. Additionally, if one or more product liability claims is brought against us for uninsured liabilities or is in excess of our insurance coverage, our financial condition and results of operations could be negatively impacted. Further, such claims may require us to recall some of our products, which could result in significant costs to us and could divert management&#8217;s attention from our business.</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We may be exposed to risks associated with acquisitions, including integration risks and risks associated with methods of financing. Accordingly, completed acquisitions may not enhance our financial position or results of operations or create value for our shareholders as they are based on projections and assumptions which are uncertain and subject to change.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Part of our growth strategy is to acquire businesses and technologies that are complementary to ours. There is no assurance that acquisition opportunities will be available on acceptable terms, or at all, or that we will be able to obtain necessary financing or regulatory approvals. Any acquisitions that we do undertake would be accompanied by the risks commonly encountered in acquisitions, including the:</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">potential disruption of our business while we evaluate opportunities, complete acquisitions and develop and implement new business strategies to take advantage of these opportunities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">inability of our management to maximize our financial and strategic position by incorporating an acquired technology or business into our existing offerings;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">our inability to achieve the cost savings and operating synergies anticipated in the acquisition, which would prevent us from achieving the positive earnings gains expected as a result of the acquisition;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">diversion of management attention from ongoing business concerns to integration matters; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">difficulty of maintaining uniform standards, controls, procedures and policies;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">challenges in demonstrating to our customers that the acquisition will not result in adverse changes in customer service standards or business focus; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">possible cash flow interruption or loss of revenue as a result of change of ownership transition matters;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">difficulty of assimilating the operations and personnel of acquired businesses;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">potential loss of key employees of acquired businesses, and the impairment of relationships with employees and customers as a result of changes in management; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">uncertainty as to the long-term success of any acquisitions we may make including the impact on contingent liabilities.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There is no assurance that any completed acquisition will be accretive to our margins or profits in the short term or in the long term. If we proceed with one or more significant acquisitions in which the consideration consists of cash, a substantial portion of our available cash could be used to consummate the acquisitions. If we consummate one or more acquisitions in which the consideration consists of capital stock, our stockholders could suffer significant dilution of their interest in us. In addition, we could incur or assume significant amounts of indebtedness in connection with acquisitions. Further, acquisitions could also result in significant goodwill and/or amortization charges for acquired businesses or technologies.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Failure to attract additional capital which we may require to expand our business could curtail our growth.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may require additional capital to expand our business. If cash generated internally is insufficient to fund capital requirements, we will require additional debt or equity financing. In addition, we may require financing to fund any significant acquisitions we may seek to make. Needed financing may not be available or, if available, may not be available on terms satisfactory to us and may result in significant stockholder dilution. Covenants in our existing financing agreements may also restrict our ability to obtain additional debt financing. If we fail to obtain sufficient additional capital in the future, we could be forced to curtail our growth strategy by reducing or delaying capital expenditures and acquisitions, selling assets, restructuring our operations or refinancing our indebtedness.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">International and national economic and industry conditions constantly change, and could materially and adversely affect our business, financial condition and results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our business, financial condition and results of operation are affected by many changing economic, industry and other conditions beyond our control.  Actual or potential changes in international, national, regional and local economic, business and financial conditions, including recession, inflation and trade protection measures, may negatively affect consumer preferences, perceptions, spending patterns or demographic trends, any of which could adversely affect our business, financial condition or results of operations.  Our customers may experience financial difficulties or be unable to borrow money to fund their </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">operations, which may adversely impact their ability or decision to purchase or pay for our products.  Disruptions in the credit markets have previously resulted, and could again result, in volatility, decreased liquidity, widening of credit spreads, and reduced availability of financing.  There can be no assurance that future financing will be available to us on acceptable terms, if at all.  An inability to obtain necessary additional financing on acceptable terms may have an adverse impact on us and on our ability to execute on our business plan.</font></div><div style="line-height:120%;text-align:justify;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We are subject to a variety of market and financial risks due to our international operations that could adversely affect those operations or our profitability and operating results.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Although our stock is traded on the NASDAQ Global Select Market, we are a global Company. Operations in countries outside of the U.S., which account for approximately </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;">&#32;percent of our net sales for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, are accompanied by certain financial and other risks that would not be faced by a Company operating purely within the U.S. We intend to continue to pursue growth opportunities in sales outside the U.S., especially in emerging markets, which could expose us to greater risks associated with international sales and operations. Our profitability and international operations are, and will continue to be, subject to a number of risks and potential costs, including:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">fluctuations in currency exchange rates;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">healthcare reform legislation;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">multiple non-U.S. regulatory requirement that are subject to change and could restrict our ability to manufacture and sell our products;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">local product preferences and product requirements;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">longer-term receivables than are typical in the U.S.;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">trade protection measures and import or export licensing requirements;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">less intellectual property protection in some countries outside the U.S. than exists in the U.S.;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">different labor regulations and workforce instability;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">political instability;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the potential payment of U.S. income taxes on earnings of certain foreign subsidiaries subject to U.S. taxation upon repatriation;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the expiration and non-renewal of foreign tax rulings;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">potential negative consequences from changes in or interpretation of tax laws; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">economic instability and inflation, recession or interest rate fluctuations.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There are recent legislative proposals to tax profits of U.S. affiliates which are earned abroad. While it is impossible for us to predict whether these and other proposals will be implemented, or how they will ultimately impact us, they may materially impact our results of operations if, for example, our profits earned abroad are subject to U.S. income tax, or we are otherwise disallowed deductions as a result of these profits.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 23, 2016, the United Kingdom (U.K.) held a referendum in which voters approved an exit from the E.U., commonly referred to as &#8220;Brexit&#8221;.&#160; As a result of the referendum, it is expected that the British government will begin negotiating the terms of the U.K.&#8217;s future relationship with the E.U.&#160; Although it is unknown what those terms will be, it is possible that there will be greater restrictions on imports and exports between the U.K. and E.U. countries and increased regulatory complexities. These changes may adversely affect our operations and financial results.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finally, changes in currency exchange rates may reduce the reported value of our revenues outside the U.S, net of expenses, and cash flows. We cannot predict changes in currency exchange rates, the impact of exchange rate changes, nor the degree to which we will be able to manage the impact of currency exchange rate changes.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Continuing worldwide economic instability, including challenges faced by the Eurozone countries, could adversely affect our revenues, financial condition or results of operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Since fiscal year 2008, the global economy has been impacted by the sequential effects of an ongoing global financial crisis. There can be no assurance that there will not be further deterioration in the global economy. Our customers and vendors may experience financial difficulties or be unable to borrow money to fund their operations which may adversely impact their ability to purchase our products or to pay for our products on a timely basis, if at all. As with our customers and vendors, these economic conditions make it more difficult for us to accurately forecast and plan our future business activities. In addition, trade receivables are in many countries (including, but not limited to, Greece, Ireland, Portugal, and Spain). Repayment of these receivables is dependent upon the financial stability of the economies of those countries.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In light of these global economic fluctuations, we continue to monitor the creditworthiness of customers located outside the U.S. Failure to receive payment of all or a significant portion of these receivables could adversely affect our results of operations. Further, there are concerns for the overall stability and suitability of the Euro as a single currency, given the economic and political challenges facing individual Eurozone countries. Continuing deterioration in the creditworthiness of the Eurozone countries, the withdrawal of one or more member countries from the EU, or the failure of the Euro as a common European currency could adversely affect our revenues, financial condition or results of operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Our business could be harmed if we lose the services of our key personnel.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our business depends upon our ability to attract and retain highly qualified personnel, including managerial, sales and technical personnel. We compete for key personnel with other companies, healthcare institutions, academic institutions, government entities and other organizations. We do not have written employment agreements with our executive officers, other than the CEO. Our ability to maintain and expand our business may be impaired if we are unable to retain our current key personnel or hire or retain other qualified personnel in the future.  In addition, our sales force is highly talented and there is high competition in the sales industry which could have an adverse effect on our business if there is significant turnover.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RISKS RELATED TO OPERATIONS</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">If we are unable to manage our growth profitably, our business, financial results and stock price could suffer.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our future financial results will depend in part on our ability to profitably manage our growth. Management will need to maintain existing customers and attract new customers, recruit, retain and effectively manage employees, as well as expand operations and integrate customer support and financial control systems. If integration</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">-</font><font style="font-family:inherit;font-size:10pt;">related expenses and capital expenditure requirements are greater than anticipated or if we are unable to manage our growth profitably, our financial results and the market price of our common stock may decline.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In recent years we have begun to implement our operational excellence initiatives which include a number of restructuring, realignment and cost reduction initiatives.  While we have realized some efficiencies from these actions, we may not realize the benefits of these initiatives to the extent we anticipated. Further, such benefits may be realized later than expected, and the ongoing difficulties in implementing these measures may be greater than anticipated, which could cause us to incur additional costs or result in business disruptions. In addition, if these measures are not successful or sustainable, we may undertake additional realignment and cost reduction efforts, which could result in significant additional charges. Moreover, if our restructuring and realignment efforts prove ineffective, our ability to achieve our other strategic goals and business plans may be adversely affected.</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We have incurred significant indebtedness which imposes operating and financial restrictions on us which, together with our debt service obligations, could significantly limit our ability to execute our business strategy and increase the risk of default under our debt obligations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have debt outstandingba of approximately </font><font style="font-family:inherit;font-size:10pt;">$92.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">.  The interest rate on these borrowings is a floating rate which could expose us to the risk of increased interest expense in the future.  The terms of our credit facilities require us to comply with certain financial maintenance covenants. In addition, the terms of our indebtedness also include certain covenants restricting or limiting our ability to take certain actions.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These covenants may adversely affect our ability to finance future operations or limit our ability to pursue certain business opportunities or take certain corporate actions. The covenants may also restrict our flexibility in planning for changes in our business and the industry and make us more vulnerable to economic downturns and adverse developments.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our ability to meet our cash requirements, including our debt service obligations, will be dependent upon our operating performance, which will be subject to general economic and competitive conditions and to financial, business and other factors affecting our operations, many of which are or may be beyond our control. We cannot provide assurance that our business operations will generate sufficient cash flows from operations to fund these cash requirements and debt service obligations. If our operating results, cash flow or capital resources prove inadequate, we could face substantial liquidity problems and might be required to dispose of material assets or operations to meet our debt and other obligations. If we are unable to service our debt, we could be forced to reduce or delay planned expansions and capital expenditures, sell assets, restructure or refinance our debt or seek additional equity capital, and we may be unable to take any of these actions on satisfactory terms or in a timely manner. Further, any of these actions may not be sufficient to allow us to service our debt obligations or may have an adverse impact on our business. Our debt agreements limit our ability to take certain of these actions. Our failure to generate sufficient </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">operating cash flow to pay our debts or to successfully undertake any of these actions could have a material adverse effect on us.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, the degree to which we are leveraged as a result of the indebtedness incurred in connection with an acquisition or otherwise could materially and adversely affect our ability to obtain additional financing for working capital, capital expenditures, acquisitions, debt service requirements or other purposes, could make us more vulnerable to general adverse economic, regulatory and industry conditions, could limit our flexibility in planning for, or reacting to, changes and opportunities in the markets in which we compete, could place us at a competitive disadvantage compared to our competitors that have less debt or could require us to dedicate a substantial portion of our cash flow to service our debt.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Despite our indebtedness, we may incur more debt, which could exacerbate the risks described above.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may be able to incur substantial additional indebtedness in the future subject to the limitations contained in the agreements governing our debt. Although these agreements restrict us from incurring additional indebtedness, these restrictions are subject to important exceptions and qualifications. For example, we are generally permitted to incur certain indebtedness, including indebtedness arising in the ordinary course of business and indebtedness relating to acquisition activities.  See &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations-Liquidity and Capital Resources&#8221;. </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Our international sales and operations are subject to risks and uncertainties that vary by country and could have a material adverse effect on our business and/or results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales outside the United States accounted for approximately </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;">&#32;of our net sales during our fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">.  We anticipate that sales from international operations will continue to represent a significant portion of our total sales, and we intend to continue our expansion into emerging and/or faster-growing markets outside the United States.  Our sales and profitability from our international operations are subject to risks and uncertainties that can vary by country, and include those related to political and economic conditions, foreign currency exchange rate fluctuations, changes in tax laws, regulatory and reimbursement programs and policies, and the protection of intellectual property rights.  These risks and uncertainties could have a material adverse effect on our business and/or results of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Foreign currency exchange rate may adversely affect our business, financial condition and results of operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are exposed to a variety of market risks, including the effects of changes in foreign currency exchange rates.  Products manufactured in, and sold into, foreign markets represent a significant portion of our operations.  When the United States&#160;dollar strengthens or weakens in relation to the foreign currencies of the countries in which we sell our products, such as the euro, our United States&#160;dollar-reported revenue and income will fluctuate.  As a result of the June 23, 2016 referendum by British voters to exit the European Union, global markets and foreign currencies have been adversely impacted and the value of the Pound Sterling has sharply declined as compared to the U.S. Dollar and other currencies. This volatility in foreign currencies is expected to continue as the U.K. negotiates and executes its exit from the European Union but it is uncertain over what time period this will occur.  The effects of currency rate fluctuations and changes in the relative values of currencies may, in some instances, have a significant effect on our business, financial condition, results of operations and cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Our goodwill, intangible assets and fixed assets are subject to potential impairment.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A significant portion of our assets consists of goodwill, intangible assets and fixed assets, the carrying value of which may be reduced if we determine that those assets are impaired.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Most of our intangible and fixed assets have finite useful lives and are amortized or depreciated over their useful lives on either a straight-line basis or over the expected period of benefit or as revenues are earned from the sales of the related products. The underlying assumptions regarding the estimated useful lives of these intangible assets are reviewed quarterly and more often if an event or circumstance occurs making it likely that the carrying value of the assets may not be recoverable and are adjusted through accelerated amortization if necessary.  Whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable we test intangible assets for impairment based on estimates of future cash flows. If an intangible asset is considered to be impaired, the amount of the impairment will equal the excess of the carrying value over the fair value of the asset.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We review our single reporting unit for potential goodwill impairment in the third fiscal quarter of each year as part of our annual goodwill impairment testing, and more often if an event or circumstance occurs making it likely that impairment exists. We conduct impairment testing based on our current business strategy in light of present industry and economic </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">conditions, as well as future expectations. The annual goodwill impairment review performed in December </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;indicated no goodwill impairments.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If actual results differ from the assumptions and estimates used in the goodwill and intangible asset calculations, we could incur future impairment or amortization charges, which could negatively impact our results of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We may be limited in our ability to utilize, or may not be able to utilize, net operating loss carryforwards to reduce our future tax liability.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">IRC Section 382 and related provisions contain rules that limit for U.S. federal income tax purposes the ability of a Company that undergoes an &#8220;ownership change&#8221; to utilize its net operating loss carryforwards and certain other tax attributes existing as of the date of such ownership change.&#160; Our Federal net operating loss carryforwards as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;after considering IRC Section&#160;382 limitations are </font><font style="font-family:inherit;font-size:10pt;">$157.8 million</font><font style="font-family:inherit;font-size:10pt;">. The expiration of the Federal net operating loss carryforwards is as follows: </font><font style="font-family:inherit;font-size:10pt;">$28.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;between 2018 and 2023 and </font><font style="font-family:inherit;font-size:10pt;">$129.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;between 2027 and 2037.&#160; Our state net operating loss carryforwards as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;after considering remaining IRC Section&#160;382 limitations are </font><font style="font-family:inherit;font-size:10pt;">$19.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;which expire in various years from 2018 to 2038.&#160; Future ownership changes within the meaning of IRC Section&#160;382 may also subject our tax loss carryforwards to annual limitations which would restrict our ability to use them to offset our taxable income in periods following the ownership changes. &#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 9 to our consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;for a further discussion of our tax loss carryovers.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fluctuations in our effective tax rate and changes to tax laws may adversely affect us.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As an international Company, we are subject to taxation in numerous countries, states and other jurisdictions.  Our effective tax rate is derived from a combination of applicable tax rates in the various countries, states and other jurisdictions in which we operate.  In preparing our financial statements, we estimate the amount of tax that will become payable in each of these jurisdictions. Our effective tax rate may, however, differ from the estimated amount due to numerous factors, including a change in the mix of our profitability from country to country and changes in tax laws.  Any of these factors could cause us to experience an effective tax rate significantly different from previous periods or our current expectations, which could have an adverse effect on our business, financial condition and results of operations and cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We rely on the proper function, availability and security of information technology systems to operate our business and a cyber-attack or other breach of these systems could have a material adverse effect on our business, financial condition or results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We rely on information technology systems to process, transmit, and store electronic information in our day-to-day operations. Similar to other large multi-national companies, the size and complexity of our information technology systems makes them vulnerable to a cyber-attack, malicious intrusion, breakdown, destruction, loss of data privacy, or other significant disruption. Our information systems require an ongoing commitment of significant resources to maintain, protect, and enhance existing systems and develop new systems to keep pace with continuing changes in information processing technology, evolving systems and regulatory standards, the increasing need to protect patient and customer information, and changing customer patterns. In addition, third parties may attempt to hack into our products to obtain data relating to patients with our products or our proprietary information. Any failure by us to maintain or protect our information technology systems and data integrity, including from cyber-attacks, intrusions or other breaches, could result in the unauthorized access to patient data and personally identifiable information, theft of intellectual property or other misappropriation of assets, or otherwise compromise our confidential or proprietary information and disrupt our operations. Any of these events, in turn, may cause us to lose existing customers, have difficulty preventing, detecting, and controlling fraud, have disputes with customers, physicians, and other health care professionals, be subject to legal claims and liability, have regulatory sanctions or penalties imposed, have increases in operating expenses, incur expenses or lose revenues as a result of a data privacy breach or theft of intellectual property, or suffer other adverse consequences, any of which could have a material adverse effect on our business, financial condition or results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Any disaster at our manufacturing facilities could disrupt our ability to manufacture our products for a substantial amount of time, which could cause our revenues to decrease. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We conduct our manufacturing and assembly at facilities in Queensbury, New York and Glens Falls, New York. It would be difficult, expensive and time-consuming to transfer resources from one facility to the other, replace, or repair these facilities and our manufacturing equipment if they were significantly affected by a disaster. Additionally, we might be forced to rely on </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">third-party manufacturers or to delay production of our products. Insurance for damage to our properties and the disruption of our business from disasters may not be sufficient to cover all of our potential losses and may not continue to be available to us on acceptable terms, or at all. In addition, if one of our principal suppliers were to experience a similar disaster, uninsured loss or under-insured loss, we might not be able to obtain adequate alternative sources of supplies or products or could face significant delays and incur substantial expense in doing so. Any significant uninsured loss, prolonged or repeated disruption, or inability to operate experienced by us or any of our principal suppliers could cause significant harm to our business, financial condition and results of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Manufacturing and assembly takes place in Queensbury, New York and Glens Falls, New York.  If we were significantly affected by a disaster, we no longer have an option to transfer manufacturing to another facility so we would be forced to rely on third-party manufacturers or would have to delay production of our products.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Anti-takeover provisions in our organizational documents and Delaware law may discourage or prevent a change of control, even if an acquisition would be beneficial to our stockholders, which could cause our stock price to decline and prevent attempts by our stockholders to replace or remove our current management.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our amended and restated certificate of incorporation and our amended and restated bylaws contain provisions that may enable our management to resist a change in control. These provisions may discourage, delay or prevent a change in the ownership of our Company or a change in our management. In addition, these provisions could limit the price that investors would be willing to pay in the future for shares of our common stock. Such provisions include:</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">our board of directors is authorized, without prior stockholder approval, to create and issue &#8220;blank check&#8221; preferred stock, with rights senior to those of our common stock;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">our board of directors is classified so that not all members of our board of directors are elected at one time, which may make it more difficult for a person who acquires control of a majority of our outstanding voting stock to replace our directors;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">advance notice requirements for stockholders to nominate individuals to serve on our board of directors or for stockholders to submit proposals that can be acted upon at stockholder meetings;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">stockholder action by written consent is prohibited; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">stockholders are not permitted to cumulatively vote for the election of directors.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are also subject to the provisions of Section&#160;203 of the Delaware General Corporation Law, which may prohibit certain business combinations with stockholders owning 15% or more of our outstanding voting stock.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These and other provisions in our amended and restated certificate of incorporation, amended and restated bylaws and Delaware law could make it more difficult for stockholders or potential acquirers to obtain control of our board of directors or initiate actions that are opposed by our then-current board of directors, including delaying or impeding a merger, tender offer or proxy contest involving our Company. Any delay or prevention of a change of control transaction or changes in our board of directors could cause the market price of our common stock to decline.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RISKS RELATED TO THE REGULATORY ENVIRONMENT</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reforms to the United States healthcare system may adversely affect our business.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In response to perceived increases in health care costs in recent years, there have been and continue to be proposals by the federal government, state governments, regulators and third-party payers to control these costs and, more generally, to reform the health care system, including U.S. health care reform legislation. Certain of these proposals could, among other things, limit the prices we are able to charge for our products or the amounts of reimbursement available for our products and could limit the acceptance and availability of our products. The adoption of some or all of these proposals could have an adverse effect on our business, results of operations, financial condition and cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Our industry is experiencing greater scrutiny and regulation by governmental authorities, which has led to certain costs and business distractions as we respond to inquiries and comply with new regulations, and may lead to greater governmental regulation in the future.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our medical devices and our business activities are subject to rigorous regulation by the FDA and numerous other federal, state and foreign governmental authorities. These authorities and members of Congress have been increasing their scrutiny of our industry. In addition, certain states, including Massachusetts, have recently passed or are considering legislation restricting our interactions with health care providers and requiring disclosure of many payments to them. The federal government has recently introduced similar legislation, which may or may not preempt state laws. Recent Supreme Court case law has clarified that the FDA&#8217;s authority over medical devices preempts state tort laws, but legislation has been introduced at the federal level to allow state intervention, which could lead to increased and inconsistent regulation at the state level. We anticipate that the government will continue to scrutinize our industry closely, and that additional regulation by governmental authorities may increase compliance costs, exposure to litigation and other adverse effects to our operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We are subject to a comprehensive system of federal, state and international laws and regulations, and we could be the subject of investigations, enforcement actions or face lawsuits and monetary or equitable judgments.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We operate in many parts of the world, and our operations are affected by complex state, federal and international laws relating to healthcare, environmental protection, antitrust, anti-corruption, anti-bribery, fraud and abuse, export control, tax, employment and laws regarding privacy, personally identifiable information and protected health information, including, for example, the Food, Drug and Cosmetic Act (&#8220;FDCA&#8221;), various FDA and international regulations relating to, among other things, the development, quality assurance, manufacturing, importation, distribution, marketing and sale of, and billing for, our products, the federal Anti-Kickback Statute and Federal False Claims Act (see Note 15), the U.S. Foreign Corrupt Practices Act (&#8220;FCPA&#8221;), the UK Bribery Act of 2010, the federal Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;), General Data Protection Regulation ("GDPR") and other foreign data protection and privacy laws, and laws and regulations relating to sanctions and money laundering. We are subject to periodic inspections to determine compliance with the FDA&#8217;s Quality System Regulation requirements, current medical device adverse event reporting regulations, and similar foreign rules and regulations. Despite our training and compliance programs, our internal control policies and procedures may not always protect us from negligent, reckless or criminal acts committed by our employees or agents. The failure to comply with these laws and regulatory standards, allegations of such non-compliance or the discovery of previously unknown problems with a product or manufacturer: (i)&#160;could result in FDA Form-483 notices and/or warning letters or the foreign equivalent, fines, delays or suspensions of regulatory clearances, investigations, detainment, seizures or recalls of products (with the attendant expenses), the banning of a particular device, an order to replace or refund the cost of any device previously manufactured or distributed, operating restrictions and/or civil or criminal prosecution, and/or penalties, as well as decreased sales as a result of negative publicity and product liability claims; and (ii)&#160;could disrupt our business and could have a material adverse effect on our business, results of operations, financial condition and/or liquidity.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Most of our products must receive clearance or approval from the FDA or comparable regulatory agencies abroad before they can be marketed or sold. State, federal and foreign registration regulations are both evolving and subject to varied levels of interpretation and enforcement. It can be costly and time-consuming to obtain and maintain regulatory approvals to market a medical device. Approvals might not be granted on a timely basis, if at all, for new devices, new indications for use or certain modifications or enhancements to previously approved products. Even after a device receives regulatory approval it remains subject to significant regulatory and quality requirements, such as manufacturing, recordkeeping, renewal, recertification or reporting and other post market approval requirements, which may include clinical, laboratory or other studies. Product approvals by the FDA and other foreign regulators can be withdrawn due to failure to comply with regulatory standards or the occurrence of unforeseen problems following initial approval or may be re-classified to a higher regulatory classification, such as requiring a Pre-Market Approval (&#8220;PMA&#8221;) for a previously cleared 510(k) device. Regulations are also subject to change as a result of legislative, administrative or judicial action, which may further increase our costs or reduce sales. Our failure to maintain approvals, obtain approval for new products or comply with other applicable regulatory requirements could adversely affect our business, results of operations, financial condition and/or liquidity.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The healthcare industry is under continued scrutiny from state, federal and international governments with respect to industry practices in the area of sales and marketing, including provisions of the Physician Payment Sunshine Act. If our marketing, sales or other activities fail to comply with the FDA&#8217;s or other comparable foreign regulatory agencies&#8217; regulations or guidelines, or other applicable laws, we may be subject to warnings from the FDA or investigations or enforcement actions from the FDA, Medicare, the Office of Inspector General of the U.S. Department of Health and Human Services or other government agencies or enforcement bodies. Additionally, in the European Union, a new draft Medical Device Regulation was published in 2016 imposing stricter requirements for the marketing and sale of medical devices and grants Notified Bodies increased post-market surveillance authority. The Company is monitoring the implementation of the regulation and has </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">undertaken initial actions to move toward compliance based on the published draft of the regulation. The Company&#8217;s failure to comply with any marketing or sales regulations or any other applicable regulatory requirements could adversely affect our business, results of operations, financial condition and/or liquidity.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the recent past, medical device manufacturers have been the subject of investigations from government agencies related to their relationships with doctors, product sales and marketing and off-label promotion of products, among other activities or practices. If an enforcement action involving the Company were to occur, it could result in penalties, fines, detainment, seizures, recalls, product bans, operating restrictions (which may include loss of a license or authorization), the exclusion of our products from reimbursement under government-funded programs and/or prohibitions on our ability to sell our products, and could have a material adverse effect on our business, results of operations, financial condition and/or liquidity. In addition, remediation of any issues identified by the FDA or other regulators could require facility upgrades, process changes, additional labeling requirements or other measures, any of which could have a material adverse effect on our business and/or results of operations. </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, lawsuits by or otherwise involving employees, customers, licensors, licensees, suppliers, vendors, business partners, distributors, shareholders or competitors with respect to how we conduct our business could be very costly and could substantially disrupt our business. Disputes from time-to-time with companies or individuals are not uncommon, and we cannot assure you that we will be able to resolve these disputes on terms favorable to us.  The occurrence of an adverse monetary or equitable judgment or a large expenditure in connection with a settlement of any of these matters could have a material adverse effect on our business, results of operations, financial condition and/or liquidity.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We are subject to healthcare fraud and abuse regulations that could result in significant liability, require us to change our business practices and restrict our operations in the future.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are subject to various federal, state and local laws targeting fraud and abuse in the healthcare industry, including anti-kickback and false claims laws. Violations of these laws are punishable by criminal or civil sanctions, including substantial fines, imprisonment and exclusion from participation in healthcare programs such as Medicare and Medicaid and health programs outside the United States. These laws and regulations are wide ranging and subject to changing interpretation and application, which could restrict our sales or marketing practices. Furthermore, since many of our customers rely on reimbursement from Medicare, Medicaid and other governmental programs to cover a substantial portion of their expenditures, our exclusion from such programs as a result of a violation of these laws could have a material adverse effect on our business, results of operations, financial condition and cash flow.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">If we or some of our suppliers fail to comply with the FDA&#8217;s Quality System Regulation, or QSR, and other applicable postmarket requirements, our manufacturing operations could be disrupted, our product sales and profitability could suffer, and we may be subject to a wide variety of FDA enforcement actions.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">After a device is placed on the market, numerous regulatory requirements apply. We are subject to inspection and marketing surveillance by the FDA to determine our compliance with all regulatory requirements. Our failure to comply with applicable regulatory requirements could result in the FDA or a court instituting a wide variety of enforcement actions against us, including a public "Warning Letter"; an order to shut down some or all manufacturing operations; a recall of products; fines or civil penalties; seizure or detention of our products; refusing our requests for 510(k) clearance or a PMA of new or modified products; withdrawing 510(k) clearance or PMA approvals already granted to us; and criminal prosecution.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our manufacturing processes and those of some of our suppliers must comply with the FDA&#8217;s Quality System Regulation, or QSR, which governs the methods used in, and the facilities and controls used for, the design, testing, manufacture, control, quality assurance, installation, servicing, labeling, packaging, storage and shipping of medical devices. The FDA enforces the QSR through unannounced inspections. If we, or one of our suppliers, fail a QSR inspection, or if a corrective action plan adopted by us or one of our suppliers is not sufficient, the FDA may bring an enforcement action, and our operations could be disrupted and our manufacturing delayed. We are also subject to the FDA&#8217;s general prohibition against promoting our products for unapproved or &#8220;off-label&#8221; uses, the FDA&#8217;s adverse event reporting requirements and the FDA&#8217;s reporting requirements for field correction or product removals. The FDA has recently placed increased emphasis on its scrutiny of compliance with the QSR and these other postmarket requirements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If we, or one of our suppliers, violate the FDA&#8217;s requirements or fail to take adequate corrective action in response to any significant compliance issue raised by the FDA, the FDA can take various enforcement actions which could cause our product sales and profitability to suffer.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, most other countries require us and our suppliers to comply with manufacturing and quality assurance standards for medical devices that are similar to those in force in the United States before marketing and selling our products in those countries. If we, or our suppliers, should fail to do so, we would lose our ability to market and sell our products in those countries.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">If we cannot obtain and maintain marketing clearance or approval from governmental agencies, we will not be able to sell our products.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our products are medical devices that are subject to extensive regulation in the United States and in the foreign countries in which they are sold. Unless an exemption applies, each medical device that we wish to market in the United States must receive either 510(k) clearance or premarket approval (PMA) from the FDA before the product can be sold. Either process can be lengthy and expensive. The FDA&#8217;s 510(k) clearance procedure, also known as &#8220;premarket notification,&#8221; is the process we have used for our current products. This process usually takes from four to twelve months from the date the premarket notification is submitted to the FDA, but may take significantly longer. Although we have obtained 510(k) clearances for our current products, our clearances may be revoked by the FDA if safety or effectiveness problems develop with the devices. The PMA process is much more costly, lengthy and uncertain. It generally takes from one to three years from the date the application is submitted to, and filed with the FDA, and may take even longer. Regulatory regimes in other countries similarly require approval or clearance prior to our marketing or selling products in those countries. We rely on our distributors to obtain regulatory clearances or approvals of our products outside of the United States. If we are unable to obtain additional clearances or approvals needed to market existing or new products in the United States or elsewhere or obtain these clearances or approvals in a timely fashion or at all, or if our existing clearances are revoked, our revenues and profitability may decline.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Modifications to our current products may require new marketing clearances or approvals or require us to cease marketing or recall the modified products until such clearances or approvals are obtained.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any modification to an FDA-cleared medical device that could significantly affect its safety or effectiveness, or that would constitute a major change or modification in its intended use, requires a new FDA 510(k) clearance or, possibly, a premarket approval. The FDA requires every manufacturer to make its own determination as to whether a modification requires a new 510(k) clearance or premarket approval, but the FDA may review and disagree with any decision reached by the manufacturer. We have modified aspects of some of our devices since receiving regulatory clearance. We believed that some of these modifications did not require new 510(k) clearance or premarket approval and, therefore, we did not seek new 510(k) clearances or premarket approvals. In the future, we may make additional modifications to our products after they have received FDA clearance or approval and, in appropriate circumstances, determine that new clearance or approval is unnecessary. Regulations in other countries in which we market or sell, or propose to market or sell, our products may also require that we make judgments about changes to our products and whether or not those changes are such that regulatory approval or clearance should be obtained. In the United States and elsewhere, regulatory authorities may disagree with our past or future decisions not to seek new clearance or approval and may require us to obtain clearance or approval for modifications to our products. If that were to occur for a previously cleared or approved product, we may be required to cease marketing or recall the modified device until we obtain the necessary clearance or approval. Under these circumstances, we may also be subject to significant regulatory fines or other penalties. If any of the foregoing were to occur, our financial condition and results of operations could be negatively impacted.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Even after receiving regulatory clearance or approval, our products may be subject to product recalls, which may harm our reputation and divert managerial and financial resources.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The FDA and similar governmental authorities in other countries have the authority to order mandatory recall of our products or order their removal from the market if there are material deficiencies or defects in design, manufacture, installation, servicing or labeling of the device, or if the governmental entity finds that our products would cause serious adverse health consequences. A government mandated voluntary recall or field action by us could occur as a result of component failures, manufacturing errors or design defects, including labeling defects. Any recall of our products may harm our reputation with customers and divert managerial and financial resources.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">We may be subject to fines, penalties, injunctions or costly investigations if we are determined to be promoting the use of our products for unapproved or &#8220;off-label&#8221; uses.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If we are incorrect in our belief that our promotional materials and training methods regarding physicians are conducted in compliance with regulations of the FDA and other applicable regulations, and the FDA determines that our promotional materials or training constitutes promotion of an unapproved use, the FDA could request that we modify our training or promotional materials or subject us to regulatory enforcement actions, including the issuance of a warning letter, injunction, </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">seizure, civil fine and criminal penalties.  It is also possible that other federal, state or foreign enforcement authorities might take action if they consider promotional or training materials to constitute promotion of an unapproved use, which could result in significant fines or penalties under other statutory authorities, such as laws prohibiting false claims for reimbursement.  Any of these results could have a material adverse effect on our financial position or results of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2014 we received a subpoena from the U.S. Department of Justice (the &#8220;DOJ&#8221;) requesting documents in relation to a criminal and civil investigation the DOJ is conducting regarding BTG International, Inc.&#8217;s LC Bead product beginning in 2003.  RITA Medical Systems and AngioDynamics, Inc., after our acquisition of RITA, was the exclusive distributor of LC Beads in the United States from 2006 through December 31, 2011.  We are cooperating fully with this investigation and at this time are unable to predict its scope, duration or outcome.  In April 2015 we received a subpoena from the DOJ requesting documents in relation to a criminal and civil investigation the DOJ is conducting regarding purported promotion of certain of our VenaCure EVLT products for un-cleared indications.  As of May 31, 2017 the Company accrued $12.5 million for these matters and in August 2017, the Company agreed in principle with the government to resolve these matters for approximately $12.5 million.  This balance was still accrued as of May 31, 2018 and was paid in the first quarter of fiscal year 2019.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">If our employees or agents violate the U.S. Foreign Corrupt Practices Act or anti-bribery laws in other jurisdictions, we may incur fines or penalties, or experience other adverse consequences.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are subject to the U.S. Foreign Corrupt Practices Act, or FCPA, and similar anti-bribery laws in international jurisdictions, including the UK Anti-Bribery Act, which generally prohibit companies and their intermediaries from making improper payments to non-U.S. officials for the purpose of obtaining or retaining business. Because of the predominance of government-sponsored healthcare systems around the world, many of our customer relationships outside of the United States are with governmental entities and are therefore subject to such anti-bribery laws. Our sales to customers and distributors outside of the United States have been increasing and we expect them to continue to increase in the future. If our employees or agents violate the provisions of the FCPA or other anti-bribery laws, we may incur fines or penalties, we may be unable to market our products in other countries or we may experience other adverse consequences which could have a material adverse effect on our operating results or financial condition.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Laws and regulations governing the export of our products could adversely impact our business.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The U.S. Department of the Treasury&#8217;s Office of Foreign Assets Control (OFAC), and the Bureau of Industry and Security at the U.S. Department of Commerce (BIS), administer certain laws and regulations that restrict U.S. persons and, in some instances, non-U.S. persons, in conducting activities, transacting business with or making investments in certain countries, governments, entities and individuals subject to U.S. economic sanctions. Due to our international operations, we are subject to such laws and regulations, which are complex, restrict our business dealings with certain countries and individuals, and are constantly changing. Further restrictions may be enacted, amended, enforced or interpreted in a manner that materially impacts our operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From time to time, certain of our subsidiaries have limited business dealings in countries subject to comprehensive sanctions, including Iran. Certain of our subsidiaries sell medical devices and surgical tools, and may provide related services, to distributors and other purchasing bodies in such countries. These business dealings represent an insignificant amount of our consolidated revenues and income, but expose us to a heightened risk of violating applicable sanctions regulations. Violations of these regulations are punishable by civil penalties, including fines, denial of export privileges, injunctions, asset seizures, debarment from government contracts and revocations or restrictions of licenses, as well as criminal fines and imprisonment. We have established policies and procedures designed to assist with our compliance with such laws and regulations. However, there can be no assurance that our policies and procedures will effectively prevent us from violating these regulations in every transaction in which we may engage, and such a violation could adversely affect our reputation, business, financial condition, results of operations and cash flows.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Changes in reimbursement levels by governmental or other third-party payors for procedures using our products may cause our revenues to decline.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our products are purchased principally by hospitals or physicians which typically bill various third-party payors, such as governmental programs (e.g. Medicare, Medicaid and comparable foreign programs), private insurance plans and managed care plans, for the healthcare services provided to their patients. The ability of our customers to obtain appropriate reimbursement for products and services from third-party payors is critical to the success of medical device companies because it affects which products customers purchase and the prices they are willing to pay. Reimbursement varies by country and can significantly impact the acceptance of new technology. Implementation of healthcare reforms in the United States and in other countries may limit, reduce or eliminate reimbursement for our products and adversely affect both our pricing flexibility and the demand for </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">our products. Even when we develop a promising new product, we may find limited demand for the product unless reimbursement approval is obtained from private and governmental third party payors.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Third-party payors have adopted, and are continuing to adopt, a number of healthcare policies intended to curb rising healthcare costs. These policies include:</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">controls on government-funded reimbursement for healthcare services and price controls on medical products and services providers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">challenges to the pricing of medical procedures or limits or prohibitions on reimbursement for specific devices and therapies through other means; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the introduction of managed care systems in which healthcare providers contract to provide comprehensive healthcare for a fixed cost per person.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are unable to predict whether federal, state or local healthcare reform legislation or regulation affecting our business may be proposed or enacted in the future, or what effect any such legislation or regulation would have on our business. Changes in healthcare systems in the United States or elsewhere in a manner that significantly reduces reimbursement for procedures using our medical devices or denies coverage for these procedures, or adverse decisions relating to our products by administrators of these systems in coverage or reimbursement issues, would have an adverse impact on the acceptance of our products and the prices which our customers are willing to pay for them.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RISKS RELATED TO INTELLECTUAL PROPERTY</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">If we fail to adequately protect our intellectual property rights, we may not be able to generate revenues from new or existing products and our business may suffer.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our success depends in part on obtaining, maintaining and enforcing our patents, trademarks and other proprietary rights, and our ability to avoid infringing the proprietary rights of others. We take precautionary steps to protect our technological advantages and intellectual property. We rely upon patent, trade secret, copyright, know-how and trademark laws, as well as license agreements and contractual provisions, to establish our intellectual property rights and protect our products. However, no assurances can be made that any pending or future patent applications will result in the issuance of patents, that any current or future patents issued to, or licensed by, us will not be challenged or circumvented by our competitors, or that our patents will not be found invalid.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Patent positions of medical device companies, including our Company, are uncertain and involve complex and evolving legal and factual questions. The coverage sought in a patent application can be denied or significantly reduced either before or after the patent is issued. Consequently, there can be no assurance that any of our pending patent applications will result in an issued patent. There is also no assurance that any existing or future patent will provide significant protection or commercial advantage, or whether any existing or future patent will be circumvented by a more basic patent, thus requiring us to obtain a license to produce and sell the product. Generally, patent applications can be maintained in secrecy for at least 18 months after their earliest priority date. In addition, publication of discoveries in the scientific or patent literature often lags behind actual discoveries. Therefore, we cannot be certain that we were the first to invent the subject matter covered by each of our pending U.S. patent applications or that we were the first to file non-U.S. patent applications for such subject matter.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additionally, we rely on trade secret protection for certain unpatented aspects of our proprietary technology. There can be no assurance that others will not independently develop or otherwise acquire substantially equivalent proprietary information or techniques, that others will not gain access to our proprietary technology or disclose such technology, or that we can meaningfully protect our trade secrets. We have a policy of requiring key employees and consultants to execute confidentiality agreements upon the commencement of an employment or consulting relationship with us. Our confidentiality agreements also require our employees to assign to us all rights to any inventions made or conceived during their employment with us. We also generally require our consultants to assign to us any inventions made during the course of their engagement by us. There can be no assurance, however, that these agreements will provide meaningful protection or adequate remedies for us in the event of unauthorized use, transfer or disclosure of confidential information or inventions.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If we are not able to adequately protect our intellectual property, our market share, financial condition and results of operations may suffer.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">If third parties claim that our products infringe their intellectual property rights, we may be forced to expend significant financial resources and management time defending against such actions and our financial condition and our results of operations could suffer.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Third parties may claim that our products infringe their patents and other intellectual property rights. Identifying third-party patent rights can be particularly difficult because, in general, patent applications can be maintained in secrecy for at least 18 months after their earliest priority date. Some companies in the medical device industry have used intellectual property infringement litigation to gain a competitive advantage. If a competitor were to challenge our patents, licenses or other intellectual property rights, or assert that our products infringe its patent or other intellectual property rights, we could incur substantial litigation costs, be forced to make expensive changes to our product design, pay royalties or other fees to license rights in order to continue manufacturing and selling our products, or pay substantial damages. Third-party infringement claims, regardless of their outcome, would not only consume our financial resources but also divert our management&#8217;s time and effort. Such claims could also cause our customers or potential customers to purchase competitors&#8217; products or defer or limit their purchase or use of our affected products until resolution of the claim. See Note 15 in the consolidated financial statements.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RISKS RELATED TO OUR STOCK PRICE</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Our future operating results are difficult to predict and may vary significantly from quarter to quarter, which may adversely affect the price of our common stock.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The ongoing introduction of new products and services that affect our overall product mix make the prediction of future operating results difficult. You should not rely on our past results as any indication of future operating results. The price of our common stock will likely fall in the event that our operating results do not meet the expectations of analysts and investors. Comparisons of our quarterly operating results are an unreliable indication of our future performance because they are likely to vary significantly based on many factors, including:</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the level of sales of our products and services in our markets;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">our ability to introduce new products or services and enhancements in a timely manner;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the demand for and acceptance of our products and services;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the success of our competition and the introduction of alternative products or services;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">our ability to command favorable pricing for our products and services;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the growth of the market for our devices and services;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the expansion and rate of success of our direct sales force in the United States and internationally and our independent distributors internationally;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">actions relating to ongoing FDA compliance;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the effect of intellectual property disputes;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the size and timing of orders from independent distributors or customers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the attraction and retention of key personnel, particularly in sales and marketing, regulatory, manufacturing and research and development;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">unanticipated delays or an inability to control costs;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">general economic conditions as well as those specific to our customers and markets; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">seasonal fluctuations in revenue due to the elective nature of some procedures.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Our stock price may be volatile, which may cause the value of our stock to decline or subject us to a securities class action litigation.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The trading price of our common stock price may be volatile and could be subject to wide fluctuations in price in response to various factors, many of which are beyond our control, including:</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">general economic, industry and market conditions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">actions by institutional or other large stockholders;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the depth and liquidity of the market for our common stock;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">volume and timing of orders for our products;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">developments generally affecting medical device companies;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the announcement of new products or product enhancements by us or our competitors;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">changes in earnings estimates or recommendations by securities analysts;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">investor perceptions of us and our business, including changes in market valuations of medical device companies; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">our results of operations and financial performance.</font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition, the stock market in general, and the NASDAQ Stock Market and the market for medical devices in particular, have experienced substantial price and volume volatility that is often seemingly unrelated to the operating performance of particular companies. These broad market fluctuations may cause the trading price of our common stock to decline. In the past, securities class action litigation has often been brought against a company after a period of volatility in the market price of its common stock. We may become involved in this type of litigation in the future. Any securities litigation claims brought against us could result in substantial expense and the diversion of management&#8217;s attention from our business.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sEB99CEE38E4C587BB968A8B10FFEABC2"></a></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:74px;"></td><td style="width:608px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;1B.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Unresolved Staff Comments.</font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:32px;font-size:14pt;"><font style="font-family:inherit;font-size:10pt;">None.</font><font style="font-family:inherit;font-size:14pt;">&#160;</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></div><hr style="page-break-after:always"><div><a name="s4437426EA4B950B59DA355755740DED0"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:74px;"></td><td style="width:608px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;2.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Properties.</font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, we operated in the following locations:</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.2421875%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:31%;"></td><td style="width:42%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Purpose</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Approx.</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Sq. Ft.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Property</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Type</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latham, NY</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate headquarters</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leased</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Glens Falls, NY</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Manufacturing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">189,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Owned</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Queensbury, NY</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Manufacturing and distribution</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">129,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Owned</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Manchester, GA</font><font style="font-family:inherit;font-size:8pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Manufacturing and distribution</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leased</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marlborough, MA</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research &amp; Development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leased</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Denmead, U.K.</font><font style="font-family:inherit;font-size:8pt;">*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Manufacturing</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,500</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leased</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amsterdam, NL</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, Marketing &amp; Administrative</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leased</font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:14pt;"><font style="font-family:inherit;font-size:10pt;">In addition, we lease sales offices in various other jurisdictions.</font><font style="font-family:inherit;font-size:14pt;">&#160;</font></div><div style="line-height:120%;text-indent:32px;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*These two locations were closed as part of the operational consolidation plan during fiscal year 2018.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></div><hr style="page-break-after:always"><div><a name="sE5439C4C59BC5CB8820AAB04F194198B"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:74px;"></td><td style="width:608px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;3.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Legal Proceedings.</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">C.R. Bard, Inc. v. AngioDynamics, Inc.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January&#160;11, 2012, C.R. Bard, Inc. (&#8220;Bard&#8221;) filed a suit in the United States District Court of Utah claiming certain of our implantable port products infringe on&#160;three&#160;U.S. patents held by Bard (the &#8220;Utah Action&#8221;). Bard&#8217;s Complaint sought unspecified damages and other relief. We filed petitions for reexamination in the U.S. Patent and Trademark Office (&#8220;USPTO&#8221;) seeking to invalidate all&#160;three&#160;patents asserted by Bard in the litigation. Our petitions were granted and 40 of Bard's 41 patent claims were rejected and, following further proceedings, the Patent Office issued a Final Rejection of all&#160;40&#160;claims subject to reexamination. Thereafter, Bard filed appeals to the USPTO Board of Appeals and Interferences for all&#160;three&#160;reexaminations. The Patent Office issued decisions in all three appeals. In one (issued on March 11, 2016 for U.S. Patent No. 7,785,302), the rejections of&#160;six&#160;of the&#160;ten&#160;claims under reexamination were affirmed, but were reversed on&#160;four&#160;of the ten claims. In the second (issued on March 24, 2016 for U.S. Patent No. 7,959,615), the rejections of&#160;eight&#160;of the&#160;ten&#160;claims under reexamination were affirmed but the rejections of the other&#160;two&#160;of the ten claims were reversed. In the third (issued on March 29 for U.S. Patent No. 7,947.022) the rejections of all&#160;twenty&#160;claims under reexamination were affirmed. Thereafter, Bard filed Requests for Rehearing in all&#160;three&#160;reexamination appeals and the Company filed Requests for Rehearing in&#160;two&#160;of the reexamination appeals (the &#8216;302 and &#8216;615 patent reexaminations). The PTO denied all three Rehearing Requests - - on February 1, 2017 for the &#8216;302 reexam; on February 17, 2017 for the &#8216;022 reexam; and on February 21, 2017 for the &#8216;615 reexam, but modified its characterization of one prior art reference for the &#8216;302 and &#8216;022 decisions.&#160; Bard filed a Notice of Appeal to the Federal Circuit Court of Appeals in all three reexams and the Company filed Cross-Appeals for the &#8216;302 and the &#8216;615 reexams. The parties have completed the process of filing the various appellate briefs. &#160;MedComp also filed an Amicus Brief in support of the Company on November 22, 2017. A date for the oral hearing has not yet been set. The Utah Action has been stayed pending final resolution of the USPTO process.&#160;We believe these claims are without merit and intend to defend them vigorously. We have not recorded an expense related to the outcome of this litigation because it is not yet possible to determine if a potential loss is probable nor reasonably estimable.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 10, 2015, C.R. Bard, Inc. (&#8220;Bard&#8221;) and Bard Peripheral Vascular, Inc. (&#8220;BPV&#8221;) filed suit in the United States District Court for the District of Delaware claiming certain of our implantable port products infringe on&#160;three&#160;U.S. patents held by Bard (the &#8220;Delaware Action&#8221;). Bard's complaint seeks unspecified damages and other relief. The patents asserted in the Delaware Action are different than those asserted in the Utah Action. On June 1, 2015, the Company filed&#160;two&#160;motions in response to Bard&#8217;s Complaint - one sought transfer to the District of Utah where the Utah Action is currently pending, and the other sought dismissal of the entire complaint on grounds that none of the claims in the asserted patents is directed to patent eligible subject matter under Section 101 of the Patent Statute and in light of recent authority from the U. S. Supreme Court. On January 12, 2016, the Court issued a decision denying both motions. A Markman hearing was held on March 10, 2017 and the Court issued its Claim Construction Order on May 19, 2017. On May 19, 2017, Bard served its Final Infringement Contentions and on June 2, 2017, the Company served its Final Invalidity Contentions.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 20, 2017, the scheduling order for the case was amended to, among other things, set a trial date commencing July 23, 2018.&#160;The parties completed Expert Discovery in January 2018.  The parties completed briefing on their respective case dispositive motions on April 27, 2018. On June 26, 2018, the Court denied all case dispositive motions, ruling that issues of material fact remained in dispute. On July 9, 2018, the Court continued the trial to a later date to be determined by the Court and the parties.  We believe these claims are without merit and intend to defend them vigorously. We have not recorded an expense related to the outcome of this litigation because it is not yet possible to determine if a potential loss is probable nor reasonably estimable.</font></div><div style="line-height:120%;text-align:left;text-indent:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">AngioDynamics, Inc. v. C.R. Bard, Inc.  </font></div><div style="line-height:120%;text-align:left;text-indent:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 30, 2017, we commenced an action in the United States District Court for the Northern District of New York entitled AngioDynamics, Inc. v. C.R. Bard, Inc. and Bard Access Systems, Inc. (&#8220;Bard&#8221;). &#160;In this action, we allege that Bard has illegally tied the sales of its tip location systems to the sales of its PICCs.&#160; We allege that this practice violates the federal antitrust laws and has had, and continues to have, an anti-competitive effect in the market for PICCs.&#160; We seek both monetary damages and injunctive relief.  Bard moved to dismiss on September 8, 2017 and the motion has been submitted to the court.&#160; The court has adjourned the initial conference in the case pending its resolution of the motion to dismiss. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Governmental Investigations</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2014 we received a subpoena from the U.S. Department of Justice (the &#8220;DOJ&#8221;) requesting documents in relation to a criminal and civil investigation the DOJ is conducting regarding BTG International, Inc.&#8217;s LC Bead&#174;&#160;product beginning in </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2003.&#160; RITA Medical Systems and AngioDynamics, Inc., after its acquisition of RITA, was the exclusive distributor of LC Beads in the United States from 2006 through December 31, 2011.&#160; We are cooperating fully with this investigation.  </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2015 we received a subpoena from the DOJ requesting documents in relation to a criminal and civil investigation the DOJ is conducting regarding purported promotion of certain of AngioDynamics&#8217; VenaCure EVLT products for un-cleared indications.&#160; We are cooperating fully with this investigation.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of May 31, 2017 the Company accrued $12.5 million for these matters and in August 2017, the Company agreed in principle with the government to resolve these matters for approximately $12.5 million.  This amount was still accrued for at May 31, 2018 and was paid in the first quarter of fiscal year 2019.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><a name="s77FDB34027475A61BF5909EA86BA33FA"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:680px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:73px;"></td><td style="width:606px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;4.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Mine Safety Disclosures.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Not applicable.</font></div><div><a name="sB600BF1DE06C5F79B8627826EBD33803"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Part II</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div><a name="s068F2576656F50D1ACCF709E46DA21E5"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:74px;"></td><td style="width:608px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;5.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities.</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our common stock is traded on The Global Select Market tier of The NASDAQ Stock Market LLC (formerly the Nasdaq National Market), under the symbol &#8220;ANGO.&#8221;</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth, for the fiscal quarters indicated, the high and low sale prices for our common stock as reported by The NASDAQ Stock Market.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:67%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Sale Price</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">High</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Low</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended May 31, 2018</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fourth Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.04</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.13</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Third Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.70</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.71</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Second Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.76</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.29</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">First Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Sale Price</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">High</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Low</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended May 31, 2017</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fourth Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.58</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.08</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Third Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.81</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.89</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Second Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.54</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.40</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">First Quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of July 20, 2018, there were 184 holders of record of our common stock.</font></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Dividends</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We did not declare any cash dividends on our common stock during our last three fiscal years. We do not anticipate paying any cash dividends on our common stock for the foreseeable future.</font></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Performance Graph</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The graph below matches AngioDynamics, Inc.&#8217;s cumulative 5-year total shareholder return on common stock with the cumulative total returns of the NASDAQ Composite index, the RDG SmallCap Medical Devices index, and the NASDAQ Medical Equipment index. The graph tracks the performance of a $100 investment in our common stock and in each index (with the reinvestment of all dividends) from May 31, 2013 to </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">. The stock price performance included in this graph is not necessarily indicative of future stock price performance.</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:6px;"><img src="a5yeargraphfy2018.jpg" alt="a5yeargraphfy2018.jpg" style="height:504px;width:682px;"></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></div><hr style="page-break-after:always"><div><a name="s3F5D762E7D035880B2758F79B82D1B9A"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:74px;"></td><td style="width:608px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;6.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Selected Financial Data.</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">You should read the following selected financial data in conjunction with our consolidated financial statements and the related notes and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included elsewhere in this Annual Report on Form 10-K. </font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated statements of operations data for the fiscal years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, and the consolidated balance sheet data as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, are derived from the consolidated financial statements that are included elsewhere in this Annual Report on Form&#160;10-K. The consolidated statements of operations data for the fiscal years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">&#32;and May&#160;31, 2014, and the consolidated balance sheet data as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2015</font><font style="font-family:inherit;font-size:10pt;">&#32;and May&#160;31, 2014, are derived from our audited consolidated financial statements not included in this Annual Report on Form 10-K. Historical results are not necessarily indicative of the results of operations to be expected for future periods. See Note 14 of &#8220;Notes to Consolidated Financial Statements&#8221; for a description of the method that we used to compute our historical basic and diluted net income per share attributable to common stockholders.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"></td></tr><tr><td style="width:41%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands, except per share information)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated Statements of Operations Data:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">344,285</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349,643</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353,890</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">356,534</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">354,425</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit (exclusive of intangible amortization)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176,875</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176,169</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">174,316</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">175,796</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180,174</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating expenses</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,459</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,269</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,053</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,594</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,124</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales and marketing</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,276</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,819</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,743</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82,351</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85,696</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,265</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,406</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,583</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,031</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,511</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,635</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,296</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,964</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,966</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,562</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">250</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,261</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">948</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,096</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,908</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition, restructuring and other items, net (a)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,432</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,510</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,591</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,257</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,873</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical device excise tax</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,837</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,416</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,142</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,829</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total operating expenses</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">166,317</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">163,202</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173,298</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">179,245</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">169,687</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,558</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,967</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,449</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,487</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total other (expenses), net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,093</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,120</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,271</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,682</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,301</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,335</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,008</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(43,590</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,388</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,347</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings (loss) per share</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.44</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.14</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.21</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.09</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.07</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.44</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.14</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.21</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.09</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.07</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;padding-left:40px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:40px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:16px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition, restructuring and one-time items include restructuring expenses or expenses incurred as part of M&amp;A, product discontinuance, legal settlements and legal costs that are related to litigation that is not in the ordinary course of business.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"></td></tr><tr><td style="width:41%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">As of May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2014</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated Balance Sheet Data:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash, cash equivalents and marketable securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,413</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,759</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,986</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,080</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,914</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Working capital</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110,731</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82,398</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79,527</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90,283</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81,071</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">705,472</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">707,961</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">726,194</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">773,058</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">798,576</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt, including current portion</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91,621</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96,320</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120,541</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">137,660</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">142,660</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,261</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,761</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,275</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,384</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67,231</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long-term liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105,576</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121,418</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">152,239</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167,444</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">195,750</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total stockholders&#8217; equity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">542,595</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">515,027</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">507,228</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">545,099</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">536,885</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-left:4px;text-align:left;padding-left:40px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;text-align:left;padding-left:40px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s0AA65678B779586CA9B070000872B023"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:74px;"></td><td style="width:608px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;7.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Management&#8217;s Discussion and Analysis of Financial Conditions and Results of Operations.</font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following information should be read together with the audited consolidated financial statements and the notes thereto and other information included elsewhere in this annual report on Form 10-K. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Forward-Looking Statements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This Annual Report on Form 10-K, including the sections entitled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements regarding AngioDynamics&#8217; expected future financial position, results of operations, cash flows, business strategy, budgets, projected costs, capital expenditures, products, competitive positions, growth opportunities, acquisitions, plans and objectives of management for future operations, as well as statements that include the words such as &#8220;expects,&#8221; &#8220;reaffirms,&#8221; &#8220;intends,&#8221; &#8220;anticipates,&#8221; &#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;seeks,&#8221; &#8220;estimates,&#8221; or variations of such words and similar expressions, are forward-looking statements. These forward looking statements are not guarantees of future performance and are subject to risks and uncertainties. Investors are cautioned that actual events or results may differ from our expectations. Factors that may affect the actual results include, without limitation, our ability to develop our existing and new products, future actions by the FDA or other regulatory agencies, results of pending or future clinical trials, the results of ongoing litigation, overall economic conditions, general market conditions, market acceptance, foreign currency exchange rate fluctuations, the effects on pricing from group purchasing organizations and competition, the loss of any of our key customers or reduction in the purchase of our products by any such customers, and our ability to integrate acquired businesses as well as the risk factors listed in Part I, Item&#160;1A of this Annual Report on Form 10-K.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Although we believe that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate and, therefore, there can be no assurance that the forward-looking statements included in this Annual Report on Form 10-K will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by us or any other person that our objectives and plans will be achieved. Any forward-looking statements are made pursuant to the Private Securities Litigation Reform Act of 1995 and, as such, speak only as of the date made. We disclaim any obligation to update the forward-looking statements.&#160;Investors are cautioned not to place undue reliance on these forward-looking statements which speak only as of the date stated, or if no date is stated, as of the date of this document.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EXECUTIVE OVERVIEW</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Company and Market </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We design, manufacture and sell a wide range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Our devices are generally used in minimally invasive, image-guided procedures. Most of our products are intended to be used once and then discarded, or they may be temporarily implanted for short- or longer-term use.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our business operations cross a variety of markets. Our financial performance is impacted by changing market dynamics, which have included an emergence of value-based purchasing by healthcare providers, consolidation of healthcare providers, the increased role of the consumer in health care decision-making and an aging population, among others. In addition, our </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">growth is impacted by changes within our sector, such as the merging of competitors to gain scale and influence; changes in the regulatory environment for medical device; and fluctuations in the global economy.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our sales and profitability growth also depends, in part, on the introduction of new and innovative products, together with ongoing enhancements to our existing products. Expansions to our product offerings are created through internal product development, technology licensing and strategic alliances. We recognize the importance of, and intend to continue to make investments in, research and development activities and business development opportunities and feel confident that our existing capital structure and free cash flow generation will allow us to properly fund those activities.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We sell our products in the United States through a direct sales force, and outside the U.S. through a combination of a direct sales and distributor relationships. We expect our businesses to grow in both sales and profitability through geographic expansion, market penetration, new product introductions and increasing our direct presence internationally.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In evaluating the operating performance of our business, management focuses on revenue, gross margin, operating income, earnings per share and cash flow from operations. A summary of these key financial metrics for the twelve months ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to the twelve months ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;follows: </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Twelve months ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;by </font><font style="font-family:inherit;font-size:10pt;">1.5%</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$344.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross margin as a percentage of sales </font><font style="font-family:inherit;font-size:10pt;">increased</font><font style="font-family:inherit;font-size:10pt;">&#32;by 100 bps to </font><font style="font-family:inherit;font-size:10pt;">51.4%</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;by </font><font style="font-family:inherit;font-size:10pt;">$2.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$10.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings per share </font><font style="font-family:inherit;font-size:10pt;">increased</font><font style="font-family:inherit;font-size:10pt;">&#32;by </font><font style="font-family:inherit;font-size:10pt;">$0.30</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$0.44</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash flow from operations </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;by </font><font style="font-family:inherit;font-size:10pt;">$14.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$41.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The decline in revenue for the year was primarily driven by declines in the Venous portfolio within Peripheral Vascular, non-BioFlo products within Vascular Access and Radiofrequency Ablation within Oncology/Surgery.   The decrease in Radiofrequency Ablation was primarily due to the discontinuation of this product line in Japan.  The decline was partially offset by increased sales of Solero, a microwave ablation device that received FDA clearance during the first quarter of fiscal year 2018, and NanoKnife capital sales in Oncology/Surgery. Other areas of growth include Fluid Management and AngioVac within Peripheral Vascular and the BioFlo family of products within Vascular Access. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Strategic Initiatives to Drive Growth</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Throughout the year, we introduced strategic moves designed to streamline our business, improve our overall business operations and position ourselves for growth. Those initiatives included:</font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Operational Consolidation</font><font style="font-family:inherit;font-size:10pt;">. The Company announced a planned consolidation of operations from the Manchester, GA and Denmead, UK facilities into the Glens Falls and Queensbury, NY manufacturing facilities in the third quarter of fiscal year 2017. The consolidation was completed during fiscal year 2018 and resulted in streamlined operations, reduced costs, optimized inventory management and gross margin improvement. As part of the plan, the Company incurred restructuring expenses, including severance and retention, equipment transfer, set-up and purchases, regulatory expenses, lease termination expenses and other miscellaneous expenses.  </font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:72px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Product development process. </font><font style="font-family:inherit;font-size:10pt;">The Company continued its robust product development process which is intended to improve the Company&#8217;s ability to bring new products to market.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">New members of the executive leadership team</font><font style="font-family:inherit;font-size:10pt;">. President and Chief Executive Officer James C. Clemmer continued to welcome new members to the AngioDynamics leadership team, including Brent Boucher, Senior Vice President and General Manager of Oncology/Surgery Global Business Unit and David Helsel, Senior Vice President Global Operations. </font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Value Creation. </font><font style="font-family:inherit;font-size:10pt;">&#32;To create value, the Company plans to practice dispassionate portfolio optimization and continue to focus on areas of compelling unmet needs including those that are patient-centric and evidenced-based.  This is evident through the updated GBU's effective June 1, 2018 which will allow for call point expansion and sales force realignment.  In addition, the Company is pursuing targeted global expansion opportunities.   </font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Critical Accounting Policies and Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our significant accounting policies are summarized in Note 1 to Notes to Consolidated Financial Statements included elsewhere in this Annual Report on Form 10-K. While all these significant accounting policies affect the reporting of our financial condition and results of operations, we view certain of these policies as critical. Policies determined to be critical are those policies that have the most significant impact on our financial statements and require us to use a greater degree of judgment and/or estimates. Actual results may differ from those estimates. The accounting policies identified as critical are as follows:</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We recognize revenue in accordance with generally accepted accounting principles as outlined in the SEC&#8217;s authoritative guidance on revenue recognition which requires that four criteria be met before revenue can be recognized: (i)&#160;persuasive evidence that an arrangement exists; (ii)&#160;the price is fixed or determinable; (iii)&#160;collectability is reasonably assured; and (iv)&#160;product delivery has occurred or services have been rendered. Decisions relative to criterion (iii)&#160;regarding collectability are based upon our judgments, as discussed under &#8220;Accounts Receivable&#8221; in Note 1, and should conditions change in the future and cause us to determine this criterion is not met; our results of operations may be affected. We recognize revenue, net of sales taxes assessed by any governmental authority, as products are shipped, based on F.O.B. shipping point terms when title and risk of loss passes to customers. We negotiate shipping and credit terms on a customer-by-customer basis and products are shipped at an agreed upon price. All product returns must be pre-approved by us and customers may be subject to a 20% restocking charge. To be accepted, a returned product must be unadulterated, undamaged and have at least 12 months remaining prior to its expiration date.  Charges for discounts, returns, rebates and other allowances are recognized as a deduction from revenue on an accrual basis in the period in which the revenue is recorded. The accrual for product returns, discounts and other allowances is based on the Company&#8217;s history. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Acquisitions and Contingent Consideration</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In a business combination, the acquisition method of accounting requires that the identifiable assets acquired and liabilities assumed be measured at their fair value, with goodwill being the excess value of consideration paid over the fair value of the net identifiable assets acquired. IP R&amp;D is capitalized and recorded as an indefinite-lived intangible asset at the acquisition date, contingent consideration is recorded at fair value at the acquisition date, and transaction costs are expensed as incurred. When the Company acquires net assets that are not accounted for as a business combination, no goodwill is recognized. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of the liability for contingent consideration recorded on the acquisition date is based on probability weighted estimated cash flow streams, discounted back to present value using a discount rate determined in accordance with accepted valuation methods. The liability for contingent consideration is remeasured to fair value at each reporting period with changes recorded in earnings until the contingency is resolved.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Goodwill and Intangible Assets</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets other than goodwill, indefinite lived intangible assets and in process research and development ("IP R&amp;D") are amortized over their estimated useful lives, which range between two to </font><font style="font-family:inherit;font-size:10pt;">eighteen</font><font style="font-family:inherit;font-size:10pt;">&#32;years, on either a straight-line basis over the expected period of benefit or as revenues are earned from the sales of the related products. We periodically review the estimated useful lives of our intangible assets and review such assets for impairment whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable.  If an intangible asset is considered to be impaired, the amount of the impairment will equal the excess of the carrying value over the fair value of the asset.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill and other intangible assets that have indefinite useful lives are not amortized, but rather, are tested for impairment annually or more frequently if impairment indicators arise. Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in each business combination. Goodwill and intangible assets have been recorded at either incurred or allocated cost. Allocated costs were based on respective fair market values at the date of acquisition. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For goodwill, the impairment test requires a comparison of the estimated fair value of the reporting unit to which the goodwill is assigned to carrying value of the assets and liabilities of that reporting unit. The determination of reporting units also requires management judgment. The Company considers whether a reporting unit exists within a reportable segment based on the availability of discrete financial information. If carrying value of the reporting unit exceeds the fair value of the reporting </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">unit, the carrying value of the reporting unit&#8217;s goodwill is reduced to its fair value through an adjustment to the goodwill balance, resulting in an impairment charge. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company operates as a single operating segment with </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">&#32;reporting unit and consequently evaluates goodwill for impairment based on an evaluation of the fair value of the Company as a whole. The Company determines the fair value of the reporting unit based on the market valuation approach and concluded that it was not more-likely-than-not that the fair value of the Company's reporting unit was less than its carrying value.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingencies</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are involved, both as a plaintiff and a defendant, in various legal proceedings that arise in the ordinary course of business, including product liability, as further discussed in Note 15 to our consolidated financial statements. Accruals recorded for various contingencies including legal proceedings, self insurance and other claims, are based on judgment, the probability of losses and, where applicable, the consideration of opinions of internal and/or external legal counsel, internal and/or external technical consultants and actuarially determined estimates. When a range is established but a best estimate cannot be made, we record the minimum loss contingency amount, which could be zero. An estimate is often initially developed substantially earlier than the ultimate loss is known and is reevaluated each accounting period. As information becomes known, additional loss provision is recorded when either a best estimate can be made or the minimum loss amount is increased. When events result in an expectation of a more favorable outcome than previously expected, our best estimate is changed to a lower amount. We record receivables from third-party insurers up to the amount of the related liability when we have determined that existing insurance policies will provide reimbursement. In making this determination, we consider applicable deductibles, policy limits and the historical payment experience of the insurance carriers. Receivables are not netted against the related liabilities for financial statement presentation.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Results of Operations for the years ended </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;and </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2017</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, we reported net income of </font><font style="font-family:inherit;font-size:10pt;">$16.3 million</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;">$0.44</font><font style="font-family:inherit;font-size:10pt;">&#32;income per diluted share, on net sales of </font><font style="font-family:inherit;font-size:10pt;">$344.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to a fiscal year </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;net income of </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;">$0.14</font><font style="font-family:inherit;font-size:10pt;">&#32;income per diluted share, on net sales of </font><font style="font-family:inherit;font-size:10pt;">$349.6 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Net Sales</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Net sales</font><font style="font-family:inherit;font-size:10pt;">&#32;- Net sales are derived from the sale of our products and related freight charges, less discounts and returns. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales for the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;were:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td style="width:65%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">% Growth</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Sales by Product Category</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Peripheral Vascular</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">202,334</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208,602</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Vascular Access</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92,760</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96,481</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Oncology/Surgery</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,191</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,560</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">344,285</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349,643</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Sales by Geography</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">273,327</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282,168</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;International</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70,958</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67,475</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">344,285</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349,643</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2)%</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, net sales </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">$5.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$344.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated and U.S. net sales decreased from the prior year as a result of decreased net sales from Peripheral Vascular and Vascular Access.  This decrease was partially offset by 10% year over year growth in our Oncology/Surgery GBU.    </font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Peripheral Vascular</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Peripheral Vascular sales decreased </font><font style="font-family:inherit;font-size:10pt;">$6.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;primarily attributable to decreased sales volume of Venous by $9.3 million and Angiographic and Core products of $1.6 million.  The decrease in Venous is primarily attributed to our largest customer discontinuing their exclusive use of our EVLT product.  This decreased sales volume was offset by an increase of volume in Fluid Management of $4.0 million and AngioVac of $0.9 million.  The increase in Fluid Management was attributed to the Fluid Management dedicated sales team being fully staffed and promoting new custom kits along with targeted R&amp;D investments.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Peripheral Vascular sales decreased $5.6 million primarily due to decreased sales volume of Venous of $9.1 million and Angiographic and Core products of $0.9 million.  This decreased sales volume was offset by an increase in volume in Fluid Management of $3.5 million and AngioVac of $1.0 million.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International Peripheral Vascular sales decreased $0.7 million.  </font></div></td></tr></table><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Vascular Access</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Vascular Access sales decreased </font><font style="font-family:inherit;font-size:10pt;">$3.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;primarily in our non-BioFlo businesses.  Our BioFlo product lines, other than BioFlo PICCs, increased $2.4 million.  This was partially offset by decreased sales of BioFlo PICCs of $2.5 million and non-BioFlo products of $3.1 million.  BioFlo product lines comprise 49% of our overall Vascular Access sales, compared to 47% a year ago.  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Vascular Access sales declined by $3.8 million due to softness across the portfolio offset by Midline, BioFlo dialysis and ports which continued to gain traction in the marketplace.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International Vascular Access sales increased $0.1 million.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Oncology/Surgery</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Oncology/Surgery sales increased </font><font style="font-family:inherit;font-size:10pt;">$4.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;year over year primarily due to increased sales of the Solero Microwave generators of $1.3 million, Solero Microwave probes of $6.4 million and other sales of $0.7 million.  Solero Microwave was approved in the first quarter of fiscal year 2018.  This was partially offset by decreased Radiofrequency Ablation sales of $3.4 million and Nanoknife disposable sales of $0.6 million.  The decrease in Radiofrequency Ablation sales was primarily due to the discontinuation of the product in Japan.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Oncology/Surgery increased by $0.6 million, driven primarily through increased Microwave sales of $3.4 million.  This increase was partially offset by decreases in Radiofrequency Ablation of $1.7 million and NanoKnife of $1.4 million. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International Oncology/Surgery sales increased $4.0 million year over year as a result of increased NanoKnife capital and disposable sales of $1.1 million and Solero Microwave capital and disposable sales of $4.3 million.  This increase was partially offset by a $1.7 million decrease in RadioFrequency Ablation.</font></div></td></tr></table><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Gross Profit, Operating expenses, and Other income (expense)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:67%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">% Change</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit (exclusive of intangible amortization)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176,875</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176,169</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit % of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,459</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">% of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling and marketing</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,276</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,819</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">% of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,265</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,406</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">% of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Gross profit</font><font style="font-family:inherit;font-size:10pt;">&#32;- Gross profit consists of net sales less the cost of goods sold, which includes the costs of materials, products purchased from third parties and sold by us, manufacturing personnel, royalties, freight, business insurance, depreciation of property and equipment and other manufacturing overhead, exclusive of intangible amortization.  </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit increased by </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to the prior year.  The increase is attributable to the following:</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The expiration of a royalty agreement of approximately $4.8 million, net productivity of $1.7 million, $0.9 million of mix and FX of $0.8 million were partially offset by volume softness and pricing headwinds of approximately $4.8 million. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$2.3 million in deferred revenue was recognized in fiscal year 2018 related to the Acculis probe recall announced in the fourth quarter of fiscal year 2017 which was partially offset by additional expense of $3.2 million that was incurred as a result of the market withdrawal of Microwave generators.  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the second quarter of fiscal year 2018, the Company decided to discontinue selling our RadioFrequency Ablation product in Japan which resulted in a $1.7 million inventory provision.    </font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Research and development expenses</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">- Research and development (&#8220;R&amp;D&#8221;) expenses include internal and external costs to develop new products, enhance existing products, validate new and enhanced products, manage clinical, regulatory and medical affairs.  </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">R&amp;D expense increased $0.2 million compared to the prior year.  The increase is attributable to the following:</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increased headcount in the R&amp;D department compared to the prior year resulted in $0.6 million in additional expense. These increases were partially offset by less project spend of $0.4 million.  </font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Sales and marketing expenses</font><font style="font-family:inherit;font-size:10pt;">&#32;- Sales and marketing (&#8220;S&amp;M&#8221;) expenses consist primarily of salaries, commissions, travel and related business expenses, attendance at medical society meetings, product promotions and marketing activities. </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">S&amp;M expense decreased by </font><font style="font-family:inherit;font-size:10pt;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to the prior year.  The decrease is attributable to the following: </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation and benefits decrease of approximately $2.7 million was primarily the result of decreased variable compensation of $2.3 million and open headcount of $0.5 million.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Open headcount resulted in increased travel of $0.5 million and recruiting expense of $0.3 million.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Lower consulting spend of $0.7 million was partially offset by increased trade show and meeting expense of $0.5 million and increased samples expense related to the Solero launch of $0.2 million.</font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">General and administrative expenses</font><font style="font-family:inherit;font-size:10pt;">&#32;- General and administrative (&#8220;G&amp;A&#8221;) expenses include executive management, finance, information technology, human resources, business development, legal, and the administrative and professional costs associated with those activities.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">G&amp;A expense remained consistent year over year. </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation and benefits increase of approximately $1.9 million was primarily the result of increased headcount year over year which was partially offset by a decrease in variable compensation expense of $0.5 million.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These increases were offset by lower depreciation expense of $0.8 million, a decrease in bad debt expense of $0.3 million and a decrease in recruiting expenses of $0.4 million.</font></div></td></tr></table><div style="line-height:120%;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"></td></tr><tr><td style="width:67%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$ Change</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of intangibles</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,635</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,296</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(661</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">250</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,261</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,511</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition, restructuring and other items, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,432</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,510</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,078</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical device excise tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,837</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,837</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,093</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,120</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Amortization of intangibles</font><font style="font-family:inherit;font-size:10pt;">&#32;- Represents the amount of amortization expense that was taken on intangibles assets held by the Company.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The decrease of $0.7 million is primarily related to intangible assets that became fully amortized in the prior year.</font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Change in fair value of contingent consideration</font><font style="font-family:inherit;font-size:10pt;">&#32;- Represents changes in contingent consideration driven by changes to estimated future payments on earn-out liabilities created through acquisitions and amortization of present value discounts on long-term contingent consideration. </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the prior year, a gain of $13.4 million was taken on the AngioVac product as a result of decreases in future sales projections that eliminated any payments above minimums and a gain of $3.1 million on the TiLo product as the milestone was determined to not be achieved. The normal amortization of the present value discount on the contingent liabilities was approximately $0.1 million for the first two quarters of fiscal year 2018.  For the last two quarters of fiscal year 2018, amortization is now less than $0.1 million per quarter as the final minimum payment was made on AngioVac in the second quarter of fiscal year 2018.  </font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Acquisition, restructuring and other items, net</font><font style="font-family:inherit;font-size:10pt;">&#32;- Acquisition, restructuring and other items, net represents costs associated with mergers and acquisitions, restructuring expenses, legal costs that are related to litigation that is not in the ordinary course of business, legal settlements and other one-time items.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition, restructuring and other items, net decreased by </font><font style="font-family:inherit;font-size:10pt;">$12.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to the prior year.  The decrease is attributable to the following:</font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the current year there was $4.7 million of expense related to the plant consolidation that was announced in the third quarter of fiscal year 2017.  The expense consisted mainly of severance of $1.4 million, costs to move the product lines including equipment transfer expenses, accelerated depreciation for assets that will not be transferred, product validation and other start-up costs of $2.9 million and $0.2 million in contract termination expenses. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the prior year, there was $1.3 million of expense related to the plant consolidation that was announced in the third quarter of fiscal year 2017.  The expense consisted of severance of $0.8 million and start-up costs to move the product lines including equipment transfer expenses and accelerated depreciation for assets that will not be transferred of $0.5 million.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the prior year there was a $2.0 million write-off of Embomedics due to termination of the agreement and a $3.6 million write-off related to the decision to discontinue our investment in the TiLo product.  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A litigation settlement accrual of $12.5 million was recorded in the fourth quarter of fiscal year 2017 for the agreement that was reached with the DOJ.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Legal expenses, related to litigation that is outside of the normal course of business, of $10.1 million were recorded in the current year compared to $7.0 million in the prior year. </font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost savings from the plant consolidation will primarily impact cost of goods sold.  While some cost savings were recognized in 2018 we expect additional savings of approximately $4.0 million to $5.0 million in fiscal year 2019.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Medical device excise tax</font><font style="font-family:inherit;font-size:10pt;">&#32;- Medical device excise tax has been assessed on our U.S. product sales subject to exclusions and adjustments.  </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Medical Device Excise Tax was suspended on January 1, 2016 and the suspension was upheld in January 2018.  In the prior year, there was a $1.8 million refund from the Internal Revenue Service related to prior medical device taxes paid.</font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Other expenses</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">- Other expenses include interest expense, foreign currency impacts, bank fees, and amortization of deferred financing costs and remained consistent with the prior year.  </font></div><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Income Tax Provision (Benefit)</font></div><div style="line-height:120%;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:78%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">For year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax expense (benefit)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,870</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,839</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective tax rate including discrete items</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(119</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our effective tax rate was a benefit of 119% for fiscal 2018 compared with an effective tax rate of 49% for the prior year. </font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The current year rate reflects an income tax benefit of $8.9 million primarily driven by the impact of the U.S. Tax Reform, the valuation allowance recorded and the deferred tax liability related to intangibles that have an indefinite reversal period ("naked credit deferred tax liability"), which as a result of U.S. Tax Reform can now be considered as a source of income to recover indefinite lived NOLs.</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is required to record deferred tax assets and liabilities based on the enacted tax rates at which they are expected to reverse in the future.  The Company has remeasured its deferred tax positions as of December 31, 2017 at the new enacted tax rate, resulting in a decrease to it net deferred tax assets and a corresponding decrease to its valuation allowance, with no net impact to tax expense. The Company recorded an income tax benefit of approximately </font><font style="font-family:inherit;font-size:10pt;">$9.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;due to the revaluation of the naked credit deferred tax liability.</font><font style="font-family:Arial;font-size:10pt;">&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">The Tax Reform Act changed the NOL carryover rules and created a new limitation on their use.  NOLs created in fiscal 2018 and beyond may be carried forwarded indefinitely in any year. As a result, the Company&#8217;s naked credit deferred tax liability can now be considered as a source of income to recover indefinite lived NOLs.  Consequently, the Company has offset certain of its naked credit deferred tax liability against its deferred tax assets resulting in a reduction in the valuation allowance and a </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;benefit in the year ended May 31, 2018.  </font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The prior year rate primarily reflects income tax expense of $4.8 million primarily driven by the impact of the U.S. valuation allowance and the naked credit deferred tax liability that could not be considered as a source of income to recover the deferred tax assets.  </font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company regularly assesses its ability to realize its deferred tax assets. Assessing the realization of deferred tax assets requires significant management judgment. In determining whether its deferred tax assets are more likely than not realizable, the Company evaluated all available positive and negative evidence, and weighted the evidence based on its objectivity. Evidence the Company considered included its history of net operating losses, which resulted in the Company recording a full valuation allowance for its deferred tax assets in fiscal 2016 and each year thereafter. The Company was marginally profitable (pretax and adjusted for permanent items) on a cumulative basis for the three years ended May 31, 2018, but substantially all of that profitability was achieved during 2018. </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on the review of all available evidence, the Company determined that it has not yet attained a sustained level of profitability and the objectively verifiable negative evidence outweighed the positive evidence and therefore the Company has provided a valuation allowance for the full amount, with the exception of the naked credit deferred tax liability, of its net deferred tax asset as of May 31, 2018.  The Company will continue to assess the level of the valuation allowance required. If sufficient positive evidence exists in future periods to support a release of some or all of the valuation allowance, such a release would likely have a material impact on the Company&#8217;s results of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Results of Operations for the years ended </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">May&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;and </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2016</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, we reported net income of </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;">$0.14</font><font style="font-family:inherit;font-size:10pt;">&#32;loss per basic and diluted common share, on net sales of </font><font style="font-family:inherit;font-size:10pt;">$349.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to a fiscal </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">&#32;net loss of </font><font style="font-family:inherit;font-size:10pt;">$43.6 million</font><font style="font-family:inherit;font-size:10pt;">, or </font><font style="font-family:inherit;font-size:10pt;">$1.21</font><font style="font-family:inherit;font-size:10pt;">&#32;per basic and diluted common share, on net sales of </font><font style="font-family:inherit;font-size:10pt;">$353.9 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Net Sales</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Net sales</font><font style="font-family:inherit;font-size:10pt;">&#32;- Net sales are derived from the sale of our products and related freight charges, less discounts and returns. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales for the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and  </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">&#32;were:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td style="width:66%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">% Growth</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Sales by Product Category</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Peripheral Vascular</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208,602</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">205,620</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Vascular Access</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96,481</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99,375</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Oncology/Surgery</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,560</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,895</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349,643</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353,890</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Sales by Geography</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282,168</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">285,824</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1)%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;International</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67,475</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,066</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349,643</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353,890</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1)%</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, net sales </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">$4.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$349.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Consolidated and U.S. net sales decreased from the prior year as a result of decreased net sales from Vascular Access and Oncology Surgery.  This decrease was partially offset by 1% year over year growth in our Peripheral Vascular franchise.  </font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Peripheral Vascular</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Peripheral Vascular sales increased </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;primarily attributable to increased sales volume of Angiographic and Core products of $9.9 million.  This increased sales volume was partially offset by a decrease of volume in Fluid Management, Venous and AngioVac of $5.6 million.  The decrease in Fluid Management was attributed to a discontinuance of our inflation device and automation challenges in the European markets.  Although AngioVac procedures were up year over year, AngioVac unit sales decreased by $1.4 million due to available inventory already in the market place.   </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Peripheral Vascular sales increased $2.8 million and international Peripheral Vascular sales increased $0.2 million which was primarily due to increased sales volume of Angiographic catheters.  This increased sales volume was offset by a decrease in volume in Fluid Management, Venous and AngioVac.  </font></div></td></tr></table><div style="line-height:120%;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Vascular Access</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Vascular Access sales decreased </font><font style="font-family:inherit;font-size:10pt;">$2.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;primarily in our non-BioFlo businesses.  Our BioFlo product line grew by $4.8 million primarily driven by growth in Midlines.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Vascular Access sales declined by 5% due to softness across the portfolio offset by Midline and BioFlo dialysis which continued to gain traction in the marketplace.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International Vascular Access sales increased 15% due to the market penetration of BioFlo PICCs.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Oncology/Surgery</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Oncology/Surgery sales decreased </font><font style="font-family:inherit;font-size:10pt;">$4.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;year over year primarily due to fewer sales of capital units in Microwave and NanoKnife as well as the $2.6 million deferral of revenue related to the Acculis probe recall that was announced in the fourth quarter of fiscal year 2017.  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Oncology/Surgery declined by 8%, driven primarily through lower capital and disposable sales in Radio Frequency and Microwave offset by NanoKnife growth.  The decrease is also attributed to a $1.4 million deferral of revenue related to the Acculis probe recall that was announced in the fourth quarter of fiscal year 2017. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International Oncology/Surgery sales decreased 10% year over year as a result of lower NanoKnife capital and disposable sales and a $1.2 million deferral of revenue related to the Acculis probe recall that was announced in the fourth quarter of fiscal year 2017.</font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Gross Profit, Operating expenses, and Other income (expense)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:67%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="10" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">% Change</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176,169</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">174,316</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit % of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,053</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">% of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling and marketing</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,819</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,743</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">% of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,406</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,583</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">% of sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Gross profit</font><font style="font-family:inherit;font-size:10pt;">&#32;- Gross profit consists of net sales less the cost of goods sold, which includes the costs of materials, products purchased from third parties and sold by us, manufacturing personnel, royalties, freight, business insurance, depreciation of property and equipment and other manufacturing overhead.  </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit increased by </font><font style="font-family:inherit;font-size:10pt;">$1.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to the prior year.  The increase is attributable to the following:</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In fiscal year 2017, a net charge of $4.5 million was recorded as a result of the Acculis probe recall.  </font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In fiscal year 2016, a $5.9 million charge related to the write-off of Celerity inventory on hand and hardware assets after the business decision to no longer pursue the Celerity Navigation project.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The remaining increase is driven by net productivity offset by price and mix of products.  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The increase in gross profit as a percentage of </font><font style="font-family:inherit;font-size:10pt;">1.1%</font><font style="font-family:inherit;font-size:10pt;">&#32;is attributed to the factors noted above.</font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Research and development expenses</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">- Research and development (&#8220;R&amp;D&#8221;) expenses include internal and external costs to develop new products, enhance existing products, validate new and enhanced products, manage clinical, regulatory and medical affairs.  </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">R&amp;D expense increased </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to the prior year.  The increase is attributable to the following:</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increased headcount in the R&amp;D department compared to the prior year resulted in $1.2 million in additional expense as well as expenses associated with consultants of $0.6 million and severance of $0.4 million.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These increases were partially offset by less project spend of $1.2 million, $0.6 million in samples and $0.2 million in travel and other expenses.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">R&amp;D expense as a percentage of sales remained consistent year over year.  </font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Sales and marketing expenses</font><font style="font-family:inherit;font-size:10pt;">&#32;- Sales and marketing (&#8220;S&amp;M&#8221;) expenses consist primarily of salaries, commissions, travel and related business expenses, attendance at medical society meetings, product promotions and marketing activities. </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">S&amp;M expense decreased by </font><font style="font-family:inherit;font-size:10pt;">$4.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to the prior year.  The decrease is attributable to the following: </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There was a decrease in headcount from the prior year which resulted in a $2.5 million decrease in salaries and benefits.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The decrease in headcount along with a focus on reduced travel spend resulted in a decrease in travel expenses of $1.3 million.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There was a $0.7 million decrease in trade shows and meeting expenses along with a $0.7 million decrease in samples as a result of a focus on reducing expenses.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These decreases were partially offset by severance of $0.8 million.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As a result of these decreases in S&amp;M expenses, the percentage of S&amp;M to sales decreased 1.2%.</font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">General and administrative expenses</font><font style="font-family:inherit;font-size:10pt;">&#32;- General and administrative (&#8220;G&amp;A&#8221;) expenses include executive management, finance, information technology, human resources, business development, legal, and the administrative and professional costs associated with those activities.  </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">G&amp;A expense increased by </font><font style="font-family:inherit;font-size:10pt;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to the prior year.  The increase is attributable to the following:</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increased stock based compensation expense related to the new grant for the CEO along with two new board members of $1.7 million.  Along with the stock based compensation increase, bonus for fiscal year 2017 was accrued at a higher rate than the prior year which resulted in a $1.0 million increase to G&amp;A expense.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Along with the appointment of new members in the executive leadership team, recruiting and relocation expenses resulted in an increase of $0.5 million from the prior year</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There was also an increase in professional fees of $0.3 million related to audit fees and director fees partially offset by a decrease in legal fees.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These increases were partially offset by decreases in compensation benefits of $0.5 million as a result of a reduction in benefit claims, depreciation expense of $0.8 million, $0.2 million in facilities expenses including insurance, lease expenses and utilities, bad debt favorability of $0.4 million and other miscellaneous decreases in expenses of $0.4 million.</font></div></td></tr></table><div style="line-height:120%;padding-top:10px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.5609756097561%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"></td></tr><tr><td style="width:67%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$ Change</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of intangibles</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,296</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,964</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(668</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of contingent consideration</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,261</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">948</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,209</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition, restructuring and other items, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,510</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,591</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,919</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical device excise tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,837</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,416</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,253</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other expense</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,120</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,271</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,151</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Amortization of intangibles</font><font style="font-family:inherit;font-size:10pt;">&#32;- Represents the amount of amortization expense that was taken on intangibles assets held by the Company.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The decrease of $0.7 million is primarily related to intangible assets that became fully amortized.</font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Change in fair value of contingent consideration</font><font style="font-family:inherit;font-size:10pt;">&#32;- Represents changes in contingent consideration driven by changes to estimated future payments on earn-out liabilities created through acquisitions and amortization of present value discounts on long-term contingent consideration. </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The decrease is due to a write-off of $13.4 million that was taken on the AngioVac product as a result of decreases in future sales projections that eliminated any payments above minimums and a write-off of $3.1 million on the TiLo product as the milestone will not be achieved. This was partially offset by normal amortization of the present value discount on the contingent liabilities.  </font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Acquisition, restructuring and other items, net</font><font style="font-family:inherit;font-size:10pt;">&#32;- Acquisition, restructuring and other items, net represents costs associated with mergers and acquisitions, restructuring expenses, legal costs that are related to litigation that is not in the ordinary course of business, legal settlements and other one-time items.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition, restructuring and other items, net increased by </font><font style="font-family:inherit;font-size:10pt;">$14.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to the prior year.  The increase is attributable to the following:</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In Q2 fiscal year 2017, the intangible assets associated with TiLo were written off for $3.6 million as a result of the decision to discontinue our investment in the TiLo product along with a $2.0 million write-off of the investment in Embomedics due to termination of the agreement.  The prior year had asset impairments of $0.4 million.  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There was $1.3 million of expense related to the plant consolidation which consisted mainly of severance and start-up costs to move the product lines including equipment transfer expenses, accelerated depreciation for assets that will not be transferred, validation and other start up costs.  The prior year had accelerated depreciation related to the Operational Excellence program of $1.0 million along with $0.5 million in other expenses.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A litigation settlement accrual for $12.5 million was recorded in the fourth quarter of fiscal year 2017.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Legal expenses of $7.0 million which was a decrease of $0.5 million from the prior year.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other miscellaneous items decreased $2.2 million from the prior year primarily attributable to a decrease in M&amp;A expenses of $2.5 million offset by a gain in the prior year of $0.7 million related to the modification of stock based compensation awards for the former CEO.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Medical device excise tax</font><font style="font-family:inherit;font-size:10pt;">&#32;- Medical device excise tax is assessed on our U.S. product sales subject to exclusions and adjustments.  </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Medical Device Excise Tax was suspended on January 1, 2016 therefore, fiscal year 2016 had seven months of the tax.  In the current year, there is a $1.8 million refund from the Internal Revenue Service related to prior medical device taxes paid.</font></div></td></tr></table><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Other expenses</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">- Other expenses include interest expense, foreign currency impacts, bank fees, and amortization of deferred financing costs.  </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The decrease in other expenses of $1.2 million was due to&#160;lower interest expense on lower outstanding debt and lower interest rates under the Credit Agreement along with unrealized foreign currency gains from re-measurement offset by the write off of the deferred financing fees from the original credit facility.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Income Tax Provision (Benefit)</font></div><div style="line-height:120%;padding-top:10px;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:78%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax expense (benefit)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,839</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,337</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective tax rate including discrete items</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,240</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our effective tax rate was </font><font style="font-family:inherit;font-size:10pt;">49%</font><font style="font-family:inherit;font-size:10pt;">&#32;for fiscal </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;compared with a benefit of </font><font style="font-family:inherit;font-size:10pt;">1,240%</font><font style="font-family:inherit;font-size:10pt;">&#32;for the prior year. The current year rate reflects expense of $4.8 million primarily driven by the impact of the U.S. valuation allowance and the deferred tax liability related to intangibles that have an indefinite reversal period and cannot be considered as a source of income to recover the deferred tax assets.  The prior year rate primarily reflects income tax expense of $40.4 million related to full valuation allowance on our U.S. net deferred tax assets that was established during fiscal 2016 and the deferred tax liability related to intangibles that have an indefinite reversal period and cannot be considered as a source of income to recover the deferred tax assets.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, we had a net deferred tax liability of $26.1 million, after a valuation allowance on our U.S. deferred tax assets of </font><font style="font-family:inherit;font-size:10pt;">$48.3 million</font><font style="font-family:inherit;font-size:10pt;">.&#160; The increase in the valuation allowance during fiscal 2017 was </font><font style="font-family:inherit;font-size:10pt;">$6.1 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A valuation allowance is provided if based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.  After careful consideration and weighing of all the available positive and negative evidence, the weight given to the three year&#160;cumulative loss and lack of a recent history of core earnings was difficult to overcome and a full valuation allowance related to the U.S. deferred tax assets was established in the period ending May 31, 2016.  Management considered all available positive and negative evidence at May 31, 2017, and considering the cumulative loss in the U.S. over the three year period, determined that the valuation allowance is still required.  Management will continue to reevaluate the positive and negative evidence at each reporting period and if future results as projected in the U.S. and the Company's tax planning strategies are favorable, the valuation allowance may be removed, which could have a favorable material impact on the Company's results of operations in the period in which it is recorded.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Liquidity and Capital Resources</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our cash and cash equivalents totaled </font><font style="font-family:inherit;font-size:10pt;">$74.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, compared with </font><font style="font-family:inherit;font-size:10pt;">$47.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">. Marketable securities totaled </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, and consist of auction rate securities. As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, total debt outstanding was </font><font style="font-family:inherit;font-size:10pt;">$92.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;comprised of a term loan.  The net debt to Consolidated EBITDA, as defined by the Credit Agreement (see Note 11), is 1.4x.  The fair value of the contingent consideration liability as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;was </font><font style="font-family:inherit;font-size:10pt;">$3.3 million</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below summarizes our cash flows for the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:68%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash provided by (used in):</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating activities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,287</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,745</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,216</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investing activities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,656</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,551</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,569</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financing activities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,551</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(37,983</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23,663</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of exchange rate changes on cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">472</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(42</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net change in cash and cash equivalents</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,552</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,211</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,942</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the twelve months ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, cash flows consisted of the following:</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Cash provided by operating activities:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended 2018:</font></div><div style="line-height:120%;text-align:left;padding-left:80px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income was driven by higher gross margin, lower operating expenses in selling and marketing, general and administrative and acquisition, restructuring and other items, net.  Partially offsetting the positive cash impact was a $9.3 million non-cash discrete tax benefit as a result of the Tax Reform Act and the revaluation of the Company's deferred tax assets and liabilities to reflect the lower statutory rate.  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company continues to focus on optimizing days sales outstanding ("DSO") which contributed $5.0 million to working capital improvement.  Working capital was also positively impacted by decreased inventory on hand of $5.7 million.  Even though the Company continued to optimize days payables outstanding ("DPO"), the decrease in raw material purchases at year end negatively impacted working capital from accounts payable and accrued liabilities.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended 2017:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income was driven by higher gross margins, lower sales and marketing expenses as well as the medical device tax refund.  Also impacting net income, were non-cash items which consisted of $15.3 million of contingent consideration gains, $2.0 million in the write-off of the Embomedics investment and $3.6 million in intangible write-offs related to TiLo. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">With regards to working capital, the Company focused on optimizing both DSO and DPO which contributed to $15.2 million of working capital improvement.  With respect to inventory, the $2.4 million reserve for Acculis inventory partially offset the inventory build related to the plant consolidation. </font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended 2016:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DSO improvement and inventory management, coupled with reductions in payables and accrued expenses contributed to $12.9 million improvement in operating activities. The $12.9 million improvement includes approximately $4.8 million in non-cash changes to inventory reserves.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Cash used in investing activities:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended 2018:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$2.4 million in fixed asset additions.  </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the third quarter, we entered into a distribution and license agreement where we recorded the upfront license fee of $1.3 million as an intangible asset that will be amortized over thirty-six months.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:80px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended 2017:</font></div><div style="line-height:120%;text-align:left;padding-left:80px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$3.0 million in fixed asset additions.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$0.5 million in proceeds from an auction rate security that was called during fiscal year 2017.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:80px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended 2016:</font></div><div style="line-height:120%;text-align:left;padding-left:80px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$2.3 million in fixed asset additions.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$2.0 million in warrant additions related to EmboMedics and $3.3 million in intangible asset additions related to the Asclera Distribution Agreement. </font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Cash used in financing activities:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended 2018:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$5.0 million in repayments on long-term debt, consistent with the required amortization payment on the Term Loan.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$2.9 million of proceeds from stock option and ESPP activity.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$9.5 million payment on earn-out liabilities.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:80px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended 2017:</font></div><div style="line-height:120%;text-align:left;padding-left:80px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net $23.9 million in repayments on long-term debt after the proceeds from the Credit Agreement and repayment of the old credit agreement. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$1.3 million in deferred financing fees related to the new credit agreement.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$10.7 million of proceeds from stock option and ESPP.  The large increase is related to the exercise of stock based awards from executive management turnover that took place in fiscal year 2017.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$9.9 million payment on earn-out liabilities.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$13.6 million from the repurchase of common shares in fiscal 2017.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:80px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year ended 2016:</font></div><div style="line-height:120%;text-align:left;padding-left:80px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net $16.3 million in repayments on long-term debt. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$2.4 million of proceeds from stock option and ESPP activity.</font></div></td></tr></table><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:80px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:56px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$9.9 million payment on earn-out liabilities.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 7, 2016, the Company entered into a Credit Agreement that provides for a </font><font style="font-family:inherit;font-size:10pt;">$100.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;senior secured term loan facility and a </font><font style="font-family:inherit;font-size:10pt;">$150.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;senior secured revolving credit facility, which includes up to a </font><font style="font-family:inherit;font-size:10pt;">$20.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;sublimit for letters of credit and a </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;sublimit for swingline loans.  On May 24, 2018, the Company entered into Amendment One of the Credit Agreement.  This amendment increased the amount of U.S. cash that can be utilized to calculate net debt from $10.0 million to $20.0 million.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We believe that our current cash and investment balances, together with cash generated from operations and access to our revolving credit facility, will provide sufficient liquidity to meet our anticipated needs for capital for at least the next 12 months. If we seek to make significant acquisitions of other businesses or technologies in the future for cash, we may require external financing.</font></div><div style="line-height:120%;padding-top:16px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our contractual obligations as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;are set forth in the table below (in thousands).  We have no variable interest entities or other off-balance sheet obligations.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"></td></tr><tr><td style="width:46%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cash Payments Due By Period as of May&#160;31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Less&#160;than</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">One&#160;Year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1-3&#160;Years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3-5&#160;Years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">After&#160;5</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Years</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contractual Obligations:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long term debt and interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103,281</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,383</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94,898</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating leases </font><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,608</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,234</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,706</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,668</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase obligations </font><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56,201</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,751</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,917</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,533</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related future obligations </font><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,308</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,208</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalties</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,500</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,500</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Litigation matters </font><font style="font-family:inherit;font-size:8pt;">(3)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">667</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">228,565</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,135</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">149,729</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,701</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,000</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The non-cancelable operating leases and inventory purchase obligations are not reflected on our consolidated balance sheets under accounting principles generally accepted in the United States of America.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition-related future obligations include scheduled minimum payments and contingent payments based upon achievement of performance measures or milestones such as sales or profitability targets, the achievement of research and development objectives or the receipt of regulatory approvals.  The amount represents the undiscounted value of contingent liabilities recorded on the balance sheet.  Timing of payments are as contractually scheduled, or where contingent, the Company's best estimate of payment timing.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This was paid in the first quarter of fiscal year 2019.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;padding-left:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recent Accounting Pronouncements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Refer to Note 1 for Recently issued Accounting Pronouncements. </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></div><hr style="page-break-after:always"><div><a name="sD1D18B5D1D9F5D46847727E9FC2A6561"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:74px;"></td><td style="width:608px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;7A.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Quantitative and Qualitative Disclosures about Market Risk.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">FOREIGN CURRENCY EXCHANGE RATE RISK</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are exposed to market risk from changes in currency exchange rates, as well as interest rate fluctuations on our credit facility and investments that could impact our results of operations and financial position.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We transact sales in currencies other than the U.S. Dollar, particularly the Euro, British pound and Canadian dollar. Approximately </font><font style="font-family:inherit;font-size:10pt;">7.1%</font><font style="font-family:inherit;font-size:10pt;">&#32;of our sales in fiscal </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">&#32;were denominated in foreign currencies. We do not have expenses denominated in foreign currencies at the level of our sales and as a result, our profitability is exposed to currency fluctuations.  When the U.S. Dollar strengthens, our sales and gross profit will be negatively impacted.  In addition, we have assets and liabilities denominated in non-functional currencies which are remeasured at each reporting period, with the offset to changes presented as a component of Other (Expenses) Income.  Significant non-functional balances include accounts receivable due from a sub-section of our international customers.   </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INTEREST RATE RISK</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 7, 2016, we entered into the Credit Agreement which provides for a $100 million senior secured Term Loan and a $150 million Revolving Facility.  Interest on both the Term Loan and Revolving Facility is based on a base rate or Eurodollar rate plus an applicable margin which increases as our total leverage ratio increases, with the base rate and Eurodollar rate having ranges of 0.50% to 1.25% and 1.50% to 2.25% respectively. In the event of default, the interest rate may be increased by 2.0%.  A 50 basis point (0.50%) increase or decrease in the interest rate would result approximately in a $2.0 million increase or decrease in interest expense over the remaining life of the agreement.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONCENTRATION OF CREDIT RISK</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments, which potentially subject the Company to significant concentrations of credit risk, consist primarily of cash and cash equivalents, our credit facility and trade accounts receivable.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company maintains cash and cash equivalents at various institutions and performs periodic evaluations of the relative credit standings of these financial institutions to ensure their credit worthiness.  In addition, the Credit Agreement is structured across five investment grade banks.  The Company has the ability to draw equally amongst the five banks which limits the concentration of credit risk of one institution.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Concentration of credit risk with respect to trade accounts receivable is limited due to the large number of customers that purchase products from the Company.  No single customer represents more than 10% of total sales.  The Company monitors the creditworthiness of its customers to which it grants credit terms in the normal course of business. Although the Company does not currently foresee a significant credit risk associated with the outstanding accounts receivable, repayment is dependent upon the financial stability of our customers.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sF191F5D89E185DCB87A027FC7019EF13"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:74px;"></td><td style="width:608px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;8.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Financial Statements and Supplementary Data.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial statements and supplementary data required by Part II, Item&#160;8 are included in Part IV of this report as indexed as Item&#160;15 (a)&#160;(1) and (2) of this report, and are incorporated by reference into this Item&#160;8.&#160;</font></div><div><a name="s55441BFDF328508CB3A497CDE8416321"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:74px;"></td><td style="width:608px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;9.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:32px;font-size:14pt;"><font style="font-family:inherit;font-size:10pt;">None.</font><font style="font-family:inherit;font-size:14pt;">&#160;</font></div><div><a name="s2C16A94A9C1B53C297FF619C7007FDB8"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:74px;"></td><td style="width:608px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;9A.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Controls and Procedures.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Evaluation of disclosure controls and procedures</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of the end of the period covered by this report, our management, under the supervision and with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13a-15(b) of the Securities Exchange Act of 1934, as amended. Based on </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that our disclosure controls and procedures as of the end of the period covered by this report were effective to provide reasonable assurance that the information required to be disclosed by us in reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms and is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Management&#8217;s Report on Internal Control Over Financial Reporting </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting for our Company. Internal control over financial reporting is defined in Rules 13a-15(f) and 15d-15(f) promulgated under the Securities Exchange Act of 1934, as amended, as a process designed by, or under the supervision of, our principal executive and principal financial officers and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States and includes those policies and procedures that:</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States, and that our receipts and expenditures are being made only in accordance with authorizations of our management and members of our board of directors; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our management has assessed the effectiveness of our internal control over financial reporting as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Internal Control-Integrated Framework</font><font style="font-family:inherit;font-size:10pt;">&#32;(2013).  Based on this evaluation, management concluded that our internal control over financial reporting was effective as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The effectiveness of our internal control over financial reporting as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;has been audited by Deloitte &amp; Touche LLP, an independent registered public accounting firm, as stated in their report which appears herein.  </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Changes in Internal Control over Financial Reporting&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There was no change in our internal control over financial reporting for the fiscal quarter ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Report of Independent Registered Public Accounting Firm</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To the shareholders and the Board of Directors of</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngioDynamics, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latham, New York </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Opinion on Internal Control over Financial Reporting</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have audited the internal control over financial reporting of AngioDynamics, Inc. and subsidiaries (the &#8220;Company&#8221;) as of May 31, 2018, based on criteria established in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Internal Control - Integrated Framework (2013)</font><font style="font-family:inherit;font-size:10pt;">&#32;issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of May 31, 2018, based on criteria established in</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;Internal Control - Integrated Framework (2013)</font><font style="font-family:inherit;font-size:10pt;">&#32;issued by COSO.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended May 31, 2018, of the Company and our report dated </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font><font style="font-family:inherit;font-size:10pt;">, expressed an unqualified opinion on those financial statements.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis for Opinion</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Definition and Limitations of Internal Control over Financial Reporting</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Deloitte &amp; Touche LLP</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Boston, Massachusetts</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s0829957ACF945163A9F21A521FCFF9E0"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:74px;"></td><td style="width:608px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;9B.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Information.</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:6px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">None.</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55</font></div></div><hr style="page-break-after:always"><div><a name="s956079E1629C5780A19B48365E1EBDD5"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Part III</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain information required by Part III is omitted from this Annual Report on Form 10-K because we will file a definitive proxy statement within 120 days after the end of our fiscal year end pursuant to Regulation 14A (the &#8220;Proxy Statement&#8221;) for our annual meeting of Stockholders, currently scheduled for October&#160;</font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">. The information included in the Proxy Statement under the respective headings noted below is incorporated herein by reference.</font></div><div style="line-height:120%;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;"><br></font></div><div><a name="s291B895F6D8A5269BB80C0F93EF38561"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:74px;"></td><td style="width:608px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;10.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Directors, Executive Officers and Corporate Governance.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information required in this Annual Report on Form 10-K with respect to Executive Officers is contained in the discussion titled &#8220;Executive Officers of the Company&#8221; in Part I of this Annual Report on Form 10-K. The balance of the information required by Item&#160;10 is incorporated herein by reference to our Proxy Statement under the heading &#8220;Election of Directors&#8221;.&#160;</font></div><div><a name="s5D1117B14BF25D4998B5549A0455EC0D"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:74px;"></td><td style="width:608px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;11.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Executive Compensation.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The information required by Item&#160;11 is incorporated herein by reference to our Proxy Statement under the heading &#8220;Executive Compensation&#8221;.&#160;</font></div><div><a name="sB10B3B80A7B65E77B78F63A5D1A28420"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:74px;"></td><td style="width:608px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;12.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The information required by this caption is incorporated herein by reference to our Proxy Statement under the heading &#8220;Ownership of Securities&#8221;.&#160;</font></div><div><a name="s38B1B8739A1E5FA6B3D65865EB526D6F"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:74px;"></td><td style="width:608px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;13.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Certain Relationships and Related Transactions, and Director Independence.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The information required by this caption is incorporated herein by reference to our Proxy Statement under the heading &#8220;Certain Relationships and Related Transactions&#8221;.&#160;</font></div><div><a name="sA0967F23374356C388FB8C7E6794F6FF"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:74px;"></td><td style="width:608px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;14.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Principal Accounting Fees and Services.</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The information required by this caption is incorporated herein by reference to our Proxy Statement under the headings &#8220;Audit Matters&#8212;Principal Accounting Fees and Services and&#8212;Policy on Audit Committee Pre-approval of Audit and Permissible Non-Audit Services of Independent Registered Public Accounting Firm&#8221;.</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56</font></div></div><hr style="page-break-after:always"><div><a name="s097E05A2B2855A639445EA7E83C32029"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Part IV</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div><a name="sD44898CFA615568392EEF9631BB9F4BE"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:683px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:74px;"></td><td style="width:608px;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;15.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Exhibits, Financial Statement Schedules.</font></div></td></tr></table></div></div><div><a name="sFFD9F3C31BBA511D81D816952C67F0CE"></a></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(a)(1)</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Financial Statements</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following consolidated financial statements and supplementary data of Registrant and its subsidiaries required by Part II, Item&#160;8, are included in Part IV of this report:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:88%;"></td><td style="width:4%;"></td><td style="width:4%;"></td><td style="width:4%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s2544985729A1579EB69E07677206A58E"><font style="font-family:inherit;font-size:10pt;">Report of Independent Registered Public Accounting Firms</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s2544985729A1579EB69E07677206A58E">58</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sD75B03FC4AC85222AF0A88CAE83C2F27"><font style="font-family:inherit;font-size:10pt;">Consolidated statements of operations&#8212;Year ended May&#160;31, 2018, 2017 and 2016</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sD75B03FC4AC85222AF0A88CAE83C2F27">60</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s4D3451D9A9225FE987DDE066DD48DE11"><font style="font-family:inherit;font-size:10pt;">Consolidated statements of comprehensive income (loss) &#8211; Year ended May&#160;31, 2018,&#160;2017 and 2016</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s4D3451D9A9225FE987DDE066DD48DE11">61</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s51B0C077B1E1579DB7DA410461FEFF3B"><font style="font-family:inherit;font-size:10pt;">Consolidated balance sheets&#8212;May 31, 2018 and May&#160;31, 2017</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s51B0C077B1E1579DB7DA410461FEFF3B">62</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sC0ED699823A35D47A19C7F557ECF31F9"><font style="font-family:inherit;font-size:10pt;">Consolidated statements of stockholders&#8217; equity&#8212;Year ended May&#160;31, 2018,&#160;2017 and 2016</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sC0ED699823A35D47A19C7F557ECF31F9">63</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s22CA08860C3959B3A2B64A4EFBBA56AA"><font style="font-family:inherit;font-size:10pt;">Consolidated statements of cash flows&#8212;Year ended May&#160;31, 2018,&#160;2017 and 2016</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s22CA08860C3959B3A2B64A4EFBBA56AA">64</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s29BDD72854D5562BB6F65B6B2A63C6F1"><font style="font-family:inherit;font-size:10pt;">Notes to consolidated financial statements</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s29BDD72854D5562BB6F65B6B2A63C6F1">66</a></div></td></tr></table></div></div><div><a name="s1CA226D37EED5B238D989468C9E2C1FC"></a></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(2)</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Financial Statement Schedules</font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following consolidated financial statement schedule is included in Part IV of this report:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:95%;"></td><td style="width:5%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s9F664818C2ED5637966866B1E863973D"><font style="font-family:inherit;font-size:10pt;">Schedule II&#8212;Valuation and qualifying accounts</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s9F664818C2ED5637966866B1E863973D">95</a></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All other schedules are omitted because they are not applicable, or not required, or because the required information is included in the consolidated financial statements or notes thereto.</font><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div><a name="s72A1190E66D55815B2DB6B7491526E84"></a></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:95%;"></td><td style="width:5%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;" href="#sA6DCF1E762A05126B7F8B5015011FAD6"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">(b) Exhibits</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sA6DCF1E762A05126B7F8B5015011FAD6">96</a></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57</font></div></div><hr style="page-break-after:always"><div><a name="s2544985729A1579EB69E07677206A58E"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Report of Independent Registered Public Accounting Firm</font></div><div style="line-height:120%;text-align:center;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To the shareholders and the Board of Directors of</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngioDynamics, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latham, New York</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Opinion on the Financial Statements</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have audited the accompanying consolidated balance sheets of AngioDynamics, Inc. and subsidiaries (the "Company") as of May 31, 2018 and 2017, the related consolidated statements of operations, comprehensive income (loss), stockholders' equity, and cash flows for each of the two years in the period ended May 31, 2018, and the related notes and the schedule for the years ended May 31, 2018 and 2017 listed in the Index at Item 15 (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of May 31, 2018 and 2017, and the results of its operations and its cash flows for each of the two years in the period ended May 31, 2018, in conformity with accounting principles generally accepted in the United States of America. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of May 31, 2018, based on criteria established in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Internal Control - Integrated Framework (2013)</font><font style="font-family:inherit;font-size:10pt;">&#32;issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;expressed an unqualified opinion on the Company's internal control over financial reporting.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis for Opinion</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Deloitte &amp; Touche LLP</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Boston, Massachusetts</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font></div><div style="line-height:120%;text-indent:96px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have served as the Company&#8217;s auditor since 2016.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;text-indent:144px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58</font></div></div><hr style="page-break-after:always"><div><a name="s558021BBB598579BB32ECDE668539B92"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Report of Independent Registered Public Accounting Firm</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To the Board of Directors and Stockholders of AngioDynamics, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In our opinion, the consolidated statement of operations, of comprehensive income (loss), of stockholders&#8217; equity, and of cash flows for the year ended May 31, 2016 present fairly, in all material respects, the results of operations and cash flows of AngioDynamics, Inc. and its subsidiaries (the Company) for the year ended May 31, 2016, in conformity with accounting principles generally accepted in the United States of America. In addition, in our opinion, the financial statement schedule listed in the index appearing under Item 15(a)(2) for the year ended May 31, 2016, presents fairly, in all material respects, the information set forth therein when read in conjunction with the related consolidated financial statements.  These financial statements and financial statement schedule are the responsibility of the Company's management.  Our responsibility is to express an opinion on these financial statements and financial statement schedule based on our audit.  We conducted our audit of these financial statements in accordance with the standards of the Public Company Accounting Oversight Board (United States).  Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.  An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation.  We believe that our audit provides a reasonable basis for our opinion. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ PricewaterhouseCoopers LLP</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Boston, Massachusetts</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">August 1, 2016</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59</font></div></div><hr style="page-break-after:always"><div><a name="sD75B03FC4AC85222AF0A88CAE83C2F27"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">AngioDynamics, Inc. and Subsidiaries</font></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONSOLIDATED STATEMENTS OF OPERATIONS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in thousands, except per share data)</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:65%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">344,285</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349,643</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353,890</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cost of sales (exclusive of intangible amortization)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167,410</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173,474</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">179,574</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176,875</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176,169</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">174,316</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Operating expenses</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,459</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,269</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,053</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales and marketing</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77,276</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,819</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,743</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,265</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,406</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,583</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,635</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,296</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,964</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,261</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">948</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition, restructuring and other items, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,432</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,510</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,591</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical device excise tax</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,837</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,416</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total operating expenses</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">166,317</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">163,202</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173,298</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,558</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,967</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other expenses</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,062</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,839</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,385</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other expense</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(281</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(886</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total other expenses, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,093</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,120</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,271</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income (loss) before income tax expense (benefit)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,465</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,847</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,253</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income tax expense (benefit)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,870</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,839</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,337</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,335</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,008</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(43,590</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Earnings (loss) per share</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.44</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.14</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.21</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.44</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.14</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.21</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted average shares outstanding</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,075</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,617</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,161</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,539</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,959</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,161</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:160px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:22px;padding-top:22px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying notes are an integral part of these consolidated financial statements.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60</font></div></div><hr style="page-break-after:always"><div><a name="s4D3451D9A9225FE987DDE066DD48DE11"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">AngioDynamics, Inc. and Subsidiaries</font></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in thousands)</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:65%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,335</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,008</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(43,590</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss), before tax:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized gain (loss) on marketable securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrealized gain on interest rate swap</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">257</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency translation gain (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(545</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(112</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss), before tax</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">372</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(533</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax benefit (expense) related to items of other comprehensive    income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(92</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss), net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">372</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(533</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total comprehensive income (loss), net of tax</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,707</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,475</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(43,548</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:400px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:22px;padding-top:22px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying notes are an integral part of these consolidated financial statements.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61</font></div></div><hr style="page-break-after:always"><div><a name="s51B0C077B1E1579DB7DA410461FEFF3B"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">AngioDynamics, Inc. and Subsidiaries</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONSOLIDATED BALANCE SHEETS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in thousands, except share data)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May&#160;31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Current Assets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74,096</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,544</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable securities, at fair value</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable, net of allowances of $2,466 and $2,945, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,401</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,523</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,916</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54,506</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,302</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,126</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168,032</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">153,914</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,461</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,234</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,417</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,886</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130,310</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145,675</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">361,252</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">361,252</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">705,472</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">707,961</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:none;">Liabilities and Stockholders' Equity</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Current Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,775</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,087</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,426</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,804</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current portion of long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current portion of contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,100</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,625</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57,301</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,516</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt, net of current portion</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86,621</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91,320</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,173</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,112</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration, net of current portion</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,161</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,136</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">621</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">850</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162,877</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">192,934</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commitments and Contingencies (Note 15)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stockholders&#8217; Equity</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preferred stock, par value $.01 per share, 5,000,000 shares authorized; no shares issued and outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock, par value $.01 per share, 75,000,000 shares authorized; 37,594,493 and 37,210,091 shares issued and 37,224,493 and 36,840,091 shares outstanding at May 31, 2018 and 2017, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">370</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">367</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additional paid-in capital</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">543,762</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">532,705</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Retained earnings (accumulated deficit)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,129</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,007</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Treasury stock, 370,000 shares, at cost at May 31, 2018 and 2017, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,714</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,714</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive loss</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(952</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,324</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Stockholders' Equity</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">542,595</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">515,027</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Liabilities and Stockholders' Equity</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">705,472</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">707,961</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying notes are an integral part of these consolidated financial statements.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">62</font></div></div><hr style="page-break-after:always"><div><a name="sC0ED699823A35D47A19C7F557ECF31F9"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">AngioDynamics, Inc. and Subsidiaries</font></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in thousands, except share data)</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="30"></td></tr><tr><td style="width:20%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td></tr><tr><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Common Stock</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Additional</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">paid in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">capital</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Retained</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">earnings (accumulated deficit)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">comprehensive</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Treasury Stock</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amount</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at May 31, 2015</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">36,043,725</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">360</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">520,101</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">27,575</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(833</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(142,305</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,104</font></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">545,099</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net loss</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(43,590</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(43,590</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Exercise of stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">101,040</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,296</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,297</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Issuance/cancellation of restricted stock units</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">137,681</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(332</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(331</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Purchase of common stock under Employee Stock Purchase Plan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">137,957</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,470</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,471</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Stock-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,240</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3,240</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other comprehensive income, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">42</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">42</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at May 31, 2016</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">36,420,403</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">363</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">525,775</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(16,015</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(791</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(142,305</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2,104</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">507,228</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,008</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,008</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Exercise of stock options</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">751,062</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,858</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,865</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Issuance/cancellation of restricted stock units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">158,341</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(587</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(586</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Issuance of performance share units</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23,405</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Purchase of common stock under Employee Stock Purchase Plan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">129,185</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,418</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,419</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Stock-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,183</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6,183</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Treasury stock retirement </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(642,305</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(9,942</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">642,305</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9,944</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Common stock repurchased</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">370,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(870,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(13,554</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(13,557</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other comprehensive loss, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(533</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(533</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at May 31, 2017</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">37,210,091</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">367</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">532,705</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(11,007</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,324</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(370,000</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(5,714</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">515,027</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Adjustment for ASU 2016-09</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">199</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(199</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16,335</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16,335</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Exercise of stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">148,937</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,916</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,917</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Issuance/cancellation of restricted stock units</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">145,522</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(232</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(231</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Purchase of common stock under Employee Stock Purchase Plan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">89,943</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,262</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,263</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Stock-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7,912</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7,912</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other comprehensive income, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">372</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">372</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance at May 31, 2018</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">37,594,493</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">370</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">543,762</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5,129</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(952</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(370,000</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(5,714</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">542,595</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:34px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:22px;padding-top:22px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying notes are an integral part of these consolidated financial statements.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63</font></div></div><hr style="page-break-after:always"><div><a name="s22CA08860C3959B3A2B64A4EFBBA56AA"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">AngioDynamics, Inc. and Subsidiaries</font></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONSOLIDATED STATEMENTS OF CASH FLOWS</font></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in thousands)</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:65%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash flows from operating activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,335</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,008</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(43,590</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23,163</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,811</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,115</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,912</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,183</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,240</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">250</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,261</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">948</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred income tax provision</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,947</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,428</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,983</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in accounts receivable allowances</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">179</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(313</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,377</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fixed and intangible asset impairments and disposals</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">540</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,930</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,190</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Write-off of other assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,685</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(605</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(586</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in operating assets and liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,044</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,479</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,131</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,740</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">687</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,976</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,231</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,520</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">712</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable, accrued and other liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,093</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,214</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,956</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash provided by operating activities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,287</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,745</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,216</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash flows from investing activities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additions to property, plant and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,391</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,001</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,326</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition of intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,265</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,268</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition of warrants</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Proceeds from sale or maturity of marketable securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">450</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash used in investing activities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,656</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,551</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7,569</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash flows from financing activities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Proceeds from issuance of and borrowings on long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116,471</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repayment of long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(140,381</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16,250</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred financing costs on long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,364</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payment of acquisition related contingent consideration </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,500</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,850</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,850</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Repurchase of common stock </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(13,557</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Proceeds from exercise of stock options and employee stock purchase plan</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,949</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,698</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,437</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash used in financing activities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,551</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(37,983</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23,663</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:108px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of exchange rate changes on cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">472</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(42</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:108px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increase in cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,552</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,211</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,942</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents at beginning of year</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,544</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,333</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,391</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents at end of year</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74,096</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,544</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,333</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying notes are an integral part of these consolidated financial statements.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">AngioDynamics, Inc. and Subsidiaries</font></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONSOLIDATED STATEMENTS OF CASH FLOWS&#8212;(Continued)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in thousands)</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:65%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Supplemental disclosure of non-cash investing and financing activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contractual obligations for purchase of fixed assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash paid (received) during the year for:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,190</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,969</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,063</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">332</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:90pt;"><font style="font-family:inherit;font-size:90pt;">&#160;</font></div><div style="line-height:120%;font-size:90pt;"><font style="font-family:inherit;font-size:90pt;">&#160;</font></div><div style="line-height:120%;padding-top:120px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:22px;padding-top:22px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accompanying notes are an integral part of these consolidated financial statements.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65</font></div></div><hr style="page-break-after:always"><div><a name="s29BDD72854D5562BB6F65B6B2A63C6F1"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">AngioDynamics, Inc. and Subsidiaries</font></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s03FFC05FB26159A5A07C30DE14A8FC47"></a></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1.  BASIS OF PRESENTATION, BUSINESS DESCRIPTION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div><div><a name="s3B9E0024D84C551E94B3670BFFD89238"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation and Description of Business</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of AngioDynamics, Inc. and its wholly owned subsidiaries,  (collectively, the &#8220;Company&#8221;).  The Company designs, manufactures and sells a wide range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and in oncology and surgical settings. The devices are generally used in minimally invasive, image-guided procedures. Most of the Company's products are intended to be used once and then discarded, or they may be temporarily implanted for short- or long-term use. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounting Principles</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements and accompanying notes have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP").</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Principles of Consolidation</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of AngioDynamics and it subsidiaries (all of which are wholly owned).  All intercompany balances and transactions have been eliminated.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements, in conformity with accounting principles generally accepted in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect reported amounts of sales and expenses during the reporting period. Actual results could differ from those estimates.</font></div><div><a name="s5AB53761C98E5BC9B27C46EB74436236"></a></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cash and Cash Equivalents</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company considers all unrestricted highly liquid investments with an initial maturity of </font><font style="font-family:inherit;font-size:10pt;">less than three months</font><font style="font-family:inherit;font-size:10pt;">&#32;at the date of purchase to be cash equivalents. The Company maintains cash and cash equivalent balances with financial institutions in the United States in excess of amounts insured by the Federal Deposit Insurance Corporation.</font></div><div><a name="sA52414DC3019503D887E9E685359440E"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Marketable Securities</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable securities, which include auction rate investments, are classified as &#8220;available-for-sale securities&#8221; and are reported at fair value, with unrealized gains and losses excluded from operations and reported as a component of accumulated other comprehensive income (loss), net of the related tax effects, in stockholders&#8217; equity. Cost is determined using the specific identification method. The Company holds an investment in auction rate securities in order to generate higher than typical money market rate investment returns. Auction rate securities typically are high credit quality, generally achieved with municipal bond insurance.  As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, in an auction rate security issued by a local government authority. The authority is current in its interest payments on the security.</font></div><div><a name="sB18C390CA7A85403961B838064D571A6"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fair Value Instruments</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The carrying amount of the Company's cash and cash equivalents, accounts receivable, accounts payable and long-term debt approximates fair value due to the short-term nature or market interest rates of these items. The Company bases the fair value of short-term investments on quoted market prices or other relevant information generated by market transactions involving identical or comparable assets. The Company measures and records derivative financial instruments at fair value. See Note 3 for further discussion of financial instruments that are carried at fair value on a recurring and nonrecurring basis.</font></div><div><a name="s68D916AD0D6658E4810F0763EFBFDD90"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounts Receivable</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable, principally trade receivables, are generally due within </font><font style="font-family:inherit;font-size:10pt;">30</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">90</font><font style="font-family:inherit;font-size:10pt;">&#32;days and are stated at amounts due from customers, net of an allowance for estimated sales returns and doubtful accounts. The Company performs ongoing credit evaluations of customers and adjusts credit limits based upon payment history and the customer&#8217;s current creditworthiness, as determined by a review of their current credit information. The Company continuously monitors aging reports, collections and payments from customers, and a provision for estimated credit losses is maintained based upon historical experience and any specific customer collection issues that have been identified. While such credit losses have historically been within expectations and the provisions established, the Company cannot guarantee that the same credit loss rates will be experienced in the future. The Company writes off accounts receivable when they are determined to be uncollectible.</font></div><div><a name="s7997746BAEE65586AC53ADC1A2EECA61"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Inventories</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories are stated at the lower of cost (using the first-in, first-out method) or market. Appropriate consideration is given to deterioration, obsolescence, expiring and other factors in evaluating net realizable value.</font></div><div><a name="s3F455C678D2A504FA8ED34528149EF4C"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Property, Plant and Equipment</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets.  Refer below for useful lives by category:</font></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:79%;"></td><td style="width:1%;"></td><td style="width:20%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated useful lives</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and building improvements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Machinery and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 to 8 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer software and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3 to 5 years</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:6px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluates property, plant and equipment for impairment periodically to determine if changes in circumstances or the occurrence of events suggest the carrying value of the asset or asset group may not be recoverable. Expenditures for repairs and maintenance are charged to expense as incurred. Renewals and betterments are capitalized.</font></div><div><a name="s1390A45A4D70563090B7312E9410B6BB"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill and Intangible Assets</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets other than goodwill and acquired IP R&amp;D are amortized over their estimated useful lives, on either a straight-line basis or proportionately to the benefit being realized.  Useful lives range from </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">eighteen</font><font style="font-family:inherit;font-size:10pt;">&#32;years. The Company periodically reviews the estimated useful lives of intangible assets and reviews such assets for impairment whenever events or changes in circumstances indicate that the carrying value of the asset or asset group is not recoverable.  If an intangible asset or asset group is considered to be impaired, the amount of the impairment will equal the excess of the carrying value over the fair value of the asset.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill is the amount by which the cost of acquired net assets in a business combination exceeded the fair value of net identifiable assets on the date of purchase.  Goodwill and other intangible assets that have indefinite useful lives are not amortized, but rather, are tested for impairment annually or more frequently if impairment indicators arise. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For goodwill, the impairment test requires a comparison of the estimated fair value of the reporting unit to which the goodwill is assigned to carrying value of the assets and liabilities of that reporting unit. The determination of reporting units also requires management judgment. The Company considers whether a reporting unit exists within a reportable segment based on the availability of discrete financial information. If carrying value of the reporting unit exceeds the fair value of the reporting unit, the carrying value of the reporting unit&#8217;s goodwill is reduced to its fair value through an adjustment to the goodwill balance, resulting in an impairment charge. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's annual testing for impairment of goodwill was completed as of December 31, 2017. The Company operates as a single operating segment with </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">&#32;reporting unit and consequently evaluates goodwill for impairment based on an evaluation of the fair value of the Company as a whole. The Company determines the fair value of the reporting unit based on the market valuation approach and concluded that it was not more-likely-than-not that the fair value of the Company's reporting unit was less than its carrying value.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67</font></div></div><hr style="page-break-after:always"><div><a name="s198FE563924159FAA867DF061095A232"></a></div><div><br></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contingent Consideration</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of the liability for contingent consideration recorded on the acquisition date for a business combination is based on probability weighted estimated cash flow streams, discounted back to present value using a discount rate determined in accordance with accepted valuation methods and reflective of the risk associated with the estimated cash flow streams. The liability for contingent consideration is remeasured to fair value at each reporting period with changes recorded in earnings until the contingency is resolved.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sFCB815DCC08F590882B335C14906EA15"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes revenue when the following four criteria has been met: (i)&#160;persuasive evidence that an arrangement exists; (ii)&#160;the price is fixed or determinable; (iii)&#160;collectability is reasonably assured; and (iv)&#160;product delivery has occurred or services have been rendered. The Company recognizes revenue, net of sales taxes assessed by any governmental authority, as products are shipped, based on shipping terms, and when title and risk of loss passes to customers. The Company negotiates shipping and credit terms on a customer-by-customer basis and products are shipped at an agreed upon price. All product returns must be pre-approved by the Company and customers may be subject to a </font><font style="font-family:inherit;font-size:10pt;">20%</font><font style="font-family:inherit;font-size:10pt;">&#32;restocking charge. To be accepted, a returned product must be unadulterated, undamaged and have at least </font><font style="font-family:inherit;font-size:10pt;">twelve months</font><font style="font-family:inherit;font-size:10pt;">&#32;remaining prior to its expiration date.  Charges for discounts, returns, rebates and other allowances are recognized as a deduction from revenue on an accrual basis in the period in which the revenue is recorded. The accrual for product returns, discounts and other allowances is based on the Company&#8217;s history. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shipping and handling costs, associated with the distribution of finished products to customers, are recorded in costs of goods sold and are recognized when the related finished product is shipped to the customer. Amounts charged to customers for shipping are recorded in net sales.</font></div><div><a name="s5A0456E56CD656E1A328176EABDA623D"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Research and Development</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development costs, including salaries, consulting fees, building costs, utilities and administrative expenses that are related to developing new products, enhancing existing products, validating new and enhanced products, managing clinical, regulatory and medical affairs are expensed as incurred.</font></div><div><a name="s07A03A6D14365C71BBC260CD9E8A008E"></a></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company calculates income tax expense for each jurisdiction in which it operates. This involves estimating actual current taxes due plus assessing temporary differences arising from differing treatment for tax and accounting purposes that are recorded as deferred tax assets and liabilities. The Company periodically evaluates deferred tax assets, capital loss carryforwards and tax credit carryforwards to determine their recoverability based primarily on the Company's ability to generate future taxable income and capital gains.  Where it is more-likely-than-not these will not be recovered, the Company estimates a valuation allowance and records a corresponding additional tax expense in the consolidated statement of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes and measures uncertain tax positions taken or expected to be taken in a tax return utilizing a two-step approach. The Company first determines if the weight of available evidence indicates that it is more likely than not that the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is that the Company measures the tax benefit as the largest amount that is more likely than not to be realized upon ultimate settlement. The Company recognizes interest and penalties related to uncertain tax positions in the provision for income taxes on the consolidated statements of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s495D938FB3055244AAAA6C4296200B93"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Warranty Costs</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company makes periodic provisions for expected warranty costs. Historically, warranty costs have been insignificant.</font></div><div><a name="sC1D8EA1554EE54DC963BE1633507D784"></a></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Stock Based Compensation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation expense reflects the fair value of stock-based awards measured at the grant date and recognized over the relevant service period. The Company estimates the fair value of each stock-based award on the measurement date using either the current market price of the stock, the Black-Scholes option valuation model, or the Monte Carlo Simulation valuation model. The Black-Scholes and Monte Carlo Simulation valuation models incorporate assumptions as to stock price volatility, the expected life of options or restricted stock units, a risk-free interest rate and dividend yield. The </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Company recognizes stock-based compensation expense related to options, restricted stock units and market based performance stock units on a straight-line basis over the service period of the award, which is generally </font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;">&#32;years for options and restricted stock units and </font><font style="font-family:inherit;font-size:10pt;">3</font><font style="font-family:inherit;font-size:10pt;">&#32;years for market based performance stock units. </font></div><div><a name="s6FFB3C47B53A5EA896C2C8C18B4C18AB"></a></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Foreign Currency Translation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The functional currency of the Company's foreign subsidiaries is the local currency in which the subsidiary operates. For foreign operations where the local currency is considered to be the functional currency, the Company translates assets and liabilities into U.S. dollars at the exchange rate on the balance sheet date. The Company translates income and expense items at average rates of exchange prevailing during each period. The Company accumulates translation adjustments in accumulated other comprehensive loss, a component of stockholders&#8217; equity.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transaction gains or losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in other expense in the statements of operations as incurred.</font></div><div><a name="sCF8D8D279DF05DEAA8672715FB606BD3"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Derivative Financial Instruments</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is exposed to market risks, including changes in foreign currency and interest rates. The Company periodically enters into certain derivative financial instruments to hedge the underlying economic exposure. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative instruments are presented in the consolidated financial statements at their fair value. Changes in the fair value of derivative financial instruments are either recognized periodically in income or in stockholders&#8217; equity as a component of accumulated other comprehensive income (loss) depending on whether the derivative financial instrument qualifies for hedge accounting and, if so, whether it qualifies as a fair value or cash flow hedge. Generally, the changes in the fair value of derivatives accounted for as fair value hedges are recorded in income along with the portions of the changes in the fair value of hedged items that relate to the hedged risks. Changes in the fair value of derivatives accounted for as cash flow hedges, to the extent they are effective as hedges, are recorded in accumulated other comprehensive income (loss). </font></div><div><a name="s8D401F0697425B23AF3A1EFDDD76FB03"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is subject to various legal proceedings that arise in the ordinary course of business, including patent infringement and product liability matters. The Company records accruals for contingencies when it is probable the liability has been incurred and the amount can be reasonably estimated.  Legal fees are expensed as incurred. Insurance recoveries related to potential claims are recognized up to the amount of the recorded liability when coverage is confirmed and the estimated recoveries are probable of payment. These recoveries are not netted against the related liabilities for financial statement presentation.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69</font></div></div><hr style="page-break-after:always"><div><a name="sC736BE72B7965E4290998C2AE5D6B694"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a description of recent accounting pronouncements that may have a material effect on the Company's consolidated financial statements:  </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:22%;"></td><td style="width:34%;"></td><td style="width:11%;"></td><td style="width:33%;"></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Issued Accounting Pronouncements - Adopted</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Standard</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Date Adopted</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Effect on the Consolidated Financial Statements</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2016-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation - Stock Based Compensation (Topic 718: Improvements to Employee Share-Based Payment Accounting)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This ASU simplifies and improves various aspects of ASC 718 for share-based payments, including income tax items and the classification of these items on the statement of cash flows.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2017</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company now recognizes unrealized excess tax benefits and will classify such benefits as an operating activity in the statement of cash flows on a prospective basis. Due to the full valuation allowance on our federal and state income taxes, the adoption of ASU 2016-09 did not impact our accounting for income taxes.                  </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company elected the accounting policy change to account for forfeitures as they occur.  This was adopted using the modified retrospective transition method by means of a cumulative-effect adjustment to equity as of June 1, 2017.  The adoption of ASU 2016-09 did not materially impact the Company's consolidated statements of income, consolidated balance sheet, equity or cash flows. </font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2017-04, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles - Goodwill and Other (Topic 350)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This ASU simplifies the subsequent measurement of goodwill by eliminating steps from the goodwill impairment test.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2017</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This adoption did not have an impact on the Company's financial statements.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASC Update No. 2015-11, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Inventory (Topic 330): Simplifying the Measurement of Inventory</font><font style="font-family:inherit;font-size:10pt;">. Update No. 2015-11</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This ASU more closely aligns the measurement of inventory in U.S. GAAP with the measurement of inventory in International Financial Reporting Standards by requiring companies using the first-in, first-out and average costs methods to measure inventory using the lower of cost and net realizable value, where net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2017</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This adoption did not have an impact on the Company's financial statements.</font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:22%;"></td><td style="width:34%;"></td><td style="width:11%;"></td><td style="width:33%;"></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Issued Accounting Pronouncements - Not Yet Applicable or Adopted</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Standard</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Effective Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Effect on the Consolidated Financial Statements</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU No. 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers (Topic 606, ASU 2014-09)</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under Topic 606, an entity is required to recognize revenue upon transfer of promised goods or services to customers in an amount that reflects the expected consideration to be received in exchange for those goods or services. Topic 606 defines a five-step process in order to achieve this core principle, which may require the use of judgment and estimates, and also requires expanded qualitative and quantitative disclosures relating to the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers, including significant judgments and estimates used. The new standard also defines accounting for certain costs related to origination and fulfillment of contracts with customers, including whether such costs should be capitalized. </font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2018</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company established an implementation team which included third-party specialists to assist in the evaluation and implementation of the new standard. The Company&#8217;s assessment has included performing analysis for each revenue stream identified, assessing the potential differences in recognition and measurement that may result from adopting this standard and assessing whether the Company meets certain practical expedients. Based on the results of the assessment, the adoption of this standard will not have a material impact on the timing or amount of revenue recognized upon adoption and there is no cumulative prior period adjustment to be recorded to the opening balance of retained earnings upon adoption.  The Company will adopt the standard using the modified retrospective method. The Company is implementing changes to accounting policies, business processes and internal controls to support the new standard as necessary. Upon adoption of Topic 606, as the disclosure requirements under the new guidance have been significantly expanded in comparison to the disclosure requirements under the current guidance, we will provide additional disclosures in the notes to the consolidated financial statements, specifically related to performance obligations, the judgments made in revenue recognition determinations, costs to obtain or fulfill contracts and contract balances.</font></div><div style="padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU No. 2016-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (ASU 2016-15)</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This ASU identifies how certain cash receipts and cash payments are presented and classified in the Statement of Cash Flows under Topic 230.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2018</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This adoption is not expected to have a material impact on the Company's financial statements.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This ASU increases transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet and disclosing key information about leasing arrangements.  For leases with a term of twelve months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and liabilities.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2019</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is currently in the process of evaluating the impact of this ASU on its consolidated financial statements.</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71</font></div></div><hr style="page-break-after:always"><div><a name="s2B07075707345BB18E72C992745A4D1F"></a></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2.  OTHER ASSETS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2015, the Company filed an 8-K stating that it executed a non-binding letter of intent to enter into a strategic relationship with privately-held EmboMedics Inc., which develops injectable and resorbable embolic microspheres. </font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company made an initial </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;purchase of non-transferable warrants in a subsidiary of EmboMedics which become exercisable upon a change of control of EmboMedics.  The Company did not have significant influence, or control of the subsidiary.  This initial investment was recorded at cost and the Company reviewed for impairment at each balance sheet date. </font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the second quarter of fiscal year 2017, the Company decided to terminate its agreements with EmboMedics.  The termination of these agreements resulted in a write-off of the initial </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;investment in EmboMedics which is included in acquisition, restructuring and other items, net on the consolidated statements of operations.  </font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s5250B52257D25EFD9079C529FD541507"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">3.  FAIR VALUE OF FINANCIAL INSTRUMENTS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On a recurring basis, the Company measures certain financial assets and financial liabilities at fair value based upon quoted market prices, where available. Where quoted market prices or other observable inputs are not available, the Company applies valuation techniques to estimate fair value. FASB ASC Topic 820,&#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements and Disclosures, </font><font style="font-family:inherit;font-size:10pt;">establishes a three-level valuation hierarchy for disclosure of fair value measurements. The categorization of financial assets and financial liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value.  The three levels of the hierarchy are defined as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 1 - Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 2 - Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 3 - Inputs to the valuation methodology are unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's financial instruments include cash and cash equivalents, marketable securities, accounts receivable, accounts payable and contingent consideration. The carrying amount of cash and cash equivalents, accounts receivable, and accounts payable approximates fair value due to their immediate or short-term maturities.  The recurring fair value measurements using significant unobservable inputs (Level 3) relate to marketable securities, which are comprised of auction rate securities, and contingent consideration liabilities. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables provide information by level for assets and liabilities that are measured at fair value on a recurring basis:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:45%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value Measurements using inputs considered as:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level&#160;1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level&#160;2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value at    May 31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Financial Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term investments*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,100</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,100</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable securities </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Financial Assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,417</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Financial Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent liability for acquisition earn outs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,261</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,261</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Financial Liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,261</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,261</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">*included in cash and cash equivalents.</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:45%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value Measurements using inputs considered as:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value at   May 31, 2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Financial Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable securities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Financial Assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Financial Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent liability for acquisition earn outs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,761</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,761</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Financial Liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,761</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,761</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There were no transfers in and out of Level 1, 2 and 3 measurements for the years ended </font><font style="font-family:inherit;font-size:9pt;">May 31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below presents the changes in fair value components of Level 3 instruments in the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;(in thousands of dollars):    </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:61%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Financial&#160;Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Financial&#160;Liabilities</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair&#160;Value&#160;Measurements<br>Using Significant<br>Unobservable Inputs<br>(Level 3)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair&#160;Value&#160;Measurements<br>Using Significant<br>Unobservable Inputs    (Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,761</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of contingent consideration, net </font><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">250</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair market value adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration payments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,750</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,261</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below presents the changes in fair value components of Level 3 instruments in the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;(in thousands of dollars):   </font></div><div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:60%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Financial&#160;Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Financial&#160;Liabilities</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair&#160;Value&#160;Measurements<br>Using Significant<br>Unobservable Inputs<br>(Level 3)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair&#160;Value&#160;Measurements<br>Using Significant<br>Unobservable Inputs    (Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,653</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,275</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of contingent consideration (1)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,261</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency (gain) loss from remeasurement</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(153</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair market value adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sale of securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(450</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration payments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,100</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,761</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1) Change in the fair value of contingent consideration is included in earnings and comprised of changes in estimated earn out payments based on projections of Company performance and amortization of the present value discount. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company made the decision to discontinue its investment in the TiLo product that was acquired in August 2013 as part of the Clinical Devices acquisition.  This decision resulted in the write-off of the acquired in-process research and development (IPR&amp;D) of </font><font style="font-family:inherit;font-size:10pt;">$3.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;along with a </font><font style="font-family:inherit;font-size:10pt;">$3.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;gain from the reduction in the fair value of contingent consideration liability associated with future milestones that will no longer be met during the second quarter of fiscal year 2017.  The write-off of the IPR&amp;D is included in acquisition, restructuring and other, net on the consolidated statement of operations. </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company revised the sales projections for the AngioVac product as a result of reviews performed by executive management across all products.  The adjustments to the sales projections resulted in a </font><font style="font-family:inherit;font-size:10pt;">$13.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;gain in the second quarter of fiscal year 2017 from the reduction in the fair value of the contingent liability that is based on lower projected sales volume over the contractual earn out period. </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Short-term Investments</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term investments consist of highly liquid investments in municipal bonds that reset on a weekly basis and can be called at any point in time. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Marketable Securities</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable securities consist solely of an auction rate security.  Assumptions associated with the auction rate security include the interest rate benchmarks, the probability of full repayment of the principal considering the credit quality and guarantees in place, and the rate of return required by investors to own such securities given the current liquidity risk.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contingent Liability for Acquisition Earn Outs</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Some of our business combinations involve the potential for the payment of future contingent consideration upon the achievement of certain product development milestones or various other performance conditions. Payment of the additional consideration is generally contingent on the acquired company reaching certain performance milestones, including attaining specified revenue levels or product development targets. Contingent consideration is recorded at the estimated fair value of the contingent payments on the acquisition date. The fair value of the contingent consideration is remeasured at the estimated fair value at each reporting period with the change in fair value recognized as income or expense within change in fair value of contingent consideration in the consolidated statements of income. </font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We measure the initial liability and remeasure the liability on a recurring basis using Level 3 inputs as defined under authoritative guidance for fair value measurements and is determined using a discounted cash flow model applied to projected net sales, using probabilities of achieving projected net sales and projected payment dates. Projected net sales are based on our </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">internal projections and extensive analysis of the target market and the sales potential. Increases or decreases in any valuation inputs in isolation may result in a significantly lower or higher fair value measurement in the future. </font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The recurring Level 3 fair value measurements of the contingent consideration liabilities include the following significant unobservable inputs as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td style="width:28%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:28%;"></td><td style="width:1%;"></td><td style="width:15%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair&#160;value&#160;at</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May&#160;31,&#160;2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Valuation</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Technique</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Input</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Range</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue based payments</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,261</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discounted cash flow</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discount rate<br>Probability of payment<br>Projected fiscal year of payment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4%<br>100%<br>2019 - 2020</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the estimated potential amount of undiscounted future contingent consideration that the Company expects to pay as a result of all completed acquisitions is approximately </font><font style="font-family:inherit;font-size:10pt;">$3.3 million</font><font style="font-family:inherit;font-size:10pt;">, which represents the remaining contractual minimum payments. </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></div><hr style="page-break-after:always"><div><a name="s25826126D59E594A89F96CBC653F50AE"></a></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">4.  MARKETABLE SECURITIES </font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, marketable securities consisted of the following:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:45%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sales securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">New York State government agency obligations</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,350</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,350</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, marketable securities consisted of the following:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:45%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sales securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">New York State government agency obligations</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,350</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(135</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,350</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(135</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amortized cost and fair value of marketable securities as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, by contractual maturity, are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:67%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of May&#160;31, 2018:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due in one year or less</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due after one through five years</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due after five through twenty years </font><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,350</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,350</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1)  This auction rate security represents investments available for current operations and are classified as current in the consolidated balance sheets.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76</font></div></div><hr style="page-break-after:always"><div><a name="s8987CF6F534C532F90CDEC438E456CFE"></a></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">5.  INVENTORIES</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, inventories consisted of the following:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:66%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,678</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,563</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,808</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,602</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,430</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,341</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,916</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54,506</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company periodically reviews its inventory for both obsolescence and loss of value.  The Company makes assumptions about the future demand for and market value of the inventory.  Based on these assumptions, the Company estimates the amount of obsolete, expiring and slow moving inventory.  The total inventory reserve at </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;was </font><font style="font-family:inherit;font-size:10pt;">$6.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$7.3 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.  Of the </font><font style="font-family:inherit;font-size:10pt;">$6.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;reserve at </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;relates to the inventory reserve for Acculis inventory as a result of the recall announced in the fourth quarter of fiscal year 2017 and </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;relates to a specific reserve related to the termination of an agreement with a Japanese distributor in the second quarter of fiscal year 2018.  Of the </font><font style="font-family:inherit;font-size:10pt;">$7.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in the prior year, </font><font style="font-family:inherit;font-size:10pt;">$2.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;relates to the reserve for Acculis inventory.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s7AA63F0008645E809027E8FCB7F71AFF"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">6.  PREPAID EXPENSES AND OTHER</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, prepaid expenses and other consisted of the following:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:67%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Software licenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,043</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">582</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">License fees</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">143</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade shows</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">223</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rent</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other prepaid taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">254</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">544</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical device excise tax receivable </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,837</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,505</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,762</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,302</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,126</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77</font></div></div><hr style="page-break-after:always"><div><a name="s964765D3F0F65A14B6367C0986F766A2"></a></div><div><br></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">7.  PROPERTY, PLANT AND EQUIPMENT, NET</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, property, plant and equipment are summarized as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:64%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and building improvements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,887</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,597</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Machinery and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,668</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,434</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer software and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,899</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,668</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Construction in progress</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,153</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,464</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,607</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,163</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less accumulated depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(48,794</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49,652</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,813</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,511</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Land and land improvements</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,648</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,723</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,461</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,234</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation expense for fiscal </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">&#32;was </font><font style="font-family:inherit;font-size:10pt;">$4.6 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$6.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$8.2 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></div><hr style="page-break-after:always"><div><a name="s3E48F810EF095BFFB34D60AB4E064251"></a></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">8.  GOODWILL AND INTANGIBLE ASSETS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's annual testing for impairment of goodwill was completed as of December 31, 2017. The Company operates as a single operating segment with </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">&#32;reporting unit and consequently evaluates goodwill for impairment based on an evaluation of the fair value of the Company as a whole. The Company determines the fair value of the reporting unit based on the market valuation approach and concluded that it was not more-likely-than-not that the fair value of the Company's reporting unit was less than its carrying value.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;">Even though the Company determined that there was </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;">&#32;goodwill impairment as of December 31, 2017, the future occurrence of a potential indicator of impairment, such as a significant adverse change in legal, regulatory, business or economic conditions or a more-likely-than-not expectation that the reporting unit or a significant portion of the reporting unit will be sold or disposed of, would require an interim assessment for the reporting unit prior to the next required annual assessment as of December 31, 2018.  The Company continued to assess for potential impairment through </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and noted no events that would be considered a triggering event.  There were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;">&#32;adjustments to goodwill for the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">.</font><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, intangible assets consisted of the following:</font></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:56%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross&#160;carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net&#160;carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product technologies</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147,175</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(68,880</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,295</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56,428</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23,237</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,191</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,400</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,809</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,591</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Licenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,752</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,357</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,395</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distributor relationships</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,250</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(412</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">838</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">239,005</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(108,695</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130,310</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:56%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross&#160;carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net&#160;carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product technologies</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147,172</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(59,696</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87,476</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56,375</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19,194</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,181</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,400</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,069</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,331</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Licenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,487</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,821</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">666</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distributor relationships</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(229</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">237,684</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(92,009</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145,675</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization expense was </font><font style="font-family:inherit;font-size:10pt;">$16.6 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$17.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$18.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for fiscal years </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Annual amortization of these intangible assets is expected to approximate the following amounts for each of the next five fiscal years:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:91%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,555</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,001</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,842</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,958</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,507</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2024 and thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,447</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130,310</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s4E33878CCD965250898A297358CE0F47"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9.  INCOME TAXES</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of income (loss) before income tax (benefit) expense for the years ended May&#160;31 are as follows:</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:47%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) before tax expense:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,274</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,825</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,444</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-U.S.</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,191</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,022</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,191</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,465</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,847</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,253</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax (benefit) expense is comprised of the following:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:47%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(148</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State and local</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">152</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">141</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non U.S.</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">217</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">411</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">354</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,947</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,428</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,983</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax (benefit) expense </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,870</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,839</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,337</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Temporary differences that give rise to deferred tax assets and liabilities are summarized as follows:</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:61%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:normal;">May&#160;31,&#160;2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:normal;">May&#160;31,&#160;2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net operating loss carryforward</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,880</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,975</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,421</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,653</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal and state R&amp;D tax credit carryforward</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,644</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,548</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,550</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,407</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expenses incurred not currently deductible</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,714</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,522</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">277</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,289</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross deferred tax asset</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,486</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,394</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Excess tax over book depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,044</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,158</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,044</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,158</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation Allowance</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,607</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(48,348</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred tax liability </font><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17,165</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,112</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1) Net deferred tax liability is inclusive of a non-U.S. </font><font style="font-family:inherit;font-size:8pt;">$0.08 million</font><font style="font-family:inherit;font-size:8pt;">&#32;deferred tax asset that is included in other assets on the Company's balance sheet for the year ended May 31, 2018.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The net deferred tax liability as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;principally relates to tax amortization of intangibles that have an indefinite reversal period for book purposes, also known as a &#8220;naked credit deferred tax liability&#8221;, that cannot be considered as a source of income to recover the deferred tax asset. </font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's Federal net operating loss carryforwards as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;after considering IRC Section&#160;382 limitations are </font><font style="font-family:inherit;font-size:10pt;">$157.8 million</font><font style="font-family:inherit;font-size:10pt;">. The expiration of the Federal net operating loss carryforwards are as follows: </font><font style="font-family:inherit;font-size:10pt;">$28.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;between 2018 and 2023 and </font><font style="font-family:inherit;font-size:10pt;">$129.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;between 2027 and 2037.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's state net operating loss carryforwards as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;after considering remaining IRC Section&#160;382 limitations are </font><font style="font-family:inherit;font-size:10pt;">$19.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;which expire in various years from 2018 to 2038.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (&#8220;Tax Reform Act&#8221;). The legislation significantly changes U.S. tax law by, among other things, lowering corporate income tax rates, implementing a territorial tax system, expanding the tax base and imposing a tax deemed repatriated earnings of foreign subsidiaries.&#160; The Tax Reform Act permanently reduces the U.S. corporate federal income tax rate from a maximum of 35% to a flat 21% rate, effective January 1, 2018. </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s estimated fiscal 2018 blended U.S. federal statutory corporate income tax rate of </font><font style="font-family:inherit;font-size:10pt;">28.6%</font><font style="font-family:inherit;font-size:10pt;">&#32;was applied in the computation of the income tax provision for the year ended May 31, 2018 and represents the average rate between the pre-enactment U.S. federal statutory corporate tax rate of </font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;">&#32;and the post-enactment U.S. federal statutory corporate tax rate of </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;">&#32;thereafter.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2017, the Securities and Exchange Commission staff issued Staff Accounting Bulletin No. 118 (SAB 118), which addresses how a company recognizes provisional amounts when a company does not have the necessary information available, prepared or analyzed (including computations) in reasonable detail to complete its accounting for the effect of the changes in the Tax Reform Act. The measurement period ends when a company has obtained, prepared and analyzed the information necessary to finalize its accounting, but cannot extend beyond one year that begins on the date of enactment of December 22, 2017. The Company has elected to apply the measurement period guidance provided in SAB 118. The final impact of the Tax Reform Act may differ from the estimates reported due to, among other things, changes in interpretations and assumptions made by us, additional guidance that may be issued by the U.S. Department of the Treasury and actions that we may take as a result.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has estimated the provision for incomes taxes in accordance with the Tax Reform Act and guidance available as of the date of this filing and as a result recorded a provisional amount of one-time income tax benefit of </font><font style="font-family:inherit;font-size:10pt;">$9.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in the third quarter of fiscal year 2018, the period in which the legislation was enacted.  This estimate has not changed as of May 31, 2018.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due to various uncertainties as described above, the Company has not completed its accounting for certain tax impacts of the Act.  A discussion of the most significant impacts of tax law changes under the Act for which the accounting is incomplete is as follows:</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is required to record deferred tax assets and liabilities based on the enacted tax rates at which they are expected to reverse in the future.  The Company has remeasured its deferred tax positions as of December 31, 2017 at the new enacted tax rate, resulting in a decrease to it net deferred tax assets and a corresponding decrease to its valuation allowance, with no net impact to tax expense. The Company recorded an income tax benefit of approximately </font><font style="font-family:inherit;font-size:10pt;">$9.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;due to the revaluation of the naked credit deferred tax liability.</font><font style="font-family:Arial;font-size:10pt;">&#32;&#32;</font><font style="font-family:inherit;font-size:10pt;">The Tax Reform Act changed the NOL carryover rules and created a new limitation on their use.  NOLs created in fiscal 2018 and beyond may be carried forwarded indefinitely in any year. As a result, the Company&#8217;s naked credit deferred tax liability can now be considered as a source of income to recover indefinite lived NOLs.  Consequently, the Company has offset certain of its naked credit deferred tax liability against its deferred tax assets resulting in a reduction in the valuation allowance and a </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;benefit in the year ended May 31, 2018.  </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Tax Reform Act imposes a one-time transition tax on the deemed repatriation of post-1986 undistributed foreign subsidiaries&#8217; earnings. Based on the information available as of December 31, 2017, the Company estimated undistributed foreign earnings of approximately </font><font style="font-family:inherit;font-size:10pt;">$4.9 million</font><font style="font-family:inherit;font-size:10pt;">. The taxable income arising from this deemed repatriation is expected to result in the utilization of net operating loss carryforwards and other tax credits, offset by changes in the valuation allowance, resulting in no net impact to tax expense.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:52px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Tax Reform Act also creates a new requirement that certain income earned by foreign subsidiaries (&#8220;GILTI&#8221;), must be included in U.S. gross income. The FASB allows an accounting policy election of either recognizing deferred taxes for temporary differences expected to reverse as GILTI in future years or recognizing such taxes as a current period expense when incurred.  The Company has not yet adopted an accounting policy.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The other provisions of the Tax Reform Act are not expected to have a material impact on the Company's financial statements.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company regularly assesses its ability to realize its deferred tax assets. Assessing the realization of deferred tax assets requires significant management judgment. In determining whether its deferred tax assets are more likely than not realizable, the Company evaluated all available positive and negative evidence, and weighted the evidence based on its objectivity. Evidence the Company considered included its history of net operating losses, which resulted in the Company recording a full valuation allowance for its deferred tax assets in fiscal 2016 and each year thereafter. The Company was marginally profitable (pretax and adjusted for permanent items) on a cumulative basis for the three years ended May 31, 2018, but substantially all of that profitability was achieved during 2018. </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on the review of all available evidence, the Company determined that it has not yet attained a sustained level of profitability and the objectively verifiable negative evidence outweighed the positive evidence and therefore the Company has provided a valuation allowance for the full amount, with the exception of the naked credit deferred tax liability, of its net deferred tax asset as of May 31, 2018.  The decrease in the valuation allowance during fiscal 2018 was principally due to the impact of tax reform as discussed above. The Company will continue to assess the level of the valuation allowance required. If sufficient positive evidence exists in future periods to support a release of some or all of the valuation allowance, such a release would likely have a material impact on the Company&#8217;s results of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's consolidated income tax expense has differed from the amount that would be provided by applying the U.S. Federal statutory income tax rate to the Company's income before income taxes for the following reasons:</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:50%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax (benefit) expense at statutory tax rate of 28.6%, 35.0% and 35.0%, respectively</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,136</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,447</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of graduated tax rates</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(98</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State income taxes, net of Federal tax benefit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(215</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Impact of Non-U.S. operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(288</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">403</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(162</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development tax credit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(951</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(403</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(499</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Impact of tax reform </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,912</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Meals and entertainment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">242</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">266</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">329</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-deductible interest on contingent payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">174</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">262</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-taxable gain on revaluation of contingent consideration liability</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,576</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(170</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in valuation allowance</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,741</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,139</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,685</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of elimination of stock compensation APIC pool</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,380</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">739</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">IPR&amp;D intangible write-off</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,224</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">700</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">474</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax (benefit) expense</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,870</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,839</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,337</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a reconciliation of the beginning and ending amount of unrecognized tax benefits:</font></div><div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:49%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrecognized tax benefits balance at June 1 </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">899</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">899</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increase in gross amounts of tax positions related to prior years</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">899</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decrease in gross amounts of tax positions related to prior years due to U.S. tax reform</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(287</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decrease due to lapse in statute of limitations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(148</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrecognized tax benefits balance at May 31</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">464</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">899</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">899</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table above includes unrecognized tax benefits associated with the calculation of limitations placed on the utilization of tax attributes related to an acquired company. If recognized </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;would result in adjustments to other tax accounts. &#160; </font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense. There are no accrued interest and penalties recognized in the consolidated balance sheet as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company files income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. In the normal course of business the Company is subject to examination by taxing authorities throughout the world.  Fiscal years 2015 through 2018 remain open to examination by the various tax authorities. </font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company does not anticipate that the amount of unrecognized tax benefits will significantly change in the next twelve months.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accumulated undistributed earnings of the Company&#8217;s foreign operations amounted to </font><font style="font-family:inherit;font-size:10pt;">$4.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$5.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;at May 31, 2018 and 2017, respectively. These earnings are considered indefinitely reinvested.  Beginning in 2018, except for </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GILTI, the Company will no longer record United States federal income tax on its share of the income of its foreign subsidiaries, nor will it record a benefit for foreign tax credits related to that income.&#160; Upon distribution of these earnings in the form of dividends or otherwise, the Company would be subject to withholding taxes payable, where applicable, to foreign countries, but would have no further federal income tax liability.</font></div><div><a name="sC963EDCD2DE15733B7E3FAEA2361C537"></a></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">10.  ACCRUED LIABILITIES</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, accrued liabilities consist of the following:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:65%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May&#160;31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payroll and related expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,235</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,383</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalties</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,537</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,885</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued severance</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,940</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,075</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales and franchise taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">683</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">856</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outside services</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,396</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,622</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Litigation matters (Note 15)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,500</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,500</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acculis recall liability</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,563</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,135</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,920</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,426</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,804</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth quarter of fiscal year 2017, the Company issued a voluntary recall of its Acculis probes that were sold over the past </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;">&#32;years and recorded a liability of </font><font style="font-family:inherit;font-size:10pt;">$2.6 million</font><font style="font-family:inherit;font-size:10pt;">.  In the third quarter of fiscal year 2018, the Company completed the replacement of Acculis probes that were returned for Solero probes. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s7DFCEECF552A52F4B5CFFA4DC9757C03"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">11.  LONG-TERM DEBT</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 7, 2016, the Company entered into a Credit Agreement with the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, Bank of America, N.A. and Keybank National Association as co-syndication agents, and JPMorgan Chase Bank, N.A., Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated and Keybank National Association as joint bookrunners and joint lead arrangers.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Credit Agreement provides for a </font><font style="font-family:inherit;font-size:10pt;">$100.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;senior secured term loan facility and a </font><font style="font-family:inherit;font-size:10pt;">$150.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;senior secured revolving credit facility, which includes up to a </font><font style="font-family:inherit;font-size:10pt;">$20.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;sublimit for letters of credit and a </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;sublimit for swingline loans.  </font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 7, 2016, the Company borrowed </font><font style="font-family:inherit;font-size:10pt;">$100.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;under the Term Loan and approximately </font><font style="font-family:inherit;font-size:10pt;">$16.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;under the Revolving Facility to repay the balance of </font><font style="font-family:inherit;font-size:10pt;">$116.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;under the former credit agreement.  As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;the carrying value of long-term debt approximates its fair market value.  </font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The proceeds of the Revolving Facility may be used for general corporate purposes of the Company and its subsidiaries. The Facilities have a </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">&#32;year maturity.&#160; Interest on both the Term Loan and Revolving Facility are based on a base rate or Eurodollar rate plus an applicable margin which increases as total leverage ratio increases, with the base rate and Eurodollar rate having ranges of </font><font style="font-family:inherit;font-size:10pt;">0.50%</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">1.25%</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">1.50%</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">2.25%</font><font style="font-family:inherit;font-size:10pt;">&#32;respectively.  In case of default, the interest rate may be increased by </font><font style="font-family:inherit;font-size:10pt;">2.0%</font><font style="font-family:inherit;font-size:10pt;">.&#160;The Revolving Facility carries a commitment fee of </font><font style="font-family:inherit;font-size:10pt;">0.20%</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">0.35%</font><font style="font-family:inherit;font-size:10pt;">&#160;per annum on the unused portion.  The interest rate on the Term Loan at </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;was </font><font style="font-family:inherit;font-size:10pt;">3.41%</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's obligations under the Facilities are unconditionally guaranteed, jointly and severally, by the Company's material direct and indirect domestic subsidiaries (the &#8220;Guarantors&#8221;). All obligations of the Company and the Guarantors under the Facilities are secured by first priority security interests in substantially all of the assets of the Company and the Guarantors.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Credit Agreement includes customary representations, warranties and covenants, and acceleration, indemnity and events of default provisions, including, among other things, two quarterly financial covenants as follows:&#160;</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;padding-left:48px;padding-top:16px;text-indent:32px;"><font style="padding-top:16px;font-family:inherit;font-size:10pt;padding-right:16px;">&#8226;</font><font style="font-family:inherit;font-size:10pt;">maximum leverage ratio of consolidated total indebtedness* to consolidated EBITDA* of not greater than </font><font style="font-family:inherit;font-size:10pt;">3.50</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">1.00</font><font style="font-family:inherit;font-size:11pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">(during certain periods following material acquisitions shall be increased to </font><font style="font-family:inherit;font-size:10pt;">3.75</font><font style="font-family:inherit;font-size:10pt;">&#32;to 1.00). </font></div><div style="line-height:120%;padding-left:48px;padding-top:16px;text-indent:32px;"><font style="padding-top:16px;font-family:inherit;font-size:10pt;padding-right:16px;">&#8226;</font><font style="font-family:inherit;font-size:10pt;">&#32;fixed charge coverage ratio of consolidated EBITDA minus consolidated capital expenditures to&#160;consolidated interest expense paid or payable in cash plus scheduled principal payments in respect of indebtedness under the Credit Agreement of not less than </font><font style="font-family:inherit;font-size:10pt;">1.25</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">1.00</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:16px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">* The definitions of consolidated total indebtedness and consolidated EBITDA are maintained in the credit agreement included as an exhibit to Form 8-k filed on November 10, 2016 and in Amendment One, dated May 24, 2018 and included as an exhibit to the fiscal 2018 Form 10-K. This amendment increased the amount of U.S. cash that can be utilized to calculate net debt from </font><font style="font-family:inherit;font-size:8pt;">$10.0 million</font><font style="font-family:inherit;font-size:8pt;">&#32;to </font><font style="font-family:inherit;font-size:8pt;">$20.0 million</font><font style="font-family:inherit;font-size:8pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company was in compliance with both covenants as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's maturities of principal obligations under the credit agreement are as follows, as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:90%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,500</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,750</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total term loan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revolving facility</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Unamortized debt issuance costs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(879</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91,621</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Current portion of long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total long-term debt, net of current portion</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86,621</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s20B0E4461D7C55388FB64A4F1479B5B5"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">12.  RETIREMENT PLANS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has a 401(k) plan under which eligible employees can defer a portion of their compensation, part of which is matched by the Company. Matching contributions were </font><font style="font-family:inherit;font-size:10pt;">$3.9 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$4.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$3.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. There are also various immaterial foreign retirement plans. </font></div><div><a name="s953D571CCE9D56A3B24048E72CF84F54"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">13.  STOCKHOLDERS&#8217; EQUITY </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Capitalization</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 29, 2014, the Board of Directors approved the Amended and Restated Certificate of Incorporation (the &#8220;Amended Certificate&#8221;). Under the Amended Certificate, the authorized capital stock is </font><font style="font-family:inherit;font-size:10pt;">80,000,000</font><font style="font-family:inherit;font-size:10pt;">&#32;shares, consisting of </font><font style="font-family:inherit;font-size:10pt;">75,000,000</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of common stock, par value </font><font style="font-family:inherit;font-size:10pt;">$.01</font><font style="font-family:inherit;font-size:10pt;">&#32;per share and </font><font style="font-family:inherit;font-size:10pt;">5,000,000</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of preferred stock, par value </font><font style="font-family:inherit;font-size:10pt;">$.01</font><font style="font-family:inherit;font-size:10pt;">&#32;per share. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The holders of common stock are entitled to </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">&#32;vote for each share held. Subject to preferences applicable to any outstanding shares of preferred stock, the holders of common stock are entitled to receive ratably dividends, if any, as may be declared by the Board of Directors out of funds legally available for dividend payments. If the Company liquidates, dissolves, or winds up, the holders of common stock are entitled to share ratably in all assets remaining after payment of liabilities and liquidation preferences of any outstanding shares of preferred stock. Holders of common stock have no pre-emptive rights or rights to convert their common stock into any other securities. There are no redemption or sinking fund provisions applicable to the common stock. The rights, preferences and privileges of the holders of common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that the Company may designate in the future.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The board of directors has the authority to (i)&#160;issue the undesignated preferred stock in one or more series, (ii)&#160;determine the powers, preferences and rights and the qualifications, limitations or restrictions granted to or imposed upon any wholly un-issued series of undesignated preferred stock and (iii)&#160;fix the number of shares constituting any series and the designation of the series, without any further vote or action by the Company's stockholders.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Stock Options</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">2004 Stock and Incentive Award Plan</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2004 Stock and Incentive Award Plan (the &#8220;2004 Plan&#8221;) provides for the grant of incentive options to employees and for the grant of non-statutory stock options, restricted stock, stock appreciation rights, performance units, performance shares and other incentive awards to employees, directors and other service providers. A total of </font><font style="font-family:inherit;font-size:10pt;">7,000,000</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of common stock have been reserved for issuance under the 2004 Plan, of which up to </font><font style="font-family:inherit;font-size:10pt;">800,000</font><font style="font-family:inherit;font-size:10pt;">&#32;shares may be issued upon the exercise of incentive stock options. The compensation committee of the Board of Directors administers the 2004 Plan. The committee determines vesting terms and the exercise price of options granted under the 2004 Plan, but for all incentive stock options the exercise price must at least be equal to the fair market value of common stock on the date of grant. The term of an incentive stock option may not exceed </font><font style="font-family:inherit;font-size:10pt;">ten years</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October&#160;25, 2016, the Company amended the 2004 Stock and Incentive Award Plan to increased the shares of common stock reserved for issuance by </font><font style="font-family:inherit;font-size:10pt;">250,000</font><font style="font-family:inherit;font-size:10pt;">&#32;shares.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, there remained approximately </font><font style="font-family:inherit;font-size:10pt;">1.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;shares available for granting under the 2004 Plan. </font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes information about stock option activity for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"></td></tr><tr><td style="width:57%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted-</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">exercise</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">remaining</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">contractual</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">life</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Aggregate</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">intrinsic</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">value (in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">thousands)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at beginning of year - June 1, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,667,443</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.01</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">518,498</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(271,344</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.83</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(204,184</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.75</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at end of year - May 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,696,413</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.58</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,520</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options exercisable at year-end</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">652,543</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.41</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.48</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,321</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options expected to vest in future periods</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,043,870</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.05</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,199</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options are granted at exercise prices equal to the quoted market price of common stock at the date of the grant. Options vest </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;">&#160;per year over </font><font style="font-family:inherit;font-size:10pt;">four years</font><font style="font-family:inherit;font-size:10pt;">&#32;for employees.  Grants to directors vest </font><font style="font-family:inherit;font-size:10pt;">33.33%</font><font style="font-family:inherit;font-size:10pt;">&#160;per year over </font><font style="font-family:inherit;font-size:10pt;">three years</font><font style="font-family:inherit;font-size:10pt;">.  Stock options granted prior to May 1, 2007 and after June 1, 2017 expire on the tenth anniversary of the grant date.  Stock options granted between May 1, 2007 through May 31, 2017 expire on the seventh anniversary of the grant date. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company measures the fair value of each stock option grant at the date of grant using a Black-Scholes option pricing model.  The weighted average grant-date fair value of options granted during the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">&#32;was </font><font style="font-family:inherit;font-size:10pt;">$4.95</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$4.70</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$4.16</font><font style="font-family:inherit;font-size:10pt;">, respectively.  The following assumptions were used in arriving at the fair value of options granted during </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively:  risk-free interest rates of </font><font style="font-family:inherit;font-size:10pt;">2.08%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">1.30%</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">1.48%</font><font style="font-family:inherit;font-size:10pt;">; expected volatility of </font><font style="font-family:inherit;font-size:10pt;">30%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">31%</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">31%</font><font style="font-family:inherit;font-size:10pt;">; and expected lives of </font><font style="font-family:inherit;font-size:10pt;">4.72 years</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">4.80 years</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">4.81 years</font><font style="font-family:inherit;font-size:10pt;">.  The Company does not declare dividends therefore a dividend yield of zero was used for the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">.  Risk-free interest rates reflect the yield on zero-coupon U.S. Treasury bonds whose maturity period equals the expected term of the option.  Expected volatilities are based on the historical volatility of the Company's stock.  The expected option lives are based on historical experience of employee exercise behavior. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The total intrinsic value of options exercised during the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">&#32;was </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$2.8 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.  As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, there was </font><font style="font-family:inherit;font-size:10pt;">$3.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of total unrecognized compensation cost related to non-vested options, which is expected to be recognized over a weighted average period of </font><font style="font-family:inherit;font-size:10pt;">3 years</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;Cash received from option exercises during 2018, 2017 and 2016 was </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$9.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.  The tax benefit realized from stock options exercised during the year ended May 31, </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">&#32;was </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">.  Due to the valuation allowance there was </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;">&#32;tax benefit realized from stock option exercises during the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Performance Share and Restricted Stock Unit Awards</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company grants restricted stock units to certain employees under the 2004 Plan which give the recipients the right to receive shares of Company stock upon vesting. The restricted stock unit awards vest in four equal annual installments beginning on the first anniversary of the grant date.  Restricted stock unit awards granted to directors vest&#160;over </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">&#32;year. Unvested restricted stock unit awards will be forfeited if the recipient ceases to be employed by the Company. </font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;The following table summarizes information about restricted stock unit activity for the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:61%;"></td><td style="width:18%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restricted Stock Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted&#160;Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Grant-Date&#160;Fair&#160;Value</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested at beginning of year, June 1, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">439,297</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.55</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">299,392</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.60</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(158,756</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canceled</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(105,431</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.25</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested at end of year, May 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">474,502</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.23</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of each restricted stock unit is the market price of Company stock on the date of grant.  The weighted average grant date fair value of restricted stock units granted during the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">&#32;was </font><font style="font-family:inherit;font-size:10pt;">$16.60</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$16.54</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$15.21</font><font style="font-family:inherit;font-size:10pt;">, respectively.  The total intrinsic value of restricted stock units (meaning the fair value of the units on the date of vest) vesting during the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">&#32;was </font><font style="font-family:inherit;font-size:10pt;">$2.7 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$2.9 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;">,&#160;respectively.  As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, there was </font><font style="font-family:inherit;font-size:10pt;">$5.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of total unrecognized compensation cost related to non-vested restricted stock awards, which is expected to be recognized over a weighted average period of </font><font style="font-family:inherit;font-size:10pt;">3 years</font><font style="font-family:inherit;font-size:10pt;">.   </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company grants performance share awards to certain employees under the 2004 Plan which gives the recipients the right to receive shares of Company stock if certain criteria is met. The performance criteria is established by the compensation committee for vesting of the performance share awards and is determined by the achievement of relative total shareholder return ("TSR"). Performance share awards are subject to additional conditions, including the recipient&#8217;s continued employment with the Company. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;The following table summarizes information about performance unit award activity for the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:61%;"></td><td style="width:18%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Performance Unit Awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted&#160;Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Grant-Date&#160;Fair&#160;Value</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested at beginning of year, June 1, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">361,164</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.54</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135,135</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.83</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canceled</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(44,443</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.76</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested at end of year, May 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">451,856</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During fiscal years 2018, 2017 and 2016, we granted performance unit awards that include a three-year market condition.  Vesting of the performance unit awards is based on the Company's level of attainment of specified total shareholder return ("TSR") targets relative to the percentage appreciation of a specified index of companies for the respective three-year periods.  It is also subject to the continued employment of the grantees.  In order to estimate the fair value of such awards, we used a </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Monte Carlo Simulation valuation model on the date of the grant.  For the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, the weighted average grant date fair market value for new grants was </font><font style="font-family:inherit;font-size:10pt;">$23.83</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$22.61</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$18.07</font><font style="font-family:inherit;font-size:10pt;">, respectively.  Compensation cost is recognized over the performance period which is typically </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;years.  As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">0.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;performance share units with a weighted average remaining contractual term of </font><font style="font-family:inherit;font-size:10pt;">2</font><font style="font-family:inherit;font-size:10pt;">&#32;years and </font><font style="font-family:inherit;font-size:10pt;">$3.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of unrecognized compensation cost were outstanding. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Compensation Expense</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables represents the break out of share-based compensation included in the Company's consolidated statement of operations:</font></div><div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"></td></tr><tr><td style="width:60%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">119</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">299</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">172</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">554</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">314</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales and marketing</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,778</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,762</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,489</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,461</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,026</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,291</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition, restructuring and other items, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(218</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,061</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,912</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,183</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,240</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The income tax benefit on the compensation expense recognized for all share-based compensation arrangements was </font><font style="font-family:inherit;font-size:10pt;">$1.8 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$2.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.  The income tax benefit for 2018, 2017 and 2016 are negated by the full valuation allowance established as of May 31, 2016.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Employee Stock Purchase Plan</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Employee Stock Purchase Plan (the &#8220;Stock Purchase Plan&#8221;) provides a means by which employees (the &#8220;participants&#8221;) are given an opportunity to purchase the Company's common stock through payroll deductions.   A total of  </font><font style="font-family:inherit;font-size:10pt;">2,500,000</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of common stock have been reserved for issuance under the Stock Purchase Plan.  Shares are offered through </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;">&#32;purchase periods, each with duration of approximately </font><font style="font-family:inherit;font-size:10pt;">6 months</font><font style="font-family:inherit;font-size:10pt;">, commencing on the first business day of the first and third fiscal quarters. An employee is eligible to participate in an offering period if, on the first day of an offering period, he or she has been employed in a full-time capacity for at least </font><font style="font-family:inherit;font-size:10pt;">six months</font><font style="font-family:inherit;font-size:10pt;">, with a customary working schedule of </font><font style="font-family:inherit;font-size:10pt;">20 or more hours per week and more than five months in a calendar year</font><font style="font-family:inherit;font-size:10pt;">. Employees who own stock possessing </font><font style="font-family:inherit;font-size:10pt;">5%</font><font style="font-family:inherit;font-size:10pt;">&#32;or more of the total combined voting power or value of all classes of stock are not eligible to participate in the Stock Purchase Plan. The purchase price of the shares of common stock acquired on each purchase date will be the lower of (i)&#160;</font><font style="font-family:inherit;font-size:10pt;">85%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the fair market value of a share of common stock on the first day of the offering period or (ii)&#160;</font><font style="font-family:inherit;font-size:10pt;">85%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the fair market value of a share of common stock on the last day of the purchase period, subject to adjustments made by the Board of Directors. The Stock Purchase Plan is intended to qualify as an &#8220;employee stock purchase plan&#8221; within the meaning of Section&#160;423 of the Internal Revenue Code.  During the year ended May 31, 2015, an additional </font><font style="font-family:inherit;font-size:10pt;">800,000</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of the Company's common stock have been reserved for issuance under the Stock Purchase Plan.  During the year ended May 31, 2017, an additional </font><font style="font-family:inherit;font-size:10pt;">500,000</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of the Company's common stock were reserved for issuance under the Stock Purchase Plan.  </font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company uses the Black-Scholes option-pricing model to calculate the purchase date fair value of the shares issued under the Stock Purchase Plan and recognize expense related to shares purchased ratably over the offering period.  During the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">89,943</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">129,185</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">137,957</font><font style="font-family:inherit;font-size:10pt;">&#32;shares, respectively, were issued at an average price of </font><font style="font-family:inherit;font-size:10pt;">$14.03</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$11.00</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$10.67</font><font style="font-family:inherit;font-size:10pt;">, respectively, under the Stock Purchase Plan.  As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">1.2</font><font style="font-family:inherit;font-size:10pt;">&#32;million shares remained available for future purchases under the Stock Purchase Plan.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Share Repurchases</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 6, 2016, the Board of Directors approved the Repurchase Program under which they authorized the Company the option to repurchase up to&#160;</font><font style="font-family:inherit;font-size:10pt;">$25.0 million</font><font style="font-family:inherit;font-size:10pt;">&#160;of its outstanding common stock during the </font><font style="font-family:inherit;font-size:10pt;">twenty-four</font><font style="font-family:inherit;font-size:10pt;">&#32;month period ending November 6, 2018.  During the second quarter of fiscal year 2017, the Company repurchased </font><font style="font-family:inherit;font-size:10pt;">500,000</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of common stock in the open market at an aggregate cost of </font><font style="font-family:inherit;font-size:10pt;">$7.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;under the Repurchase Program.  During the fourth quarter of fiscal year 2017, the Company repurchased </font><font style="font-family:inherit;font-size:10pt;">370,000</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of common stock in the open market at an aggregate cost of </font><font style="font-family:inherit;font-size:10pt;">$5.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;under the Repurchase Program.  As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$11.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;remained available for repurchase under the Repurchase Program.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2017, the Company retired </font><font style="font-family:inherit;font-size:10pt;">642,305</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of treasury stock.  These retired shares are now included in the Company&#8217;s pool of authorized but unissued shares.  The retired stock had a carrying value of approximately </font><font style="font-family:inherit;font-size:10pt;">$9.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$0.01</font><font style="font-family:inherit;font-size:10pt;">&#32;was the par value that was deducted from common stock and the remaining </font><font style="font-family:inherit;font-size:10pt;">$9.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;was deducted from additional paid-in capital. </font></div><div><a name="s260AE8C457D753ECA8FA083B66708173"></a></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">14.  EARNINGS PER SHARE</font></div><div style="line-height:120%;padding-top:18px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings per share are based on the weighted average number of common shares outstanding.  In addition, diluted earnings per share include the dilutive effect of potential common stock consisting of stock options, restricted stock units and performance stock units, provided that the inclusion of such securities is not anti-dilutive.  In periods with a net loss, stock options and restricted stock units are not included in the computation of basic loss per share as the impact would be anti-dilutive. </font></div><div style="line-height:120%;padding-top:18px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table reconciles basic to diluted weighted average shares outstanding for the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:18px;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"></td></tr><tr><td style="width:45%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:2%;"></td><td style="width:16%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,074,797</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,616,859</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,161,383</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of dilutive securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">464,603</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342,391</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,539,400</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,959,250</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,161,383</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Securities excluded as their inclusion would be anti-dilutive</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,077,256</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,058,790</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,277,037</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s2FB2FEA4840756AE83C21048ECFB1234"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">15.  COMMITMENTS AND CONTINGENCIES</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Leases</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is committed under non-cancelable operating leases for facilities and equipment. During fiscal </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, aggregate rental costs under all operating leases were approximately </font><font style="font-family:inherit;font-size:10pt;">$2.8 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. Future annual payments under non-cancelable operating leases in the aggregate, of which one includes an escalation clause, with initial remaining terms of more than one year at </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, are summarized as follows (in thousands):</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:81%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,234</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,829</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">993</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">884</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023 and thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,668</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,608</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Commitments and Contingencies </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the Company's other future commitments and contingencies as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"></td></tr><tr><td style="width:41%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2023 and thereafter</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase obligations (1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56,201</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,751</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,243</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,485</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,189</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,533</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalties</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,500</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">667</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">166</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101,868</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,918</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,910</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,152</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,855</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,033</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The non-cancelable inventory purchase obligations are not reflected on our consolidated balance sheets under accounting principles generally accepted in the United States of America.</font></div></td></tr></table><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Legal Proceedings</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is involved in various legal proceedings, including commercial, intellectual property, product liability, and regulatory matters of a nature considered normal for its business. The Company accrues for amounts related to these matters if it is probable that a liability has been incurred, and an amount can be reasonably estimated. The Company discloses such matters when there is at least a reasonable possibility that a material loss may have been incurred. However, the Company cannot predict the outcome of any litigation or the potential for future litigation.</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">C.R. Bard, Inc. v. AngioDynamics, Inc.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January&#160;11, 2012, C.R. Bard, Inc. (&#8220;Bard&#8221;) filed a suit in the United States District Court of Utah claiming certain of our implantable port products infringe on&#160;</font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;U.S. patents held by Bard (the &#8220;Utah Action&#8221;). Bard&#8217;s Complaint sought unspecified damages and other relief. We filed petitions for reexamination in the U.S. Patent and Trademark Office (&#8220;USPTO&#8221;) seeking to invalidate all </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;patents asserted by Bard in the litigation. Our petitions were granted and </font><font style="font-family:inherit;font-size:10pt;">40 of Bard's 41 patent</font><font style="font-family:inherit;font-size:10pt;">&#32;patent claims were rejected and, following further proceedings, the Patent Office issued a Final Rejection of all </font><font style="font-family:inherit;font-size:10pt;">40</font><font style="font-family:inherit;font-size:10pt;">&#32;claims subject to reexamination. Thereafter, Bard filed appeals to the USPTO Board of Appeals and Interferences for all&#160;three&#160;reexaminations. The Patent Office issued decisions in all </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;appeals. In one (issued on March 11, 2016 for U.S. Patent No. 7,785,302), the rejections of </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;">&#32;of the </font><font style="font-family:inherit;font-size:10pt;">ten</font><font style="font-family:inherit;font-size:10pt;">&#32;claims under reexamination were affirmed, but were reversed on </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;">&#32;of the ten claims. &#160;&#160;In the second (issued on March 24, 2016 for U.S. Patent No. 7,959,615), the rejections of&#160;</font><font style="font-family:inherit;font-size:10pt;">eight</font><font style="font-family:inherit;font-size:10pt;">&#32;of the </font><font style="font-family:inherit;font-size:10pt;">ten</font><font style="font-family:inherit;font-size:10pt;">&#32;claims under reexamination were affirmed but the rejections of the other </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;">&#32;of the ten claims were reversed. In the third (issued on March 29 for U.S. Patent No. 7,947.022) the rejections of all&#160; </font><font style="font-family:inherit;font-size:10pt;">twenty</font><font style="font-family:inherit;font-size:10pt;">&#32;claims under reexamination were affirmed. Thereafter, Bard filed Requests for Rehearing in all&#160;</font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;reexamination appeals and the Company filed Requests for Rehearing in </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;">&#32;of the reexamination appeals (the &#8216;302 and &#8216;615 patent reexaminations). The PTO denied all three Rehearing Requests - - on February 1, 2017 for the &#8216;302 reexam; on February 17, 2017 for the &#8216;022 reexam; and on February 21, 2017 for the &#8216;615 reexam, but modified its characterization of one prior art reference for the &#8216;302 and &#8216;022 decisions.&#160; Bard filed a Notice of Appeal to the Federal Circuit Court of Appeals in all three reexams and the Company filed Cross-Appeals for the &#8216;302 and the &#8216;615 reexams. The parties have completed the process of filing the various appellate briefs. &#160;MedComp also filed an Amicus Brief in support of the Company on November 22, 2017. A date for the oral hearing has not yet been set. The Utah Action has been stayed pending final resolution of the USPTO process.&#160;We believe these claims are without merit and intend to defend them vigorously. We have not recorded an expense related to the outcome of this litigation because it is not yet possible to determine if a potential loss is probable nor reasonably estimable.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">90</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 10, 2015, C.R. Bard, Inc. (&#8220;Bard&#8221;) and Bard Peripheral Vascular, Inc. (&#8220;BPV&#8221;) filed suit in the United States District Court for the District of Delaware claiming certain of our implantable port products infringe on&#160; </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;U.S. patents held by Bard (the &#8220;Delaware Action&#8221;). Bard's complaint seeks unspecified damages and other relief. The patents asserted in the Delaware Action are different than those asserted in the Utah Action. On June 1, 2015, the Company filed </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;">&#32;motions in response to Bard&#8217;s Complaint - one sought transfer to the District of Utah where the Utah Action is currently pending, and the other sought dismissal of the entire complaint on grounds that none of the claims in the asserted patents is directed to patent eligible subject matter under Section 101 of the Patent Statute and in light of recent authority from the U. S. Supreme Court. On January 12, 2016, the Court issued a decision denying both motions. A Markman hearing was held on March 10, 2017 and the Court issued its Claim Construction Order on May 19, 2017. On May 19, 2017, Bard served its Final Infringement Contentions and on June 2, 2017, the Company served its Final Invalidity Contentions.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 20, 2017, the scheduling order for the case was amended to, among other things, set a trial date commencing July 23, 2018.&#160;The parties completed Expert Discovery in January 2018.  The parties completed briefing on their respective case dispositive motions on April 27, 2018. On June 26, 2018, the Court denied all case dispositive motions, ruling that issues of material fact remained in dispute. On July 9, 2018, the Court continued the trial to a later date to be determined by the Court and the parties.  We believe these claims are without merit and intend to defend them vigorously. We have not recorded an expense related to the outcome of this litigation because it is not yet possible to determine if a potential loss is probable nor reasonably estimable.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">AngioDynamics, Inc. v. C.R. Bard, Inc.  </font></div><div style="line-height:120%;text-align:left;text-indent:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 30, 2017, we commenced an action in the United States District Court for the Northern District of New York entitled AngioDynamics, Inc. v. C.R. Bard, Inc. and Bard Access Systems, Inc. (&#8220;Bard&#8221;). &#160;In this action, we allege that Bard has illegally tied the sales of its tip location systems to the sales of its PICCs.&#160; We allege that this practice violates the federal antitrust laws and has had, and continues to have, an anti-competitive effect in the market for PICCs.&#160; We seek both monetary damages and injunctive relief.  Bard moved to dismiss on September 8, 2017 and the motion has been submitted to the court.&#160; The court has adjourned the initial conference in the case pending its resolution of the motion to dismiss. </font></div><div style="line-height:120%;text-align:left;text-indent:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Governmental Investigations</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2014 we received a subpoena from the U.S. Department of Justice (the &#8220;DOJ&#8221;) requesting documents in relation to a criminal and civil investigation the DOJ is conducting regarding BTG International, Inc.&#8217;s LC Bead&#174;&#160;product beginning in 2003.&#160; RITA Medical Systems and AngioDynamics, Inc., after its acquisition of RITA, was the exclusive distributor of LC Beads in the United States from 2006 through December 31, 2011.&#160; We are cooperating fully with this investigation.  </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2015 we received a subpoena from the DOJ requesting documents in relation to a criminal and civil investigation the DOJ is conducting regarding purported promotion of certain of AngioDynamics&#8217; VenaCure EVLT products for un-cleared indications.&#160; We are cooperating fully with this investigation.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of May 31, 2017 the Company accrued </font><font style="font-family:inherit;font-size:10pt;">$12.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for these matters and in August 2017, the Company agreed in principle with the government to resolve these matters for approximately </font><font style="font-family:inherit;font-size:10pt;">$12.5 million</font><font style="font-family:inherit;font-size:10pt;">.  This amount was still accrued for at May 31, 2018 and was paid in the first quarter of fiscal year 2019.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s729CFE8F2108578487FE425117CC2795"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">16.  SEGMENTS AND GEOGRAPHIC INFORMATION</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Segment information</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company considers its business to be a single segment entity related to the development, manufacture and sale on a global basis of medical devices for vascular access, surgery, peripheral vascular disease and oncology. The Company's chief operating decision maker (CEO) evaluates the various global product portfolios on a net sales basis. Executives reporting in to the CEO include those responsible for operations and supply chain management, research and development, sales, franchise marketing and certain corporate functions. The CEO evaluates profitability, investment and cash flow metrics on a consolidated worldwide basis due to shared infrastructure and resources. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total sales by product category are summarized below (in thousands):</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:50%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales by Product Category</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Peripheral Vascular</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">202,334</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208,602</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">205,620</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vascular Access</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92,760</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96,481</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99,375</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Oncology/Surgery</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,191</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,560</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,895</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">344,285</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349,643</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353,890</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Geographic information</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total sales for geographic areas are summarized below (in thousands):</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:50%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales by Geography</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">273,327</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282,168</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">285,824</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70,958</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67,475</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,066</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">344,285</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349,643</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353,890</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For fiscal years </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, International sales as a percentage of total net sales were </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">19%</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">19%</font><font style="font-family:inherit;font-size:10pt;">, respectively. Sales to any </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">&#32;country outside the U.S., as determined by shipment destination, did not comprise a material portion of net sales in any of the last three fiscal years. In addition, no one customer represents more than 10% of consolidated net sales.  </font><font style="font-family:inherit;font-size:10pt;">99%</font><font style="font-family:inherit;font-size:10pt;">&#32;of long-lived assets are located within the United States.  </font></div><div><a name="s4CB174123D8B51BAB6C97ED5413B60BB"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">17.  ACQUISITION, RESTRUCTURING AND OTHER ITEMS, NET</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">&#32;acquisition, restructuring and other items, net consisted of:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"></td></tr><tr><td style="width:47%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Legal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,067</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,480</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,487</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible and other asset impairment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,604</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">352</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,674</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,348</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,462</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">691</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,078</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,290</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,432</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,510</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,591</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Of the </font><font style="font-family:inherit;font-size:10pt;">$19.5</font><font style="font-family:inherit;font-size:10pt;">&#32;million in legal for fiscal year 2017, </font><font style="font-family:inherit;font-size:10pt;">$12.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;relates to a reserve for DOJ litigation settlement (see Note 15) and the remaining legal expenses relates to DOJ matters.  The remaining legal expenses relate to litigation that is outside of the normal course of business. </font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Restructuring</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluates its performance and looks for opportunities to improve the overall operations of the Company on an ongoing basis.  As a result of this evaluation, certain restructuring initiatives are taken to enhance the Company&#8217;s overall operations.  </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Operational Consolidation </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 1, 2017, the Company announced to employees an operational consolidation plan (the &#8220;plan&#8221;) to consolidate manufacturing facilities in Manchester, GA and Denmead, UK into the Glens Falls and Queensbury, NY facilities.  This plan will streamline and optimize the manufacturing functions into one centralized location increasing the utilization of the Glens Falls and Queensbury facilities, optimizing inventory and reducing cost of goods sold through savings in overhead expenses and direct labor.  The restructuring activities associated with the plan were completed in the fourth quarter of fiscal year 2018 with immaterial validation costs to be incurred in the first quarter of fiscal year 2019.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recorded restructuring charges related to the plan during the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;">$4.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.  Total restructuring charges recorded as part of the plan were </font><font style="font-family:inherit;font-size:10pt;">$6.0 million</font><font style="font-family:inherit;font-size:10pt;">.  Termination benefits are only earned if an employee stays until their termination date; therefore, the expenses related to termination benefits are being recorded ratably over the service period.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents a rollforward of the restructuring reserve for the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25"></td></tr><tr><td style="width:25%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Contract</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Termination</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Plant </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Regulatory</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cancellation </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Benefits</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Consolidation</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Filings</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Costs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Costs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Charges</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">851</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">494</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,348</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-cash adjustments </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(108</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(108</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(275</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(278</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">851</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">962</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Charges</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,440</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,892</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,674</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-cash adjustments </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(276</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(276</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,453</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,706</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(56</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(74</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,289</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">838</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,071</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s restructuring liability of </font><font style="font-family:inherit;font-size:10pt;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;is mainly comprised of accruals for termination benefits which are expected to be paid in the next twelve months and are included in accrued expenses on the consolidated balance sheet.  </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></div><hr style="page-break-after:always"><div><a name="s2B857B0A441357658E8979388EA68D6F"></a></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">18.  ACCUMULATED OTHER COMPREHESIVE INCOME (LOSS)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in each component of accumulated other comprehensive income (loss), net of tax, are as follows for fiscal </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"></td></tr><tr><td style="width:64%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign currency translation gain (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unrealized gain (loss) on marketable securities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(760</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(791</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss) before reclassifications, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(545</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(533</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reclassified from accumulated other comprehensive income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net other comprehensive income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(545</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(533</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,305</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,324</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income before reclassifications, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">372</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reclassified from accumulated other comprehensive income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net other comprehensive income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">372</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,035</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(952</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s56A29ABBB5D15C928873C7EB8313C725"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">19.  QUARTERLY INFORMATION (unaudited)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quarterly results of operations during the fiscal years ended May 31, </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;are as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:41%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">First</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Second</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Third</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fourth</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands, except per share data)</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85,411</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86,706</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,851</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,317</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,229</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,731</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,448</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,467</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) </font><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">249</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings (loss) per common share</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.00</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.06</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.00</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.01</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.37</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.06</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:41%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">First</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Second</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Third</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fourth</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands, except per share data)</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,098</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,029</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85,602</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86,914</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,032</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,010</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,792</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,335</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) </font><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,734</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,887</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,913</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings (loss) per common share</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.04</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.08</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.04</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.37</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.08</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.35</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1) Included within net income during the third quarter of fiscal 2018 is a </font><font style="font-family:inherit;font-size:10pt;">$9.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;discrete tax benefit as a result of the Tax Reform Act and the revaluation of the Company's deferred tax assets, liabilities and valuation allowance to reflect the lower U.S. federal statutory rate (see Note 9).</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94</font></div></div><hr style="page-break-after:always"><div><br></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2) Included within net income (loss) during the fourth quarter of fiscal 2017 is the </font><font style="font-family:inherit;font-size:10pt;">$12.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;charge for a litigation reserve (see Note 15) and </font><font style="font-family:inherit;font-size:10pt;">$4.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;impact relating to the Acculis recall (see Note 10).  </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The data in the schedules above has been intentionally rounded to the nearest thousand and therefore the quarterly&#160;&#160;&#160;&#160; amounts may not sum to the full year amounts. </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s9F664818C2ED5637966866B1E863973D"></a></div><div style="line-height:120%;padding-top:24px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">AngioDynamics, Inc. and Subsidiaries</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:46%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">SCHEDULE&#160;II&#160;-VALUATION&#160;AND&#160;QUALIFYING&#160; ACCOUNTS</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Column A</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Column&#160;B</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Column&#160;C</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Column&#160;D</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Column&#160;E</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Description</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance&#160;at</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Beginning</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">of&#160;Year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Additions&#160;-</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Charged&#160; to</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">costs and</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deductions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance&#160;at</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">End&#160;of&#160;Period</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year Ended May&#160;31, 2016</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for deferred tax asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,791</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,685</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(267</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,209</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for sales returns and doubtful accounts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,043</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,748</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,372</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year Ended May&#160;31, 2017</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for deferred tax asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,209</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,348</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for sales returns and doubtful accounts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,372</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(291</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,136</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,945</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year Ended May&#160;31, 2018</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for deferred tax asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,348</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,741</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,607</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for sales returns and doubtful accounts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,945</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">608</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,087</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,466</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;padding-left:4px;text-align:left;padding-left:40px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;text-align:left;padding-left:40px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:22px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95</font></div></div><hr style="page-break-after:always"><div><a name="sA6DCF1E762A05126B7F8B5015011FAD6"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">EXHIBITS</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:10%;"></td><td style="width:53%;"></td><td style="width:11%;"></td><td style="width:13%;"></td><td style="width:13%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Incorporated by Reference</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit Number</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Description of Exhibits </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Filing Date</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stockholders Agreement, dated as of May 22, 2012, among AngioDynamics, Inc. and the stockholders set forth on the signature pages thereto.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 25, 2012</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock Purchase Agreement, dated as of October 8, 2012, by and among AngioDynamics, Inc., Vortex Medical, Inc. (&#8220;Vortex&#8221;), the stockholders of Vortex set forth on the signature pages thereto, the option holders of Vortex set forth on the signature pages thereto and CHTP Management Services, Inc., as sellers&#8217; representative.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">October 12, 2012</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1.1</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amended and Restated Certificate of Incorporation.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10-Q</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">October 7, 2005</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certificate of Amendment to the Amended and Restated Certificate of Incorporation of AngioDynamics, Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10-K</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.1.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">August 10, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.2</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Second Amended and Restated By-Laws, effective October 16, 2015.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">October 21, 2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Credit Agreement, dated as of November 7, 2016, by and among AngioDynamics, Inc., the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, Bank of America, N.A. and Keybank National Association as co-syndication agents,&#160; and JPMorgan Chase Bank, N.A., Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated and Keybank National Association as joint bookrunners and joint lead arrangers.</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 10, 2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1.1</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ex1011amendmentno1.htm"><font style="font-family:inherit;font-size:10pt;">Amendment One to the Credit Agreement dated May 24, 2018.</font></a></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngioDynamics, Inc. 1997 Stock Option Plan, as amended by the Board and Shareholders on February 27, 2004.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">S-1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 5, 2004</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1.3</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngioDynamics, Inc. 2004 Stock and Incentive Award Plan (as amended).</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DEF14A</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">September 15, 2016</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1.4</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngioDynamics 2014 Total Shareholder Return Performance Unit Agreement Program.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10-K/A</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1.4</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">January 12, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1.5</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngioDynamics 2015 Total Shareholder Return Performance Unit Agreement Program.</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10-K</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1.5</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">August 10, 2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1.6</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngioDynamics 2016 Total Shareholder Return Performance Unit Agreement Program.</font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10-K</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1.6</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">August 1, 2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1.7</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ex1017totalshareholderretu.htm"><font style="font-family:inherit;font-size:10pt;">AngioDynamics 2017 Total Shareholder Return Performance Unit Agreement Program.</font></a></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngioDynamics, Inc. Employee Stock Purchase Plan (as amended).</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">DEF14A</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">September 15, 2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.3</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form of Non-Statutory Stock Option Agreement pursuant to the AngioDynamics, Inc. Stock and Incentive Award Plan.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10-Q</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">October 12, 2004</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.3.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ex1031stockoptionagreement.htm"><font style="font-family:inherit;font-size:10pt;">Form of Non-Statutory Stock Option Agreement pursuant to the AngioDynamics, Inc. Stock and Incentive Award Plan.</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.4.2</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form of 2014 Performance Share Award Agreement pursuant to the AngioDynamics, Inc. 2004 Stock and Incentive Award Plan.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10-K/A</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.4.2</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">January 12, 2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.4.3</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form of 2015 Performance Share Award Agreement pursuant to the AngioDyanmics, Inc. 2004 Stock and Incentive Award Plan.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10-K</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.4.3</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">August 10, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.4.4</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form of 2016 Performance Share Award Agreement pursuant to the AngioDyanmics, Inc. 2004 Stock and Incentive Award Plan.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10-K</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.4.3</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">August 1, 2016</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.4.5</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ex1045performanceunitaward.htm"><font style="font-family:inherit;font-size:10pt;">Form of 2017 Performance Share Award Agreement pursuant to the AngioDyanmics, Inc. 2004 Stock and Incentive Award Plan.</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:10%;"></td><td style="width:53%;"></td><td style="width:11%;"></td><td style="width:13%;"></td><td style="width:13%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Incorporated by Reference</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit Number</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Description of Exhibits </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Filing Date</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.5</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form of Restricted Stock Award Agreement pursuant to the AngioDynamics, Inc. 2004 Stock and Incentive Award Plan.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.3</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 12, 2005</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.6</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rita Medical Systems, Inc. 1994 Incentive Stock Plan.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">S-1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 3, 2000</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Horizon Medical Products, Inc. 1998 Stock Incentive Plan.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">S-1</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.11</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 3, 1998</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.8</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rita Medical Systems, Inc. 2000 Stock Plan.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">S-1/A</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.3</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 14, 2000</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.9</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rita Medical Systems, Inc. 2000 Directors&#8217; Stock Plan, as amended on June 8, 2005.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">S-8</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.2</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">July 8, 2005</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.10</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rita Medical Systems, Inc. 2005 Stock and Incentive Plan.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">S-8</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">July 8, 2005</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.11</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form of Indemnification Agreement of AngioDynamics, Inc.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 12, 2006</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.11.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employment Agreement, dated April 1, 2016, between AngioDynamics, Inc. and James C. Clemmer.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 6, 2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.11.2</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Employment letter, dated August 18, 2016, between AngioDynamics, Inc. and Michael C. Greiner.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">July 25, 2016</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.12</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in Control Agreement, dated April 1, 2016, between AngioDynamics, Inc. and James C. Clemmer.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.2</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 6, 2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.12.1</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form of Severance Agreement of AngioDynamics, Inc.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">October 31, 2007</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.13</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Form of Change in Control Agreement.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10-K/A</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.13</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">January 12, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.13.1</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in Control Agreement, dated August 18, 2016, between AngioDynamics, Inc. and Michael C. Greiner.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10-Q</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.3</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">October 5, 2016</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.14</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Performance Share Award Agreement, with a grant date of April 4, 2016, between AngioDynamics, Inc. and James C. Clemmer.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.3</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 6, 2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.15</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngioDynamics, Inc. Total Shareholder Return Performance Share Award Program - Performance Period Ending July 2019.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.4</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 6, 2016</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.16</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock Option Award Agreement, with a grant date of April 4, 2016, between AngioDynamics, Inc. and James C. Clemmer.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.5</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 6, 2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.17</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted Stock Unit Award Agreement, with a grant date of April 4, 2016, between AngioDynamics, Inc. and James C. Clemmer.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.6</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 6, 2016</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.18</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Separation Agreement and General Release, dated April 22, 2016, between AngioDynamics, Inc. and Joseph M. DeVivo.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">April 27, 2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Code of Ethics.</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 21, 2006</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td colspan="4" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ex2153118.htm"><font style="font-family:inherit;font-size:10pt;">Subsidiaries </font></a></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td colspan="4" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ex23angio2018consentofdelo.htm"><font style="font-family:inherit;font-size:10pt;">Consent of Deloitte &amp; Touche LLP, an independent registered public accounting firm.</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.1</font></div></td><td colspan="4" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ex231angio2018consentofpri.htm"><font style="font-family:inherit;font-size:10pt;">Consent of PricewaterhouseCoopers LLP, an independent registered public accounting firm. </font></a></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.1</font></div></td><td colspan="4" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ex3115311810-k.htm"><font style="font-family:inherit;font-size:10pt;">Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.2</font></div></td><td colspan="4" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ex3125311810-k.htm"><font style="font-family:inherit;font-size:10pt;">Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</font></a></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.1</font></div></td><td colspan="4" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ex3215311810-k.htm"><font style="font-family:inherit;font-size:10pt;">Certification by the Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</font></a></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.2</font></div></td><td colspan="4" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="ex3225311810-k.htm"><font style="font-family:inherit;font-size:10pt;">Certification by the Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</font></a></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.INS</font></div></td><td colspan="4" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Instance Document</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.SCH</font></div></td><td colspan="4" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Schema Document</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.CAL</font></div></td><td colspan="4" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Calculation Linkbase Documents</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.DEF</font></div></td><td colspan="4" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Definition Linkbase Document</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.LAB</font></div></td><td colspan="4" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Labels Linkbase Documents</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:10%;"></td><td style="width:53%;"></td><td style="width:11%;"></td><td style="width:13%;"></td><td style="width:13%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.PRE</font></div></td><td colspan="4" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Presentation Linkbase Documents</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s307F1BFB6B8B5BD4A9C8C3B78BF0D99B"></a></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;padding-top:10px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:44%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:44%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ANGIODYNAMICS, INC.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/</font><font style="font-family:inherit;font-size:8pt;">S</font><font style="font-family:inherit;font-size:10pt;">/&#160;&#160;&#160;&#160;H</font><font style="font-family:inherit;font-size:8pt;">OWARD</font><font style="font-family:inherit;font-size:10pt;">&#160;W. D</font><font style="font-family:inherit;font-size:8pt;">ONNELLY&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Howard W. Donnelly,</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Chairman of the Board, Director</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:10px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:44%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/</font><font style="font-family:inherit;font-size:8pt;">S</font><font style="font-family:inherit;font-size:10pt;">/&#160;&#160;&#160;&#160;H</font><font style="font-family:inherit;font-size:8pt;">OWARD</font><font style="font-family:inherit;font-size:10pt;">&#160;W. D</font><font style="font-family:inherit;font-size:8pt;">ONNELLY&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Howard W. Donnelly,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Chairman of the Board, Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/</font><font style="font-family:inherit;font-size:8pt;">S</font><font style="font-family:inherit;font-size:10pt;">/&#160;&#160;&#160;&#160;JAMES C. CLEMMER</font><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">James C. Clemmer,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">President, Chief Executive Officer</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Principal Executive Officer)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/</font><font style="font-family:inherit;font-size:8pt;">S</font><font style="font-family:inherit;font-size:10pt;">/&#160;&#160;&#160;&#160;MICHAEL C. GREINER</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Michael C. Greiner </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Executive Vice President, Chief Financial Officer,                         (Principal Financial and Accounting Officer)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/</font><font style="font-family:inherit;font-size:8pt;">S</font><font style="font-family:inherit;font-size:10pt;">/&#160;&#160;&#160;&#160;W</font><font style="font-family:inherit;font-size:8pt;">ESLEY</font><font style="font-family:inherit;font-size:10pt;">&#160;E. J</font><font style="font-family:inherit;font-size:8pt;">OHNSON</font><font style="font-family:inherit;font-size:10pt;">, J</font><font style="font-family:inherit;font-size:8pt;">R</font><font style="font-family:inherit;font-size:10pt;">.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Wesley E. Johnson, Jr.,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/</font><font style="font-family:inherit;font-size:8pt;">S</font><font style="font-family:inherit;font-size:10pt;">/&#160;&#160;&#160;&#160;J</font><font style="font-family:inherit;font-size:8pt;">EFFREY</font><font style="font-family:inherit;font-size:10pt;">&#160;G. G</font><font style="font-family:inherit;font-size:8pt;">OLD&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Jeffrey G. Gold,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/</font><font style="font-family:inherit;font-size:8pt;">S</font><font style="font-family:inherit;font-size:10pt;">/&#160;&#160;&#160;&#160;D</font><font style="font-family:inherit;font-size:8pt;">ENNIS</font><font style="font-family:inherit;font-size:10pt;">&#160;S. M</font><font style="font-family:inherit;font-size:8pt;">ETENY&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Dennis S. Meteny,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/</font><font style="font-family:inherit;font-size:8pt;">S</font><font style="font-family:inherit;font-size:10pt;">/&#160;&#160;&#160;&#160;S</font><font style="font-family:inherit;font-size:8pt;">TEVEN R.</font><font style="font-family:inherit;font-size:10pt;">&#160;L</font><font style="font-family:inherit;font-size:8pt;">A</font><font style="font-family:inherit;font-size:10pt;">P</font><font style="font-family:inherit;font-size:8pt;">ORTE&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Steven R. LaPorte,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/</font><font style="font-family:inherit;font-size:8pt;">S</font><font style="font-family:inherit;font-size:10pt;">/&#160;&#160;&#160;&#160;K</font><font style="font-family:inherit;font-size:8pt;">EVIN</font><font style="font-family:inherit;font-size:10pt;">&#160;J. G</font><font style="font-family:inherit;font-size:8pt;">OULD&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Kevin J. Gould,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/</font><font style="font-family:inherit;font-size:8pt;">S</font><font style="font-family:inherit;font-size:10pt;">/&#160;&#160;&#160;&#160;JAN REED</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Jan Reed,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Director</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/</font><font style="font-family:inherit;font-size:8pt;">S</font><font style="font-family:inherit;font-size:10pt;">/&#160;&#160;&#160;&#160;EILEEN AUEN</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Eileen Auen,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Director</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1.1
<SEQUENCE>2
<FILENAME>ex1011amendmentno1.htm
<DESCRIPTION>EXHIBIT 10.1.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>ex1011amendmentno1</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:791;"><!-- ex1011amendmentno1001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1011amendmentno1001.jpg" title="slide1" width="791" height="1024">
<DIV><FONT size="1" style="font-size:1pt;color:white">                                                                    EXECUTION COPY                                     AMENDMENT NO. 1                                    Dated as of May 24, 2018                                             to                                    CREDIT AGREEMENT                                  Dated as of November 7, 2016                THIS AMENDMENT NO. 1 (this &#8220;Amendment&#8221;) is made as of May 24, 2018 by and  among AngioDynamics, Inc., a Delaware corporation (the &#8220;Borrower&#8221;), the financial institutions listed on  the  signature  pages  hereof  and  JPMorgan  Chase  Bank,  N.A.,  as  Administrative  Agent  (the  &#8220;Administrative  Agent&#8217;),  under  that  certain  Credit  Agreement  dated  as  of  November  7,  2016  by  and  among the Borrower, the Lenders and the Administrative Agent (as amended, restated, supplemented or  otherwise modified from time to time, the &#8220;Credit Agreement&#8221;).  Capitalized terms used herein and not  otherwise defined herein shall have the respective meanings given to them in the Credit Agreement.                WHEREAS,  the  Borrower  has  requested  that  the  requisite  Lenders and  the  Administrative Agent agree to make certain amendments to the Credit Agreement;                WHEREAS, the Borrower, the Lenders party hereto and the Administrative Agent have  so agreed on the terms and conditions set forth herein;                NOW,  THEREFORE,  in  consideration  of  the  premises  set  forth  above, the terms and  conditions  contained  herein,  and  other  good  and  valuable  consideration,  the  receipt  and  sufficiency  of  which are hereby acknowledged, the Borrower, the Lenders party hereto and the Administrative Agent  hereby agree to enter into this Amendment.                1.     Amendments  to  the  Credit  Agreement.   Effective  as  of  the  Amendment  No.  1  Effective Date (as defined below), the parties hereto agree that the Credit Agreement shall be amended as  follows:                (a)    Clause (a) of Section 6.12 of the Credit Agreement is hereby amended to replace  the reference of &#8220;$10,000,000&#8221; appearing therein with &#8220;$20,000,000&#8221;.                2.     Conditions  of  Effectiveness.   The  effectiveness  of  this  Amendment  (the  &#8220;Amendment No. 1 Effective Date&#8221;) is subject to the satisfaction of the following conditions precedent:                (a)    The Administrative Agent (or its counsel) shall have received counterparts of (i)  this Amendment duly executed by the Borrower, the Required Lenders and the Administrative Agent and  (ii) the Consent and Reaffirmation attached hereto duly executed by the Subsidiary Guarantors.                (b)    The Administrative Agent shall have received, for the account of each applicable  Lender party hereto that delivers its executed signature page to this Amendment by no later than the date  and  time  specified  by  the  Administrative  Agent,  an  amendment  fee  in  an  amount  equal  to  the  amount  previously disclosed to the Lenders.                (c)    The  Administrative  Agent  shall  have  received  payment  of  the  Administrative     US-DOCS\101225498.3  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex1011amendmentno1002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1011amendmentno1002.jpg" title="slide2" width="791" height="1024">
<DIV><FONT size="1" style="font-size:1pt;color:white">Agent&#8217;s  and  its  affiliates&#8217;  fees  and  reasonable  and  documented out-of-pocket  expenses  (including  reasonable  fees  and  expenses  of  counsel  for  the  Administrative Agent)  in  connection  with  this  Amendment  and  the  other  Loan  Documents  to  the  extent  earned,  due  and  owing  and  otherwise  reimbursable pursuant to the terms of the Credit Agreement or this Amendment.                3.     Representations  and  Warranties  of  the  Borrower.   The  Borrower  hereby  represents and warrants as follows:                (a)    This Amendment and the Credit Agreement as modified hereby constitute legal,  valid  and  binding  obligations  of  the  Borrower,  enforceable  in  accordance  with  their  respective  terms,  subject  to  applicable  bankruptcy,  insolvency,  reorganization,  moratorium  or  other  laws  affecting  creditors&#8217; rights generally and subject to general principles of equity, regardless of whether considered in  a proceeding in equity or at law.                (b)    As of the date hereof and after giving effect to the terms of this Amendment, (i)  no Default or Event of Default has occurred and is continuing and (ii) the representations and warranties  of the Borrower set forth in the Credit Agreement are true and correct in all material respects (except to  the extent such representation or warranty is qualified by materiality or Material Adverse Effect, in which  case such representation and warranty is true and correct in all respects).                4.     Reference to and Effect on the Credit Agreement.                (a)    Upon  the  effectiveness  hereof,  each  reference  to  the  Credit  Agreement  in  the  Credit Agreement or any other Loan Document shall mean and be a reference to the Credit Agreement as  amended hereby.                (b)    The  Credit  Agreement  and  all  other  documents,  instruments  and  agreements  executed  and/or  delivered  in  connection  therewith  shall  remain in  full  force  and  effect  and  are  hereby  ratified and confirmed.                (c)    Except  with  respect  to  the  subject  matter  hereof,  the  execution,  delivery  and  effectiveness  of  this  Amendment  shall  not  operate  as  a  waiver  of  any  right,  power  or  remedy  of  the  Administrative Agent or the Lenders, nor constitute a waiver of any provision of the Credit Agreement or  any other documents, instruments and agreements executed and/or delivered in connection therewith.                (d)    This Amendment is a Loan Document.                5.     Governing  Law.   This  Amendment  shall  be  construed  in  accordance with and  governed by the law of the State of New York.                6.     Headings.  Section headings used herein are for convenience of reference only,  are not part of this Amendment and shall not affect the construction of, or be taken into consideration in  interpreting, this Amendment.                                                  2    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex1011amendmentno1003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1011amendmentno1003.jpg" title="slide3" width="791" height="1024">
<DIV><FONT size="1" style="font-size:1pt;color:white">             7.     Counterparts.   This  Amendment  may  be  executed  in  counterparts  (and  by  different parties hereto on different counterparts), each of which shall constitute an original, but all of  which when taken together shall constitute a single contract.  Delivery of an executed counterpart of a  signature  page  of  this  Amendment  by  telecopy,  e-mailed  .pdf  or any  other  electronic  means  that  reproduces an image of the actual executed signature page shall be effective as delivery of a manually  executed counterpart of this Amendment.                                    [Signature Pages Follow]                                                  3    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex1011amendmentno1004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1011amendmentno1004.jpg" title="slide4" width="791" height="1024">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex1011amendmentno1005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1011amendmentno1005.jpg" title="slide5" width="791" height="1024">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex1011amendmentno1006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1011amendmentno1006.jpg" title="slide6" width="791" height="1024">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex1011amendmentno1007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1011amendmentno1007.jpg" title="slide7" width="791" height="1024">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex1011amendmentno1008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1011amendmentno1008.jpg" title="slide8" width="791" height="1024">
<DIV><FONT size="1" style="font-size:1pt;color:white">                 SUNTRUST BANK,                   as a Lender                                                          By:_______________________________________                   Name:    Philip VanFossan                  Title:    Vice President       Signature Page to Amendment No. 1 to  Credit Agreement dated as of November 7, 2016              AngioDynamics, Inc.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex1011amendmentno1009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1011amendmentno1009.jpg" title="slide9" width="791" height="1024">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex1011amendmentno1010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1011amendmentno1010.jpg" title="slide10" width="791" height="1024">
<DIV><FONT size="1" style="font-size:1pt;color:white">                           CONSENT AND REAFFIRMATION                Each  of  the  undersigned  hereby  acknowledges  receipt  of  a  copy  of  the  foregoing  Amendment  No.  1  to  the  Credit  Agreement  dated  as  of  November  7,  2016  (as  amended,  restated,  supplemented  or  otherwise  modified,  the  &#8220;Credit  Agreement&#8221;)  by and  among  AngioDynamics,  Inc.,  a  Delaware  corporation,  the  financial  institutions  from  time  to  time  party  thereto  (the  &#8220;Lenders&#8221;)  and  JPMorgan Chase Bank, N.A., as Administrative Agent (the &#8220;Administrative Agent&#8221;), which Amendment  No.  1  is  dated  as  of  May  24,  2018  (the  &#8220;Amendment&#8221;).   Capitalized  terms  used  in  this  Consent  and  Reaffirmation  and not  defined  herein shall  have  the  meanings  given  to  them  in  the  Credit  Agreement.   Without in any way establishing a course of dealing by the Administrative Agent or any Lender, each of  the  undersigned  consents  to  the  Amendment  and  reaffirms  the  terms  and  conditions  of  the  Credit  Agreement and any other Loan Document executed by it and acknowledges and agrees that such Credit  Agreement and each and every such Loan Document executed by the undersigned in connection with the  Credit Agreement remains in full force and effect and is hereby reaffirmed, ratified and confirmed.  All  references to the Credit Agreement contained in the above-referenced documents shall be a reference to  the Credit Agreement as so modified by the Amendment.   Dated:  May 24, 2018                                    [Signature Page Follows]                                                     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- ex1011amendmentno1011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="ex1011amendmentno1011.jpg" title="slide11" width="791" height="1024">
<DIV><FONT size="1" style="font-size:1pt;color:white"> </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1.7
<SEQUENCE>3
<FILENAME>ex1017totalshareholderretu.htm
<DESCRIPTION>EXHIBIT 10.1.7
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s11256902CE71F67C024AB80220C69BA5"></a></div><div></div><div><br></div><div style="line-height:144%;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br></font></div><div style="line-height:144%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Total Shareholder Return Performance Unit Award Program (the &#8220;Program&#8221;)</font></div><div style="line-height:144%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Performance Period July 12, 2018 &#8211; July, 2021</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;padding-left:0px;text-align:left;text-indent:0px;"><font style="text-align:left;font-family:inherit;font-size:12pt;font-weight:bold;padding-right:48px;">I.</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Purpose of the Program</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The purpose of the Program is to align AngioDynamics&#8217; executive compensation program with the interests of shareholders and to reinforce the concept of pay for performance by comparing the relative Total Shareholder Return (&#8220;TSR&#8221;) of shares of AngioDynamics&#8217; Common Stock (the &#8220;Common Stock&#8221;) to the TSR of a pre-defined peer group (the &#8220;Peer Group&#8221;) of companies over a three-year period beginning on July 12, 2018. </font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Program entails the grant of Performance Unit Awards, and the program shall be administered under the AngioDynamics 2004 Stock and Incentive Award Plan, as amended (the &#8220;Plan&#8221;). Terms not defined in this Program document but defined in the Plan shall have the meaning ascribed to such term in the Plan.  The Program is established under section 5.II of the Plan and is intended to qualify for the performance-based compensation exception under Section 162(m) of the Internal Revenue Code (&#8220;Code&#8221;). </font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">II. &#160;&#160;&#160;&#160;Eligible Participants</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Program covers members of the Executive Management Team (&#8220;EMT&#8221;) on the date that awards are granted under the Program as determined and in the amounts established by the Board of Directors (the &#8220;Board&#8221;).</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Board may review Program eligibility criteria for Participants in the Program from time to time and may revise such criteria at any time, even within a Program year, with or without notice and within its sole discretion.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:144%;font-size:12pt;padding-left:0px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">III.</font></div></td><td style="vertical-align:top;"><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Performance Share Units</font></div></td></tr></table><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Pursuant to the Plan and this Program, the Board may, in its sole discretion, grant Performance Unit Awards to members of the EMT (the &#8220;Grant Date&#8221;).  Each Performance Unit Award shall specify a target number of shares of Common Stock underlying the Performance Unit Award (the &#8220;Target Amount&#8221;).  Shares of Common Stock underlying the Performance Unit Award granted under the Program (the &#8220;Performance Unit Awards&#8221;) shall be issued only upon satisfaction of both the performance vesting criteria described in this Section III and the payment eligibility criteria described in Section VII.  The applicable performance criteria are based on the TSR of AngioDynamics&#8217; Common Stock relative to the TSR of the common stock of the companies in the Peer Group.</font></div><div><a name="sFC12C589E86F9056B7E8B80220E1C28C"></a></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The TSR for AngioDynamics and all other companies in the Peer Group will be measured over a three-year period in accordance with Article IV below (the &#8220;Performance Period&#8221;). </font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The number of shares of Common Stock that vest under the Performance Unit Award will be in a range of 0% to 200% of the Target Amount of shares of Common Stock pursuant to the Performance Unit Award granted to the Participant based upon AngioDynamics&#8217; TSR percentile ranking relative to the Peer Group as follows: </font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:63.46153846153846%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:47%;"></td><td style="width:53%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-top:2px;text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">TSR Performance</font></div><div style="padding-top:2px;text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Percentile Rank</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-top:2px;text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Performance Share Units</font></div><div style="padding-top:2px;text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">as a Percent of Target </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">75th Percentile or above</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">200%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">50th Percentile</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">100%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">25th Percentile</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">50%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Below 25th Percentile</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">0%</font></div></td></tr></table></div></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">If the minimum level of performance set forth above is achieved for the Performance Period, the number of shares of Common Stock vesting under the Performance Unit Award will be calculated linearly between each set of data points. </font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Following the end of the Performance Period, the Board shall determine the number of shares of Common Stock, based upon the total number of shares of Common Stock underlying the Target amount of the Performance Unit Award, that shall become vested pursuant to AngioDynamics&#8217; relative TRS percentile rank during the Performance Period pursuant to the table set forth above.</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Board shall issue a number of shares of Common Stock underlying the Performance Unit Award to the Participant in accordance with this Program and the applicable grant agreement equal to the number of shares of Common Stock, if any, that vested in the Performance Period.</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Board&#8217;s determination regarding the Company&#8217;s performance to the performance criteria with respect to the Performance Period shall be final and binding.  </font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Shares of Common Stock will be delivered or otherwise made available to the Participant as soon as practicable (and in all events within sixty (60) days) after the end of the Performance Period.  Any shares of Common Stock underlying a Performance Unit Award as to which the performance criteria of this Section III have not been satisfied as of the end of the Performance Period will be forfeited in their entirety.</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:98.07692307692307%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:3%;"></td><td style="width:97%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">IV.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-27px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#160;&#160;&#160;Calculation of Total Shareholder Return and Definitions</font></div></td></tr></table></div></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The TSR for AngioDynamics and each other company in the Peer Group shall include any cash dividends paid during the Performance Period and shall be determined as follows:</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Total Shareholder Return for each Performance Cycle</font><font style="font-family:inherit;font-size:12pt;">&#32;= </font></div><div style="line-height:144%;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(Change in Stock Price + Dividends Paid) / Beginning Stock Price</font></div><div style="line-height:144%;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Beginning Stock Price</font><font style="font-family:inherit;font-size:12pt;">&#8221; with respect to AngioDynamics and each company in the Peer Group means the daily average closing price as quoted on the New York Stock Exchange or the NASDAQ Global Select Market, as applicable, of one (1) share of common stock for the period beginning on July 2, 2018 and ending on July 23, 2021.</font></div><div style="line-height:144%;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Change in Stock Price</font><font style="font-family:inherit;font-size:12pt;">&#8221; means the difference between the Beginning Stock Price and the Ending Stock Price.</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Dividends Paid</font><font style="font-family:inherit;font-size:12pt;">&#8221; means the total of all cash dividends paid on one (1) share of stock during the Performance Period.</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Ending Stock Price</font><font style="font-family:inherit;font-size:12pt;">&#8221; with respect to AngioDynamics and each company in the Peer Group means the daily average closing price as quoted on the New York Stock Exchange or the NASDAQ Global Select Market, as applicable, of one (1) share of common stock for the period beginning nine (9) calendar days prior to the date AngioDynamics announces its financial results for the fiscal year ended May 31, 2020 and ending 10 calendar days after the date AngioDynamics announces its financial results for the fiscal year ended May 31, 2020.  If either date falls on a day on which the financial markets are closed, the next day on which the financial markets are open shall be used.</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Example: </font><font style="font-family:inherit;font-size:12pt;">If the Beginning Stock Price for a company was $25.00 per share, and the company paid $2.50 in dividends over the Performance Period, and the Ending Stock Price was $30.00 per share (thereby making the Change in Stock Price $5.00 ($30.00 minus $25.00)), then the TSR for that company would be thirty percent (30%). The calculation is as follows: </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">0.30</font><font style="font-family:inherit;font-size:12pt;">&#32;= ($5.00 + $2.50) / $25.00</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.14529914529915%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:3%;"></td><td style="width:97%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">V.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Calculation of Percentile Performance</font></div></td></tr></table></div></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Following the calculation of the TSR for the Performance Period</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:12pt;">for AngioDynamics and each other company in the Peer Group, AngioDynamics and the other companies in the Peer Group will be ranked, in order of maximum to minimum, according to their respective TSR for the Performance Period.</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">After this ranking, the percentile performance of AngioDynamics as compared to the other companies in the Peer Group shall be determined by the following formula:</font></div><div style="line-height:144%;padding-top:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;padding-top:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#8220;P&#8221;</font><font style="font-family:inherit;font-size:12pt;">&#32;represents the percentile performance which will be rounded, if necessary, to the nearest whole percentile by application of standard scientific rounding conventions. </font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#8220;N&#8221;</font><font style="font-family:inherit;font-size:12pt;">&#32;represents the number of companies in the Peer Group, including AngioDynamics.</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#8220;R&#8221;</font><font style="font-family:inherit;font-size:12pt;">&#32;represents AngioDynamics&#8217; ranking versus the other companies in the Peer Group. </font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">Example: </font><font style="font-family:inherit;font-size:12pt;">If AngioDynamics ranked 10</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">th</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;out of 56 companies, the performance (&#8220;P&#8221;) therefore will be in the 84</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">th</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;percentile.</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This calculation is as follows: </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">0.837</font><font style="font-family:inherit;font-size:12pt;">&#32;= 1 - (10 - 1) / (56 - 1)</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:20.51282051282051%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:37%;"></td><td style="width:63%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">VI.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Peer Group</font></div></td></tr></table></div></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The companies in the Peer Group can be found in </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Appendix A</font><font style="font-family:inherit;font-size:12pt;">&#32;attached hereto. </font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">If, during the Performance Period, two companies in the Peer Group merge, the surviving company shall remain in the Peer Group. </font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">If, during the Performance Period, a company in the Peer Group merges with, or is acquired by, a company that is not in the Peer Group, and the company in the Peer Group is the surviving company, then the surviving company shall not be included in the Peer Group. </font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">If, during the Performance Period, a company in the Peer Group merges with, or is acquired by, a company that is not in the Peer Group, and the company in the Peer Group is not the surviving company or the surviving company is no longer publicly traded, then the surviving company shall not be included in the Peer Group.</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">If, during the Performance Period, a company in the Peer Group sells all or substantially all of its assets, such company shall not be included in the Peer Group.</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">If, during the Performance Period, a company in the Peer Group splits-off or spins-off or consummates any other extraordinary reorganization transaction, and such spin-off, split-off or reorganization comprises more than 20% of the assets of the company prior to such spin-off, split-off or reorganization, such company shall not be included in the Peer Group.</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">If, during the Performance Period, a company in the Peer Group files for bankruptcy or otherwise ceases to be traded or quoted on any national exchange, such Company shall remain in the Peer Group.  If no public stock price information is available for such company after it files for bankruptcy or otherwise ceases to be traded or quoted on a national securities exchange, the TSR for such company shall equal a total loss of equity (or -100%) during the Performance Period for which no stock price information is available.</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The triggering event for determining whether a company shall be excluded from the Peer Group pursuant to this Section VI shall be the first official announcement of an SEC reportable event.</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:38.24786324786324%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:20%;"></td><td style="width:80%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">VII.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Payment Eligibility Criteria</font></div></td></tr></table></div></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Except as set forth below with respect to a Change in Control or termination of employment due to Retirement, death, or Disability, (i) no shares of Common Stock underlying the Performance Unit Award shall issue prior to the end of the Performance Period and (ii) a participant must be employed by the Company (as defined below) through the end of the Performance Period to be eligible to receive shares of Common Stock that have vested under the Performance Unit Award pursuant to Section III of this Program. </font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Death</font><font style="font-family:inherit;font-size:12pt;">. If the Participant&#8217;s employment with AngioDynamics or its subsidiaries or affiliates is terminated due to death on or after the Grant Date, but prior to the end of the Performance Period, the Performance Unit Award shall remain eligible to vest following the end date of the Performance Period according to the vesting provisions set forth in Section III of this Program and the Participant shall receive a pro-rated portion of the Common Stock underlying the Performance Unit Award that would otherwise vest based upon the provisions set forth in Section III of this Program on the end date of the Performance Period, with the pro-rata portion based on the Participant&#8217;s whole months of service with the Company during the Performance Period prior to the date of such termination; provided that a partial month of employment will be considered a whole &#8220;month of service&#8221; for purposes of this Program only if the Participant was employed by AngioDynamics for at least fifteen (15) days during such month.  Any portion of the Performance Unit Award that remains unvested on the end date of the Performance Period (after giving effect to such pro-ration) shall be considered to have terminated on such date.  The Participant may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit granted to the Participant under this Program is to be paid in case of his or her death before he or she receives any or all such benefit.  Each such designation shall revoke all prior designations by the Participant, shall be in a form prescribed by AngioDynamics, and will be effective only when filed by the Participant in writing with the Secretary of the Company during the Participant&#8217;s lifetime.  In the absence of any such designation, benefits remaining unpaid at the Participant&#8217;s death shall be paid to the Participant&#8217;s estate.</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Retirement or Disability</font><font style="font-family:inherit;font-size:12pt;">. If the Participant&#8217;s employment with AngioDynamics or its subsidiaries or affiliates is terminated due to Retirement or Disability on or after the Grant Date, but prior to the end of the Performance Period, the Performance Unit Award shall remain eligible to vest pursuant to Section III of this Program on the end date of the Performance Period and the Participant shall receive a pro-rated portion of the Common Stock underlying the Performance Unit Award that would otherwise vest pursuant to Section III of this Program based on performance during the Performance Period, with the pro-rata portion based on the Participant&#8217;s whole months of service with AngioDynamics during the Performance Period prior to the date of such termination; provided that a partial month of employment will be considered a whole &#8220;month of service&#8221; for purposes of this Agreement only if the Participant was employed by AngioDynamics for at least fifteen (15) days during such month.  Any portion of the Performance Unit Award that remains unvested on the end date of the Performance Period (after giving effect to such pro-ration) shall be considered to have terminated on such date.</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Other Termination of Employment -- Eligibility Conditions</font><font style="font-family:inherit;font-size:12pt;">. If the Participant&#8217;s employment with AngioDynamics or any and of its subsidiaries or affiliates is terminated or the Participant separates from AngioDynamics or its affiliates or subsidiaries for any reason other than death, Retirement or Disability, the Performance Unit Award shall terminate and no shares of Common Stock shall be issued.  </font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Change in Control of the Company</font><font style="font-family:inherit;font-size:12pt;">.  Notwithstanding anything to the contrary in this Agreement, in the event of a Change in Control (as defined in this Program) of AngioDynamics on or after the Grant Date, but prior to the end of the Performance Period and prior to the Participant&#8217;s termination of employment for any reason, the Participant shall immediately vest in 100% of the Target Amount of shares of Common Stock subject to the Performance Unit Award. Notwithstanding anything to the contrary in this Agreement, in the event the Participant&#8217;s employment with AngioDynamics or any of its subsidiaries or affiliates terminates due to one of the reasons expressly covered above (except as described in &#8220;Other Termination of Employment&#8221; set forth above) and a Change in Control of AngioDynamics occurs subsequent to such a termination of employment (but during the Performance Period), the pro-rata vesting provided for in such sections shall be based on the Target Amount of shares of Common Stock subject to the Performance Unit Award.  Any shares of Common Stock subject to the Performance Unit Award that become vested pursuant to this section of the Program shall be issued to the Participant upon or as soon as practicable (and in all events within thirty (30) days) after the effective date of the Change in Control of AngioDynamics (or, if so provided by the Board, immediately prior to the Change in Control).  In the event a Change in Control of AngioDynamics occurs following the last day of the Performance Period, prior to the Participant&#8217;s termination of employment for any reason, and prior to the date all vested shares of Common Stock underlying the Performance Unit Award are issued pursuant to this Program, any shares of Common Stock subject to the Performance Unit Award that became vested pursuant to this paragraph of the Program shall be issued to the Participant upon or as soon as practicable (and in all events within thirty (30) days) after the effective date of the Change in Control of AngioDynamics (or, if so provided by the Board, immediately prior to the Change in Control).</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">For the purposes of this Program, Change in Control shall mean shall mean that any of the following events has occurred:</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(i) &#160;&#160;&#160;&#160;any Person is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company's then outstanding securities, excluding any Person who becomes such a Beneficial Owner in connection with a transaction described in clause (A) of paragraph (iii) below; or </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(ii) &#160;&#160;&#160;&#160;the following individuals cease for any reason to constitute a  majority of the number of directors serving on the Board: individuals who, at the beginning of any period of two consecutive years or less (not including any period prior to the date of this Agreement), constitute the Board and any new director (other than a director whose initial assumption of office is in connection with an actual or threatened election contest, including but not limited to a consent solicitation, relating to the election of directors of the Company) whose appointment or election by the Board or nomination for election by the Company's shareholders was approved or recommended by a vote of at least two-thirds (2/3) of the directors then still in office who either were directors at the beginning of such period or whose appointment, election or nomination for election was previously so approved or recommended; or </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iii) &#160;&#160;&#160;&#160;there is consummated a merger or consolidation of the Company or any Subsidiary with any other corporation, other than (A) a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or any parent thereof), in combination with the ownership of any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary, at least 60% of the combined voting power of the securities of the Company or such surviving entity or any parent thereof outstanding immediately after such merger or consolidation, or (B) a merger or consolidation effected to implement a recapitalization of the Company (or similar transaction) in which no Person is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company's then outstanding securities; or </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:justify;padding-left:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">(iv) &#160;&#160;&#160;&#160;the shareholders of the Company approve a plan of complete liquidation or dissolution of the Company or there is consummated an agreement for the sale or disposition by the Company of all or substantially all of the Company's assets, other than a sale or disposition by the Company of all or substantially all of the Company's assets to an entity, at least 60% of the combined voting power of the voting securities of which are owned by shareholders of the Company in substantially the same proportions as their ownership of the Company immediately prior to such sale.</font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:91.23931623931624%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:8%;"></td><td style="width:92%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">VIII.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Termination, Suspension or Modification and Interpretation of the Program</font></div></td></tr></table></div></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Board has sole authority over administration and interpretation of the Program and retains the right to exercise discretion as it sees fit, except that, the Board shall have no discretion to increase the number of shares of Common Stock in which a Participant may vest above the amount described in Section III.  The Board may terminate, suspend or modify and if suspended, may reinstate with or without modification all or part of the Program at any time, with or without notice to the Participant.  The Board reserves the exclusive right to determine eligibility to participate in this Program and to interpret all applicable terms and conditions, including eligibility criteria.</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">IX.</font><font style="font-family:inherit;font-size:12pt;">&#32;</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Other</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This document sets forth the terms of the Program and is not intended to be a contract or employment agreement between the Participant and AngioDynamics, its subsidiaries or affiliates.  As applicable, it is understood that both the Participant and AngioDynamics have the right to terminate the Participant&#8217;s employment with the company at any time, with or without cause and with or without notice, in acknowledgement of the fact that their employment relationship is &#8220;at will.&#8221; </font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">To the extent section 409A of the Code (&#8220;Section 409A&#8221;) applies to any Performance Unit Award under this Program, the Performance Unit Award shall be interpreted in a manner consistent with Section 409A. Where Section 409A applies, in the case of any payment made on termination of employment, a termination of employment shall not be deemed to have occurred unless such termination is also a &#8220;separation from service&#8221; within the meaning of Section 409A and, for purposes of any such provision, references to a &#8220;termination,&#8221; &#8220;termination of employment,&#8221; or like terms shall mean &#8220;separation from service.&#8221;  Where Section 409A applies, in the case of a payment made upon a Change in Control, a Change in Control shall not be deemed to have occurred unless there is a change in the ownership or effective control of AngioDynamics, or in the ownership of a substantial portion of the assets of AngioDynamics, as defined in Section 409A.  Where required by Section 409A in the case of a specified employee (as determined under Section 409A), payments on termination shall be made on the first business day of the seventh month following termination.</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><a name="s4988CD8E85FB2AF461E3B80220F6C20B"></a></div><div style="line-height:144%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">APPENDIX A</font></div><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.52136752136752%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:47%;"></td><td style="width:53%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Abaxis Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Integra Lifesciences Holdings Corporation</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Abiomed Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Intricon Corporation</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Accuray Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Intuitive Surgical, Inc.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">AlphaTec Holdings Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Invacare Corporation</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Articure, Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Lakeland Industries Inc.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Atrion Corporation</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Lemaitre Vascular, Inc.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Becton, Dickinson &amp; Company</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Masimo Corporation</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Boston Scientific Corporation</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Merit Medical Systems, Inc.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Cantel Medical Corp.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Mine Safety Appliances Company</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Conmed Corporation</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Natus Medical Incorporated</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">CryoLife, Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">NuVasive, Inc.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Cutera, Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">NxStage Medical, Inc.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Dexcom, Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Resmed Inc.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Digirad Corp</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">RTI Surgical, Inc.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Edwards Lifesciences Corporation</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Steris Corporation</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Endologix, Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Stryker Corporation</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Haemonetics Corporation</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Teleflex Incorporated</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ICU Medical, Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Varian Medical Systems, Inc.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Insulet Corporation</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Wright Medical</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:138%;padding-bottom:13px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1</font></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3.1
<SEQUENCE>4
<FILENAME>ex1031stockoptionagreement.htm
<DESCRIPTION>EXHIBIT 10.3.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s8E938DC5933885AAA050B8009E47D7F0"></a></div><div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">NON&#8209;STATUTORY STOCK OPTION AGREEMENT</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">THIS AGREEMENT is made as of</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;________ </font><font style="font-family:inherit;font-size:12pt;">between AngioDynamics, Inc., ("Company") and </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">__________ </font><font style="font-family:inherit;font-size:12pt;">("Optionee"). Terms used herein have the same meaning as in the Company's 2004 Stock and Incentive Award Plan ("Plan").</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Company hereby grants to Optionee a Non&#8209;Statutory Stock Option to purchase </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">______ </font><font style="font-family:inherit;font-size:12pt;">shares (the &#8220;Shares&#8221;) of Common Stock pursuant and subject to the terms of the Plan, a copy of which has been delivered to Optionee and which is incorporated herein by reference.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2.&#160;&#160;&#160;&#160;The option price per Share shall be </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">$_____.</font><font style="font-family:inherit;font-size:12pt;">&#32;</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Option shall expire ten years from the grant date unless earlier terminated.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In the event Optionee becomes employed by, associated in any way with, or the beneficial owner of more than 1% of the equity of any business which competes, directly or indirectly, with the Company's business in any geographical area where the Company then does business, the Option shall immediately expire and Optionee shall have no rights hereunder.  </font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Except as provided hereinafter and in the Plan, the Option shall become exercisable as to the Shares covered hereby, at a cumulative rate of </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">25%</font><font style="font-family:inherit;font-size:12pt;">&#32;on each of the first </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">four</font><font style="font-family:inherit;font-size:12pt;">&#32;anniversaries of </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">________ </font><font style="font-family:inherit;font-size:12pt;">provided that the Optionee has remained in the continuous employ of the Company from the date of this Agreement. Upon approval by the Compensation Committee of the Board of Directors of the Company, for purposes of this Agreement, service as a consultant or director of the Company shall be deemed to be employment by the Company. </font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Notwithstanding the foregoing, the Option shall be exercisable as to all Shares covered hereby upon a Change of Control&#8221; (if the Option has not expired under Section 3 or 4).  </font></div><div style="line-height:120%;text-align:left;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Option may be exercised in accordance with the Plan prior to the expiration date (or earlier termination or cancellation date under Section 3 or 4) at any time, and may be exercised in whole or in part as to the Shares then available for purchase.  This Option may be exercised only to acquire whole shares.  No fractional shares shall be issued, and an exercise that would otherwise result in the issuance of fractional shares shall be disregarded to the extent of the fraction.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">6.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Option shall not be transferable otherwise than by will or by the laws of descent and distribution and during the lifetime of Optionee shall be exercisable only by Optionee.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">7.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In the event Optionee ceases to be employed by the Company for any reason other than death or disability, the Option may be exercised (if it has not expired under Sections 3 or 4 and is exercisable under Section 5), to the extent the Optionee is entitled to do so on the date of termination, only during the period ending three months from the date of such cessation.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:96px;text-indent:-48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:96px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Notwithstanding the foregoing, in the event the Optionee&#8217;s employment is terminated by the Company for cause, the Option shall terminate at the time of such termination.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">8.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In the event Optionee ceases to be employed by the Company by reason of death or disability, the Option may be fully exercised as to all Shares covered hereby (if it has not expired under Sections 3 or 4 but regardless of whether it is exercisable under Section 5) only during the period ending one year from the date of such cessation.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">9.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Nothing herein or in the Plan shall confer upon any employee of the Company any right to continue in the employment of the Company.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">10.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Option and the Plan are subject to adjustments, modifications and amendments as provided in the Plan.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">11.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Subject to the Plan, this Agreement shall bind and inure to the benefit of the Company, Optionee and their respective successors, permitted assigns and personal representatives.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">12.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Agreement will be governed by and construed under the laws of Delaware.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:48px;"><font style="font-family:inherit;font-size:12pt;">13.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Any disputes, claims or interpretive issues arising hereunder shall be resolved by the Committee in its sole and absolute discretion, and the Committee's determinations shall be final and incontestable.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">IN WITNESS WHEREOF, the undersigned have executed this Agreement to be effective from the date first above written.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:96px;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ANGIODYNAMICS, INC.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By: ____________________________</font></div><div style="line-height:120%;text-align:left;text-indent:192px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Michael Greiner</font></div><div style="line-height:120%;text-align:left;text-indent:192px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">EVP &amp; Chief Financial Officer</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:144px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">BY: ___________________________</font></div><div style="line-height:120%;text-align:left;text-indent:192px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">[Employee]</font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4.5
<SEQUENCE>5
<FILENAME>ex1045performanceunitaward.htm
<DESCRIPTION>EXHIBIT 10.4.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s1A21A25F8766C310DC0AB80443B06EEC"></a></div><div></div><div><br></div><div style="line-height:144%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">PERFORMANCE UNIT AWARD AGREEMENT</font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Performance Unit Award Agreement (this &#8220;Agreement&#8221;), dated as of the 18</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">th</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;day of July, 2018 (the &#8220;Grant Date&#8221;), is between AngioDynamics, Inc., a Delaware corporation (the &#8220;Company&#8221;), and the (&#8220;Participant&#8221;), an employee of the Company or any of its affiliates or subsidiaries and whose name appears on the signature page hereto.  All capitalized terms not otherwise defined herein shall have the meaning ascribed thereto in either the AngioDynamics 2004 Stock and Incentive Award Plan, as amended (the &#8220;Plan&#8221;) or in the Total Shareholder Return Performance Unit Award Program (the &#8220;Program&#8221;) for the performance period calculated pursuant to the Program (the &#8220;Performance Period&#8221;).</font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">1. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Grant and Acceptance of Award</font><font style="font-family:inherit;font-size:12pt;">. Effective as of the Grant Date, the Company hereby grants to the Participant a Performance Unit Award (the &#8220;Performance Unit Award&#8221;), subject to the terms and conditions set forth in this Agreement, the Program and the Plan, with respect to [TARGET AMOUNT] (the &#8220;Target Amount&#8221;) shares of the Company&#8217;s common stock, par value $0.01 per share (the &#8220;Common Stock&#8221;).  The grant of this Performance Unit Award shall not confer any right to the Participant (or any other participant) to be granted any Performance Unit Awards in the future under the Program.</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">2. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Eligibility Conditions upon Performance Unit Award</font><font style="font-family:inherit;font-size:12pt;">. The Participant hereby acknowledges the vesting of any shares of Common Stock underlying the Performance Unit Award is subject to certain eligibility, performance and other conditions set forth herein.  All shares of Common Stock vested pursuant to the terms of this Agreement, the Program and the Plan shall be issued to the Participant as soon as practicable (and in all events within sixty (60) days) after the end of the Performance Period. </font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">3. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Satisfaction of Performance-Based Conditions</font><font style="font-family:inherit;font-size:12pt;">. Subject to the eligibility conditions described in Section 7 of this Agreement, except as otherwise provided in Sections 5, 6 and 8 of this Agreement, and the satisfaction of the performance conditions set forth on </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Appendix A</font><font style="font-family:inherit;font-size:12pt;">&#32;to this Agreement during the Performance Period, shares of Common Stock subject to the Performance Unit Award will vest pursuant to the terms and in accordance with the conditions set forth in the Program.  Except as set forth in Sections 5, 6 and 8 of this Agreement, no shares of Common Stock in settlement of vested shares of Common Stock underlying the Performance Unit Award shall be issued to the Participant prior to the end of the Performance Period.</font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">4. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Participant&#8217;s Rights in Common Stock</font><font style="font-family:inherit;font-size:12pt;">. The shares of Common Stock, if and when issued hereunder, shall be registered in the name of the Participant and evidenced in the manner as the Company may determine.  During the period prior to the issuance of Stock (including any Vesting Date according to the Vesting Schedule), the Participant will have no rights of a stockholder of the Company with respect to the Common Stock underlying the Performance Unit Award, including no right to receive dividends or vote the shares of Common Stock underlying each Performance Unit Award.</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">5. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Death</font><font style="font-family:inherit;font-size:12pt;">. In the event that the Participant&#8217;s employment with the Company or its subsidiaries or affiliates is terminated due to death on or after the Grant Date, but prior to the end of the Performance Period, the Performance Unit Award shall remain eligible to vest following the end date of the Performance Period (subject to satisfaction of the performance conditions set forth on </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Appendix A</font><font style="font-family:inherit;font-size:12pt;">&#32;to this Agreement) and the Participant shall receive a pro-rated portion of the Common Stock underlying the Performance Unit Award that would otherwise vest based on performance on the Vesting Date, with the pro-rata portion based on the Participant&#8217;s whole months of service with the Company during the Performance Period prior to the date of such termination; provided that a partial month of employment will be considered a whole &#8220;month of service&#8221; for purposes of this Agreement only if the Participant was employed by the Company for at least fifteen (15) days during such month.  Any portion of the Performance Unit Award that remains unvested on the Vesting Date (after giving effect to such pro-ration) shall be considered to have terminated on the Vesting Date.  The Participant may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under this Agreement is to be paid in case of his or her death before he or she receives any or all such benefit.  Each such designation shall revoke all prior designations by the Participant, shall be in a form prescribed by the Company, and will be effective only when filed by the Participant in writing with the Secretary of the Company during the Participant&#8217;s lifetime.  In the absence of any such designation, benefits remaining unpaid at the Participant&#8217;s death shall be paid to the Participant&#8217;s estate.</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">6. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Retirement or Disability</font><font style="font-family:inherit;font-size:12pt;">. In the event that the Participant&#8217;s employment with the Company or its subsidiaries or affiliates is terminated due to Retirement or Disability on or after the Grant Date, but prior to the end of the Performance Period, the Performance Unit Award shall remain eligible to vest following the end date of the Performance Period (subject to satisfaction of the performance conditions set forth on </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Appendix A</font><font style="font-family:inherit;font-size:12pt;">&#32;to this Agreement) and the Participant shall receive a pro-rated portion of the Common Stock underlying the Performance Unit Award that would otherwise vest based on performance on the Vesting Date, with the pro-rata portion based on the Participant&#8217;s whole months of service with the Company during the Performance Period prior to the date of such termination; provided that a partial month of employment will be considered a whole &#8220;month of service&#8221; for purposes of this Agreement only if the Participant was employed by the Company for at least fifteen (15) days during such month.  Any portion of the Performance Unit Award that remains unvested on the Vesting Date (after giving effect to such pro-ration) shall be considered to have terminated on the Vesting Date. </font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">7. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Other Termination of Employment -- Eligibility Conditions</font><font style="font-family:inherit;font-size:12pt;">. If the Participant&#8217;s employment with the Company and its affiliates or subsidiaries is terminated or the Participant separates from the Company and its affiliates or subsidiaries for any reason other than death, Retirement or Disability, the Performance Unit Award shall terminate and no shares of Common Stock shall be issued.  Except as set forth in Sections 5, 6 and 8, eligibility to be issued shares of Common Stock underlying the Performance Unit Award is conditioned on the Participant&#8217;s continuous employment with the Company through the last day of the Performance Period.</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">8. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Change in Control of the Company</font><font style="font-family:inherit;font-size:12pt;">.  Notwithstanding anything to the contrary in this Agreement, in the event of a Change in Control (as defined in the Program) of the Company on or after the Grant Date, but prior to the end of the Performance Period and prior to the Participant&#8217;s termination of employment for any reason, the Participant shall immediately vest in 100% of the Target Amount of shares of Common Stock subject to the Performance Unit Award. Notwithstanding anything to the contrary in this Agreement, in the event the Participant&#8217;s employment with the Company or any Subsidiary terminates due to one of the reasons expressly covered by Section 5 or Section 6 of this Agreement and a Change in Control of the Company occurs subsequent to such a termination of employment (but during the Performance Period), the pro-rata vesting provided for in such sections shall be based on the Target Amount of shares of Common Stock subject to the Performance Unit Award.  Any shares of Common Stock subject to the Performance Unit Award that become vested pursuant to this Section 8 shall be issued to the Participant upon or as soon as practicable (and in all events within thirty (30) days) after the effective date of the Change in Control of the Company (or, if so provided by the Board of Directors, immediately prior to the Change in Control).  In the event a Change in Control of the Company occurs following the last day of the Performance Period, prior to the Participant&#8217;s termination of employment for any reason, and prior to the date all vested shares of Common Stock underlying the Performance Unit Award are issued pursuant to Section 2 above, any shares of Common Stock subject to the Performance Unit Award that became vested pursuant to the terms of this Agreement and the Program shall be issued to the Participant upon or as soon as practicable (and in all events within thirty (30) days) after the effective date of the Change in Control of the Company (or, if so provided by the Company&#8217;s Board of Directors, immediately prior to the Change in Control).</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">9. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Consideration for Stock</font><font style="font-family:inherit;font-size:12pt;">. The shares of Common Stock underlying the Performance Unit Award that are issued pursuant to this Agreement and the Program will be issued for no cash consideration.</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">10. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Issuance of Stock</font><font style="font-family:inherit;font-size:12pt;">. The Company shall not be obligated to issue any shares of Common Stock underlying the Performance Unit Award that become vested pursuant to the terms of this Agreement and the Program until (i) all federal and state laws and regulations as the Company may deem applicable have been complied with; (ii) the shares have been listed or authorized for listing upon official notice to the Nasdaq Global Select Market or have otherwise been accorded trading privileges; and (iii) all other legal matters in connection with the issuance and delivery of the shares have been approved by the Company&#8217;s legal department.</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">11. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Tax Withholding</font><font style="font-family:inherit;font-size:12pt;">. The Participant acknowledges that he or she shall be responsible for the payment of any taxes of any kind required by any national, state or local law to be paid with respect to the Performance Unit Award or the shares of Common Stock to be awarded hereunder, including, without limitation, the payment of any applicable withholding, income, social and similar taxes or obligations. The Participant further acknowledges that the Company (1) makes no representations or undertakings regarding the treatment of any tax-related matters in connection with any aspect of this Agreement, including the grant of this Performance Unit Award, the vesting of any shares of Common Stock underlying this Performance Unit Award, the issuance of shares of Common Stock hereunder, the subsequent sale of any shares of Common Stock acquired hereunder and the receipt of any dividends; and (2) does not commit and is under no obligation to structure the terms of the grant or any aspect of the Performance Unit Award to reduce or eliminate the Participant&#8217;s liability for tax-related matters or achieve any particular tax result. Further, if the Participant becomes subject to tax and/or social security contributions in more than one jurisdiction between the Date of Grant and the date of any relevant taxable, tax and/or social security contribution withholding event, as applicable, the Participant acknowledges that the Company may be required to withhold or account for tax-related matters in more than one jurisdiction.  Prior to any relevant taxable, tax and/or social security contribution withholding event, the Participant shall pay or make adequate arrangements satisfactory to the Company to satisfy all tax-related matters. In this regard, the Participant authorizes the Company, at its sole discretion, to satisfy the obligations with respect to tax-related matters by one or a combination of the following: (i) withholding from the Participant&#8217;s wages or other cash compensation paid to him or her by the Company; or (ii) withholding from the proceeds of the sale of shares of Common Stock acquired hereunder, either through a voluntary sale or through a mandatory sale arranged by the Company (on the Participant&#8217;s behalf pursuant to this authorization); or (iii) withholding in shares of Common Stock to be issued hereunder.  To avoid negative accounting treatment, the Company will withhold or account for tax-related matters by considering applicable minimum statutory withholding amounts or other applicable withholding rates.  If the obligation for tax-related matters is satisfied by withholding in shares of Common Stock, for tax purposes, the Participant will be deemed to have been issued the full number of shares of Common Stock subject to the vested portion of this Performance Unit Award, notwithstanding that a number of the shares of Common Stock is held back solely for the purpose of paying the tax-related matters due as a result of any aspect of the Participant&#8217;s participation in the Program.  Finally, the Participant shall pay to the Company any amount of tax-related matters that the Company may be required to withhold or account for as a result of Participant&#8217;s participation in the Program that cannot be satisfied by the means described in this Section 11. The Company may refuse to issue or deliver shares of Common Stock or the proceeds of the sale of shares of Common Stock to the Participant if the Participant fails to comply with Participant&#8217;s obligation in connection with any tax-related matters.</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">12. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Compliance with Section 409A</font><font style="font-family:inherit;font-size:12pt;">. This Agreement is intended to comply with the requirements of Section 409A.  Accordingly, all provisions herein shall be construed and interpreted to comply with Section 409A.  This Agreement may be amended at any time, without the consent of any party, to avoid the application of Section 409A in a particular circumstance or that is necessary or desirable to satisfy any of the requirements under Section 409A, but the Company shall not be under any obligation to make any such amendment.  Nothing in the Agreement shall provide a basis for any person to take action against the Company or any of its subsidiaries or affiliate based on matters covered by Section 409A, including the tax treatment of any amount paid or Performance Unit Award granted under this Agreement, and neither the Company nor any of its subsidiaries or affiliates shall under any circumstances have any liability to any participant or his or her estate or any other party for any taxes, penalties or interest due on amounts paid or payable under the this Agreement, including taxes, penalties or interest imposed under Section 409A. Notwithstanding any provision to the contrary in this Agreement, if shares of Common Stock or other amounts become issuable or distributable under this Agreement by reason of the Participant&#8217;s Separation from Service and the Participant is a &#8220;specified employee,&#8221; within the meaning of Section 409A, at the time of such Separation from Service, the shares of Common Stock shall not be issued or distributed to the Participant prior to the earlier of (i) the first day of the seventh (7th) month following the date of the Participant&#8217;s Separation from Service or (ii) the date of the Participant&#8217;s death, if such delayed commencement is otherwise required in order to avoid a prohibited distribution under Section 409A(a)(2).  Upon the expiration of the applicable Section 409A(a)(2) deferral period, all shares of Common Stock underlying the Performance Unit Award issued pursuant to this Agreement or other amounts deferred pursuant to this Section 12 shall be issued or distributed in a lump sum to the Participant.  For purposes of this Agreement, &#8220;Separation from Service&#8221; means the Participant&#8217;s separation from service as determined in accordance with Section 409A and the applicable standards of the Treasury Regulations issued thereunder.</font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">13. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Recapitalization</font><font style="font-family:inherit;font-size:12pt;">. In the event there is any change in the Company&#8217;s Common Stock through the declaration of stock dividends or through recapitalization resulting in stock split-ups or through merger, consolidation, exchange of shares of Common Stock, or otherwise, the number and class of shares of Common Stock subject to this Performance Unit Award shall be equitably adjusted by the Company, in the manner determined in its sole discretion, to prevent dilution or enlargement of rights.</font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">14. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Investment Intent</font><font style="font-family:inherit;font-size:12pt;">. The Participant acknowledges that the acquisition of shares of Common Stock to be issued hereunder is for investment purposes without a view to distribution thereof.</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">15. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Limits on Transferability; Restrictions on Shares; Legend on Certificate</font><font style="font-family:inherit;font-size:12pt;">. Until the eligibility conditions of this Performance Unit Award have been satisfied and shares of Common Stock have been issued in accordance with the terms of this Agreement or by action of the Company&#8217;s Board of Directors, this Performance Unit Award is not transferable and shall not be sold, transferred, assigned, pledged, gifted, hypothecated or otherwise disposed of or encumbered by the Participant.  Transfers of shares of Common Stock by the Participant are subject to the Company&#8217;s Insider Trading Policy and applicable securities laws.  Shares of Common Stock issued to the Participant in certificate form or to the Participant&#8217;s book entry account upon satisfaction of the vesting and other conditions of this Performance Unit Award may be restricted from transfer or sale by the Company and evidenced by stop-transfer instructions upon the Participant&#8217;s book entry account or restricted legend(s) affixed to certificates in the form as the Company or its counsel may require with respect to any applicable restrictions on sale or transfer.</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">16. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Award Subject to the Plan and the Program</font><font style="font-family:inherit;font-size:12pt;">. The Performance Unit Award made pursuant to this Agreement is made subject to the Plan and the Program.  The terms and provisions of the Plan and the Program, as each may be amended from time to time are hereby incorporated herein by reference.  In the event of a conflict between any term or provision contained in this Agreement and a term or provision of the Plan or the Program, the applicable terms and conditions of the Plan or Program will govern and prevail.  However, no amendment of the Plan or the Program after the date hereof may adversely alter or impair the issuance of the Common Stock underlying the Performance Unit Award to be made pursuant to this Agreement.</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">17. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">No Rights to Continued Employment</font><font style="font-family:inherit;font-size:12pt;">. This Agreement shall not confer upon the Participant any right to continuation of employment with the Company, its subsidiaries or affiliates, nor shall this Agreement interfere in any way with the Company&#8217;s right to terminate the Participant&#8217;s employment at any time with or without cause.</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">18. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Legal Notices</font><font style="font-family:inherit;font-size:12pt;">. Any legal notice necessary under this Agreement shall be addressed to the Company in care of its General Counsel at the principal executive offices of the Company and to the Participant at the address appearing in the personnel records of the Company for such Participant or to either party at such other address as either party may designate in writing to the other.  Any such notice shall be deemed effective upon receipt thereof by the addressee.</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">19. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Governing Law</font><font style="font-family:inherit;font-size:12pt;">. The interpretation, performance and enforcement of this Agreement shall be governed by the laws of the State of New York (without regard to the conflict of laws principles thereof) and applicable federal laws.  For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties evidenced by this Agreement, the parties hereby submit and consent to the exclusive jurisdiction of the State of New York and agree that such litigation shall be conducted only in the State of New York, or the federal courts for the United States for the Northern District of New York, and no other courts, where this Performance Unit Award is made and/or to be performed.</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">20. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Headings</font><font style="font-family:inherit;font-size:12pt;">. The headings contained in this Agreement are for convenience only and shall not affect the meaning or interpretation of this Agreement.</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;text-indent:48px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">21. </font><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">Counterparts</font><font style="font-family:inherit;font-size:12pt;">. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original and all of which together shall be deemed to be one and the same instrument.</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><a name="s8DDEF46C1E10029365A5B80443D00294"></a></div><div style="line-height:120%;padding-bottom:32px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This Agreement is being signed as of the Grant Date.</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style='display:inline-block; width:100%;'><div style='float:left; width:48%;'><div><a name="s6E441FBC1D092EF75F95B80443E339BF"></a></div><div style="line-height:120%;padding-bottom:24px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">AngioDynamics, Inc.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By:&#160;&#160;&#160;&#160;______________________________</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Name:&#160;&#160;&#160;&#160;______________________________</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Title:&#160;&#160;&#160;&#160;______________________________</font></div><div style="line-height:120%;padding-bottom:24px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:inherit;font-size:12pt;">Participant</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By:&#160;&#160;&#160;&#160;______________________________</font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Name:&#160;&#160;&#160;&#160;______________________________</font></div></div></div><div><a name="sEE98D2A3D4B79452D72CB804443C00B1"></a></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><a name="s3AD3F06EBD19BC9B858EB80444408BAF"></a></div><div style="line-height:144%;padding-bottom:16px;padding-top:16px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">APPENDIX A</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:144%;font-size:12pt;padding-left:24px;"><font style="font-family:inherit;font-size:12pt;">I.</font></div></td><td style="vertical-align:top;"><div style="line-height:144%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Company Performance Levels</font></div></td></tr></table><div style="line-height:144%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Performance Share Units will pay out in shares of Common Stock in a range of 0% to 200% of the number of Performance Share Units as follows:</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:63.46153846153846%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:47%;"></td><td style="width:53%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-top:2px;text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">TSR Performance</font></div><div style="padding-top:2px;text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Percentile Rank</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-top:2px;text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Performance Share Units</font></div><div style="padding-top:2px;text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">as a Percent of Target </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">75th Percentile or above</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">200%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">50th Percentile</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">100%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">25th Percentile</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">50%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Below 25th Percentile</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;padding-left:2px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">0%</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:24px;"><font style="font-family:inherit;font-size:12pt;">II.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Peer Group (as defined in the Program) with respect to this Agreement is set forth below.</font></div></td></tr></table><div style="line-height:120%;text-align:center;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.52136752136752%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:47%;"></td><td style="width:53%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Abaxis Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Integra Lifesciences Holdings Corporation</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Abiomed Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Intricon Corporation</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Accuray Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Intuitive Surgical, Inc.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">AlphaTec Holdings Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Invacare Corporation</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Articure, Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Lakeland Industries Inc.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Atrion Corporation</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Lemaitre Vascular, Inc.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Becton, Dickinson &amp; Company</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Masimo Corporation</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Boston Scientific Corporation</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Merit Medical Systems, Inc.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Cantel Medical Corp.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Mine Safety Appliances Company</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Conmed Corporation</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Natus Medical Incorporated</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">CryoLife, Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">NuVasive, Inc.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Cutera, Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">NxStage Medical, Inc.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Dexcom, Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Resmed Inc.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Digirad Corp</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">RTI Surgical, Inc.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Edwards Lifesciences Corporation</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Steris Corporation</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Endologix, Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Stryker Corporation</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Haemonetics Corporation</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Teleflex Incorporated</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">ICU Medical, Inc.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Varian Medical Systems, Inc.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Insulet Corporation</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Wright Medical</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:138%;padding-bottom:13px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">B-1</font></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>6
<FILENAME>ex2153118.htm
<DESCRIPTION>EXHIBIT 21
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s235B5CE3A1C45871BD92559303D72727"></a></div><div style="line-height:120%;padding-top:12px;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 21</font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Subsidiaries of AngioDynamics, Inc. </font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:51%;"></td><td style="width:2%;"></td><td style="width:47%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:left;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Subsidiary</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:left;font-size:7.5pt;"><font style="font-family:inherit;font-size:7.5pt;font-weight:bold;">State of Incorporation or Organization</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vortex Medical</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">NM Holding Company, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Navilyst Medical Holdings, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Navilyst Medical, Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngioDynamics UK Limited</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United Kingdom</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngioDynamics Netherlands B. V.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Netherlands</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:6px;padding-bottom:6px;padding-right:2px;"><div style="padding-bottom:6px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">RITA Medical Systems, LLC</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngioDynamics France, SARL</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">France</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">AngioDynamics Canada Inc.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">British Columbia</font></div></td></tr></table></div></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div><br></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>7
<FILENAME>ex23angio2018consentofdelo.htm
<DESCRIPTION>EXHIBIT 23
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s6728E3CCA94953D4B6BA6A12578A06FD"></a></div><div style="line-height:120%;padding-top:12px;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 23</font></div><div style="line-height:120%;padding-bottom:32px;padding-top:32px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We consent to the incorporation by reference in Registration Statement Nos. 333-120057, 333-138456, 333-140627, 333-161355, 333-162844, 333-170619, 333-190640 and 333-203441 on Form S-8 and No.&#160;333-190642 on Form S-3 of our reports dated </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;relating to the financial statements and financial statement schedule of AngioDynamics, Inc., and the effectiveness of AngioDynamics Inc.'s internal control over financial reporting, appearing in this Annual Report on Form 10-K of AngioDynamics, Inc. for the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Deloitte &amp; Touche LLP </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Boston, Massachusetts</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>8
<FILENAME>ex231angio2018consentofpri.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sEFAB98EF5C04590ABBF6AF5E2DD51A61"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:12px;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 23.1</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We hereby consent to the incorporation by reference in the Registration Statement on Form S&#8209;3 (No. 333-190642) of AngioDynamics, Inc. of our report dated August 1, 2016  relating to the consolidated financial statements and financial statement schedule, which appears in this Form 10&#8209;K.</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt"> </sup>&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ PricewaterhouseCoopers LLP&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Boston, Massachusetts&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>9
<FILENAME>ex3115311810-k.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s95F9090A43A954B6B9CCB6FAA2153665"></a></div><div><div style="line-height:110%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:144%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 31.1</font></div><div style="line-height:144%;padding-top:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CERTIFICATION</font></div><div style="line-height:144%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I, James C. Clemmer, certify that:</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I have reviewed this annual report on Form 10-K of AngioDynamics, Inc.;</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:144%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:144%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:144%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:144%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div></td></tr></table><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:144%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:144%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div></td></tr></table><div style="line-height:144%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:180%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/ S / JAMES C. CLEMMER</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">James C. Clemmer, President,</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Executive Officer</font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>10
<FILENAME>ex3125311810-k.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sA2850FBCD93B5C8889D238498F4454AF"></a></div><div><div style="line-height:110%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:144%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 31.2</font></div><div style="line-height:144%;padding-top:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CERTIFICATION</font></div><div style="line-height:144%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I, Michael C. Greiner, certify that:</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I have reviewed this annual report on Form 10-K of AngioDynamics, Inc.;</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:144%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:144%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:144%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:144%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div></td></tr></table><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:144%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:144%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div></td></tr></table><div style="line-height:144%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/ S / MICHAEL C. GREINER</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Michael C. Greiner, Executive Vice President,</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Financial Officer</font></div><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>11
<FILENAME>ex3215311810-k.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s03DBF5C76E695F2BAA2B4EE23CAB9BB8"></a></div><div><div style="line-height:110%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:144%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 32.1</font></div><div style="line-height:144%;padding-top:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO TITLE 18,</font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">UNITED STATES CODE, SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="line-height:144%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I, James C. Clemmer, President, Chief Executive Officer and Director of ANGIODYNAMICS, Inc. (the &#8220;Company&#8221;), certify, pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section&#160;1350, that, to the best of my knowledge:</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the annual report on Form 10-K of the Company for the fiscal year ended May&#160;31, 2018 (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></td></tr></table></div></div><div style="line-height:144%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ James C. Clemmer</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">James C. Clemmer, President,</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Executive Officer</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>12
<FILENAME>ex3225311810-k.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s13AB88C33A665B08B5CE06C399BFBB44"></a></div><div><div style="line-height:110%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:144%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 32.2</font></div><div style="line-height:144%;padding-top:12px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO TITLE 18,</font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">UNITED STATES CODE, SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="line-height:144%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I, Michael C. Greiner, Chief Financial Officer of ANGIODYNAMICS, Inc. (the &#8220;Company&#8221;), certify, pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section&#160;1350, that, to the best of my knowledge:</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the annual report on Form 10-K of the Company for the fiscal year ended May&#160;31, 2018 (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and</font></div></td></tr></table></div></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:5%;"></td><td style="width:95%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></td></tr></table></div></div><div style="line-height:110%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: </font><font style="font-family:inherit;font-size:10pt;color:#000000;font-weight:normal;">July 23, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Michael C. Greiner</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Michael C. Greiner, Executive Vice President,</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Financial Officer</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>13
<FILENAME>ango-20180531.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:17C3EBA9B4605E60A6CE28CFA26870B8,x:0913318c66a54d95b2d39407e20e5718-->
<xbrli:xbrl xmlns:acec="http://fasb.org/dis/acec/2018-01-31" xmlns:ango="http://www.angiodynamics.com/20180531" xmlns:ap="http://fasb.org/dis/ap/2018-01-31" xmlns:aro="http://fasb.org/dis/aro/2018-01-31" xmlns:bc="http://fasb.org/dis/bc/2018-01-31" xmlns:bsoff="http://fasb.org/dis/bsoff/2018-01-31" xmlns:cc="http://fasb.org/dis/cc/2018-01-31" xmlns:cce="http://fasb.org/dis/cce/2018-01-31" xmlns:codification-part="http://fasb.org/codification-part/2018-01-31" xmlns:com="http://fasb.org/stm/com/2018-01-31" xmlns:con="http://fasb.org/dis/con/2018-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:country-all="http://xbrl.sec.gov/country-all/2017-01-31" xmlns:country-ent-all="http://xbrl.sec.gov/country-ent-all/2017-01-31" xmlns:country-ent-std="http://xbrl.sec.gov/country-ent-std/2017-01-31" xmlns:country-std="http://xbrl.sec.gov/country-std/2017-01-31" xmlns:crcgen="http://fasb.org/dis/crcgen/2018-01-31" xmlns:crcpb="http://fasb.org/dis/crcpb/2018-01-31" xmlns:crcrb="http://fasb.org/dis/crcrb/2018-01-31" xmlns:crcsbp="http://fasb.org/dis/crcsbp/2018-01-31" xmlns:ctbl="http://fasb.org/dis/ctbl/2018-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2017-01-31" xmlns:currency-all="http://xbrl.sec.gov/currency-all/2017-01-31" xmlns:currency-ent-all="http://xbrl.sec.gov/currency-ent-all/2017-01-31" xmlns:currency-ent-std="http://xbrl.sec.gov/currency-ent-std/2017-01-31" xmlns:currency-std="http://xbrl.sec.gov/currency-std/2017-01-31" xmlns:dccpoa="http://fasb.org/dis/dccpoa/2018-01-31" xmlns:debt="http://fasb.org/dis/debt/2018-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:dei-all="http://xbrl.sec.gov/dei-all/2018-01-31" xmlns:dei-ent-all="http://xbrl.sec.gov/dei-ent-all/2018-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2018-01-31" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2018-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:deprecated1="http://www.xbrl.org/2009/role/deprecated" xmlns:diha="http://fasb.org/dis/diha/2018-01-31" xmlns:disops="http://fasb.org/dis/disops/2018-01-31" xmlns:dr="http://fasb.org/dis/dr/2018-01-31" xmlns:edco="http://fasb.org/dis/edco/2018-01-31" xmlns:ei="http://fasb.org/dis/ei/2018-01-31" xmlns:emjv="http://fasb.org/dis/emjv/2018-01-31" xmlns:eps="http://fasb.org/dis/eps/2018-01-31" xmlns:equity="http://fasb.org/dis/equity/2018-01-31" xmlns:ero="http://fasb.org/dis/ero/2018-01-31" xmlns:eui="http://fasb.org/dis/eui/2018-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2018-01-31" xmlns:exch-all="http://xbrl.sec.gov/exch-all/2018-01-31" xmlns:exch-ent-all="http://xbrl.sec.gov/exch-ent-all/2018-01-31" xmlns:exch-ent-std="http://xbrl.sec.gov/exch-ent-std/2018-01-31" xmlns:exch-std="http://xbrl.sec.gov/exch-std/2018-01-31" xmlns:fifvd="http://fasb.org/dis/fifvd/2018-01-31" xmlns:foct="http://fasb.org/dis/foct/2018-01-31" xmlns:fs-bd="http://fasb.org/dis/fs-bd/2018-01-31" xmlns:fs-bt="http://fasb.org/dis/fs-bt/2018-01-31" xmlns:fs-fhlb="http://fasb.org/dis/fs-fhlb/2018-01-31" xmlns:fs-ins="http://fasb.org/dis/fs-ins/2018-01-31" xmlns:fs-interest="http://fasb.org/dis/fs-interest/2018-01-31" xmlns:fs-mort="http://fasb.org/dis/fs-mort/2018-01-31" xmlns:guar="http://fasb.org/dis/guar/2018-01-31" xmlns:hco="http://fasb.org/dis/hco/2018-01-31" xmlns:iago="http://fasb.org/dis/iago/2018-01-31" xmlns:iaoi="http://fasb.org/dis/iaoi/2018-01-31" xmlns:ides="http://fasb.org/dis/ides/2018-01-31" xmlns:inctax="http://fasb.org/dis/inctax/2018-01-31" xmlns:inv="http://fasb.org/dis/inv/2018-01-31" xmlns:invco="http://fasb.org/dis/invco/2018-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:invest-all="http://xbrl.sec.gov/invest-all/2013-01-31" xmlns:invest-ent-all="http://xbrl.sec.gov/invest-ent-all/2013-01-31" xmlns:invest-ent-std="http://xbrl.sec.gov/invest-ent-std/2013-01-31" xmlns:invest-std="http://xbrl.sec.gov/invest-std/2013-01-31" xmlns:ir="http://fasb.org/dis/ir/2018-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:lea="http://fasb.org/dis/lea/2018-01-31" xmlns:leas="http://fasb.org/dis/leas/2018-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:naics-all="http://xbrl.sec.gov/naics-all/2017-01-31" xmlns:naics-ent-all="http://xbrl.sec.gov/naics-ent-all/2017-01-31" xmlns:naics-ent-std="http://xbrl.sec.gov/naics-ent-std/2017-01-31" xmlns:naics-std="http://xbrl.sec.gov/naics-std/2017-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:ni="http://fasb.org/dis/ni/2018-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:nt="http://fasb.org/dis/nt/2018-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ocpfs="http://fasb.org/dis/ocpfs/2018-01-31" xmlns:oi="http://fasb.org/dis/oi/2018-01-31" xmlns:otherexp="http://fasb.org/dis/otherexp/2018-01-31" xmlns:othliab="http://fasb.org/dis/othliab/2018-01-31" xmlns:pay="http://fasb.org/dis/pay/2018-01-31" xmlns:ppe="http://fasb.org/dis/ppe/2018-01-31" xmlns:rcc="http://fasb.org/dis/rcc/2018-01-31" xmlns:rd="http://fasb.org/dis/rd/2018-01-31" xmlns:re="http://fasb.org/dis/re/2018-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:reference="http://www.xbrl.org/2009/role/reference" xmlns:regop="http://fasb.org/dis/regop/2018-01-31" xmlns:reorg="http://fasb.org/dis/reorg/2018-01-31" xmlns:rlnro="http://fasb.org/dis/rlnro/2018-01-31" xmlns:rpd="http://fasb.org/dis/rpd/2018-01-31" xmlns:ru="http://fasb.org/dis/ru/2018-01-31" xmlns:scf-dbo="http://fasb.org/stm/scf-dbo/2018-01-31" xmlns:scf-dir="http://fasb.org/stm/scf-dir/2018-01-31" xmlns:scf-indir="http://fasb.org/stm/scf-indir/2018-01-31" xmlns:scf-indira="http://fasb.org/stm/scf-indira/2018-01-31" xmlns:scf-inv="http://fasb.org/stm/scf-inv/2018-01-31" xmlns:scf-re="http://fasb.org/stm/scf-re/2018-01-31" xmlns:scf-sbo="http://fasb.org/stm/scf-sbo/2018-01-31" xmlns:scf-sd="http://fasb.org/stm/scf-sd/2018-01-31" xmlns:schedoi-fednote="http://fasb.org/dis/schedoi-fednote/2018-01-31" xmlns:schedoi-hold="http://fasb.org/dis/schedoi-hold/2018-01-31" xmlns:schedoi-iiaa="http://fasb.org/dis/schedoi-iiaa/2018-01-31" xmlns:schedoi-oocw="http://fasb.org/dis/schedoi-oocw/2018-01-31" xmlns:schedoi-otsh="http://fasb.org/dis/schedoi-otsh/2018-01-31" xmlns:schedoi-shorthold="http://fasb.org/dis/schedoi-shorthold/2018-01-31" xmlns:schedoi-sumhold="http://fasb.org/dis/schedoi-sumhold/2018-01-31" xmlns:se="http://fasb.org/dis/se/2018-01-31" xmlns:sec-cndfir="http://fasb.org/dis/sec-cndfir/2018-01-31" xmlns:sec-mort="http://fasb.org/dis/sec-mort/2018-01-31" xmlns:sec-re="http://fasb.org/dis/sec-re/2018-01-31" xmlns:sec-reins="http://fasb.org/dis/sec-reins/2018-01-31" xmlns:sec-sum="http://fasb.org/dis/sec-sum/2018-01-31" xmlns:sec-supins="http://fasb.org/dis/sec-supins/2018-01-31" xmlns:sec-suppc="http://fasb.org/dis/sec-suppc/2018-01-31" xmlns:sec-vq="http://fasb.org/dis/sec-vq/2018-01-31" xmlns:sfp-clreo="http://fasb.org/stm/sfp-clreo/2018-01-31" xmlns:sfp-cls="http://fasb.org/stm/sfp-cls/2018-01-31" xmlns:sfp-dbo="http://fasb.org/stm/sfp-dbo/2018-01-31" xmlns:sfp-ibo="http://fasb.org/stm/sfp-ibo/2018-01-31" xmlns:sfp-sbo="http://fasb.org/stm/sfp-sbo/2018-01-31" xmlns:sfp-ucreo="http://fasb.org/stm/sfp-ucreo/2018-01-31" xmlns:sheci="http://fasb.org/stm/sheci/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:sic-all="http://xbrl.sec.gov/sic-all/2011-01-31" xmlns:sic-ent-all="http://xbrl.sec.gov/sic-ent-all/2011-01-31" xmlns:sic-ent-std="http://xbrl.sec.gov/sic-ent-std/2011-01-31" xmlns:sic-std="http://xbrl.sec.gov/sic-std/2011-01-31" xmlns:soc="http://fasb.org/stm/soc/2018-01-31" xmlns:soi="http://fasb.org/stm/soi/2018-01-31" xmlns:soi-egm="http://fasb.org/stm/soi-egm/2018-01-31" xmlns:soi-indira="http://fasb.org/stm/soi-indira/2018-01-31" xmlns:soi-ins="http://fasb.org/stm/soi-ins/2018-01-31" xmlns:soi-int="http://fasb.org/stm/soi-int/2018-01-31" xmlns:soi-re="http://fasb.org/stm/soi-re/2018-01-31" xmlns:soi-reit="http://fasb.org/stm/soi-reit/2018-01-31" xmlns:soi-sbi="http://fasb.org/stm/soi-sbi/2018-01-31" xmlns:spc="http://fasb.org/stm/spc/2018-01-31" xmlns:sr="http://fasb.org/dis/sr/2018-01-31" xmlns:srt="http://fasb.org/srt/2018-01-31" xmlns:srt-all="http://fasb.org/srt-all/2018-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2018-01-31" xmlns:srt-std="http://fasb.org/srt-std/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2018-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:stpr-all="http://xbrl.sec.gov/stpr-all-all-all/2018-01-31" xmlns:stpr-ent-all="http://xbrl.sec.gov/stpr-ent-all-all-all/2018-01-31" xmlns:stpr-ent-std="http://xbrl.sec.gov/stpr-ent-std-std-std/2018-01-31" xmlns:stpr-std="http://xbrl.sec.gov/stpr-std-std-std/2018-01-31" xmlns:te="http://fasb.org/dis/te/2018-01-31" xmlns:tin-part="http://fasb.org/tin-part/2018-01-31" xmlns:ts="http://fasb.org/dis/ts/2018-01-31" xmlns:us-arcroles="http://fasb.org/us-arcroles/2018-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:us-gaap-all="http://fasb.org/us-gaap-all/2018-01-31" xmlns:us-gaap-ent-std="http://fasb.org/us-gaap-ent-std/2018-01-31" xmlns:us-gaap-entryPoint-all="http://fasb.org/us-gaap-entryPoint-all/2018-01-31" xmlns:us-gaap-std="http://fasb.org/us-gaap-std/2018-01-31" xmlns:us-roles="http://fasb.org/us-roles/2018-01-31" xmlns:us-types="http://fasb.org/us-types/2018-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
	<link:schemaRef xlink:href="ango-20180531.xsd" xlink:type="simple" />
	<xbrli:context id="FD2018Q4YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2019Q1">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-07-20</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q2">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-11-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q2QTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-01</xbrli:startDate>
			<xbrli:endDate>2016-11-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q3">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-12-07</xbrli:startDate>
			<xbrli:endDate>2015-12-07</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_DisposalGroupClassificationAxis_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ango_DiscontinuedInvestmentinTiLoProductMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ango:DiscontinuedInvestmentinTiLoProductMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_DisposalGroupClassificationAxis_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ango_DiscontinuedInvestmentinTiLoProductMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">ango:DiscontinuedInvestmentinTiLoProductMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q2QTD_us-gaap_BusinessAcquisitionAxis_ango_AngioVacProductMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">ango:AngioVacProductMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-01</xbrli:startDate>
			<xbrli:endDate>2016-11-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ValuationTechniqueAxis_ango_RevenueBasedPaymentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ango:RevenueBasedPaymentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_ango_RevenueBasedPaymentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ango:RevenueBasedPaymentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_ango_ContingentConsiderationEarnOutLiabilityMember_us-gaap_ValuationTechniqueAxis_ango_RevenueBasedPaymentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ango:ContingentConsiderationEarnOutLiabilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">ango:RevenueBasedPaymentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_CounterpartyNameAxis_ango_UndisclosedInventoryDistributorMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ango:UndisclosedInventoryDistributorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_ango_InventoryTypeAxis_ango_AcculisInventoryMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ango:InventoryTypeAxis">ango:AcculisInventoryMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_ango_InventoryTypeAxis_ango_AcculisInventoryMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="ango:InventoryTypeAxis">ango:AcculisInventoryMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ango_DistributorRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ango:DistributorRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ango_ProductTechnologiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ango:ProductTechnologiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicenseAgreementTermsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseAgreementTermsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ango_ProductTechnologiesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ango:ProductTechnologiesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicenseAgreementTermsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseAgreementTermsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ango_DistributorRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ango:DistributorRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q3Jun01-Dec31">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2017-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2108Q4Jan01-May31">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q3QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-12-01</xbrli:startDate>
			<xbrli:endDate>2018-02-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember_us-gaap_TaxPeriodAxis_ango_TaxPeriodTwoMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">ango:TaxPeriodTwoMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember_us-gaap_TaxPeriodAxis_ango_TaxPeriodOneMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">ango:TaxPeriodOneMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember_us-gaap_TaxPeriodAxis_ango_TaxPeriodThreeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">ango:TaxPeriodThreeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q2Nov7_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ango:JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-11-07</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q2Nov7_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ango:JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-11-07</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q2Nov7_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ango:JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-11-07</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q2Nov7_srt_RangeAxis_srt_MaximumMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ango:JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-11-07</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q2Nov7_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ango:JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-11-07</xbrli:startDate>
			<xbrli:endDate>2016-11-07</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q2Nov7_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ango:JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-11-07</xbrli:startDate>
			<xbrli:endDate>2016-11-07</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q2Nov7_srt_RangeAxis_srt_MaximumMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ango:JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-11-07</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q2Nov7_us-gaap_DebtInstrumentAxis_ango_FormerCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ango:FormerCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ango:JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-11-07</xbrli:startDate>
			<xbrli:endDate>2016-11-07</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q2Nov7_srt_RangeAxis_srt_MinimumMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ango:JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-11-07</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ango:JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q2Nov7_srt_RangeAxis_srt_MinimumMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ango:JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-11-07</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q2Nov7_us-gaap_CreditFacilityAxis_us-gaap_SecuredDebtMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ango:JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-11-07</xbrli:startDate>
			<xbrli:endDate>2016-11-07</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q4May24_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ango:JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-24</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q2Nov7_srt_RangeAxis_srt_MinimumMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ango:JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-11-07</xbrli:startDate>
			<xbrli:endDate>2016-11-07</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q2Nov7_us-gaap_CreditFacilityAxis_us-gaap_SecuredDebtMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ango:JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-11-07</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q2Nov7_us-gaap_CreditFacilityAxis_us-gaap_BridgeLoanMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ango:JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-11-07</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q2Nov7_srt_RangeAxis_srt_MaximumMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ango:JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-11-07</xbrli:startDate>
			<xbrli:endDate>2016-11-07</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_CreditFacilityAxis_us-gaap_SecuredDebtMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_AwardTypeAxis_ango_PerformanceSharesIncludingThreeYearMarketConditionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ango:PerformanceSharesIncludingThreeYearMarketConditionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ango:StockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2014Q2Oct29">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2014-10-29</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ango:StockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ango:StockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3Feb2017_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-02-01</xbrli:startDate>
			<xbrli:endDate>2017-02-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_AwardTypeAxis_ango_PerformanceShareAndRestrictedStockUnitAwardsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ango:PerformanceShareAndRestrictedStockUnitAwardsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q3">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-02-28</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_AwardTypeAxis_ango_PerformanceShareAndRestrictedStockUnitAwardsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ango:PerformanceShareAndRestrictedStockUnitAwardsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q4YTD_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ango:StockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-06-01</xbrli:startDate>
			<xbrli:endDate>2015-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q2Oct25_us-gaap_PlanNameAxis_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ango:TwoThousandAndFourStockAndIncentiveAwardPlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-10-25</xbrli:startDate>
			<xbrli:endDate>2016-10-25</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ango:StockPurchasePlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_AwardTypeAxis_ango_PerformanceSharesIncludingThreeYearMarketConditionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ango:PerformanceSharesIncludingThreeYearMarketConditionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_AwardTypeAxis_ango_PerformanceSharesIncludingThreeYearMarketConditionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ango:PerformanceSharesIncludingThreeYearMarketConditionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_ango_PerformanceSharesIncludingThreeYearMarketConditionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ango:PerformanceSharesIncludingThreeYearMarketConditionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_PlanNameAxis_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ango:TwoThousandAndFourStockAndIncentiveAwardPlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_PlanNameAxis_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ango:TwoThousandAndFourStockAndIncentiveAwardPlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ango:TwoThousandAndFourStockAndIncentiveAwardPlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q2Nov6_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-11-06</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q2QTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-01</xbrli:startDate>
			<xbrli:endDate>2016-11-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3Feb2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-02-01</xbrli:startDate>
			<xbrli:endDate>2017-02-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_OptionIndexedToIssuersEquityEquityAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2014Q2Oct29">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-10-29</xbrli:startDate>
			<xbrli:endDate>2014-10-29</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4QTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_AwardTypeAxis_ango_PerformanceShareAndRestrictedStockUnitAwardsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ango:PerformanceShareAndRestrictedStockUnitAwardsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q2Nov6_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-11-06</xbrli:startDate>
			<xbrli:endDate>2016-11-06</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_ango_ResearchAndDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:ResearchAndDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_ango_SalesandMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:SalesandMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_ango_SalesandMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:SalesandMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_ango_AcquisitionRestructuringAndOtherItemsNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:AcquisitionRestructuringAndOtherItemsNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_IncomeStatementLocationAxis_ango_AcquisitionRestructuringAndOtherItemsNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:AcquisitionRestructuringAndOtherItemsNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_IncomeStatementLocationAxis_ango_ResearchAndDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:ResearchAndDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_ango_AcquisitionRestructuringAndOtherItemsNetMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:AcquisitionRestructuringAndOtherItemsNetMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_IncomeStatementLocationAxis_ango_SalesandMarketingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:SalesandMarketingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_ango_ResearchAndDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ango:ResearchAndDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q4March24_srt_LitigationCaseAxis_ango_TheUtahActionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ango:TheUtahActionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-03-24</xbrli:startDate>
			<xbrli:endDate>2016-03-24</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q3YTD_srt_LitigationCaseAxis_ango_TheUtahActionMember_us-gaap_LitigationStatusAxis_us-gaap_PendingLitigationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ango:TheUtahActionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-02-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2012Q3Jan11_srt_LitigationCaseAxis_ango_TheUtahActionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ango:TheUtahActionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2012-01-11</xbrli:startDate>
			<xbrli:endDate>2012-01-11</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q4March11_srt_LitigationCaseAxis_ango_TheUtahActionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ango:TheUtahActionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-03-11</xbrli:startDate>
			<xbrli:endDate>2016-03-11</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q4March11_srt_LitigationCaseAxis_ango_TheUtahActionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ango:TheUtahActionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-03-11</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2016Q4March29_srt_LitigationCaseAxis_ango_TheUtahActionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ango:TheUtahActionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-03-29</xbrli:startDate>
			<xbrli:endDate>2016-03-29</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q3YTD_srt_LitigationCaseAxis_ango_C.R.BardInc.Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ango:C.R.BardInc.Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-02-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q3YTD_dei_LegalEntityAxis_ango_C.R.BardInc.Member_srt_LitigationCaseAxis_ango_TheUtahActionMember_us-gaap_LitigationStatusAxis_us-gaap_PendingLitigationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dei:LegalEntityAxis">ango:C.R.BardInc.Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ango:TheUtahActionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-02-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2012Q1Jan11_srt_LitigationCaseAxis_ango_C.R.BardInc.Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ango:C.R.BardInc.Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2012-01-11</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2015Q1June1_srt_LitigationCaseAxis_ango_TheDelawareActionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ango:TheDelawareActionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2015-06-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2016Q4March24_srt_LitigationCaseAxis_ango_TheUtahActionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ango:TheUtahActionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-03-24</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2015Q4March10_srt_LitigationCaseAxis_ango_TheDelawareActionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ango:TheDelawareActionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-03-10</xbrli:startDate>
			<xbrli:endDate>2015-03-10</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ango_PeripheralVascularMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:PeripheralVascularMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_srt_ProductOrServiceAxis_ango_AccessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:AccessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ango_PeripheralVascularMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:PeripheralVascularMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ango_AccessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:AccessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_srt_ProductOrServiceAxis_ango_OncologySurgeryMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:OncologySurgeryMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ango_AccessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:AccessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_srt_ProductOrServiceAxis_ango_OncologySurgeryMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:OncologySurgeryMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_srt_ProductOrServiceAxis_ango_PeripheralVascularMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:PeripheralVascularMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_ProductOrServiceAxis_ango_OncologySurgeryMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:OncologySurgeryMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_srt_StatementGeographicalAxis_ango_InternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ango:InternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_StatementGeographicalAxis_ango_InternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ango:InternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_srt_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_srt_StatementGeographicalAxis_ango_InternationalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ango:InternationalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_ContractTerminationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:ContractTerminationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_ContractTerminationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:ContractTerminationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_ango_RegulatoryFilingsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ango:RegulatoryFilingsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_ContractTerminationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:ContractTerminationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_ango_EquipmentTransferMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ango:EquipmentTransferMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_RegulatoryFilingsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ango:RegulatoryFilingsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_EquipmentTransferMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ango:EquipmentTransferMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_EquipmentTransferMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ango:EquipmentTransferMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_RestructuringCostAndReserveAxis_ango_RegulatoryFilingsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ango:RegulatoryFilingsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_RestructuringCostAndReserveAxis_ango_RegulatoryFilingsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ango:RegulatoryFilingsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_RegulatoryFilingsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ango:RegulatoryFilingsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_RestructuringCostAndReserveAxis_ango_EquipmentTransferMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ango:EquipmentTransferMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_ContractTerminationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:ContractTerminationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_RestructuringCostAndReserveAxis_ango_EquipmentTransferMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ango:EquipmentTransferMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_ContractTerminationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:ContractTerminationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OneTimeTerminationBenefitsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_RestructuringPlanAxis_ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ango:ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_BalanceSheetLocationAxis_ango_AccruedExpensesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">ango:AccruedExpensesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_srt_LitigationCaseAxis_ango_DOJLitigationMember_us-gaap_RestructuringCostAndReserveAxis_ango_LegalCostsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ango:DOJLitigationMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ango:LegalCostsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_RestructuringPlanAxis_ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ango:ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q4Feb01-May31_us-gaap_RestructuringPlanAxis_ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">ango:ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-02-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_LegalCostsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ango:LegalCostsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_LegalCostsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ango:LegalCostsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_IntangibleImpairmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ango:IntangibleImpairmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_IntangibleImpairmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ango:IntangibleImpairmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:FacilityClosingMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_IntangibleImpairmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ango:IntangibleImpairmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_LegalCostsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">ango:LegalCostsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4QTD_srt_ProductOrServiceAxis_ango_AcculisCapitalSystemsMember_us-gaap_DisposalGroupClassificationAxis_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ango:AcculisCapitalSystemsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2017-08-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-03-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q2QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-09-01</xbrli:startDate>
			<xbrli:endDate>2017-11-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q3QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-12-01</xbrli:startDate>
			<xbrli:endDate>2017-02-28</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q2QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-01</xbrli:startDate>
			<xbrli:endDate>2016-11-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2016-08-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ango:AllowanceForSalesReturnsAndDoubtfulAccountsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ango:AllowanceForSalesReturnsAndDoubtfulAccountsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ango:AllowanceForSalesReturnsAndDoubtfulAccountsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ango:AllowanceForSalesReturnsAndDoubtfulAccountsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2015-06-01</xbrli:startDate>
			<xbrli:endDate>2016-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-06-01</xbrli:startDate>
			<xbrli:endDate>2017-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ango:AllowanceForSalesReturnsAndDoubtfulAccountsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ango:AllowanceForSalesReturnsAndDoubtfulAccountsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2015Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">ango:AllowanceForSalesReturnsAndDoubtfulAccountsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2015-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-06-01</xbrli:startDate>
			<xbrli:endDate>2018-05-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-05-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:unit id="number">
		<xbrli:measure>xbrli:pure</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="segment">
		<xbrli:measure>ango:segment</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="usdPerShare">
		<xbrli:divide>
			<xbrli:unitNumerator>
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unitNumerator>
			<xbrli:unitDenominator>
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unitDenominator>
		</xbrli:divide>
	</xbrli:unit>
	<xbrli:unit id="usd">
		<xbrli:measure>iso4217:USD</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="Segment">
		<xbrli:measure>ango:Segment</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="unit">
		<xbrli:measure>ango:unit</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="shares">
		<xbrli:measure>xbrli:shares</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="working_hour">
		<xbrli:measure>ango:working_hour</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="motion">
		<xbrli:measure>ango:motion</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="Petition">
		<xbrli:measure>ango:Petition</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="reexamination_appeal">
		<xbrli:measure>ango:reexamination_appeal</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="patent">
		<xbrli:measure>ango:patent</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="claim">
		<xbrli:measure>ango:claim</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="Employees">
		<xbrli:measure>ango:Employees</xbrli:measure>
	</xbrli:unit>
	<ango:AccountsReceivableDuePeriod contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember" id="Fact-D53D72695343E9B5278A8C8B3CF87446">P90D</ango:AccountsReceivableDuePeriod>
	<ango:AccountsReceivableDuePeriod contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember" id="Fact-0D1E760913FEA4E8D70B8C8B3CE8E67B">P30D</ango:AccountsReceivableDuePeriod>
	<ango:AccruedLitigation contextRef="FI2017Q4" decimals="-3" id="Fact-DB9EC1F222605D41F9738C8B3CF833FF" unitRef="usd">12500000</ango:AccruedLitigation>
	<ango:AccruedLitigation contextRef="FI2018Q4" decimals="-3" id="Fact-B3DB7AC87190D704C0648C8B3CF8BBB4" unitRef="usd">12500000</ango:AccruedLitigation>
	<ango:AccruedRecallLiability contextRef="FI2017Q4" decimals="-3" id="Fact-F6C49F8EA0C0DB81F1098C8B3CF8A1B9" unitRef="usd">2563000</ango:AccruedRecallLiability>
	<ango:AccruedRecallLiability contextRef="FI2018Q4" decimals="-3" id="Fact-BECEA8093A10291C69F28C8B3CF8FB1C" unitRef="usd">0</ango:AccruedRecallLiability>
	<ango:AcquisitionRestructuringAndOtherItemsNet contextRef="FD2016Q4YTD" decimals="-3" id="Fact-047C82DD32BBB9F94AD78C8B3CD9732D" unitRef="usd">12591000</ango:AcquisitionRestructuringAndOtherItemsNet>
	<ango:AcquisitionRestructuringAndOtherItemsNet contextRef="FD2016Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_IntangibleImpairmentMember" decimals="-3" id="Fact-3EC3DA65A8C147222F428C8B3CAAED02" unitRef="usd">352000</ango:AcquisitionRestructuringAndOtherItemsNet>
	<ango:AcquisitionRestructuringAndOtherItemsNet contextRef="FD2016Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_LegalCostsMember" decimals="-3" id="Fact-DFA2EA4E2BB2B9C93A018C8B3CAA117C" unitRef="usd">7487000</ango:AcquisitionRestructuringAndOtherItemsNet>
	<ango:AcquisitionRestructuringAndOtherItemsNet contextRef="FD2016Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" decimals="-3" id="Fact-A334087400975E5B330B8C8B3CB9D97D" unitRef="usd">1462000</ango:AcquisitionRestructuringAndOtherItemsNet>
	<ango:AcquisitionRestructuringAndOtherItemsNet contextRef="FD2016Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember" decimals="-3" id="Fact-720336473EBF0DCFE3FA8C8B3CAAC620" unitRef="usd">3290000</ango:AcquisitionRestructuringAndOtherItemsNet>
	<ango:AcquisitionRestructuringAndOtherItemsNet contextRef="FD2017Q4YTD" decimals="-3" id="Fact-A7CB82B9199EC392AC0B8C8B3D07F308" unitRef="usd">27510000</ango:AcquisitionRestructuringAndOtherItemsNet>
	<ango:AcquisitionRestructuringAndOtherItemsNet contextRef="FD2017Q4YTD_srt_LitigationCaseAxis_ango_DOJLitigationMember_us-gaap_RestructuringCostAndReserveAxis_ango_LegalCostsMember" decimals="-5" id="Fact-CFA2554D679BF0C64E2B8C8B3D27000E" unitRef="usd">12500000</ango:AcquisitionRestructuringAndOtherItemsNet>
	<ango:AcquisitionRestructuringAndOtherItemsNet contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_IntangibleImpairmentMember" decimals="-3" id="Fact-5D92A8FD351B7CD7C66B8C8B3CAA424C" unitRef="usd">5604000</ango:AcquisitionRestructuringAndOtherItemsNet>
	<ango:AcquisitionRestructuringAndOtherItemsNet contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_LegalCostsMember" decimals="-5" id="Fact-B58F31EC7F353B8E15DE8C8B3D27405B" unitRef="usd">19500000</ango:AcquisitionRestructuringAndOtherItemsNet>
	<ango:AcquisitionRestructuringAndOtherItemsNet contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_LegalCostsMember" decimals="-3" id="Fact-E9670149A2FAB56883D28C8B3CB91AFA" unitRef="usd">19480000</ango:AcquisitionRestructuringAndOtherItemsNet>
	<ango:AcquisitionRestructuringAndOtherItemsNet contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" decimals="-3" id="Fact-E4E2A9F689FC11C888D88C8B3CB90667" unitRef="usd">1348000</ango:AcquisitionRestructuringAndOtherItemsNet>
	<ango:AcquisitionRestructuringAndOtherItemsNet contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember" decimals="-3" id="Fact-1625910E5E5E4D92C9B48C8B3CAA48F6" unitRef="usd">1078000</ango:AcquisitionRestructuringAndOtherItemsNet>
	<ango:AcquisitionRestructuringAndOtherItemsNet contextRef="FD2018Q4YTD" decimals="-3" id="Fact-36000E7E65BB01C6FA848C8B3D074100" unitRef="usd">15432000</ango:AcquisitionRestructuringAndOtherItemsNet>
	<ango:AcquisitionRestructuringAndOtherItemsNet contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_IntangibleImpairmentMember" decimals="-3" id="Fact-E200359B40A251B70E0B8C8B3CB95DE8" unitRef="usd">0</ango:AcquisitionRestructuringAndOtherItemsNet>
	<ango:AcquisitionRestructuringAndOtherItemsNet contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_LegalCostsMember" decimals="-3" id="Fact-A195913F045D006E077B8C8B3CB9D543" unitRef="usd">10067000</ango:AcquisitionRestructuringAndOtherItemsNet>
	<ango:AcquisitionRestructuringAndOtherItemsNet contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_FacilityClosingMember" decimals="-3" id="Fact-87B56BA05AC4CA35B2C28C8B3CAABA7B" unitRef="usd">4674000</ango:AcquisitionRestructuringAndOtherItemsNet>
	<ango:AcquisitionRestructuringAndOtherItemsNet contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember" decimals="-3" id="Fact-7284542AB9468B07496A8C8B3CC9E9E9" unitRef="usd">691000</ango:AcquisitionRestructuringAndOtherItemsNet>
	<ango:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost contextRef="FI2018Q4" decimals="-3" id="Fact-688ED67B75526A04DCFB8C8B3CAADCD7" unitRef="usd">1350000</ango:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost>
	<ango:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue contextRef="FI2018Q4" decimals="-3" id="Fact-09A982D50E479B2440C28C8B3CAA932C" unitRef="usd">1317000</ango:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue>
	<ango:CapitalStockSharesAuthorized contextRef="I2014Q2Oct29" decimals="INF" id="Fact-3CAED4F4107C152EC9D28C8B3CAADDDD" unitRef="shares">80000000</ango:CapitalStockSharesAuthorized>
	<ango:ChangeInFairValueOfContingentConsideration contextRef="FD2016Q4YTD" decimals="-3" id="Fact-213F47FB6B79AEFB324F8C8B3D078AAC" unitRef="usd">948000</ango:ChangeInFairValueOfContingentConsideration>
	<ango:ChangeInFairValueOfContingentConsideration contextRef="FD2017Q4YTD" decimals="-3" id="Fact-D237D9A4E5E8066D7B348C8B3D07E4E2" unitRef="usd">-15261000</ango:ChangeInFairValueOfContingentConsideration>
	<ango:ChangeInFairValueOfContingentConsideration contextRef="FD2018Q4YTD" decimals="-3" id="Fact-4F6900B53AF949D37C128C8B3CC9B343" unitRef="usd">250000</ango:ChangeInFairValueOfContingentConsideration>
	<ango:CommonStockVotesPerShare contextRef="D2014Q2Oct29" decimals="INF" id="Fact-D9B1F9EB06682A0D3F068C8B3C9A5EA0" unitRef="number">1</ango:CommonStockVotesPerShare>
	<ango:CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription contextRef="FD2018Q4YTD_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember" id="Fact-DB88A911E0609611DD428C8B3CAA2423">20 or more hours per week and more than five months in a calendar year</ango:CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription>
	<ango:DebtInstrumentIncreaseInInterestRateInCaseOfDefault contextRef="D2016Q2Nov7_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="INF" id="Fact-574ABDF7CA00858151688C8B3C9A996B" unitRef="number">0.020</ango:DebtInstrumentIncreaseInInterestRateInCaseOfDefault>
	<ango:DebtInstrumentMaximumCashAmountForNetDebtCalculation contextRef="I2016Q2Nov7_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="INF" id="Fact-00941698D77AB06CC66C900A53740948" unitRef="usd">10000000.0</ango:DebtInstrumentMaximumCashAmountForNetDebtCalculation>
	<ango:DebtInstrumentMaximumCashAmountForNetDebtCalculation contextRef="I2018Q4May24_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="INF" id="Fact-1BA8A7A496C22D1D5638900B04443EF8" unitRef="usd">20000000.0</ango:DebtInstrumentMaximumCashAmountForNetDebtCalculation>
	<ango:DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA contextRef="D2016Q2Nov7_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="INF" id="Fact-7908DBE0CCC9CD13A6AC8C8B3D36285B" unitRef="number">3.5</ango:DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA>
	<ango:DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions contextRef="D2016Q2Nov7_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="INF" id="Fact-11F485FE0819857B9C3E8C8B3D361692" unitRef="number">3.75</ango:DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions>
	<ango:DebtServiceCoverageRatio contextRef="D2016Q2Nov7_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="INF" id="Fact-ABEFE8FB669FA5E98B9A8C8B3D17FFEA" unitRef="number">1.25</ango:DebtServiceCoverageRatio>
	<ango:DeferredIncomeTaxRelatedToOperatingActivity contextRef="FD2016Q4YTD" decimals="-3" id="Fact-EBE6989D98930F0FE1628C8B3D175871" unitRef="usd">39983000</ango:DeferredIncomeTaxRelatedToOperatingActivity>
	<ango:DeferredIncomeTaxRelatedToOperatingActivity contextRef="FD2017Q4YTD" decimals="-3" id="Fact-37DF09600E171625960F8C8B3D07BF73" unitRef="usd">4428000</ango:DeferredIncomeTaxRelatedToOperatingActivity>
	<ango:DeferredIncomeTaxRelatedToOperatingActivity contextRef="FD2018Q4YTD" decimals="-3" id="Fact-30170BC3B91074452B1E8C8B3CF8B4E0" unitRef="usd">-8947000</ango:DeferredIncomeTaxRelatedToOperatingActivity>
	<ango:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount contextRef="FD2016Q4YTD" decimals="-3" id="Fact-577D87EDF7C9AA2DC65AA3F4F23A1D5C" unitRef="usd">0</ango:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount>
	<ango:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount contextRef="FD2017Q4YTD" decimals="-3" id="Fact-02B6170E741E8C241BAAA3F4F22B480A" unitRef="usd">0</ango:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount>
	<ango:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount contextRef="FD2018Q4YTD" decimals="-3" id="Fact-F237B206DCDE7351C604A3F4F22B664B" unitRef="usd">10912000</ango:EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount>
	<ango:EmployeePlanParticipatingEligibilityPeriod contextRef="FD2018Q4YTD_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember" id="Fact-99BC003F4BE50EDBC6538C8B3CAAE7D4">P6M</ango:EmployeePlanParticipatingEligibilityPeriod>
	<ango:EmployeePlanParticipatingEligibilityThresholdPercentage contextRef="FD2018Q4YTD_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember" decimals="2" id="Fact-099C0B65A3CD20AD32F38C8B3D077E6C" unitRef="number">0.05</ango:EmployeePlanParticipatingEligibilityThresholdPercentage>
	<ango:FairValueInputsProbabilityOfPayment contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_FinancialInstrumentAxis_ango_ContingentConsiderationEarnOutLiabilityMember_us-gaap_ValuationTechniqueAxis_ango_RevenueBasedPaymentMember" decimals="INF" id="Fact-27CEE6759E4FCDA02AA08C8B3CAA6A7B" unitRef="number">1</ango:FairValueInputsProbabilityOfPayment>
	<ango:FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings contextRef="FD2017Q4YTD" decimals="-3" id="Fact-63F19B89EE82F9480E678C8B3CD957C8" unitRef="usd">-15261000</ango:FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings>
	<ango:FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings contextRef="FD2018Q4YTD" decimals="-3" id="Fact-215BA13EFF49B770675E8C8B3CD96AA8" unitRef="usd">250000</ango:FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings>
	<ango:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration contextRef="FD2017Q4YTD" decimals="-3" id="Fact-9BB2D5A9E488A5B8447F8C8B3CD971C6" unitRef="usd">0</ango:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration>
	<ango:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration contextRef="FD2018Q4YTD" decimals="-3" id="Fact-3F027B8F0687E23B72648C8B3CD9CB12" unitRef="usd">0</ango:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration>
	<ango:IncomeTaxReconciliationEffectOfForeignOperations contextRef="FD2016Q4YTD" decimals="-3" id="Fact-6E8CE1972B1CEA98F3018C8B3CE8079E" unitRef="usd">-162000</ango:IncomeTaxReconciliationEffectOfForeignOperations>
	<ango:IncomeTaxReconciliationEffectOfForeignOperations contextRef="FD2017Q4YTD" decimals="-3" id="Fact-78F87073D5F6725160C18C8B3CF8D7C5" unitRef="usd">403000</ango:IncomeTaxReconciliationEffectOfForeignOperations>
	<ango:IncomeTaxReconciliationEffectOfForeignOperations contextRef="FD2018Q4YTD" decimals="-3" id="Fact-77D21BB845EFCD18BFA08C8B3CE84F22" unitRef="usd">-288000</ango:IncomeTaxReconciliationEffectOfForeignOperations>
	<ango:IncomeTaxReconciliationEffectofEliminationofASC718APICPool contextRef="FD2016Q4YTD" decimals="-3" id="Fact-BC68F122E61F3515BECD8C8B3D17FF2C" unitRef="usd">-739000</ango:IncomeTaxReconciliationEffectofEliminationofASC718APICPool>
	<ango:IncomeTaxReconciliationEffectofEliminationofASC718APICPool contextRef="FD2017Q4YTD" decimals="-3" id="Fact-41F331768AD7EDA1597E8C8B3CF8F079" unitRef="usd">-1380000</ango:IncomeTaxReconciliationEffectofEliminationofASC718APICPool>
	<ango:IncomeTaxReconciliationEffectofEliminationofASC718APICPool contextRef="FD2018Q4YTD" decimals="-3" id="Fact-AFC9FAA07FB0B52621378C8B3CE8E964" unitRef="usd">0</ango:IncomeTaxReconciliationEffectofEliminationofASC718APICPool>
	<ango:IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability contextRef="FD2016Q4YTD" decimals="-3" id="Fact-A6E4EECEFEA9990C53048C8B3CE87341" unitRef="usd">170000</ango:IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability>
	<ango:IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability contextRef="FD2017Q4YTD" decimals="-3" id="Fact-8759D6D8CD0C46B446288C8B3CF8FECA" unitRef="usd">5576000</ango:IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability>
	<ango:IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability contextRef="FD2018Q4YTD" decimals="-3" id="Fact-240C829A7BADAA58CF048C8B3CF8BEF8" unitRef="usd">0</ango:IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability>
	<ango:IncomeTaxReconciliationNondeductibleInterestOnContingentPayment contextRef="FD2016Q4YTD" decimals="-3" id="Fact-F1BB9407BE88F5FDDAB38C8B3D17A570" unitRef="usd">262000</ango:IncomeTaxReconciliationNondeductibleInterestOnContingentPayment>
	<ango:IncomeTaxReconciliationNondeductibleInterestOnContingentPayment contextRef="FD2017Q4YTD" decimals="-3" id="Fact-61F2655372CE7016A69D8C8B3CE8F5D3" unitRef="usd">174000</ango:IncomeTaxReconciliationNondeductibleInterestOnContingentPayment>
	<ango:IncomeTaxReconciliationNondeductibleInterestOnContingentPayment contextRef="FD2018Q4YTD" decimals="-3" id="Fact-343CAF24936FFE6F2DA38C8B3CE8B99D" unitRef="usd">0</ango:IncomeTaxReconciliationNondeductibleInterestOnContingentPayment>
	<ango:InvestmentsExcludingMarketableSecuritiesFairValueDisclosure contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-D6B04968407E36ECF8588EFADB67B032" unitRef="usd">2100000</ango:InvestmentsExcludingMarketableSecuritiesFairValueDisclosure>
	<ango:InvestmentsExcludingMarketableSecuritiesFairValueDisclosure contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-8119EF4316D3842ED54A8EFADFDFEB80" unitRef="usd">0</ango:InvestmentsExcludingMarketableSecuritiesFairValueDisclosure>
	<ango:InvestmentsExcludingMarketableSecuritiesFairValueDisclosure contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-51C881268A24F81466E38EFAE46F9B77" unitRef="usd">0</ango:InvestmentsExcludingMarketableSecuritiesFairValueDisclosure>
	<ango:InvestmentsExcludingMarketableSecuritiesFairValueDisclosure contextRef="FI2018Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-DD278C59A28E5E83F28F8EFAE9210749" unitRef="usd">2100000</ango:InvestmentsExcludingMarketableSecuritiesFairValueDisclosure>
	<ango:LossContingencyClaimsReversedNumber contextRef="D2016Q4March11_srt_LitigationCaseAxis_ango_TheUtahActionMember" decimals="INF" id="Fact-C0C6AE5322EBA19EB3AD8C8B3D07B6C0" unitRef="claim">4</ango:LossContingencyClaimsReversedNumber>
	<ango:LossContingencyClaimsReversedNumber contextRef="D2016Q4March24_srt_LitigationCaseAxis_ango_TheUtahActionMember" decimals="INF" id="Fact-B1F5638C3CDF71A25DDB8C8B3D178DCB" unitRef="claim">2</ango:LossContingencyClaimsReversedNumber>
	<ango:LossContingencyReexaminationsNumber contextRef="D2012Q3Jan11_srt_LitigationCaseAxis_ango_TheUtahActionMember" decimals="INF" id="Fact-0D612408F8EFD46F4E888C8B3D17DD4D" unitRef="reexamination_appeal">3</ango:LossContingencyReexaminationsNumber>
	<ango:LossContingencyReexaminationsNumber contextRef="FD2017Q3YTD_dei_LegalEntityAxis_ango_C.R.BardInc.Member_srt_LitigationCaseAxis_ango_TheUtahActionMember_us-gaap_LitigationStatusAxis_us-gaap_PendingLitigationMember" decimals="INF" id="Fact-BF0EB9643B4831EC06128C8B3D1748E1" unitRef="reexamination_appeal">3</ango:LossContingencyReexaminationsNumber>
	<ango:LossContingencyReexaminationsNumber contextRef="FD2017Q3YTD_srt_LitigationCaseAxis_ango_TheUtahActionMember_us-gaap_LitigationStatusAxis_us-gaap_PendingLitigationMember" decimals="INF" id="Fact-3F501D23D59EB1E5AF048C8B3D1713CB" unitRef="reexamination_appeal">2</ango:LossContingencyReexaminationsNumber>
	<ango:LossContingencyU.S.PatentsNumber contextRef="I2012Q1Jan11_srt_LitigationCaseAxis_ango_C.R.BardInc.Member" decimals="INF" id="Fact-E222023103E1F1AD49378C8B3D174E30" unitRef="patent">3</ango:LossContingencyU.S.PatentsNumber>
	<ango:MedicalDeviceExciseTax contextRef="FD2016Q4YTD" decimals="-3" id="Fact-C0BEE12FC6D6EC58E9888C8B3CC96D21" unitRef="usd">2416000</ango:MedicalDeviceExciseTax>
	<ango:MedicalDeviceExciseTax contextRef="FD2017Q4YTD" decimals="-3" id="Fact-F92A1B51A90C0C8052418C8B3CC9DBD3" unitRef="usd">-1837000</ango:MedicalDeviceExciseTax>
	<ango:MedicalDeviceExciseTax contextRef="FD2018Q4YTD" decimals="-3" id="Fact-1B7A26E2AAB64CF028858C8B3D07DB0F" unitRef="usd">0</ango:MedicalDeviceExciseTax>
	<ango:MedicalDeviceExciseTaxReceivable contextRef="FI2017Q4" decimals="-3" id="Fact-21833B5EA3FEB6999F148C8B3D0708C6" unitRef="usd">1837000</ango:MedicalDeviceExciseTaxReceivable>
	<ango:MedicalDeviceExciseTaxReceivable contextRef="FI2018Q4" decimals="-3" id="Fact-DFBD91331E0C3C75A77E8C8B3D076FA7" unitRef="usd">0</ango:MedicalDeviceExciseTaxReceivable>
	<ango:NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember" id="Fact-EDC7C517BC3DD7D84E5B8C8B3CD929CD">P12M</ango:NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct>
	<ango:NumberOfPatentsAssertedForReexamination contextRef="FD2017Q3YTD_srt_LitigationCaseAxis_ango_C.R.BardInc.Member" decimals="INF" id="Fact-19EFC9EF2B6378FB47B88C8B3D27FF5F" unitRef="Petition">3</ango:NumberOfPatentsAssertedForReexamination>
	<ango:NumberOfSharePurchasePeriod contextRef="FD2018Q4YTD_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember" decimals="INF" id="Fact-97DDAFADF398AF6501F28C8B3C9ABC03" unitRef="Employees">2</ango:NumberOfSharePurchasePeriod>
	<ango:OperatingLeasesFutureMinimumPaymentsDueAfterFourYears contextRef="FI2018Q4" decimals="-3" id="Fact-2834BC787AED089E68C08C8B3D17E654" unitRef="usd">1668000</ango:OperatingLeasesFutureMinimumPaymentsDueAfterFourYears>
	<ango:OperatingLossCarryforwardsAmountAfterLimitationOfUse contextRef="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember" decimals="-5" id="Fact-998C0C28DEAE734825508C8B3CF8D323" unitRef="usd">157800000</ango:OperatingLossCarryforwardsAmountAfterLimitationOfUse>
	<ango:OperatingLossCarryforwardsAmountAfterLimitationOfUse contextRef="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember_us-gaap_TaxPeriodAxis_ango_TaxPeriodTwoMember" decimals="-5" id="Fact-262629F07EE3858FD61F8C8B3D27B009" unitRef="usd">129000000</ango:OperatingLossCarryforwardsAmountAfterLimitationOfUse>
	<ango:PaymentsToAcquireIntangibleAssetsNetOfCashAcquired contextRef="FD2016Q4YTD" decimals="-3" id="Fact-8BDF0813A5318BF827368C8B3CB91CB9" unitRef="usd">3268000</ango:PaymentsToAcquireIntangibleAssetsNetOfCashAcquired>
	<ango:PaymentsToAcquireIntangibleAssetsNetOfCashAcquired contextRef="FD2017Q4YTD" decimals="-3" id="Fact-D9D4C9485125314C97F48C8B3CF871EA" unitRef="usd">0</ango:PaymentsToAcquireIntangibleAssetsNetOfCashAcquired>
	<ango:PaymentsToAcquireIntangibleAssetsNetOfCashAcquired contextRef="FD2018Q4YTD" decimals="-3" id="Fact-E60FF8D3AB59BE281EAD8C8B3CB92776" unitRef="usd">1265000</ango:PaymentsToAcquireIntangibleAssetsNetOfCashAcquired>
	<ango:PercentageOfDomesticAssets contextRef="FI2018Q4" decimals="2" id="Fact-BECB167479837654FA048C8B3D274D3A" unitRef="number">0.99</ango:PercentageOfDomesticAssets>
	<ango:PercentageOfInternationalSalesToNetSales contextRef="FD2016Q4YTD" decimals="2" id="Fact-A17A5F46D273A8FDF8908C8B3D274451" unitRef="number">0.19</ango:PercentageOfInternationalSalesToNetSales>
	<ango:PercentageOfInternationalSalesToNetSales contextRef="FD2017Q4YTD" decimals="2" id="Fact-F4F4EF49ED283C6C43C28C8B3D2781AE" unitRef="number">0.19</ango:PercentageOfInternationalSalesToNetSales>
	<ango:PercentageOfInternationalSalesToNetSales contextRef="FD2018Q4YTD" decimals="2" id="Fact-49DDCF2DF5DD5CAEC2608C8B3D173CBD" unitRef="number">0.21</ango:PercentageOfInternationalSalesToNetSales>
	<ango:PercentageOfRestockingCharge contextRef="FD2018Q4YTD" decimals="INF" id="Fact-6D096E30D0B6B11AF7478C8B3CF851B3" unitRef="number">0.2</ango:PercentageOfRestockingCharge>
	<ango:PrepaidIncomeandOtherTaxes contextRef="FI2017Q4" decimals="-3" id="Fact-B4BBD0FCEA8FF78F8B358C8B3CF82583" unitRef="usd">544000</ango:PrepaidIncomeandOtherTaxes>
	<ango:PrepaidIncomeandOtherTaxes contextRef="FI2018Q4" decimals="-3" id="Fact-CA468D6FD455E93A035A8C8B3CF889DB" unitRef="usd">254000</ango:PrepaidIncomeandOtherTaxes>
	<ango:PrepaidLicenseeFees contextRef="FI2017Q4" decimals="-3" id="Fact-E541A10ED02EB078B0798C8B3CF88505" unitRef="usd">118000</ango:PrepaidLicenseeFees>
	<ango:PrepaidLicenseeFees contextRef="FI2018Q4" decimals="-3" id="Fact-439F773896FF9C84A42B8C8B3CF8A83E" unitRef="usd">143000</ango:PrepaidLicenseeFees>
	<ango:PropertyPlantAndEquipmentExcludingLandAndLandImprovements contextRef="FI2017Q4" decimals="-3" id="Fact-A8FA0A6CE7E77B7B82EC8C8B3D178B46" unitRef="usd">43511000</ango:PropertyPlantAndEquipmentExcludingLandAndLandImprovements>
	<ango:PropertyPlantAndEquipmentExcludingLandAndLandImprovements contextRef="FI2018Q4" decimals="-3" id="Fact-2AEC45006FF786C1B6218C8B3CB92F0F" unitRef="usd">40813000</ango:PropertyPlantAndEquipmentExcludingLandAndLandImprovements>
	<ango:RecallPeriod contextRef="FD2017Q4QTD" id="Fact-618E0E719DC26C5BD86E8C8B3CF82EB5">P2Y</ango:RecallPeriod>
	<ango:Royalties contextRef="FI2018Q4" decimals="-3" id="Fact-A0F2D8E53DAD81AF5E4B8C8B3CAAA284" unitRef="usd">45000000</ango:Royalties>
	<ango:RoyaltiesDueAfterFifthYear contextRef="FI2018Q4" decimals="-3" id="Fact-D59495CE8BA15EAF31838C8B3CAAA0CE" unitRef="usd">31500000</ango:RoyaltiesDueAfterFifthYear>
	<ango:RoyaltiesDueinFifthYear contextRef="FI2018Q4" decimals="-3" id="Fact-3D3702DD2745F0A5D08B8C8B3CAAE646" unitRef="usd">3500000</ango:RoyaltiesDueinFifthYear>
	<ango:RoyaltiesDueinFourthYear contextRef="FI2018Q4" decimals="-3" id="Fact-FE64C90229A57E10515A8C8B3CAAB62E" unitRef="usd">3500000</ango:RoyaltiesDueinFourthYear>
	<ango:RoyaltiesDueinSecondYear contextRef="FI2018Q4" decimals="-3" id="Fact-AAC3EB0BA6ECB55111328C8B3CAA1324" unitRef="usd">3000000</ango:RoyaltiesDueinSecondYear>
	<ango:RoyaltiesDueinThirdYear contextRef="FI2018Q4" decimals="-3" id="Fact-A07B5A0ABAFD2F896F9F8C8B3CAA64B0" unitRef="usd">3500000</ango:RoyaltiesDueinThirdYear>
	<ango:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" decimals="2" id="Fact-7CB6FB60B29D87A2431C8C8B3CAA681B" unitRef="number">0.25</ango:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage>
	<ango:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1 contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" id="Fact-C7AA6691398617BD9CB68C8B3CB9D195">P4Y</ango:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1>
	<ango:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage contextRef="FD2018Q4YTD" decimals="4" id="Fact-A48BF2E91CA7751A78808C8B3C9A298A" unitRef="number">0.3333</ango:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage>
	<ango:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod contextRef="FD2018Q4YTD" id="Fact-73A6E74762501DBAE5DC8C8B3C9ACFA6">P3Y</ango:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod>
	<ango:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod contextRef="FD2018Q4YTD_us-gaap_PlanNameAxis_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember" id="Fact-69F8A66237A2805D597D8C8B3C9A035F">P10Y</ango:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod>
	<ango:SharePurchasePeriod contextRef="FD2018Q4YTD_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember" id="Fact-41432A678E2775BD6A588C8B3CB9EFE3">P6M</ango:SharePurchasePeriod>
	<ango:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod contextRef="FD2018Q4YTD_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember" decimals="2" id="Fact-2792BDF086C2D6D3B0428C8B3C9AA180" unitRef="number">0.85</ango:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod>
	<ango:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_ango_PerformanceSharesIncludingThreeYearMarketConditionMember" id="Fact-B14CFEACA4F3A77BB3268C8B3D075281">P3Y</ango:SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod>
	<ango:SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible contextRef="FD2018Q4YTD_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember" decimals="INF" id="Fact-88AF32051702547B7E9B8C8B3D17080E" unitRef="working_hour">20</ango:SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible>
	<ango:SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible contextRef="FD2018Q4YTD_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember" id="Fact-CEF29E887807CE0633FF8C8B3D276E0A">P5M</ango:SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible>
	<ango:ShortTermInvestmentsMaturityPeriod contextRef="FD2018Q4YTD" id="Fact-303D698EB0F970A2FC108C8B3CE84932">less than three months</ango:ShortTermInvestmentsMaturityPeriod>
	<ango:SoftwareLicenses contextRef="FI2017Q4" decimals="-3" id="Fact-9B116CA7A26F004C778D8C8B3CF8F18B" unitRef="usd">582000</ango:SoftwareLicenses>
	<ango:SoftwareLicenses contextRef="FI2018Q4" decimals="-3" id="Fact-6893D4F3B325A733581B8C8B3CF83347" unitRef="usd">1043000</ango:SoftwareLicenses>
	<ango:TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit contextRef="D2108Q4Jan01-May31" decimals="-5" id="Fact-8BCF773E616A4B4DA837A4C605ADB29F" unitRef="usd">3000000</ango:TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit>
	<ango:TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit contextRef="D2108Q4Jan01-May31" decimals="-5" id="Fact-7B9D1DF99E84C1CDA1F3A426D2B96247" unitRef="usd">-9300000</ango:TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit>
	<ango:TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit contextRef="FD2018Q3QTD" decimals="-5" id="Fact-41C1A7A17172DA83A18CA423E80A194D" unitRef="usd">-9300000</ango:TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit>
	<ango:TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit contextRef="FD2018Q3QTD" decimals="-5" id="Fact-4118B0D28A59F0A1F7219016AE40FE92" unitRef="usd">-9300000</ango:TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit>
	<ango:TradeShows contextRef="FI2017Q4" decimals="-3" id="Fact-FA2E40D5F4E03EB3B6158C8B3CF86124" unitRef="usd">162000</ango:TradeShows>
	<ango:TradeShows contextRef="FI2018Q4" decimals="-3" id="Fact-F61ACD390760656A72608C8B3CF8894B" unitRef="usd">223000</ango:TradeShows>
	<ango:UndiscountedContingentConsiderationFairValueFairValueDisclosure contextRef="FI2018Q4" decimals="-5" id="Fact-2D37F39B2BE4805E0F298C8B3CD9B791" unitRef="usd">3300000</ango:UndiscountedContingentConsiderationFairValueFairValueDisclosure>
	<dei:AmendmentFlag contextRef="FD2018Q4YTD" id="Fact-DE36B298493560ED32448C8B3CE8F90A">false</dei:AmendmentFlag>
	<dei:CurrentFiscalYearEndDate contextRef="FD2018Q4YTD" id="Fact-18CE88CBCF24909855DF8C8B3CE87DED">--05-31</dei:CurrentFiscalYearEndDate>
	<dei:DocumentFiscalPeriodFocus contextRef="FD2018Q4YTD" id="Fact-94523801C5EC2A485DBE8C8B3CE88B5B">FY</dei:DocumentFiscalPeriodFocus>
	<dei:DocumentFiscalYearFocus contextRef="FD2018Q4YTD" id="Fact-CAD310A25089F42BF6B28C8B3CD93B9A">2018</dei:DocumentFiscalYearFocus>
	<dei:DocumentPeriodEndDate contextRef="FD2018Q4YTD" id="Fact-143886884BE6D56855C18C8B3CE8C7C7">2018-05-31</dei:DocumentPeriodEndDate>
	<dei:DocumentType contextRef="FD2018Q4YTD" id="Fact-EF2FD1F543867C4DC5268C8B3CE80802">10-K</dei:DocumentType>
	<dei:EntityCentralIndexKey contextRef="FD2018Q4YTD" id="Fact-0A7B2ECB51BF1BF988B88C8B3CE8606A">0001275187</dei:EntityCentralIndexKey>
	<dei:EntityCommonStockSharesOutstanding contextRef="I2019Q1" decimals="INF" id="Fact-8671A0597E25B39009628C8B3CE87B9E" unitRef="shares">36885765</dei:EntityCommonStockSharesOutstanding>
	<dei:EntityCurrentReportingStatus contextRef="FD2018Q4YTD" id="Fact-970B7FE019EEA16486248C8B3CE88E8A">Yes</dei:EntityCurrentReportingStatus>
	<dei:EntityFilerCategory contextRef="FD2018Q4YTD" id="Fact-D6AADA7F86EA058F2F1A8C8B3CE87B33">Accelerated Filer</dei:EntityFilerCategory>
	<dei:EntityPublicFloat contextRef="FI2018Q2" decimals="0" id="Fact-6749DFCAFB39E69A43D68C8B3CE846CB" unitRef="usd">631826627</dei:EntityPublicFloat>
	<dei:EntityRegistrantName contextRef="FD2018Q4YTD" id="Fact-285948597C449FA3DFE98C8B3CE8AE53">ANGIODYNAMICS INC</dei:EntityRegistrantName>
	<dei:EntityVoluntaryFilers contextRef="FD2018Q4YTD" id="Fact-21C2EF44B488F099A2938C8B3CD9E8BB">No</dei:EntityVoluntaryFilers>
	<dei:EntityWellKnownSeasonedIssuer contextRef="FD2018Q4YTD" id="Fact-CD14AC7F55117AF5F08C8C8B3CE8F969">No</dei:EntityWellKnownSeasonedIssuer>
	<us-gaap:AccountsPayableCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-5002D56A77731E6EBFEB8C8B3CE80A54" unitRef="usd">18087000</us-gaap:AccountsPayableCurrent>
	<us-gaap:AccountsPayableCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-3139850D4C1DD70D34FF8C8B3CC96D8C" unitRef="usd">15775000</us-gaap:AccountsPayableCurrent>
	<us-gaap:AccountsReceivableNetCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-00817FC8BE5811D22B668C8B3CD95569" unitRef="usd">44523000</us-gaap:AccountsReceivableNetCurrent>
	<us-gaap:AccountsReceivableNetCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-8A2B0DEC5A523BACE5008C8B3CC94F6F" unitRef="usd">39401000</us-gaap:AccountsReceivableNetCurrent>
	<us-gaap:AccruedLiabilitiesCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-4994DCED7C44ED8DC6CB8C8B3CE8CB75" unitRef="usd">38804000</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-ED8E5214922859FC3F578C8B3CC9B150" unitRef="usd">34426000</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-582CE4FFB67DF698AD128C8B3CF836EB" unitRef="usd">1622000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
	<us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-FBE5D408D4BD9664769A8C8B3CF84655" unitRef="usd">2396000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
	<us-gaap:AccruedRoyaltiesCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-7DC9F77F523A7A70B1A58C8B3CF87AF1" unitRef="usd">2885000</us-gaap:AccruedRoyaltiesCurrent>
	<us-gaap:AccruedRoyaltiesCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-D647897AB1BE1FC3B2978C8B3CF87CA4" unitRef="usd">1537000</us-gaap:AccruedRoyaltiesCurrent>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="FI2017Q4" decimals="-3" id="Fact-2F1C41732110CD9DD0718C8B3CB93D66" unitRef="usd">49652000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="FI2018Q4" decimals="-3" id="Fact-315AB987616792760CBB8C8B3CC9A615" unitRef="usd">48794000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2017Q4" decimals="-3" id="Fact-F7BDE72E601CE24767EE8C8B3CD94907" unitRef="usd">-1324000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2018Q4" decimals="-3" id="Fact-2F949B3424D4C2BF83818C8B3CE8094A" unitRef="usd">-952000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AdditionalPaidInCapitalCommonStock contextRef="FI2017Q4" decimals="-3" id="Fact-B88164F23506FFFDF9FC8C8B3CE8A84C" unitRef="usd">532705000</us-gaap:AdditionalPaidInCapitalCommonStock>
	<us-gaap:AdditionalPaidInCapitalCommonStock contextRef="FI2018Q4" decimals="-3" id="Fact-24B4CE46D98193BC88C88C8B3CE8B25F" unitRef="usd">543762000</us-gaap:AdditionalPaidInCapitalCommonStock>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="FD2016Q4YTD" decimals="-3" id="Fact-675E545697E049EFF80F93F159E3DDE7" unitRef="usd">3240000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-928336FCEF2A968911E28C8B3D27944D" unitRef="usd">3240000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="FD2017Q4YTD" decimals="-3" id="Fact-98919A29F4B53E7C474693F1596636EF" unitRef="usd">6183000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-837C9DAF215A3128A9A493F15A409A4A" unitRef="usd">6183000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="FD2018Q4YTD" decimals="-3" id="Fact-7CC768925F4F6353706593F15A9EFA38" unitRef="usd">7912000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-1BB43E08D2550ED187848C8B3CB9993D" unitRef="usd">7912000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2016Q4YTD" decimals="-3" id="Fact-48F1A9C6A0FBCB8EB9208C8B3CF85462" unitRef="usd">3240000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2016Q4YTD_us-gaap_IncomeStatementLocationAxis_ango_AcquisitionRestructuringAndOtherItemsNetMember" decimals="-3" id="Fact-5EC16E17C80D31B694738C8B3D079FFB" unitRef="usd">-1061000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2016Q4YTD_us-gaap_IncomeStatementLocationAxis_ango_ResearchAndDevelopmentMember" decimals="-3" id="Fact-9A15C738B679E18B19338C8B3CF846A6" unitRef="usd">349000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2016Q4YTD_us-gaap_IncomeStatementLocationAxis_ango_SalesandMarketingMember" decimals="-3" id="Fact-ADF2E2B8557E78D754528C8B3D07D5BD" unitRef="usd">1489000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2016Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" decimals="-3" id="Fact-1B6BE984B7B2A635830A8C8B3D07637D" unitRef="usd">172000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2016Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember" decimals="-3" id="Fact-A05567AA5A5A0ADFE5C58C8B3CF84BCC" unitRef="usd">2291000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2017Q4YTD" decimals="-3" id="Fact-D7014E200427656F850D8C8B3D07CC1F" unitRef="usd">6183000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_ango_AcquisitionRestructuringAndOtherItemsNetMember" decimals="-3" id="Fact-FE84553FFF5AEA77EAB58C8B3D07CE51" unitRef="usd">-218000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_ango_ResearchAndDevelopmentMember" decimals="-3" id="Fact-CB6EA429C7A748C754078C8B3CF8EB40" unitRef="usd">314000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_ango_SalesandMarketingMember" decimals="-3" id="Fact-6CBFB1D1DD198BF324848C8B3D07D66A" unitRef="usd">1762000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" decimals="-3" id="Fact-9C1D7D40F92C4FB5EFB08C8B3D079BBE" unitRef="usd">299000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember" decimals="-3" id="Fact-CF174C7661AA8478076F8C8B3CF8AB0E" unitRef="usd">4026000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2018Q4YTD" decimals="-3" id="Fact-4D2C50D3BAE1436DFEC48C8B3CF8DBFC" unitRef="usd">7912000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_ango_AcquisitionRestructuringAndOtherItemsNetMember" decimals="-3" id="Fact-E2C1D23F91B06C633B6E8C8B3D0712E8" unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_ango_ResearchAndDevelopmentMember" decimals="-3" id="Fact-DDCBD2E5D6B712641EA28C8B3CF895EC" unitRef="usd">554000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_ango_SalesandMarketingMember" decimals="-3" id="Fact-FFFC5600DF6E04B90BF98C8B3D178E61" unitRef="usd">1778000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" decimals="-3" id="Fact-2DFBD7CEA8F1A61D5F3D8C8B3D078C49" unitRef="usd">119000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllocatedShareBasedCompensationExpense contextRef="FD2018Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember" decimals="-3" id="Fact-965B2905BD0A16EF90388C8B3D070E71" unitRef="usd">5461000</us-gaap:AllocatedShareBasedCompensationExpense>
	<us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-3D8415176096F1552BD78C8B3CB9A076" unitRef="usd">2945000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
	<us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-C601ED3AF6D480B2A8828C8B3CB99D6F" unitRef="usd">2466000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
	<us-gaap:AmortizationOfIntangibleAssets contextRef="FD2016Q4YTD" decimals="-5" id="Fact-4FCBF71EBDF3DB8A1BCB8C8B3D07826B" unitRef="usd">18000000</us-gaap:AmortizationOfIntangibleAssets>
	<us-gaap:AmortizationOfIntangibleAssets contextRef="FD2016Q4YTD" decimals="-3" id="Fact-F624A6DC34E01F40EC5A8C8B3CC9F496" unitRef="usd">17964000</us-gaap:AmortizationOfIntangibleAssets>
	<us-gaap:AmortizationOfIntangibleAssets contextRef="FD2017Q4YTD" decimals="-5" id="Fact-F5872B6DDE20648CE2388C8B3D07C785" unitRef="usd">17300000</us-gaap:AmortizationOfIntangibleAssets>
	<us-gaap:AmortizationOfIntangibleAssets contextRef="FD2017Q4YTD" decimals="-3" id="Fact-40E2BDC9C121948CAF5E8C8B3CC9232A" unitRef="usd">17296000</us-gaap:AmortizationOfIntangibleAssets>
	<us-gaap:AmortizationOfIntangibleAssets contextRef="FD2018Q4YTD" decimals="-3" id="Fact-50128F4A17451EC88ED18C8B3CC97922" unitRef="usd">16635000</us-gaap:AmortizationOfIntangibleAssets>
	<us-gaap:AmortizationOfIntangibleAssets contextRef="FD2018Q4YTD" decimals="-5" id="Fact-255BE918E88F7749DF848C8B3D17D1E6" unitRef="usd">16600000</us-gaap:AmortizationOfIntangibleAssets>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="FD2016Q4YTD" decimals="0" id="Fact-358F534F198C157724FC8C8B3CAA1BE7" unitRef="shares">3277037</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="FD2017Q4YTD" decimals="0" id="Fact-F8842FC8BC1321F356258C8B3CAA7E22" unitRef="shares">1058790</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="FD2018Q4YTD" decimals="0" id="Fact-F899B37CA4D9AEF528928C8B3CAA9730" unitRef="shares">1077256</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:AssetImpairmentCharges contextRef="FD2017Q2QTD_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_srt_AffiliatedEntityMember" decimals="-5" id="Fact-921DB14AC807AA519C3E8C8B3CD90AA2" unitRef="usd">2000000</us-gaap:AssetImpairmentCharges>
	<us-gaap:Assets contextRef="FI2017Q4" decimals="-3" id="Fact-47415DB16CB9DF3C20528C8B3CC901F7" unitRef="usd">707961000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2018Q4" decimals="-3" id="Fact-01AB5957D5E4F36AE2A08C8B3CC9FA42" unitRef="usd">705472000</us-gaap:Assets>
	<us-gaap:AssetsCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-FCBBAE17A4B9EF55A7458C8B3CE81885" unitRef="usd">153914000</us-gaap:AssetsCurrent>
	<us-gaap:AssetsCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-C373CC374703957361538C8B3CE81850" unitRef="usd">168032000</us-gaap:AssetsCurrent>
	<us-gaap:AssetsFairValueDisclosure contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-CED83B4DE0ECEB5BDAB38C8B3D07F30C" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
	<us-gaap:AssetsFairValueDisclosure contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-84D1515A45FDA23047A18C8B3D0739F4" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
	<us-gaap:AssetsFairValueDisclosure contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-9A7C763A98BA34F8A2418C8B3D07D47C" unitRef="usd">1215000</us-gaap:AssetsFairValueDisclosure>
	<us-gaap:AssetsFairValueDisclosure contextRef="FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-C9CB95909C3F0831E6348C8B3D07D641" unitRef="usd">1215000</us-gaap:AssetsFairValueDisclosure>
	<us-gaap:AssetsFairValueDisclosure contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-1D0202F7AFD81A8FC3168C8B3CB9280C" unitRef="usd">2100000</us-gaap:AssetsFairValueDisclosure>
	<us-gaap:AssetsFairValueDisclosure contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-2F968A5C9AF907D6A42E8C8B3CB97D94" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
	<us-gaap:AssetsFairValueDisclosure contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-B1099C466B85D6DF78E48C8B3CB9BF7C" unitRef="usd">1317000</us-gaap:AssetsFairValueDisclosure>
	<us-gaap:AssetsFairValueDisclosure contextRef="FI2018Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-EA0EC94F3A8B83ED6F308C8B3CB96CA0" unitRef="usd">3417000</us-gaap:AssetsFairValueDisclosure>
	<us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="FI2017Q4" decimals="-3" id="Fact-AC5C025BAA5B2A2EBF1D8C8B3CF82EC1" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" decimals="-3" id="Fact-FB5AB692B461C316F8768C8B3CB9E753" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="FI2018Q4" decimals="-3" id="Fact-A98583A6E79E8AB079D28C8B3CC9CBF9" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" decimals="-3" id="Fact-FAD93DE7BA196317C4838C8B3CAAE0D2" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
	<us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="FI2017Q4" decimals="-3" id="Fact-3929DD1FFBFC2D990CD68C8B3D076789" unitRef="usd">135000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
	<us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" decimals="-3" id="Fact-0933575F1D64DE9313148C8B3CF864AB" unitRef="usd">135000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
	<us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="FI2018Q4" decimals="-3" id="Fact-795E6D54E4748B9D10288C8B3CC9220A" unitRef="usd">33000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
	<us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" decimals="-3" id="Fact-561BFA17BA549F2CD1128C8B3CC91B2C" unitRef="usd">33000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
	<us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="FI2017Q4" decimals="-3" id="Fact-A788B40804BF6E248D848C8B3CF875A0" unitRef="usd">1350000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
	<us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" decimals="-3" id="Fact-501922208F211F8EB4998C8B3CF80F72" unitRef="usd">1350000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
	<us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="FI2018Q4" decimals="-3" id="Fact-BB76AE490ABB09144A1A8C8B3C9A2F6E" unitRef="usd">1350000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
	<us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" decimals="-3" id="Fact-9EB1B6ACF1CFFDBE9D058C8B3CC98BDF" unitRef="usd">1350000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
	<us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost contextRef="FI2018Q4" decimals="-3" id="Fact-1FD547A4CCB13EE3035B8C8B3C9A1426" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue contextRef="FI2018Q4" decimals="-3" id="Fact-42DCA062C4A9C92CAAB48C8B3CAA1AC3" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
	<us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost contextRef="FI2018Q4" decimals="-3" id="Fact-25614BE83061D710C3038C8B3C9A67AF" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
	<us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue contextRef="FI2018Q4" decimals="-3" id="Fact-067EAEA52E6E1C05B3F08C8B3C9AE972" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
	<us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-DBD9D587BF13CB2F1F848C8B3D07CEE4" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
	<us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-C9E9E98537C44EA7997C8C8B3D072126" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
	<us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-5FA68EA110D75BF2D18A8C8B3D075E48" unitRef="usd">1215000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
	<us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-3FCFF1585C0A7F8F8C0E8C8B3D07BF67" unitRef="usd">1215000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
	<us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="FI2018Q4" decimals="-3" id="Fact-D02CB211C4E16BEBCBD18C8B3CAAFC07" unitRef="usd">1317000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
	<us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-8F3A52B2C2FAC6FDEBFF8C8B3CB93726" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
	<us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-6F07821076DBA8CCE1008C8B3CB93EB8" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
	<us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-6A9988AFE24700D5A47F8C8B3CB9EE8E" unitRef="usd">1317000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
	<us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="FI2018Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-B0E6AB01BB751DA4161A8C8B3CB9FD9E" unitRef="usd">1317000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
	<us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-61D2279574F80AEA9CF58C8B3CE887B5" unitRef="usd">1215000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
	<us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="FI2017Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" decimals="-3" id="Fact-9CE1804E53D0CCAC6AD68C8B3CE8C46B" unitRef="usd">1215000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
	<us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="FI2018Q4" decimals="-5" id="Fact-28C7E0C210BAAE1BDA5D8C8B3C9A3DE7" unitRef="usd">1300000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
	<us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-697B6DC4F24C725B03688C8B3CC944F9" unitRef="usd">1317000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
	<us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="FI2018Q4_us-gaap_FinancialInstrumentAxis_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" decimals="-3" id="Fact-03F47E5833E558EFD35C8C8B3CC91645" unitRef="usd">1317000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="FD2016Q4YTD" decimals="-3" id="Fact-4FFD10EF2ECC774FED838C8B3CF89DF3" unitRef="usd">-9850000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="FD2017Q4YTD" decimals="-3" id="Fact-537451BBD03844689E158C8B3CE84704" unitRef="usd">-9850000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
	<us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="FD2018Q4YTD" decimals="-3" id="Fact-E2796E50FA479A8CC2838C8B3CF8E59C" unitRef="usd">-9500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-6C0819C9DF6287C90C1C8C8B3D07B6E5" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-6B74AFB492AD4D30FAC78C8B3D070DF3" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-B7D15BC7B30205C1B7D38C8B3D07E390" unitRef="usd">12761000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-573CE6141104ECB7511E8C8B3D07C586" unitRef="usd">12761000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-7A17EDDB829EF7F9F7668C8B3CB9083A" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-0045FF6E3382017318B78C8B3CB9F1B9" unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-CF58A9387120E68D48DE8C8B3CB9D04B" unitRef="usd">3261000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_ValuationTechniqueAxis_ango_RevenueBasedPaymentMember" decimals="-3" id="Fact-EB38D902BFEBBFCF25E38C8B3CAAB6C3" unitRef="usd">3261000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2018Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-3B7084606AA39F685DCB8C8B3CB9C8CB" unitRef="usd">3261000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-DDD701B92C06FE37D9A68C8B3CC97A95" unitRef="usd">9625000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-34EC85DB152E3FDC740E8C8B3CE88DA5" unitRef="usd">2100000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputDiscountRateMember_us-gaap_ValuationTechniqueAxis_ango_RevenueBasedPaymentMember" decimals="2" id="Fact-12F141028F55BF2EC54E8C8B3CAA8E73" unitRef="number">0.04</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-EFA757E5C31E896A56168C8B3CC9B5D4" unitRef="usd">3136000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
	<us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-1C0DE279CB23ABEC1F1C8C8B3CC96151" unitRef="usd">1161000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2015Q4" decimals="-3" id="Fact-C0B53717BC2E24F929EF8C8B3CAAD25C" unitRef="usd">18391000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2016Q4" decimals="-3" id="Fact-4D4199B184D27026D7E68C8B3CF8BB18" unitRef="usd">32333000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2017Q4" decimals="-3" id="Fact-879338EAA7937CF21AD28C8B3CF8749A" unitRef="usd">47544000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2018Q4" decimals="-3" id="Fact-293D038943A3902EBBAB8C8B3CE8C474" unitRef="usd">74096000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="FD2016Q4YTD" decimals="-3" id="Fact-1282EC22161B6E8E45AB8C8B3D07A5E6" unitRef="usd">13942000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="FD2017Q4YTD" decimals="-3" id="Fact-C139F29246FF5165D24A8C8B3CAA6593" unitRef="usd">15211000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="FD2018Q4YTD" decimals="-3" id="Fact-D740B0BC4BFDA79A36C78C8B3CE8E911" unitRef="usd">26552000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CommitmentsAndContingencies contextRef="FI2017Q4" id="Fact-7C23C3A31E05CC1FF0D28C8B3CC95FC6" unitRef="usd" xsi:nil="true" />
	<us-gaap:CommitmentsAndContingencies contextRef="FI2018Q4" id="Fact-D72CEFE4F0EAEA9B85828C8B3CD91E42" unitRef="usd" xsi:nil="true" />
	<us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="FI2018Q4_us-gaap_PlanNameAxis_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember" decimals="INF" id="Fact-8FB1979BB0618ED142968C8B3CAAC469" unitRef="shares">7000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="FI2017Q3" decimals="2" id="Fact-825CDDB56F30632FA0BD8C8B3D27F933" unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="FI2017Q4" decimals="INF" id="Fact-CE2CECCC7C708FF8711F8C8B3CB9D460" unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="FI2018Q4" decimals="INF" id="Fact-0E32D9D1405AFAA1DB4D8C8B3CB9BAF1" unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="I2014Q2Oct29" decimals="INF" id="Fact-8069F74026ABE22171918C8B3CAA9CFD" unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockSharesAuthorized contextRef="FI2017Q4" decimals="INF" id="Fact-BA8EAB4A7DFDA6BE1EE98C8B3CB9ECDC" unitRef="shares">75000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesAuthorized contextRef="FI2018Q4" decimals="INF" id="Fact-6BAEE423764DFA6D55058C8B3CB9D29C" unitRef="shares">75000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesAuthorized contextRef="I2014Q2Oct29" decimals="INF" id="Fact-15F39776873E33DF3E188C8B3C9AB352" unitRef="shares">75000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesIssued contextRef="FI2017Q4" decimals="INF" id="Fact-AB00FA3D9141A30BF6658C8B3CAA280B" unitRef="shares">37210091</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesIssued contextRef="FI2018Q4" decimals="INF" id="Fact-EA4D1BF8C533498AC6928C8B3CB9CAAE" unitRef="shares">37594493</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesOutstanding contextRef="FI2017Q4" decimals="INF" id="Fact-34EA539D49A9FDF804858C8B3CB91DFE" unitRef="shares">36840091</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:CommonStockSharesOutstanding contextRef="FI2018Q4" decimals="INF" id="Fact-C6F929286E5368B12AC68C8B3CAA87E8" unitRef="shares">37224493</us-gaap:CommonStockSharesOutstanding>
	<us-gaap:CommonStockValue contextRef="FI2017Q4" decimals="-3" id="Fact-5CA5EDADA6B48B5A73508C8B3CD93646" unitRef="usd">367000</us-gaap:CommonStockValue>
	<us-gaap:CommonStockValue contextRef="FI2018Q4" decimals="-3" id="Fact-BF15171ACD32D198C07B8C8B3CE84787" unitRef="usd">370000</us-gaap:CommonStockValue>
	<us-gaap:ContractualObligation contextRef="FI2018Q4" decimals="-3" id="Fact-2A2F25AA888747891ABD8C8B3CAA7F3F" unitRef="usd">101868000</us-gaap:ContractualObligation>
	<us-gaap:ContractualObligationDueAfterFifthYear contextRef="FI2018Q4" decimals="-3" id="Fact-4082D36FC9CB01DC55988C8B3CAA1DDB" unitRef="usd">37033000</us-gaap:ContractualObligationDueAfterFifthYear>
	<us-gaap:ContractualObligationDueInFifthYear contextRef="FI2018Q4" decimals="-3" id="Fact-BD7C321711D297710C1C8C8B3CAA3D9D" unitRef="usd">12855000</us-gaap:ContractualObligationDueInFifthYear>
	<us-gaap:ContractualObligationDueInFourthYear contextRef="FI2018Q4" decimals="-3" id="Fact-0A9691D807A1D9BE219C8C8B3CAA5AF2" unitRef="usd">19152000</us-gaap:ContractualObligationDueInFourthYear>
	<us-gaap:ContractualObligationDueInSecondYear contextRef="FI2018Q4" decimals="-3" id="Fact-1019C38D9FD738F4F8258C8B3CAA49A5" unitRef="usd">14918000</us-gaap:ContractualObligationDueInSecondYear>
	<us-gaap:ContractualObligationDueInThirdYear contextRef="FI2018Q4" decimals="-3" id="Fact-B31CAEC156835A7212738C8B3CB93216" unitRef="usd">17910000</us-gaap:ContractualObligationDueInThirdYear>
	<us-gaap:CostOfGoodsAndServicesSold contextRef="FD2016Q4YTD" decimals="-3" id="Fact-7AEB63BCB7403184F4FC8C8B3D0786E2" unitRef="usd">179574000</us-gaap:CostOfGoodsAndServicesSold>
	<us-gaap:CostOfGoodsAndServicesSold contextRef="FD2017Q4YTD" decimals="-3" id="Fact-E332BF2749D4B9A141888C8B3CC99495" unitRef="usd">173474000</us-gaap:CostOfGoodsAndServicesSold>
	<us-gaap:CostOfGoodsAndServicesSold contextRef="FD2018Q4YTD" decimals="-3" id="Fact-5E8C4A477D67DA83B3768C8B3CC9D5D4" unitRef="usd">167410000</us-gaap:CostOfGoodsAndServicesSold>
	<us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption contextRef="FI2017Q4" decimals="-3" id="Fact-6D91480ECB44164450F793F8016A4309" unitRef="usd">0</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
	<us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-2A604E66CB8BC9E43CD493F80165D775" unitRef="usd">199000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
	<us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="-3" id="Fact-BBEC97185DE9825708AD93F801608856" unitRef="usd">-199000</us-gaap:CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption>
	<us-gaap:CurrentFederalTaxExpenseBenefit contextRef="FD2016Q4YTD" decimals="-3" id="Fact-546086AE3960526561738C8B3D3693AB" unitRef="usd">34000</us-gaap:CurrentFederalTaxExpenseBenefit>
	<us-gaap:CurrentFederalTaxExpenseBenefit contextRef="FD2017Q4YTD" decimals="-3" id="Fact-E90771C223AE103DABA08C8B3D3696B2" unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
	<us-gaap:CurrentFederalTaxExpenseBenefit contextRef="FD2018Q4YTD" decimals="-3" id="Fact-8E322FE610C7DBD05E8D8C8B3D272A95" unitRef="usd">-148000</us-gaap:CurrentFederalTaxExpenseBenefit>
	<us-gaap:CurrentForeignTaxExpenseBenefit contextRef="FD2016Q4YTD" decimals="-3" id="Fact-4171352D15E82542F0E88C8B3D27ED6E" unitRef="usd">217000</us-gaap:CurrentForeignTaxExpenseBenefit>
	<us-gaap:CurrentForeignTaxExpenseBenefit contextRef="FD2017Q4YTD" decimals="-3" id="Fact-4381F61CBD0BF2B554AB8C8B3D366841" unitRef="usd">270000</us-gaap:CurrentForeignTaxExpenseBenefit>
	<us-gaap:CurrentForeignTaxExpenseBenefit contextRef="FD2018Q4YTD" decimals="-3" id="Fact-97F8B8A5475B3F5AFB058C8B3D3697AF" unitRef="usd">73000</us-gaap:CurrentForeignTaxExpenseBenefit>
	<us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="FD2016Q4YTD" decimals="-3" id="Fact-F7000926DE58035662A88C8B3D270C2B" unitRef="usd">354000</us-gaap:CurrentIncomeTaxExpenseBenefit>
	<us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="FD2017Q4YTD" decimals="-3" id="Fact-BC4EF55C0A705F88745D8C8B3D271DCC" unitRef="usd">411000</us-gaap:CurrentIncomeTaxExpenseBenefit>
	<us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="FD2018Q4YTD" decimals="-3" id="Fact-8F61570836D7920D06388C8B3D36DF10" unitRef="usd">77000</us-gaap:CurrentIncomeTaxExpenseBenefit>
	<us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="FD2016Q4YTD" decimals="-3" id="Fact-9B17EFA5D52A5DBBE31F8C8B3D365815" unitRef="usd">103000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
	<us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="FD2017Q4YTD" decimals="-3" id="Fact-7743B3F10329101160EC8C8B3D36206D" unitRef="usd">141000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
	<us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="FD2018Q4YTD" decimals="-3" id="Fact-2B0BA2AF14EF7D9EA4F48C8B3D367818" unitRef="usd">152000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
	<us-gaap:DebtInstrumentCarryingAmount contextRef="FI2018Q4" decimals="-3" id="Fact-096111AFAB1A34D42AC88C8B3D1777CA" unitRef="usd">92500000</us-gaap:DebtInstrumentCarryingAmount>
	<us-gaap:DebtInstrumentCarryingAmount contextRef="FI2018Q4_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="-3" id="Fact-1DDD9E45981A0AA6F6F68C8B3D179831" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
	<us-gaap:DebtInstrumentCarryingAmount contextRef="FI2018Q4_us-gaap_CreditFacilityAxis_us-gaap_SecuredDebtMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="-3" id="Fact-2B8E0DB9FD95A11FA6698C8B3D17BDDC" unitRef="usd">92500000</us-gaap:DebtInstrumentCarryingAmount>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="FI2018Q4_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="INF" id="Fact-B384D13CF5A6899670B28C8B3D17FE9F" unitRef="number">0.0341</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="I2016Q2Nov7_srt_RangeAxis_srt_MaximumMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember" decimals="INF" id="Fact-B9F07570EAE4EEC48F238C8B3D177015" unitRef="number">0.0125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="I2016Q2Nov7_srt_RangeAxis_srt_MaximumMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember" decimals="INF" id="Fact-6CAAB30A56FE346BBB948C8B3C9A7D0D" unitRef="number">0.0225</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="I2016Q2Nov7_srt_RangeAxis_srt_MinimumMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_us-gaap_VariableRateAxis_us-gaap_BaseRateMember" decimals="INF" id="Fact-0CC8CE139B93931AD9498C8B3C9AFFA2" unitRef="number">0.0050</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="I2016Q2Nov7_srt_RangeAxis_srt_MinimumMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember_us-gaap_VariableRateAxis_us-gaap_EurodollarMember" decimals="INF" id="Fact-B9B27B7BFBA9611F5A5D8C8B3C9AB88C" unitRef="number">0.0150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentTerm contextRef="D2016Q2Nov7_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" id="Fact-7DDE8E31CDAA7E0558058C8B3D17052A">P5Y</us-gaap:DebtInstrumentTerm>
	<us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet contextRef="FI2018Q4" decimals="-3" id="Fact-537CFE2B2396F6C442778C8B3D07AB75" unitRef="usd">879000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
	<us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="FD2016Q4YTD" decimals="-3" id="Fact-0059F949E944F46DE1BC8C8B3D36157A" unitRef="usd">39983000</us-gaap:DeferredIncomeTaxExpenseBenefit>
	<us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="FD2017Q4YTD" decimals="-3" id="Fact-AF4B235BD0DA4233468D8C8B3D3623B3" unitRef="usd">4428000</us-gaap:DeferredIncomeTaxExpenseBenefit>
	<us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="FD2018Q4YTD" decimals="-3" id="Fact-E93505AD5103D5363A6F8C8B3D36006E" unitRef="usd">-8947000</us-gaap:DeferredIncomeTaxExpenseBenefit>
	<us-gaap:DeferredIncomeTaxLiabilities contextRef="FI2017Q4" decimals="-3" id="Fact-EFD956AE4735D91CF2468C8B3CE8A65C" unitRef="usd">49158000</us-gaap:DeferredIncomeTaxLiabilities>
	<us-gaap:DeferredIncomeTaxLiabilities contextRef="FI2018Q4" decimals="-3" id="Fact-96D26E04960109F4F6AF8C8B3CE8CF26" unitRef="usd">34044000</us-gaap:DeferredIncomeTaxLiabilities>
	<us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-D16CA8B912A9DB2A10AB8C8B3CD9CC06" unitRef="usd">26112000</us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent>
	<us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-9EEFF4F6D37208FDFE408C8B3CE8E9CA" unitRef="usd">17173000</us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent>
	<us-gaap:DeferredTaxAssetsDeferredIncome contextRef="FI2017Q4" decimals="-3" id="Fact-D9B3392A422D1C7CB8378C8B3CE84318" unitRef="usd">1289000</us-gaap:DeferredTaxAssetsDeferredIncome>
	<us-gaap:DeferredTaxAssetsDeferredIncome contextRef="FI2018Q4" decimals="-3" id="Fact-946417B0B40ACCF851588C8B3CE83E63" unitRef="usd">277000</us-gaap:DeferredTaxAssetsDeferredIncome>
	<us-gaap:DeferredTaxAssetsGross contextRef="FI2017Q4" decimals="-3" id="Fact-233499E9E93073BBC7C48C8B3CE85351" unitRef="usd">71394000</us-gaap:DeferredTaxAssetsGross>
	<us-gaap:DeferredTaxAssetsGross contextRef="FI2018Q4" decimals="-3" id="Fact-B587CEE0A7432E6AD95B8C8B3CE82834" unitRef="usd">43486000</us-gaap:DeferredTaxAssetsGross>
	<us-gaap:DeferredTaxAssetsInventory contextRef="FI2017Q4" decimals="-3" id="Fact-73A96ED08A74D7F7D4A38C8B3CE89B0C" unitRef="usd">2407000</us-gaap:DeferredTaxAssetsInventory>
	<us-gaap:DeferredTaxAssetsInventory contextRef="FI2018Q4" decimals="-3" id="Fact-F2AF0DA01D013ED838BB8C8B3CE88AFE" unitRef="usd">1550000</us-gaap:DeferredTaxAssetsInventory>
	<us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="FI2017Q4" decimals="-3" id="Fact-532DE79C464FFA363D6A8C8B3CE8B6F5" unitRef="usd">55975000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
	<us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="FI2018Q4" decimals="-3" id="Fact-AFDFBC778B100A52F7DA8C8B3CE871ED" unitRef="usd">33880000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
	<us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="FI2017Q4" decimals="-3" id="Fact-CFBF2214B551C0E19E6B8C8B3CE8CBF6" unitRef="usd">2548000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
	<us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="FI2018Q4" decimals="-3" id="Fact-401354DF505846DE4F828C8B3CE856D2" unitRef="usd">3644000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
	<us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="FI2017Q4" decimals="-3" id="Fact-849494D8E99556D3A6778C8B3CE82120" unitRef="usd">2653000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
	<us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="FI2018Q4" decimals="-3" id="Fact-390788206D8BB23B035D8C8B3CE8E24C" unitRef="usd">2421000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
	<us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="FI2017Q4" decimals="-3" id="Fact-0A0943D31D600855DC3A8C8B3CE8C1E3" unitRef="usd">6522000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
	<us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="FI2018Q4" decimals="-3" id="Fact-4449982BCBFC30C3F5EB8C8B3CE8E806" unitRef="usd">1714000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
	<us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_ForeignCountryMember" decimals="-4" id="Fact-0C9FB29B06EE8B2285F3B4733DCE27DB" unitRef="usd">80000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
	<us-gaap:DeferredTaxAssetsValuationAllowance contextRef="FI2017Q4" decimals="-3" id="Fact-A71EAAAA1A0DE179C5F18C8B3CE8B803" unitRef="usd">48348000</us-gaap:DeferredTaxAssetsValuationAllowance>
	<us-gaap:DeferredTaxAssetsValuationAllowance contextRef="FI2018Q4" decimals="-3" id="Fact-27517C89870188E764548C8B3CE8E587" unitRef="usd">26607000</us-gaap:DeferredTaxAssetsValuationAllowance>
	<us-gaap:DeferredTaxLiabilities contextRef="FI2017Q4" decimals="-3" id="Fact-B75BCCA4EC8C43BBB3EE8C8B3CE89A25" unitRef="usd">26112000</us-gaap:DeferredTaxLiabilities>
	<us-gaap:DeferredTaxLiabilities contextRef="FI2018Q4" decimals="-3" id="Fact-8B6A4F253069EC1A67F58C8B3CE8ABBE" unitRef="usd">17165000</us-gaap:DeferredTaxLiabilities>
	<us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="FI2017Q4" decimals="-3" id="Fact-0F07B6095A34A754718C8C8B3CE8DB26" unitRef="usd">49158000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
	<us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="FI2018Q4" decimals="-3" id="Fact-E4BA49F461A22DB39CD88C8B3CE83092" unitRef="usd">34044000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
	<us-gaap:DefinedContributionPlanCostRecognized contextRef="FD2016Q4YTD" decimals="-5" id="Fact-C2EC726FCEA8CA7F94138C8B3CF89D25" unitRef="usd">3700000</us-gaap:DefinedContributionPlanCostRecognized>
	<us-gaap:DefinedContributionPlanCostRecognized contextRef="FD2017Q4YTD" decimals="-5" id="Fact-F57DEF5D180DFAE96CF68C8B3CF8BE8C" unitRef="usd">4200000</us-gaap:DefinedContributionPlanCostRecognized>
	<us-gaap:DefinedContributionPlanCostRecognized contextRef="FD2018Q4YTD" decimals="-5" id="Fact-5FABC6BC841FF7EDF5288C8B3CF8C328" unitRef="usd">3900000</us-gaap:DefinedContributionPlanCostRecognized>
	<us-gaap:Depreciation contextRef="FD2016Q4YTD" decimals="-5" id="Fact-253F5C142519B11937F98C8B3CD93494" unitRef="usd">8200000</us-gaap:Depreciation>
	<us-gaap:Depreciation contextRef="FD2017Q4YTD" decimals="-5" id="Fact-CC2590D00340845B9F538C8B3CD936A1" unitRef="usd">6000000</us-gaap:Depreciation>
	<us-gaap:Depreciation contextRef="FD2018Q4YTD" decimals="-5" id="Fact-A2999FC7627EB3A748C48C8B3CE89E67" unitRef="usd">4600000</us-gaap:Depreciation>
	<us-gaap:DepreciationAndAmortization contextRef="FD2016Q4YTD" decimals="-3" id="Fact-769260A9FCE89C92D4058C8B3CB91FBC" unitRef="usd">28115000</us-gaap:DepreciationAndAmortization>
	<us-gaap:DepreciationAndAmortization contextRef="FD2017Q4YTD" decimals="-3" id="Fact-74786BECBEEBA93AFBE78C8B3CD96027" unitRef="usd">24811000</us-gaap:DepreciationAndAmortization>
	<us-gaap:DepreciationAndAmortization contextRef="FD2018Q4YTD" decimals="-3" id="Fact-F6BCE178343C320405858C8B3CE8D851" unitRef="usd">23163000</us-gaap:DepreciationAndAmortization>
	<us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue contextRef="FI2017Q4" decimals="-5" id="Fact-135BFACB039486F69EFE8C8B3CF8ED38" unitRef="usd">2600000</us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue>
	<us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss contextRef="FD2017Q4QTD_srt_ProductOrServiceAxis_ango_AcculisCapitalSystemsMember_us-gaap_DisposalGroupClassificationAxis_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember" decimals="-5" id="Fact-92E29D0E54B49F531C2E8C8B3D2715A6" unitRef="usd">4500000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
	<us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown contextRef="FD2018Q4YTD_us-gaap_DisposalGroupClassificationAxis_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ango_DiscontinuedInvestmentinTiLoProductMember" decimals="-5" id="Fact-BF1DA7E5EEA0CF0CD2B58C8B3CD95023" unitRef="usd">3600000</us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown>
	<us-gaap:Dividends contextRef="FD2016Q4YTD" decimals="INF" id="Fact-103CE2A18EF014A30F038C8B3C9AB509" unitRef="usd">0</us-gaap:Dividends>
	<us-gaap:Dividends contextRef="FD2017Q4YTD" decimals="INF" id="Fact-9117799087F1B1C5B8998C8B3C9AD8CB" unitRef="usd">0</us-gaap:Dividends>
	<us-gaap:Dividends contextRef="FD2018Q4YTD" decimals="INF" id="Fact-6ED7DE64059FE0B0F8CB8C8B3C9AD642" unitRef="usd">0</us-gaap:Dividends>
	<us-gaap:EarningsPerShareBasic contextRef="FD2016Q4YTD" decimals="2" id="Fact-619DDDFCD4BCA33BFEA58C8B3D0784E3" unitRef="usdPerShare">-1.21</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2017Q1QTD" decimals="2" id="Fact-C3C37CD946B00EBD88C28C8B3D27339D" unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2017Q2QTD" decimals="2" id="Fact-F2E42B9F22BF4577A8D18C8B3D276436" unitRef="usdPerShare">0.37</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2017Q3QTD" decimals="2" id="Fact-BE95ED1A0AF0B63C37DD8C8B3D271DB1" unitRef="usdPerShare">0.08</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2017Q4QTD" decimals="2" id="Fact-22190E54DA1D605F96A58C8B3D1790D8" unitRef="usdPerShare">-0.35</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2017Q4YTD" decimals="2" id="Fact-6ED69AEE627C186A52CF8C8B3D077C5D" unitRef="usdPerShare">0.14</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2018Q1QTD" decimals="2" id="Fact-ED253677B1711C63A00E8C8B3CB9B888" unitRef="usdPerShare">0.00</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2018Q2QTD" decimals="2" id="Fact-A9CBBA6C5B47D73FE40D8C8B3CB99D41" unitRef="usdPerShare">0.01</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2018Q3QTD" decimals="2" id="Fact-683FC96C2A093BA96CCB8C8B3CB9CBCC" unitRef="usdPerShare">0.38</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2018Q4QTD" decimals="2" id="Fact-747626086B4F795F1DD58C8B3CC9D60F" unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2018Q4YTD" decimals="2" id="Fact-7343A0D527E1C67771838C8B3D07D599" unitRef="usdPerShare">0.44</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2016Q4YTD" decimals="2" id="Fact-F30282DD8688F07599D58C8B3D0759E5" unitRef="usdPerShare">-1.21</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2017Q1QTD" decimals="2" id="Fact-23F83A38CE1C035951B18C8B3D27F14B" unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2017Q2QTD" decimals="2" id="Fact-A19CD7FBD1A2FC9AA56C8C8B3D17883F" unitRef="usdPerShare">0.37</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2017Q3QTD" decimals="2" id="Fact-3F3B0EF3E720A64C47C28C8B3D270B05" unitRef="usdPerShare">0.08</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2017Q4QTD" decimals="2" id="Fact-6796BDD018D7F4C5D3138C8B3D27DD6F" unitRef="usdPerShare">-0.35</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2017Q4YTD" decimals="2" id="Fact-90CF60DA7132F19E46658C8B3CB90D76" unitRef="usdPerShare">0.14</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2018Q1QTD" decimals="2" id="Fact-EA5C4169B1688AE2AA168C8B3CC9DB97" unitRef="usdPerShare">0.00</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2018Q2QTD" decimals="2" id="Fact-CB57A20594E7DA45C7E98C8B3CB9FA4A" unitRef="usdPerShare">0.01</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2018Q3QTD" decimals="2" id="Fact-32BF089328AC7365A98F8C8B3CB90F4B" unitRef="usdPerShare">0.37</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2018Q4QTD" decimals="2" id="Fact-F286A67C38A421B965618C8B3CC99BA3" unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2018Q4YTD" decimals="2" id="Fact-918B51DD8856B3E0497B8C8B3CD91D9A" unitRef="usdPerShare">0.44</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="FD2016Q4YTD" decimals="-3" id="Fact-709D10248863B4219B058C8B3CE83D56" unitRef="usd">-42000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
	<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="FD2017Q4YTD" decimals="-3" id="Fact-A0C20AAA4F29BDF15D2A8C8B3CF84E90" unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
	<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="FD2018Q4YTD" decimals="-3" id="Fact-D72E2B71D22D5D7A39AD8C8B3CD98019" unitRef="usd">472000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
	<us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="FD2016Q4YTD" decimals="3" id="Fact-BE163004E4EE938333638C8B3D1755A7" unitRef="number">0.350</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
	<us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="FD2017Q4YTD" decimals="3" id="Fact-48F8FE52895471ABCE2F8C8B3D175D99" unitRef="number">0.350</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
	<us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="FD2018Q4YTD" decimals="3" id="Fact-6070C4175C96318652928C8B3D175D9B" unitRef="number">0.286</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
	<us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="FD2018Q4YTD" decimals="3" id="Fact-F075DDC17C57C1D654AFA41BD2CFEB2B" unitRef="number">0.286</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
	<us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-391AEA318C933E1112B08C8B3CE8AE55" unitRef="usd">11383000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
	<us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-CCA2C5A805A3CC6246048C8B3CF8F884" unitRef="usd">10235000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="FI2018Q4_us-gaap_AwardTypeAxis_ango_PerformanceSharesIncludingThreeYearMarketConditionMember" decimals="-5" id="Fact-9DC49628A120FF9EE2388C8B3D27C051" unitRef="usd">3900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="-5" id="Fact-88AAF18B7FF0C2C7A44C8C8B3CAADADB" unitRef="usd">5100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" id="Fact-9B056AC6E5D4DC93D30A8F3F4B2D574A">P4Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockMember" id="Fact-6726B36F4C09C00171248F3DFC2B6C78">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" id="Fact-8C5BE3B3B608C98B6C4A8C8B3C9AAA36">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="FD2018Q4YTD_us-gaap_OptionIndexedToIssuersEquityEquityAxis_us-gaap_EmployeeStockOptionMember" id="Fact-2FE32510476B19614EA28C8B3C9A6397">P3Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="FI2018Q4" decimals="-5" id="Fact-80F0A7CF42CAF0EEF2E68C8B3CAACF94" unitRef="usd">3900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
	<us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="FD2016Q4YTD" decimals="-5" id="Fact-62FE8BCB102E21D27CA98C8B3D17B9DF" unitRef="usd">1000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
	<us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="FD2016Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" decimals="-5" id="Fact-44067D880B33A5A57091943D0D986F64" unitRef="usd">100000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
	<us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="FD2017Q4YTD" decimals="-5" id="Fact-F2AFAAF15B61DF6441B78C8B3CAA3E58" unitRef="usd">2200000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
	<us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" decimals="INF" id="Fact-E6D8A5C1DFEDB47A9611944D54B296C0" unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
	<us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="FD2018Q4YTD" decimals="-5" id="Fact-DB058CB290F148C1A74F8C8B3CAA59C1" unitRef="usd">1800000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
	<us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" decimals="INF" id="Fact-75A714567172D93CE0618C8B3CAA00D4" unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss contextRef="FD2017Q2QTD_us-gaap_BusinessAcquisitionAxis_ango_AngioVacProductMember" decimals="-5" id="Fact-B389882EB20E5572EBFD8C8B3CD953C3" unitRef="usd">13400000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss contextRef="FD2018Q4YTD_us-gaap_DisposalGroupClassificationAxis_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ango_DiscontinuedInvestmentinTiLoProductMember" decimals="-5" id="Fact-5E1DCC773F5BD965B5C58C8B3CD98548" unitRef="usd">3100000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 contextRef="FD2017Q4YTD" decimals="-3" id="Fact-A4A0A5AD104B846B465C8C8B3CD93664" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements contextRef="FD2017Q4YTD" decimals="-3" id="Fact-AC9601B95FF0E63E312A8C8B3CD94C06" unitRef="usd">12000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements contextRef="FD2018Q4YTD" decimals="-3" id="Fact-74277A71EEBA062462B58C8B3CD90763" unitRef="usd">102000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales contextRef="FD2017Q4YTD" decimals="-3" id="Fact-B8AF1D23AE1AAFED3AE18F75744A175E" unitRef="usd">450000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet contextRef="FD2017Q4YTD" decimals="-3" id="Fact-FCF04567B7C28AD538B88C8B3CD94879" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet contextRef="FD2018Q4YTD" decimals="-3" id="Fact-7878999EDFCB842952288C8B3CD9F594" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="FI2016Q4" decimals="-3" id="Fact-120C897CC854A419B8EF8C8B3CD9FC8F" unitRef="usd">1653000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="FI2017Q4" decimals="-3" id="Fact-EF0688D3E94E5C734E008C8B3CD9BC63" unitRef="usd">1215000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue contextRef="FI2018Q4" decimals="-3" id="Fact-6F69B34069D4F59876C98C8B3CD9079F" unitRef="usd">1317000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="FD2017Q4YTD" decimals="-3" id="Fact-1BD6B02443C9AE4444DD8C8B3CD9E118" unitRef="usd">-153000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements contextRef="FD2017Q4YTD" decimals="-3" id="Fact-B408F1583702C5CB3E388C8B3CD91BD8" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements contextRef="FD2018Q4YTD" decimals="-3" id="Fact-8B3D12FD0599CC4ECF748C8B3CD98325" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales contextRef="FD2017Q4YTD" decimals="-3" id="Fact-0E70D5A2980D9CDCB36C8F755F8F6B38" unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet contextRef="FD2017Q4YTD" decimals="-3" id="Fact-64A9B7111AF402DA5C2B8C8B3CD9ADA0" unitRef="usd">-10100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet contextRef="FD2018Q4YTD" decimals="-3" id="Fact-22BA021A55E5405E8EB98C8B3CD99C4B" unitRef="usd">-9750000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2016Q4" decimals="-3" id="Fact-E213BE77FDF9A1EEC8F58C8B3CD97DF1" unitRef="usd">38275000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2017Q4" decimals="-3" id="Fact-5791870EB81AC8B1B7198C8B3CD9018A" unitRef="usd">12761000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="FI2018Q4" decimals="-3" id="Fact-8014B2523DFA093AC0238C8B3CD9427C" unitRef="usd">3261000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
	<us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember" id="Fact-8A003B45E8F02A44D4838F34C04499AC">P18Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
	<us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember" id="Fact-6237D4124A3FDBD44F9A8F35EFAD0B84">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4" decimals="-3" id="Fact-C1D7C8A240F97BF053718C8B3CD9B248" unitRef="usd">92009000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ango_DistributorRelationshipsMember" decimals="-3" id="Fact-518AC3F3821C5464E0448C8B3CD985D3" unitRef="usd">229000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ango_ProductTechnologiesMember" decimals="-3" id="Fact-EDABC9FB2EB6D3EF80FF8C8B3CD978D0" unitRef="usd">59696000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-3" id="Fact-2EC0302675701CF5A5CC8C8B3D073012" unitRef="usd">19194000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicenseAgreementTermsMember" decimals="-3" id="Fact-DE520CCEEBB7ADDD12B28C8B3CD995F2" unitRef="usd">3821000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember" decimals="-3" id="Fact-8AEF2096A4E3679C26248C8B3CD96D19" unitRef="usd">9069000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q4" decimals="-3" id="Fact-DA346121B7E823317FF68C8B3CD9B92D" unitRef="usd">108695000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ango_DistributorRelationshipsMember" decimals="-3" id="Fact-62A5BCF97D4DA8ADE5378C8B3CD9CD0A" unitRef="usd">412000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ango_ProductTechnologiesMember" decimals="-3" id="Fact-73FDD1CFFA4189E0C0948C8B3CD92D53" unitRef="usd">68880000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-3" id="Fact-9631DAE591C22335576E8C8B3CD9018B" unitRef="usd">23237000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicenseAgreementTermsMember" decimals="-3" id="Fact-B7FDAA866808D9FA34FE8C8B3CD980B0" unitRef="usd">4357000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember" decimals="-3" id="Fact-00055C546AE917EF836C8C8B3CD9DC6E" unitRef="usd">11809000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="FI2018Q4" decimals="-3" id="Fact-5C2338B6E6B62B57402E8C8B3CB9C1D4" unitRef="usd">59447000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="FI2018Q4" decimals="-3" id="Fact-BDA805B01D552BCA56E98C8B3CB9453C" unitRef="usd">16555000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="FI2018Q4" decimals="-3" id="Fact-CC739FDFB4A5FE538FA48C8B3CB935E3" unitRef="usd">12507000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="FI2018Q4" decimals="-3" id="Fact-42E26353D742CA9F919B8C8B3CB95BA3" unitRef="usd">12958000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="FI2018Q4" decimals="-3" id="Fact-2ABFFF0BA95B82B078B28C8B3CB99FB1" unitRef="usd">13842000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="FI2018Q4" decimals="-3" id="Fact-439D488BE78D15CB43CD8C8B3CB9FD47" unitRef="usd">15001000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4" decimals="-3" id="Fact-356B905E781D55CCDB518C8B3D074321" unitRef="usd">237684000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ango_DistributorRelationshipsMember" decimals="-3" id="Fact-4412EF47623EB99367C48C8B3CE857D1" unitRef="usd">1250000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ango_ProductTechnologiesMember" decimals="-3" id="Fact-845764A6A4DA707A2D938C8B3CD9F750" unitRef="usd">147172000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-3" id="Fact-EDA9393774C6FA7787BE8C8B3CD9DBA0" unitRef="usd">56375000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicenseAgreementTermsMember" decimals="-3" id="Fact-01276FA3C9D5CCFE88E58C8B3D07DF03" unitRef="usd">4487000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember" decimals="-3" id="Fact-A47D108705DE40A854368C8B3CD98DDD" unitRef="usd">28400000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q4" decimals="-3" id="Fact-8A962F8F2D93DB167C4C8C8B3CD96E28" unitRef="usd">239005000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ango_DistributorRelationshipsMember" decimals="-3" id="Fact-899F1EB904BDEBA6ADCD8C8B3CD9050C" unitRef="usd">1250000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ango_ProductTechnologiesMember" decimals="-3" id="Fact-5D37CD4050F59D75EFF88C8B3CD951F6" unitRef="usd">147175000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-3" id="Fact-3081B3D75F18FDC55DF08C8B3CD91070" unitRef="usd">56428000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicenseAgreementTermsMember" decimals="-3" id="Fact-3BB399C5CC3BB416BF458C8B3CD92C38" unitRef="usd">5752000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember" decimals="-3" id="Fact-910D615A2D17C19085868C8B3CD9C6B5" unitRef="usd">28400000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2017Q4" decimals="-3" id="Fact-35170182EC00101C18CF8C8B3CD9B76B" unitRef="usd">145675000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ango_DistributorRelationshipsMember" decimals="-3" id="Fact-64BF5D90E91570A576A88C8B3CD916D7" unitRef="usd">1021000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ango_ProductTechnologiesMember" decimals="-3" id="Fact-1EFEC9A42E5A060720898C8B3CD92662" unitRef="usd">87476000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-3" id="Fact-F725305EA858974FDA758C8B3D079C64" unitRef="usd">37181000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicenseAgreementTermsMember" decimals="-3" id="Fact-2D67B16347FE81B9D0078C8B3CF88666" unitRef="usd">666000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember" decimals="-3" id="Fact-8651B74D0C9DF8B5F8A58C8B3CD91332" unitRef="usd">19331000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2018Q4" decimals="-3" id="Fact-A858C2C52BA0B8E1E4838C8B3CD994E2" unitRef="usd">130310000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ango_DistributorRelationshipsMember" decimals="-3" id="Fact-52951C5198D91E86BFE58C8B3CD9A7E4" unitRef="usd">838000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ango_ProductTechnologiesMember" decimals="-3" id="Fact-58C43A2F7219167866C78C8B3CD9A68D" unitRef="usd">78295000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-3" id="Fact-8D97FFC5F0377BA32AF08C8B3CD91541" unitRef="usd">33191000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_LicenseAgreementTermsMember" decimals="-3" id="Fact-4B9543323BCF3ABBF9138C8B3CD934EC" unitRef="usd">1395000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:FiniteLivedIntangibleAssetsNet contextRef="FI2018Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TrademarksMember" decimals="-3" id="Fact-B16E0B21F3FC69F433BF8C8B3CD9C321" unitRef="usd">16591000</us-gaap:FiniteLivedIntangibleAssetsNet>
	<us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="FD2016Q4YTD" decimals="-3" id="Fact-A98CD3555E6C65B484FA8C8B3CF873B6" unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
	<us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="FD2017Q4YTD" decimals="-3" id="Fact-77D77DEEA3115F4D96028C8B3CAAE073" unitRef="usd">-2685000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
	<us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="FD2018Q4YTD" decimals="-3" id="Fact-F29ED678579DD14D72C18C8B3CE8D52B" unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
	<us-gaap:GeneralAndAdministrativeExpense contextRef="FD2016Q4YTD" decimals="-3" id="Fact-050BA20BB948F721B8398C8B3CC9BD1F" unitRef="usd">30583000</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense contextRef="FD2017Q4YTD" decimals="-3" id="Fact-D07F69F259EA363865FA8C8B3CC9F37B" unitRef="usd">31406000</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense contextRef="FD2018Q4YTD" decimals="-3" id="Fact-7B4351B1A85DC9DF61968C8B3D072D8F" unitRef="usd">31265000</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:Goodwill contextRef="FI2017Q4" decimals="-3" id="Fact-DA10B915727F1298510E8C8B3CE8BDCA" unitRef="usd">361252000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2018Q4" decimals="-3" id="Fact-18DCB3720A5A9B2070158C8B3CC973BD" unitRef="usd">361252000</us-gaap:Goodwill>
	<us-gaap:GoodwillImpairmentLoss contextRef="D2018Q3Jun01-Dec31" decimals="INF" id="Fact-90BC91D7D3993A742C668C8B3D0734B5" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
	<us-gaap:GoodwillPeriodIncreaseDecrease contextRef="FD2017Q4YTD" decimals="INF" id="Fact-B845FC10BECEA8C658FB8C8B3CF8BFBA" unitRef="usd">0</us-gaap:GoodwillPeriodIncreaseDecrease>
	<us-gaap:GoodwillPeriodIncreaseDecrease contextRef="FD2018Q4YTD" decimals="INF" id="Fact-3C155FD6488E2B913D018C8B3D17224E" unitRef="usd">0</us-gaap:GoodwillPeriodIncreaseDecrease>
	<us-gaap:GrossProfit contextRef="FD2016Q4YTD" decimals="-3" id="Fact-7EFD6A5D99266ADD4B6F8C8B3CD9A783" unitRef="usd">174316000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit contextRef="FD2017Q1QTD" decimals="-3" id="Fact-D87C870DF7A119184BAE8C8B3D27116D" unitRef="usd">45032000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit contextRef="FD2017Q2QTD" decimals="-3" id="Fact-3C33C0BA760BDF9FD5F08C8B3D1772B6" unitRef="usd">45010000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit contextRef="FD2017Q3QTD" decimals="-3" id="Fact-873867B63935CE79C00D8C8B3D3694DA" unitRef="usd">43792000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit contextRef="FD2017Q4QTD" decimals="-3" id="Fact-968A2AA7E4D46AD97EC28C8B3D17E5E8" unitRef="usd">42335000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit contextRef="FD2017Q4YTD" decimals="-3" id="Fact-85799CA45CC1BE6C4D7F8C8B3CC97464" unitRef="usd">176169000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit contextRef="FD2018Q1QTD" decimals="-3" id="Fact-81FA4875D91298EBACEC8C8B3CC96991" unitRef="usd">41229000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit contextRef="FD2018Q2QTD" decimals="-3" id="Fact-7A3FC0815B29D6C5458B8C8B3CB98EEA" unitRef="usd">42731000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit contextRef="FD2018Q3QTD" decimals="-3" id="Fact-57F0FEBE3C830CD623DE8C8B3CB9A983" unitRef="usd">45448000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit contextRef="FD2018Q4QTD" decimals="-3" id="Fact-0136DD04EC373DF4BE628C8B3CB9EB77" unitRef="usd">47467000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit contextRef="FD2018Q4YTD" decimals="-3" id="Fact-61DB99CC7F84D55ECF848C8B3CC97760" unitRef="usd">176875000</us-gaap:GrossProfit>
	<us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="FD2016Q4YTD" decimals="-3" id="Fact-562C29B8E2C624B409A18C8B3D07CF2C" unitRef="usd">1190000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
	<us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="FD2017Q4YTD" decimals="-3" id="Fact-434868E90DFA16A170808C8B3D0786AD" unitRef="usd">3930000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
	<us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="FD2018Q4YTD" decimals="-3" id="Fact-C2F0778FD583DB068A0C8C8B3D075640" unitRef="usd">540000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="FD2016Q4YTD" decimals="-3" id="Fact-0FC407197F4F3879BC9E8C8B3D172A9B" unitRef="usd">-4444000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="FD2017Q4YTD" decimals="-3" id="Fact-00F1EB57CC8541E30D448C8B3C9ABE0E" unitRef="usd">8825000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="FD2018Q4YTD" decimals="-3" id="Fact-C33B096AEA3213A8E4618C8B3D17CDA2" unitRef="usd">6274000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="FD2016Q4YTD" decimals="-3" id="Fact-AAB5FCC01B369614A5518C8B3D07EAA3" unitRef="usd">1191000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="FD2017Q4YTD" decimals="-3" id="Fact-7037656D5085BFD2DF0A8C8B3CF890F5" unitRef="usd">1022000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="FD2018Q4YTD" decimals="-3" id="Fact-B26C5A8D4FECDE06A3518C8B3C9AD66C" unitRef="usd">1191000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="FD2016Q4YTD" decimals="-3" id="Fact-4BD064C7E175550119EB8C8B3D17959A" unitRef="usd">-3253000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="FD2017Q4YTD" decimals="-3" id="Fact-C7B3103407F64B9318638C8B3D071128" unitRef="usd">9847000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="FD2018Q4YTD" decimals="-3" id="Fact-00B6B36D2BFE79EF8CC48C8B3CC9C01E" unitRef="usd">7465000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2016Q4YTD" decimals="-3" id="Fact-981631AE60D8133B3BCF8C8B3CD90A99" unitRef="usd">40337000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2017Q4YTD" decimals="-3" id="Fact-81489A315855537EFFD58C8B3CC9ADA8" unitRef="usd">4839000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2018Q4YTD" decimals="-3" id="Fact-013C2D882872CA0377448C8B3D07310D" unitRef="usd">-8870000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="FD2016Q4YTD" decimals="-3" id="Fact-A05CB14DAD4748B61C648C8B3CE84AA8" unitRef="usd">40685000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
	<us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="FD2017Q4YTD" decimals="-3" id="Fact-A1AC8D048A0C6E0D2CBD8C8B3CF8913F" unitRef="usd">6139000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
	<us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="FD2018Q4YTD" decimals="-3" id="Fact-AF355E35B7D192698F5F8C8B3D17ECF4" unitRef="usd">-21741000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
	<us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="FD2016Q4YTD" decimals="-3" id="Fact-1863D294FE2EC9DBCDA08C8B3D17EF97" unitRef="usd">33000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
	<us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="FD2017Q4YTD" decimals="-3" id="Fact-A381E56C5A1CCEB63EE28C8B3CF8AF64" unitRef="usd">-98000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
	<us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="FD2018Q4YTD" decimals="-3" id="Fact-A1CD8D5696591360052E8C8B3CE8B67A" unitRef="usd">0</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
	<us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="FD2016Q4YTD" decimals="-3" id="Fact-C5793AB829FE8F2145278C8B3CE8B52C" unitRef="usd">-1139000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
	<us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="FD2017Q4YTD" decimals="-3" id="Fact-E5BD6BB99705ACB597878C8B3CE83E39" unitRef="usd">3447000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
	<us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="FD2018Q4YTD" decimals="-3" id="Fact-EBBF46728B7C9538FEAF8C8B3CF8A1B3" unitRef="usd">2136000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
	<us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment contextRef="FD2016Q4YTD" decimals="-3" id="Fact-DAC68FCF7BF003BE1E448C8B3D17E6A1" unitRef="usd">329000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment>
	<us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment contextRef="FD2017Q4YTD" decimals="-3" id="Fact-F08B4549A081EB2224C38C8B3CF8B8DA" unitRef="usd">266000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment>
	<us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment contextRef="FD2018Q4YTD" decimals="-3" id="Fact-493D89FB4CA84096A0318C8B3CE8E4F2" unitRef="usd">242000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment>
	<us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="FD2016Q4YTD" decimals="-3" id="Fact-69C62840D72E2477799B8C8B3CE840AD" unitRef="usd">0</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
	<us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="FD2017Q4YTD" decimals="-3" id="Fact-9FB6FB960AFAAAA78A528C8B3CF82B4B" unitRef="usd">-1224000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
	<us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="FD2018Q4YTD" decimals="-3" id="Fact-F6DC378FCFCECC29A8048C8B3CF8FDF4" unitRef="usd">0</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
	<us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="FD2016Q4YTD" decimals="-3" id="Fact-51B1ECFD6F9E5C25961A8C8B3CF845EF" unitRef="usd">474000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
	<us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="FD2017Q4YTD" decimals="-3" id="Fact-337CF9FFD5FDFFDD9E6B8C8B3CE8FB98" unitRef="usd">353000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
	<us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="FD2018Q4YTD" decimals="-3" id="Fact-122886E60D0FE7E7F8DE8C8B3D174D4C" unitRef="usd">700000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
	<us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="FD2016Q4YTD" decimals="-3" id="Fact-B149B7A576BD8FBCEEF58C8B3CE8BB00" unitRef="usd">-215000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
	<us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="FD2017Q4YTD" decimals="-3" id="Fact-85C01433D77753C64F0A8C8B3CE8CBE3" unitRef="usd">-22000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
	<us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="FD2018Q4YTD" decimals="-3" id="Fact-DD258576A207F462216E8C8B3D17B508" unitRef="usd">120000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
	<us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="FD2016Q4YTD" decimals="-3" id="Fact-7618187EEEA2CA7CC1888C8B3D1780D6" unitRef="usd">499000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
	<us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="FD2017Q4YTD" decimals="-3" id="Fact-8306E1926124E28B01738C8B3CE8F9DA" unitRef="usd">403000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
	<us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="FD2018Q4YTD" decimals="-3" id="Fact-93BBD2F5F7E6E0080AD48C8B3CE8628B" unitRef="usd">951000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
	<us-gaap:IncomeTaxesPaidNet contextRef="FD2016Q4YTD" decimals="-3" id="Fact-F6736F29DF9B369202C1942D49CEE23C" unitRef="usd">332000</us-gaap:IncomeTaxesPaidNet>
	<us-gaap:IncomeTaxesPaidNet contextRef="FD2017Q4YTD" decimals="-3" id="Fact-1A82303CBDFEB9A707DE942D49CEFFBE" unitRef="usd">-102000</us-gaap:IncomeTaxesPaidNet>
	<us-gaap:IncomeTaxesPaidNet contextRef="FD2018Q4YTD" decimals="-3" id="Fact-0D8983E3E415043EB170942D49CE2F61" unitRef="usd">36000</us-gaap:IncomeTaxesPaidNet>
	<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="FD2016Q4YTD" decimals="-3" id="Fact-54BC12B693BB6D8B3D9C8C8B3CF881D1" unitRef="usd">-2956000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="FD2017Q4YTD" decimals="-3" id="Fact-E87D6C8641DD02FAE7D48C8B3CD912C2" unitRef="usd">19214000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="FD2018Q4YTD" decimals="-3" id="Fact-20CCE30A45A6559FD5CB8C8B3D170687" unitRef="usd">-7093000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="FD2016Q4YTD" decimals="-3" id="Fact-C340F62F92A2C7052AC08C8B3D17146A" unitRef="usd">-3131000</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="FD2017Q4YTD" decimals="-3" id="Fact-D8C21606D572469D00948C8B3CAA2868" unitRef="usd">-8479000</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="FD2018Q4YTD" decimals="-3" id="Fact-B4E0BB583E18253928958C8B3CC914F9" unitRef="usd">-5044000</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInInventories contextRef="FD2016Q4YTD" decimals="-3" id="Fact-20D7A7367FA73C42A9278C8B3D07EF5A" unitRef="usd">-11976000</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInInventories contextRef="FD2017Q4YTD" decimals="-3" id="Fact-D8C5C3DFD0E8C654ECA18C8B3D172CD0" unitRef="usd">-687000</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInInventories contextRef="FD2018Q4YTD" decimals="-3" id="Fact-AAFCA63EE77DBE4CC43E8C8B3CAAB663" unitRef="usd">-5740000</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="FD2016Q4YTD" decimals="-3" id="Fact-C711A5F747E06E53633A8C8B3CE8BB1A" unitRef="usd">-712000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
	<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="FD2017Q4YTD" decimals="-3" id="Fact-4E3050BFFE7D606607978C8B3CD9AFBB" unitRef="usd">3520000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
	<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="FD2018Q4YTD" decimals="-3" id="Fact-DF47A86275431CC9E7348C8B3D07538F" unitRef="usd">1231000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
	<us-gaap:IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible contextRef="FI2018Q4" decimals="-5" id="Fact-D0C7E0E90695FD760B708C8B3CF8A458" unitRef="usd">500000</us-gaap:IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="FI2017Q4" decimals="-3" id="Fact-C6EB7B5933108872F0518C8B3CD9BA67" unitRef="usd">145675000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="FI2018Q4" decimals="-3" id="Fact-3D68EAC617C6E564913E8C8B3CC9F1B0" unitRef="usd">130310000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:InterestExpense contextRef="FD2016Q4YTD" decimals="-3" id="Fact-AD933954E12FD20BA2968C8B3D0778F0" unitRef="usd">3385000</us-gaap:InterestExpense>
	<us-gaap:InterestExpense contextRef="FD2017Q4YTD" decimals="-3" id="Fact-5A5955CDECAA97B5E9348C8B3CC9932C" unitRef="usd">2839000</us-gaap:InterestExpense>
	<us-gaap:InterestExpense contextRef="FD2018Q4YTD" decimals="-3" id="Fact-70FBE805CF534C67FE638C8B3D17BADD" unitRef="usd">3062000</us-gaap:InterestExpense>
	<us-gaap:InterestPaid contextRef="FD2016Q4YTD" decimals="-3" id="Fact-9A0CD5C13808A20539928C8B3CE88180" unitRef="usd">3063000</us-gaap:InterestPaid>
	<us-gaap:InterestPaid contextRef="FD2017Q4YTD" decimals="-3" id="Fact-37E517C32E1681EB9B0D8C8B3CF86545" unitRef="usd">2969000</us-gaap:InterestPaid>
	<us-gaap:InterestPaid contextRef="FD2018Q4YTD" decimals="-3" id="Fact-1EE06E25A484ED6CA61C8C8B3CF8D49E" unitRef="usd">3190000</us-gaap:InterestPaid>
	<us-gaap:InventoryFinishedGoods contextRef="FI2017Q4" decimals="-3" id="Fact-E7ADFC3B5DAA2E782B718C8B3CB99A7B" unitRef="usd">24341000</us-gaap:InventoryFinishedGoods>
	<us-gaap:InventoryFinishedGoods contextRef="FI2018Q4" decimals="-3" id="Fact-D0365CE6267C8A402A398C8B3CB92F6A" unitRef="usd">19430000</us-gaap:InventoryFinishedGoods>
	<us-gaap:InventoryNet contextRef="FI2017Q4" decimals="-3" id="Fact-238305A04120A51E85928C8B3CC9D161" unitRef="usd">54506000</us-gaap:InventoryNet>
	<us-gaap:InventoryNet contextRef="FI2018Q4" decimals="-3" id="Fact-017791FAD5806B0FEB918C8B3CC9FD9C" unitRef="usd">48916000</us-gaap:InventoryNet>
	<us-gaap:InventoryRawMaterials contextRef="FI2017Q4" decimals="-3" id="Fact-1C867552ABD0760A9A528C8B3CB929AB" unitRef="usd">17563000</us-gaap:InventoryRawMaterials>
	<us-gaap:InventoryRawMaterials contextRef="FI2018Q4" decimals="-3" id="Fact-544F0C21E144EF92566A8C8B3CB94BD6" unitRef="usd">18678000</us-gaap:InventoryRawMaterials>
	<us-gaap:InventoryValuationReserves contextRef="FI2017Q4" decimals="-5" id="Fact-8A646D3392309FA53E888C8B3CE8CBE6" unitRef="usd">7300000</us-gaap:InventoryValuationReserves>
	<us-gaap:InventoryValuationReserves contextRef="FI2018Q4" decimals="-5" id="Fact-AC3191DB11B3737286918C8B3CE84708" unitRef="usd">6100000</us-gaap:InventoryValuationReserves>
	<us-gaap:InventoryWorkInProcess contextRef="FI2017Q4" decimals="-3" id="Fact-B9D79922157F184D4E138C8B3CB9D8A7" unitRef="usd">12602000</us-gaap:InventoryWorkInProcess>
	<us-gaap:InventoryWorkInProcess contextRef="FI2018Q4" decimals="-3" id="Fact-BC78445E1963C3CCD8EC8C8B3CB956D8" unitRef="usd">10808000</us-gaap:InventoryWorkInProcess>
	<us-gaap:InventoryWriteDown contextRef="FD2017Q4YTD_ango_InventoryTypeAxis_ango_AcculisInventoryMember" decimals="-5" id="Fact-151D8A32A8EBC21926C28C8B3D27757D" unitRef="usd">2400000</us-gaap:InventoryWriteDown>
	<us-gaap:InventoryWriteDown contextRef="FD2018Q4YTD_ango_InventoryTypeAxis_ango_AcculisInventoryMember" decimals="-5" id="Fact-68057724625275E5950B8C8B3CAA5735" unitRef="usd">1600000</us-gaap:InventoryWriteDown>
	<us-gaap:InventoryWriteDown contextRef="FD2018Q4YTD_srt_CounterpartyNameAxis_ango_UndisclosedInventoryDistributorMember" decimals="-5" id="Fact-0842A3919CD967AD18F18FBBD661DACB" unitRef="usd">700000</us-gaap:InventoryWriteDown>
	<us-gaap:LandAndLandImprovements contextRef="FI2017Q4" decimals="-3" id="Fact-26AC6E79A7FBEDB9A6E98C8B3CC95F2C" unitRef="usd">1723000</us-gaap:LandAndLandImprovements>
	<us-gaap:LandAndLandImprovements contextRef="FI2018Q4" decimals="-3" id="Fact-AE0E46667294A79B09EB8C8B3CC97123" unitRef="usd">1648000</us-gaap:LandAndLandImprovements>
	<us-gaap:LeaseAndRentalExpense contextRef="FD2016Q4YTD" decimals="-5" id="Fact-69AB3C20B6B58E15A59C8C8B3D173305" unitRef="usd">2500000</us-gaap:LeaseAndRentalExpense>
	<us-gaap:LeaseAndRentalExpense contextRef="FD2017Q4YTD" decimals="-5" id="Fact-2198A7825054451815F08C8B3D17B643" unitRef="usd">2500000</us-gaap:LeaseAndRentalExpense>
	<us-gaap:LeaseAndRentalExpense contextRef="FD2018Q4YTD" decimals="-5" id="Fact-13A9C61C2EA3647F6D768C8B3D27F00F" unitRef="usd">2800000</us-gaap:LeaseAndRentalExpense>
	<us-gaap:Liabilities contextRef="FI2017Q4" decimals="-3" id="Fact-BCA59EDCFE1D879E37F68C8B3CD9293E" unitRef="usd">192934000</us-gaap:Liabilities>
	<us-gaap:Liabilities contextRef="FI2018Q4" decimals="-3" id="Fact-C27B698869172D3AE5878C8B3CC9B59C" unitRef="usd">162877000</us-gaap:Liabilities>
	<us-gaap:LiabilitiesAndStockholdersEquity contextRef="FI2017Q4" decimals="-3" id="Fact-DA6A7A4F1E5FE8733A938C8B3CC9164B" unitRef="usd">707961000</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity contextRef="FI2018Q4" decimals="-3" id="Fact-F2115C3FD2BC89FB14EC8C8B3CC9843C" unitRef="usd">705472000</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-B735B59F9CB1C3EB0A678C8B3CD9BBFB" unitRef="usd">71516000</us-gaap:LiabilitiesCurrent>
	<us-gaap:LiabilitiesCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-84B61F1971CC582236788C8B3CC9D342" unitRef="usd">57301000</us-gaap:LiabilitiesCurrent>
	<us-gaap:LiabilitiesFairValueDisclosure contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-38E74A0E4E7F357E615B8C8B3D0766DB" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
	<us-gaap:LiabilitiesFairValueDisclosure contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-0CB7A567B447649C7B8D8C8B3D071C2A" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
	<us-gaap:LiabilitiesFairValueDisclosure contextRef="FI2017Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-7A11DB14FC30252650158C8B3D0734DF" unitRef="usd">12761000</us-gaap:LiabilitiesFairValueDisclosure>
	<us-gaap:LiabilitiesFairValueDisclosure contextRef="FI2017Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-CEC86F1797D114B14A288C8B3D0798FB" unitRef="usd">12761000</us-gaap:LiabilitiesFairValueDisclosure>
	<us-gaap:LiabilitiesFairValueDisclosure contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-339056CE3A51572019038C8B3CB9C892" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
	<us-gaap:LiabilitiesFairValueDisclosure contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-F0504E90E9E13233AE2D8C8B3CB915F5" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
	<us-gaap:LiabilitiesFairValueDisclosure contextRef="FI2018Q4_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-C42D1098DC75A3E782CC8C8B3CB92B38" unitRef="usd">3261000</us-gaap:LiabilitiesFairValueDisclosure>
	<us-gaap:LiabilitiesFairValueDisclosure contextRef="FI2018Q4_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" decimals="-3" id="Fact-4F5013D59FC921A499D78C8B3CB92486" unitRef="usd">3261000</us-gaap:LiabilitiesFairValueDisclosure>
	<us-gaap:LineOfCreditFacilityCommitmentFeePercentage contextRef="D2016Q2Nov7_srt_RangeAxis_srt_MaximumMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="INF" id="Fact-5F3750BEC88A74BF3AB58C8B3D17A7C3" unitRef="number">0.0035</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
	<us-gaap:LineOfCreditFacilityCommitmentFeePercentage contextRef="D2016Q2Nov7_srt_RangeAxis_srt_MinimumMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="INF" id="Fact-F9E6DD74AA694F6416868C8B3C9AB34E" unitRef="number">0.0020</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
	<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="I2016Q2Nov7_us-gaap_CreditFacilityAxis_us-gaap_BridgeLoanMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="INF" id="Fact-FFF1D0AA13834BF33B878C8B3D17E8AE" unitRef="usd">5000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
	<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="I2016Q2Nov7_us-gaap_CreditFacilityAxis_us-gaap_LetterOfCreditMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="INF" id="Fact-5FEAEB392B45C15E4A8D8C8B3D174ABD" unitRef="usd">20000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
	<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="I2016Q2Nov7_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="INF" id="Fact-285EE6969549DFDDEC288C8B3D17F689" unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
	<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="I2016Q2Nov7_us-gaap_CreditFacilityAxis_us-gaap_SecuredDebtMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="INF" id="Fact-840B78CC103B5482ACF48C8B3D173A28" unitRef="usd">100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
	<us-gaap:LitigationReserve contextRef="FI2017Q4" decimals="-5" id="Fact-9DD90DAEDA49CD6A70888C8B3D27A2DA" unitRef="usd">12500000</us-gaap:LitigationReserve>
	<us-gaap:LongTermDebt contextRef="FI2018Q4" decimals="-3" id="Fact-43FDE8684593AA2FBF378C8B3D17B289" unitRef="usd">91621000</us-gaap:LongTermDebt>
	<us-gaap:LongTermDebtCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-C7ABD45AAC9ACAA605D58C8B3CD97A8D" unitRef="usd">5000000</us-gaap:LongTermDebtCurrent>
	<us-gaap:LongTermDebtCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-160B22BA90832D0CB25B8C8B3CE87BBA" unitRef="usd">5000000</us-gaap:LongTermDebtCurrent>
	<us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive contextRef="FI2018Q4_us-gaap_CreditFacilityAxis_us-gaap_SecuredDebtMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="-3" id="Fact-2418C9BA5543C91B38078C8B3D170B19" unitRef="usd">68750000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
	<us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="FI2018Q4_us-gaap_CreditFacilityAxis_us-gaap_SecuredDebtMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="-3" id="Fact-3AD7858787BC27E33FB48C8B3CF879CB" unitRef="usd">11250000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
	<us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="FI2018Q4_us-gaap_CreditFacilityAxis_us-gaap_SecuredDebtMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="-3" id="Fact-6AD9BA6A5FCFF85D57D98C8B3CF8CA40" unitRef="usd">7500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
	<us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="FI2018Q4_us-gaap_CreditFacilityAxis_us-gaap_SecuredDebtMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="-3" id="Fact-E3E16FD95F8737EFA1838C8B3CAA9516" unitRef="usd">5000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
	<us-gaap:LongTermDebtNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-6A09CE57B7F0615F711D8C8B3D270862" unitRef="usd">86621000</us-gaap:LongTermDebtNoncurrent>
	<us-gaap:LongTermLoansPayable contextRef="FI2017Q4" decimals="-3" id="Fact-4A05DFB0983CC1E473248C8B3CC9F0FC" unitRef="usd">91320000</us-gaap:LongTermLoansPayable>
	<us-gaap:LongTermLoansPayable contextRef="FI2018Q4" decimals="-3" id="Fact-660D800942CDBE6CD06E8C8B3CD9ADE5" unitRef="usd">86621000</us-gaap:LongTermLoansPayable>
	<us-gaap:LossContingencyAccrualAtCarryingValue contextRef="FI2017Q4" decimals="-5" id="Fact-CCFDD9E6051BB335D3948C8B3D17FA8D" unitRef="usd">12500000</us-gaap:LossContingencyAccrualAtCarryingValue>
	<us-gaap:LossContingencyClaimsDismissedNumber contextRef="D2012Q3Jan11_srt_LitigationCaseAxis_ango_TheUtahActionMember" decimals="INF" id="Fact-392B680BEF5D3E7A15028C8B3D275605" unitRef="claim">40</us-gaap:LossContingencyClaimsDismissedNumber>
	<us-gaap:LossContingencyClaimsDismissedNumber contextRef="D2016Q4March11_srt_LitigationCaseAxis_ango_TheUtahActionMember" decimals="INF" id="Fact-D3F3D248B8BDB936AF768C8B3D07B3BA" unitRef="claim">6</us-gaap:LossContingencyClaimsDismissedNumber>
	<us-gaap:LossContingencyClaimsDismissedNumber contextRef="D2016Q4March24_srt_LitigationCaseAxis_ango_TheUtahActionMember" decimals="INF" id="Fact-EC5422B095DEC51A29148C8B3D17EE86" unitRef="claim">8</us-gaap:LossContingencyClaimsDismissedNumber>
	<us-gaap:LossContingencyClaimsDismissedNumber contextRef="D2016Q4March29_srt_LitigationCaseAxis_ango_TheUtahActionMember" decimals="INF" id="Fact-FE5BB408B8874B2CB22C8C8B3D27AE2C" unitRef="claim">20</us-gaap:LossContingencyClaimsDismissedNumber>
	<us-gaap:LossContingencyNewClaimsFiledNumber contextRef="D2012Q3Jan11_srt_LitigationCaseAxis_ango_TheUtahActionMember" decimals="INF" id="Fact-7F5742A392ABF17D52EB8C8B3CB9BA75" unitRef="claim">41</us-gaap:LossContingencyNewClaimsFiledNumber>
	<us-gaap:LossContingencyPatentsAllegedlyInfringedNumber contextRef="D2015Q1June1_srt_LitigationCaseAxis_ango_TheDelawareActionMember" decimals="INF" id="Fact-EDB56B626E75908BBAF98C8B3D0737CD" unitRef="motion">2</us-gaap:LossContingencyPatentsAllegedlyInfringedNumber>
	<us-gaap:LossContingencyPatentsAllegedlyInfringedNumber contextRef="D2015Q4March10_srt_LitigationCaseAxis_ango_TheDelawareActionMember" decimals="INF" id="Fact-84856498B188DC2E79F18C8B3D179F0B" unitRef="patent">3</us-gaap:LossContingencyPatentsAllegedlyInfringedNumber>
	<us-gaap:LossContingencyPendingClaimsNumber contextRef="I2016Q4March11_srt_LitigationCaseAxis_ango_TheUtahActionMember" decimals="INF" id="Fact-1D682B375B87890C2D698C8B3D27B2EB" unitRef="claim">10</us-gaap:LossContingencyPendingClaimsNumber>
	<us-gaap:LossContingencyPendingClaimsNumber contextRef="I2016Q4March24_srt_LitigationCaseAxis_ango_TheUtahActionMember" decimals="INF" id="Fact-1CA7A34D4DC786C5C0208C8B3D177F38" unitRef="claim">10</us-gaap:LossContingencyPendingClaimsNumber>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="FD2016Q4YTD" decimals="-3" id="Fact-6F1C6BB19DE2280D1BEC8C8B3CF87E16" unitRef="usd">-23663000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="FD2017Q4YTD" decimals="-3" id="Fact-BF467AD625C5F823C45E8C8B3D074435" unitRef="usd">-37983000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="FD2018Q4YTD" decimals="-3" id="Fact-36FCAF4F81CEAC21FE658C8B3CF81B85" unitRef="usd">-11551000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="FD2016Q4YTD" decimals="-3" id="Fact-F9785A74D755A5F508218C8B3CAA4035" unitRef="usd">-7569000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="FD2017Q4YTD" decimals="-3" id="Fact-DAEC2B8262E6253E5FC88C8B3CE8824D" unitRef="usd">-2551000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="FD2018Q4YTD" decimals="-3" id="Fact-C71A54ACA29E259944598C8B3CD984B5" unitRef="usd">-3656000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="FD2016Q4YTD" decimals="-3" id="Fact-F584C2FC97CA412C51898C8B3CE840D7" unitRef="usd">45216000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="FD2017Q4YTD" decimals="-3" id="Fact-6AD561933135E16E10BF8C8B3CF83B97" unitRef="usd">55745000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="FD2018Q4YTD" decimals="-3" id="Fact-C5C93E1DF89FB24DAE6A8C8B3CE8C1B0" unitRef="usd">41287000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetIncomeLoss contextRef="FD2016Q4YTD" decimals="-3" id="Fact-F6DD102162699F7B01D08C8B3CC97617" unitRef="usd">-43590000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="-3" id="Fact-5551492EF8450AA1A7C98C8B3CC9DC6B" unitRef="usd">-43590000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2017Q1QTD" decimals="-3" id="Fact-4AF0871AEAEFA9A4978C8C8B3D270EB3" unitRef="usd">1300000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2017Q2QTD" decimals="-3" id="Fact-8300259A3E942EFDD9778C8B3D179FC1" unitRef="usd">13734000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2017Q3QTD" decimals="-3" id="Fact-FF4BA27DC8FD311FEDE68C8B3D2738E5" unitRef="usd">2887000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2017Q4QTD" decimals="-3" id="Fact-5A73156AF31ACFD62FEC8C8B3D178CB3" unitRef="usd">-12913000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2017Q4YTD" decimals="-3" id="Fact-1759BF510936322BC2808C8B3D07C2F3" unitRef="usd">5008000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="-3" id="Fact-3A6306053DCBCD6F68068C8B3D36B8F3" unitRef="usd">5008000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2018Q1QTD" decimals="-3" id="Fact-922DF3E33FFF80D2425D8C8B3CB9C8B3" unitRef="usd">-35000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2018Q2QTD" decimals="-3" id="Fact-50C541FC4C547E834BBB8C8B3CB90191" unitRef="usd">249000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2018Q3QTD" decimals="-3" id="Fact-20CDB67F34EA31AC84CA8C8B3CC9600E" unitRef="usd">14019000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2018Q4QTD" decimals="-3" id="Fact-98CFB3D876201EAE496C8C8B3CC965E2" unitRef="usd">2102000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2018Q4YTD" decimals="-3" id="Fact-BC2A9DE3D37DB5E6B7CC8C8B3CD95184" unitRef="usd">16335000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="-3" id="Fact-051C8FBF4471B5512F778C8B3CE8CAC7" unitRef="usd">16335000</us-gaap:NetIncomeLoss>
	<us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1 contextRef="FD2016Q4YTD" decimals="-3" id="Fact-20915F36DAED4A4E28E28C8B3CE80FA3" unitRef="usd">75000</us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1>
	<us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1 contextRef="FD2017Q4YTD" decimals="-3" id="Fact-800293D05BA680F5FA8E8C8B3CD97356" unitRef="usd">26000</us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1>
	<us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1 contextRef="FD2018Q4YTD" decimals="-3" id="Fact-5338F772008F2C31EAFB8C8B3CF8F5BE" unitRef="usd">56000</us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1>
	<us-gaap:NumberOfOperatingSegments contextRef="FD2018Q4YTD" decimals="INF" id="Fact-DD186EEADAA00DE1F58AA489EA6697BC" unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
	<us-gaap:NumberOfReportableSegments contextRef="FD2018Q4YTD" decimals="INF" id="Fact-A59CB0587BF04339711B8C8B3D17D734" unitRef="Segment">1</us-gaap:NumberOfReportableSegments>
	<us-gaap:NumberOfReportingUnits contextRef="FD2018Q4YTD" decimals="INF" id="Fact-D4AB17BE984AEC573C90A487C53579BA" unitRef="unit">1</us-gaap:NumberOfReportingUnits>
	<us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-3" id="Fact-A67C412E6A6FFD19D4B08C8B3CB9F5EA" unitRef="usd">12000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
	<us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-C81B99C97315134AC9A58C8B3D27FED9" unitRef="usd">-533000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
	<us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-3" id="Fact-FDE780B01CDFE69551E88C8B3D36C2EB" unitRef="usd">-545000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
	<us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-3" id="Fact-7E2401F51A60C32715658C8B3D36CCFA" unitRef="usd">102000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
	<us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-3321A1FC8226B346020C8C8B3D271034" unitRef="usd">372000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
	<us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-3" id="Fact-B2DD0EFC1742757532ED8C8B3D36E012" unitRef="usd">270000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
	<us-gaap:OperatingExpenses contextRef="FD2016Q4YTD" decimals="-3" id="Fact-324B376896A4E89A15268C8B3CC956B9" unitRef="usd">173298000</us-gaap:OperatingExpenses>
	<us-gaap:OperatingExpenses contextRef="FD2017Q4YTD" decimals="-3" id="Fact-0C8AEB287D38E0AB6FE18C8B3CC97969" unitRef="usd">163202000</us-gaap:OperatingExpenses>
	<us-gaap:OperatingExpenses contextRef="FD2018Q4YTD" decimals="-3" id="Fact-D63C007EB590F6CB42688C8B3CB92AFD" unitRef="usd">166317000</us-gaap:OperatingExpenses>
	<us-gaap:OperatingIncomeLoss contextRef="FD2016Q4YTD" decimals="-3" id="Fact-CB59E1B0875B481770808C8B3CD9336D" unitRef="usd">1018000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2017Q4YTD" decimals="-3" id="Fact-00936575AE69E200F5198C8B3CC95252" unitRef="usd">12967000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2018Q4YTD" decimals="-3" id="Fact-C68E85A07B20B7CD9B288C8B3CB9289B" unitRef="usd">10558000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="FI2018Q4" decimals="-3" id="Fact-ADBA1EEC83F2ED0309E68C8B3D1726DF" unitRef="usd">7608000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-DDAC0851F3EFBA62D5428C8B3D172A47" unitRef="usd">2234000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears contextRef="FI2018Q4" decimals="-3" id="Fact-8C1D529D79BAD4DF069D8C8B3D071687" unitRef="usd">884000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears contextRef="FI2018Q4" decimals="-3" id="Fact-AE783198499D909C939C8C8B3CF84AE9" unitRef="usd">993000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
	<us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="FI2018Q4" decimals="-3" id="Fact-99DEFDEA89EA9E8AB14C8C8B3D07E297" unitRef="usd">1829000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
	<us-gaap:OperatingLossCarryforwards contextRef="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_DomesticCountryMember_us-gaap_TaxPeriodAxis_ango_TaxPeriodOneMember" decimals="-5" id="Fact-180B802841651235DA5D8C8B3D2782B4" unitRef="usd">28800000</us-gaap:OperatingLossCarryforwards>
	<us-gaap:OperatingLossCarryforwards contextRef="FI2018Q4_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember_us-gaap_TaxPeriodAxis_ango_TaxPeriodThreeMember" decimals="-5" id="Fact-47AB3E012F78ED1832F28C8B3CF89CC8" unitRef="usd">19100000</us-gaap:OperatingLossCarryforwards>
	<us-gaap:OtherAccruedLiabilitiesCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-C59A56CDA3347F9A41548C8B3CF8ED9E" unitRef="usd">4920000</us-gaap:OtherAccruedLiabilitiesCurrent>
	<us-gaap:OtherAccruedLiabilitiesCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-D81D1F1CECC2A7C1BD688C8B3CF8073A" unitRef="usd">5135000</us-gaap:OtherAccruedLiabilitiesCurrent>
	<us-gaap:OtherAssetsNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-D81D7734E5A42E4B003F8C8B3CF84688" unitRef="usd">1886000</us-gaap:OtherAssetsNoncurrent>
	<us-gaap:OtherAssetsNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-A5FD0EF807E5237AB6468C8B3CE87151" unitRef="usd">3417000</us-gaap:OtherAssetsNoncurrent>
	<us-gaap:OtherCommitment contextRef="FI2018Q4" decimals="-3" id="Fact-7858697E86B08240AE228C8B3CB93B13" unitRef="usd">667000</us-gaap:OtherCommitment>
	<us-gaap:OtherCommitmentDueAfterFifthYear contextRef="FI2018Q4" decimals="-3" id="Fact-839316F75E8A2FA435648C8B3CAAA514" unitRef="usd">0</us-gaap:OtherCommitmentDueAfterFifthYear>
	<us-gaap:OtherCommitmentDueInFifthYear contextRef="FI2018Q4" decimals="-3" id="Fact-EBC436403C6F7116DF258C8B3CAA2C0D" unitRef="usd">166000</us-gaap:OtherCommitmentDueInFifthYear>
	<us-gaap:OtherCommitmentDueInFourthYear contextRef="FI2018Q4" decimals="-3" id="Fact-D0956CCF61D6357650A58C8B3CAA00A3" unitRef="usd">167000</us-gaap:OtherCommitmentDueInFourthYear>
	<us-gaap:OtherCommitmentDueInSecondYear contextRef="FI2018Q4" decimals="-3" id="Fact-8611C84D1F091E5757528C8B3CB99FEF" unitRef="usd">167000</us-gaap:OtherCommitmentDueInSecondYear>
	<us-gaap:OtherCommitmentDueInThirdYear contextRef="FI2018Q4" decimals="-3" id="Fact-00659ABF3024403FC1368C8B3CAA1FD8" unitRef="usd">167000</us-gaap:OtherCommitmentDueInThirdYear>
	<us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent contextRef="FD2016Q4YTD" decimals="-3" id="Fact-6B2965C443E17A30F0D28C8B3D36B9D5" unitRef="usd">134000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent contextRef="FD2017Q4YTD" decimals="-3" id="Fact-2747A0FF8562BDEF42228C8B3CC904A2" unitRef="usd">-533000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent contextRef="FD2018Q4YTD" decimals="-3" id="Fact-791DC04019B95FA56D658C8B3D362E26" unitRef="usd">372000</us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax contextRef="FD2016Q4YTD" decimals="-3" id="Fact-A404530CC69491A93F89A47676C97CBA" unitRef="usd">-112000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax contextRef="FD2017Q4YTD" decimals="-3" id="Fact-B19F9F976837362380D0A47676C9D970" unitRef="usd">-545000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
	<us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax contextRef="FD2018Q4YTD" decimals="-3" id="Fact-C2056B8C51EEE97047F98C8B3D179003" unitRef="usd">270000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2016Q4YTD" decimals="-3" id="Fact-BFA71B0C556159357FD8A476769A8C81" unitRef="usd">42000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-66677C0E085EA758E62C8C8B3CC9AEEA" unitRef="usd">42000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2017Q4YTD" decimals="-3" id="Fact-0C1A6F53A21A4A050039A476768A5902" unitRef="usd">-533000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-7A3C6B89AADF1CDF62198C8B3D27F191" unitRef="usd">-533000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2018Q4YTD" decimals="-3" id="Fact-7D3D9D3DB965755EBA2AA47676A95968" unitRef="usd">372000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-BDE45C745791135CD23D93F1583BA83B" unitRef="usd">372000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="FD2016Q4YTD" decimals="-3" id="Fact-FFB546BD1AEF32709E3E8C8B3D36DDC8" unitRef="usd">-43548000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="FD2017Q4YTD" decimals="-3" id="Fact-14D0E268D28F7D4E96238C8B3D362DDC" unitRef="usd">4475000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-3" id="Fact-FDC8354AD87E63DD14A58C8B3D27E1C4" unitRef="usd">12000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-A3BF003C6C9075C272B58C8B3D17B8A9" unitRef="usd">-533000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-3" id="Fact-2AE8B359D8B11BBBEC538C8B3D079885" unitRef="usd">-545000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="FD2018Q4YTD" decimals="-3" id="Fact-4D0BE7D2698FDE8B07B98C8B3CC90DBC" unitRef="usd">16707000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-3" id="Fact-1A98C77F8C5124264D508C8B3D278B58" unitRef="usd">102000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-DF57BC4285C1D61BEC408C8B3D070A34" unitRef="usd">372000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-3" id="Fact-52BCD921031F69A7D5C78C8B3D276DA7" unitRef="usd">270000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="FD2016Q4YTD" decimals="-3" id="Fact-6F9738D7C6D1EFB8A498A47676B9006D" unitRef="usd">92000</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
	<us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="FD2017Q4YTD" decimals="-3" id="Fact-C0575E275EDF2700CFA9A476767B27F5" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
	<us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 contextRef="FD2018Q4YTD" decimals="-3" id="Fact-A3BB559A2944B182127AA476767B763B" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToParent1>
	<us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax contextRef="FD2016Q4YTD" decimals="-3" id="Fact-71808D2A0A7CEB044EB5A476768A9634" unitRef="usd">257000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
	<us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax contextRef="FD2017Q4YTD" decimals="-3" id="Fact-546B08D7278C89C2988AA47676B992E5" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
	<us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax contextRef="FD2018Q4YTD" decimals="-3" id="Fact-F3B23FE2AB882E273E6EA476766B037F" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
	<us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax contextRef="FD2016Q4YTD" decimals="-3" id="Fact-CF053E953AA50D77A4D7A47676A9A0C2" unitRef="usd">-11000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
	<us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax contextRef="FD2017Q4YTD" decimals="-3" id="Fact-95724CF93A7F41DBDF39A47676D89313" unitRef="usd">12000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
	<us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax contextRef="FD2018Q4YTD" decimals="-3" id="Fact-D5B21E3C5F780475DB658C8B3D07E3FE" unitRef="usd">102000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
	<us-gaap:OtherLiabilitiesNoncurrent contextRef="FI2017Q4" decimals="-3" id="Fact-04C5400529167D4D8B188C8B3CC93E16" unitRef="usd">850000</us-gaap:OtherLiabilitiesNoncurrent>
	<us-gaap:OtherLiabilitiesNoncurrent contextRef="FI2018Q4" decimals="-3" id="Fact-6EA48A9031D07F1EFEBA8C8B3CE81CF8" unitRef="usd">621000</us-gaap:OtherLiabilitiesNoncurrent>
	<us-gaap:OtherNoncashIncomeExpense contextRef="FD2016Q4YTD" decimals="-3" id="Fact-95E57D554E63ADC4A9FE8C8B3CE84BBC" unitRef="usd">-90000</us-gaap:OtherNoncashIncomeExpense>
	<us-gaap:OtherNoncashIncomeExpense contextRef="FD2017Q4YTD" decimals="-3" id="Fact-B24E76F65035A0F941818C8B3CE8C039" unitRef="usd">586000</us-gaap:OtherNoncashIncomeExpense>
	<us-gaap:OtherNoncashIncomeExpense contextRef="FD2018Q4YTD" decimals="-3" id="Fact-657DCB2E7F23670079098C8B3CF869EF" unitRef="usd">605000</us-gaap:OtherNoncashIncomeExpense>
	<us-gaap:OtherNonoperatingExpense contextRef="FD2016Q4YTD" decimals="-3" id="Fact-34BD100DEE01BB9517F98C8B3D07E515" unitRef="usd">886000</us-gaap:OtherNonoperatingExpense>
	<us-gaap:OtherNonoperatingExpense contextRef="FD2017Q4YTD" decimals="-3" id="Fact-8A1DC43195C917B102FB8C8B3CD91D7C" unitRef="usd">281000</us-gaap:OtherNonoperatingExpense>
	<us-gaap:OtherNonoperatingExpense contextRef="FD2018Q4YTD" decimals="-3" id="Fact-04034739D716FCE7F8B68C8B3CC9CE22" unitRef="usd">31000</us-gaap:OtherNonoperatingExpense>
	<us-gaap:OtherNonoperatingIncomeExpense contextRef="FD2016Q4YTD" decimals="-3" id="Fact-F624C71CB22E682FBDBF8C8B3D073B7D" unitRef="usd">-4271000</us-gaap:OtherNonoperatingIncomeExpense>
	<us-gaap:OtherNonoperatingIncomeExpense contextRef="FD2017Q4YTD" decimals="-3" id="Fact-6C9527D026717CD1B5448C8B3CC9DEF2" unitRef="usd">-3120000</us-gaap:OtherNonoperatingIncomeExpense>
	<us-gaap:OtherNonoperatingIncomeExpense contextRef="FD2018Q4YTD" decimals="-3" id="Fact-787A5A025ADDF4CA49F88C8B3D071544" unitRef="usd">-3093000</us-gaap:OtherNonoperatingIncomeExpense>
	<us-gaap:OtherPrepaidExpenseCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-3C42F50F43506AD03F368C8B3CF8C460" unitRef="usd">2762000</us-gaap:OtherPrepaidExpenseCurrent>
	<us-gaap:OtherPrepaidExpenseCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-4610C1B6A6216B1F629C8C8B3CF88145" unitRef="usd">2505000</us-gaap:OtherPrepaidExpenseCurrent>
	<us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="FD2016Q4YTD" decimals="-3" id="Fact-FE14ABE31FF97E53823A8C8B3CB9ADDD" unitRef="usd">2000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
	<us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="FD2017Q4YTD" decimals="-3" id="Fact-37C5009211B7046DB8E68C8B3CAA5EAC" unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
	<us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="FD2018Q4YTD" decimals="-3" id="Fact-0969904C441BE5FE7A658C8B3CC92386" unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
	<us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="FD2016Q4YTD" decimals="-3" id="Fact-2249C9F6C0B70B2DE44F8C8B3CAA829D" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
	<us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="FD2017Q4QTD" decimals="-5" id="Fact-2600BA33D4AD8419CBD28C8B3CAA081B" unitRef="usd">5700000</us-gaap:PaymentsForRepurchaseOfCommonStock>
	<us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="FD2017Q4YTD" decimals="-3" id="Fact-417592A5542BE0838E248C8B3CB96543" unitRef="usd">13557000</us-gaap:PaymentsForRepurchaseOfCommonStock>
	<us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="FD2018Q4YTD" decimals="-3" id="Fact-D8F0FED4DFEDF3BC32B28C8B3CAAC8D4" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
	<us-gaap:PaymentsForRestructuring contextRef="FD2017Q4YTD" decimals="-3" id="Fact-878AC8E47349CF632954902B9F3B42F9" unitRef="usd">278000</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsForRestructuring contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_EquipmentTransferMember" decimals="-3" id="Fact-046AB9DB6E6376E05A98902B97FEB961" unitRef="usd">275000</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsForRestructuring contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_RegulatoryFilingsMember" decimals="-3" id="Fact-E1AC3D5E6998FDC2BF71902B99CE6036" unitRef="usd">0</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsForRestructuring contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_ContractTerminationMember" decimals="-3" id="Fact-B935B3B342128AA4FA61902B9B97F8D6" unitRef="usd">0</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsForRestructuring contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember" decimals="-3" id="Fact-87D1F35E61181FD13CC6902B9536896E" unitRef="usd">0</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsForRestructuring contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember" decimals="-3" id="Fact-CB09931EDCADA9837F5B902B9D4ADE7A" unitRef="usd">3000</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsForRestructuring contextRef="FD2018Q4YTD" decimals="-3" id="Fact-A9CAA0849798FEE89B108C8B3D27BA7A" unitRef="usd">4289000</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsForRestructuring contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_EquipmentTransferMember" decimals="-3" id="Fact-CDA291E1C557605BA5638C8B3D270B82" unitRef="usd">2706000</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsForRestructuring contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_RegulatoryFilingsMember" decimals="-3" id="Fact-F0A8014ED9E25EBF12B58C8B3D17A59D" unitRef="usd">56000</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsForRestructuring contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_ContractTerminationMember" decimals="-3" id="Fact-E631779AB84F276916368C8B3D278D4F" unitRef="usd">0</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsForRestructuring contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember" decimals="-3" id="Fact-B2C791E842AFC0F01D388C8B3C9AF9CA" unitRef="usd">1453000</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsForRestructuring contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember" decimals="-3" id="Fact-33ECE9973563AF4223958C8B3CB9B115" unitRef="usd">74000</us-gaap:PaymentsForRestructuring>
	<us-gaap:PaymentsOfDebtIssuanceCosts contextRef="FD2016Q4YTD" decimals="-3" id="Fact-C2E80305DB9BA03C78E98C8B3D07E8E2" unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
	<us-gaap:PaymentsOfDebtIssuanceCosts contextRef="FD2017Q4YTD" decimals="-3" id="Fact-EE0F8446EAF2B3F1AD5E8C8B3CE8F5D3" unitRef="usd">1364000</us-gaap:PaymentsOfDebtIssuanceCosts>
	<us-gaap:PaymentsOfDebtIssuanceCosts contextRef="FD2018Q4YTD" decimals="-3" id="Fact-B021C28E51C7169F8D748C8B3C9AB4F7" unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
	<us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="D2016Q3" decimals="-5" id="Fact-BB043A06D236B60E06D88C8B3CC98DB9" unitRef="usd">2000000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="FD2016Q4YTD" decimals="-3" id="Fact-9E2D08821DBCE75C0E458C8B3D07CBDF" unitRef="usd">2326000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="FD2017Q4YTD" decimals="-3" id="Fact-192EC79B265FD527D5838C8B3CF823AD" unitRef="usd">3001000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="FD2018Q4YTD" decimals="-3" id="Fact-F229A29779E30305CDBC8C8B3CAA930E" unitRef="usd">2391000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="FI2017Q4" decimals="INF" id="Fact-9E30DAEF01507DC03EA18C8B3CB9B037" unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="FI2018Q4" decimals="INF" id="Fact-2B9F553000848DE47C768C8B3CB9FD2F" unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="I2014Q2Oct29" decimals="INF" id="Fact-31840C979E91290BB36A8C8B3CAAA011" unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockSharesAuthorized contextRef="FI2017Q4" decimals="INF" id="Fact-6A31292B56A1E9779FF28C8B3CB98718" unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesAuthorized contextRef="FI2018Q4" decimals="INF" id="Fact-F1DA62BF855793460E138C8B3CB9E645" unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesAuthorized contextRef="I2014Q2Oct29" decimals="INF" id="Fact-DA52FD190486E9ADBE078C8B3CB9FE03" unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesIssued contextRef="FI2017Q4" decimals="INF" id="Fact-C5F2FAF8CD5B2907E9B68C8B3CB96E0E" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
	<us-gaap:PreferredStockSharesIssued contextRef="FI2018Q4" decimals="INF" id="Fact-9526A19ECCB02453E25E8C8B3CAAAB5F" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
	<us-gaap:PreferredStockSharesOutstanding contextRef="FI2017Q4" decimals="INF" id="Fact-BEFC7505E9D1FACE36128C8B3CB98212" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
	<us-gaap:PreferredStockSharesOutstanding contextRef="FI2018Q4" decimals="INF" id="Fact-F9A9C87793B9FE07D50D8C8B3CB94AB9" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
	<us-gaap:PreferredStockValue contextRef="FI2017Q4" decimals="-3" id="Fact-429C4FD4BCEFF9A056338C8B3CD9A002" unitRef="usd">0</us-gaap:PreferredStockValue>
	<us-gaap:PreferredStockValue contextRef="FI2018Q4" decimals="-3" id="Fact-3A765A5941F2D127F4428C8B3CE81710" unitRef="usd">0</us-gaap:PreferredStockValue>
	<us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-F386DBE7CA67C158595B8C8B3CD9E7EE" unitRef="usd">6126000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
	<us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-AF8FAAC694F17C5804EE8C8B3CD931DE" unitRef="usd">4302000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
	<us-gaap:PrepaidRent contextRef="FI2017Q4" decimals="-3" id="Fact-E9202DE38A0EAC1194B98C8B3CF8626A" unitRef="usd">121000</us-gaap:PrepaidRent>
	<us-gaap:PrepaidRent contextRef="FI2018Q4" decimals="-3" id="Fact-FDFCD930A5D301B9DC318C8B3CF89EAC" unitRef="usd">134000</us-gaap:PrepaidRent>
	<us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="D2016Q2Nov7_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="-5" id="Fact-5F33D666D106AE505B3F8C8B3D172F6C" unitRef="usd">16500000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
	<us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="D2016Q2Nov7_us-gaap_CreditFacilityAxis_us-gaap_SecuredDebtMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="-5" id="Fact-0225226AF715B2898E958C8B3C9A7BDE" unitRef="usd">100000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
	<us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="FD2016Q4YTD" decimals="-3" id="Fact-16D049822F412654F4698C8B3CE8AC02" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
	<us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="FD2017Q4YTD" decimals="-3" id="Fact-FF53F8DA45BEDCFD00758C8B3CAA7A73" unitRef="usd">116471000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
	<us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="FD2018Q4YTD" decimals="-3" id="Fact-CD2F8C036BED6F614DA78C8B3CAA4132" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
	<us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="FD2016Q4YTD" decimals="-3" id="Fact-EA096E6C530E0C010D068C8B3CF8E13B" unitRef="usd">2437000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
	<us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="FD2017Q4YTD" decimals="-3" id="Fact-E597C651C6CE5177C5688C8B3CF8E6D6" unitRef="usd">10698000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
	<us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="FD2018Q4YTD" decimals="-3" id="Fact-ACA022FAD2DC7071DB1B8C8B3CD95D6B" unitRef="usd">2949000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
	<us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="FD2016Q4YTD" decimals="-3" id="Fact-0A49D2369CB400341F238C8B3CE872DF" unitRef="usd">25000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
	<us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="FD2017Q4YTD" decimals="-3" id="Fact-E560819C86504C0C01108C8B3CE84194" unitRef="usd">450000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
	<us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="FD2018Q4YTD" decimals="-3" id="Fact-79AD0E28C36522CD42778C8B3CF84628" unitRef="usd">0</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
	<us-gaap:ProceedsFromStockOptionsExercised contextRef="FD2016Q4YTD" decimals="-5" id="Fact-C2EDBBC0C1112A16A0CC8C8B3CAA866E" unitRef="usd">1300000</us-gaap:ProceedsFromStockOptionsExercised>
	<us-gaap:ProceedsFromStockOptionsExercised contextRef="FD2017Q4YTD" decimals="-5" id="Fact-892CBBA09B2B5928541E8C8B3CAA6C5A" unitRef="usd">9900000</us-gaap:ProceedsFromStockOptionsExercised>
	<us-gaap:ProceedsFromStockOptionsExercised contextRef="FD2018Q4YTD" decimals="-5" id="Fact-E4302EAF61985578FAA88C8B3C9A930D" unitRef="usd">2000000</us-gaap:ProceedsFromStockOptionsExercised>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2017Q4" decimals="-3" id="Fact-BB6AEC57BDEDBF17D9628C8B3CB93811" unitRef="usd">93163000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2017Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember" decimals="-3" id="Fact-D7FBC5A268FC520B6D3F8C8B3D171C06" unitRef="usd">40597000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2017Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember" decimals="-3" id="Fact-8C997AFA93BC6A3CBD1A8C8B3CB9821E" unitRef="usd">25668000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2017Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember" decimals="-3" id="Fact-AF521C40DF90BC59B7718C8B3D07A87B" unitRef="usd">1464000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2017Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember" decimals="-3" id="Fact-ED19BC89BAE626D05EBA8C8B3CC9EB16" unitRef="usd">25434000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2018Q4" decimals="-3" id="Fact-52C4BC26B23EBC2ABD7A8C8B3CC9ABFD" unitRef="usd">89607000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember" decimals="-3" id="Fact-C4D07759F4648B3D29BA8C8B3CB9D15F" unitRef="usd">39887000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember" decimals="-3" id="Fact-8E5D105808A73FA7082B8C8B3D171391" unitRef="usd">24899000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ConstructionInProgressMember" decimals="-3" id="Fact-D7586E27B94F411D00FC8C8B3CB9FEA3" unitRef="usd">2153000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2018Q4_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember" decimals="-3" id="Fact-34CCDFC7FD7598285ADA8C8B3CC97D0F" unitRef="usd">22668000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentNet contextRef="FI2017Q4" decimals="-3" id="Fact-6D22443DC688CCCA989A8C8B3CE87E30" unitRef="usd">45234000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet contextRef="FI2018Q4" decimals="-3" id="Fact-EA4E45189C86B691A1548C8B3CC9B76F" unitRef="usd">42461000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember" id="Fact-C14ECAF6AD32D672A7948C8B3D07C1EC">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MaximumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember" id="Fact-02E7B7550DFDC2EE6A1A8C8B3D17F4BE">P8Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_ComputerEquipmentMember" id="Fact-F7F452F93E684A0193D48C8B3CAAB63D">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="FD2018Q4YTD_srt_RangeAxis_srt_MinimumMember_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_MachineryAndEquipmentMember" id="Fact-FA1C87D7F02C116C02758C8B3D071C6C">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="FD2018Q4YTD_us-gaap_PropertyPlantAndEquipmentByTypeAxis_us-gaap_BuildingAndBuildingImprovementsMember" id="Fact-4BFB86840607627551C38C8B3CAAE33B">P39Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
	<us-gaap:ProvisionForDoubtfulAccounts contextRef="FD2016Q4YTD" decimals="-3" id="Fact-811EC4368B3434A0EAFC8C8B3CF8D233" unitRef="usd">2377000</us-gaap:ProvisionForDoubtfulAccounts>
	<us-gaap:ProvisionForDoubtfulAccounts contextRef="FD2017Q4YTD" decimals="-3" id="Fact-023C07F6C68F6A9190338C8B3CF86B90" unitRef="usd">-313000</us-gaap:ProvisionForDoubtfulAccounts>
	<us-gaap:ProvisionForDoubtfulAccounts contextRef="FD2018Q4YTD" decimals="-3" id="Fact-BF83BDBB5253B1BCCF908C8B3CB9CF7E" unitRef="usd">179000</us-gaap:ProvisionForDoubtfulAccounts>
	<us-gaap:PurchaseObligation contextRef="FI2018Q4" decimals="-3" id="Fact-25F45C42C00EF18990DB8C8B3CAA5BEB" unitRef="usd">56201000</us-gaap:PurchaseObligation>
	<us-gaap:PurchaseObligationDueAfterFifthYear contextRef="FI2018Q4" decimals="-3" id="Fact-E944ADA93F1197037EDF8C8B3CAAA3FE" unitRef="usd">5533000</us-gaap:PurchaseObligationDueAfterFifthYear>
	<us-gaap:PurchaseObligationDueInFifthYear contextRef="FI2018Q4" decimals="-3" id="Fact-D0BCF8742F58146C542E8C8B3CAA2125" unitRef="usd">9189000</us-gaap:PurchaseObligationDueInFifthYear>
	<us-gaap:PurchaseObligationDueInFourthYear contextRef="FI2018Q4" decimals="-3" id="Fact-22AAD6F64E742935840D8C8B3CAA9945" unitRef="usd">15485000</us-gaap:PurchaseObligationDueInFourthYear>
	<us-gaap:PurchaseObligationDueInSecondYear contextRef="FI2018Q4" decimals="-3" id="Fact-EEB57D82807A31A9EB4E8C8B3CAA85F7" unitRef="usd">11751000</us-gaap:PurchaseObligationDueInSecondYear>
	<us-gaap:PurchaseObligationDueInThirdYear contextRef="FI2018Q4" decimals="-3" id="Fact-B8AAD6DBE0FABF61D88B8C8B3CAA3ABA" unitRef="usd">14243000</us-gaap:PurchaseObligationDueInThirdYear>
	<us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-3" id="Fact-E16AA00CAB0AEB4BD0BA8C8B3D17D704" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
	<us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-3365EB706C81B921E7EE8C8B3D27316A" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
	<us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-3" id="Fact-019757C04B8E4A3380618C8B3D173C35" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
	<us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-3" id="Fact-75C61F36F1ECD7EC2B908C8B3D17B98E" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
	<us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-F2F968DE385CBA22E5918C8B3D17ACF6" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
	<us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-3" id="Fact-F783745995E47118AE538C8B3D175DBF" unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent>
	<us-gaap:RepaymentsOfLongTermDebt contextRef="D2016Q2Nov7_us-gaap_DebtInstrumentAxis_ango_FormerCreditAgreementMember_us-gaap_LineOfCreditFacilityAxis_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_us-gaap_LongtermDebtTypeAxis_us-gaap_LineOfCreditMember" decimals="-5" id="Fact-602D6DAC606782FFFAD78C8B3C9A73FF" unitRef="usd">116500000</us-gaap:RepaymentsOfLongTermDebt>
	<us-gaap:RepaymentsOfLongTermDebt contextRef="FD2016Q4YTD" decimals="-3" id="Fact-BA4140ED5021C4C0C2108C8B3CF8BAD0" unitRef="usd">16250000</us-gaap:RepaymentsOfLongTermDebt>
	<us-gaap:RepaymentsOfLongTermDebt contextRef="FD2017Q4YTD" decimals="-3" id="Fact-B7C880EE818273DD8BC78C8B3CE80255" unitRef="usd">140381000</us-gaap:RepaymentsOfLongTermDebt>
	<us-gaap:RepaymentsOfLongTermDebt contextRef="FD2018Q4YTD" decimals="-3" id="Fact-00B4731D5A5B990BB5608C8B3CAA11EF" unitRef="usd">5000000</us-gaap:RepaymentsOfLongTermDebt>
	<us-gaap:ResearchAndDevelopmentExpense contextRef="FD2016Q4YTD" decimals="-3" id="Fact-7658732875C0EF3E71B88C8B3CB9BFD5" unitRef="usd">25053000</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:ResearchAndDevelopmentExpense contextRef="FD2017Q4YTD" decimals="-3" id="Fact-42D2F236EF1BC7F8345F8C8B3CB90B4A" unitRef="usd">25269000</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:ResearchAndDevelopmentExpense contextRef="FD2018Q4YTD" decimals="-3" id="Fact-C6D6265A048B74D9E16E8C8B3CC96271" unitRef="usd">25459000</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:RestructuringCharges contextRef="D2018Q4Feb01-May31_us-gaap_RestructuringPlanAxis_ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember" decimals="-5" id="Fact-329FDCA5AA5020C075A0903A4A866645" unitRef="usd">6000000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2017Q4YTD" decimals="-3" id="Fact-DE9E064FFBF4D8427D69902B87234D72" unitRef="usd">1348000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_EquipmentTransferMember" decimals="-3" id="Fact-099129D2F4B40FE6FE1D902B7E216F4C" unitRef="usd">494000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_RegulatoryFilingsMember" decimals="-3" id="Fact-6A151A0D0381F5F25873902B80488318" unitRef="usd">0</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_ContractTerminationMember" decimals="-3" id="Fact-368E37DEE8693EB28D6C902B826CA034" unitRef="usd">0</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember" decimals="-3" id="Fact-6FDF6E414B3445BDD6AB902B7C11A82D" unitRef="usd">851000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember" decimals="-3" id="Fact-789C580045245DB05102902B852379B8" unitRef="usd">3000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2017Q4YTD_us-gaap_RestructuringPlanAxis_ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember" decimals="-5" id="Fact-36707519C7FE8D6BFF3D9038DACFD043" unitRef="usd">1300000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2018Q4YTD" decimals="-3" id="Fact-0DEA86870E923061E9028C8B3D273F83" unitRef="usd">4674000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_EquipmentTransferMember" decimals="-3" id="Fact-61C4D69035F07D0BA4468C8B3D27265E" unitRef="usd">2892000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_RegulatoryFilingsMember" decimals="-3" id="Fact-01C8414CB4763759F6A48C8B3D2791B0" unitRef="usd">68000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_ContractTerminationMember" decimals="-3" id="Fact-C4A0FAA0F24F79A2412A8C8B3C9AA3F3" unitRef="usd">200000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember" decimals="-3" id="Fact-EED51A80B2E0410041338C8B3CB96E74" unitRef="usd">1440000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember" decimals="-3" id="Fact-DCA65DB549C19766817B8C8B3CAA3398" unitRef="usd">74000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2018Q4YTD_us-gaap_RestructuringPlanAxis_ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember" decimals="-5" id="Fact-8361768A2A12794A8DB68C8B3D27373C" unitRef="usd">4700000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringReserve contextRef="FI2016Q4" decimals="-3" id="Fact-E3F2BCEDFDF4B030DC72902B7B65A10E" unitRef="usd">0</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2016Q4_us-gaap_RestructuringCostAndReserveAxis_ango_EquipmentTransferMember" decimals="-3" id="Fact-1BA47219B28E6422F4A5902B7515C8A4" unitRef="usd">0</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2016Q4_us-gaap_RestructuringCostAndReserveAxis_ango_RegulatoryFilingsMember" decimals="-3" id="Fact-E2901604086CC9672A25902B76CB54BB" unitRef="usd">0</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2016Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_ContractTerminationMember" decimals="-3" id="Fact-61C8335D56206DB1BECB902B7879D1EB" unitRef="usd">0</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2016Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember" decimals="-3" id="Fact-4440BE69A7C2FB930645902B7331C98D" unitRef="usd">0</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2016Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember" decimals="-3" id="Fact-DC00528A8617F622164D902B79E8B8FF" unitRef="usd">0</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2017Q4" decimals="-3" id="Fact-22DFB66B7FFE85BF9DF68C8B3CB96614" unitRef="usd">962000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2017Q4_us-gaap_RestructuringCostAndReserveAxis_ango_EquipmentTransferMember" decimals="-3" id="Fact-15942F09DF9D3A129F648C8B3D271E62" unitRef="usd">111000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2017Q4_us-gaap_RestructuringCostAndReserveAxis_ango_RegulatoryFilingsMember" decimals="-3" id="Fact-E6236EAA9EA13338C7308C8B3CAAB6C2" unitRef="usd">0</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2017Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_ContractTerminationMember" decimals="-3" id="Fact-1FF286D5D1E3153CABB08C8B3CAADFCA" unitRef="usd">0</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2017Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember" decimals="-3" id="Fact-7055C7C3206A695A9F168C8B3C9A71E8" unitRef="usd">851000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2017Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember" decimals="-3" id="Fact-B020292E8250D6C58A948C8B3D2797B5" unitRef="usd">0</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2018Q4" decimals="-3" id="Fact-AE34D18451281D5C94D08C8B3CAA6C70" unitRef="usd">1071000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2018Q4_us-gaap_BalanceSheetLocationAxis_ango_AccruedExpensesMember" decimals="-5" id="Fact-FAA7F43FD265ACA377978C8B3D27742B" unitRef="usd">1100000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_ango_EquipmentTransferMember" decimals="-3" id="Fact-51B0AF478D1E024ED2C18C8B3C9AF2F3" unitRef="usd">21000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_ango_RegulatoryFilingsMember" decimals="-3" id="Fact-235A9291033A2EC87E4F8C8B3CAA290D" unitRef="usd">12000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_ContractTerminationMember" decimals="-3" id="Fact-A97284E0B73F96C4743E8C8B3D272D96" unitRef="usd">200000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember" decimals="-3" id="Fact-B1D414B64AB185863C928C8B3CAAF620" unitRef="usd">838000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2018Q4_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember" decimals="-3" id="Fact-13577912DD998B930BEF8C8B3D27E0D1" unitRef="usd">0</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserveCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-89E90A776D84539785C98C8B3CF83BC1" unitRef="usd">2075000</us-gaap:RestructuringReserveCurrent>
	<us-gaap:RestructuringReserveCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-97B7971B66FD778250338C8B3CF8762B" unitRef="usd">1940000</us-gaap:RestructuringReserveCurrent>
	<us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="FD2017Q4YTD" decimals="-3" id="Fact-49A4C95F73ED2C4C26DE902B9457DFDE" unitRef="usd">108000</us-gaap:RestructuringReserveSettledWithoutCash2>
	<us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_EquipmentTransferMember" decimals="-3" id="Fact-65B09536B63D9C0B5F6A902B89F573AE" unitRef="usd">108000</us-gaap:RestructuringReserveSettledWithoutCash2>
	<us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_RegulatoryFilingsMember" decimals="-3" id="Fact-0C13BA825179BD665F2D902B8C0FEC85" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
	<us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_ContractTerminationMember" decimals="-3" id="Fact-BB2BC6C9326B6711CC93902B8FCAAD8D" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
	<us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember" decimals="-3" id="Fact-43FB9856CAFE7438D7C4902B87C69706" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
	<us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="FD2017Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember" decimals="-3" id="Fact-DBB16F5D94A7A56CED64902B91DE513E" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
	<us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="FD2018Q4YTD" decimals="-3" id="Fact-4018825B9A5A5A7516C48C8B3D273081" unitRef="usd">276000</us-gaap:RestructuringReserveSettledWithoutCash2>
	<us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_EquipmentTransferMember" decimals="-3" id="Fact-527B05800381A59CA9ED8C8B3C9AB6FF" unitRef="usd">276000</us-gaap:RestructuringReserveSettledWithoutCash2>
	<us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_ango_RegulatoryFilingsMember" decimals="-3" id="Fact-F62E839996EA2E6296FB8C8B3D176849" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
	<us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_ContractTerminationMember" decimals="-3" id="Fact-D4958D8A40C5DA9719CA8C8B3D2721BF" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
	<us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OneTimeTerminationBenefitsMember" decimals="-3" id="Fact-CB9AA6FC67FB3BD02D298C8B3D17238E" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
	<us-gaap:RestructuringReserveSettledWithoutCash2 contextRef="FD2018Q4YTD_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember" decimals="-3" id="Fact-60DAB83DFAEC094C26E38C8B3CAA14CA" unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
	<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="FI2017Q4" decimals="-3" id="Fact-074CD2DEE3F1E5CA028E8C8B3CE8D26C" unitRef="usd">-11007000</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="FI2018Q4" decimals="-3" id="Fact-4314A0E693F1B40227AF8C8B3CC97BFE" unitRef="usd">5129000</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:Revenues contextRef="FD2016Q4YTD" decimals="-3" id="Fact-2A6F5ED6FADBC8345A1E8C8B3CB9D960" unitRef="usd">353890000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2016Q4YTD_srt_ProductOrServiceAxis_ango_AccessMember" decimals="-3" id="Fact-22553CC09F17DBD6AD8E8C8B3D27E3CE" unitRef="usd">99375000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2016Q4YTD_srt_ProductOrServiceAxis_ango_OncologySurgeryMember" decimals="-3" id="Fact-26FC7EF57724EBF63CC28C8B3D27B887" unitRef="usd">48895000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2016Q4YTD_srt_ProductOrServiceAxis_ango_PeripheralVascularMember" decimals="-3" id="Fact-1E0AAAC287D46F0C59C78C8B3D17B4F3" unitRef="usd">205620000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2016Q4YTD_srt_StatementGeographicalAxis_ango_InternationalMember" decimals="-3" id="Fact-867EF4C7040F18A3CCBD8C8B3D078BFC" unitRef="usd">68066000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2016Q4YTD_srt_StatementGeographicalAxis_country_US" decimals="-3" id="Fact-BCE81A4683DC4CD98EC98C8B3D07D550" unitRef="usd">285824000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q1QTD" decimals="-3" id="Fact-738C20B298230D3D050B8C8B3D2704E7" unitRef="usd">88098000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q2QTD" decimals="-3" id="Fact-35766583253C3D9DC1A98C8B3D172909" unitRef="usd">89029000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q3QTD" decimals="-3" id="Fact-9E9C0AF6C168849E79158C8B3D179A7F" unitRef="usd">85602000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q4QTD" decimals="-3" id="Fact-34B572889CCD2C9D4B7E8C8B3D178413" unitRef="usd">86914000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q4YTD" decimals="-3" id="Fact-3728B55B27E581980A6B8C8B3CB9A4B7" unitRef="usd">349643000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ango_AccessMember" decimals="-3" id="Fact-95BD67DB224085CB965B8C8B3D2794D2" unitRef="usd">96481000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ango_OncologySurgeryMember" decimals="-3" id="Fact-DE5C01B6CB06CDF7877D8C8B3D176D6C" unitRef="usd">44560000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q4YTD_srt_ProductOrServiceAxis_ango_PeripheralVascularMember" decimals="-3" id="Fact-7C37D3355A3C6A9EF67F8C8B3D279C88" unitRef="usd">208602000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q4YTD_srt_StatementGeographicalAxis_ango_InternationalMember" decimals="-3" id="Fact-63604201030E480AFDB18C8B3D075233" unitRef="usd">67475000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q4YTD_srt_StatementGeographicalAxis_country_US" decimals="-3" id="Fact-FC90875D693A3FAC1E9A8C8B3D17688B" unitRef="usd">282168000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q1QTD" decimals="-3" id="Fact-53551BDDCAF15D1F9E1A8C8B3CC97A94" unitRef="usd">85411000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q2QTD" decimals="-3" id="Fact-AB568D7D35863C45B8F28C8B3CC9D649" unitRef="usd">86706000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q3QTD" decimals="-3" id="Fact-3492112BD3BF02B8F06A8C8B3CC97B47" unitRef="usd">83851000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q4QTD" decimals="-3" id="Fact-4ECEB263C1966AAF80DE8C8B3CB9AA18" unitRef="usd">88317000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q4YTD" decimals="-3" id="Fact-ACC81FD658D8806AF77B8C8B3CC98C66" unitRef="usd">344285000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ango_AccessMember" decimals="-3" id="Fact-34C4230A978418449DAF8C8B3D2798E2" unitRef="usd">92760000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ango_OncologySurgeryMember" decimals="-3" id="Fact-FD80D205D27D841818508C8B3D277240" unitRef="usd">49191000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q4YTD_srt_ProductOrServiceAxis_ango_PeripheralVascularMember" decimals="-3" id="Fact-1AD7E1E94A28522B74818C8B3D174B89" unitRef="usd">202334000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q4YTD_srt_StatementGeographicalAxis_ango_InternationalMember" decimals="-3" id="Fact-470F23F090DA52E53EB38C8B3D1771AB" unitRef="usd">70958000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q4YTD_srt_StatementGeographicalAxis_country_US" decimals="-3" id="Fact-6DBA7F4D4D1A3BB6A35B8C8B3D17FE94" unitRef="usd">273327000</us-gaap:Revenues>
	<us-gaap:SalesAndExciseTaxPayableCurrent contextRef="FI2017Q4" decimals="-3" id="Fact-C9AC2F4F9D85DF1B25AE8C8B3CF8B0BE" unitRef="usd">856000</us-gaap:SalesAndExciseTaxPayableCurrent>
	<us-gaap:SalesAndExciseTaxPayableCurrent contextRef="FI2018Q4" decimals="-3" id="Fact-562C5F10BC90250732008C8B3CE82534" unitRef="usd">683000</us-gaap:SalesAndExciseTaxPayableCurrent>
	<us-gaap:SellingAndMarketingExpense contextRef="FD2016Q4YTD" decimals="-3" id="Fact-477C9807F7D3EAD8587F8C8B3CC9CD49" unitRef="usd">83743000</us-gaap:SellingAndMarketingExpense>
	<us-gaap:SellingAndMarketingExpense contextRef="FD2017Q4YTD" decimals="-3" id="Fact-805F0E29641B2E783CD68C8B3D170535" unitRef="usd">78819000</us-gaap:SellingAndMarketingExpense>
	<us-gaap:SellingAndMarketingExpense contextRef="FD2018Q4YTD" decimals="-3" id="Fact-6BB979D165D951607D178C8B3D07BB8E" unitRef="usd">77276000</us-gaap:SellingAndMarketingExpense>
	<us-gaap:ShareBasedCompensation contextRef="FD2016Q4YTD" decimals="-3" id="Fact-9743E3A2FD165529DA758C8B3CE8E9D0" unitRef="usd">3240000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="FD2017Q4YTD" decimals="-3" id="Fact-ACF649367B6AC4A75C928C8B3D27DB9A" unitRef="usd">6183000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="FD2018Q4YTD" decimals="-3" id="Fact-1F9EDDDC5B651A3F63158C8B3CF82C2E" unitRef="usd">7912000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" id="Fact-7132BFFD28F208E84A8F945BFE170B5B">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="INF" id="Fact-630D940440723BEA03BC8C8B3CF811C4" unitRef="shares">44443</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="INF" id="Fact-F53E70C346F8D8D424448C8B3D1753F8" unitRef="shares">105431</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-55071044AC2098834D2B8C8B3CF8EA08" unitRef="usdPerShare">22.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="2" id="Fact-D22C3AB76AEC0DDD13848C8B3D17C68D" unitRef="usdPerShare">18.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="INF" id="Fact-D72E8E3E9FCB433B4BEB8C8B3CF848A6" unitRef="shares">135135</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="INF" id="Fact-3B45A2CEE6142B0237B38C8B3D17CCDF" unitRef="shares">299392</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2016Q4YTD" decimals="2" id="Fact-A7A00ED5D451D93B57EC8C8B3CF856B7" unitRef="usdPerShare">15.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2017Q4YTD" decimals="2" id="Fact-B1FBFB4CA9099715E9558C8B3CAA437A" unitRef="usdPerShare">16.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-3095CB7B8607239D83B58C8B3D07281C" unitRef="usdPerShare">23.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="2" id="Fact-0BAEA3981C74A72AF25C8C8B3D175452" unitRef="usdPerShare">16.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="INF" id="Fact-76EDB1E29C51C4C69A138C8B3CF8B1BD" unitRef="shares">361164</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="INF" id="Fact-A593EAF20C8B9D8D03248C8B3D17A62A" unitRef="shares">439297</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="FI2018Q4_us-gaap_AwardTypeAxis_ango_PerformanceSharesIncludingThreeYearMarketConditionMember" decimals="-5" id="Fact-5A3064CF8EA75EEA597E8C8B3C9A363C" unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="INF" id="Fact-0BEC00A328D42812F49E8C8B3CF86332" unitRef="shares">451856</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="INF" id="Fact-75AA315DE946933F8FFA8C8B3D17C358" unitRef="shares">474502</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2016Q4_us-gaap_AwardTypeAxis_ango_PerformanceSharesIncludingThreeYearMarketConditionMember" decimals="2" id="Fact-A78D38D59ED7337C061C8C8B3CAA0D7D" unitRef="usdPerShare">18.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2017Q4_us-gaap_AwardTypeAxis_ango_PerformanceSharesIncludingThreeYearMarketConditionMember" decimals="2" id="Fact-0DA6B90BEF8E6617279D8C8B3C9ABCB2" unitRef="usdPerShare">22.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-5AB3641A29ECC4CAB6298C8B3CF8A7A4" unitRef="usdPerShare">18.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2017Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="2" id="Fact-DF730BDEEDF52A9CEB818C8B3D172E29" unitRef="usdPerShare">15.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2018Q4_us-gaap_AwardTypeAxis_ango_PerformanceSharesIncludingThreeYearMarketConditionMember" decimals="2" id="Fact-DE748F3E10BEFAC9B2D48C8B3CAA08C2" unitRef="usdPerShare">23.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-C31DEA7B47D1C1FAF2618C8B3CF8D449" unitRef="usdPerShare">19.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2018Q4_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="2" id="Fact-2A11742CEFF60CBA47CE8C8B3D178C14" unitRef="usdPerShare">16.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_ango_PerformanceSharesIncludingThreeYearMarketConditionMember" id="Fact-729727CE98A802D30FAF8C8B3D073767">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="INF" id="Fact-5E7DB60F3B7E2A2322D88C8B3CF8C904" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="INF" id="Fact-C42A11769CE654C81F2A8C8B3D175513" unitRef="shares">158756</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="FD2016Q4YTD_us-gaap_AwardTypeAxis_ango_PerformanceShareAndRestrictedStockUnitAwardsMember" decimals="-5" id="Fact-441A5F89219EC404EAFC8C8B3D079E8F" unitRef="usd">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_ango_PerformanceShareAndRestrictedStockUnitAwardsMember" decimals="-5" id="Fact-65AC7F796B576DF505028C8B3D0786F9" unitRef="usd">2900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_ango_PerformanceShareAndRestrictedStockUnitAwardsMember" decimals="-5" id="Fact-FEAD1C1BCE54ACFF3D1E8C8B3CAA4962" unitRef="usd">2700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-3A121451CF28A8208C008C8B3D0717DE" unitRef="usdPerShare">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="2" id="Fact-7F83E2FBE6762193D4408C8B3D17DDD7" unitRef="usdPerShare">16.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="FD2016Q4YTD" decimals="2" id="Fact-19658215A63BCF1A8AA98C8B3CAAF556" unitRef="number">0.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="FD2017Q4YTD" decimals="2" id="Fact-9DFD14411517C0FADDCA8C8B3CAA24CD" unitRef="number">0.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="FD2018Q4YTD" decimals="2" id="Fact-E2D4DA99C2740B8344B28C8B3CAAFEC4" unitRef="number">0.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="FD2016Q4YTD" decimals="4" id="Fact-8365F983EFD8C5CFDDE58C8B3CAABE7B" unitRef="number">0.0148</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="FD2017Q4YTD" decimals="4" id="Fact-79858C94D8C99017EAAF8C8B3C9A0616" unitRef="number">0.0130</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="FD2018Q4YTD" decimals="4" id="Fact-50F76D70DBA4804351568C8B3CF8A18F" unitRef="number">0.0208</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee contextRef="D2016Q2Oct25_us-gaap_PlanNameAxis_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember" decimals="INF" id="Fact-1749D7C6EECB1AE4FB098C8B3CAABE7B" unitRef="shares">250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized contextRef="FD2015Q4YTD_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember" decimals="INF" id="Fact-481DA522ECECBD54AE168C8B3D17B5FD" unitRef="shares">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized contextRef="FD2017Q4YTD_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember" decimals="INF" id="Fact-EB8F52EE0505771C66998C8B3D270804" unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="FI2018Q4_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember" decimals="INF" id="Fact-13C7458DDAC67BE2E4488C8B3CAA8690" unitRef="shares">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="FI2018Q4_srt_RangeAxis_srt_MaximumMember_us-gaap_PlanNameAxis_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember" decimals="INF" id="Fact-A59BA7F7305775E71D428C8B3CAA85B8" unitRef="shares">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="FI2018Q4_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember" decimals="INF" id="Fact-2789762AF08BC45BF20D8C8B3CB99EC2" unitRef="shares">1200000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="FI2018Q4_us-gaap_PlanNameAxis_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember" decimals="-5" id="Fact-92451AEA3B811FE50B7C8C8B3CAA1493" unitRef="shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="FI2018Q4" decimals="INF" id="Fact-50A1411A68526BD1C6E38C8B3D170136" unitRef="shares">652543</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="FI2018Q4" decimals="2" id="Fact-28BCA8FCEA42AE60AF398C8B3D074AAA" unitRef="usdPerShare">14.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="FD2016Q4YTD" decimals="-5" id="Fact-EC1A81FA58679C0751878C8B3CAA3E20" unitRef="usd">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="FD2017Q4YTD" decimals="-5" id="Fact-C40CAE519A20261249988C8B3C9A794B" unitRef="usd">2800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="FD2018Q4YTD" decimals="-5" id="Fact-19CAEDBC6B318E9F0A4E8C8B3D27B797" unitRef="usd">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="FD2018Q4YTD" decimals="INF" id="Fact-C0EB0CD0041DC8AD01AB8C8B3D072DF6" unitRef="shares">14000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="FD2018Q4YTD" decimals="INF" id="Fact-1C9C29A35398020CD4178C8B3D077613" unitRef="shares">204184</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="FD2018Q4YTD" decimals="INF" id="Fact-69C7580C194336B0C5C88C8B3D07345F" unitRef="shares">518498</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2016Q4YTD" decimals="2" id="Fact-FEFAF4424F1A7E83E43D8C8B3CAAF99D" unitRef="usdPerShare">4.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2017Q4YTD" decimals="2" id="Fact-C2457184788A529F7A018C8B3CAAB115" unitRef="usdPerShare">4.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2018Q4YTD" decimals="2" id="Fact-A8115C877CAE26575A648C8B3CAA37CB" unitRef="usdPerShare">4.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="FI2018Q4" decimals="-3" id="Fact-1741551778B6381905ED8C8B3D079A4D" unitRef="usd">9520000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="FI2017Q4" decimals="INF" id="Fact-42EFE7CDBACAE139300D8C8B3D070AEA" unitRef="shares">1667443</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="FI2018Q4" decimals="INF" id="Fact-3A3BFC140C0D061639B98C8B3D07AD83" unitRef="shares">1696413</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="FI2017Q4" decimals="2" id="Fact-7B162BF1FAA56B2B2A5E8C8B3D2780A7" unitRef="usdPerShare">15.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="FI2018Q4" decimals="2" id="Fact-867990C9BAA40666359C8C8B3D170501" unitRef="usdPerShare">15.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="FI2018Q4" decimals="-3" id="Fact-1870E60C0E4290B657428C8B3CF87269" unitRef="usd">5199000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="FI2018Q4" decimals="INF" id="Fact-AB30D0D1FE2BF6E2274B8C8B3D07F49F" unitRef="shares">1043870</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice contextRef="FI2018Q4" decimals="2" id="Fact-3C8D45D6B66758DFBBD98C8B3D073FF8" unitRef="usdPerShare">16.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased contextRef="FI2016Q4" decimals="2" id="Fact-D533015515A0192B9ED98C8B3CAA8A6C" unitRef="usdPerShare">10.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased contextRef="FI2017Q4" decimals="2" id="Fact-C612A1E1EB93AAC7B8B68C8B3D17C209" unitRef="usdPerShare">11.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased contextRef="FI2018Q4" decimals="2" id="Fact-21AC3A77724F97C340838C8B3CAAE15F" unitRef="usdPerShare">14.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased>
	<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="FD2018Q4YTD" decimals="2" id="Fact-FB0D8EB0DF517D21B4838C8B3D27CFAD" unitRef="usdPerShare">14.83</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="FD2018Q4YTD" decimals="2" id="Fact-EC304B031198F55D57368C8B3D27EEDF" unitRef="usdPerShare">15.75</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="FD2018Q4YTD" decimals="2" id="Fact-984C4C5A37DDDA1113E48C8B3D07B857" unitRef="usdPerShare">16.24</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="FD2018Q4YTD" decimals="2" id="Fact-FF6F50DF0E35EEF7E2CE8C8B3D17986F" unitRef="usdPerShare">16.78</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="INF" id="Fact-DBE6A8BFB698AE729466A4EE65588C39" unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="FD2016Q4YTD" id="Fact-A08ED8B0DE1F9CD1490B8C8B3C9A78D2">P4Y9M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="FD2017Q4YTD" id="Fact-8CD4DC59862C1534EAB18C8B3C9A1335">P4Y9M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="FD2018Q4YTD" id="Fact-A911E9217E0369E52D9D8C8B3C9A0757">P4Y8M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="FI2018Q4" decimals="-3" id="Fact-A256FCDB6BD34EF2D1518C8B3D07E73A" unitRef="usd">4321000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="FD2018Q4YTD" id="Fact-1574C375E841D444AF268C8B3D076BD7">P3Y5M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="FD2018Q4YTD" id="Fact-DA6ADE8D04C823103ECE8C8B3D07B144">P5Y6M30D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="FD2018Q4YTD" id="Fact-27E4717B45A8B10392258C8B3CF83183">P6Y10M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent contextRef="FD2018Q4YTD_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember" decimals="2" id="Fact-C7584CABC57954CF18E88C8B3CAAD04F" unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
	<us-gaap:SharesIssued contextRef="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-0107636028506F3DAA4C8C8B3CD98D42" unitRef="shares">36043725</us-gaap:SharesIssued>
	<us-gaap:SharesIssued contextRef="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" decimals="INF" id="Fact-BCE9AA938F52348138358C8B3D3683D5" unitRef="shares">142305.000</us-gaap:SharesIssued>
	<us-gaap:SharesIssued contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-D7D5402DCA19E34D790793F159663A9E" unitRef="shares">36420403.000</us-gaap:SharesIssued>
	<us-gaap:SharesIssued contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" decimals="INF" id="Fact-9C4F6671C8949C8429AC93F158F94A19" unitRef="shares">-142305.000</us-gaap:SharesIssued>
	<us-gaap:SharesIssued contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-7042B4A66ACB882222628C8B3D273E9F" unitRef="shares">37210091</us-gaap:SharesIssued>
	<us-gaap:SharesIssued contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" decimals="INF" id="Fact-1709EDCF0ED5C7B20A958C8B3D27C65F" unitRef="shares">370000</us-gaap:SharesIssued>
	<us-gaap:SharesIssued contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-E4E6D6329A0E931659CB8C8B3D36264A" unitRef="shares">37594493</us-gaap:SharesIssued>
	<us-gaap:SharesIssued contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" decimals="INF" id="Fact-B3D73BCCD855B5651DC38C8B3CC953BC" unitRef="shares">370000</us-gaap:SharesIssued>
	<us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="FD2016Q4YTD_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember" decimals="INF" id="Fact-9C18F9D61DF41AA9431F8C8B3C9AF91E" unitRef="shares">137957</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
	<us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-F136820CBA450C62A3988C8B3D27CD2B" unitRef="shares">137957</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
	<us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="FD2017Q4YTD_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember" decimals="INF" id="Fact-4C951A56DBF4030475EB8C8B3C9A3815" unitRef="shares">129185</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
	<us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-29644F8E82523536869D8C8B3CC958B2" unitRef="shares">129185</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
	<us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="FD2018Q4YTD_us-gaap_PlanNameAxis_ango_StockPurchasePlanMember" decimals="INF" id="Fact-567C29C25B775CB0A03C8C8B3C9AE017" unitRef="shares">89943</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
	<us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-67A76B6023EB1617BF7293F157CEAD60" unitRef="shares">89943</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
	<us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-9A3703D913C586841C098C8B3D27043C" unitRef="shares">137681</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-D6628EB0005D72049A7B8C8B3D361828" unitRef="shares">23405</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-FF639E97005302E8F5B78C8B3D27B517" unitRef="shares">158341</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-6F2D753D43C517C4BA4E93F1586AF07B" unitRef="shares">145522</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-10FE81311000F9662F208C8B3D27F9E0" unitRef="shares">101040</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-82303587F00238A7895F8C8B3D27E495" unitRef="shares">751062</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="FD2018Q4YTD" decimals="INF" id="Fact-F787103B8FE4D09DAFF08C8B3D07A61D" unitRef="shares">271344</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-335A7290584DD27DD35F93F15985E692" unitRef="shares">148937</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="FD2016Q4YTD" decimals="-3" id="Fact-37EF05171097C3E7EC7993F15A311573" unitRef="usd">1471000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
	<us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-9EB7679632C3D2A53C148C8B3CC98BE3" unitRef="usd">1470000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
	<us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-CEDC0BB5A5896CE3E1B28C8B3CB996D6" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
	<us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="FD2017Q4YTD" decimals="-3" id="Fact-2FBD0E831D768C99EE5693F159D3AAF3" unitRef="usd">1419000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
	<us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-9F0DEDA55A79C27C97358C8B3D27F91D" unitRef="usd">1418000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
	<us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-6D70FDA3C352F8ABDAE38C8B3D367806" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
	<us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="FD2018Q4YTD" decimals="-3" id="Fact-A0810C308222296FA80593F1580D79B5" unitRef="usd">1263000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
	<us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-B667814833D04F512F7593F15A5F44FD" unitRef="usd">1262000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
	<us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-864779B538D4B468CCBA93F15A7F29E0" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
	<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="FD2016Q4YTD" decimals="-3" id="Fact-C7E5D395393777E3C19293F159D37E3B" unitRef="usd">-331000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-F6EC7E4C227DB94741628C8B3D362D65" unitRef="usd">-332000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-205309ECC7D6ABFB46888C8B3CD916D3" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="-3" id="Fact-7775D5C16EE0F146091193F1F92F84A6" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-E9AE3730292198991C7F8C8B3CC93469" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-A74BCEDEB4BD09873A368C8B3D365991" unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="-3" id="Fact-2D6EF7CE56F4E67E04E393F157BFC040" unitRef="usd">-586000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-8CBF133D45EC51EEC04D8C8B3CE89A68" unitRef="usd">-587000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="FD2017Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-4A207E707AA5CDE57F5A8C8B3D3659D8" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="-3" id="Fact-4E8500104D3BFA8572D493F159271CA1" unitRef="usd">-231000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-D1861EF1B99F62DFB64D93F159375953" unitRef="usd">-232000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="FD2018Q4YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-DF80BCBD43E35C17935893F159B4F082" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="FD2016Q4YTD" decimals="-3" id="Fact-CDC1D3CB03127F56663393F159A48896" unitRef="usd">1297000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-B2F801B8186624B59D138C8B3D27D7D2" unitRef="usd">1296000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="FD2016Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-9E3297EA53E5F8AAECBA8C8B3D278DDE" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="FD2017Q4YTD" decimals="-3" id="Fact-08F3BEED920E22DB4B5D93F1585B4090" unitRef="usd">9865000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-9A071CADCCFDD6FDF3638C8B3D365FF5" unitRef="usd">9858000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-49577D5BBDDFD7C92E8E8C8B3D27F098" unitRef="usd">7000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="FD2018Q4YTD" decimals="-3" id="Fact-F44B9361EE88E257B8EE93F159182DDF" unitRef="usd">1917000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-F53C9A75DC7A72D196D593F158AB0C83" unitRef="usd">1916000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="FD2018Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-F790951828F5CC602AF293F158E923F3" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
	<us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="I2016Q2Nov6_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember" decimals="-5" id="Fact-2998713DF63C1AD6A71D8C8B3D276777" unitRef="usd">25000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
	<us-gaap:StockRepurchaseProgramPeriodInForce1 contextRef="D2016Q2Nov6_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember" id="Fact-C0493F97772B096B3AF08C8B3CAA6FFF">P24M</us-gaap:StockRepurchaseProgramPeriodInForce1>
	<us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="FI2018Q4_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember" decimals="-5" id="Fact-8A840AD297C3DCB33FBC8C8B3D171614" unitRef="usd">11400000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
	<us-gaap:StockRepurchasedDuringPeriodShares contextRef="FD2017Q4QTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember" decimals="0" id="Fact-2BAD5A57F383E7DB20DC8C8B3C9AFE51" unitRef="shares">370000</us-gaap:StockRepurchasedDuringPeriodShares>
	<us-gaap:StockholdersEquity contextRef="FI2015Q4" decimals="-3" id="Fact-FDCD48C6D04EB59F9ACD8C8B3D278801" unitRef="usd">545099000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-022963378DEFB7BBC3428C8B3D368982" unitRef="usd">-833000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-9EC106253A2346D532A68C8B3D36426D" unitRef="usd">520101000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-75E2A7C4905E38CF01AF8C8B3D27A8B9" unitRef="usd">360000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="-3" id="Fact-37FE89B0E2C76F2F8C698C8B3CD9AE52" unitRef="usd">27575000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2015Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" decimals="-3" id="Fact-3522AB094863FB541CAF8C8B3CC96F00" unitRef="usd">-2104000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2016Q4" decimals="-3" id="Fact-2B3527FC123496D2548593F157ED2D43" unitRef="usd">507228000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-3" id="Fact-16B6273FCE7EB172C9E18C8B3D07179B" unitRef="usd">-31000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-28559AF80BEC3CC97C3B93F15A11B82D" unitRef="usd">-791000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-3" id="Fact-BFFFB1E4F2AF48597CD28C8B3D07E0C8" unitRef="usd">-760000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-0777CE6B2F77B90D56C993F158CA4948" unitRef="usd">525775000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-09D11DF2BB0FCA48836C93F1581C6505" unitRef="usd">363000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="-3" id="Fact-52DAC511D38DFECC87AF93F1588BE6AC" unitRef="usd">-16015000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" decimals="-3" id="Fact-A8BEA227265A851F755B93F159F24882" unitRef="usd">-2104000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2017Q4" decimals="-3" id="Fact-E7FC8EDA32755CEAB4678C8B3CC9CCE0" unitRef="usd">515027000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-3" id="Fact-E6A8853F18918B4BF6138C8B3D075AC2" unitRef="usd">-19000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-343217BAA1919A9DD4098C8B3CC908DA" unitRef="usd">-1324000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-3" id="Fact-38138BBFE4862994DA0B8C8B3D170751" unitRef="usd">-1305000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-E74014E77DA68E5B52E08C8B3D36C883" unitRef="usd">532705000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-2FEFFBAB888E6A1B6E408C8B3CC9C430" unitRef="usd">367000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="-3" id="Fact-387E3BAA091DD380F5AA8C8B3CC9061F" unitRef="usd">-11007000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" decimals="-3" id="Fact-9261D45C51B709B6D5F28C8B3CD98C68" unitRef="usd">-5714000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q4" decimals="-3" id="Fact-4F722B3A872D0B2AEEE48C8B3CC9B945" unitRef="usd">542595000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-3" id="Fact-EE3568A598AA4972EB878C8B3D17A4E3" unitRef="usd">83000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-3" id="Fact-3C07060A3FA74020CF038C8B3D278EBB" unitRef="usd">-952000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-3" id="Fact-85544735963FD6E060298C8B3D276D3C" unitRef="usd">-1035000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-D2B9BFB63168F565D25E8C8B3D277417" unitRef="usd">543762000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-7067866839F47FAFED3E8C8B3CD9EEE2" unitRef="usd">370000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_RetainedEarningsMember" decimals="-3" id="Fact-AFCF10FF60D57A9BFA628C8B3CE811B4" unitRef="usd">5129000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" decimals="-3" id="Fact-9119B8419E08C6F4D6C28C8B3CD9F7D1" unitRef="usd">-5714000</us-gaap:StockholdersEquity>
	<us-gaap:TreasuryStockRetiredParValueMethodAmount contextRef="D2017Q3Feb2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-5" id="Fact-9B6D10A5278B0241F0D28C8B3D071307" unitRef="usd">9900000</us-gaap:TreasuryStockRetiredParValueMethodAmount>
	<us-gaap:TreasuryStockRetiredParValueMethodAmount contextRef="D2017Q3Feb2017_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-5" id="Fact-56DB9E53548662161EAF8C8B3CAA0EA6" unitRef="usd">9900000</us-gaap:TreasuryStockRetiredParValueMethodAmount>
	<us-gaap:TreasuryStockRetiredParValueMethodAmount contextRef="FD2017Q4YTD" decimals="-3" id="Fact-99D0AAE3662D292C4CB593F217E5A6B5" unitRef="usd">0</us-gaap:TreasuryStockRetiredParValueMethodAmount>
	<us-gaap:TreasuryStockRetiredParValueMethodAmount contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AdditionalPaidInCapitalMember" decimals="-3" id="Fact-DE8D2B7C6F4785E464D68C8B3CC9D3B7" unitRef="usd">-9942000</us-gaap:TreasuryStockRetiredParValueMethodAmount>
	<us-gaap:TreasuryStockRetiredParValueMethodAmount contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-A4178399819B7338AA078C8B3CE81866" unitRef="usd">-2000</us-gaap:TreasuryStockRetiredParValueMethodAmount>
	<us-gaap:TreasuryStockRetiredParValueMethodAmount contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" decimals="-3" id="Fact-1736EF8A00A06DD64DB68C8B3D36B619" unitRef="usd">9944000</us-gaap:TreasuryStockRetiredParValueMethodAmount>
	<us-gaap:TreasuryStockShares contextRef="FI2017Q4" decimals="INF" id="Fact-B2160866E8795543535C8C8B3CB936F5" unitRef="shares">370000</us-gaap:TreasuryStockShares>
	<us-gaap:TreasuryStockShares contextRef="FI2018Q4" decimals="INF" id="Fact-AFE8103C236E62F113578C8B3CB9179A" unitRef="shares">370000</us-gaap:TreasuryStockShares>
	<us-gaap:TreasuryStockSharesAcquired contextRef="FD2017Q2QTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember" decimals="0" id="Fact-5B46D391EFD0FAB94AFE8C8B3D174B1D" unitRef="shares">500000</us-gaap:TreasuryStockSharesAcquired>
	<us-gaap:TreasuryStockSharesAcquired contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-026DD4EC1D2138E3907E8C8B3CC9732A" unitRef="shares">370000</us-gaap:TreasuryStockSharesAcquired>
	<us-gaap:TreasuryStockSharesAcquired contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" decimals="INF" id="Fact-E17085AD2C84A3021F0F8C8B3CE8A36C" unitRef="shares">870000</us-gaap:TreasuryStockSharesAcquired>
	<us-gaap:TreasuryStockSharesRetired contextRef="D2017Q3Feb2017_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="0" id="Fact-C706DD9EE48D3C4A436A8C8B3CB93D17" unitRef="shares">642305</us-gaap:TreasuryStockSharesRetired>
	<us-gaap:TreasuryStockSharesRetired contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="INF" id="Fact-E02814B19D89BF63630D8C8B3CC972C4" unitRef="shares">-642305</us-gaap:TreasuryStockSharesRetired>
	<us-gaap:TreasuryStockSharesRetired contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" decimals="INF" id="Fact-A1406AF3B1C06568561B8C8B3D2765C6" unitRef="shares">642305</us-gaap:TreasuryStockSharesRetired>
	<us-gaap:TreasuryStockValue contextRef="FI2017Q4" decimals="-3" id="Fact-DA5ECFAA4ECFB4E3B8DA8C8B3CE89FE2" unitRef="usd">5714000</us-gaap:TreasuryStockValue>
	<us-gaap:TreasuryStockValue contextRef="FI2018Q4" decimals="-3" id="Fact-C3E87ACCC1685853EC348C8B3CC9E492" unitRef="usd">5714000</us-gaap:TreasuryStockValue>
	<us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="FD2017Q2QTD_us-gaap_StatementClassOfStockAxis_us-gaap_CommonStockMember" decimals="-5" id="Fact-E01BF4D9CE450008D7088C8B3D07B0A8" unitRef="usd">7800000</us-gaap:TreasuryStockValueAcquiredCostMethod>
	<us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="FD2017Q4YTD" decimals="-3" id="Fact-2194C02D73ECC354849393F219028718" unitRef="usd">13557000</us-gaap:TreasuryStockValueAcquiredCostMethod>
	<us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember" decimals="-3" id="Fact-67971CD8D8C65D945EF48C8B3D367E95" unitRef="usd">-3000</us-gaap:TreasuryStockValueAcquiredCostMethod>
	<us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="FD2017Q4YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_TreasuryStockMember" decimals="-3" id="Fact-2EA0D0A36419036217848C8B3D27E0AF" unitRef="usd">13554000</us-gaap:TreasuryStockValueAcquiredCostMethod>
	<us-gaap:UndistributedEarningsOfForeignSubsidiaries contextRef="FI2017Q4" decimals="-5" id="Fact-AAE780A9953854CA4B48A4C3A7645DCC" unitRef="usd">5300000</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
	<us-gaap:UndistributedEarningsOfForeignSubsidiaries contextRef="FI2018Q4" decimals="-5" id="Fact-8E5B87658E34D38DAE98A42B95E14226" unitRef="usd">4900000</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
	<us-gaap:UnrecognizedTaxBenefits contextRef="FI2015Q4" decimals="-3" id="Fact-19585D3E8A9A2EF153948C8B3CC919CE" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
	<us-gaap:UnrecognizedTaxBenefits contextRef="FI2016Q4" decimals="-3" id="Fact-13890FED320A6CE9D8AD8C8B3CC9AD19" unitRef="usd">899000</us-gaap:UnrecognizedTaxBenefits>
	<us-gaap:UnrecognizedTaxBenefits contextRef="FI2017Q4" decimals="-3" id="Fact-F6F3D05AD9DADD234EB68C8B3CC92796" unitRef="usd">899000</us-gaap:UnrecognizedTaxBenefits>
	<us-gaap:UnrecognizedTaxBenefits contextRef="FI2018Q4" decimals="-3" id="Fact-B3795083337BE5BCB9498C8B3CC9A26F" unitRef="usd">464000</us-gaap:UnrecognizedTaxBenefits>
	<us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="FD2016Q4YTD" decimals="-3" id="Fact-5481D277678BD9D99EEAA43A02B0DA8D" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
	<us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="FD2017Q4YTD" decimals="-3" id="Fact-A5D494DA23E01DF3ED14A43A02994D45" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
	<us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="FD2018Q4YTD" decimals="-3" id="Fact-F2DC6981AC8E0BBAEA58A4399B11718D" unitRef="usd">287000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
	<us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="FI2016Q4" decimals="INF" id="Fact-D3F18FF7015095AFA16F8C8B3D17424E" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
	<us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="FI2017Q4" decimals="INF" id="Fact-114662F2187BD5CFAE5C8C8B3D176EC8" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
	<us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="FI2018Q4" decimals="INF" id="Fact-4F2B7810C5D52ED362918C8B3D170D20" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
	<us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="FD2016Q4YTD" decimals="-3" id="Fact-5E0F3B22005BF3E313838C8B3CC97D8B" unitRef="usd">899000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
	<us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="FD2017Q4YTD" decimals="-3" id="Fact-FC2A9D4D95B8D96488228C8B3CD905F7" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
	<us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="FD2018Q4YTD" decimals="-3" id="Fact-A5E79DBC5A7A27171A9B8C8B3CC96C7E" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
	<us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="FD2016Q4YTD" decimals="-3" id="Fact-74C540F4B81620C767568C8B3CB9B1F5" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
	<us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="FD2017Q4YTD" decimals="-3" id="Fact-08D1B58F1DE4A1C7B2828C8B3D2790E2" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
	<us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="FD2018Q4YTD" decimals="-3" id="Fact-E8D7784660A7BA966B3B8C8B3D07E195" unitRef="usd">148000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2015Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember" decimals="-3" id="Fact-D2D574138D5D561476828C8B3D27B8D5" unitRef="usd">3043000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2015Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-A9FDC6B5C79C33888C7B8C8B3CAAFE71" unitRef="usd">1791000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2016Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember" decimals="-3" id="Fact-AA7A961B0BE02A72D47E8C8B3D279ED8" unitRef="usd">4372000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2016Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-B807EF645EBEE0FBDE828C8B3CC9352E" unitRef="usd">42209000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember" decimals="-3" id="Fact-90C3017C151B767A2B958C8B3D27DA50" unitRef="usd">2945000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2017Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-4C5D9768AE61A67C2E138C8B3D17D58B" unitRef="usd">48348000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember" decimals="-3" id="Fact-4A67482C32A48227C2C78C8B3D27FDC0" unitRef="usd">2466000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesBalance contextRef="FI2018Q4_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-3741FFDDC29557ABEAD98C8B3CC9C29F" unitRef="usd">26607000</us-gaap:ValuationAllowancesAndReservesBalance>
	<us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="FD2016Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember" decimals="-3" id="Fact-BF2B378788674B0ED2668C8B3D27F7D2" unitRef="usd">3748000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
	<us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="FD2016Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-943A7AE62BB32B3FA7B08C8B3CC920FB" unitRef="usd">40685000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
	<us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember" decimals="-3" id="Fact-5268698345FD671A3C1D8C8B3D176023" unitRef="usd">-291000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
	<us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-CD7FF5FBECCDCB502F2A8C8B3D178DB1" unitRef="usd">6139000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
	<us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember" decimals="-3" id="Fact-D6CACDDB5CB4A76A6D7B8C8B3CAA842D" unitRef="usd">608000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
	<us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-99F69F7107DB53B3CF9C8C8B3D27A4D6" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
	<us-gaap:ValuationAllowancesAndReservesDeductions contextRef="FD2016Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember" decimals="-3" id="Fact-D0E67133074B848FB2188C8B3CC99A55" unitRef="usd">2419000</us-gaap:ValuationAllowancesAndReservesDeductions>
	<us-gaap:ValuationAllowancesAndReservesDeductions contextRef="FD2016Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-F4CE911716029C8D97578C8B3D27949B" unitRef="usd">267000</us-gaap:ValuationAllowancesAndReservesDeductions>
	<us-gaap:ValuationAllowancesAndReservesDeductions contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember" decimals="-3" id="Fact-80188C758F922809D4BF8C8B3D27D350" unitRef="usd">1136000</us-gaap:ValuationAllowancesAndReservesDeductions>
	<us-gaap:ValuationAllowancesAndReservesDeductions contextRef="FD2017Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-AAFB751321949AA1F0328C8B3D1771DB" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesDeductions>
	<us-gaap:ValuationAllowancesAndReservesDeductions contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember" decimals="-3" id="Fact-4399D4E33CA16F51D4F78C8B3CC9D463" unitRef="usd">1087000</us-gaap:ValuationAllowancesAndReservesDeductions>
	<us-gaap:ValuationAllowancesAndReservesDeductions contextRef="FD2018Q4YTD_us-gaap_ValuationAllowancesAndReservesTypeAxis_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" decimals="-3" id="Fact-845F84476C196F0951308C8B3D1707AA" unitRef="usd">21741000</us-gaap:ValuationAllowancesAndReservesDeductions>
	<us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="FD2016Q4YTD" decimals="0" id="Fact-47DFA21FBF25EA65D4798C8B3CAA2B81" unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
	<us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="FD2017Q4YTD" decimals="0" id="Fact-3D650B8C54BE5FB438988C8B3CAA5B69" unitRef="shares">342391</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
	<us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="FD2018Q4YTD" decimals="0" id="Fact-586730228A806C30F9208C8B3CB9C6DD" unitRef="shares">464603</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="FD2016Q4YTD" decimals="-3" id="Fact-8AA142D02D53FB2160728C8B3D07B09C" unitRef="shares">36161000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="FD2016Q4YTD" decimals="0" id="Fact-080ED981F52B6F2E52A08C8B3CAADE99" unitRef="shares">36161383</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="FD2017Q4YTD" decimals="0" id="Fact-AAE0F78434A5812EC9488C8B3CB9ABD4" unitRef="shares">36959250</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="FD2017Q4YTD" decimals="-3" id="Fact-02DCF545BC49CD29DD5B8C8B3D0741CA" unitRef="shares">36959000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="FD2018Q4YTD" decimals="-3" id="Fact-ECE2F6761C91DDA9B8118C8B3CC9B342" unitRef="shares">37539000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="FD2018Q4YTD" decimals="0" id="Fact-BACE58AD3DC59DD877878C8B3CAA649F" unitRef="shares">37539400</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="FD2016Q4YTD" decimals="-3" id="Fact-C6C302655AC5DA4AD04B8C8B3D179B01" unitRef="shares">36161000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="FD2016Q4YTD" decimals="0" id="Fact-F90D17CDE7D656999B098C8B3CAA497A" unitRef="shares">36161383</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="FD2017Q4YTD" decimals="0" id="Fact-B9533068C60658B774828C8B3CAA186F" unitRef="shares">36616859</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="FD2017Q4YTD" decimals="-3" id="Fact-379F9CC5F279FF1637D78C8B3CB97663" unitRef="shares">36617000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="FD2018Q4YTD" decimals="0" id="Fact-3AEF6847EFBBF9C373C38C8B3CB920AD" unitRef="shares">37074797</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="FD2018Q4YTD" decimals="-3" id="Fact-1B71BE2B59F5378EC2868C8B3CC9CEE0" unitRef="shares">37075000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<ango:PrepaidExpensesAndOtherTableTextBlock contextRef="FD2018Q4YTD" id="Fact-BE146678BD6217FC5B8D8C8B3CAAD8B3">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, prepaid expenses and other consisted of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:67%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Software licenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,043&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;582&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;License fees&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;143&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;118&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Trade shows&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;223&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;162&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Rent&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;134&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;121&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other prepaid taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;254&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;544&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Medical device excise tax receivable &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,837&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,505&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,762&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,302&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,126&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</ango:PrepaidExpensesAndOtherTableTextBlock>
	<ango:PrepaidExpensesAndOtherTextBlock contextRef="FD2018Q4YTD" id="Fact-ACE1F85FB44490ED6A6D8C8B3CAA15C5">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;PREPAID EXPENSES AND OTHER&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, prepaid expenses and other consisted of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:67%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Software licenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,043&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;582&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;License fees&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;143&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;118&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Trade shows&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;223&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;162&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Rent&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;134&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;121&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other prepaid taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;254&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;544&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Medical device excise tax receivable &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,837&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,505&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,762&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,302&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,126&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ango:PrepaidExpensesAndOtherTextBlock>
	<ango:ScheduleOfIntangibleAssetsTableTextBlock contextRef="FD2018Q4YTD" id="Fact-191503D963DAAD4E9F9E8C8B3D0788FD">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, intangible assets consisted of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:56%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Gross&amp;#160;carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Net&amp;#160;carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Product technologies&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;147,175&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(68,880&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;78,295&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Customer relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;56,428&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(23,237&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;33,191&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Trademarks&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;28,400&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(11,809&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,591&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Licenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,752&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4,357&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,395&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Distributor relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,250&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(412&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;838&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;239,005&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(108,695&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;130,310&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:56%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Gross&amp;#160;carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Net&amp;#160;carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Product technologies&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;147,172&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(59,696&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;87,476&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Customer relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;56,375&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(19,194&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;37,181&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Trademarks&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;28,400&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(9,069&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,331&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Licenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,487&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(3,821&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;666&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Distributor relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,250&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(229&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;237,684&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(92,009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;145,675&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ango:ScheduleOfIntangibleAssetsTableTextBlock>
	<ango:ScheduleOfNetRevenueByProductGroupTableTextBlock contextRef="FD2018Q4YTD" id="Fact-3D05F5F16FF768EC3D708C8B3D279190">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total sales by product category are summarized below (in thousands):&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:50%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Year ended May 31, &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net sales by Product Category&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Peripheral Vascular&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;202,334&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;208,602&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;205,620&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Vascular Access&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;92,760&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;96,481&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;99,375&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Oncology/Surgery&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;49,191&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;44,560&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;48,895&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;344,285&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;349,643&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;353,890&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</ango:ScheduleOfNetRevenueByProductGroupTableTextBlock>
	<srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-C4281390676B9EFF25A48C8B3CC9B2B9">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&lt;/font&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;SCHEDULE&amp;#160;II&amp;#160;-VALUATION&amp;#160;AND&amp;#160;QUALIFYING&amp;#160; ACCOUNTS&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Column A&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Column&amp;#160;B&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Column&amp;#160;C&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Column&amp;#160;D&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Column&amp;#160;E&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Description&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Balance&amp;#160;at&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Beginning&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;of&amp;#160;Year&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Additions&amp;#160;-&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Charged&amp;#160; to&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;costs and&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;expenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Deductions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Balance&amp;#160;at&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;End&amp;#160;of&amp;#160;Period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Year Ended May&amp;#160;31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Allowance for deferred tax asset&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,791&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40,685&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(267&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;42,209&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Allowance for sales returns and doubtful accounts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,043&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,748&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2,419&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,372&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Year Ended May&amp;#160;31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Allowance for deferred tax asset&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;42,209&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,139&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;48,348&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Allowance for sales returns and doubtful accounts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,372&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(291&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,136&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,945&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Year Ended May&amp;#160;31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Allowance for deferred tax asset&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;48,348&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(21,741&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;26,607&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Allowance for sales returns and doubtful accounts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,945&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;608&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,087&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,466&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
	<us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-49187631E7D672711D6C8C8B3D07F1A6">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;ACCRUED LIABILITIES&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, accrued liabilities consist of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May&amp;#160;31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Payroll and related expenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,235&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,383&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Royalties&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,537&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,885&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued severance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,940&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,075&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Sales and franchise taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;683&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;856&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Outside services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,396&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,622&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Litigation matters (Note 15)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acculis recall liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,563&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,135&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,920&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;34,426&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;38,804&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In the fourth quarter of fiscal year 2017, the Company issued a voluntary recall of its Acculis probes that were sold over the past &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;two&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years and recorded a liability of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  In the third quarter of fiscal year 2018, the Company completed the replacement of Acculis probes that were returned for Solero probes.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
	<us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-ADA8B2431B020E9099DA8C8B3CB9D2D2">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Basis of Presentation and Description of Business&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The consolidated financial statements include the accounts of AngioDynamics, Inc. and its wholly owned subsidiaries,  (collectively, the &amp;#8220;Company&amp;#8221;).  The Company designs, manufactures and sells a wide range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and in oncology and surgical settings. The devices are generally used in minimally invasive, image-guided procedures. Most of the Company's products are intended to be used once and then discarded, or they may be temporarily implanted for short- or long-term use. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Accounting Principles&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The consolidated financial statements and accompanying notes have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP").&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Principles of Consolidation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The consolidated financial statements include the accounts of AngioDynamics and it subsidiaries (all of which are wholly owned).  All intercompany balances and transactions have been eliminated.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Use of Estimates&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The preparation of financial statements, in conformity with accounting principles generally accepted in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect reported amounts of sales and expenses during the reporting period. Actual results could differ from those estimates.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
	<us-gaap:BusinessCombinationsPolicy contextRef="FD2018Q4YTD" id="Fact-CE899B383C1CF5EBFA678C8B3D077A7A">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Contingent Consideration&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The fair value of the liability for contingent consideration recorded on the acquisition date for a business combination is based on probability weighted estimated cash flow streams, discounted back to present value using a discount rate determined in accordance with accepted valuation methods and reflective of the risk associated with the estimated cash flow streams. The liability for contingent consideration is remeasured to fair value at each reporting period with changes recorded in earnings until the contingency is resolved.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
	<us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-454D0C16239BE78998FF8C8B3CE861D8">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Cash and Cash Equivalents&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company considers all unrestricted highly liquid investments with an initial maturity of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;less than three months&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; at the date of purchase to be cash equivalents. The Company maintains cash and cash equivalent balances with financial institutions in the United States in excess of amounts insured by the Federal Deposit Insurance Corporation.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
	<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-5D549807E9A8119F89618C8B3D171755">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;COMMITMENTS AND CONTINGENCIES&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Leases&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company is committed under non-cancelable operating leases for facilities and equipment. During fiscal &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, aggregate rental costs under all operating leases were approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively. Future annual payments under non-cancelable operating leases in the aggregate, of which one includes an escalation clause, with initial remaining terms of more than one year at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, are summarized as follows (in thousands):&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:81%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,234&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,829&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;993&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;884&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2023 and thereafter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,668&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,608&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Other Commitments and Contingencies &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes the Company's other future commitments and contingencies as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="24" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:41%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:7%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:7%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:7%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:7%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:7%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:7%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2023 and thereafter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Purchase obligations (1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;56,201&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,751&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,243&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,485&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,189&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,533&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Royalties&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;45,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;31,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;667&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;167&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;167&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;167&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;166&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;101,868&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,918&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;17,910&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,152&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,855&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;37,033&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:36px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:0px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The non-cancelable inventory purchase obligations are not reflected on our consolidated balance sheets under accounting principles generally accepted in the United States of America.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Legal Proceedings&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company is involved in various legal proceedings, including commercial, intellectual property, product liability, and regulatory matters of a nature considered normal for its business. The Company accrues for amounts related to these matters if it is probable that a liability has been incurred, and an amount can be reasonably estimated. The Company discloses such matters when there is at least a reasonable possibility that a material loss may have been incurred. However, the Company cannot predict the outcome of any litigation or the potential for future litigation.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;C.R. Bard, Inc. v. AngioDynamics, Inc.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On January&amp;#160;11, 2012, C.R. Bard, Inc. (&amp;#8220;Bard&amp;#8221;) filed a suit in the United States District Court of Utah claiming certain of our implantable port products infringe on&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; U.S. patents held by Bard (the &amp;#8220;Utah Action&amp;#8221;). Bard&amp;#8217;s Complaint sought unspecified damages and other relief. We filed petitions for reexamination in the U.S. Patent and Trademark Office (&amp;#8220;USPTO&amp;#8221;) seeking to invalidate all &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; patents asserted by Bard in the litigation. Our petitions were granted and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40 of Bard's 41 patent&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; patent claims were rejected and, following further proceedings, the Patent Office issued a Final Rejection of all &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; claims subject to reexamination. Thereafter, Bard filed appeals to the USPTO Board of Appeals and Interferences for all&amp;#160;three&amp;#160;reexaminations. The Patent Office issued decisions in all &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; appeals. In one (issued on March 11, 2016 for U.S. Patent No. 7,785,302), the rejections of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;six&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ten&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; claims under reexamination were affirmed, but were reversed on &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;four&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the ten claims. &amp;#160;&amp;#160;In the second (issued on March 24, 2016 for U.S. Patent No. 7,959,615), the rejections of&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;eight&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ten&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; claims under reexamination were affirmed but the rejections of the other &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;two&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the ten claims were reversed. In the third (issued on March 29 for U.S. Patent No. 7,947.022) the rejections of all&amp;#160; &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;twenty&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; claims under reexamination were affirmed. Thereafter, Bard filed Requests for Rehearing in all&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; reexamination appeals and the Company filed Requests for Rehearing in &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;two&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the reexamination appeals (the &amp;#8216;302 and &amp;#8216;615 patent reexaminations). The PTO denied all three Rehearing Requests - - on February 1, 2017 for the &amp;#8216;302 reexam; on February 17, 2017 for the &amp;#8216;022 reexam; and on February 21, 2017 for the &amp;#8216;615 reexam, but modified its characterization of one prior art reference for the &amp;#8216;302 and &amp;#8216;022 decisions.&amp;#160; Bard filed a Notice of Appeal to the Federal Circuit Court of Appeals in all three reexams and the Company filed Cross-Appeals for the &amp;#8216;302 and the &amp;#8216;615 reexams. The parties have completed the process of filing the various appellate briefs. &amp;#160;MedComp also filed an Amicus Brief in support of the Company on November 22, 2017. A date for the oral hearing has not yet been set. The Utah Action has been stayed pending final resolution of the USPTO process.&amp;#160;We believe these claims are without merit and intend to defend them vigorously. We have not recorded an expense related to the outcome of this litigation because it is not yet possible to determine if a potential loss is probable nor reasonably estimable.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On March 10, 2015, C.R. Bard, Inc. (&amp;#8220;Bard&amp;#8221;) and Bard Peripheral Vascular, Inc. (&amp;#8220;BPV&amp;#8221;) filed suit in the United States District Court for the District of Delaware claiming certain of our implantable port products infringe on&amp;#160; &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; U.S. patents held by Bard (the &amp;#8220;Delaware Action&amp;#8221;). Bard's complaint seeks unspecified damages and other relief. The patents asserted in the Delaware Action are different than those asserted in the Utah Action. On June 1, 2015, the Company filed &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;two&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; motions in response to Bard&amp;#8217;s Complaint - one sought transfer to the District of Utah where the Utah Action is currently pending, and the other sought dismissal of the entire complaint on grounds that none of the claims in the asserted patents is directed to patent eligible subject matter under Section 101 of the Patent Statute and in light of recent authority from the U. S. Supreme Court. On January 12, 2016, the Court issued a decision denying both motions. A Markman hearing was held on March 10, 2017 and the Court issued its Claim Construction Order on May 19, 2017. On May 19, 2017, Bard served its Final Infringement Contentions and on June 2, 2017, the Company served its Final Invalidity Contentions.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On October 20, 2017, the scheduling order for the case was amended to, among other things, set a trial date commencing July 23, 2018.&amp;#160;The parties completed Expert Discovery in January 2018.  The parties completed briefing on their respective case dispositive motions on April 27, 2018. On June 26, 2018, the Court denied all case dispositive motions, ruling that issues of material fact remained in dispute. On July 9, 2018, the Court continued the trial to a later date to be determined by the Court and the parties.  We believe these claims are without merit and intend to defend them vigorously. We have not recorded an expense related to the outcome of this litigation because it is not yet possible to determine if a potential loss is probable nor reasonably estimable.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;AngioDynamics, Inc. v. C.R. Bard, Inc.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:64px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On May 30, 2017, we commenced an action in the United States District Court for the Northern District of New York entitled AngioDynamics, Inc. v. C.R. Bard, Inc. and Bard Access Systems, Inc. (&amp;#8220;Bard&amp;#8221;). &amp;#160;In this action, we allege that Bard has illegally tied the sales of its tip location systems to the sales of its PICCs.&amp;#160; We allege that this practice violates the federal antitrust laws and has had, and continues to have, an anti-competitive effect in the market for PICCs.&amp;#160; We seek both monetary damages and injunctive relief.  Bard moved to dismiss on September 8, 2017 and the motion has been submitted to the court.&amp;#160; The court has adjourned the initial conference in the case pending its resolution of the motion to dismiss. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:64px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Governmental Investigations&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In June 2014 we received a subpoena from the U.S. Department of Justice (the &amp;#8220;DOJ&amp;#8221;) requesting documents in relation to a criminal and civil investigation the DOJ is conducting regarding BTG International, Inc.&amp;#8217;s LC Bead&amp;#174;&amp;#160;product beginning in 2003.&amp;#160; RITA Medical Systems and AngioDynamics, Inc., after its acquisition of RITA, was the exclusive distributor of LC Beads in the United States from 2006 through December 31, 2011.&amp;#160; We are cooperating fully with this investigation.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In April 2015 we received a subpoena from the DOJ requesting documents in relation to a criminal and civil investigation the DOJ is conducting regarding purported promotion of certain of AngioDynamics&amp;#8217; VenaCure EVLT products for un-cleared indications.&amp;#160; We are cooperating fully with this investigation.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of May 31, 2017 the Company accrued &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$12.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for these matters and in August 2017, the Company agreed in principle with the government to resolve these matters for approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$12.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  This amount was still accrued for at May 31, 2018 and was paid in the first quarter of fiscal year 2019.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
	<us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-CD1C19B75D8A032A558F8C8B3CD97F29">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Contingencies&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company is subject to various legal proceedings that arise in the ordinary course of business, including patent infringement and product liability matters. The Company records accruals for contingencies when it is probable the liability has been incurred and the amount can be reasonably estimated.  Legal fees are expensed as incurred. Insurance recoveries related to potential claims are recognized up to the amount of the recorded liability when coverage is confirmed and the estimated recoveries are probable of payment. These recoveries are not netted against the related liabilities for financial statement presentation.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
	<us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="FD2018Q4YTD" id="Fact-E610996AA1A334627AFE902022A5FD51">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;ACCUMULATED OTHER COMPREHESIVE INCOME (LOSS)&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:24px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Changes in each component of accumulated other comprehensive income (loss), net of tax, are as follows for fiscal &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:64%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Foreign currency translation gain (loss)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Unrealized gain (loss) on marketable securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at May 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(760&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(31&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(791&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other comprehensive income (loss) before reclassifications, net of tax&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(545&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(533&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Amounts reclassified from accumulated other comprehensive income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net other comprehensive income (loss)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(545&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(533&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at May 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,305&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(19&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,324&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other comprehensive income before reclassifications, net of tax&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;270&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;102&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;372&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Amounts reclassified from accumulated other comprehensive income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net other comprehensive income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;270&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;102&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;372&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,035&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;83&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(952&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
	<us-gaap:ContractualObligationFiscalYearMaturityScheduleTableTextBlock contextRef="FD2018Q4YTD" id="Fact-4015B3FC8BEA9CA6B01F8C8B3D171CFF">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Future annual payments under non-cancelable operating leases in the aggregate, of which one includes an escalation clause, with initial remaining terms of more than one year at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, are summarized as follows (in thousands):&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:81%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,234&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,829&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;993&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;884&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2023 and thereafter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,668&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,608&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ContractualObligationFiscalYearMaturityScheduleTableTextBlock>
	<us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock contextRef="FD2018Q4YTD" id="Fact-AEAFB6D2D25AF1D224C38C8B3CE86FDA">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, marketable securities consisted of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Amortized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Gains&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Losses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Available-for-sales securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;New York State government agency obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,350&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(33&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,317&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,350&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(33&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,317&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, marketable securities consisted of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Amortized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Gains&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Losses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Available-for-sales securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;New York State government agency obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,350&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(135&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,215&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,350&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(135&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,215&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
	<us-gaap:DerivativesPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-56908C93DFCF1A734E9D8C8B3C9AE88C">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Derivative Financial Instruments&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company is exposed to market risks, including changes in foreign currency and interest rates. The Company periodically enters into certain derivative financial instruments to hedge the underlying economic exposure. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Derivative instruments are presented in the consolidated financial statements at their fair value. Changes in the fair value of derivative financial instruments are either recognized periodically in income or in stockholders&amp;#8217; equity as a component of accumulated other comprehensive income (loss) depending on whether the derivative financial instrument qualifies for hedge accounting and, if so, whether it qualifies as a fair value or cash flow hedge. Generally, the changes in the fair value of derivatives accounted for as fair value hedges are recorded in income along with the portions of the changes in the fair value of hedged items that relate to the hedged risks. Changes in the fair value of derivatives accounted for as cash flow hedges, to the extent they are effective as hedges, are recorded in accumulated other comprehensive income (loss).&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
	<us-gaap:EarningsPerShareTextBlock contextRef="FD2018Q4YTD" id="Fact-92E288EB7FF719C451B18C8B3CF8C536">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;EARNINGS PER SHARE&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:18px;text-indent:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Basic earnings per share are based on the weighted average number of common shares outstanding.  In addition, diluted earnings per share include the dilutive effect of potential common stock consisting of stock options, restricted stock units and performance stock units, provided that the inclusion of such securities is not anti-dilutive.  In periods with a net loss, stock options and restricted stock units are not included in the computation of basic loss per share as the impact would be anti-dilutive. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:18px;text-indent:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table reconciles basic to diluted weighted average shares outstanding for the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:18px;text-align:left;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Year ended May 31, &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;37,074,797&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,616,859&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,161,383&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Effect of dilutive securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;464,603&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;342,391&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;37,539,400&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,959,250&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,161,383&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Securities excluded as their inclusion would be anti-dilutive&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,077,256&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,058,790&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,277,037&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
	<us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="FD2018Q4YTD" id="Fact-5205AB71BA3CC75979408C8B3CD9457D">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The table below presents the changes in fair value components of Level 3 instruments in the year ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (in thousands of dollars):    &lt;/font&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:61%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Financial&amp;#160;Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Financial&amp;#160;Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair&amp;#160;Value&amp;#160;Measurements&lt;br clear="none"/&gt;Using Significant&lt;br clear="none"/&gt;Unobservable Inputs&lt;br clear="none"/&gt;(Level 3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair&amp;#160;Value&amp;#160;Measurements&lt;br clear="none"/&gt;Using Significant&lt;br clear="none"/&gt;Unobservable Inputs    (Level 3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at May 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,215&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,761&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Change in fair value of contingent consideration, net &lt;/font&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;250&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fair market value adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;102&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contingent consideration payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(9,750&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,317&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,261&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:24px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The table below presents the changes in fair value components of Level 3 instruments in the year ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (in thousands of dollars):   &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:60%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Financial&amp;#160;Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Financial&amp;#160;Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair&amp;#160;Value&amp;#160;Measurements&lt;br clear="none"/&gt;Using Significant&lt;br clear="none"/&gt;Unobservable Inputs&lt;br clear="none"/&gt;(Level 3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair&amp;#160;Value&amp;#160;Measurements&lt;br clear="none"/&gt;Using Significant&lt;br clear="none"/&gt;Unobservable Inputs    (Level 3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at May 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,653&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;38,275&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Change in fair value of contingent consideration (1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(15,261&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Currency (gain) loss from remeasurement&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(153&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fair market value adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Sale of securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(450&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contingent consideration payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(10,100&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at May 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,215&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,761&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1) Change in the fair value of contingent consideration is included in earnings and comprised of changes in estimated earn out payments based on projections of Company performance and amortization of the present value discount. &lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
	<us-gaap:FairValueDisclosuresTextBlock contextRef="FD2018Q4YTD" id="Fact-04D1120AC904E4FBB1878C8B3CD9C52A">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;FAIR VALUE OF FINANCIAL INSTRUMENTS&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On a recurring basis, the Company measures certain financial assets and financial liabilities at fair value based upon quoted market prices, where available. Where quoted market prices or other observable inputs are not available, the Company applies valuation techniques to estimate fair value. FASB ASC Topic 820,&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Fair Value Measurements and Disclosures, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;establishes a three-level valuation hierarchy for disclosure of fair value measurements. The categorization of financial assets and financial liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value.  The three levels of the hierarchy are defined as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Level 1 - Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Level 2 - Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Level 3 - Inputs to the valuation methodology are unobservable inputs based on management&amp;#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's financial instruments include cash and cash equivalents, marketable securities, accounts receivable, accounts payable and contingent consideration. The carrying amount of cash and cash equivalents, accounts receivable, and accounts payable approximates fair value due to their immediate or short-term maturities.  The recurring fair value measurements using significant unobservable inputs (Level 3) relate to marketable securities, which are comprised of auction rate securities, and contingent consideration liabilities. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following tables provide information by level for assets and liabilities that are measured at fair value on a recurring basis:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair Value Measurements using inputs considered as:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Level&amp;#160;1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Level&amp;#160;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Level 3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair Value at    May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;text-decoration:underline;"&gt;Financial Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Short-term investments*&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,100&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,100&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Marketable securities &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,317&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,317&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total Financial Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,100&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,317&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,417&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;text-decoration:underline;"&gt;Financial Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contingent liability for acquisition earn outs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,261&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,261&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total Financial Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,261&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,261&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;*included in cash and cash equivalents.&lt;/font&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair Value Measurements using inputs considered as:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Level 1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Level 2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Level 3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair Value at   May 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;text-decoration:underline;"&gt;Financial Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Marketable securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,215&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,215&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total Financial Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,215&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,215&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;text-decoration:underline;"&gt;Financial Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contingent liability for acquisition earn outs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,761&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,761&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total Financial Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,761&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,761&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;There were no transfers in and out of Level 1, 2 and 3 measurements for the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;May 31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The table below presents the changes in fair value components of Level 3 instruments in the year ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (in thousands of dollars):    &lt;/font&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:61%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Financial&amp;#160;Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Financial&amp;#160;Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair&amp;#160;Value&amp;#160;Measurements&lt;br clear="none"/&gt;Using Significant&lt;br clear="none"/&gt;Unobservable Inputs&lt;br clear="none"/&gt;(Level 3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair&amp;#160;Value&amp;#160;Measurements&lt;br clear="none"/&gt;Using Significant&lt;br clear="none"/&gt;Unobservable Inputs    (Level 3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at May 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,215&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,761&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Change in fair value of contingent consideration, net &lt;/font&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;250&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fair market value adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;102&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contingent consideration payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(9,750&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,317&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,261&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:24px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The table below presents the changes in fair value components of Level 3 instruments in the year ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (in thousands of dollars):   &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:60%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Financial&amp;#160;Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Financial&amp;#160;Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair&amp;#160;Value&amp;#160;Measurements&lt;br clear="none"/&gt;Using Significant&lt;br clear="none"/&gt;Unobservable Inputs&lt;br clear="none"/&gt;(Level 3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair&amp;#160;Value&amp;#160;Measurements&lt;br clear="none"/&gt;Using Significant&lt;br clear="none"/&gt;Unobservable Inputs    (Level 3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at May 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,653&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;38,275&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Change in fair value of contingent consideration (1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(15,261&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Currency (gain) loss from remeasurement&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(153&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fair market value adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Sale of securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(450&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contingent consideration payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(10,100&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at May 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,215&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,761&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1) Change in the fair value of contingent consideration is included in earnings and comprised of changes in estimated earn out payments based on projections of Company performance and amortization of the present value discount. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company made the decision to discontinue its investment in the TiLo product that was acquired in August 2013 as part of the Clinical Devices acquisition.  This decision resulted in the write-off of the acquired in-process research and development (IPR&amp;amp;D) of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; along with a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; gain from the reduction in the fair value of contingent consideration liability associated with future milestones that will no longer be met during the second quarter of fiscal year 2017.  The write-off of the IPR&amp;amp;D is included in acquisition, restructuring and other, net on the consolidated statement of operations. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:24px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company revised the sales projections for the AngioVac product as a result of reviews performed by executive management across all products.  The adjustments to the sales projections resulted in a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$13.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; gain in the second quarter of fiscal year 2017 from the reduction in the fair value of the contingent liability that is based on lower projected sales volume over the contractual earn out period. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:24px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Short-term Investments&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:24px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Short-term investments consist of highly liquid investments in municipal bonds that reset on a weekly basis and can be called at any point in time. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Marketable Securities&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Marketable securities consist solely of an auction rate security.  Assumptions associated with the auction rate security include the interest rate benchmarks, the probability of full repayment of the principal considering the credit quality and guarantees in place, and the rate of return required by investors to own such securities given the current liquidity risk.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Contingent Liability for Acquisition Earn Outs&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Some of our business combinations involve the potential for the payment of future contingent consideration upon the achievement of certain product development milestones or various other performance conditions. Payment of the additional consideration is generally contingent on the acquired company reaching certain performance milestones, including attaining specified revenue levels or product development targets. Contingent consideration is recorded at the estimated fair value of the contingent payments on the acquisition date. The fair value of the contingent consideration is remeasured at the estimated fair value at each reporting period with the change in fair value recognized as income or expense within change in fair value of contingent consideration in the consolidated statements of income. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;We measure the initial liability and remeasure the liability on a recurring basis using Level 3 inputs as defined under authoritative guidance for fair value measurements and is determined using a discounted cash flow model applied to projected net sales, using probabilities of achieving projected net sales and projected payment dates. Projected net sales are based on our internal projections and extensive analysis of the target market and the sales potential. Increases or decreases in any valuation inputs in isolation may result in a significantly lower or higher fair value measurement in the future. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The recurring Level 3 fair value measurements of the contingent consideration liabilities include the following significant unobservable inputs as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="10" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:28%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:28%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair&amp;#160;value&amp;#160;at&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May&amp;#160;31,&amp;#160;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Valuation&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Technique&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Unobservable&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Input&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Range&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Revenue based payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,261&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Discounted cash flow&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Discount rate&lt;br clear="none"/&gt;Probability of payment&lt;br clear="none"/&gt;Projected fiscal year of payment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4%&lt;br clear="none"/&gt;100%&lt;br clear="none"/&gt;2019 - 2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;At &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the estimated potential amount of undiscounted future contingent consideration that the Company expects to pay as a result of all completed acquisitions is approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which represents the remaining contractual minimum payments.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock contextRef="FD2018Q4YTD" id="Fact-E0302F8DDB19689907168C8B3CD96B1C">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The recurring Level 3 fair value measurements of the contingent consideration liabilities include the following significant unobservable inputs as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="10" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:28%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:28%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair&amp;#160;value&amp;#160;at&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May&amp;#160;31,&amp;#160;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Valuation&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Technique&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Unobservable&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Input&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Range&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Revenue based payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,261&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Discounted cash flow&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Discount rate&lt;br clear="none"/&gt;Probability of payment&lt;br clear="none"/&gt;Projected fiscal year of payment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4%&lt;br clear="none"/&gt;100%&lt;br clear="none"/&gt;2019 - 2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
	<us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="FD2018Q4YTD" id="Fact-7A8B0B3FD2C3E6A8A67E8C8B3CF8DE57">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Fair Value Instruments&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The carrying amount of the Company's cash and cash equivalents, accounts receivable, accounts payable and long-term debt approximates fair value due to the short-term nature or market interest rates of these items. The Company bases the fair value of short-term investments on quoted market prices or other relevant information generated by market transactions involving identical or comparable assets. The Company measures and records derivative financial instruments at fair value. See Note 3 for further discussion of financial instruments that are carried at fair value on a recurring and nonrecurring basis.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
	<us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-636CD31D32307508F7E58C8B3CE8005B">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Foreign Currency Translation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The functional currency of the Company's foreign subsidiaries is the local currency in which the subsidiary operates. For foreign operations where the local currency is considered to be the functional currency, the Company translates assets and liabilities into U.S. dollars at the exchange rate on the balance sheet date. The Company translates income and expense items at average rates of exchange prevailing during each period. The Company accumulates translation adjustments in accumulated other comprehensive loss, a component of stockholders&amp;#8217; equity.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Transaction gains or losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in other expense in the statements of operations as incurred.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
	<us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-BD0319211FA9745104968C8B3D178525">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;GOODWILL AND INTANGIBLE ASSETS&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's annual testing for impairment of goodwill was completed as of December 31, 2017. The Company operates as a single operating segment with &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;one&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; reporting unit and consequently evaluates goodwill for impairment based on an evaluation of the fair value of the Company as a whole. The Company determines the fair value of the reporting unit based on the market valuation approach and concluded that it was not more-likely-than-not that the fair value of the Company's reporting unit was less than its carrying value.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:12pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Even though the Company determined that there was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;no&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; goodwill impairment as of December 31, 2017, the future occurrence of a potential indicator of impairment, such as a significant adverse change in legal, regulatory, business or economic conditions or a more-likely-than-not expectation that the reporting unit or a significant portion of the reporting unit will be sold or disposed of, would require an interim assessment for the reporting unit prior to the next required annual assessment as of December 31, 2018.  The Company continued to assess for potential impairment through &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and noted no events that would be considered a triggering event.  There were &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;no&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; adjustments to goodwill for the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;font style="font-family:inherit;font-size:12pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, intangible assets consisted of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:56%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Gross&amp;#160;carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Net&amp;#160;carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Product technologies&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;147,175&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(68,880&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;78,295&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Customer relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;56,428&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(23,237&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;33,191&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Trademarks&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;28,400&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(11,809&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,591&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Licenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,752&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4,357&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,395&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Distributor relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,250&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(412&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;838&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;239,005&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(108,695&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;130,310&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:56%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Gross&amp;#160;carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Net&amp;#160;carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Product technologies&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;147,172&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(59,696&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;87,476&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Customer relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;56,375&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(19,194&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;37,181&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Trademarks&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;28,400&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(9,069&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,331&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Licenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,487&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(3,821&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;666&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Distributor relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,250&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(229&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;237,684&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(92,009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;145,675&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Amortization expense was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$16.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$17.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$18.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for fiscal years &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Annual amortization of these intangible assets is expected to approximate the following amounts for each of the next five fiscal years:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:91%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:7%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,555&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,001&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13,842&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,958&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2023&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,507&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2024 and thereafter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;59,447&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;130,310&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
	<us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-7DE4D27FDCB3E7FED0318C8B3CB9C5DA">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Goodwill and Intangible Assets&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Intangible assets other than goodwill and acquired IP R&amp;amp;D are amortized over their estimated useful lives, on either a straight-line basis or proportionately to the benefit being realized.  Useful lives range from &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;two&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;eighteen&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years. The Company periodically reviews the estimated useful lives of intangible assets and reviews such assets for impairment whenever events or changes in circumstances indicate that the carrying value of the asset or asset group is not recoverable.  If an intangible asset or asset group is considered to be impaired, the amount of the impairment will equal the excess of the carrying value over the fair value of the asset.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Goodwill is the amount by which the cost of acquired net assets in a business combination exceeded the fair value of net identifiable assets on the date of purchase.  Goodwill and other intangible assets that have indefinite useful lives are not amortized, but rather, are tested for impairment annually or more frequently if impairment indicators arise. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;For goodwill, the impairment test requires a comparison of the estimated fair value of the reporting unit to which the goodwill is assigned to carrying value of the assets and liabilities of that reporting unit. The determination of reporting units also requires management judgment. The Company considers whether a reporting unit exists within a reportable segment based on the availability of discrete financial information. If carrying value of the reporting unit exceeds the fair value of the reporting unit, the carrying value of the reporting unit&amp;#8217;s goodwill is reduced to its fair value through an adjustment to the goodwill balance, resulting in an impairment charge. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's annual testing for impairment of goodwill was completed as of December 31, 2017. The Company operates as a single operating segment with &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;one&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; reporting unit and consequently evaluates goodwill for impairment based on an evaluation of the fair value of the Company as a whole. The Company determines the fair value of the reporting unit based on the market valuation approach and concluded that it was not more-likely-than-not that the fair value of the Company's reporting unit was less than its carrying value.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
	<us-gaap:IncomeTaxDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-ACA28A96081263CAE0558C8B3CF8A444">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;INCOME TAXES&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The components of income (loss) before income tax (benefit) expense for the years ended May&amp;#160;31 are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:47%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Income (loss) before tax expense:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;U.S.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,274&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,825&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4,444&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-U.S.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,191&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,191&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,465&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,847&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(3,253&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Income tax (benefit) expense is comprised of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:47%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Federal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(148&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;34&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;State and local&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;152&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;141&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;103&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non U.S.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;73&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;270&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;217&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;77&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;411&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;354&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(8,947&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,428&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;39,983&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Income tax (benefit) expense &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(8,870&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,839&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40,337&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Temporary differences that give rise to deferred tax assets and liabilities are summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:61%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:normal;"&gt;May&amp;#160;31,&amp;#160;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:normal;"&gt;May&amp;#160;31,&amp;#160;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred tax assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net operating loss carryforward&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;33,880&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;55,975&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Stock-based compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,421&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,653&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Federal and state R&amp;amp;D tax credit carryforward&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,644&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,548&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Inventories&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,550&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,407&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Expenses incurred not currently deductible&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,714&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,522&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;277&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,289&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Gross deferred tax asset&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;43,486&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;71,394&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred tax liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Excess tax over book depreciation and amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;34,044&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;49,158&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;34,044&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;49,158&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Valuation Allowance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(26,607&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(48,348&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net deferred tax liability &lt;/font&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(17,165&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(26,112&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(1) Net deferred tax liability is inclusive of a non-U.S. &lt;/font&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;$0.08 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt; deferred tax asset that is included in other assets on the Company's balance sheet for the year ended May 31, 2018.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The net deferred tax liability as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; principally relates to tax amortization of intangibles that have an indefinite reversal period for book purposes, also known as a &amp;#8220;naked credit deferred tax liability&amp;#8221;, that cannot be considered as a source of income to recover the deferred tax asset. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's Federal net operating loss carryforwards as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; after considering IRC Section&amp;#160;382 limitations are &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$157.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The expiration of the Federal net operating loss carryforwards are as follows: &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$28.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; between 2018 and 2023 and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$129.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; between 2027 and 2037.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's state net operating loss carryforwards as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; after considering remaining IRC Section&amp;#160;382 limitations are &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$19.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; which expire in various years from 2018 to 2038.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (&amp;#8220;Tax Reform Act&amp;#8221;). The legislation significantly changes U.S. tax law by, among other things, lowering corporate income tax rates, implementing a territorial tax system, expanding the tax base and imposing a tax deemed repatriated earnings of foreign subsidiaries.&amp;#160; The Tax Reform Act permanently reduces the U.S. corporate federal income tax rate from a maximum of 35% to a flat 21% rate, effective January 1, 2018. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company&amp;#8217;s estimated fiscal 2018 blended U.S. federal statutory corporate income tax rate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;28.6%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was applied in the computation of the income tax provision for the year ended May 31, 2018 and represents the average rate between the pre-enactment U.S. federal statutory corporate tax rate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and the post-enactment U.S. federal statutory corporate tax rate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; thereafter.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In December 2017, the Securities and Exchange Commission staff issued Staff Accounting Bulletin No. 118 (SAB 118), which addresses how a company recognizes provisional amounts when a company does not have the necessary information available, prepared or analyzed (including computations) in reasonable detail to complete its accounting for the effect of the changes in the Tax Reform Act. The measurement period ends when a company has obtained, prepared and analyzed the information necessary to finalize its accounting, but cannot extend beyond one year that begins on the date of enactment of December 22, 2017. The Company has elected to apply the measurement period guidance provided in SAB 118. The final impact of the Tax Reform Act may differ from the estimates reported due to, among other things, changes in interpretations and assumptions made by us, additional guidance that may be issued by the U.S. Department of the Treasury and actions that we may take as a result.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company has estimated the provision for incomes taxes in accordance with the Tax Reform Act and guidance available as of the date of this filing and as a result recorded a provisional amount of one-time income tax benefit of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$9.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in the third quarter of fiscal year 2018, the period in which the legislation was enacted.  This estimate has not changed as of May 31, 2018.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Due to various uncertainties as described above, the Company has not completed its accounting for certain tax impacts of the Act.  A discussion of the most significant impacts of tax law changes under the Act for which the accounting is incomplete is as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company is required to record deferred tax assets and liabilities based on the enacted tax rates at which they are expected to reverse in the future.  The Company has remeasured its deferred tax positions as of December 31, 2017 at the new enacted tax rate, resulting in a decrease to it net deferred tax assets and a corresponding decrease to its valuation allowance, with no net impact to tax expense. The Company recorded an income tax benefit of approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$9.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; due to the revaluation of the naked credit deferred tax liability.&lt;/font&gt;&lt;font style="font-family:Arial;font-size:10pt;"&gt;  &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Tax Reform Act changed the NOL carryover rules and created a new limitation on their use.  NOLs created in fiscal 2018 and beyond may be carried forwarded indefinitely in any year. As a result, the Company&amp;#8217;s naked credit deferred tax liability can now be considered as a source of income to recover indefinite lived NOLs.  Consequently, the Company has offset certain of its naked credit deferred tax liability against its deferred tax assets resulting in a reduction in the valuation allowance and a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; benefit in the year ended May 31, 2018.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Tax Reform Act imposes a one-time transition tax on the deemed repatriation of post-1986 undistributed foreign subsidiaries&amp;#8217; earnings. Based on the information available as of December 31, 2017, the Company estimated undistributed foreign earnings of approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The taxable income arising from this deemed repatriation is expected to result in the utilization of net operating loss carryforwards and other tax credits, offset by changes in the valuation allowance, resulting in no net impact to tax expense.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:52px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Tax Reform Act also creates a new requirement that certain income earned by foreign subsidiaries (&amp;#8220;GILTI&amp;#8221;), must be included in U.S. gross income. The FASB allows an accounting policy election of either recognizing deferred taxes for temporary differences expected to reverse as GILTI in future years or recognizing such taxes as a current period expense when incurred.  The Company has not yet adopted an accounting policy.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The other provisions of the Tax Reform Act are not expected to have a material impact on the Company's financial statements.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company regularly assesses its ability to realize its deferred tax assets. Assessing the realization of deferred tax assets requires significant management judgment. In determining whether its deferred tax assets are more likely than not realizable, the Company evaluated all available positive and negative evidence, and weighted the evidence based on its objectivity. Evidence the Company considered included its history of net operating losses, which resulted in the Company recording a full valuation allowance for its deferred tax assets in fiscal 2016 and each year thereafter. The Company was marginally profitable (pretax and adjusted for permanent items) on a cumulative basis for the three years ended May 31, 2018, but substantially all of that profitability was achieved during 2018. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Based on the review of all available evidence, the Company determined that it has not yet attained a sustained level of profitability and the objectively verifiable negative evidence outweighed the positive evidence and therefore the Company has provided a valuation allowance for the full amount, with the exception of the naked credit deferred tax liability, of its net deferred tax asset as of May 31, 2018.  The decrease in the valuation allowance during fiscal 2018 was principally due to the impact of tax reform as discussed above. The Company will continue to assess the level of the valuation allowance required. If sufficient positive evidence exists in future periods to support a release of some or all of the valuation allowance, such a release would likely have a material impact on the Company&amp;#8217;s results of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's consolidated income tax expense has differed from the amount that would be provided by applying the U.S. Federal statutory income tax rate to the Company's income before income taxes for the following reasons:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:50%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Year ended May 31, &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Income tax (benefit) expense at statutory tax rate of 28.6%, 35.0% and 35.0%, respectively&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,136&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,447&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,139&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Effect of graduated tax rates&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(98&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;33&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;State income taxes, net of Federal tax benefit&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;120&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(22&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(215&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Impact of Non-U.S. operations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(288&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;403&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(162&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Research and development tax credit&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(951&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(403&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(499&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Impact of tax reform &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,912&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Meals and entertainment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;242&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;266&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;329&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-deductible interest on contingent payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;174&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;262&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-taxable gain on revaluation of contingent consideration liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5,576&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(170&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Change in valuation allowance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(21,741&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,139&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40,685&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Effect of elimination of stock compensation APIC pool&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,380&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;739&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;IPR&amp;amp;D intangible write-off&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,224&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;700&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;353&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;474&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Income tax (benefit) expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(8,870&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,839&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40,337&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table provides a reconciliation of the beginning and ending amount of unrecognized tax benefits:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:49%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Year ended May 31, &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Unrecognized tax benefits balance at June 1 &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;899&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;899&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Increase in gross amounts of tax positions related to prior years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;899&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Decrease in gross amounts of tax positions related to prior years due to U.S. tax reform&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(287&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Decrease due to lapse in statute of limitations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(148&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Unrecognized tax benefits balance at May 31&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;464&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;899&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;899&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The table above includes unrecognized tax benefits associated with the calculation of limitations placed on the utilization of tax attributes related to an acquired company. If recognized &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; would result in adjustments to other tax accounts. &amp;#160; &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense. There are no accrued interest and penalties recognized in the consolidated balance sheet as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company files income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. In the normal course of business the Company is subject to examination by taxing authorities throughout the world.  Fiscal years 2015 through 2018 remain open to examination by the various tax authorities. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company does not anticipate that the amount of unrecognized tax benefits will significantly change in the next twelve months.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The accumulated undistributed earnings of the Company&amp;#8217;s foreign operations amounted to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; at May 31, 2018 and 2017, respectively. These earnings are considered indefinitely reinvested.  Beginning in 2018, except for GILTI, the Company will no longer record United States federal income tax on its share of the income of its foreign subsidiaries, nor will it record a benefit for foreign tax credits related to that income.&amp;#160; Upon distribution of these earnings in the form of dividends or otherwise, the Company would be subject to withholding taxes payable, where applicable, to foreign countries, but would have no further federal income tax liability.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
	<us-gaap:IncomeTaxPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-CC2CF87EF2371AD16D508C8B3CAA32DF">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Income Taxes&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company calculates income tax expense for each jurisdiction in which it operates. This involves estimating actual current taxes due plus assessing temporary differences arising from differing treatment for tax and accounting purposes that are recorded as deferred tax assets and liabilities. The Company periodically evaluates deferred tax assets, capital loss carryforwards and tax credit carryforwards to determine their recoverability based primarily on the Company's ability to generate future taxable income and capital gains.  Where it is more-likely-than-not these will not be recovered, the Company estimates a valuation allowance and records a corresponding additional tax expense in the consolidated statement of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company recognizes and measures uncertain tax positions taken or expected to be taken in a tax return utilizing a two-step approach. The Company first determines if the weight of available evidence indicates that it is more likely than not that the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is that the Company measures the tax benefit as the largest amount that is more likely than not to be realized upon ultimate settlement. The Company recognizes interest and penalties related to uncertain tax positions in the provision for income taxes on the consolidated statements of operations.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
	<us-gaap:InventoryDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-4E59419C581D8588F86D8C8B3CAA9670">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;INVENTORIES&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, inventories consisted of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:66%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Raw materials&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,678&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;17,563&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Work in process&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,808&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,602&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Finished goods&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,430&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;24,341&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;48,916&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;54,506&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company periodically reviews its inventory for both obsolescence and loss of value.  The Company makes assumptions about the future demand for and market value of the inventory.  Based on these assumptions, the Company estimates the amount of obsolete, expiring and slow moving inventory.  The total inventory reserve at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$6.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively.  Of the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$6.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; reserve at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; relates to the inventory reserve for Acculis inventory as a result of the recall announced in the fourth quarter of fiscal year 2017 and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; relates to a specific reserve related to the termination of an agreement with a Japanese distributor in the second quarter of fiscal year 2018.  Of the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in the prior year, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; relates to the reserve for Acculis inventory.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
	<us-gaap:InventoryPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-6C13B09C604A8C45D6DB8C8B3CC9D111">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Inventories&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Inventories are stated at the lower of cost (using the first-in, first-out method) or market. Appropriate consideration is given to deterioration, obsolescence, expiring and other factors in evaluating net realizable value.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
	<us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock contextRef="FD2018Q4YTD" id="Fact-9B263B3411FC31B770F48C8B3CE8A5FB">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The amortized cost and fair value of marketable securities as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, by contractual maturity, are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:67%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Amortized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of May&amp;#160;31, 2018:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Due in one year or less&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Due after one through five years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Due after five through twenty years &lt;/font&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,350&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,317&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,350&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,317&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1)  This auction rate security represents investments available for current operations and are classified as current in the consolidated balance sheets.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
	<us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-AE643302D5097141725F8C8B3CE85226">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;MARKETABLE SECURITIES &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, marketable securities consisted of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Amortized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Gains&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Losses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Available-for-sales securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;New York State government agency obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,350&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(33&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,317&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,350&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(33&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,317&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, marketable securities consisted of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Amortized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Gains&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Losses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Available-for-sales securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;New York State government agency obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,350&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(135&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,215&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,350&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(135&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,215&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The amortized cost and fair value of marketable securities as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, by contractual maturity, are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:67%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Amortized&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of May&amp;#160;31, 2018:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Due in one year or less&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Due after one through five years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Due after five through twenty years &lt;/font&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,350&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,317&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,350&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,317&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1)  This auction rate security represents investments available for current operations and are classified as current in the consolidated balance sheets.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
	<us-gaap:LongTermDebtTextBlock contextRef="FD2018Q4YTD" id="Fact-B2B17A11D223EE6E0A1E8C8B3D36357D">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;LONG-TERM DEBT&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On November 7, 2016, the Company entered into a Credit Agreement with the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, Bank of America, N.A. and Keybank National Association as co-syndication agents, and JPMorgan Chase Bank, N.A., Merrill Lynch, Pierce, Fenner &amp;amp; Smith Incorporated and Keybank National Association as joint bookrunners and joint lead arrangers.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Credit Agreement provides for a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$100.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; senior secured term loan facility and a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$150.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; senior secured revolving credit facility, which includes up to a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$20.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; sublimit for letters of credit and a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; sublimit for swingline loans.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On November 7, 2016, the Company borrowed &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$100.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; under the Term Loan and approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$16.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; under the Revolving Facility to repay the balance of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$116.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; under the former credit agreement.  As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; the carrying value of long-term debt approximates its fair market value.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The proceeds of the Revolving Facility may be used for general corporate purposes of the Company and its subsidiaries. The Facilities have a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;five&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; year maturity.&amp;#160; Interest on both the Term Loan and Revolving Facility are based on a base rate or Eurodollar rate plus an applicable margin which increases as total leverage ratio increases, with the base rate and Eurodollar rate having ranges of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.50%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.25%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.50%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.25%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; respectively.  In case of default, the interest rate may be increased by &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.0%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&amp;#160;The Revolving Facility carries a commitment fee of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.20%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.35%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;per annum on the unused portion.  The interest rate on the Term Loan at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.41%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's obligations under the Facilities are unconditionally guaranteed, jointly and severally, by the Company's material direct and indirect domestic subsidiaries (the &amp;#8220;Guarantors&amp;#8221;). All obligations of the Company and the Guarantors under the Facilities are secured by first priority security interests in substantially all of the assets of the Company and the Guarantors.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Credit Agreement includes customary representations, warranties and covenants, and acceleration, indemnity and events of default provisions, including, among other things, two quarterly financial covenants as follows:&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:48px;padding-top:16px;text-indent:32px;"&gt;&lt;font style="padding-top:16px;font-family:inherit;font-size:10pt;padding-right:16px;"&gt;&amp;#8226;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;maximum leverage ratio of consolidated total indebtedness* to consolidated EBITDA* of not greater than &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.50&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.00&lt;/font&gt;&lt;font style="font-family:inherit;font-size:11pt;"&gt; &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(during certain periods following material acquisitions shall be increased to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.75&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to 1.00). &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:48px;padding-top:16px;text-indent:32px;"&gt;&lt;font style="padding-top:16px;font-family:inherit;font-size:10pt;padding-right:16px;"&gt;&amp;#8226;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; fixed charge coverage ratio of consolidated EBITDA minus consolidated capital expenditures to&amp;#160;consolidated interest expense paid or payable in cash plus scheduled principal payments in respect of indebtedness under the Credit Agreement of not less than &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.25&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.00&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;* The definitions of consolidated total indebtedness and consolidated EBITDA are maintained in the credit agreement included as an exhibit to Form 8-k filed on November 10, 2016 and in Amendment One, dated May 24, 2018 and included as an exhibit to the fiscal 2018 Form 10-K. This amendment increased the amount of U.S. cash that can be utilized to calculate net debt from &lt;/font&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;$10.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;$20.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company was in compliance with both covenants as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's maturities of principal obligations under the credit agreement are as follows, as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:90%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,250&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;68,750&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total term loan&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;92,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Revolving facility&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total debt&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;92,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Less: Unamortized debt issuance costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(879&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;91,621&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Less: Current portion of long-term debt&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total long-term debt, net of current portion&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;86,621&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
	<us-gaap:MarketableSecuritiesPolicy contextRef="FD2018Q4YTD" id="Fact-D9C6CFE21A6E92568B738C8B3C9A9652">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Marketable Securities&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Marketable securities, which include auction rate investments, are classified as &amp;#8220;available-for-sale securities&amp;#8221; and are reported at fair value, with unrealized gains and losses excluded from operations and reported as a component of accumulated other comprehensive income (loss), net of the related tax effects, in stockholders&amp;#8217; equity. Cost is determined using the specific identification method. The Company holds an investment in auction rate securities in order to generate higher than typical money market rate investment returns. Auction rate securities typically are high credit quality, generally achieved with municipal bond insurance. &lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesPolicy>
	<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-D54A2FE3EAB8AF1286ED8C8B3CE8B450">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table provides a description of recent accounting pronouncements that may have a material effect on the Company's consolidated financial statements:  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:22%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:34%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:33%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Recently Issued Accounting Pronouncements - Adopted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Standard&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Description&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Date Adopted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Effect on the Consolidated Financial Statements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ASU 2016-09, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Compensation - Stock Based Compensation (Topic 718: Improvements to Employee Share-Based Payment Accounting)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This ASU simplifies and improves various aspects of ASC 718 for share-based payments, including income tax items and the classification of these items on the statement of cash flows.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;June 1, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company now recognizes unrealized excess tax benefits and will classify such benefits as an operating activity in the statement of cash flows on a prospective basis. Due to the full valuation allowance on our federal and state income taxes, the adoption of ASU 2016-09 did not impact our accounting for income taxes.                  &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company elected the accounting policy change to account for forfeitures as they occur.  This was adopted using the modified retrospective transition method by means of a cumulative-effect adjustment to equity as of June 1, 2017.  The adoption of ASU 2016-09 did not materially impact the Company's consolidated statements of income, consolidated balance sheet, equity or cash flows. &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ASU 2017-04, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Intangibles - Goodwill and Other (Topic 350)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This ASU simplifies the subsequent measurement of goodwill by eliminating steps from the goodwill impairment test.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;June 1, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This adoption did not have an impact on the Company's financial statements.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ASC Update No. 2015-11, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Inventory (Topic 330): Simplifying the Measurement of Inventory&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. Update No. 2015-11&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This ASU more closely aligns the measurement of inventory in U.S. GAAP with the measurement of inventory in International Financial Reporting Standards by requiring companies using the first-in, first-out and average costs methods to measure inventory using the lower of cost and net realizable value, where net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;June 1, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This adoption did not have an impact on the Company's financial statements.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:22%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:34%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:33%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Recently Issued Accounting Pronouncements - Not Yet Applicable or Adopted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Standard&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Description&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Effective Date&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Effect on the Consolidated Financial Statements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ASU No. 2014-09, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Revenue from Contracts with Customers (Topic 606, ASU 2014-09)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Under Topic 606, an entity is required to recognize revenue upon transfer of promised goods or services to customers in an amount that reflects the expected consideration to be received in exchange for those goods or services. Topic 606 defines a five-step process in order to achieve this core principle, which may require the use of judgment and estimates, and also requires expanded qualitative and quantitative disclosures relating to the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers, including significant judgments and estimates used. The new standard also defines accounting for certain costs related to origination and fulfillment of contracts with customers, including whether such costs should be capitalized. &lt;/font&gt;&lt;/div&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;June 1, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="padding-bottom:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company established an implementation team which included third-party specialists to assist in the evaluation and implementation of the new standard. The Company&amp;#8217;s assessment has included performing analysis for each revenue stream identified, assessing the potential differences in recognition and measurement that may result from adopting this standard and assessing whether the Company meets certain practical expedients. Based on the results of the assessment, the adoption of this standard will not have a material impact on the timing or amount of revenue recognized upon adoption and there is no cumulative prior period adjustment to be recorded to the opening balance of retained earnings upon adoption.  The Company will adopt the standard using the modified retrospective method. The Company is implementing changes to accounting policies, business processes and internal controls to support the new standard as necessary. Upon adoption of Topic 606, as the disclosure requirements under the new guidance have been significantly expanded in comparison to the disclosure requirements under the current guidance, we will provide additional disclosures in the notes to the consolidated financial statements, specifically related to performance obligations, the judgments made in revenue recognition determinations, costs to obtain or fulfill contracts and contract balances.&lt;/font&gt;&lt;/div&gt;&lt;div style="padding-bottom:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ASU No. 2016-15, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (ASU 2016-15)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This ASU identifies how certain cash receipts and cash payments are presented and classified in the Statement of Cash Flows under Topic 230.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;June 1, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This adoption is not expected to have a material impact on the Company's financial statements.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ASU 2016-02, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Leases (Topic 842)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This ASU increases transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet and disclosing key information about leasing arrangements.  For leases with a term of twelve months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and liabilities.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;June 1, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company is currently in the process of evaluating the impact of this ASU on its consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
	<us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="FD2018Q4YTD" id="Fact-B904B47928ED01C62BB68C8B3C9ACB70">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:12px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;BASIS OF PRESENTATION, BUSINESS DESCRIPTION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Basis of Presentation and Description of Business&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The consolidated financial statements include the accounts of AngioDynamics, Inc. and its wholly owned subsidiaries,  (collectively, the &amp;#8220;Company&amp;#8221;).  The Company designs, manufactures and sells a wide range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and in oncology and surgical settings. The devices are generally used in minimally invasive, image-guided procedures. Most of the Company's products are intended to be used once and then discarded, or they may be temporarily implanted for short- or long-term use. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Accounting Principles&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The consolidated financial statements and accompanying notes have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP").&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Principles of Consolidation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The consolidated financial statements include the accounts of AngioDynamics and it subsidiaries (all of which are wholly owned).  All intercompany balances and transactions have been eliminated.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Use of Estimates&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The preparation of financial statements, in conformity with accounting principles generally accepted in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect reported amounts of sales and expenses during the reporting period. Actual results could differ from those estimates.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Cash and Cash Equivalents&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company considers all unrestricted highly liquid investments with an initial maturity of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;less than three months&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; at the date of purchase to be cash equivalents. The Company maintains cash and cash equivalent balances with financial institutions in the United States in excess of amounts insured by the Federal Deposit Insurance Corporation.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Marketable Securities&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Marketable securities, which include auction rate investments, are classified as &amp;#8220;available-for-sale securities&amp;#8221; and are reported at fair value, with unrealized gains and losses excluded from operations and reported as a component of accumulated other comprehensive income (loss), net of the related tax effects, in stockholders&amp;#8217; equity. Cost is determined using the specific identification method. The Company holds an investment in auction rate securities in order to generate higher than typical money market rate investment returns. Auction rate securities typically are high credit quality, generally achieved with municipal bond insurance.  As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company had &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, in an auction rate security issued by a local government authority. The authority is current in its interest payments on the security.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Fair Value Instruments&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The carrying amount of the Company's cash and cash equivalents, accounts receivable, accounts payable and long-term debt approximates fair value due to the short-term nature or market interest rates of these items. The Company bases the fair value of short-term investments on quoted market prices or other relevant information generated by market transactions involving identical or comparable assets. The Company measures and records derivative financial instruments at fair value. See Note 3 for further discussion of financial instruments that are carried at fair value on a recurring and nonrecurring basis.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Accounts Receivable&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accounts receivable, principally trade receivables, are generally due within &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;30&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;90&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; days and are stated at amounts due from customers, net of an allowance for estimated sales returns and doubtful accounts. The Company performs ongoing credit evaluations of customers and adjusts credit limits based upon payment history and the customer&amp;#8217;s current creditworthiness, as determined by a review of their current credit information. The Company continuously monitors aging reports, collections and payments from customers, and a provision for estimated credit losses is maintained based upon historical experience and any specific customer collection issues that have been identified. While such credit losses have historically been within expectations and the provisions established, the Company cannot guarantee that the same credit loss rates will be experienced in the future. The Company writes off accounts receivable when they are determined to be uncollectible.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Inventories&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Inventories are stated at the lower of cost (using the first-in, first-out method) or market. Appropriate consideration is given to deterioration, obsolescence, expiring and other factors in evaluating net realizable value.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Property, Plant and Equipment&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:24px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Property, plant and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets.  Refer below for useful lives by category:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="3" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:79%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:20%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Estimated useful lives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Building and building improvements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;39 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Machinery and equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5 to 8 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Computer software and equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3 to 5 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:24px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company evaluates property, plant and equipment for impairment periodically to determine if changes in circumstances or the occurrence of events suggest the carrying value of the asset or asset group may not be recoverable. Expenditures for repairs and maintenance are charged to expense as incurred. Renewals and betterments are capitalized.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Goodwill and Intangible Assets&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Intangible assets other than goodwill and acquired IP R&amp;amp;D are amortized over their estimated useful lives, on either a straight-line basis or proportionately to the benefit being realized.  Useful lives range from &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;two&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;eighteen&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years. The Company periodically reviews the estimated useful lives of intangible assets and reviews such assets for impairment whenever events or changes in circumstances indicate that the carrying value of the asset or asset group is not recoverable.  If an intangible asset or asset group is considered to be impaired, the amount of the impairment will equal the excess of the carrying value over the fair value of the asset.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Goodwill is the amount by which the cost of acquired net assets in a business combination exceeded the fair value of net identifiable assets on the date of purchase.  Goodwill and other intangible assets that have indefinite useful lives are not amortized, but rather, are tested for impairment annually or more frequently if impairment indicators arise. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;For goodwill, the impairment test requires a comparison of the estimated fair value of the reporting unit to which the goodwill is assigned to carrying value of the assets and liabilities of that reporting unit. The determination of reporting units also requires management judgment. The Company considers whether a reporting unit exists within a reportable segment based on the availability of discrete financial information. If carrying value of the reporting unit exceeds the fair value of the reporting unit, the carrying value of the reporting unit&amp;#8217;s goodwill is reduced to its fair value through an adjustment to the goodwill balance, resulting in an impairment charge. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's annual testing for impairment of goodwill was completed as of December 31, 2017. The Company operates as a single operating segment with &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;one&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; reporting unit and consequently evaluates goodwill for impairment based on an evaluation of the fair value of the Company as a whole. The Company determines the fair value of the reporting unit based on the market valuation approach and concluded that it was not more-likely-than-not that the fair value of the Company's reporting unit was less than its carrying value.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Contingent Consideration&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The fair value of the liability for contingent consideration recorded on the acquisition date for a business combination is based on probability weighted estimated cash flow streams, discounted back to present value using a discount rate determined in accordance with accepted valuation methods and reflective of the risk associated with the estimated cash flow streams. The liability for contingent consideration is remeasured to fair value at each reporting period with changes recorded in earnings until the contingency is resolved.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Revenue Recognition&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company recognizes revenue when the following four criteria has been met: (i)&amp;#160;persuasive evidence that an arrangement exists; (ii)&amp;#160;the price is fixed or determinable; (iii)&amp;#160;collectability is reasonably assured; and (iv)&amp;#160;product delivery has occurred or services have been rendered. The Company recognizes revenue, net of sales taxes assessed by any governmental authority, as products are shipped, based on shipping terms, and when title and risk of loss passes to customers. The Company negotiates shipping and credit terms on a customer-by-customer basis and products are shipped at an agreed upon price. All product returns must be pre-approved by the Company and customers may be subject to a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;20%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; restocking charge. To be accepted, a returned product must be unadulterated, undamaged and have at least &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;twelve months&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; remaining prior to its expiration date.  Charges for discounts, returns, rebates and other allowances are recognized as a deduction from revenue on an accrual basis in the period in which the revenue is recorded. The accrual for product returns, discounts and other allowances is based on the Company&amp;#8217;s history. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Shipping and handling costs, associated with the distribution of finished products to customers, are recorded in costs of goods sold and are recognized when the related finished product is shipped to the customer. Amounts charged to customers for shipping are recorded in net sales.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Research and Development&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Research and development costs, including salaries, consulting fees, building costs, utilities and administrative expenses that are related to developing new products, enhancing existing products, validating new and enhanced products, managing clinical, regulatory and medical affairs are expensed as incurred.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Income Taxes&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company calculates income tax expense for each jurisdiction in which it operates. This involves estimating actual current taxes due plus assessing temporary differences arising from differing treatment for tax and accounting purposes that are recorded as deferred tax assets and liabilities. The Company periodically evaluates deferred tax assets, capital loss carryforwards and tax credit carryforwards to determine their recoverability based primarily on the Company's ability to generate future taxable income and capital gains.  Where it is more-likely-than-not these will not be recovered, the Company estimates a valuation allowance and records a corresponding additional tax expense in the consolidated statement of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company recognizes and measures uncertain tax positions taken or expected to be taken in a tax return utilizing a two-step approach. The Company first determines if the weight of available evidence indicates that it is more likely than not that the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is that the Company measures the tax benefit as the largest amount that is more likely than not to be realized upon ultimate settlement. The Company recognizes interest and penalties related to uncertain tax positions in the provision for income taxes on the consolidated statements of operations.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Warranty Costs&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company makes periodic provisions for expected warranty costs. Historically, warranty costs have been insignificant.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Stock Based Compensation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Stock-based compensation expense reflects the fair value of stock-based awards measured at the grant date and recognized over the relevant service period. The Company estimates the fair value of each stock-based award on the measurement date using either the current market price of the stock, the Black-Scholes option valuation model, or the Monte Carlo Simulation valuation model. The Black-Scholes and Monte Carlo Simulation valuation models incorporate assumptions as to stock price volatility, the expected life of options or restricted stock units, a risk-free interest rate and dividend yield. The Company recognizes stock-based compensation expense related to options, restricted stock units and market based performance stock units on a straight-line basis over the service period of the award, which is generally &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years for options and restricted stock units and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years for market based performance stock units.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Foreign Currency Translation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The functional currency of the Company's foreign subsidiaries is the local currency in which the subsidiary operates. For foreign operations where the local currency is considered to be the functional currency, the Company translates assets and liabilities into U.S. dollars at the exchange rate on the balance sheet date. The Company translates income and expense items at average rates of exchange prevailing during each period. The Company accumulates translation adjustments in accumulated other comprehensive loss, a component of stockholders&amp;#8217; equity.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Transaction gains or losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in other expense in the statements of operations as incurred.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Derivative Financial Instruments&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company is exposed to market risks, including changes in foreign currency and interest rates. The Company periodically enters into certain derivative financial instruments to hedge the underlying economic exposure. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Derivative instruments are presented in the consolidated financial statements at their fair value. Changes in the fair value of derivative financial instruments are either recognized periodically in income or in stockholders&amp;#8217; equity as a component of accumulated other comprehensive income (loss) depending on whether the derivative financial instrument qualifies for hedge accounting and, if so, whether it qualifies as a fair value or cash flow hedge. Generally, the changes in the fair value of derivatives accounted for as fair value hedges are recorded in income along with the portions of the changes in the fair value of hedged items that relate to the hedged risks. Changes in the fair value of derivatives accounted for as cash flow hedges, to the extent they are effective as hedges, are recorded in accumulated other comprehensive income (loss).&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Contingencies&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company is subject to various legal proceedings that arise in the ordinary course of business, including patent infringement and product liability matters. The Company records accruals for contingencies when it is probable the liability has been incurred and the amount can be reasonably estimated.  Legal fees are expensed as incurred. Insurance recoveries related to potential claims are recognized up to the amount of the recorded liability when coverage is confirmed and the estimated recoveries are probable of payment. These recoveries are not netted against the related liabilities for financial statement presentation.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table provides a description of recent accounting pronouncements that may have a material effect on the Company's consolidated financial statements:  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:22%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:34%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:33%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Recently Issued Accounting Pronouncements - Adopted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Standard&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Description&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Date Adopted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Effect on the Consolidated Financial Statements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ASU 2016-09, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Compensation - Stock Based Compensation (Topic 718: Improvements to Employee Share-Based Payment Accounting)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This ASU simplifies and improves various aspects of ASC 718 for share-based payments, including income tax items and the classification of these items on the statement of cash flows.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;June 1, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company now recognizes unrealized excess tax benefits and will classify such benefits as an operating activity in the statement of cash flows on a prospective basis. Due to the full valuation allowance on our federal and state income taxes, the adoption of ASU 2016-09 did not impact our accounting for income taxes.                  &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company elected the accounting policy change to account for forfeitures as they occur.  This was adopted using the modified retrospective transition method by means of a cumulative-effect adjustment to equity as of June 1, 2017.  The adoption of ASU 2016-09 did not materially impact the Company's consolidated statements of income, consolidated balance sheet, equity or cash flows. &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ASU 2017-04, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Intangibles - Goodwill and Other (Topic 350)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This ASU simplifies the subsequent measurement of goodwill by eliminating steps from the goodwill impairment test.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;June 1, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This adoption did not have an impact on the Company's financial statements.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ASC Update No. 2015-11, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Inventory (Topic 330): Simplifying the Measurement of Inventory&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. Update No. 2015-11&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This ASU more closely aligns the measurement of inventory in U.S. GAAP with the measurement of inventory in International Financial Reporting Standards by requiring companies using the first-in, first-out and average costs methods to measure inventory using the lower of cost and net realizable value, where net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;June 1, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This adoption did not have an impact on the Company's financial statements.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:22%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:34%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:33%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Recently Issued Accounting Pronouncements - Not Yet Applicable or Adopted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Standard&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Description&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Effective Date&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Effect on the Consolidated Financial Statements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ASU No. 2014-09, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Revenue from Contracts with Customers (Topic 606, ASU 2014-09)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Under Topic 606, an entity is required to recognize revenue upon transfer of promised goods or services to customers in an amount that reflects the expected consideration to be received in exchange for those goods or services. Topic 606 defines a five-step process in order to achieve this core principle, which may require the use of judgment and estimates, and also requires expanded qualitative and quantitative disclosures relating to the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers, including significant judgments and estimates used. The new standard also defines accounting for certain costs related to origination and fulfillment of contracts with customers, including whether such costs should be capitalized. &lt;/font&gt;&lt;/div&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;June 1, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="padding-bottom:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company established an implementation team which included third-party specialists to assist in the evaluation and implementation of the new standard. The Company&amp;#8217;s assessment has included performing analysis for each revenue stream identified, assessing the potential differences in recognition and measurement that may result from adopting this standard and assessing whether the Company meets certain practical expedients. Based on the results of the assessment, the adoption of this standard will not have a material impact on the timing or amount of revenue recognized upon adoption and there is no cumulative prior period adjustment to be recorded to the opening balance of retained earnings upon adoption.  The Company will adopt the standard using the modified retrospective method. The Company is implementing changes to accounting policies, business processes and internal controls to support the new standard as necessary. Upon adoption of Topic 606, as the disclosure requirements under the new guidance have been significantly expanded in comparison to the disclosure requirements under the current guidance, we will provide additional disclosures in the notes to the consolidated financial statements, specifically related to performance obligations, the judgments made in revenue recognition determinations, costs to obtain or fulfill contracts and contract balances.&lt;/font&gt;&lt;/div&gt;&lt;div style="padding-bottom:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ASU No. 2016-15, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (ASU 2016-15)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This ASU identifies how certain cash receipts and cash payments are presented and classified in the Statement of Cash Flows under Topic 230.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;June 1, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This adoption is not expected to have a material impact on the Company's financial statements.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ASU 2016-02, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Leases (Topic 842)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This ASU increases transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet and disclosing key information about leasing arrangements.  For leases with a term of twelve months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and liabilities.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;June 1, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company is currently in the process of evaluating the impact of this ASU on its consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
	<us-gaap:OtherAssetsDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-696634FF10DE5E58415A8C8B3CD96986">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;OTHER ASSETS&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In 2015, the Company filed an 8-K stating that it executed a non-binding letter of intent to enter into a strategic relationship with privately-held EmboMedics Inc., which develops injectable and resorbable embolic microspheres. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company made an initial &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; purchase of non-transferable warrants in a subsidiary of EmboMedics which become exercisable upon a change of control of EmboMedics.  The Company did not have significant influence, or control of the subsidiary.  This initial investment was recorded at cost and the Company reviewed for impairment at each balance sheet date. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In the second quarter of fiscal year 2017, the Company decided to terminate its agreements with EmboMedics.  The termination of these agreements resulted in a write-off of the initial &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; investment in EmboMedics which is included in acquisition, restructuring and other items, net on the consolidated statements of operations.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:OtherAssetsDisclosureTextBlock>
	<us-gaap:OtherCommitmentsTableTextBlock contextRef="FD2018Q4YTD" id="Fact-7382BFAC4DF7F351C4838C8B3D276ED8">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes the Company's other future commitments and contingencies as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="24" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:41%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:7%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:7%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:7%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:7%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:7%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:7%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2023 and thereafter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Purchase obligations (1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;56,201&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,751&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,243&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,485&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,189&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,533&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Royalties&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;45,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;31,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;667&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;167&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;167&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;167&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;166&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;101,868&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,918&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;17,910&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,152&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,855&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;37,033&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:36px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:0px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The non-cancelable inventory purchase obligations are not reflected on our consolidated balance sheets under accounting principles generally accepted in the United States of America.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherCommitmentsTableTextBlock>
	<us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-2A62515ADECD96EEFB3B8C8B3CF81BD6">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;RETIREMENT PLANS&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company has a 401(k) plan under which eligible employees can defer a portion of their compensation, part of which is matched by the Company. Matching contributions were &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively. There are also various immaterial foreign retirement plans.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
	<us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-665FABB954CF5A22485A8C8B3CD99931">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;PROPERTY, PLANT AND EQUIPMENT, NET&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, property, plant and equipment are summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:64%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Building and building improvements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;39,887&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40,597&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Machinery and equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;22,668&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25,434&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Computer software and equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;24,899&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25,668&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Construction in progress&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,153&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,464&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;89,607&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;93,163&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Less accumulated depreciation and amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(48,794&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(49,652&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40,813&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;43,511&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Land and land improvements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,648&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,723&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;42,461&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;45,234&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Depreciation expense for fiscal &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$6.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$8.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
	<us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-998F9C531EF790D5E8188C8B3CB90AB3">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Property, Plant and Equipment&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:24px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Property, plant and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets.  Refer below for useful lives by category:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="3" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:79%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:20%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Estimated useful lives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Building and building improvements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;39 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Machinery and equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5 to 8 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Computer software and equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3 to 5 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:24px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company evaluates property, plant and equipment for impairment periodically to determine if changes in circumstances or the occurrence of events suggest the carrying value of the asset or asset group may not be recoverable. Expenditures for repairs and maintenance are charged to expense as incurred. Renewals and betterments are capitalized.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
	<us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="FD2018Q4YTD" id="Fact-5F9EB8866246BE6BE53D8C8B3CB9BB1C">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:24px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Refer below for useful lives by category:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="3" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:79%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:20%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Estimated useful lives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Building and building improvements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;39 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Machinery and equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5 to 8 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Computer software and equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3 to 5 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, property, plant and equipment are summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:64%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Building and building improvements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;39,887&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40,597&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Machinery and equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;22,668&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25,434&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Computer software and equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;24,899&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25,668&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Construction in progress&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,153&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,464&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;89,607&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;93,163&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Less accumulated depreciation and amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(48,794&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(49,652&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40,813&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;43,511&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Land and land improvements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,648&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,723&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;42,461&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;45,234&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
	<us-gaap:QuarterlyFinancialInformationTextBlock contextRef="FD2018Q4YTD" id="Fact-428A7E2935946F5F8C288C8B3D272CA0">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;QUARTERLY INFORMATION (unaudited)&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Quarterly results of operations during the fiscal years ended May 31, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:41%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;First&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Second&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Third&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fourth&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands, except per share data)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net sales&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;85,411&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;86,706&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;83,851&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;88,317&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Gross profit&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;41,229&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;42,731&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;45,448&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;47,467&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net income (loss) &lt;/font&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(35&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;249&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,102&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Earnings (loss) per common share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.01&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.38&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.06&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.01&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.37&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.06&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:41%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;First&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Second&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Third&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fourth&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands, except per share data)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net sales&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;88,098&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;89,029&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;85,602&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;86,914&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Gross profit&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;45,032&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;45,010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;43,792&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;42,335&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net income (loss) &lt;/font&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,300&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13,734&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,887&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(12,913&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Earnings (loss) per common share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.04&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.37&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.08&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.35&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.04&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.37&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.08&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.35&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1) Included within net income during the third quarter of fiscal 2018 is a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$9.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; discrete tax benefit as a result of the Tax Reform Act and the revaluation of the Company's deferred tax assets, liabilities and valuation allowance to reflect the lower U.S. federal statutory rate (see Note 9).&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2) Included within net income (loss) during the fourth quarter of fiscal 2017 is the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$12.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; charge for a litigation reserve (see Note 15) and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; impact relating to the Acculis recall (see Note 10).  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The data in the schedules above has been intentionally rounded to the nearest thousand and therefore the quarterly&amp;#160;&amp;#160;&amp;#160;&amp;#160; amounts may not sum to the full year amounts.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
	<us-gaap:ReceivablesPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-413CE41C0CBE66E993398C8B3CAA5456">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Accounts Receivable&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accounts receivable, principally trade receivables, are generally due within &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;30&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;90&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; days and are stated at amounts due from customers, net of an allowance for estimated sales returns and doubtful accounts. The Company performs ongoing credit evaluations of customers and adjusts credit limits based upon payment history and the customer&amp;#8217;s current creditworthiness, as determined by a review of their current credit information. The Company continuously monitors aging reports, collections and payments from customers, and a provision for estimated credit losses is maintained based upon historical experience and any specific customer collection issues that have been identified. While such credit losses have historically been within expectations and the provisions established, the Company cannot guarantee that the same credit loss rates will be experienced in the future. The Company writes off accounts receivable when they are determined to be uncollectible.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
	<us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="FD2018Q4YTD" id="Fact-3D6E42546D89059764358C8B3CAA343F">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Research and Development&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Research and development costs, including salaries, consulting fees, building costs, utilities and administrative expenses that are related to developing new products, enhancing existing products, validating new and enhanced products, managing clinical, regulatory and medical affairs are expensed as incurred.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
	<us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-9DC1B35DA376A3EFF9758C8B3D275510">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;ACQUISITION, RESTRUCTURING AND OTHER ITEMS, NET&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;For the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; acquisition, restructuring and other items, net consisted of:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:47%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Year ended May 31, &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Legal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,067&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,480&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,487&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Intangible and other asset impairment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,604&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;352&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Restructuring&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,674&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,348&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,462&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;691&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,078&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,290&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,432&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;27,510&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,591&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Of the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$19.5&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; million in legal for fiscal year 2017, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$12.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; relates to a reserve for DOJ litigation settlement (see Note 15) and the remaining legal expenses relates to DOJ matters.  The remaining legal expenses relate to litigation that is outside of the normal course of business. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Restructuring&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company evaluates its performance and looks for opportunities to improve the overall operations of the Company on an ongoing basis.  As a result of this evaluation, certain restructuring initiatives are taken to enhance the Company&amp;#8217;s overall operations.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Operational Consolidation &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On February 1, 2017, the Company announced to employees an operational consolidation plan (the &amp;#8220;plan&amp;#8221;) to consolidate manufacturing facilities in Manchester, GA and Denmead, UK into the Glens Falls and Queensbury, NY facilities.  This plan will streamline and optimize the manufacturing functions into one centralized location increasing the utilization of the Glens Falls and Queensbury facilities, optimizing inventory and reducing cost of goods sold through savings in overhead expenses and direct labor.  The restructuring activities associated with the plan were completed in the fourth quarter of fiscal year 2018 with immaterial validation costs to be incurred in the first quarter of fiscal year 2019.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company recorded restructuring charges related to the plan during the year ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively.  Total restructuring charges recorded as part of the plan were &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$6.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  Termination benefits are only earned if an employee stays until their termination date; therefore, the expenses related to termination benefits are being recorded ratably over the service period.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table presents a rollforward of the restructuring reserve for the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="25" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:25%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Contract&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Termination&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Plant &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Regulatory&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Cancellation &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Consolidation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Filings&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Total &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at May 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Charges&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;851&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;494&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,348&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-cash adjustments &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(108&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(108&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cash payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(275&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(278&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at May 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;851&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;111&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;962&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Charges&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,440&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,892&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;68&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;200&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;74&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,674&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-cash adjustments &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(276&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(276&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cash payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,453&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2,706&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(56&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(74&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4,289&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;838&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;200&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,071&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company&amp;#8217;s restructuring liability of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; is mainly comprised of accruals for termination benefits which are expected to be paid in the next twelve months and are included in accrued expenses on the consolidated balance sheet.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
	<us-gaap:RevenueRecognitionPolicyTextBlock contextRef="FD2018Q4YTD" id="Fact-3440AC132C6D4733668C8C8B3CD96FA0">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Revenue Recognition&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company recognizes revenue when the following four criteria has been met: (i)&amp;#160;persuasive evidence that an arrangement exists; (ii)&amp;#160;the price is fixed or determinable; (iii)&amp;#160;collectability is reasonably assured; and (iv)&amp;#160;product delivery has occurred or services have been rendered. The Company recognizes revenue, net of sales taxes assessed by any governmental authority, as products are shipped, based on shipping terms, and when title and risk of loss passes to customers. The Company negotiates shipping and credit terms on a customer-by-customer basis and products are shipped at an agreed upon price. All product returns must be pre-approved by the Company and customers may be subject to a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;20%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; restocking charge. To be accepted, a returned product must be unadulterated, undamaged and have at least &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;twelve months&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; remaining prior to its expiration date.  Charges for discounts, returns, rebates and other allowances are recognized as a deduction from revenue on an accrual basis in the period in which the revenue is recorded. The accrual for product returns, discounts and other allowances is based on the Company&amp;#8217;s history. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Shipping and handling costs, associated with the distribution of finished products to customers, are recorded in costs of goods sold and are recognized when the related finished product is shipped to the customer. Amounts charged to customers for shipping are recorded in net sales.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
	<us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="FD2018Q4YTD" id="Fact-E68AEFC2EA6C5D3DFB7B8C8B3CF8DA69">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, accrued liabilities consist of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May&amp;#160;31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Payroll and related expenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,235&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,383&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Royalties&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,537&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,885&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued severance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,940&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,075&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Sales and franchise taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;683&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;856&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Outside services&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,396&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,622&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Litigation matters (Note 15)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acculis recall liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,563&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,135&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,920&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;34,426&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;38,804&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
	<us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="FD2018Q4YTD" id="Fact-71ACF43DD28B036190F88C8B3CC9933C">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:24px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Changes in each component of accumulated other comprehensive income (loss), net of tax, are as follows for fiscal &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:64%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Foreign currency translation gain (loss)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Unrealized gain (loss) on marketable securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at May 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(760&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(31&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(791&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other comprehensive income (loss) before reclassifications, net of tax&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(545&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(533&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Amounts reclassified from accumulated other comprehensive income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net other comprehensive income (loss)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(545&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(533&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at May 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,305&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(19&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,324&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other comprehensive income before reclassifications, net of tax&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;270&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;102&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;372&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Amounts reclassified from accumulated other comprehensive income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net other comprehensive income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;270&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;102&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;372&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,035&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;83&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(952&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
	<us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="FD2018Q4YTD" id="Fact-CF572DB96465C50F48538C8B3CF82E84">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Income tax (benefit) expense is comprised of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:47%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Current&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Federal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(148&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;34&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;State and local&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;152&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;141&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;103&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non U.S.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;73&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;270&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;217&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;77&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;411&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;354&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(8,947&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,428&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;39,983&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Income tax (benefit) expense &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(8,870&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,839&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40,337&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
	<us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="FD2018Q4YTD" id="Fact-F3A23BA97AAB58C98AE28C8B3CF8BFE8">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Temporary differences that give rise to deferred tax assets and liabilities are summarized as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:61%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:normal;"&gt;May&amp;#160;31,&amp;#160;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:normal;"&gt;May&amp;#160;31,&amp;#160;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred tax assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net operating loss carryforward&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;33,880&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;55,975&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Stock-based compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,421&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,653&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Federal and state R&amp;amp;D tax credit carryforward&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,644&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,548&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Inventories&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,550&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,407&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Expenses incurred not currently deductible&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,714&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,522&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;277&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,289&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Gross deferred tax asset&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;43,486&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;71,394&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred tax liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Excess tax over book depreciation and amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;34,044&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;49,158&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;34,044&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;49,158&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Valuation Allowance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(26,607&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(48,348&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net deferred tax liability &lt;/font&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(17,165&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(26,112&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(1) Net deferred tax liability is inclusive of a non-U.S. &lt;/font&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;$0.08 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt; deferred tax asset that is included in other assets on the Company's balance sheet for the year ended May 31, 2018.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
	<us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="FD2018Q4YTD" id="Fact-13E2D8511D817F9624128C8B3D369B78">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's consolidated income tax expense has differed from the amount that would be provided by applying the U.S. Federal statutory income tax rate to the Company's income before income taxes for the following reasons:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:50%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Year ended May 31, &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Income tax (benefit) expense at statutory tax rate of 28.6%, 35.0% and 35.0%, respectively&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,136&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,447&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,139&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Effect of graduated tax rates&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(98&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;33&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;State income taxes, net of Federal tax benefit&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;120&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(22&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(215&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Impact of Non-U.S. operations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(288&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;403&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(162&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Research and development tax credit&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(951&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(403&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(499&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Impact of tax reform &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,912&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Meals and entertainment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;242&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;266&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;329&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-deductible interest on contingent payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;174&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;262&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-taxable gain on revaluation of contingent consideration liability&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5,576&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(170&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Change in valuation allowance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(21,741&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,139&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40,685&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Effect of elimination of stock compensation APIC pool&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,380&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;739&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;IPR&amp;amp;D intangible write-off&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,224&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;700&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;353&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;474&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Income tax (benefit) expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(8,870&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,839&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40,337&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
	<us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="FD2018Q4YTD" id="Fact-97EC24895477556AF5C98C8B3CB936A9">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following tables represents the break out of share-based compensation included in the Company's consolidated statement of operations:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:60%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Year ended May 31, &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cost of sales&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;119&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;299&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;172&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Research and development&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;554&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;314&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;349&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Sales and marketing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,778&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,762&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,489&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;General and administrative&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,461&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,026&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,291&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquisition, restructuring and other items, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(218&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,061&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,912&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,183&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,240&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
	<us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="FD2018Q4YTD" id="Fact-8454D6DD73EECAD93EFE8C8B3CD9AEC0">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following tables provide information by level for assets and liabilities that are measured at fair value on a recurring basis:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair Value Measurements using inputs considered as:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Level&amp;#160;1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Level&amp;#160;2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Level 3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair Value at    May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;text-decoration:underline;"&gt;Financial Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Short-term investments*&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,100&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,100&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Marketable securities &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,317&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,317&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total Financial Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,100&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,317&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,417&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;text-decoration:underline;"&gt;Financial Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contingent liability for acquisition earn outs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,261&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,261&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total Financial Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,261&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,261&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;*included in cash and cash equivalents.&lt;/font&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair Value Measurements using inputs considered as:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Level 1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Level 2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Level 3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fair Value at   May 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;text-decoration:underline;"&gt;Financial Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Marketable securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,215&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,215&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total Financial Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,215&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,215&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;text-decoration:underline;"&gt;Financial Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Contingent liability for acquisition earn outs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,761&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,761&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total Financial Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,761&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,761&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
	<us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="FD2018Q4YTD" id="Fact-A07E8DE151E01DE9E4308C8B3D3682D9">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The components of income (loss) before income tax (benefit) expense for the years ended May&amp;#160;31 are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:47%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Income (loss) before tax expense:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;U.S.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,274&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,825&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4,444&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-U.S.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,191&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,191&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,465&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,847&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(3,253&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
	<us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="FD2018Q4YTD" id="Fact-6F283CEA185494D83CD98C8B3CE83A72">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, inventories consisted of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:66%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;May 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Raw materials&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18,678&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;17,563&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Work in process&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,808&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,602&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Finished goods&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,430&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;24,341&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;48,916&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;54,506&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
	<us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="FD2018Q4YTD" id="Fact-8E4DC29B4D933BB4F1588C8B3D36378E">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's maturities of principal obligations under the credit agreement are as follows, as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:90%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11,250&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;68,750&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total term loan&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;92,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Revolving facility&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total debt&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;92,500&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Less: Unamortized debt issuance costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(879&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;91,621&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Less: Current portion of long-term debt&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Total long-term debt, net of current portion&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;86,621&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
	<us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock contextRef="FD2018Q4YTD" id="Fact-3EF6101BDAA5E5B691138F5078E02508">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table provides a description of recent accounting pronouncements that may have a material effect on the Company's consolidated financial statements:  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:22%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:34%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:33%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Recently Issued Accounting Pronouncements - Adopted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Standard&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Description&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Date Adopted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Effect on the Consolidated Financial Statements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ASU 2016-09, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Compensation - Stock Based Compensation (Topic 718: Improvements to Employee Share-Based Payment Accounting)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This ASU simplifies and improves various aspects of ASC 718 for share-based payments, including income tax items and the classification of these items on the statement of cash flows.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;June 1, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company now recognizes unrealized excess tax benefits and will classify such benefits as an operating activity in the statement of cash flows on a prospective basis. Due to the full valuation allowance on our federal and state income taxes, the adoption of ASU 2016-09 did not impact our accounting for income taxes.                  &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company elected the accounting policy change to account for forfeitures as they occur.  This was adopted using the modified retrospective transition method by means of a cumulative-effect adjustment to equity as of June 1, 2017.  The adoption of ASU 2016-09 did not materially impact the Company's consolidated statements of income, consolidated balance sheet, equity or cash flows. &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ASU 2017-04, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Intangibles - Goodwill and Other (Topic 350)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This ASU simplifies the subsequent measurement of goodwill by eliminating steps from the goodwill impairment test.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;June 1, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This adoption did not have an impact on the Company's financial statements.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ASC Update No. 2015-11, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Inventory (Topic 330): Simplifying the Measurement of Inventory&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. Update No. 2015-11&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This ASU more closely aligns the measurement of inventory in U.S. GAAP with the measurement of inventory in International Financial Reporting Standards by requiring companies using the first-in, first-out and average costs methods to measure inventory using the lower of cost and net realizable value, where net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;June 1, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This adoption did not have an impact on the Company's financial statements.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:22%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:34%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:33%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Recently Issued Accounting Pronouncements - Not Yet Applicable or Adopted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Standard&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Description&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Effective Date&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Effect on the Consolidated Financial Statements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ASU No. 2014-09, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Revenue from Contracts with Customers (Topic 606, ASU 2014-09)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Under Topic 606, an entity is required to recognize revenue upon transfer of promised goods or services to customers in an amount that reflects the expected consideration to be received in exchange for those goods or services. Topic 606 defines a five-step process in order to achieve this core principle, which may require the use of judgment and estimates, and also requires expanded qualitative and quantitative disclosures relating to the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers, including significant judgments and estimates used. The new standard also defines accounting for certain costs related to origination and fulfillment of contracts with customers, including whether such costs should be capitalized. &lt;/font&gt;&lt;/div&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;June 1, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="padding-bottom:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company established an implementation team which included third-party specialists to assist in the evaluation and implementation of the new standard. The Company&amp;#8217;s assessment has included performing analysis for each revenue stream identified, assessing the potential differences in recognition and measurement that may result from adopting this standard and assessing whether the Company meets certain practical expedients. Based on the results of the assessment, the adoption of this standard will not have a material impact on the timing or amount of revenue recognized upon adoption and there is no cumulative prior period adjustment to be recorded to the opening balance of retained earnings upon adoption.  The Company will adopt the standard using the modified retrospective method. The Company is implementing changes to accounting policies, business processes and internal controls to support the new standard as necessary. Upon adoption of Topic 606, as the disclosure requirements under the new guidance have been significantly expanded in comparison to the disclosure requirements under the current guidance, we will provide additional disclosures in the notes to the consolidated financial statements, specifically related to performance obligations, the judgments made in revenue recognition determinations, costs to obtain or fulfill contracts and contract balances.&lt;/font&gt;&lt;/div&gt;&lt;div style="padding-bottom:10px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ASU No. 2016-15, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (ASU 2016-15)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This ASU identifies how certain cash receipts and cash payments are presented and classified in the Statement of Cash Flows under Topic 230.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;June 1, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="padding-bottom:10px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This adoption is not expected to have a material impact on the Company's financial statements.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ASU 2016-02, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Leases (Topic 842)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;This ASU increases transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet and disclosing key information about leasing arrangements.  For leases with a term of twelve months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and liabilities.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;June 1, 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company is currently in the process of evaluating the impact of this ASU on its consolidated financial statements.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
	<us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="FD2018Q4YTD" id="Fact-D1D68B095B2C17E5D0458C8B3CAAB43A">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;The following table summarizes information about performance unit award activity for the year ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:61%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Performance Unit Awards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Weighted&amp;#160;Average&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Grant-Date&amp;#160;Fair&amp;#160;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-vested at beginning of year, June 1, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;361,164&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18.54&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;135,135&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;23.83&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Vested&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Canceled&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(44,443&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;22.76&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-vested at end of year, May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;451,856&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19.75&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;The following table summarizes information about restricted stock unit activity for the year ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:61%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Restricted Stock Units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Weighted&amp;#160;Average&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Grant-Date&amp;#160;Fair&amp;#160;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-vested at beginning of year, June 1, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;439,297&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15.55&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;299,392&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16.60&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Vested&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(158,756&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16.83&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Canceled&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(105,431&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18.25&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-vested at end of year, May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;474,502&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16.23&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
	<us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock contextRef="FD2018Q4YTD" id="Fact-715C40A1EAD948EE003A8C8B3D278DD2">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Quarterly results of operations during the fiscal years ended May 31, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:41%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;First&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Second&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Third&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fourth&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands, except per share data)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net sales&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;85,411&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;86,706&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;83,851&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;88,317&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Gross profit&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;41,229&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;42,731&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;45,448&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;47,467&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net income (loss) &lt;/font&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(35&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;249&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14,019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,102&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Earnings (loss) per common share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.01&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.38&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.06&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.01&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.37&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.06&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:41%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;First&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Second&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Third&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Fourth&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;quarter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands, except per share data)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net sales&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;88,098&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;89,029&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;85,602&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;86,914&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Gross profit&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;45,032&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;45,010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;43,792&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;42,335&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net income (loss) &lt;/font&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,300&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13,734&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,887&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(12,913&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Earnings (loss) per common share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.04&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.37&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.08&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.35&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.04&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.37&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.08&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.35&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1) Included within net income during the third quarter of fiscal 2018 is a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$9.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; discrete tax benefit as a result of the Tax Reform Act and the revaluation of the Company's deferred tax assets, liabilities and valuation allowance to reflect the lower U.S. federal statutory rate (see Note 9).&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2) Included within net income (loss) during the fourth quarter of fiscal 2017 is the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$12.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; charge for a litigation reserve (see Note 15) and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; impact relating to the Acculis recall (see Note 10).  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The data in the schedules above has been intentionally rounded to the nearest thousand and therefore the quarterly&amp;#160;&amp;#160;&amp;#160;&amp;#160; amounts may not sum to the full year amounts.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
	<us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock contextRef="FD2018Q4YTD" id="Fact-1C6C5F5F6321EC5F3E9E8C8B3D27E8D3">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;For the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; acquisition, restructuring and other items, net consisted of:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:47%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Year ended May 31, &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Legal&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10,067&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19,480&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,487&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Intangible and other asset impairment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,604&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;352&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Restructuring&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,674&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,348&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,462&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;691&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,078&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,290&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,432&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;27,510&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,591&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table presents a rollforward of the restructuring reserve for the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="25" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:25%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Contract&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Termination&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Plant &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Regulatory&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Cancellation &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Consolidation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Filings&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Total &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at May 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Charges&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;851&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;494&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,348&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-cash adjustments &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(108&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(108&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cash payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(275&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(278&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at May 31, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;851&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;111&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;962&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Charges&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,440&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,892&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;68&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;200&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;74&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,674&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-cash adjustments &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(276&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(276&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cash payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,453&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2,706&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(56&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(74&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4,289&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance at May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;838&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;200&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,071&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
	<us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock contextRef="FD2018Q4YTD" id="Fact-0CC74D65FBF0D6A919478C8B3D279CA8">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total sales for geographic areas are summarized below (in thousands):&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:50%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Year ended May 31, &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net sales by Geography&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;United States&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;273,327&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;282,168&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;285,824&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;International&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;70,958&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;67,475&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;68,066&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;344,285&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;349,643&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;353,890&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
	<us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="FD2018Q4YTD" id="Fact-C99FD1094BBDA0DD534B8C8B3CAA0B49">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes information about stock option activity for the fiscal year ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:57%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Weighted-&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;average&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;exercise&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Weighted&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;average&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;remaining&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;contractual&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;life&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Aggregate&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;intrinsic&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;value (in&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Outstanding at beginning of year - June 1, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,667,443&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15.01&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;518,498&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16.78&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Exercised&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(271,344&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14.83&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Forfeited&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(204,184&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16.24&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Expired&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(14,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15.75&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Outstanding at end of year - May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,696,413&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15.42&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.58&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,520&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Options exercisable at year-end&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;652,543&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14.41&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.48&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,321&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Options expected to vest in future periods&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,043,870&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16.05&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6.90&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,199&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
	<us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="FD2018Q4YTD" id="Fact-408D8E2C206F62FD2103A3DCA49A9FA3">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table provides a reconciliation of the beginning and ending amount of unrecognized tax benefits:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:49%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Year ended May 31, &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Unrecognized tax benefits balance at June 1 &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;899&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;899&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Increase in gross amounts of tax positions related to prior years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;899&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Decrease in gross amounts of tax positions related to prior years due to U.S. tax reform&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(287&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Decrease due to lapse in statute of limitations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(148&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Unrecognized tax benefits balance at May 31&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;464&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;899&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;899&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
	<us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock contextRef="FD2018Q4YTD" id="Fact-5D9146498E23A7D9A5DB8C8B3D176A72">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;text-indent:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table reconciles basic to diluted weighted average shares outstanding for the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:18px;text-align:left;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="9" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:2%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Year ended May 31, &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Basic&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;37,074,797&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,616,859&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,161,383&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Effect of dilutive securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;464,603&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;342,391&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Diluted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;37,539,400&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,959,250&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36,161,383&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Securities excluded as their inclusion would be anti-dilutive&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,077,256&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,058,790&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,277,037&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
	<us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="FD2018Q4YTD" id="Fact-B016D3408BC1D2C532208C8B3D07BFE5">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Annual amortization of these intangible assets is expected to approximate the following amounts for each of the next five fiscal years:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:91%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:7%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16,555&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15,001&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13,842&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,958&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2023&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12,507&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2024 and thereafter&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;59,447&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;130,310&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
	<us-gaap:SegmentReportingDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-F8678EFA78E02BCF51418C8B3D27A4B8">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;SEGMENTS AND GEOGRAPHIC INFORMATION&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Segment information&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company considers its business to be a single segment entity related to the development, manufacture and sale on a global basis of medical devices for vascular access, surgery, peripheral vascular disease and oncology. The Company's chief operating decision maker (CEO) evaluates the various global product portfolios on a net sales basis. Executives reporting in to the CEO include those responsible for operations and supply chain management, research and development, sales, franchise marketing and certain corporate functions. The CEO evaluates profitability, investment and cash flow metrics on a consolidated worldwide basis due to shared infrastructure and resources. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total sales by product category are summarized below (in thousands):&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:50%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Year ended May 31, &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net sales by Product Category&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Peripheral Vascular&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;202,334&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;208,602&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;205,620&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Vascular Access&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;92,760&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;96,481&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;99,375&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Oncology/Surgery&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;49,191&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;44,560&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;48,895&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;344,285&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;349,643&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;353,890&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Geographic information&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total sales for geographic areas are summarized below (in thousands):&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="12" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:50%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Year ended May 31, &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net sales by Geography&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;United States&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;273,327&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;282,168&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;285,824&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;International&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;70,958&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;67,475&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;68,066&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;344,285&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;349,643&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;353,890&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;For fiscal years &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, International sales as a percentage of total net sales were &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively. Sales to any &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;one&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; country outside the U.S., as determined by shipment destination, did not comprise a material portion of net sales in any of the last three fiscal years. In addition, no one customer represents more than 10% of consolidated net sales.  &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;99%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of long-lived assets are located within the United States.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
	<us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="FD2018Q4YTD" id="Fact-3D4BA459FD5512E000BE8C8B3D172697">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:18px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Stock Based Compensation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Stock-based compensation expense reflects the fair value of stock-based awards measured at the grant date and recognized over the relevant service period. The Company estimates the fair value of each stock-based award on the measurement date using either the current market price of the stock, the Black-Scholes option valuation model, or the Monte Carlo Simulation valuation model. The Black-Scholes and Monte Carlo Simulation valuation models incorporate assumptions as to stock price volatility, the expected life of options or restricted stock units, a risk-free interest rate and dividend yield. The Company recognizes stock-based compensation expense related to options, restricted stock units and market based performance stock units on a straight-line basis over the service period of the award, which is generally &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years for options and restricted stock units and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years for market based performance stock units.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
	<us-gaap:StandardProductWarrantyPolicy contextRef="FD2018Q4YTD" id="Fact-AA97DBBAA71DE89A24B08C8B3CE85A2E">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Warranty Costs&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company makes periodic provisions for expected warranty costs. Historically, warranty costs have been insignificant.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:StandardProductWarrantyPolicy>
	<us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="FD2018Q4YTD" id="Fact-4EBD74ACD629A3E3F79E8C8B3CF8CA5B">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;STOCKHOLDERS&amp;#8217; EQUITY &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Capitalization&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On October 29, 2014, the Board of Directors approved the Amended and Restated Certificate of Incorporation (the &amp;#8220;Amended Certificate&amp;#8221;). Under the Amended Certificate, the authorized capital stock is &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;80,000,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares, consisting of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;75,000,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of common stock, par value &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$.01&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,000,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of preferred stock, par value &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$.01&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The holders of common stock are entitled to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;one&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; vote for each share held. Subject to preferences applicable to any outstanding shares of preferred stock, the holders of common stock are entitled to receive ratably dividends, if any, as may be declared by the Board of Directors out of funds legally available for dividend payments. If the Company liquidates, dissolves, or winds up, the holders of common stock are entitled to share ratably in all assets remaining after payment of liabilities and liquidation preferences of any outstanding shares of preferred stock. Holders of common stock have no pre-emptive rights or rights to convert their common stock into any other securities. There are no redemption or sinking fund provisions applicable to the common stock. The rights, preferences and privileges of the holders of common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that the Company may designate in the future.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The board of directors has the authority to (i)&amp;#160;issue the undesignated preferred stock in one or more series, (ii)&amp;#160;determine the powers, preferences and rights and the qualifications, limitations or restrictions granted to or imposed upon any wholly un-issued series of undesignated preferred stock and (iii)&amp;#160;fix the number of shares constituting any series and the designation of the series, without any further vote or action by the Company's stockholders.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Stock Options&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;2004 Stock and Incentive Award Plan&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The 2004 Stock and Incentive Award Plan (the &amp;#8220;2004 Plan&amp;#8221;) provides for the grant of incentive options to employees and for the grant of non-statutory stock options, restricted stock, stock appreciation rights, performance units, performance shares and other incentive awards to employees, directors and other service providers. A total of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,000,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of common stock have been reserved for issuance under the 2004 Plan, of which up to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;800,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares may be issued upon the exercise of incentive stock options. The compensation committee of the Board of Directors administers the 2004 Plan. The committee determines vesting terms and the exercise price of options granted under the 2004 Plan, but for all incentive stock options the exercise price must at least be equal to the fair market value of common stock on the date of grant. The term of an incentive stock option may not exceed &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;ten years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On October&amp;#160;25, 2016, the Company amended the 2004 Stock and Incentive Award Plan to increased the shares of common stock reserved for issuance by &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;250,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, there remained approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares available for granting under the 2004 Plan. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table summarizes information about stock option activity for the fiscal year ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:9pt;"&gt;&lt;font style="font-family:inherit;font-size:9pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:57%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Weighted-&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;average&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;exercise&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Weighted&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;average&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;remaining&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;contractual&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;life&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Aggregate&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;intrinsic&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;value (in&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Outstanding at beginning of year - June 1, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,667,443&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15.01&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;518,498&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16.78&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Exercised&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(271,344&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14.83&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Forfeited&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(204,184&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16.24&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Expired&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(14,000&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15.75&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Outstanding at end of year - May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,696,413&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15.42&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.58&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9,520&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Options exercisable at year-end&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;652,543&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14.41&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.48&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,321&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Options expected to vest in future periods&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,043,870&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16.05&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6.90&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,199&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Stock options are granted at exercise prices equal to the quoted market price of common stock at the date of the grant. Options vest &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;per year over &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;four years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for employees.  Grants to directors vest &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;33.33%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;per year over &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  Stock options granted prior to May 1, 2007 and after June 1, 2017 expire on the tenth anniversary of the grant date.  Stock options granted between May 1, 2007 through May 31, 2017 expire on the seventh anniversary of the grant date. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company measures the fair value of each stock option grant at the date of grant using a Black-Scholes option pricing model.  The weighted average grant-date fair value of options granted during the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.95&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.70&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.16&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively.  The following assumptions were used in arriving at the fair value of options granted during &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively:  risk-free interest rates of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.08%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.30%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.48%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;; expected volatility of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;30%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;31%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;31%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;; and expected lives of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.72 years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.80 years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.81 years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  The Company does not declare dividends therefore a dividend yield of zero was used for the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  Risk-free interest rates reflect the yield on zero-coupon U.S. Treasury bonds whose maturity period equals the expected term of the option.  Expected volatilities are based on the historical volatility of the Company's stock.  The expected option lives are based on historical experience of employee exercise behavior. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The total intrinsic value of options exercised during the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively.  As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, there was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of total unrecognized compensation cost related to non-vested options, which is expected to be recognized over a weighted average period of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3 years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Cash received from option exercises during 2018, 2017 and 2016 was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$9.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively.  The tax benefit realized from stock options exercised during the year ended May 31, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.  Due to the valuation allowance there was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;no&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; tax benefit realized from stock option exercises during the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Performance Share and Restricted Stock Unit Awards&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company grants restricted stock units to certain employees under the 2004 Plan which give the recipients the right to receive shares of Company stock upon vesting. The restricted stock unit awards vest in four equal annual installments beginning on the first anniversary of the grant date.  Restricted stock unit awards granted to directors vest&amp;#160;over &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;one&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; year. Unvested restricted stock unit awards will be forfeited if the recipient ceases to be employed by the Company. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;The following table summarizes information about restricted stock unit activity for the year ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:61%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Restricted Stock Units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Weighted&amp;#160;Average&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Grant-Date&amp;#160;Fair&amp;#160;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-vested at beginning of year, June 1, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;439,297&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15.55&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;299,392&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16.60&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Vested&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(158,756&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16.83&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Canceled&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(105,431&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18.25&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-vested at end of year, May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;474,502&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16.23&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The fair value of each restricted stock unit is the market price of Company stock on the date of grant.  The weighted average grant date fair value of restricted stock units granted during the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$16.60&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$16.54&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$15.21&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively.  The total intrinsic value of restricted stock units (meaning the fair value of the units on the date of vest) vesting during the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;,&amp;#160;respectively.  As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, there was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of total unrecognized compensation cost related to non-vested restricted stock awards, which is expected to be recognized over a weighted average period of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3 years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.   &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company grants performance share awards to certain employees under the 2004 Plan which gives the recipients the right to receive shares of Company stock if certain criteria is met. The performance criteria is established by the compensation committee for vesting of the performance share awards and is determined by the achievement of relative total shareholder return ("TSR"). Performance share awards are subject to additional conditions, including the recipient&amp;#8217;s continued employment with the Company. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;The following table summarizes information about performance unit award activity for the year ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="7" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:61%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:18%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Performance Unit Awards&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Weighted&amp;#160;Average&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Grant-Date&amp;#160;Fair&amp;#160;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-vested at beginning of year, June 1, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;361,164&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;18.54&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;135,135&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;23.83&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Vested&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Canceled&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(44,443&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;22.76&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-vested at end of year, May 31, 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;451,856&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19.75&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During fiscal years 2018, 2017 and 2016, we granted performance unit awards that include a three-year market condition.  Vesting of the performance unit awards is based on the Company's level of attainment of specified total shareholder return ("TSR") targets relative to the percentage appreciation of a specified index of companies for the respective three-year periods.  It is also subject to the continued employment of the grantees.  In order to estimate the fair value of such awards, we used a Monte Carlo Simulation valuation model on the date of the grant.  For the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the weighted average grant date fair market value for new grants was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$23.83&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$22.61&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$18.07&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively.  Compensation cost is recognized over the performance period which is typically &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years.  As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; performance share units with a weighted average remaining contractual term of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of unrecognized compensation cost were outstanding. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Compensation Expense&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following tables represents the break out of share-based compensation included in the Company's consolidated statement of operations:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="13" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:60%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;Year ended May 31, &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;(in thousands)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cost of sales&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;119&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;299&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;172&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Research and development&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;554&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;314&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;349&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Sales and marketing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,778&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,762&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,489&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;General and administrative&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,461&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,026&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,291&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquisition, restructuring and other items, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(218&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1,061&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,912&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6,183&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,240&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The income tax benefit on the compensation expense recognized for all share-based compensation arrangements was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively.  The income tax benefit for 2018, 2017 and 2016 are negated by the full valuation allowance established as of May 31, 2016.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Employee Stock Purchase Plan&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Employee Stock Purchase Plan (the &amp;#8220;Stock Purchase Plan&amp;#8221;) provides a means by which employees (the &amp;#8220;participants&amp;#8221;) are given an opportunity to purchase the Company's common stock through payroll deductions.   A total of  &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,500,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of common stock have been reserved for issuance under the Stock Purchase Plan.  Shares are offered through &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;two&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; purchase periods, each with duration of approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6 months&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, commencing on the first business day of the first and third fiscal quarters. An employee is eligible to participate in an offering period if, on the first day of an offering period, he or she has been employed in a full-time capacity for at least &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;six months&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, with a customary working schedule of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;20 or more hours per week and more than five months in a calendar year&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. Employees who own stock possessing &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; or more of the total combined voting power or value of all classes of stock are not eligible to participate in the Stock Purchase Plan. The purchase price of the shares of common stock acquired on each purchase date will be the lower of (i)&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;85%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the fair market value of a share of common stock on the first day of the offering period or (ii)&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;85%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the fair market value of a share of common stock on the last day of the purchase period, subject to adjustments made by the Board of Directors. The Stock Purchase Plan is intended to qualify as an &amp;#8220;employee stock purchase plan&amp;#8221; within the meaning of Section&amp;#160;423 of the Internal Revenue Code.  During the year ended May 31, 2015, an additional &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;800,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of the Company's common stock have been reserved for issuance under the Stock Purchase Plan.  During the year ended May 31, 2017, an additional &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;500,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of the Company's common stock were reserved for issuance under the Stock Purchase Plan.  &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company uses the Black-Scholes option-pricing model to calculate the purchase date fair value of the shares issued under the Stock Purchase Plan and recognize expense related to shares purchased ratably over the offering period.  During the years ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;89,943&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;129,185&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;137,957&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares, respectively, were issued at an average price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$14.03&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$11.00&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$10.67&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, under the Stock Purchase Plan.  As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.2&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; million shares remained available for future purchases under the Stock Purchase Plan.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"&gt;Share Repurchases&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On November 6, 2016, the Board of Directors approved the Repurchase Program under which they authorized the Company the option to repurchase up to&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$25.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;of its outstanding common stock during the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;twenty-four&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; month period ending November 6, 2018.  During the second quarter of fiscal year 2017, the Company repurchased &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;500,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of common stock in the open market at an aggregate cost of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$7.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; under the Repurchase Program.  During the fourth quarter of fiscal year 2017, the Company repurchased &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;370,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of common stock in the open market at an aggregate cost of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; under the Repurchase Program.  As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;May&amp;#160;31, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$11.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; remained available for repurchase under the Repurchase Program.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In February 2017, the Company retired &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;642,305&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; shares of treasury stock.  These retired shares are now included in the Company&amp;#8217;s pool of authorized but unissued shares.  The retired stock had a carrying value of approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$9.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.01&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was the par value that was deducted from common stock and the remaining &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$9.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was deducted from additional paid-in capital.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
	<link:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
	</link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>14
<FILENAME>ango-20180531.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.angiodynamics.com/20180531" xmlns:ango="http://www.angiodynamics.com/20180531" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt/2018-01-31" schemaLocation="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-roles-2018-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2018-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2018/elts/us-types-2018-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2017-01-31" schemaLocation="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2018-01-31" schemaLocation="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2018-01-31" schemaLocation="https://xbrl.sec.gov/exch/2018/exch-2018-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ango-20180531_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ango-20180531_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ango-20180531_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ango-20180531_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="AccruedLiabilities" roleURI="http://www.angiodynamics.com/role/AccruedLiabilities">
        <link:definition>2110100 - Disclosure - Accrued Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesAccruedLiabilitesDetailsTextual" roleURI="http://www.angiodynamics.com/role/AccruedLiabilitiesAccruedLiabilitesDetailsTextual">
        <link:definition>2410403 - Disclosure - Accrued Liabilities Accrued Liabilites (Details) (Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesDetails" roleURI="http://www.angiodynamics.com/role/AccruedLiabilitiesDetails">
        <link:definition>2410402 - Disclosure - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesTables" roleURI="http://www.angiodynamics.com/role/AccruedLiabilitiesTables">
        <link:definition>2310301 - Disclosure - Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLoss" roleURI="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLoss">
        <link:definition>2120100 - Disclosure - Accumulated Other Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>2420402 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeLossTables" roleURI="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLossTables">
        <link:definition>2320301 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionRestructuringAndOtherItemsNet" roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNet">
        <link:definition>2118100 - Disclosure - Acquisition, Restructuring and Other Items, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionRestructuringAndOtherItemsNetDetails" roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails">
        <link:definition>2418402 - Disclosure - Acquisition, Restructuring and Other Items, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionRestructuringAndOtherItemsNetDetails1" roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails1">
        <link:definition>2418403 - Disclosure - Acquisition, Restructuring and Other Items, net (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionRestructuringAndOtherItemsNetDetails2" roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails2">
        <link:definition>2418404 - Disclosure - Acquisition, Restructuring and Other Items, net (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionRestructuringAndOtherItemsNetTables" roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetTables">
        <link:definition>2318301 - Disclosure - Acquisition, Restructuring and Other Items, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPolicies" roleURI="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPolicies">
        <link:definition>2101100 - Disclosure - Basis of Presentation, Business Description and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesDetailsTextual" roleURI="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesDetailsTextual">
        <link:definition>2401403 - Disclosure - Basis of Presentation, Business Description and Summary of Significant Accounting Policies (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>2201201 - Disclosure - Basis of Presentation, Business Description and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesTables" roleURI="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>2301302 - Disclosure - Basis of Presentation, Business Description and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingencies" roleURI="http://www.angiodynamics.com/role/CommitmentsAndContingencies">
        <link:definition>2116100 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingenciesDetails" roleURI="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetails">
        <link:definition>2416403 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingenciesDetails1" roleURI="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetails1">
        <link:definition>2416404 - Disclosure - Commitments and Contingencies (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingenciesDetailsTextual" roleURI="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetailsTextual">
        <link:definition>2416402 - Disclosure - Commitments and Contingencies (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingenciesTables" roleURI="http://www.angiodynamics.com/role/CommitmentsAndContingenciesTables">
        <link:definition>2316301 - Disclosure - Commitments And Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.angiodynamics.com/role/ConsolidatedBalanceSheets">
        <link:definition>1003000 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1003501 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsComprehensiveIncomeLoss" roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsComprehensiveIncomeLoss">
        <link:definition>1002000 - Statement - Consolidated Statements Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfCashFlows" roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsOfCashFlows">
        <link:definition>1005000 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfOperations" roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsOfOperations">
        <link:definition>1001000 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfStockholdersEquity" roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsOfStockholdersEquity">
        <link:definition>1004000 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DocumentAndEntityInformation" roleURI="http://www.angiodynamics.com/role/DocumentAndEntityInformation">
        <link:definition>0001000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.angiodynamics.com/role/EarningsPerShare">
        <link:definition>2115100 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareDetails" roleURI="http://www.angiodynamics.com/role/EarningsPerShareDetails">
        <link:definition>2415402 - Disclosure - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.angiodynamics.com/role/EarningsPerShareTables">
        <link:definition>2315301 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueOfFinancialInstruments" roleURI="http://www.angiodynamics.com/role/FairValueOfFinancialInstruments">
        <link:definition>2103100 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" roleURI="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails">
        <link:definition>2403402 - Disclosure - Fair Value of Financial Instruments Fair Value of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails2" roleURI="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails2">
        <link:definition>2403403 - Disclosure - Fair Value of Financial Instruments Fair Value of Financial Instruments (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails3" roleURI="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails3">
        <link:definition>2403404 - Disclosure - Fair Value of Financial Instruments Fair Value of Financial Instruments (Details 3)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsTables" roleURI="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsTables">
        <link:definition>2303301 - Disclosure - Fair Value of Financial Instruments Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndIntangibleAssets" roleURI="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssets">
        <link:definition>2108100 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndIntangibleAssetsDetails1" roleURI="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetails1">
        <link:definition>2408403 - Disclosure - Goodwill and Intangible Assets (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndIntangibleAssetsDetails2" roleURI="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetails2">
        <link:definition>2408404 - Disclosure - Goodwill and Intangible Assets (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndIntangibleAssetsDetailsTextual" roleURI="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetailsTextual">
        <link:definition>2408402 - Disclosure - Goodwill and Intangible Assets (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillAndIntangibleAssetsTables" roleURI="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsTables">
        <link:definition>2308301 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.angiodynamics.com/role/IncomeTaxes">
        <link:definition>2109100 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetails">
        <link:definition>2409402 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails2" roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetails2">
        <link:definition>2409403 - Disclosure - Income Taxes (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails3" roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetails3">
        <link:definition>2409405 - Disclosure - Income Taxes (Details 3)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails4" roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetails4">
        <link:definition>2409406 - Disclosure - Income Taxes (Details 4)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetailsTextual" roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetailsTextual">
        <link:definition>2409404 - Disclosure - Income Taxes (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxesDetails5" roleURI="http://www.angiodynamics.com/role/IncomeTaxesIncomeTaxesDetails5">
        <link:definition>2409407 - Disclosure - Income Taxes Income Taxes (Details 5)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.angiodynamics.com/role/IncomeTaxesTables">
        <link:definition>2309301 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.angiodynamics.com/role/Inventories">
        <link:definition>2105100 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://www.angiodynamics.com/role/InventoriesDetails">
        <link:definition>2405402 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.angiodynamics.com/role/InventoriesTables">
        <link:definition>2305301 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.angiodynamics.com/role/LongTermDebt">
        <link:definition>2112100 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtDetails1" roleURI="http://www.angiodynamics.com/role/LongTermDebtDetails1">
        <link:definition>2412403 - Disclosure - Long-Term Debt (Details1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtDetails1Calc2" roleURI="http://www.angiodynamics.com/role/LongTermDebtDetails1Calc2">
        <link:definition>2412403 - Disclosure - Long-Term Debt (Details1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtDetailsTextual" roleURI="http://www.angiodynamics.com/role/LongTermDebtDetailsTextual">
        <link:definition>2412402 - Disclosure - Long-Term Debt (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.angiodynamics.com/role/LongTermDebtTables">
        <link:definition>2312301 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecurities" roleURI="http://www.angiodynamics.com/role/MarketableSecurities">
        <link:definition>2104100 - Disclosure - Marketable Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesDetails" roleURI="http://www.angiodynamics.com/role/MarketableSecuritiesDetails">
        <link:definition>2404402 - Disclosure - Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesDetails1" roleURI="http://www.angiodynamics.com/role/MarketableSecuritiesDetails1">
        <link:definition>2404403 - Disclosure - Marketable Securities (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesTables" roleURI="http://www.angiodynamics.com/role/MarketableSecuritiesTables">
        <link:definition>2304301 - Disclosure - Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssets" roleURI="http://www.angiodynamics.com/role/OtherAssets">
        <link:definition>2102100 - Disclosure - Other Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsDetails" roleURI="http://www.angiodynamics.com/role/OtherAssetsDetails">
        <link:definition>2402401 - Disclosure - Other Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidExpensesAndOther" roleURI="http://www.angiodynamics.com/role/PrepaidExpensesAndOther">
        <link:definition>2106100 - Disclosure - Prepaid Expenses and Other</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidExpensesAndOtherDetails" roleURI="http://www.angiodynamics.com/role/PrepaidExpensesAndOtherDetails">
        <link:definition>2406402 - Disclosure - Prepaid Expenses and Other (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidExpensesAndOtherTables" roleURI="http://www.angiodynamics.com/role/PrepaidExpensesAndOtherTables">
        <link:definition>2306301 - Disclosure - Prepaid Expenses and Other (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantAndEquipmentNet" roleURI="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNet">
        <link:definition>2107100 - Disclosure - Property, Plant and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantAndEquipmentNetDetails" roleURI="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNetDetails">
        <link:definition>2407402 - Disclosure - Property, Plant, and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantAndEquipmentNetTables" roleURI="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNetTables">
        <link:definition>2307301 - Disclosure - Property, Plant and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyInformationUnaudited" roleURI="http://www.angiodynamics.com/role/QuarterlyInformationUnaudited">
        <link:definition>2121100 - Disclosure - Quarterly Information (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyInformationUnauditedDetails" roleURI="http://www.angiodynamics.com/role/QuarterlyInformationUnauditedDetails">
        <link:definition>2421402 - Disclosure - Quarterly Information (unaudited) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="QuarterlyInformationUnauditedTables" roleURI="http://www.angiodynamics.com/role/QuarterlyInformationUnauditedTables">
        <link:definition>2321301 - Disclosure - Quarterly Information (unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlans" roleURI="http://www.angiodynamics.com/role/RetirementPlans">
        <link:definition>2113100 - Disclosure - Retirement Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansDetails" roleURI="http://www.angiodynamics.com/role/RetirementPlansDetails">
        <link:definition>2413401 - Disclosure - Retirement Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsAndGeographicInformation" roleURI="http://www.angiodynamics.com/role/SegmentsAndGeographicInformation">
        <link:definition>2117100 - Disclosure - Segments and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsAndGeographicInformationDetails" roleURI="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetails">
        <link:definition>2417402 - Disclosure - Segments and Geographic Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsAndGeographicInformationDetails1" roleURI="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetails1">
        <link:definition>2417403 - Disclosure - Segments and Geographic Information (Details 1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsAndGeographicInformationDetailsTextual" roleURI="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetailsTextual">
        <link:definition>2417404 - Disclosure - Segments and Geographic Information (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsAndGeographicInformationTables" roleURI="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationTables">
        <link:definition>2317301 - Disclosure - Segments and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.angiodynamics.com/role/StockholdersEquity">
        <link:definition>2114100 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDetails" roleURI="http://www.angiodynamics.com/role/StockholdersEquityDetails">
        <link:definition>2414403 - Disclosure - Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDetails2" roleURI="http://www.angiodynamics.com/role/StockholdersEquityDetails2">
        <link:definition>2414404 - Disclosure - Stockholders' Equity (Details 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDetails3" roleURI="http://www.angiodynamics.com/role/StockholdersEquityDetails3">
        <link:definition>2414405 - Disclosure - Stockholders' Equity (Details 3)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDetailsTextual" roleURI="http://www.angiodynamics.com/role/StockholdersEquityDetailsTextual">
        <link:definition>2414402 - Disclosure - Stockholders' Equity (Details Textual)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.angiodynamics.com/role/StockholdersEquityTables">
        <link:definition>2314301 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ValuationAndQualifyingAccounts" roleURI="http://www.angiodynamics.com/role/ValuationAndQualifyingAccounts">
        <link:definition>2122100 - Schedule - Valuation and Qualifying Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ValuationAndQualifyingAccountsDetails" roleURI="http://www.angiodynamics.com/role/ValuationAndQualifyingAccountsDetails">
        <link:definition>2422401 - Schedule - Valuation and Qualifying Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="ango_AccessMember" name="AccessMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_AccountsReceivableDuePeriod" name="AccountsReceivableDuePeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_AccruedExpensesMember" name="AccruedExpensesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_AccruedLitigation" name="AccruedLitigation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ango_AccruedRecallLiability" name="AccruedRecallLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ango_AcculisCapitalSystemsMember" name="AcculisCapitalSystemsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_AcculisInventoryMember" name="AcculisInventoryMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_AcquisitionRestructuringAndOtherItemsNet" name="AcquisitionRestructuringAndOtherItemsNet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_AcquisitionRestructuringAndOtherItemsNetMember" name="AcquisitionRestructuringAndOtherItemsNetMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember" name="AllowanceForSalesReturnsAndDoubtfulAccountsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_AngioVacProductMember" name="AngioVacProductMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost" name="AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue" name="AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ango_C.R.BardInc.Member" name="C.R.BardInc.Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_CapitalStockSharesAuthorized" name="CapitalStockSharesAuthorized" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ango_CashPaidDuringPeriodAbstract" name="CashPaidDuringPeriodAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_ChangeInFairValueOfContingentConsideration" name="ChangeInFairValueOfContingentConsideration" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ango_CommonStockVotesPerShare" name="CommonStockVotesPerShare" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_ContingentConsiderationEarnOutLiabilityMember" name="ContingentConsiderationEarnOutLiabilityMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription" name="CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_DOJLitigationMember" name="DOJLitigationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_DebtInstrumentIncreaseInInterestRateInCaseOfDefault" name="DebtInstrumentIncreaseInInterestRateInCaseOfDefault" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_DebtInstrumentMaximumCashAmountForNetDebtCalculation" name="DebtInstrumentMaximumCashAmountForNetDebtCalculation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA" name="DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions" name="DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_DebtServiceCoverageRatio" name="DebtServiceCoverageRatio" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_DeferredIncomeTaxRelatedToOperatingActivity" name="DeferredIncomeTaxRelatedToOperatingActivity" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_DiscontinuedInvestmentinTiLoProductMember" name="DiscontinuedInvestmentinTiLoProductMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_DistributorRelationshipsMember" name="DistributorRelationshipsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount" name="EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ango_EmployeePlanParticipatingEligibilityPeriod" name="EmployeePlanParticipatingEligibilityPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_EmployeePlanParticipatingEligibilityThresholdPercentage" name="EmployeePlanParticipatingEligibilityThresholdPercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_EquipmentTransferMember" name="EquipmentTransferMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_FairValueInputsProbabilityOfPayment" name="FairValueInputsProbabilityOfPayment" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract" name="FairValueLiabilitiesMeasuredOnRecurringBasisAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" name="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings" name="FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ango_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration" name="FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_FormerCreditAgreementMember" name="FormerCreditAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_GoodwillAndIntangibleAssetsTextualAbstract" name="GoodwillAndIntangibleAssetsTextualAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_IncomeTaxReconciliationEffectOfForeignOperations" name="IncomeTaxReconciliationEffectOfForeignOperations" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ango_IncomeTaxReconciliationEffectofEliminationofASC718APICPool" name="IncomeTaxReconciliationEffectofEliminationofASC718APICPool" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ango_IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability" name="IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ango_IncomeTaxReconciliationNondeductibleInterestOnContingentPayment" name="IncomeTaxReconciliationNondeductibleInterestOnContingentPayment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_IncomeTaxesTextualAbstract" name="IncomeTaxesTextualAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_IntangibleImpairmentMember" name="IntangibleImpairmentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_InternationalMember" name="InternationalMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_InventoryTypeAxis" name="InventoryTypeAxis" nillable="true" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_InventoryTypeDomain" name="InventoryTypeDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure" name="InvestmentsExcludingMarketableSecuritiesFairValueDisclosure" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember" name="JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_LegalCostsMember" name="LegalCostsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_LossContingencyClaimsReversedNumber" name="LossContingencyClaimsReversedNumber" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_LossContingencyReexaminationsNumber" name="LossContingencyReexaminationsNumber" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_LossContingencyU.S.PatentsNumber" name="LossContingencyU.S.PatentsNumber" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember" name="ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_MedicalDeviceExciseTax" name="MedicalDeviceExciseTax" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ango_MedicalDeviceExciseTaxReceivable" name="MedicalDeviceExciseTaxReceivable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ango_NetSalesByProductCategoryAbstract" name="NetSalesByProductCategoryAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct" name="NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_NumberOfPatentsAssertedForReexamination" name="NumberOfPatentsAssertedForReexamination" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_NumberOfSharePurchasePeriod" name="NumberOfSharePurchasePeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_OncologySurgeryMember" name="OncologySurgeryMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_OperatingLeasesFutureMinimumPaymentsDueAfterFourYears" name="OperatingLeasesFutureMinimumPaymentsDueAfterFourYears" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse" name="OperatingLossCarryforwardsAmountAfterLimitationOfUse" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="ango_PaymentsToAcquireIntangibleAssetsNetOfCashAcquired" name="PaymentsToAcquireIntangibleAssetsNetOfCashAcquired" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ango_PercentageOfDomesticAssets" name="PercentageOfDomesticAssets" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant" />
  <xsd:element id="ango_PercentageOfInternationalSalesToNetSales" name="PercentageOfInternationalSalesToNetSales" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_PercentageOfRestockingCharge" name="PercentageOfRestockingCharge" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_PerformanceShareAndRestrictedStockUnitAwardsMember" name="PerformanceShareAndRestrictedStockUnitAwardsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_PerformanceSharesIncludingThreeYearMarketConditionMember" name="PerformanceSharesIncludingThreeYearMarketConditionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_PeripheralVascularMember" name="PeripheralVascularMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_PrepaidExpensesAndOtherTableTextBlock" name="PrepaidExpensesAndOtherTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_PrepaidExpensesAndOtherTextBlock" name="PrepaidExpensesAndOtherTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_PrepaidIncomeandOtherTaxes" name="PrepaidIncomeandOtherTaxes" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="ango_PrepaidLicenseeFees" name="PrepaidLicenseeFees" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ango_ProductTechnologiesMember" name="ProductTechnologiesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements" name="PropertyPlantAndEquipmentExcludingLandAndLandImprovements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="ango_RecallPeriod" name="RecallPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_RegulatoryFilingsMember" name="RegulatoryFilingsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_ResearchAndDevelopmentMember" name="ResearchAndDevelopmentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_RetirementPlansTextualAbstract" name="RetirementPlansTextualAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_RevenueBasedPaymentMember" name="RevenueBasedPaymentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_Royalties" name="Royalties" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ango_RoyaltiesDueAfterFifthYear" name="RoyaltiesDueAfterFifthYear" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ango_RoyaltiesDueinFifthYear" name="RoyaltiesDueinFifthYear" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ango_RoyaltiesDueinFourthYear" name="RoyaltiesDueinFourthYear" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ango_RoyaltiesDueinSecondYear" name="RoyaltiesDueinSecondYear" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="ango_RoyaltiesDueinThirdYear" name="RoyaltiesDueinThirdYear" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ango_SalesandMarketingMember" name="SalesandMarketingMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_ScheduleOfIntangibleAssetsTableTextBlock" name="ScheduleOfIntangibleAssetsTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_ScheduleOfNetRevenueByProductGroupTableTextBlock" name="ScheduleOfNetRevenueByProductGroupTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_ScheduleofIncomeTaxLineItems" name="ScheduleofIncomeTaxLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_ScheduleofIncomeTaxTable" name="ScheduleofIncomeTaxTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_SharePurchasePeriod" name="SharePurchasePeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod" name="SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod" name="SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible" name="SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible" name="SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_ShortTermInvestmentsMaturityPeriod" name="ShortTermInvestmentsMaturityPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_SoftwareLicenses" name="SoftwareLicenses" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ango_StockPurchasePlanMember" name="StockPurchasePlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_SummaryOfSalesForGeographicAreasAbstract" name="SummaryOfSalesForGeographicAreasAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit" name="TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit" name="TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="ango_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit" name="TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_TaxPeriodOneMember" name="TaxPeriodOneMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_TaxPeriodThreeMember" name="TaxPeriodThreeMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_TaxPeriodTwoMember" name="TaxPeriodTwoMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_TheDelawareActionMember" name="TheDelawareActionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_TheUtahActionMember" name="TheUtahActionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_TradeShows" name="TradeShows" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember" name="TwoThousandAndFourStockAndIncentiveAwardPlanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="ango_UndisclosedInventoryDistributorMember" name="UndisclosedInventoryDistributorMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="ango_UndiscountedContingentConsiderationFairValueFairValueDisclosure" name="UndiscountedContingentConsiderationFairValueFairValueDisclosure" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>15
<FILENAME>ango-20180531_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccruedLiabilities" xlink:href="ango-20180531.xsd#AccruedLiabilities" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccruedLiabilitiesAccruedLiabilitesDetailsTextual" xlink:href="ango-20180531.xsd#AccruedLiabilitiesAccruedLiabilitesDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccruedLiabilitiesDetails" xlink:href="ango-20180531.xsd#AccruedLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccruedLiabilitiesTables" xlink:href="ango-20180531.xsd#AccruedLiabilitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:href="ango-20180531.xsd#AccumulatedOtherComprehensiveIncomeLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="ango-20180531.xsd#AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:href="ango-20180531.xsd#AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNet" xlink:href="ango-20180531.xsd#AcquisitionRestructuringAndOtherItemsNet" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails" xlink:href="ango-20180531.xsd#AcquisitionRestructuringAndOtherItemsNetDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails1" xlink:href="ango-20180531.xsd#AcquisitionRestructuringAndOtherItemsNetDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails2" xlink:href="ango-20180531.xsd#AcquisitionRestructuringAndOtherItemsNetDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetTables" xlink:href="ango-20180531.xsd#AcquisitionRestructuringAndOtherItemsNetTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPolicies" xlink:href="ango-20180531.xsd#BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesDetailsTextual" xlink:href="ango-20180531.xsd#BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ango-20180531.xsd#BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesTables" xlink:href="ango-20180531.xsd#BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/CommitmentsAndContingencies" xlink:href="ango-20180531.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetails" xlink:href="ango-20180531.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetails1" xlink:href="ango-20180531.xsd#CommitmentsAndContingenciesDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetailsTextual" xlink:href="ango-20180531.xsd#CommitmentsAndContingenciesDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/CommitmentsAndContingenciesTables" xlink:href="ango-20180531.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedBalanceSheets" xlink:href="ango-20180531.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="ango-20180531.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsComprehensiveIncomeLoss" xlink:href="ango-20180531.xsd#ConsolidatedStatementsComprehensiveIncomeLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="ango-20180531.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsOfOperations" xlink:href="ango-20180531.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="ango-20180531.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/DocumentAndEntityInformation" xlink:href="ango-20180531.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/EarningsPerShare" xlink:href="ango-20180531.xsd#EarningsPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/EarningsPerShareDetails" xlink:href="ango-20180531.xsd#EarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/EarningsPerShareTables" xlink:href="ango-20180531.xsd#EarningsPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueOfFinancialInstruments" xlink:href="ango-20180531.xsd#FairValueOfFinancialInstruments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" xlink:href="ango-20180531.xsd#FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails2" xlink:href="ango-20180531.xsd#FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails3" xlink:href="ango-20180531.xsd#FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsTables" xlink:href="ango-20180531.xsd#FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssets" xlink:href="ango-20180531.xsd#GoodwillAndIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetails1" xlink:href="ango-20180531.xsd#GoodwillAndIntangibleAssetsDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetails2" xlink:href="ango-20180531.xsd#GoodwillAndIntangibleAssetsDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetailsTextual" xlink:href="ango-20180531.xsd#GoodwillAndIntangibleAssetsDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsTables" xlink:href="ango-20180531.xsd#GoodwillAndIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxes" xlink:href="ango-20180531.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetails" xlink:href="ango-20180531.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetails2" xlink:href="ango-20180531.xsd#IncomeTaxesDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetails3" xlink:href="ango-20180531.xsd#IncomeTaxesDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetails4" xlink:href="ango-20180531.xsd#IncomeTaxesDetails4" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetailsTextual" xlink:href="ango-20180531.xsd#IncomeTaxesDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesIncomeTaxesDetails5" xlink:href="ango-20180531.xsd#IncomeTaxesIncomeTaxesDetails5" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesTables" xlink:href="ango-20180531.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/Inventories" xlink:href="ango-20180531.xsd#Inventories" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/InventoriesDetails" xlink:href="ango-20180531.xsd#InventoriesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/InventoriesTables" xlink:href="ango-20180531.xsd#InventoriesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LongTermDebt" xlink:href="ango-20180531.xsd#LongTermDebt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LongTermDebtDetails1" xlink:href="ango-20180531.xsd#LongTermDebtDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LongTermDebtDetails1Calc2" xlink:href="ango-20180531.xsd#LongTermDebtDetails1Calc2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LongTermDebtDetailsTextual" xlink:href="ango-20180531.xsd#LongTermDebtDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LongTermDebtTables" xlink:href="ango-20180531.xsd#LongTermDebtTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/MarketableSecurities" xlink:href="ango-20180531.xsd#MarketableSecurities" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/MarketableSecuritiesDetails" xlink:href="ango-20180531.xsd#MarketableSecuritiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/MarketableSecuritiesDetails1" xlink:href="ango-20180531.xsd#MarketableSecuritiesDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/MarketableSecuritiesTables" xlink:href="ango-20180531.xsd#MarketableSecuritiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/OtherAssets" xlink:href="ango-20180531.xsd#OtherAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/OtherAssetsDetails" xlink:href="ango-20180531.xsd#OtherAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/PrepaidExpensesAndOther" xlink:href="ango-20180531.xsd#PrepaidExpensesAndOther" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/PrepaidExpensesAndOtherDetails" xlink:href="ango-20180531.xsd#PrepaidExpensesAndOtherDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/PrepaidExpensesAndOtherTables" xlink:href="ango-20180531.xsd#PrepaidExpensesAndOtherTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNet" xlink:href="ango-20180531.xsd#PropertyPlantAndEquipmentNet" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNetDetails" xlink:href="ango-20180531.xsd#PropertyPlantAndEquipmentNetDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNetTables" xlink:href="ango-20180531.xsd#PropertyPlantAndEquipmentNetTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/QuarterlyInformationUnaudited" xlink:href="ango-20180531.xsd#QuarterlyInformationUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/QuarterlyInformationUnauditedDetails" xlink:href="ango-20180531.xsd#QuarterlyInformationUnauditedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/QuarterlyInformationUnauditedTables" xlink:href="ango-20180531.xsd#QuarterlyInformationUnauditedTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/RetirementPlans" xlink:href="ango-20180531.xsd#RetirementPlans" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/RetirementPlansDetails" xlink:href="ango-20180531.xsd#RetirementPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentsAndGeographicInformation" xlink:href="ango-20180531.xsd#SegmentsAndGeographicInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetails" xlink:href="ango-20180531.xsd#SegmentsAndGeographicInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetails1" xlink:href="ango-20180531.xsd#SegmentsAndGeographicInformationDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetailsTextual" xlink:href="ango-20180531.xsd#SegmentsAndGeographicInformationDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationTables" xlink:href="ango-20180531.xsd#SegmentsAndGeographicInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/StockholdersEquity" xlink:href="ango-20180531.xsd#StockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/StockholdersEquityDetails" xlink:href="ango-20180531.xsd#StockholdersEquityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/StockholdersEquityDetails2" xlink:href="ango-20180531.xsd#StockholdersEquityDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/StockholdersEquityDetails3" xlink:href="ango-20180531.xsd#StockholdersEquityDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/StockholdersEquityDetailsTextual" xlink:href="ango-20180531.xsd#StockholdersEquityDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/StockholdersEquityTables" xlink:href="ango-20180531.xsd#StockholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ValuationAndQualifyingAccounts" xlink:href="ango-20180531.xsd#ValuationAndQualifyingAccounts" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ValuationAndQualifyingAccountsDetails" xlink:href="ango-20180531.xsd#ValuationAndQualifyingAccountsDetails" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/AccruedLiabilities" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/AccruedLiabilitiesAccruedLiabilitesDetailsTextual" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8422f2c5-408e-d123-b935-f3115e023941" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b0e2721e-44a1-957d-5aaa-294b580a15e3" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8422f2c5-408e-d123-b935-f3115e023941" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b0e2721e-44a1-957d-5aaa-294b580a15e3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_dd3f0ff4-453d-8a72-0356-517c43549266" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8422f2c5-408e-d123-b935-f3115e023941" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_dd3f0ff4-453d-8a72-0356-517c43549266" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserveCurrent" xlink:label="loc_us-gaap_RestructuringReserveCurrent_a96bd12b-bf0d-8f9b-e78d-e34cf5aa9942" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8422f2c5-408e-d123-b935-f3115e023941" xlink:to="loc_us-gaap_RestructuringReserveCurrent_a96bd12b-bf0d-8f9b-e78d-e34cf5aa9942" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent_246557bf-247d-ae14-75c6-f807977be209" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8422f2c5-408e-d123-b935-f3115e023941" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrent_246557bf-247d-ae14-75c6-f807977be209" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_ec9fe1cf-61c8-da62-2a45-8641f1ab9af1" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8422f2c5-408e-d123-b935-f3115e023941" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_ec9fe1cf-61c8-da62-2a45-8641f1ab9af1" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AccruedLitigation" xlink:label="loc_ango_AccruedLitigation_15b0b44d-705f-836d-5bb6-8c8b53e99cd6" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8422f2c5-408e-d123-b935-f3115e023941" xlink:to="loc_ango_AccruedLitigation_15b0b44d-705f-836d-5bb6-8c8b53e99cd6" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AccruedRecallLiability" xlink:label="loc_ango_AccruedRecallLiability_8eaf2888-15a3-635e-cc34-8c8b53e09ba5" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8422f2c5-408e-d123-b935-f3115e023941" xlink:to="loc_ango_AccruedRecallLiability_8eaf2888-15a3-635e-cc34-8c8b53e09ba5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d9354686-0832-bbe3-9389-140489c487e8" xlink:type="locator" />
    <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8422f2c5-408e-d123-b935-f3115e023941" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_d9354686-0832-bbe3-9389-140489c487e8" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/AccruedLiabilitiesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_59645a08-ce25-9000-2f65-e4bfddb1182e" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_9292fd96-7b9c-f301-2bac-839264a803a4" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_59645a08-ce25-9000-2f65-e4bfddb1182e" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_9292fd96-7b9c-f301-2bac-839264a803a4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_122fa1c0-1a28-405c-1e3a-c537cfd612c7" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_59645a08-ce25-9000-2f65-e4bfddb1182e" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_122fa1c0-1a28-405c-1e3a-c537cfd612c7" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNet" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails1" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails2" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesDetailsTextual" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/CommitmentsAndContingencies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_30d028f9-2f3a-4a0c-02f8-ea9552d875b6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_fe404cae-7fcc-3489-844f-4d90e9776180" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_30d028f9-2f3a-4a0c-02f8-ea9552d875b6" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_fe404cae-7fcc-3489-844f-4d90e9776180" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_OperatingLeasesFutureMinimumPaymentsDueAfterFourYears" xlink:label="loc_ango_OperatingLeasesFutureMinimumPaymentsDueAfterFourYears_428f99fa-cb9f-80e6-adbd-8c8b5395693b" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_30d028f9-2f3a-4a0c-02f8-ea9552d875b6" xlink:to="loc_ango_OperatingLeasesFutureMinimumPaymentsDueAfterFourYears_428f99fa-cb9f-80e6-adbd-8c8b5395693b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_39e76369-4fdc-9d5f-860a-45d0795e5fb0" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_30d028f9-2f3a-4a0c-02f8-ea9552d875b6" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_39e76369-4fdc-9d5f-860a-45d0795e5fb0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_ccaff3fc-3d87-e58a-0083-69dda0c10f9d" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_30d028f9-2f3a-4a0c-02f8-ea9552d875b6" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_ccaff3fc-3d87-e58a-0083-69dda0c10f9d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_f67237f3-7c78-8a5c-b7b3-17f1eb0b017a" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_30d028f9-2f3a-4a0c-02f8-ea9552d875b6" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_f67237f3-7c78-8a5c-b7b3-17f1eb0b017a" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetails1" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligation" xlink:label="loc_us-gaap_ContractualObligation_969c363d-ca7d-3828-00db-919559604b29" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInSecondYear" xlink:label="loc_us-gaap_ContractualObligationDueInSecondYear_4534d2fe-37ac-e651-3737-accd5c658da4" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_969c363d-ca7d-3828-00db-919559604b29" xlink:to="loc_us-gaap_ContractualObligationDueInSecondYear_4534d2fe-37ac-e651-3737-accd5c658da4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInThirdYear" xlink:label="loc_us-gaap_ContractualObligationDueInThirdYear_ed1eea2b-a48a-4242-eb9b-b8e39209496a" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_969c363d-ca7d-3828-00db-919559604b29" xlink:to="loc_us-gaap_ContractualObligationDueInThirdYear_ed1eea2b-a48a-4242-eb9b-b8e39209496a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInFourthYear" xlink:label="loc_us-gaap_ContractualObligationDueInFourthYear_2a22a63a-481e-0a6f-f006-7a54404f656a" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_969c363d-ca7d-3828-00db-919559604b29" xlink:to="loc_us-gaap_ContractualObligationDueInFourthYear_2a22a63a-481e-0a6f-f006-7a54404f656a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInFifthYear" xlink:label="loc_us-gaap_ContractualObligationDueInFifthYear_c8ac47de-8112-baf9-b0c8-b18ac76d14d1" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_969c363d-ca7d-3828-00db-919559604b29" xlink:to="loc_us-gaap_ContractualObligationDueInFifthYear_c8ac47de-8112-baf9-b0c8-b18ac76d14d1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueAfterFifthYear" xlink:label="loc_us-gaap_ContractualObligationDueAfterFifthYear_bac4330b-f1b6-21c8-4943-166e44477d15" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_969c363d-ca7d-3828-00db-919559604b29" xlink:to="loc_us-gaap_ContractualObligationDueAfterFifthYear_bac4330b-f1b6-21c8-4943-166e44477d15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitment" xlink:label="loc_us-gaap_OtherCommitment_01617088-e15d-df87-fac1-8159c99c8265" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInSecondYear" xlink:label="loc_us-gaap_OtherCommitmentDueInSecondYear_0a55f62b-dd36-df29-dde0-6b43aadaa50d" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherCommitment_01617088-e15d-df87-fac1-8159c99c8265" xlink:to="loc_us-gaap_OtherCommitmentDueInSecondYear_0a55f62b-dd36-df29-dde0-6b43aadaa50d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInThirdYear" xlink:label="loc_us-gaap_OtherCommitmentDueInThirdYear_1e3f4530-c8c6-e204-389d-78ee78e5bc31" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherCommitment_01617088-e15d-df87-fac1-8159c99c8265" xlink:to="loc_us-gaap_OtherCommitmentDueInThirdYear_1e3f4530-c8c6-e204-389d-78ee78e5bc31" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInFourthYear" xlink:label="loc_us-gaap_OtherCommitmentDueInFourthYear_348c6de2-f0e3-1a42-8cc3-6adc90f4f37d" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherCommitment_01617088-e15d-df87-fac1-8159c99c8265" xlink:to="loc_us-gaap_OtherCommitmentDueInFourthYear_348c6de2-f0e3-1a42-8cc3-6adc90f4f37d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInFifthYear" xlink:label="loc_us-gaap_OtherCommitmentDueInFifthYear_301aa4c9-532b-55d6-4b33-5a20e9265539" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherCommitment_01617088-e15d-df87-fac1-8159c99c8265" xlink:to="loc_us-gaap_OtherCommitmentDueInFifthYear_301aa4c9-532b-55d6-4b33-5a20e9265539" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueAfterFifthYear" xlink:label="loc_us-gaap_OtherCommitmentDueAfterFifthYear_9134f0f8-db71-fdd7-2915-2155d1a159af" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherCommitment_01617088-e15d-df87-fac1-8159c99c8265" xlink:to="loc_us-gaap_OtherCommitmentDueAfterFifthYear_9134f0f8-db71-fdd7-2915-2155d1a159af" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaap_PurchaseObligation_b47daf2a-d854-dfa3-d525-85a178db5970" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_88f9dced-4ae9-a7b4-5bbb-4e138bdeec2a" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_b47daf2a-d854-dfa3-d525-85a178db5970" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_88f9dced-4ae9-a7b4-5bbb-4e138bdeec2a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_f6b6b6cf-d833-15d8-b984-3052c3d8f47b" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_b47daf2a-d854-dfa3-d525-85a178db5970" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_f6b6b6cf-d833-15d8-b984-3052c3d8f47b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_c587ed4b-1c17-dd3d-2c54-f43bb99e468b" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_b47daf2a-d854-dfa3-d525-85a178db5970" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_c587ed4b-1c17-dd3d-2c54-f43bb99e468b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear_d5c2cd47-ec14-09d3-da74-4eb71bd3be08" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_b47daf2a-d854-dfa3-d525-85a178db5970" xlink:to="loc_us-gaap_PurchaseObligationDueInFifthYear_d5c2cd47-ec14-09d3-da74-4eb71bd3be08" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueAfterFifthYear" xlink:label="loc_us-gaap_PurchaseObligationDueAfterFifthYear_91fd2bc9-b654-2d1d-53c5-6b25699e74bc" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_b47daf2a-d854-dfa3-d525-85a178db5970" xlink:to="loc_us-gaap_PurchaseObligationDueAfterFifthYear_91fd2bc9-b654-2d1d-53c5-6b25699e74bc" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_Royalties" xlink:label="loc_ango_Royalties_2d226657-38ef-9d28-dccb-8c8b533e687d" xlink:type="locator" />
    <link:loc xlink:href="ango-20180531.xsd#ango_RoyaltiesDueinSecondYear" xlink:label="loc_ango_RoyaltiesDueinSecondYear_2a2ee5b1-0fc1-3ab9-a1bf-8c8b530618ed" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ango_Royalties_2d226657-38ef-9d28-dccb-8c8b533e687d" xlink:to="loc_ango_RoyaltiesDueinSecondYear_2a2ee5b1-0fc1-3ab9-a1bf-8c8b530618ed" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_RoyaltiesDueinThirdYear" xlink:label="loc_ango_RoyaltiesDueinThirdYear_92b55455-6db3-7a65-0efa-8c8b532850be" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ango_Royalties_2d226657-38ef-9d28-dccb-8c8b533e687d" xlink:to="loc_ango_RoyaltiesDueinThirdYear_92b55455-6db3-7a65-0efa-8c8b532850be" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_RoyaltiesDueinFourthYear" xlink:label="loc_ango_RoyaltiesDueinFourthYear_69c88cf1-4ac1-1b31-c5c1-8c8b5320849e" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ango_Royalties_2d226657-38ef-9d28-dccb-8c8b533e687d" xlink:to="loc_ango_RoyaltiesDueinFourthYear_69c88cf1-4ac1-1b31-c5c1-8c8b5320849e" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_RoyaltiesDueinFifthYear" xlink:label="loc_ango_RoyaltiesDueinFifthYear_260eb7c6-18bc-945a-d513-8c8b53296a56" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ango_Royalties_2d226657-38ef-9d28-dccb-8c8b533e687d" xlink:to="loc_ango_RoyaltiesDueinFifthYear_260eb7c6-18bc-945a-d513-8c8b53296a56" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_RoyaltiesDueAfterFifthYear" xlink:label="loc_ango_RoyaltiesDueAfterFifthYear_c5d373b2-d381-28a9-5b03-8c8b53cf3ad5" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ango_Royalties_2d226657-38ef-9d28-dccb-8c8b533e687d" xlink:to="loc_ango_RoyaltiesDueAfterFifthYear_c5d373b2-d381-28a9-5b03-8c8b53cf3ad5" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetailsTextual" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/CommitmentsAndContingenciesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_63817d40-f759-fa9c-45a5-8bbbb36ed5c9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_63817d40-f759-fa9c-45a5-8bbbb36ed5c9" xlink:to="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_c2c48170-d0ff-2c37-effc-ff5f53e30dcb" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_AccountsPayableCurrent_c2c48170-d0ff-2c37-effc-ff5f53e30dcb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8422f2c5-408e-d123-b935-f3115e023941" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_8422f2c5-408e-d123-b935-f3115e023941" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_0d8925ae-714a-26e4-aa69-2d9eac65a5c6" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_LongTermDebtCurrent_0d8925ae-714a-26e4-aa69-2d9eac65a5c6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_4d10fc1d-2b1e-a08d-3574-d1bbfff59d2f" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_2dcbbde2-9146-a0ba-7f6c-c71b481e0841" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_4d10fc1d-2b1e-a08d-3574-d1bbfff59d2f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermLoansPayable" xlink:label="loc_us-gaap_LongTermLoansPayable_9c54b986-7704-2461-2ae3-5c2117973d55" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_LongTermLoansPayable_9c54b986-7704-2461-2ae3-5c2117973d55" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_7eb8342a-0386-745b-8c8f-c164c8567e15" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_7eb8342a-0386-745b-8c8f-c164c8567e15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_1c24f6a3-e8ba-9221-ee1e-4678b4a6cab8" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_1c24f6a3-e8ba-9221-ee1e-4678b4a6cab8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_bba08e5f-78e8-6c25-01a4-6720051135cc" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_066608da-f041-4af6-3da0-95354b640e11" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_bba08e5f-78e8-6c25-01a4-6720051135cc" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_63817d40-f759-fa9c-45a5-8bbbb36ed5c9" xlink:to="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_ea289a9d-deba-2cde-21e4-3d0ae7a1f011" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_PreferredStockValue_ea289a9d-deba-2cde-21e4-3d0ae7a1f011" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_aefe3f0c-abe4-5b83-9a64-da77d8e253dd" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_CommonStockValue_aefe3f0c-abe4-5b83-9a64-da77d8e253dd" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_df284507-8ac7-eed1-41db-05e81b70be6d" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_df284507-8ac7-eed1-41db-05e81b70be6d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a59bc5ae-63a0-c9bc-32f7-e2bd9f32bd26" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a59bc5ae-63a0-c9bc-32f7-e2bd9f32bd26" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_70b30340-b55c-aed7-73f5-36d397294f84" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_TreasuryStockValue_70b30340-b55c-aed7-73f5-36d397294f84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_798442bf-12e1-d944-3fa1-8b797b67482e" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_6765f135-8c69-bebc-a116-d59a52a5b2f2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_798442bf-12e1-d944-3fa1-8b797b67482e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_f0c68f4f-7ec1-d447-8ba7-0f2766abbe67" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_63817d40-f759-fa9c-45a5-8bbbb36ed5c9" xlink:to="loc_us-gaap_CommitmentsAndContingencies_f0c68f4f-7ec1-d447-8ba7-0f2766abbe67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_32f41ea9-05c6-e713-464b-586a571d1c1f" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_32f41ea9-05c6-e713-464b-586a571d1c1f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_d32a2417-a96e-df92-8909-70df29d31528" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_d32a2417-a96e-df92-8909-70df29d31528" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_928a1618-af56-709a-989c-a303706b8ca2" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_928a1618-af56-709a-989c-a303706b8ca2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_66bcd79a-a1c3-c24d-b8b4-7a0ce373714b" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_InventoryNet_66bcd79a-a1c3-c24d-b8b4-7a0ce373714b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ce9014ac-0ac4-6ed2-b53f-a0edc046d6b4" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d79dcc1c-93de-0ecd-2bd5-7c1f224c9b98" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ce9014ac-0ac4-6ed2-b53f-a0edc046d6b4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f37ad080-c77a-efc5-c936-389b16abc420" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f37ad080-c77a-efc5-c936-389b16abc420" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ddb0d184-2205-2a10-5b0e-faf2ccd717ae" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ddb0d184-2205-2a10-5b0e-faf2ccd717ae" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_af012273-e8ee-655c-daa2-86b96989d377" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_af012273-e8ee-655c-daa2-86b96989d377" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_831ad0b9-9dba-3997-20e6-e99a19aa28db" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_96dd7052-744e-d270-4e77-67944ec39152" xlink:to="loc_us-gaap_Goodwill_831ad0b9-9dba-3997-20e6-e99a19aa28db" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedStatementsComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_59645a08-ce25-9000-2f65-e4bfddb1182e" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e68ce304-18e4-96c0-3260-363a872863db" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_59645a08-ce25-9000-2f65-e4bfddb1182e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e68ce304-18e4-96c0-3260-363a872863db" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_107dc47f-3e8e-936e-b56d-159a71d56806" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e68ce304-18e4-96c0-3260-363a872863db" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_107dc47f-3e8e-936e-b56d-159a71d56806" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_426e7037-e52e-6d57-8593-8389365a6ce7" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_107dc47f-3e8e-936e-b56d-159a71d56806" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_426e7037-e52e-6d57-8593-8389365a6ce7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_a9ea9b87-2e88-619e-dfdb-01be6f7f0668" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_107dc47f-3e8e-936e-b56d-159a71d56806" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_a9ea9b87-2e88-619e-dfdb-01be6f7f0668" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_7cf8d201-6043-c5b4-c413-80aeee19ca82" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_107dc47f-3e8e-936e-b56d-159a71d56806" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_7cf8d201-6043-c5b4-c413-80aeee19ca82" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_d84f6a7f-e40b-fc44-e6cf-69cd696f9ea9" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e68ce304-18e4-96c0-3260-363a872863db" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_d84f6a7f-e40b-fc44-e6cf-69cd696f9ea9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_59645a08-ce25-9000-2f65-e4bfddb1182e" xlink:to="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_ad8f5587-cd30-97dd-9cf0-81ed4f58516c" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_ad8f5587-cd30-97dd-9cf0-81ed4f58516c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization_97b88949-d4fc-dff4-be7f-d39018557f4e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_DepreciationAndAmortization_97b88949-d4fc-dff4-be7f-d39018557f4e" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_DeferredIncomeTaxRelatedToOperatingActivity" xlink:label="loc_ango_DeferredIncomeTaxRelatedToOperatingActivity_e7ae3bce-5cdc-729d-e653-8c8b534f6627" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_ango_DeferredIncomeTaxRelatedToOperatingActivity_e7ae3bce-5cdc-729d-e653-8c8b534f6627" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_90cbc3ab-f555-6407-b3b4-b2bfa84c9f18" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_ShareBasedCompensation_90cbc3ab-f555-6407-b3b4-b2bfa84c9f18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_72092153-6d23-6ed2-386d-5561faf5c226" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_72092153-6d23-6ed2-386d-5561faf5c226" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ChangeInFairValueOfContingentConsideration" xlink:label="loc_ango_ChangeInFairValueOfContingentConsideration_fa92dcad-bf1b-a16f-574c-8c8b5377fd1b" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_ango_ChangeInFairValueOfContingentConsideration_fa92dcad-bf1b-a16f-574c-8c8b5377fd1b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_738aeaa1-702f-1ab2-20c0-283eab56e2ae" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_738aeaa1-702f-1ab2-20c0-283eab56e2ae" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_29b0a481-c653-23c1-27cf-114dadcce1af" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_29b0a481-c653-23c1-27cf-114dadcce1af" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f96c19e-85fe-99f6-cec0-c2c9d7470ed4" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f96c19e-85fe-99f6-cec0-c2c9d7470ed4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_334f1d33-7cae-7fd2-9d83-bb387fc2f3dd" xlink:type="locator" />
    <link:calculationArc order="9" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_334f1d33-7cae-7fd2-9d83-bb387fc2f3dd" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0e4168a9-901d-abb5-15c0-3622e9e2c070" xlink:type="locator" />
    <link:calculationArc order="10" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0e4168a9-901d-abb5-15c0-3622e9e2c070" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_91c354d1-d18f-051e-80cb-f13c01058b9d" xlink:type="locator" />
    <link:calculationArc order="11" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_91c354d1-d18f-051e-80cb-f13c01058b9d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_82e8758d-2519-6da2-6cfb-eda5d7152782" xlink:type="locator" />
    <link:calculationArc order="12" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_82e8758d-2519-6da2-6cfb-eda5d7152782" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:type="locator" />
    <link:calculationArc order="13" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1bd0bd4e-4a6f-b052-029c-0ecb0c520251" xlink:to="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_ad8f5587-cd30-97dd-9cf0-81ed4f58516c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PaymentsToAcquireIntangibleAssetsNetOfCashAcquired" xlink:label="loc_ango_PaymentsToAcquireIntangibleAssetsNetOfCashAcquired_e7d75b66-0308-b619-c899-8c8b53b2c1a7" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:to="loc_ango_PaymentsToAcquireIntangibleAssetsNetOfCashAcquired_e7d75b66-0308-b619-c899-8c8b53b2c1a7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6d89f221-3ede-36b2-fcad-4a4ce1606f6a" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6d89f221-3ede-36b2-fcad-4a4ce1606f6a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_501ceb78-782e-aec9-eff2-2bd0a073c870" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_501ceb78-782e-aec9-eff2-2bd0a073c870" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_54e087e7-dea1-4188-710c-f95dcb130e6e" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_28655e34-499f-b7bf-c54f-5de0990d0c65" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_54e087e7-dea1-4188-710c-f95dcb130e6e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_ad8f5587-cd30-97dd-9cf0-81ed4f58516c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_cfa1e746-5920-c3b5-33ed-a7dee018f26c" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_cfa1e746-5920-c3b5-33ed-a7dee018f26c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_60ab1096-bf53-5d61-76bd-431fe857fc03" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_60ab1096-bf53-5d61-76bd-431fe857fc03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ee462479-f066-2ef4-feb4-a24474e585e7" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ee462479-f066-2ef4-feb4-a24474e585e7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9dbcf839-4ba1-0e2b-8942-4c8a9981ac5b" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9dbcf839-4ba1-0e2b-8942-4c8a9981ac5b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_6accd1a2-f190-7888-29dd-29802af49bdc" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_6accd1a2-f190-7888-29dd-29802af49bdc" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d4a92697-d008-996b-823a-bd9a56a04b3a" xlink:type="locator" />
    <link:calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8917e24-06dd-060d-a290-e426c7895e54" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d4a92697-d008-996b-823a-bd9a56a04b3a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_e0089888-8677-d95e-95e6-00fe630f2dcb" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_ad8f5587-cd30-97dd-9cf0-81ed4f58516c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_e0089888-8677-d95e-95e6-00fe630f2dcb" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19dfad62-5a43-dcc4-04a8-012732c1ed97" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a10eea14-f4db-3125-d183-77bb54500e95" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19dfad62-5a43-dcc4-04a8-012732c1ed97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_41e96f8d-e499-8de8-69a8-27f1c7d4df6e" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="loc_us-gaap_OtherNonoperatingExpense_ad9a1667-c1b9-8615-5030-bd1ee29123e6" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_41e96f8d-e499-8de8-69a8-27f1c7d4df6e" xlink:to="loc_us-gaap_OtherNonoperatingExpense_ad9a1667-c1b9-8615-5030-bd1ee29123e6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_a56b34b7-57ab-a07c-7f03-8366849a14f0" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_41e96f8d-e499-8de8-69a8-27f1c7d4df6e" xlink:to="loc_us-gaap_InterestExpense_a56b34b7-57ab-a07c-7f03-8366849a14f0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:to="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_MedicalDeviceExciseTax" xlink:label="loc_ango_MedicalDeviceExciseTax_3035c8ba-6c7e-8c6c-e367-8c8b53419500" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:to="loc_ango_MedicalDeviceExciseTax_3035c8ba-6c7e-8c6c-e367-8c8b53419500" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AcquisitionRestructuringAndOtherItemsNet" xlink:label="loc_ango_AcquisitionRestructuringAndOtherItemsNet_e8465f37-1cf3-9f26-58d6-8c8b530a8356" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:to="loc_ango_AcquisitionRestructuringAndOtherItemsNet_e8465f37-1cf3-9f26-58d6-8c8b530a8356" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_11c9d7e5-c56e-e78a-ae7b-17989a817204" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_11c9d7e5-c56e-e78a-ae7b-17989a817204" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_334a0036-49ae-85df-fa8d-a7de18d975ef" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:to="loc_us-gaap_SellingAndMarketingExpense_334a0036-49ae-85df-fa8d-a7de18d975ef" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_a698662c-5d68-9b87-98fe-02485cda58f8" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_a698662c-5d68-9b87-98fe-02485cda58f8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_afd0f625-a29a-3806-bad0-ad0ca19e7015" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_afd0f625-a29a-3806-bad0-ad0ca19e7015" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ChangeInFairValueOfContingentConsideration" xlink:label="loc_ango_ChangeInFairValueOfContingentConsideration_fa92dcad-bf1b-a16f-574c-8c8b5377fd1b" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a2f4cf19-54a3-c9c5-9b4d-23b76125e270" xlink:to="loc_ango_ChangeInFairValueOfContingentConsideration_fa92dcad-bf1b-a16f-574c-8c8b5377fd1b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_df00e688-c7aa-f044-9cba-c48e7c14e35b" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_5c890570-5904-7978-36d8-35b96dcf45ab" xlink:to="loc_us-gaap_GrossProfit_df00e688-c7aa-f044-9cba-c48e7c14e35b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_435f940b-a471-4122-5132-a245458f6913" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_df00e688-c7aa-f044-9cba-c48e7c14e35b" xlink:to="loc_us-gaap_Revenues_435f940b-a471-4122-5132-a245458f6913" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_1c65a201-fd8e-32d7-dad9-c6d1d5719594" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_df00e688-c7aa-f044-9cba-c48e7c14e35b" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_1c65a201-fd8e-32d7-dad9-c6d1d5719594" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/DocumentAndEntityInformation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/EarningsPerShare" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21ce4f2f-397c-6c02-8635-7c94146a06a0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2dd9a981-e559-d141-f1c2-4db79f71a7ef" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21ce4f2f-397c-6c02-8635-7c94146a06a0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2dd9a981-e559-d141-f1c2-4db79f71a7ef" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_d342f32b-4cc6-0bef-3743-616005090121" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_21ce4f2f-397c-6c02-8635-7c94146a06a0" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_d342f32b-4cc6-0bef-3743-616005090121" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/EarningsPerShareTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/FairValueOfFinancialInstruments" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_4f2d2e40-e149-3246-b591-f2ca332c7df6" xlink:type="locator" />
    <link:loc xlink:href="ango-20180531.xsd#ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure" xlink:label="loc_ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure_976B158431FD43AE67508EFEABC42452" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_4f2d2e40-e149-3246-b591-f2ca332c7df6" xlink:to="loc_ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure_976B158431FD43AE67508EFEABC42452" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5ab305fa-195a-59cf-c0de-4b5d05fc9de4" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_4f2d2e40-e149-3246-b591-f2ca332c7df6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5ab305fa-195a-59cf-c0de-4b5d05fc9de4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_6bae24fb-c89c-2c1d-91e1-c77efe1775f1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_eed137f7-f4cf-61e8-5dd4-67d3dd178f58" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_6bae24fb-c89c-2c1d-91e1-c77efe1775f1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_eed137f7-f4cf-61e8-5dd4-67d3dd178f58" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails2" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails3" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssets" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetails1" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7a49df76-38f6-6baa-87dd-2e9a7efd8303" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_7a49df76-38f6-6baa-87dd-2e9a7efd8303" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c9279b6a-f262-f140-7696-5ec40778343f" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c9279b6a-f262-f140-7696-5ec40778343f" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetails2" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_423e6bba-f43d-931c-5711-51d5522b2aaa" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_423e6bba-f43d-931c-5711-51d5522b2aaa" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_28c91f3b-370e-e76f-4199-69e4166aabc6" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_28c91f3b-370e-e76f-4199-69e4166aabc6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f7796428-4176-97fe-5145-79a026d8547a" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f7796428-4176-97fe-5145-79a026d8547a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_71fd8e03-8eaf-f20c-786b-5e0492fb281b" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_71fd8e03-8eaf-f20c-786b-5e0492fb281b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_8d652bfd-fc92-51b1-30d6-b90c4a94f960" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_8d652bfd-fc92-51b1-30d6-b90c4a94f960" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0e7343bd-e798-afc0-7fcc-ed296ae9f91c" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d3bdc20c-5c58-6be6-d756-0ace6a97f212" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0e7343bd-e798-afc0-7fcc-ed296ae9f91c" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetailsTextual" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxes" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19dfad62-5a43-dcc4-04a8-012732c1ed97" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_a4e74316-f31b-80bc-a44a-3464e9dcdb33" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19dfad62-5a43-dcc4-04a8-012732c1ed97" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_a4e74316-f31b-80bc-a44a-3464e9dcdb33" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e6f9d43e-fcd6-745d-b634-9ed4792095b2" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_19dfad62-5a43-dcc4-04a8-012732c1ed97" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e6f9d43e-fcd6-745d-b634-9ed4792095b2" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesDetails2" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e8a9abf2-38d3-77d1-fb6b-693fef632294" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e8a9abf2-38d3-77d1-fb6b-693fef632294" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_816edbc5-9d4b-113c-7ce2-6c08dd555314" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_816edbc5-9d4b-113c-7ce2-6c08dd555314" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_bbb5a6cc-fe5e-18f1-e9f0-76884d58b714" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_816edbc5-9d4b-113c-7ce2-6c08dd555314" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_bbb5a6cc-fe5e-18f1-e9f0-76884d58b714" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4d365c95-da3d-c3cb-6f6b-7945d285af9f" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_816edbc5-9d4b-113c-7ce2-6c08dd555314" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4d365c95-da3d-c3cb-6f6b-7945d285af9f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_b975ff9b-a11f-f2b5-e104-e0266dbbbfc6" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_816edbc5-9d4b-113c-7ce2-6c08dd555314" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_b975ff9b-a11f-f2b5-e104-e0266dbbbfc6" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesDetails3" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_cee36967-7b64-56b0-03ea-66fbd4d14899" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d9af76c3-a64a-3b37-1d7d-4e9be8c70af6" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_cee36967-7b64-56b0-03ea-66fbd4d14899" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d9af76c3-a64a-3b37-1d7d-4e9be8c70af6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_cee36967-7b64-56b0-03ea-66fbd4d14899" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_877d9548-0a6d-f5af-1e31-5b1edfc4107e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_877d9548-0a6d-f5af-1e31-5b1edfc4107e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_187bb760-9cde-c4af-d9e1-306e7a6330eb" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_187bb760-9cde-c4af-d9e1-306e7a6330eb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_8d3f7f58-e2d6-8ff0-86f5-8d249c7b8257" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_8d3f7f58-e2d6-8ff0-86f5-8d249c7b8257" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_475c85ca-97e4-c8e8-9ee2-6c534eb18ace" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_475c85ca-97e4-c8e8-9ee2-6c534eb18ace" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_3f588827-4aa5-a500-5cc2-21e3b2dd8dc2" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_3f588827-4aa5-a500-5cc2-21e3b2dd8dc2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_0e2dc226-85ed-d782-cf37-e83741c371ce" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_d91ede05-f13f-9c89-cfbf-3dfb1dd1a1a6" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_0e2dc226-85ed-d782-cf37-e83741c371ce" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_5ca8e732-540c-5527-8ee3-c835dafc5838" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_cee36967-7b64-56b0-03ea-66fbd4d14899" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_5ca8e732-540c-5527-8ee3-c835dafc5838" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_4ed01819-014a-ce74-957e-ddc9b0c1d62e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5ca8e732-540c-5527-8ee3-c835dafc5838" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_4ed01819-014a-ce74-957e-ddc9b0c1d62e" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesDetails4" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_46fd3e47-b379-3d5b-dad7-1fdc5e88b67f" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_46fd3e47-b379-3d5b-dad7-1fdc5e88b67f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_b8a6f67f-d570-db88-37fa-3568c826ebc5" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_b8a6f67f-d570-db88-37fa-3568c826ebc5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_147896db-b2dd-402f-9f5b-8c57c745a45a" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_147896db-b2dd-402f-9f5b-8c57c745a45a" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_IncomeTaxReconciliationEffectOfForeignOperations" xlink:label="loc_ango_IncomeTaxReconciliationEffectOfForeignOperations_88018469-20a6-2b08-ae9c-8c8b535529f9" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_ango_IncomeTaxReconciliationEffectOfForeignOperations_88018469-20a6-2b08-ae9c-8c8b535529f9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_1c8f4a72-9556-38d6-3d32-089e2d1a35fe" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_1c8f4a72-9556-38d6-3d32-089e2d1a35fe" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_IncomeTaxReconciliationNondeductibleInterestOnContingentPayment" xlink:label="loc_ango_IncomeTaxReconciliationNondeductibleInterestOnContingentPayment_5ca7625c-1788-9532-c206-8c8b53b3b6f9" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_ango_IncomeTaxReconciliationNondeductibleInterestOnContingentPayment_5ca7625c-1788-9532-c206-8c8b53b3b6f9" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability" xlink:label="loc_ango_IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability_990e08ce-6dfa-7663-c10f-8c8b52d78cad" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_ango_IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability_990e08ce-6dfa-7663-c10f-8c8b52d78cad" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_IncomeTaxReconciliationEffectofEliminationofASC718APICPool" xlink:label="loc_ango_IncomeTaxReconciliationEffectofEliminationofASC718APICPool_57e1987d-744c-914e-57e4-8c8b53cabf5d" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_ango_IncomeTaxReconciliationEffectofEliminationofASC718APICPool_57e1987d-744c-914e-57e4-8c8b53cabf5d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_2fc8d554-3ed0-9aae-a23b-3842180d9904" xlink:type="locator" />
    <link:calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_2fc8d554-3ed0-9aae-a23b-3842180d9904" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_7c88fa1f-0edb-d24c-9b87-0646da5010cf" xlink:type="locator" />
    <link:calculationArc order="10" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_7c88fa1f-0edb-d24c-9b87-0646da5010cf" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_cd5d6b42-02c0-feb4-e73a-32cda2d1ac2e" xlink:type="locator" />
    <link:calculationArc order="11" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_cd5d6b42-02c0-feb4-e73a-32cda2d1ac2e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_403b8245-2a5c-b405-4865-11cfdebd2992" xlink:type="locator" />
    <link:calculationArc order="12" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_403b8245-2a5c-b405-4865-11cfdebd2992" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount" xlink:label="loc_ango_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_001887C5F716691B36A2A444D843BD0F" xlink:type="locator" />
    <link:calculationArc order="13" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_97bbae57-7f84-4da9-acab-610e56204929" xlink:to="loc_ango_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_001887C5F716691B36A2A444D843BD0F" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesDetailsTextual" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesIncomeTaxesDetails5" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/Inventories" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_66bcd79a-a1c3-c24d-b8b4-7a0ce373714b" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaap_InventoryRawMaterials_aec9630a-9e19-cd8f-8217-90be7ac55d44" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_66bcd79a-a1c3-c24d-b8b4-7a0ce373714b" xlink:to="loc_us-gaap_InventoryRawMaterials_aec9630a-9e19-cd8f-8217-90be7ac55d44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaap_InventoryWorkInProcess_9a39fd9b-6ecf-21de-0dc6-98f2a03e9440" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_66bcd79a-a1c3-c24d-b8b4-7a0ce373714b" xlink:to="loc_us-gaap_InventoryWorkInProcess_9a39fd9b-6ecf-21de-0dc6-98f2a03e9440" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaap_InventoryFinishedGoods_4e166bbb-377c-800b-7f59-05671dfec1ab" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_66bcd79a-a1c3-c24d-b8b4-7a0ce373714b" xlink:to="loc_us-gaap_InventoryFinishedGoods_4e166bbb-377c-800b-7f59-05671dfec1ab" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/InventoriesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/LongTermDebt" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/LongTermDebtDetails1" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_80dca0ba-44dc-8565-fb9b-c2edfc8c357d" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_88b8f1df-ff6f-5cd6-e45f-5878f70c11d5" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_80dca0ba-44dc-8565-fb9b-c2edfc8c357d" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_88b8f1df-ff6f-5cd6-e45f-5878f70c11d5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_53634569-cdf7-3d1b-42b0-596cb4175c67" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_88b8f1df-ff6f-5cd6-e45f-5878f70c11d5" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_53634569-cdf7-3d1b-42b0-596cb4175c67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c4573bf7-1f66-8dfe-59b9-b6903f55406f" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_88b8f1df-ff6f-5cd6-e45f-5878f70c11d5" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c4573bf7-1f66-8dfe-59b9-b6903f55406f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e00da32d-ed06-bb21-8b28-7e7ede769972" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_88b8f1df-ff6f-5cd6-e45f-5878f70c11d5" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_e00da32d-ed06-bb21-8b28-7e7ede769972" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_89018c92-f86f-28e7-853c-438f4a34e1f6" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_88b8f1df-ff6f-5cd6-e45f-5878f70c11d5" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_89018c92-f86f-28e7-853c-438f4a34e1f6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_2741d981-c21a-e533-a8bb-deb13ff09cbf" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_80dca0ba-44dc-8565-fb9b-c2edfc8c357d" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_2741d981-c21a-e533-a8bb-deb13ff09cbf" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/LongTermDebtDetails1Calc2" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_76AE3827A59C62369E6F900279057AC2_80dca0ba-44dc-8565-fb9b-c2edfc8c357d" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_76AE3827A59C62369E6F900279057AC2_0d8925ae-714a-26e4-aa69-2d9eac65a5c6" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_76AE3827A59C62369E6F900279057AC2_80dca0ba-44dc-8565-fb9b-c2edfc8c357d" xlink:to="loc_us-gaap_LongTermDebtCurrent_76AE3827A59C62369E6F900279057AC2_0d8925ae-714a-26e4-aa69-2d9eac65a5c6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_76AE3827A59C62369E6F900279057AC2_fcfc6b17-bfc5-2ebc-3fc1-751aa446a572" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_76AE3827A59C62369E6F900279057AC2_80dca0ba-44dc-8565-fb9b-c2edfc8c357d" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_76AE3827A59C62369E6F900279057AC2_fcfc6b17-bfc5-2ebc-3fc1-751aa446a572" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/LongTermDebtDetailsTextual" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/LongTermDebtTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/MarketableSecurities" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/MarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f0bf2241-14f8-6ef1-e8d7-f724d52ad9c1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5d23fa7e-7f76-6507-b72f-382f81b88e34" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f0bf2241-14f8-6ef1-e8d7-f724d52ad9c1" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5d23fa7e-7f76-6507-b72f-382f81b88e34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e0f935d0-20e2-15fc-55a1-79c116fbc07c" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f0bf2241-14f8-6ef1-e8d7-f724d52ad9c1" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e0f935d0-20e2-15fc-55a1-79c116fbc07c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_d32a2417-a96e-df92-8909-70df29d31528" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f0bf2241-14f8-6ef1-e8d7-f724d52ad9c1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_d32a2417-a96e-df92-8909-70df29d31528" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/MarketableSecuritiesDetails1" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f0bf2241-14f8-6ef1-e8d7-f724d52ad9c1" xlink:type="locator" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost" xlink:label="loc_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost_d213296d-3509-f514-3018-8c8b533d7de2" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f0bf2241-14f8-6ef1-e8d7-f724d52ad9c1" xlink:to="loc_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost_d213296d-3509-f514-3018-8c8b533d7de2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_ad47d869-5bf7-62ba-8427-e58f9319b050" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f0bf2241-14f8-6ef1-e8d7-f724d52ad9c1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_ad47d869-5bf7-62ba-8427-e58f9319b050" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_a97722c4-c88e-0258-6d8c-8f5c45929660" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_f0bf2241-14f8-6ef1-e8d7-f724d52ad9c1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_a97722c4-c88e-0258-6d8c-8f5c45929660" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5ab305fa-195a-59cf-c0de-4b5d05fc9de4" xlink:type="locator" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue" xlink:label="loc_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue_07a85dbc-2d9f-a2bf-caae-8c8b53d1eacd" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5ab305fa-195a-59cf-c0de-4b5d05fc9de4" xlink:to="loc_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue_07a85dbc-2d9f-a2bf-caae-8c8b53d1eacd" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_bb6f3730-d49d-30bc-8e52-6eba94f7dba4" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5ab305fa-195a-59cf-c0de-4b5d05fc9de4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_bb6f3730-d49d-30bc-8e52-6eba94f7dba4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_329a232f-6b5a-4dfb-de74-33d6f53aa8f1" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5ab305fa-195a-59cf-c0de-4b5d05fc9de4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_329a232f-6b5a-4dfb-de74-33d6f53aa8f1" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/MarketableSecuritiesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/OtherAssets" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/OtherAssetsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/PrepaidExpensesAndOther" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/PrepaidExpensesAndOtherDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ce9014ac-0ac4-6ed2-b53f-a0edc046d6b4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_f8bba565-b2b1-7745-e5f2-79c3ddd7f45e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ce9014ac-0ac4-6ed2-b53f-a0edc046d6b4" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_f8bba565-b2b1-7745-e5f2-79c3ddd7f45e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidRent" xlink:label="loc_us-gaap_PrepaidRent_bb681f43-ece5-4187-41d8-fd751addc1ac" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ce9014ac-0ac4-6ed2-b53f-a0edc046d6b4" xlink:to="loc_us-gaap_PrepaidRent_bb681f43-ece5-4187-41d8-fd751addc1ac" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PrepaidLicenseeFees" xlink:label="loc_ango_PrepaidLicenseeFees_7e3eb4b8-fb28-e454-f425-8c8b5370de0c" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ce9014ac-0ac4-6ed2-b53f-a0edc046d6b4" xlink:to="loc_ango_PrepaidLicenseeFees_7e3eb4b8-fb28-e454-f425-8c8b5370de0c" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_SoftwareLicenses" xlink:label="loc_ango_SoftwareLicenses_f4ee532a-974e-c707-1d35-8c8b53a0799a" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ce9014ac-0ac4-6ed2-b53f-a0edc046d6b4" xlink:to="loc_ango_SoftwareLicenses_f4ee532a-974e-c707-1d35-8c8b53a0799a" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_TradeShows" xlink:label="loc_ango_TradeShows_c2e5d55a-b45d-60cd-280e-8c8b53e512a5" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ce9014ac-0ac4-6ed2-b53f-a0edc046d6b4" xlink:to="loc_ango_TradeShows_c2e5d55a-b45d-60cd-280e-8c8b53e512a5" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PrepaidIncomeandOtherTaxes" xlink:label="loc_ango_PrepaidIncomeandOtherTaxes_73290e4b-b65c-1f4c-e337-8c8b53cc2dd5" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ce9014ac-0ac4-6ed2-b53f-a0edc046d6b4" xlink:to="loc_ango_PrepaidIncomeandOtherTaxes_73290e4b-b65c-1f4c-e337-8c8b53cc2dd5" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_MedicalDeviceExciseTaxReceivable" xlink:label="loc_ango_MedicalDeviceExciseTaxReceivable_e4ac7a0e-fbf2-7853-2098-8c8b53deaa26" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ce9014ac-0ac4-6ed2-b53f-a0edc046d6b4" xlink:to="loc_ango_MedicalDeviceExciseTaxReceivable_e4ac7a0e-fbf2-7853-2098-8c8b53deaa26" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/PrepaidExpensesAndOtherTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNet" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f37ad080-c77a-efc5-c936-389b16abc420" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LandAndLandImprovements" xlink:label="loc_us-gaap_LandAndLandImprovements_e240a8fd-cf4b-1549-e89e-9829b9a44d17" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f37ad080-c77a-efc5-c936-389b16abc420" xlink:to="loc_us-gaap_LandAndLandImprovements_e240a8fd-cf4b-1549-e89e-9829b9a44d17" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements" xlink:label="loc_ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements_33954e10-3ff1-03b1-b36f-8c8b53a208cc" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_f37ad080-c77a-efc5-c936-389b16abc420" xlink:to="loc_ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements_33954e10-3ff1-03b1-b36f-8c8b53a208cc" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0a08cda9-11b3-e7ac-3fc9-3a23c67d9b96" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements_33954e10-3ff1-03b1-b36f-8c8b53a208cc" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0a08cda9-11b3-e7ac-3fc9-3a23c67d9b96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_78662f7f-2a6a-5d68-ba8a-7947ed287be5" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements_33954e10-3ff1-03b1-b36f-8c8b53a208cc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_78662f7f-2a6a-5d68-ba8a-7947ed287be5" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNetTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/QuarterlyInformationUnaudited" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/QuarterlyInformationUnauditedDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/QuarterlyInformationUnauditedTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/RetirementPlans" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/RetirementPlansDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/SegmentsAndGeographicInformation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetails1" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetailsTextual" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/StockholdersEquity" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/StockholdersEquityDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/StockholdersEquityDetails2" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/StockholdersEquityDetails3" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/StockholdersEquityDetailsTextual" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/StockholdersEquityTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/ValuationAndQualifyingAccounts" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.angiodynamics.com/role/ValuationAndQualifyingAccountsDetails" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>16
<FILENAME>ango-20180531_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccruedLiabilities" xlink:href="ango-20180531.xsd#AccruedLiabilities" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccruedLiabilitiesAccruedLiabilitesDetailsTextual" xlink:href="ango-20180531.xsd#AccruedLiabilitiesAccruedLiabilitesDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccruedLiabilitiesDetails" xlink:href="ango-20180531.xsd#AccruedLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccruedLiabilitiesTables" xlink:href="ango-20180531.xsd#AccruedLiabilitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:href="ango-20180531.xsd#AccumulatedOtherComprehensiveIncomeLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="ango-20180531.xsd#AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:href="ango-20180531.xsd#AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNet" xlink:href="ango-20180531.xsd#AcquisitionRestructuringAndOtherItemsNet" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails" xlink:href="ango-20180531.xsd#AcquisitionRestructuringAndOtherItemsNetDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails1" xlink:href="ango-20180531.xsd#AcquisitionRestructuringAndOtherItemsNetDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails2" xlink:href="ango-20180531.xsd#AcquisitionRestructuringAndOtherItemsNetDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetTables" xlink:href="ango-20180531.xsd#AcquisitionRestructuringAndOtherItemsNetTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPolicies" xlink:href="ango-20180531.xsd#BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesDetailsTextual" xlink:href="ango-20180531.xsd#BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ango-20180531.xsd#BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesTables" xlink:href="ango-20180531.xsd#BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/CommitmentsAndContingencies" xlink:href="ango-20180531.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetails" xlink:href="ango-20180531.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetails1" xlink:href="ango-20180531.xsd#CommitmentsAndContingenciesDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetailsTextual" xlink:href="ango-20180531.xsd#CommitmentsAndContingenciesDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/CommitmentsAndContingenciesTables" xlink:href="ango-20180531.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedBalanceSheets" xlink:href="ango-20180531.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="ango-20180531.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsComprehensiveIncomeLoss" xlink:href="ango-20180531.xsd#ConsolidatedStatementsComprehensiveIncomeLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="ango-20180531.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsOfOperations" xlink:href="ango-20180531.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="ango-20180531.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/DocumentAndEntityInformation" xlink:href="ango-20180531.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/EarningsPerShare" xlink:href="ango-20180531.xsd#EarningsPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/EarningsPerShareDetails" xlink:href="ango-20180531.xsd#EarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/EarningsPerShareTables" xlink:href="ango-20180531.xsd#EarningsPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueOfFinancialInstruments" xlink:href="ango-20180531.xsd#FairValueOfFinancialInstruments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" xlink:href="ango-20180531.xsd#FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails2" xlink:href="ango-20180531.xsd#FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails3" xlink:href="ango-20180531.xsd#FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsTables" xlink:href="ango-20180531.xsd#FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssets" xlink:href="ango-20180531.xsd#GoodwillAndIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetails1" xlink:href="ango-20180531.xsd#GoodwillAndIntangibleAssetsDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetails2" xlink:href="ango-20180531.xsd#GoodwillAndIntangibleAssetsDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetailsTextual" xlink:href="ango-20180531.xsd#GoodwillAndIntangibleAssetsDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsTables" xlink:href="ango-20180531.xsd#GoodwillAndIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxes" xlink:href="ango-20180531.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetails" xlink:href="ango-20180531.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetails2" xlink:href="ango-20180531.xsd#IncomeTaxesDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetails3" xlink:href="ango-20180531.xsd#IncomeTaxesDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetails4" xlink:href="ango-20180531.xsd#IncomeTaxesDetails4" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetailsTextual" xlink:href="ango-20180531.xsd#IncomeTaxesDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesIncomeTaxesDetails5" xlink:href="ango-20180531.xsd#IncomeTaxesIncomeTaxesDetails5" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesTables" xlink:href="ango-20180531.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/Inventories" xlink:href="ango-20180531.xsd#Inventories" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/InventoriesDetails" xlink:href="ango-20180531.xsd#InventoriesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/InventoriesTables" xlink:href="ango-20180531.xsd#InventoriesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LongTermDebt" xlink:href="ango-20180531.xsd#LongTermDebt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LongTermDebtDetails1" xlink:href="ango-20180531.xsd#LongTermDebtDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LongTermDebtDetailsTextual" xlink:href="ango-20180531.xsd#LongTermDebtDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LongTermDebtTables" xlink:href="ango-20180531.xsd#LongTermDebtTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/MarketableSecurities" xlink:href="ango-20180531.xsd#MarketableSecurities" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/MarketableSecuritiesDetails" xlink:href="ango-20180531.xsd#MarketableSecuritiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/MarketableSecuritiesDetails1" xlink:href="ango-20180531.xsd#MarketableSecuritiesDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/MarketableSecuritiesTables" xlink:href="ango-20180531.xsd#MarketableSecuritiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/OtherAssets" xlink:href="ango-20180531.xsd#OtherAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/OtherAssetsDetails" xlink:href="ango-20180531.xsd#OtherAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/PrepaidExpensesAndOther" xlink:href="ango-20180531.xsd#PrepaidExpensesAndOther" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/PrepaidExpensesAndOtherDetails" xlink:href="ango-20180531.xsd#PrepaidExpensesAndOtherDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/PrepaidExpensesAndOtherTables" xlink:href="ango-20180531.xsd#PrepaidExpensesAndOtherTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNet" xlink:href="ango-20180531.xsd#PropertyPlantAndEquipmentNet" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNetDetails" xlink:href="ango-20180531.xsd#PropertyPlantAndEquipmentNetDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNetTables" xlink:href="ango-20180531.xsd#PropertyPlantAndEquipmentNetTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/QuarterlyInformationUnaudited" xlink:href="ango-20180531.xsd#QuarterlyInformationUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/QuarterlyInformationUnauditedDetails" xlink:href="ango-20180531.xsd#QuarterlyInformationUnauditedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/QuarterlyInformationUnauditedTables" xlink:href="ango-20180531.xsd#QuarterlyInformationUnauditedTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/RetirementPlans" xlink:href="ango-20180531.xsd#RetirementPlans" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/RetirementPlansDetails" xlink:href="ango-20180531.xsd#RetirementPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentsAndGeographicInformation" xlink:href="ango-20180531.xsd#SegmentsAndGeographicInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetails" xlink:href="ango-20180531.xsd#SegmentsAndGeographicInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetails1" xlink:href="ango-20180531.xsd#SegmentsAndGeographicInformationDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetailsTextual" xlink:href="ango-20180531.xsd#SegmentsAndGeographicInformationDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationTables" xlink:href="ango-20180531.xsd#SegmentsAndGeographicInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/StockholdersEquity" xlink:href="ango-20180531.xsd#StockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/StockholdersEquityDetails" xlink:href="ango-20180531.xsd#StockholdersEquityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/StockholdersEquityDetails2" xlink:href="ango-20180531.xsd#StockholdersEquityDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/StockholdersEquityDetails3" xlink:href="ango-20180531.xsd#StockholdersEquityDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/StockholdersEquityDetailsTextual" xlink:href="ango-20180531.xsd#StockholdersEquityDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/StockholdersEquityTables" xlink:href="ango-20180531.xsd#StockholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ValuationAndQualifyingAccounts" xlink:href="ango-20180531.xsd#ValuationAndQualifyingAccounts" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ValuationAndQualifyingAccountsDetails" xlink:href="ango-20180531.xsd#ValuationAndQualifyingAccountsDetails" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/AccruedLiabilities" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/AccruedLiabilitiesAccruedLiabilitesDetailsTextual" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15A0D3891B93629B7A468F96E19FF3BF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_FA9295DDFC897B6643768F96E198CB15" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15A0D3891B93629B7A468F96E19FF3BF" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_FA9295DDFC897B6643768F96E198CB15" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_33F76C65CA03B583EBE08F96E1985EBC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_FA9295DDFC897B6643768F96E198CB15" xlink:to="loc_srt_ProductOrServiceAxis_33F76C65CA03B583EBE08F96E1985EBC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_B149E86D8A451FBCF4B48F96E19D577B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_33F76C65CA03B583EBE08F96E1985EBC" xlink:to="loc_srt_ProductsAndServicesDomain_B149E86D8A451FBCF4B48F96E19D577B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_B149E86D8A451FBCF4B48F96E19D577B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_33F76C65CA03B583EBE08F96E1985EBC" xlink:to="loc_srt_ProductsAndServicesDomain_B149E86D8A451FBCF4B48F96E19D577B" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AcculisCapitalSystemsMember" xlink:label="loc_ango_AcculisCapitalSystemsMember_C655142BF4323042E7888F96E19E7F7F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_B149E86D8A451FBCF4B48F96E19D577B" xlink:to="loc_ango_AcculisCapitalSystemsMember_C655142BF4323042E7888F96E19E7F7F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupClassificationAxis" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_D5355D97C43728000EB08F96E19E4807" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_FA9295DDFC897B6643768F96E198CB15" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_D5355D97C43728000EB08F96E19E4807" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupClassificationDomain" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_CD6196E23598C24126348F96E19ECE95_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_D5355D97C43728000EB08F96E19E4807" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_CD6196E23598C24126348F96E19ECE95_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupClassificationDomain" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_CD6196E23598C24126348F96E19ECE95" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_D5355D97C43728000EB08F96E19E4807" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_CD6196E23598C24126348F96E19ECE95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_7EE91CD357AF7E14D2728F96E19E6DAE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_CD6196E23598C24126348F96E19ECE95" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_7EE91CD357AF7E14D2728F96E19E6DAE" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_RecallPeriod" xlink:label="loc_ango_RecallPeriod_D81E278FEF90B3FF2C5E8F96E19F082E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15A0D3891B93629B7A468F96E19FF3BF" xlink:to="loc_ango_RecallPeriod_D81E278FEF90B3FF2C5E8F96E19F082E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_609DE31ECD86849828DA8F96E19F69C0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15A0D3891B93629B7A468F96E19FF3BF" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_609DE31ECD86849828DA8F96E19F69C0" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/AccruedLiabilitiesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/AccruedLiabilitiesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_E6CD8631E5AFC64E8E0DA8E2D564B249" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_5A642BCABB7293A7C0C9A8E2D5643B36" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_E6CD8631E5AFC64E8E0DA8E2D564B249" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_5A642BCABB7293A7C0C9A8E2D5643B36" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6F194A796B01D1E23BBEA8E2D56408DB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_5A642BCABB7293A7C0C9A8E2D5643B36" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6F194A796B01D1E23BBEA8E2D56408DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_3A0C079B7301AEAAE285A8E2D564E5B9_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6F194A796B01D1E23BBEA8E2D56408DB" xlink:to="loc_us-gaap_EquityComponentDomain_3A0C079B7301AEAAE285A8E2D564E5B9_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_3A0C079B7301AEAAE285A8E2D564E5B9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6F194A796B01D1E23BBEA8E2D56408DB" xlink:to="loc_us-gaap_EquityComponentDomain_3A0C079B7301AEAAE285A8E2D564E5B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_5E25DBB25CDA2D6F84E3A8E2D5640D3C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3A0C079B7301AEAAE285A8E2D564E5B9" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_5E25DBB25CDA2D6F84E3A8E2D5640D3C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_EC62A31E57B01E6BD6A3A8E2D564E05A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3A0C079B7301AEAAE285A8E2D564E5B9" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_EC62A31E57B01E6BD6A3A8E2D564E05A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_11560EF746BF3B221074A8E2D5647934" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3A0C079B7301AEAAE285A8E2D564E5B9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_11560EF746BF3B221074A8E2D5647934" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B3F7D0970A097A342126A8E2D564539F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_E6CD8631E5AFC64E8E0DA8E2D564B249" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B3F7D0970A097A342126A8E2D564539F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_5AAA0E22D1FCDADB915FA8E2D56433EB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B3F7D0970A097A342126A8E2D564539F" xlink:to="loc_us-gaap_StockholdersEquity_5AAA0E22D1FCDADB915FA8E2D56433EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_0CB8CBE199BA475F630FA8E2D564D5F6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B3F7D0970A097A342126A8E2D564539F" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_0CB8CBE199BA475F630FA8E2D564D5F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_A4B1AAC81F1D7DB65463A8E2D5647DCE" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B3F7D0970A097A342126A8E2D564539F" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_A4B1AAC81F1D7DB65463A8E2D5647DCE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_110DFF3F83037EFE56E6A8E2D564B4D7" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B3F7D0970A097A342126A8E2D564539F" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_110DFF3F83037EFE56E6A8E2D564B4D7" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNet" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_0702E954AD5168DA370F8F96E05774B1" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_AA670B84CE2647F665B48F96E055E67C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0702E954AD5168DA370F8F96E05774B1" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_AA670B84CE2647F665B48F96E055E67C" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_DB805338EB9B9583D1AA8F96E05602ED" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_AA670B84CE2647F665B48F96E055E67C" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_DB805338EB9B9583D1AA8F96E05602ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_D7A545DDAB0E700D47C08F96E05675CB_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_DB805338EB9B9583D1AA8F96E05602ED" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_D7A545DDAB0E700D47C08F96E05675CB_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_D7A545DDAB0E700D47C08F96E05675CB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_DB805338EB9B9583D1AA8F96E05602ED" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_D7A545DDAB0E700D47C08F96E05675CB" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_LegalCostsMember" xlink:label="loc_ango_LegalCostsMember_9B53C65DD7E485142A3C8F96E0566CFA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_D7A545DDAB0E700D47C08F96E05675CB" xlink:to="loc_ango_LegalCostsMember_9B53C65DD7E485142A3C8F96E0566CFA" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_IntangibleImpairmentMember" xlink:label="loc_ango_IntangibleImpairmentMember_D2B2FC9E5B262C42E7328F96E057DC07" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_D7A545DDAB0E700D47C08F96E05675CB" xlink:to="loc_ango_IntangibleImpairmentMember_D2B2FC9E5B262C42E7328F96E057DC07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FacilityClosingMember" xlink:label="loc_us-gaap_FacilityClosingMember_95F8508717DCB4C140FB8F96E05754FF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_D7A545DDAB0E700D47C08F96E05675CB" xlink:to="loc_us-gaap_FacilityClosingMember_95F8508717DCB4C140FB8F96E05754FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherRestructuringMember" xlink:label="loc_us-gaap_OtherRestructuringMember_E5956215026DBE4787C38F96E057360A" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_D7A545DDAB0E700D47C08F96E05675CB" xlink:to="loc_us-gaap_OtherRestructuringMember_E5956215026DBE4787C38F96E057360A" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AcquisitionRestructuringAndOtherItemsNet" xlink:label="loc_ango_AcquisitionRestructuringAndOtherItemsNet_9E23AF382877EFB431288F96E0578762" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0702E954AD5168DA370F8F96E05774B1" xlink:to="loc_ango_AcquisitionRestructuringAndOtherItemsNet_9E23AF382877EFB431288F96E0578762" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails1" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_22F1BF9DF8D44F01FFC694C42DFA4299" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2C8A4641F592C6FFDF0994C42DFA7A4C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_22F1BF9DF8D44F01FFC694C42DFA4299" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2C8A4641F592C6FFDF0994C42DFA7A4C" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_DEE05F2FBD29A9F65A4F94C42DFA33A6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2C8A4641F592C6FFDF0994C42DFA7A4C" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_DEE05F2FBD29A9F65A4F94C42DFA33A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_BAEF598532B7E6B87F9494C42DFA2F7E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_DEE05F2FBD29A9F65A4F94C42DFA33A6" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_BAEF598532B7E6B87F9494C42DFA2F7E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_BAEF598532B7E6B87F9494C42DFA2F7E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_DEE05F2FBD29A9F65A4F94C42DFA33A6" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_BAEF598532B7E6B87F9494C42DFA2F7E" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_LegalCostsMember" xlink:label="loc_ango_LegalCostsMember_3E159C70DB7FCE3747A194C42DFA013F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_BAEF598532B7E6B87F9494C42DFA2F7E" xlink:to="loc_ango_LegalCostsMember_3E159C70DB7FCE3747A194C42DFA013F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_LitigationCaseAxis" xlink:label="loc_srt_LitigationCaseAxis_F4D49CF8C228B240211B94CD75BC82A8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2C8A4641F592C6FFDF0994C42DFA7A4C" xlink:to="loc_srt_LitigationCaseAxis_F4D49CF8C228B240211B94CD75BC82A8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_5876C9F98738ED20464094CD75EBFA3D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_F4D49CF8C228B240211B94CD75BC82A8" xlink:to="loc_srt_LitigationCaseTypeDomain_5876C9F98738ED20464094CD75EBFA3D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_5876C9F98738ED20464094CD75EBFA3D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_F4D49CF8C228B240211B94CD75BC82A8" xlink:to="loc_srt_LitigationCaseTypeDomain_5876C9F98738ED20464094CD75EBFA3D" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_DOJLitigationMember" xlink:label="loc_ango_DOJLitigationMember_82D767CB17DF7D76364D94CE16648AF8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_5876C9F98738ED20464094CD75EBFA3D" xlink:to="loc_ango_DOJLitigationMember_82D767CB17DF7D76364D94CE16648AF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_F5A03560C792DE58728594C42DFA226A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2C8A4641F592C6FFDF0994C42DFA7A4C" xlink:to="loc_us-gaap_RestructuringPlanAxis_F5A03560C792DE58728594C42DFA226A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_1F1E70B2186368220B5494C42DFAAA46_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_F5A03560C792DE58728594C42DFA226A" xlink:to="loc_us-gaap_RestructuringPlanDomain_1F1E70B2186368220B5494C42DFAAA46_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_1F1E70B2186368220B5494C42DFAAA46" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_F5A03560C792DE58728594C42DFA226A" xlink:to="loc_us-gaap_RestructuringPlanDomain_1F1E70B2186368220B5494C42DFAAA46" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember" xlink:label="loc_ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember_1381BABCD63B34828FF994C42DFA1B04" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_1F1E70B2186368220B5494C42DFAAA46" xlink:to="loc_ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember_1381BABCD63B34828FF994C42DFA1B04" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_12E491B6EA31B07586D794C42DFAA7A5" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2C8A4641F592C6FFDF0994C42DFA7A4C" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_12E491B6EA31B07586D794C42DFAA7A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_551DC2DDEFD3D5F4D9BB94C42DFAF701_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_12E491B6EA31B07586D794C42DFAA7A5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_551DC2DDEFD3D5F4D9BB94C42DFAF701_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_551DC2DDEFD3D5F4D9BB94C42DFAF701" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_12E491B6EA31B07586D794C42DFAA7A5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_551DC2DDEFD3D5F4D9BB94C42DFAF701" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AccruedExpensesMember" xlink:label="loc_ango_AccruedExpensesMember_861AE7BDFD006779AB1594C42DFA6810" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_551DC2DDEFD3D5F4D9BB94C42DFAF701" xlink:to="loc_ango_AccruedExpensesMember_861AE7BDFD006779AB1594C42DFA6810" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AcquisitionRestructuringAndOtherItemsNet" xlink:label="loc_ango_AcquisitionRestructuringAndOtherItemsNet_C25BB7E790524A8AB42B94C42DFAE3EC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_22F1BF9DF8D44F01FFC694C42DFA4299" xlink:to="loc_ango_AcquisitionRestructuringAndOtherItemsNet_C25BB7E790524A8AB42B94C42DFAE3EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_2A5263B5C4243BCF953F94C42DFAAE23" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_22F1BF9DF8D44F01FFC694C42DFA4299" xlink:to="loc_us-gaap_RestructuringCharges_2A5263B5C4243BCF953F94C42DFAAE23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_A2651B8BAA7C98263AA594C42DFA536B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_22F1BF9DF8D44F01FFC694C42DFA4299" xlink:to="loc_us-gaap_RestructuringReserve_A2651B8BAA7C98263AA594C42DFA536B" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails2" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_0DAEE1EB9AA6C9C97B948F96E0498C69" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_FDD6713F96AE17969B2D8F96E0462A4E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0DAEE1EB9AA6C9C97B948F96E0498C69" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_FDD6713F96AE17969B2D8F96E0462A4E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_B1481B1745C59046DFF48F96E04758D1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_FDD6713F96AE17969B2D8F96E0462A4E" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_B1481B1745C59046DFF48F96E04758D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_1DC6085EA41772D8CC4D8F96E0474E04_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_B1481B1745C59046DFF48F96E04758D1" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_1DC6085EA41772D8CC4D8F96E0474E04_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_1DC6085EA41772D8CC4D8F96E0474E04" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_B1481B1745C59046DFF48F96E04758D1" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_1DC6085EA41772D8CC4D8F96E0474E04" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OneTimeTerminationBenefitsMember" xlink:label="loc_us-gaap_OneTimeTerminationBenefitsMember_C974D09689CD61B291838F96E04851D3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_1DC6085EA41772D8CC4D8F96E0474E04" xlink:to="loc_us-gaap_OneTimeTerminationBenefitsMember_C974D09689CD61B291838F96E04851D3" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_EquipmentTransferMember" xlink:label="loc_ango_EquipmentTransferMember_36CB5B4B76B0CE722CC08F96E04802DD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_1DC6085EA41772D8CC4D8F96E0474E04" xlink:to="loc_ango_EquipmentTransferMember_36CB5B4B76B0CE722CC08F96E04802DD" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_RegulatoryFilingsMember" xlink:label="loc_ango_RegulatoryFilingsMember_8808ADA3F47C79C0505C8F96E0485972" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_1DC6085EA41772D8CC4D8F96E0474E04" xlink:to="loc_ango_RegulatoryFilingsMember_8808ADA3F47C79C0505C8F96E0485972" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractTerminationMember" xlink:label="loc_us-gaap_ContractTerminationMember_AC28BE37F457050E24ED8F96E048BEAB" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_1DC6085EA41772D8CC4D8F96E0474E04" xlink:to="loc_us-gaap_ContractTerminationMember_AC28BE37F457050E24ED8F96E048BEAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherRestructuringMember" xlink:label="loc_us-gaap_OtherRestructuringMember_1E4571F54B6EC68FCE058F96E0489989" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_1DC6085EA41772D8CC4D8F96E0474E04" xlink:to="loc_us-gaap_OtherRestructuringMember_1E4571F54B6EC68FCE058F96E0489989" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_DB7398215B9DE3E5B1D4904068695ABB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0DAEE1EB9AA6C9C97B948F96E0498C69" xlink:to="loc_us-gaap_RestructuringReserveRollForward_DB7398215B9DE3E5B1D4904068695ABB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_D51D29B3FFBD55AC19178F96E0491860" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_DB7398215B9DE3E5B1D4904068695ABB" xlink:to="loc_us-gaap_RestructuringReserve_D51D29B3FFBD55AC19178F96E0491860" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_CCE404C21C2007E75D1B8F96E0493D58" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_DB7398215B9DE3E5B1D4904068695ABB" xlink:to="loc_us-gaap_RestructuringCharges_CCE404C21C2007E75D1B8F96E0493D58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_263FFE42C9020B2D671F8F96E049F0FE" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_DB7398215B9DE3E5B1D4904068695ABB" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_263FFE42C9020B2D671F8F96E049F0FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_F402B5DFC5D125CCA2FC8F96E049687F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_DB7398215B9DE3E5B1D4904068695ABB" xlink:to="loc_us-gaap_PaymentsForRestructuring_F402B5DFC5D125CCA2FC8F96E049687F" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesDetailsTextual" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1EE559B88EC37DDDBBFBA3DCC60FEC9F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1EE559B88EC37DDDBBFBA3DCC60FEC9F" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6752DD6F92F00CCE3342A3DCC60F4426" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1EE559B88EC37DDDBBFBA3DCC60FEC9F" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6752DD6F92F00CCE3342A3DCC60F4426" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_89D62285B5E739B845FDA3DCC60F7441_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6752DD6F92F00CCE3342A3DCC60F4426" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_89D62285B5E739B845FDA3DCC60F7441_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_89D62285B5E739B845FDA3DCC60F7441" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6752DD6F92F00CCE3342A3DCC60F4426" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_89D62285B5E739B845FDA3DCC60F7441" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_333D2942293AB8562172A3DCC60F167A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_89D62285B5E739B845FDA3DCC60F7441" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_333D2942293AB8562172A3DCC60F167A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_9FCD81A215BF1FBF842EA3DCC60F573D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_89D62285B5E739B845FDA3DCC60F7441" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_9FCD81A215BF1FBF842EA3DCC60F573D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_B4AA4305B5F519EBEA34A3DCC60F9AE3" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_89D62285B5E739B845FDA3DCC60F7441" xlink:to="loc_us-gaap_ComputerEquipmentMember_B4AA4305B5F519EBEA34A3DCC60F9AE3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_2BDF733CBFCF2ED4206AA3DCC60FC302" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1EE559B88EC37DDDBBFBA3DCC60FEC9F" xlink:to="loc_srt_RangeAxis_2BDF733CBFCF2ED4206AA3DCC60FC302" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_A31835FFF98E2CBD7BD6A3DCC60F512C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2BDF733CBFCF2ED4206AA3DCC60FC302" xlink:to="loc_srt_RangeMember_A31835FFF98E2CBD7BD6A3DCC60F512C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_A31835FFF98E2CBD7BD6A3DCC60F512C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2BDF733CBFCF2ED4206AA3DCC60FC302" xlink:to="loc_srt_RangeMember_A31835FFF98E2CBD7BD6A3DCC60F512C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_A00FB39D9839846429B0A3DCC60FCD2F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_A31835FFF98E2CBD7BD6A3DCC60F512C" xlink:to="loc_srt_MinimumMember_A00FB39D9839846429B0A3DCC60FCD2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_9878A8E830E7C27D15BFA3DCC60F5FA9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_A31835FFF98E2CBD7BD6A3DCC60F512C" xlink:to="loc_srt_MaximumMember_9878A8E830E7C27D15BFA3DCC60F5FA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_FD6AC8F0A290B5D5D12DA3DCC60F6C72" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1EE559B88EC37DDDBBFBA3DCC60FEC9F" xlink:to="loc_us-gaap_AwardTypeAxis_FD6AC8F0A290B5D5D12DA3DCC60F6C72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_CA5E9246B2936ED5F81BA3DCC60FA54B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_FD6AC8F0A290B5D5D12DA3DCC60F6C72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_CA5E9246B2936ED5F81BA3DCC60FA54B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_CA5E9246B2936ED5F81BA3DCC60FA54B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_FD6AC8F0A290B5D5D12DA3DCC60F6C72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_CA5E9246B2936ED5F81BA3DCC60FA54B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_461B0888C07AED492615A3DCC60FA9F4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_CA5E9246B2936ED5F81BA3DCC60FA54B" xlink:to="loc_us-gaap_EmployeeStockOptionMember_461B0888C07AED492615A3DCC60FA9F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_ABD8D33D525C88B2EE8EA3DCC60FA2AE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_CA5E9246B2936ED5F81BA3DCC60FA54B" xlink:to="loc_us-gaap_RestrictedStockMember_ABD8D33D525C88B2EE8EA3DCC60FA2AE" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ShortTermInvestmentsMaturityPeriod" xlink:label="loc_ango_ShortTermInvestmentsMaturityPeriod_884913E3F0E4FDBC85C3A3DCC60F427F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_ango_ShortTermInvestmentsMaturityPeriod_884913E3F0E4FDBC85C3A3DCC60F427F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_0F230512C253553C4B50A3DCC60FFFC6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_0F230512C253553C4B50A3DCC60FFFC6" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AccountsReceivableDuePeriod" xlink:label="loc_ango_AccountsReceivableDuePeriod_0F8FEF993E57A1C5E291A3DCC60FB07C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_ango_AccountsReceivableDuePeriod_0F8FEF993E57A1C5E291A3DCC60FB07C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_7AD6912A861D85686857A3DCC60FD37C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_7AD6912A861D85686857A3DCC60FD37C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0E9A14464093220683DBA3DCC60F4E91" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0E9A14464093220683DBA3DCC60F4E91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_935FBFAB55C8E395E3DEA489EA197A18" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_us-gaap_NumberOfOperatingSegments_935FBFAB55C8E395E3DEA489EA197A18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfReportingUnits" xlink:label="loc_us-gaap_NumberOfReportingUnits_4024B8E7DC0413312DD3A487C517C2C6" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_us-gaap_NumberOfReportingUnits_4024B8E7DC0413312DD3A487C517C2C6" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PercentageOfRestockingCharge" xlink:label="loc_ango_PercentageOfRestockingCharge_CED6780383119A5919F1A3DCC60F6530" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_ango_PercentageOfRestockingCharge_CED6780383119A5919F1A3DCC60F6530" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct" xlink:label="loc_ango_NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct_52B179141A38BB4D3327A3DCC60F66FE" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_ango_NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct_52B179141A38BB4D3327A3DCC60F66FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7EDB6C3E4E7963D2062CA3DCC60FEAF2" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7EDB6C3E4E7963D2062CA3DCC60FEAF2" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/CommitmentsAndContingencies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetails1" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetailsTextual" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_FF59D3AC3F1FECAB5973A3DCC39DB983" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_us-gaap_LossContingenciesTable_FF59D3AC3F1FECAB5973A3DCC39DB983" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_LitigationCaseAxis" xlink:label="loc_srt_LitigationCaseAxis_FEB808C61343FD0B9BBEA3DCC39DBAC3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_FF59D3AC3F1FECAB5973A3DCC39DB983" xlink:to="loc_srt_LitigationCaseAxis_FEB808C61343FD0B9BBEA3DCC39DBAC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_F1FC3D259C27BD51E2FAA3DCC39D0E12_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_FEB808C61343FD0B9BBEA3DCC39DBAC3" xlink:to="loc_srt_LitigationCaseTypeDomain_F1FC3D259C27BD51E2FAA3DCC39D0E12_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_F1FC3D259C27BD51E2FAA3DCC39D0E12" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_FEB808C61343FD0B9BBEA3DCC39DBAC3" xlink:to="loc_srt_LitigationCaseTypeDomain_F1FC3D259C27BD51E2FAA3DCC39D0E12" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_C.R.BardInc.Member" xlink:label="loc_ango_C.R.BardInc.Member_CB2415401C5761249E42A3DCC39DFD9B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_F1FC3D259C27BD51E2FAA3DCC39D0E12" xlink:to="loc_ango_C.R.BardInc.Member_CB2415401C5761249E42A3DCC39DFD9B" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_TheUtahActionMember" xlink:label="loc_ango_TheUtahActionMember_3E6260B1016F9DCB3DF9A3DCC39D276F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_F1FC3D259C27BD51E2FAA3DCC39D0E12" xlink:to="loc_ango_TheUtahActionMember_3E6260B1016F9DCB3DF9A3DCC39D276F" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_TheDelawareActionMember" xlink:label="loc_ango_TheDelawareActionMember_40048F51ACA720E29630A3DCC39D5E33" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_F1FC3D259C27BD51E2FAA3DCC39D0E12" xlink:to="loc_ango_TheDelawareActionMember_40048F51ACA720E29630A3DCC39D5E33" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_DE156BA22BEB574A581BA3DCC39D7E83" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_FF59D3AC3F1FECAB5973A3DCC39DB983" xlink:to="loc_dei_LegalEntityAxis_DE156BA22BEB574A581BA3DCC39D7E83" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_45696E8D6959014BE10FA3DCC39D8B31_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_DE156BA22BEB574A581BA3DCC39D7E83" xlink:to="loc_dei_EntityDomain_45696E8D6959014BE10FA3DCC39D8B31_default" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_45696E8D6959014BE10FA3DCC39D8B31" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_DE156BA22BEB574A581BA3DCC39D7E83" xlink:to="loc_dei_EntityDomain_45696E8D6959014BE10FA3DCC39D8B31" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_C.R.BardInc.Member" xlink:label="loc_ango_C.R.BardInc.Member_D9BAB579E9BAD7499210A3DCC39D758F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_45696E8D6959014BE10FA3DCC39D8B31" xlink:to="loc_ango_C.R.BardInc.Member_D9BAB579E9BAD7499210A3DCC39D758F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LitigationStatusAxis" xlink:label="loc_us-gaap_LitigationStatusAxis_C89EEF918246E3CA2588A3DCC39D6DDA" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_FF59D3AC3F1FECAB5973A3DCC39DB983" xlink:to="loc_us-gaap_LitigationStatusAxis_C89EEF918246E3CA2588A3DCC39D6DDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LitigationStatusDomain" xlink:label="loc_us-gaap_LitigationStatusDomain_5DD66CF36697BCD1C011A3DCC39D39E7_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_C89EEF918246E3CA2588A3DCC39D6DDA" xlink:to="loc_us-gaap_LitigationStatusDomain_5DD66CF36697BCD1C011A3DCC39D39E7_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LitigationStatusDomain" xlink:label="loc_us-gaap_LitigationStatusDomain_5DD66CF36697BCD1C011A3DCC39D39E7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_C89EEF918246E3CA2588A3DCC39D6DDA" xlink:to="loc_us-gaap_LitigationStatusDomain_5DD66CF36697BCD1C011A3DCC39D39E7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PendingLitigationMember" xlink:label="loc_us-gaap_PendingLitigationMember_5AFF1CC6D1D0DD6C8041A3DCC39DBF96" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_5DD66CF36697BCD1C011A3DCC39D39E7" xlink:to="loc_us-gaap_PendingLitigationMember_5AFF1CC6D1D0DD6C8041A3DCC39DBF96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaap_LeaseAndRentalExpense_4882F622AB3C8EA972D9A3DCC39D40B3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_us-gaap_LeaseAndRentalExpense_4882F622AB3C8EA972D9A3DCC39D40B3" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_LossContingencyU.S.PatentsNumber" xlink:label="loc_ango_LossContingencyU.S.PatentsNumber_2C555613EE91CC778477A3DCC39D08BE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_ango_LossContingencyU.S.PatentsNumber_2C555613EE91CC778477A3DCC39D08BE" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_NumberOfPatentsAssertedForReexamination" xlink:label="loc_ango_NumberOfPatentsAssertedForReexamination_ECF7B41805803A7865CCA3DCC39D94EA" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_ango_NumberOfPatentsAssertedForReexamination_ECF7B41805803A7865CCA3DCC39D94EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingencyClaimsDismissedNumber" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_9971BFA360A7B7A10CA1A3DCC39DD155" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_us-gaap_LossContingencyClaimsDismissedNumber_9971BFA360A7B7A10CA1A3DCC39DD155" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_LossContingencyReexaminationsNumber" xlink:label="loc_ango_LossContingencyReexaminationsNumber_69DFAD4DB5928A658D5BA3DCC39DD1B9" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_ango_LossContingencyReexaminationsNumber_69DFAD4DB5928A658D5BA3DCC39DD1B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_E8F3ED95E9C5FB2C3385A3DCC39D9C7B" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_E8F3ED95E9C5FB2C3385A3DCC39D9C7B" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_LossContingencyClaimsReversedNumber" xlink:label="loc_ango_LossContingencyClaimsReversedNumber_0C93F1680DEE7D752AA2A3DCC39DA20F" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_ango_LossContingencyClaimsReversedNumber_0C93F1680DEE7D752AA2A3DCC39DA20F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_57487B6E1A84A88FFBE7A3DCC39DFAB8" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_57487B6E1A84A88FFBE7A3DCC39DFAB8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_7DA558AC4087CB12EE40A3DCC39DD1BA" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_7DA558AC4087CB12EE40A3DCC39DD1BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_85348F21850884DE806AA3DCC39DDA7F" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_85348F21850884DE806AA3DCC39DDA7F" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/CommitmentsAndContingenciesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedBalanceSheets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedStatementsComprehensiveIncomeLoss" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedStatementsOfOperations" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_CE5795E396C6CCC7B42F94C430A53147" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_StatementTable_CE5795E396C6CCC7B42F94C430A53147" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8502F25166B68F3E0DBF94C430A67382" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_CE5795E396C6CCC7B42F94C430A53147" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8502F25166B68F3E0DBF94C430A67382" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_BC215ACAF584DD83B5C194C430A61CC8_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8502F25166B68F3E0DBF94C430A67382" xlink:to="loc_us-gaap_EquityComponentDomain_BC215ACAF584DD83B5C194C430A61CC8_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_BC215ACAF584DD83B5C194C430A61CC8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8502F25166B68F3E0DBF94C430A67382" xlink:to="loc_us-gaap_EquityComponentDomain_BC215ACAF584DD83B5C194C430A61CC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_E2CAC91072325CEA685394C430A6AD96" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_BC215ACAF584DD83B5C194C430A61CC8" xlink:to="loc_us-gaap_CommonStockMember_E2CAC91072325CEA685394C430A6AD96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_0CAE04B517CDA2CFD0B094C430A6A219" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_BC215ACAF584DD83B5C194C430A61CC8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_0CAE04B517CDA2CFD0B094C430A6A219" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_FB0668D2EB7A8C4CEC4094C430A75C39" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_BC215ACAF584DD83B5C194C430A61CC8" xlink:to="loc_us-gaap_RetainedEarningsMember_FB0668D2EB7A8C4CEC4094C430A75C39" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_F569058485E3692D58BC94C430A7336D" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_BC215ACAF584DD83B5C194C430A61CC8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_F569058485E3692D58BC94C430A7336D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_F5338E18D1FF34455E4A94C430A79EF2" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_BC215ACAF584DD83B5C194C430A61CC8" xlink:to="loc_us-gaap_TreasuryStockMember_F5338E18D1FF34455E4A94C430A79EF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_31C4CB63569701C42F5494C430A77C17" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_CE5795E396C6CCC7B42F94C430A53147" xlink:to="loc_us-gaap_AwardTypeAxis_31C4CB63569701C42F5494C430A77C17" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_413C9424A5570E39064D94C430A7C49E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_31C4CB63569701C42F5494C430A77C17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_413C9424A5570E39064D94C430A7C49E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_413C9424A5570E39064D94C430A7C49E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_31C4CB63569701C42F5494C430A77C17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_413C9424A5570E39064D94C430A7C49E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6F6CC796611B00CA387894C430A8ABFC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_413C9424A5570E39064D94C430A7C49E" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6F6CC796611B00CA387894C430A8ABFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_201DF8E1B7E30383032A94C430A8FE92" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_413C9424A5570E39064D94C430A7C49E" xlink:to="loc_us-gaap_PerformanceSharesMember_201DF8E1B7E30383032A94C430A8FE92" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_7A04215DE421998BBF2094C430A8DA0B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_StockholdersEquity_7A04215DE421998BBF2094C430A8DA0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_D8D95162170BED66572D94C430A8A356" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_SharesIssued_D8D95162170BED66572D94C430A8A356" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_A6B2EFDCF896141674D894C430A9BA0E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_A6B2EFDCF896141674D894C430A9BA0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_C7B90EAA69CBB25082C994C430A94AC5" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_NetIncomeLoss_C7B90EAA69CBB25082C994C430A94AC5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_A934F38FA31E071C8C7594C430A9EC0E" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_A934F38FA31E071C8C7594C430A9EC0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_EC2F35177F981DC1855794C430A91528" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_EC2F35177F981DC1855794C430A91528" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_A1CAEB1338E0819C4EF194C430A98984" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_A1CAEB1338E0819C4EF194C430A98984" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_BD895E901625AC8486B994C430A9840F" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_BD895E901625AC8486B994C430A9840F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_A01CBA043B4A8F17D9A894C430AA622F" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_A01CBA043B4A8F17D9A894C430AA622F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_D07D6E2445FB5CA15F9C94C430AA6637" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_D07D6E2445FB5CA15F9C94C430AA6637" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_E81AB732E443841492C494C430AAA645" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_E81AB732E443841492C494C430AAA645" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockRetiredParValueMethodAmount" xlink:label="loc_us-gaap_TreasuryStockRetiredParValueMethodAmount_3D1597327963B9AC0FA694C430AAC419" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_TreasuryStockRetiredParValueMethodAmount_3D1597327963B9AC0FA694C430AAC419" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockSharesRetired" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_D3B167D42C0E7600A8AD94C430AAA9B4" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_D3B167D42C0E7600A8AD94C430AAA9B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_818620A29181A742C07994C430AB1AF0" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_818620A29181A742C07994C430AB1AF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_E9B1E7FBA9A8E262B08694C430AB63F4" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_E9B1E7FBA9A8E262B08694C430AB63F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_C0595E72FA4367B6226994C430AB6488" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_C0595E72FA4367B6226994C430AB6488" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/DocumentAndEntityInformation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/EarningsPerShare" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/EarningsPerShareDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/EarningsPerShareTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/FairValueOfFinancialInstruments" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_071B08D0F7CF8F33FF7D8F22D14BF1DF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7A230FF4ADA784AD1A308F22D13B742C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_071B08D0F7CF8F33FF7D8F22D14BF1DF" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7A230FF4ADA784AD1A308F22D13B742C" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_072E3838430B2C7EA93A8F22D13BA273" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7A230FF4ADA784AD1A308F22D13B742C" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_072E3838430B2C7EA93A8F22D13BA273" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_87CE90DEA79F6D4A36298F22D13B7126_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_072E3838430B2C7EA93A8F22D13BA273" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_87CE90DEA79F6D4A36298F22D13B7126_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_87CE90DEA79F6D4A36298F22D13B7126" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_072E3838430B2C7EA93A8F22D13BA273" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_87CE90DEA79F6D4A36298F22D13B7126" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_E9094AD6517DB9B7FCE88F22D13BF956" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_87CE90DEA79F6D4A36298F22D13B7126" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_E9094AD6517DB9B7FCE88F22D13BF956" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_88E8212613D323964B018F22D13BD7F2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7A230FF4ADA784AD1A308F22D13B742C" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_88E8212613D323964B018F22D13BD7F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A47FC87DC962672709258F22D13B3536_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_88E8212613D323964B018F22D13BD7F2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A47FC87DC962672709258F22D13B3536_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A47FC87DC962672709258F22D13B3536" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_88E8212613D323964B018F22D13BD7F2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A47FC87DC962672709258F22D13B3536" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_63F90B036AC09CB60D3B8F22D13B0EA2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A47FC87DC962672709258F22D13B3536" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_63F90B036AC09CB60D3B8F22D13B0EA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_340FBA2BC06022BCA6518F22D13B29E1" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A47FC87DC962672709258F22D13B3536" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_340FBA2BC06022BCA6518F22D13B29E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_AE3E2ABF58191EE4CC538F22D13B51A3" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A47FC87DC962672709258F22D13B3536" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_AE3E2ABF58191EE4CC538F22D13B51A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_B8673782AD6960E1479D8F22D14B010C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_071B08D0F7CF8F33FF7D8F22D14BF1DF" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_B8673782AD6960E1479D8F22D14B010C" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure" xlink:label="loc_ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure_87EB6EB7AF427B3DD6FC8F22D14BAB0C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_B8673782AD6960E1479D8F22D14B010C" xlink:to="loc_ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure_87EB6EB7AF427B3DD6FC8F22D14BAB0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_76DED84C5EE648D7CC058F22D14BC667" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_B8673782AD6960E1479D8F22D14B010C" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_76DED84C5EE648D7CC058F22D14BC667" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_6000A47BB4885AE457738F22D14B1347" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_B8673782AD6960E1479D8F22D14B010C" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_6000A47BB4885AE457738F22D14B1347" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_BEF9DC3DCD8D0F1346EE8F22D14B01D8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_071B08D0F7CF8F33FF7D8F22D14BF1DF" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_BEF9DC3DCD8D0F1346EE8F22D14B01D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_F7C8E76C5658324642838F53E07128AB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_BEF9DC3DCD8D0F1346EE8F22D14B01D8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_F7C8E76C5658324642838F53E07128AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_6DB6376DA140DD0D87CD8F22D14BD3CF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_BEF9DC3DCD8D0F1346EE8F22D14B01D8" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_6DB6376DA140DD0D87CD8F22D14BD3CF" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails2" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails3" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0E9BA51384B1F192BF268F96E2EFAE36" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0E9BA51384B1F192BF268F96E2EFAE36" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_647D6B1F75B1427F8E338F96E2E1136E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_647D6B1F75B1427F8E338F96E2E1136E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_D5EFE218247D4B6173B58F96E2E2F1AE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_647D6B1F75B1427F8E338F96E2E1136E" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_D5EFE218247D4B6173B58F96E2E2F1AE_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_D5EFE218247D4B6173B58F96E2E2F1AE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_647D6B1F75B1427F8E338F96E2E1136E" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_D5EFE218247D4B6173B58F96E2E2F1AE" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_DiscontinuedInvestmentinTiLoProductMember" xlink:label="loc_ango_DiscontinuedInvestmentinTiLoProductMember_A9428397F7132C5310CD8F96E2E24FD2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_D5EFE218247D4B6173B58F96E2E2F1AE" xlink:to="loc_ango_DiscontinuedInvestmentinTiLoProductMember_A9428397F7132C5310CD8F96E2E24FD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupClassificationAxis" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_A8FCF2A1A45691CEB56F8F96E2E2E5D5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_A8FCF2A1A45691CEB56F8F96E2E2E5D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupClassificationDomain" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_FA69CA0FFD83DD117A298F96E2E31293_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_A8FCF2A1A45691CEB56F8F96E2E2E5D5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_FA69CA0FFD83DD117A298F96E2E31293_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupClassificationDomain" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_FA69CA0FFD83DD117A298F96E2E31293" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_A8FCF2A1A45691CEB56F8F96E2E2E5D5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_FA69CA0FFD83DD117A298F96E2E31293" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember" xlink:label="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_B8BA6F7685D22C096A968F96E2E39D4A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_FA69CA0FFD83DD117A298F96E2E31293" xlink:to="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_B8BA6F7685D22C096A968F96E2E39D4A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6A6C2AAB31EA4A7204568F96E2E308B1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6A6C2AAB31EA4A7204568F96E2E308B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5B726547806D526554938F96E2E40544_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6A6C2AAB31EA4A7204568F96E2E308B1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5B726547806D526554938F96E2E40544_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5B726547806D526554938F96E2E40544" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6A6C2AAB31EA4A7204568F96E2E308B1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5B726547806D526554938F96E2E40544" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_70AFF8FCF3E1D6D49B848F96E2E4F032" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5B726547806D526554938F96E2E40544" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_70AFF8FCF3E1D6D49B848F96E2E4F032" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_00AD8F105F1E173F5FC98F96E2E02E0C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_00AD8F105F1E173F5FC98F96E2E02E0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3770291B037E673AB1128F96E2E1DCC1_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_00AD8F105F1E173F5FC98F96E2E02E0C" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3770291B037E673AB1128F96E2E1DCC1_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3770291B037E673AB1128F96E2E1DCC1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_00AD8F105F1E173F5FC98F96E2E02E0C" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3770291B037E673AB1128F96E2E1DCC1" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AngioVacProductMember" xlink:label="loc_ango_AngioVacProductMember_B3AE2D0444919E9997508F96E2E12980" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3770291B037E673AB1128F96E2E1DCC1" xlink:to="loc_ango_AngioVacProductMember_B3AE2D0444919E9997508F96E2E12980" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaap_ValuationTechniqueAxis_AF8A41A82EF80DA0A4498F96E2E45FA3" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_us-gaap_ValuationTechniqueAxis_AF8A41A82EF80DA0A4498F96E2E45FA3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_11B101C358F68C4447BB8F96E2E49B81_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_AF8A41A82EF80DA0A4498F96E2E45FA3" xlink:to="loc_us-gaap_ValuationTechniqueDomain_11B101C358F68C4447BB8F96E2E49B81_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_11B101C358F68C4447BB8F96E2E49B81" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_AF8A41A82EF80DA0A4498F96E2E45FA3" xlink:to="loc_us-gaap_ValuationTechniqueDomain_11B101C358F68C4447BB8F96E2E49B81" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_RevenueBasedPaymentMember" xlink:label="loc_ango_RevenueBasedPaymentMember_520CFAC5C5F022C238EC8F96E2E5C7D9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_11B101C358F68C4447BB8F96E2E49B81" xlink:to="loc_ango_RevenueBasedPaymentMember_520CFAC5C5F022C238EC8F96E2E5C7D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_E781F8B153B67DCC9E388F96E2E5444D" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_E781F8B153B67DCC9E388F96E2E5444D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_717D3D04FD51A3AD21C88F96E2E59A99_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_E781F8B153B67DCC9E388F96E2E5444D" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_717D3D04FD51A3AD21C88F96E2E59A99_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_717D3D04FD51A3AD21C88F96E2E59A99" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_E781F8B153B67DCC9E388F96E2E5444D" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_717D3D04FD51A3AD21C88F96E2E59A99" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_EB994D6C9A2189B617DB8F96E2E66572" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_717D3D04FD51A3AD21C88F96E2E59A99" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_EB994D6C9A2189B617DB8F96E2E66572" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_F6CE53F36E51EFC90C838F96E2E63948" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_srt_RangeAxis_F6CE53F36E51EFC90C838F96E2E63948" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_9A57D7D54EC65176EEB98F96E2E6733F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_F6CE53F36E51EFC90C838F96E2E63948" xlink:to="loc_srt_RangeMember_9A57D7D54EC65176EEB98F96E2E6733F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_9A57D7D54EC65176EEB98F96E2E6733F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_F6CE53F36E51EFC90C838F96E2E63948" xlink:to="loc_srt_RangeMember_9A57D7D54EC65176EEB98F96E2E6733F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_55AD73E017AF05DFCFB88F96E2E7190B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9A57D7D54EC65176EEB98F96E2E6733F" xlink:to="loc_srt_MaximumMember_55AD73E017AF05DFCFB88F96E2E7190B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0ADDAFE06B5F346C550B8F96E2E7DFA2" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0ADDAFE06B5F346C550B8F96E2E7DFA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_84539F353F60402AAF108F96E2E702FA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0ADDAFE06B5F346C550B8F96E2E7DFA2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_84539F353F60402AAF108F96E2E702FA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_84539F353F60402AAF108F96E2E702FA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0ADDAFE06B5F346C550B8F96E2E7DFA2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_84539F353F60402AAF108F96E2E702FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_DF116CA5EF98231A44548F96E2E848A8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_84539F353F60402AAF108F96E2E702FA" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_DF116CA5EF98231A44548F96E2E848A8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_F2D6F2CC9594AE6CA7308F96E2EE6880" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_F2D6F2CC9594AE6CA7308F96E2EE6880" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_D6B1DBEBFF1879B93A148F96E2EE7682_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_F2D6F2CC9594AE6CA7308F96E2EE6880" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_D6B1DBEBFF1879B93A148F96E2EE7682_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_D6B1DBEBFF1879B93A148F96E2EE7682" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_F2D6F2CC9594AE6CA7308F96E2EE6880" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_D6B1DBEBFF1879B93A148F96E2EE7682" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_75714E7FF8F01F0FEE6F8F96E2EF2D34" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_D6B1DBEBFF1879B93A148F96E2EE7682" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_75714E7FF8F01F0FEE6F8F96E2EF2D34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_F16FA6EC16DAA5E8596E8F96E2E89FB2" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_us-gaap_FinancialInstrumentAxis_F16FA6EC16DAA5E8596E8F96E2E89FB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_EFEA3A432E2A22D5C7FD8F96E2E87F81_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_F16FA6EC16DAA5E8596E8F96E2E89FB2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_EFEA3A432E2A22D5C7FD8F96E2E87F81_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_EFEA3A432E2A22D5C7FD8F96E2E87F81" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_F16FA6EC16DAA5E8596E8F96E2E89FB2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_EFEA3A432E2A22D5C7FD8F96E2E87F81" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ContingentConsiderationEarnOutLiabilityMember" xlink:label="loc_ango_ContingentConsiderationEarnOutLiabilityMember_2E7752E2A489FA5509768F96E2E84C50" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_EFEA3A432E2A22D5C7FD8F96E2E87F81" xlink:to="loc_ango_ContingentConsiderationEarnOutLiabilityMember_2E7752E2A489FA5509768F96E2E84C50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_BFD7B17CE2F9DD4691CC8F96E2EF586E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0E9BA51384B1F192BF268F96E2EFAE36" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_BFD7B17CE2F9DD4691CC8F96E2EF586E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_7D87655589BC6575023E8F96E2F07BD0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0E9BA51384B1F192BF268F96E2EFAE36" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_7D87655589BC6575023E8F96E2F07BD0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_AAF0BC5E9B2F90CEE1BF8F96E2F018B0" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0E9BA51384B1F192BF268F96E2EFAE36" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_AAF0BC5E9B2F90CEE1BF8F96E2F018B0" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_UndiscountedContingentConsiderationFairValueFairValueDisclosure" xlink:label="loc_ango_UndiscountedContingentConsiderationFairValueFairValueDisclosure_19BB6020D566E3E6678B8F96E2F080D5" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0E9BA51384B1F192BF268F96E2EFAE36" xlink:to="loc_ango_UndiscountedContingentConsiderationFairValueFairValueDisclosure_19BB6020D566E3E6678B8F96E2F080D5" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract" xlink:label="loc_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract_95A629AA3585BA4D6B308F96E2F04768" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0E9BA51384B1F192BF268F96E2EFAE36" xlink:to="loc_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract_95A629AA3585BA4D6B308F96E2F04768" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_E03CFB62B2AB357F09FD8F96E2EFD510" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract_95A629AA3585BA4D6B308F96E2F04768" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_E03CFB62B2AB357F09FD8F96E2EFD510" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_700A3E66D930109D36138F96E2F03258" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract_95A629AA3585BA4D6B308F96E2F04768" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_700A3E66D930109D36138F96E2F03258" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_FairValueInputsProbabilityOfPayment" xlink:label="loc_ango_FairValueInputsProbabilityOfPayment_94A8284046EC8CED96B58F96E2F1A761" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract_95A629AA3585BA4D6B308F96E2F04768" xlink:to="loc_ango_FairValueInputsProbabilityOfPayment_94A8284046EC8CED96B58F96E2F1A761" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetails1" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0B9C582B9D39376519828F96E2425B19" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3322CD6BB543197372D88F96E23FA872" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0B9C582B9D39376519828F96E2425B19" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3322CD6BB543197372D88F96E23FA872" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_C4139B887D52893A904D8FDA66CD694B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3322CD6BB543197372D88F96E23FA872" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_C4139B887D52893A904D8FDA66CD694B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ECAA01D9E4E6394B53F28FDA66CF11D9_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_C4139B887D52893A904D8FDA66CD694B" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ECAA01D9E4E6394B53F28FDA66CF11D9_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ECAA01D9E4E6394B53F28FDA66CF11D9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_C4139B887D52893A904D8FDA66CD694B" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ECAA01D9E4E6394B53F28FDA66CF11D9" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ProductTechnologiesMember" xlink:label="loc_ango_ProductTechnologiesMember_21B7484EFE3768C65D5E8FDA66ECB9AC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ECAA01D9E4E6394B53F28FDA66CF11D9" xlink:to="loc_ango_ProductTechnologiesMember_21B7484EFE3768C65D5E8FDA66ECB9AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3767D9A786ADC9089EDD8FDA66F83CAE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ECAA01D9E4E6394B53F28FDA66CF11D9" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3767D9A786ADC9089EDD8FDA66F83CAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaap_TrademarksMember_5E98E0704ECA994363AC8FDA67057974" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ECAA01D9E4E6394B53F28FDA66CF11D9" xlink:to="loc_us-gaap_TrademarksMember_5E98E0704ECA994363AC8FDA67057974" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LicenseAgreementTermsMember" xlink:label="loc_us-gaap_LicenseAgreementTermsMember_F4764064E39F6E12FA1D8FDA671284CE" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ECAA01D9E4E6394B53F28FDA66CF11D9" xlink:to="loc_us-gaap_LicenseAgreementTermsMember_F4764064E39F6E12FA1D8FDA671284CE" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_DistributorRelationshipsMember" xlink:label="loc_ango_DistributorRelationshipsMember_44D4ABBC51B0B0606DFC8FDA6720308E" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ECAA01D9E4E6394B53F28FDA66CF11D9" xlink:to="loc_ango_DistributorRelationshipsMember_44D4ABBC51B0B0606DFC8FDA6720308E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_08F0F287C237BAA06A998F96E243E21A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0B9C582B9D39376519828F96E2425B19" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_08F0F287C237BAA06A998F96E243E21A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8E1AFE750542BCAB1D348F96E243DADC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0B9C582B9D39376519828F96E2425B19" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8E1AFE750542BCAB1D348F96E243DADC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_F4F8EF69173EC00542248F96E2436F07" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0B9C582B9D39376519828F96E2425B19" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_F4F8EF69173EC00542248F96E2436F07" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetails2" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetailsTextual" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_D66E1937E77583F7121D8F96E251EB7B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_E2B9B8798C560ED459998F96E24FC5B6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_D66E1937E77583F7121D8F96E251EB7B" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_E2B9B8798C560ED459998F96E24FC5B6" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_C2BF2CE051BD0E06266A8F96E250D18D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_E2B9B8798C560ED459998F96E24FC5B6" xlink:to="loc_srt_RangeAxis_C2BF2CE051BD0E06266A8F96E250D18D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_9849960FFD88F15369E18F96E2504FC5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_C2BF2CE051BD0E06266A8F96E250D18D" xlink:to="loc_srt_RangeMember_9849960FFD88F15369E18F96E2504FC5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_9849960FFD88F15369E18F96E2504FC5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_C2BF2CE051BD0E06266A8F96E250D18D" xlink:to="loc_srt_RangeMember_9849960FFD88F15369E18F96E2504FC5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_8C723D1E52296EA6F0888F96E250D644" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9849960FFD88F15369E18F96E2504FC5" xlink:to="loc_srt_MinimumMember_8C723D1E52296EA6F0888F96E250D644" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_CDFE5BAEFDA64CF1867F8F96E251514E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9849960FFD88F15369E18F96E2504FC5" xlink:to="loc_srt_MaximumMember_CDFE5BAEFDA64CF1867F8F96E251514E" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_GoodwillAndIntangibleAssetsTextualAbstract" xlink:label="loc_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_D66E1937E77583F7121D8F96E251EB7B" xlink:to="loc_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_AF824F218AEDEDED2B898F96E2523DD6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4" xlink:to="loc_us-gaap_NumberOfReportableSegments_AF824F218AEDEDED2B898F96E2523DD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_891DC580AF2E8CCA85F28F96E252B996" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_891DC580AF2E8CCA85F28F96E252B996" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_0CC6AAF8D58A712921988F96E2525D40" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_0CC6AAF8D58A712921988F96E2525D40" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9208FEA134DECF6F2AA58F96E2531795" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9208FEA134DECF6F2AA58F96E2531795" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxes" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesDetails2" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesDetails3" xlink:type="extended">
    <link:loc xlink:href="ango-20180531.xsd#ango_ScheduleofIncomeTaxLineItems" xlink:label="loc_ango_ScheduleofIncomeTaxLineItems_26D0B111A2B7C0601784B82FBBEE25A7" xlink:type="locator" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ScheduleofIncomeTaxTable" xlink:label="loc_ango_ScheduleofIncomeTaxTable_5B45A446B1C74FF93699B82FBBEC9F22" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ango_ScheduleofIncomeTaxLineItems_26D0B111A2B7C0601784B82FBBEE25A7" xlink:to="loc_ango_ScheduleofIncomeTaxTable_5B45A446B1C74FF93699B82FBBEC9F22" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_7560DA31215159BFCBBCB82FBBEDD1BA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ango_ScheduleofIncomeTaxTable_5B45A446B1C74FF93699B82FBBEC9F22" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_7560DA31215159BFCBBCB82FBBEDD1BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_1E2043B87DFB2195E479B82FBBED7F0F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_7560DA31215159BFCBBCB82FBBEDD1BA" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_1E2043B87DFB2195E479B82FBBED7F0F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_1E2043B87DFB2195E479B82FBBED7F0F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_7560DA31215159BFCBBCB82FBBEDD1BA" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_1E2043B87DFB2195E479B82FBBED7F0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_1C683F6206D6A065AAB7B82FBBEEC11B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1E2043B87DFB2195E479B82FBBED7F0F" xlink:to="loc_us-gaap_ForeignCountryMember_1C683F6206D6A065AAB7B82FBBEEC11B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_5F2331F0719988054220B82FBBEEF081" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ango_ScheduleofIncomeTaxLineItems_26D0B111A2B7C0601784B82FBBEE25A7" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_5F2331F0719988054220B82FBBEEF081" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5F2331F0719988054220B82FBBEEF081" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_95217B647F42B6FCF580B82FBBEFD76F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_95217B647F42B6FCF580B82FBBEFD76F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0804B9D4F46453C8C3B1B82FBBF1F48D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0804B9D4F46453C8C3B1B82FBBF1F48D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_0EA7725A892AA06171F5B82FBBF12BDC" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_0EA7725A892AA06171F5B82FBBF12BDC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_E4818BB632E238CD180BB82FBBF2119C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_E4818BB632E238CD180BB82FBBF2119C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_FD6B95589132DD70BEC6B82FBBF2F92F" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_FD6B95589132DD70BEC6B82FBBF2F92F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_357EED0FC5824503385EB82FBBF2B9DB" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_357EED0FC5824503385EB82FBBF2B9DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_6659C47F16EFE8968588B830C95F7C17" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_6659C47F16EFE8968588B830C95F7C17" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_F2F9D5914254466B5BDFB82FBBF2AFCE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5F2331F0719988054220B82FBBEEF081" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_F2F9D5914254466B5BDFB82FBBF2AFCE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_E4A1C1F18C8B2AF7CF9EB82FBBF2ED21" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_F2F9D5914254466B5BDFB82FBBF2AFCE" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_E4A1C1F18C8B2AF7CF9EB82FBBF2ED21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_0C8EDCA718FD92BC4EE7B82FBBF34EFE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_F2F9D5914254466B5BDFB82FBBF2AFCE" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_0C8EDCA718FD92BC4EE7B82FBBF34EFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7A88E6FB65D8552C5689B82FBBF3C3DB" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5F2331F0719988054220B82FBBEEF081" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7A88E6FB65D8552C5689B82FBBF3C3DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_39830613E18FCA643828B82FBBF35C4C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5F2331F0719988054220B82FBBEEF081" xlink:to="loc_us-gaap_DeferredTaxLiabilities_39830613E18FCA643828B82FBBF35C4C" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesDetails4" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesDetailsTextual" xlink:type="extended">
    <link:loc xlink:href="ango-20180531.xsd#ango_ScheduleofIncomeTaxLineItems" xlink:label="loc_ango_ScheduleofIncomeTaxLineItems_624DF44F0E8634F5CF92B47ACF11D287" xlink:type="locator" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ScheduleofIncomeTaxTable" xlink:label="loc_ango_ScheduleofIncomeTaxTable_C99EC36A42EFADBB5771B466A275A6C7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ango_ScheduleofIncomeTaxLineItems_624DF44F0E8634F5CF92B47ACF11D287" xlink:to="loc_ango_ScheduleofIncomeTaxTable_C99EC36A42EFADBB5771B466A275A6C7" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="loc_us-gaap_TaxPeriodAxis_CABF1B9931344E075AE3B466A27552E4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ango_ScheduleofIncomeTaxTable_C99EC36A42EFADBB5771B466A275A6C7" xlink:to="loc_us-gaap_TaxPeriodAxis_CABF1B9931344E075AE3B466A27552E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaap_TaxPeriodDomain_65981571EE212AE3284AB466A2753F2F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_CABF1B9931344E075AE3B466A27552E4" xlink:to="loc_us-gaap_TaxPeriodDomain_65981571EE212AE3284AB466A2753F2F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaap_TaxPeriodDomain_65981571EE212AE3284AB466A2753F2F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_CABF1B9931344E075AE3B466A27552E4" xlink:to="loc_us-gaap_TaxPeriodDomain_65981571EE212AE3284AB466A2753F2F" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_TaxPeriodOneMember" xlink:label="loc_ango_TaxPeriodOneMember_ECA715C52C175BF935BBB466A276FA61" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_65981571EE212AE3284AB466A2753F2F" xlink:to="loc_ango_TaxPeriodOneMember_ECA715C52C175BF935BBB466A276FA61" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_TaxPeriodTwoMember" xlink:label="loc_ango_TaxPeriodTwoMember_6D3C2D2F99B308076169B466A2761F56" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_65981571EE212AE3284AB466A2753F2F" xlink:to="loc_ango_TaxPeriodTwoMember_6D3C2D2F99B308076169B466A2761F56" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_TaxPeriodThreeMember" xlink:label="loc_ango_TaxPeriodThreeMember_F37D98D67A718064BDCAB466A276AFCB" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_65981571EE212AE3284AB466A2753F2F" xlink:to="loc_ango_TaxPeriodThreeMember_F37D98D67A718064BDCAB466A276AFCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_85AB03440940E65C6011B466A276B079" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ango_ScheduleofIncomeTaxTable_C99EC36A42EFADBB5771B466A275A6C7" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_85AB03440940E65C6011B466A276B079" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_785C29F032A0E6250D6FB466A2774B97_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_85AB03440940E65C6011B466A276B079" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_785C29F032A0E6250D6FB466A2774B97_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_785C29F032A0E6250D6FB466A2774B97" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_85AB03440940E65C6011B466A276B079" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_785C29F032A0E6250D6FB466A2774B97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_32EF58E2685502B97208B466A277AB2F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_785C29F032A0E6250D6FB466A2774B97" xlink:to="loc_us-gaap_DomesticCountryMember_32EF58E2685502B97208B466A277AB2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_C648E05A1F22D1010D4DB466A277AA8C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_785C29F032A0E6250D6FB466A2774B97" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_C648E05A1F22D1010D4DB466A277AA8C" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_IncomeTaxesTextualAbstract" xlink:label="loc_ango_IncomeTaxesTextualAbstract_0937FAACE18BDB17C485B47ACF11E834" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ango_ScheduleofIncomeTaxLineItems_624DF44F0E8634F5CF92B47ACF11D287" xlink:to="loc_ango_IncomeTaxesTextualAbstract_0937FAACE18BDB17C485B47ACF11E834" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit" xlink:label="loc_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit_2FF80C5D7D24B3C79506B47ACF11A5BD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ango_IncomeTaxesTextualAbstract_0937FAACE18BDB17C485B47ACF11E834" xlink:to="loc_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit_2FF80C5D7D24B3C79506B47ACF11A5BD" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse" xlink:label="loc_ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse_B0A038DB152917554960B47ACF119D4E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ango_IncomeTaxesTextualAbstract_0937FAACE18BDB17C485B47ACF11E834" xlink:to="loc_ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse_B0A038DB152917554960B47ACF119D4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_5D6F9123A505238A55BDB47ACF11F4C6" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ango_IncomeTaxesTextualAbstract_0937FAACE18BDB17C485B47ACF11E834" xlink:to="loc_us-gaap_OperatingLossCarryforwards_5D6F9123A505238A55BDB47ACF11F4C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_EE0378BA097175990506B47ACF116BBF" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ango_IncomeTaxesTextualAbstract_0937FAACE18BDB17C485B47ACF11E834" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_EE0378BA097175990506B47ACF116BBF" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit" xlink:label="loc_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit_7C4502C9BBA7DBBF0E12B47ACF11C50E" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ango_IncomeTaxesTextualAbstract_0937FAACE18BDB17C485B47ACF11E834" xlink:to="loc_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit_7C4502C9BBA7DBBF0E12B47ACF11C50E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_B78BCC564B6974D9FF23B47ACF117883" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ango_IncomeTaxesTextualAbstract_0937FAACE18BDB17C485B47ACF11E834" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_B78BCC564B6974D9FF23B47ACF117883" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:label="loc_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_C7A81412E5D7B4E28D56B47ACF11B926" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ango_IncomeTaxesTextualAbstract_0937FAACE18BDB17C485B47ACF11E834" xlink:to="loc_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_C7A81412E5D7B4E28D56B47ACF11B926" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_13AAB3F8AD8C8CC9D906B47ACF1182CD" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ango_IncomeTaxesTextualAbstract_0937FAACE18BDB17C485B47ACF11E834" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_13AAB3F8AD8C8CC9D906B47ACF1182CD" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesIncomeTaxesDetails5" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/Inventories" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryLineItems" xlink:label="loc_us-gaap_InventoryLineItems_7B06AE4BAD800E3D9CA88FC083347E55" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryCurrentTable" xlink:label="loc_us-gaap_InventoryCurrentTable_E00279057826009D9D758FC0833460B2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InventoryLineItems_7B06AE4BAD800E3D9CA88FC083347E55" xlink:to="loc_us-gaap_InventoryCurrentTable_E00279057826009D9D758FC0833460B2" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="ango-20180531.xsd#ango_InventoryTypeAxis" xlink:label="loc_ango_InventoryTypeAxis_DBED2854E4F3B3C5D2118FC38153BB71" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InventoryCurrentTable_E00279057826009D9D758FC0833460B2" xlink:to="loc_ango_InventoryTypeAxis_DBED2854E4F3B3C5D2118FC38153BB71" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_InventoryTypeDomain" xlink:label="loc_ango_InventoryTypeDomain_0E82336477FED56A69078FC38168A954_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ango_InventoryTypeAxis_DBED2854E4F3B3C5D2118FC38153BB71" xlink:to="loc_ango_InventoryTypeDomain_0E82336477FED56A69078FC38168A954_default" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_InventoryTypeDomain" xlink:label="loc_ango_InventoryTypeDomain_0E82336477FED56A69078FC38168A954" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ango_InventoryTypeAxis_DBED2854E4F3B3C5D2118FC38153BB71" xlink:to="loc_ango_InventoryTypeDomain_0E82336477FED56A69078FC38168A954" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AcculisInventoryMember" xlink:label="loc_ango_AcculisInventoryMember_54217A263833431B684E8FC41AA3041E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ango_InventoryTypeDomain_0E82336477FED56A69078FC38168A954" xlink:to="loc_ango_AcculisInventoryMember_54217A263833431B684E8FC41AA3041E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_5B0BB487E5B0330B24228FC62A2391EE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InventoryCurrentTable_E00279057826009D9D758FC0833460B2" xlink:to="loc_srt_CounterpartyNameAxis_5B0BB487E5B0330B24228FC62A2391EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_E02C9E6B7DDB22508DEF8FC69AC26849_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_5B0BB487E5B0330B24228FC62A2391EE" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_E02C9E6B7DDB22508DEF8FC69AC26849_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_E02C9E6B7DDB22508DEF8FC69AC26849" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_5B0BB487E5B0330B24228FC62A2391EE" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_E02C9E6B7DDB22508DEF8FC69AC26849" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_UndisclosedInventoryDistributorMember" xlink:label="loc_ango_UndisclosedInventoryDistributorMember_A81C7B616361BCE46D998FC7A34BF1D7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_E02C9E6B7DDB22508DEF8FC69AC26849" xlink:to="loc_ango_UndisclosedInventoryDistributorMember_A81C7B616361BCE46D998FC7A34BF1D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E69B4D863700D67B75318FD9E6CB7F4E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InventoryCurrentTable_E00279057826009D9D758FC0833460B2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E69B4D863700D67B75318FD9E6CB7F4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E69B4D863700D67B75318FD9E6CB7F4E" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E69B4D863700D67B75318FD9E6CB7F4E" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ProductTechnologiesMember" xlink:label="loc_ango_ProductTechnologiesMember_F9600E3630085DB2878F8FD9E6CC5B09" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923" xlink:to="loc_ango_ProductTechnologiesMember_F9600E3630085DB2878F8FD9E6CC5B09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_04F02CDAF3EC5395A5458FD9E6CD24B4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923" xlink:to="loc_us-gaap_CustomerRelationshipsMember_04F02CDAF3EC5395A5458FD9E6CD24B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaap_TrademarksMember_CDF5C08493C51726436F8FD9E6CD729A" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923" xlink:to="loc_us-gaap_TrademarksMember_CDF5C08493C51726436F8FD9E6CD729A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LicenseAgreementTermsMember" xlink:label="loc_us-gaap_LicenseAgreementTermsMember_3458B1762E417930C84D8FD9E6CD5002" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923" xlink:to="loc_us-gaap_LicenseAgreementTermsMember_3458B1762E417930C84D8FD9E6CD5002" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_DistributorRelationshipsMember" xlink:label="loc_ango_DistributorRelationshipsMember_19640D110147879EB1B38FD9E6CDD764" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923" xlink:to="loc_ango_DistributorRelationshipsMember_19640D110147879EB1B38FD9E6CDD764" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaap_InventoryWriteDown_2CA7AC091FFB81049CB28F96E2A0F612" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_7B06AE4BAD800E3D9CA88FC083347E55" xlink:to="loc_us-gaap_InventoryWriteDown_2CA7AC091FFB81049CB28F96E2A0F612" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/InventoriesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/LongTermDebt" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/LongTermDebtDetails1" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_A5235589D2A40C2A787F8F96E186ABE8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_22929C02D1BB38F3A7008F96E17F1E6A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A5235589D2A40C2A787F8F96E186ABE8" xlink:to="loc_us-gaap_DebtInstrumentTable_22929C02D1BB38F3A7008F96E17F1E6A" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_82C1D6811B10107C96AB8F96E1862829" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_22929C02D1BB38F3A7008F96E17F1E6A" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_82C1D6811B10107C96AB8F96E1862829" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_74EEECDFCDA6DC9521FF8F96E1861BA7_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_82C1D6811B10107C96AB8F96E1862829" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_74EEECDFCDA6DC9521FF8F96E1861BA7_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_74EEECDFCDA6DC9521FF8F96E1861BA7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_82C1D6811B10107C96AB8F96E1862829" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_74EEECDFCDA6DC9521FF8F96E1861BA7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_90E54799C00A5DDE2E8B8F96E1869AAB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_74EEECDFCDA6DC9521FF8F96E1861BA7" xlink:to="loc_us-gaap_LineOfCreditMember_90E54799C00A5DDE2E8B8F96E1869AAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_BD5BFECC86A2C73B00148F96E18438D4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_22929C02D1BB38F3A7008F96E17F1E6A" xlink:to="loc_us-gaap_CreditFacilityAxis_BD5BFECC86A2C73B00148F96E18438D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_D2C2E6DCACB82A2864448F96E1854D70_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_BD5BFECC86A2C73B00148F96E18438D4" xlink:to="loc_us-gaap_CreditFacilityDomain_D2C2E6DCACB82A2864448F96E1854D70_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_D2C2E6DCACB82A2864448F96E1854D70" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_BD5BFECC86A2C73B00148F96E18438D4" xlink:to="loc_us-gaap_CreditFacilityDomain_D2C2E6DCACB82A2864448F96E1854D70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember_B44B9F98D71B28FE58B28F96E1855D83" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_D2C2E6DCACB82A2864448F96E1854D70" xlink:to="loc_us-gaap_SecuredDebtMember_B44B9F98D71B28FE58B28F96E1855D83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_B769567191A05EF7EF488F96E185952F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_D2C2E6DCACB82A2864448F96E1854D70" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_B769567191A05EF7EF488F96E185952F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A5235589D2A40C2A787F8F96E186ABE8" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3A1FC55B6C4EC0E6DCDF8F96E1873323" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3A1FC55B6C4EC0E6DCDF8F96E1873323" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_E6D8B0B9B852505653278F96E187583F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_E6D8B0B9B852505653278F96E187583F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7151635934973BF5323B8F96E18718F8" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7151635934973BF5323B8F96E18718F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_FB47855D543D2C0DA3538F96E187A69D" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_FB47855D543D2C0DA3538F96E187A69D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_38F30DCE4B0CEFA85E4A8F96E188756F" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_38F30DCE4B0CEFA85E4A8F96E188756F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_B91505A4AAAC3189F4E88F96E1886E5B" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_B91505A4AAAC3189F4E88F96E1886E5B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_60850FB2EECA86CCC34E8F96E1883A4F" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:to="loc_us-gaap_LongTermDebt_60850FB2EECA86CCC34E8F96E1883A4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_D4F7B9457642FA983E118F96E1880FD7" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:to="loc_us-gaap_LongTermDebtCurrent_D4F7B9457642FA983E118F96E1880FD7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_13AEB222AD6BA25AB05C8F96E1884F20" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_13AEB222AD6BA25AB05C8F96E1884F20" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/LongTermDebtDetailsTextual" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_BEEF0CA0581A5D3AC09D8F96E1696FFD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_us-gaap_DebtInstrumentTable_BEEF0CA0581A5D3AC09D8F96E1696FFD" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_DC4AE858003BAE2A28F18F96E16B2BD5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_BEEF0CA0581A5D3AC09D8F96E1696FFD" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_DC4AE858003BAE2A28F18F96E16B2BD5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_D2B163499C03CB1D9AFC8F96E16B8FF3_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_DC4AE858003BAE2A28F18F96E16B2BD5" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_D2B163499C03CB1D9AFC8F96E16B8FF3_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_D2B163499C03CB1D9AFC8F96E16B8FF3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_DC4AE858003BAE2A28F18F96E16B2BD5" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_D2B163499C03CB1D9AFC8F96E16B8FF3" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember" xlink:label="loc_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_4B9CD97D8E27889E44888F96E16B09D0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_D2B163499C03CB1D9AFC8F96E16B8FF3" xlink:to="loc_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_4B9CD97D8E27889E44888F96E16B09D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2E2D279C2369D911C6348F96E16E6CEF" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_BEEF0CA0581A5D3AC09D8F96E1696FFD" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2E2D279C2369D911C6348F96E16E6CEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_B1918DEE91360C49286B8F96E16EF74A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2E2D279C2369D911C6348F96E16E6CEF" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_B1918DEE91360C49286B8F96E16EF74A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_B1918DEE91360C49286B8F96E16EF74A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2E2D279C2369D911C6348F96E16E6CEF" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_B1918DEE91360C49286B8F96E16EF74A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_8F6543A4F51C08BDA28A8F96E16E1928" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_B1918DEE91360C49286B8F96E16EF74A" xlink:to="loc_us-gaap_LineOfCreditMember_8F6543A4F51C08BDA28A8F96E16E1928" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_1C58C744417F8EF1F5168F96E16C4A2D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_BEEF0CA0581A5D3AC09D8F96E1696FFD" xlink:to="loc_us-gaap_CreditFacilityAxis_1C58C744417F8EF1F5168F96E16C4A2D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_C13291A081C93F493EF38F96E16CA64C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_1C58C744417F8EF1F5168F96E16C4A2D" xlink:to="loc_us-gaap_CreditFacilityDomain_C13291A081C93F493EF38F96E16CA64C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_C13291A081C93F493EF38F96E16CA64C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_1C58C744417F8EF1F5168F96E16C4A2D" xlink:to="loc_us-gaap_CreditFacilityDomain_C13291A081C93F493EF38F96E16CA64C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember_52317591F3C6063109778F96E16CEDEB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_C13291A081C93F493EF38F96E16CA64C" xlink:to="loc_us-gaap_SecuredDebtMember_52317591F3C6063109778F96E16CEDEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_A01FED7664875D7E071A8F96E16DAFE8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_C13291A081C93F493EF38F96E16CA64C" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_A01FED7664875D7E071A8F96E16DAFE8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaap_LetterOfCreditMember_9E1A7A346AAC7924120D8F96E16CC583" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_C13291A081C93F493EF38F96E16CA64C" xlink:to="loc_us-gaap_LetterOfCreditMember_9E1A7A346AAC7924120D8F96E16CC583" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BridgeLoanMember" xlink:label="loc_us-gaap_BridgeLoanMember_872E21A2F4EA3FF0EB148F96E16D251C" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_C13291A081C93F493EF38F96E16CA64C" xlink:to="loc_us-gaap_BridgeLoanMember_872E21A2F4EA3FF0EB148F96E16D251C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_B0AF8C2D0A90E80E60DC8F96E16A91D7" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_BEEF0CA0581A5D3AC09D8F96E1696FFD" xlink:to="loc_us-gaap_DebtInstrumentAxis_B0AF8C2D0A90E80E60DC8F96E16A91D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_18A25C72F3F2D148BCE78F96E16A6041_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_B0AF8C2D0A90E80E60DC8F96E16A91D7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_18A25C72F3F2D148BCE78F96E16A6041_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_18A25C72F3F2D148BCE78F96E16A6041" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_B0AF8C2D0A90E80E60DC8F96E16A91D7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_18A25C72F3F2D148BCE78F96E16A6041" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_FormerCreditAgreementMember" xlink:label="loc_ango_FormerCreditAgreementMember_934D4C383FBE30EE655E8F96E16A7614" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18A25C72F3F2D148BCE78F96E16A6041" xlink:to="loc_ango_FormerCreditAgreementMember_934D4C383FBE30EE655E8F96E16A7614" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_14498A48883BB4EBC7838F96E1698BAE" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_BEEF0CA0581A5D3AC09D8F96E1696FFD" xlink:to="loc_us-gaap_VariableRateAxis_14498A48883BB4EBC7838F96E1698BAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_6A5EB4D88C9AAA1DE2908F96E1695527_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_14498A48883BB4EBC7838F96E1698BAE" xlink:to="loc_us-gaap_VariableRateDomain_6A5EB4D88C9AAA1DE2908F96E1695527_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_6A5EB4D88C9AAA1DE2908F96E1695527" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_14498A48883BB4EBC7838F96E1698BAE" xlink:to="loc_us-gaap_VariableRateDomain_6A5EB4D88C9AAA1DE2908F96E1695527" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BaseRateMember" xlink:label="loc_us-gaap_BaseRateMember_C2E756AB61157FA520638F96E169B04F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_6A5EB4D88C9AAA1DE2908F96E1695527" xlink:to="loc_us-gaap_BaseRateMember_C2E756AB61157FA520638F96E169B04F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EurodollarMember" xlink:label="loc_us-gaap_EurodollarMember_4A63EBC5E9C0B9D382D28F96E16A54CA" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_6A5EB4D88C9AAA1DE2908F96E1695527" xlink:to="loc_us-gaap_EurodollarMember_4A63EBC5E9C0B9D382D28F96E16A54CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_17A07E27DF15296249338F96E16D325C" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_BEEF0CA0581A5D3AC09D8F96E1696FFD" xlink:to="loc_srt_RangeAxis_17A07E27DF15296249338F96E16D325C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_D8A44AD7DCF94BBB4BF98F96E16DD2B7_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_17A07E27DF15296249338F96E16D325C" xlink:to="loc_srt_RangeMember_D8A44AD7DCF94BBB4BF98F96E16DD2B7_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_D8A44AD7DCF94BBB4BF98F96E16DD2B7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_17A07E27DF15296249338F96E16D325C" xlink:to="loc_srt_RangeMember_D8A44AD7DCF94BBB4BF98F96E16DD2B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_0A8BCC58DF6AF1182E508F96E16D8FF8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_D8A44AD7DCF94BBB4BF98F96E16DD2B7" xlink:to="loc_srt_MaximumMember_0A8BCC58DF6AF1182E508F96E16D8FF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_6E02F0C63645CA25D22C8F96E16EA088" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_D8A44AD7DCF94BBB4BF98F96E16DD2B7" xlink:to="loc_srt_MinimumMember_6E02F0C63645CA25D22C8F96E16EA088" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2A9D596F2AB55EE7EA578F96E16F1E49" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2A9D596F2AB55EE7EA578F96E16F1E49" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_AB178F7EBA245FE4C6768F96E1704064" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_AB178F7EBA245FE4C6768F96E1704064" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_DB73835573EE4F4BB0C08F96E1708E91" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_DB73835573EE4F4BB0C08F96E1708E91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_440FAA6451E7CE4508718F96E170DF35" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_us-gaap_DebtInstrumentTerm_440FAA6451E7CE4508718F96E170DF35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6DE133E7CCD04B9909928F96E170FCCD" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6DE133E7CCD04B9909928F96E170FCCD" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_DebtInstrumentIncreaseInInterestRateInCaseOfDefault" xlink:label="loc_ango_DebtInstrumentIncreaseInInterestRateInCaseOfDefault_9113A505CA0F1CD410298F96E170CA2D" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_ango_DebtInstrumentIncreaseInInterestRateInCaseOfDefault_9113A505CA0F1CD410298F96E170CA2D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_63EB5B79B1AA839D79AC8F96E17189A0" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_63EB5B79B1AA839D79AC8F96E17189A0" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA" xlink:label="loc_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA_50E04B96ADF981FF78A08F96E171093D" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA_50E04B96ADF981FF78A08F96E171093D" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions" xlink:label="loc_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions_FAA8206B57927E05D9C18F96E1712FD2" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions_FAA8206B57927E05D9C18F96E1712FD2" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_DebtServiceCoverageRatio" xlink:label="loc_ango_DebtServiceCoverageRatio_838AE497F488B6480E478F96E1710EFD" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_ango_DebtServiceCoverageRatio_838AE497F488B6480E478F96E1710EFD" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_DebtInstrumentMaximumCashAmountForNetDebtCalculation" xlink:label="loc_ango_DebtInstrumentMaximumCashAmountForNetDebtCalculation_30B54B880A7199BB2F5E900A532642D3" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_ango_DebtInstrumentMaximumCashAmountForNetDebtCalculation_30B54B880A7199BB2F5E900A532642D3" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/LongTermDebtTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/MarketableSecurities" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/MarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5E296C8EB7075B7A70C08F96E2C69ED7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_CDEF05A73D6FFF8FE74F8F96E2BF7B58" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5E296C8EB7075B7A70C08F96E2C69ED7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_CDEF05A73D6FFF8FE74F8F96E2BF7B58" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6757D5ADC0FA0F8C698E8F96E2BFC98F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_CDEF05A73D6FFF8FE74F8F96E2BF7B58" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6757D5ADC0FA0F8C698E8F96E2BFC98F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_75351D897C252A1197748F96E2C5D651_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6757D5ADC0FA0F8C698E8F96E2BFC98F" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_75351D897C252A1197748F96E2C5D651_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_75351D897C252A1197748F96E2C5D651" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6757D5ADC0FA0F8C698E8F96E2BFC98F" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_75351D897C252A1197748F96E2C5D651" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_FAF39EF2A68392FE2B448F96E2C54D5E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_75351D897C252A1197748F96E2C5D651" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_FAF39EF2A68392FE2B448F96E2C54D5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_E46A7160C2D79FBBAECA8F96E2C6CC76" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5E296C8EB7075B7A70C08F96E2C69ED7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_E46A7160C2D79FBBAECA8F96E2C6CC76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_A3FF4A9F356AEAE99E518F96E2C706C7" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5E296C8EB7075B7A70C08F96E2C69ED7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_A3FF4A9F356AEAE99E518F96E2C706C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_BD922B6520540F41AE768F96E2C74D9F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5E296C8EB7075B7A70C08F96E2C69ED7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_BD922B6520540F41AE768F96E2C74D9F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_5BDF692AA3A87BEAA12E8F96E2C7F94A" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5E296C8EB7075B7A70C08F96E2C69ED7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_5BDF692AA3A87BEAA12E8F96E2C7F94A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/MarketableSecuritiesDetails1" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/MarketableSecuritiesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/OtherAssets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/OtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems_2C715C81B34FDED991828F22D14B9427" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesTable" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesTable_323D2B4400424380CC038F22D14B70B9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems_2C715C81B34FDED991828F22D14B9427" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesTable_323D2B4400424380CC038F22D14B70B9" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_437AFD6D27EC0F59893D8F22D14B2252" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesTable_323D2B4400424380CC038F22D14B70B9" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_437AFD6D27EC0F59893D8F22D14B2252" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_8A79C29ABBABB73E830D8F22D14BFBCC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_437AFD6D27EC0F59893D8F22D14B2252" xlink:to="loc_us-gaap_RelatedPartyDomain_8A79C29ABBABB73E830D8F22D14BFBCC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_8A79C29ABBABB73E830D8F22D14BFBCC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_437AFD6D27EC0F59893D8F22D14B2252" xlink:to="loc_us-gaap_RelatedPartyDomain_8A79C29ABBABB73E830D8F22D14BFBCC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_AffiliatedEntityMember" xlink:label="loc_srt_AffiliatedEntityMember_AB8374953F9EF75D9ED08F22D14BABC5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_8A79C29ABBABB73E830D8F22D14BFBCC" xlink:to="loc_srt_AffiliatedEntityMember_AB8374953F9EF75D9ED08F22D14BABC5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_60FF2B88161FC9CCE7AA8F22D14B9B82" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems_2C715C81B34FDED991828F22D14B9427" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_60FF2B88161FC9CCE7AA8F22D14B9B82" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_B4E813FC3777C2F941378F22D14B9745" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems_2C715C81B34FDED991828F22D14B9427" xlink:to="loc_us-gaap_AssetImpairmentCharges_B4E813FC3777C2F941378F22D14B9745" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/PrepaidExpensesAndOther" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/PrepaidExpensesAndOtherDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/PrepaidExpensesAndOtherTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNet" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2F92076A3EE4B27C2FF48C8B9A111EFF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_B866B260E45BF143EA478C8B9A113073" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2F92076A3EE4B27C2FF48C8B9A111EFF" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_B866B260E45BF143EA478C8B9A113073" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_665BA1825D9349AF39DA8C8B9A11161C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_B866B260E45BF143EA478C8B9A113073" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_665BA1825D9349AF39DA8C8B9A11161C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_665BA1825D9349AF39DA8C8B9A11161C" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_665BA1825D9349AF39DA8C8B9A11161C" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_2E5B9217F3F63628812C8C8B9A116C9D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_2E5B9217F3F63628812C8C8B9A116C9D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_820B0266DCED69389B798C8B9A119C90" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_820B0266DCED69389B798C8B9A119C90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_A2012ACBC0F95E1794DE8C8B9A113F0C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96" xlink:to="loc_us-gaap_ComputerEquipmentMember_A2012ACBC0F95E1794DE8C8B9A113F0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="loc_us-gaap_ConstructionInProgressMember_A72B659315D994CE991A8C8B9A11D131" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96" xlink:to="loc_us-gaap_ConstructionInProgressMember_A72B659315D994CE991A8C8B9A11D131" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2F92076A3EE4B27C2FF48C8B9A111EFF" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_C6E0DE96869D9D1E20698C8B9A11EFAE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_C6E0DE96869D9D1E20698C8B9A11EFAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_B52FD1D61F055E43072F8C8B9A1150BD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_B52FD1D61F055E43072F8C8B9A1150BD" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements" xlink:label="loc_ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements_10AA323DB108213CCDDA8C8B9A113B1F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A" xlink:to="loc_ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements_10AA323DB108213CCDDA8C8B9A113B1F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LandAndLandImprovements" xlink:label="loc_us-gaap_LandAndLandImprovements_3991D85FE99C720BB4188C8B9A11A5C1" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A" xlink:to="loc_us-gaap_LandAndLandImprovements_3991D85FE99C720BB4188C8B9A11A5C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_E77A0F2748ACD3FBE46F8C8B9A11F114" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_E77A0F2748ACD3FBE46F8C8B9A11F114" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_2396232D1B0271DE7A148C8B9A112DDE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2F92076A3EE4B27C2FF48C8B9A111EFF" xlink:to="loc_us-gaap_Depreciation_2396232D1B0271DE7A148C8B9A112DDE" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNetTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/QuarterlyInformationUnaudited" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/QuarterlyInformationUnauditedDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_365B9693C63F13E9C21A94C42DBBADAE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81FEA8688D316E28C9E294C42DBBF77B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_365B9693C63F13E9C21A94C42DBBADAE" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81FEA8688D316E28C9E294C42DBBF77B" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupClassificationAxis" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_D3C19CA361DF773648B594C42DBB9660" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81FEA8688D316E28C9E294C42DBBF77B" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_D3C19CA361DF773648B594C42DBB9660" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupClassificationDomain" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_7B3F9B6698AA41E5317994C42DBB28DF_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_D3C19CA361DF773648B594C42DBB9660" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_7B3F9B6698AA41E5317994C42DBB28DF_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupClassificationDomain" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_7B3F9B6698AA41E5317994C42DBB28DF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_D3C19CA361DF773648B594C42DBB9660" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_7B3F9B6698AA41E5317994C42DBB28DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_72AC917C26F3CAD1BF4694C42DBBCDB7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_7B3F9B6698AA41E5317994C42DBB28DF" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_72AC917C26F3CAD1BF4694C42DBBCDB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_62D10A9529CF2E2EBCBA94C42DBBD07E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81FEA8688D316E28C9E294C42DBBF77B" xlink:to="loc_srt_ProductOrServiceAxis_62D10A9529CF2E2EBCBA94C42DBBD07E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_19AA8772CD4BF986526394C42DBBF5D4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_62D10A9529CF2E2EBCBA94C42DBBD07E" xlink:to="loc_srt_ProductsAndServicesDomain_19AA8772CD4BF986526394C42DBBF5D4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_19AA8772CD4BF986526394C42DBBF5D4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_62D10A9529CF2E2EBCBA94C42DBBD07E" xlink:to="loc_srt_ProductsAndServicesDomain_19AA8772CD4BF986526394C42DBBF5D4" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AcculisCapitalSystemsMember" xlink:label="loc_ango_AcculisCapitalSystemsMember_BCAB0C555609C18D44A994C42DBBB283" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_19AA8772CD4BF986526394C42DBBF5D4" xlink:to="loc_ango_AcculisCapitalSystemsMember_BCAB0C555609C18D44A994C42DBBB283" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit" xlink:label="loc_ango_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_B6BBBE8CC8D04CAB483B94C42DBB6454" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_365B9693C63F13E9C21A94C42DBBADAE" xlink:to="loc_ango_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_B6BBBE8CC8D04CAB483B94C42DBB6454" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_3A4C03BEAB27AA40AC3E94C42DBBE65F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_365B9693C63F13E9C21A94C42DBBADAE" xlink:to="loc_us-gaap_LitigationReserve_3A4C03BEAB27AA40AC3E94C42DBBE65F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_8DB58A14C9A5FFF95C4494C42DBB1EFA" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_365B9693C63F13E9C21A94C42DBBADAE" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_8DB58A14C9A5FFF95C4494C42DBB1EFA" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/QuarterlyInformationUnauditedTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/RetirementPlans" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/RetirementPlansDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/SegmentsAndGeographicInformation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_D4D9D83D48C6937452778F96E0722F0A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_CDB40E08D39B456414488F96E0702B2F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_D4D9D83D48C6937452778F96E0722F0A" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_CDB40E08D39B456414488F96E0702B2F" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_152E97255C53227510818F96E0717C2F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_CDB40E08D39B456414488F96E0702B2F" xlink:to="loc_srt_ProductOrServiceAxis_152E97255C53227510818F96E0717C2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_E728D17A31E38082B9598F96E071FBC9_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_152E97255C53227510818F96E0717C2F" xlink:to="loc_srt_ProductsAndServicesDomain_E728D17A31E38082B9598F96E071FBC9_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_E728D17A31E38082B9598F96E071FBC9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_152E97255C53227510818F96E0717C2F" xlink:to="loc_srt_ProductsAndServicesDomain_E728D17A31E38082B9598F96E071FBC9" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PeripheralVascularMember" xlink:label="loc_ango_PeripheralVascularMember_443593E35AC0D07E08988F96E071CF17" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_E728D17A31E38082B9598F96E071FBC9" xlink:to="loc_ango_PeripheralVascularMember_443593E35AC0D07E08988F96E071CF17" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AccessMember" xlink:label="loc_ango_AccessMember_3C0B3B8550975A3DD6118F96E0720108" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_E728D17A31E38082B9598F96E071FBC9" xlink:to="loc_ango_AccessMember_3C0B3B8550975A3DD6118F96E0720108" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_OncologySurgeryMember" xlink:label="loc_ango_OncologySurgeryMember_3AA53AB95FC9AE8A6BE78F96E072FD90" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_E728D17A31E38082B9598F96E071FBC9" xlink:to="loc_ango_OncologySurgeryMember_3AA53AB95FC9AE8A6BE78F96E072FD90" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_NetSalesByProductCategoryAbstract" xlink:label="loc_ango_NetSalesByProductCategoryAbstract_3BACADA5C08994F3C0B78F96E072C7E3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_D4D9D83D48C6937452778F96E0722F0A" xlink:to="loc_ango_NetSalesByProductCategoryAbstract_3BACADA5C08994F3C0B78F96E072C7E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_B72B3C9F8464DF4100948F96E07266B0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ango_NetSalesByProductCategoryAbstract_3BACADA5C08994F3C0B78F96E072C7E3" xlink:to="loc_us-gaap_Revenues_B72B3C9F8464DF4100948F96E07266B0" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetails1" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_645EB5D2C00278FBD7B78F96E06C8354" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_C547B032EAD9A5B2C3878F96E06AE338" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_645EB5D2C00278FBD7B78F96E06C8354" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_C547B032EAD9A5B2C3878F96E06AE338" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_671A26CE649439C2E3C38F96E06B55D4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_C547B032EAD9A5B2C3878F96E06AE338" xlink:to="loc_srt_StatementGeographicalAxis_671A26CE649439C2E3C38F96E06B55D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_B8AD87DAD7D5C828DE7A8F96E06BF15C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_671A26CE649439C2E3C38F96E06B55D4" xlink:to="loc_srt_SegmentGeographicalDomain_B8AD87DAD7D5C828DE7A8F96E06BF15C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_B8AD87DAD7D5C828DE7A8F96E06BF15C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_671A26CE649439C2E3C38F96E06B55D4" xlink:to="loc_srt_SegmentGeographicalDomain_B8AD87DAD7D5C828DE7A8F96E06BF15C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_7302D3358AA36ACD7C298F96E06B5883" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_B8AD87DAD7D5C828DE7A8F96E06BF15C" xlink:to="loc_country_US_7302D3358AA36ACD7C298F96E06B5883" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_InternationalMember" xlink:label="loc_ango_InternationalMember_8135E22137AF41692F328F96E06C411D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_B8AD87DAD7D5C828DE7A8F96E06BF15C" xlink:to="loc_ango_InternationalMember_8135E22137AF41692F328F96E06C411D" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_SummaryOfSalesForGeographicAreasAbstract" xlink:label="loc_ango_SummaryOfSalesForGeographicAreasAbstract_01503E946DB7A7DF93E18F96E06C5B75" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_645EB5D2C00278FBD7B78F96E06C8354" xlink:to="loc_ango_SummaryOfSalesForGeographicAreasAbstract_01503E946DB7A7DF93E18F96E06C5B75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentsGeographicalAreasAbstract" xlink:label="loc_us-gaap_SegmentsGeographicalAreasAbstract_C7D36481BB89932273A78F96E06C7032" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ango_SummaryOfSalesForGeographicAreasAbstract_01503E946DB7A7DF93E18F96E06C5B75" xlink:to="loc_us-gaap_SegmentsGeographicalAreasAbstract_C7D36481BB89932273A78F96E06C7032" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_69E904C96033AC3AFE558F96E06D1C56" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentsGeographicalAreasAbstract_C7D36481BB89932273A78F96E06C7032" xlink:to="loc_us-gaap_Revenues_69E904C96033AC3AFE558F96E06D1C56" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetailsTextual" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/StockholdersEquity" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/StockholdersEquityDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/StockholdersEquityDetails2" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10EE9F6E310D10821935949FCC001953" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_501BED2C49B5CF55B653949FCBF939FD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10EE9F6E310D10821935949FCC001953" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_501BED2C49B5CF55B653949FCBF939FD" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1B62EB16FA99C55B3A14949FCBFAEE23" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_501BED2C49B5CF55B653949FCBF939FD" xlink:to="loc_us-gaap_AwardTypeAxis_1B62EB16FA99C55B3A14949FCBFAEE23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0A1C07C8BED708127DE9949FCBFA0275_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1B62EB16FA99C55B3A14949FCBFAEE23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0A1C07C8BED708127DE9949FCBFA0275_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0A1C07C8BED708127DE9949FCBFA0275" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1B62EB16FA99C55B3A14949FCBFAEE23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0A1C07C8BED708127DE9949FCBFA0275" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5ECD8FA9C2754BDE3978949FCBFAD51E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0A1C07C8BED708127DE9949FCBFA0275" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5ECD8FA9C2754BDE3978949FCBFAD51E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_E3FA128646A65FCB6B15949FCBFBAA0B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0A1C07C8BED708127DE9949FCBFA0275" xlink:to="loc_us-gaap_PerformanceSharesMember_E3FA128646A65FCB6B15949FCBFBAA0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_D9F8F2579235E153009D949FCC00E6F4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10EE9F6E310D10821935949FCC001953" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_D9F8F2579235E153009D949FCC00E6F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_EC5F4E32D0FC6850477F949FCC0195B0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_D9F8F2579235E153009D949FCC00E6F4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_EC5F4E32D0FC6850477F949FCC0195B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DED16955126613DDA587949FCC018245" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_D9F8F2579235E153009D949FCC00E6F4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DED16955126613DDA587949FCC018245" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_94C1334E1E0200040163949FCC013A72" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_D9F8F2579235E153009D949FCC00E6F4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_94C1334E1E0200040163949FCC013A72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_63F7845BEE7D8B287272949FCC017E07" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_D9F8F2579235E153009D949FCC00E6F4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_63F7845BEE7D8B287272949FCC017E07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7A74E29FA60CC4B8866F94B6D1A664C3" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10EE9F6E310D10821935949FCC001953" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7A74E29FA60CC4B8866F94B6D1A664C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_887B76ACEF842D72C65F949FCC01ED85" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7A74E29FA60CC4B8866F94B6D1A664C3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_887B76ACEF842D72C65F949FCC01ED85" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_56C929926B2D6133F79C949FCC0249DE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7A74E29FA60CC4B8866F94B6D1A664C3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_56C929926B2D6133F79C949FCC0249DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2D6AF38A52523EE6FA53949FCC02A577" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7A74E29FA60CC4B8866F94B6D1A664C3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2D6AF38A52523EE6FA53949FCC02A577" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8A56D90C58660904108A949FCC020491" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7A74E29FA60CC4B8866F94B6D1A664C3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8A56D90C58660904108A949FCC020491" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/StockholdersEquityDetails3" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1234E42466412828134E949FCBE9F51F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1C6E5FB8805E218B5B25949FCBE751AC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1234E42466412828134E949FCBE9F51F" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1C6E5FB8805E218B5B25949FCBE751AC" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_423196CE84BE8EB5D404949FCBE8DDE9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1C6E5FB8805E218B5B25949FCBE751AC" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_423196CE84BE8EB5D404949FCBE8DDE9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_423196CE84BE8EB5D404949FCBE8DDE9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_423196CE84BE8EB5D404949FCBE8DDE9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_806AAFF216A3809417B7949FCBE8B911" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86" xlink:to="loc_us-gaap_CostOfSalesMember_806AAFF216A3809417B7949FCBE8B911" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ResearchAndDevelopmentMember" xlink:label="loc_ango_ResearchAndDevelopmentMember_AB3C25032D663E11107C949FCBE9BE8B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86" xlink:to="loc_ango_ResearchAndDevelopmentMember_AB3C25032D663E11107C949FCBE9BE8B" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_SalesandMarketingMember" xlink:label="loc_ango_SalesandMarketingMember_15085B2BD1E110381982949FCBE942DE" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86" xlink:to="loc_ango_SalesandMarketingMember_15085B2BD1E110381982949FCBE942DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_873AD77C529EFA4E5EFA949FCBE900E7" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_873AD77C529EFA4E5EFA949FCBE900E7" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AcquisitionRestructuringAndOtherItemsNetMember" xlink:label="loc_ango_AcquisitionRestructuringAndOtherItemsNetMember_5AE5FE71CB256CFA269F949FCBE91065" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86" xlink:to="loc_ango_AcquisitionRestructuringAndOtherItemsNetMember_5AE5FE71CB256CFA269F949FCBE91065" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_A8433594669F83DAC9F4949FCBE9A077" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1234E42466412828134E949FCBE9F51F" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_A8433594669F83DAC9F4949FCBE9A077" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/StockholdersEquityDetailsTextual" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherOwnershipInterestsLineItems" xlink:label="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfOtherOwnershipInterestsTable" xlink:label="loc_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_D7F776FEE857607A9287A4E39D9EC08F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:to="loc_us-gaap_PlanNameAxis_D7F776FEE857607A9287A4E39D9EC08F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_8E06DA3C45AF458EA832A4E39D9E9028_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_D7F776FEE857607A9287A4E39D9EC08F" xlink:to="loc_us-gaap_PlanNameDomain_8E06DA3C45AF458EA832A4E39D9E9028_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_8E06DA3C45AF458EA832A4E39D9E9028" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_D7F776FEE857607A9287A4E39D9EC08F" xlink:to="loc_us-gaap_PlanNameDomain_8E06DA3C45AF458EA832A4E39D9E9028" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember" xlink:label="loc_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember_59F7E69FA3B12DD04499A4E39D9F8711" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_8E06DA3C45AF458EA832A4E39D9E9028" xlink:to="loc_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember_59F7E69FA3B12DD04499A4E39D9F8711" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_StockPurchasePlanMember" xlink:label="loc_ango_StockPurchasePlanMember_A0B236EB0ACFB7C89AF1A4E39D9F7771" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_8E06DA3C45AF458EA832A4E39D9E9028" xlink:to="loc_ango_StockPurchasePlanMember_A0B236EB0ACFB7C89AF1A4E39D9F7771" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_0FB21A5ED03CCC2495EAA4E39D9F8F65" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:to="loc_srt_RangeAxis_0FB21A5ED03CCC2495EAA4E39D9F8F65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_103088B1232CA44D8470A4E39D9F0D1C_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0FB21A5ED03CCC2495EAA4E39D9F8F65" xlink:to="loc_srt_RangeMember_103088B1232CA44D8470A4E39D9F0D1C_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_103088B1232CA44D8470A4E39D9F0D1C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0FB21A5ED03CCC2495EAA4E39D9F8F65" xlink:to="loc_srt_RangeMember_103088B1232CA44D8470A4E39D9F0D1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_45FC8860ADE1EDB13351A4E39D9F6C2B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_103088B1232CA44D8470A4E39D9F0D1C" xlink:to="loc_srt_MaximumMember_45FC8860ADE1EDB13351A4E39D9F6C2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_67FF31A331536611A805A4E39D9F1351" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_67FF31A331536611A805A4E39D9F1351" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_B5EC80741D20F85DA1D5A4E39D9F59C7_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_67FF31A331536611A805A4E39D9F1351" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_B5EC80741D20F85DA1D5A4E39D9F59C7_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_B5EC80741D20F85DA1D5A4E39D9F59C7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_67FF31A331536611A805A4E39D9F1351" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_B5EC80741D20F85DA1D5A4E39D9F59C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_AD1B6F7750D1DE7370A8A4E39D9FFEEA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_B5EC80741D20F85DA1D5A4E39D9F59C7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_AD1B6F7750D1DE7370A8A4E39D9FFEEA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_13C7B7981A577540FF69A4E39D9F1E60" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:to="loc_us-gaap_AwardTypeAxis_13C7B7981A577540FF69A4E39D9F1E60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_B7A8DB8F92BBFDE501AFA4E39D9F7D5E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_13C7B7981A577540FF69A4E39D9F1E60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_B7A8DB8F92BBFDE501AFA4E39D9F7D5E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_B7A8DB8F92BBFDE501AFA4E39D9F7D5E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_13C7B7981A577540FF69A4E39D9F1E60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_B7A8DB8F92BBFDE501AFA4E39D9F7D5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3AD33327A6D941B6ED6CA4E39D9F84D1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_B7A8DB8F92BBFDE501AFA4E39D9F7D5E" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3AD33327A6D941B6ED6CA4E39D9F84D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_EEAB13F3E6AD8BF9F0BAA4E39D9F1260" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_B7A8DB8F92BBFDE501AFA4E39D9F7D5E" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_EEAB13F3E6AD8BF9F0BAA4E39D9F1260" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PerformanceShareAndRestrictedStockUnitAwardsMember" xlink:label="loc_ango_PerformanceShareAndRestrictedStockUnitAwardsMember_489C625B1FF74612BB6FA4E39D9F2A58" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_B7A8DB8F92BBFDE501AFA4E39D9F7D5E" xlink:to="loc_ango_PerformanceShareAndRestrictedStockUnitAwardsMember_489C625B1FF74612BB6FA4E39D9F2A58" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PerformanceSharesIncludingThreeYearMarketConditionMember" xlink:label="loc_ango_PerformanceSharesIncludingThreeYearMarketConditionMember_93653F31E8B97323116CA4E39D9F8795" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_B7A8DB8F92BBFDE501AFA4E39D9F7D5E" xlink:to="loc_ango_PerformanceSharesIncludingThreeYearMarketConditionMember_93653F31E8B97323116CA4E39D9F8795" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_FC613BD4F85BC7D341CFA4E39D9FD784" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:to="loc_us-gaap_StatementClassOfStockAxis_FC613BD4F85BC7D341CFA4E39D9FD784" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_2628990EA1C8DBC09BCAA4E39D9F053A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_FC613BD4F85BC7D341CFA4E39D9FD784" xlink:to="loc_us-gaap_ClassOfStockDomain_2628990EA1C8DBC09BCAA4E39D9F053A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_2628990EA1C8DBC09BCAA4E39D9F053A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_FC613BD4F85BC7D341CFA4E39D9FD784" xlink:to="loc_us-gaap_ClassOfStockDomain_2628990EA1C8DBC09BCAA4E39D9F053A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_E694DF2CE92DFD78F286A4E39D9F0441" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_2628990EA1C8DBC09BCAA4E39D9F053A" xlink:to="loc_us-gaap_CommonStockMember_E694DF2CE92DFD78F286A4E39D9F0441" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_B6AEAA791EC528C520B2A4E39D9FD9D0" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_B6AEAA791EC528C520B2A4E39D9FD9D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_FE5F1D7A24AB62169294A4E39D9F596B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_B6AEAA791EC528C520B2A4E39D9FD9D0" xlink:to="loc_us-gaap_EquityComponentDomain_FE5F1D7A24AB62169294A4E39D9F596B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_FE5F1D7A24AB62169294A4E39D9F596B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_B6AEAA791EC528C520B2A4E39D9FD9D0" xlink:to="loc_us-gaap_EquityComponentDomain_FE5F1D7A24AB62169294A4E39D9F596B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_A78FD8A41F0CA24496A7A4E39D9F32D2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_FE5F1D7A24AB62169294A4E39D9F596B" xlink:to="loc_us-gaap_CommonStockMember_A78FD8A41F0CA24496A7A4E39D9F32D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_23E85E881163BB3472C1A4E39D9F6DAE" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_FE5F1D7A24AB62169294A4E39D9F596B" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_23E85E881163BB3472C1A4E39D9F6DAE" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_CapitalStockSharesAuthorized" xlink:label="loc_ango_CapitalStockSharesAuthorized_663B4E031396C2158C59A4E39D9F9642" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_CapitalStockSharesAuthorized_663B4E031396C2158C59A4E39D9F9642" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_668EBD43417C82D55B78A4E39D9F444C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_668EBD43417C82D55B78A4E39D9F444C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_3B25A9699109328AA17FA4E39D9FDD29" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_3B25A9699109328AA17FA4E39D9FDD29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_E8F54EC24ED7A4629D56A4E39D9FE6DF" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_E8F54EC24ED7A4629D56A4E39D9FE6DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_B9D4A76AB86BD2DED003A4E39D9F9E32" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_B9D4A76AB86BD2DED003A4E39D9F9E32" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_CommonStockVotesPerShare" xlink:label="loc_ango_CommonStockVotesPerShare_D7FB9B216E7B385F5053A4E39D9F68FF" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_CommonStockVotesPerShare_D7FB9B216E7B385F5053A4E39D9F68FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9C9203805EBAE576EAC2A4E39D9F3B5F" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9C9203805EBAE576EAC2A4E39D9F3B5F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_34A6CF663FB8B610DE33A4E39D9F9971" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_34A6CF663FB8B610DE33A4E39D9F9971" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod" xlink:label="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod_A25FF259DBE985943E5AA4E39D9FAE12" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod_A25FF259DBE985943E5AA4E39D9FAE12" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_44BCA0779E314ECEA592A4E39D9F1C98" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_44BCA0779E314ECEA592A4E39D9F1C98" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage" xlink:label="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage_C8DE3681AE580D796DD2A4E39D9FD86E" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage_C8DE3681AE580D796DD2A4E39D9FD86E" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1" xlink:label="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1_68B6169DEE4C27299677A4E39D9F9E68" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1_68B6169DEE4C27299677A4E39D9F9E68" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage" xlink:label="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage_47839A2B780079CD3851A4E39D9F7365" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage_47839A2B780079CD3851A4E39D9F7365" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod" xlink:label="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod_C7C6007FD83463C16F6EA4E39D9F77FA" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod_C7C6007FD83463C16F6EA4E39D9F77FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3A970D6F805FEB0A870DA4E39D9FE41E" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3A970D6F805FEB0A870DA4E39D9FE41E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1B2032CF888D83C821E3A4E39D9FC1A3" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1B2032CF888D83C821E3A4E39D9FC1A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8466A082C47ACC4A4E46A4E39D9F2E8C" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8466A082C47ACC4A4E46A4E39D9F2E8C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_44E008FD583EB4FE12D0A4E39D9FE0CB" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_44E008FD583EB4FE12D0A4E39D9FE0CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Dividends" xlink:label="loc_us-gaap_Dividends_F96A21DCA949BEA26055A4E39D9F3E75" xlink:type="locator" />
    <link:definitionArc order="19" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_Dividends_F96A21DCA949BEA26055A4E39D9F3E75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4B91C4DE519536B56D6AA4E39D9FC661" xlink:type="locator" />
    <link:definitionArc order="20" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4B91C4DE519536B56D6AA4E39D9FC661" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_C1E6C65FF68F25C3A879A4E39D9F4F4C" xlink:type="locator" />
    <link:definitionArc order="21" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_C1E6C65FF68F25C3A879A4E39D9F4F4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_F7C031E8DA3B51ACF9D2A4E39D9F17F4" xlink:type="locator" />
    <link:definitionArc order="22" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_F7C031E8DA3B51ACF9D2A4E39D9F17F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_6CB4F755E1FC73FDCD32A4E39D9F93DA" xlink:type="locator" />
    <link:definitionArc order="23" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_6CB4F755E1FC73FDCD32A4E39D9F93DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_EA7D60AA45AD4B85DAA7A4E39D9FDE8F" xlink:type="locator" />
    <link:definitionArc order="24" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_EA7D60AA45AD4B85DAA7A4E39D9FDE8F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_38DB2AA9438F1010E590A4EE65282947" xlink:type="locator" />
    <link:definitionArc order="25" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_38DB2AA9438F1010E590A4EE65282947" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D64D7FBD7A00472BDD5FA4E39D9FDEE1" xlink:type="locator" />
    <link:definitionArc order="26" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D64D7FBD7A00472BDD5FA4E39D9FDEE1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ADE91AE45A52DB048E3BA4E39D9F07C8" xlink:type="locator" />
    <link:definitionArc order="27" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ADE91AE45A52DB048E3BA4E39D9F07C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_22710570C5359CBB6F63A4E39D9F973F" xlink:type="locator" />
    <link:definitionArc order="28" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_22710570C5359CBB6F63A4E39D9F973F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BF5F264DD9D80587B334A4E39D9F6EA3" xlink:type="locator" />
    <link:definitionArc order="29" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BF5F264DD9D80587B334A4E39D9F6EA3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4FFE6391D0EE6DE7F991A4E39D9F3325" xlink:type="locator" />
    <link:definitionArc order="30" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4FFE6391D0EE6DE7F991A4E39D9F3325" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod" xlink:label="loc_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod_B168C3FC43B6481C6B4BA4E39D9FB421" xlink:type="locator" />
    <link:definitionArc order="31" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod_B168C3FC43B6481C6B4BA4E39D9FB421" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6FDC888F62A79556059CA4E39D9F0CB7" xlink:type="locator" />
    <link:definitionArc order="32" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6FDC888F62A79556059CA4E39D9F0CB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_CACA45F88AF35A46F02EA4E39D9FD887" xlink:type="locator" />
    <link:definitionArc order="33" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_CACA45F88AF35A46F02EA4E39D9FD887" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_947D67FFDBBDA5FD72EBA4E39DAEDC49" xlink:type="locator" />
    <link:definitionArc order="34" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_947D67FFDBBDA5FD72EBA4E39DAEDC49" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_NumberOfSharePurchasePeriod" xlink:label="loc_ango_NumberOfSharePurchasePeriod_F6CE2245D82D1D87EAC4A4E39DAE6565" xlink:type="locator" />
    <link:definitionArc order="35" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_NumberOfSharePurchasePeriod_F6CE2245D82D1D87EAC4A4E39DAE6565" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_SharePurchasePeriod" xlink:label="loc_ango_SharePurchasePeriod_D675AED3AB1EE3058007A4E39DAE40EE" xlink:type="locator" />
    <link:definitionArc order="36" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_SharePurchasePeriod_D675AED3AB1EE3058007A4E39DAE40EE" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_EmployeePlanParticipatingEligibilityPeriod" xlink:label="loc_ango_EmployeePlanParticipatingEligibilityPeriod_961151DEBE928C180179A4E39DAEC9E0" xlink:type="locator" />
    <link:definitionArc order="37" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_EmployeePlanParticipatingEligibilityPeriod_961151DEBE928C180179A4E39DAEC9E0" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription" xlink:label="loc_ango_CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription_EFF1E0F4E1D97CE80678A4E39DAE48B0" xlink:type="locator" />
    <link:definitionArc order="38" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription_EFF1E0F4E1D97CE80678A4E39DAE48B0" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible" xlink:label="loc_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible_6872B2C5FF2D76DE3343A4E39DAEC16B" xlink:type="locator" />
    <link:definitionArc order="39" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible_6872B2C5FF2D76DE3343A4E39DAEC16B" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible" xlink:label="loc_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible_F66E7C98DEDF24E35DD7A4E39DAE7DD3" xlink:type="locator" />
    <link:definitionArc order="40" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible_F66E7C98DEDF24E35DD7A4E39DAE7DD3" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_EmployeePlanParticipatingEligibilityThresholdPercentage" xlink:label="loc_ango_EmployeePlanParticipatingEligibilityThresholdPercentage_8DCDF47E716EC334BBD3A4E39DAEC56F" xlink:type="locator" />
    <link:definitionArc order="41" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_EmployeePlanParticipatingEligibilityThresholdPercentage_8DCDF47E716EC334BBD3A4E39DAEC56F" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod" xlink:label="loc_ango_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod_0CD8AC009BBB9AF57F2AA4E39DAE5EC3" xlink:type="locator" />
    <link:definitionArc order="42" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod_0CD8AC009BBB9AF57F2AA4E39DAE5EC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_151EE5C1921DA024D100A4E39DAE0280" xlink:type="locator" />
    <link:definitionArc order="43" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_151EE5C1921DA024D100A4E39DAE0280" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_799F1415099F36E9DF20A4E39DAE089A" xlink:type="locator" />
    <link:definitionArc order="44" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_799F1415099F36E9DF20A4E39DAE089A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_C30EAFD61A3FE64FE0F5A4E39DAE1B62" xlink:type="locator" />
    <link:definitionArc order="45" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_C30EAFD61A3FE64FE0F5A4E39DAE1B62" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_6CE507B636E7844C056CA4E39DAE3717" xlink:type="locator" />
    <link:definitionArc order="46" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_6CE507B636E7844C056CA4E39DAE3717" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_49CEA1DC0BF0F8BA2D04A4E39DAE1118" xlink:type="locator" />
    <link:definitionArc order="47" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_49CEA1DC0BF0F8BA2D04A4E39DAE1118" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_7855C19EEE2D4BFB3896A4E39DAE74FB" xlink:type="locator" />
    <link:definitionArc order="48" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_7855C19EEE2D4BFB3896A4E39DAE74FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_A420C5CD383E945ED1A6A4E39DAE31F0" xlink:type="locator" />
    <link:definitionArc order="49" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_A420C5CD383E945ED1A6A4E39DAE31F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6140CFBB49A4DBE5DF2EA4E39DAE0E2A" xlink:type="locator" />
    <link:definitionArc order="50" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6140CFBB49A4DBE5DF2EA4E39DAE0E2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_E5200A5B4679D008BC8AA4E39DAE4136" xlink:type="locator" />
    <link:definitionArc order="51" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_E5200A5B4679D008BC8AA4E39DAE4136" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_F6C8054D51D917B157CEA4E39DAE4FAA" xlink:type="locator" />
    <link:definitionArc order="52" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_F6C8054D51D917B157CEA4E39DAE4FAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_EC336066734F814F2C76A4E39DAE2DBF" xlink:type="locator" />
    <link:definitionArc order="53" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_EC336066734F814F2C76A4E39DAE2DBF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockSharesRetired" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_133840925563EFEE02EFA4E39DAE6D84" xlink:type="locator" />
    <link:definitionArc order="54" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_133840925563EFEE02EFA4E39DAE6D84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockRetiredParValueMethodAmount" xlink:label="loc_us-gaap_TreasuryStockRetiredParValueMethodAmount_DB654D69E3D5CD7CC865A4E39DAED796" xlink:type="locator" />
    <link:definitionArc order="55" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_TreasuryStockRetiredParValueMethodAmount_DB654D69E3D5CD7CC865A4E39DAED796" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/StockholdersEquityTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/ValuationAndQualifyingAccounts" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.angiodynamics.com/role/ValuationAndQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_C57A871DD343D874504B8C8B9CC1784F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_6B979FEDCCF2D24255268C8B9CC1FDE6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_C57A871DD343D874504B8C8B9CC1784F" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_6B979FEDCCF2D24255268C8B9CC1FDE6" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_BEA2D68F3EF981ED27E08C8B9CC1E5F7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_6B979FEDCCF2D24255268C8B9CC1FDE6" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_BEA2D68F3EF981ED27E08C8B9CC1E5F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_1B8ACAFAA78C642F87A88C8B9CC1D76B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_BEA2D68F3EF981ED27E08C8B9CC1E5F7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_1B8ACAFAA78C642F87A88C8B9CC1D76B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_1B8ACAFAA78C642F87A88C8B9CC1D76B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_BEA2D68F3EF981ED27E08C8B9CC1E5F7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_1B8ACAFAA78C642F87A88C8B9CC1D76B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_A16DB6570D609D3F6CDC8C8B9CC143E0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_1B8ACAFAA78C642F87A88C8B9CC1D76B" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_A16DB6570D609D3F6CDC8C8B9CC143E0" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember" xlink:label="loc_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember_348F3360238428CA57688C8B9CC1E729" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_1B8ACAFAA78C642F87A88C8B9CC1D76B" xlink:to="loc_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember_348F3360238428CA57688C8B9CC1E729" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_517043EB34B0E527FE0C8C8B9CC1534B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_C57A871DD343D874504B8C8B9CC1784F" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_517043EB34B0E527FE0C8C8B9CC1534B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_E9A5DB517A041695D3FB8C8B9CC1909F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_517043EB34B0E527FE0C8C8B9CC1534B" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_E9A5DB517A041695D3FB8C8B9CC1909F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_6B5DA7F4B9A47FD25F8A8C8B9CC109D0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_517043EB34B0E527FE0C8C8B9CC1534B" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_6B5DA7F4B9A47FD25F8A8C8B9CC109D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_355EC014F6298C2A55CB8C8B9CC1CA26" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_517043EB34B0E527FE0C8C8B9CC1534B" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_355EC014F6298C2A55CB8C8B9CC1CA26" xlink:type="arc" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>17
<FILENAME>ango-20180531_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_EquityAbstract_59F455476AC5FA0757F7901D60BB7C97_label_en-US" xlink:label="lab_us-gaap_EquityAbstract_59F455476AC5FA0757F7901D60BB7C97" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_59F455476AC5FA0757F7901D60BB7C97" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract_59F455476AC5FA0757F7901D60BB7C97" xlink:to="lab_us-gaap_EquityAbstract_59F455476AC5FA0757F7901D60BB7C97" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_E30EA0C88DAF8925FF06901D613593EA_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_E30EA0C88DAF8925FF06901D613593EA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_E30EA0C88DAF8925FF06901D613593EA_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_E30EA0C88DAF8925FF06901D613593EA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_E30EA0C88DAF8925FF06901D613593EA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_E30EA0C88DAF8925FF06901D613593EA" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_E30EA0C88DAF8925FF06901D613593EA" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0676AF030BB2D38847DF8F96E2CE61DD_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0676AF030BB2D38847DF8F96E2CE61DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0676AF030BB2D38847DF8F96E2CE61DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0676AF030BB2D38847DF8F96E2CE61DD" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0676AF030BB2D38847DF8F96E2CE61DD" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_8BE40389B54FA84A9A788F96E2CEAB4D_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_8BE40389B54FA84A9A788F96E2CEAB4D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">MARKETABLE SECURITIES</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_8BE40389B54FA84A9A788F96E2CEAB4D_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_8BE40389B54FA84A9A788F96E2CEAB4D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_8BE40389B54FA84A9A788F96E2CEAB4D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_8BE40389B54FA84A9A788F96E2CEAB4D" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_8BE40389B54FA84A9A788F96E2CEAB4D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_AD3DF84910FB95DAD0B08C8B9BE702C8_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_AD3DF84910FB95DAD0B08C8B9BE702C8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_AD3DF84910FB95DAD0B08C8B9BE702C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_AD3DF84910FB95DAD0B08C8B9BE702C8" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_AD3DF84910FB95DAD0B08C8B9BE702C8" xlink:type="arc" />
    <link:label id="lab_ango_PrepaidExpensesAndOtherTableTextBlock_9E83015E0C304320B0E98C8B9BE702EB_verboseLabel_en-US" xlink:label="lab_ango_PrepaidExpensesAndOtherTableTextBlock_9E83015E0C304320B0E98C8B9BE702EB" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_ango_PrepaidExpensesAndOtherTableTextBlock_9E83015E0C304320B0E98C8B9BE702EB_label_en-US" xlink:label="lab_ango_PrepaidExpensesAndOtherTableTextBlock_9E83015E0C304320B0E98C8B9BE702EB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expenses and Other [Table Text Block]</link:label>
    <link:label id="lab_ango_PrepaidExpensesAndOtherTableTextBlock_9E83015E0C304320B0E98C8B9BE702EB_documentation_en-US" xlink:label="lab_ango_PrepaidExpensesAndOtherTableTextBlock_9E83015E0C304320B0E98C8B9BE702EB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tabular disclosure of prepaid expenses and other current assets.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_PrepaidExpensesAndOtherTableTextBlock" xlink:label="loc_ango_PrepaidExpensesAndOtherTableTextBlock_9E83015E0C304320B0E98C8B9BE702EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_PrepaidExpensesAndOtherTableTextBlock_9E83015E0C304320B0E98C8B9BE702EB" xlink:to="lab_ango_PrepaidExpensesAndOtherTableTextBlock_9E83015E0C304320B0E98C8B9BE702EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_A67A17A2FCB37F77ABEA8C8B9C545CAE_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract_A67A17A2FCB37F77ABEA8C8B9C545CAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_A67A17A2FCB37F77ABEA8C8B9C545CAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_A67A17A2FCB37F77ABEA8C8B9C545CAE" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract_A67A17A2FCB37F77ABEA8C8B9C545CAE" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_D4FB77496F5C6F4C30558C8B9C54BE5F_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_D4FB77496F5C6F4C30558C8B9C54BE5F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">ACCRUED LIABILITIES</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_D4FB77496F5C6F4C30558C8B9C54BE5F_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_D4FB77496F5C6F4C30558C8B9C54BE5F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_D4FB77496F5C6F4C30558C8B9C54BE5F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_D4FB77496F5C6F4C30558C8B9C54BE5F" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_D4FB77496F5C6F4C30558C8B9C54BE5F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_5A642BCABB7293A7C0C9A8E2D5643B36_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable_5A642BCABB7293A7C0C9A8E2D5643B36" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_5A642BCABB7293A7C0C9A8E2D5643B36_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable_5A642BCABB7293A7C0C9A8E2D5643B36" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_5A642BCABB7293A7C0C9A8E2D5643B36" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_5A642BCABB7293A7C0C9A8E2D5643B36" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable_5A642BCABB7293A7C0C9A8E2D5643B36" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_6F194A796B01D1E23BBEA8E2D56408DB_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_6F194A796B01D1E23BBEA8E2D56408DB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_6F194A796B01D1E23BBEA8E2D56408DB_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_6F194A796B01D1E23BBEA8E2D56408DB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6F194A796B01D1E23BBEA8E2D56408DB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6F194A796B01D1E23BBEA8E2D56408DB" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_6F194A796B01D1E23BBEA8E2D56408DB" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityComponentDomain_3A0C079B7301AEAAE285A8E2D564E5B9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_3A0C079B7301AEAAE285A8E2D564E5B9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_3A0C079B7301AEAAE285A8E2D564E5B9_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_3A0C079B7301AEAAE285A8E2D564E5B9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_3A0C079B7301AEAAE285A8E2D564E5B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain_3A0C079B7301AEAAE285A8E2D564E5B9" xlink:to="lab_us-gaap_EquityComponentDomain_3A0C079B7301AEAAE285A8E2D564E5B9" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_5E25DBB25CDA2D6F84E3A8E2D5640D3C_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember_5E25DBB25CDA2D6F84E3A8E2D5640D3C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation gain (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_5E25DBB25CDA2D6F84E3A8E2D5640D3C_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember_5E25DBB25CDA2D6F84E3A8E2D5640D3C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_5E25DBB25CDA2D6F84E3A8E2D5640D3C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember_5E25DBB25CDA2D6F84E3A8E2D5640D3C" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember_5E25DBB25CDA2D6F84E3A8E2D5640D3C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_EC62A31E57B01E6BD6A3A8E2D564E05A_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_EC62A31E57B01E6BD6A3A8E2D564E05A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gain (loss) on marketable securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_EC62A31E57B01E6BD6A3A8E2D564E05A_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_EC62A31E57B01E6BD6A3A8E2D564E05A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Net Investment Gain (Loss) Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_EC62A31E57B01E6BD6A3A8E2D564E05A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_EC62A31E57B01E6BD6A3A8E2D564E05A" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_EC62A31E57B01E6BD6A3A8E2D564E05A" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_11560EF746BF3B221074A8E2D5647934_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_11560EF746BF3B221074A8E2D5647934" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_11560EF746BF3B221074A8E2D5647934_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_11560EF746BF3B221074A8E2D5647934" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_11560EF746BF3B221074A8E2D5647934" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_11560EF746BF3B221074A8E2D5647934" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_11560EF746BF3B221074A8E2D5647934" xlink:type="arc" />
    <link:label id="lab_us-gaap_ClassOfStockLineItems_E6CD8631E5AFC64E8E0DA8E2D564B249_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems_E6CD8631E5AFC64E8E0DA8E2D564B249" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_E6CD8631E5AFC64E8E0DA8E2D564B249_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems_E6CD8631E5AFC64E8E0DA8E2D564B249" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_E6CD8631E5AFC64E8E0DA8E2D564B249" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems_E6CD8631E5AFC64E8E0DA8E2D564B249" xlink:to="lab_us-gaap_ClassOfStockLineItems_E6CD8631E5AFC64E8E0DA8E2D564B249" xlink:type="arc" />
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B3F7D0970A097A342126A8E2D564539F_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B3F7D0970A097A342126A8E2D564539F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B3F7D0970A097A342126A8E2D564539F_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B3F7D0970A097A342126A8E2D564539F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B3F7D0970A097A342126A8E2D564539F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B3F7D0970A097A342126A8E2D564539F" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B3F7D0970A097A342126A8E2D564539F" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquity_5AAA0E22D1FCDADB915FA8E2D56433EB_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity_5AAA0E22D1FCDADB915FA8E2D56433EB" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_5AAA0E22D1FCDADB915FA8E2D56433EB_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity_5AAA0E22D1FCDADB915FA8E2D56433EB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_5AAA0E22D1FCDADB915FA8E2D56433EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_5AAA0E22D1FCDADB915FA8E2D56433EB" xlink:to="lab_us-gaap_StockholdersEquity_5AAA0E22D1FCDADB915FA8E2D56433EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_0CB8CBE199BA475F630FA8E2D564D5F6_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_0CB8CBE199BA475F630FA8E2D564D5F6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss) before reclassifications, net of tax</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_0CB8CBE199BA475F630FA8E2D564D5F6_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_0CB8CBE199BA475F630FA8E2D564D5F6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OCI, before Reclassifications, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_0CB8CBE199BA475F630FA8E2D564D5F6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_0CB8CBE199BA475F630FA8E2D564D5F6" xlink:to="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_0CB8CBE199BA475F630FA8E2D564D5F6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_A4B1AAC81F1D7DB65463A8E2D5647DCE_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_A4B1AAC81F1D7DB65463A8E2D5647DCE" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_A4B1AAC81F1D7DB65463A8E2D5647DCE_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_A4B1AAC81F1D7DB65463A8E2D5647DCE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_A4B1AAC81F1D7DB65463A8E2D5647DCE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_A4B1AAC81F1D7DB65463A8E2D5647DCE" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_A4B1AAC81F1D7DB65463A8E2D5647DCE" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_110DFF3F83037EFE56E6A8E2D564B4D7_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_110DFF3F83037EFE56E6A8E2D564B4D7" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_110DFF3F83037EFE56E6A8E2D564B4D7_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_110DFF3F83037EFE56E6A8E2D564B4D7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_110DFF3F83037EFE56E6A8E2D564B4D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_110DFF3F83037EFE56E6A8E2D564B4D7" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_110DFF3F83037EFE56E6A8E2D564B4D7" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquity_94DC0F3B8FD5CE280E42A8E2D5645341_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity_94DC0F3B8FD5CE280E42A8E2D5645341" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_94DC0F3B8FD5CE280E42A8E2D5645341" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_94DC0F3B8FD5CE280E42A8E2D5645341" xlink:to="lab_us-gaap_StockholdersEquity_94DC0F3B8FD5CE280E42A8E2D5645341" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingAbstract_662CC68FC600E341690D8C8B9D3EA0E3_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract_662CC68FC600E341690D8C8B9D3EA0E3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_662CC68FC600E341690D8C8B9D3EA0E3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract_662CC68FC600E341690D8C8B9D3EA0E3" xlink:to="lab_us-gaap_SegmentReportingAbstract_662CC68FC600E341690D8C8B9D3EA0E3" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_FD1D859451D874F11B458C8B9D3E9895_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_FD1D859451D874F11B458C8B9D3E9895" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">SEGMENTS AND GEOGRAPHIC INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_FD1D859451D874F11B458C8B9D3E9895_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_FD1D859451D874F11B458C8B9D3E9895" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_FD1D859451D874F11B458C8B9D3E9895" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock_FD1D859451D874F11B458C8B9D3E9895" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock_FD1D859451D874F11B458C8B9D3E9895" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_440E38FFCDD37C7EDE088C8B9D6D8913_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_440E38FFCDD37C7EDE088C8B9D6D8913" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_440E38FFCDD37C7EDE088C8B9D6D8913_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_440E38FFCDD37C7EDE088C8B9D6D8913" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_440E38FFCDD37C7EDE088C8B9D6D8913" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_440E38FFCDD37C7EDE088C8B9D6D8913" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_440E38FFCDD37C7EDE088C8B9D6D8913" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6CEF9A3CABFC25B348AC949FCC232D67_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6CEF9A3CABFC25B348AC949FCC232D67" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule summarizes stock option activity</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6CEF9A3CABFC25B348AC949FCC232D67_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6CEF9A3CABFC25B348AC949FCC232D67" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6CEF9A3CABFC25B348AC949FCC232D67" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6CEF9A3CABFC25B348AC949FCC232D67" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6CEF9A3CABFC25B348AC949FCC232D67" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_59FE7FC6F1B766F6E00B949FCC233077_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_59FE7FC6F1B766F6E00B949FCC233077" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Shares Outstanding at beginning of year (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_59FE7FC6F1B766F6E00B949FCC233077_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_59FE7FC6F1B766F6E00B949FCC233077" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_59FE7FC6F1B766F6E00B949FCC233077" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_59FE7FC6F1B766F6E00B949FCC233077" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_59FE7FC6F1B766F6E00B949FCC233077" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_D7C53F16E85B001504AD949FCC24E3CF_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_D7C53F16E85B001504AD949FCC24E3CF" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_D7C53F16E85B001504AD949FCC24E3CF_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_D7C53F16E85B001504AD949FCC24E3CF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_D7C53F16E85B001504AD949FCC24E3CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_D7C53F16E85B001504AD949FCC24E3CF" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_D7C53F16E85B001504AD949FCC24E3CF" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3DA4B2DA571ABE22E3D2949FCC241EDB_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3DA4B2DA571ABE22E3D2949FCC241EDB" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Shares Exercised (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3DA4B2DA571ABE22E3D2949FCC241EDB_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3DA4B2DA571ABE22E3D2949FCC241EDB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3DA4B2DA571ABE22E3D2949FCC241EDB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3DA4B2DA571ABE22E3D2949FCC241EDB" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3DA4B2DA571ABE22E3D2949FCC241EDB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_D941CDD862DB925CF3CB949FCC2490FA_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_D941CDD862DB925CF3CB949FCC2490FA" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Shares Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_D941CDD862DB925CF3CB949FCC2490FA_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_D941CDD862DB925CF3CB949FCC2490FA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_D941CDD862DB925CF3CB949FCC2490FA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_D941CDD862DB925CF3CB949FCC2490FA" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_D941CDD862DB925CF3CB949FCC2490FA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3FDBC8E97D2AF6B8B624949FCC2437D4_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3FDBC8E97D2AF6B8B624949FCC2437D4" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Shares Expired (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3FDBC8E97D2AF6B8B624949FCC2437D4_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3FDBC8E97D2AF6B8B624949FCC2437D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3FDBC8E97D2AF6B8B624949FCC2437D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3FDBC8E97D2AF6B8B624949FCC2437D4" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3FDBC8E97D2AF6B8B624949FCC2437D4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_512BAF11F31C4CE1E1BF949FCC24C974_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_512BAF11F31C4CE1E1BF949FCC24C974" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Shares Outstanding at end of year (shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_512BAF11F31C4CE1E1BF949FCC24C974" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_512BAF11F31C4CE1E1BF949FCC24C974" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_512BAF11F31C4CE1E1BF949FCC24C974" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91AB42653C79670ACE0594A4636AA62C_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91AB42653C79670ACE0594A4636AA62C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91AB42653C79670ACE0594A4636AA62C_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91AB42653C79670ACE0594A4636AA62C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91AB42653C79670ACE0594A4636AA62C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91AB42653C79670ACE0594A4636AA62C" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91AB42653C79670ACE0594A4636AA62C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_E9340773F5E15128624594A4637CFBCC_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_E9340773F5E15128624594A4637CFBCC" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, Outstanding at beginning of year (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_E9340773F5E15128624594A4637CFBCC_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_E9340773F5E15128624594A4637CFBCC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_E9340773F5E15128624594A4637CFBCC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_E9340773F5E15128624594A4637CFBCC" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_E9340773F5E15128624594A4637CFBCC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_76F5202471CD22C0A99194A4637C35CC_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_76F5202471CD22C0A99194A4637C35CC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price Granted (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_76F5202471CD22C0A99194A4637C35CC_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_76F5202471CD22C0A99194A4637C35CC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_76F5202471CD22C0A99194A4637C35CC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_76F5202471CD22C0A99194A4637C35CC" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_76F5202471CD22C0A99194A4637C35CC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_93EC7394860274B0AC9A94A4637DEB24_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_93EC7394860274B0AC9A94A4637DEB24" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price Exercised (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_93EC7394860274B0AC9A94A4637DEB24_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_93EC7394860274B0AC9A94A4637DEB24" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_93EC7394860274B0AC9A94A4637DEB24" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_93EC7394860274B0AC9A94A4637DEB24" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_93EC7394860274B0AC9A94A4637DEB24" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1AD1B5C268E7A026597F94A4637D8F9B_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1AD1B5C268E7A026597F94A4637D8F9B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price Forfeited (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1AD1B5C268E7A026597F94A4637D8F9B_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1AD1B5C268E7A026597F94A4637D8F9B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1AD1B5C268E7A026597F94A4637D8F9B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1AD1B5C268E7A026597F94A4637D8F9B" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1AD1B5C268E7A026597F94A4637D8F9B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_4104F30312B68A6A89B694A4637DC19E_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_4104F30312B68A6A89B694A4637DC19E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price Expired (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_4104F30312B68A6A89B694A4637DC19E_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_4104F30312B68A6A89B694A4637DC19E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_4104F30312B68A6A89B694A4637DC19E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_4104F30312B68A6A89B694A4637DC19E" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_4104F30312B68A6A89B694A4637DC19E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_BB1B90C93463EFB97E8B94A4637D1755_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_BB1B90C93463EFB97E8B94A4637D1755" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, Outstanding at end of year (usd per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_BB1B90C93463EFB97E8B94A4637D1755" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_BB1B90C93463EFB97E8B94A4637D1755" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_BB1B90C93463EFB97E8B94A4637D1755" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_77C2CA648E588927833D949FCC24F1AA_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_77C2CA648E588927833D949FCC24F1AA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares Options exercisable at year-end (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_77C2CA648E588927833D949FCC24F1AA_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_77C2CA648E588927833D949FCC24F1AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_77C2CA648E588927833D949FCC24F1AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_77C2CA648E588927833D949FCC24F1AA" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_77C2CA648E588927833D949FCC24F1AA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_069C0CF29368A24B5FA6949FCC24ACFE_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_069C0CF29368A24B5FA6949FCC24ACFE" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares Options expected to vest in future periods (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_069C0CF29368A24B5FA6949FCC24ACFE_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_069C0CF29368A24B5FA6949FCC24ACFE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_069C0CF29368A24B5FA6949FCC24ACFE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_069C0CF29368A24B5FA6949FCC24ACFE" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_069C0CF29368A24B5FA6949FCC24ACFE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_C0E4B206E026109F2716949FCC263F83_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_C0E4B206E026109F2716949FCC263F83" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, Options exercisable at year end (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_C0E4B206E026109F2716949FCC263F83_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_C0E4B206E026109F2716949FCC263F83" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_C0E4B206E026109F2716949FCC263F83" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_C0E4B206E026109F2716949FCC263F83" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_C0E4B206E026109F2716949FCC263F83" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_300D396C6AFD520CEBFA949FCC26861D_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_300D396C6AFD520CEBFA949FCC26861D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, Options expected to vest in future periods (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_300D396C6AFD520CEBFA949FCC26861D_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_300D396C6AFD520CEBFA949FCC26861D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_300D396C6AFD520CEBFA949FCC26861D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_300D396C6AFD520CEBFA949FCC26861D" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_300D396C6AFD520CEBFA949FCC26861D" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_51BB6DF4F60EB41257D5949FCC260E56_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_51BB6DF4F60EB41257D5949FCC260E56" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_51BB6DF4F60EB41257D5949FCC260E56_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_51BB6DF4F60EB41257D5949FCC260E56" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_51BB6DF4F60EB41257D5949FCC260E56" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_51BB6DF4F60EB41257D5949FCC260E56" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_51BB6DF4F60EB41257D5949FCC260E56" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2B7FAE4E4589AD542102949FCC262A80_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2B7FAE4E4589AD542102949FCC262A80" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual life, Option exercisable at year end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2B7FAE4E4589AD542102949FCC262A80_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2B7FAE4E4589AD542102949FCC262A80" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2B7FAE4E4589AD542102949FCC262A80" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2B7FAE4E4589AD542102949FCC262A80" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2B7FAE4E4589AD542102949FCC262A80" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_6D86B77F36F041489CE8949FCC2693BC_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_6D86B77F36F041489CE8949FCC2693BC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual life, Option expected to vest in future periods</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_6D86B77F36F041489CE8949FCC2693BC_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_6D86B77F36F041489CE8949FCC2693BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_6D86B77F36F041489CE8949FCC2693BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_6D86B77F36F041489CE8949FCC2693BC" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_6D86B77F36F041489CE8949FCC2693BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F0377F264E1814CB07E2949FCC26B167_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F0377F264E1814CB07E2949FCC26B167" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value, Outstanding at end of year</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F0377F264E1814CB07E2949FCC26B167_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F0377F264E1814CB07E2949FCC26B167" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F0377F264E1814CB07E2949FCC26B167" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F0377F264E1814CB07E2949FCC26B167" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F0377F264E1814CB07E2949FCC26B167" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_B803A62478A7DDEEBAEF949FCC262331_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_B803A62478A7DDEEBAEF949FCC262331" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value, Options exercisable at year end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_B803A62478A7DDEEBAEF949FCC262331_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_B803A62478A7DDEEBAEF949FCC262331" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_B803A62478A7DDEEBAEF949FCC262331" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_B803A62478A7DDEEBAEF949FCC262331" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_B803A62478A7DDEEBAEF949FCC262331" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_6DB57F1B04395BF5045E949FCC269963_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_6DB57F1B04395BF5045E949FCC269963" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value, Option expected to vest in future periods</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_6DB57F1B04395BF5045E949FCC269963_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_6DB57F1B04395BF5045E949FCC269963" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_6DB57F1B04395BF5045E949FCC269963" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_6DB57F1B04395BF5045E949FCC269963" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_6DB57F1B04395BF5045E949FCC269963" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7E34A427A3AAFD149C098F96E24F2635_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7E34A427A3AAFD149C098F96E24F2635" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7E34A427A3AAFD149C098F96E24F2635" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7E34A427A3AAFD149C098F96E24F2635" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7E34A427A3AAFD149C098F96E24F2635" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_E2B9B8798C560ED459998F96E24FC5B6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_E2B9B8798C560ED459998F96E24FC5B6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_E2B9B8798C560ED459998F96E24FC5B6_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_E2B9B8798C560ED459998F96E24FC5B6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_E2B9B8798C560ED459998F96E24FC5B6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_E2B9B8798C560ED459998F96E24FC5B6" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_E2B9B8798C560ED459998F96E24FC5B6" xlink:type="arc" />
    <link:label id="lab_srt_RangeAxis_C2BF2CE051BD0E06266A8F96E250D18D_terseLabel_en-US" xlink:label="lab_srt_RangeAxis_C2BF2CE051BD0E06266A8F96E250D18D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_C2BF2CE051BD0E06266A8F96E250D18D_label_en-US" xlink:label="lab_srt_RangeAxis_C2BF2CE051BD0E06266A8F96E250D18D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_C2BF2CE051BD0E06266A8F96E250D18D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis_C2BF2CE051BD0E06266A8F96E250D18D" xlink:to="lab_srt_RangeAxis_C2BF2CE051BD0E06266A8F96E250D18D" xlink:type="arc" />
    <link:label id="lab_srt_RangeMember_9849960FFD88F15369E18F96E2504FC5_terseLabel_en-US" xlink:label="lab_srt_RangeMember_9849960FFD88F15369E18F96E2504FC5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_9849960FFD88F15369E18F96E2504FC5_label_en-US" xlink:label="lab_srt_RangeMember_9849960FFD88F15369E18F96E2504FC5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_9849960FFD88F15369E18F96E2504FC5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember_9849960FFD88F15369E18F96E2504FC5" xlink:to="lab_srt_RangeMember_9849960FFD88F15369E18F96E2504FC5" xlink:type="arc" />
    <link:label id="lab_srt_MinimumMember_8C723D1E52296EA6F0888F96E250D644_verboseLabel_en-US" xlink:label="lab_srt_MinimumMember_8C723D1E52296EA6F0888F96E250D644" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_8C723D1E52296EA6F0888F96E250D644_label_en-US" xlink:label="lab_srt_MinimumMember_8C723D1E52296EA6F0888F96E250D644" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_8C723D1E52296EA6F0888F96E250D644" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember_8C723D1E52296EA6F0888F96E250D644" xlink:to="lab_srt_MinimumMember_8C723D1E52296EA6F0888F96E250D644" xlink:type="arc" />
    <link:label id="lab_srt_MaximumMember_CDFE5BAEFDA64CF1867F8F96E251514E_verboseLabel_en-US" xlink:label="lab_srt_MaximumMember_CDFE5BAEFDA64CF1867F8F96E251514E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_CDFE5BAEFDA64CF1867F8F96E251514E_label_en-US" xlink:label="lab_srt_MaximumMember_CDFE5BAEFDA64CF1867F8F96E251514E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_CDFE5BAEFDA64CF1867F8F96E251514E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember_CDFE5BAEFDA64CF1867F8F96E251514E" xlink:to="lab_srt_MaximumMember_CDFE5BAEFDA64CF1867F8F96E251514E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_D66E1937E77583F7121D8F96E251EB7B_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_D66E1937E77583F7121D8F96E251EB7B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_D66E1937E77583F7121D8F96E251EB7B_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_D66E1937E77583F7121D8F96E251EB7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_D66E1937E77583F7121D8F96E251EB7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_D66E1937E77583F7121D8F96E251EB7B" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_D66E1937E77583F7121D8F96E251EB7B" xlink:type="arc" />
    <link:label id="lab_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4_verboseLabel_en-US" xlink:label="lab_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets (Textual) [Abstract]</link:label>
    <link:label id="lab_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4_label_en-US" xlink:label="lab_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets (Textual) [Abstract]</link:label>
    <link:label id="lab_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4_documentation_en-US" xlink:label="lab_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Goodwill and intangible assets.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_GoodwillAndIntangibleAssetsTextualAbstract" xlink:label="loc_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4" xlink:to="lab_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfReportableSegments_AF824F218AEDEDED2B898F96E2523DD6_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments_AF824F218AEDEDED2B898F96E2523DD6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_AF824F218AEDEDED2B898F96E2523DD6_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments_AF824F218AEDEDED2B898F96E2523DD6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_AF824F218AEDEDED2B898F96E2523DD6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments_AF824F218AEDEDED2B898F96E2523DD6" xlink:to="lab_us-gaap_NumberOfReportableSegments_AF824F218AEDEDED2B898F96E2523DD6" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_891DC580AF2E8CCA85F28F96E252B996_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss_891DC580AF2E8CCA85F28F96E252B996" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_891DC580AF2E8CCA85F28F96E252B996_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss_891DC580AF2E8CCA85F28F96E252B996" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_891DC580AF2E8CCA85F28F96E252B996" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss_891DC580AF2E8CCA85F28F96E252B996" xlink:to="lab_us-gaap_GoodwillImpairmentLoss_891DC580AF2E8CCA85F28F96E252B996" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_0CC6AAF8D58A712921988F96E2525D40_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease_0CC6AAF8D58A712921988F96E2525D40" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill, period increase (decrease)</link:label>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_0CC6AAF8D58A712921988F96E2525D40_label_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease_0CC6AAF8D58A712921988F96E2525D40" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_0CC6AAF8D58A712921988F96E2525D40" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPeriodIncreaseDecrease_0CC6AAF8D58A712921988F96E2525D40" xlink:to="lab_us-gaap_GoodwillPeriodIncreaseDecrease_0CC6AAF8D58A712921988F96E2525D40" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_9208FEA134DECF6F2AA58F96E2531795_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_9208FEA134DECF6F2AA58F96E2531795" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_9208FEA134DECF6F2AA58F96E2531795_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_9208FEA134DECF6F2AA58F96E2531795" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9208FEA134DECF6F2AA58F96E2531795" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets_9208FEA134DECF6F2AA58F96E2531795" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets_9208FEA134DECF6F2AA58F96E2531795" xlink:type="arc" />
    <link:label id="lab_ango_ScheduleOfIntangibleAssetsTableTextBlock_DEDFAD2806E08E7794C78C8B9AEB8CBE_verboseLabel_en-US" xlink:label="lab_ango_ScheduleOfIntangibleAssetsTableTextBlock_DEDFAD2806E08E7794C78C8B9AEB8CBE" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_ango_ScheduleOfIntangibleAssetsTableTextBlock_DEDFAD2806E08E7794C78C8B9AEB8CBE_label_en-US" xlink:label="lab_ango_ScheduleOfIntangibleAssetsTableTextBlock_DEDFAD2806E08E7794C78C8B9AEB8CBE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Intangible Assets [Table Text Block]</link:label>
    <link:label id="lab_ango_ScheduleOfIntangibleAssetsTableTextBlock_DEDFAD2806E08E7794C78C8B9AEB8CBE_documentation_en-US" xlink:label="lab_ango_ScheduleOfIntangibleAssetsTableTextBlock_DEDFAD2806E08E7794C78C8B9AEB8CBE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of intangible assets.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_ScheduleOfIntangibleAssetsTableTextBlock" xlink:label="loc_ango_ScheduleOfIntangibleAssetsTableTextBlock_DEDFAD2806E08E7794C78C8B9AEB8CBE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ScheduleOfIntangibleAssetsTableTextBlock_DEDFAD2806E08E7794C78C8B9AEB8CBE" xlink:to="lab_ango_ScheduleOfIntangibleAssetsTableTextBlock_DEDFAD2806E08E7794C78C8B9AEB8CBE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_7D9BAB5E0746B9D2A5068C8B9AEB6870_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_7D9BAB5E0746B9D2A5068C8B9AEB6870" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expected amortization expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_7D9BAB5E0746B9D2A5068C8B9AEB6870_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_7D9BAB5E0746B9D2A5068C8B9AEB6870" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_7D9BAB5E0746B9D2A5068C8B9AEB6870" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_7D9BAB5E0746B9D2A5068C8B9AEB6870" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_7D9BAB5E0746B9D2A5068C8B9AEB6870" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_D920A1A08EC9EACB7CFD8F22D13B4D3F_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract_D920A1A08EC9EACB7CFD8F22D13B4D3F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_D920A1A08EC9EACB7CFD8F22D13B4D3F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_D920A1A08EC9EACB7CFD8F22D13B4D3F" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract_D920A1A08EC9EACB7CFD8F22D13B4D3F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7A230FF4ADA784AD1A308F22D13B742C_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7A230FF4ADA784AD1A308F22D13B742C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7A230FF4ADA784AD1A308F22D13B742C_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7A230FF4ADA784AD1A308F22D13B742C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7A230FF4ADA784AD1A308F22D13B742C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7A230FF4ADA784AD1A308F22D13B742C" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7A230FF4ADA784AD1A308F22D13B742C" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_072E3838430B2C7EA93A8F22D13BA273_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis_072E3838430B2C7EA93A8F22D13BA273" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value By Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_072E3838430B2C7EA93A8F22D13BA273_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis_072E3838430B2C7EA93A8F22D13BA273" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_072E3838430B2C7EA93A8F22D13BA273" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_072E3838430B2C7EA93A8F22D13BA273" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis_072E3838430B2C7EA93A8F22D13BA273" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_87CE90DEA79F6D4A36298F22D13B7126_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain_87CE90DEA79F6D4A36298F22D13B7126" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_87CE90DEA79F6D4A36298F22D13B7126_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain_87CE90DEA79F6D4A36298F22D13B7126" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_87CE90DEA79F6D4A36298F22D13B7126" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_87CE90DEA79F6D4A36298F22D13B7126" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain_87CE90DEA79F6D4A36298F22D13B7126" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_E9094AD6517DB9B7FCE88F22D13BF956_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember_E9094AD6517DB9B7FCE88F22D13BF956" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_E9094AD6517DB9B7FCE88F22D13BF956_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember_E9094AD6517DB9B7FCE88F22D13BF956" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurements, Recurring [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_E9094AD6517DB9B7FCE88F22D13BF956" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember_E9094AD6517DB9B7FCE88F22D13BF956" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember_E9094AD6517DB9B7FCE88F22D13BF956" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_88E8212613D323964B018F22D13BD7F2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_88E8212613D323964B018F22D13BD7F2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value By Fair Value Hierarchy Level [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_88E8212613D323964B018F22D13BD7F2_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_88E8212613D323964B018F22D13BD7F2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_88E8212613D323964B018F22D13BD7F2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_88E8212613D323964B018F22D13BD7F2" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_88E8212613D323964B018F22D13BD7F2" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A47FC87DC962672709258F22D13B3536_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A47FC87DC962672709258F22D13B3536" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A47FC87DC962672709258F22D13B3536_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A47FC87DC962672709258F22D13B3536" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A47FC87DC962672709258F22D13B3536" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A47FC87DC962672709258F22D13B3536" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A47FC87DC962672709258F22D13B3536" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_63F90B036AC09CB60D3B8F22D13B0EA2_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_63F90B036AC09CB60D3B8F22D13B0EA2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_63F90B036AC09CB60D3B8F22D13B0EA2_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_63F90B036AC09CB60D3B8F22D13B0EA2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_63F90B036AC09CB60D3B8F22D13B0EA2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member_63F90B036AC09CB60D3B8F22D13B0EA2" xlink:to="lab_us-gaap_FairValueInputsLevel1Member_63F90B036AC09CB60D3B8F22D13B0EA2" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_340FBA2BC06022BCA6518F22D13B29E1_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_340FBA2BC06022BCA6518F22D13B29E1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_340FBA2BC06022BCA6518F22D13B29E1_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_340FBA2BC06022BCA6518F22D13B29E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_340FBA2BC06022BCA6518F22D13B29E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member_340FBA2BC06022BCA6518F22D13B29E1" xlink:to="lab_us-gaap_FairValueInputsLevel2Member_340FBA2BC06022BCA6518F22D13B29E1" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_AE3E2ABF58191EE4CC538F22D13B51A3_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_AE3E2ABF58191EE4CC538F22D13B51A3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_AE3E2ABF58191EE4CC538F22D13B51A3_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_AE3E2ABF58191EE4CC538F22D13B51A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_AE3E2ABF58191EE4CC538F22D13B51A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member_AE3E2ABF58191EE4CC538F22D13B51A3" xlink:to="lab_us-gaap_FairValueInputsLevel3Member_AE3E2ABF58191EE4CC538F22D13B51A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_071B08D0F7CF8F33FF7D8F22D14BF1DF_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_071B08D0F7CF8F33FF7D8F22D14BF1DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_071B08D0F7CF8F33FF7D8F22D14BF1DF_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_071B08D0F7CF8F33FF7D8F22D14BF1DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_071B08D0F7CF8F33FF7D8F22D14BF1DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_071B08D0F7CF8F33FF7D8F22D14BF1DF" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_071B08D0F7CF8F33FF7D8F22D14BF1DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_B8673782AD6960E1479D8F22D14B010C_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract_B8673782AD6960E1479D8F22D14B010C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Financial Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_B8673782AD6960E1479D8F22D14B010C_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract_B8673782AD6960E1479D8F22D14B010C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_B8673782AD6960E1479D8F22D14B010C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_B8673782AD6960E1479D8F22D14B010C" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract_B8673782AD6960E1479D8F22D14B010C" xlink:type="arc" />
    <link:label id="lab_ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure_87EB6EB7AF427B3DD6FC8F22D14BAB0C_terseLabel_en-US" xlink:label="lab_ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure_87EB6EB7AF427B3DD6FC8F22D14BAB0C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure_87EB6EB7AF427B3DD6FC8F22D14BAB0C_label_en-US" xlink:label="lab_ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure_87EB6EB7AF427B3DD6FC8F22D14BAB0C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments Excluding Marketable Securities, Fair Value Disclosure</link:label>
    <link:label id="lab_ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure_87EB6EB7AF427B3DD6FC8F22D14BAB0C_documentation_en-US" xlink:label="lab_ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure_87EB6EB7AF427B3DD6FC8F22D14BAB0C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investments Excluding Marketable Securities, Fair Value Disclosure</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure" xlink:label="loc_ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure_87EB6EB7AF427B3DD6FC8F22D14BAB0C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure_87EB6EB7AF427B3DD6FC8F22D14BAB0C" xlink:to="lab_ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure_87EB6EB7AF427B3DD6FC8F22D14BAB0C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_76DED84C5EE648D7CC058F22D14BC667_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_76DED84C5EE648D7CC058F22D14BC667" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_76DED84C5EE648D7CC058F22D14BC667_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_76DED84C5EE648D7CC058F22D14BC667" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_76DED84C5EE648D7CC058F22D14BC667" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_76DED84C5EE648D7CC058F22D14BC667" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_76DED84C5EE648D7CC058F22D14BC667" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_6000A47BB4885AE457738F22D14B1347_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure_6000A47BB4885AE457738F22D14B1347" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Financial Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_6000A47BB4885AE457738F22D14B1347_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure_6000A47BB4885AE457738F22D14B1347" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_6000A47BB4885AE457738F22D14B1347" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_6000A47BB4885AE457738F22D14B1347" xlink:to="lab_us-gaap_AssetsFairValueDisclosure_6000A47BB4885AE457738F22D14B1347" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_BEF9DC3DCD8D0F1346EE8F22D14B01D8_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_BEF9DC3DCD8D0F1346EE8F22D14B01D8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Financial Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_BEF9DC3DCD8D0F1346EE8F22D14B01D8_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_BEF9DC3DCD8D0F1346EE8F22D14B01D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_BEF9DC3DCD8D0F1346EE8F22D14B01D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_BEF9DC3DCD8D0F1346EE8F22D14B01D8" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_BEF9DC3DCD8D0F1346EE8F22D14B01D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_F7C8E76C5658324642838F53E07128AB_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_F7C8E76C5658324642838F53E07128AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent liability for acquisition earn outs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_F7C8E76C5658324642838F53E07128AB_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_F7C8E76C5658324642838F53E07128AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_F7C8E76C5658324642838F53E07128AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_F7C8E76C5658324642838F53E07128AB" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_F7C8E76C5658324642838F53E07128AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_6DB6376DA140DD0D87CD8F22D14BD3CF_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure_6DB6376DA140DD0D87CD8F22D14BD3CF" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Financial Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_6DB6376DA140DD0D87CD8F22D14BD3CF_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure_6DB6376DA140DD0D87CD8F22D14BD3CF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_6DB6376DA140DD0D87CD8F22D14BD3CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_6DB6376DA140DD0D87CD8F22D14BD3CF" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure_6DB6376DA140DD0D87CD8F22D14BD3CF" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_5960CB00C2ED0E7F9453B82FBBE9701C_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract_5960CB00C2ED0E7F9453B82FBBE9701C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5960CB00C2ED0E7F9453B82FBBE9701C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5960CB00C2ED0E7F9453B82FBBE9701C" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract_5960CB00C2ED0E7F9453B82FBBE9701C" xlink:type="arc" />
    <link:label id="lab_ango_ScheduleofIncomeTaxTable_5B45A446B1C74FF93699B82FBBEC9F22_terseLabel_en-US" xlink:label="lab_ango_ScheduleofIncomeTaxTable_5B45A446B1C74FF93699B82FBBEC9F22" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Income Tax [Table]</link:label>
    <link:label id="lab_ango_ScheduleofIncomeTaxTable_5B45A446B1C74FF93699B82FBBEC9F22_label_en-US" xlink:label="lab_ango_ScheduleofIncomeTaxTable_5B45A446B1C74FF93699B82FBBEC9F22" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Income Tax [Table]</link:label>
    <link:label id="lab_ango_ScheduleofIncomeTaxTable_5B45A446B1C74FF93699B82FBBEC9F22_documentation_en-US" xlink:label="lab_ango_ScheduleofIncomeTaxTable_5B45A446B1C74FF93699B82FBBEC9F22" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Income Tax [Table]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_ScheduleofIncomeTaxTable" xlink:label="loc_ango_ScheduleofIncomeTaxTable_5B45A446B1C74FF93699B82FBBEC9F22" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ScheduleofIncomeTaxTable_5B45A446B1C74FF93699B82FBBEC9F22" xlink:to="lab_ango_ScheduleofIncomeTaxTable_5B45A446B1C74FF93699B82FBBEC9F22" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_7560DA31215159BFCBBCB82FBBEDD1BA_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_7560DA31215159BFCBBCB82FBBEDD1BA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_7560DA31215159BFCBBCB82FBBEDD1BA_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_7560DA31215159BFCBBCB82FBBEDD1BA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_7560DA31215159BFCBBCB82FBBEDD1BA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_7560DA31215159BFCBBCB82FBBEDD1BA" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis_7560DA31215159BFCBBCB82FBBEDD1BA" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_1E2043B87DFB2195E479B82FBBED7F0F_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain_1E2043B87DFB2195E479B82FBBED7F0F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_1E2043B87DFB2195E479B82FBBED7F0F_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain_1E2043B87DFB2195E479B82FBBED7F0F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_1E2043B87DFB2195E479B82FBBED7F0F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1E2043B87DFB2195E479B82FBBED7F0F" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain_1E2043B87DFB2195E479B82FBBED7F0F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCountryMember_1C683F6206D6A065AAB7B82FBBEEC11B_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember_1C683F6206D6A065AAB7B82FBBEEC11B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-U.S.</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_1C683F6206D6A065AAB7B82FBBEEC11B_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember_1C683F6206D6A065AAB7B82FBBEEC11B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_1C683F6206D6A065AAB7B82FBBEEC11B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember_1C683F6206D6A065AAB7B82FBBEEC11B" xlink:to="lab_us-gaap_ForeignCountryMember_1C683F6206D6A065AAB7B82FBBEEC11B" xlink:type="arc" />
    <link:label id="lab_ango_ScheduleofIncomeTaxLineItems_26D0B111A2B7C0601784B82FBBEE25A7_terseLabel_en-US" xlink:label="lab_ango_ScheduleofIncomeTaxLineItems_26D0B111A2B7C0601784B82FBBEE25A7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax [Line Items]</link:label>
    <link:label id="lab_ango_ScheduleofIncomeTaxLineItems_26D0B111A2B7C0601784B82FBBEE25A7_label_en-US" xlink:label="lab_ango_ScheduleofIncomeTaxLineItems_26D0B111A2B7C0601784B82FBBEE25A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Income Tax [Line Items]</link:label>
    <link:label id="lab_ango_ScheduleofIncomeTaxLineItems_26D0B111A2B7C0601784B82FBBEE25A7_documentation_en-US" xlink:label="lab_ango_ScheduleofIncomeTaxLineItems_26D0B111A2B7C0601784B82FBBEE25A7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Income Tax [Line Items]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_ScheduleofIncomeTaxLineItems" xlink:label="loc_ango_ScheduleofIncomeTaxLineItems_26D0B111A2B7C0601784B82FBBEE25A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ScheduleofIncomeTaxLineItems_26D0B111A2B7C0601784B82FBBEE25A7" xlink:to="lab_ango_ScheduleofIncomeTaxLineItems_26D0B111A2B7C0601784B82FBBEE25A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_5F2331F0719988054220B82FBBEEF081_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract_5F2331F0719988054220B82FBBEEF081" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of deferred tax assets and liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_5F2331F0719988054220B82FBBEEF081_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract_5F2331F0719988054220B82FBBEEF081" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_5F2331F0719988054220B82FBBEEF081" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5F2331F0719988054220B82FBBEEF081" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract_5F2331F0719988054220B82FBBEEF081" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459_verboseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_95217B647F42B6FCF580B82FBBEFD76F_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_95217B647F42B6FCF580B82FBBEFD76F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_95217B647F42B6FCF580B82FBBEFD76F_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_95217B647F42B6FCF580B82FBBEFD76F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_95217B647F42B6FCF580B82FBBEFD76F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_95217B647F42B6FCF580B82FBBEFD76F" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_95217B647F42B6FCF580B82FBBEFD76F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0804B9D4F46453C8C3B1B82FBBF1F48D_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0804B9D4F46453C8C3B1B82FBBF1F48D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0804B9D4F46453C8C3B1B82FBBF1F48D_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0804B9D4F46453C8C3B1B82FBBF1F48D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0804B9D4F46453C8C3B1B82FBBF1F48D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0804B9D4F46453C8C3B1B82FBBF1F48D" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0804B9D4F46453C8C3B1B82FBBF1F48D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_0EA7725A892AA06171F5B82FBBF12BDC_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_0EA7725A892AA06171F5B82FBBF12BDC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Federal and state R&amp;D tax credit carryforward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_0EA7725A892AA06171F5B82FBBF12BDC_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_0EA7725A892AA06171F5B82FBBF12BDC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_0EA7725A892AA06171F5B82FBBF12BDC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_0EA7725A892AA06171F5B82FBBF12BDC" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_0EA7725A892AA06171F5B82FBBF12BDC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_E4818BB632E238CD180BB82FBBF2119C_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory_E4818BB632E238CD180BB82FBBF2119C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_E4818BB632E238CD180BB82FBBF2119C_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory_E4818BB632E238CD180BB82FBBF2119C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_E4818BB632E238CD180BB82FBBF2119C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory_E4818BB632E238CD180BB82FBBF2119C" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory_E4818BB632E238CD180BB82FBBF2119C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_FD6B95589132DD70BEC6B82FBBF2F92F_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_FD6B95589132DD70BEC6B82FBBF2F92F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expenses incurred not currently deductible</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_FD6B95589132DD70BEC6B82FBBF2F92F_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_FD6B95589132DD70BEC6B82FBBF2F92F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Other</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_FD6B95589132DD70BEC6B82FBBF2F92F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_FD6B95589132DD70BEC6B82FBBF2F92F" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_FD6B95589132DD70BEC6B82FBBF2F92F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_357EED0FC5824503385EB82FBBF2B9DB_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome_357EED0FC5824503385EB82FBBF2B9DB" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_357EED0FC5824503385EB82FBBF2B9DB_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome_357EED0FC5824503385EB82FBBF2B9DB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Deferred Income</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_357EED0FC5824503385EB82FBBF2B9DB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsDeferredIncome_357EED0FC5824503385EB82FBBF2B9DB" xlink:to="lab_us-gaap_DeferredTaxAssetsDeferredIncome_357EED0FC5824503385EB82FBBF2B9DB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_6659C47F16EFE8968588B830C95F7C17_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross_6659C47F16EFE8968588B830C95F7C17" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross deferred tax asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_6659C47F16EFE8968588B830C95F7C17_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross_6659C47F16EFE8968588B830C95F7C17" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_6659C47F16EFE8968588B830C95F7C17" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_6659C47F16EFE8968588B830C95F7C17" xlink:to="lab_us-gaap_DeferredTaxAssetsGross_6659C47F16EFE8968588B830C95F7C17" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_F2F9D5914254466B5BDFB82FBBF2AFCE_verboseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_F2F9D5914254466B5BDFB82FBBF2AFCE" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_F2F9D5914254466B5BDFB82FBBF2AFCE_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_F2F9D5914254466B5BDFB82FBBF2AFCE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_F2F9D5914254466B5BDFB82FBBF2AFCE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_F2F9D5914254466B5BDFB82FBBF2AFCE" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_F2F9D5914254466B5BDFB82FBBF2AFCE" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_E4A1C1F18C8B2AF7CF9EB82FBBF2ED21_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_E4A1C1F18C8B2AF7CF9EB82FBBF2ED21" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Excess tax over book depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_E4A1C1F18C8B2AF7CF9EB82FBBF2ED21_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_E4A1C1F18C8B2AF7CF9EB82FBBF2ED21" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_E4A1C1F18C8B2AF7CF9EB82FBBF2ED21" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_E4A1C1F18C8B2AF7CF9EB82FBBF2ED21" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_E4A1C1F18C8B2AF7CF9EB82FBBF2ED21" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_0C8EDCA718FD92BC4EE7B82FBBF34EFE_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities_0C8EDCA718FD92BC4EE7B82FBBF34EFE" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_0C8EDCA718FD92BC4EE7B82FBBF34EFE_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities_0C8EDCA718FD92BC4EE7B82FBBF34EFE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_0C8EDCA718FD92BC4EE7B82FBBF34EFE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_0C8EDCA718FD92BC4EE7B82FBBF34EFE" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities_0C8EDCA718FD92BC4EE7B82FBBF34EFE" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_7A88E6FB65D8552C5689B82FBBF3C3DB_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_7A88E6FB65D8552C5689B82FBBF3C3DB" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_7A88E6FB65D8552C5689B82FBBF3C3DB_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance_7A88E6FB65D8552C5689B82FBBF3C3DB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7A88E6FB65D8552C5689B82FBBF3C3DB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7A88E6FB65D8552C5689B82FBBF3C3DB" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance_7A88E6FB65D8552C5689B82FBBF3C3DB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_39830613E18FCA643828B82FBBF35C4C_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities_39830613E18FCA643828B82FBBF35C4C" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_39830613E18FCA643828B82FBBF35C4C_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities_39830613E18FCA643828B82FBBF35C4C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_39830613E18FCA643828B82FBBF35C4C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities_39830613E18FCA643828B82FBBF35C4C" xlink:to="lab_us-gaap_DeferredTaxLiabilities_39830613E18FCA643828B82FBBF35C4C" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxPeriodAxis_CABF1B9931344E075AE3B466A27552E4_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis_CABF1B9931344E075AE3B466A27552E4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_CABF1B9931344E075AE3B466A27552E4_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis_CABF1B9931344E075AE3B466A27552E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="loc_us-gaap_TaxPeriodAxis_CABF1B9931344E075AE3B466A27552E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis_CABF1B9931344E075AE3B466A27552E4" xlink:to="lab_us-gaap_TaxPeriodAxis_CABF1B9931344E075AE3B466A27552E4" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxPeriodDomain_65981571EE212AE3284AB466A2753F2F_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain_65981571EE212AE3284AB466A2753F2F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_65981571EE212AE3284AB466A2753F2F_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain_65981571EE212AE3284AB466A2753F2F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaap_TaxPeriodDomain_65981571EE212AE3284AB466A2753F2F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain_65981571EE212AE3284AB466A2753F2F" xlink:to="lab_us-gaap_TaxPeriodDomain_65981571EE212AE3284AB466A2753F2F" xlink:type="arc" />
    <link:label id="lab_ango_TaxPeriodOneMember_ECA715C52C175BF935BBB466A276FA61_terseLabel_en-US" xlink:label="lab_ango_TaxPeriodOneMember_ECA715C52C175BF935BBB466A276FA61" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Year 2018 To 2023</link:label>
    <link:label id="lab_ango_TaxPeriodOneMember_ECA715C52C175BF935BBB466A276FA61_label_en-US" xlink:label="lab_ango_TaxPeriodOneMember_ECA715C52C175BF935BBB466A276FA61" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period One [Member]</link:label>
    <link:label id="lab_ango_TaxPeriodOneMember_ECA715C52C175BF935BBB466A276FA61_documentation_en-US" xlink:label="lab_ango_TaxPeriodOneMember_ECA715C52C175BF935BBB466A276FA61" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Period One [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_TaxPeriodOneMember" xlink:label="loc_ango_TaxPeriodOneMember_ECA715C52C175BF935BBB466A276FA61" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_TaxPeriodOneMember_ECA715C52C175BF935BBB466A276FA61" xlink:to="lab_ango_TaxPeriodOneMember_ECA715C52C175BF935BBB466A276FA61" xlink:type="arc" />
    <link:label id="lab_ango_TaxPeriodTwoMember_6D3C2D2F99B308076169B466A2761F56_terseLabel_en-US" xlink:label="lab_ango_TaxPeriodTwoMember_6D3C2D2F99B308076169B466A2761F56" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Year 2027 To 2037</link:label>
    <link:label id="lab_ango_TaxPeriodTwoMember_6D3C2D2F99B308076169B466A2761F56_label_en-US" xlink:label="lab_ango_TaxPeriodTwoMember_6D3C2D2F99B308076169B466A2761F56" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period Two [Member]</link:label>
    <link:label id="lab_ango_TaxPeriodTwoMember_6D3C2D2F99B308076169B466A2761F56_documentation_en-US" xlink:label="lab_ango_TaxPeriodTwoMember_6D3C2D2F99B308076169B466A2761F56" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Period Two [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_TaxPeriodTwoMember" xlink:label="loc_ango_TaxPeriodTwoMember_6D3C2D2F99B308076169B466A2761F56" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_TaxPeriodTwoMember_6D3C2D2F99B308076169B466A2761F56" xlink:to="lab_ango_TaxPeriodTwoMember_6D3C2D2F99B308076169B466A2761F56" xlink:type="arc" />
    <link:label id="lab_ango_TaxPeriodThreeMember_F37D98D67A718064BDCAB466A276AFCB_terseLabel_en-US" xlink:label="lab_ango_TaxPeriodThreeMember_F37D98D67A718064BDCAB466A276AFCB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Year 2018 To 2038</link:label>
    <link:label id="lab_ango_TaxPeriodThreeMember_F37D98D67A718064BDCAB466A276AFCB_label_en-US" xlink:label="lab_ango_TaxPeriodThreeMember_F37D98D67A718064BDCAB466A276AFCB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Period Three [Member]</link:label>
    <link:label id="lab_ango_TaxPeriodThreeMember_F37D98D67A718064BDCAB466A276AFCB_documentation_en-US" xlink:label="lab_ango_TaxPeriodThreeMember_F37D98D67A718064BDCAB466A276AFCB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Period Three [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_TaxPeriodThreeMember" xlink:label="loc_ango_TaxPeriodThreeMember_F37D98D67A718064BDCAB466A276AFCB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_TaxPeriodThreeMember_F37D98D67A718064BDCAB466A276AFCB" xlink:to="lab_ango_TaxPeriodThreeMember_F37D98D67A718064BDCAB466A276AFCB" xlink:type="arc" />
    <link:label id="lab_us-gaap_DomesticCountryMember_32EF58E2685502B97208B466A277AB2F_verboseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember_32EF58E2685502B97208B466A277AB2F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_32EF58E2685502B97208B466A277AB2F_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember_32EF58E2685502B97208B466A277AB2F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_32EF58E2685502B97208B466A277AB2F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember_32EF58E2685502B97208B466A277AB2F" xlink:to="lab_us-gaap_DomesticCountryMember_32EF58E2685502B97208B466A277AB2F" xlink:type="arc" />
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_C648E05A1F22D1010D4DB466A277AA8C_verboseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember_C648E05A1F22D1010D4DB466A277AA8C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_C648E05A1F22D1010D4DB466A277AA8C_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember_C648E05A1F22D1010D4DB466A277AA8C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_C648E05A1F22D1010D4DB466A277AA8C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember_C648E05A1F22D1010D4DB466A277AA8C" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember_C648E05A1F22D1010D4DB466A277AA8C" xlink:type="arc" />
    <link:label id="lab_ango_IncomeTaxesTextualAbstract_0937FAACE18BDB17C485B47ACF11E834_verboseLabel_en-US" xlink:label="lab_ango_IncomeTaxesTextualAbstract_0937FAACE18BDB17C485B47ACF11E834" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes (Textual) [Abstract]</link:label>
    <link:label id="lab_ango_IncomeTaxesTextualAbstract_0937FAACE18BDB17C485B47ACF11E834_label_en-US" xlink:label="lab_ango_IncomeTaxesTextualAbstract_0937FAACE18BDB17C485B47ACF11E834" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes (Textual) [Abstract]</link:label>
    <link:label id="lab_ango_IncomeTaxesTextualAbstract_0937FAACE18BDB17C485B47ACF11E834_documentation_en-US" xlink:label="lab_ango_IncomeTaxesTextualAbstract_0937FAACE18BDB17C485B47ACF11E834" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Taxes (Textual) [Abstract]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_IncomeTaxesTextualAbstract" xlink:label="loc_ango_IncomeTaxesTextualAbstract_0937FAACE18BDB17C485B47ACF11E834" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_IncomeTaxesTextualAbstract_0937FAACE18BDB17C485B47ACF11E834" xlink:to="lab_ango_IncomeTaxesTextualAbstract_0937FAACE18BDB17C485B47ACF11E834" xlink:type="arc" />
    <link:label id="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit_2FF80C5D7D24B3C79506B47ACF11A5BD_negatedTerseLabel_en-US" xlink:label="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit_2FF80C5D7D24B3C79506B47ACF11A5BD" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Tax benefit due to revaluation of indefinite lived deferred tax liability</link:label>
    <link:label id="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit_2FF80C5D7D24B3C79506B47ACF11A5BD_label_en-US" xlink:label="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit_2FF80C5D7D24B3C79506B47ACF11A5BD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Change In Tax Rate, Deferred Tax Liability, Provisional Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit_2FF80C5D7D24B3C79506B47ACF11A5BD_documentation_en-US" xlink:label="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit_2FF80C5D7D24B3C79506B47ACF11A5BD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Change In Tax Rate, Deferred Tax Liability, Provisional Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit" xlink:label="loc_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit_2FF80C5D7D24B3C79506B47ACF11A5BD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit_2FF80C5D7D24B3C79506B47ACF11A5BD" xlink:to="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit_2FF80C5D7D24B3C79506B47ACF11A5BD" xlink:type="arc" />
    <link:label id="lab_ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse_B0A038DB152917554960B47ACF119D4E_terseLabel_en-US" xlink:label="lab_ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse_B0A038DB152917554960B47ACF119D4E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards after considering limitations of use</link:label>
    <link:label id="lab_ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse_B0A038DB152917554960B47ACF119D4E_label_en-US" xlink:label="lab_ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse_B0A038DB152917554960B47ACF119D4E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards, Amount After Limitation Of Use</link:label>
    <link:label id="lab_ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse_B0A038DB152917554960B47ACF119D4E_documentation_en-US" xlink:label="lab_ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse_B0A038DB152917554960B47ACF119D4E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards, Amount After Limitation Of Use</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse" xlink:label="loc_ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse_B0A038DB152917554960B47ACF119D4E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse_B0A038DB152917554960B47ACF119D4E" xlink:to="lab_ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse_B0A038DB152917554960B47ACF119D4E" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_5D6F9123A505238A55BDB47ACF11F4C6_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards_5D6F9123A505238A55BDB47ACF11F4C6" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Federal and State net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_5D6F9123A505238A55BDB47ACF11F4C6_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards_5D6F9123A505238A55BDB47ACF11F4C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_5D6F9123A505238A55BDB47ACF11F4C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards_5D6F9123A505238A55BDB47ACF11F4C6" xlink:to="lab_us-gaap_OperatingLossCarryforwards_5D6F9123A505238A55BDB47ACF11F4C6" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_EE0378BA097175990506B47ACF116BBF_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_EE0378BA097175990506B47ACF116BBF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated blended corporate income tax rate (as percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_EE0378BA097175990506B47ACF116BBF_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_EE0378BA097175990506B47ACF116BBF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_EE0378BA097175990506B47ACF116BBF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_EE0378BA097175990506B47ACF116BBF" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_EE0378BA097175990506B47ACF116BBF" xlink:type="arc" />
    <link:label id="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit_7C4502C9BBA7DBBF0E12B47ACF11C50E_terseLabel_en-US" xlink:label="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit_7C4502C9BBA7DBBF0E12B47ACF11C50E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax benefit</link:label>
    <link:label id="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit_7C4502C9BBA7DBBF0E12B47ACF11C50E_label_en-US" xlink:label="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit_7C4502C9BBA7DBBF0E12B47ACF11C50E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Change In Tax Rate, Deferred Tax Liability, Provisional Income Tax Benefit</link:label>
    <link:label id="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit_7C4502C9BBA7DBBF0E12B47ACF11C50E_documentation_en-US" xlink:label="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit_7C4502C9BBA7DBBF0E12B47ACF11C50E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Change In Tax Rate, Deferred Tax Liability, Provisional Income Tax Benefit</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit" xlink:label="loc_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit_7C4502C9BBA7DBBF0E12B47ACF11C50E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit_7C4502C9BBA7DBBF0E12B47ACF11C50E" xlink:to="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit_7C4502C9BBA7DBBF0E12B47ACF11C50E" xlink:type="arc" />
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_B78BCC564B6974D9FF23B47ACF117883_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_B78BCC564B6974D9FF23B47ACF117883" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign subsidiary undistributed earnings</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_B78BCC564B6974D9FF23B47ACF117883_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_B78BCC564B6974D9FF23B47ACF117883" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_B78BCC564B6974D9FF23B47ACF117883" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_B78BCC564B6974D9FF23B47ACF117883" xlink:to="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_B78BCC564B6974D9FF23B47ACF117883" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_C7A81412E5D7B4E28D56B47ACF11B926_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_C7A81412E5D7B4E28D56B47ACF11B926" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional unrecognized tax benefit</link:label>
    <link:label id="lab_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_C7A81412E5D7B4E28D56B47ACF11B926_label_en-US" xlink:label="lab_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_C7A81412E5D7B4E28D56B47ACF11B926" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:label="loc_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_C7A81412E5D7B4E28D56B47ACF11B926" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_C7A81412E5D7B4E28D56B47ACF11B926" xlink:to="lab_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_C7A81412E5D7B4E28D56B47ACF11B926" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_13AAB3F8AD8C8CC9D906B47ACF1182CD_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_13AAB3F8AD8C8CC9D906B47ACF1182CD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued interest and penalties</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_13AAB3F8AD8C8CC9D906B47ACF1182CD_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_13AAB3F8AD8C8CC9D906B47ACF1182CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_13AAB3F8AD8C8CC9D906B47ACF1182CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_13AAB3F8AD8C8CC9D906B47ACF1182CD" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_13AAB3F8AD8C8CC9D906B47ACF1182CD" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_6A146EAC6651CB3998578F96E1AA9485_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_6A146EAC6651CB3998578F96E1AA9485" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_6A146EAC6651CB3998578F96E1AA9485_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_6A146EAC6651CB3998578F96E1AA9485" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_6A146EAC6651CB3998578F96E1AA9485" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_6A146EAC6651CB3998578F96E1AA9485" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_6A146EAC6651CB3998578F96E1AA9485" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_67A4EC61C7202D65D8718F96E1AB33A8_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_67A4EC61C7202D65D8718F96E1AB33A8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Payroll and related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_67A4EC61C7202D65D8718F96E1AB33A8_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_67A4EC61C7202D65D8718F96E1AB33A8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_67A4EC61C7202D65D8718F96E1AB33A8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_67A4EC61C7202D65D8718F96E1AB33A8" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_67A4EC61C7202D65D8718F96E1AB33A8" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_E71C638E7C8ADD6ACD478F96E1AB3AFA_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent_E71C638E7C8ADD6ACD478F96E1AB3AFA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_E71C638E7C8ADD6ACD478F96E1AB3AFA_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent_E71C638E7C8ADD6ACD478F96E1AB3AFA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_E71C638E7C8ADD6ACD478F96E1AB3AFA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent_E71C638E7C8ADD6ACD478F96E1AB3AFA" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent_E71C638E7C8ADD6ACD478F96E1AB3AFA" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_13B7357BE28AD2337A558F96E1ABBC3A_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent_13B7357BE28AD2337A558F96E1ABBC3A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued severance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_13B7357BE28AD2337A558F96E1ABBC3A_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent_13B7357BE28AD2337A558F96E1ABBC3A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserveCurrent" xlink:label="loc_us-gaap_RestructuringReserveCurrent_13B7357BE28AD2337A558F96E1ABBC3A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent_13B7357BE28AD2337A558F96E1ABBC3A" xlink:to="lab_us-gaap_RestructuringReserveCurrent_13B7357BE28AD2337A558F96E1ABBC3A" xlink:type="arc" />
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrent_B0281B86AAA89B685B7E8F96E1AB398B_verboseLabel_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrent_B0281B86AAA89B685B7E8F96E1AB398B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Sales and franchise taxes</link:label>
    <link:label id="lab_us-gaap_SalesAndExciseTaxPayableCurrent_B0281B86AAA89B685B7E8F96E1AB398B_label_en-US" xlink:label="lab_us-gaap_SalesAndExciseTaxPayableCurrent_B0281B86AAA89B685B7E8F96E1AB398B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales and Excise Tax Payable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent_B0281B86AAA89B685B7E8F96E1AB398B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesAndExciseTaxPayableCurrent_B0281B86AAA89B685B7E8F96E1AB398B" xlink:to="lab_us-gaap_SalesAndExciseTaxPayableCurrent_B0281B86AAA89B685B7E8F96E1AB398B" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_EBF153940205607565A58F96E1ABF3CF_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_EBF153940205607565A58F96E1ABF3CF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outside services</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_EBF153940205607565A58F96E1ABF3CF_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_EBF153940205607565A58F96E1ABF3CF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Professional Fees</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_EBF153940205607565A58F96E1ABF3CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_EBF153940205607565A58F96E1ABF3CF" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_EBF153940205607565A58F96E1ABF3CF" xlink:type="arc" />
    <link:label id="lab_ango_AccruedLitigation_89953E2CAB89B02806218F96E1ACC821_terseLabel_en-US" xlink:label="lab_ango_AccruedLitigation_89953E2CAB89B02806218F96E1ACC821" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation matters (Note 15)</link:label>
    <link:label id="lab_ango_AccruedLitigation_89953E2CAB89B02806218F96E1ACC821_label_en-US" xlink:label="lab_ango_AccruedLitigation_89953E2CAB89B02806218F96E1ACC821" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Litigation</link:label>
    <link:label id="lab_ango_AccruedLitigation_89953E2CAB89B02806218F96E1ACC821_documentation_en-US" xlink:label="lab_ango_AccruedLitigation_89953E2CAB89B02806218F96E1ACC821" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Litigation</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_AccruedLitigation" xlink:label="loc_ango_AccruedLitigation_89953E2CAB89B02806218F96E1ACC821" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_AccruedLitigation_89953E2CAB89B02806218F96E1ACC821" xlink:to="lab_ango_AccruedLitigation_89953E2CAB89B02806218F96E1ACC821" xlink:type="arc" />
    <link:label id="lab_ango_AccruedRecallLiability_A0246026EA1BAC07A36F8F96E1AC97D3_terseLabel_en-US" xlink:label="lab_ango_AccruedRecallLiability_A0246026EA1BAC07A36F8F96E1AC97D3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acculis recall liability</link:label>
    <link:label id="lab_ango_AccruedRecallLiability_A0246026EA1BAC07A36F8F96E1AC97D3_label_en-US" xlink:label="lab_ango_AccruedRecallLiability_A0246026EA1BAC07A36F8F96E1AC97D3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Recall Liability</link:label>
    <link:label id="lab_ango_AccruedRecallLiability_A0246026EA1BAC07A36F8F96E1AC97D3_documentation_en-US" xlink:label="lab_ango_AccruedRecallLiability_A0246026EA1BAC07A36F8F96E1AC97D3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Recall Liability</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_AccruedRecallLiability" xlink:label="loc_ango_AccruedRecallLiability_A0246026EA1BAC07A36F8F96E1AC97D3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_AccruedRecallLiability_A0246026EA1BAC07A36F8F96E1AC97D3" xlink:to="lab_ango_AccruedRecallLiability_A0246026EA1BAC07A36F8F96E1AC97D3" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_091ADC30F376820BDDA18F96E1ACF27A_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent_091ADC30F376820BDDA18F96E1ACF27A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_091ADC30F376820BDDA18F96E1ACF27A_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent_091ADC30F376820BDDA18F96E1ACF27A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_091ADC30F376820BDDA18F96E1ACF27A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_091ADC30F376820BDDA18F96E1ACF27A" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent_091ADC30F376820BDDA18F96E1ACF27A" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_CB96EE5F3D2FB60D50E28F96E1AC6F0B_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent_CB96EE5F3D2FB60D50E28F96E1AC6F0B" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_CB96EE5F3D2FB60D50E28F96E1AC6F0B_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent_CB96EE5F3D2FB60D50E28F96E1AC6F0B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_CB96EE5F3D2FB60D50E28F96E1AC6F0B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_CB96EE5F3D2FB60D50E28F96E1AC6F0B" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent_CB96EE5F3D2FB60D50E28F96E1AC6F0B" xlink:type="arc" />
    <link:label id="lab_ango_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_33526E1C2D65D84360C28F96E2FC8B6A_verboseLabel_en-US" xlink:label="lab_ango_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_33526E1C2D65D84360C28F96E2FC8B6A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements using Significant Unobservable Inputs</link:label>
    <link:label id="lab_ango_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_33526E1C2D65D84360C28F96E2FC8B6A_label_en-US" xlink:label="lab_ango_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_33526E1C2D65D84360C28F96E2FC8B6A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Liabilities Measured on Recurring Basis Unobservable Input Reconciliation [Abstract]</link:label>
    <link:label id="lab_ango_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_33526E1C2D65D84360C28F96E2FC8B6A_documentation_en-US" xlink:label="lab_ango_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_33526E1C2D65D84360C28F96E2FC8B6A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Abstract]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:label="loc_ango_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_33526E1C2D65D84360C28F96E2FC8B6A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_33526E1C2D65D84360C28F96E2FC8B6A" xlink:to="lab_ango_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_33526E1C2D65D84360C28F96E2FC8B6A" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_08756C5DCCF817FF100A8F96E2FD9DF7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_08756C5DCCF817FF100A8F96E2FD9DF7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_08756C5DCCF817FF100A8F96E2FD9DF7_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_08756C5DCCF817FF100A8F96E2FD9DF7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_08756C5DCCF817FF100A8F96E2FD9DF7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_08756C5DCCF817FF100A8F96E2FD9DF7" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_08756C5DCCF817FF100A8F96E2FD9DF7" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_F5F9318974088A6201A38F96E2FD0177_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_F5F9318974088A6201A38F96E2FD0177" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_F5F9318974088A6201A38F96E2FD0177_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_F5F9318974088A6201A38F96E2FD0177" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_F5F9318974088A6201A38F96E2FD0177" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_F5F9318974088A6201A38F96E2FD0177" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_F5F9318974088A6201A38F96E2FD0177" xlink:type="arc" />
    <link:label id="lab_ango_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration_B97524F871CB8C114ACC8F9EC38C5C72_terseLabel_en-US" xlink:label="lab_ango_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration_B97524F871CB8C114ACC8F9EC38C5C72" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_ango_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration_B97524F871CB8C114ACC8F9EC38C5C72_label_en-US" xlink:label="lab_ango_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration_B97524F871CB8C114ACC8F9EC38C5C72" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Change In Contingent Consideration</link:label>
    <link:label id="lab_ango_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration_B97524F871CB8C114ACC8F9EC38C5C72_documentation_en-US" xlink:label="lab_ango_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration_B97524F871CB8C114ACC8F9EC38C5C72" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Change In Contingent Consideration</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration" xlink:label="loc_ango_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration_B97524F871CB8C114ACC8F9EC38C5C72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration_B97524F871CB8C114ACC8F9EC38C5C72" xlink:to="lab_ango_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration_B97524F871CB8C114ACC8F9EC38C5C72" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_56D1DD691012EDCBF6BD8F96E2FD8E71_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_56D1DD691012EDCBF6BD8F96E2FD8E71" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Currency (gain) loss from remeasurement</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_56D1DD691012EDCBF6BD8F96E2FD8E71_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_56D1DD691012EDCBF6BD8F96E2FD8E71" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_56D1DD691012EDCBF6BD8F96E2FD8E71" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_56D1DD691012EDCBF6BD8F96E2FD8E71" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_56D1DD691012EDCBF6BD8F96E2FD8E71" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_5464F1ABD2F70E4750328F96E2FE6ECA_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_5464F1ABD2F70E4750328F96E2FE6ECA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair market value adjustments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_5464F1ABD2F70E4750328F96E2FE6ECA_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_5464F1ABD2F70E4750328F96E2FE6ECA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_5464F1ABD2F70E4750328F96E2FE6ECA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_5464F1ABD2F70E4750328F96E2FE6ECA" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_5464F1ABD2F70E4750328F96E2FE6ECA" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1905C4FE322394EA7F2F8F96E2FE9EFA_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1905C4FE322394EA7F2F8F96E2FE9EFA" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Sale of securities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1905C4FE322394EA7F2F8F96E2FE9EFA_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1905C4FE322394EA7F2F8F96E2FE9EFA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1905C4FE322394EA7F2F8F96E2FE9EFA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1905C4FE322394EA7F2F8F96E2FE9EFA" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1905C4FE322394EA7F2F8F96E2FE9EFA" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_297F80B43779DA37C6AD8F96E2FE6D55_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_297F80B43779DA37C6AD8F96E2FE6D55" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration payments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_297F80B43779DA37C6AD8F96E2FE6D55_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_297F80B43779DA37C6AD8F96E2FE6D55" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_297F80B43779DA37C6AD8F96E2FE6D55" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_297F80B43779DA37C6AD8F96E2FE6D55" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_297F80B43779DA37C6AD8F96E2FE6D55" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_9B7EE09209C33CA465FE8F96E2FE0046_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_9B7EE09209C33CA465FE8F96E2FE0046" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_9B7EE09209C33CA465FE8F96E2FE0046" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_9B7EE09209C33CA465FE8F96E2FE0046" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_9B7EE09209C33CA465FE8F96E2FE0046" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8B7B8BE6AAE63A4EC2528F96E2FE7B9C_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8B7B8BE6AAE63A4EC2528F96E2FE7B9C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8B7B8BE6AAE63A4EC2528F96E2FE7B9C_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8B7B8BE6AAE63A4EC2528F96E2FE7B9C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8B7B8BE6AAE63A4EC2528F96E2FE7B9C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8B7B8BE6AAE63A4EC2528F96E2FE7B9C" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8B7B8BE6AAE63A4EC2528F96E2FE7B9C" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_502897FD16A16DF76F958F96E2FFF5B6_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_502897FD16A16DF76F958F96E2FFF5B6" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_502897FD16A16DF76F958F96E2FFF5B6_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_502897FD16A16DF76F958F96E2FFF5B6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_502897FD16A16DF76F958F96E2FFF5B6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_502897FD16A16DF76F958F96E2FFF5B6" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_502897FD16A16DF76F958F96E2FFF5B6" xlink:type="arc" />
    <link:label id="lab_ango_FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings_1F110B23D9972C69E6F38F96E2FF1FDB_terseLabel_en-US" xlink:label="lab_ango_FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings_1F110B23D9972C69E6F38F96E2FF1FDB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_ango_FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings_1F110B23D9972C69E6F38F96E2FF1FDB_label_en-US" xlink:label="lab_ango_FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings_1F110B23D9972C69E6F38F96E2FF1FDB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Liabilities Measured on Recurring Basis Gain Included in Earnings</link:label>
    <link:label id="lab_ango_FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings_1F110B23D9972C69E6F38F96E2FF1FDB_documentation_en-US" xlink:label="lab_ango_FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings_1F110B23D9972C69E6F38F96E2FF1FDB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Liabilities Measured on Recurring Basis Gain Included in Earnings</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings" xlink:label="loc_ango_FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings_1F110B23D9972C69E6F38F96E2FF1FDB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings_1F110B23D9972C69E6F38F96E2FF1FDB" xlink:to="lab_ango_FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings_1F110B23D9972C69E6F38F96E2FF1FDB" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_3AF4C533AEB054B0DD3C8FAB661C1D16_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_3AF4C533AEB054B0DD3C8FAB661C1D16" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Currency (gain) loss from remeasurement</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_3AF4C533AEB054B0DD3C8FAB661C1D16_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_3AF4C533AEB054B0DD3C8FAB661C1D16" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_3AF4C533AEB054B0DD3C8FAB661C1D16" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_3AF4C533AEB054B0DD3C8FAB661C1D16" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_3AF4C533AEB054B0DD3C8FAB661C1D16" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_B5F0B7054132221CA2018F96E2FFA4F8_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_B5F0B7054132221CA2018F96E2FFA4F8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair market value adjustments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_B5F0B7054132221CA2018F96E2FFA4F8_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_B5F0B7054132221CA2018F96E2FFA4F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_B5F0B7054132221CA2018F96E2FFA4F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_B5F0B7054132221CA2018F96E2FFA4F8" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_B5F0B7054132221CA2018F96E2FFA4F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_6A0F381B7674E40E27EA8F96E3007969_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_6A0F381B7674E40E27EA8F96E3007969" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Sale of securities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_6A0F381B7674E40E27EA8F96E3007969_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_6A0F381B7674E40E27EA8F96E3007969" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Sales</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_6A0F381B7674E40E27EA8F96E3007969" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_6A0F381B7674E40E27EA8F96E3007969" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_6A0F381B7674E40E27EA8F96E3007969" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_145AF87C1615769BEE4E8F96E3006BC1_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_145AF87C1615769BEE4E8F96E3006BC1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration payments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_145AF87C1615769BEE4E8F96E3006BC1_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_145AF87C1615769BEE4E8F96E3006BC1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_145AF87C1615769BEE4E8F96E3006BC1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_145AF87C1615769BEE4E8F96E3006BC1" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_145AF87C1615769BEE4E8F96E3006BC1" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6FBF5819AAEE6B97BF938F96E300F98E_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6FBF5819AAEE6B97BF938F96E300F98E" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6FBF5819AAEE6B97BF938F96E300F98E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6FBF5819AAEE6B97BF938F96E300F98E" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6FBF5819AAEE6B97BF938F96E300F98E" xlink:type="arc" />
    <link:label id="lab_ango_PercentageOfInternationalSalesToNetSales_E15BB84EE1C7A7A400238F96E06755B2_verboseLabel_en-US" xlink:label="lab_ango_PercentageOfInternationalSalesToNetSales_E15BB84EE1C7A7A400238F96E06755B2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">International sales percentage of total net sales</link:label>
    <link:label id="lab_ango_PercentageOfInternationalSalesToNetSales_E15BB84EE1C7A7A400238F96E06755B2_label_en-US" xlink:label="lab_ango_PercentageOfInternationalSalesToNetSales_E15BB84EE1C7A7A400238F96E06755B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of International Sales to Net Sales</link:label>
    <link:label id="lab_ango_PercentageOfInternationalSalesToNetSales_E15BB84EE1C7A7A400238F96E06755B2_documentation_en-US" xlink:label="lab_ango_PercentageOfInternationalSalesToNetSales_E15BB84EE1C7A7A400238F96E06755B2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of international sales to net sales.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_PercentageOfInternationalSalesToNetSales" xlink:label="loc_ango_PercentageOfInternationalSalesToNetSales_E15BB84EE1C7A7A400238F96E06755B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_PercentageOfInternationalSalesToNetSales_E15BB84EE1C7A7A400238F96E06755B2" xlink:to="lab_ango_PercentageOfInternationalSalesToNetSales_E15BB84EE1C7A7A400238F96E06755B2" xlink:type="arc" />
    <link:label id="lab_ango_PercentageOfDomesticAssets_9535D11162C4AF5289C38F96E067C096_verboseLabel_en-US" xlink:label="lab_ango_PercentageOfDomesticAssets_9535D11162C4AF5289C38F96E067C096" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total assets are located within the United States</link:label>
    <link:label id="lab_ango_PercentageOfDomesticAssets_9535D11162C4AF5289C38F96E067C096_label_en-US" xlink:label="lab_ango_PercentageOfDomesticAssets_9535D11162C4AF5289C38F96E067C096" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of Domestic Assets</link:label>
    <link:label id="lab_ango_PercentageOfDomesticAssets_9535D11162C4AF5289C38F96E067C096_documentation_en-US" xlink:label="lab_ango_PercentageOfDomesticAssets_9535D11162C4AF5289C38F96E067C096" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of domestic assets.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_PercentageOfDomesticAssets" xlink:label="loc_ango_PercentageOfDomesticAssets_9535D11162C4AF5289C38F96E067C096" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_PercentageOfDomesticAssets_9535D11162C4AF5289C38F96E067C096" xlink:to="lab_ango_PercentageOfDomesticAssets_9535D11162C4AF5289C38F96E067C096" xlink:type="arc" />
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_640094EE364E48BE017A8C8B9CC147E0_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract_640094EE364E48BE017A8C8B9CC147E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_640094EE364E48BE017A8C8B9CC147E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_640094EE364E48BE017A8C8B9CC147E0" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract_640094EE364E48BE017A8C8B9CC147E0" xlink:type="arc" />
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_6B979FEDCCF2D24255268C8B9CC1FDE6_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_6B979FEDCCF2D24255268C8B9CC1FDE6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_6B979FEDCCF2D24255268C8B9CC1FDE6_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_6B979FEDCCF2D24255268C8B9CC1FDE6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_6B979FEDCCF2D24255268C8B9CC1FDE6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_6B979FEDCCF2D24255268C8B9CC1FDE6" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_6B979FEDCCF2D24255268C8B9CC1FDE6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_BEA2D68F3EF981ED27E08C8B9CC1E5F7_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_BEA2D68F3EF981ED27E08C8B9CC1E5F7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_BEA2D68F3EF981ED27E08C8B9CC1E5F7_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_BEA2D68F3EF981ED27E08C8B9CC1E5F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_BEA2D68F3EF981ED27E08C8B9CC1E5F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_BEA2D68F3EF981ED27E08C8B9CC1E5F7" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_BEA2D68F3EF981ED27E08C8B9CC1E5F7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_1B8ACAFAA78C642F87A88C8B9CC1D76B_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain_1B8ACAFAA78C642F87A88C8B9CC1D76B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_1B8ACAFAA78C642F87A88C8B9CC1D76B_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain_1B8ACAFAA78C642F87A88C8B9CC1D76B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_1B8ACAFAA78C642F87A88C8B9CC1D76B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_1B8ACAFAA78C642F87A88C8B9CC1D76B" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain_1B8ACAFAA78C642F87A88C8B9CC1D76B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_A16DB6570D609D3F6CDC8C8B9CC143E0_verboseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_A16DB6570D609D3F6CDC8C8B9CC143E0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Allowance for deferred tax asset</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_A16DB6570D609D3F6CDC8C8B9CC143E0_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_A16DB6570D609D3F6CDC8C8B9CC143E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_A16DB6570D609D3F6CDC8C8B9CC143E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_A16DB6570D609D3F6CDC8C8B9CC143E0" xlink:to="lab_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_A16DB6570D609D3F6CDC8C8B9CC143E0" xlink:type="arc" />
    <link:label id="lab_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember_348F3360238428CA57688C8B9CC1E729_verboseLabel_en-US" xlink:label="lab_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember_348F3360238428CA57688C8B9CC1E729" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Allowance for sales returns and doubtful accounts</link:label>
    <link:label id="lab_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember_348F3360238428CA57688C8B9CC1E729_label_en-US" xlink:label="lab_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember_348F3360238428CA57688C8B9CC1E729" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allowance for Sales Returns and Doubtful Accounts [Member]</link:label>
    <link:label id="lab_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember_348F3360238428CA57688C8B9CC1E729_documentation_en-US" xlink:label="lab_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember_348F3360238428CA57688C8B9CC1E729" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Allowance for Sales Returns and Doubtful Accounts [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember" xlink:label="loc_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember_348F3360238428CA57688C8B9CC1E729" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember_348F3360238428CA57688C8B9CC1E729" xlink:to="lab_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember_348F3360238428CA57688C8B9CC1E729" xlink:type="arc" />
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_C57A871DD343D874504B8C8B9CC1784F_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_C57A871DD343D874504B8C8B9CC1784F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_C57A871DD343D874504B8C8B9CC1784F_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_C57A871DD343D874504B8C8B9CC1784F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_C57A871DD343D874504B8C8B9CC1784F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_C57A871DD343D874504B8C8B9CC1784F" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_C57A871DD343D874504B8C8B9CC1784F" xlink:type="arc" />
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_517043EB34B0E527FE0C8C8B9CC1534B_verboseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_517043EB34B0E527FE0C8C8B9CC1534B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Valuation and Qualifying Accounts</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_517043EB34B0E527FE0C8C8B9CC1534B_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_517043EB34B0E527FE0C8C8B9CC1534B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_517043EB34B0E527FE0C8C8B9CC1534B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_517043EB34B0E527FE0C8C8B9CC1534B" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_517043EB34B0E527FE0C8C8B9CC1534B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_E9A5DB517A041695D3FB8C8B9CC1909F_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance_E9A5DB517A041695D3FB8C8B9CC1909F" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at Beginning of Year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_E9A5DB517A041695D3FB8C8B9CC1909F_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance_E9A5DB517A041695D3FB8C8B9CC1909F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_E9A5DB517A041695D3FB8C8B9CC1909F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance_E9A5DB517A041695D3FB8C8B9CC1909F" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance_E9A5DB517A041695D3FB8C8B9CC1909F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_6B5DA7F4B9A47FD25F8A8C8B9CC109D0_verboseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_6B5DA7F4B9A47FD25F8A8C8B9CC109D0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Additions - Charged to costs and expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_6B5DA7F4B9A47FD25F8A8C8B9CC109D0_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_6B5DA7F4B9A47FD25F8A8C8B9CC109D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_6B5DA7F4B9A47FD25F8A8C8B9CC109D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_6B5DA7F4B9A47FD25F8A8C8B9CC109D0" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_6B5DA7F4B9A47FD25F8A8C8B9CC109D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_355EC014F6298C2A55CB8C8B9CC1CA26_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions_355EC014F6298C2A55CB8C8B9CC1CA26" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deductions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_355EC014F6298C2A55CB8C8B9CC1CA26_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions_355EC014F6298C2A55CB8C8B9CC1CA26" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_355EC014F6298C2A55CB8C8B9CC1CA26" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions_355EC014F6298C2A55CB8C8B9CC1CA26" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions_355EC014F6298C2A55CB8C8B9CC1CA26" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_F391CC0FB722EB74851F8C8B9CC1BF58_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance_F391CC0FB722EB74851F8C8B9CC1BF58" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at End of Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_F391CC0FB722EB74851F8C8B9CC1BF58" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance_F391CC0FB722EB74851F8C8B9CC1BF58" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance_F391CC0FB722EB74851F8C8B9CC1BF58" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_78F1EF3F0D02006CB7968C8B9C547F4B_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract_78F1EF3F0D02006CB7968C8B9C547F4B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_78F1EF3F0D02006CB7968C8B9C547F4B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_78F1EF3F0D02006CB7968C8B9C547F4B" xlink:to="lab_us-gaap_EarningsPerShareAbstract_78F1EF3F0D02006CB7968C8B9C547F4B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_D6A4F3BFD2FED3A75C628C8B9C545C03_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_D6A4F3BFD2FED3A75C628C8B9C545C03" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Weighted Average Number of Shares</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_D6A4F3BFD2FED3A75C628C8B9C545C03_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_D6A4F3BFD2FED3A75C628C8B9C545C03" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_D6A4F3BFD2FED3A75C628C8B9C545C03" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_D6A4F3BFD2FED3A75C628C8B9C545C03" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_D6A4F3BFD2FED3A75C628C8B9C545C03" xlink:type="arc" />
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_3BC6AC942064BA8CFEA08C8B9A406F96_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_3BC6AC942064BA8CFEA08C8B9A406F96" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3BC6AC942064BA8CFEA08C8B9A406F96" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3BC6AC942064BA8CFEA08C8B9A406F96" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_3BC6AC942064BA8CFEA08C8B9A406F96" xlink:type="arc" />
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_DF832C26BC613CE0D5248C8B9A40C2E6_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_DF832C26BC613CE0D5248C8B9A40C2E6" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">RETIREMENT PLANS</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_DF832C26BC613CE0D5248C8B9A40C2E6_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_DF832C26BC613CE0D5248C8B9A40C2E6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension and Other Postretirement Benefits Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_DF832C26BC613CE0D5248C8B9A40C2E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_DF832C26BC613CE0D5248C8B9A40C2E6" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_DF832C26BC613CE0D5248C8B9A40C2E6" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_268235749FA94D44D188B417916A4FBD_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_268235749FA94D44D188B417916A4FBD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_268235749FA94D44D188B417916A4FBD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_268235749FA94D44D188B417916A4FBD" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_268235749FA94D44D188B417916A4FBD" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_608AD79ABC85EB5C9E44B417916A1E0A_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_608AD79ABC85EB5C9E44B417916A1E0A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_608AD79ABC85EB5C9E44B417916A1E0A_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_608AD79ABC85EB5C9E44B417916A1E0A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_608AD79ABC85EB5C9E44B417916A1E0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_608AD79ABC85EB5C9E44B417916A1E0A" xlink:to="lab_us-gaap_NetIncomeLoss_608AD79ABC85EB5C9E44B417916A1E0A" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_46CA2690D60BDAF342B9B417916A991E_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_46CA2690D60BDAF342B9B417916A991E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), before tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_46CA2690D60BDAF342B9B417916A991E_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_46CA2690D60BDAF342B9B417916A991E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_46CA2690D60BDAF342B9B417916A991E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_46CA2690D60BDAF342B9B417916A991E" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_46CA2690D60BDAF342B9B417916A991E" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_6F1B9D7187F20A4082F8B417916A9FA2_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_6F1B9D7187F20A4082F8B417916A9FA2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gain (loss) on marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_6F1B9D7187F20A4082F8B417916A9FA2_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_6F1B9D7187F20A4082F8B417916A9FA2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_6F1B9D7187F20A4082F8B417916A9FA2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_6F1B9D7187F20A4082F8B417916A9FA2" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_6F1B9D7187F20A4082F8B417916A9FA2" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_F06901C8AE24FB511730B417916A8FD0_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_F06901C8AE24FB511730B417916A8FD0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gain on interest rate swap</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_F06901C8AE24FB511730B417916A8FD0_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_F06901C8AE24FB511730B417916A8FD0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_F06901C8AE24FB511730B417916A8FD0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_F06901C8AE24FB511730B417916A8FD0" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_F06901C8AE24FB511730B417916A8FD0" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_8FF67137177BCEF3463CB417916A65B3_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_8FF67137177BCEF3463CB417916A65B3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation gain (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_8FF67137177BCEF3463CB417916A65B3_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_8FF67137177BCEF3463CB417916A65B3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_8FF67137177BCEF3463CB417916A65B3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_8FF67137177BCEF3463CB417916A65B3" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_8FF67137177BCEF3463CB417916A65B3" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_C8523832036A8799F3D3B417916AAFB9_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_C8523832036A8799F3D3B417916AAFB9" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), before tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_C8523832036A8799F3D3B417916AAFB9_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_C8523832036A8799F3D3B417916AAFB9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_C8523832036A8799F3D3B417916AAFB9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_C8523832036A8799F3D3B417916AAFB9" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_C8523832036A8799F3D3B417916AAFB9" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_FD50BC7E929A76B441A7B417916A83CF_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_FD50BC7E929A76B441A7B417916A83CF" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Income tax benefit (expense) related to items of other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_FD50BC7E929A76B441A7B417916A83CF_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_FD50BC7E929A76B441A7B417916A83CF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_FD50BC7E929A76B441A7B417916A83CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_FD50BC7E929A76B441A7B417916A83CF" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_FD50BC7E929A76B441A7B417916A83CF" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5419B2F5B259A8714E16B417916AE341_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5419B2F5B259A8714E16B417916AE341" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5419B2F5B259A8714E16B417916AE341_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5419B2F5B259A8714E16B417916AE341" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5419B2F5B259A8714E16B417916AE341" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5419B2F5B259A8714E16B417916AE341" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5419B2F5B259A8714E16B417916AE341" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_D9BC147522BB7B2D6179949FCFB8EB22_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_D9BC147522BB7B2D6179949FCFB8EB22" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_D9BC147522BB7B2D6179949FCFB8EB22" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_D9BC147522BB7B2D6179949FCFB8EB22" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_D9BC147522BB7B2D6179949FCFB8EB22" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsAbstract_6EB29A502ED8C0E4A0C8949FCFB8D721_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract_6EB29A502ED8C0E4A0C8949FCFB8D721" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_6EB29A502ED8C0E4A0C8949FCFB8D721_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract_6EB29A502ED8C0E4A0C8949FCFB8D721" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_6EB29A502ED8C0E4A0C8949FCFB8D721" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_6EB29A502ED8C0E4A0C8949FCFB8D721" xlink:to="lab_us-gaap_AssetsAbstract_6EB29A502ED8C0E4A0C8949FCFB8D721" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_C6F9C8BE5299FD0F973A949FCFB84EEA_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_C6F9C8BE5299FD0F973A949FCFB84EEA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_C6F9C8BE5299FD0F973A949FCFB84EEA_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_C6F9C8BE5299FD0F973A949FCFB84EEA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_C6F9C8BE5299FD0F973A949FCFB84EEA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_C6F9C8BE5299FD0F973A949FCFB84EEA" xlink:to="lab_us-gaap_AssetsCurrentAbstract_C6F9C8BE5299FD0F973A949FCFB84EEA" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_8C1B9583CAD2C0004211949FCFB84450_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_8C1B9583CAD2C0004211949FCFB84450" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_8C1B9583CAD2C0004211949FCFB84450_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_8C1B9583CAD2C0004211949FCFB84450" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8C1B9583CAD2C0004211949FCFB84450" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8C1B9583CAD2C0004211949FCFB84450" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_8C1B9583CAD2C0004211949FCFB84450" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_C61ED14FDE87CF7D93E7949FCFB9D7CF_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_C61ED14FDE87CF7D93E7949FCFB9D7CF" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities, at fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_C61ED14FDE87CF7D93E7949FCFB9D7CF_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_C61ED14FDE87CF7D93E7949FCFB9D7CF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_C61ED14FDE87CF7D93E7949FCFB9D7CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_C61ED14FDE87CF7D93E7949FCFB9D7CF" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_C61ED14FDE87CF7D93E7949FCFB9D7CF" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_DF4773E2195601BD5D62949FCFB9D098_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_DF4773E2195601BD5D62949FCFB9D098" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net of allowances of $2,466 and $2,945, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_DF4773E2195601BD5D62949FCFB9D098_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_DF4773E2195601BD5D62949FCFB9D098" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Net, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_DF4773E2195601BD5D62949FCFB9D098" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_DF4773E2195601BD5D62949FCFB9D098" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent_DF4773E2195601BD5D62949FCFB9D098" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryNet_B0EB0428D49924B738F2949FCFB9073A_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet_B0EB0428D49924B738F2949FCFB9073A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_B0EB0428D49924B738F2949FCFB9073A_label_en-US" xlink:label="lab_us-gaap_InventoryNet_B0EB0428D49924B738F2949FCFB9073A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_B0EB0428D49924B738F2949FCFB9073A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_B0EB0428D49924B738F2949FCFB9073A" xlink:to="lab_us-gaap_InventoryNet_B0EB0428D49924B738F2949FCFB9073A" xlink:type="arc" />
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4A37A5BE01A5500B5411949FCFB97DC6_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4A37A5BE01A5500B5411949FCFB97DC6" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4A37A5BE01A5500B5411949FCFB97DC6_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4A37A5BE01A5500B5411949FCFB97DC6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4A37A5BE01A5500B5411949FCFB97DC6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4A37A5BE01A5500B5411949FCFB97DC6" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4A37A5BE01A5500B5411949FCFB97DC6" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrent_E60FF6C5DFC54949AB2B949FCFB920A0_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent_E60FF6C5DFC54949AB2B949FCFB920A0" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_E60FF6C5DFC54949AB2B949FCFB920A0_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent_E60FF6C5DFC54949AB2B949FCFB920A0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_E60FF6C5DFC54949AB2B949FCFB920A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_E60FF6C5DFC54949AB2B949FCFB920A0" xlink:to="lab_us-gaap_AssetsCurrent_E60FF6C5DFC54949AB2B949FCFB920A0" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_37760B35759CC21BFA0A949FCFBA797C_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_37760B35759CC21BFA0A949FCFBA797C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_37760B35759CC21BFA0A949FCFBA797C_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_37760B35759CC21BFA0A949FCFBA797C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_37760B35759CC21BFA0A949FCFBA797C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_37760B35759CC21BFA0A949FCFBA797C" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_37760B35759CC21BFA0A949FCFBA797C" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_118D3D1A9373527BC10A949FCFBA1C6E_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_118D3D1A9373527BC10A949FCFBA1C6E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_118D3D1A9373527BC10A949FCFBA1C6E_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_118D3D1A9373527BC10A949FCFBA1C6E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_118D3D1A9373527BC10A949FCFBA1C6E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_118D3D1A9373527BC10A949FCFBA1C6E" xlink:to="lab_us-gaap_OtherAssetsNoncurrent_118D3D1A9373527BC10A949FCFBA1C6E" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_CA25319AC5D00EFD99C2949FCFBA3561_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_CA25319AC5D00EFD99C2949FCFBA3561" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_CA25319AC5D00EFD99C2949FCFBA3561_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_CA25319AC5D00EFD99C2949FCFBA3561" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_CA25319AC5D00EFD99C2949FCFBA3561" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_CA25319AC5D00EFD99C2949FCFBA3561" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_CA25319AC5D00EFD99C2949FCFBA3561" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_CF0B520C6B0562FBB940949FCFBA422B_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill_CF0B520C6B0562FBB940949FCFBA422B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_CF0B520C6B0562FBB940949FCFBA422B_label_en-US" xlink:label="lab_us-gaap_Goodwill_CF0B520C6B0562FBB940949FCFBA422B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_CF0B520C6B0562FBB940949FCFBA422B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_CF0B520C6B0562FBB940949FCFBA422B" xlink:to="lab_us-gaap_Goodwill_CF0B520C6B0562FBB940949FCFBA422B" xlink:type="arc" />
    <link:label id="lab_us-gaap_Assets_D697239EC20B2888DD5D949FCFBA97AC_totalLabel_en-US" xlink:label="lab_us-gaap_Assets_D697239EC20B2888DD5D949FCFBA97AC" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_D697239EC20B2888DD5D949FCFBA97AC_label_en-US" xlink:label="lab_us-gaap_Assets_D697239EC20B2888DD5D949FCFBA97AC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_D697239EC20B2888DD5D949FCFBA97AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_D697239EC20B2888DD5D949FCFBA97AC" xlink:to="lab_us-gaap_Assets_D697239EC20B2888DD5D949FCFBA97AC" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5666799C28EE2D0386B3949FCFBA9EF1_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5666799C28EE2D0386B3949FCFBA9EF1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5666799C28EE2D0386B3949FCFBA9EF1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5666799C28EE2D0386B3949FCFBA9EF1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5666799C28EE2D0386B3949FCFBA9EF1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5666799C28EE2D0386B3949FCFBA9EF1" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5666799C28EE2D0386B3949FCFBA9EF1" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_412363185C2241D759D2949FCFBB84F3_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_412363185C2241D759D2949FCFBB84F3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_412363185C2241D759D2949FCFBB84F3_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_412363185C2241D759D2949FCFBB84F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_412363185C2241D759D2949FCFBB84F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_412363185C2241D759D2949FCFBB84F3" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_412363185C2241D759D2949FCFBB84F3" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsPayableCurrent_B044F7FEDA39C3369FD6949FCFBB6C0B_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_B044F7FEDA39C3369FD6949FCFBB6C0B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_B044F7FEDA39C3369FD6949FCFBB6C0B_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_B044F7FEDA39C3369FD6949FCFBB6C0B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_B044F7FEDA39C3369FD6949FCFBB6C0B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent_B044F7FEDA39C3369FD6949FCFBB6C0B" xlink:to="lab_us-gaap_AccountsPayableCurrent_B044F7FEDA39C3369FD6949FCFBB6C0B" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_77BEA6A587AB6F339097949FCFBB0D24_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent_77BEA6A587AB6F339097949FCFBB0D24" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_77BEA6A587AB6F339097949FCFBB0D24" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_77BEA6A587AB6F339097949FCFBB0D24" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent_77BEA6A587AB6F339097949FCFBB0D24" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtCurrent_C5EE43D92DDAF8F8BFC5949FCFBBB0CA_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent_C5EE43D92DDAF8F8BFC5949FCFBBB0CA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_C5EE43D92DDAF8F8BFC5949FCFBBB0CA_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent_C5EE43D92DDAF8F8BFC5949FCFBBB0CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_C5EE43D92DDAF8F8BFC5949FCFBBB0CA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent_C5EE43D92DDAF8F8BFC5949FCFBBB0CA" xlink:to="lab_us-gaap_LongTermDebtCurrent_C5EE43D92DDAF8F8BFC5949FCFBBB0CA" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_AD1EE8D355D9D79DAE19949FCFBBD53A_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_AD1EE8D355D9D79DAE19949FCFBBD53A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current portion of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_AD1EE8D355D9D79DAE19949FCFBBD53A_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_AD1EE8D355D9D79DAE19949FCFBBD53A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_AD1EE8D355D9D79DAE19949FCFBBD53A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_AD1EE8D355D9D79DAE19949FCFBBD53A" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_AD1EE8D355D9D79DAE19949FCFBBD53A" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrent_ADD72C43D568F43D03F0949FCFBC18C8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_ADD72C43D568F43D03F0949FCFBC18C8" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_ADD72C43D568F43D03F0949FCFBC18C8_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_ADD72C43D568F43D03F0949FCFBC18C8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_ADD72C43D568F43D03F0949FCFBC18C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_ADD72C43D568F43D03F0949FCFBC18C8" xlink:to="lab_us-gaap_LiabilitiesCurrent_ADD72C43D568F43D03F0949FCFBC18C8" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermLoansPayable_A2DAEB4FCA66D3A2580F949FCFBCC136_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermLoansPayable_A2DAEB4FCA66D3A2580F949FCFBCC136" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermLoansPayable_A2DAEB4FCA66D3A2580F949FCFBCC136_label_en-US" xlink:label="lab_us-gaap_LongTermLoansPayable_A2DAEB4FCA66D3A2580F949FCFBCC136" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loans Payable, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermLoansPayable" xlink:label="loc_us-gaap_LongTermLoansPayable_A2DAEB4FCA66D3A2580F949FCFBCC136" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermLoansPayable_A2DAEB4FCA66D3A2580F949FCFBCC136" xlink:to="lab_us-gaap_LongTermLoansPayable_A2DAEB4FCA66D3A2580F949FCFBCC136" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_E7A0BA69F66F38600911949FCFBC0A55_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_E7A0BA69F66F38600911949FCFBC0A55" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_E7A0BA69F66F38600911949FCFBC0A55_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_E7A0BA69F66F38600911949FCFBC0A55" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Taxes and Other Tax Liabilities, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_E7A0BA69F66F38600911949FCFBC0A55" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_E7A0BA69F66F38600911949FCFBC0A55" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_E7A0BA69F66F38600911949FCFBC0A55" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_80BD15627221E0BB49AC949FCFBC5E94_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_80BD15627221E0BB49AC949FCFBC5E94" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Contingent consideration, net of current portion</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_80BD15627221E0BB49AC949FCFBC5E94_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_80BD15627221E0BB49AC949FCFBC5E94" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_80BD15627221E0BB49AC949FCFBC5E94" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_80BD15627221E0BB49AC949FCFBC5E94" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_80BD15627221E0BB49AC949FCFBC5E94" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_3322628B7D729A23C963949FCFBC72C8_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_3322628B7D729A23C963949FCFBC72C8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_3322628B7D729A23C963949FCFBC72C8_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_3322628B7D729A23C963949FCFBC72C8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3322628B7D729A23C963949FCFBC72C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_3322628B7D729A23C963949FCFBC72C8" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent_3322628B7D729A23C963949FCFBC72C8" xlink:type="arc" />
    <link:label id="lab_us-gaap_Liabilities_45573062CD4109CC52B9949FCFBC0153_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities_45573062CD4109CC52B9949FCFBC0153" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_45573062CD4109CC52B9949FCFBC0153_label_en-US" xlink:label="lab_us-gaap_Liabilities_45573062CD4109CC52B9949FCFBC0153" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_45573062CD4109CC52B9949FCFBC0153" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities_45573062CD4109CC52B9949FCFBC0153" xlink:to="lab_us-gaap_Liabilities_45573062CD4109CC52B9949FCFBC0153" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_41FF43AC510DEA4BA261949FCFBD195F_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies_41FF43AC510DEA4BA261949FCFBD195F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies (Note 15)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_41FF43AC510DEA4BA261949FCFBD195F_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies_41FF43AC510DEA4BA261949FCFBD195F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_41FF43AC510DEA4BA261949FCFBD195F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies_41FF43AC510DEA4BA261949FCFBD195F" xlink:to="lab_us-gaap_CommitmentsAndContingencies_41FF43AC510DEA4BA261949FCFBD195F" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_2D956B675FE97896AAA6949FCFBD90AA_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_2D956B675FE97896AAA6949FCFBD90AA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_2D956B675FE97896AAA6949FCFBD90AA_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_2D956B675FE97896AAA6949FCFBD90AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_2D956B675FE97896AAA6949FCFBD90AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2D956B675FE97896AAA6949FCFBD90AA" xlink:to="lab_us-gaap_StockholdersEquityAbstract_2D956B675FE97896AAA6949FCFBD90AA" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockValue_880C339942DC02AE5F68949FCFBDF73F_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue_880C339942DC02AE5F68949FCFBDF73F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value $.01 per share, 5,000,000 shares authorized; no shares issued and outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_880C339942DC02AE5F68949FCFBDF73F_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue_880C339942DC02AE5F68949FCFBDF73F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_880C339942DC02AE5F68949FCFBDF73F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue_880C339942DC02AE5F68949FCFBDF73F" xlink:to="lab_us-gaap_PreferredStockValue_880C339942DC02AE5F68949FCFBDF73F" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockValue_6678989D348FDD812DAC949FCFBD022C_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue_6678989D348FDD812DAC949FCFBD022C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value $.01 per share, 75,000,000 shares authorized; 37,594,493 and 37,210,091 shares issued and 37,224,493 and 36,840,091 shares outstanding at May 31, 2018 and 2017, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_6678989D348FDD812DAC949FCFBD022C_label_en-US" xlink:label="lab_us-gaap_CommonStockValue_6678989D348FDD812DAC949FCFBD022C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_6678989D348FDD812DAC949FCFBD022C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_6678989D348FDD812DAC949FCFBD022C" xlink:to="lab_us-gaap_CommonStockValue_6678989D348FDD812DAC949FCFBD022C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_36DF6D7D4A281B55F2A3949FCFBD1306_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock_36DF6D7D4A281B55F2A3949FCFBD1306" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_36DF6D7D4A281B55F2A3949FCFBD1306_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock_36DF6D7D4A281B55F2A3949FCFBD1306" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_36DF6D7D4A281B55F2A3949FCFBD1306" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock_36DF6D7D4A281B55F2A3949FCFBD1306" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock_36DF6D7D4A281B55F2A3949FCFBD1306" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_68DF9F80E96AFFF92AD0949FCFBEDC70_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_68DF9F80E96AFFF92AD0949FCFBEDC70" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings (accumulated deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_68DF9F80E96AFFF92AD0949FCFBEDC70_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_68DF9F80E96AFFF92AD0949FCFBEDC70" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_68DF9F80E96AFFF92AD0949FCFBEDC70" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_68DF9F80E96AFFF92AD0949FCFBEDC70" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_68DF9F80E96AFFF92AD0949FCFBEDC70" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValue_8DE18B16CE2734DA24C4949FCFBE216D_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_8DE18B16CE2734DA24C4949FCFBE216D" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, 370,000 shares, at cost at May 31, 2018 and 2017, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_8DE18B16CE2734DA24C4949FCFBE216D_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_8DE18B16CE2734DA24C4949FCFBE216D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_8DE18B16CE2734DA24C4949FCFBE216D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_8DE18B16CE2734DA24C4949FCFBE216D" xlink:to="lab_us-gaap_TreasuryStockValue_8DE18B16CE2734DA24C4949FCFBE216D" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_AE7F20DEAE4FED4AACAF949FCFBE514E_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_AE7F20DEAE4FED4AACAF949FCFBE514E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_AE7F20DEAE4FED4AACAF949FCFBE514E_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_AE7F20DEAE4FED4AACAF949FCFBE514E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_AE7F20DEAE4FED4AACAF949FCFBE514E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_AE7F20DEAE4FED4AACAF949FCFBE514E" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_AE7F20DEAE4FED4AACAF949FCFBE514E" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquity_68EC8209D79D426DABAD949FCFBE48FF_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity_68EC8209D79D426DABAD949FCFBE48FF" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Stockholders' Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_68EC8209D79D426DABAD949FCFBE48FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_68EC8209D79D426DABAD949FCFBE48FF" xlink:to="lab_us-gaap_StockholdersEquity_68EC8209D79D426DABAD949FCFBE48FF" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_1A6043A26C3FE53C0062949FCFBEFE5D_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_1A6043A26C3FE53C0062949FCFBEFE5D" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_1A6043A26C3FE53C0062949FCFBEFE5D_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_1A6043A26C3FE53C0062949FCFBEFE5D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_1A6043A26C3FE53C0062949FCFBEFE5D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1A6043A26C3FE53C0062949FCFBEFE5D" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_1A6043A26C3FE53C0062949FCFBEFE5D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_B632CCB958C8F26F5740A3D9E4E7505C_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_B632CCB958C8F26F5740A3D9E4E7505C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Components of income (loss) before income tax provision</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_B632CCB958C8F26F5740A3D9E4E7505C_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_B632CCB958C8F26F5740A3D9E4E7505C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_B632CCB958C8F26F5740A3D9E4E7505C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_B632CCB958C8F26F5740A3D9E4E7505C" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_B632CCB958C8F26F5740A3D9E4E7505C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_292EADAA6F6F9A46CAD7A3D9E4E724E2_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_292EADAA6F6F9A46CAD7A3D9E4E724E2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of Income tax (benefit) provision analyzed by category</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_292EADAA6F6F9A46CAD7A3D9E4E724E2_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_292EADAA6F6F9A46CAD7A3D9E4E724E2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_292EADAA6F6F9A46CAD7A3D9E4E724E2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_292EADAA6F6F9A46CAD7A3D9E4E724E2" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_292EADAA6F6F9A46CAD7A3D9E4E724E2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_A8D05896CC665883FB8AA3D9E4E70576_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_A8D05896CC665883FB8AA3D9E4E70576" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of deferred tax asset and liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_A8D05896CC665883FB8AA3D9E4E70576_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_A8D05896CC665883FB8AA3D9E4E70576" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_A8D05896CC665883FB8AA3D9E4E70576" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_A8D05896CC665883FB8AA3D9E4E70576" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_A8D05896CC665883FB8AA3D9E4E70576" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_D2756B0ACDB766C2606EA3D9E4E7255E_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_D2756B0ACDB766C2606EA3D9E4E7255E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of Income tax rate reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_D2756B0ACDB766C2606EA3D9E4E7255E_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_D2756B0ACDB766C2606EA3D9E4E7255E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_D2756B0ACDB766C2606EA3D9E4E7255E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_D2756B0ACDB766C2606EA3D9E4E7255E" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_D2756B0ACDB766C2606EA3D9E4E7255E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_83825BA01BD1A057DA1BA3DCA48A8F79_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_83825BA01BD1A057DA1BA3DCA48A8F79" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of unrecognized tax benefits reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_83825BA01BD1A057DA1BA3DCA48A8F79_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_83825BA01BD1A057DA1BA3DCA48A8F79" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_83825BA01BD1A057DA1BA3DCA48A8F79" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_83825BA01BD1A057DA1BA3DCA48A8F79" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_83825BA01BD1A057DA1BA3DCA48A8F79" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_8F36FF450C3F12C5D4498C8B9A013225_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract_8F36FF450C3F12C5D4498C8B9A013225" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_8F36FF450C3F12C5D4498C8B9A013225" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8F36FF450C3F12C5D4498C8B9A013225" xlink:to="lab_us-gaap_InventoryDisclosureAbstract_8F36FF450C3F12C5D4498C8B9A013225" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_3FA4DA4771F2BC426E8A8C8B9A018D76_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_3FA4DA4771F2BC426E8A8C8B9A018D76" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_3FA4DA4771F2BC426E8A8C8B9A018D76_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_3FA4DA4771F2BC426E8A8C8B9A018D76" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_3FA4DA4771F2BC426E8A8C8B9A018D76" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_3FA4DA4771F2BC426E8A8C8B9A018D76" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_3FA4DA4771F2BC426E8A8C8B9A018D76" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_0EA8D5D60BC90181DC7D8C8B9A5FC40C_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_0EA8D5D60BC90181DC7D8C8B9A5FC40C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">GOODWILL AND INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_0EA8D5D60BC90181DC7D8C8B9A5FC40C_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_0EA8D5D60BC90181DC7D8C8B9A5FC40C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_0EA8D5D60BC90181DC7D8C8B9A5FC40C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_0EA8D5D60BC90181DC7D8C8B9A5FC40C" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_0EA8D5D60BC90181DC7D8C8B9A5FC40C" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_22FE1337E0949B29CFEA8F96E0624156_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_22FE1337E0949B29CFEA8F96E0624156" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_22FE1337E0949B29CFEA8F96E0624156" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_22FE1337E0949B29CFEA8F96E0624156" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_22FE1337E0949B29CFEA8F96E0624156" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_E5B91234A1B635DA03AA8F96E062FEB9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_E5B91234A1B635DA03AA8F96E062FEB9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition, Restructuring and Other Items, net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_E5B91234A1B635DA03AA8F96E062FEB9_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_E5B91234A1B635DA03AA8F96E062FEB9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_E5B91234A1B635DA03AA8F96E062FEB9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_E5B91234A1B635DA03AA8F96E062FEB9" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_E5B91234A1B635DA03AA8F96E062FEB9" xlink:type="arc" />
    <link:label id="lab_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0_label_en-US" xlink:label="lab_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
    <link:label id="lab_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0_documentation_en-US" xlink:label="lab_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_DocumentAndEntityInformationAbstract" xlink:label="loc_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0" xlink:to="lab_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_8FE76E8181C19E03B1F98C8B9A01BCA6_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_8FE76E8181C19E03B1F98C8B9A01BCA6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_8FE76E8181C19E03B1F98C8B9A01BCA6_label_en-US" xlink:label="lab_dei_EntityRegistrantName_8FE76E8181C19E03B1F98C8B9A01BCA6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_8FE76E8181C19E03B1F98C8B9A01BCA6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_8FE76E8181C19E03B1F98C8B9A01BCA6" xlink:to="lab_dei_EntityRegistrantName_8FE76E8181C19E03B1F98C8B9A01BCA6" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_D65271C647CA7B8389468C8B9A015AA6_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_D65271C647CA7B8389468C8B9A015AA6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_D65271C647CA7B8389468C8B9A015AA6_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_D65271C647CA7B8389468C8B9A015AA6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_D65271C647CA7B8389468C8B9A015AA6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_D65271C647CA7B8389468C8B9A015AA6" xlink:to="lab_dei_EntityCentralIndexKey_D65271C647CA7B8389468C8B9A015AA6" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_EA5DD47E28358396DB938C8B9A01DEDD_terseLabel_en-US" xlink:label="lab_dei_DocumentType_EA5DD47E28358396DB938C8B9A01DEDD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_EA5DD47E28358396DB938C8B9A01DEDD_label_en-US" xlink:label="lab_dei_DocumentType_EA5DD47E28358396DB938C8B9A01DEDD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_EA5DD47E28358396DB938C8B9A01DEDD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_EA5DD47E28358396DB938C8B9A01DEDD" xlink:to="lab_dei_DocumentType_EA5DD47E28358396DB938C8B9A01DEDD" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_C8AE8C28F8F9F436B6988C8B9A01F74A_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_C8AE8C28F8F9F436B6988C8B9A01F74A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_C8AE8C28F8F9F436B6988C8B9A01F74A_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_C8AE8C28F8F9F436B6988C8B9A01F74A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_C8AE8C28F8F9F436B6988C8B9A01F74A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_C8AE8C28F8F9F436B6988C8B9A01F74A" xlink:to="lab_dei_DocumentPeriodEndDate_C8AE8C28F8F9F436B6988C8B9A01F74A" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_A1601A7B5B26B1F05CB38C8B9A012505_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_A1601A7B5B26B1F05CB38C8B9A012505" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_A1601A7B5B26B1F05CB38C8B9A012505_label_en-US" xlink:label="lab_dei_AmendmentFlag_A1601A7B5B26B1F05CB38C8B9A012505" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_A1601A7B5B26B1F05CB38C8B9A012505" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_A1601A7B5B26B1F05CB38C8B9A012505" xlink:to="lab_dei_AmendmentFlag_A1601A7B5B26B1F05CB38C8B9A012505" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalYearFocus_8244A10CDD4F6055EA718C8B9A014078_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_8244A10CDD4F6055EA718C8B9A014078" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_8244A10CDD4F6055EA718C8B9A014078_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_8244A10CDD4F6055EA718C8B9A014078" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_8244A10CDD4F6055EA718C8B9A014078" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_8244A10CDD4F6055EA718C8B9A014078" xlink:to="lab_dei_DocumentFiscalYearFocus_8244A10CDD4F6055EA718C8B9A014078" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_915230217A5123F480458C8B9A01EA2F_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_915230217A5123F480458C8B9A01EA2F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_915230217A5123F480458C8B9A01EA2F_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_915230217A5123F480458C8B9A01EA2F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_915230217A5123F480458C8B9A01EA2F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_915230217A5123F480458C8B9A01EA2F" xlink:to="lab_dei_DocumentFiscalPeriodFocus_915230217A5123F480458C8B9A01EA2F" xlink:type="arc" />
    <link:label id="lab_dei_CurrentFiscalYearEndDate_9958D75334C86F498C6F8C8B9A0151FB_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_9958D75334C86F498C6F8C8B9A0151FB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_9958D75334C86F498C6F8C8B9A0151FB_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_9958D75334C86F498C6F8C8B9A0151FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_9958D75334C86F498C6F8C8B9A0151FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_9958D75334C86F498C6F8C8B9A0151FB" xlink:to="lab_dei_CurrentFiscalYearEndDate_9958D75334C86F498C6F8C8B9A0151FB" xlink:type="arc" />
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_2C4578FCF0D2E59B4C658C8B9A01BB01_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer_2C4578FCF0D2E59B4C658C8B9A01BB01" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well Known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_2C4578FCF0D2E59B4C658C8B9A01BB01_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer_2C4578FCF0D2E59B4C658C8B9A01BB01" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_2C4578FCF0D2E59B4C658C8B9A01BB01" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer_2C4578FCF0D2E59B4C658C8B9A01BB01" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer_2C4578FCF0D2E59B4C658C8B9A01BB01" xlink:type="arc" />
    <link:label id="lab_dei_EntityVoluntaryFilers_49AB52A6E13DB359C2CC8C8B9A01C5A8_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers_49AB52A6E13DB359C2CC8C8B9A01C5A8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_49AB52A6E13DB359C2CC8C8B9A01C5A8_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers_49AB52A6E13DB359C2CC8C8B9A01C5A8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_49AB52A6E13DB359C2CC8C8B9A01C5A8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers_49AB52A6E13DB359C2CC8C8B9A01C5A8" xlink:to="lab_dei_EntityVoluntaryFilers_49AB52A6E13DB359C2CC8C8B9A01C5A8" xlink:type="arc" />
    <link:label id="lab_dei_EntityCurrentReportingStatus_41E5029ED64BBCA013458C8B9A015324_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus_41E5029ED64BBCA013458C8B9A015324" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_41E5029ED64BBCA013458C8B9A015324_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus_41E5029ED64BBCA013458C8B9A015324" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_41E5029ED64BBCA013458C8B9A015324" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus_41E5029ED64BBCA013458C8B9A015324" xlink:to="lab_dei_EntityCurrentReportingStatus_41E5029ED64BBCA013458C8B9A015324" xlink:type="arc" />
    <link:label id="lab_dei_EntityFilerCategory_807F1FFCA912E6B0D3FC8C8B9A01C1B5_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory_807F1FFCA912E6B0D3FC8C8B9A01C1B5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_807F1FFCA912E6B0D3FC8C8B9A01C1B5_label_en-US" xlink:label="lab_dei_EntityFilerCategory_807F1FFCA912E6B0D3FC8C8B9A01C1B5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_807F1FFCA912E6B0D3FC8C8B9A01C1B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_807F1FFCA912E6B0D3FC8C8B9A01C1B5" xlink:to="lab_dei_EntityFilerCategory_807F1FFCA912E6B0D3FC8C8B9A01C1B5" xlink:type="arc" />
    <link:label id="lab_dei_EntityPublicFloat_A07F440A451A4250C8698C8B9A010C3C_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat_A07F440A451A4250C8698C8B9A010C3C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_A07F440A451A4250C8698C8B9A010C3C_label_en-US" xlink:label="lab_dei_EntityPublicFloat_A07F440A451A4250C8698C8B9A010C3C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_A07F440A451A4250C8698C8B9A010C3C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat_A07F440A451A4250C8698C8B9A010C3C" xlink:to="lab_dei_EntityPublicFloat_A07F440A451A4250C8698C8B9A010C3C" xlink:type="arc" />
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_18E8C575A3D06ED584108C8B9A013950_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_18E8C575A3D06ED584108C8B9A013950" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_18E8C575A3D06ED584108C8B9A013950_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_18E8C575A3D06ED584108C8B9A013950" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_18E8C575A3D06ED584108C8B9A013950" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_18E8C575A3D06ED584108C8B9A013950" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_18E8C575A3D06ED584108C8B9A013950" xlink:type="arc" />
    <link:label id="lab_ango_PrepaidExpensesAndOtherTextBlock_AEE2D03E744CF9D7E66C8F96E294291D_verboseLabel_en-US" xlink:label="lab_ango_PrepaidExpensesAndOtherTextBlock_AEE2D03E744CF9D7E66C8F96E294291D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">PREPAID EXPENSES AND OTHER</link:label>
    <link:label id="lab_ango_PrepaidExpensesAndOtherTextBlock_AEE2D03E744CF9D7E66C8F96E294291D_label_en-US" xlink:label="lab_ango_PrepaidExpensesAndOtherTextBlock_AEE2D03E744CF9D7E66C8F96E294291D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expenses and Other [Text Block]</link:label>
    <link:label id="lab_ango_PrepaidExpensesAndOtherTextBlock_AEE2D03E744CF9D7E66C8F96E294291D_documentation_en-US" xlink:label="lab_ango_PrepaidExpensesAndOtherTextBlock_AEE2D03E744CF9D7E66C8F96E294291D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_PrepaidExpensesAndOtherTextBlock" xlink:label="loc_ango_PrepaidExpensesAndOtherTextBlock_AEE2D03E744CF9D7E66C8F96E294291D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_PrepaidExpensesAndOtherTextBlock_AEE2D03E744CF9D7E66C8F96E294291D" xlink:to="lab_ango_PrepaidExpensesAndOtherTextBlock_AEE2D03E744CF9D7E66C8F96E294291D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_09C1C47616F0C39F2CE58C8B9A9D8277_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract_09C1C47616F0C39F2CE58C8B9A9D8277" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_09C1C47616F0C39F2CE58C8B9A9D8277" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract_09C1C47616F0C39F2CE58C8B9A9D8277" xlink:to="lab_us-gaap_DebtDisclosureAbstract_09C1C47616F0C39F2CE58C8B9A9D8277" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_B07C5E224601F17A242C8C8B9A9D19C7_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_B07C5E224601F17A242C8C8B9A9D19C7" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Future minimum principal payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_B07C5E224601F17A242C8C8B9A9D19C7_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_B07C5E224601F17A242C8C8B9A9D19C7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_B07C5E224601F17A242C8C8B9A9D19C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_B07C5E224601F17A242C8C8B9A9D19C7" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_B07C5E224601F17A242C8C8B9A9D19C7" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_8EF2E1194F413DF323A98F96E33D3E1A_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_8EF2E1194F413DF323A98F96E33D3E1A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8EF2E1194F413DF323A98F96E33D3E1A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8EF2E1194F413DF323A98F96E33D3E1A" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_8EF2E1194F413DF323A98F96E33D3E1A" xlink:type="arc" />
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_F3C493ED760F412F32C08F96E33D1B67_verboseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_F3C493ED760F412F32C08F96E33D1B67" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">BASIS OF PRESENTATION, BUSINESS DESCRIPTION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_F3C493ED760F412F32C08F96E33D1B67_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_F3C493ED760F412F32C08F96E33D1B67" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_F3C493ED760F412F32C08F96E33D1B67" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_F3C493ED760F412F32C08F96E33D1B67" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_F3C493ED760F412F32C08F96E33D1B67" xlink:type="arc" />
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_E0EF0E86A822C6FEBD168F96E031D21E_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_E0EF0E86A822C6FEBD168F96E031D21E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_E0EF0E86A822C6FEBD168F96E031D21E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_E0EF0E86A822C6FEBD168F96E031D21E" xlink:to="lab_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_E0EF0E86A822C6FEBD168F96E031D21E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_47632D791F30B3842CA38F96E03112A2_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_47632D791F30B3842CA38F96E03112A2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of Quarterly Financial Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_47632D791F30B3842CA38F96E03112A2_label_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_47632D791F30B3842CA38F96E03112A2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_47632D791F30B3842CA38F96E03112A2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_47632D791F30B3842CA38F96E03112A2" xlink:to="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_47632D791F30B3842CA38F96E03112A2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32A67722EA40C14610D7A3DC14A5B474_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32A67722EA40C14610D7A3DC14A5B474" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32A67722EA40C14610D7A3DC14A5B474_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32A67722EA40C14610D7A3DC14A5B474" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32A67722EA40C14610D7A3DC14A5B474" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32A67722EA40C14610D7A3DC14A5B474" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32A67722EA40C14610D7A3DC14A5B474" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_F9229F40F70F04476457A3DC14A549F8_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_F9229F40F70F04476457A3DC14A549F8" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits, beginning balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_F9229F40F70F04476457A3DC14A549F8_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_F9229F40F70F04476457A3DC14A549F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_F9229F40F70F04476457A3DC14A549F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_F9229F40F70F04476457A3DC14A549F8" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_F9229F40F70F04476457A3DC14A549F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_AA229DDAFB7462F80B18A3DC14A58701_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_AA229DDAFB7462F80B18A3DC14A58701" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in gross amounts of tax positions related to prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_AA229DDAFB7462F80B18A3DC14A58701_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_AA229DDAFB7462F80B18A3DC14A58701" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_AA229DDAFB7462F80B18A3DC14A58701" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_AA229DDAFB7462F80B18A3DC14A58701" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_AA229DDAFB7462F80B18A3DC14A58701" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_42BA1D35A13EB9E03279A4399E0A4E0B_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_42BA1D35A13EB9E03279A4399E0A4E0B" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Decrease in gross amounts of tax positions related to prior years due to U.S. tax reform</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_42BA1D35A13EB9E03279A4399E0A4E0B_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_42BA1D35A13EB9E03279A4399E0A4E0B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_42BA1D35A13EB9E03279A4399E0A4E0B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_42BA1D35A13EB9E03279A4399E0A4E0B" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_42BA1D35A13EB9E03279A4399E0A4E0B" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_EA7016CC6F128260C25BA3DC14AAED8F_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_EA7016CC6F128260C25BA3DC14AAED8F" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Decrease due to lapse in statute of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_EA7016CC6F128260C25BA3DC14AAED8F_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_EA7016CC6F128260C25BA3DC14AAED8F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_EA7016CC6F128260C25BA3DC14AAED8F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_EA7016CC6F128260C25BA3DC14AAED8F" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_EA7016CC6F128260C25BA3DC14AAED8F" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_FE9008DD7F355543A7D2A3DC14AAB47B_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits_FE9008DD7F355543A7D2A3DC14AAB47B" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits, ending balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_FE9008DD7F355543A7D2A3DC14AAB47B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits_FE9008DD7F355543A7D2A3DC14AAB47B" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits_FE9008DD7F355543A7D2A3DC14AAB47B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_874EBAA3718B50BFDE5B8C8B9B0B414B_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_874EBAA3718B50BFDE5B8C8B9B0B414B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule summarizes stock option activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_874EBAA3718B50BFDE5B8C8B9B0B414B_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_874EBAA3718B50BFDE5B8C8B9B0B414B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation, Stock Options, Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_874EBAA3718B50BFDE5B8C8B9B0B414B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_874EBAA3718B50BFDE5B8C8B9B0B414B" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_874EBAA3718B50BFDE5B8C8B9B0B414B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_137E02101F91AAA4EDB28C8B9B1A56AD_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_137E02101F91AAA4EDB28C8B9B1A56AD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share based compensation arrangement by share based payment award nonvested shares and weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_137E02101F91AAA4EDB28C8B9B1A56AD_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_137E02101F91AAA4EDB28C8B9B1A56AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Nonvested Share Activity [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_137E02101F91AAA4EDB28C8B9B1A56AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_137E02101F91AAA4EDB28C8B9B1A56AD" xlink:to="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_137E02101F91AAA4EDB28C8B9B1A56AD" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_D354A4AD0DF16E38C61D8C8B9B1A0BEF_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_D354A4AD0DF16E38C61D8C8B9B1A0BEF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_D354A4AD0DF16E38C61D8C8B9B1A0BEF_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_D354A4AD0DF16E38C61D8C8B9B1A0BEF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_D354A4AD0DF16E38C61D8C8B9B1A0BEF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_D354A4AD0DF16E38C61D8C8B9B1A0BEF" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_D354A4AD0DF16E38C61D8C8B9B1A0BEF" xlink:type="arc" />
    <link:label id="lab_ango_RetirementPlansTextualAbstract_3BF6C293673FE9893ED38C8B9DAB7AAC_verboseLabel_en-US" xlink:label="lab_ango_RetirementPlansTextualAbstract_3BF6C293673FE9893ED38C8B9DAB7AAC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Retirement Plans (Textual) [Abstract]</link:label>
    <link:label id="lab_ango_RetirementPlansTextualAbstract_3BF6C293673FE9893ED38C8B9DAB7AAC_label_en-US" xlink:label="lab_ango_RetirementPlansTextualAbstract_3BF6C293673FE9893ED38C8B9DAB7AAC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Plans (Textual) [Abstract]</link:label>
    <link:label id="lab_ango_RetirementPlansTextualAbstract_3BF6C293673FE9893ED38C8B9DAB7AAC_documentation_en-US" xlink:label="lab_ango_RetirementPlansTextualAbstract_3BF6C293673FE9893ED38C8B9DAB7AAC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Retirement Plans (Textual) [Abstract]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_RetirementPlansTextualAbstract" xlink:label="loc_ango_RetirementPlansTextualAbstract_3BF6C293673FE9893ED38C8B9DAB7AAC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_RetirementPlansTextualAbstract_3BF6C293673FE9893ED38C8B9DAB7AAC" xlink:to="lab_ango_RetirementPlansTextualAbstract_3BF6C293673FE9893ED38C8B9DAB7AAC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_E296A9F6F7D87AA6F64B8C8B9DAB4F26_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized_E296A9F6F7D87AA6F64B8C8B9DAB4F26" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Matching contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_E296A9F6F7D87AA6F64B8C8B9DAB4F26_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized_E296A9F6F7D87AA6F64B8C8B9DAB4F26" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_E296A9F6F7D87AA6F64B8C8B9DAB4F26" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized_E296A9F6F7D87AA6F64B8C8B9DAB4F26" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized_E296A9F6F7D87AA6F64B8C8B9DAB4F26" xlink:type="arc" />
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_1EFEB204B01789226A068C8B9DABE40B_verboseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_1EFEB204B01789226A068C8B9DABE40B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">VALUATION AND QUALIFYING ACCOUNTS</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_1EFEB204B01789226A068C8B9DABE40B_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_1EFEB204B01789226A068C8B9DABE40B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_1EFEB204B01789226A068C8B9DABE40B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_1EFEB204B01789226A068C8B9DABE40B" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_1EFEB204B01789226A068C8B9DABE40B" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3BE52EEDF555982D23F893D32965AEB4_verboseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3BE52EEDF555982D23F893D32965AEB4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, allowances</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3BE52EEDF555982D23F893D32965AEB4_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3BE52EEDF555982D23F893D32965AEB4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allowance for Doubtful Accounts Receivable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3BE52EEDF555982D23F893D32965AEB4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3BE52EEDF555982D23F893D32965AEB4" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3BE52EEDF555982D23F893D32965AEB4" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_56EAFD3F50C86F56AC5C93D32965DA45_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare_56EAFD3F50C86F56AC5C93D32965DA45" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_56EAFD3F50C86F56AC5C93D32965DA45_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare_56EAFD3F50C86F56AC5C93D32965DA45" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_56EAFD3F50C86F56AC5C93D32965DA45" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare_56EAFD3F50C86F56AC5C93D32965DA45" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare_56EAFD3F50C86F56AC5C93D32965DA45" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_A81356261E88E281188793D32965627F_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized_A81356261E88E281188793D32965627F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_A81356261E88E281188793D32965627F_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized_A81356261E88E281188793D32965627F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_A81356261E88E281188793D32965627F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized_A81356261E88E281188793D32965627F" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized_A81356261E88E281188793D32965627F" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_B6613263C4A2254025AE93D329651068_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued_B6613263C4A2254025AE93D329651068" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares issued (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_B6613263C4A2254025AE93D329651068_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued_B6613263C4A2254025AE93D329651068" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_B6613263C4A2254025AE93D329651068" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued_B6613263C4A2254025AE93D329651068" xlink:to="lab_us-gaap_PreferredStockSharesIssued_B6613263C4A2254025AE93D329651068" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_CA6E8BB204EAA961832593D32966CF99_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding_CA6E8BB204EAA961832593D32966CF99" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_CA6E8BB204EAA961832593D32966CF99_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding_CA6E8BB204EAA961832593D32966CF99" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_CA6E8BB204EAA961832593D32966CF99" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding_CA6E8BB204EAA961832593D32966CF99" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding_CA6E8BB204EAA961832593D32966CF99" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_16C67C6A89D2A1145CE993D3296662C2_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_16C67C6A89D2A1145CE993D3296662C2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_16C67C6A89D2A1145CE993D3296662C2_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_16C67C6A89D2A1145CE993D3296662C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_16C67C6A89D2A1145CE993D3296662C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare_16C67C6A89D2A1145CE993D3296662C2" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare_16C67C6A89D2A1145CE993D3296662C2" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_F87F03C8F1DD92C0CC4D93D32966461B_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_F87F03C8F1DD92C0CC4D93D32966461B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_F87F03C8F1DD92C0CC4D93D32966461B_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_F87F03C8F1DD92C0CC4D93D32966461B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_F87F03C8F1DD92C0CC4D93D32966461B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_F87F03C8F1DD92C0CC4D93D32966461B" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_F87F03C8F1DD92C0CC4D93D32966461B" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesIssued_05DC32601B2E33D3696B93D32966D584_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_05DC32601B2E33D3696B93D32966D584" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_05DC32601B2E33D3696B93D32966D584_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_05DC32601B2E33D3696B93D32966D584" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_05DC32601B2E33D3696B93D32966D584" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_05DC32601B2E33D3696B93D32966D584" xlink:to="lab_us-gaap_CommonStockSharesIssued_05DC32601B2E33D3696B93D32966D584" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_10C45BE2F1607AA7757E93D32966F258_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_10C45BE2F1607AA7757E93D32966F258" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_10C45BE2F1607AA7757E93D32966F258_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding_10C45BE2F1607AA7757E93D32966F258" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_10C45BE2F1607AA7757E93D32966F258" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding_10C45BE2F1607AA7757E93D32966F258" xlink:to="lab_us-gaap_CommonStockSharesOutstanding_10C45BE2F1607AA7757E93D32966F258" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockShares_9382671FD08C1845B64493D32966D499_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_9382671FD08C1845B64493D32966D499" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, shares (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_9382671FD08C1845B64493D32966D499_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_9382671FD08C1845B64493D32966D499" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_9382671FD08C1845B64493D32966D499" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares_9382671FD08C1845B64493D32966D499" xlink:to="lab_us-gaap_TreasuryStockShares_9382671FD08C1845B64493D32966D499" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_AEDD37AADB6356894E418F96E3123C58_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock_AEDD37AADB6356894E418F96E3123C58" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">FAIR VALUE OF FINANCIAL INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_AEDD37AADB6356894E418F96E3123C58_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock_AEDD37AADB6356894E418F96E3123C58" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_AEDD37AADB6356894E418F96E3123C58" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock_AEDD37AADB6356894E418F96E3123C58" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock_AEDD37AADB6356894E418F96E3123C58" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_F3AE4C11CDAF4ACF34008C8B9A7E715D_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_F3AE4C11CDAF4ACF34008C8B9A7E715D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_F3AE4C11CDAF4ACF34008C8B9A7E715D_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_F3AE4C11CDAF4ACF34008C8B9A7E715D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_F3AE4C11CDAF4ACF34008C8B9A7E715D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock_F3AE4C11CDAF4ACF34008C8B9A7E715D" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock_F3AE4C11CDAF4ACF34008C8B9A7E715D" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_97828F8CC5683F6603F48C8B9D0049CA_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract_97828F8CC5683F6603F48C8B9D0049CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_97828F8CC5683F6603F48C8B9D0049CA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_97828F8CC5683F6603F48C8B9D0049CA" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract_97828F8CC5683F6603F48C8B9D0049CA" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_CA4CABE1D7F9F98DB7CB8C8B9D007CA0_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_CA4CABE1D7F9F98DB7CB8C8B9D007CA0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_CA4CABE1D7F9F98DB7CB8C8B9D007CA0_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_CA4CABE1D7F9F98DB7CB8C8B9D007CA0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_CA4CABE1D7F9F98DB7CB8C8B9D007CA0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_CA4CABE1D7F9F98DB7CB8C8B9D007CA0" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_CA4CABE1D7F9F98DB7CB8C8B9D007CA0" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_0043494DA7CB25CF2C5394C430A55163_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract_0043494DA7CB25CF2C5394C430A55163" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0043494DA7CB25CF2C5394C430A55163" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0043494DA7CB25CF2C5394C430A55163" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract_0043494DA7CB25CF2C5394C430A55163" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementTable_CE5795E396C6CCC7B42F94C430A53147_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable_CE5795E396C6CCC7B42F94C430A53147" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_CE5795E396C6CCC7B42F94C430A53147_label_en-US" xlink:label="lab_us-gaap_StatementTable_CE5795E396C6CCC7B42F94C430A53147" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_CE5795E396C6CCC7B42F94C430A53147" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable_CE5795E396C6CCC7B42F94C430A53147" xlink:to="lab_us-gaap_StatementTable_CE5795E396C6CCC7B42F94C430A53147" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockMember_E2CAC91072325CEA685394C430A6AD96_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember_E2CAC91072325CEA685394C430A6AD96" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_E2CAC91072325CEA685394C430A6AD96_label_en-US" xlink:label="lab_us-gaap_CommonStockMember_E2CAC91072325CEA685394C430A6AD96" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_E2CAC91072325CEA685394C430A6AD96" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_E2CAC91072325CEA685394C430A6AD96" xlink:to="lab_us-gaap_CommonStockMember_E2CAC91072325CEA685394C430A6AD96" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_0CAE04B517CDA2CFD0B094C430A6A219_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember_0CAE04B517CDA2CFD0B094C430A6A219" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_0CAE04B517CDA2CFD0B094C430A6A219_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember_0CAE04B517CDA2CFD0B094C430A6A219" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_0CAE04B517CDA2CFD0B094C430A6A219" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember_0CAE04B517CDA2CFD0B094C430A6A219" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember_0CAE04B517CDA2CFD0B094C430A6A219" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsMember_FB0668D2EB7A8C4CEC4094C430A75C39_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_FB0668D2EB7A8C4CEC4094C430A75C39" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings (accumulated deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_FB0668D2EB7A8C4CEC4094C430A75C39_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember_FB0668D2EB7A8C4CEC4094C430A75C39" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_FB0668D2EB7A8C4CEC4094C430A75C39" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember_FB0668D2EB7A8C4CEC4094C430A75C39" xlink:to="lab_us-gaap_RetainedEarningsMember_FB0668D2EB7A8C4CEC4094C430A75C39" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_F569058485E3692D58BC94C430A7336D_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_F569058485E3692D58BC94C430A7336D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_F569058485E3692D58BC94C430A7336D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_F569058485E3692D58BC94C430A7336D" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_F569058485E3692D58BC94C430A7336D" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockMember_F5338E18D1FF34455E4A94C430A79EF2_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember_F5338E18D1FF34455E4A94C430A79EF2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_F5338E18D1FF34455E4A94C430A79EF2_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember_F5338E18D1FF34455E4A94C430A79EF2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_F5338E18D1FF34455E4A94C430A79EF2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember_F5338E18D1FF34455E4A94C430A79EF2" xlink:to="lab_us-gaap_TreasuryStockMember_F5338E18D1FF34455E4A94C430A79EF2" xlink:type="arc" />
    <link:label id="lab_us-gaap_AwardTypeAxis_31C4CB63569701C42F5494C430A77C17_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_31C4CB63569701C42F5494C430A77C17" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_31C4CB63569701C42F5494C430A77C17_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_31C4CB63569701C42F5494C430A77C17" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_31C4CB63569701C42F5494C430A77C17" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis_31C4CB63569701C42F5494C430A77C17" xlink:to="lab_us-gaap_AwardTypeAxis_31C4CB63569701C42F5494C430A77C17" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_413C9424A5570E39064D94C430A7C49E_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_413C9424A5570E39064D94C430A7C49E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_413C9424A5570E39064D94C430A7C49E_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_413C9424A5570E39064D94C430A7C49E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_413C9424A5570E39064D94C430A7C49E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_413C9424A5570E39064D94C430A7C49E" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_413C9424A5570E39064D94C430A7C49E" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_6F6CC796611B00CA387894C430A8ABFC_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_6F6CC796611B00CA387894C430A8ABFC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_6F6CC796611B00CA387894C430A8ABFC_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_6F6CC796611B00CA387894C430A8ABFC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6F6CC796611B00CA387894C430A8ABFC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_6F6CC796611B00CA387894C430A8ABFC" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember_6F6CC796611B00CA387894C430A8ABFC" xlink:type="arc" />
    <link:label id="lab_us-gaap_PerformanceSharesMember_201DF8E1B7E30383032A94C430A8FE92_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_201DF8E1B7E30383032A94C430A8FE92" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_201DF8E1B7E30383032A94C430A8FE92_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_201DF8E1B7E30383032A94C430A8FE92" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_201DF8E1B7E30383032A94C430A8FE92" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember_201DF8E1B7E30383032A94C430A8FE92" xlink:to="lab_us-gaap_PerformanceSharesMember_201DF8E1B7E30383032A94C430A8FE92" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77_label_en-US" xlink:label="lab_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="lab_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharesIssued_D8D95162170BED66572D94C430A8A356_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued_D8D95162170BED66572D94C430A8A356" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Balance, Shares</link:label>
    <link:label id="lab_us-gaap_SharesIssued_D8D95162170BED66572D94C430A8A356_label_en-US" xlink:label="lab_us-gaap_SharesIssued_D8D95162170BED66572D94C430A8A356" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_D8D95162170BED66572D94C430A8A356" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued_D8D95162170BED66572D94C430A8A356" xlink:to="lab_us-gaap_SharesIssued_D8D95162170BED66572D94C430A8A356" xlink:type="arc" />
    <link:label id="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_A6B2EFDCF896141674D894C430A9BA0E_terseLabel_en-US" xlink:label="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_A6B2EFDCF896141674D894C430A9BA0E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment for ASU 2016-09</link:label>
    <link:label id="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_A6B2EFDCF896141674D894C430A9BA0E_label_en-US" xlink:label="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_A6B2EFDCF896141674D894C430A9BA0E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative Effect of New Accounting Principle in Period of Adoption</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_A6B2EFDCF896141674D894C430A9BA0E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_A6B2EFDCF896141674D894C430A9BA0E" xlink:to="lab_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_A6B2EFDCF896141674D894C430A9BA0E" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_C7B90EAA69CBB25082C994C430A94AC5_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_C7B90EAA69CBB25082C994C430A94AC5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_C7B90EAA69CBB25082C994C430A94AC5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_C7B90EAA69CBB25082C994C430A94AC5" xlink:to="lab_us-gaap_NetIncomeLoss_C7B90EAA69CBB25082C994C430A94AC5" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_A934F38FA31E071C8C7594C430A9EC0E_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_A934F38FA31E071C8C7594C430A9EC0E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_A934F38FA31E071C8C7594C430A9EC0E_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_A934F38FA31E071C8C7594C430A9EC0E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_A934F38FA31E071C8C7594C430A9EC0E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_A934F38FA31E071C8C7594C430A9EC0E" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_A934F38FA31E071C8C7594C430A9EC0E" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_EC2F35177F981DC1855794C430A91528_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_EC2F35177F981DC1855794C430A91528" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Exercise of stock options, Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_EC2F35177F981DC1855794C430A91528" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_EC2F35177F981DC1855794C430A91528" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_EC2F35177F981DC1855794C430A91528" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_A1CAEB1338E0819C4EF194C430A98984_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_A1CAEB1338E0819C4EF194C430A98984" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance/cancellation of common stock units</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_A1CAEB1338E0819C4EF194C430A98984_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_A1CAEB1338E0819C4EF194C430A98984" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_A1CAEB1338E0819C4EF194C430A98984" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_A1CAEB1338E0819C4EF194C430A98984" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_A1CAEB1338E0819C4EF194C430A98984" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_BD895E901625AC8486B994C430A9840F_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_BD895E901625AC8486B994C430A9840F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance/cancellation of common stock units, Shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_BD895E901625AC8486B994C430A9840F_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_BD895E901625AC8486B994C430A9840F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_BD895E901625AC8486B994C430A9840F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_BD895E901625AC8486B994C430A9840F" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_BD895E901625AC8486B994C430A9840F" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_A01CBA043B4A8F17D9A894C430AA622F_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_A01CBA043B4A8F17D9A894C430AA622F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Purchase of common stock under Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_A01CBA043B4A8F17D9A894C430AA622F_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_A01CBA043B4A8F17D9A894C430AA622F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_A01CBA043B4A8F17D9A894C430AA622F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_A01CBA043B4A8F17D9A894C430AA622F" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_A01CBA043B4A8F17D9A894C430AA622F" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_D07D6E2445FB5CA15F9C94C430AA6637_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_D07D6E2445FB5CA15F9C94C430AA6637" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Purchase of common stock under Employee Stock Purchase Plan, Shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_D07D6E2445FB5CA15F9C94C430AA6637_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_D07D6E2445FB5CA15F9C94C430AA6637" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_D07D6E2445FB5CA15F9C94C430AA6637" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_D07D6E2445FB5CA15F9C94C430AA6637" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_D07D6E2445FB5CA15F9C94C430AA6637" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_E81AB732E443841492C494C430AAA645_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_E81AB732E443841492C494C430AAA645" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_E81AB732E443841492C494C430AAA645_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_E81AB732E443841492C494C430AAA645" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_E81AB732E443841492C494C430AAA645" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_E81AB732E443841492C494C430AAA645" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_E81AB732E443841492C494C430AAA645" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockRetiredParValueMethodAmount_3D1597327963B9AC0FA694C430AAC419_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredParValueMethodAmount_3D1597327963B9AC0FA694C430AAC419" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock retirement</link:label>
    <link:label id="lab_us-gaap_TreasuryStockRetiredParValueMethodAmount_3D1597327963B9AC0FA694C430AAC419_label_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredParValueMethodAmount_3D1597327963B9AC0FA694C430AAC419" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Retired, Par Value Method, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockRetiredParValueMethodAmount" xlink:label="loc_us-gaap_TreasuryStockRetiredParValueMethodAmount_3D1597327963B9AC0FA694C430AAC419" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockRetiredParValueMethodAmount_3D1597327963B9AC0FA694C430AAC419" xlink:to="lab_us-gaap_TreasuryStockRetiredParValueMethodAmount_3D1597327963B9AC0FA694C430AAC419" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_D3B167D42C0E7600A8AD94C430AAA9B4_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired_D3B167D42C0E7600A8AD94C430AAA9B4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock retirement, Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_D3B167D42C0E7600A8AD94C430AAA9B4_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired_D3B167D42C0E7600A8AD94C430AAA9B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Retired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockSharesRetired" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_D3B167D42C0E7600A8AD94C430AAA9B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesRetired_D3B167D42C0E7600A8AD94C430AAA9B4" xlink:to="lab_us-gaap_TreasuryStockSharesRetired_D3B167D42C0E7600A8AD94C430AAA9B4" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_818620A29181A742C07994C430AB1AF0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_818620A29181A742C07994C430AB1AF0" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Common stock repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_818620A29181A742C07994C430AB1AF0_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_818620A29181A742C07994C430AB1AF0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_818620A29181A742C07994C430AB1AF0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_818620A29181A742C07994C430AB1AF0" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_818620A29181A742C07994C430AB1AF0" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_E9B1E7FBA9A8E262B08694C430AB63F4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_E9B1E7FBA9A8E262B08694C430AB63F4" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Common stock repurchased, Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_E9B1E7FBA9A8E262B08694C430AB63F4_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_E9B1E7FBA9A8E262B08694C430AB63F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_E9B1E7FBA9A8E262B08694C430AB63F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired_E9B1E7FBA9A8E262B08694C430AB63F4" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired_E9B1E7FBA9A8E262B08694C430AB63F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_C0595E72FA4367B6226994C430AB6488_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_C0595E72FA4367B6226994C430AB6488" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_C0595E72FA4367B6226994C430AB6488" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_C0595E72FA4367B6226994C430AB6488" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_C0595E72FA4367B6226994C430AB6488" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharesIssued_C1DCA2582C97F9CE01D894C430AB037E_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued_C1DCA2582C97F9CE01D894C430AB037E" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Balance, Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_C1DCA2582C97F9CE01D894C430AB037E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued_C1DCA2582C97F9CE01D894C430AB037E" xlink:to="lab_us-gaap_SharesIssued_C1DCA2582C97F9CE01D894C430AB037E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_144E7E0041A0100D75458C8B9D2F565A_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_144E7E0041A0100D75458C8B9D2F565A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_144E7E0041A0100D75458C8B9D2F565A_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_144E7E0041A0100D75458C8B9D2F565A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_144E7E0041A0100D75458C8B9D2F565A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_144E7E0041A0100D75458C8B9D2F565A" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_144E7E0041A0100D75458C8B9D2F565A" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryNetAbstract_DD7888BE9A058B2230C58F96E29FAC66_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract_DD7888BE9A058B2230C58F96E29FAC66" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_DD7888BE9A058B2230C58F96E29FAC66_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract_DD7888BE9A058B2230C58F96E29FAC66" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNetAbstract" xlink:label="loc_us-gaap_InventoryNetAbstract_DD7888BE9A058B2230C58F96E29FAC66" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract_DD7888BE9A058B2230C58F96E29FAC66" xlink:to="lab_us-gaap_InventoryNetAbstract_DD7888BE9A058B2230C58F96E29FAC66" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryRawMaterials_2F2F4D1CAA915EDA6A718F96E29F8A96_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials_2F2F4D1CAA915EDA6A718F96E29F8A96" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_2F2F4D1CAA915EDA6A718F96E29F8A96_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials_2F2F4D1CAA915EDA6A718F96E29F8A96" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaap_InventoryRawMaterials_2F2F4D1CAA915EDA6A718F96E29F8A96" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials_2F2F4D1CAA915EDA6A718F96E29F8A96" xlink:to="lab_us-gaap_InventoryRawMaterials_2F2F4D1CAA915EDA6A718F96E29F8A96" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryWorkInProcess_A14012B56F77B6F34BD28F96E29F513B_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess_A14012B56F77B6F34BD28F96E29F513B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_A14012B56F77B6F34BD28F96E29F513B_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess_A14012B56F77B6F34BD28F96E29F513B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaap_InventoryWorkInProcess_A14012B56F77B6F34BD28F96E29F513B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess_A14012B56F77B6F34BD28F96E29F513B" xlink:to="lab_us-gaap_InventoryWorkInProcess_A14012B56F77B6F34BD28F96E29F513B" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryFinishedGoods_5D73E7D467286DD942E48F96E29F4547_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods_5D73E7D467286DD942E48F96E29F4547" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_5D73E7D467286DD942E48F96E29F4547_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods_5D73E7D467286DD942E48F96E29F4547" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaap_InventoryFinishedGoods_5D73E7D467286DD942E48F96E29F4547" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods_5D73E7D467286DD942E48F96E29F4547" xlink:to="lab_us-gaap_InventoryFinishedGoods_5D73E7D467286DD942E48F96E29F4547" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryNet_C5594FBB2BC50F1F72558F96E2A0CF0A_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet_C5594FBB2BC50F1F72558F96E2A0CF0A" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_C5594FBB2BC50F1F72558F96E2A0CF0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_C5594FBB2BC50F1F72558F96E2A0CF0A" xlink:to="lab_us-gaap_InventoryNet_C5594FBB2BC50F1F72558F96E2A0CF0A" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryValuationReserves_3C754D10BF17E33374D28F96E2A0E539_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves_3C754D10BF17E33374D28F96E2A0E539" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory valuation reserve</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_3C754D10BF17E33374D28F96E2A0E539_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves_3C754D10BF17E33374D28F96E2A0E539" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaap_InventoryValuationReserves_3C754D10BF17E33374D28F96E2A0E539" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves_3C754D10BF17E33374D28F96E2A0E539" xlink:to="lab_us-gaap_InventoryValuationReserves_3C754D10BF17E33374D28F96E2A0E539" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryCurrentTable_E00279057826009D9D758FC0833460B2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable_E00279057826009D9D758FC0833460B2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:label id="lab_us-gaap_InventoryCurrentTable_E00279057826009D9D758FC0833460B2_label_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable_E00279057826009D9D758FC0833460B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryCurrentTable" xlink:label="loc_us-gaap_InventoryCurrentTable_E00279057826009D9D758FC0833460B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryCurrentTable_E00279057826009D9D758FC0833460B2" xlink:to="lab_us-gaap_InventoryCurrentTable_E00279057826009D9D758FC0833460B2" xlink:type="arc" />
    <link:label id="lab_ango_InventoryTypeAxis_DBED2854E4F3B3C5D2118FC38153BB71_terseLabel_en-US" xlink:label="lab_ango_InventoryTypeAxis_DBED2854E4F3B3C5D2118FC38153BB71" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory Type [Axis]</link:label>
    <link:label id="lab_ango_InventoryTypeAxis_DBED2854E4F3B3C5D2118FC38153BB71_label_en-US" xlink:label="lab_ango_InventoryTypeAxis_DBED2854E4F3B3C5D2118FC38153BB71" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Type [Axis]</link:label>
    <link:label id="lab_ango_InventoryTypeAxis_DBED2854E4F3B3C5D2118FC38153BB71_documentation_en-US" xlink:label="lab_ango_InventoryTypeAxis_DBED2854E4F3B3C5D2118FC38153BB71" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Inventory Type [Axis]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_InventoryTypeAxis" xlink:label="loc_ango_InventoryTypeAxis_DBED2854E4F3B3C5D2118FC38153BB71" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_InventoryTypeAxis_DBED2854E4F3B3C5D2118FC38153BB71" xlink:to="lab_ango_InventoryTypeAxis_DBED2854E4F3B3C5D2118FC38153BB71" xlink:type="arc" />
    <link:label id="lab_ango_InventoryTypeDomain_0E82336477FED56A69078FC38168A954_terseLabel_en-US" xlink:label="lab_ango_InventoryTypeDomain_0E82336477FED56A69078FC38168A954" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory Type [Domain]</link:label>
    <link:label id="lab_ango_InventoryTypeDomain_0E82336477FED56A69078FC38168A954_label_en-US" xlink:label="lab_ango_InventoryTypeDomain_0E82336477FED56A69078FC38168A954" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Type [Domain]</link:label>
    <link:label id="lab_ango_InventoryTypeDomain_0E82336477FED56A69078FC38168A954_documentation_en-US" xlink:label="lab_ango_InventoryTypeDomain_0E82336477FED56A69078FC38168A954" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Inventory Type [Axis]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_InventoryTypeDomain" xlink:label="loc_ango_InventoryTypeDomain_0E82336477FED56A69078FC38168A954" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_InventoryTypeDomain_0E82336477FED56A69078FC38168A954" xlink:to="lab_ango_InventoryTypeDomain_0E82336477FED56A69078FC38168A954" xlink:type="arc" />
    <link:label id="lab_ango_AcculisInventoryMember_54217A263833431B684E8FC41AA3041E_terseLabel_en-US" xlink:label="lab_ango_AcculisInventoryMember_54217A263833431B684E8FC41AA3041E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acculis inventory</link:label>
    <link:label id="lab_ango_AcculisInventoryMember_54217A263833431B684E8FC41AA3041E_label_en-US" xlink:label="lab_ango_AcculisInventoryMember_54217A263833431B684E8FC41AA3041E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acculis Inventory [Member]</link:label>
    <link:label id="lab_ango_AcculisInventoryMember_54217A263833431B684E8FC41AA3041E_documentation_en-US" xlink:label="lab_ango_AcculisInventoryMember_54217A263833431B684E8FC41AA3041E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Acculis Inventory [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_AcculisInventoryMember" xlink:label="loc_ango_AcculisInventoryMember_54217A263833431B684E8FC41AA3041E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_AcculisInventoryMember_54217A263833431B684E8FC41AA3041E" xlink:to="lab_ango_AcculisInventoryMember_54217A263833431B684E8FC41AA3041E" xlink:type="arc" />
    <link:label id="lab_srt_CounterpartyNameAxis_5B0BB487E5B0330B24228FC62A2391EE_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis_5B0BB487E5B0330B24228FC62A2391EE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_5B0BB487E5B0330B24228FC62A2391EE_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis_5B0BB487E5B0330B24228FC62A2391EE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_5B0BB487E5B0330B24228FC62A2391EE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis_5B0BB487E5B0330B24228FC62A2391EE" xlink:to="lab_srt_CounterpartyNameAxis_5B0BB487E5B0330B24228FC62A2391EE" xlink:type="arc" />
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_E02C9E6B7DDB22508DEF8FC69AC26849_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain_E02C9E6B7DDB22508DEF8FC69AC26849" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_E02C9E6B7DDB22508DEF8FC69AC26849_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain_E02C9E6B7DDB22508DEF8FC69AC26849" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_E02C9E6B7DDB22508DEF8FC69AC26849" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_E02C9E6B7DDB22508DEF8FC69AC26849" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain_E02C9E6B7DDB22508DEF8FC69AC26849" xlink:type="arc" />
    <link:label id="lab_ango_UndisclosedInventoryDistributorMember_A81C7B616361BCE46D998FC7A34BF1D7_terseLabel_en-US" xlink:label="lab_ango_UndisclosedInventoryDistributorMember_A81C7B616361BCE46D998FC7A34BF1D7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Japanese inventory distributor</link:label>
    <link:label id="lab_ango_UndisclosedInventoryDistributorMember_A81C7B616361BCE46D998FC7A34BF1D7_label_en-US" xlink:label="lab_ango_UndisclosedInventoryDistributorMember_A81C7B616361BCE46D998FC7A34BF1D7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Undisclosed Inventory Distributor [Member]</link:label>
    <link:label id="lab_ango_UndisclosedInventoryDistributorMember_A81C7B616361BCE46D998FC7A34BF1D7_documentation_en-US" xlink:label="lab_ango_UndisclosedInventoryDistributorMember_A81C7B616361BCE46D998FC7A34BF1D7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Undisclosed Inventory Distributor [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_UndisclosedInventoryDistributorMember" xlink:label="loc_ango_UndisclosedInventoryDistributorMember_A81C7B616361BCE46D998FC7A34BF1D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_UndisclosedInventoryDistributorMember_A81C7B616361BCE46D998FC7A34BF1D7" xlink:to="lab_ango_UndisclosedInventoryDistributorMember_A81C7B616361BCE46D998FC7A34BF1D7" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E69B4D863700D67B75318FD9E6CB7F4E_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E69B4D863700D67B75318FD9E6CB7F4E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E69B4D863700D67B75318FD9E6CB7F4E_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E69B4D863700D67B75318FD9E6CB7F4E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E69B4D863700D67B75318FD9E6CB7F4E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E69B4D863700D67B75318FD9E6CB7F4E" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E69B4D863700D67B75318FD9E6CB7F4E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923" xlink:type="arc" />
    <link:label id="lab_ango_ProductTechnologiesMember_F9600E3630085DB2878F8FD9E6CC5B09_verboseLabel_en-US" xlink:label="lab_ango_ProductTechnologiesMember_F9600E3630085DB2878F8FD9E6CC5B09" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Product technologies</link:label>
    <link:label id="lab_ango_ProductTechnologiesMember_F9600E3630085DB2878F8FD9E6CC5B09_label_en-US" xlink:label="lab_ango_ProductTechnologiesMember_F9600E3630085DB2878F8FD9E6CC5B09" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Technologies [Member]</link:label>
    <link:label id="lab_ango_ProductTechnologiesMember_F9600E3630085DB2878F8FD9E6CC5B09_documentation_en-US" xlink:label="lab_ango_ProductTechnologiesMember_F9600E3630085DB2878F8FD9E6CC5B09" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Product technologies.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_ProductTechnologiesMember" xlink:label="loc_ango_ProductTechnologiesMember_F9600E3630085DB2878F8FD9E6CC5B09" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ProductTechnologiesMember_F9600E3630085DB2878F8FD9E6CC5B09" xlink:to="lab_ango_ProductTechnologiesMember_F9600E3630085DB2878F8FD9E6CC5B09" xlink:type="arc" />
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_04F02CDAF3EC5395A5458FD9E6CD24B4_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_04F02CDAF3EC5395A5458FD9E6CD24B4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_04F02CDAF3EC5395A5458FD9E6CD24B4_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_04F02CDAF3EC5395A5458FD9E6CD24B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_04F02CDAF3EC5395A5458FD9E6CD24B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember_04F02CDAF3EC5395A5458FD9E6CD24B4" xlink:to="lab_us-gaap_CustomerRelationshipsMember_04F02CDAF3EC5395A5458FD9E6CD24B4" xlink:type="arc" />
    <link:label id="lab_us-gaap_TrademarksMember_CDF5C08493C51726436F8FD9E6CD729A_verboseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember_CDF5C08493C51726436F8FD9E6CD729A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_CDF5C08493C51726436F8FD9E6CD729A_label_en-US" xlink:label="lab_us-gaap_TrademarksMember_CDF5C08493C51726436F8FD9E6CD729A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaap_TrademarksMember_CDF5C08493C51726436F8FD9E6CD729A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember_CDF5C08493C51726436F8FD9E6CD729A" xlink:to="lab_us-gaap_TrademarksMember_CDF5C08493C51726436F8FD9E6CD729A" xlink:type="arc" />
    <link:label id="lab_us-gaap_LicenseAgreementTermsMember_3458B1762E417930C84D8FD9E6CD5002_verboseLabel_en-US" xlink:label="lab_us-gaap_LicenseAgreementTermsMember_3458B1762E417930C84D8FD9E6CD5002" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Licenses</link:label>
    <link:label id="lab_us-gaap_LicenseAgreementTermsMember_3458B1762E417930C84D8FD9E6CD5002_label_en-US" xlink:label="lab_us-gaap_LicenseAgreementTermsMember_3458B1762E417930C84D8FD9E6CD5002" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement Terms [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LicenseAgreementTermsMember" xlink:label="loc_us-gaap_LicenseAgreementTermsMember_3458B1762E417930C84D8FD9E6CD5002" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseAgreementTermsMember_3458B1762E417930C84D8FD9E6CD5002" xlink:to="lab_us-gaap_LicenseAgreementTermsMember_3458B1762E417930C84D8FD9E6CD5002" xlink:type="arc" />
    <link:label id="lab_ango_DistributorRelationshipsMember_19640D110147879EB1B38FD9E6CDD764_verboseLabel_en-US" xlink:label="lab_ango_DistributorRelationshipsMember_19640D110147879EB1B38FD9E6CDD764" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Distributor relationships</link:label>
    <link:label id="lab_ango_DistributorRelationshipsMember_19640D110147879EB1B38FD9E6CDD764_label_en-US" xlink:label="lab_ango_DistributorRelationshipsMember_19640D110147879EB1B38FD9E6CDD764" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Distributor Relationships [Member]</link:label>
    <link:label id="lab_ango_DistributorRelationshipsMember_19640D110147879EB1B38FD9E6CDD764_documentation_en-US" xlink:label="lab_ango_DistributorRelationshipsMember_19640D110147879EB1B38FD9E6CDD764" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Distributor relationships.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_DistributorRelationshipsMember" xlink:label="loc_ango_DistributorRelationshipsMember_19640D110147879EB1B38FD9E6CDD764" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_DistributorRelationshipsMember_19640D110147879EB1B38FD9E6CDD764" xlink:to="lab_ango_DistributorRelationshipsMember_19640D110147879EB1B38FD9E6CDD764" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryLineItems_7B06AE4BAD800E3D9CA88FC083347E55_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLineItems_7B06AE4BAD800E3D9CA88FC083347E55" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:label id="lab_us-gaap_InventoryLineItems_7B06AE4BAD800E3D9CA88FC083347E55_label_en-US" xlink:label="lab_us-gaap_InventoryLineItems_7B06AE4BAD800E3D9CA88FC083347E55" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryLineItems" xlink:label="loc_us-gaap_InventoryLineItems_7B06AE4BAD800E3D9CA88FC083347E55" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLineItems_7B06AE4BAD800E3D9CA88FC083347E55" xlink:to="lab_us-gaap_InventoryLineItems_7B06AE4BAD800E3D9CA88FC083347E55" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryWriteDown_2CA7AC091FFB81049CB28F96E2A0F612_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown_2CA7AC091FFB81049CB28F96E2A0F612" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory write-off</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_2CA7AC091FFB81049CB28F96E2A0F612_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown_2CA7AC091FFB81049CB28F96E2A0F612" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaap_InventoryWriteDown_2CA7AC091FFB81049CB28F96E2A0F612" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown_2CA7AC091FFB81049CB28F96E2A0F612" xlink:to="lab_us-gaap_InventoryWriteDown_2CA7AC091FFB81049CB28F96E2A0F612" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_E03350FC0551764398CA8E95127ADB77_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_E03350FC0551764398CA8E95127ADB77" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amortized cost and fair value of marketable securities by contractual maturity</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_E03350FC0551764398CA8E95127ADB77_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_E03350FC0551764398CA8E95127ADB77" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-sale Securities, Debt Maturities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_E03350FC0551764398CA8E95127ADB77" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_E03350FC0551764398CA8E95127ADB77" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_E03350FC0551764398CA8E95127ADB77" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_25100B7E40F6E2B3ABB08E95127A0876_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_25100B7E40F6E2B3ABB08E95127A0876" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortized cost, Due in one year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_25100B7E40F6E2B3ABB08E95127A0876_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_25100B7E40F6E2B3ABB08E95127A0876" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_25100B7E40F6E2B3ABB08E95127A0876" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_25100B7E40F6E2B3ABB08E95127A0876" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_25100B7E40F6E2B3ABB08E95127A0876" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_AE2AB907559C96EC497D8E95127A077C_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_AE2AB907559C96EC497D8E95127A077C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortized cost, Due after one through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_AE2AB907559C96EC497D8E95127A077C_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_AE2AB907559C96EC497D8E95127A077C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_AE2AB907559C96EC497D8E95127A077C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_AE2AB907559C96EC497D8E95127A077C" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_AE2AB907559C96EC497D8E95127A077C" xlink:type="arc" />
    <link:label id="lab_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost_FC8AD7DBD7AB7F3190038E95127A13DB_verboseLabel_en-US" xlink:label="lab_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost_FC8AD7DBD7AB7F3190038E95127A13DB" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amortized cost, Due after five through twenty years</link:label>
    <link:label id="lab_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost_FC8AD7DBD7AB7F3190038E95127A13DB_label_en-US" xlink:label="lab_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost_FC8AD7DBD7AB7F3190038E95127A13DB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available for Sale Securities Debt Maturities After Five Through Twenty Years Amortized Cost</link:label>
    <link:label id="lab_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost_FC8AD7DBD7AB7F3190038E95127A13DB_documentation_en-US" xlink:label="lab_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost_FC8AD7DBD7AB7F3190038E95127A13DB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Available for sale securities debt maturities after five through twenty years amortized cost.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost" xlink:label="loc_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost_FC8AD7DBD7AB7F3190038E95127A13DB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost_FC8AD7DBD7AB7F3190038E95127A13DB" xlink:to="lab_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost_FC8AD7DBD7AB7F3190038E95127A13DB" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_38E73C2B7766202EB4C18E95127AC07C_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_38E73C2B7766202EB4C18E95127AC07C" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_38E73C2B7766202EB4C18E95127AC07C_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_38E73C2B7766202EB4C18E95127AC07C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_38E73C2B7766202EB4C18E95127AC07C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_38E73C2B7766202EB4C18E95127AC07C" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_38E73C2B7766202EB4C18E95127AC07C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_162983AEEF1300BEEF0C8E95127A74DE_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_162983AEEF1300BEEF0C8E95127A74DE" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Due in one year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_162983AEEF1300BEEF0C8E95127A74DE_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_162983AEEF1300BEEF0C8E95127A74DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_162983AEEF1300BEEF0C8E95127A74DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_162983AEEF1300BEEF0C8E95127A74DE" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_162983AEEF1300BEEF0C8E95127A74DE" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0CD0E8DE9DA229507CA18E95127A7329_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0CD0E8DE9DA229507CA18E95127A7329" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Due after one through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0CD0E8DE9DA229507CA18E95127A7329_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0CD0E8DE9DA229507CA18E95127A7329" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0CD0E8DE9DA229507CA18E95127A7329" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0CD0E8DE9DA229507CA18E95127A7329" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0CD0E8DE9DA229507CA18E95127A7329" xlink:type="arc" />
    <link:label id="lab_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue_ED3FBE11693995AD1DDD8E95127AC888_terseLabel_en-US" xlink:label="lab_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue_ED3FBE11693995AD1DDD8E95127AC888" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Due after five through twenty years</link:label>
    <link:label id="lab_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue_ED3FBE11693995AD1DDD8E95127AC888_label_en-US" xlink:label="lab_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue_ED3FBE11693995AD1DDD8E95127AC888" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available for Sale Securities Debt Maturities After Five Through Twenty Years Fair Value</link:label>
    <link:label id="lab_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue_ED3FBE11693995AD1DDD8E95127AC888_documentation_en-US" xlink:label="lab_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue_ED3FBE11693995AD1DDD8E95127AC888" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Available for sale securities debt maturities after five through twenty years fair value.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue" xlink:label="loc_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue_ED3FBE11693995AD1DDD8E95127AC888" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue_ED3FBE11693995AD1DDD8E95127AC888" xlink:to="lab_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue_ED3FBE11693995AD1DDD8E95127AC888" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5C0A2CF04FF85C9F19218E95127AFAEA_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5C0A2CF04FF85C9F19218E95127AFAEA" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Total</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5C0A2CF04FF85C9F19218E95127AFAEA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5C0A2CF04FF85C9F19218E95127AFAEA" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5C0A2CF04FF85C9F19218E95127AFAEA" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_647D6B1F75B1427F8E338F96E2E1136E_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_647D6B1F75B1427F8E338F96E2E1136E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_647D6B1F75B1427F8E338F96E2E1136E_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_647D6B1F75B1427F8E338F96E2E1136E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_647D6B1F75B1427F8E338F96E2E1136E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_647D6B1F75B1427F8E338F96E2E1136E" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_647D6B1F75B1427F8E338F96E2E1136E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_D5EFE218247D4B6173B58F96E2E2F1AE_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_D5EFE218247D4B6173B58F96E2E2F1AE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_D5EFE218247D4B6173B58F96E2E2F1AE_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_D5EFE218247D4B6173B58F96E2E2F1AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_D5EFE218247D4B6173B58F96E2E2F1AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_D5EFE218247D4B6173B58F96E2E2F1AE" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_D5EFE218247D4B6173B58F96E2E2F1AE" xlink:type="arc" />
    <link:label id="lab_ango_DiscontinuedInvestmentinTiLoProductMember_A9428397F7132C5310CD8F96E2E24FD2_terseLabel_en-US" xlink:label="lab_ango_DiscontinuedInvestmentinTiLoProductMember_A9428397F7132C5310CD8F96E2E24FD2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued Investment in TiLo Product</link:label>
    <link:label id="lab_ango_DiscontinuedInvestmentinTiLoProductMember_A9428397F7132C5310CD8F96E2E24FD2_label_en-US" xlink:label="lab_ango_DiscontinuedInvestmentinTiLoProductMember_A9428397F7132C5310CD8F96E2E24FD2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Investment in TiLo Product [Member]</link:label>
    <link:label id="lab_ango_DiscontinuedInvestmentinTiLoProductMember_A9428397F7132C5310CD8F96E2E24FD2_documentation_en-US" xlink:label="lab_ango_DiscontinuedInvestmentinTiLoProductMember_A9428397F7132C5310CD8F96E2E24FD2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Discontinued Investment in TiLo Product [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_DiscontinuedInvestmentinTiLoProductMember" xlink:label="loc_ango_DiscontinuedInvestmentinTiLoProductMember_A9428397F7132C5310CD8F96E2E24FD2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_DiscontinuedInvestmentinTiLoProductMember_A9428397F7132C5310CD8F96E2E24FD2" xlink:to="lab_ango_DiscontinuedInvestmentinTiLoProductMember_A9428397F7132C5310CD8F96E2E24FD2" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_A8FCF2A1A45691CEB56F8F96E2E2E5D5_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis_A8FCF2A1A45691CEB56F8F96E2E2E5D5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_A8FCF2A1A45691CEB56F8F96E2E2E5D5_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis_A8FCF2A1A45691CEB56F8F96E2E2E5D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupClassificationAxis" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_A8FCF2A1A45691CEB56F8F96E2E2E5D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_A8FCF2A1A45691CEB56F8F96E2E2E5D5" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis_A8FCF2A1A45691CEB56F8F96E2E2E5D5" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_FA69CA0FFD83DD117A298F96E2E31293_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain_FA69CA0FFD83DD117A298F96E2E31293" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_FA69CA0FFD83DD117A298F96E2E31293_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain_FA69CA0FFD83DD117A298F96E2E31293" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupClassificationDomain" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_FA69CA0FFD83DD117A298F96E2E31293" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_FA69CA0FFD83DD117A298F96E2E31293" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain_FA69CA0FFD83DD117A298F96E2E31293" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_B8BA6F7685D22C096A968F96E2E39D4A_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_B8BA6F7685D22C096A968F96E2E39D4A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations, Abandonment</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_B8BA6F7685D22C096A968F96E2E39D4A_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_B8BA6F7685D22C096A968F96E2E39D4A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations, Abandonment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember" xlink:label="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_B8BA6F7685D22C096A968F96E2E39D4A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_B8BA6F7685D22C096A968F96E2E39D4A" xlink:to="lab_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_B8BA6F7685D22C096A968F96E2E39D4A" xlink:type="arc" />
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_70AFF8FCF3E1D6D49B848F96E2E4F032_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember_70AFF8FCF3E1D6D49B848F96E2E4F032" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">In Process Research and Development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_70AFF8FCF3E1D6D49B848F96E2E4F032_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember_70AFF8FCF3E1D6D49B848F96E2E4F032" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_70AFF8FCF3E1D6D49B848F96E2E4F032" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember_70AFF8FCF3E1D6D49B848F96E2E4F032" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember_70AFF8FCF3E1D6D49B848F96E2E4F032" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_00AD8F105F1E173F5FC98F96E2E02E0C_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_00AD8F105F1E173F5FC98F96E2E02E0C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_00AD8F105F1E173F5FC98F96E2E02E0C_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_00AD8F105F1E173F5FC98F96E2E02E0C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_00AD8F105F1E173F5FC98F96E2E02E0C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_00AD8F105F1E173F5FC98F96E2E02E0C" xlink:to="lab_us-gaap_BusinessAcquisitionAxis_00AD8F105F1E173F5FC98F96E2E02E0C" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_3770291B037E673AB1128F96E2E1DCC1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_3770291B037E673AB1128F96E2E1DCC1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_3770291B037E673AB1128F96E2E1DCC1_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_3770291B037E673AB1128F96E2E1DCC1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3770291B037E673AB1128F96E2E1DCC1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3770291B037E673AB1128F96E2E1DCC1" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain_3770291B037E673AB1128F96E2E1DCC1" xlink:type="arc" />
    <link:label id="lab_ango_AngioVacProductMember_B3AE2D0444919E9997508F96E2E12980_terseLabel_en-US" xlink:label="lab_ango_AngioVacProductMember_B3AE2D0444919E9997508F96E2E12980" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AngioVac Product</link:label>
    <link:label id="lab_ango_AngioVacProductMember_B3AE2D0444919E9997508F96E2E12980_label_en-US" xlink:label="lab_ango_AngioVacProductMember_B3AE2D0444919E9997508F96E2E12980" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AngioVac Product [Member]</link:label>
    <link:label id="lab_ango_AngioVacProductMember_B3AE2D0444919E9997508F96E2E12980_documentation_en-US" xlink:label="lab_ango_AngioVacProductMember_B3AE2D0444919E9997508F96E2E12980" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AngioVac Product [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_AngioVacProductMember" xlink:label="loc_ango_AngioVacProductMember_B3AE2D0444919E9997508F96E2E12980" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_AngioVacProductMember_B3AE2D0444919E9997508F96E2E12980" xlink:to="lab_ango_AngioVacProductMember_B3AE2D0444919E9997508F96E2E12980" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_AF8A41A82EF80DA0A4498F96E2E45FA3_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis_AF8A41A82EF80DA0A4498F96E2E45FA3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_AF8A41A82EF80DA0A4498F96E2E45FA3_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis_AF8A41A82EF80DA0A4498F96E2E45FA3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaap_ValuationTechniqueAxis_AF8A41A82EF80DA0A4498F96E2E45FA3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis_AF8A41A82EF80DA0A4498F96E2E45FA3" xlink:to="lab_us-gaap_ValuationTechniqueAxis_AF8A41A82EF80DA0A4498F96E2E45FA3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_11B101C358F68C4447BB8F96E2E49B81_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain_11B101C358F68C4447BB8F96E2E49B81" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_11B101C358F68C4447BB8F96E2E49B81_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain_11B101C358F68C4447BB8F96E2E49B81" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_11B101C358F68C4447BB8F96E2E49B81" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain_11B101C358F68C4447BB8F96E2E49B81" xlink:to="lab_us-gaap_ValuationTechniqueDomain_11B101C358F68C4447BB8F96E2E49B81" xlink:type="arc" />
    <link:label id="lab_ango_RevenueBasedPaymentMember_520CFAC5C5F022C238EC8F96E2E5C7D9_terseLabel_en-US" xlink:label="lab_ango_RevenueBasedPaymentMember_520CFAC5C5F022C238EC8F96E2E5C7D9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue based payments</link:label>
    <link:label id="lab_ango_RevenueBasedPaymentMember_520CFAC5C5F022C238EC8F96E2E5C7D9_label_en-US" xlink:label="lab_ango_RevenueBasedPaymentMember_520CFAC5C5F022C238EC8F96E2E5C7D9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Based Payment [Member]</link:label>
    <link:label id="lab_ango_RevenueBasedPaymentMember_520CFAC5C5F022C238EC8F96E2E5C7D9_documentation_en-US" xlink:label="lab_ango_RevenueBasedPaymentMember_520CFAC5C5F022C238EC8F96E2E5C7D9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue Based Payment [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_RevenueBasedPaymentMember" xlink:label="loc_ango_RevenueBasedPaymentMember_520CFAC5C5F022C238EC8F96E2E5C7D9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_RevenueBasedPaymentMember_520CFAC5C5F022C238EC8F96E2E5C7D9" xlink:to="lab_ango_RevenueBasedPaymentMember_520CFAC5C5F022C238EC8F96E2E5C7D9" xlink:type="arc" />
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_F2D6F2CC9594AE6CA7308F96E2EE6880_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis_F2D6F2CC9594AE6CA7308F96E2EE6880" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_F2D6F2CC9594AE6CA7308F96E2EE6880_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis_F2D6F2CC9594AE6CA7308F96E2EE6880" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_F2D6F2CC9594AE6CA7308F96E2EE6880" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_F2D6F2CC9594AE6CA7308F96E2EE6880" xlink:to="lab_us-gaap_MeasurementInputTypeAxis_F2D6F2CC9594AE6CA7308F96E2EE6880" xlink:type="arc" />
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_D6B1DBEBFF1879B93A148F96E2EE7682_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain_D6B1DBEBFF1879B93A148F96E2EE7682" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_D6B1DBEBFF1879B93A148F96E2EE7682_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain_D6B1DBEBFF1879B93A148F96E2EE7682" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_D6B1DBEBFF1879B93A148F96E2EE7682" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_D6B1DBEBFF1879B93A148F96E2EE7682" xlink:to="lab_us-gaap_MeasurementInputTypeDomain_D6B1DBEBFF1879B93A148F96E2EE7682" xlink:type="arc" />
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_75714E7FF8F01F0FEE6F8F96E2EF2D34_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember_75714E7FF8F01F0FEE6F8F96E2EF2D34" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_75714E7FF8F01F0FEE6F8F96E2EF2D34_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember_75714E7FF8F01F0FEE6F8F96E2EF2D34" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_75714E7FF8F01F0FEE6F8F96E2EF2D34" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember_75714E7FF8F01F0FEE6F8F96E2EF2D34" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember_75714E7FF8F01F0FEE6F8F96E2EF2D34" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_F16FA6EC16DAA5E8596E8F96E2E89FB2_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis_F16FA6EC16DAA5E8596E8F96E2E89FB2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_F16FA6EC16DAA5E8596E8F96E2E89FB2_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis_F16FA6EC16DAA5E8596E8F96E2E89FB2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_F16FA6EC16DAA5E8596E8F96E2E89FB2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis_F16FA6EC16DAA5E8596E8F96E2E89FB2" xlink:to="lab_us-gaap_FinancialInstrumentAxis_F16FA6EC16DAA5E8596E8F96E2E89FB2" xlink:type="arc" />
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_EFEA3A432E2A22D5C7FD8F96E2E87F81_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_EFEA3A432E2A22D5C7FD8F96E2E87F81" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_EFEA3A432E2A22D5C7FD8F96E2E87F81_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_EFEA3A432E2A22D5C7FD8F96E2E87F81" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_EFEA3A432E2A22D5C7FD8F96E2E87F81" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_EFEA3A432E2A22D5C7FD8F96E2E87F81" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_EFEA3A432E2A22D5C7FD8F96E2E87F81" xlink:type="arc" />
    <link:label id="lab_ango_ContingentConsiderationEarnOutLiabilityMember_2E7752E2A489FA5509768F96E2E84C50_terseLabel_en-US" xlink:label="lab_ango_ContingentConsiderationEarnOutLiabilityMember_2E7752E2A489FA5509768F96E2E84C50" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent Consideration Earn Out Liability</link:label>
    <link:label id="lab_ango_ContingentConsiderationEarnOutLiabilityMember_2E7752E2A489FA5509768F96E2E84C50_label_en-US" xlink:label="lab_ango_ContingentConsiderationEarnOutLiabilityMember_2E7752E2A489FA5509768F96E2E84C50" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Consideration Earn Out Liability [Member]</link:label>
    <link:label id="lab_ango_ContingentConsiderationEarnOutLiabilityMember_2E7752E2A489FA5509768F96E2E84C50_documentation_en-US" xlink:label="lab_ango_ContingentConsiderationEarnOutLiabilityMember_2E7752E2A489FA5509768F96E2E84C50" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent consideration earn out liability.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_ContingentConsiderationEarnOutLiabilityMember" xlink:label="loc_ango_ContingentConsiderationEarnOutLiabilityMember_2E7752E2A489FA5509768F96E2E84C50" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ContingentConsiderationEarnOutLiabilityMember_2E7752E2A489FA5509768F96E2E84C50" xlink:to="lab_ango_ContingentConsiderationEarnOutLiabilityMember_2E7752E2A489FA5509768F96E2E84C50" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_BFD7B17CE2F9DD4691CC8F96E2EF586E_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_BFD7B17CE2F9DD4691CC8F96E2EF586E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Write-down</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_BFD7B17CE2F9DD4691CC8F96E2EF586E_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_BFD7B17CE2F9DD4691CC8F96E2EF586E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_BFD7B17CE2F9DD4691CC8F96E2EF586E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_BFD7B17CE2F9DD4691CC8F96E2EF586E" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_BFD7B17CE2F9DD4691CC8F96E2EF586E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_7D87655589BC6575023E8F96E2F07BD0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_7D87655589BC6575023E8F96E2F07BD0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain from reduction</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_7D87655589BC6575023E8F96E2F07BD0_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_7D87655589BC6575023E8F96E2F07BD0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Change in Unrealized Gain (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_7D87655589BC6575023E8F96E2F07BD0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_7D87655589BC6575023E8F96E2F07BD0" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_7D87655589BC6575023E8F96E2F07BD0" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_AAF0BC5E9B2F90CEE1BF8F96E2F018B0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_AAF0BC5E9B2F90CEE1BF8F96E2F018B0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase of non-transferable warrants</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_AAF0BC5E9B2F90CEE1BF8F96E2F018B0_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_AAF0BC5E9B2F90CEE1BF8F96E2F018B0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_AAF0BC5E9B2F90CEE1BF8F96E2F018B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_AAF0BC5E9B2F90CEE1BF8F96E2F018B0" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_AAF0BC5E9B2F90CEE1BF8F96E2F018B0" xlink:type="arc" />
    <link:label id="lab_ango_UndiscountedContingentConsiderationFairValueFairValueDisclosure_19BB6020D566E3E6678B8F96E2F080D5_verboseLabel_en-US" xlink:label="lab_ango_UndiscountedContingentConsiderationFairValueFairValueDisclosure_19BB6020D566E3E6678B8F96E2F080D5" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Potential amount of undiscounted future contingent consideration</link:label>
    <link:label id="lab_ango_UndiscountedContingentConsiderationFairValueFairValueDisclosure_19BB6020D566E3E6678B8F96E2F080D5_label_en-US" xlink:label="lab_ango_UndiscountedContingentConsiderationFairValueFairValueDisclosure_19BB6020D566E3E6678B8F96E2F080D5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Undiscounted Contingent Consideration Fair Value Fair Value Disclosure</link:label>
    <link:label id="lab_ango_UndiscountedContingentConsiderationFairValueFairValueDisclosure_19BB6020D566E3E6678B8F96E2F080D5_documentation_en-US" xlink:label="lab_ango_UndiscountedContingentConsiderationFairValueFairValueDisclosure_19BB6020D566E3E6678B8F96E2F080D5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Undiscounted contingent consideration fair value fair value disclosure.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_UndiscountedContingentConsiderationFairValueFairValueDisclosure" xlink:label="loc_ango_UndiscountedContingentConsiderationFairValueFairValueDisclosure_19BB6020D566E3E6678B8F96E2F080D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_UndiscountedContingentConsiderationFairValueFairValueDisclosure_19BB6020D566E3E6678B8F96E2F080D5" xlink:to="lab_ango_UndiscountedContingentConsiderationFairValueFairValueDisclosure_19BB6020D566E3E6678B8F96E2F080D5" xlink:type="arc" />
    <link:label id="lab_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract_95A629AA3585BA4D6B308F96E2F04768_verboseLabel_en-US" xlink:label="lab_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract_95A629AA3585BA4D6B308F96E2F04768" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary showing the recurring fair value measurements of the contingent consideration liability</link:label>
    <link:label id="lab_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract_95A629AA3585BA4D6B308F96E2F04768_label_en-US" xlink:label="lab_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract_95A629AA3585BA4D6B308F96E2F04768" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Liabilities Measured on Recurring Basis [Abstract]</link:label>
    <link:label id="lab_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract_95A629AA3585BA4D6B308F96E2F04768_documentation_en-US" xlink:label="lab_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract_95A629AA3585BA4D6B308F96E2F04768" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Liabilities Measured On Recurring Basis [Abstract]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract" xlink:label="loc_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract_95A629AA3585BA4D6B308F96E2F04768" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract_95A629AA3585BA4D6B308F96E2F04768" xlink:to="lab_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract_95A629AA3585BA4D6B308F96E2F04768" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_E03CFB62B2AB357F09FD8F96E2EFD510_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_E03CFB62B2AB357F09FD8F96E2EFD510" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenue based payments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_E03CFB62B2AB357F09FD8F96E2EFD510" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_E03CFB62B2AB357F09FD8F96E2EFD510" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_E03CFB62B2AB357F09FD8F96E2EFD510" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_700A3E66D930109D36138F96E2F03258_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_700A3E66D930109D36138F96E2F03258" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount rate used in fair value calculation</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_700A3E66D930109D36138F96E2F03258_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_700A3E66D930109D36138F96E2F03258" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_700A3E66D930109D36138F96E2F03258" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_700A3E66D930109D36138F96E2F03258" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_700A3E66D930109D36138F96E2F03258" xlink:type="arc" />
    <link:label id="lab_ango_FairValueInputsProbabilityOfPayment_94A8284046EC8CED96B58F96E2F1A761_verboseLabel_en-US" xlink:label="lab_ango_FairValueInputsProbabilityOfPayment_94A8284046EC8CED96B58F96E2F1A761" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Probability of payment</link:label>
    <link:label id="lab_ango_FairValueInputsProbabilityOfPayment_94A8284046EC8CED96B58F96E2F1A761_label_en-US" xlink:label="lab_ango_FairValueInputsProbabilityOfPayment_94A8284046EC8CED96B58F96E2F1A761" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Inputs Probability of Payment</link:label>
    <link:label id="lab_ango_FairValueInputsProbabilityOfPayment_94A8284046EC8CED96B58F96E2F1A761_documentation_en-US" xlink:label="lab_ango_FairValueInputsProbabilityOfPayment_94A8284046EC8CED96B58F96E2F1A761" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair value inputs probability of payment.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_FairValueInputsProbabilityOfPayment" xlink:label="loc_ango_FairValueInputsProbabilityOfPayment_94A8284046EC8CED96B58F96E2F1A761" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_FairValueInputsProbabilityOfPayment_94A8284046EC8CED96B58F96E2F1A761" xlink:to="lab_ango_FairValueInputsProbabilityOfPayment_94A8284046EC8CED96B58F96E2F1A761" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_8FBEFAC3EE1F4DFE3CB6A3DC1B0F17D8_verboseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_8FBEFAC3EE1F4DFE3CB6A3DC1B0F17D8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of Income tax (benefit) provision analyzed by category</link:label>
    <link:label id="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_8FBEFAC3EE1F4DFE3CB6A3DC1B0F17D8_label_en-US" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_8FBEFAC3EE1F4DFE3CB6A3DC1B0F17D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_8FBEFAC3EE1F4DFE3CB6A3DC1B0F17D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_8FBEFAC3EE1F4DFE3CB6A3DC1B0F17D8" xlink:to="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_8FBEFAC3EE1F4DFE3CB6A3DC1B0F17D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_DFFC512D20DE1C7A65C4A3DC1B0F1AFA_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_DFFC512D20DE1C7A65C4A3DC1B0F1AFA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_DFFC512D20DE1C7A65C4A3DC1B0F1AFA_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_DFFC512D20DE1C7A65C4A3DC1B0F1AFA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_DFFC512D20DE1C7A65C4A3DC1B0F1AFA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_DFFC512D20DE1C7A65C4A3DC1B0F1AFA" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_DFFC512D20DE1C7A65C4A3DC1B0F1AFA" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_3E0A1950D08D33B22918A3DC1B0F903E_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit_3E0A1950D08D33B22918A3DC1B0F903E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_3E0A1950D08D33B22918A3DC1B0F903E_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit_3E0A1950D08D33B22918A3DC1B0F903E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_3E0A1950D08D33B22918A3DC1B0F903E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit_3E0A1950D08D33B22918A3DC1B0F903E" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit_3E0A1950D08D33B22918A3DC1B0F903E" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_C44480FE539E5BB143D4A3DC1B0FF67F_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_C44480FE539E5BB143D4A3DC1B0FF67F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_C44480FE539E5BB143D4A3DC1B0FF67F_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_C44480FE539E5BB143D4A3DC1B0FF67F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_C44480FE539E5BB143D4A3DC1B0FF67F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_C44480FE539E5BB143D4A3DC1B0FF67F" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_C44480FE539E5BB143D4A3DC1B0FF67F" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_B9D0BDF0DC3C32DC3E95A3DC1B0F20C8_verboseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit_B9D0BDF0DC3C32DC3E95A3DC1B0F20C8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non U.S.</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_B9D0BDF0DC3C32DC3E95A3DC1B0F20C8_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit_B9D0BDF0DC3C32DC3E95A3DC1B0F20C8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_B9D0BDF0DC3C32DC3E95A3DC1B0F20C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit_B9D0BDF0DC3C32DC3E95A3DC1B0F20C8" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit_B9D0BDF0DC3C32DC3E95A3DC1B0F20C8" xlink:type="arc" />
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_F221AC436466D2DF90A8A3DC1B0FF60B_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_F221AC436466D2DF90A8A3DC1B0FF60B" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_F221AC436466D2DF90A8A3DC1B0FF60B_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_F221AC436466D2DF90A8A3DC1B0FF60B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_F221AC436466D2DF90A8A3DC1B0FF60B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_F221AC436466D2DF90A8A3DC1B0FF60B" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_F221AC436466D2DF90A8A3DC1B0FF60B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_4E095BA62218FFA57D90A3DC1B0FCAC4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_4E095BA62218FFA57D90A3DC1B0FCAC4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_4E095BA62218FFA57D90A3DC1B0FCAC4_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_4E095BA62218FFA57D90A3DC1B0FCAC4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4E095BA62218FFA57D90A3DC1B0FCAC4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4E095BA62218FFA57D90A3DC1B0FCAC4" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_4E095BA62218FFA57D90A3DC1B0FCAC4" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_0711ABF430F364C0F368A3DC1B0FF235_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_0711ABF430F364C0F368A3DC1B0FF235" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income tax (benefit) expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_0711ABF430F364C0F368A3DC1B0FF235_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_0711ABF430F364C0F368A3DC1B0FF235" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0711ABF430F364C0F368A3DC1B0FF235" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_0711ABF430F364C0F368A3DC1B0FF235" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_0711ABF430F364C0F368A3DC1B0FF235" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_13C7D99BC238496CF4648C8B9DAB6A86_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_13C7D99BC238496CF4648C8B9DAB6A86" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_13C7D99BC238496CF4648C8B9DAB6A86" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_13C7D99BC238496CF4648C8B9DAB6A86" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_13C7D99BC238496CF4648C8B9DAB6A86" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_FA22A6625612C5375AA18C8B9DABBD3C_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_FA22A6625612C5375AA18C8B9DABBD3C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Aggregate of future annual payments under non cancelable operating leases for facilities and equipment</link:label>
    <link:label id="lab_us-gaap_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_FA22A6625612C5375AA18C8B9DABBD3C_label_en-US" xlink:label="lab_us-gaap_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_FA22A6625612C5375AA18C8B9DABBD3C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligation, Fiscal Year Maturity Schedule [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:label="loc_us-gaap_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_FA22A6625612C5375AA18C8B9DABBD3C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_FA22A6625612C5375AA18C8B9DABBD3C" xlink:to="lab_us-gaap_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_FA22A6625612C5375AA18C8B9DABBD3C" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherCommitmentsTableTextBlock_562CA588D8A2AB30173E8C8B9DAB3F04_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTableTextBlock_562CA588D8A2AB30173E8C8B9DAB3F04" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTableTextBlock_562CA588D8A2AB30173E8C8B9DAB3F04_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTableTextBlock_562CA588D8A2AB30173E8C8B9DAB3F04" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitments [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentsTableTextBlock" xlink:label="loc_us-gaap_OtherCommitmentsTableTextBlock_562CA588D8A2AB30173E8C8B9DAB3F04" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTableTextBlock_562CA588D8A2AB30173E8C8B9DAB3F04" xlink:to="lab_us-gaap_OtherCommitmentsTableTextBlock_562CA588D8A2AB30173E8C8B9DAB3F04" xlink:type="arc" />
    <link:label id="lab_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock_472EC5C6699BED0030228C8B9D7DB783_verboseLabel_en-US" xlink:label="lab_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock_472EC5C6699BED0030228C8B9D7DB783" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of total net sales by product category</link:label>
    <link:label id="lab_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock_472EC5C6699BED0030228C8B9D7DB783_label_en-US" xlink:label="lab_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock_472EC5C6699BED0030228C8B9D7DB783" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Net Revenue by Product Group [Table Text Block]</link:label>
    <link:label id="lab_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock_472EC5C6699BED0030228C8B9D7DB783_documentation_en-US" xlink:label="lab_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock_472EC5C6699BED0030228C8B9D7DB783" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of net revenue by product group.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_ScheduleOfNetRevenueByProductGroupTableTextBlock" xlink:label="loc_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock_472EC5C6699BED0030228C8B9D7DB783" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock_472EC5C6699BED0030228C8B9D7DB783" xlink:to="lab_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock_472EC5C6699BED0030228C8B9D7DB783" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_5509339048608B344B748C8B9D7D70FB_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_5509339048608B344B748C8B9D7D70FB" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of net sales for geographic areas</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_5509339048608B344B748C8B9D7D70FB_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_5509339048608B344B748C8B9D7D70FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_5509339048608B344B748C8B9D7D70FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_5509339048608B344B748C8B9D7D70FB" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_5509339048608B344B748C8B9D7D70FB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_3CE70ABD26687DB838CE8F5078CF645F_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_3CE70ABD26687DB838CE8F5078CF645F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recent accounting pronouncements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_3CE70ABD26687DB838CE8F5078CF645F_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_3CE70ABD26687DB838CE8F5078CF645F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_3CE70ABD26687DB838CE8F5078CF645F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_3CE70ABD26687DB838CE8F5078CF645F" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_3CE70ABD26687DB838CE8F5078CF645F" xlink:type="arc" />
    <link:label id="lab_us-gaap_PurchaseObligation_2E91F05566BA017848CFA3DCC3AFBDFD_totalLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligation_2E91F05566BA017848CFA3DCC3AFBDFD" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Purchase obligation</link:label>
    <link:label id="lab_us-gaap_PurchaseObligation_2E91F05566BA017848CFA3DCC3AFBDFD_label_en-US" xlink:label="lab_us-gaap_PurchaseObligation_2E91F05566BA017848CFA3DCC3AFBDFD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaap_PurchaseObligation_2E91F05566BA017848CFA3DCC3AFBDFD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligation_2E91F05566BA017848CFA3DCC3AFBDFD" xlink:to="lab_us-gaap_PurchaseObligation_2E91F05566BA017848CFA3DCC3AFBDFD" xlink:type="arc" />
    <link:label id="lab_us-gaap_PurchaseObligationDueInSecondYear_3054A61E57C8C81E4AC4A3DCC3AF231D_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInSecondYear_3054A61E57C8C81E4AC4A3DCC3AF231D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase obligation, 2019</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInSecondYear_3054A61E57C8C81E4AC4A3DCC3AF231D_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInSecondYear_3054A61E57C8C81E4AC4A3DCC3AF231D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation, Due in Second Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_3054A61E57C8C81E4AC4A3DCC3AF231D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInSecondYear_3054A61E57C8C81E4AC4A3DCC3AF231D" xlink:to="lab_us-gaap_PurchaseObligationDueInSecondYear_3054A61E57C8C81E4AC4A3DCC3AF231D" xlink:type="arc" />
    <link:label id="lab_us-gaap_PurchaseObligationDueInThirdYear_2080441B6058563E3219A3DCC3AF4C85_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInThirdYear_2080441B6058563E3219A3DCC3AF4C85" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase obligation, 2020</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInThirdYear_2080441B6058563E3219A3DCC3AF4C85_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInThirdYear_2080441B6058563E3219A3DCC3AF4C85" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation, Due in Third Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_2080441B6058563E3219A3DCC3AF4C85" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInThirdYear_2080441B6058563E3219A3DCC3AF4C85" xlink:to="lab_us-gaap_PurchaseObligationDueInThirdYear_2080441B6058563E3219A3DCC3AF4C85" xlink:type="arc" />
    <link:label id="lab_us-gaap_PurchaseObligationDueInFourthYear_DEB79A80750032A6EB45A3DCC3AF289D_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFourthYear_DEB79A80750032A6EB45A3DCC3AF289D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase obligation, 2021</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFourthYear_DEB79A80750032A6EB45A3DCC3AF289D_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFourthYear_DEB79A80750032A6EB45A3DCC3AF289D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation, Due in Fourth Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_DEB79A80750032A6EB45A3DCC3AF289D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInFourthYear_DEB79A80750032A6EB45A3DCC3AF289D" xlink:to="lab_us-gaap_PurchaseObligationDueInFourthYear_DEB79A80750032A6EB45A3DCC3AF289D" xlink:type="arc" />
    <link:label id="lab_us-gaap_PurchaseObligationDueInFifthYear_FA847D12E9D284C82DD1A3DCC3AFC032_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFifthYear_FA847D12E9D284C82DD1A3DCC3AFC032" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase obligation, 2022</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInFifthYear_FA847D12E9D284C82DD1A3DCC3AFC032_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInFifthYear_FA847D12E9D284C82DD1A3DCC3AFC032" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation, Due in Fifth Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear_FA847D12E9D284C82DD1A3DCC3AFC032" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInFifthYear_FA847D12E9D284C82DD1A3DCC3AFC032" xlink:to="lab_us-gaap_PurchaseObligationDueInFifthYear_FA847D12E9D284C82DD1A3DCC3AFC032" xlink:type="arc" />
    <link:label id="lab_us-gaap_PurchaseObligationDueAfterFifthYear_37E46D9C44CE3C59D76BA3DCC3AFE2F9_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueAfterFifthYear_37E46D9C44CE3C59D76BA3DCC3AFE2F9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase obligation, 2023 and thereafter</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueAfterFifthYear_37E46D9C44CE3C59D76BA3DCC3AFE2F9_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueAfterFifthYear_37E46D9C44CE3C59D76BA3DCC3AFE2F9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation, Due after Fifth Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueAfterFifthYear" xlink:label="loc_us-gaap_PurchaseObligationDueAfterFifthYear_37E46D9C44CE3C59D76BA3DCC3AFE2F9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueAfterFifthYear_37E46D9C44CE3C59D76BA3DCC3AFE2F9" xlink:to="lab_us-gaap_PurchaseObligationDueAfterFifthYear_37E46D9C44CE3C59D76BA3DCC3AFE2F9" xlink:type="arc" />
    <link:label id="lab_ango_Royalties_F9A6E414B222F11533FCA3DCC3AF2251_totalLabel_en-US" xlink:label="lab_ango_Royalties_F9A6E414B222F11533FCA3DCC3AF2251" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_ango_Royalties_F9A6E414B222F11533FCA3DCC3AF2251_label_en-US" xlink:label="lab_ango_Royalties_F9A6E414B222F11533FCA3DCC3AF2251" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_ango_Royalties_F9A6E414B222F11533FCA3DCC3AF2251_documentation_en-US" xlink:label="lab_ango_Royalties_F9A6E414B222F11533FCA3DCC3AF2251" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalties</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_Royalties" xlink:label="loc_ango_Royalties_F9A6E414B222F11533FCA3DCC3AF2251" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_Royalties_F9A6E414B222F11533FCA3DCC3AF2251" xlink:to="lab_ango_Royalties_F9A6E414B222F11533FCA3DCC3AF2251" xlink:type="arc" />
    <link:label id="lab_ango_RoyaltiesDueinSecondYear_6DC87DC50B08189D611EA3DCC3AFDBC7_terseLabel_en-US" xlink:label="lab_ango_RoyaltiesDueinSecondYear_6DC87DC50B08189D611EA3DCC3AFDBC7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalties, 2019</link:label>
    <link:label id="lab_ango_RoyaltiesDueinSecondYear_6DC87DC50B08189D611EA3DCC3AFDBC7_label_en-US" xlink:label="lab_ango_RoyaltiesDueinSecondYear_6DC87DC50B08189D611EA3DCC3AFDBC7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalties, Due in Second Year</link:label>
    <link:label id="lab_ango_RoyaltiesDueinSecondYear_6DC87DC50B08189D611EA3DCC3AFDBC7_documentation_en-US" xlink:label="lab_ango_RoyaltiesDueinSecondYear_6DC87DC50B08189D611EA3DCC3AFDBC7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalties, Due in Second Year</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_RoyaltiesDueinSecondYear" xlink:label="loc_ango_RoyaltiesDueinSecondYear_6DC87DC50B08189D611EA3DCC3AFDBC7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_RoyaltiesDueinSecondYear_6DC87DC50B08189D611EA3DCC3AFDBC7" xlink:to="lab_ango_RoyaltiesDueinSecondYear_6DC87DC50B08189D611EA3DCC3AFDBC7" xlink:type="arc" />
    <link:label id="lab_ango_RoyaltiesDueinThirdYear_0F8AA6DD850B84E1C8E7A3DCC3AFC11A_terseLabel_en-US" xlink:label="lab_ango_RoyaltiesDueinThirdYear_0F8AA6DD850B84E1C8E7A3DCC3AFC11A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalties, 2020</link:label>
    <link:label id="lab_ango_RoyaltiesDueinThirdYear_0F8AA6DD850B84E1C8E7A3DCC3AFC11A_label_en-US" xlink:label="lab_ango_RoyaltiesDueinThirdYear_0F8AA6DD850B84E1C8E7A3DCC3AFC11A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalties, Due in Third Year</link:label>
    <link:label id="lab_ango_RoyaltiesDueinThirdYear_0F8AA6DD850B84E1C8E7A3DCC3AFC11A_documentation_en-US" xlink:label="lab_ango_RoyaltiesDueinThirdYear_0F8AA6DD850B84E1C8E7A3DCC3AFC11A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalties, Due in Third Year</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_RoyaltiesDueinThirdYear" xlink:label="loc_ango_RoyaltiesDueinThirdYear_0F8AA6DD850B84E1C8E7A3DCC3AFC11A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_RoyaltiesDueinThirdYear_0F8AA6DD850B84E1C8E7A3DCC3AFC11A" xlink:to="lab_ango_RoyaltiesDueinThirdYear_0F8AA6DD850B84E1C8E7A3DCC3AFC11A" xlink:type="arc" />
    <link:label id="lab_ango_RoyaltiesDueinFourthYear_33C2BE7B6A272575EEDFA3DCC3AF69C9_terseLabel_en-US" xlink:label="lab_ango_RoyaltiesDueinFourthYear_33C2BE7B6A272575EEDFA3DCC3AF69C9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalties, 2021</link:label>
    <link:label id="lab_ango_RoyaltiesDueinFourthYear_33C2BE7B6A272575EEDFA3DCC3AF69C9_label_en-US" xlink:label="lab_ango_RoyaltiesDueinFourthYear_33C2BE7B6A272575EEDFA3DCC3AF69C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalties, Due in Fourth Year</link:label>
    <link:label id="lab_ango_RoyaltiesDueinFourthYear_33C2BE7B6A272575EEDFA3DCC3AF69C9_documentation_en-US" xlink:label="lab_ango_RoyaltiesDueinFourthYear_33C2BE7B6A272575EEDFA3DCC3AF69C9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalties, Due in Fourth Year</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_RoyaltiesDueinFourthYear" xlink:label="loc_ango_RoyaltiesDueinFourthYear_33C2BE7B6A272575EEDFA3DCC3AF69C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_RoyaltiesDueinFourthYear_33C2BE7B6A272575EEDFA3DCC3AF69C9" xlink:to="lab_ango_RoyaltiesDueinFourthYear_33C2BE7B6A272575EEDFA3DCC3AF69C9" xlink:type="arc" />
    <link:label id="lab_ango_RoyaltiesDueinFifthYear_52928C3F035A6B7F4531A3DCC3AF947D_terseLabel_en-US" xlink:label="lab_ango_RoyaltiesDueinFifthYear_52928C3F035A6B7F4531A3DCC3AF947D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalties, 2022</link:label>
    <link:label id="lab_ango_RoyaltiesDueinFifthYear_52928C3F035A6B7F4531A3DCC3AF947D_label_en-US" xlink:label="lab_ango_RoyaltiesDueinFifthYear_52928C3F035A6B7F4531A3DCC3AF947D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalties, Due in Fifth Year</link:label>
    <link:label id="lab_ango_RoyaltiesDueinFifthYear_52928C3F035A6B7F4531A3DCC3AF947D_documentation_en-US" xlink:label="lab_ango_RoyaltiesDueinFifthYear_52928C3F035A6B7F4531A3DCC3AF947D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalties, Due in Fifth Year</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_RoyaltiesDueinFifthYear" xlink:label="loc_ango_RoyaltiesDueinFifthYear_52928C3F035A6B7F4531A3DCC3AF947D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_RoyaltiesDueinFifthYear_52928C3F035A6B7F4531A3DCC3AF947D" xlink:to="lab_ango_RoyaltiesDueinFifthYear_52928C3F035A6B7F4531A3DCC3AF947D" xlink:type="arc" />
    <link:label id="lab_ango_RoyaltiesDueAfterFifthYear_A316C47ED7965602BBDFA3DCC3AFFE6E_terseLabel_en-US" xlink:label="lab_ango_RoyaltiesDueAfterFifthYear_A316C47ED7965602BBDFA3DCC3AFFE6E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalties, 2023 and thereafter</link:label>
    <link:label id="lab_ango_RoyaltiesDueAfterFifthYear_A316C47ED7965602BBDFA3DCC3AFFE6E_label_en-US" xlink:label="lab_ango_RoyaltiesDueAfterFifthYear_A316C47ED7965602BBDFA3DCC3AFFE6E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalties, Due After Fifth Year</link:label>
    <link:label id="lab_ango_RoyaltiesDueAfterFifthYear_A316C47ED7965602BBDFA3DCC3AFFE6E_documentation_en-US" xlink:label="lab_ango_RoyaltiesDueAfterFifthYear_A316C47ED7965602BBDFA3DCC3AFFE6E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalties, Due After Fifth Year</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_RoyaltiesDueAfterFifthYear" xlink:label="loc_ango_RoyaltiesDueAfterFifthYear_A316C47ED7965602BBDFA3DCC3AFFE6E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_RoyaltiesDueAfterFifthYear_A316C47ED7965602BBDFA3DCC3AFFE6E" xlink:to="lab_ango_RoyaltiesDueAfterFifthYear_A316C47ED7965602BBDFA3DCC3AFFE6E" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherCommitment_8DFD04AACB68C11EACE7A3DCC3AF9428_totalLabel_en-US" xlink:label="lab_us-gaap_OtherCommitment_8DFD04AACB68C11EACE7A3DCC3AF9428" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherCommitment_8DFD04AACB68C11EACE7A3DCC3AF9428_label_en-US" xlink:label="lab_us-gaap_OtherCommitment_8DFD04AACB68C11EACE7A3DCC3AF9428" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitment" xlink:label="loc_us-gaap_OtherCommitment_8DFD04AACB68C11EACE7A3DCC3AF9428" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitment_8DFD04AACB68C11EACE7A3DCC3AF9428" xlink:to="lab_us-gaap_OtherCommitment_8DFD04AACB68C11EACE7A3DCC3AF9428" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherCommitmentDueInSecondYear_D2D34CD046ABD2EBD732A3DCC3AF5EF5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueInSecondYear_D2D34CD046ABD2EBD732A3DCC3AF5EF5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other, 2019</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentDueInSecondYear_D2D34CD046ABD2EBD732A3DCC3AF5EF5_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueInSecondYear_D2D34CD046ABD2EBD732A3DCC3AF5EF5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitment, Due in Second Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInSecondYear" xlink:label="loc_us-gaap_OtherCommitmentDueInSecondYear_D2D34CD046ABD2EBD732A3DCC3AF5EF5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentDueInSecondYear_D2D34CD046ABD2EBD732A3DCC3AF5EF5" xlink:to="lab_us-gaap_OtherCommitmentDueInSecondYear_D2D34CD046ABD2EBD732A3DCC3AF5EF5" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherCommitmentDueInThirdYear_C140D104F783482008CFA3DCC3AF8CFC_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueInThirdYear_C140D104F783482008CFA3DCC3AF8CFC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other, 2020</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentDueInThirdYear_C140D104F783482008CFA3DCC3AF8CFC_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueInThirdYear_C140D104F783482008CFA3DCC3AF8CFC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitment, Due in Third Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInThirdYear" xlink:label="loc_us-gaap_OtherCommitmentDueInThirdYear_C140D104F783482008CFA3DCC3AF8CFC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentDueInThirdYear_C140D104F783482008CFA3DCC3AF8CFC" xlink:to="lab_us-gaap_OtherCommitmentDueInThirdYear_C140D104F783482008CFA3DCC3AF8CFC" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherCommitmentDueInFourthYear_E0538169409743E29295A3DCC3AF69C4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueInFourthYear_E0538169409743E29295A3DCC3AF69C4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other, 2021</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentDueInFourthYear_E0538169409743E29295A3DCC3AF69C4_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueInFourthYear_E0538169409743E29295A3DCC3AF69C4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitment, Due in Fourth Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInFourthYear" xlink:label="loc_us-gaap_OtherCommitmentDueInFourthYear_E0538169409743E29295A3DCC3AF69C4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentDueInFourthYear_E0538169409743E29295A3DCC3AF69C4" xlink:to="lab_us-gaap_OtherCommitmentDueInFourthYear_E0538169409743E29295A3DCC3AF69C4" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherCommitmentDueInFifthYear_18A970CD345820062B67A3DCC3AF2EC9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueInFifthYear_18A970CD345820062B67A3DCC3AF2EC9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other, 2022</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentDueInFifthYear_18A970CD345820062B67A3DCC3AF2EC9_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueInFifthYear_18A970CD345820062B67A3DCC3AF2EC9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitment, Due in Fifth Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInFifthYear" xlink:label="loc_us-gaap_OtherCommitmentDueInFifthYear_18A970CD345820062B67A3DCC3AF2EC9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentDueInFifthYear_18A970CD345820062B67A3DCC3AF2EC9" xlink:to="lab_us-gaap_OtherCommitmentDueInFifthYear_18A970CD345820062B67A3DCC3AF2EC9" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherCommitmentDueAfterFifthYear_715E5EED6956A9E68264A3DCC3AFCB78_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueAfterFifthYear_715E5EED6956A9E68264A3DCC3AFCB78" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other, 2023 and thereafter</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentDueAfterFifthYear_715E5EED6956A9E68264A3DCC3AFCB78_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueAfterFifthYear_715E5EED6956A9E68264A3DCC3AFCB78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitment, Due after Fifth Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueAfterFifthYear" xlink:label="loc_us-gaap_OtherCommitmentDueAfterFifthYear_715E5EED6956A9E68264A3DCC3AFCB78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentDueAfterFifthYear_715E5EED6956A9E68264A3DCC3AFCB78" xlink:to="lab_us-gaap_OtherCommitmentDueAfterFifthYear_715E5EED6956A9E68264A3DCC3AFCB78" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractualObligation_C68EEB013837EF772A94A3DCC3AFE5C5_totalLabel_en-US" xlink:label="lab_us-gaap_ContractualObligation_C68EEB013837EF772A94A3DCC3AFE5C5" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_ContractualObligation_C68EEB013837EF772A94A3DCC3AFE5C5_label_en-US" xlink:label="lab_us-gaap_ContractualObligation_C68EEB013837EF772A94A3DCC3AFE5C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligation" xlink:label="loc_us-gaap_ContractualObligation_C68EEB013837EF772A94A3DCC3AFE5C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligation_C68EEB013837EF772A94A3DCC3AFE5C5" xlink:to="lab_us-gaap_ContractualObligation_C68EEB013837EF772A94A3DCC3AFE5C5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractualObligationDueInSecondYear_6C319F5055C3F29E710FA3DCC3AFACE7_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInSecondYear_6C319F5055C3F29E710FA3DCC3AFACE7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total, 2019</link:label>
    <link:label id="lab_us-gaap_ContractualObligationDueInSecondYear_6C319F5055C3F29E710FA3DCC3AFACE7_label_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInSecondYear_6C319F5055C3F29E710FA3DCC3AFACE7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligation, Due in Second Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInSecondYear" xlink:label="loc_us-gaap_ContractualObligationDueInSecondYear_6C319F5055C3F29E710FA3DCC3AFACE7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationDueInSecondYear_6C319F5055C3F29E710FA3DCC3AFACE7" xlink:to="lab_us-gaap_ContractualObligationDueInSecondYear_6C319F5055C3F29E710FA3DCC3AFACE7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractualObligationDueInThirdYear_57384BBAF40E0B7D5686A3DCC3AF15DF_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInThirdYear_57384BBAF40E0B7D5686A3DCC3AF15DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total, 2020</link:label>
    <link:label id="lab_us-gaap_ContractualObligationDueInThirdYear_57384BBAF40E0B7D5686A3DCC3AF15DF_label_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInThirdYear_57384BBAF40E0B7D5686A3DCC3AF15DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligation, Due in Third Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInThirdYear" xlink:label="loc_us-gaap_ContractualObligationDueInThirdYear_57384BBAF40E0B7D5686A3DCC3AF15DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationDueInThirdYear_57384BBAF40E0B7D5686A3DCC3AF15DF" xlink:to="lab_us-gaap_ContractualObligationDueInThirdYear_57384BBAF40E0B7D5686A3DCC3AF15DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractualObligationDueInFourthYear_4555E8DC765E77999E6CA3DCC3AF26EB_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInFourthYear_4555E8DC765E77999E6CA3DCC3AF26EB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total, 2021</link:label>
    <link:label id="lab_us-gaap_ContractualObligationDueInFourthYear_4555E8DC765E77999E6CA3DCC3AF26EB_label_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInFourthYear_4555E8DC765E77999E6CA3DCC3AF26EB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligation, Due in Fourth Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInFourthYear" xlink:label="loc_us-gaap_ContractualObligationDueInFourthYear_4555E8DC765E77999E6CA3DCC3AF26EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationDueInFourthYear_4555E8DC765E77999E6CA3DCC3AF26EB" xlink:to="lab_us-gaap_ContractualObligationDueInFourthYear_4555E8DC765E77999E6CA3DCC3AF26EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractualObligationDueInFifthYear_F80FFE8E059E8914A226A3DCC3AF037A_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInFifthYear_F80FFE8E059E8914A226A3DCC3AF037A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total, 2022</link:label>
    <link:label id="lab_us-gaap_ContractualObligationDueInFifthYear_F80FFE8E059E8914A226A3DCC3AF037A_label_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInFifthYear_F80FFE8E059E8914A226A3DCC3AF037A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligation, Due in Fifth Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInFifthYear" xlink:label="loc_us-gaap_ContractualObligationDueInFifthYear_F80FFE8E059E8914A226A3DCC3AF037A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationDueInFifthYear_F80FFE8E059E8914A226A3DCC3AF037A" xlink:to="lab_us-gaap_ContractualObligationDueInFifthYear_F80FFE8E059E8914A226A3DCC3AF037A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractualObligationDueAfterFifthYear_73D90780058800939510A3DCC3AF9B06_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationDueAfterFifthYear_73D90780058800939510A3DCC3AF9B06" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total, 2023 and thereafter</link:label>
    <link:label id="lab_us-gaap_ContractualObligationDueAfterFifthYear_73D90780058800939510A3DCC3AF9B06_label_en-US" xlink:label="lab_us-gaap_ContractualObligationDueAfterFifthYear_73D90780058800939510A3DCC3AF9B06" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligation, Due after Fifth Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueAfterFifthYear" xlink:label="loc_us-gaap_ContractualObligationDueAfterFifthYear_73D90780058800939510A3DCC3AF9B06" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationDueAfterFifthYear_73D90780058800939510A3DCC3AF9B06" xlink:to="lab_us-gaap_ContractualObligationDueAfterFifthYear_73D90780058800939510A3DCC3AF9B06" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingenciesTable_FF59D3AC3F1FECAB5973A3DCC39DB983_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable_FF59D3AC3F1FECAB5973A3DCC39DB983" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_FF59D3AC3F1FECAB5973A3DCC39DB983_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable_FF59D3AC3F1FECAB5973A3DCC39DB983" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_FF59D3AC3F1FECAB5973A3DCC39DB983" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable_FF59D3AC3F1FECAB5973A3DCC39DB983" xlink:to="lab_us-gaap_LossContingenciesTable_FF59D3AC3F1FECAB5973A3DCC39DB983" xlink:type="arc" />
    <link:label id="lab_srt_LitigationCaseAxis_FEB808C61343FD0B9BBEA3DCC39DBAC3_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis_FEB808C61343FD0B9BBEA3DCC39DBAC3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_FEB808C61343FD0B9BBEA3DCC39DBAC3_label_en-US" xlink:label="lab_srt_LitigationCaseAxis_FEB808C61343FD0B9BBEA3DCC39DBAC3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_LitigationCaseAxis" xlink:label="loc_srt_LitigationCaseAxis_FEB808C61343FD0B9BBEA3DCC39DBAC3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis_FEB808C61343FD0B9BBEA3DCC39DBAC3" xlink:to="lab_srt_LitigationCaseAxis_FEB808C61343FD0B9BBEA3DCC39DBAC3" xlink:type="arc" />
    <link:label id="lab_srt_LitigationCaseTypeDomain_F1FC3D259C27BD51E2FAA3DCC39D0E12_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain_F1FC3D259C27BD51E2FAA3DCC39D0E12" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_F1FC3D259C27BD51E2FAA3DCC39D0E12_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain_F1FC3D259C27BD51E2FAA3DCC39D0E12" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_F1FC3D259C27BD51E2FAA3DCC39D0E12" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain_F1FC3D259C27BD51E2FAA3DCC39D0E12" xlink:to="lab_srt_LitigationCaseTypeDomain_F1FC3D259C27BD51E2FAA3DCC39D0E12" xlink:type="arc" />
    <link:label id="lab_ango_C.R.BardInc.Member_CB2415401C5761249E42A3DCC39DFD9B_terseLabel_en-US" xlink:label="lab_ango_C.R.BardInc.Member_CB2415401C5761249E42A3DCC39DFD9B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">C.R. Bard, Inc.</link:label>
    <link:label id="lab_ango_C.R.BardInc.Member_CB2415401C5761249E42A3DCC39DFD9B_label_en-US" xlink:label="lab_ango_C.R.BardInc.Member_CB2415401C5761249E42A3DCC39DFD9B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">C.R. Bard, Inc. [Member]</link:label>
    <link:label id="lab_ango_C.R.BardInc.Member_CB2415401C5761249E42A3DCC39DFD9B_documentation_en-US" xlink:label="lab_ango_C.R.BardInc.Member_CB2415401C5761249E42A3DCC39DFD9B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">C.R. Bard, Inc. [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_C.R.BardInc.Member" xlink:label="loc_ango_C.R.BardInc.Member_CB2415401C5761249E42A3DCC39DFD9B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_C.R.BardInc.Member_CB2415401C5761249E42A3DCC39DFD9B" xlink:to="lab_ango_C.R.BardInc.Member_CB2415401C5761249E42A3DCC39DFD9B" xlink:type="arc" />
    <link:label id="lab_ango_TheUtahActionMember_3E6260B1016F9DCB3DF9A3DCC39D276F_terseLabel_en-US" xlink:label="lab_ango_TheUtahActionMember_3E6260B1016F9DCB3DF9A3DCC39D276F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The Utah Action</link:label>
    <link:label id="lab_ango_TheUtahActionMember_3E6260B1016F9DCB3DF9A3DCC39D276F_label_en-US" xlink:label="lab_ango_TheUtahActionMember_3E6260B1016F9DCB3DF9A3DCC39D276F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The Utah Action [Member]</link:label>
    <link:label id="lab_ango_TheUtahActionMember_3E6260B1016F9DCB3DF9A3DCC39D276F_documentation_en-US" xlink:label="lab_ango_TheUtahActionMember_3E6260B1016F9DCB3DF9A3DCC39D276F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The Utah Action</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_TheUtahActionMember" xlink:label="loc_ango_TheUtahActionMember_3E6260B1016F9DCB3DF9A3DCC39D276F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_TheUtahActionMember_3E6260B1016F9DCB3DF9A3DCC39D276F" xlink:to="lab_ango_TheUtahActionMember_3E6260B1016F9DCB3DF9A3DCC39D276F" xlink:type="arc" />
    <link:label id="lab_ango_TheDelawareActionMember_40048F51ACA720E29630A3DCC39D5E33_terseLabel_en-US" xlink:label="lab_ango_TheDelawareActionMember_40048F51ACA720E29630A3DCC39D5E33" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The Delaware Action</link:label>
    <link:label id="lab_ango_TheDelawareActionMember_40048F51ACA720E29630A3DCC39D5E33_label_en-US" xlink:label="lab_ango_TheDelawareActionMember_40048F51ACA720E29630A3DCC39D5E33" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The Delaware Action [Member]</link:label>
    <link:label id="lab_ango_TheDelawareActionMember_40048F51ACA720E29630A3DCC39D5E33_documentation_en-US" xlink:label="lab_ango_TheDelawareActionMember_40048F51ACA720E29630A3DCC39D5E33" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The Delaware Action</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_TheDelawareActionMember" xlink:label="loc_ango_TheDelawareActionMember_40048F51ACA720E29630A3DCC39D5E33" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_TheDelawareActionMember_40048F51ACA720E29630A3DCC39D5E33" xlink:to="lab_ango_TheDelawareActionMember_40048F51ACA720E29630A3DCC39D5E33" xlink:type="arc" />
    <link:label id="lab_dei_LegalEntityAxis_DE156BA22BEB574A581BA3DCC39D7E83_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis_DE156BA22BEB574A581BA3DCC39D7E83" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_DE156BA22BEB574A581BA3DCC39D7E83_label_en-US" xlink:label="lab_dei_LegalEntityAxis_DE156BA22BEB574A581BA3DCC39D7E83" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_DE156BA22BEB574A581BA3DCC39D7E83" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis_DE156BA22BEB574A581BA3DCC39D7E83" xlink:to="lab_dei_LegalEntityAxis_DE156BA22BEB574A581BA3DCC39D7E83" xlink:type="arc" />
    <link:label id="lab_dei_EntityDomain_45696E8D6959014BE10FA3DCC39D8B31_terseLabel_en-US" xlink:label="lab_dei_EntityDomain_45696E8D6959014BE10FA3DCC39D8B31" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_45696E8D6959014BE10FA3DCC39D8B31_label_en-US" xlink:label="lab_dei_EntityDomain_45696E8D6959014BE10FA3DCC39D8B31" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_45696E8D6959014BE10FA3DCC39D8B31" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain_45696E8D6959014BE10FA3DCC39D8B31" xlink:to="lab_dei_EntityDomain_45696E8D6959014BE10FA3DCC39D8B31" xlink:type="arc" />
    <link:label id="lab_us-gaap_LitigationStatusAxis_C89EEF918246E3CA2588A3DCC39D6DDA_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis_C89EEF918246E3CA2588A3DCC39D6DDA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_C89EEF918246E3CA2588A3DCC39D6DDA_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis_C89EEF918246E3CA2588A3DCC39D6DDA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LitigationStatusAxis" xlink:label="loc_us-gaap_LitigationStatusAxis_C89EEF918246E3CA2588A3DCC39D6DDA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis_C89EEF918246E3CA2588A3DCC39D6DDA" xlink:to="lab_us-gaap_LitigationStatusAxis_C89EEF918246E3CA2588A3DCC39D6DDA" xlink:type="arc" />
    <link:label id="lab_us-gaap_LitigationStatusDomain_5DD66CF36697BCD1C011A3DCC39D39E7_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain_5DD66CF36697BCD1C011A3DCC39D39E7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_5DD66CF36697BCD1C011A3DCC39D39E7_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain_5DD66CF36697BCD1C011A3DCC39D39E7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LitigationStatusDomain" xlink:label="loc_us-gaap_LitigationStatusDomain_5DD66CF36697BCD1C011A3DCC39D39E7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain_5DD66CF36697BCD1C011A3DCC39D39E7" xlink:to="lab_us-gaap_LitigationStatusDomain_5DD66CF36697BCD1C011A3DCC39D39E7" xlink:type="arc" />
    <link:label id="lab_us-gaap_PendingLitigationMember_5AFF1CC6D1D0DD6C8041A3DCC39DBF96_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember_5AFF1CC6D1D0DD6C8041A3DCC39DBF96" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_5AFF1CC6D1D0DD6C8041A3DCC39DBF96_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember_5AFF1CC6D1D0DD6C8041A3DCC39DBF96" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PendingLitigationMember" xlink:label="loc_us-gaap_PendingLitigationMember_5AFF1CC6D1D0DD6C8041A3DCC39DBF96" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember_5AFF1CC6D1D0DD6C8041A3DCC39DBF96" xlink:to="lab_us-gaap_PendingLitigationMember_5AFF1CC6D1D0DD6C8041A3DCC39DBF96" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="lab_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseAndRentalExpense_4882F622AB3C8EA972D9A3DCC39D40B3_verboseLabel_en-US" xlink:label="lab_us-gaap_LeaseAndRentalExpense_4882F622AB3C8EA972D9A3DCC39D40B3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Aggregate rental costs under operating leases</link:label>
    <link:label id="lab_us-gaap_LeaseAndRentalExpense_4882F622AB3C8EA972D9A3DCC39D40B3_label_en-US" xlink:label="lab_us-gaap_LeaseAndRentalExpense_4882F622AB3C8EA972D9A3DCC39D40B3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Rent Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaap_LeaseAndRentalExpense_4882F622AB3C8EA972D9A3DCC39D40B3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseAndRentalExpense_4882F622AB3C8EA972D9A3DCC39D40B3" xlink:to="lab_us-gaap_LeaseAndRentalExpense_4882F622AB3C8EA972D9A3DCC39D40B3" xlink:type="arc" />
    <link:label id="lab_ango_LossContingencyU.S.PatentsNumber_2C555613EE91CC778477A3DCC39D08BE_terseLabel_en-US" xlink:label="lab_ango_LossContingencyU.S.PatentsNumber_2C555613EE91CC778477A3DCC39D08BE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of patents</link:label>
    <link:label id="lab_ango_LossContingencyU.S.PatentsNumber_2C555613EE91CC778477A3DCC39D08BE_label_en-US" xlink:label="lab_ango_LossContingencyU.S.PatentsNumber_2C555613EE91CC778477A3DCC39D08BE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, U.S. Patents, Number</link:label>
    <link:label id="lab_ango_LossContingencyU.S.PatentsNumber_2C555613EE91CC778477A3DCC39D08BE_documentation_en-US" xlink:label="lab_ango_LossContingencyU.S.PatentsNumber_2C555613EE91CC778477A3DCC39D08BE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, U.S. Patents, Number</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_LossContingencyU.S.PatentsNumber" xlink:label="loc_ango_LossContingencyU.S.PatentsNumber_2C555613EE91CC778477A3DCC39D08BE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_LossContingencyU.S.PatentsNumber_2C555613EE91CC778477A3DCC39D08BE" xlink:to="lab_ango_LossContingencyU.S.PatentsNumber_2C555613EE91CC778477A3DCC39D08BE" xlink:type="arc" />
    <link:label id="lab_ango_NumberOfPatentsAssertedForReexamination_ECF7B41805803A7865CCA3DCC39D94EA_verboseLabel_en-US" xlink:label="lab_ango_NumberOfPatentsAssertedForReexamination_ECF7B41805803A7865CCA3DCC39D94EA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Number of petitions filed for reexamination of patents</link:label>
    <link:label id="lab_ango_NumberOfPatentsAssertedForReexamination_ECF7B41805803A7865CCA3DCC39D94EA_label_en-US" xlink:label="lab_ango_NumberOfPatentsAssertedForReexamination_ECF7B41805803A7865CCA3DCC39D94EA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Patents Asserted for Reexamination</link:label>
    <link:label id="lab_ango_NumberOfPatentsAssertedForReexamination_ECF7B41805803A7865CCA3DCC39D94EA_documentation_en-US" xlink:label="lab_ango_NumberOfPatentsAssertedForReexamination_ECF7B41805803A7865CCA3DCC39D94EA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of patents asserted for reexamination.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_NumberOfPatentsAssertedForReexamination" xlink:label="loc_ango_NumberOfPatentsAssertedForReexamination_ECF7B41805803A7865CCA3DCC39D94EA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_NumberOfPatentsAssertedForReexamination_ECF7B41805803A7865CCA3DCC39D94EA" xlink:to="lab_ango_NumberOfPatentsAssertedForReexamination_ECF7B41805803A7865CCA3DCC39D94EA" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_9971BFA360A7B7A10CA1A3DCC39DD155_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber_9971BFA360A7B7A10CA1A3DCC39DD155" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of claims rejected (claim)</link:label>
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_9971BFA360A7B7A10CA1A3DCC39DD155_label_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber_9971BFA360A7B7A10CA1A3DCC39DD155" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Claims Dismissed, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingencyClaimsDismissedNumber" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_9971BFA360A7B7A10CA1A3DCC39DD155" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyClaimsDismissedNumber_9971BFA360A7B7A10CA1A3DCC39DD155" xlink:to="lab_us-gaap_LossContingencyClaimsDismissedNumber_9971BFA360A7B7A10CA1A3DCC39DD155" xlink:type="arc" />
    <link:label id="lab_ango_LossContingencyReexaminationsNumber_69DFAD4DB5928A658D5BA3DCC39DD1B9_terseLabel_en-US" xlink:label="lab_ango_LossContingencyReexaminationsNumber_69DFAD4DB5928A658D5BA3DCC39DD1B9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reexaminations (reexamination appeal)</link:label>
    <link:label id="lab_ango_LossContingencyReexaminationsNumber_69DFAD4DB5928A658D5BA3DCC39DD1B9_label_en-US" xlink:label="lab_ango_LossContingencyReexaminationsNumber_69DFAD4DB5928A658D5BA3DCC39DD1B9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Reexaminations, Number</link:label>
    <link:label id="lab_ango_LossContingencyReexaminationsNumber_69DFAD4DB5928A658D5BA3DCC39DD1B9_documentation_en-US" xlink:label="lab_ango_LossContingencyReexaminationsNumber_69DFAD4DB5928A658D5BA3DCC39DD1B9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Reexaminations, Number</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_LossContingencyReexaminationsNumber" xlink:label="loc_ango_LossContingencyReexaminationsNumber_69DFAD4DB5928A658D5BA3DCC39DD1B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_LossContingencyReexaminationsNumber_69DFAD4DB5928A658D5BA3DCC39DD1B9" xlink:to="lab_ango_LossContingencyReexaminationsNumber_69DFAD4DB5928A658D5BA3DCC39DD1B9" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_E8F3ED95E9C5FB2C3385A3DCC39D9C7B_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber_E8F3ED95E9C5FB2C3385A3DCC39D9C7B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of pending claims (claim)</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_E8F3ED95E9C5FB2C3385A3DCC39D9C7B_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber_E8F3ED95E9C5FB2C3385A3DCC39D9C7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_E8F3ED95E9C5FB2C3385A3DCC39D9C7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber_E8F3ED95E9C5FB2C3385A3DCC39D9C7B" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber_E8F3ED95E9C5FB2C3385A3DCC39D9C7B" xlink:type="arc" />
    <link:label id="lab_ango_LossContingencyClaimsReversedNumber_0C93F1680DEE7D752AA2A3DCC39DA20F_terseLabel_en-US" xlink:label="lab_ango_LossContingencyClaimsReversedNumber_0C93F1680DEE7D752AA2A3DCC39DA20F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of claims reversed (claim)</link:label>
    <link:label id="lab_ango_LossContingencyClaimsReversedNumber_0C93F1680DEE7D752AA2A3DCC39DA20F_label_en-US" xlink:label="lab_ango_LossContingencyClaimsReversedNumber_0C93F1680DEE7D752AA2A3DCC39DA20F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Claims Reversed, Number</link:label>
    <link:label id="lab_ango_LossContingencyClaimsReversedNumber_0C93F1680DEE7D752AA2A3DCC39DA20F_documentation_en-US" xlink:label="lab_ango_LossContingencyClaimsReversedNumber_0C93F1680DEE7D752AA2A3DCC39DA20F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss Contingency, Claims Reversed, Number</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_LossContingencyClaimsReversedNumber" xlink:label="loc_ango_LossContingencyClaimsReversedNumber_0C93F1680DEE7D752AA2A3DCC39DA20F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_LossContingencyClaimsReversedNumber_0C93F1680DEE7D752AA2A3DCC39DA20F" xlink:to="lab_ango_LossContingencyClaimsReversedNumber_0C93F1680DEE7D752AA2A3DCC39DA20F" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_57487B6E1A84A88FFBE7A3DCC39DFAB8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_57487B6E1A84A88FFBE7A3DCC39DFAB8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of patents allegedly infringed (patent)</link:label>
    <link:label id="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_57487B6E1A84A88FFBE7A3DCC39DFAB8_label_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_57487B6E1A84A88FFBE7A3DCC39DFAB8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Patents Allegedly Infringed, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_57487B6E1A84A88FFBE7A3DCC39DFAB8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_57487B6E1A84A88FFBE7A3DCC39DFAB8" xlink:to="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_57487B6E1A84A88FFBE7A3DCC39DFAB8" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_7DA558AC4087CB12EE40A3DCC39DD1BA_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber_7DA558AC4087CB12EE40A3DCC39DD1BA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss contingency, new claims filed, number</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_7DA558AC4087CB12EE40A3DCC39DD1BA_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber_7DA558AC4087CB12EE40A3DCC39DD1BA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_7DA558AC4087CB12EE40A3DCC39DD1BA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber_7DA558AC4087CB12EE40A3DCC39DD1BA" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber_7DA558AC4087CB12EE40A3DCC39DD1BA" xlink:type="arc" />
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_85348F21850884DE806AA3DCC39DDA7F_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue_85348F21850884DE806AA3DCC39DDA7F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reserve</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_85348F21850884DE806AA3DCC39DDA7F_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue_85348F21850884DE806AA3DCC39DDA7F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_85348F21850884DE806AA3DCC39DDA7F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue_85348F21850884DE806AA3DCC39DDA7F" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue_85348F21850884DE806AA3DCC39DDA7F" xlink:type="arc" />
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0AAEC967359377E805EF8F22D1741E83_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0AAEC967359377E805EF8F22D1741E83" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Description of Business</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0AAEC967359377E805EF8F22D1741E83_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0AAEC967359377E805EF8F22D1741E83" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0AAEC967359377E805EF8F22D1741E83" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0AAEC967359377E805EF8F22D1741E83" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0AAEC967359377E805EF8F22D1741E83" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_A2A0F8EE09EE6B643BD38F22D175DD20_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_A2A0F8EE09EE6B643BD38F22D175DD20" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_A2A0F8EE09EE6B643BD38F22D175DD20_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_A2A0F8EE09EE6B643BD38F22D175DD20" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_A2A0F8EE09EE6B643BD38F22D175DD20" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_A2A0F8EE09EE6B643BD38F22D175DD20" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_A2A0F8EE09EE6B643BD38F22D175DD20" xlink:type="arc" />
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_F08A551E183A0F0F13748F22D1753A0F_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy_F08A551E183A0F0F13748F22D1753A0F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_F08A551E183A0F0F13748F22D1753A0F_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy_F08A551E183A0F0F13748F22D1753A0F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_F08A551E183A0F0F13748F22D1753A0F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy_F08A551E183A0F0F13748F22D1753A0F" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy_F08A551E183A0F0F13748F22D1753A0F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_12B53F4C1BE123EA7EA48F22D175258C_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_12B53F4C1BE123EA7EA48F22D175258C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_12B53F4C1BE123EA7EA48F22D175258C_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_12B53F4C1BE123EA7EA48F22D175258C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_12B53F4C1BE123EA7EA48F22D175258C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_12B53F4C1BE123EA7EA48F22D175258C" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_12B53F4C1BE123EA7EA48F22D175258C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_9EB405521F508B88FCCA8F22D175DCC0_verboseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock_9EB405521F508B88FCCA8F22D175DCC0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_9EB405521F508B88FCCA8F22D175DCC0_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock_9EB405521F508B88FCCA8F22D175DCC0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_9EB405521F508B88FCCA8F22D175DCC0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock_9EB405521F508B88FCCA8F22D175DCC0" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock_9EB405521F508B88FCCA8F22D175DCC0" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_A7A02946C67C66B4CEE48F22D17539B8_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock_A7A02946C67C66B4CEE48F22D17539B8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_A7A02946C67C66B4CEE48F22D17539B8_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock_A7A02946C67C66B4CEE48F22D17539B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_A7A02946C67C66B4CEE48F22D17539B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock_A7A02946C67C66B4CEE48F22D17539B8" xlink:to="lab_us-gaap_InventoryPolicyTextBlock_A7A02946C67C66B4CEE48F22D17539B8" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_FEE2D5C4AD89292AC58B8F22D175442A_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_FEE2D5C4AD89292AC58B8F22D175442A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_FEE2D5C4AD89292AC58B8F22D175442A_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_FEE2D5C4AD89292AC58B8F22D175442A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_FEE2D5C4AD89292AC58B8F22D175442A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_FEE2D5C4AD89292AC58B8F22D175442A" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_FEE2D5C4AD89292AC58B8F22D175442A" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_B14BAD34FCA82939157E8F22D176D1C8_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_B14BAD34FCA82939157E8F22D176D1C8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_B14BAD34FCA82939157E8F22D176D1C8_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_B14BAD34FCA82939157E8F22D176D1C8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_B14BAD34FCA82939157E8F22D176D1C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_B14BAD34FCA82939157E8F22D176D1C8" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_B14BAD34FCA82939157E8F22D176D1C8" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_D8C194887689556236088F22D1768D2F_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy_D8C194887689556236088F22D1768D2F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_D8C194887689556236088F22D1768D2F_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy_D8C194887689556236088F22D1768D2F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_D8C194887689556236088F22D1768D2F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy_D8C194887689556236088F22D1768D2F" xlink:to="lab_us-gaap_BusinessCombinationsPolicy_D8C194887689556236088F22D1768D2F" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_461EB036D6047F8BAB9F8F22D176AA67_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock_461EB036D6047F8BAB9F8F22D176AA67" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_461EB036D6047F8BAB9F8F22D176AA67_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock_461EB036D6047F8BAB9F8F22D176AA67" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Recognition, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_461EB036D6047F8BAB9F8F22D176AA67" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock_461EB036D6047F8BAB9F8F22D176AA67" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock_461EB036D6047F8BAB9F8F22D176AA67" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_3DA98EC0A15D045C65398F22D176057B_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_3DA98EC0A15D045C65398F22D176057B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_3DA98EC0A15D045C65398F22D176057B_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_3DA98EC0A15D045C65398F22D176057B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_3DA98EC0A15D045C65398F22D176057B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_3DA98EC0A15D045C65398F22D176057B" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_3DA98EC0A15D045C65398F22D176057B" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_19A1C80DC6F9195C8F4F8F22D1769C4B_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock_19A1C80DC6F9195C8F4F8F22D1769C4B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_19A1C80DC6F9195C8F4F8F22D1769C4B_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock_19A1C80DC6F9195C8F4F8F22D1769C4B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_19A1C80DC6F9195C8F4F8F22D1769C4B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock_19A1C80DC6F9195C8F4F8F22D1769C4B" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock_19A1C80DC6F9195C8F4F8F22D1769C4B" xlink:type="arc" />
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_D8461F283977188844B28F22D176B2AD_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy_D8461F283977188844B28F22D176B2AD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warranty Costs</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_D8461F283977188844B28F22D176B2AD_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy_D8461F283977188844B28F22D176B2AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard Product Warranty, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_D8461F283977188844B28F22D176B2AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyPolicy_D8461F283977188844B28F22D176B2AD" xlink:to="lab_us-gaap_StandardProductWarrantyPolicy_D8461F283977188844B28F22D176B2AD" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_09FF7CB1E21366362AE68F22D1775F69_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_09FF7CB1E21366362AE68F22D1775F69" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_09FF7CB1E21366362AE68F22D1775F69_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_09FF7CB1E21366362AE68F22D1775F69" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_09FF7CB1E21366362AE68F22D1775F69" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_09FF7CB1E21366362AE68F22D1775F69" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_09FF7CB1E21366362AE68F22D1775F69" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_967AEBF63332990BBA6B8F22D17773C3_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_967AEBF63332990BBA6B8F22D17773C3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_967AEBF63332990BBA6B8F22D17773C3_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_967AEBF63332990BBA6B8F22D17773C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_967AEBF63332990BBA6B8F22D17773C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_967AEBF63332990BBA6B8F22D17773C3" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_967AEBF63332990BBA6B8F22D17773C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_DB9429C5CB97CB9B463D8F22D177274A_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock_DB9429C5CB97CB9B463D8F22D177274A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_DB9429C5CB97CB9B463D8F22D177274A_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock_DB9429C5CB97CB9B463D8F22D177274A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_DB9429C5CB97CB9B463D8F22D177274A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock_DB9429C5CB97CB9B463D8F22D177274A" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock_DB9429C5CB97CB9B463D8F22D177274A" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_32F2F956C9CC7EBD3B3A8F22D177FB80_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_32F2F956C9CC7EBD3B3A8F22D177FB80" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_32F2F956C9CC7EBD3B3A8F22D177FB80_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_32F2F956C9CC7EBD3B3A8F22D177FB80" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_32F2F956C9CC7EBD3B3A8F22D177FB80" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_32F2F956C9CC7EBD3B3A8F22D177FB80" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_32F2F956C9CC7EBD3B3A8F22D177FB80" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_A67235B96AD31766BBA78F22D1778819_verboseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_A67235B96AD31766BBA78F22D1778819" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Recently Issued Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_A67235B96AD31766BBA78F22D1778819_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_A67235B96AD31766BBA78F22D1778819" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_A67235B96AD31766BBA78F22D1778819" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_A67235B96AD31766BBA78F22D1778819" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_A67235B96AD31766BBA78F22D1778819" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_B866B260E45BF143EA478C8B9A113073_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_B866B260E45BF143EA478C8B9A113073" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_B866B260E45BF143EA478C8B9A113073_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_B866B260E45BF143EA478C8B9A113073" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_B866B260E45BF143EA478C8B9A113073" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_B866B260E45BF143EA478C8B9A113073" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_B866B260E45BF143EA478C8B9A113073" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_665BA1825D9349AF39DA8C8B9A11161C_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_665BA1825D9349AF39DA8C8B9A11161C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_665BA1825D9349AF39DA8C8B9A11161C_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_665BA1825D9349AF39DA8C8B9A11161C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_665BA1825D9349AF39DA8C8B9A11161C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_665BA1825D9349AF39DA8C8B9A11161C" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_665BA1825D9349AF39DA8C8B9A11161C" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96" xlink:type="arc" />
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_2E5B9217F3F63628812C8C8B9A116C9D_verboseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember_2E5B9217F3F63628812C8C8B9A116C9D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Building and building improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_2E5B9217F3F63628812C8C8B9A116C9D_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember_2E5B9217F3F63628812C8C8B9A116C9D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_2E5B9217F3F63628812C8C8B9A116C9D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember_2E5B9217F3F63628812C8C8B9A116C9D" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember_2E5B9217F3F63628812C8C8B9A116C9D" xlink:type="arc" />
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_820B0266DCED69389B798C8B9A119C90_verboseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember_820B0266DCED69389B798C8B9A119C90" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_820B0266DCED69389B798C8B9A119C90_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember_820B0266DCED69389B798C8B9A119C90" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_820B0266DCED69389B798C8B9A119C90" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember_820B0266DCED69389B798C8B9A119C90" xlink:to="lab_us-gaap_MachineryAndEquipmentMember_820B0266DCED69389B798C8B9A119C90" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComputerEquipmentMember_A2012ACBC0F95E1794DE8C8B9A113F0C_verboseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember_A2012ACBC0F95E1794DE8C8B9A113F0C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Computer software and equipment</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_A2012ACBC0F95E1794DE8C8B9A113F0C_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember_A2012ACBC0F95E1794DE8C8B9A113F0C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_A2012ACBC0F95E1794DE8C8B9A113F0C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember_A2012ACBC0F95E1794DE8C8B9A113F0C" xlink:to="lab_us-gaap_ComputerEquipmentMember_A2012ACBC0F95E1794DE8C8B9A113F0C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConstructionInProgressMember_A72B659315D994CE991A8C8B9A11D131_verboseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember_A72B659315D994CE991A8C8B9A11D131" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_A72B659315D994CE991A8C8B9A11D131_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember_A72B659315D994CE991A8C8B9A11D131" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="loc_us-gaap_ConstructionInProgressMember_A72B659315D994CE991A8C8B9A11D131" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember_A72B659315D994CE991A8C8B9A11D131" xlink:to="lab_us-gaap_ConstructionInProgressMember_A72B659315D994CE991A8C8B9A11D131" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_2F92076A3EE4B27C2FF48C8B9A111EFF_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems_2F92076A3EE4B27C2FF48C8B9A111EFF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_2F92076A3EE4B27C2FF48C8B9A111EFF_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems_2F92076A3EE4B27C2FF48C8B9A111EFF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2F92076A3EE4B27C2FF48C8B9A111EFF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2F92076A3EE4B27C2FF48C8B9A111EFF" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems_2F92076A3EE4B27C2FF48C8B9A111EFF" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_C6E0DE96869D9D1E20698C8B9A11EFAE_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross_C6E0DE96869D9D1E20698C8B9A11EFAE" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_C6E0DE96869D9D1E20698C8B9A11EFAE_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross_C6E0DE96869D9D1E20698C8B9A11EFAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_C6E0DE96869D9D1E20698C8B9A11EFAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_C6E0DE96869D9D1E20698C8B9A11EFAE" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross_C6E0DE96869D9D1E20698C8B9A11EFAE" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_B52FD1D61F055E43072F8C8B9A1150BD_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_B52FD1D61F055E43072F8C8B9A1150BD" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_B52FD1D61F055E43072F8C8B9A1150BD_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_B52FD1D61F055E43072F8C8B9A1150BD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_B52FD1D61F055E43072F8C8B9A1150BD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_B52FD1D61F055E43072F8C8B9A1150BD" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_B52FD1D61F055E43072F8C8B9A1150BD" xlink:type="arc" />
    <link:label id="lab_ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements_10AA323DB108213CCDDA8C8B9A113B1F_totalLabel_en-US" xlink:label="lab_ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements_10AA323DB108213CCDDA8C8B9A113B1F" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment excluding land and land improvements</link:label>
    <link:label id="lab_ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements_10AA323DB108213CCDDA8C8B9A113B1F_label_en-US" xlink:label="lab_ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements_10AA323DB108213CCDDA8C8B9A113B1F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property Plant and Equipment Excluding Land and Land Improvements</link:label>
    <link:label id="lab_ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements_10AA323DB108213CCDDA8C8B9A113B1F_documentation_en-US" xlink:label="lab_ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements_10AA323DB108213CCDDA8C8B9A113B1F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Property plant and equipment excluding land and land improvements.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements" xlink:label="loc_ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements_10AA323DB108213CCDDA8C8B9A113B1F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements_10AA323DB108213CCDDA8C8B9A113B1F" xlink:to="lab_ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements_10AA323DB108213CCDDA8C8B9A113B1F" xlink:type="arc" />
    <link:label id="lab_us-gaap_LandAndLandImprovements_3991D85FE99C720BB4188C8B9A11A5C1_verboseLabel_en-US" xlink:label="lab_us-gaap_LandAndLandImprovements_3991D85FE99C720BB4188C8B9A11A5C1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Land and land improvements</link:label>
    <link:label id="lab_us-gaap_LandAndLandImprovements_3991D85FE99C720BB4188C8B9A11A5C1_label_en-US" xlink:label="lab_us-gaap_LandAndLandImprovements_3991D85FE99C720BB4188C8B9A11A5C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Land and Land Improvements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LandAndLandImprovements" xlink:label="loc_us-gaap_LandAndLandImprovements_3991D85FE99C720BB4188C8B9A11A5C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandAndLandImprovements_3991D85FE99C720BB4188C8B9A11A5C1" xlink:to="lab_us-gaap_LandAndLandImprovements_3991D85FE99C720BB4188C8B9A11A5C1" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_E77A0F2748ACD3FBE46F8C8B9A11F114_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_E77A0F2748ACD3FBE46F8C8B9A11F114" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_E77A0F2748ACD3FBE46F8C8B9A11F114" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_E77A0F2748ACD3FBE46F8C8B9A11F114" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_E77A0F2748ACD3FBE46F8C8B9A11F114" xlink:type="arc" />
    <link:label id="lab_us-gaap_Depreciation_2396232D1B0271DE7A148C8B9A112DDE_verboseLabel_en-US" xlink:label="lab_us-gaap_Depreciation_2396232D1B0271DE7A148C8B9A112DDE" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_2396232D1B0271DE7A148C8B9A112DDE_label_en-US" xlink:label="lab_us-gaap_Depreciation_2396232D1B0271DE7A148C8B9A112DDE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_2396232D1B0271DE7A148C8B9A112DDE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation_2396232D1B0271DE7A148C8B9A112DDE" xlink:to="lab_us-gaap_Depreciation_2396232D1B0271DE7A148C8B9A112DDE" xlink:type="arc" />
    <link:label id="lab_us-gaap_Revenues_E86E1DBE8AF2C8D67EF094C42DAC3E87_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues_E86E1DBE8AF2C8D67EF094C42DAC3E87" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_Revenues_E86E1DBE8AF2C8D67EF094C42DAC3E87_label_en-US" xlink:label="lab_us-gaap_Revenues_E86E1DBE8AF2C8D67EF094C42DAC3E87" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_E86E1DBE8AF2C8D67EF094C42DAC3E87" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_E86E1DBE8AF2C8D67EF094C42DAC3E87" xlink:to="lab_us-gaap_Revenues_E86E1DBE8AF2C8D67EF094C42DAC3E87" xlink:type="arc" />
    <link:label id="lab_us-gaap_GrossProfit_294B9CBED0314A97730594C42DBB1515_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit_294B9CBED0314A97730594C42DBB1515" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_294B9CBED0314A97730594C42DBB1515_label_en-US" xlink:label="lab_us-gaap_GrossProfit_294B9CBED0314A97730594C42DBB1515" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_294B9CBED0314A97730594C42DBB1515" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit_294B9CBED0314A97730594C42DBB1515" xlink:to="lab_us-gaap_GrossProfit_294B9CBED0314A97730594C42DBB1515" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_9F94DDA11E9F191D011B94C42DBB8FDA_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract_9F94DDA11E9F191D011B94C42DBB8FDA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings (loss) per common share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9F94DDA11E9F191D011B94C42DBB8FDA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9F94DDA11E9F191D011B94C42DBB8FDA" xlink:to="lab_us-gaap_EarningsPerShareAbstract_9F94DDA11E9F191D011B94C42DBB8FDA" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasic_D265DDA55DE945ACDE5094C42DBB82FC_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_D265DDA55DE945ACDE5094C42DBB82FC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic (usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_D265DDA55DE945ACDE5094C42DBB82FC_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_D265DDA55DE945ACDE5094C42DBB82FC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_D265DDA55DE945ACDE5094C42DBB82FC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_D265DDA55DE945ACDE5094C42DBB82FC" xlink:to="lab_us-gaap_EarningsPerShareBasic_D265DDA55DE945ACDE5094C42DBB82FC" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_5E085E672F43C098424C94C42DBB380F_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_5E085E672F43C098424C94C42DBB380F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted (usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_5E085E672F43C098424C94C42DBB380F_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_5E085E672F43C098424C94C42DBB380F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5E085E672F43C098424C94C42DBB380F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_5E085E672F43C098424C94C42DBB380F" xlink:to="lab_us-gaap_EarningsPerShareDiluted_5E085E672F43C098424C94C42DBB380F" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81FEA8688D316E28C9E294C42DBBF77B_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81FEA8688D316E28C9E294C42DBBF77B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81FEA8688D316E28C9E294C42DBBF77B_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81FEA8688D316E28C9E294C42DBBF77B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81FEA8688D316E28C9E294C42DBBF77B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81FEA8688D316E28C9E294C42DBBF77B" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81FEA8688D316E28C9E294C42DBBF77B" xlink:type="arc" />
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_72AC917C26F3CAD1BF4694C42DBBCDB7_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_72AC917C26F3CAD1BF4694C42DBBCDB7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued Operations, Disposed of by Means Other than Sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_72AC917C26F3CAD1BF4694C42DBBCDB7_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_72AC917C26F3CAD1BF4694C42DBBCDB7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operations, Disposed of by Means Other than Sale [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_72AC917C26F3CAD1BF4694C42DBBCDB7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_72AC917C26F3CAD1BF4694C42DBBCDB7" xlink:to="lab_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_72AC917C26F3CAD1BF4694C42DBBCDB7" xlink:type="arc" />
    <link:label id="lab_srt_ProductOrServiceAxis_62D10A9529CF2E2EBCBA94C42DBBD07E_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis_62D10A9529CF2E2EBCBA94C42DBBD07E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_62D10A9529CF2E2EBCBA94C42DBBD07E_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis_62D10A9529CF2E2EBCBA94C42DBBD07E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_62D10A9529CF2E2EBCBA94C42DBBD07E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis_62D10A9529CF2E2EBCBA94C42DBBD07E" xlink:to="lab_srt_ProductOrServiceAxis_62D10A9529CF2E2EBCBA94C42DBBD07E" xlink:type="arc" />
    <link:label id="lab_srt_ProductsAndServicesDomain_19AA8772CD4BF986526394C42DBBF5D4_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain_19AA8772CD4BF986526394C42DBBF5D4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_19AA8772CD4BF986526394C42DBBF5D4_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain_19AA8772CD4BF986526394C42DBBF5D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_19AA8772CD4BF986526394C42DBBF5D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain_19AA8772CD4BF986526394C42DBBF5D4" xlink:to="lab_srt_ProductsAndServicesDomain_19AA8772CD4BF986526394C42DBBF5D4" xlink:type="arc" />
    <link:label id="lab_ango_AcculisCapitalSystemsMember_BCAB0C555609C18D44A994C42DBBB283_terseLabel_en-US" xlink:label="lab_ango_AcculisCapitalSystemsMember_BCAB0C555609C18D44A994C42DBBB283" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acculis Capital Systems</link:label>
    <link:label id="lab_ango_AcculisCapitalSystemsMember_BCAB0C555609C18D44A994C42DBBB283_label_en-US" xlink:label="lab_ango_AcculisCapitalSystemsMember_BCAB0C555609C18D44A994C42DBBB283" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acculis Capital Systems [Member]</link:label>
    <link:label id="lab_ango_AcculisCapitalSystemsMember_BCAB0C555609C18D44A994C42DBBB283_documentation_en-US" xlink:label="lab_ango_AcculisCapitalSystemsMember_BCAB0C555609C18D44A994C42DBBB283" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Acculis Capital Systems [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_AcculisCapitalSystemsMember" xlink:label="loc_ango_AcculisCapitalSystemsMember_BCAB0C555609C18D44A994C42DBBB283" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_AcculisCapitalSystemsMember_BCAB0C555609C18D44A994C42DBBB283" xlink:to="lab_ango_AcculisCapitalSystemsMember_BCAB0C555609C18D44A994C42DBBB283" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_365B9693C63F13E9C21A94C42DBBADAE_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_365B9693C63F13E9C21A94C42DBBADAE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_365B9693C63F13E9C21A94C42DBBADAE_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_365B9693C63F13E9C21A94C42DBBADAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_365B9693C63F13E9C21A94C42DBBADAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_365B9693C63F13E9C21A94C42DBBADAE" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_365B9693C63F13E9C21A94C42DBBADAE" xlink:type="arc" />
    <link:label id="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_B6BBBE8CC8D04CAB483B94C42DBB6454_negatedTerseLabel_en-US" xlink:label="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_B6BBBE8CC8D04CAB483B94C42DBB6454" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Discrete tax benefit</link:label>
    <link:label id="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_B6BBBE8CC8D04CAB483B94C42DBB6454_label_en-US" xlink:label="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_B6BBBE8CC8D04CAB483B94C42DBB6454" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Provisional Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_B6BBBE8CC8D04CAB483B94C42DBB6454_documentation_en-US" xlink:label="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_B6BBBE8CC8D04CAB483B94C42DBB6454" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Provisional Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit" xlink:label="loc_ango_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_B6BBBE8CC8D04CAB483B94C42DBB6454" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_B6BBBE8CC8D04CAB483B94C42DBB6454" xlink:to="lab_ango_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_B6BBBE8CC8D04CAB483B94C42DBB6454" xlink:type="arc" />
    <link:label id="lab_us-gaap_LitigationReserve_3A4C03BEAB27AA40AC3E94C42DBBE65F_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve_3A4C03BEAB27AA40AC3E94C42DBBE65F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated litigation liability</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_3A4C03BEAB27AA40AC3E94C42DBBE65F_label_en-US" xlink:label="lab_us-gaap_LitigationReserve_3A4C03BEAB27AA40AC3E94C42DBBE65F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_3A4C03BEAB27AA40AC3E94C42DBBE65F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve_3A4C03BEAB27AA40AC3E94C42DBBE65F" xlink:to="lab_us-gaap_LitigationReserve_3A4C03BEAB27AA40AC3E94C42DBBE65F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_8DB58A14C9A5FFF95C4494C42DBB1EFA_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_8DB58A14C9A5FFF95C4494C42DBB1EFA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal group, impact to income</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_8DB58A14C9A5FFF95C4494C42DBB1EFA_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_8DB58A14C9A5FFF95C4494C42DBB1EFA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_8DB58A14C9A5FFF95C4494C42DBB1EFA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_8DB58A14C9A5FFF95C4494C42DBB1EFA" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_8DB58A14C9A5FFF95C4494C42DBB1EFA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1C6E5FB8805E218B5B25949FCBE751AC_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1C6E5FB8805E218B5B25949FCBE751AC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1C6E5FB8805E218B5B25949FCBE751AC_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1C6E5FB8805E218B5B25949FCBE751AC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1C6E5FB8805E218B5B25949FCBE751AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1C6E5FB8805E218B5B25949FCBE751AC" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1C6E5FB8805E218B5B25949FCBE751AC" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_423196CE84BE8EB5D404949FCBE8DDE9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_423196CE84BE8EB5D404949FCBE8DDE9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_423196CE84BE8EB5D404949FCBE8DDE9_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_423196CE84BE8EB5D404949FCBE8DDE9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_423196CE84BE8EB5D404949FCBE8DDE9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_423196CE84BE8EB5D404949FCBE8DDE9" xlink:to="lab_us-gaap_IncomeStatementLocationAxis_423196CE84BE8EB5D404949FCBE8DDE9" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86" xlink:to="lab_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfSalesMember_806AAFF216A3809417B7949FCBE8B911_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember_806AAFF216A3809417B7949FCBE8B911" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_806AAFF216A3809417B7949FCBE8B911_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember_806AAFF216A3809417B7949FCBE8B911" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_806AAFF216A3809417B7949FCBE8B911" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember_806AAFF216A3809417B7949FCBE8B911" xlink:to="lab_us-gaap_CostOfSalesMember_806AAFF216A3809417B7949FCBE8B911" xlink:type="arc" />
    <link:label id="lab_ango_ResearchAndDevelopmentMember_AB3C25032D663E11107C949FCBE9BE8B_terseLabel_en-US" xlink:label="lab_ango_ResearchAndDevelopmentMember_AB3C25032D663E11107C949FCBE9BE8B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_ango_ResearchAndDevelopmentMember_AB3C25032D663E11107C949FCBE9BE8B_label_en-US" xlink:label="lab_ango_ResearchAndDevelopmentMember_AB3C25032D663E11107C949FCBE9BE8B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development [Member]</link:label>
    <link:label id="lab_ango_ResearchAndDevelopmentMember_AB3C25032D663E11107C949FCBE9BE8B_documentation_en-US" xlink:label="lab_ango_ResearchAndDevelopmentMember_AB3C25032D663E11107C949FCBE9BE8B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research and development.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_ResearchAndDevelopmentMember" xlink:label="loc_ango_ResearchAndDevelopmentMember_AB3C25032D663E11107C949FCBE9BE8B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ResearchAndDevelopmentMember_AB3C25032D663E11107C949FCBE9BE8B" xlink:to="lab_ango_ResearchAndDevelopmentMember_AB3C25032D663E11107C949FCBE9BE8B" xlink:type="arc" />
    <link:label id="lab_ango_SalesandMarketingMember_15085B2BD1E110381982949FCBE942DE_terseLabel_en-US" xlink:label="lab_ango_SalesandMarketingMember_15085B2BD1E110381982949FCBE942DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_ango_SalesandMarketingMember_15085B2BD1E110381982949FCBE942DE_label_en-US" xlink:label="lab_ango_SalesandMarketingMember_15085B2BD1E110381982949FCBE942DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales and Marketing [Member]</link:label>
    <link:label id="lab_ango_SalesandMarketingMember_15085B2BD1E110381982949FCBE942DE_documentation_en-US" xlink:label="lab_ango_SalesandMarketingMember_15085B2BD1E110381982949FCBE942DE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sales and Marketing [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_SalesandMarketingMember" xlink:label="loc_ango_SalesandMarketingMember_15085B2BD1E110381982949FCBE942DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_SalesandMarketingMember_15085B2BD1E110381982949FCBE942DE" xlink:to="lab_ango_SalesandMarketingMember_15085B2BD1E110381982949FCBE942DE" xlink:type="arc" />
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_873AD77C529EFA4E5EFA949FCBE900E7_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember_873AD77C529EFA4E5EFA949FCBE900E7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_873AD77C529EFA4E5EFA949FCBE900E7_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember_873AD77C529EFA4E5EFA949FCBE900E7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_873AD77C529EFA4E5EFA949FCBE900E7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember_873AD77C529EFA4E5EFA949FCBE900E7" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember_873AD77C529EFA4E5EFA949FCBE900E7" xlink:type="arc" />
    <link:label id="lab_ango_AcquisitionRestructuringAndOtherItemsNetMember_5AE5FE71CB256CFA269F949FCBE91065_terseLabel_en-US" xlink:label="lab_ango_AcquisitionRestructuringAndOtherItemsNetMember_5AE5FE71CB256CFA269F949FCBE91065" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition, restructuring and other items, net</link:label>
    <link:label id="lab_ango_AcquisitionRestructuringAndOtherItemsNetMember_5AE5FE71CB256CFA269F949FCBE91065_label_en-US" xlink:label="lab_ango_AcquisitionRestructuringAndOtherItemsNetMember_5AE5FE71CB256CFA269F949FCBE91065" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisition, Restructuring And Other Items, Net [Member]</link:label>
    <link:label id="lab_ango_AcquisitionRestructuringAndOtherItemsNetMember_5AE5FE71CB256CFA269F949FCBE91065_documentation_en-US" xlink:label="lab_ango_AcquisitionRestructuringAndOtherItemsNetMember_5AE5FE71CB256CFA269F949FCBE91065" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Acquisition, Restructuring And Other Items, Net [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_AcquisitionRestructuringAndOtherItemsNetMember" xlink:label="loc_ango_AcquisitionRestructuringAndOtherItemsNetMember_5AE5FE71CB256CFA269F949FCBE91065" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_AcquisitionRestructuringAndOtherItemsNetMember_5AE5FE71CB256CFA269F949FCBE91065" xlink:to="lab_ango_AcquisitionRestructuringAndOtherItemsNetMember_5AE5FE71CB256CFA269F949FCBE91065" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1234E42466412828134E949FCBE9F51F_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1234E42466412828134E949FCBE9F51F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1234E42466412828134E949FCBE9F51F_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1234E42466412828134E949FCBE9F51F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1234E42466412828134E949FCBE9F51F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1234E42466412828134E949FCBE9F51F" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1234E42466412828134E949FCBE9F51F" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_A8433594669F83DAC9F4949FCBE9A077_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_A8433594669F83DAC9F4949FCBE9A077" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock based compensation pre tax amount</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_A8433594669F83DAC9F4949FCBE9A077_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense_A8433594669F83DAC9F4949FCBE9A077" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allocated Share-based Compensation Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_A8433594669F83DAC9F4949FCBE9A077" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense_A8433594669F83DAC9F4949FCBE9A077" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense_A8433594669F83DAC9F4949FCBE9A077" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_65F253BAD87E4E608C908C8B9C739448_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_65F253BAD87E4E608C908C8B9C739448" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_65F253BAD87E4E608C908C8B9C739448_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_65F253BAD87E4E608C908C8B9C739448" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_65F253BAD87E4E608C908C8B9C739448" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_65F253BAD87E4E608C908C8B9C739448" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_65F253BAD87E4E608C908C8B9C739448" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_703FEF15D2B3AF74B3B48C8B9D9CD468_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock_703FEF15D2B3AF74B3B48C8B9D9CD468" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">LONG-TERM DEBT</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_703FEF15D2B3AF74B3B48C8B9D9CD468_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock_703FEF15D2B3AF74B3B48C8B9D9CD468" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaap_LongTermDebtTextBlock_703FEF15D2B3AF74B3B48C8B9D9CD468" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock_703FEF15D2B3AF74B3B48C8B9D9CD468" xlink:to="lab_us-gaap_LongTermDebtTextBlock_703FEF15D2B3AF74B3B48C8B9D9CD468" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_CDEF05A73D6FFF8FE74F8F96E2BF7B58_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_CDEF05A73D6FFF8FE74F8F96E2BF7B58" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_CDEF05A73D6FFF8FE74F8F96E2BF7B58_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_CDEF05A73D6FFF8FE74F8F96E2BF7B58" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_CDEF05A73D6FFF8FE74F8F96E2BF7B58" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_CDEF05A73D6FFF8FE74F8F96E2BF7B58" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_CDEF05A73D6FFF8FE74F8F96E2BF7B58" xlink:type="arc" />
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_FAF39EF2A68392FE2B448F96E2C54D5E_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_FAF39EF2A68392FE2B448F96E2C54D5E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New York State government agency obligations</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_FAF39EF2A68392FE2B448F96E2C54D5E_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_FAF39EF2A68392FE2B448F96E2C54D5E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_FAF39EF2A68392FE2B448F96E2C54D5E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_FAF39EF2A68392FE2B448F96E2C54D5E" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_FAF39EF2A68392FE2B448F96E2C54D5E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5E296C8EB7075B7A70C08F96E2C69ED7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5E296C8EB7075B7A70C08F96E2C69ED7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5E296C8EB7075B7A70C08F96E2C69ED7_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5E296C8EB7075B7A70C08F96E2C69ED7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5E296C8EB7075B7A70C08F96E2C69ED7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5E296C8EB7075B7A70C08F96E2C69ED7" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5E296C8EB7075B7A70C08F96E2C69ED7" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_A3FF4A9F356AEAE99E518F96E2C706C7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_A3FF4A9F356AEAE99E518F96E2C706C7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_A3FF4A9F356AEAE99E518F96E2C706C7_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_A3FF4A9F356AEAE99E518F96E2C706C7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_A3FF4A9F356AEAE99E518F96E2C706C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_A3FF4A9F356AEAE99E518F96E2C706C7" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_A3FF4A9F356AEAE99E518F96E2C706C7" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_BD922B6520540F41AE768F96E2C74D9F_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_BD922B6520540F41AE768F96E2C74D9F" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_BD922B6520540F41AE768F96E2C74D9F_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_BD922B6520540F41AE768F96E2C74D9F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_BD922B6520540F41AE768F96E2C74D9F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_BD922B6520540F41AE768F96E2C74D9F" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_BD922B6520540F41AE768F96E2C74D9F" xlink:type="arc" />
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_5BDF692AA3A87BEAA12E8F96E2C7F94A_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_5BDF692AA3A87BEAA12E8F96E2C7F94A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_5BDF692AA3A87BEAA12E8F96E2C7F94A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_5BDF692AA3A87BEAA12E8F96E2C7F94A" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_5BDF692AA3A87BEAA12E8F96E2C7F94A" xlink:type="arc" />
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1FB87BF6CF177F558FFD8C8B9D7DA1D0_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1FB87BF6CF177F558FFD8C8B9D7DA1D0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1FB87BF6CF177F558FFD8C8B9D7DA1D0_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1FB87BF6CF177F558FFD8C8B9D7DA1D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1FB87BF6CF177F558FFD8C8B9D7DA1D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1FB87BF6CF177F558FFD8C8B9D7DA1D0" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1FB87BF6CF177F558FFD8C8B9D7DA1D0" xlink:type="arc" />
    <link:label id="lab_ango_SoftwareLicenses_AE4D5DD181C249D067E88C8B9D7D222D_verboseLabel_en-US" xlink:label="lab_ango_SoftwareLicenses_AE4D5DD181C249D067E88C8B9D7D222D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Software licenses</link:label>
    <link:label id="lab_ango_SoftwareLicenses_AE4D5DD181C249D067E88C8B9D7D222D_label_en-US" xlink:label="lab_ango_SoftwareLicenses_AE4D5DD181C249D067E88C8B9D7D222D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Software Licenses</link:label>
    <link:label id="lab_ango_SoftwareLicenses_AE4D5DD181C249D067E88C8B9D7D222D_documentation_en-US" xlink:label="lab_ango_SoftwareLicenses_AE4D5DD181C249D067E88C8B9D7D222D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying amount as of the balance sheet date of payments made for software licenses.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_SoftwareLicenses" xlink:label="loc_ango_SoftwareLicenses_AE4D5DD181C249D067E88C8B9D7D222D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_SoftwareLicenses_AE4D5DD181C249D067E88C8B9D7D222D" xlink:to="lab_ango_SoftwareLicenses_AE4D5DD181C249D067E88C8B9D7D222D" xlink:type="arc" />
    <link:label id="lab_ango_PrepaidLicenseeFees_37F969C91A305BB201E18C8B9D7D6BF1_verboseLabel_en-US" xlink:label="lab_ango_PrepaidLicenseeFees_37F969C91A305BB201E18C8B9D7D6BF1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">License fees</link:label>
    <link:label id="lab_ango_PrepaidLicenseeFees_37F969C91A305BB201E18C8B9D7D6BF1_label_en-US" xlink:label="lab_ango_PrepaidLicenseeFees_37F969C91A305BB201E18C8B9D7D6BF1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Licensee Fees</link:label>
    <link:label id="lab_ango_PrepaidLicenseeFees_37F969C91A305BB201E18C8B9D7D6BF1_documentation_en-US" xlink:label="lab_ango_PrepaidLicenseeFees_37F969C91A305BB201E18C8B9D7D6BF1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying amount as of the balance sheet date of prepaid licensee fees.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_PrepaidLicenseeFees" xlink:label="loc_ango_PrepaidLicenseeFees_37F969C91A305BB201E18C8B9D7D6BF1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_PrepaidLicenseeFees_37F969C91A305BB201E18C8B9D7D6BF1" xlink:to="lab_ango_PrepaidLicenseeFees_37F969C91A305BB201E18C8B9D7D6BF1" xlink:type="arc" />
    <link:label id="lab_ango_TradeShows_79D50CF26F6C2849ADF28C8B9D7DD77E_terseLabel_en-US" xlink:label="lab_ango_TradeShows_79D50CF26F6C2849ADF28C8B9D7DD77E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade shows</link:label>
    <link:label id="lab_ango_TradeShows_79D50CF26F6C2849ADF28C8B9D7DD77E_label_en-US" xlink:label="lab_ango_TradeShows_79D50CF26F6C2849ADF28C8B9D7DD77E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade Shows</link:label>
    <link:label id="lab_ango_TradeShows_79D50CF26F6C2849ADF28C8B9D7DD77E_documentation_en-US" xlink:label="lab_ango_TradeShows_79D50CF26F6C2849ADF28C8B9D7DD77E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying amount as of the balance sheet date of payments made in advance related to trade shows.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_TradeShows" xlink:label="loc_ango_TradeShows_79D50CF26F6C2849ADF28C8B9D7DD77E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_TradeShows_79D50CF26F6C2849ADF28C8B9D7DD77E" xlink:to="lab_ango_TradeShows_79D50CF26F6C2849ADF28C8B9D7DD77E" xlink:type="arc" />
    <link:label id="lab_us-gaap_PrepaidRent_7EAEDE20139E3CEF162B8C8B9D7D2F5D_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidRent_7EAEDE20139E3CEF162B8C8B9D7D2F5D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Rent</link:label>
    <link:label id="lab_us-gaap_PrepaidRent_7EAEDE20139E3CEF162B8C8B9D7D2F5D_label_en-US" xlink:label="lab_us-gaap_PrepaidRent_7EAEDE20139E3CEF162B8C8B9D7D2F5D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Rent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidRent" xlink:label="loc_us-gaap_PrepaidRent_7EAEDE20139E3CEF162B8C8B9D7D2F5D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidRent_7EAEDE20139E3CEF162B8C8B9D7D2F5D" xlink:to="lab_us-gaap_PrepaidRent_7EAEDE20139E3CEF162B8C8B9D7D2F5D" xlink:type="arc" />
    <link:label id="lab_ango_PrepaidIncomeandOtherTaxes_67B16D4E03A9FE2A22A28C8B9D7D9560_terseLabel_en-US" xlink:label="lab_ango_PrepaidIncomeandOtherTaxes_67B16D4E03A9FE2A22A28C8B9D7D9560" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other prepaid taxes</link:label>
    <link:label id="lab_ango_PrepaidIncomeandOtherTaxes_67B16D4E03A9FE2A22A28C8B9D7D9560_label_en-US" xlink:label="lab_ango_PrepaidIncomeandOtherTaxes_67B16D4E03A9FE2A22A28C8B9D7D9560" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Income and Other Taxes</link:label>
    <link:label id="lab_ango_PrepaidIncomeandOtherTaxes_67B16D4E03A9FE2A22A28C8B9D7D9560_documentation_en-US" xlink:label="lab_ango_PrepaidIncomeandOtherTaxes_67B16D4E03A9FE2A22A28C8B9D7D9560" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prepaid Income and Other Taxes</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_PrepaidIncomeandOtherTaxes" xlink:label="loc_ango_PrepaidIncomeandOtherTaxes_67B16D4E03A9FE2A22A28C8B9D7D9560" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_PrepaidIncomeandOtherTaxes_67B16D4E03A9FE2A22A28C8B9D7D9560" xlink:to="lab_ango_PrepaidIncomeandOtherTaxes_67B16D4E03A9FE2A22A28C8B9D7D9560" xlink:type="arc" />
    <link:label id="lab_ango_MedicalDeviceExciseTaxReceivable_C1F3E78CD22A016DEB748C8B9D7D6266_terseLabel_en-US" xlink:label="lab_ango_MedicalDeviceExciseTaxReceivable_C1F3E78CD22A016DEB748C8B9D7D6266" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medical device excise tax receivable</link:label>
    <link:label id="lab_ango_MedicalDeviceExciseTaxReceivable_C1F3E78CD22A016DEB748C8B9D7D6266_label_en-US" xlink:label="lab_ango_MedicalDeviceExciseTaxReceivable_C1F3E78CD22A016DEB748C8B9D7D6266" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medical Device Excise Tax Receivable</link:label>
    <link:label id="lab_ango_MedicalDeviceExciseTaxReceivable_C1F3E78CD22A016DEB748C8B9D7D6266_documentation_en-US" xlink:label="lab_ango_MedicalDeviceExciseTaxReceivable_C1F3E78CD22A016DEB748C8B9D7D6266" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medical Device Excise Tax Receivable</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_MedicalDeviceExciseTaxReceivable" xlink:label="loc_ango_MedicalDeviceExciseTaxReceivable_C1F3E78CD22A016DEB748C8B9D7D6266" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_MedicalDeviceExciseTaxReceivable_C1F3E78CD22A016DEB748C8B9D7D6266" xlink:to="lab_ango_MedicalDeviceExciseTaxReceivable_C1F3E78CD22A016DEB748C8B9D7D6266" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_62BA991CC76DA8C771598C8B9D7D853C_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent_62BA991CC76DA8C771598C8B9D7D853C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_62BA991CC76DA8C771598C8B9D7D853C_label_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent_62BA991CC76DA8C771598C8B9D7D853C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Prepaid Expense, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_62BA991CC76DA8C771598C8B9D7D853C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPrepaidExpenseCurrent_62BA991CC76DA8C771598C8B9D7D853C" xlink:to="lab_us-gaap_OtherPrepaidExpenseCurrent_62BA991CC76DA8C771598C8B9D7D853C" xlink:type="arc" />
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_EC6A78B0AFF101ACC2788C8B9D7D8863_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_EC6A78B0AFF101ACC2788C8B9D7D8863" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_EC6A78B0AFF101ACC2788C8B9D7D8863" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_EC6A78B0AFF101ACC2788C8B9D7D8863" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_EC6A78B0AFF101ACC2788C8B9D7D8863" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_CDB40E08D39B456414488F96E0702B2F_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_CDB40E08D39B456414488F96E0702B2F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_CDB40E08D39B456414488F96E0702B2F_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_CDB40E08D39B456414488F96E0702B2F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_CDB40E08D39B456414488F96E0702B2F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_CDB40E08D39B456414488F96E0702B2F" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_CDB40E08D39B456414488F96E0702B2F" xlink:type="arc" />
    <link:label id="lab_ango_PeripheralVascularMember_443593E35AC0D07E08988F96E071CF17_verboseLabel_en-US" xlink:label="lab_ango_PeripheralVascularMember_443593E35AC0D07E08988F96E071CF17" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Peripheral Vascular</link:label>
    <link:label id="lab_ango_PeripheralVascularMember_443593E35AC0D07E08988F96E071CF17_label_en-US" xlink:label="lab_ango_PeripheralVascularMember_443593E35AC0D07E08988F96E071CF17" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peripheral Vascular [Member]</link:label>
    <link:label id="lab_ango_PeripheralVascularMember_443593E35AC0D07E08988F96E071CF17_documentation_en-US" xlink:label="lab_ango_PeripheralVascularMember_443593E35AC0D07E08988F96E071CF17" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Peripheral Vascular.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_PeripheralVascularMember" xlink:label="loc_ango_PeripheralVascularMember_443593E35AC0D07E08988F96E071CF17" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_PeripheralVascularMember_443593E35AC0D07E08988F96E071CF17" xlink:to="lab_ango_PeripheralVascularMember_443593E35AC0D07E08988F96E071CF17" xlink:type="arc" />
    <link:label id="lab_ango_AccessMember_3C0B3B8550975A3DD6118F96E0720108_verboseLabel_en-US" xlink:label="lab_ango_AccessMember_3C0B3B8550975A3DD6118F96E0720108" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Vascular Access</link:label>
    <link:label id="lab_ango_AccessMember_3C0B3B8550975A3DD6118F96E0720108_label_en-US" xlink:label="lab_ango_AccessMember_3C0B3B8550975A3DD6118F96E0720108" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Access [Member]</link:label>
    <link:label id="lab_ango_AccessMember_3C0B3B8550975A3DD6118F96E0720108_documentation_en-US" xlink:label="lab_ango_AccessMember_3C0B3B8550975A3DD6118F96E0720108" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Access.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_AccessMember" xlink:label="loc_ango_AccessMember_3C0B3B8550975A3DD6118F96E0720108" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_AccessMember_3C0B3B8550975A3DD6118F96E0720108" xlink:to="lab_ango_AccessMember_3C0B3B8550975A3DD6118F96E0720108" xlink:type="arc" />
    <link:label id="lab_ango_OncologySurgeryMember_3AA53AB95FC9AE8A6BE78F96E072FD90_verboseLabel_en-US" xlink:label="lab_ango_OncologySurgeryMember_3AA53AB95FC9AE8A6BE78F96E072FD90" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Oncology/Surgery</link:label>
    <link:label id="lab_ango_OncologySurgeryMember_3AA53AB95FC9AE8A6BE78F96E072FD90_label_en-US" xlink:label="lab_ango_OncologySurgeryMember_3AA53AB95FC9AE8A6BE78F96E072FD90" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Oncology Surgery [Member]</link:label>
    <link:label id="lab_ango_OncologySurgeryMember_3AA53AB95FC9AE8A6BE78F96E072FD90_documentation_en-US" xlink:label="lab_ango_OncologySurgeryMember_3AA53AB95FC9AE8A6BE78F96E072FD90" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Oncology Surgery.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_OncologySurgeryMember" xlink:label="loc_ango_OncologySurgeryMember_3AA53AB95FC9AE8A6BE78F96E072FD90" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_OncologySurgeryMember_3AA53AB95FC9AE8A6BE78F96E072FD90" xlink:to="lab_ango_OncologySurgeryMember_3AA53AB95FC9AE8A6BE78F96E072FD90" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_D4D9D83D48C6937452778F96E0722F0A_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_D4D9D83D48C6937452778F96E0722F0A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_D4D9D83D48C6937452778F96E0722F0A_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_D4D9D83D48C6937452778F96E0722F0A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_D4D9D83D48C6937452778F96E0722F0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_D4D9D83D48C6937452778F96E0722F0A" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_D4D9D83D48C6937452778F96E0722F0A" xlink:type="arc" />
    <link:label id="lab_ango_NetSalesByProductCategoryAbstract_3BACADA5C08994F3C0B78F96E072C7E3_verboseLabel_en-US" xlink:label="lab_ango_NetSalesByProductCategoryAbstract_3BACADA5C08994F3C0B78F96E072C7E3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net sales by Product Category</link:label>
    <link:label id="lab_ango_NetSalesByProductCategoryAbstract_3BACADA5C08994F3C0B78F96E072C7E3_label_en-US" xlink:label="lab_ango_NetSalesByProductCategoryAbstract_3BACADA5C08994F3C0B78F96E072C7E3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Sales by Product Category [Abstract]</link:label>
    <link:label id="lab_ango_NetSalesByProductCategoryAbstract_3BACADA5C08994F3C0B78F96E072C7E3_documentation_en-US" xlink:label="lab_ango_NetSalesByProductCategoryAbstract_3BACADA5C08994F3C0B78F96E072C7E3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net Sales by Product Category [Abstract]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_NetSalesByProductCategoryAbstract" xlink:label="loc_ango_NetSalesByProductCategoryAbstract_3BACADA5C08994F3C0B78F96E072C7E3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_NetSalesByProductCategoryAbstract_3BACADA5C08994F3C0B78F96E072C7E3" xlink:to="lab_ango_NetSalesByProductCategoryAbstract_3BACADA5C08994F3C0B78F96E072C7E3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2C8A4641F592C6FFDF0994C42DFA7A4C_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2C8A4641F592C6FFDF0994C42DFA7A4C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2C8A4641F592C6FFDF0994C42DFA7A4C_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2C8A4641F592C6FFDF0994C42DFA7A4C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2C8A4641F592C6FFDF0994C42DFA7A4C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2C8A4641F592C6FFDF0994C42DFA7A4C" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2C8A4641F592C6FFDF0994C42DFA7A4C" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_DEE05F2FBD29A9F65A4F94C42DFA33A6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis_DEE05F2FBD29A9F65A4F94C42DFA33A6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_DEE05F2FBD29A9F65A4F94C42DFA33A6_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis_DEE05F2FBD29A9F65A4F94C42DFA33A6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_DEE05F2FBD29A9F65A4F94C42DFA33A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_DEE05F2FBD29A9F65A4F94C42DFA33A6" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis_DEE05F2FBD29A9F65A4F94C42DFA33A6" xlink:type="arc" />
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_BAEF598532B7E6B87F9494C42DFA2F7E_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain_BAEF598532B7E6B87F9494C42DFA2F7E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_BAEF598532B7E6B87F9494C42DFA2F7E_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain_BAEF598532B7E6B87F9494C42DFA2F7E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_BAEF598532B7E6B87F9494C42DFA2F7E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_BAEF598532B7E6B87F9494C42DFA2F7E" xlink:to="lab_us-gaap_TypeOfRestructuringDomain_BAEF598532B7E6B87F9494C42DFA2F7E" xlink:type="arc" />
    <link:label id="lab_ango_LegalCostsMember_3E159C70DB7FCE3747A194C42DFA013F_terseLabel_en-US" xlink:label="lab_ango_LegalCostsMember_3E159C70DB7FCE3747A194C42DFA013F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal</link:label>
    <link:label id="lab_ango_LegalCostsMember_3E159C70DB7FCE3747A194C42DFA013F_label_en-US" xlink:label="lab_ango_LegalCostsMember_3E159C70DB7FCE3747A194C42DFA013F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Costs [Member]</link:label>
    <link:label id="lab_ango_LegalCostsMember_3E159C70DB7FCE3747A194C42DFA013F_documentation_en-US" xlink:label="lab_ango_LegalCostsMember_3E159C70DB7FCE3747A194C42DFA013F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Legal Costs [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_LegalCostsMember" xlink:label="loc_ango_LegalCostsMember_3E159C70DB7FCE3747A194C42DFA013F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_LegalCostsMember_3E159C70DB7FCE3747A194C42DFA013F" xlink:to="lab_ango_LegalCostsMember_3E159C70DB7FCE3747A194C42DFA013F" xlink:type="arc" />
    <link:label id="lab_ango_DOJLitigationMember_82D767CB17DF7D76364D94CE16648AF8_terseLabel_en-US" xlink:label="lab_ango_DOJLitigationMember_82D767CB17DF7D76364D94CE16648AF8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">DOJ Litigation</link:label>
    <link:label id="lab_ango_DOJLitigationMember_82D767CB17DF7D76364D94CE16648AF8_label_en-US" xlink:label="lab_ango_DOJLitigationMember_82D767CB17DF7D76364D94CE16648AF8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">DOJ Litigation [Member]</link:label>
    <link:label id="lab_ango_DOJLitigationMember_82D767CB17DF7D76364D94CE16648AF8_documentation_en-US" xlink:label="lab_ango_DOJLitigationMember_82D767CB17DF7D76364D94CE16648AF8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">DOJ Litigation [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_DOJLitigationMember" xlink:label="loc_ango_DOJLitigationMember_82D767CB17DF7D76364D94CE16648AF8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_DOJLitigationMember_82D767CB17DF7D76364D94CE16648AF8" xlink:to="lab_ango_DOJLitigationMember_82D767CB17DF7D76364D94CE16648AF8" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringPlanAxis_F5A03560C792DE58728594C42DFA226A_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis_F5A03560C792DE58728594C42DFA226A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_F5A03560C792DE58728594C42DFA226A_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis_F5A03560C792DE58728594C42DFA226A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_F5A03560C792DE58728594C42DFA226A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis_F5A03560C792DE58728594C42DFA226A" xlink:to="lab_us-gaap_RestructuringPlanAxis_F5A03560C792DE58728594C42DFA226A" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringPlanDomain_1F1E70B2186368220B5494C42DFAAA46_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain_1F1E70B2186368220B5494C42DFAAA46" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_1F1E70B2186368220B5494C42DFAAA46_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain_1F1E70B2186368220B5494C42DFAAA46" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_1F1E70B2186368220B5494C42DFAAA46" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain_1F1E70B2186368220B5494C42DFAAA46" xlink:to="lab_us-gaap_RestructuringPlanDomain_1F1E70B2186368220B5494C42DFAAA46" xlink:type="arc" />
    <link:label id="lab_ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember_1381BABCD63B34828FF994C42DFA1B04_terseLabel_en-US" xlink:label="lab_ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember_1381BABCD63B34828FF994C42DFA1B04" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Manchester, GA and Denmead, UK into Glens Falls and Queensbury, NY</link:label>
    <link:label id="lab_ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember_1381BABCD63B34828FF994C42DFA1B04_label_en-US" xlink:label="lab_ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember_1381BABCD63B34828FF994C42DFA1B04" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Manchester, GA and Denmead, UK into Glens Falls and Queensbury, NY [Member]</link:label>
    <link:label id="lab_ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember_1381BABCD63B34828FF994C42DFA1B04_documentation_en-US" xlink:label="lab_ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember_1381BABCD63B34828FF994C42DFA1B04" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Manchester, GA and Denmead, UK into Glens Falls and Queensbury, NY [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember" xlink:label="loc_ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember_1381BABCD63B34828FF994C42DFA1B04" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember_1381BABCD63B34828FF994C42DFA1B04" xlink:to="lab_ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember_1381BABCD63B34828FF994C42DFA1B04" xlink:type="arc" />
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_12E491B6EA31B07586D794C42DFAA7A5_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis_12E491B6EA31B07586D794C42DFAA7A5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_12E491B6EA31B07586D794C42DFAA7A5_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis_12E491B6EA31B07586D794C42DFAA7A5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_12E491B6EA31B07586D794C42DFAA7A5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_12E491B6EA31B07586D794C42DFAA7A5" xlink:to="lab_us-gaap_BalanceSheetLocationAxis_12E491B6EA31B07586D794C42DFAA7A5" xlink:type="arc" />
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_551DC2DDEFD3D5F4D9BB94C42DFAF701_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain_551DC2DDEFD3D5F4D9BB94C42DFAF701" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_551DC2DDEFD3D5F4D9BB94C42DFAF701_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain_551DC2DDEFD3D5F4D9BB94C42DFAF701" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_551DC2DDEFD3D5F4D9BB94C42DFAF701" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_551DC2DDEFD3D5F4D9BB94C42DFAF701" xlink:to="lab_us-gaap_BalanceSheetLocationDomain_551DC2DDEFD3D5F4D9BB94C42DFAF701" xlink:type="arc" />
    <link:label id="lab_ango_AccruedExpensesMember_861AE7BDFD006779AB1594C42DFA6810_terseLabel_en-US" xlink:label="lab_ango_AccruedExpensesMember_861AE7BDFD006779AB1594C42DFA6810" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued Expenses</link:label>
    <link:label id="lab_ango_AccruedExpensesMember_861AE7BDFD006779AB1594C42DFA6810_label_en-US" xlink:label="lab_ango_AccruedExpensesMember_861AE7BDFD006779AB1594C42DFA6810" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Expenses [Member]</link:label>
    <link:label id="lab_ango_AccruedExpensesMember_861AE7BDFD006779AB1594C42DFA6810_documentation_en-US" xlink:label="lab_ango_AccruedExpensesMember_861AE7BDFD006779AB1594C42DFA6810" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Expenses [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_AccruedExpensesMember" xlink:label="loc_ango_AccruedExpensesMember_861AE7BDFD006779AB1594C42DFA6810" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_AccruedExpensesMember_861AE7BDFD006779AB1594C42DFA6810" xlink:to="lab_ango_AccruedExpensesMember_861AE7BDFD006779AB1594C42DFA6810" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_22F1BF9DF8D44F01FFC694C42DFA4299_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems_22F1BF9DF8D44F01FFC694C42DFA4299" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_22F1BF9DF8D44F01FFC694C42DFA4299_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems_22F1BF9DF8D44F01FFC694C42DFA4299" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_22F1BF9DF8D44F01FFC694C42DFA4299" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_22F1BF9DF8D44F01FFC694C42DFA4299" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems_22F1BF9DF8D44F01FFC694C42DFA4299" xlink:type="arc" />
    <link:label id="lab_ango_AcquisitionRestructuringAndOtherItemsNet_C25BB7E790524A8AB42B94C42DFAE3EC_verboseLabel_en-US" xlink:label="lab_ango_AcquisitionRestructuringAndOtherItemsNet_C25BB7E790524A8AB42B94C42DFAE3EC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Acquisition, restructuring and other items, net</link:label>
    <link:label id="lab_ango_AcquisitionRestructuringAndOtherItemsNet_C25BB7E790524A8AB42B94C42DFAE3EC_label_en-US" xlink:label="lab_ango_AcquisitionRestructuringAndOtherItemsNet_C25BB7E790524A8AB42B94C42DFAE3EC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisition Restructuring and Other Items Net</link:label>
    <link:label id="lab_ango_AcquisitionRestructuringAndOtherItemsNet_C25BB7E790524A8AB42B94C42DFAE3EC_documentation_en-US" xlink:label="lab_ango_AcquisitionRestructuringAndOtherItemsNet_C25BB7E790524A8AB42B94C42DFAE3EC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Acquisition Restructuring And Other Items Net.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_AcquisitionRestructuringAndOtherItemsNet" xlink:label="loc_ango_AcquisitionRestructuringAndOtherItemsNet_C25BB7E790524A8AB42B94C42DFAE3EC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_AcquisitionRestructuringAndOtherItemsNet_C25BB7E790524A8AB42B94C42DFAE3EC" xlink:to="lab_ango_AcquisitionRestructuringAndOtherItemsNet_C25BB7E790524A8AB42B94C42DFAE3EC" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCharges_2A5263B5C4243BCF953F94C42DFAAE23_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges_2A5263B5C4243BCF953F94C42DFAAE23" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_2A5263B5C4243BCF953F94C42DFAAE23_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges_2A5263B5C4243BCF953F94C42DFAAE23" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_2A5263B5C4243BCF953F94C42DFAAE23" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges_2A5263B5C4243BCF953F94C42DFAAE23" xlink:to="lab_us-gaap_RestructuringCharges_2A5263B5C4243BCF953F94C42DFAAE23" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserve_A2651B8BAA7C98263AA594C42DFA536B_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve_A2651B8BAA7C98263AA594C42DFA536B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_A2651B8BAA7C98263AA594C42DFA536B_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve_A2651B8BAA7C98263AA594C42DFA536B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_A2651B8BAA7C98263AA594C42DFA536B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve_A2651B8BAA7C98263AA594C42DFA536B" xlink:to="lab_us-gaap_RestructuringReserve_A2651B8BAA7C98263AA594C42DFA536B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_65AF9D98C99D71C6E7AE8C8B9BE79ECD_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_65AF9D98C99D71C6E7AE8C8B9BE79ECD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair value of assets and liabilities measured on recurring basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_65AF9D98C99D71C6E7AE8C8B9BE79ECD_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_65AF9D98C99D71C6E7AE8C8B9BE79ECD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_65AF9D98C99D71C6E7AE8C8B9BE79ECD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_65AF9D98C99D71C6E7AE8C8B9BE79ECD" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_65AF9D98C99D71C6E7AE8C8B9BE79ECD" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_22271D9F10B1C8F87B478C8B9BE7150E_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_22271D9F10B1C8F87B478C8B9BE7150E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_22271D9F10B1C8F87B478C8B9BE7150E_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_22271D9F10B1C8F87B478C8B9BE7150E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_22271D9F10B1C8F87B478C8B9BE7150E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_22271D9F10B1C8F87B478C8B9BE7150E" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_22271D9F10B1C8F87B478C8B9BE7150E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_01DAA424F8E709C5D1528C8B9BE72910_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_01DAA424F8E709C5D1528C8B9BE72910" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_01DAA424F8E709C5D1528C8B9BE72910_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_01DAA424F8E709C5D1528C8B9BE72910" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_01DAA424F8E709C5D1528C8B9BE72910" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_01DAA424F8E709C5D1528C8B9BE72910" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_01DAA424F8E709C5D1528C8B9BE72910" xlink:type="arc" />
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_4A1D352141892263CEF28F96E0337FCA_verboseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock_4A1D352141892263CEF28F96E0337FCA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">QUARTERLY INFORMATION (unaudited)</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_4A1D352141892263CEF28F96E0337FCA_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock_4A1D352141892263CEF28F96E0337FCA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_4A1D352141892263CEF28F96E0337FCA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock_4A1D352141892263CEF28F96E0337FCA" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock_4A1D352141892263CEF28F96E0337FCA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3322CD6BB543197372D88F96E23FA872_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3322CD6BB543197372D88F96E23FA872" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3322CD6BB543197372D88F96E23FA872_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3322CD6BB543197372D88F96E23FA872" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3322CD6BB543197372D88F96E23FA872" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3322CD6BB543197372D88F96E23FA872" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3322CD6BB543197372D88F96E23FA872" xlink:type="arc" />
    <link:label id="lab_ango_ProductTechnologiesMember_21B7484EFE3768C65D5E8FDA66ECB9AC_terseLabel_en-US" xlink:label="lab_ango_ProductTechnologiesMember_21B7484EFE3768C65D5E8FDA66ECB9AC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product technologies</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_ProductTechnologiesMember" xlink:label="loc_ango_ProductTechnologiesMember_21B7484EFE3768C65D5E8FDA66ECB9AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ProductTechnologiesMember_21B7484EFE3768C65D5E8FDA66ECB9AC" xlink:to="lab_ango_ProductTechnologiesMember_21B7484EFE3768C65D5E8FDA66ECB9AC" xlink:type="arc" />
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_3767D9A786ADC9089EDD8FDA66F83CAE_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_3767D9A786ADC9089EDD8FDA66F83CAE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3767D9A786ADC9089EDD8FDA66F83CAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember_3767D9A786ADC9089EDD8FDA66F83CAE" xlink:to="lab_us-gaap_CustomerRelationshipsMember_3767D9A786ADC9089EDD8FDA66F83CAE" xlink:type="arc" />
    <link:label id="lab_us-gaap_TrademarksMember_5E98E0704ECA994363AC8FDA67057974_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember_5E98E0704ECA994363AC8FDA67057974" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trademarks</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaap_TrademarksMember_5E98E0704ECA994363AC8FDA67057974" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember_5E98E0704ECA994363AC8FDA67057974" xlink:to="lab_us-gaap_TrademarksMember_5E98E0704ECA994363AC8FDA67057974" xlink:type="arc" />
    <link:label id="lab_us-gaap_LicenseAgreementTermsMember_F4764064E39F6E12FA1D8FDA671284CE_terseLabel_en-US" xlink:label="lab_us-gaap_LicenseAgreementTermsMember_F4764064E39F6E12FA1D8FDA671284CE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Licenses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LicenseAgreementTermsMember" xlink:label="loc_us-gaap_LicenseAgreementTermsMember_F4764064E39F6E12FA1D8FDA671284CE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseAgreementTermsMember_F4764064E39F6E12FA1D8FDA671284CE" xlink:to="lab_us-gaap_LicenseAgreementTermsMember_F4764064E39F6E12FA1D8FDA671284CE" xlink:type="arc" />
    <link:label id="lab_ango_DistributorRelationshipsMember_44D4ABBC51B0B0606DFC8FDA6720308E_terseLabel_en-US" xlink:label="lab_ango_DistributorRelationshipsMember_44D4ABBC51B0B0606DFC8FDA6720308E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distributor relationships</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_DistributorRelationshipsMember" xlink:label="loc_ango_DistributorRelationshipsMember_44D4ABBC51B0B0606DFC8FDA6720308E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_DistributorRelationshipsMember_44D4ABBC51B0B0606DFC8FDA6720308E" xlink:to="lab_ango_DistributorRelationshipsMember_44D4ABBC51B0B0606DFC8FDA6720308E" xlink:type="arc" />
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0B9C582B9D39376519828F96E2425B19_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0B9C582B9D39376519828F96E2425B19" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0B9C582B9D39376519828F96E2425B19_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0B9C582B9D39376519828F96E2425B19" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0B9C582B9D39376519828F96E2425B19" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0B9C582B9D39376519828F96E2425B19" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0B9C582B9D39376519828F96E2425B19" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_08F0F287C237BAA06A998F96E243E21A_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_08F0F287C237BAA06A998F96E243E21A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Gross carrying value, finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_08F0F287C237BAA06A998F96E243E21A_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_08F0F287C237BAA06A998F96E243E21A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_08F0F287C237BAA06A998F96E243E21A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross_08F0F287C237BAA06A998F96E243E21A" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross_08F0F287C237BAA06A998F96E243E21A" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8E1AFE750542BCAB1D348F96E243DADC_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8E1AFE750542BCAB1D348F96E243DADC" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8E1AFE750542BCAB1D348F96E243DADC_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8E1AFE750542BCAB1D348F96E243DADC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8E1AFE750542BCAB1D348F96E243DADC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8E1AFE750542BCAB1D348F96E243DADC" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8E1AFE750542BCAB1D348F96E243DADC" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_F4F8EF69173EC00542248F96E2436F07_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_F4F8EF69173EC00542248F96E2436F07" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net carrying value, finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_F4F8EF69173EC00542248F96E2436F07_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet_F4F8EF69173EC00542248F96E2436F07" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_F4F8EF69173EC00542248F96E2436F07" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_F4F8EF69173EC00542248F96E2436F07" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet_F4F8EF69173EC00542248F96E2436F07" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_A91FA86808A0E4CED4C0A965BCAAD9AD_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_A91FA86808A0E4CED4C0A965BCAAD9AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_A91FA86808A0E4CED4C0A965BCAAD9AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_A91FA86808A0E4CED4C0A965BCAAD9AD" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_A91FA86808A0E4CED4C0A965BCAAD9AD" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_21425BB961DE959BAF76A965BCAD6D81_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_21425BB961DE959BAF76A965BCAD6D81" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_21425BB961DE959BAF76A965BCAD6D81_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_21425BB961DE959BAF76A965BCAD6D81" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_21425BB961DE959BAF76A965BCAD6D81" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_21425BB961DE959BAF76A965BCAD6D81" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_21425BB961DE959BAF76A965BCAD6D81" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_201F6D988BA49B4691E2A965BCAD2CC0_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_201F6D988BA49B4691E2A965BCAD2CC0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_201F6D988BA49B4691E2A965BCAD2CC0_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_201F6D988BA49B4691E2A965BCAD2CC0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_201F6D988BA49B4691E2A965BCAD2CC0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_201F6D988BA49B4691E2A965BCAD2CC0" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_201F6D988BA49B4691E2A965BCAD2CC0" xlink:type="arc" />
    <link:label id="lab_us-gaap_DepreciationAndAmortization_3AAE2F27ACF6F8B7C28DA965BCAD2B09_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization_3AAE2F27ACF6F8B7C28DA965BCAD2B09" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_3AAE2F27ACF6F8B7C28DA965BCAD2B09_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization_3AAE2F27ACF6F8B7C28DA965BCAD2B09" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization_3AAE2F27ACF6F8B7C28DA965BCAD2B09" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization_3AAE2F27ACF6F8B7C28DA965BCAD2B09" xlink:to="lab_us-gaap_DepreciationAndAmortization_3AAE2F27ACF6F8B7C28DA965BCAD2B09" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensation_3C61AAAAEADC61C51BECA965BCAD23FA_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_3C61AAAAEADC61C51BECA965BCAD23FA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_3C61AAAAEADC61C51BECA965BCAD23FA_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_3C61AAAAEADC61C51BECA965BCAD23FA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_3C61AAAAEADC61C51BECA965BCAD23FA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_3C61AAAAEADC61C51BECA965BCAD23FA" xlink:to="lab_us-gaap_ShareBasedCompensation_3C61AAAAEADC61C51BECA965BCAD23FA" xlink:type="arc" />
    <link:label id="lab_ango_ChangeInFairValueOfContingentConsideration_CD4E5DACC61608E77515A965BCADB037_terseLabel_en-US" xlink:label="lab_ango_ChangeInFairValueOfContingentConsideration_CD4E5DACC61608E77515A965BCADB037" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_ango_ChangeInFairValueOfContingentConsideration_CD4E5DACC61608E77515A965BCADB037_label_en-US" xlink:label="lab_ango_ChangeInFairValueOfContingentConsideration_CD4E5DACC61608E77515A965BCADB037" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value of Contingent Consideration</link:label>
    <link:label id="lab_ango_ChangeInFairValueOfContingentConsideration_CD4E5DACC61608E77515A965BCADB037_documentation_en-US" xlink:label="lab_ango_ChangeInFairValueOfContingentConsideration_CD4E5DACC61608E77515A965BCADB037" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The expense charged against earnings in the period resulting from remeasurement to fair value of contingent earn out liabilities related to  acquisitions.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_ChangeInFairValueOfContingentConsideration" xlink:label="loc_ango_ChangeInFairValueOfContingentConsideration_CD4E5DACC61608E77515A965BCADB037" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ChangeInFairValueOfContingentConsideration_CD4E5DACC61608E77515A965BCADB037" xlink:to="lab_ango_ChangeInFairValueOfContingentConsideration_CD4E5DACC61608E77515A965BCADB037" xlink:type="arc" />
    <link:label id="lab_ango_DeferredIncomeTaxRelatedToOperatingActivity_0491F00F3221537B4F6DA965BCADAFF0_verboseLabel_en-US" xlink:label="lab_ango_DeferredIncomeTaxRelatedToOperatingActivity_0491F00F3221537B4F6DA965BCADAFF0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred income tax provision</link:label>
    <link:label id="lab_ango_DeferredIncomeTaxRelatedToOperatingActivity_0491F00F3221537B4F6DA965BCADAFF0_label_en-US" xlink:label="lab_ango_DeferredIncomeTaxRelatedToOperatingActivity_0491F00F3221537B4F6DA965BCADAFF0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Related To Operating Activity</link:label>
    <link:label id="lab_ango_DeferredIncomeTaxRelatedToOperatingActivity_0491F00F3221537B4F6DA965BCADAFF0_documentation_en-US" xlink:label="lab_ango_DeferredIncomeTaxRelatedToOperatingActivity_0491F00F3221537B4F6DA965BCADAFF0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities related to components of deferred income tax assets.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_DeferredIncomeTaxRelatedToOperatingActivity" xlink:label="loc_ango_DeferredIncomeTaxRelatedToOperatingActivity_0491F00F3221537B4F6DA965BCADAFF0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_DeferredIncomeTaxRelatedToOperatingActivity_0491F00F3221537B4F6DA965BCADAFF0" xlink:to="lab_ango_DeferredIncomeTaxRelatedToOperatingActivity_0491F00F3221537B4F6DA965BCADAFF0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_9AEF74F416D571F36E2EA965BCAD5ECA_verboseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts_9AEF74F416D571F36E2EA965BCAD5ECA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Changes in accounts receivable allowances</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_9AEF74F416D571F36E2EA965BCAD5ECA_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts_9AEF74F416D571F36E2EA965BCAD5ECA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provision for Doubtful Accounts</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_9AEF74F416D571F36E2EA965BCAD5ECA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts_9AEF74F416D571F36E2EA965BCAD5ECA" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts_9AEF74F416D571F36E2EA965BCAD5ECA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_108DC086086AEEBFF4F3A965BCAD2E3B_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_108DC086086AEEBFF4F3A965BCAD2E3B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fixed and intangible asset impairments and disposals</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_108DC086086AEEBFF4F3A965BCAD2E3B_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_108DC086086AEEBFF4F3A965BCAD2E3B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of Long-Lived Assets Held-for-use</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_108DC086086AEEBFF4F3A965BCAD2E3B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_108DC086086AEEBFF4F3A965BCAD2E3B" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_108DC086086AEEBFF4F3A965BCAD2E3B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_8D553D2E397F623F66E9A965BCAFFA7D_negatedLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_8D553D2E397F623F66E9A965BCAFFA7D" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Write-off of other assets</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_8D553D2E397F623F66E9A965BCAFFA7D_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_8D553D2E397F623F66E9A965BCAFFA7D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Unrealized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_8D553D2E397F623F66E9A965BCAFFA7D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_8D553D2E397F623F66E9A965BCAFFA7D" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_8D553D2E397F623F66E9A965BCAFFA7D" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_00BF8F02AAF5F7E1F010A965BCAFE054_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense_00BF8F02AAF5F7E1F010A965BCAFE054" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_00BF8F02AAF5F7E1F010A965BCAFE054_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense_00BF8F02AAF5F7E1F010A965BCAFE054" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_00BF8F02AAF5F7E1F010A965BCAFE054" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense_00BF8F02AAF5F7E1F010A965BCAFE054" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense_00BF8F02AAF5F7E1F010A965BCAFE054" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_C6F06B80A7630AFECA53A965BCAFF2A3_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_C6F06B80A7630AFECA53A965BCAFF2A3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_C6F06B80A7630AFECA53A965BCAFF2A3_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_C6F06B80A7630AFECA53A965BCAFF2A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_C6F06B80A7630AFECA53A965BCAFF2A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_C6F06B80A7630AFECA53A965BCAFF2A3" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_C6F06B80A7630AFECA53A965BCAFF2A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_6EA832C93B2039DD9E8AA965BCAF71FD_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_6EA832C93B2039DD9E8AA965BCAF71FD" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_6EA832C93B2039DD9E8AA965BCAF71FD_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_6EA832C93B2039DD9E8AA965BCAF71FD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6EA832C93B2039DD9E8AA965BCAF71FD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6EA832C93B2039DD9E8AA965BCAF71FD" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_6EA832C93B2039DD9E8AA965BCAF71FD" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_D70E6CDDF595401D49A1A965BCAFB7C1_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_D70E6CDDF595401D49A1A965BCAFB7C1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_D70E6CDDF595401D49A1A965BCAFB7C1_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_D70E6CDDF595401D49A1A965BCAFB7C1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_D70E6CDDF595401D49A1A965BCAFB7C1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories_D70E6CDDF595401D49A1A965BCAFB7C1" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories_D70E6CDDF595401D49A1A965BCAFB7C1" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_99EBBEF7BC4D00C7A21CA965BCAF4336_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_99EBBEF7BC4D00C7A21CA965BCAF4336" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_99EBBEF7BC4D00C7A21CA965BCAF4336_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_99EBBEF7BC4D00C7A21CA965BCAF4336" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_99EBBEF7BC4D00C7A21CA965BCAF4336" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_99EBBEF7BC4D00C7A21CA965BCAF4336" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_99EBBEF7BC4D00C7A21CA965BCAF4336" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_F50D17CF5322F4F0606CA965BCAF8ED3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_F50D17CF5322F4F0606CA965BCAF8ED3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable, accrued and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_F50D17CF5322F4F0606CA965BCAF8ED3_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_F50D17CF5322F4F0606CA965BCAF8ED3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_F50D17CF5322F4F0606CA965BCAF8ED3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_F50D17CF5322F4F0606CA965BCAF8ED3" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_F50D17CF5322F4F0606CA965BCAF8ED3" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_53CA7B44075015EFFF20A965BCAF31F1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_53CA7B44075015EFFF20A965BCAF31F1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_53CA7B44075015EFFF20A965BCAF31F1_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_53CA7B44075015EFFF20A965BCAF31F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_53CA7B44075015EFFF20A965BCAF31F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_53CA7B44075015EFFF20A965BCAF31F1" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_53CA7B44075015EFFF20A965BCAF31F1" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_568CE8299769C3936363A965BCAF553F_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_568CE8299769C3936363A965BCAF553F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_568CE8299769C3936363A965BCAF553F_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_568CE8299769C3936363A965BCAF553F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_568CE8299769C3936363A965BCAF553F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_568CE8299769C3936363A965BCAF553F" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_568CE8299769C3936363A965BCAF553F" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_58CA1448C0592DBDE646A965BCAF8368_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_58CA1448C0592DBDE646A965BCAF8368" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Additions to property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_58CA1448C0592DBDE646A965BCAF8368_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_58CA1448C0592DBDE646A965BCAF8368" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_58CA1448C0592DBDE646A965BCAF8368" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_58CA1448C0592DBDE646A965BCAF8368" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_58CA1448C0592DBDE646A965BCAF8368" xlink:type="arc" />
    <link:label id="lab_ango_PaymentsToAcquireIntangibleAssetsNetOfCashAcquired_44546BE7BB36C5F32154A965BCB2BD2B_negatedLabel_en-US" xlink:label="lab_ango_PaymentsToAcquireIntangibleAssetsNetOfCashAcquired_44546BE7BB36C5F32154A965BCB2BD2B" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Acquisition of intangibles</link:label>
    <link:label id="lab_ango_PaymentsToAcquireIntangibleAssetsNetOfCashAcquired_44546BE7BB36C5F32154A965BCB2BD2B_label_en-US" xlink:label="lab_ango_PaymentsToAcquireIntangibleAssetsNetOfCashAcquired_44546BE7BB36C5F32154A965BCB2BD2B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments To Acquire Intangible Assets Net Of Cash Acquired</link:label>
    <link:label id="lab_ango_PaymentsToAcquireIntangibleAssetsNetOfCashAcquired_44546BE7BB36C5F32154A965BCB2BD2B_documentation_en-US" xlink:label="lab_ango_PaymentsToAcquireIntangibleAssetsNetOfCashAcquired_44546BE7BB36C5F32154A965BCB2BD2B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The cash outflow associated with the acquisition of intangible assets, net of cash acquired from the purchase.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_PaymentsToAcquireIntangibleAssetsNetOfCashAcquired" xlink:label="loc_ango_PaymentsToAcquireIntangibleAssetsNetOfCashAcquired_44546BE7BB36C5F32154A965BCB2BD2B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_PaymentsToAcquireIntangibleAssetsNetOfCashAcquired_44546BE7BB36C5F32154A965BCB2BD2B" xlink:to="lab_ango_PaymentsToAcquireIntangibleAssetsNetOfCashAcquired_44546BE7BB36C5F32154A965BCB2BD2B" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_629A477D34FDCC1C6C42A965BCB29861_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_629A477D34FDCC1C6C42A965BCB29861" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Acquisition of warrants</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_629A477D34FDCC1C6C42A965BCB29861_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_629A477D34FDCC1C6C42A965BCB29861" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_629A477D34FDCC1C6C42A965BCB29861" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_629A477D34FDCC1C6C42A965BCB29861" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_629A477D34FDCC1C6C42A965BCB29861" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_B1A5EFB348F1FBC1DA5EA965BCB21EF8_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_B1A5EFB348F1FBC1DA5EA965BCB21EF8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale or maturity of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_B1A5EFB348F1FBC1DA5EA965BCB21EF8_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_B1A5EFB348F1FBC1DA5EA965BCB21EF8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_B1A5EFB348F1FBC1DA5EA965BCB21EF8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_B1A5EFB348F1FBC1DA5EA965BCB21EF8" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_B1A5EFB348F1FBC1DA5EA965BCB21EF8" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_B84B87CABACD1FBC27DAA965BCB27EBE_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_B84B87CABACD1FBC27DAA965BCB27EBE" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_B84B87CABACD1FBC27DAA965BCB27EBE_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_B84B87CABACD1FBC27DAA965BCB27EBE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_B84B87CABACD1FBC27DAA965BCB27EBE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_B84B87CABACD1FBC27DAA965BCB27EBE" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_B84B87CABACD1FBC27DAA965BCB27EBE" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4C9B88821A350B9A800AA965BCB2CD0C_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4C9B88821A350B9A800AA965BCB2CD0C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4C9B88821A350B9A800AA965BCB2CD0C_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4C9B88821A350B9A800AA965BCB2CD0C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4C9B88821A350B9A800AA965BCB2CD0C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4C9B88821A350B9A800AA965BCB2CD0C" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4C9B88821A350B9A800AA965BCB2CD0C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_FC990FBBA4138C984C6FA965BCB25AF5_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_FC990FBBA4138C984C6FA965BCB25AF5" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of and borrowings on long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_FC990FBBA4138C984C6FA965BCB25AF5_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_FC990FBBA4138C984C6FA965BCB25AF5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_FC990FBBA4138C984C6FA965BCB25AF5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_FC990FBBA4138C984C6FA965BCB25AF5" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_FC990FBBA4138C984C6FA965BCB25AF5" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_A668588540992A6C27CBA965BCB4F252_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_A668588540992A6C27CBA965BCB4F252" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repayment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_A668588540992A6C27CBA965BCB4F252_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_A668588540992A6C27CBA965BCB4F252" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_A668588540992A6C27CBA965BCB4F252" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt_A668588540992A6C27CBA965BCB4F252" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt_A668588540992A6C27CBA965BCB4F252" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_DFE5E689FCD13A98744FA965BCB4998E_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts_DFE5E689FCD13A98744FA965BCB4998E" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Deferred financing costs on long-term debt</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_DFE5E689FCD13A98744FA965BCB4998E_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts_DFE5E689FCD13A98744FA965BCB4998E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_DFE5E689FCD13A98744FA965BCB4998E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts_DFE5E689FCD13A98744FA965BCB4998E" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts_DFE5E689FCD13A98744FA965BCB4998E" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5461E29A281BB7867AD0A965BCB41BD0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5461E29A281BB7867AD0A965BCB41BD0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payment of acquisition related contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5461E29A281BB7867AD0A965BCB41BD0_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5461E29A281BB7867AD0A965BCB41BD0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5461E29A281BB7867AD0A965BCB41BD0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5461E29A281BB7867AD0A965BCB41BD0" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5461E29A281BB7867AD0A965BCB41BD0" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_BD355BAF51E59D96D3F2A965BCB45F5C_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_BD355BAF51E59D96D3F2A965BCB45F5C" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_BD355BAF51E59D96D3F2A965BCB45F5C_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_BD355BAF51E59D96D3F2A965BCB45F5C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_BD355BAF51E59D96D3F2A965BCB45F5C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_BD355BAF51E59D96D3F2A965BCB45F5C" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_BD355BAF51E59D96D3F2A965BCB45F5C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_79594330539F964D671AA965BCB438CD_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_79594330539F964D671AA965BCB438CD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from exercise of stock options and employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_79594330539F964D671AA965BCB438CD_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_79594330539F964D671AA965BCB438CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_79594330539F964D671AA965BCB438CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_79594330539F964D671AA965BCB438CD" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_79594330539F964D671AA965BCB438CD" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_2330855204DBFD7A0B55A965BCB4D420_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_2330855204DBFD7A0B55A965BCB4D420" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_2330855204DBFD7A0B55A965BCB4D420_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_2330855204DBFD7A0B55A965BCB4D420" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2330855204DBFD7A0B55A965BCB4D420" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2330855204DBFD7A0B55A965BCB4D420" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_2330855204DBFD7A0B55A965BCB4D420" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_17FC7FC6FA26A70F0DACA965BCB46F35_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_17FC7FC6FA26A70F0DACA965BCB46F35" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_17FC7FC6FA26A70F0DACA965BCB46F35_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_17FC7FC6FA26A70F0DACA965BCB46F35" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_17FC7FC6FA26A70F0DACA965BCB46F35" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_17FC7FC6FA26A70F0DACA965BCB46F35" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_17FC7FC6FA26A70F0DACA965BCB46F35" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_85AC5AF14B88C5D40E05A965BCB4FA61_totalLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_85AC5AF14B88C5D40E05A965BCB4FA61" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_85AC5AF14B88C5D40E05A965BCB4FA61_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_85AC5AF14B88C5D40E05A965BCB4FA61" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_85AC5AF14B88C5D40E05A965BCB4FA61" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_85AC5AF14B88C5D40E05A965BCB4FA61" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_85AC5AF14B88C5D40E05A965BCB4FA61" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_4E885C70E15120478471A965BCB4240D_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_4E885C70E15120478471A965BCB4240D" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at beginning of year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4E885C70E15120478471A965BCB4240D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4E885C70E15120478471A965BCB4240D" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_4E885C70E15120478471A965BCB4240D" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_AD3814B4B979CAEB74DFA965BCB4713F_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_AD3814B4B979CAEB74DFA965BCB4713F" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at end of year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_AD3814B4B979CAEB74DFA965BCB4713F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_AD3814B4B979CAEB74DFA965BCB4713F" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_AD3814B4B979CAEB74DFA965BCB4713F" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8552BC9F7CA6F4A0CB50A965BCB4DDAA_verboseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8552BC9F7CA6F4A0CB50A965BCB4DDAA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8552BC9F7CA6F4A0CB50A965BCB4DDAA_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8552BC9F7CA6F4A0CB50A965BCB4DDAA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8552BC9F7CA6F4A0CB50A965BCB4DDAA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8552BC9F7CA6F4A0CB50A965BCB4DDAA" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8552BC9F7CA6F4A0CB50A965BCB4DDAA" xlink:type="arc" />
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_605370C61E6261909695A965BCB7FD49_verboseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_605370C61E6261909695A965BCB7FD49" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Contractual obligations for purchase of fixed assets</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_605370C61E6261909695A965BCB7FD49_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_605370C61E6261909695A965BCB7FD49" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_605370C61E6261909695A965BCB7FD49" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_605370C61E6261909695A965BCB7FD49" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_605370C61E6261909695A965BCB7FD49" xlink:type="arc" />
    <link:label id="lab_ango_CashPaidDuringPeriodAbstract_AE40BCF4E0620125AD97A965BCB7B4CF_verboseLabel_en-US" xlink:label="lab_ango_CashPaidDuringPeriodAbstract_AE40BCF4E0620125AD97A965BCB7B4CF" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash paid (received) during the year for:</link:label>
    <link:label id="lab_ango_CashPaidDuringPeriodAbstract_AE40BCF4E0620125AD97A965BCB7B4CF_label_en-US" xlink:label="lab_ango_CashPaidDuringPeriodAbstract_AE40BCF4E0620125AD97A965BCB7B4CF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Paid During Period [Abstract]</link:label>
    <link:label id="lab_ango_CashPaidDuringPeriodAbstract_AE40BCF4E0620125AD97A965BCB7B4CF_documentation_en-US" xlink:label="lab_ango_CashPaidDuringPeriodAbstract_AE40BCF4E0620125AD97A965BCB7B4CF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Paid During Period [Abstract]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_CashPaidDuringPeriodAbstract" xlink:label="loc_ango_CashPaidDuringPeriodAbstract_AE40BCF4E0620125AD97A965BCB7B4CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_CashPaidDuringPeriodAbstract_AE40BCF4E0620125AD97A965BCB7B4CF" xlink:to="lab_ango_CashPaidDuringPeriodAbstract_AE40BCF4E0620125AD97A965BCB7B4CF" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestPaid_C44E269E539FA7F5E33CA965BCB74C4E_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestPaid_C44E269E539FA7F5E33CA965BCB74C4E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_us-gaap_InterestPaid_C44E269E539FA7F5E33CA965BCB74C4E_label_en-US" xlink:label="lab_us-gaap_InterestPaid_C44E269E539FA7F5E33CA965BCB74C4E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaap_InterestPaid_C44E269E539FA7F5E33CA965BCB74C4E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaid_C44E269E539FA7F5E33CA965BCB74C4E" xlink:to="lab_us-gaap_InterestPaid_C44E269E539FA7F5E33CA965BCB74C4E" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_7C6BCF5D3564DA5FD417A9A3AC962A7C_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet_7C6BCF5D3564DA5FD417A9A3AC962A7C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_7C6BCF5D3564DA5FD417A9A3AC962A7C_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet_7C6BCF5D3564DA5FD417A9A3AC962A7C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_7C6BCF5D3564DA5FD417A9A3AC962A7C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet_7C6BCF5D3564DA5FD417A9A3AC962A7C" xlink:to="lab_us-gaap_IncomeTaxesPaidNet_7C6BCF5D3564DA5FD417A9A3AC962A7C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentTable_22929C02D1BB38F3A7008F96E17F1E6A_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_22929C02D1BB38F3A7008F96E17F1E6A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_22929C02D1BB38F3A7008F96E17F1E6A_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_22929C02D1BB38F3A7008F96E17F1E6A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_22929C02D1BB38F3A7008F96E17F1E6A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable_22929C02D1BB38F3A7008F96E17F1E6A" xlink:to="lab_us-gaap_DebtInstrumentTable_22929C02D1BB38F3A7008F96E17F1E6A" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_82C1D6811B10107C96AB8F96E1862829_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis_82C1D6811B10107C96AB8F96E1862829" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_82C1D6811B10107C96AB8F96E1862829_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis_82C1D6811B10107C96AB8F96E1862829" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_82C1D6811B10107C96AB8F96E1862829" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_82C1D6811B10107C96AB8F96E1862829" xlink:to="lab_us-gaap_LongtermDebtTypeAxis_82C1D6811B10107C96AB8F96E1862829" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_74EEECDFCDA6DC9521FF8F96E1861BA7_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain_74EEECDFCDA6DC9521FF8F96E1861BA7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_74EEECDFCDA6DC9521FF8F96E1861BA7_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain_74EEECDFCDA6DC9521FF8F96E1861BA7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_74EEECDFCDA6DC9521FF8F96E1861BA7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_74EEECDFCDA6DC9521FF8F96E1861BA7" xlink:to="lab_us-gaap_LongtermDebtTypeDomain_74EEECDFCDA6DC9521FF8F96E1861BA7" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditMember_90E54799C00A5DDE2E8B8F96E1869AAB_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember_90E54799C00A5DDE2E8B8F96E1869AAB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_90E54799C00A5DDE2E8B8F96E1869AAB_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember_90E54799C00A5DDE2E8B8F96E1869AAB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_90E54799C00A5DDE2E8B8F96E1869AAB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember_90E54799C00A5DDE2E8B8F96E1869AAB" xlink:to="lab_us-gaap_LineOfCreditMember_90E54799C00A5DDE2E8B8F96E1869AAB" xlink:type="arc" />
    <link:label id="lab_us-gaap_CreditFacilityAxis_BD5BFECC86A2C73B00148F96E18438D4_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis_BD5BFECC86A2C73B00148F96E18438D4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_BD5BFECC86A2C73B00148F96E18438D4_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis_BD5BFECC86A2C73B00148F96E18438D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_BD5BFECC86A2C73B00148F96E18438D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis_BD5BFECC86A2C73B00148F96E18438D4" xlink:to="lab_us-gaap_CreditFacilityAxis_BD5BFECC86A2C73B00148F96E18438D4" xlink:type="arc" />
    <link:label id="lab_us-gaap_CreditFacilityDomain_D2C2E6DCACB82A2864448F96E1854D70_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain_D2C2E6DCACB82A2864448F96E1854D70" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_D2C2E6DCACB82A2864448F96E1854D70_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain_D2C2E6DCACB82A2864448F96E1854D70" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_D2C2E6DCACB82A2864448F96E1854D70" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain_D2C2E6DCACB82A2864448F96E1854D70" xlink:to="lab_us-gaap_CreditFacilityDomain_D2C2E6DCACB82A2864448F96E1854D70" xlink:type="arc" />
    <link:label id="lab_us-gaap_SecuredDebtMember_B44B9F98D71B28FE58B28F96E1855D83_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember_B44B9F98D71B28FE58B28F96E1855D83" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_B44B9F98D71B28FE58B28F96E1855D83_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember_B44B9F98D71B28FE58B28F96E1855D83" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember_B44B9F98D71B28FE58B28F96E1855D83" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember_B44B9F98D71B28FE58B28F96E1855D83" xlink:to="lab_us-gaap_SecuredDebtMember_B44B9F98D71B28FE58B28F96E1855D83" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_B769567191A05EF7EF488F96E185952F_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember_B769567191A05EF7EF488F96E185952F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_B769567191A05EF7EF488F96E185952F_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember_B769567191A05EF7EF488F96E185952F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_B769567191A05EF7EF488F96E185952F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember_B769567191A05EF7EF488F96E185952F" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember_B769567191A05EF7EF488F96E185952F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_A5235589D2A40C2A787F8F96E186ABE8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_A5235589D2A40C2A787F8F96E186ABE8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_A5235589D2A40C2A787F8F96E186ABE8_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_A5235589D2A40C2A787F8F96E186ABE8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_A5235589D2A40C2A787F8F96E186ABE8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A5235589D2A40C2A787F8F96E186ABE8" xlink:to="lab_us-gaap_DebtInstrumentLineItems_A5235589D2A40C2A787F8F96E186ABE8" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Future minimum principal payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC_label_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:to="lab_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3A1FC55B6C4EC0E6DCDF8F96E1873323_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3A1FC55B6C4EC0E6DCDF8F96E1873323" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2019</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3A1FC55B6C4EC0E6DCDF8F96E1873323_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3A1FC55B6C4EC0E6DCDF8F96E1873323" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3A1FC55B6C4EC0E6DCDF8F96E1873323" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3A1FC55B6C4EC0E6DCDF8F96E1873323" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3A1FC55B6C4EC0E6DCDF8F96E1873323" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_E6D8B0B9B852505653278F96E187583F_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_E6D8B0B9B852505653278F96E187583F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_E6D8B0B9B852505653278F96E187583F_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_E6D8B0B9B852505653278F96E187583F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_E6D8B0B9B852505653278F96E187583F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_E6D8B0B9B852505653278F96E187583F" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_E6D8B0B9B852505653278F96E187583F" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7151635934973BF5323B8F96E18718F8_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7151635934973BF5323B8F96E18718F8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7151635934973BF5323B8F96E18718F8_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7151635934973BF5323B8F96E18718F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7151635934973BF5323B8F96E18718F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7151635934973BF5323B8F96E18718F8" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7151635934973BF5323B8F96E18718F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_FB47855D543D2C0DA3538F96E187A69D_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_FB47855D543D2C0DA3538F96E187A69D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_FB47855D543D2C0DA3538F96E187A69D_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_FB47855D543D2C0DA3538F96E187A69D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Maturities, Repayments of Principal in Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_FB47855D543D2C0DA3538F96E187A69D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_FB47855D543D2C0DA3538F96E187A69D" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_FB47855D543D2C0DA3538F96E187A69D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_38F30DCE4B0CEFA85E4A8F96E188756F_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount_38F30DCE4B0CEFA85E4A8F96E188756F" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_38F30DCE4B0CEFA85E4A8F96E188756F_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount_38F30DCE4B0CEFA85E4A8F96E188756F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_38F30DCE4B0CEFA85E4A8F96E188756F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_38F30DCE4B0CEFA85E4A8F96E188756F" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount_38F30DCE4B0CEFA85E4A8F96E188756F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_B91505A4AAAC3189F4E88F96E1886E5B_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_B91505A4AAAC3189F4E88F96E1886E5B" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_B91505A4AAAC3189F4E88F96E1886E5B_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_B91505A4AAAC3189F4E88F96E1886E5B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_B91505A4AAAC3189F4E88F96E1886E5B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_B91505A4AAAC3189F4E88F96E1886E5B" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_B91505A4AAAC3189F4E88F96E1886E5B" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebt_60850FB2EECA86CCC34E8F96E1883A4F_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt_60850FB2EECA86CCC34E8F96E1883A4F" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_60850FB2EECA86CCC34E8F96E1883A4F_label_en-US" xlink:label="lab_us-gaap_LongTermDebt_60850FB2EECA86CCC34E8F96E1883A4F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_60850FB2EECA86CCC34E8F96E1883A4F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt_60850FB2EECA86CCC34E8F96E1883A4F" xlink:to="lab_us-gaap_LongTermDebt_60850FB2EECA86CCC34E8F96E1883A4F" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtCurrent_D4F7B9457642FA983E118F96E1880FD7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent_D4F7B9457642FA983E118F96E1880FD7" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: Current portion of long-term debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_D4F7B9457642FA983E118F96E1880FD7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent_D4F7B9457642FA983E118F96E1880FD7" xlink:to="lab_us-gaap_LongTermDebtCurrent_D4F7B9457642FA983E118F96E1880FD7" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_13AEB222AD6BA25AB05C8F96E1884F20_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent_13AEB222AD6BA25AB05C8F96E1884F20" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total long-term debt, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_13AEB222AD6BA25AB05C8F96E1884F20_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent_13AEB222AD6BA25AB05C8F96E1884F20" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_13AEB222AD6BA25AB05C8F96E1884F20" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_13AEB222AD6BA25AB05C8F96E1884F20" xlink:to="lab_us-gaap_LongTermDebtNoncurrent_13AEB222AD6BA25AB05C8F96E1884F20" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesTable_323D2B4400424380CC038F22D14B70B9_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesTable_323D2B4400424380CC038F22D14B70B9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments in and Advances to Affiliates [Table]</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesTable_323D2B4400424380CC038F22D14B70B9_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesTable_323D2B4400424380CC038F22D14B70B9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in and Advances to Affiliates [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesTable" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesTable_323D2B4400424380CC038F22D14B70B9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesTable_323D2B4400424380CC038F22D14B70B9" xlink:to="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesTable_323D2B4400424380CC038F22D14B70B9" xlink:type="arc" />
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_437AFD6D27EC0F59893D8F22D14B2252_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_437AFD6D27EC0F59893D8F22D14B2252" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_437AFD6D27EC0F59893D8F22D14B2252_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_437AFD6D27EC0F59893D8F22D14B2252" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_437AFD6D27EC0F59893D8F22D14B2252" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_437AFD6D27EC0F59893D8F22D14B2252" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_437AFD6D27EC0F59893D8F22D14B2252" xlink:type="arc" />
    <link:label id="lab_us-gaap_RelatedPartyDomain_8A79C29ABBABB73E830D8F22D14BFBCC_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain_8A79C29ABBABB73E830D8F22D14BFBCC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_8A79C29ABBABB73E830D8F22D14BFBCC_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain_8A79C29ABBABB73E830D8F22D14BFBCC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_8A79C29ABBABB73E830D8F22D14BFBCC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain_8A79C29ABBABB73E830D8F22D14BFBCC" xlink:to="lab_us-gaap_RelatedPartyDomain_8A79C29ABBABB73E830D8F22D14BFBCC" xlink:type="arc" />
    <link:label id="lab_srt_AffiliatedEntityMember_AB8374953F9EF75D9ED08F22D14BABC5_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember_AB8374953F9EF75D9ED08F22D14BABC5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Affiliated Entity</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_AB8374953F9EF75D9ED08F22D14BABC5_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember_AB8374953F9EF75D9ED08F22D14BABC5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_AffiliatedEntityMember" xlink:label="loc_srt_AffiliatedEntityMember_AB8374953F9EF75D9ED08F22D14BABC5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember_AB8374953F9EF75D9ED08F22D14BABC5" xlink:to="lab_srt_AffiliatedEntityMember_AB8374953F9EF75D9ED08F22D14BABC5" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems_2C715C81B34FDED991828F22D14B9427_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems_2C715C81B34FDED991828F22D14B9427" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments in and Advances to Affiliates [Line Items]</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems_2C715C81B34FDED991828F22D14B9427_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems_2C715C81B34FDED991828F22D14B9427" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in and Advances to Affiliates [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems_2C715C81B34FDED991828F22D14B9427" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems_2C715C81B34FDED991828F22D14B9427" xlink:to="lab_us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems_2C715C81B34FDED991828F22D14B9427" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetImpairmentCharges_B4E813FC3777C2F941378F22D14B9745_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges_B4E813FC3777C2F941378F22D14B9745" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Write-off of investment</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_B4E813FC3777C2F941378F22D14B9745_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges_B4E813FC3777C2F941378F22D14B9745" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_B4E813FC3777C2F941378F22D14B9745" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges_B4E813FC3777C2F941378F22D14B9745" xlink:to="lab_us-gaap_AssetImpairmentCharges_B4E813FC3777C2F941378F22D14B9745" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_501BED2C49B5CF55B653949FCBF939FD_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_501BED2C49B5CF55B653949FCBF939FD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_501BED2C49B5CF55B653949FCBF939FD_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_501BED2C49B5CF55B653949FCBF939FD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_501BED2C49B5CF55B653949FCBF939FD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_501BED2C49B5CF55B653949FCBF939FD" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_501BED2C49B5CF55B653949FCBF939FD" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10EE9F6E310D10821935949FCC001953_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10EE9F6E310D10821935949FCC001953" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10EE9F6E310D10821935949FCC001953_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10EE9F6E310D10821935949FCC001953" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10EE9F6E310D10821935949FCC001953" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10EE9F6E310D10821935949FCC001953" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10EE9F6E310D10821935949FCC001953" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_D9F8F2579235E153009D949FCC00E6F4_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_D9F8F2579235E153009D949FCC00E6F4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_D9F8F2579235E153009D949FCC00E6F4_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_D9F8F2579235E153009D949FCC00E6F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_D9F8F2579235E153009D949FCC00E6F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_D9F8F2579235E153009D949FCC00E6F4" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_D9F8F2579235E153009D949FCC00E6F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_EC5F4E32D0FC6850477F949FCC0195B0_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_EC5F4E32D0FC6850477F949FCC0195B0" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Non-Vested Stock Award Units Beginning Balance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_EC5F4E32D0FC6850477F949FCC0195B0_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_EC5F4E32D0FC6850477F949FCC0195B0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_EC5F4E32D0FC6850477F949FCC0195B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_EC5F4E32D0FC6850477F949FCC0195B0" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_EC5F4E32D0FC6850477F949FCC0195B0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DED16955126613DDA587949FCC018245_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DED16955126613DDA587949FCC018245" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non-Vested Stock Award Units, Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DED16955126613DDA587949FCC018245_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DED16955126613DDA587949FCC018245" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DED16955126613DDA587949FCC018245" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DED16955126613DDA587949FCC018245" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DED16955126613DDA587949FCC018245" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_94C1334E1E0200040163949FCC013A72_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_94C1334E1E0200040163949FCC013A72" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Non-Vested Stock Award Units, Vested (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_94C1334E1E0200040163949FCC013A72_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_94C1334E1E0200040163949FCC013A72" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_94C1334E1E0200040163949FCC013A72" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_94C1334E1E0200040163949FCC013A72" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_94C1334E1E0200040163949FCC013A72" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_63F7845BEE7D8B287272949FCC017E07_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_63F7845BEE7D8B287272949FCC017E07" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Non-Vested Stock Award Units, Cancelled (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_63F7845BEE7D8B287272949FCC017E07_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_63F7845BEE7D8B287272949FCC017E07" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_63F7845BEE7D8B287272949FCC017E07" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_63F7845BEE7D8B287272949FCC017E07" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_63F7845BEE7D8B287272949FCC017E07" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7D999CFD9F9D4C340060949FCC012991_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7D999CFD9F9D4C340060949FCC012991" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Non-Vested Stock Award Units Ending Balance (shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7D999CFD9F9D4C340060949FCC012991" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7D999CFD9F9D4C340060949FCC012991" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7D999CFD9F9D4C340060949FCC012991" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7A74E29FA60CC4B8866F94B6D1A664C3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7A74E29FA60CC4B8866F94B6D1A664C3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Grant-Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7A74E29FA60CC4B8866F94B6D1A664C3_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7A74E29FA60CC4B8866F94B6D1A664C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7A74E29FA60CC4B8866F94B6D1A664C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7A74E29FA60CC4B8866F94B6D1A664C3" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7A74E29FA60CC4B8866F94B6D1A664C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_887B76ACEF842D72C65F949FCC01ED85_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_887B76ACEF842D72C65F949FCC01ED85" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Grant-Date Fair Value Beginning Balance (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_887B76ACEF842D72C65F949FCC01ED85_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_887B76ACEF842D72C65F949FCC01ED85" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_887B76ACEF842D72C65F949FCC01ED85" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_887B76ACEF842D72C65F949FCC01ED85" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_887B76ACEF842D72C65F949FCC01ED85" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_56C929926B2D6133F79C949FCC0249DE_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_56C929926B2D6133F79C949FCC0249DE" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Granted (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_56C929926B2D6133F79C949FCC0249DE_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_56C929926B2D6133F79C949FCC0249DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_56C929926B2D6133F79C949FCC0249DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_56C929926B2D6133F79C949FCC0249DE" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_56C929926B2D6133F79C949FCC0249DE" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2D6AF38A52523EE6FA53949FCC02A577_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2D6AF38A52523EE6FA53949FCC02A577" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Vested (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2D6AF38A52523EE6FA53949FCC02A577_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2D6AF38A52523EE6FA53949FCC02A577" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2D6AF38A52523EE6FA53949FCC02A577" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2D6AF38A52523EE6FA53949FCC02A577" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2D6AF38A52523EE6FA53949FCC02A577" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8A56D90C58660904108A949FCC020491_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8A56D90C58660904108A949FCC020491" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Cancelled (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8A56D90C58660904108A949FCC020491_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8A56D90C58660904108A949FCC020491" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8A56D90C58660904108A949FCC020491" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8A56D90C58660904108A949FCC020491" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8A56D90C58660904108A949FCC020491" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_C36335188DB86F62A2B9949FCC029B49_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_C36335188DB86F62A2B9949FCC029B49" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Grant-Date Fair Value Ending Balance (usd per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_C36335188DB86F62A2B9949FCC029B49" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_C36335188DB86F62A2B9949FCC029B49" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_C36335188DB86F62A2B9949FCC029B49" xlink:type="arc" />
    <link:label id="lab_ango_IntangibleImpairmentMember_D2B2FC9E5B262C42E7328F96E057DC07_terseLabel_en-US" xlink:label="lab_ango_IntangibleImpairmentMember_D2B2FC9E5B262C42E7328F96E057DC07" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible and other asset impairment</link:label>
    <link:label id="lab_ango_IntangibleImpairmentMember_D2B2FC9E5B262C42E7328F96E057DC07_label_en-US" xlink:label="lab_ango_IntangibleImpairmentMember_D2B2FC9E5B262C42E7328F96E057DC07" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Impairment [Member]</link:label>
    <link:label id="lab_ango_IntangibleImpairmentMember_D2B2FC9E5B262C42E7328F96E057DC07_documentation_en-US" xlink:label="lab_ango_IntangibleImpairmentMember_D2B2FC9E5B262C42E7328F96E057DC07" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Intangible Impairment [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_IntangibleImpairmentMember" xlink:label="loc_ango_IntangibleImpairmentMember_D2B2FC9E5B262C42E7328F96E057DC07" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_IntangibleImpairmentMember_D2B2FC9E5B262C42E7328F96E057DC07" xlink:to="lab_ango_IntangibleImpairmentMember_D2B2FC9E5B262C42E7328F96E057DC07" xlink:type="arc" />
    <link:label id="lab_us-gaap_FacilityClosingMember_95F8508717DCB4C140FB8F96E05754FF_terseLabel_en-US" xlink:label="lab_us-gaap_FacilityClosingMember_95F8508717DCB4C140FB8F96E05754FF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_us-gaap_FacilityClosingMember_95F8508717DCB4C140FB8F96E05754FF_label_en-US" xlink:label="lab_us-gaap_FacilityClosingMember_95F8508717DCB4C140FB8F96E05754FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Facility Closing [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FacilityClosingMember" xlink:label="loc_us-gaap_FacilityClosingMember_95F8508717DCB4C140FB8F96E05754FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FacilityClosingMember_95F8508717DCB4C140FB8F96E05754FF" xlink:to="lab_us-gaap_FacilityClosingMember_95F8508717DCB4C140FB8F96E05754FF" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherRestructuringMember_E5956215026DBE4787C38F96E057360A_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember_E5956215026DBE4787C38F96E057360A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_E5956215026DBE4787C38F96E057360A_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember_E5956215026DBE4787C38F96E057360A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherRestructuringMember" xlink:label="loc_us-gaap_OtherRestructuringMember_E5956215026DBE4787C38F96E057360A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember_E5956215026DBE4787C38F96E057360A" xlink:to="lab_us-gaap_OtherRestructuringMember_E5956215026DBE4787C38F96E057360A" xlink:type="arc" />
    <link:label id="lab_ango_AcquisitionRestructuringAndOtherItemsNet_9E23AF382877EFB431288F96E0578762_terseLabel_en-US" xlink:label="lab_ango_AcquisitionRestructuringAndOtherItemsNet_9E23AF382877EFB431288F96E0578762" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_AcquisitionRestructuringAndOtherItemsNet" xlink:label="loc_ango_AcquisitionRestructuringAndOtherItemsNet_9E23AF382877EFB431288F96E0578762" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_AcquisitionRestructuringAndOtherItemsNet_9E23AF382877EFB431288F96E0578762" xlink:to="lab_ango_AcquisitionRestructuringAndOtherItemsNet_9E23AF382877EFB431288F96E0578762" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_92158C5C44A778F88224A3DCC3AFDA79_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_92158C5C44A778F88224A3DCC3AFDA79" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Aggregate of future annual payments under non cancelable operating leases for facilities and equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_92158C5C44A778F88224A3DCC3AFDA79_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_92158C5C44A778F88224A3DCC3AFDA79" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_92158C5C44A778F88224A3DCC3AFDA79" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_92158C5C44A778F88224A3DCC3AFDA79" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_92158C5C44A778F88224A3DCC3AFDA79" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_9865C07B38ED2445D9FEA3DCC3AFA223_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_9865C07B38ED2445D9FEA3DCC3AFA223" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2019</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_9865C07B38ED2445D9FEA3DCC3AFA223_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_9865C07B38ED2445D9FEA3DCC3AFA223" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_9865C07B38ED2445D9FEA3DCC3AFA223" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_9865C07B38ED2445D9FEA3DCC3AFA223" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_9865C07B38ED2445D9FEA3DCC3AFA223" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_892FDECD2DF94358C99AA3DCC3AF62A3_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_892FDECD2DF94358C99AA3DCC3AF62A3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_892FDECD2DF94358C99AA3DCC3AF62A3_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_892FDECD2DF94358C99AA3DCC3AF62A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_892FDECD2DF94358C99AA3DCC3AF62A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_892FDECD2DF94358C99AA3DCC3AF62A3" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_892FDECD2DF94358C99AA3DCC3AF62A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_DAE2268975A015ED1675A3DCC3AF269C_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_DAE2268975A015ED1675A3DCC3AF269C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_DAE2268975A015ED1675A3DCC3AF269C_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_DAE2268975A015ED1675A3DCC3AF269C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_DAE2268975A015ED1675A3DCC3AF269C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_DAE2268975A015ED1675A3DCC3AF269C" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_DAE2268975A015ED1675A3DCC3AF269C" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_15F5E5EB9F8FB18E3677A3DCC3AF62D4_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_15F5E5EB9F8FB18E3677A3DCC3AF62D4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_15F5E5EB9F8FB18E3677A3DCC3AF62D4_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_15F5E5EB9F8FB18E3677A3DCC3AF62D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_15F5E5EB9F8FB18E3677A3DCC3AF62D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_15F5E5EB9F8FB18E3677A3DCC3AF62D4" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_15F5E5EB9F8FB18E3677A3DCC3AF62D4" xlink:type="arc" />
    <link:label id="lab_ango_OperatingLeasesFutureMinimumPaymentsDueAfterFourYears_26E08C76DECC010B5407A3DCC3AF6D25_verboseLabel_en-US" xlink:label="lab_ango_OperatingLeasesFutureMinimumPaymentsDueAfterFourYears_26E08C76DECC010B5407A3DCC3AF6D25" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2023 and thereafter</link:label>
    <link:label id="lab_ango_OperatingLeasesFutureMinimumPaymentsDueAfterFourYears_26E08C76DECC010B5407A3DCC3AF6D25_label_en-US" xlink:label="lab_ango_OperatingLeasesFutureMinimumPaymentsDueAfterFourYears_26E08C76DECC010B5407A3DCC3AF6D25" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases Future Minimum Payments Due After Four Years</link:label>
    <link:label id="lab_ango_OperatingLeasesFutureMinimumPaymentsDueAfterFourYears_26E08C76DECC010B5407A3DCC3AF6D25_documentation_en-US" xlink:label="lab_ango_OperatingLeasesFutureMinimumPaymentsDueAfterFourYears_26E08C76DECC010B5407A3DCC3AF6D25" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating leases future minimum payments due after four years.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_OperatingLeasesFutureMinimumPaymentsDueAfterFourYears" xlink:label="loc_ango_OperatingLeasesFutureMinimumPaymentsDueAfterFourYears_26E08C76DECC010B5407A3DCC3AF6D25" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_OperatingLeasesFutureMinimumPaymentsDueAfterFourYears_26E08C76DECC010B5407A3DCC3AF6D25" xlink:to="lab_ango_OperatingLeasesFutureMinimumPaymentsDueAfterFourYears_26E08C76DECC010B5407A3DCC3AF6D25" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_DE42A947AAEE422868D9A3DCC3AFAD81_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_DE42A947AAEE422868D9A3DCC3AFAD81" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_DE42A947AAEE422868D9A3DCC3AFAD81_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_DE42A947AAEE422868D9A3DCC3AFAD81" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_DE42A947AAEE422868D9A3DCC3AFAD81" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_DE42A947AAEE422868D9A3DCC3AFAD81" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_DE42A947AAEE422868D9A3DCC3AFAD81" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Reasons for consolidated income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_FD1D37188E96FAAFB720B305C35FEE5F_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_FD1D37188E96FAAFB720B305C35FEE5F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Effective income tax rate (as percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_FD1D37188E96FAAFB720B305C35FEE5F_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_FD1D37188E96FAAFB720B305C35FEE5F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_FD1D37188E96FAAFB720B305C35FEE5F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_FD1D37188E96FAAFB720B305C35FEE5F" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_FD1D37188E96FAAFB720B305C35FEE5F" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_F02FAA17CC69CF7F865EB305C36025A9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_F02FAA17CC69CF7F865EB305C36025A9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax (benefit) expense at statutory tax rate of 28.6%, 35.0% and 35.0%, respectively</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_F02FAA17CC69CF7F865EB305C36025A9_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_F02FAA17CC69CF7F865EB305C36025A9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_F02FAA17CC69CF7F865EB305C36025A9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_F02FAA17CC69CF7F865EB305C36025A9" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_F02FAA17CC69CF7F865EB305C36025A9" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_AE0BF4ED4DB0EA8728CAB305C360B9FB_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_AE0BF4ED4DB0EA8728CAB305C360B9FB" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Effect of graduated tax rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_AE0BF4ED4DB0EA8728CAB305C360B9FB_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_AE0BF4ED4DB0EA8728CAB305C360B9FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_AE0BF4ED4DB0EA8728CAB305C360B9FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_AE0BF4ED4DB0EA8728CAB305C360B9FB" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_AE0BF4ED4DB0EA8728CAB305C360B9FB" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_57F611731ABAA0709E51B305C3600C38_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_57F611731ABAA0709E51B305C3600C38" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">State income taxes, net of Federal tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_57F611731ABAA0709E51B305C3600C38_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_57F611731ABAA0709E51B305C3600C38" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_57F611731ABAA0709E51B305C3600C38" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_57F611731ABAA0709E51B305C3600C38" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_57F611731ABAA0709E51B305C3600C38" xlink:type="arc" />
    <link:label id="lab_ango_IncomeTaxReconciliationEffectOfForeignOperations_02DAC4ADD48082E5ED5DB305C360E1A4_verboseLabel_en-US" xlink:label="lab_ango_IncomeTaxReconciliationEffectOfForeignOperations_02DAC4ADD48082E5ED5DB305C360E1A4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Impact of Non US operations</link:label>
    <link:label id="lab_ango_IncomeTaxReconciliationEffectOfForeignOperations_02DAC4ADD48082E5ED5DB305C360E1A4_label_en-US" xlink:label="lab_ango_IncomeTaxReconciliationEffectOfForeignOperations_02DAC4ADD48082E5ED5DB305C360E1A4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Reconciliation Effect of Foreign Operations</link:label>
    <link:label id="lab_ango_IncomeTaxReconciliationEffectOfForeignOperations_02DAC4ADD48082E5ED5DB305C360E1A4_documentation_en-US" xlink:label="lab_ango_IncomeTaxReconciliationEffectOfForeignOperations_02DAC4ADD48082E5ED5DB305C360E1A4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The portion of the difference, between total income tax expense or benefit as reported in the Income Statement for the period and the expected income tax expense or benefit computed by applying the domestic federal statutory income tax rates to pretax income from continuing operations, that is attributable to the impact of non US operations.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_IncomeTaxReconciliationEffectOfForeignOperations" xlink:label="loc_ango_IncomeTaxReconciliationEffectOfForeignOperations_02DAC4ADD48082E5ED5DB305C360E1A4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_IncomeTaxReconciliationEffectOfForeignOperations_02DAC4ADD48082E5ED5DB305C360E1A4" xlink:to="lab_ango_IncomeTaxReconciliationEffectOfForeignOperations_02DAC4ADD48082E5ED5DB305C360E1A4" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_D608133D38FDF34867DBB305C360867A_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_D608133D38FDF34867DBB305C360867A" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Research and development tax credit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_D608133D38FDF34867DBB305C360867A_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_D608133D38FDF34867DBB305C360867A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_D608133D38FDF34867DBB305C360867A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_D608133D38FDF34867DBB305C360867A" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_D608133D38FDF34867DBB305C360867A" xlink:type="arc" />
    <link:label id="lab_ango_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_D750CDEEB8CBA3746A5FB305C360FE1C_terseLabel_en-US" xlink:label="lab_ango_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_D750CDEEB8CBA3746A5FB305C360FE1C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impact of tax reform</link:label>
    <link:label id="lab_ango_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_D750CDEEB8CBA3746A5FB305C360FE1C_label_en-US" xlink:label="lab_ango_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_D750CDEEB8CBA3746A5FB305C360FE1C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Cuts And Jobs Act Of 2017, Amount</link:label>
    <link:label id="lab_ango_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_D750CDEEB8CBA3746A5FB305C360FE1C_documentation_en-US" xlink:label="lab_ango_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_D750CDEEB8CBA3746A5FB305C360FE1C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Cuts And Jobs Act Of 2017, Amount</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount" xlink:label="loc_ango_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_D750CDEEB8CBA3746A5FB305C360FE1C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_D750CDEEB8CBA3746A5FB305C360FE1C" xlink:to="lab_ango_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_D750CDEEB8CBA3746A5FB305C360FE1C" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_F7C2323FB99D72812604B305C3613263_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_F7C2323FB99D72812604B305C3613263" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Meals and entertainment</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_F7C2323FB99D72812604B305C3613263_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_F7C2323FB99D72812604B305C3613263" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_F7C2323FB99D72812604B305C3613263" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_F7C2323FB99D72812604B305C3613263" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_F7C2323FB99D72812604B305C3613263" xlink:type="arc" />
    <link:label id="lab_ango_IncomeTaxReconciliationNondeductibleInterestOnContingentPayment_3DA334502D97BF5867C0B305C36158DD_verboseLabel_en-US" xlink:label="lab_ango_IncomeTaxReconciliationNondeductibleInterestOnContingentPayment_3DA334502D97BF5867C0B305C36158DD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Nondeductible interest on contingent payments</link:label>
    <link:label id="lab_ango_IncomeTaxReconciliationNondeductibleInterestOnContingentPayment_3DA334502D97BF5867C0B305C36158DD_label_en-US" xlink:label="lab_ango_IncomeTaxReconciliationNondeductibleInterestOnContingentPayment_3DA334502D97BF5867C0B305C36158DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Reconciliation Nondeductible Interest on Contingent Payment</link:label>
    <link:label id="lab_ango_IncomeTaxReconciliationNondeductibleInterestOnContingentPayment_3DA334502D97BF5867C0B305C36158DD_documentation_en-US" xlink:label="lab_ango_IncomeTaxReconciliationNondeductibleInterestOnContingentPayment_3DA334502D97BF5867C0B305C36158DD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income tax reconciliation nondeductible interest on contingent payment.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_IncomeTaxReconciliationNondeductibleInterestOnContingentPayment" xlink:label="loc_ango_IncomeTaxReconciliationNondeductibleInterestOnContingentPayment_3DA334502D97BF5867C0B305C36158DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_IncomeTaxReconciliationNondeductibleInterestOnContingentPayment_3DA334502D97BF5867C0B305C36158DD" xlink:to="lab_ango_IncomeTaxReconciliationNondeductibleInterestOnContingentPayment_3DA334502D97BF5867C0B305C36158DD" xlink:type="arc" />
    <link:label id="lab_ango_IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability_4713BBA92EA7B161E69DB305C36147B0_negatedTerseLabel_en-US" xlink:label="lab_ango_IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability_4713BBA92EA7B161E69DB305C36147B0" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Nontaxable gain on revaluation of contingent consideration liability</link:label>
    <link:label id="lab_ango_IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability_4713BBA92EA7B161E69DB305C36147B0_label_en-US" xlink:label="lab_ango_IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability_4713BBA92EA7B161E69DB305C36147B0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Reconciliation, Gain on Revaluation of Contingent Consideration Liability</link:label>
    <link:label id="lab_ango_IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability_4713BBA92EA7B161E69DB305C36147B0_documentation_en-US" xlink:label="lab_ango_IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability_4713BBA92EA7B161E69DB305C36147B0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Tax Reconciliation, Gain on Revaluation of Contingent Consideration Liability</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability" xlink:label="loc_ango_IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability_4713BBA92EA7B161E69DB305C36147B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability_4713BBA92EA7B161E69DB305C36147B0" xlink:to="lab_ango_IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability_4713BBA92EA7B161E69DB305C36147B0" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_3B3C93D14CCF5F9AD2EEB305C361ED2D_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_3B3C93D14CCF5F9AD2EEB305C361ED2D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_3B3C93D14CCF5F9AD2EEB305C361ED2D_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_3B3C93D14CCF5F9AD2EEB305C361ED2D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_3B3C93D14CCF5F9AD2EEB305C361ED2D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_3B3C93D14CCF5F9AD2EEB305C361ED2D" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_3B3C93D14CCF5F9AD2EEB305C361ED2D" xlink:type="arc" />
    <link:label id="lab_ango_IncomeTaxReconciliationEffectofEliminationofASC718APICPool_2974383BBC25439CBA08B305C3617D26_negatedTerseLabel_en-US" xlink:label="lab_ango_IncomeTaxReconciliationEffectofEliminationofASC718APICPool_2974383BBC25439CBA08B305C3617D26" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Effect of elimination of stock compensation APIC pool</link:label>
    <link:label id="lab_ango_IncomeTaxReconciliationEffectofEliminationofASC718APICPool_2974383BBC25439CBA08B305C3617D26_label_en-US" xlink:label="lab_ango_IncomeTaxReconciliationEffectofEliminationofASC718APICPool_2974383BBC25439CBA08B305C3617D26" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Reconciliation, Effect of Elimination of ASC 718 APIC Pool</link:label>
    <link:label id="lab_ango_IncomeTaxReconciliationEffectofEliminationofASC718APICPool_2974383BBC25439CBA08B305C3617D26_documentation_en-US" xlink:label="lab_ango_IncomeTaxReconciliationEffectofEliminationofASC718APICPool_2974383BBC25439CBA08B305C3617D26" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Tax Reconciliation, Effect of Elimination of ASC 718 APIC Pool</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_IncomeTaxReconciliationEffectofEliminationofASC718APICPool" xlink:label="loc_ango_IncomeTaxReconciliationEffectofEliminationofASC718APICPool_2974383BBC25439CBA08B305C3617D26" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_IncomeTaxReconciliationEffectofEliminationofASC718APICPool_2974383BBC25439CBA08B305C3617D26" xlink:to="lab_ango_IncomeTaxReconciliationEffectofEliminationofASC718APICPool_2974383BBC25439CBA08B305C3617D26" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_AF76CACDE10D0D726C13B305C36286B8_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_AF76CACDE10D0D726C13B305C36286B8" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Nondeductible stock-based compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_AF76CACDE10D0D726C13B305C36286B8_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_AF76CACDE10D0D726C13B305C36286B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Compensation Cost, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_AF76CACDE10D0D726C13B305C36286B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_AF76CACDE10D0D726C13B305C36286B8" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_AF76CACDE10D0D726C13B305C36286B8" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_EF0850D6014FE6682921B305C36230D9_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_EF0850D6014FE6682921B305C36230D9" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_EF0850D6014FE6682921B305C36230D9_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_EF0850D6014FE6682921B305C36230D9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_EF0850D6014FE6682921B305C36230D9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_EF0850D6014FE6682921B305C36230D9" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_EF0850D6014FE6682921B305C36230D9" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_C69526708F152D2C23C78F96E0D3669B_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_C69526708F152D2C23C78F96E0D3669B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_C69526708F152D2C23C78F96E0D3669B_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_C69526708F152D2C23C78F96E0D3669B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_C69526708F152D2C23C78F96E0D3669B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock_C69526708F152D2C23C78F96E0D3669B" xlink:to="lab_us-gaap_EarningsPerShareTextBlock_C69526708F152D2C23C78F96E0D3669B" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5495A6A9F4FA641D0DDC8F96E0C8B324_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5495A6A9F4FA641D0DDC8F96E0C8B324" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5495A6A9F4FA641D0DDC8F96E0C8B324_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5495A6A9F4FA641D0DDC8F96E0C8B324" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5495A6A9F4FA641D0DDC8F96E0C8B324" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5495A6A9F4FA641D0DDC8F96E0C8B324" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5495A6A9F4FA641D0DDC8F96E0C8B324" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_D940FA12D1A15098EF5E8F96E0C8268A_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_D940FA12D1A15098EF5E8F96E0C8268A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Effect of dilutive securities</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_D940FA12D1A15098EF5E8F96E0C8268A_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_D940FA12D1A15098EF5E8F96E0C8268A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_D940FA12D1A15098EF5E8F96E0C8268A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_D940FA12D1A15098EF5E8F96E0C8268A" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_D940FA12D1A15098EF5E8F96E0C8268A" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_B0E310E7E9B272F748BC8F96E0C8FB95_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_B0E310E7E9B272F748BC8F96E0C8FB95" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_B0E310E7E9B272F748BC8F96E0C8FB95_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_B0E310E7E9B272F748BC8F96E0C8FB95" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_B0E310E7E9B272F748BC8F96E0C8FB95" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_B0E310E7E9B272F748BC8F96E0C8FB95" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_B0E310E7E9B272F748BC8F96E0C8FB95" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_792BEBA2B032412E3C408F96E0C8B6FD_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_792BEBA2B032412E3C408F96E0C8B6FD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Securities excluded as their inclusion would be anti-dilutive</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_792BEBA2B032412E3C408F96E0C8B6FD_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_792BEBA2B032412E3C408F96E0C8B6FD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_792BEBA2B032412E3C408F96E0C8B6FD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_792BEBA2B032412E3C408F96E0C8B6FD" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_792BEBA2B032412E3C408F96E0C8B6FD" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_7D61345A0C16C34A1B878F05E0576DB7_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_7D61345A0C16C34A1B878F05E0576DB7" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_7D61345A0C16C34A1B878F05E0576DB7_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_7D61345A0C16C34A1B878F05E0576DB7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_7D61345A0C16C34A1B878F05E0576DB7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_7D61345A0C16C34A1B878F05E0576DB7" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_7D61345A0C16C34A1B878F05E0576DB7" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_519F95500091726D6F388E9512898E30_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_519F95500091726D6F388E9512898E30" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amortized cost and fair value of marketable securities by contractual maturity</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_519F95500091726D6F388E9512898E30_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_519F95500091726D6F388E9512898E30" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_519F95500091726D6F388E9512898E30" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_519F95500091726D6F388E9512898E30" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_519F95500091726D6F388E9512898E30" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsDisclosureTextBlock_D4B353FEFB4246169A668F96E31BB75B_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsDisclosureTextBlock_D4B353FEFB4246169A668F96E31BB75B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">OTHER ASSETS</link:label>
    <link:label id="lab_us-gaap_OtherAssetsDisclosureTextBlock_D4B353FEFB4246169A668F96E31BB75B_label_en-US" xlink:label="lab_us-gaap_OtherAssetsDisclosureTextBlock_D4B353FEFB4246169A668F96E31BB75B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_OtherAssetsDisclosureTextBlock_D4B353FEFB4246169A668F96E31BB75B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsDisclosureTextBlock_D4B353FEFB4246169A668F96E31BB75B" xlink:to="lab_us-gaap_OtherAssetsDisclosureTextBlock_D4B353FEFB4246169A668F96E31BB75B" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1E5CB1A869E18A2CF675B4179032CD30_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1E5CB1A869E18A2CF675B4179032CD30" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Income (loss) before tax expense:</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1E5CB1A869E18A2CF675B4179032CD30_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1E5CB1A869E18A2CF675B4179032CD30" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1E5CB1A869E18A2CF675B4179032CD30" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1E5CB1A869E18A2CF675B4179032CD30" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1E5CB1A869E18A2CF675B4179032CD30" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_98CC2B058D9B4E846407B4179032BBC6_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_98CC2B058D9B4E846407B4179032BBC6" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_98CC2B058D9B4E846407B4179032BBC6_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_98CC2B058D9B4E846407B4179032BBC6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_98CC2B058D9B4E846407B4179032BBC6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_98CC2B058D9B4E846407B4179032BBC6" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_98CC2B058D9B4E846407B4179032BBC6" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0C8241FAA17C17812013B4179032AA2D_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0C8241FAA17C17812013B4179032AA2D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non-U.S.</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0C8241FAA17C17812013B4179032AA2D_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0C8241FAA17C17812013B4179032AA2D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0C8241FAA17C17812013B4179032AA2D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0C8241FAA17C17812013B4179032AA2D" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0C8241FAA17C17812013B4179032AA2D" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_F69A3AEC6009B4833913B4179032DD01_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_F69A3AEC6009B4833913B4179032DD01" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income (loss) before tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_F69A3AEC6009B4833913B4179032DD01_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_F69A3AEC6009B4833913B4179032DD01" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_F69A3AEC6009B4833913B4179032DD01" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_F69A3AEC6009B4833913B4179032DD01" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_F69A3AEC6009B4833913B4179032DD01" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1EE559B88EC37DDDBBFBA3DCC60FEC9F_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1EE559B88EC37DDDBBFBA3DCC60FEC9F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1EE559B88EC37DDDBBFBA3DCC60FEC9F_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1EE559B88EC37DDDBBFBA3DCC60FEC9F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1EE559B88EC37DDDBBFBA3DCC60FEC9F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1EE559B88EC37DDDBBFBA3DCC60FEC9F" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1EE559B88EC37DDDBBFBA3DCC60FEC9F" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6752DD6F92F00CCE3342A3DCC60F4426_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6752DD6F92F00CCE3342A3DCC60F4426" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6752DD6F92F00CCE3342A3DCC60F4426" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6752DD6F92F00CCE3342A3DCC60F4426" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6752DD6F92F00CCE3342A3DCC60F4426" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_461B0888C07AED492615A3DCC60FA9F4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_461B0888C07AED492615A3DCC60FA9F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_461B0888C07AED492615A3DCC60FA9F4_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_461B0888C07AED492615A3DCC60FA9F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_461B0888C07AED492615A3DCC60FA9F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember_461B0888C07AED492615A3DCC60FA9F4" xlink:to="lab_us-gaap_EmployeeStockOptionMember_461B0888C07AED492615A3DCC60FA9F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedStockMember_ABD8D33D525C88B2EE8EA3DCC60FA2AE_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember_ABD8D33D525C88B2EE8EA3DCC60FA2AE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_ABD8D33D525C88B2EE8EA3DCC60FA2AE_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember_ABD8D33D525C88B2EE8EA3DCC60FA2AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_ABD8D33D525C88B2EE8EA3DCC60FA2AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember_ABD8D33D525C88B2EE8EA3DCC60FA2AE" xlink:to="lab_us-gaap_RestrictedStockMember_ABD8D33D525C88B2EE8EA3DCC60FA2AE" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:type="arc" />
    <link:label id="lab_ango_ShortTermInvestmentsMaturityPeriod_884913E3F0E4FDBC85C3A3DCC60F427F_terseLabel_en-US" xlink:label="lab_ango_ShortTermInvestmentsMaturityPeriod_884913E3F0E4FDBC85C3A3DCC60F427F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maturity period</link:label>
    <link:label id="lab_ango_ShortTermInvestmentsMaturityPeriod_884913E3F0E4FDBC85C3A3DCC60F427F_label_en-US" xlink:label="lab_ango_ShortTermInvestmentsMaturityPeriod_884913E3F0E4FDBC85C3A3DCC60F427F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short Term Investments Maturity Period</link:label>
    <link:label id="lab_ango_ShortTermInvestmentsMaturityPeriod_884913E3F0E4FDBC85C3A3DCC60F427F_documentation_en-US" xlink:label="lab_ango_ShortTermInvestmentsMaturityPeriod_884913E3F0E4FDBC85C3A3DCC60F427F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Short term investments maturity period.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_ShortTermInvestmentsMaturityPeriod" xlink:label="loc_ango_ShortTermInvestmentsMaturityPeriod_884913E3F0E4FDBC85C3A3DCC60F427F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ShortTermInvestmentsMaturityPeriod_884913E3F0E4FDBC85C3A3DCC60F427F" xlink:to="lab_ango_ShortTermInvestmentsMaturityPeriod_884913E3F0E4FDBC85C3A3DCC60F427F" xlink:type="arc" />
    <link:label id="lab_ango_AccountsReceivableDuePeriod_0F8FEF993E57A1C5E291A3DCC60FB07C_verboseLabel_en-US" xlink:label="lab_ango_AccountsReceivableDuePeriod_0F8FEF993E57A1C5E291A3DCC60FB07C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivables period due</link:label>
    <link:label id="lab_ango_AccountsReceivableDuePeriod_0F8FEF993E57A1C5E291A3DCC60FB07C_label_en-US" xlink:label="lab_ango_AccountsReceivableDuePeriod_0F8FEF993E57A1C5E291A3DCC60FB07C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable Due Period</link:label>
    <link:label id="lab_ango_AccountsReceivableDuePeriod_0F8FEF993E57A1C5E291A3DCC60FB07C_documentation_en-US" xlink:label="lab_ango_AccountsReceivableDuePeriod_0F8FEF993E57A1C5E291A3DCC60FB07C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounts receivable due period.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_AccountsReceivableDuePeriod" xlink:label="loc_ango_AccountsReceivableDuePeriod_0F8FEF993E57A1C5E291A3DCC60FB07C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_AccountsReceivableDuePeriod_0F8FEF993E57A1C5E291A3DCC60FB07C" xlink:to="lab_ango_AccountsReceivableDuePeriod_0F8FEF993E57A1C5E291A3DCC60FB07C" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_7AD6912A861D85686857A3DCC60FD37C_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_7AD6912A861D85686857A3DCC60FD37C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_7AD6912A861D85686857A3DCC60FD37C_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_7AD6912A861D85686857A3DCC60FD37C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_7AD6912A861D85686857A3DCC60FD37C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_7AD6912A861D85686857A3DCC60FD37C" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_7AD6912A861D85686857A3DCC60FD37C" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0E9A14464093220683DBA3DCC60F4E91_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0E9A14464093220683DBA3DCC60F4E91" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimates useful life of intangible assets other than goodwill</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0E9A14464093220683DBA3DCC60F4E91_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0E9A14464093220683DBA3DCC60F4E91" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0E9A14464093220683DBA3DCC60F4E91" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0E9A14464093220683DBA3DCC60F4E91" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0E9A14464093220683DBA3DCC60F4E91" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_935FBFAB55C8E395E3DEA489EA197A18_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments_935FBFAB55C8E395E3DEA489EA197A18" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_935FBFAB55C8E395E3DEA489EA197A18_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments_935FBFAB55C8E395E3DEA489EA197A18" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_935FBFAB55C8E395E3DEA489EA197A18" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments_935FBFAB55C8E395E3DEA489EA197A18" xlink:to="lab_us-gaap_NumberOfOperatingSegments_935FBFAB55C8E395E3DEA489EA197A18" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfReportingUnits_4024B8E7DC0413312DD3A487C517C2C6_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits_4024B8E7DC0413312DD3A487C517C2C6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_4024B8E7DC0413312DD3A487C517C2C6_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits_4024B8E7DC0413312DD3A487C517C2C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfReportingUnits" xlink:label="loc_us-gaap_NumberOfReportingUnits_4024B8E7DC0413312DD3A487C517C2C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits_4024B8E7DC0413312DD3A487C517C2C6" xlink:to="lab_us-gaap_NumberOfReportingUnits_4024B8E7DC0413312DD3A487C517C2C6" xlink:type="arc" />
    <link:label id="lab_ango_PercentageOfRestockingCharge_CED6780383119A5919F1A3DCC60F6530_verboseLabel_en-US" xlink:label="lab_ango_PercentageOfRestockingCharge_CED6780383119A5919F1A3DCC60F6530" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restocking charge percentage</link:label>
    <link:label id="lab_ango_PercentageOfRestockingCharge_CED6780383119A5919F1A3DCC60F6530_label_en-US" xlink:label="lab_ango_PercentageOfRestockingCharge_CED6780383119A5919F1A3DCC60F6530" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of Restocking Charge</link:label>
    <link:label id="lab_ango_PercentageOfRestockingCharge_CED6780383119A5919F1A3DCC60F6530_documentation_en-US" xlink:label="lab_ango_PercentageOfRestockingCharge_CED6780383119A5919F1A3DCC60F6530" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of restocking charge.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_PercentageOfRestockingCharge" xlink:label="loc_ango_PercentageOfRestockingCharge_CED6780383119A5919F1A3DCC60F6530" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_PercentageOfRestockingCharge_CED6780383119A5919F1A3DCC60F6530" xlink:to="lab_ango_PercentageOfRestockingCharge_CED6780383119A5919F1A3DCC60F6530" xlink:type="arc" />
    <link:label id="lab_ango_NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct_52B179141A38BB4D3327A3DCC60F66FE_verboseLabel_en-US" xlink:label="lab_ango_NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct_52B179141A38BB4D3327A3DCC60F66FE" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Undamaged product expiration date</link:label>
    <link:label id="lab_ango_NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct_52B179141A38BB4D3327A3DCC60F66FE_label_en-US" xlink:label="lab_ango_NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct_52B179141A38BB4D3327A3DCC60F66FE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Months Remaining for Product to be Accepted Prior to Expiration Date of Product</link:label>
    <link:label id="lab_ango_NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct_52B179141A38BB4D3327A3DCC60F66FE_documentation_en-US" xlink:label="lab_ango_NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct_52B179141A38BB4D3327A3DCC60F66FE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of months remaining for product to be accepted prior to expiration date of product</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct" xlink:label="loc_ango_NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct_52B179141A38BB4D3327A3DCC60F66FE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct_52B179141A38BB4D3327A3DCC60F66FE" xlink:to="lab_ango_NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct_52B179141A38BB4D3327A3DCC60F66FE" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7EDB6C3E4E7963D2062CA3DCC60FEAF2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7EDB6C3E4E7963D2062CA3DCC60FEAF2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Period of recognition for costs not yet recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7EDB6C3E4E7963D2062CA3DCC60FEAF2_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7EDB6C3E4E7963D2062CA3DCC60FEAF2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7EDB6C3E4E7963D2062CA3DCC60FEAF2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7EDB6C3E4E7963D2062CA3DCC60FEAF2" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7EDB6C3E4E7963D2062CA3DCC60FEAF2" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_DC4AE858003BAE2A28F18F96E16B2BD5_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis_DC4AE858003BAE2A28F18F96E16B2BD5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_DC4AE858003BAE2A28F18F96E16B2BD5_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis_DC4AE858003BAE2A28F18F96E16B2BD5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_DC4AE858003BAE2A28F18F96E16B2BD5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_DC4AE858003BAE2A28F18F96E16B2BD5" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis_DC4AE858003BAE2A28F18F96E16B2BD5" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_D2B163499C03CB1D9AFC8F96E16B8FF3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain_D2B163499C03CB1D9AFC8F96E16B8FF3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_D2B163499C03CB1D9AFC8F96E16B8FF3_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain_D2B163499C03CB1D9AFC8F96E16B8FF3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_D2B163499C03CB1D9AFC8F96E16B8FF3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_D2B163499C03CB1D9AFC8F96E16B8FF3" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain_D2B163499C03CB1D9AFC8F96E16B8FF3" xlink:type="arc" />
    <link:label id="lab_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_4B9CD97D8E27889E44888F96E16B09D0_terseLabel_en-US" xlink:label="lab_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_4B9CD97D8E27889E44888F96E16B09D0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">JPMorgan Chase Bank, N.A., Bank of America, N.A., Keybank National Association</link:label>
    <link:label id="lab_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_4B9CD97D8E27889E44888F96E16B09D0_label_en-US" xlink:label="lab_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_4B9CD97D8E27889E44888F96E16B09D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">JPMorgan Chase Bank, N.A., Bank of America, N.A., Keybank National Association [Member]</link:label>
    <link:label id="lab_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_4B9CD97D8E27889E44888F96E16B09D0_documentation_en-US" xlink:label="lab_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_4B9CD97D8E27889E44888F96E16B09D0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">JPMorgan Chase Bank, N.A., Bank of America, N.A., Keybank National Association [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember" xlink:label="loc_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_4B9CD97D8E27889E44888F96E16B09D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_4B9CD97D8E27889E44888F96E16B09D0" xlink:to="lab_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_4B9CD97D8E27889E44888F96E16B09D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_LetterOfCreditMember_9E1A7A346AAC7924120D8F96E16CC583_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember_9E1A7A346AAC7924120D8F96E16CC583" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_9E1A7A346AAC7924120D8F96E16CC583_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember_9E1A7A346AAC7924120D8F96E16CC583" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaap_LetterOfCreditMember_9E1A7A346AAC7924120D8F96E16CC583" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember_9E1A7A346AAC7924120D8F96E16CC583" xlink:to="lab_us-gaap_LetterOfCreditMember_9E1A7A346AAC7924120D8F96E16CC583" xlink:type="arc" />
    <link:label id="lab_us-gaap_BridgeLoanMember_872E21A2F4EA3FF0EB148F96E16D251C_terseLabel_en-US" xlink:label="lab_us-gaap_BridgeLoanMember_872E21A2F4EA3FF0EB148F96E16D251C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bridge Loan</link:label>
    <link:label id="lab_us-gaap_BridgeLoanMember_872E21A2F4EA3FF0EB148F96E16D251C_label_en-US" xlink:label="lab_us-gaap_BridgeLoanMember_872E21A2F4EA3FF0EB148F96E16D251C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bridge Loan [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BridgeLoanMember" xlink:label="loc_us-gaap_BridgeLoanMember_872E21A2F4EA3FF0EB148F96E16D251C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BridgeLoanMember_872E21A2F4EA3FF0EB148F96E16D251C" xlink:to="lab_us-gaap_BridgeLoanMember_872E21A2F4EA3FF0EB148F96E16D251C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentAxis_B0AF8C2D0A90E80E60DC8F96E16A91D7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_B0AF8C2D0A90E80E60DC8F96E16A91D7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_B0AF8C2D0A90E80E60DC8F96E16A91D7_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_B0AF8C2D0A90E80E60DC8F96E16A91D7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_B0AF8C2D0A90E80E60DC8F96E16A91D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis_B0AF8C2D0A90E80E60DC8F96E16A91D7" xlink:to="lab_us-gaap_DebtInstrumentAxis_B0AF8C2D0A90E80E60DC8F96E16A91D7" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_18A25C72F3F2D148BCE78F96E16A6041_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_18A25C72F3F2D148BCE78F96E16A6041" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_18A25C72F3F2D148BCE78F96E16A6041_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_18A25C72F3F2D148BCE78F96E16A6041" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_18A25C72F3F2D148BCE78F96E16A6041" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18A25C72F3F2D148BCE78F96E16A6041" xlink:to="lab_us-gaap_DebtInstrumentNameDomain_18A25C72F3F2D148BCE78F96E16A6041" xlink:type="arc" />
    <link:label id="lab_ango_FormerCreditAgreementMember_934D4C383FBE30EE655E8F96E16A7614_terseLabel_en-US" xlink:label="lab_ango_FormerCreditAgreementMember_934D4C383FBE30EE655E8F96E16A7614" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Former Credit Agreement</link:label>
    <link:label id="lab_ango_FormerCreditAgreementMember_934D4C383FBE30EE655E8F96E16A7614_label_en-US" xlink:label="lab_ango_FormerCreditAgreementMember_934D4C383FBE30EE655E8F96E16A7614" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Former Credit Agreement [Member]</link:label>
    <link:label id="lab_ango_FormerCreditAgreementMember_934D4C383FBE30EE655E8F96E16A7614_documentation_en-US" xlink:label="lab_ango_FormerCreditAgreementMember_934D4C383FBE30EE655E8F96E16A7614" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Former Credit Agreement [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_FormerCreditAgreementMember" xlink:label="loc_ango_FormerCreditAgreementMember_934D4C383FBE30EE655E8F96E16A7614" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_FormerCreditAgreementMember_934D4C383FBE30EE655E8F96E16A7614" xlink:to="lab_ango_FormerCreditAgreementMember_934D4C383FBE30EE655E8F96E16A7614" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableRateAxis_14498A48883BB4EBC7838F96E1698BAE_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis_14498A48883BB4EBC7838F96E1698BAE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_14498A48883BB4EBC7838F96E1698BAE_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis_14498A48883BB4EBC7838F96E1698BAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_14498A48883BB4EBC7838F96E1698BAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis_14498A48883BB4EBC7838F96E1698BAE" xlink:to="lab_us-gaap_VariableRateAxis_14498A48883BB4EBC7838F96E1698BAE" xlink:type="arc" />
    <link:label id="lab_us-gaap_VariableRateDomain_6A5EB4D88C9AAA1DE2908F96E1695527_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain_6A5EB4D88C9AAA1DE2908F96E1695527" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_6A5EB4D88C9AAA1DE2908F96E1695527_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain_6A5EB4D88C9AAA1DE2908F96E1695527" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_6A5EB4D88C9AAA1DE2908F96E1695527" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain_6A5EB4D88C9AAA1DE2908F96E1695527" xlink:to="lab_us-gaap_VariableRateDomain_6A5EB4D88C9AAA1DE2908F96E1695527" xlink:type="arc" />
    <link:label id="lab_us-gaap_BaseRateMember_C2E756AB61157FA520638F96E169B04F_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember_C2E756AB61157FA520638F96E169B04F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_C2E756AB61157FA520638F96E169B04F_label_en-US" xlink:label="lab_us-gaap_BaseRateMember_C2E756AB61157FA520638F96E169B04F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BaseRateMember" xlink:label="loc_us-gaap_BaseRateMember_C2E756AB61157FA520638F96E169B04F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember_C2E756AB61157FA520638F96E169B04F" xlink:to="lab_us-gaap_BaseRateMember_C2E756AB61157FA520638F96E169B04F" xlink:type="arc" />
    <link:label id="lab_us-gaap_EurodollarMember_4A63EBC5E9C0B9D382D28F96E16A54CA_terseLabel_en-US" xlink:label="lab_us-gaap_EurodollarMember_4A63EBC5E9C0B9D382D28F96E16A54CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Eurodollar</link:label>
    <link:label id="lab_us-gaap_EurodollarMember_4A63EBC5E9C0B9D382D28F96E16A54CA_label_en-US" xlink:label="lab_us-gaap_EurodollarMember_4A63EBC5E9C0B9D382D28F96E16A54CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Eurodollar [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EurodollarMember" xlink:label="loc_us-gaap_EurodollarMember_4A63EBC5E9C0B9D382D28F96E16A54CA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EurodollarMember_4A63EBC5E9C0B9D382D28F96E16A54CA" xlink:to="lab_us-gaap_EurodollarMember_4A63EBC5E9C0B9D382D28F96E16A54CA" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2A9D596F2AB55EE7EA578F96E16F1E49_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2A9D596F2AB55EE7EA578F96E16F1E49" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit facility borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2A9D596F2AB55EE7EA578F96E16F1E49_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2A9D596F2AB55EE7EA578F96E16F1E49" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2A9D596F2AB55EE7EA578F96E16F1E49" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2A9D596F2AB55EE7EA578F96E16F1E49" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2A9D596F2AB55EE7EA578F96E16F1E49" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentTerm_440FAA6451E7CE4508718F96E170DF35_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm_440FAA6451E7CE4508718F96E170DF35" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_440FAA6451E7CE4508718F96E170DF35_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm_440FAA6451E7CE4508718F96E170DF35" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_440FAA6451E7CE4508718F96E170DF35" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm_440FAA6451E7CE4508718F96E170DF35" xlink:to="lab_us-gaap_DebtInstrumentTerm_440FAA6451E7CE4508718F96E170DF35" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_6DE133E7CCD04B9909928F96E170FCCD_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_6DE133E7CCD04B9909928F96E170FCCD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_6DE133E7CCD04B9909928F96E170FCCD_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_6DE133E7CCD04B9909928F96E170FCCD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6DE133E7CCD04B9909928F96E170FCCD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6DE133E7CCD04B9909928F96E170FCCD" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_6DE133E7CCD04B9909928F96E170FCCD" xlink:type="arc" />
    <link:label id="lab_ango_DebtInstrumentIncreaseInInterestRateInCaseOfDefault_9113A505CA0F1CD410298F96E170CA2D_verboseLabel_en-US" xlink:label="lab_ango_DebtInstrumentIncreaseInInterestRateInCaseOfDefault_9113A505CA0F1CD410298F96E170CA2D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Percentage of increase in interest</link:label>
    <link:label id="lab_ango_DebtInstrumentIncreaseInInterestRateInCaseOfDefault_9113A505CA0F1CD410298F96E170CA2D_label_en-US" xlink:label="lab_ango_DebtInstrumentIncreaseInInterestRateInCaseOfDefault_9113A505CA0F1CD410298F96E170CA2D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Increase in Interest Rate in Case of Default</link:label>
    <link:label id="lab_ango_DebtInstrumentIncreaseInInterestRateInCaseOfDefault_9113A505CA0F1CD410298F96E170CA2D_documentation_en-US" xlink:label="lab_ango_DebtInstrumentIncreaseInInterestRateInCaseOfDefault_9113A505CA0F1CD410298F96E170CA2D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt instrument increase in interest rate in case of default.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_DebtInstrumentIncreaseInInterestRateInCaseOfDefault" xlink:label="loc_ango_DebtInstrumentIncreaseInInterestRateInCaseOfDefault_9113A505CA0F1CD410298F96E170CA2D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_DebtInstrumentIncreaseInInterestRateInCaseOfDefault_9113A505CA0F1CD410298F96E170CA2D" xlink:to="lab_ango_DebtInstrumentIncreaseInInterestRateInCaseOfDefault_9113A505CA0F1CD410298F96E170CA2D" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_63EB5B79B1AA839D79AC8F96E17189A0_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_63EB5B79B1AA839D79AC8F96E17189A0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_63EB5B79B1AA839D79AC8F96E17189A0_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_63EB5B79B1AA839D79AC8F96E17189A0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_63EB5B79B1AA839D79AC8F96E17189A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_63EB5B79B1AA839D79AC8F96E17189A0" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_63EB5B79B1AA839D79AC8F96E17189A0" xlink:type="arc" />
    <link:label id="lab_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA_50E04B96ADF981FF78A08F96E171093D_terseLabel_en-US" xlink:label="lab_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA_50E04B96ADF981FF78A08F96E171093D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, maximum leverage ratio of total indebtedness to adjusted EBITDA</link:label>
    <link:label id="lab_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA_50E04B96ADF981FF78A08F96E171093D_label_en-US" xlink:label="lab_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA_50E04B96ADF981FF78A08F96E171093D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Maximum Leverage Ratio of Total Indebtedness to Adjusted EBITDA</link:label>
    <link:label id="lab_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA_50E04B96ADF981FF78A08F96E171093D_documentation_en-US" xlink:label="lab_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA_50E04B96ADF981FF78A08F96E171093D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Maximum Leverage Ratio of Total Indebtedness to Adjusted EBITDA</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA" xlink:label="loc_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA_50E04B96ADF981FF78A08F96E171093D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA_50E04B96ADF981FF78A08F96E171093D" xlink:to="lab_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA_50E04B96ADF981FF78A08F96E171093D" xlink:type="arc" />
    <link:label id="lab_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions_FAA8206B57927E05D9C18F96E1712FD2_terseLabel_en-US" xlink:label="lab_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions_FAA8206B57927E05D9C18F96E1712FD2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, maximum leverage ratio of total indebtedness to adjusted EBITDA, following material acquisitions</link:label>
    <link:label id="lab_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions_FAA8206B57927E05D9C18F96E1712FD2_label_en-US" xlink:label="lab_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions_FAA8206B57927E05D9C18F96E1712FD2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Maximum Leverage Ratio of Total Indebtedness to Adjusted EBITDA, Following Material Acquisitions</link:label>
    <link:label id="lab_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions_FAA8206B57927E05D9C18F96E1712FD2_documentation_en-US" xlink:label="lab_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions_FAA8206B57927E05D9C18F96E1712FD2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Maximum Leverage Ratio of Total Indebtedness to Adjusted EBITDA, Following Material Acquisitions</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions" xlink:label="loc_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions_FAA8206B57927E05D9C18F96E1712FD2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions_FAA8206B57927E05D9C18F96E1712FD2" xlink:to="lab_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions_FAA8206B57927E05D9C18F96E1712FD2" xlink:type="arc" />
    <link:label id="lab_ango_DebtServiceCoverageRatio_838AE497F488B6480E478F96E1710EFD_verboseLabel_en-US" xlink:label="lab_ango_DebtServiceCoverageRatio_838AE497F488B6480E478F96E1710EFD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Ratio for debt service coverage</link:label>
    <link:label id="lab_ango_DebtServiceCoverageRatio_838AE497F488B6480E478F96E1710EFD_label_en-US" xlink:label="lab_ango_DebtServiceCoverageRatio_838AE497F488B6480E478F96E1710EFD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Service Coverage Ratio</link:label>
    <link:label id="lab_ango_DebtServiceCoverageRatio_838AE497F488B6480E478F96E1710EFD_documentation_en-US" xlink:label="lab_ango_DebtServiceCoverageRatio_838AE497F488B6480E478F96E1710EFD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt service coverage ratio.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_DebtServiceCoverageRatio" xlink:label="loc_ango_DebtServiceCoverageRatio_838AE497F488B6480E478F96E1710EFD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_DebtServiceCoverageRatio_838AE497F488B6480E478F96E1710EFD" xlink:to="lab_ango_DebtServiceCoverageRatio_838AE497F488B6480E478F96E1710EFD" xlink:type="arc" />
    <link:label id="lab_ango_DebtInstrumentMaximumCashAmountForNetDebtCalculation_30B54B880A7199BB2F5E900A532642D3_terseLabel_en-US" xlink:label="lab_ango_DebtInstrumentMaximumCashAmountForNetDebtCalculation_30B54B880A7199BB2F5E900A532642D3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum cash amount that can be utilized to calculate net debt</link:label>
    <link:label id="lab_ango_DebtInstrumentMaximumCashAmountForNetDebtCalculation_30B54B880A7199BB2F5E900A532642D3_label_en-US" xlink:label="lab_ango_DebtInstrumentMaximumCashAmountForNetDebtCalculation_30B54B880A7199BB2F5E900A532642D3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Maximum Cash Amount For Net Debt Calculation</link:label>
    <link:label id="lab_ango_DebtInstrumentMaximumCashAmountForNetDebtCalculation_30B54B880A7199BB2F5E900A532642D3_documentation_en-US" xlink:label="lab_ango_DebtInstrumentMaximumCashAmountForNetDebtCalculation_30B54B880A7199BB2F5E900A532642D3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Maximum Cash Amount For Net Debt Calculation</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_DebtInstrumentMaximumCashAmountForNetDebtCalculation" xlink:label="loc_ango_DebtInstrumentMaximumCashAmountForNetDebtCalculation_30B54B880A7199BB2F5E900A532642D3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_DebtInstrumentMaximumCashAmountForNetDebtCalculation_30B54B880A7199BB2F5E900A532642D3" xlink:to="lab_ango_DebtInstrumentMaximumCashAmountForNetDebtCalculation_30B54B880A7199BB2F5E900A532642D3" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_BD1DA484922E65EE96668F96E2ACD864_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock_BD1DA484922E65EE96668F96E2ACD864" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">INVENTORIES</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_BD1DA484922E65EE96668F96E2ACD864_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock_BD1DA484922E65EE96668F96E2ACD864" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_BD1DA484922E65EE96668F96E2ACD864" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock_BD1DA484922E65EE96668F96E2ACD864" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock_BD1DA484922E65EE96668F96E2ACD864" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementAbstract_0725FEB1D83A299B0D52A965BCFAC268_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract_0725FEB1D83A299B0D52A965BCFAC268" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_0725FEB1D83A299B0D52A965BCFAC268" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_0725FEB1D83A299B0D52A965BCFAC268" xlink:to="lab_us-gaap_IncomeStatementAbstract_0725FEB1D83A299B0D52A965BCFAC268" xlink:type="arc" />
    <link:label id="lab_us-gaap_Revenues_15792AFF06EA94DB23E1A965BCFA7A44_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues_15792AFF06EA94DB23E1A965BCFA7A44" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net sales</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_15792AFF06EA94DB23E1A965BCFA7A44" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_15792AFF06EA94DB23E1A965BCFA7A44" xlink:to="lab_us-gaap_Revenues_15792AFF06EA94DB23E1A965BCFA7A44" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_0C172319C8B3467CF138A9686993CDFB_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold_0C172319C8B3467CF138A9686993CDFB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of sales (exclusive of intangible amortization)</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_0C172319C8B3467CF138A9686993CDFB_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold_0C172319C8B3467CF138A9686993CDFB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_0C172319C8B3467CF138A9686993CDFB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold_0C172319C8B3467CF138A9686993CDFB" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold_0C172319C8B3467CF138A9686993CDFB" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_D28E3D4AA4A8D2713A4EA965BCFA4E2B_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_D28E3D4AA4A8D2713A4EA965BCFA4E2B" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_D28E3D4AA4A8D2713A4EA965BCFA4E2B_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_D28E3D4AA4A8D2713A4EA965BCFA4E2B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_D28E3D4AA4A8D2713A4EA965BCFA4E2B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract_D28E3D4AA4A8D2713A4EA965BCFA4E2B" xlink:to="lab_us-gaap_OperatingExpensesAbstract_D28E3D4AA4A8D2713A4EA965BCFA4E2B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_F9FD858961445FAA5D83A965BCFAA564_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_F9FD858961445FAA5D83A965BCFAA564" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_F9FD858961445FAA5D83A965BCFAA564_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_F9FD858961445FAA5D83A965BCFAA564" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_F9FD858961445FAA5D83A965BCFAA564" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_F9FD858961445FAA5D83A965BCFAA564" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense_F9FD858961445FAA5D83A965BCFAA564" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_9FA43D89AD433411FAEFA965BCFD8C29_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense_9FA43D89AD433411FAEFA965BCFD8C29" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_9FA43D89AD433411FAEFA965BCFD8C29_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense_9FA43D89AD433411FAEFA965BCFD8C29" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_9FA43D89AD433411FAEFA965BCFD8C29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense_9FA43D89AD433411FAEFA965BCFD8C29" xlink:to="lab_us-gaap_SellingAndMarketingExpense_9FA43D89AD433411FAEFA965BCFD8C29" xlink:type="arc" />
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_1AC58E38A1453845BD1BA965BCFDB8FB_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense_1AC58E38A1453845BD1BA965BCFDB8FB" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_1AC58E38A1453845BD1BA965BCFDB8FB_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense_1AC58E38A1453845BD1BA965BCFDB8FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_1AC58E38A1453845BD1BA965BCFDB8FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_1AC58E38A1453845BD1BA965BCFDB8FB" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense_1AC58E38A1453845BD1BA965BCFDB8FB" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_B4F55108FE0FAC4E5B73A965BCFD85BF_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_B4F55108FE0FAC4E5B73A965BCFD85BF" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_B4F55108FE0FAC4E5B73A965BCFD85BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets_B4F55108FE0FAC4E5B73A965BCFD85BF" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets_B4F55108FE0FAC4E5B73A965BCFD85BF" xlink:type="arc" />
    <link:label id="lab_ango_ChangeInFairValueOfContingentConsideration_AB86E1B34145E2C7DC81A965BCFDEA13_verboseLabel_en-US" xlink:label="lab_ango_ChangeInFairValueOfContingentConsideration_AB86E1B34145E2C7DC81A965BCFDEA13" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_ChangeInFairValueOfContingentConsideration" xlink:label="loc_ango_ChangeInFairValueOfContingentConsideration_AB86E1B34145E2C7DC81A965BCFDEA13" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ChangeInFairValueOfContingentConsideration_AB86E1B34145E2C7DC81A965BCFDEA13" xlink:to="lab_ango_ChangeInFairValueOfContingentConsideration_AB86E1B34145E2C7DC81A965BCFDEA13" xlink:type="arc" />
    <link:label id="lab_ango_MedicalDeviceExciseTax_A4CEFAEBD895EC2214E7A965BCFD86BC_verboseLabel_en-US" xlink:label="lab_ango_MedicalDeviceExciseTax_A4CEFAEBD895EC2214E7A965BCFD86BC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Medical device excise tax</link:label>
    <link:label id="lab_ango_MedicalDeviceExciseTax_A4CEFAEBD895EC2214E7A965BCFD86BC_label_en-US" xlink:label="lab_ango_MedicalDeviceExciseTax_A4CEFAEBD895EC2214E7A965BCFD86BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medical Device Excise Tax</link:label>
    <link:label id="lab_ango_MedicalDeviceExciseTax_A4CEFAEBD895EC2214E7A965BCFD86BC_documentation_en-US" xlink:label="lab_ango_MedicalDeviceExciseTax_A4CEFAEBD895EC2214E7A965BCFD86BC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The amount of excise tax imposed on the sale of certain medical devices.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_MedicalDeviceExciseTax" xlink:label="loc_ango_MedicalDeviceExciseTax_A4CEFAEBD895EC2214E7A965BCFD86BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_MedicalDeviceExciseTax_A4CEFAEBD895EC2214E7A965BCFD86BC" xlink:to="lab_ango_MedicalDeviceExciseTax_A4CEFAEBD895EC2214E7A965BCFD86BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingExpenses_E0E6398019C148D6C844A965BCFD3F6C_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses_E0E6398019C148D6C844A965BCFD3F6C" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_E0E6398019C148D6C844A965BCFD3F6C_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses_E0E6398019C148D6C844A965BCFD3F6C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_E0E6398019C148D6C844A965BCFD3F6C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_E0E6398019C148D6C844A965BCFD3F6C" xlink:to="lab_us-gaap_OperatingExpenses_E0E6398019C148D6C844A965BCFD3F6C" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_725B869099BBCA3E5058A965BCFDD08F_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_725B869099BBCA3E5058A965BCFDD08F" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_725B869099BBCA3E5058A965BCFDD08F_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_725B869099BBCA3E5058A965BCFDD08F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_725B869099BBCA3E5058A965BCFDD08F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_725B869099BBCA3E5058A965BCFDD08F" xlink:to="lab_us-gaap_OperatingIncomeLoss_725B869099BBCA3E5058A965BCFDD08F" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_A3172D0529319E7756DAA965BCFDAA76_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_A3172D0529319E7756DAA965BCFDAA76" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other expenses</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_A3172D0529319E7756DAA965BCFDAA76_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_A3172D0529319E7756DAA965BCFDAA76" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_A3172D0529319E7756DAA965BCFDAA76" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_A3172D0529319E7756DAA965BCFDAA76" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_A3172D0529319E7756DAA965BCFDAA76" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestExpense_0CCF30EA96B454379A06A965BCFDB3E1_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense_0CCF30EA96B454379A06A965BCFDB3E1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpense_0CCF30EA96B454379A06A965BCFDB3E1_label_en-US" xlink:label="lab_us-gaap_InterestExpense_0CCF30EA96B454379A06A965BCFDB3E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_0CCF30EA96B454379A06A965BCFDB3E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense_0CCF30EA96B454379A06A965BCFDB3E1" xlink:to="lab_us-gaap_InterestExpense_0CCF30EA96B454379A06A965BCFDB3E1" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNonoperatingExpense_4EE79CB19594C977DFBBA965BCFDFE3A_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingExpense_4EE79CB19594C977DFBBA965BCFDFE3A" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other expense</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingExpense_4EE79CB19594C977DFBBA965BCFDFE3A_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingExpense_4EE79CB19594C977DFBBA965BCFDFE3A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="loc_us-gaap_OtherNonoperatingExpense_4EE79CB19594C977DFBBA965BCFDFE3A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingExpense_4EE79CB19594C977DFBBA965BCFDFE3A" xlink:to="lab_us-gaap_OtherNonoperatingExpense_4EE79CB19594C977DFBBA965BCFDFE3A" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_C0F4102F6A12E28D1E85A965BCFD9702_totalLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_C0F4102F6A12E28D1E85A965BCFD9702" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other expenses, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_C0F4102F6A12E28D1E85A965BCFD9702_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_C0F4102F6A12E28D1E85A965BCFD9702" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_C0F4102F6A12E28D1E85A965BCFD9702" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_C0F4102F6A12E28D1E85A965BCFD9702" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense_C0F4102F6A12E28D1E85A965BCFD9702" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0E5DE5C13C63B4FB01AEA965BCFDF7FD_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0E5DE5C13C63B4FB01AEA965BCFDF7FD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income (loss) before income tax expense (benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0E5DE5C13C63B4FB01AEA965BCFDF7FD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0E5DE5C13C63B4FB01AEA965BCFDF7FD" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0E5DE5C13C63B4FB01AEA965BCFDF7FD" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_A2F6E384E0495DB6BC1CA965BCFD68D9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_A2F6E384E0495DB6BC1CA965BCFD68D9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_A2F6E384E0495DB6BC1CA965BCFD68D9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_A2F6E384E0495DB6BC1CA965BCFD68D9" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_A2F6E384E0495DB6BC1CA965BCFD68D9" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_B3607CBFE05B3235C659A965BCFFED7E_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_B3607CBFE05B3235C659A965BCFFED7E" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income (loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_B3607CBFE05B3235C659A965BCFFED7E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_B3607CBFE05B3235C659A965BCFFED7E" xlink:to="lab_us-gaap_NetIncomeLoss_B3607CBFE05B3235C659A965BCFFED7E" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_8D7E461935D8D3AD976BA965BCFFEDDF_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract_8D7E461935D8D3AD976BA965BCFFEDDF" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Earnings (loss) per share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8D7E461935D8D3AD976BA965BCFFEDDF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8D7E461935D8D3AD976BA965BCFFEDDF" xlink:to="lab_us-gaap_EarningsPerShareAbstract_8D7E461935D8D3AD976BA965BCFFEDDF" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_7EF4D80537C0736A9B10A965BCFFCB62_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_7EF4D80537C0736A9B10A965BCFFCB62" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares outstanding</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_7EF4D80537C0736A9B10A965BCFFCB62_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_7EF4D80537C0736A9B10A965BCFFCB62" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_7EF4D80537C0736A9B10A965BCFFCB62" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_7EF4D80537C0736A9B10A965BCFFCB62" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_7EF4D80537C0736A9B10A965BCFFCB62" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8B574E79EAF2680635DAA965BCFF33D9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8B574E79EAF2680635DAA965BCFF33D9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8B574E79EAF2680635DAA965BCFF33D9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8B574E79EAF2680635DAA965BCFF33D9" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8B574E79EAF2680635DAA965BCFF33D9" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_76882EA83AD688D8EE84A965BCFF7F48_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_76882EA83AD688D8EE84A965BCFF7F48" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_76882EA83AD688D8EE84A965BCFF7F48" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_76882EA83AD688D8EE84A965BCFF7F48" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_76882EA83AD688D8EE84A965BCFF7F48" xlink:type="arc" />
    <link:label id="lab_us-gaap_OneTimeTerminationBenefitsMember_C974D09689CD61B291838F96E04851D3_terseLabel_en-US" xlink:label="lab_us-gaap_OneTimeTerminationBenefitsMember_C974D09689CD61B291838F96E04851D3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Benefits</link:label>
    <link:label id="lab_us-gaap_OneTimeTerminationBenefitsMember_C974D09689CD61B291838F96E04851D3_label_en-US" xlink:label="lab_us-gaap_OneTimeTerminationBenefitsMember_C974D09689CD61B291838F96E04851D3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">One-time Termination Benefits [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OneTimeTerminationBenefitsMember" xlink:label="loc_us-gaap_OneTimeTerminationBenefitsMember_C974D09689CD61B291838F96E04851D3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OneTimeTerminationBenefitsMember_C974D09689CD61B291838F96E04851D3" xlink:to="lab_us-gaap_OneTimeTerminationBenefitsMember_C974D09689CD61B291838F96E04851D3" xlink:type="arc" />
    <link:label id="lab_ango_EquipmentTransferMember_36CB5B4B76B0CE722CC08F96E04802DD_terseLabel_en-US" xlink:label="lab_ango_EquipmentTransferMember_36CB5B4B76B0CE722CC08F96E04802DD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plant Consolidation</link:label>
    <link:label id="lab_ango_EquipmentTransferMember_36CB5B4B76B0CE722CC08F96E04802DD_label_en-US" xlink:label="lab_ango_EquipmentTransferMember_36CB5B4B76B0CE722CC08F96E04802DD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equipment Transfer [Member]</link:label>
    <link:label id="lab_ango_EquipmentTransferMember_36CB5B4B76B0CE722CC08F96E04802DD_documentation_en-US" xlink:label="lab_ango_EquipmentTransferMember_36CB5B4B76B0CE722CC08F96E04802DD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equipment Transfer [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_EquipmentTransferMember" xlink:label="loc_ango_EquipmentTransferMember_36CB5B4B76B0CE722CC08F96E04802DD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_EquipmentTransferMember_36CB5B4B76B0CE722CC08F96E04802DD" xlink:to="lab_ango_EquipmentTransferMember_36CB5B4B76B0CE722CC08F96E04802DD" xlink:type="arc" />
    <link:label id="lab_ango_RegulatoryFilingsMember_8808ADA3F47C79C0505C8F96E0485972_terseLabel_en-US" xlink:label="lab_ango_RegulatoryFilingsMember_8808ADA3F47C79C0505C8F96E0485972" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Regulatory Filings</link:label>
    <link:label id="lab_ango_RegulatoryFilingsMember_8808ADA3F47C79C0505C8F96E0485972_label_en-US" xlink:label="lab_ango_RegulatoryFilingsMember_8808ADA3F47C79C0505C8F96E0485972" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Regulatory Filings [Member]</link:label>
    <link:label id="lab_ango_RegulatoryFilingsMember_8808ADA3F47C79C0505C8F96E0485972_documentation_en-US" xlink:label="lab_ango_RegulatoryFilingsMember_8808ADA3F47C79C0505C8F96E0485972" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Regulatory Filings [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_RegulatoryFilingsMember" xlink:label="loc_ango_RegulatoryFilingsMember_8808ADA3F47C79C0505C8F96E0485972" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_RegulatoryFilingsMember_8808ADA3F47C79C0505C8F96E0485972" xlink:to="lab_ango_RegulatoryFilingsMember_8808ADA3F47C79C0505C8F96E0485972" xlink:type="arc" />
    <link:label id="lab_us-gaap_ContractTerminationMember_AC28BE37F457050E24ED8F96E048BEAB_terseLabel_en-US" xlink:label="lab_us-gaap_ContractTerminationMember_AC28BE37F457050E24ED8F96E048BEAB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract Cancellation</link:label>
    <link:label id="lab_us-gaap_ContractTerminationMember_AC28BE37F457050E24ED8F96E048BEAB_label_en-US" xlink:label="lab_us-gaap_ContractTerminationMember_AC28BE37F457050E24ED8F96E048BEAB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract Termination [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractTerminationMember" xlink:label="loc_us-gaap_ContractTerminationMember_AC28BE37F457050E24ED8F96E048BEAB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractTerminationMember_AC28BE37F457050E24ED8F96E048BEAB" xlink:to="lab_us-gaap_ContractTerminationMember_AC28BE37F457050E24ED8F96E048BEAB" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherRestructuringMember_1E4571F54B6EC68FCE058F96E0489989_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember_1E4571F54B6EC68FCE058F96E0489989" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherRestructuringMember" xlink:label="loc_us-gaap_OtherRestructuringMember_1E4571F54B6EC68FCE058F96E0489989" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember_1E4571F54B6EC68FCE058F96E0489989" xlink:to="lab_us-gaap_OtherRestructuringMember_1E4571F54B6EC68FCE058F96E0489989" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_DB7398215B9DE3E5B1D4904068695ABB_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward_DB7398215B9DE3E5B1D4904068695ABB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_DB7398215B9DE3E5B1D4904068695ABB_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward_DB7398215B9DE3E5B1D4904068695ABB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_DB7398215B9DE3E5B1D4904068695ABB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward_DB7398215B9DE3E5B1D4904068695ABB" xlink:to="lab_us-gaap_RestructuringReserveRollForward_DB7398215B9DE3E5B1D4904068695ABB" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserve_D51D29B3FFBD55AC19178F96E0491860_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve_D51D29B3FFBD55AC19178F96E0491860" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Restructuring Reserve, beginning of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_D51D29B3FFBD55AC19178F96E0491860" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve_D51D29B3FFBD55AC19178F96E0491860" xlink:to="lab_us-gaap_RestructuringReserve_D51D29B3FFBD55AC19178F96E0491860" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCharges_CCE404C21C2007E75D1B8F96E0493D58_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges_CCE404C21C2007E75D1B8F96E0493D58" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_CCE404C21C2007E75D1B8F96E0493D58" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges_CCE404C21C2007E75D1B8F96E0493D58" xlink:to="lab_us-gaap_RestructuringCharges_CCE404C21C2007E75D1B8F96E0493D58" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_263FFE42C9020B2D671F8F96E049F0FE_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2_263FFE42C9020B2D671F8F96E049F0FE" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Non-cash adjustments</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_263FFE42C9020B2D671F8F96E049F0FE_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2_263FFE42C9020B2D671F8F96E049F0FE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_263FFE42C9020B2D671F8F96E049F0FE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2_263FFE42C9020B2D671F8F96E049F0FE" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2_263FFE42C9020B2D671F8F96E049F0FE" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRestructuring_F402B5DFC5D125CCA2FC8F96E049687F_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring_F402B5DFC5D125CCA2FC8F96E049687F" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_F402B5DFC5D125CCA2FC8F96E049687F_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring_F402B5DFC5D125CCA2FC8F96E049687F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_F402B5DFC5D125CCA2FC8F96E049687F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring_F402B5DFC5D125CCA2FC8F96E049687F" xlink:to="lab_us-gaap_PaymentsForRestructuring_F402B5DFC5D125CCA2FC8F96E049687F" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserve_B758F5F6C67DD13D9D148F96E0492DB5_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve_B758F5F6C67DD13D9D148F96E0492DB5" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Restructuring Reserve, end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_B758F5F6C67DD13D9D148F96E0492DB5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve_B758F5F6C67DD13D9D148F96E0492DB5" xlink:to="lab_us-gaap_RestructuringReserve_B758F5F6C67DD13D9D148F96E0492DB5" xlink:type="arc" />
    <link:label id="lab_ango_RecallPeriod_D81E278FEF90B3FF2C5E8F96E19F082E_terseLabel_en-US" xlink:label="lab_ango_RecallPeriod_D81E278FEF90B3FF2C5E8F96E19F082E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recall period</link:label>
    <link:label id="lab_ango_RecallPeriod_D81E278FEF90B3FF2C5E8F96E19F082E_label_en-US" xlink:label="lab_ango_RecallPeriod_D81E278FEF90B3FF2C5E8F96E19F082E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recall Period</link:label>
    <link:label id="lab_ango_RecallPeriod_D81E278FEF90B3FF2C5E8F96E19F082E_documentation_en-US" xlink:label="lab_ango_RecallPeriod_D81E278FEF90B3FF2C5E8F96E19F082E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Recall Period</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_RecallPeriod" xlink:label="loc_ango_RecallPeriod_D81E278FEF90B3FF2C5E8F96E19F082E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_RecallPeriod_D81E278FEF90B3FF2C5E8F96E19F082E" xlink:to="lab_ango_RecallPeriod_D81E278FEF90B3FF2C5E8F96E19F082E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_609DE31ECD86849828DA8F96E19F69C0_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_609DE31ECD86849828DA8F96E19F69C0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal group, deferral of revenue</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_609DE31ECD86849828DA8F96E19F69C0_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_609DE31ECD86849828DA8F96E19F69C0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Deferred Revenue</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_609DE31ECD86849828DA8F96E19F69C0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_609DE31ECD86849828DA8F96E19F69C0" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_609DE31ECD86849828DA8F96E19F69C0" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_81D7ADA68B3762B6A4F98F96E22A1578_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_81D7ADA68B3762B6A4F98F96E22A1578" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expected amortization expense</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_81D7ADA68B3762B6A4F98F96E22A1578_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_81D7ADA68B3762B6A4F98F96E22A1578" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_81D7ADA68B3762B6A4F98F96E22A1578" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_81D7ADA68B3762B6A4F98F96E22A1578" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_81D7ADA68B3762B6A4F98F96E22A1578" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2CA1576D94B2D871F3E38F96E22A4A1C_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2CA1576D94B2D871F3E38F96E22A4A1C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2019</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2CA1576D94B2D871F3E38F96E22A4A1C_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2CA1576D94B2D871F3E38F96E22A4A1C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2CA1576D94B2D871F3E38F96E22A4A1C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2CA1576D94B2D871F3E38F96E22A4A1C" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2CA1576D94B2D871F3E38F96E22A4A1C" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_DF92EA3F917D6FDDA1E68F96E22A5FB5_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_DF92EA3F917D6FDDA1E68F96E22A5FB5" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_DF92EA3F917D6FDDA1E68F96E22A5FB5_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_DF92EA3F917D6FDDA1E68F96E22A5FB5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_DF92EA3F917D6FDDA1E68F96E22A5FB5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_DF92EA3F917D6FDDA1E68F96E22A5FB5" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_DF92EA3F917D6FDDA1E68F96E22A5FB5" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_D1DB329DED02A938B88E8F96E22BEE3D_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_D1DB329DED02A938B88E8F96E22BEE3D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_D1DB329DED02A938B88E8F96E22BEE3D_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_D1DB329DED02A938B88E8F96E22BEE3D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_D1DB329DED02A938B88E8F96E22BEE3D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_D1DB329DED02A938B88E8F96E22BEE3D" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_D1DB329DED02A938B88E8F96E22BEE3D" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_CF7879D73876C3F92FEF8F96E22B486F_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_CF7879D73876C3F92FEF8F96E22B486F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_CF7879D73876C3F92FEF8F96E22B486F_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_CF7879D73876C3F92FEF8F96E22B486F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_CF7879D73876C3F92FEF8F96E22B486F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_CF7879D73876C3F92FEF8F96E22B486F" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_CF7879D73876C3F92FEF8F96E22B486F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_50B404BFA3B83C22BBB08F96E22B6BAD_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_50B404BFA3B83C22BBB08F96E22B6BAD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_50B404BFA3B83C22BBB08F96E22B6BAD_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_50B404BFA3B83C22BBB08F96E22B6BAD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_50B404BFA3B83C22BBB08F96E22B6BAD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_50B404BFA3B83C22BBB08F96E22B6BAD" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_50B404BFA3B83C22BBB08F96E22B6BAD" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_C0D36D0AC9C0F24289FC8F96E22B3F93_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_C0D36D0AC9C0F24289FC8F96E22B3F93" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 and thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_C0D36D0AC9C0F24289FC8F96E22B3F93_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_C0D36D0AC9C0F24289FC8F96E22B3F93" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, after Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_C0D36D0AC9C0F24289FC8F96E22B3F93" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_C0D36D0AC9C0F24289FC8F96E22B3F93" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_C0D36D0AC9C0F24289FC8F96E22B3F93" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_8E227DB0387D54F69AC78F96E27A241C_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_8E227DB0387D54F69AC78F96E27A241C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">PROPERTY, PLANT AND EQUIPMENT, NET</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_8E227DB0387D54F69AC78F96E27A241C_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_8E227DB0387D54F69AC78F96E27A241C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_8E227DB0387D54F69AC78F96E27A241C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_8E227DB0387D54F69AC78F96E27A241C" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_8E227DB0387D54F69AC78F96E27A241C" xlink:type="arc" />
    <link:label id="lab_srt_StatementGeographicalAxis_671A26CE649439C2E3C38F96E06B55D4_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis_671A26CE649439C2E3C38F96E06B55D4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_671A26CE649439C2E3C38F96E06B55D4_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis_671A26CE649439C2E3C38F96E06B55D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_671A26CE649439C2E3C38F96E06B55D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis_671A26CE649439C2E3C38F96E06B55D4" xlink:to="lab_srt_StatementGeographicalAxis_671A26CE649439C2E3C38F96E06B55D4" xlink:type="arc" />
    <link:label id="lab_srt_SegmentGeographicalDomain_B8AD87DAD7D5C828DE7A8F96E06BF15C_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain_B8AD87DAD7D5C828DE7A8F96E06BF15C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment, Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_B8AD87DAD7D5C828DE7A8F96E06BF15C_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain_B8AD87DAD7D5C828DE7A8F96E06BF15C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_B8AD87DAD7D5C828DE7A8F96E06BF15C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain_B8AD87DAD7D5C828DE7A8F96E06BF15C" xlink:to="lab_srt_SegmentGeographicalDomain_B8AD87DAD7D5C828DE7A8F96E06BF15C" xlink:type="arc" />
    <link:label id="lab_country_US_7302D3358AA36ACD7C298F96E06B5883_verboseLabel_en-US" xlink:label="lab_country_US_7302D3358AA36ACD7C298F96E06B5883" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_7302D3358AA36ACD7C298F96E06B5883_label_en-US" xlink:label="lab_country_US_7302D3358AA36ACD7C298F96E06B5883" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_7302D3358AA36ACD7C298F96E06B5883" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US_7302D3358AA36ACD7C298F96E06B5883" xlink:to="lab_country_US_7302D3358AA36ACD7C298F96E06B5883" xlink:type="arc" />
    <link:label id="lab_ango_InternationalMember_8135E22137AF41692F328F96E06C411D_verboseLabel_en-US" xlink:label="lab_ango_InternationalMember_8135E22137AF41692F328F96E06C411D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">International</link:label>
    <link:label id="lab_ango_InternationalMember_8135E22137AF41692F328F96E06C411D_label_en-US" xlink:label="lab_ango_InternationalMember_8135E22137AF41692F328F96E06C411D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">International [Member]</link:label>
    <link:label id="lab_ango_InternationalMember_8135E22137AF41692F328F96E06C411D_documentation_en-US" xlink:label="lab_ango_InternationalMember_8135E22137AF41692F328F96E06C411D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">International [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_InternationalMember" xlink:label="loc_ango_InternationalMember_8135E22137AF41692F328F96E06C411D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_InternationalMember_8135E22137AF41692F328F96E06C411D" xlink:to="lab_ango_InternationalMember_8135E22137AF41692F328F96E06C411D" xlink:type="arc" />
    <link:label id="lab_ango_SummaryOfSalesForGeographicAreasAbstract_01503E946DB7A7DF93E18F96E06C5B75_verboseLabel_en-US" xlink:label="lab_ango_SummaryOfSalesForGeographicAreasAbstract_01503E946DB7A7DF93E18F96E06C5B75" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Summary of net sales for geographic areas</link:label>
    <link:label id="lab_ango_SummaryOfSalesForGeographicAreasAbstract_01503E946DB7A7DF93E18F96E06C5B75_label_en-US" xlink:label="lab_ango_SummaryOfSalesForGeographicAreasAbstract_01503E946DB7A7DF93E18F96E06C5B75" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary of Sales for Geographic Areas [Abstract]</link:label>
    <link:label id="lab_ango_SummaryOfSalesForGeographicAreasAbstract_01503E946DB7A7DF93E18F96E06C5B75_documentation_en-US" xlink:label="lab_ango_SummaryOfSalesForGeographicAreasAbstract_01503E946DB7A7DF93E18F96E06C5B75" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Summary Of Sales For Geographic Areas [Abstract]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_SummaryOfSalesForGeographicAreasAbstract" xlink:label="loc_ango_SummaryOfSalesForGeographicAreasAbstract_01503E946DB7A7DF93E18F96E06C5B75" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_SummaryOfSalesForGeographicAreasAbstract_01503E946DB7A7DF93E18F96E06C5B75" xlink:to="lab_ango_SummaryOfSalesForGeographicAreasAbstract_01503E946DB7A7DF93E18F96E06C5B75" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentsGeographicalAreasAbstract_C7D36481BB89932273A78F96E06C7032_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentsGeographicalAreasAbstract_C7D36481BB89932273A78F96E06C7032" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net sales by Geography</link:label>
    <link:label id="lab_us-gaap_SegmentsGeographicalAreasAbstract_C7D36481BB89932273A78F96E06C7032_label_en-US" xlink:label="lab_us-gaap_SegmentsGeographicalAreasAbstract_C7D36481BB89932273A78F96E06C7032" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments, Geographical Areas [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentsGeographicalAreasAbstract" xlink:label="loc_us-gaap_SegmentsGeographicalAreasAbstract_C7D36481BB89932273A78F96E06C7032" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentsGeographicalAreasAbstract_C7D36481BB89932273A78F96E06C7032" xlink:to="lab_us-gaap_SegmentsGeographicalAreasAbstract_C7D36481BB89932273A78F96E06C7032" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_5DFE69001EF68A5743F08F96E064A26E_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_5DFE69001EF68A5743F08F96E064A26E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ACQUISITION, RESTRUCTURING AND OTHER ITEMS, NET</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_5DFE69001EF68A5743F08F96E064A26E_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_5DFE69001EF68A5743F08F96E064A26E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_5DFE69001EF68A5743F08F96E064A26E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_5DFE69001EF68A5743F08F96E064A26E" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_5DFE69001EF68A5743F08F96E064A26E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_388E561CCF5E27E592C3902022784BC2_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_388E561CCF5E27E592C3902022784BC2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ACCUMULATED OTHER COMPREHESIVE INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_388E561CCF5E27E592C3902022784BC2_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_388E561CCF5E27E592C3902022784BC2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_388E561CCF5E27E592C3902022784BC2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_388E561CCF5E27E592C3902022784BC2" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_388E561CCF5E27E592C3902022784BC2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Ownership Interests [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Other Ownership Interests [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfOtherOwnershipInterestsTable" xlink:label="loc_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:to="lab_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:type="arc" />
    <link:label id="lab_us-gaap_PlanNameAxis_D7F776FEE857607A9287A4E39D9EC08F_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis_D7F776FEE857607A9287A4E39D9EC08F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_D7F776FEE857607A9287A4E39D9EC08F_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis_D7F776FEE857607A9287A4E39D9EC08F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_D7F776FEE857607A9287A4E39D9EC08F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis_D7F776FEE857607A9287A4E39D9EC08F" xlink:to="lab_us-gaap_PlanNameAxis_D7F776FEE857607A9287A4E39D9EC08F" xlink:type="arc" />
    <link:label id="lab_us-gaap_PlanNameDomain_8E06DA3C45AF458EA832A4E39D9E9028_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain_8E06DA3C45AF458EA832A4E39D9E9028" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_8E06DA3C45AF458EA832A4E39D9E9028_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain_8E06DA3C45AF458EA832A4E39D9E9028" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_8E06DA3C45AF458EA832A4E39D9E9028" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain_8E06DA3C45AF458EA832A4E39D9E9028" xlink:to="lab_us-gaap_PlanNameDomain_8E06DA3C45AF458EA832A4E39D9E9028" xlink:type="arc" />
    <link:label id="lab_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember_59F7E69FA3B12DD04499A4E39D9F8711_verboseLabel_en-US" xlink:label="lab_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember_59F7E69FA3B12DD04499A4E39D9F8711" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2004 Stock and Incentive Award Plan</link:label>
    <link:label id="lab_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember_59F7E69FA3B12DD04499A4E39D9F8711_label_en-US" xlink:label="lab_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember_59F7E69FA3B12DD04499A4E39D9F8711" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand and Four Stock and Incentive Award Plan [Member]</link:label>
    <link:label id="lab_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember_59F7E69FA3B12DD04499A4E39D9F8711_documentation_en-US" xlink:label="lab_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember_59F7E69FA3B12DD04499A4E39D9F8711" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two Thousand and Four Stock and Incentive Award Plan [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember" xlink:label="loc_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember_59F7E69FA3B12DD04499A4E39D9F8711" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember_59F7E69FA3B12DD04499A4E39D9F8711" xlink:to="lab_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember_59F7E69FA3B12DD04499A4E39D9F8711" xlink:type="arc" />
    <link:label id="lab_ango_StockPurchasePlanMember_A0B236EB0ACFB7C89AF1A4E39D9F7771_terseLabel_en-US" xlink:label="lab_ango_StockPurchasePlanMember_A0B236EB0ACFB7C89AF1A4E39D9F7771" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Purchase Plan</link:label>
    <link:label id="lab_ango_StockPurchasePlanMember_A0B236EB0ACFB7C89AF1A4E39D9F7771_label_en-US" xlink:label="lab_ango_StockPurchasePlanMember_A0B236EB0ACFB7C89AF1A4E39D9F7771" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_ango_StockPurchasePlanMember_A0B236EB0ACFB7C89AF1A4E39D9F7771_documentation_en-US" xlink:label="lab_ango_StockPurchasePlanMember_A0B236EB0ACFB7C89AF1A4E39D9F7771" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_StockPurchasePlanMember" xlink:label="loc_ango_StockPurchasePlanMember_A0B236EB0ACFB7C89AF1A4E39D9F7771" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_StockPurchasePlanMember_A0B236EB0ACFB7C89AF1A4E39D9F7771" xlink:to="lab_ango_StockPurchasePlanMember_A0B236EB0ACFB7C89AF1A4E39D9F7771" xlink:type="arc" />
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_67FF31A331536611A805A4E39D9F1351_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_67FF31A331536611A805A4E39D9F1351" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Option Indexed to Issuer's Equity [Axis]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_67FF31A331536611A805A4E39D9F1351_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_67FF31A331536611A805A4E39D9F1351" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Option Indexed to Issuer's Equity [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_67FF31A331536611A805A4E39D9F1351" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_67FF31A331536611A805A4E39D9F1351" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_67FF31A331536611A805A4E39D9F1351" xlink:type="arc" />
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_B5EC80741D20F85DA1D5A4E39D9F59C7_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_B5EC80741D20F85DA1D5A4E39D9F59C7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_B5EC80741D20F85DA1D5A4E39D9F59C7_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_B5EC80741D20F85DA1D5A4E39D9F59C7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_B5EC80741D20F85DA1D5A4E39D9F59C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_B5EC80741D20F85DA1D5A4E39D9F59C7" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_B5EC80741D20F85DA1D5A4E39D9F59C7" xlink:type="arc" />
    <link:label id="lab_ango_PerformanceShareAndRestrictedStockUnitAwardsMember_489C625B1FF74612BB6FA4E39D9F2A58_verboseLabel_en-US" xlink:label="lab_ango_PerformanceShareAndRestrictedStockUnitAwardsMember_489C625B1FF74612BB6FA4E39D9F2A58" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Performance Share and Restricted Stock Unit Awards</link:label>
    <link:label id="lab_ango_PerformanceShareAndRestrictedStockUnitAwardsMember_489C625B1FF74612BB6FA4E39D9F2A58_label_en-US" xlink:label="lab_ango_PerformanceShareAndRestrictedStockUnitAwardsMember_489C625B1FF74612BB6FA4E39D9F2A58" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Share and Restricted Stock Unit Awards [Member]</link:label>
    <link:label id="lab_ango_PerformanceShareAndRestrictedStockUnitAwardsMember_489C625B1FF74612BB6FA4E39D9F2A58_documentation_en-US" xlink:label="lab_ango_PerformanceShareAndRestrictedStockUnitAwardsMember_489C625B1FF74612BB6FA4E39D9F2A58" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Performance Share and Restricted Stock Unit Awards [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_PerformanceShareAndRestrictedStockUnitAwardsMember" xlink:label="loc_ango_PerformanceShareAndRestrictedStockUnitAwardsMember_489C625B1FF74612BB6FA4E39D9F2A58" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_PerformanceShareAndRestrictedStockUnitAwardsMember_489C625B1FF74612BB6FA4E39D9F2A58" xlink:to="lab_ango_PerformanceShareAndRestrictedStockUnitAwardsMember_489C625B1FF74612BB6FA4E39D9F2A58" xlink:type="arc" />
    <link:label id="lab_ango_PerformanceSharesIncludingThreeYearMarketConditionMember_93653F31E8B97323116CA4E39D9F8795_terseLabel_en-US" xlink:label="lab_ango_PerformanceSharesIncludingThreeYearMarketConditionMember_93653F31E8B97323116CA4E39D9F8795" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_ango_PerformanceSharesIncludingThreeYearMarketConditionMember_93653F31E8B97323116CA4E39D9F8795_label_en-US" xlink:label="lab_ango_PerformanceSharesIncludingThreeYearMarketConditionMember_93653F31E8B97323116CA4E39D9F8795" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Shares, Including Three-Year Market Condition [Member]</link:label>
    <link:label id="lab_ango_PerformanceSharesIncludingThreeYearMarketConditionMember_93653F31E8B97323116CA4E39D9F8795_documentation_en-US" xlink:label="lab_ango_PerformanceSharesIncludingThreeYearMarketConditionMember_93653F31E8B97323116CA4E39D9F8795" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Performance Shares, Including Three-Year Market Condition [Member]</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_PerformanceSharesIncludingThreeYearMarketConditionMember" xlink:label="loc_ango_PerformanceSharesIncludingThreeYearMarketConditionMember_93653F31E8B97323116CA4E39D9F8795" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_PerformanceSharesIncludingThreeYearMarketConditionMember_93653F31E8B97323116CA4E39D9F8795" xlink:to="lab_ango_PerformanceSharesIncludingThreeYearMarketConditionMember_93653F31E8B97323116CA4E39D9F8795" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_FC613BD4F85BC7D341CFA4E39D9FD784_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis_FC613BD4F85BC7D341CFA4E39D9FD784" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_FC613BD4F85BC7D341CFA4E39D9FD784_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis_FC613BD4F85BC7D341CFA4E39D9FD784" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_FC613BD4F85BC7D341CFA4E39D9FD784" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis_FC613BD4F85BC7D341CFA4E39D9FD784" xlink:to="lab_us-gaap_StatementClassOfStockAxis_FC613BD4F85BC7D341CFA4E39D9FD784" xlink:type="arc" />
    <link:label id="lab_us-gaap_ClassOfStockDomain_2628990EA1C8DBC09BCAA4E39D9F053A_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain_2628990EA1C8DBC09BCAA4E39D9F053A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_2628990EA1C8DBC09BCAA4E39D9F053A_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain_2628990EA1C8DBC09BCAA4E39D9F053A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_2628990EA1C8DBC09BCAA4E39D9F053A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain_2628990EA1C8DBC09BCAA4E39D9F053A" xlink:to="lab_us-gaap_ClassOfStockDomain_2628990EA1C8DBC09BCAA4E39D9F053A" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockMember_A78FD8A41F0CA24496A7A4E39D9F32D2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember_A78FD8A41F0CA24496A7A4E39D9F32D2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_A78FD8A41F0CA24496A7A4E39D9F32D2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember_A78FD8A41F0CA24496A7A4E39D9F32D2" xlink:to="lab_us-gaap_CommonStockMember_A78FD8A41F0CA24496A7A4E39D9F32D2" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Ownership Interests [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4_label_en-US" xlink:label="lab_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Ownership Interests [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherOwnershipInterestsLineItems" xlink:label="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="lab_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:type="arc" />
    <link:label id="lab_ango_CapitalStockSharesAuthorized_663B4E031396C2158C59A4E39D9F9642_verboseLabel_en-US" xlink:label="lab_ango_CapitalStockSharesAuthorized_663B4E031396C2158C59A4E39D9F9642" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Authorized capital stock (shares)</link:label>
    <link:label id="lab_ango_CapitalStockSharesAuthorized_663B4E031396C2158C59A4E39D9F9642_label_en-US" xlink:label="lab_ango_CapitalStockSharesAuthorized_663B4E031396C2158C59A4E39D9F9642" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Stock Shares Authorized</link:label>
    <link:label id="lab_ango_CapitalStockSharesAuthorized_663B4E031396C2158C59A4E39D9F9642_documentation_en-US" xlink:label="lab_ango_CapitalStockSharesAuthorized_663B4E031396C2158C59A4E39D9F9642" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capital stock shares authorized.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_CapitalStockSharesAuthorized" xlink:label="loc_ango_CapitalStockSharesAuthorized_663B4E031396C2158C59A4E39D9F9642" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_CapitalStockSharesAuthorized_663B4E031396C2158C59A4E39D9F9642" xlink:to="lab_ango_CapitalStockSharesAuthorized_663B4E031396C2158C59A4E39D9F9642" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_668EBD43417C82D55B78A4E39D9F444C_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_668EBD43417C82D55B78A4E39D9F444C" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares of common stock (shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_668EBD43417C82D55B78A4E39D9F444C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_668EBD43417C82D55B78A4E39D9F444C" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_668EBD43417C82D55B78A4E39D9F444C" xlink:type="arc" />
    <link:label id="lab_ango_CommonStockVotesPerShare_D7FB9B216E7B385F5053A4E39D9F68FF_terseLabel_en-US" xlink:label="lab_ango_CommonStockVotesPerShare_D7FB9B216E7B385F5053A4E39D9F68FF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, votes per share</link:label>
    <link:label id="lab_ango_CommonStockVotesPerShare_D7FB9B216E7B385F5053A4E39D9F68FF_label_en-US" xlink:label="lab_ango_CommonStockVotesPerShare_D7FB9B216E7B385F5053A4E39D9F68FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Votes Per Share</link:label>
    <link:label id="lab_ango_CommonStockVotesPerShare_D7FB9B216E7B385F5053A4E39D9F68FF_documentation_en-US" xlink:label="lab_ango_CommonStockVotesPerShare_D7FB9B216E7B385F5053A4E39D9F68FF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Votes Per Share</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_CommonStockVotesPerShare" xlink:label="loc_ango_CommonStockVotesPerShare_D7FB9B216E7B385F5053A4E39D9F68FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_CommonStockVotesPerShare_D7FB9B216E7B385F5053A4E39D9F68FF" xlink:to="lab_ango_CommonStockVotesPerShare_D7FB9B216E7B385F5053A4E39D9F68FF" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9C9203805EBAE576EAC2A4E39D9F3B5F_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9C9203805EBAE576EAC2A4E39D9F3B5F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total number of common stock reserved for issuance (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9C9203805EBAE576EAC2A4E39D9F3B5F_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9C9203805EBAE576EAC2A4E39D9F3B5F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9C9203805EBAE576EAC2A4E39D9F3B5F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9C9203805EBAE576EAC2A4E39D9F3B5F" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9C9203805EBAE576EAC2A4E39D9F3B5F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_34A6CF663FB8B610DE33A4E39D9F9971_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_34A6CF663FB8B610DE33A4E39D9F9971" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total number of common stock available to be issued (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_34A6CF663FB8B610DE33A4E39D9F9971_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_34A6CF663FB8B610DE33A4E39D9F9971" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_34A6CF663FB8B610DE33A4E39D9F9971" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_34A6CF663FB8B610DE33A4E39D9F9971" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_34A6CF663FB8B610DE33A4E39D9F9971" xlink:type="arc" />
    <link:label id="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod_A25FF259DBE985943E5AA4E39D9FAE12_verboseLabel_en-US" xlink:label="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod_A25FF259DBE985943E5AA4E39D9FAE12" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Options exercisable period</link:label>
    <link:label id="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod_A25FF259DBE985943E5AA4E39D9FAE12_label_en-US" xlink:label="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod_A25FF259DBE985943E5AA4E39D9FAE12" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award Options Maximum Exercisable Period</link:label>
    <link:label id="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod_A25FF259DBE985943E5AA4E39D9FAE12_documentation_en-US" xlink:label="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod_A25FF259DBE985943E5AA4E39D9FAE12" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share based compensation arrangement by share based payment award options maximum exercisable period.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod" xlink:label="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod_A25FF259DBE985943E5AA4E39D9FAE12" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod_A25FF259DBE985943E5AA4E39D9FAE12" xlink:to="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod_A25FF259DBE985943E5AA4E39D9FAE12" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_44BCA0779E314ECEA592A4E39D9F1C98_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_44BCA0779E314ECEA592A4E39D9F1C98" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Incentive award plan to increase the minimum number of shares (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_44BCA0779E314ECEA592A4E39D9F1C98_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_44BCA0779E314ECEA592A4E39D9F1C98" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_44BCA0779E314ECEA592A4E39D9F1C98" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_44BCA0779E314ECEA592A4E39D9F1C98" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_44BCA0779E314ECEA592A4E39D9F1C98" xlink:type="arc" />
    <link:label id="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage_C8DE3681AE580D796DD2A4E39D9FD86E_verboseLabel_en-US" xlink:label="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage_C8DE3681AE580D796DD2A4E39D9FD86E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Percentage of grants to employees vesting</link:label>
    <link:label id="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage_C8DE3681AE580D796DD2A4E39D9FD86E_label_en-US" xlink:label="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage_C8DE3681AE580D796DD2A4E39D9FD86E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award Award Granted to Employees Vesting Percentage</link:label>
    <link:label id="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage_C8DE3681AE580D796DD2A4E39D9FD86E_documentation_en-US" xlink:label="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage_C8DE3681AE580D796DD2A4E39D9FD86E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share based compensation arrangement by share based payment award award granted to employees vesting percentage.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage" xlink:label="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage_C8DE3681AE580D796DD2A4E39D9FD86E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage_C8DE3681AE580D796DD2A4E39D9FD86E" xlink:to="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage_C8DE3681AE580D796DD2A4E39D9FD86E" xlink:type="arc" />
    <link:label id="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1_68B6169DEE4C27299677A4E39D9F9E68_verboseLabel_en-US" xlink:label="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1_68B6169DEE4C27299677A4E39D9F9E68" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Option grants to employees vesting period</link:label>
    <link:label id="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1_68B6169DEE4C27299677A4E39D9F9E68_label_en-US" xlink:label="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1_68B6169DEE4C27299677A4E39D9F9E68" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award Award Granted to Employees Vesting Period 1</link:label>
    <link:label id="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1_68B6169DEE4C27299677A4E39D9F9E68_documentation_en-US" xlink:label="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1_68B6169DEE4C27299677A4E39D9F9E68" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share based compensation arrangement by share based payment award award granted to employees vesting period1.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1" xlink:label="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1_68B6169DEE4C27299677A4E39D9F9E68" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1_68B6169DEE4C27299677A4E39D9F9E68" xlink:to="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1_68B6169DEE4C27299677A4E39D9F9E68" xlink:type="arc" />
    <link:label id="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage_47839A2B780079CD3851A4E39D9F7365_verboseLabel_en-US" xlink:label="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage_47839A2B780079CD3851A4E39D9F7365" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Subsequent grants for directors vesting</link:label>
    <link:label id="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage_47839A2B780079CD3851A4E39D9F7365_label_en-US" xlink:label="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage_47839A2B780079CD3851A4E39D9F7365" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award Award Subsequent Grants to Directors Vesting Percentage</link:label>
    <link:label id="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage_47839A2B780079CD3851A4E39D9F7365_documentation_en-US" xlink:label="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage_47839A2B780079CD3851A4E39D9F7365" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share based compensation arrangement by share based payment award award subsequent grants to directors vesting percentage.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage" xlink:label="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage_47839A2B780079CD3851A4E39D9F7365" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage_47839A2B780079CD3851A4E39D9F7365" xlink:to="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage_47839A2B780079CD3851A4E39D9F7365" xlink:type="arc" />
    <link:label id="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod_C7C6007FD83463C16F6EA4E39D9F77FA_verboseLabel_en-US" xlink:label="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod_C7C6007FD83463C16F6EA4E39D9F77FA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Subsequent grants for directors vesting period</link:label>
    <link:label id="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod_C7C6007FD83463C16F6EA4E39D9F77FA_label_en-US" xlink:label="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod_C7C6007FD83463C16F6EA4E39D9F77FA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award Award Subsequent Grants to Directors Vesting Period</link:label>
    <link:label id="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod_C7C6007FD83463C16F6EA4E39D9F77FA_documentation_en-US" xlink:label="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod_C7C6007FD83463C16F6EA4E39D9F77FA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share based compensation arrangement by share based payment award award subsequent grants to directors vesting period.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod" xlink:label="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod_C7C6007FD83463C16F6EA4E39D9F77FA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod_C7C6007FD83463C16F6EA4E39D9F77FA" xlink:to="lab_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod_C7C6007FD83463C16F6EA4E39D9F77FA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3A970D6F805FEB0A870DA4E39D9FE41E_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3A970D6F805FEB0A870DA4E39D9FE41E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Option grants in the period, weighted average grant date fair value (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3A970D6F805FEB0A870DA4E39D9FE41E_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3A970D6F805FEB0A870DA4E39D9FE41E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3A970D6F805FEB0A870DA4E39D9FE41E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3A970D6F805FEB0A870DA4E39D9FE41E" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3A970D6F805FEB0A870DA4E39D9FE41E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1B2032CF888D83C821E3A4E39D9FC1A3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1B2032CF888D83C821E3A4E39D9FC1A3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1B2032CF888D83C821E3A4E39D9FC1A3_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1B2032CF888D83C821E3A4E39D9FC1A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1B2032CF888D83C821E3A4E39D9FC1A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1B2032CF888D83C821E3A4E39D9FC1A3" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1B2032CF888D83C821E3A4E39D9FC1A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8466A082C47ACC4A4E46A4E39D9F2E8C_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8466A082C47ACC4A4E46A4E39D9F2E8C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8466A082C47ACC4A4E46A4E39D9F2E8C_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8466A082C47ACC4A4E46A4E39D9F2E8C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8466A082C47ACC4A4E46A4E39D9F2E8C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8466A082C47ACC4A4E46A4E39D9F2E8C" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8466A082C47ACC4A4E46A4E39D9F2E8C" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_44E008FD583EB4FE12D0A4E39D9FE0CB_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_44E008FD583EB4FE12D0A4E39D9FE0CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_44E008FD583EB4FE12D0A4E39D9FE0CB_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_44E008FD583EB4FE12D0A4E39D9FE0CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_44E008FD583EB4FE12D0A4E39D9FE0CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_44E008FD583EB4FE12D0A4E39D9FE0CB" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_44E008FD583EB4FE12D0A4E39D9FE0CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_Dividends_F96A21DCA949BEA26055A4E39D9F3E75_terseLabel_en-US" xlink:label="lab_us-gaap_Dividends_F96A21DCA949BEA26055A4E39D9F3E75" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_Dividends_F96A21DCA949BEA26055A4E39D9F3E75_label_en-US" xlink:label="lab_us-gaap_Dividends_F96A21DCA949BEA26055A4E39D9F3E75" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Dividends" xlink:label="loc_us-gaap_Dividends_F96A21DCA949BEA26055A4E39D9F3E75" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends_F96A21DCA949BEA26055A4E39D9F3E75" xlink:to="lab_us-gaap_Dividends_F96A21DCA949BEA26055A4E39D9F3E75" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4B91C4DE519536B56D6AA4E39D9FC661_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4B91C4DE519536B56D6AA4E39D9FC661" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">The total intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4B91C4DE519536B56D6AA4E39D9FC661_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4B91C4DE519536B56D6AA4E39D9FC661" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4B91C4DE519536B56D6AA4E39D9FC661" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4B91C4DE519536B56D6AA4E39D9FC661" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4B91C4DE519536B56D6AA4E39D9FC661" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_C1E6C65FF68F25C3A879A4E39D9F4F4C_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_C1E6C65FF68F25C3A879A4E39D9F4F4C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation not yet recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_C1E6C65FF68F25C3A879A4E39D9F4F4C_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_C1E6C65FF68F25C3A879A4E39D9F4F4C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_C1E6C65FF68F25C3A879A4E39D9F4F4C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_C1E6C65FF68F25C3A879A4E39D9F4F4C" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_C1E6C65FF68F25C3A879A4E39D9F4F4C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_6CB4F755E1FC73FDCD32A4E39D9F93DA_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised_6CB4F755E1FC73FDCD32A4E39D9F93DA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from stock options exercised</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_6CB4F755E1FC73FDCD32A4E39D9F93DA_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised_6CB4F755E1FC73FDCD32A4E39D9F93DA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_6CB4F755E1FC73FDCD32A4E39D9F93DA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised_6CB4F755E1FC73FDCD32A4E39D9F93DA" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised_6CB4F755E1FC73FDCD32A4E39D9F93DA" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_EA7D60AA45AD4B85DAA7A4E39D9FDE8F_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_EA7D60AA45AD4B85DAA7A4E39D9FDE8F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_EA7D60AA45AD4B85DAA7A4E39D9FDE8F_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_EA7D60AA45AD4B85DAA7A4E39D9FDE8F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Tax Benefit from Compensation Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_EA7D60AA45AD4B85DAA7A4E39D9FDE8F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_EA7D60AA45AD4B85DAA7A4E39D9FDE8F" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_EA7D60AA45AD4B85DAA7A4E39D9FDE8F" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_38DB2AA9438F1010E590A4EE65282947_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_38DB2AA9438F1010E590A4EE65282947" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting percentage (as percent)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_38DB2AA9438F1010E590A4EE65282947_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_38DB2AA9438F1010E590A4EE65282947" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_38DB2AA9438F1010E590A4EE65282947" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_38DB2AA9438F1010E590A4EE65282947" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_38DB2AA9438F1010E590A4EE65282947" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D64D7FBD7A00472BDD5FA4E39D9FDEE1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D64D7FBD7A00472BDD5FA4E39D9FDEE1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D64D7FBD7A00472BDD5FA4E39D9FDEE1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D64D7FBD7A00472BDD5FA4E39D9FDEE1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D64D7FBD7A00472BDD5FA4E39D9FDEE1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D64D7FBD7A00472BDD5FA4E39D9FDEE1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D64D7FBD7A00472BDD5FA4E39D9FDEE1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ADE91AE45A52DB048E3BA4E39D9F07C8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ADE91AE45A52DB048E3BA4E39D9F07C8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grants in the period, weighted average grant date fair value (usd per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ADE91AE45A52DB048E3BA4E39D9F07C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ADE91AE45A52DB048E3BA4E39D9F07C8" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ADE91AE45A52DB048E3BA4E39D9F07C8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_22710570C5359CBB6F63A4E39D9F973F_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_22710570C5359CBB6F63A4E39D9F973F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total fair value of restricted stock awards vesting</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_22710570C5359CBB6F63A4E39D9F973F_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_22710570C5359CBB6F63A4E39D9F973F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_22710570C5359CBB6F63A4E39D9F973F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_22710570C5359CBB6F63A4E39D9F973F" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_22710570C5359CBB6F63A4E39D9F973F" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BF5F264DD9D80587B334A4E39D9F6EA3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BF5F264DD9D80587B334A4E39D9F6EA3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee service, compensation cost not yet recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BF5F264DD9D80587B334A4E39D9F6EA3_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BF5F264DD9D80587B334A4E39D9F6EA3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BF5F264DD9D80587B334A4E39D9F6EA3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BF5F264DD9D80587B334A4E39D9F6EA3" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BF5F264DD9D80587B334A4E39D9F6EA3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4FFE6391D0EE6DE7F991A4E39D9F3325_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4FFE6391D0EE6DE7F991A4E39D9F3325" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nonvested compensation, weighted average grant date fair value (usd per share)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4FFE6391D0EE6DE7F991A4E39D9F3325" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4FFE6391D0EE6DE7F991A4E39D9F3325" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4FFE6391D0EE6DE7F991A4E39D9F3325" xlink:type="arc" />
    <link:label id="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod_B168C3FC43B6481C6B4BA4E39D9FB421_terseLabel_en-US" xlink:label="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod_B168C3FC43B6481C6B4BA4E39D9FB421" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance period</link:label>
    <link:label id="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod_B168C3FC43B6481C6B4BA4E39D9FB421_label_en-US" xlink:label="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod_B168C3FC43B6481C6B4BA4E39D9FB421" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Compensation Cost Probable Recognition Performance Period</link:label>
    <link:label id="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod_B168C3FC43B6481C6B4BA4E39D9FB421_documentation_en-US" xlink:label="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod_B168C3FC43B6481C6B4BA4E39D9FB421" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Compensation Cost Probable Recognition Performance Period</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod" xlink:label="loc_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod_B168C3FC43B6481C6B4BA4E39D9FB421" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod_B168C3FC43B6481C6B4BA4E39D9FB421" xlink:to="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod_B168C3FC43B6481C6B4BA4E39D9FB421" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6FDC888F62A79556059CA4E39D9F0CB7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6FDC888F62A79556059CA4E39D9F0CB7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nonvested compensation (shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6FDC888F62A79556059CA4E39D9F0CB7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6FDC888F62A79556059CA4E39D9F0CB7" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6FDC888F62A79556059CA4E39D9F0CB7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_CACA45F88AF35A46F02EA4E39D9FD887_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_CACA45F88AF35A46F02EA4E39D9FD887" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_CACA45F88AF35A46F02EA4E39D9FD887_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_CACA45F88AF35A46F02EA4E39D9FD887" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_CACA45F88AF35A46F02EA4E39D9FD887" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_CACA45F88AF35A46F02EA4E39D9FD887" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_CACA45F88AF35A46F02EA4E39D9FD887" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_947D67FFDBBDA5FD72EBA4E39DAEDC49_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_947D67FFDBBDA5FD72EBA4E39DAEDC49" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum number of shares to be offered</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_947D67FFDBBDA5FD72EBA4E39DAEDC49_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_947D67FFDBBDA5FD72EBA4E39DAEDC49" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_947D67FFDBBDA5FD72EBA4E39DAEDC49" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_947D67FFDBBDA5FD72EBA4E39DAEDC49" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_947D67FFDBBDA5FD72EBA4E39DAEDC49" xlink:type="arc" />
    <link:label id="lab_ango_NumberOfSharePurchasePeriod_F6CE2245D82D1D87EAC4A4E39DAE6565_verboseLabel_en-US" xlink:label="lab_ango_NumberOfSharePurchasePeriod_F6CE2245D82D1D87EAC4A4E39DAE6565" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share purchase periods</link:label>
    <link:label id="lab_ango_NumberOfSharePurchasePeriod_F6CE2245D82D1D87EAC4A4E39DAE6565_label_en-US" xlink:label="lab_ango_NumberOfSharePurchasePeriod_F6CE2245D82D1D87EAC4A4E39DAE6565" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Share Purchase Period</link:label>
    <link:label id="lab_ango_NumberOfSharePurchasePeriod_F6CE2245D82D1D87EAC4A4E39DAE6565_documentation_en-US" xlink:label="lab_ango_NumberOfSharePurchasePeriod_F6CE2245D82D1D87EAC4A4E39DAE6565" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of share purchase period.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_NumberOfSharePurchasePeriod" xlink:label="loc_ango_NumberOfSharePurchasePeriod_F6CE2245D82D1D87EAC4A4E39DAE6565" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_NumberOfSharePurchasePeriod_F6CE2245D82D1D87EAC4A4E39DAE6565" xlink:to="lab_ango_NumberOfSharePurchasePeriod_F6CE2245D82D1D87EAC4A4E39DAE6565" xlink:type="arc" />
    <link:label id="lab_ango_SharePurchasePeriod_D675AED3AB1EE3058007A4E39DAE40EE_verboseLabel_en-US" xlink:label="lab_ango_SharePurchasePeriod_D675AED3AB1EE3058007A4E39DAE40EE" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Duration of purchase of shares</link:label>
    <link:label id="lab_ango_SharePurchasePeriod_D675AED3AB1EE3058007A4E39DAE40EE_label_en-US" xlink:label="lab_ango_SharePurchasePeriod_D675AED3AB1EE3058007A4E39DAE40EE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Purchase Period</link:label>
    <link:label id="lab_ango_SharePurchasePeriod_D675AED3AB1EE3058007A4E39DAE40EE_documentation_en-US" xlink:label="lab_ango_SharePurchasePeriod_D675AED3AB1EE3058007A4E39DAE40EE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share purchase period.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_SharePurchasePeriod" xlink:label="loc_ango_SharePurchasePeriod_D675AED3AB1EE3058007A4E39DAE40EE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_SharePurchasePeriod_D675AED3AB1EE3058007A4E39DAE40EE" xlink:to="lab_ango_SharePurchasePeriod_D675AED3AB1EE3058007A4E39DAE40EE" xlink:type="arc" />
    <link:label id="lab_ango_EmployeePlanParticipatingEligibilityPeriod_961151DEBE928C180179A4E39DAEC9E0_verboseLabel_en-US" xlink:label="lab_ango_EmployeePlanParticipatingEligibilityPeriod_961151DEBE928C180179A4E39DAEC9E0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Employee eligible in participating in offering period</link:label>
    <link:label id="lab_ango_EmployeePlanParticipatingEligibilityPeriod_961151DEBE928C180179A4E39DAEC9E0_label_en-US" xlink:label="lab_ango_EmployeePlanParticipatingEligibilityPeriod_961151DEBE928C180179A4E39DAEC9E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Plan Participating Eligibility Period</link:label>
    <link:label id="lab_ango_EmployeePlanParticipatingEligibilityPeriod_961151DEBE928C180179A4E39DAEC9E0_documentation_en-US" xlink:label="lab_ango_EmployeePlanParticipatingEligibilityPeriod_961151DEBE928C180179A4E39DAEC9E0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee plan participating eligibility period.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_EmployeePlanParticipatingEligibilityPeriod" xlink:label="loc_ango_EmployeePlanParticipatingEligibilityPeriod_961151DEBE928C180179A4E39DAEC9E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_EmployeePlanParticipatingEligibilityPeriod_961151DEBE928C180179A4E39DAEC9E0" xlink:to="lab_ango_EmployeePlanParticipatingEligibilityPeriod_961151DEBE928C180179A4E39DAEC9E0" xlink:type="arc" />
    <link:label id="lab_ango_CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription_EFF1E0F4E1D97CE80678A4E39DAE48B0_verboseLabel_en-US" xlink:label="lab_ango_CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription_EFF1E0F4E1D97CE80678A4E39DAE48B0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Working schedule of employee to participate in offering period</link:label>
    <link:label id="lab_ango_CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription_EFF1E0F4E1D97CE80678A4E39DAE48B0_label_en-US" xlink:label="lab_ango_CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription_EFF1E0F4E1D97CE80678A4E39DAE48B0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customary Working Schedule to Participate in Employee Offering Period Description</link:label>
    <link:label id="lab_ango_CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription_EFF1E0F4E1D97CE80678A4E39DAE48B0_documentation_en-US" xlink:label="lab_ango_CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription_EFF1E0F4E1D97CE80678A4E39DAE48B0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customary working schedule to participate in employee offering period description.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription" xlink:label="loc_ango_CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription_EFF1E0F4E1D97CE80678A4E39DAE48B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription_EFF1E0F4E1D97CE80678A4E39DAE48B0" xlink:to="lab_ango_CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription_EFF1E0F4E1D97CE80678A4E39DAE48B0" xlink:type="arc" />
    <link:label id="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible_6872B2C5FF2D76DE3343A4E39DAEC16B_terseLabel_en-US" xlink:label="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible_6872B2C5FF2D76DE3343A4E39DAEC16B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of working hours to be eligible (working hour)</link:label>
    <link:label id="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible_6872B2C5FF2D76DE3343A4E39DAEC16B_label_en-US" xlink:label="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible_6872B2C5FF2D76DE3343A4E39DAEC16B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Working Hours Per Week to be Eligible</link:label>
    <link:label id="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible_6872B2C5FF2D76DE3343A4E39DAEC16B_documentation_en-US" xlink:label="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible_6872B2C5FF2D76DE3343A4E39DAEC16B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Working Hours Per Week to be Eligible</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible" xlink:label="loc_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible_6872B2C5FF2D76DE3343A4E39DAEC16B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible_6872B2C5FF2D76DE3343A4E39DAEC16B" xlink:to="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible_6872B2C5FF2D76DE3343A4E39DAEC16B" xlink:type="arc" />
    <link:label id="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible_F66E7C98DEDF24E35DD7A4E39DAE7DD3_terseLabel_en-US" xlink:label="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible_F66E7C98DEDF24E35DD7A4E39DAE7DD3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of working months to be eligible</link:label>
    <link:label id="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible_F66E7C98DEDF24E35DD7A4E39DAE7DD3_label_en-US" xlink:label="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible_F66E7C98DEDF24E35DD7A4E39DAE7DD3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Working Months Per Year to be Eligible</link:label>
    <link:label id="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible_F66E7C98DEDF24E35DD7A4E39DAE7DD3_documentation_en-US" xlink:label="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible_F66E7C98DEDF24E35DD7A4E39DAE7DD3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Working Months Per Year to be Eligible</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible" xlink:label="loc_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible_F66E7C98DEDF24E35DD7A4E39DAE7DD3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible_F66E7C98DEDF24E35DD7A4E39DAE7DD3" xlink:to="lab_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible_F66E7C98DEDF24E35DD7A4E39DAE7DD3" xlink:type="arc" />
    <link:label id="lab_ango_EmployeePlanParticipatingEligibilityThresholdPercentage_8DCDF47E716EC334BBD3A4E39DAEC56F_verboseLabel_en-US" xlink:label="lab_ango_EmployeePlanParticipatingEligibilityThresholdPercentage_8DCDF47E716EC334BBD3A4E39DAEC56F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Employees ownership threshold</link:label>
    <link:label id="lab_ango_EmployeePlanParticipatingEligibilityThresholdPercentage_8DCDF47E716EC334BBD3A4E39DAEC56F_label_en-US" xlink:label="lab_ango_EmployeePlanParticipatingEligibilityThresholdPercentage_8DCDF47E716EC334BBD3A4E39DAEC56F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Plan Participating Eligibility Threshold Percentage</link:label>
    <link:label id="lab_ango_EmployeePlanParticipatingEligibilityThresholdPercentage_8DCDF47E716EC334BBD3A4E39DAEC56F_documentation_en-US" xlink:label="lab_ango_EmployeePlanParticipatingEligibilityThresholdPercentage_8DCDF47E716EC334BBD3A4E39DAEC56F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Ownership threshold for participating plan eligibility.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_EmployeePlanParticipatingEligibilityThresholdPercentage" xlink:label="loc_ango_EmployeePlanParticipatingEligibilityThresholdPercentage_8DCDF47E716EC334BBD3A4E39DAEC56F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_EmployeePlanParticipatingEligibilityThresholdPercentage_8DCDF47E716EC334BBD3A4E39DAEC56F" xlink:to="lab_ango_EmployeePlanParticipatingEligibilityThresholdPercentage_8DCDF47E716EC334BBD3A4E39DAEC56F" xlink:type="arc" />
    <link:label id="lab_ango_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod_0CD8AC009BBB9AF57F2AA4E39DAE5EC3_verboseLabel_en-US" xlink:label="lab_ango_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod_0CD8AC009BBB9AF57F2AA4E39DAE5EC3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Percentage of fair market value of a share of common stock on the first day of the offering period</link:label>
    <link:label id="lab_ango_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod_0CD8AC009BBB9AF57F2AA4E39DAE5EC3_label_en-US" xlink:label="lab_ango_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod_0CD8AC009BBB9AF57F2AA4E39DAE5EC3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share based Compensation Arrangement by Share based Payment Award Purchase Price of Common Stock Percent on First Day of Offering Period</link:label>
    <link:label id="lab_ango_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod_0CD8AC009BBB9AF57F2AA4E39DAE5EC3_documentation_en-US" xlink:label="lab_ango_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod_0CD8AC009BBB9AF57F2AA4E39DAE5EC3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sharebased compensation arrangement by sharebased payment award purchase price of common stock percent on first day of offering period.</link:label>
    <link:loc xlink:href="ango-20180531.xsd#ango_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod" xlink:label="loc_ango_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod_0CD8AC009BBB9AF57F2AA4E39DAE5EC3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ango_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod_0CD8AC009BBB9AF57F2AA4E39DAE5EC3" xlink:to="lab_ango_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod_0CD8AC009BBB9AF57F2AA4E39DAE5EC3" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_151EE5C1921DA024D100A4E39DAE0280_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_151EE5C1921DA024D100A4E39DAE0280" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Percentage of fair market value of a share of common stock on the last day of the offering period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_151EE5C1921DA024D100A4E39DAE0280_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_151EE5C1921DA024D100A4E39DAE0280" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_151EE5C1921DA024D100A4E39DAE0280" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_151EE5C1921DA024D100A4E39DAE0280" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_151EE5C1921DA024D100A4E39DAE0280" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_799F1415099F36E9DF20A4E39DAE089A_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_799F1415099F36E9DF20A4E39DAE089A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of additional shares reserved for issuance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_799F1415099F36E9DF20A4E39DAE089A_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_799F1415099F36E9DF20A4E39DAE089A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_799F1415099F36E9DF20A4E39DAE089A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_799F1415099F36E9DF20A4E39DAE089A" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_799F1415099F36E9DF20A4E39DAE089A" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_C30EAFD61A3FE64FE0F5A4E39DAE1B62_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_C30EAFD61A3FE64FE0F5A4E39DAE1B62" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum number of shares to be offered under the Stock Purchase Plan</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_C30EAFD61A3FE64FE0F5A4E39DAE1B62" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_C30EAFD61A3FE64FE0F5A4E39DAE1B62" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_C30EAFD61A3FE64FE0F5A4E39DAE1B62" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_6CE507B636E7844C056CA4E39DAE3717_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_6CE507B636E7844C056CA4E39DAE3717" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Average price of share issued</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_6CE507B636E7844C056CA4E39DAE3717_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_6CE507B636E7844C056CA4E39DAE3717" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_6CE507B636E7844C056CA4E39DAE3717" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_6CE507B636E7844C056CA4E39DAE3717" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_6CE507B636E7844C056CA4E39DAE3717" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_49CEA1DC0BF0F8BA2D04A4E39DAE1118_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_49CEA1DC0BF0F8BA2D04A4E39DAE1118" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share repurchases, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_49CEA1DC0BF0F8BA2D04A4E39DAE1118_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_49CEA1DC0BF0F8BA2D04A4E39DAE1118" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_49CEA1DC0BF0F8BA2D04A4E39DAE1118" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_49CEA1DC0BF0F8BA2D04A4E39DAE1118" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_49CEA1DC0BF0F8BA2D04A4E39DAE1118" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_7855C19EEE2D4BFB3896A4E39DAE74FB_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_7855C19EEE2D4BFB3896A4E39DAE74FB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share repurchase program period</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_7855C19EEE2D4BFB3896A4E39DAE74FB_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_7855C19EEE2D4BFB3896A4E39DAE74FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Period in Force</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_7855C19EEE2D4BFB3896A4E39DAE74FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_7855C19EEE2D4BFB3896A4E39DAE74FB" xlink:to="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_7855C19EEE2D4BFB3896A4E39DAE74FB" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_A420C5CD383E945ED1A6A4E39DAE31F0_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired_A420C5CD383E945ED1A6A4E39DAE31F0" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock repurchased (shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_A420C5CD383E945ED1A6A4E39DAE31F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired_A420C5CD383E945ED1A6A4E39DAE31F0" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired_A420C5CD383E945ED1A6A4E39DAE31F0" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_6140CFBB49A4DBE5DF2EA4E39DAE0E2A_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_6140CFBB49A4DBE5DF2EA4E39DAE0E2A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock repurchased</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6140CFBB49A4DBE5DF2EA4E39DAE0E2A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6140CFBB49A4DBE5DF2EA4E39DAE0E2A" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_6140CFBB49A4DBE5DF2EA4E39DAE0E2A" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_E5200A5B4679D008BC8AA4E39DAE4136_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares_E5200A5B4679D008BC8AA4E39DAE4136" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share repurchases</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_E5200A5B4679D008BC8AA4E39DAE4136_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares_E5200A5B4679D008BC8AA4E39DAE4136" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_E5200A5B4679D008BC8AA4E39DAE4136" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares_E5200A5B4679D008BC8AA4E39DAE4136" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares_E5200A5B4679D008BC8AA4E39DAE4136" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_F6C8054D51D917B157CEA4E39DAE4FAA_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_F6C8054D51D917B157CEA4E39DAE4FAA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_F6C8054D51D917B157CEA4E39DAE4FAA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_F6C8054D51D917B157CEA4E39DAE4FAA" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_F6C8054D51D917B157CEA4E39DAE4FAA" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_EC336066734F814F2C76A4E39DAE2DBF_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_EC336066734F814F2C76A4E39DAE2DBF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share repurchases, remaining shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_EC336066734F814F2C76A4E39DAE2DBF_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_EC336066734F814F2C76A4E39DAE2DBF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_EC336066734F814F2C76A4E39DAE2DBF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_EC336066734F814F2C76A4E39DAE2DBF" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_EC336066734F814F2C76A4E39DAE2DBF" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_133840925563EFEE02EFA4E39DAE6D84_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired_133840925563EFEE02EFA4E39DAE6D84" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock retirement (shares)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockSharesRetired" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_133840925563EFEE02EFA4E39DAE6D84" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesRetired_133840925563EFEE02EFA4E39DAE6D84" xlink:to="lab_us-gaap_TreasuryStockSharesRetired_133840925563EFEE02EFA4E39DAE6D84" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>18
<FILENAME>ango-20180531_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccruedLiabilities" xlink:href="ango-20180531.xsd#AccruedLiabilities" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccruedLiabilitiesAccruedLiabilitesDetailsTextual" xlink:href="ango-20180531.xsd#AccruedLiabilitiesAccruedLiabilitesDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccruedLiabilitiesDetails" xlink:href="ango-20180531.xsd#AccruedLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccruedLiabilitiesTables" xlink:href="ango-20180531.xsd#AccruedLiabilitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:href="ango-20180531.xsd#AccumulatedOtherComprehensiveIncomeLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:href="ango-20180531.xsd#AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:href="ango-20180531.xsd#AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNet" xlink:href="ango-20180531.xsd#AcquisitionRestructuringAndOtherItemsNet" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails" xlink:href="ango-20180531.xsd#AcquisitionRestructuringAndOtherItemsNetDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails1" xlink:href="ango-20180531.xsd#AcquisitionRestructuringAndOtherItemsNetDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails2" xlink:href="ango-20180531.xsd#AcquisitionRestructuringAndOtherItemsNetDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetTables" xlink:href="ango-20180531.xsd#AcquisitionRestructuringAndOtherItemsNetTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPolicies" xlink:href="ango-20180531.xsd#BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesDetailsTextual" xlink:href="ango-20180531.xsd#BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ango-20180531.xsd#BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesTables" xlink:href="ango-20180531.xsd#BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/CommitmentsAndContingencies" xlink:href="ango-20180531.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetails" xlink:href="ango-20180531.xsd#CommitmentsAndContingenciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetails1" xlink:href="ango-20180531.xsd#CommitmentsAndContingenciesDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetailsTextual" xlink:href="ango-20180531.xsd#CommitmentsAndContingenciesDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/CommitmentsAndContingenciesTables" xlink:href="ango-20180531.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedBalanceSheets" xlink:href="ango-20180531.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="ango-20180531.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsComprehensiveIncomeLoss" xlink:href="ango-20180531.xsd#ConsolidatedStatementsComprehensiveIncomeLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="ango-20180531.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsOfOperations" xlink:href="ango-20180531.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:href="ango-20180531.xsd#ConsolidatedStatementsOfStockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/DocumentAndEntityInformation" xlink:href="ango-20180531.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/EarningsPerShare" xlink:href="ango-20180531.xsd#EarningsPerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/EarningsPerShareDetails" xlink:href="ango-20180531.xsd#EarningsPerShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/EarningsPerShareTables" xlink:href="ango-20180531.xsd#EarningsPerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueOfFinancialInstruments" xlink:href="ango-20180531.xsd#FairValueOfFinancialInstruments" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" xlink:href="ango-20180531.xsd#FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails2" xlink:href="ango-20180531.xsd#FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails3" xlink:href="ango-20180531.xsd#FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsTables" xlink:href="ango-20180531.xsd#FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssets" xlink:href="ango-20180531.xsd#GoodwillAndIntangibleAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetails1" xlink:href="ango-20180531.xsd#GoodwillAndIntangibleAssetsDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetails2" xlink:href="ango-20180531.xsd#GoodwillAndIntangibleAssetsDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetailsTextual" xlink:href="ango-20180531.xsd#GoodwillAndIntangibleAssetsDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsTables" xlink:href="ango-20180531.xsd#GoodwillAndIntangibleAssetsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxes" xlink:href="ango-20180531.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetails" xlink:href="ango-20180531.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetails2" xlink:href="ango-20180531.xsd#IncomeTaxesDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetails3" xlink:href="ango-20180531.xsd#IncomeTaxesDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetails4" xlink:href="ango-20180531.xsd#IncomeTaxesDetails4" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesDetailsTextual" xlink:href="ango-20180531.xsd#IncomeTaxesDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesIncomeTaxesDetails5" xlink:href="ango-20180531.xsd#IncomeTaxesIncomeTaxesDetails5" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/IncomeTaxesTables" xlink:href="ango-20180531.xsd#IncomeTaxesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/Inventories" xlink:href="ango-20180531.xsd#Inventories" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/InventoriesDetails" xlink:href="ango-20180531.xsd#InventoriesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/InventoriesTables" xlink:href="ango-20180531.xsd#InventoriesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LongTermDebt" xlink:href="ango-20180531.xsd#LongTermDebt" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LongTermDebtDetails1" xlink:href="ango-20180531.xsd#LongTermDebtDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LongTermDebtDetailsTextual" xlink:href="ango-20180531.xsd#LongTermDebtDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/LongTermDebtTables" xlink:href="ango-20180531.xsd#LongTermDebtTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/MarketableSecurities" xlink:href="ango-20180531.xsd#MarketableSecurities" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/MarketableSecuritiesDetails" xlink:href="ango-20180531.xsd#MarketableSecuritiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/MarketableSecuritiesDetails1" xlink:href="ango-20180531.xsd#MarketableSecuritiesDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/MarketableSecuritiesTables" xlink:href="ango-20180531.xsd#MarketableSecuritiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/OtherAssets" xlink:href="ango-20180531.xsd#OtherAssets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/OtherAssetsDetails" xlink:href="ango-20180531.xsd#OtherAssetsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/PrepaidExpensesAndOther" xlink:href="ango-20180531.xsd#PrepaidExpensesAndOther" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/PrepaidExpensesAndOtherDetails" xlink:href="ango-20180531.xsd#PrepaidExpensesAndOtherDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/PrepaidExpensesAndOtherTables" xlink:href="ango-20180531.xsd#PrepaidExpensesAndOtherTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNet" xlink:href="ango-20180531.xsd#PropertyPlantAndEquipmentNet" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNetDetails" xlink:href="ango-20180531.xsd#PropertyPlantAndEquipmentNetDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNetTables" xlink:href="ango-20180531.xsd#PropertyPlantAndEquipmentNetTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/QuarterlyInformationUnaudited" xlink:href="ango-20180531.xsd#QuarterlyInformationUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/QuarterlyInformationUnauditedDetails" xlink:href="ango-20180531.xsd#QuarterlyInformationUnauditedDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/QuarterlyInformationUnauditedTables" xlink:href="ango-20180531.xsd#QuarterlyInformationUnauditedTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/RetirementPlans" xlink:href="ango-20180531.xsd#RetirementPlans" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/RetirementPlansDetails" xlink:href="ango-20180531.xsd#RetirementPlansDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentsAndGeographicInformation" xlink:href="ango-20180531.xsd#SegmentsAndGeographicInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetails" xlink:href="ango-20180531.xsd#SegmentsAndGeographicInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetails1" xlink:href="ango-20180531.xsd#SegmentsAndGeographicInformationDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetailsTextual" xlink:href="ango-20180531.xsd#SegmentsAndGeographicInformationDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationTables" xlink:href="ango-20180531.xsd#SegmentsAndGeographicInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/StockholdersEquity" xlink:href="ango-20180531.xsd#StockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/StockholdersEquityDetails" xlink:href="ango-20180531.xsd#StockholdersEquityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/StockholdersEquityDetails2" xlink:href="ango-20180531.xsd#StockholdersEquityDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/StockholdersEquityDetails3" xlink:href="ango-20180531.xsd#StockholdersEquityDetails3" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/StockholdersEquityDetailsTextual" xlink:href="ango-20180531.xsd#StockholdersEquityDetailsTextual" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/StockholdersEquityTables" xlink:href="ango-20180531.xsd#StockholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ValuationAndQualifyingAccounts" xlink:href="ango-20180531.xsd#ValuationAndQualifyingAccounts" xlink:type="simple" />
  <link:roleRef roleURI="http://www.angiodynamics.com/role/ValuationAndQualifyingAccountsDetails" xlink:href="ango-20180531.xsd#ValuationAndQualifyingAccountsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AccruedLiabilities" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_A67A17A2FCB37F77ABEA8C8B9C545CAE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_D4FB77496F5C6F4C30558C8B9C54BE5F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_A67A17A2FCB37F77ABEA8C8B9C545CAE" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_D4FB77496F5C6F4C30558C8B9C54BE5F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AccruedLiabilitiesAccruedLiabilitesDetailsTextual" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_C4983B782962AC1262958F96E197544B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_FA9295DDFC897B6643768F96E198CB15" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_C4983B782962AC1262958F96E197544B" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_FA9295DDFC897B6643768F96E198CB15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_33F76C65CA03B583EBE08F96E1985EBC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_FA9295DDFC897B6643768F96E198CB15" xlink:to="loc_srt_ProductOrServiceAxis_33F76C65CA03B583EBE08F96E1985EBC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_B149E86D8A451FBCF4B48F96E19D577B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_33F76C65CA03B583EBE08F96E1985EBC" xlink:to="loc_srt_ProductsAndServicesDomain_B149E86D8A451FBCF4B48F96E19D577B" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AcculisCapitalSystemsMember" xlink:label="loc_ango_AcculisCapitalSystemsMember_C655142BF4323042E7888F96E19E7F7F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_B149E86D8A451FBCF4B48F96E19D577B" xlink:to="loc_ango_AcculisCapitalSystemsMember_C655142BF4323042E7888F96E19E7F7F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupClassificationAxis" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_D5355D97C43728000EB08F96E19E4807" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_FA9295DDFC897B6643768F96E198CB15" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_D5355D97C43728000EB08F96E19E4807" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupClassificationDomain" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_CD6196E23598C24126348F96E19ECE95" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_D5355D97C43728000EB08F96E19E4807" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_CD6196E23598C24126348F96E19ECE95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_7EE91CD357AF7E14D2728F96E19E6DAE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_CD6196E23598C24126348F96E19ECE95" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_7EE91CD357AF7E14D2728F96E19E6DAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15A0D3891B93629B7A468F96E19FF3BF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_FA9295DDFC897B6643768F96E198CB15" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15A0D3891B93629B7A468F96E19FF3BF" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_RecallPeriod" xlink:label="loc_ango_RecallPeriod_D81E278FEF90B3FF2C5E8F96E19F082E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15A0D3891B93629B7A468F96E19FF3BF" xlink:to="loc_ango_RecallPeriod_D81E278FEF90B3FF2C5E8F96E19F082E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_609DE31ECD86849828DA8F96E19F69C0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_15A0D3891B93629B7A468F96E19FF3BF" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue_609DE31ECD86849828DA8F96E19F69C0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_21788953AFC15BDB4DCE8F96E1AA9D2F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_6A146EAC6651CB3998578F96E1AA9485" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_21788953AFC15BDB4DCE8F96E1AA9D2F" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_6A146EAC6651CB3998578F96E1AA9485" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_67A4EC61C7202D65D8718F96E1AB33A8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_6A146EAC6651CB3998578F96E1AA9485" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_67A4EC61C7202D65D8718F96E1AB33A8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_E71C638E7C8ADD6ACD478F96E1AB3AFA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_6A146EAC6651CB3998578F96E1AA9485" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_E71C638E7C8ADD6ACD478F96E1AB3AFA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserveCurrent" xlink:label="loc_us-gaap_RestructuringReserveCurrent_13B7357BE28AD2337A558F96E1ABBC3A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_6A146EAC6651CB3998578F96E1AA9485" xlink:to="loc_us-gaap_RestructuringReserveCurrent_13B7357BE28AD2337A558F96E1ABBC3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaap_SalesAndExciseTaxPayableCurrent_B0281B86AAA89B685B7E8F96E1AB398B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_6A146EAC6651CB3998578F96E1AA9485" xlink:to="loc_us-gaap_SalesAndExciseTaxPayableCurrent_B0281B86AAA89B685B7E8F96E1AB398B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_EBF153940205607565A58F96E1ABF3CF" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_6A146EAC6651CB3998578F96E1AA9485" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_EBF153940205607565A58F96E1ABF3CF" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AccruedLitigation" xlink:label="loc_ango_AccruedLitigation_89953E2CAB89B02806218F96E1ACC821" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_6A146EAC6651CB3998578F96E1AA9485" xlink:to="loc_ango_AccruedLitigation_89953E2CAB89B02806218F96E1ACC821" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AccruedRecallLiability" xlink:label="loc_ango_AccruedRecallLiability_A0246026EA1BAC07A36F8F96E1AC97D3" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_6A146EAC6651CB3998578F96E1AA9485" xlink:to="loc_ango_AccruedRecallLiability_A0246026EA1BAC07A36F8F96E1AC97D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_091ADC30F376820BDDA18F96E1ACF27A" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_6A146EAC6651CB3998578F96E1AA9485" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_091ADC30F376820BDDA18F96E1ACF27A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_CB96EE5F3D2FB60D50E28F96E1AC6F0B" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_6A146EAC6651CB3998578F96E1AA9485" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_CB96EE5F3D2FB60D50E28F96E1AC6F0B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AccruedLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_5F092985B400262AFC368C8B9D2F38A5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_144E7E0041A0100D75458C8B9D2F565A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_5F092985B400262AFC368C8B9D2F38A5" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_144E7E0041A0100D75458C8B9D2F565A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_735D21F90C38A88684038F96E0412751" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_388E561CCF5E27E592C3902022784BC2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_735D21F90C38A88684038F96E0412751" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_388E561CCF5E27E592C3902022784BC2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_70D57C184DD843B16797A8E2D5641F67" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_5A642BCABB7293A7C0C9A8E2D5643B36" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_70D57C184DD843B16797A8E2D5641F67" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_5A642BCABB7293A7C0C9A8E2D5643B36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6F194A796B01D1E23BBEA8E2D56408DB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_5A642BCABB7293A7C0C9A8E2D5643B36" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6F194A796B01D1E23BBEA8E2D56408DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_3A0C079B7301AEAAE285A8E2D564E5B9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6F194A796B01D1E23BBEA8E2D56408DB" xlink:to="loc_us-gaap_EquityComponentDomain_3A0C079B7301AEAAE285A8E2D564E5B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_5E25DBB25CDA2D6F84E3A8E2D5640D3C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3A0C079B7301AEAAE285A8E2D564E5B9" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_5E25DBB25CDA2D6F84E3A8E2D5640D3C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_EC62A31E57B01E6BD6A3A8E2D564E05A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3A0C079B7301AEAAE285A8E2D564E5B9" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_EC62A31E57B01E6BD6A3A8E2D564E05A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_11560EF746BF3B221074A8E2D5647934" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3A0C079B7301AEAAE285A8E2D564E5B9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_11560EF746BF3B221074A8E2D5647934" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="loc_us-gaap_ClassOfStockLineItems_E6CD8631E5AFC64E8E0DA8E2D564B249" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_5A642BCABB7293A7C0C9A8E2D5643B36" xlink:to="loc_us-gaap_ClassOfStockLineItems_E6CD8631E5AFC64E8E0DA8E2D564B249" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B3F7D0970A097A342126A8E2D564539F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_E6CD8631E5AFC64E8E0DA8E2D564B249" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B3F7D0970A097A342126A8E2D564539F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_5AAA0E22D1FCDADB915FA8E2D56433EB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B3F7D0970A097A342126A8E2D564539F" xlink:to="loc_us-gaap_StockholdersEquity_5AAA0E22D1FCDADB915FA8E2D56433EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_0CB8CBE199BA475F630FA8E2D564D5F6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B3F7D0970A097A342126A8E2D564539F" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_0CB8CBE199BA475F630FA8E2D564D5F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_A4B1AAC81F1D7DB65463A8E2D5647DCE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B3F7D0970A097A342126A8E2D564539F" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_A4B1AAC81F1D7DB65463A8E2D5647DCE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_110DFF3F83037EFE56E6A8E2D564B4D7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B3F7D0970A097A342126A8E2D564539F" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_110DFF3F83037EFE56E6A8E2D564B4D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_94DC0F3B8FD5CE280E42A8E2D5645341" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_B3F7D0970A097A342126A8E2D564539F" xlink:to="loc_us-gaap_StockholdersEquity_94DC0F3B8FD5CE280E42A8E2D5645341" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLossTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_59F455476AC5FA0757F7901D60BB7C97" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_E30EA0C88DAF8925FF06901D613593EA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_59F455476AC5FA0757F7901D60BB7C97" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_E30EA0C88DAF8925FF06901D613593EA" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNet" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_627B521FCEB48806A4DF8F96E0645538" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_5DFE69001EF68A5743F08F96E064A26E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_627B521FCEB48806A4DF8F96E0645538" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_5DFE69001EF68A5743F08F96E064A26E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7B577D86886B620EC72A8F96E055F344" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_AA670B84CE2647F665B48F96E055E67C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7B577D86886B620EC72A8F96E055F344" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_AA670B84CE2647F665B48F96E055E67C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_DB805338EB9B9583D1AA8F96E05602ED" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_AA670B84CE2647F665B48F96E055E67C" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_DB805338EB9B9583D1AA8F96E05602ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_D7A545DDAB0E700D47C08F96E05675CB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_DB805338EB9B9583D1AA8F96E05602ED" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_D7A545DDAB0E700D47C08F96E05675CB" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_LegalCostsMember" xlink:label="loc_ango_LegalCostsMember_9B53C65DD7E485142A3C8F96E0566CFA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_D7A545DDAB0E700D47C08F96E05675CB" xlink:to="loc_ango_LegalCostsMember_9B53C65DD7E485142A3C8F96E0566CFA" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_IntangibleImpairmentMember" xlink:label="loc_ango_IntangibleImpairmentMember_D2B2FC9E5B262C42E7328F96E057DC07" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_D7A545DDAB0E700D47C08F96E05675CB" xlink:to="loc_ango_IntangibleImpairmentMember_D2B2FC9E5B262C42E7328F96E057DC07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FacilityClosingMember" xlink:label="loc_us-gaap_FacilityClosingMember_95F8508717DCB4C140FB8F96E05754FF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_D7A545DDAB0E700D47C08F96E05675CB" xlink:to="loc_us-gaap_FacilityClosingMember_95F8508717DCB4C140FB8F96E05754FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherRestructuringMember" xlink:label="loc_us-gaap_OtherRestructuringMember_E5956215026DBE4787C38F96E057360A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_D7A545DDAB0E700D47C08F96E05675CB" xlink:to="loc_us-gaap_OtherRestructuringMember_E5956215026DBE4787C38F96E057360A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_0702E954AD5168DA370F8F96E05774B1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_AA670B84CE2647F665B48F96E055E67C" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_0702E954AD5168DA370F8F96E05774B1" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AcquisitionRestructuringAndOtherItemsNet" xlink:label="loc_ango_AcquisitionRestructuringAndOtherItemsNet_9E23AF382877EFB431288F96E0578762" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0702E954AD5168DA370F8F96E05774B1" xlink:to="loc_ango_AcquisitionRestructuringAndOtherItemsNet_9E23AF382877EFB431288F96E0578762" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails1" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7B47CBD78CF940DB3FA394C42DFA3EB9" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2C8A4641F592C6FFDF0994C42DFA7A4C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_7B47CBD78CF940DB3FA394C42DFA3EB9" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2C8A4641F592C6FFDF0994C42DFA7A4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_DEE05F2FBD29A9F65A4F94C42DFA33A6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2C8A4641F592C6FFDF0994C42DFA7A4C" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_DEE05F2FBD29A9F65A4F94C42DFA33A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_BAEF598532B7E6B87F9494C42DFA2F7E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_DEE05F2FBD29A9F65A4F94C42DFA33A6" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_BAEF598532B7E6B87F9494C42DFA2F7E" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_LegalCostsMember" xlink:label="loc_ango_LegalCostsMember_3E159C70DB7FCE3747A194C42DFA013F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_BAEF598532B7E6B87F9494C42DFA2F7E" xlink:to="loc_ango_LegalCostsMember_3E159C70DB7FCE3747A194C42DFA013F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_LitigationCaseAxis" xlink:label="loc_srt_LitigationCaseAxis_F4D49CF8C228B240211B94CD75BC82A8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2C8A4641F592C6FFDF0994C42DFA7A4C" xlink:to="loc_srt_LitigationCaseAxis_F4D49CF8C228B240211B94CD75BC82A8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_5876C9F98738ED20464094CD75EBFA3D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_F4D49CF8C228B240211B94CD75BC82A8" xlink:to="loc_srt_LitigationCaseTypeDomain_5876C9F98738ED20464094CD75EBFA3D" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_DOJLitigationMember" xlink:label="loc_ango_DOJLitigationMember_82D767CB17DF7D76364D94CE16648AF8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_5876C9F98738ED20464094CD75EBFA3D" xlink:to="loc_ango_DOJLitigationMember_82D767CB17DF7D76364D94CE16648AF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_F5A03560C792DE58728594C42DFA226A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2C8A4641F592C6FFDF0994C42DFA7A4C" xlink:to="loc_us-gaap_RestructuringPlanAxis_F5A03560C792DE58728594C42DFA226A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_1F1E70B2186368220B5494C42DFAAA46" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_F5A03560C792DE58728594C42DFA226A" xlink:to="loc_us-gaap_RestructuringPlanDomain_1F1E70B2186368220B5494C42DFAAA46" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember" xlink:label="loc_ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember_1381BABCD63B34828FF994C42DFA1B04" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_1F1E70B2186368220B5494C42DFAAA46" xlink:to="loc_ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember_1381BABCD63B34828FF994C42DFA1B04" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_12E491B6EA31B07586D794C42DFAA7A5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2C8A4641F592C6FFDF0994C42DFA7A4C" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_12E491B6EA31B07586D794C42DFAA7A5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_551DC2DDEFD3D5F4D9BB94C42DFAF701" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_12E491B6EA31B07586D794C42DFAA7A5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_551DC2DDEFD3D5F4D9BB94C42DFAF701" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AccruedExpensesMember" xlink:label="loc_ango_AccruedExpensesMember_861AE7BDFD006779AB1594C42DFA6810" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_551DC2DDEFD3D5F4D9BB94C42DFAF701" xlink:to="loc_ango_AccruedExpensesMember_861AE7BDFD006779AB1594C42DFA6810" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_22F1BF9DF8D44F01FFC694C42DFA4299" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_2C8A4641F592C6FFDF0994C42DFA7A4C" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_22F1BF9DF8D44F01FFC694C42DFA4299" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AcquisitionRestructuringAndOtherItemsNet" xlink:label="loc_ango_AcquisitionRestructuringAndOtherItemsNet_C25BB7E790524A8AB42B94C42DFAE3EC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_22F1BF9DF8D44F01FFC694C42DFA4299" xlink:to="loc_ango_AcquisitionRestructuringAndOtherItemsNet_C25BB7E790524A8AB42B94C42DFAE3EC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_2A5263B5C4243BCF953F94C42DFAAE23" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_22F1BF9DF8D44F01FFC694C42DFA4299" xlink:to="loc_us-gaap_RestructuringCharges_2A5263B5C4243BCF953F94C42DFAAE23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_A2651B8BAA7C98263AA594C42DFA536B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_22F1BF9DF8D44F01FFC694C42DFA4299" xlink:to="loc_us-gaap_RestructuringReserve_A2651B8BAA7C98263AA594C42DFA536B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails2" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_DEDF02873244D7FE1C828F96E0467DD3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_FDD6713F96AE17969B2D8F96E0462A4E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_DEDF02873244D7FE1C828F96E0467DD3" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_FDD6713F96AE17969B2D8F96E0462A4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_B1481B1745C59046DFF48F96E04758D1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_FDD6713F96AE17969B2D8F96E0462A4E" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_B1481B1745C59046DFF48F96E04758D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_1DC6085EA41772D8CC4D8F96E0474E04" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_B1481B1745C59046DFF48F96E04758D1" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_1DC6085EA41772D8CC4D8F96E0474E04" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OneTimeTerminationBenefitsMember" xlink:label="loc_us-gaap_OneTimeTerminationBenefitsMember_C974D09689CD61B291838F96E04851D3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_1DC6085EA41772D8CC4D8F96E0474E04" xlink:to="loc_us-gaap_OneTimeTerminationBenefitsMember_C974D09689CD61B291838F96E04851D3" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_EquipmentTransferMember" xlink:label="loc_ango_EquipmentTransferMember_36CB5B4B76B0CE722CC08F96E04802DD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_1DC6085EA41772D8CC4D8F96E0474E04" xlink:to="loc_ango_EquipmentTransferMember_36CB5B4B76B0CE722CC08F96E04802DD" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_RegulatoryFilingsMember" xlink:label="loc_ango_RegulatoryFilingsMember_8808ADA3F47C79C0505C8F96E0485972" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_1DC6085EA41772D8CC4D8F96E0474E04" xlink:to="loc_ango_RegulatoryFilingsMember_8808ADA3F47C79C0505C8F96E0485972" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractTerminationMember" xlink:label="loc_us-gaap_ContractTerminationMember_AC28BE37F457050E24ED8F96E048BEAB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_1DC6085EA41772D8CC4D8F96E0474E04" xlink:to="loc_us-gaap_ContractTerminationMember_AC28BE37F457050E24ED8F96E048BEAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherRestructuringMember" xlink:label="loc_us-gaap_OtherRestructuringMember_1E4571F54B6EC68FCE058F96E0489989" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_1DC6085EA41772D8CC4D8F96E0474E04" xlink:to="loc_us-gaap_OtherRestructuringMember_1E4571F54B6EC68FCE058F96E0489989" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_0DAEE1EB9AA6C9C97B948F96E0498C69" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_FDD6713F96AE17969B2D8F96E0462A4E" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_0DAEE1EB9AA6C9C97B948F96E0498C69" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_DB7398215B9DE3E5B1D4904068695ABB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0DAEE1EB9AA6C9C97B948F96E0498C69" xlink:to="loc_us-gaap_RestructuringReserveRollForward_DB7398215B9DE3E5B1D4904068695ABB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_D51D29B3FFBD55AC19178F96E0491860" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_DB7398215B9DE3E5B1D4904068695ABB" xlink:to="loc_us-gaap_RestructuringReserve_D51D29B3FFBD55AC19178F96E0491860" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_CCE404C21C2007E75D1B8F96E0493D58" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_DB7398215B9DE3E5B1D4904068695ABB" xlink:to="loc_us-gaap_RestructuringCharges_CCE404C21C2007E75D1B8F96E0493D58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_263FFE42C9020B2D671F8F96E049F0FE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_DB7398215B9DE3E5B1D4904068695ABB" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_263FFE42C9020B2D671F8F96E049F0FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="loc_us-gaap_PaymentsForRestructuring_F402B5DFC5D125CCA2FC8F96E049687F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_DB7398215B9DE3E5B1D4904068695ABB" xlink:to="loc_us-gaap_PaymentsForRestructuring_F402B5DFC5D125CCA2FC8F96E049687F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_B758F5F6C67DD13D9D148F96E0492DB5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_DB7398215B9DE3E5B1D4904068695ABB" xlink:to="loc_us-gaap_RestructuringReserve_B758F5F6C67DD13D9D148F96E0492DB5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_22FE1337E0949B29CFEA8F96E0624156" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_E5B91234A1B635DA03AA8F96E062FEB9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_22FE1337E0949B29CFEA8F96E0624156" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_E5B91234A1B635DA03AA8F96E062FEB9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8EF2E1194F413DF323A98F96E33D3E1A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_F3C493ED760F412F32C08F96E33D1B67" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8EF2E1194F413DF323A98F96E33D3E1A" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_F3C493ED760F412F32C08F96E33D1B67" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesDetailsTextual" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_907FFF8F55D002D82DAEA3DCC60F51C7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1EE559B88EC37DDDBBFBA3DCC60FEC9F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_907FFF8F55D002D82DAEA3DCC60F51C7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1EE559B88EC37DDDBBFBA3DCC60FEC9F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6752DD6F92F00CCE3342A3DCC60F4426" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1EE559B88EC37DDDBBFBA3DCC60FEC9F" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6752DD6F92F00CCE3342A3DCC60F4426" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_89D62285B5E739B845FDA3DCC60F7441" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6752DD6F92F00CCE3342A3DCC60F4426" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_89D62285B5E739B845FDA3DCC60F7441" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_333D2942293AB8562172A3DCC60F167A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_89D62285B5E739B845FDA3DCC60F7441" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_333D2942293AB8562172A3DCC60F167A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_9FCD81A215BF1FBF842EA3DCC60F573D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_89D62285B5E739B845FDA3DCC60F7441" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_9FCD81A215BF1FBF842EA3DCC60F573D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_B4AA4305B5F519EBEA34A3DCC60F9AE3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_89D62285B5E739B845FDA3DCC60F7441" xlink:to="loc_us-gaap_ComputerEquipmentMember_B4AA4305B5F519EBEA34A3DCC60F9AE3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_2BDF733CBFCF2ED4206AA3DCC60FC302" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1EE559B88EC37DDDBBFBA3DCC60FEC9F" xlink:to="loc_srt_RangeAxis_2BDF733CBFCF2ED4206AA3DCC60FC302" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_A31835FFF98E2CBD7BD6A3DCC60F512C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2BDF733CBFCF2ED4206AA3DCC60FC302" xlink:to="loc_srt_RangeMember_A31835FFF98E2CBD7BD6A3DCC60F512C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_A00FB39D9839846429B0A3DCC60FCD2F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_A31835FFF98E2CBD7BD6A3DCC60F512C" xlink:to="loc_srt_MinimumMember_A00FB39D9839846429B0A3DCC60FCD2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_9878A8E830E7C27D15BFA3DCC60F5FA9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_A31835FFF98E2CBD7BD6A3DCC60F512C" xlink:to="loc_srt_MaximumMember_9878A8E830E7C27D15BFA3DCC60F5FA9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_FD6AC8F0A290B5D5D12DA3DCC60F6C72" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1EE559B88EC37DDDBBFBA3DCC60FEC9F" xlink:to="loc_us-gaap_AwardTypeAxis_FD6AC8F0A290B5D5D12DA3DCC60F6C72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_CA5E9246B2936ED5F81BA3DCC60FA54B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_FD6AC8F0A290B5D5D12DA3DCC60F6C72" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_CA5E9246B2936ED5F81BA3DCC60FA54B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_461B0888C07AED492615A3DCC60FA9F4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_CA5E9246B2936ED5F81BA3DCC60FA54B" xlink:to="loc_us-gaap_EmployeeStockOptionMember_461B0888C07AED492615A3DCC60FA9F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaap_RestrictedStockMember_ABD8D33D525C88B2EE8EA3DCC60FA2AE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_CA5E9246B2936ED5F81BA3DCC60FA54B" xlink:to="loc_us-gaap_RestrictedStockMember_ABD8D33D525C88B2EE8EA3DCC60FA2AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1EE559B88EC37DDDBBFBA3DCC60FEC9F" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ShortTermInvestmentsMaturityPeriod" xlink:label="loc_ango_ShortTermInvestmentsMaturityPeriod_884913E3F0E4FDBC85C3A3DCC60F427F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_ango_ShortTermInvestmentsMaturityPeriod_884913E3F0E4FDBC85C3A3DCC60F427F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_0F230512C253553C4B50A3DCC60FFFC6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_0F230512C253553C4B50A3DCC60FFFC6" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AccountsReceivableDuePeriod" xlink:label="loc_ango_AccountsReceivableDuePeriod_0F8FEF993E57A1C5E291A3DCC60FB07C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_ango_AccountsReceivableDuePeriod_0F8FEF993E57A1C5E291A3DCC60FB07C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_7AD6912A861D85686857A3DCC60FD37C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_7AD6912A861D85686857A3DCC60FD37C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0E9A14464093220683DBA3DCC60F4E91" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_0E9A14464093220683DBA3DCC60F4E91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_935FBFAB55C8E395E3DEA489EA197A18" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_us-gaap_NumberOfOperatingSegments_935FBFAB55C8E395E3DEA489EA197A18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfReportingUnits" xlink:label="loc_us-gaap_NumberOfReportingUnits_4024B8E7DC0413312DD3A487C517C2C6" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_us-gaap_NumberOfReportingUnits_4024B8E7DC0413312DD3A487C517C2C6" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PercentageOfRestockingCharge" xlink:label="loc_ango_PercentageOfRestockingCharge_CED6780383119A5919F1A3DCC60F6530" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_ango_PercentageOfRestockingCharge_CED6780383119A5919F1A3DCC60F6530" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct" xlink:label="loc_ango_NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct_52B179141A38BB4D3327A3DCC60F66FE" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_ango_NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct_52B179141A38BB4D3327A3DCC60F66FE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7EDB6C3E4E7963D2062CA3DCC60FEAF2" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_8DA75B49B652906AD19BA3DCC60FCFA8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7EDB6C3E4E7963D2062CA3DCC60FEAF2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_22F97DCC5836A669CE438F22D174D423" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0AAEC967359377E805EF8F22D1741E83" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22F97DCC5836A669CE438F22D174D423" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0AAEC967359377E805EF8F22D1741E83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_A2A0F8EE09EE6B643BD38F22D175DD20" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22F97DCC5836A669CE438F22D174D423" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_A2A0F8EE09EE6B643BD38F22D175DD20" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_F08A551E183A0F0F13748F22D1753A0F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22F97DCC5836A669CE438F22D174D423" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_F08A551E183A0F0F13748F22D1753A0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_12B53F4C1BE123EA7EA48F22D175258C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22F97DCC5836A669CE438F22D174D423" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_12B53F4C1BE123EA7EA48F22D175258C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_9EB405521F508B88FCCA8F22D175DCC0" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22F97DCC5836A669CE438F22D174D423" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_9EB405521F508B88FCCA8F22D175DCC0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_A7A02946C67C66B4CEE48F22D17539B8" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22F97DCC5836A669CE438F22D174D423" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_A7A02946C67C66B4CEE48F22D17539B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_FEE2D5C4AD89292AC58B8F22D175442A" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22F97DCC5836A669CE438F22D174D423" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_FEE2D5C4AD89292AC58B8F22D175442A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_B14BAD34FCA82939157E8F22D176D1C8" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22F97DCC5836A669CE438F22D174D423" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_B14BAD34FCA82939157E8F22D176D1C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_D8C194887689556236088F22D1768D2F" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22F97DCC5836A669CE438F22D174D423" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_D8C194887689556236088F22D1768D2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_461EB036D6047F8BAB9F8F22D176AA67" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22F97DCC5836A669CE438F22D174D423" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_461EB036D6047F8BAB9F8F22D176AA67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_3DA98EC0A15D045C65398F22D176057B" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22F97DCC5836A669CE438F22D174D423" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_3DA98EC0A15D045C65398F22D176057B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_19A1C80DC6F9195C8F4F8F22D1769C4B" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22F97DCC5836A669CE438F22D174D423" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_19A1C80DC6F9195C8F4F8F22D1769C4B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_D8461F283977188844B28F22D176B2AD" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22F97DCC5836A669CE438F22D174D423" xlink:to="loc_us-gaap_StandardProductWarrantyPolicy_D8461F283977188844B28F22D176B2AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_09FF7CB1E21366362AE68F22D1775F69" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22F97DCC5836A669CE438F22D174D423" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_09FF7CB1E21366362AE68F22D1775F69" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_967AEBF63332990BBA6B8F22D17773C3" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22F97DCC5836A669CE438F22D174D423" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_967AEBF63332990BBA6B8F22D17773C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_DB9429C5CB97CB9B463D8F22D177274A" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22F97DCC5836A669CE438F22D174D423" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_DB9429C5CB97CB9B463D8F22D177274A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_32F2F956C9CC7EBD3B3A8F22D177FB80" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22F97DCC5836A669CE438F22D174D423" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_32F2F956C9CC7EBD3B3A8F22D177FB80" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_A67235B96AD31766BBA78F22D1778819" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22F97DCC5836A669CE438F22D174D423" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_A67235B96AD31766BBA78F22D1778819" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1C8248537E9F44539A5F8F22D16F53D3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_CDB2DDCB9547BF487E668F22D170C35F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1C8248537E9F44539A5F8F22D16F53D3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_CDB2DDCB9547BF487E668F22D170C35F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_3CE70ABD26687DB838CE8F5078CF645F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1C8248537E9F44539A5F8F22D16F53D3" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_3CE70ABD26687DB838CE8F5078CF645F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/CommitmentsAndContingencies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_111375C2C2AEB16BCDD38C8B9C736A1B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_65F253BAD87E4E608C908C8B9C739448" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_111375C2C2AEB16BCDD38C8B9C736A1B" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_65F253BAD87E4E608C908C8B9C739448" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4B9B8605340029DF673FA3DCC3AF31D5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_92158C5C44A778F88224A3DCC3AFDA79" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4B9B8605340029DF673FA3DCC3AF31D5" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_92158C5C44A778F88224A3DCC3AFDA79" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_9865C07B38ED2445D9FEA3DCC3AFA223" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_92158C5C44A778F88224A3DCC3AFDA79" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_9865C07B38ED2445D9FEA3DCC3AFA223" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_892FDECD2DF94358C99AA3DCC3AF62A3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_92158C5C44A778F88224A3DCC3AFDA79" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_892FDECD2DF94358C99AA3DCC3AF62A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_DAE2268975A015ED1675A3DCC3AF269C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_92158C5C44A778F88224A3DCC3AFDA79" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_DAE2268975A015ED1675A3DCC3AF269C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_15F5E5EB9F8FB18E3677A3DCC3AF62D4" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_92158C5C44A778F88224A3DCC3AFDA79" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_15F5E5EB9F8FB18E3677A3DCC3AF62D4" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_OperatingLeasesFutureMinimumPaymentsDueAfterFourYears" xlink:label="loc_ango_OperatingLeasesFutureMinimumPaymentsDueAfterFourYears_26E08C76DECC010B5407A3DCC3AF6D25" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_92158C5C44A778F88224A3DCC3AFDA79" xlink:to="loc_ango_OperatingLeasesFutureMinimumPaymentsDueAfterFourYears_26E08C76DECC010B5407A3DCC3AF6D25" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_DE42A947AAEE422868D9A3DCC3AFAD81" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract_92158C5C44A778F88224A3DCC3AFDA79" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_DE42A947AAEE422868D9A3DCC3AFAD81" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetails1" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligation" xlink:label="loc_us-gaap_PurchaseObligation_2E91F05566BA017848CFA3DCC3AFBDFD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_us-gaap_PurchaseObligation_2E91F05566BA017848CFA3DCC3AFBDFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInSecondYear" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_3054A61E57C8C81E4AC4A3DCC3AF231D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_3054A61E57C8C81E4AC4A3DCC3AF231D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInThirdYear" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_2080441B6058563E3219A3DCC3AF4C85" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_2080441B6058563E3219A3DCC3AF4C85" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInFourthYear" xlink:label="loc_us-gaap_PurchaseObligationDueInFourthYear_DEB79A80750032A6EB45A3DCC3AF289D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_us-gaap_PurchaseObligationDueInFourthYear_DEB79A80750032A6EB45A3DCC3AF289D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueInFifthYear" xlink:label="loc_us-gaap_PurchaseObligationDueInFifthYear_FA847D12E9D284C82DD1A3DCC3AFC032" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_us-gaap_PurchaseObligationDueInFifthYear_FA847D12E9D284C82DD1A3DCC3AFC032" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PurchaseObligationDueAfterFifthYear" xlink:label="loc_us-gaap_PurchaseObligationDueAfterFifthYear_37E46D9C44CE3C59D76BA3DCC3AFE2F9" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_us-gaap_PurchaseObligationDueAfterFifthYear_37E46D9C44CE3C59D76BA3DCC3AFE2F9" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_Royalties" xlink:label="loc_ango_Royalties_F9A6E414B222F11533FCA3DCC3AF2251" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_ango_Royalties_F9A6E414B222F11533FCA3DCC3AF2251" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_RoyaltiesDueinSecondYear" xlink:label="loc_ango_RoyaltiesDueinSecondYear_6DC87DC50B08189D611EA3DCC3AFDBC7" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_ango_RoyaltiesDueinSecondYear_6DC87DC50B08189D611EA3DCC3AFDBC7" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_RoyaltiesDueinThirdYear" xlink:label="loc_ango_RoyaltiesDueinThirdYear_0F8AA6DD850B84E1C8E7A3DCC3AFC11A" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_ango_RoyaltiesDueinThirdYear_0F8AA6DD850B84E1C8E7A3DCC3AFC11A" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_RoyaltiesDueinFourthYear" xlink:label="loc_ango_RoyaltiesDueinFourthYear_33C2BE7B6A272575EEDFA3DCC3AF69C9" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_ango_RoyaltiesDueinFourthYear_33C2BE7B6A272575EEDFA3DCC3AF69C9" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_RoyaltiesDueinFifthYear" xlink:label="loc_ango_RoyaltiesDueinFifthYear_52928C3F035A6B7F4531A3DCC3AF947D" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_ango_RoyaltiesDueinFifthYear_52928C3F035A6B7F4531A3DCC3AF947D" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_RoyaltiesDueAfterFifthYear" xlink:label="loc_ango_RoyaltiesDueAfterFifthYear_A316C47ED7965602BBDFA3DCC3AFFE6E" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_ango_RoyaltiesDueAfterFifthYear_A316C47ED7965602BBDFA3DCC3AFFE6E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitment" xlink:label="loc_us-gaap_OtherCommitment_8DFD04AACB68C11EACE7A3DCC3AF9428" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_us-gaap_OtherCommitment_8DFD04AACB68C11EACE7A3DCC3AF9428" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInSecondYear" xlink:label="loc_us-gaap_OtherCommitmentDueInSecondYear_D2D34CD046ABD2EBD732A3DCC3AF5EF5" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_us-gaap_OtherCommitmentDueInSecondYear_D2D34CD046ABD2EBD732A3DCC3AF5EF5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInThirdYear" xlink:label="loc_us-gaap_OtherCommitmentDueInThirdYear_C140D104F783482008CFA3DCC3AF8CFC" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_us-gaap_OtherCommitmentDueInThirdYear_C140D104F783482008CFA3DCC3AF8CFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInFourthYear" xlink:label="loc_us-gaap_OtherCommitmentDueInFourthYear_E0538169409743E29295A3DCC3AF69C4" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_us-gaap_OtherCommitmentDueInFourthYear_E0538169409743E29295A3DCC3AF69C4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueInFifthYear" xlink:label="loc_us-gaap_OtherCommitmentDueInFifthYear_18A970CD345820062B67A3DCC3AF2EC9" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_us-gaap_OtherCommitmentDueInFifthYear_18A970CD345820062B67A3DCC3AF2EC9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentDueAfterFifthYear" xlink:label="loc_us-gaap_OtherCommitmentDueAfterFifthYear_715E5EED6956A9E68264A3DCC3AFCB78" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_us-gaap_OtherCommitmentDueAfterFifthYear_715E5EED6956A9E68264A3DCC3AFCB78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligation" xlink:label="loc_us-gaap_ContractualObligation_C68EEB013837EF772A94A3DCC3AFE5C5" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_us-gaap_ContractualObligation_C68EEB013837EF772A94A3DCC3AFE5C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInSecondYear" xlink:label="loc_us-gaap_ContractualObligationDueInSecondYear_6C319F5055C3F29E710FA3DCC3AFACE7" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_us-gaap_ContractualObligationDueInSecondYear_6C319F5055C3F29E710FA3DCC3AFACE7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInThirdYear" xlink:label="loc_us-gaap_ContractualObligationDueInThirdYear_57384BBAF40E0B7D5686A3DCC3AF15DF" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_us-gaap_ContractualObligationDueInThirdYear_57384BBAF40E0B7D5686A3DCC3AF15DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInFourthYear" xlink:label="loc_us-gaap_ContractualObligationDueInFourthYear_4555E8DC765E77999E6CA3DCC3AF26EB" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_us-gaap_ContractualObligationDueInFourthYear_4555E8DC765E77999E6CA3DCC3AF26EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueInFifthYear" xlink:label="loc_us-gaap_ContractualObligationDueInFifthYear_F80FFE8E059E8914A226A3DCC3AF037A" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_us-gaap_ContractualObligationDueInFifthYear_F80FFE8E059E8914A226A3DCC3AF037A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationDueAfterFifthYear" xlink:label="loc_us-gaap_ContractualObligationDueAfterFifthYear_73D90780058800939510A3DCC3AF9B06" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_532444B460253F403B71A3DCC3AF3726" xlink:to="loc_us-gaap_ContractualObligationDueAfterFifthYear_73D90780058800939510A3DCC3AF9B06" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetailsTextual" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7997133C5BEB0FBAA073A3DCC39D29AF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingenciesTable" xlink:label="loc_us-gaap_LossContingenciesTable_FF59D3AC3F1FECAB5973A3DCC39DB983" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7997133C5BEB0FBAA073A3DCC39D29AF" xlink:to="loc_us-gaap_LossContingenciesTable_FF59D3AC3F1FECAB5973A3DCC39DB983" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_LitigationCaseAxis" xlink:label="loc_srt_LitigationCaseAxis_FEB808C61343FD0B9BBEA3DCC39DBAC3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_FF59D3AC3F1FECAB5973A3DCC39DB983" xlink:to="loc_srt_LitigationCaseAxis_FEB808C61343FD0B9BBEA3DCC39DBAC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_LitigationCaseTypeDomain" xlink:label="loc_srt_LitigationCaseTypeDomain_F1FC3D259C27BD51E2FAA3DCC39D0E12" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_FEB808C61343FD0B9BBEA3DCC39DBAC3" xlink:to="loc_srt_LitigationCaseTypeDomain_F1FC3D259C27BD51E2FAA3DCC39D0E12" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_C.R.BardInc.Member" xlink:label="loc_ango_C.R.BardInc.Member_D9BAB579E9BAD7499210A3DCC39D758F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_F1FC3D259C27BD51E2FAA3DCC39D0E12" xlink:to="loc_ango_C.R.BardInc.Member_D9BAB579E9BAD7499210A3DCC39D758F" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_TheUtahActionMember" xlink:label="loc_ango_TheUtahActionMember_3E6260B1016F9DCB3DF9A3DCC39D276F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_F1FC3D259C27BD51E2FAA3DCC39D0E12" xlink:to="loc_ango_TheUtahActionMember_3E6260B1016F9DCB3DF9A3DCC39D276F" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_TheDelawareActionMember" xlink:label="loc_ango_TheDelawareActionMember_40048F51ACA720E29630A3DCC39D5E33" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_F1FC3D259C27BD51E2FAA3DCC39D0E12" xlink:to="loc_ango_TheDelawareActionMember_40048F51ACA720E29630A3DCC39D5E33" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_DE156BA22BEB574A581BA3DCC39D7E83" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_FF59D3AC3F1FECAB5973A3DCC39DB983" xlink:to="loc_dei_LegalEntityAxis_DE156BA22BEB574A581BA3DCC39D7E83" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_45696E8D6959014BE10FA3DCC39D8B31" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_DE156BA22BEB574A581BA3DCC39D7E83" xlink:to="loc_dei_EntityDomain_45696E8D6959014BE10FA3DCC39D8B31" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_45696E8D6959014BE10FA3DCC39D8B31" xlink:to="loc_ango_C.R.BardInc.Member_D9BAB579E9BAD7499210A3DCC39D758F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LitigationStatusAxis" xlink:label="loc_us-gaap_LitigationStatusAxis_C89EEF918246E3CA2588A3DCC39D6DDA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_FF59D3AC3F1FECAB5973A3DCC39DB983" xlink:to="loc_us-gaap_LitigationStatusAxis_C89EEF918246E3CA2588A3DCC39D6DDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LitigationStatusDomain" xlink:label="loc_us-gaap_LitigationStatusDomain_5DD66CF36697BCD1C011A3DCC39D39E7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_C89EEF918246E3CA2588A3DCC39D6DDA" xlink:to="loc_us-gaap_LitigationStatusDomain_5DD66CF36697BCD1C011A3DCC39D39E7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PendingLitigationMember" xlink:label="loc_us-gaap_PendingLitigationMember_5AFF1CC6D1D0DD6C8041A3DCC39DBF96" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_5DD66CF36697BCD1C011A3DCC39D39E7" xlink:to="loc_us-gaap_PendingLitigationMember_5AFF1CC6D1D0DD6C8041A3DCC39DBF96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingenciesLineItems" xlink:label="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_FF59D3AC3F1FECAB5973A3DCC39DB983" xlink:to="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaap_LeaseAndRentalExpense_4882F622AB3C8EA972D9A3DCC39D40B3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_us-gaap_LeaseAndRentalExpense_4882F622AB3C8EA972D9A3DCC39D40B3" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_LossContingencyU.S.PatentsNumber" xlink:label="loc_ango_LossContingencyU.S.PatentsNumber_2C555613EE91CC778477A3DCC39D08BE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_ango_LossContingencyU.S.PatentsNumber_2C555613EE91CC778477A3DCC39D08BE" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_NumberOfPatentsAssertedForReexamination" xlink:label="loc_ango_NumberOfPatentsAssertedForReexamination_ECF7B41805803A7865CCA3DCC39D94EA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_ango_NumberOfPatentsAssertedForReexamination_ECF7B41805803A7865CCA3DCC39D94EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingencyClaimsDismissedNumber" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_9971BFA360A7B7A10CA1A3DCC39DD155" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_us-gaap_LossContingencyClaimsDismissedNumber_9971BFA360A7B7A10CA1A3DCC39DD155" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_LossContingencyReexaminationsNumber" xlink:label="loc_ango_LossContingencyReexaminationsNumber_69DFAD4DB5928A658D5BA3DCC39DD1B9" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_ango_LossContingencyReexaminationsNumber_69DFAD4DB5928A658D5BA3DCC39DD1B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_E8F3ED95E9C5FB2C3385A3DCC39D9C7B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_E8F3ED95E9C5FB2C3385A3DCC39D9C7B" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_LossContingencyClaimsReversedNumber" xlink:label="loc_ango_LossContingencyClaimsReversedNumber_0C93F1680DEE7D752AA2A3DCC39DA20F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_ango_LossContingencyClaimsReversedNumber_0C93F1680DEE7D752AA2A3DCC39DA20F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_57487B6E1A84A88FFBE7A3DCC39DFAB8" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_57487B6E1A84A88FFBE7A3DCC39DFAB8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_7DA558AC4087CB12EE40A3DCC39DD1BA" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_7DA558AC4087CB12EE40A3DCC39DD1BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_85348F21850884DE806AA3DCC39DDA7F" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ED38C16B6E6697CC13B9A3DCC39D4AD5" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_85348F21850884DE806AA3DCC39DDA7F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/CommitmentsAndContingenciesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_13C7D99BC238496CF4648C8B9DAB6A86" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:label="loc_us-gaap_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_FA22A6625612C5375AA18C8B9DABBD3C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_13C7D99BC238496CF4648C8B9DAB6A86" xlink:to="loc_us-gaap_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_FA22A6625612C5375AA18C8B9DABBD3C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherCommitmentsTableTextBlock" xlink:label="loc_us-gaap_OtherCommitmentsTableTextBlock_562CA588D8A2AB30173E8C8B9DAB3F04" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_13C7D99BC238496CF4648C8B9DAB6A86" xlink:to="loc_us-gaap_OtherCommitmentsTableTextBlock_562CA588D8A2AB30173E8C8B9DAB3F04" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_D9BC147522BB7B2D6179949FCFB8EB22" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_6EB29A502ED8C0E4A0C8949FCFB8D721" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_D9BC147522BB7B2D6179949FCFB8EB22" xlink:to="loc_us-gaap_AssetsAbstract_6EB29A502ED8C0E4A0C8949FCFB8D721" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_C6F9C8BE5299FD0F973A949FCFB84EEA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6EB29A502ED8C0E4A0C8949FCFB8D721" xlink:to="loc_us-gaap_AssetsCurrentAbstract_C6F9C8BE5299FD0F973A949FCFB84EEA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8C1B9583CAD2C0004211949FCFB84450" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_C6F9C8BE5299FD0F973A949FCFB84EEA" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8C1B9583CAD2C0004211949FCFB84450" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_C61ED14FDE87CF7D93E7949FCFB9D7CF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_C6F9C8BE5299FD0F973A949FCFB84EEA" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_C61ED14FDE87CF7D93E7949FCFB9D7CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_DF4773E2195601BD5D62949FCFB9D098" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_C6F9C8BE5299FD0F973A949FCFB84EEA" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_DF4773E2195601BD5D62949FCFB9D098" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_B0EB0428D49924B738F2949FCFB9073A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_C6F9C8BE5299FD0F973A949FCFB84EEA" xlink:to="loc_us-gaap_InventoryNet_B0EB0428D49924B738F2949FCFB9073A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4A37A5BE01A5500B5411949FCFB97DC6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_C6F9C8BE5299FD0F973A949FCFB84EEA" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4A37A5BE01A5500B5411949FCFB97DC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_E60FF6C5DFC54949AB2B949FCFB920A0" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_C6F9C8BE5299FD0F973A949FCFB84EEA" xlink:to="loc_us-gaap_AssetsCurrent_E60FF6C5DFC54949AB2B949FCFB920A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_37760B35759CC21BFA0A949FCFBA797C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6EB29A502ED8C0E4A0C8949FCFB8D721" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_37760B35759CC21BFA0A949FCFBA797C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_118D3D1A9373527BC10A949FCFBA1C6E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6EB29A502ED8C0E4A0C8949FCFB8D721" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_118D3D1A9373527BC10A949FCFBA1C6E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_CA25319AC5D00EFD99C2949FCFBA3561" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6EB29A502ED8C0E4A0C8949FCFB8D721" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_CA25319AC5D00EFD99C2949FCFBA3561" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_CF0B520C6B0562FBB940949FCFBA422B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6EB29A502ED8C0E4A0C8949FCFB8D721" xlink:to="loc_us-gaap_Goodwill_CF0B520C6B0562FBB940949FCFBA422B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_D697239EC20B2888DD5D949FCFBA97AC" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6EB29A502ED8C0E4A0C8949FCFB8D721" xlink:to="loc_us-gaap_Assets_D697239EC20B2888DD5D949FCFBA97AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5666799C28EE2D0386B3949FCFBA9EF1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_D9BC147522BB7B2D6179949FCFB8EB22" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5666799C28EE2D0386B3949FCFBA9EF1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_412363185C2241D759D2949FCFBB84F3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5666799C28EE2D0386B3949FCFBA9EF1" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_412363185C2241D759D2949FCFBB84F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_B044F7FEDA39C3369FD6949FCFBB6C0B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_412363185C2241D759D2949FCFBB84F3" xlink:to="loc_us-gaap_AccountsPayableCurrent_B044F7FEDA39C3369FD6949FCFBB6C0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_77BEA6A587AB6F339097949FCFBB0D24" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_412363185C2241D759D2949FCFBB84F3" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_77BEA6A587AB6F339097949FCFBB0D24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_C5EE43D92DDAF8F8BFC5949FCFBBB0CA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_412363185C2241D759D2949FCFBB84F3" xlink:to="loc_us-gaap_LongTermDebtCurrent_C5EE43D92DDAF8F8BFC5949FCFBBB0CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_AD1EE8D355D9D79DAE19949FCFBBD53A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_412363185C2241D759D2949FCFBB84F3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_AD1EE8D355D9D79DAE19949FCFBBD53A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_ADD72C43D568F43D03F0949FCFBC18C8" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_412363185C2241D759D2949FCFBB84F3" xlink:to="loc_us-gaap_LiabilitiesCurrent_ADD72C43D568F43D03F0949FCFBC18C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermLoansPayable" xlink:label="loc_us-gaap_LongTermLoansPayable_A2DAEB4FCA66D3A2580F949FCFBCC136" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5666799C28EE2D0386B3949FCFBA9EF1" xlink:to="loc_us-gaap_LongTermLoansPayable_A2DAEB4FCA66D3A2580F949FCFBCC136" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_E7A0BA69F66F38600911949FCFBC0A55" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5666799C28EE2D0386B3949FCFBA9EF1" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_E7A0BA69F66F38600911949FCFBC0A55" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_80BD15627221E0BB49AC949FCFBC5E94" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5666799C28EE2D0386B3949FCFBA9EF1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_80BD15627221E0BB49AC949FCFBC5E94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3322628B7D729A23C963949FCFBC72C8" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5666799C28EE2D0386B3949FCFBA9EF1" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_3322628B7D729A23C963949FCFBC72C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_45573062CD4109CC52B9949FCFBC0153" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5666799C28EE2D0386B3949FCFBA9EF1" xlink:to="loc_us-gaap_Liabilities_45573062CD4109CC52B9949FCFBC0153" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_41FF43AC510DEA4BA261949FCFBD195F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5666799C28EE2D0386B3949FCFBA9EF1" xlink:to="loc_us-gaap_CommitmentsAndContingencies_41FF43AC510DEA4BA261949FCFBD195F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_2D956B675FE97896AAA6949FCFBD90AA" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5666799C28EE2D0386B3949FCFBA9EF1" xlink:to="loc_us-gaap_StockholdersEquityAbstract_2D956B675FE97896AAA6949FCFBD90AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_880C339942DC02AE5F68949FCFBDF73F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2D956B675FE97896AAA6949FCFBD90AA" xlink:to="loc_us-gaap_PreferredStockValue_880C339942DC02AE5F68949FCFBDF73F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_6678989D348FDD812DAC949FCFBD022C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2D956B675FE97896AAA6949FCFBD90AA" xlink:to="loc_us-gaap_CommonStockValue_6678989D348FDD812DAC949FCFBD022C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_36DF6D7D4A281B55F2A3949FCFBD1306" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2D956B675FE97896AAA6949FCFBD90AA" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_36DF6D7D4A281B55F2A3949FCFBD1306" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_68DF9F80E96AFFF92AD0949FCFBEDC70" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2D956B675FE97896AAA6949FCFBD90AA" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_68DF9F80E96AFFF92AD0949FCFBEDC70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_8DE18B16CE2734DA24C4949FCFBE216D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2D956B675FE97896AAA6949FCFBD90AA" xlink:to="loc_us-gaap_TreasuryStockValue_8DE18B16CE2734DA24C4949FCFBE216D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_AE7F20DEAE4FED4AACAF949FCFBE514E" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2D956B675FE97896AAA6949FCFBD90AA" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_AE7F20DEAE4FED4AACAF949FCFBE514E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_68EC8209D79D426DABAD949FCFBE48FF" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2D956B675FE97896AAA6949FCFBD90AA" xlink:to="loc_us-gaap_StockholdersEquity_68EC8209D79D426DABAD949FCFBE48FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_1A6043A26C3FE53C0062949FCFBEFE5D" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5666799C28EE2D0386B3949FCFBA9EF1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_1A6043A26C3FE53C0062949FCFBEFE5D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_9D18AB5ECD84F7B1E61B93D32964ACDF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3BE52EEDF555982D23F893D32965AEB4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9D18AB5ECD84F7B1E61B93D32964ACDF" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3BE52EEDF555982D23F893D32965AEB4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_56EAFD3F50C86F56AC5C93D32965DA45" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9D18AB5ECD84F7B1E61B93D32964ACDF" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_56EAFD3F50C86F56AC5C93D32965DA45" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_A81356261E88E281188793D32965627F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9D18AB5ECD84F7B1E61B93D32964ACDF" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_A81356261E88E281188793D32965627F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_B6613263C4A2254025AE93D329651068" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9D18AB5ECD84F7B1E61B93D32964ACDF" xlink:to="loc_us-gaap_PreferredStockSharesIssued_B6613263C4A2254025AE93D329651068" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_CA6E8BB204EAA961832593D32966CF99" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9D18AB5ECD84F7B1E61B93D32964ACDF" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_CA6E8BB204EAA961832593D32966CF99" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_16C67C6A89D2A1145CE993D3296662C2" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9D18AB5ECD84F7B1E61B93D32964ACDF" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_16C67C6A89D2A1145CE993D3296662C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_F87F03C8F1DD92C0CC4D93D32966461B" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9D18AB5ECD84F7B1E61B93D32964ACDF" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_F87F03C8F1DD92C0CC4D93D32966461B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_05DC32601B2E33D3696B93D32966D584" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9D18AB5ECD84F7B1E61B93D32964ACDF" xlink:to="loc_us-gaap_CommonStockSharesIssued_05DC32601B2E33D3696B93D32966D584" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_10C45BE2F1607AA7757E93D32966F258" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9D18AB5ECD84F7B1E61B93D32964ACDF" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_10C45BE2F1607AA7757E93D32966F258" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_9382671FD08C1845B64493D32966D499" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9D18AB5ECD84F7B1E61B93D32964ACDF" xlink:to="loc_us-gaap_TreasuryStockShares_9382671FD08C1845B64493D32966D499" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedStatementsComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_268235749FA94D44D188B417916A4FBD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_608AD79ABC85EB5C9E44B417916A1E0A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_268235749FA94D44D188B417916A4FBD" xlink:to="loc_us-gaap_NetIncomeLoss_608AD79ABC85EB5C9E44B417916A1E0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_46CA2690D60BDAF342B9B417916A991E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_268235749FA94D44D188B417916A4FBD" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_46CA2690D60BDAF342B9B417916A991E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_6F1B9D7187F20A4082F8B417916A9FA2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_46CA2690D60BDAF342B9B417916A991E" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_6F1B9D7187F20A4082F8B417916A9FA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_F06901C8AE24FB511730B417916A8FD0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_46CA2690D60BDAF342B9B417916A991E" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_F06901C8AE24FB511730B417916A8FD0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_8FF67137177BCEF3463CB417916A65B3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_46CA2690D60BDAF342B9B417916A991E" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_8FF67137177BCEF3463CB417916A65B3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_C8523832036A8799F3D3B417916AAFB9" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_46CA2690D60BDAF342B9B417916A991E" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_C8523832036A8799F3D3B417916AAFB9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_FD50BC7E929A76B441A7B417916A83CF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_268235749FA94D44D188B417916A4FBD" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1_FD50BC7E929A76B441A7B417916A83CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5419B2F5B259A8714E16B417916AE341" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_268235749FA94D44D188B417916A4FBD" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5419B2F5B259A8714E16B417916AE341" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4A88E4FF3660A0029D32B417916A47D7" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_268235749FA94D44D188B417916A4FBD" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4A88E4FF3660A0029D32B417916A47D7" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_A91FA86808A0E4CED4C0A965BCAAD9AD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_21425BB961DE959BAF76A965BCAD6D81" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_A91FA86808A0E4CED4C0A965BCAAD9AD" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_21425BB961DE959BAF76A965BCAD6D81" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_FBB30A732353B47352E3A965BCAD4107" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_21425BB961DE959BAF76A965BCAD6D81" xlink:to="loc_us-gaap_NetIncomeLoss_FBB30A732353B47352E3A965BCAD4107" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_201F6D988BA49B4691E2A965BCAD2CC0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_21425BB961DE959BAF76A965BCAD6D81" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_201F6D988BA49B4691E2A965BCAD2CC0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaap_DepreciationAndAmortization_3AAE2F27ACF6F8B7C28DA965BCAD2B09" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_201F6D988BA49B4691E2A965BCAD2CC0" xlink:to="loc_us-gaap_DepreciationAndAmortization_3AAE2F27ACF6F8B7C28DA965BCAD2B09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_3C61AAAAEADC61C51BECA965BCAD23FA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_201F6D988BA49B4691E2A965BCAD2CC0" xlink:to="loc_us-gaap_ShareBasedCompensation_3C61AAAAEADC61C51BECA965BCAD23FA" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ChangeInFairValueOfContingentConsideration" xlink:label="loc_ango_ChangeInFairValueOfContingentConsideration_CD4E5DACC61608E77515A965BCADB037" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_201F6D988BA49B4691E2A965BCAD2CC0" xlink:to="loc_ango_ChangeInFairValueOfContingentConsideration_CD4E5DACC61608E77515A965BCADB037" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_DeferredIncomeTaxRelatedToOperatingActivity" xlink:label="loc_ango_DeferredIncomeTaxRelatedToOperatingActivity_0491F00F3221537B4F6DA965BCADAFF0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_201F6D988BA49B4691E2A965BCAD2CC0" xlink:to="loc_ango_DeferredIncomeTaxRelatedToOperatingActivity_0491F00F3221537B4F6DA965BCADAFF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_9AEF74F416D571F36E2EA965BCAD5ECA" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_201F6D988BA49B4691E2A965BCAD2CC0" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_9AEF74F416D571F36E2EA965BCAD5ECA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_108DC086086AEEBFF4F3A965BCAD2E3B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_201F6D988BA49B4691E2A965BCAD2CC0" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_108DC086086AEEBFF4F3A965BCAD2E3B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_8D553D2E397F623F66E9A965BCAFFA7D" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_201F6D988BA49B4691E2A965BCAD2CC0" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_8D553D2E397F623F66E9A965BCAFFA7D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_00BF8F02AAF5F7E1F010A965BCAFE054" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_201F6D988BA49B4691E2A965BCAD2CC0" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_00BF8F02AAF5F7E1F010A965BCAFE054" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_C6F06B80A7630AFECA53A965BCAFF2A3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_21425BB961DE959BAF76A965BCAD6D81" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_C6F06B80A7630AFECA53A965BCAFF2A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6EA832C93B2039DD9E8AA965BCAF71FD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_C6F06B80A7630AFECA53A965BCAFF2A3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6EA832C93B2039DD9E8AA965BCAF71FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_D70E6CDDF595401D49A1A965BCAFB7C1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_C6F06B80A7630AFECA53A965BCAFF2A3" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_D70E6CDDF595401D49A1A965BCAFB7C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_99EBBEF7BC4D00C7A21CA965BCAF4336" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_C6F06B80A7630AFECA53A965BCAFF2A3" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_99EBBEF7BC4D00C7A21CA965BCAF4336" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_F50D17CF5322F4F0606CA965BCAF8ED3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_C6F06B80A7630AFECA53A965BCAFF2A3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_F50D17CF5322F4F0606CA965BCAF8ED3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_53CA7B44075015EFFF20A965BCAF31F1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_21425BB961DE959BAF76A965BCAD6D81" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_53CA7B44075015EFFF20A965BCAF31F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_568CE8299769C3936363A965BCAF553F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_A91FA86808A0E4CED4C0A965BCAAD9AD" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_568CE8299769C3936363A965BCAF553F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_58CA1448C0592DBDE646A965BCAF8368" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_568CE8299769C3936363A965BCAF553F" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_58CA1448C0592DBDE646A965BCAF8368" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PaymentsToAcquireIntangibleAssetsNetOfCashAcquired" xlink:label="loc_ango_PaymentsToAcquireIntangibleAssetsNetOfCashAcquired_44546BE7BB36C5F32154A965BCB2BD2B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_568CE8299769C3936363A965BCAF553F" xlink:to="loc_ango_PaymentsToAcquireIntangibleAssetsNetOfCashAcquired_44546BE7BB36C5F32154A965BCB2BD2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_629A477D34FDCC1C6C42A965BCB29861" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_568CE8299769C3936363A965BCAF553F" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_629A477D34FDCC1C6C42A965BCB29861" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_B1A5EFB348F1FBC1DA5EA965BCB21EF8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_568CE8299769C3936363A965BCAF553F" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_B1A5EFB348F1FBC1DA5EA965BCB21EF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_B84B87CABACD1FBC27DAA965BCB27EBE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_568CE8299769C3936363A965BCAF553F" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_B84B87CABACD1FBC27DAA965BCB27EBE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4C9B88821A350B9A800AA965BCB2CD0C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_A91FA86808A0E4CED4C0A965BCAAD9AD" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4C9B88821A350B9A800AA965BCB2CD0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_FC990FBBA4138C984C6FA965BCB25AF5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4C9B88821A350B9A800AA965BCB2CD0C" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_FC990FBBA4138C984C6FA965BCB25AF5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_A668588540992A6C27CBA965BCB4F252" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4C9B88821A350B9A800AA965BCB2CD0C" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_A668588540992A6C27CBA965BCB4F252" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_DFE5E689FCD13A98744FA965BCB4998E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4C9B88821A350B9A800AA965BCB2CD0C" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_DFE5E689FCD13A98744FA965BCB4998E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5461E29A281BB7867AD0A965BCB41BD0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4C9B88821A350B9A800AA965BCB2CD0C" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5461E29A281BB7867AD0A965BCB41BD0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_BD355BAF51E59D96D3F2A965BCB45F5C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4C9B88821A350B9A800AA965BCB2CD0C" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_BD355BAF51E59D96D3F2A965BCB45F5C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_79594330539F964D671AA965BCB438CD" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4C9B88821A350B9A800AA965BCB2CD0C" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_79594330539F964D671AA965BCB438CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2330855204DBFD7A0B55A965BCB4D420" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4C9B88821A350B9A800AA965BCB2CD0C" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2330855204DBFD7A0B55A965BCB4D420" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_17FC7FC6FA26A70F0DACA965BCB46F35" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_A91FA86808A0E4CED4C0A965BCAAD9AD" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_17FC7FC6FA26A70F0DACA965BCB46F35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_85AC5AF14B88C5D40E05A965BCB4FA61" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_A91FA86808A0E4CED4C0A965BCAAD9AD" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_85AC5AF14B88C5D40E05A965BCB4FA61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4E885C70E15120478471A965BCB4240D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_A91FA86808A0E4CED4C0A965BCAAD9AD" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4E885C70E15120478471A965BCB4240D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_AD3814B4B979CAEB74DFA965BCB4713F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_A91FA86808A0E4CED4C0A965BCAAD9AD" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_AD3814B4B979CAEB74DFA965BCB4713F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8552BC9F7CA6F4A0CB50A965BCB4DDAA" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_A91FA86808A0E4CED4C0A965BCAAD9AD" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8552BC9F7CA6F4A0CB50A965BCB4DDAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_605370C61E6261909695A965BCB7FD49" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_8552BC9F7CA6F4A0CB50A965BCB4DDAA" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_605370C61E6261909695A965BCB7FD49" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_CashPaidDuringPeriodAbstract" xlink:label="loc_ango_CashPaidDuringPeriodAbstract_AE40BCF4E0620125AD97A965BCB7B4CF" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_A91FA86808A0E4CED4C0A965BCAAD9AD" xlink:to="loc_ango_CashPaidDuringPeriodAbstract_AE40BCF4E0620125AD97A965BCB7B4CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaap_InterestPaid_C44E269E539FA7F5E33CA965BCB74C4E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_CashPaidDuringPeriodAbstract_AE40BCF4E0620125AD97A965BCB7B4CF" xlink:to="loc_us-gaap_InterestPaid_C44E269E539FA7F5E33CA965BCB74C4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_7C6BCF5D3564DA5FD417A9A3AC962A7C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_CashPaidDuringPeriodAbstract_AE40BCF4E0620125AD97A965BCB7B4CF" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_7C6BCF5D3564DA5FD417A9A3AC962A7C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedStatementsOfOperations" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_0725FEB1D83A299B0D52A965BCFAC268" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_15792AFF06EA94DB23E1A965BCFA7A44" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0725FEB1D83A299B0D52A965BCFAC268" xlink:to="loc_us-gaap_Revenues_15792AFF06EA94DB23E1A965BCFA7A44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_0C172319C8B3467CF138A9686993CDFB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0725FEB1D83A299B0D52A965BCFAC268" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_0C172319C8B3467CF138A9686993CDFB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_11E54122C8A7E05B0B0BA965BCFABDEC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0725FEB1D83A299B0D52A965BCFAC268" xlink:to="loc_us-gaap_GrossProfit_11E54122C8A7E05B0B0BA965BCFABDEC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_D28E3D4AA4A8D2713A4EA965BCFA4E2B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0725FEB1D83A299B0D52A965BCFAC268" xlink:to="loc_us-gaap_OperatingExpensesAbstract_D28E3D4AA4A8D2713A4EA965BCFA4E2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_F9FD858961445FAA5D83A965BCFAA564" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_D28E3D4AA4A8D2713A4EA965BCFA4E2B" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_F9FD858961445FAA5D83A965BCFAA564" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_9FA43D89AD433411FAEFA965BCFD8C29" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_D28E3D4AA4A8D2713A4EA965BCFA4E2B" xlink:to="loc_us-gaap_SellingAndMarketingExpense_9FA43D89AD433411FAEFA965BCFD8C29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_1AC58E38A1453845BD1BA965BCFDB8FB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_D28E3D4AA4A8D2713A4EA965BCFA4E2B" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_1AC58E38A1453845BD1BA965BCFDB8FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_B4F55108FE0FAC4E5B73A965BCFD85BF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_D28E3D4AA4A8D2713A4EA965BCFA4E2B" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_B4F55108FE0FAC4E5B73A965BCFD85BF" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ChangeInFairValueOfContingentConsideration" xlink:label="loc_ango_ChangeInFairValueOfContingentConsideration_AB86E1B34145E2C7DC81A965BCFDEA13" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_D28E3D4AA4A8D2713A4EA965BCFA4E2B" xlink:to="loc_ango_ChangeInFairValueOfContingentConsideration_AB86E1B34145E2C7DC81A965BCFDEA13" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AcquisitionRestructuringAndOtherItemsNet" xlink:label="loc_ango_AcquisitionRestructuringAndOtherItemsNet_F629CB0A278F3883B75FA965BCFDEAFE" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_D28E3D4AA4A8D2713A4EA965BCFA4E2B" xlink:to="loc_ango_AcquisitionRestructuringAndOtherItemsNet_F629CB0A278F3883B75FA965BCFDEAFE" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_MedicalDeviceExciseTax" xlink:label="loc_ango_MedicalDeviceExciseTax_A4CEFAEBD895EC2214E7A965BCFD86BC" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_D28E3D4AA4A8D2713A4EA965BCFA4E2B" xlink:to="loc_ango_MedicalDeviceExciseTax_A4CEFAEBD895EC2214E7A965BCFD86BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_E0E6398019C148D6C844A965BCFD3F6C" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_D28E3D4AA4A8D2713A4EA965BCFA4E2B" xlink:to="loc_us-gaap_OperatingExpenses_E0E6398019C148D6C844A965BCFD3F6C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_725B869099BBCA3E5058A965BCFDD08F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0725FEB1D83A299B0D52A965BCFAC268" xlink:to="loc_us-gaap_OperatingIncomeLoss_725B869099BBCA3E5058A965BCFDD08F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_A3172D0529319E7756DAA965BCFDAA76" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0725FEB1D83A299B0D52A965BCFAC268" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_A3172D0529319E7756DAA965BCFDAA76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_0CCF30EA96B454379A06A965BCFDB3E1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_A3172D0529319E7756DAA965BCFDAA76" xlink:to="loc_us-gaap_InterestExpense_0CCF30EA96B454379A06A965BCFDB3E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="loc_us-gaap_OtherNonoperatingExpense_4EE79CB19594C977DFBBA965BCFDFE3A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_A3172D0529319E7756DAA965BCFDAA76" xlink:to="loc_us-gaap_OtherNonoperatingExpense_4EE79CB19594C977DFBBA965BCFDFE3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_C0F4102F6A12E28D1E85A965BCFD9702" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_A3172D0529319E7756DAA965BCFDAA76" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_C0F4102F6A12E28D1E85A965BCFD9702" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0E5DE5C13C63B4FB01AEA965BCFDF7FD" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0725FEB1D83A299B0D52A965BCFAC268" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0E5DE5C13C63B4FB01AEA965BCFDF7FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_A2F6E384E0495DB6BC1CA965BCFD68D9" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0725FEB1D83A299B0D52A965BCFAC268" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_A2F6E384E0495DB6BC1CA965BCFD68D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_B3607CBFE05B3235C659A965BCFFED7E" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0725FEB1D83A299B0D52A965BCFAC268" xlink:to="loc_us-gaap_NetIncomeLoss_B3607CBFE05B3235C659A965BCFFED7E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8D7E461935D8D3AD976BA965BCFFEDDF" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0725FEB1D83A299B0D52A965BCFAC268" xlink:to="loc_us-gaap_EarningsPerShareAbstract_8D7E461935D8D3AD976BA965BCFFEDDF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_7DB261FC4801CDAF8EDDA965BCFFF0F5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8D7E461935D8D3AD976BA965BCFFEDDF" xlink:to="loc_us-gaap_EarningsPerShareBasic_7DB261FC4801CDAF8EDDA965BCFFF0F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6A6CE7AFFAE3229E55FAA965BCFFACA0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8D7E461935D8D3AD976BA965BCFFEDDF" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6A6CE7AFFAE3229E55FAA965BCFFACA0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_7EF4D80537C0736A9B10A965BCFFCB62" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0725FEB1D83A299B0D52A965BCFAC268" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_7EF4D80537C0736A9B10A965BCFFCB62" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8B574E79EAF2680635DAA965BCFF33D9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_7EF4D80537C0736A9B10A965BCFFCB62" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8B574E79EAF2680635DAA965BCFF33D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_76882EA83AD688D8EE84A965BCFF7F48" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_7EF4D80537C0736A9B10A965BCFFCB62" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_76882EA83AD688D8EE84A965BCFF7F48" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/ConsolidatedStatementsOfStockholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_0043494DA7CB25CF2C5394C430A55163" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaap_StatementTable_CE5795E396C6CCC7B42F94C430A53147" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_0043494DA7CB25CF2C5394C430A55163" xlink:to="loc_us-gaap_StatementTable_CE5795E396C6CCC7B42F94C430A53147" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8502F25166B68F3E0DBF94C430A67382" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_CE5795E396C6CCC7B42F94C430A53147" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8502F25166B68F3E0DBF94C430A67382" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_BC215ACAF584DD83B5C194C430A61CC8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8502F25166B68F3E0DBF94C430A67382" xlink:to="loc_us-gaap_EquityComponentDomain_BC215ACAF584DD83B5C194C430A61CC8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_E2CAC91072325CEA685394C430A6AD96" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_BC215ACAF584DD83B5C194C430A61CC8" xlink:to="loc_us-gaap_CommonStockMember_E2CAC91072325CEA685394C430A6AD96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_0CAE04B517CDA2CFD0B094C430A6A219" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_BC215ACAF584DD83B5C194C430A61CC8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_0CAE04B517CDA2CFD0B094C430A6A219" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaap_RetainedEarningsMember_FB0668D2EB7A8C4CEC4094C430A75C39" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_BC215ACAF584DD83B5C194C430A61CC8" xlink:to="loc_us-gaap_RetainedEarningsMember_FB0668D2EB7A8C4CEC4094C430A75C39" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_F569058485E3692D58BC94C430A7336D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_BC215ACAF584DD83B5C194C430A61CC8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_F569058485E3692D58BC94C430A7336D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaap_TreasuryStockMember_F5338E18D1FF34455E4A94C430A79EF2" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_BC215ACAF584DD83B5C194C430A61CC8" xlink:to="loc_us-gaap_TreasuryStockMember_F5338E18D1FF34455E4A94C430A79EF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_31C4CB63569701C42F5494C430A77C17" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_CE5795E396C6CCC7B42F94C430A53147" xlink:to="loc_us-gaap_AwardTypeAxis_31C4CB63569701C42F5494C430A77C17" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_413C9424A5570E39064D94C430A7C49E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_31C4CB63569701C42F5494C430A77C17" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_413C9424A5570E39064D94C430A7C49E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_6F6CC796611B00CA387894C430A8ABFC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_413C9424A5570E39064D94C430A7C49E" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_6F6CC796611B00CA387894C430A8ABFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_201DF8E1B7E30383032A94C430A8FE92" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_413C9424A5570E39064D94C430A7C49E" xlink:to="loc_us-gaap_PerformanceSharesMember_201DF8E1B7E30383032A94C430A8FE92" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_CE5795E396C6CCC7B42F94C430A53147" xlink:to="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_7A04215DE421998BBF2094C430A8DA0B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_StockholdersEquity_7A04215DE421998BBF2094C430A8DA0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_D8D95162170BED66572D94C430A8A356" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_SharesIssued_D8D95162170BED66572D94C430A8A356" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption" xlink:label="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_A6B2EFDCF896141674D894C430A9BA0E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption_A6B2EFDCF896141674D894C430A9BA0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_C7B90EAA69CBB25082C994C430A94AC5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_NetIncomeLoss_C7B90EAA69CBB25082C994C430A94AC5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_A934F38FA31E071C8C7594C430A9EC0E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_A934F38FA31E071C8C7594C430A9EC0E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_EC2F35177F981DC1855794C430A91528" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_EC2F35177F981DC1855794C430A91528" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_A1CAEB1338E0819C4EF194C430A98984" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_A1CAEB1338E0819C4EF194C430A98984" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_BD895E901625AC8486B994C430A9840F" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_BD895E901625AC8486B994C430A9840F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_A01CBA043B4A8F17D9A894C430AA622F" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_A01CBA043B4A8F17D9A894C430AA622F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_D07D6E2445FB5CA15F9C94C430AA6637" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_D07D6E2445FB5CA15F9C94C430AA6637" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_E81AB732E443841492C494C430AAA645" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_E81AB732E443841492C494C430AAA645" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockRetiredParValueMethodAmount" xlink:label="loc_us-gaap_TreasuryStockRetiredParValueMethodAmount_3D1597327963B9AC0FA694C430AAC419" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_TreasuryStockRetiredParValueMethodAmount_3D1597327963B9AC0FA694C430AAC419" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockSharesRetired" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_D3B167D42C0E7600A8AD94C430AAA9B4" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_D3B167D42C0E7600A8AD94C430AAA9B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_818620A29181A742C07994C430AB1AF0" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_818620A29181A742C07994C430AB1AF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_E9B1E7FBA9A8E262B08694C430AB63F4" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_E9B1E7FBA9A8E262B08694C430AB63F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_C0595E72FA4367B6226994C430AB6488" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_C0595E72FA4367B6226994C430AB6488" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_9AF84B0B9E66EC18787494C430AB2765" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_StockholdersEquity_9AF84B0B9E66EC18787494C430AB2765" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaap_SharesIssued_C1DCA2582C97F9CE01D894C430AB037E" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_D91BC1B7FC08F94EE00694C430A8FD77" xlink:to="loc_us-gaap_SharesIssued_C1DCA2582C97F9CE01D894C430AB037E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <link:loc xlink:href="ango-20180531.xsd#ango_DocumentAndEntityInformationAbstract" xlink:label="loc_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_8FE76E8181C19E03B1F98C8B9A01BCA6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0" xlink:to="loc_dei_EntityRegistrantName_8FE76E8181C19E03B1F98C8B9A01BCA6" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_D65271C647CA7B8389468C8B9A015AA6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0" xlink:to="loc_dei_EntityCentralIndexKey_D65271C647CA7B8389468C8B9A015AA6" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_EA5DD47E28358396DB938C8B9A01DEDD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0" xlink:to="loc_dei_DocumentType_EA5DD47E28358396DB938C8B9A01DEDD" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_C8AE8C28F8F9F436B6988C8B9A01F74A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0" xlink:to="loc_dei_DocumentPeriodEndDate_C8AE8C28F8F9F436B6988C8B9A01F74A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_A1601A7B5B26B1F05CB38C8B9A012505" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0" xlink:to="loc_dei_AmendmentFlag_A1601A7B5B26B1F05CB38C8B9A012505" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_8244A10CDD4F6055EA718C8B9A014078" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0" xlink:to="loc_dei_DocumentFiscalYearFocus_8244A10CDD4F6055EA718C8B9A014078" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_915230217A5123F480458C8B9A01EA2F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_915230217A5123F480458C8B9A01EA2F" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_9958D75334C86F498C6F8C8B9A0151FB" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0" xlink:to="loc_dei_CurrentFiscalYearEndDate_9958D75334C86F498C6F8C8B9A0151FB" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_2C4578FCF0D2E59B4C658C8B9A01BB01" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_2C4578FCF0D2E59B4C658C8B9A01BB01" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_dei_EntityVoluntaryFilers_49AB52A6E13DB359C2CC8C8B9A01C5A8" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0" xlink:to="loc_dei_EntityVoluntaryFilers_49AB52A6E13DB359C2CC8C8B9A01C5A8" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_dei_EntityCurrentReportingStatus_41E5029ED64BBCA013458C8B9A015324" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0" xlink:to="loc_dei_EntityCurrentReportingStatus_41E5029ED64BBCA013458C8B9A015324" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_807F1FFCA912E6B0D3FC8C8B9A01C1B5" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0" xlink:to="loc_dei_EntityFilerCategory_807F1FFCA912E6B0D3FC8C8B9A01C1B5" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_dei_EntityPublicFloat_A07F440A451A4250C8698C8B9A010C3C" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0" xlink:to="loc_dei_EntityPublicFloat_A07F440A451A4250C8698C8B9A010C3C" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_18E8C575A3D06ED584108C8B9A013950" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_DocumentAndEntityInformationAbstract_9BBF339223A81140F1F48C8B9A01B3C0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_18E8C575A3D06ED584108C8B9A013950" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_30659CCE403F953B41308F96E0D3E734" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_C69526708F152D2C23C78F96E0D3669B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_30659CCE403F953B41308F96E0D3E734" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_C69526708F152D2C23C78F96E0D3669B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1B0374E6E574A11015F48F96E0C7E14F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5495A6A9F4FA641D0DDC8F96E0C8B324" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1B0374E6E574A11015F48F96E0C7E14F" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5495A6A9F4FA641D0DDC8F96E0C8B324" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_D940FA12D1A15098EF5E8F96E0C8268A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1B0374E6E574A11015F48F96E0C7E14F" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_D940FA12D1A15098EF5E8F96E0C8268A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_B0E310E7E9B272F748BC8F96E0C8FB95" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1B0374E6E574A11015F48F96E0C7E14F" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_B0E310E7E9B272F748BC8F96E0C8FB95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_792BEBA2B032412E3C408F96E0C8B6FD" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1B0374E6E574A11015F48F96E0C7E14F" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_792BEBA2B032412E3C408F96E0C8B6FD" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_78F1EF3F0D02006CB7968C8B9C547F4B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_D6A4F3BFD2FED3A75C628C8B9C545C03" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_78F1EF3F0D02006CB7968C8B9C547F4B" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_D6A4F3BFD2FED3A75C628C8B9C545C03" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/FairValueOfFinancialInstruments" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8A622FAE6B1F402B88618F96E312B2BD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_AEDD37AADB6356894E418F96E3123C58" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8A622FAE6B1F402B88618F96E312B2BD" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_AEDD37AADB6356894E418F96E3123C58" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_D920A1A08EC9EACB7CFD8F22D13B4D3F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7A230FF4ADA784AD1A308F22D13B742C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_D920A1A08EC9EACB7CFD8F22D13B4D3F" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7A230FF4ADA784AD1A308F22D13B742C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_072E3838430B2C7EA93A8F22D13BA273" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7A230FF4ADA784AD1A308F22D13B742C" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_072E3838430B2C7EA93A8F22D13BA273" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_87CE90DEA79F6D4A36298F22D13B7126" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_072E3838430B2C7EA93A8F22D13BA273" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_87CE90DEA79F6D4A36298F22D13B7126" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_E9094AD6517DB9B7FCE88F22D13BF956" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_87CE90DEA79F6D4A36298F22D13B7126" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_E9094AD6517DB9B7FCE88F22D13BF956" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_88E8212613D323964B018F22D13BD7F2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7A230FF4ADA784AD1A308F22D13B742C" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_88E8212613D323964B018F22D13BD7F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A47FC87DC962672709258F22D13B3536" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_88E8212613D323964B018F22D13BD7F2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A47FC87DC962672709258F22D13B3536" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_63F90B036AC09CB60D3B8F22D13B0EA2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A47FC87DC962672709258F22D13B3536" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_63F90B036AC09CB60D3B8F22D13B0EA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_340FBA2BC06022BCA6518F22D13B29E1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A47FC87DC962672709258F22D13B3536" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_340FBA2BC06022BCA6518F22D13B29E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_AE3E2ABF58191EE4CC538F22D13B51A3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_A47FC87DC962672709258F22D13B3536" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_AE3E2ABF58191EE4CC538F22D13B51A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_071B08D0F7CF8F33FF7D8F22D14BF1DF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7A230FF4ADA784AD1A308F22D13B742C" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_071B08D0F7CF8F33FF7D8F22D14BF1DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_B8673782AD6960E1479D8F22D14B010C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_071B08D0F7CF8F33FF7D8F22D14BF1DF" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_B8673782AD6960E1479D8F22D14B010C" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure" xlink:label="loc_ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure_87EB6EB7AF427B3DD6FC8F22D14BAB0C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_B8673782AD6960E1479D8F22D14B010C" xlink:to="loc_ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure_87EB6EB7AF427B3DD6FC8F22D14BAB0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_76DED84C5EE648D7CC058F22D14BC667" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_B8673782AD6960E1479D8F22D14B010C" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_76DED84C5EE648D7CC058F22D14BC667" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_6000A47BB4885AE457738F22D14B1347" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_B8673782AD6960E1479D8F22D14B010C" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_6000A47BB4885AE457738F22D14B1347" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_BEF9DC3DCD8D0F1346EE8F22D14B01D8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_071B08D0F7CF8F33FF7D8F22D14BF1DF" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_BEF9DC3DCD8D0F1346EE8F22D14B01D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_F7C8E76C5658324642838F53E07128AB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_BEF9DC3DCD8D0F1346EE8F22D14B01D8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_F7C8E76C5658324642838F53E07128AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_6DB6376DA140DD0D87CD8F22D14BD3CF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_BEF9DC3DCD8D0F1346EE8F22D14B01D8" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_6DB6376DA140DD0D87CD8F22D14BD3CF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails2" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_E56A52CD674B0B5359448F96E2FCCBEA" xlink:type="locator" />
    <link:loc xlink:href="ango-20180531.xsd#ango_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:label="loc_ango_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_33526E1C2D65D84360C28F96E2FC8B6A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_E56A52CD674B0B5359448F96E2FCCBEA" xlink:to="loc_ango_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_33526E1C2D65D84360C28F96E2FC8B6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_08756C5DCCF817FF100A8F96E2FD9DF7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_33526E1C2D65D84360C28F96E2FC8B6A" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_08756C5DCCF817FF100A8F96E2FD9DF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_F5F9318974088A6201A38F96E2FD0177" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_08756C5DCCF817FF100A8F96E2FD9DF7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_F5F9318974088A6201A38F96E2FD0177" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration" xlink:label="loc_ango_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration_B97524F871CB8C114ACC8F9EC38C5C72" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_08756C5DCCF817FF100A8F96E2FD9DF7" xlink:to="loc_ango_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration_B97524F871CB8C114ACC8F9EC38C5C72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_56D1DD691012EDCBF6BD8F96E2FD8E71" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_08756C5DCCF817FF100A8F96E2FD9DF7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_56D1DD691012EDCBF6BD8F96E2FD8E71" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_5464F1ABD2F70E4750328F96E2FE6ECA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_08756C5DCCF817FF100A8F96E2FD9DF7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements_5464F1ABD2F70E4750328F96E2FE6ECA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1905C4FE322394EA7F2F8F96E2FE9EFA" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_08756C5DCCF817FF100A8F96E2FD9DF7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_1905C4FE322394EA7F2F8F96E2FE9EFA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_297F80B43779DA37C6AD8F96E2FE6D55" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_08756C5DCCF817FF100A8F96E2FD9DF7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_297F80B43779DA37C6AD8F96E2FE6D55" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_9B7EE09209C33CA465FE8F96E2FE0046" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_08756C5DCCF817FF100A8F96E2FD9DF7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_9B7EE09209C33CA465FE8F96E2FE0046" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8B7B8BE6AAE63A4EC2528F96E2FE7B9C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_33526E1C2D65D84360C28F96E2FC8B6A" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8B7B8BE6AAE63A4EC2528F96E2FE7B9C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_502897FD16A16DF76F958F96E2FFF5B6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8B7B8BE6AAE63A4EC2528F96E2FE7B9C" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_502897FD16A16DF76F958F96E2FFF5B6" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings" xlink:label="loc_ango_FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings_1F110B23D9972C69E6F38F96E2FF1FDB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8B7B8BE6AAE63A4EC2528F96E2FE7B9C" xlink:to="loc_ango_FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings_1F110B23D9972C69E6F38F96E2FF1FDB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_3AF4C533AEB054B0DD3C8FAB661C1D16" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8B7B8BE6AAE63A4EC2528F96E2FE7B9C" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_3AF4C533AEB054B0DD3C8FAB661C1D16" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_B5F0B7054132221CA2018F96E2FFA4F8" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8B7B8BE6AAE63A4EC2528F96E2FE7B9C" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_B5F0B7054132221CA2018F96E2FFA4F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_6A0F381B7674E40E27EA8F96E3007969" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8B7B8BE6AAE63A4EC2528F96E2FE7B9C" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_6A0F381B7674E40E27EA8F96E3007969" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_145AF87C1615769BEE4E8F96E3006BC1" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8B7B8BE6AAE63A4EC2528F96E2FE7B9C" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet_145AF87C1615769BEE4E8F96E3006BC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6FBF5819AAEE6B97BF938F96E300F98E" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8B7B8BE6AAE63A4EC2528F96E2FE7B9C" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6FBF5819AAEE6B97BF938F96E300F98E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails3" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9B3C1702693E4B0BEF1A8F96E2E09434" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9B3C1702693E4B0BEF1A8F96E2E09434" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_647D6B1F75B1427F8E338F96E2E1136E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_647D6B1F75B1427F8E338F96E2E1136E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_D5EFE218247D4B6173B58F96E2E2F1AE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_647D6B1F75B1427F8E338F96E2E1136E" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_D5EFE218247D4B6173B58F96E2E2F1AE" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_DiscontinuedInvestmentinTiLoProductMember" xlink:label="loc_ango_DiscontinuedInvestmentinTiLoProductMember_A9428397F7132C5310CD8F96E2E24FD2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_D5EFE218247D4B6173B58F96E2E2F1AE" xlink:to="loc_ango_DiscontinuedInvestmentinTiLoProductMember_A9428397F7132C5310CD8F96E2E24FD2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupClassificationAxis" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_A8FCF2A1A45691CEB56F8F96E2E2E5D5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_A8FCF2A1A45691CEB56F8F96E2E2E5D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupClassificationDomain" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_FA69CA0FFD83DD117A298F96E2E31293" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_A8FCF2A1A45691CEB56F8F96E2E2E5D5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_FA69CA0FFD83DD117A298F96E2E31293" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember" xlink:label="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_B8BA6F7685D22C096A968F96E2E39D4A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_FA69CA0FFD83DD117A298F96E2E31293" xlink:to="loc_us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember_B8BA6F7685D22C096A968F96E2E39D4A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6A6C2AAB31EA4A7204568F96E2E308B1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6A6C2AAB31EA4A7204568F96E2E308B1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5B726547806D526554938F96E2E40544" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6A6C2AAB31EA4A7204568F96E2E308B1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5B726547806D526554938F96E2E40544" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_70AFF8FCF3E1D6D49B848F96E2E4F032" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5B726547806D526554938F96E2E40544" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_70AFF8FCF3E1D6D49B848F96E2E4F032" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_00AD8F105F1E173F5FC98F96E2E02E0C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_00AD8F105F1E173F5FC98F96E2E02E0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3770291B037E673AB1128F96E2E1DCC1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_00AD8F105F1E173F5FC98F96E2E02E0C" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3770291B037E673AB1128F96E2E1DCC1" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AngioVacProductMember" xlink:label="loc_ango_AngioVacProductMember_B3AE2D0444919E9997508F96E2E12980" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3770291B037E673AB1128F96E2E1DCC1" xlink:to="loc_ango_AngioVacProductMember_B3AE2D0444919E9997508F96E2E12980" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaap_ValuationTechniqueAxis_AF8A41A82EF80DA0A4498F96E2E45FA3" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_us-gaap_ValuationTechniqueAxis_AF8A41A82EF80DA0A4498F96E2E45FA3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaap_ValuationTechniqueDomain_11B101C358F68C4447BB8F96E2E49B81" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_AF8A41A82EF80DA0A4498F96E2E45FA3" xlink:to="loc_us-gaap_ValuationTechniqueDomain_11B101C358F68C4447BB8F96E2E49B81" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_RevenueBasedPaymentMember" xlink:label="loc_ango_RevenueBasedPaymentMember_520CFAC5C5F022C238EC8F96E2E5C7D9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_11B101C358F68C4447BB8F96E2E49B81" xlink:to="loc_ango_RevenueBasedPaymentMember_520CFAC5C5F022C238EC8F96E2E5C7D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_E781F8B153B67DCC9E388F96E2E5444D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_E781F8B153B67DCC9E388F96E2E5444D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_717D3D04FD51A3AD21C88F96E2E59A99" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_E781F8B153B67DCC9E388F96E2E5444D" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_717D3D04FD51A3AD21C88F96E2E59A99" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_EB994D6C9A2189B617DB8F96E2E66572" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_717D3D04FD51A3AD21C88F96E2E59A99" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_EB994D6C9A2189B617DB8F96E2E66572" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_F6CE53F36E51EFC90C838F96E2E63948" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_srt_RangeAxis_F6CE53F36E51EFC90C838F96E2E63948" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_9A57D7D54EC65176EEB98F96E2E6733F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_F6CE53F36E51EFC90C838F96E2E63948" xlink:to="loc_srt_RangeMember_9A57D7D54EC65176EEB98F96E2E6733F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_55AD73E017AF05DFCFB88F96E2E7190B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9A57D7D54EC65176EEB98F96E2E6733F" xlink:to="loc_srt_MaximumMember_55AD73E017AF05DFCFB88F96E2E7190B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0ADDAFE06B5F346C550B8F96E2E7DFA2" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0ADDAFE06B5F346C550B8F96E2E7DFA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_84539F353F60402AAF108F96E2E702FA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0ADDAFE06B5F346C550B8F96E2E7DFA2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_84539F353F60402AAF108F96E2E702FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_DF116CA5EF98231A44548F96E2E848A8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_84539F353F60402AAF108F96E2E702FA" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_DF116CA5EF98231A44548F96E2E848A8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_F2D6F2CC9594AE6CA7308F96E2EE6880" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_F2D6F2CC9594AE6CA7308F96E2EE6880" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_D6B1DBEBFF1879B93A148F96E2EE7682" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_F2D6F2CC9594AE6CA7308F96E2EE6880" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_D6B1DBEBFF1879B93A148F96E2EE7682" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_75714E7FF8F01F0FEE6F8F96E2EF2D34" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_D6B1DBEBFF1879B93A148F96E2EE7682" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_75714E7FF8F01F0FEE6F8F96E2EF2D34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_F16FA6EC16DAA5E8596E8F96E2E89FB2" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_us-gaap_FinancialInstrumentAxis_F16FA6EC16DAA5E8596E8F96E2E89FB2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_EFEA3A432E2A22D5C7FD8F96E2E87F81" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_F16FA6EC16DAA5E8596E8F96E2E89FB2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_EFEA3A432E2A22D5C7FD8F96E2E87F81" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ContingentConsiderationEarnOutLiabilityMember" xlink:label="loc_ango_ContingentConsiderationEarnOutLiabilityMember_2E7752E2A489FA5509768F96E2E84C50" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_EFEA3A432E2A22D5C7FD8F96E2E87F81" xlink:to="loc_ango_ContingentConsiderationEarnOutLiabilityMember_2E7752E2A489FA5509768F96E2E84C50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0E9BA51384B1F192BF268F96E2EFAE36" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_E9445034E9A67FBFA6578F96E2E0B63C" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0E9BA51384B1F192BF268F96E2EFAE36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_BFD7B17CE2F9DD4691CC8F96E2EF586E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0E9BA51384B1F192BF268F96E2EFAE36" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_BFD7B17CE2F9DD4691CC8F96E2EF586E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_7D87655589BC6575023E8F96E2F07BD0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0E9BA51384B1F192BF268F96E2EFAE36" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_7D87655589BC6575023E8F96E2F07BD0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_AAF0BC5E9B2F90CEE1BF8F96E2F018B0" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0E9BA51384B1F192BF268F96E2EFAE36" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_AAF0BC5E9B2F90CEE1BF8F96E2F018B0" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_UndiscountedContingentConsiderationFairValueFairValueDisclosure" xlink:label="loc_ango_UndiscountedContingentConsiderationFairValueFairValueDisclosure_19BB6020D566E3E6678B8F96E2F080D5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0E9BA51384B1F192BF268F96E2EFAE36" xlink:to="loc_ango_UndiscountedContingentConsiderationFairValueFairValueDisclosure_19BB6020D566E3E6678B8F96E2F080D5" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract" xlink:label="loc_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract_95A629AA3585BA4D6B308F96E2F04768" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0E9BA51384B1F192BF268F96E2EFAE36" xlink:to="loc_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract_95A629AA3585BA4D6B308F96E2F04768" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_E03CFB62B2AB357F09FD8F96E2EFD510" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract_95A629AA3585BA4D6B308F96E2F04768" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_E03CFB62B2AB357F09FD8F96E2EFD510" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_700A3E66D930109D36138F96E2F03258" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract_95A629AA3585BA4D6B308F96E2F04768" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_700A3E66D930109D36138F96E2F03258" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_FairValueInputsProbabilityOfPayment" xlink:label="loc_ango_FairValueInputsProbabilityOfPayment_94A8284046EC8CED96B58F96E2F1A761" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract_95A629AA3585BA4D6B308F96E2F04768" xlink:to="loc_ango_FairValueInputsProbabilityOfPayment_94A8284046EC8CED96B58F96E2F1A761" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9D2F3C3C39730B82FEC68C8B9BE72A09" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_65AF9D98C99D71C6E7AE8C8B9BE79ECD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9D2F3C3C39730B82FEC68C8B9BE72A09" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_65AF9D98C99D71C6E7AE8C8B9BE79ECD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_22271D9F10B1C8F87B478C8B9BE7150E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9D2F3C3C39730B82FEC68C8B9BE72A09" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_22271D9F10B1C8F87B478C8B9BE7150E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_01DAA424F8E709C5D1528C8B9BE72910" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9D2F3C3C39730B82FEC68C8B9BE72A09" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_01DAA424F8E709C5D1528C8B9BE72910" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_F60379595D5AF0E18B748C8B9A5FAF49" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_0EA8D5D60BC90181DC7D8C8B9A5FC40C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_F60379595D5AF0E18B748C8B9A5FAF49" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_0EA8D5D60BC90181DC7D8C8B9A5FC40C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetails1" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8A487E8EBACB65CA42608F96E23FD11E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3322CD6BB543197372D88F96E23FA872" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8A487E8EBACB65CA42608F96E23FD11E" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3322CD6BB543197372D88F96E23FA872" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_C4139B887D52893A904D8FDA66CD694B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3322CD6BB543197372D88F96E23FA872" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_C4139B887D52893A904D8FDA66CD694B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ECAA01D9E4E6394B53F28FDA66CF11D9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_C4139B887D52893A904D8FDA66CD694B" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ECAA01D9E4E6394B53F28FDA66CF11D9" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ProductTechnologiesMember" xlink:label="loc_ango_ProductTechnologiesMember_21B7484EFE3768C65D5E8FDA66ECB9AC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ECAA01D9E4E6394B53F28FDA66CF11D9" xlink:to="loc_ango_ProductTechnologiesMember_21B7484EFE3768C65D5E8FDA66ECB9AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3767D9A786ADC9089EDD8FDA66F83CAE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ECAA01D9E4E6394B53F28FDA66CF11D9" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3767D9A786ADC9089EDD8FDA66F83CAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaap_TrademarksMember_5E98E0704ECA994363AC8FDA67057974" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ECAA01D9E4E6394B53F28FDA66CF11D9" xlink:to="loc_us-gaap_TrademarksMember_5E98E0704ECA994363AC8FDA67057974" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LicenseAgreementTermsMember" xlink:label="loc_us-gaap_LicenseAgreementTermsMember_F4764064E39F6E12FA1D8FDA671284CE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ECAA01D9E4E6394B53F28FDA66CF11D9" xlink:to="loc_us-gaap_LicenseAgreementTermsMember_F4764064E39F6E12FA1D8FDA671284CE" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_DistributorRelationshipsMember" xlink:label="loc_ango_DistributorRelationshipsMember_44D4ABBC51B0B0606DFC8FDA6720308E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ECAA01D9E4E6394B53F28FDA66CF11D9" xlink:to="loc_ango_DistributorRelationshipsMember_44D4ABBC51B0B0606DFC8FDA6720308E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0B9C582B9D39376519828F96E2425B19" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_3322CD6BB543197372D88F96E23FA872" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0B9C582B9D39376519828F96E2425B19" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_08F0F287C237BAA06A998F96E243E21A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0B9C582B9D39376519828F96E2425B19" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_08F0F287C237BAA06A998F96E243E21A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8E1AFE750542BCAB1D348F96E243DADC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0B9C582B9D39376519828F96E2425B19" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8E1AFE750542BCAB1D348F96E243DADC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_F4F8EF69173EC00542248F96E2436F07" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_0B9C582B9D39376519828F96E2425B19" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_F4F8EF69173EC00542248F96E2436F07" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetails2" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_892A6C687B0A2A24310D8F96E2299B6A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_81D7ADA68B3762B6A4F98F96E22A1578" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_892A6C687B0A2A24310D8F96E2299B6A" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_81D7ADA68B3762B6A4F98F96E22A1578" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2CA1576D94B2D871F3E38F96E22A4A1C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_81D7ADA68B3762B6A4F98F96E22A1578" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_2CA1576D94B2D871F3E38F96E22A4A1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_DF92EA3F917D6FDDA1E68F96E22A5FB5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_81D7ADA68B3762B6A4F98F96E22A1578" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_DF92EA3F917D6FDDA1E68F96E22A5FB5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_D1DB329DED02A938B88E8F96E22BEE3D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_81D7ADA68B3762B6A4F98F96E22A1578" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_D1DB329DED02A938B88E8F96E22BEE3D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_CF7879D73876C3F92FEF8F96E22B486F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_81D7ADA68B3762B6A4F98F96E22A1578" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_CF7879D73876C3F92FEF8F96E22B486F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_50B404BFA3B83C22BBB08F96E22B6BAD" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_81D7ADA68B3762B6A4F98F96E22A1578" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_50B404BFA3B83C22BBB08F96E22B6BAD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_C0D36D0AC9C0F24289FC8F96E22B3F93" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_81D7ADA68B3762B6A4F98F96E22A1578" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_C0D36D0AC9C0F24289FC8F96E22B3F93" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_206328B7D4DC814FBA5C8F96E22B9FCD" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_81D7ADA68B3762B6A4F98F96E22A1578" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_206328B7D4DC814FBA5C8F96E22B9FCD" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetailsTextual" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7E34A427A3AAFD149C098F96E24F2635" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_E2B9B8798C560ED459998F96E24FC5B6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7E34A427A3AAFD149C098F96E24F2635" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_E2B9B8798C560ED459998F96E24FC5B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_C2BF2CE051BD0E06266A8F96E250D18D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_E2B9B8798C560ED459998F96E24FC5B6" xlink:to="loc_srt_RangeAxis_C2BF2CE051BD0E06266A8F96E250D18D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_9849960FFD88F15369E18F96E2504FC5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_C2BF2CE051BD0E06266A8F96E250D18D" xlink:to="loc_srt_RangeMember_9849960FFD88F15369E18F96E2504FC5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_8C723D1E52296EA6F0888F96E250D644" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9849960FFD88F15369E18F96E2504FC5" xlink:to="loc_srt_MinimumMember_8C723D1E52296EA6F0888F96E250D644" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_CDFE5BAEFDA64CF1867F8F96E251514E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9849960FFD88F15369E18F96E2504FC5" xlink:to="loc_srt_MaximumMember_CDFE5BAEFDA64CF1867F8F96E251514E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_D66E1937E77583F7121D8F96E251EB7B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_E2B9B8798C560ED459998F96E24FC5B6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_D66E1937E77583F7121D8F96E251EB7B" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_GoodwillAndIntangibleAssetsTextualAbstract" xlink:label="loc_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_D66E1937E77583F7121D8F96E251EB7B" xlink:to="loc_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_AF824F218AEDEDED2B898F96E2523DD6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4" xlink:to="loc_us-gaap_NumberOfReportableSegments_AF824F218AEDEDED2B898F96E2523DD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_891DC580AF2E8CCA85F28F96E252B996" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_891DC580AF2E8CCA85F28F96E252B996" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_0CC6AAF8D58A712921988F96E2525D40" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_0CC6AAF8D58A712921988F96E2525D40" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9208FEA134DECF6F2AA58F96E2531795" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_GoodwillAndIntangibleAssetsTextualAbstract_414580EE86BE1C3FC17D8F96E25173F4" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9208FEA134DECF6F2AA58F96E2531795" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_818F03362F242AB0A04F8C8B9AEB604A" xlink:type="locator" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ScheduleOfIntangibleAssetsTableTextBlock" xlink:label="loc_ango_ScheduleOfIntangibleAssetsTableTextBlock_DEDFAD2806E08E7794C78C8B9AEB8CBE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_818F03362F242AB0A04F8C8B9AEB604A" xlink:to="loc_ango_ScheduleOfIntangibleAssetsTableTextBlock_DEDFAD2806E08E7794C78C8B9AEB8CBE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_7D9BAB5E0746B9D2A5068C8B9AEB6870" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_818F03362F242AB0A04F8C8B9AEB604A" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_7D9BAB5E0746B9D2A5068C8B9AEB6870" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_75D735BE014DF47BBBC28C8B9A7EC977" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_F3AE4C11CDAF4ACF34008C8B9A7E715D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_75D735BE014DF47BBBC28C8B9A7EC977" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_F3AE4C11CDAF4ACF34008C8B9A7E715D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2BA9538A40842C95DD53B4179032E753" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1E5CB1A869E18A2CF675B4179032CD30" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2BA9538A40842C95DD53B4179032E753" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1E5CB1A869E18A2CF675B4179032CD30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_98CC2B058D9B4E846407B4179032BBC6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1E5CB1A869E18A2CF675B4179032CD30" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_98CC2B058D9B4E846407B4179032BBC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0C8241FAA17C17812013B4179032AA2D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1E5CB1A869E18A2CF675B4179032CD30" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0C8241FAA17C17812013B4179032AA2D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_F69A3AEC6009B4833913B4179032DD01" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract_1E5CB1A869E18A2CF675B4179032CD30" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_F69A3AEC6009B4833913B4179032DD01" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesDetails2" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3562428B70174708EE13A3DC1B0F2335" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_8FBEFAC3EE1F4DFE3CB6A3DC1B0F17D8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3562428B70174708EE13A3DC1B0F2335" xlink:to="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_8FBEFAC3EE1F4DFE3CB6A3DC1B0F17D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_DFFC512D20DE1C7A65C4A3DC1B0F1AFA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_8FBEFAC3EE1F4DFE3CB6A3DC1B0F17D8" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_DFFC512D20DE1C7A65C4A3DC1B0F1AFA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_3E0A1950D08D33B22918A3DC1B0F903E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_DFFC512D20DE1C7A65C4A3DC1B0F1AFA" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_3E0A1950D08D33B22918A3DC1B0F903E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_C44480FE539E5BB143D4A3DC1B0FF67F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_DFFC512D20DE1C7A65C4A3DC1B0F1AFA" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_C44480FE539E5BB143D4A3DC1B0FF67F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_B9D0BDF0DC3C32DC3E95A3DC1B0F20C8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_DFFC512D20DE1C7A65C4A3DC1B0F1AFA" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_B9D0BDF0DC3C32DC3E95A3DC1B0F20C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_F221AC436466D2DF90A8A3DC1B0FF60B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_DFFC512D20DE1C7A65C4A3DC1B0F1AFA" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_F221AC436466D2DF90A8A3DC1B0FF60B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4E095BA62218FFA57D90A3DC1B0FCAC4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_8FBEFAC3EE1F4DFE3CB6A3DC1B0F17D8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4E095BA62218FFA57D90A3DC1B0FCAC4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0711ABF430F364C0F368A3DC1B0FF235" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_8FBEFAC3EE1F4DFE3CB6A3DC1B0F17D8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0711ABF430F364C0F368A3DC1B0FF235" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesDetails3" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5960CB00C2ED0E7F9453B82FBBE9701C" xlink:type="locator" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ScheduleofIncomeTaxTable" xlink:label="loc_ango_ScheduleofIncomeTaxTable_5B45A446B1C74FF93699B82FBBEC9F22" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5960CB00C2ED0E7F9453B82FBBE9701C" xlink:to="loc_ango_ScheduleofIncomeTaxTable_5B45A446B1C74FF93699B82FBBEC9F22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_7560DA31215159BFCBBCB82FBBEDD1BA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_ScheduleofIncomeTaxTable_5B45A446B1C74FF93699B82FBBEC9F22" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_7560DA31215159BFCBBCB82FBBEDD1BA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_1E2043B87DFB2195E479B82FBBED7F0F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_7560DA31215159BFCBBCB82FBBEDD1BA" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_1E2043B87DFB2195E479B82FBBED7F0F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ForeignCountryMember" xlink:label="loc_us-gaap_ForeignCountryMember_1C683F6206D6A065AAB7B82FBBEEC11B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_1E2043B87DFB2195E479B82FBBED7F0F" xlink:to="loc_us-gaap_ForeignCountryMember_1C683F6206D6A065AAB7B82FBBEEC11B" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ScheduleofIncomeTaxLineItems" xlink:label="loc_ango_ScheduleofIncomeTaxLineItems_26D0B111A2B7C0601784B82FBBEE25A7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_ScheduleofIncomeTaxTable_5B45A446B1C74FF93699B82FBBEC9F22" xlink:to="loc_ango_ScheduleofIncomeTaxLineItems_26D0B111A2B7C0601784B82FBBEE25A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_5F2331F0719988054220B82FBBEEF081" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_ScheduleofIncomeTaxLineItems_26D0B111A2B7C0601784B82FBBEE25A7" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_5F2331F0719988054220B82FBBEEF081" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5F2331F0719988054220B82FBBEEF081" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_95217B647F42B6FCF580B82FBBEFD76F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_95217B647F42B6FCF580B82FBBEFD76F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0804B9D4F46453C8C3B1B82FBBF1F48D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0804B9D4F46453C8C3B1B82FBBF1F48D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_0EA7725A892AA06171F5B82FBBF12BDC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_0EA7725A892AA06171F5B82FBBF12BDC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_E4818BB632E238CD180BB82FBBF2119C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_E4818BB632E238CD180BB82FBBF2119C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_FD6B95589132DD70BEC6B82FBBF2F92F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_FD6B95589132DD70BEC6B82FBBF2F92F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_357EED0FC5824503385EB82FBBF2B9DB" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_357EED0FC5824503385EB82FBBF2B9DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_6659C47F16EFE8968588B830C95F7C17" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_68730635EE2DAEB570D2B82FBBEF1459" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_6659C47F16EFE8968588B830C95F7C17" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_F2F9D5914254466B5BDFB82FBBF2AFCE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5F2331F0719988054220B82FBBEEF081" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_F2F9D5914254466B5BDFB82FBBF2AFCE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_E4A1C1F18C8B2AF7CF9EB82FBBF2ED21" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_F2F9D5914254466B5BDFB82FBBF2AFCE" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_E4A1C1F18C8B2AF7CF9EB82FBBF2ED21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_0C8EDCA718FD92BC4EE7B82FBBF34EFE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_F2F9D5914254466B5BDFB82FBBF2AFCE" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_0C8EDCA718FD92BC4EE7B82FBBF34EFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7A88E6FB65D8552C5689B82FBBF3C3DB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5F2331F0719988054220B82FBBEEF081" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7A88E6FB65D8552C5689B82FBBF3C3DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaap_DeferredTaxLiabilities_39830613E18FCA643828B82FBBF35C4C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_5F2331F0719988054220B82FBBEEF081" xlink:to="loc_us-gaap_DeferredTaxLiabilities_39830613E18FCA643828B82FBBF35C4C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesDetails4" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5AB497D51BE12AEED755B305C35FF15A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5AB497D51BE12AEED755B305C35FF15A" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_FD1D37188E96FAAFB720B305C35FEE5F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_FD1D37188E96FAAFB720B305C35FEE5F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_F02FAA17CC69CF7F865EB305C36025A9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_F02FAA17CC69CF7F865EB305C36025A9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_AE0BF4ED4DB0EA8728CAB305C360B9FB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_AE0BF4ED4DB0EA8728CAB305C360B9FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_57F611731ABAA0709E51B305C3600C38" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_57F611731ABAA0709E51B305C3600C38" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_IncomeTaxReconciliationEffectOfForeignOperations" xlink:label="loc_ango_IncomeTaxReconciliationEffectOfForeignOperations_02DAC4ADD48082E5ED5DB305C360E1A4" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:to="loc_ango_IncomeTaxReconciliationEffectOfForeignOperations_02DAC4ADD48082E5ED5DB305C360E1A4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_D608133D38FDF34867DBB305C360867A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_D608133D38FDF34867DBB305C360867A" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount" xlink:label="loc_ango_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_D750CDEEB8CBA3746A5FB305C360FE1C" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:to="loc_ango_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount_D750CDEEB8CBA3746A5FB305C360FE1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_F7C2323FB99D72812604B305C3613263" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_F7C2323FB99D72812604B305C3613263" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_IncomeTaxReconciliationNondeductibleInterestOnContingentPayment" xlink:label="loc_ango_IncomeTaxReconciliationNondeductibleInterestOnContingentPayment_3DA334502D97BF5867C0B305C36158DD" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:to="loc_ango_IncomeTaxReconciliationNondeductibleInterestOnContingentPayment_3DA334502D97BF5867C0B305C36158DD" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability" xlink:label="loc_ango_IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability_4713BBA92EA7B161E69DB305C36147B0" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:to="loc_ango_IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability_4713BBA92EA7B161E69DB305C36147B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_3B3C93D14CCF5F9AD2EEB305C361ED2D" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_3B3C93D14CCF5F9AD2EEB305C361ED2D" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_IncomeTaxReconciliationEffectofEliminationofASC718APICPool" xlink:label="loc_ango_IncomeTaxReconciliationEffectofEliminationofASC718APICPool_2974383BBC25439CBA08B305C3617D26" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:to="loc_ango_IncomeTaxReconciliationEffectofEliminationofASC718APICPool_2974383BBC25439CBA08B305C3617D26" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_AF76CACDE10D0D726C13B305C36286B8" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_AF76CACDE10D0D726C13B305C36286B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_EF0850D6014FE6682921B305C36230D9" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_EF0850D6014FE6682921B305C36230D9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_FD78F39A8516079A9FDEB305C36209B0" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_994F30DBAA22A318EBCAB305C35FCEA8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_FD78F39A8516079A9FDEB305C36209B0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesDetailsTextual" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_A7DD682A156A0260CAA9B466A275CE48" xlink:type="locator" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ScheduleofIncomeTaxTable" xlink:label="loc_ango_ScheduleofIncomeTaxTable_C99EC36A42EFADBB5771B466A275A6C7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_A7DD682A156A0260CAA9B466A275CE48" xlink:to="loc_ango_ScheduleofIncomeTaxTable_C99EC36A42EFADBB5771B466A275A6C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxPeriodAxis" xlink:label="loc_us-gaap_TaxPeriodAxis_CABF1B9931344E075AE3B466A27552E4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_ScheduleofIncomeTaxTable_C99EC36A42EFADBB5771B466A275A6C7" xlink:to="loc_us-gaap_TaxPeriodAxis_CABF1B9931344E075AE3B466A27552E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TaxPeriodDomain" xlink:label="loc_us-gaap_TaxPeriodDomain_65981571EE212AE3284AB466A2753F2F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_CABF1B9931344E075AE3B466A27552E4" xlink:to="loc_us-gaap_TaxPeriodDomain_65981571EE212AE3284AB466A2753F2F" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_TaxPeriodOneMember" xlink:label="loc_ango_TaxPeriodOneMember_ECA715C52C175BF935BBB466A276FA61" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_65981571EE212AE3284AB466A2753F2F" xlink:to="loc_ango_TaxPeriodOneMember_ECA715C52C175BF935BBB466A276FA61" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_TaxPeriodTwoMember" xlink:label="loc_ango_TaxPeriodTwoMember_6D3C2D2F99B308076169B466A2761F56" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_65981571EE212AE3284AB466A2753F2F" xlink:to="loc_ango_TaxPeriodTwoMember_6D3C2D2F99B308076169B466A2761F56" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_TaxPeriodThreeMember" xlink:label="loc_ango_TaxPeriodThreeMember_F37D98D67A718064BDCAB466A276AFCB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_65981571EE212AE3284AB466A2753F2F" xlink:to="loc_ango_TaxPeriodThreeMember_F37D98D67A718064BDCAB466A276AFCB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_85AB03440940E65C6011B466A276B079" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_ScheduleofIncomeTaxTable_C99EC36A42EFADBB5771B466A275A6C7" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_85AB03440940E65C6011B466A276B079" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_785C29F032A0E6250D6FB466A2774B97" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_85AB03440940E65C6011B466A276B079" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_785C29F032A0E6250D6FB466A2774B97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaap_DomesticCountryMember_32EF58E2685502B97208B466A277AB2F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_785C29F032A0E6250D6FB466A2774B97" xlink:to="loc_us-gaap_DomesticCountryMember_32EF58E2685502B97208B466A277AB2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_C648E05A1F22D1010D4DB466A277AA8C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_785C29F032A0E6250D6FB466A2774B97" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_C648E05A1F22D1010D4DB466A277AA8C" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ScheduleofIncomeTaxLineItems" xlink:label="loc_ango_ScheduleofIncomeTaxLineItems_624DF44F0E8634F5CF92B47ACF11D287" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_ScheduleofIncomeTaxTable_C99EC36A42EFADBB5771B466A275A6C7" xlink:to="loc_ango_ScheduleofIncomeTaxLineItems_624DF44F0E8634F5CF92B47ACF11D287" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_IncomeTaxesTextualAbstract" xlink:label="loc_ango_IncomeTaxesTextualAbstract_BDC8BB5C102D93FCEFD2B466A2772D78" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_ScheduleofIncomeTaxLineItems_624DF44F0E8634F5CF92B47ACF11D287" xlink:to="loc_ango_IncomeTaxesTextualAbstract_BDC8BB5C102D93FCEFD2B466A2772D78" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit" xlink:label="loc_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit_91C162D840DF14BD5D50B466A278C44B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_IncomeTaxesTextualAbstract_BDC8BB5C102D93FCEFD2B466A2772D78" xlink:to="loc_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit_91C162D840DF14BD5D50B466A278C44B" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse" xlink:label="loc_ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse_47513A10D7A47ECD71E8B466A278F65A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_IncomeTaxesTextualAbstract_BDC8BB5C102D93FCEFD2B466A2772D78" xlink:to="loc_ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse_47513A10D7A47ECD71E8B466A278F65A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaap_OperatingLossCarryforwards_7A97EEDF5A1575CFB5D1B466A2786AED" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_IncomeTaxesTextualAbstract_BDC8BB5C102D93FCEFD2B466A2772D78" xlink:to="loc_us-gaap_OperatingLossCarryforwards_7A97EEDF5A1575CFB5D1B466A2786AED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2311A438041B1F4DBCC4B466A278FAFF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_IncomeTaxesTextualAbstract_BDC8BB5C102D93FCEFD2B466A2772D78" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2311A438041B1F4DBCC4B466A278FAFF" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit" xlink:label="loc_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit_DE45F6C885B0E0AB1E0AB466A27803D5" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_IncomeTaxesTextualAbstract_BDC8BB5C102D93FCEFD2B466A2772D78" xlink:to="loc_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit_DE45F6C885B0E0AB1E0AB466A27803D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_BDEF9023BB323DBDD700B466A27916FB" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_IncomeTaxesTextualAbstract_BDC8BB5C102D93FCEFD2B466A2772D78" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_BDEF9023BB323DBDD700B466A27916FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:label="loc_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_FF1D91B39FC15F0256C7B466A2791569" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_IncomeTaxesTextualAbstract_BDC8BB5C102D93FCEFD2B466A2772D78" xlink:to="loc_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_FF1D91B39FC15F0256C7B466A2791569" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_5D4A4DD4FB1B7107850CB466A27916C2" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_IncomeTaxesTextualAbstract_BDC8BB5C102D93FCEFD2B466A2772D78" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_5D4A4DD4FB1B7107850CB466A27916C2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesIncomeTaxesDetails5" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_13351CB017468B2C035FA3DC14A54AEE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32A67722EA40C14610D7A3DC14A5B474" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_13351CB017468B2C035FA3DC14A54AEE" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32A67722EA40C14610D7A3DC14A5B474" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_F9229F40F70F04476457A3DC14A549F8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32A67722EA40C14610D7A3DC14A5B474" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_F9229F40F70F04476457A3DC14A549F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_AA229DDAFB7462F80B18A3DC14A58701" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32A67722EA40C14610D7A3DC14A5B474" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_AA229DDAFB7462F80B18A3DC14A58701" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_42BA1D35A13EB9E03279A4399E0A4E0B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32A67722EA40C14610D7A3DC14A5B474" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_42BA1D35A13EB9E03279A4399E0A4E0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_EA7016CC6F128260C25BA3DC14AAED8F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32A67722EA40C14610D7A3DC14A5B474" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_EA7016CC6F128260C25BA3DC14AAED8F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_FE9008DD7F355543A7D2A3DC14AAB47B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_32A67722EA40C14610D7A3DC14A5B474" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_FE9008DD7F355543A7D2A3DC14AAB47B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_F431FC016802DFF008B5A3D9E4E7C72F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_B632CCB958C8F26F5740A3D9E4E7505C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_F431FC016802DFF008B5A3D9E4E7C72F" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_B632CCB958C8F26F5740A3D9E4E7505C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_292EADAA6F6F9A46CAD7A3D9E4E724E2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_F431FC016802DFF008B5A3D9E4E7C72F" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_292EADAA6F6F9A46CAD7A3D9E4E724E2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_A8D05896CC665883FB8AA3D9E4E70576" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_F431FC016802DFF008B5A3D9E4E7C72F" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_A8D05896CC665883FB8AA3D9E4E70576" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_D2756B0ACDB766C2606EA3D9E4E7255E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_F431FC016802DFF008B5A3D9E4E7C72F" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_D2756B0ACDB766C2606EA3D9E4E7255E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_83825BA01BD1A057DA1BA3DCA48A8F79" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_F431FC016802DFF008B5A3D9E4E7C72F" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_83825BA01BD1A057DA1BA3DCA48A8F79" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_7D2066EEEC420158A2408F96E2AC1A12" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_BD1DA484922E65EE96668F96E2ACD864" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_7D2066EEEC420158A2408F96E2AC1A12" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_BD1DA484922E65EE96668F96E2ACD864" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_D691C6C0CD4760EE7D6E8F96E29E0D0B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNetAbstract" xlink:label="loc_us-gaap_InventoryNetAbstract_DD7888BE9A058B2230C58F96E29FAC66" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_D691C6C0CD4760EE7D6E8F96E29E0D0B" xlink:to="loc_us-gaap_InventoryNetAbstract_DD7888BE9A058B2230C58F96E29FAC66" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaap_InventoryRawMaterials_2F2F4D1CAA915EDA6A718F96E29F8A96" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_DD7888BE9A058B2230C58F96E29FAC66" xlink:to="loc_us-gaap_InventoryRawMaterials_2F2F4D1CAA915EDA6A718F96E29F8A96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaap_InventoryWorkInProcess_A14012B56F77B6F34BD28F96E29F513B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_DD7888BE9A058B2230C58F96E29FAC66" xlink:to="loc_us-gaap_InventoryWorkInProcess_A14012B56F77B6F34BD28F96E29F513B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaap_InventoryFinishedGoods_5D73E7D467286DD942E48F96E29F4547" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_DD7888BE9A058B2230C58F96E29FAC66" xlink:to="loc_us-gaap_InventoryFinishedGoods_5D73E7D467286DD942E48F96E29F4547" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_C5594FBB2BC50F1F72558F96E2A0CF0A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_DD7888BE9A058B2230C58F96E29FAC66" xlink:to="loc_us-gaap_InventoryNet_C5594FBB2BC50F1F72558F96E2A0CF0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaap_InventoryValuationReserves_3C754D10BF17E33374D28F96E2A0E539" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_DD7888BE9A058B2230C58F96E29FAC66" xlink:to="loc_us-gaap_InventoryValuationReserves_3C754D10BF17E33374D28F96E2A0E539" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryCurrentTable" xlink:label="loc_us-gaap_InventoryCurrentTable_E00279057826009D9D758FC0833460B2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_D691C6C0CD4760EE7D6E8F96E29E0D0B" xlink:to="loc_us-gaap_InventoryCurrentTable_E00279057826009D9D758FC0833460B2" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_InventoryTypeAxis" xlink:label="loc_ango_InventoryTypeAxis_DBED2854E4F3B3C5D2118FC38153BB71" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_E00279057826009D9D758FC0833460B2" xlink:to="loc_ango_InventoryTypeAxis_DBED2854E4F3B3C5D2118FC38153BB71" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_InventoryTypeDomain" xlink:label="loc_ango_InventoryTypeDomain_0E82336477FED56A69078FC38168A954" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_InventoryTypeAxis_DBED2854E4F3B3C5D2118FC38153BB71" xlink:to="loc_ango_InventoryTypeDomain_0E82336477FED56A69078FC38168A954" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AcculisInventoryMember" xlink:label="loc_ango_AcculisInventoryMember_54217A263833431B684E8FC41AA3041E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_InventoryTypeDomain_0E82336477FED56A69078FC38168A954" xlink:to="loc_ango_AcculisInventoryMember_54217A263833431B684E8FC41AA3041E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_5B0BB487E5B0330B24228FC62A2391EE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_E00279057826009D9D758FC0833460B2" xlink:to="loc_srt_CounterpartyNameAxis_5B0BB487E5B0330B24228FC62A2391EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_E02C9E6B7DDB22508DEF8FC69AC26849" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_5B0BB487E5B0330B24228FC62A2391EE" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_E02C9E6B7DDB22508DEF8FC69AC26849" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_UndisclosedInventoryDistributorMember" xlink:label="loc_ango_UndisclosedInventoryDistributorMember_A81C7B616361BCE46D998FC7A34BF1D7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_E02C9E6B7DDB22508DEF8FC69AC26849" xlink:to="loc_ango_UndisclosedInventoryDistributorMember_A81C7B616361BCE46D998FC7A34BF1D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E69B4D863700D67B75318FD9E6CB7F4E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_E00279057826009D9D758FC0833460B2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E69B4D863700D67B75318FD9E6CB7F4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_E69B4D863700D67B75318FD9E6CB7F4E" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ProductTechnologiesMember" xlink:label="loc_ango_ProductTechnologiesMember_F9600E3630085DB2878F8FD9E6CC5B09" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923" xlink:to="loc_ango_ProductTechnologiesMember_F9600E3630085DB2878F8FD9E6CC5B09" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_04F02CDAF3EC5395A5458FD9E6CD24B4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923" xlink:to="loc_us-gaap_CustomerRelationshipsMember_04F02CDAF3EC5395A5458FD9E6CD24B4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaap_TrademarksMember_CDF5C08493C51726436F8FD9E6CD729A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923" xlink:to="loc_us-gaap_TrademarksMember_CDF5C08493C51726436F8FD9E6CD729A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LicenseAgreementTermsMember" xlink:label="loc_us-gaap_LicenseAgreementTermsMember_3458B1762E417930C84D8FD9E6CD5002" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923" xlink:to="loc_us-gaap_LicenseAgreementTermsMember_3458B1762E417930C84D8FD9E6CD5002" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_DistributorRelationshipsMember" xlink:label="loc_ango_DistributorRelationshipsMember_19640D110147879EB1B38FD9E6CDD764" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8E62014CD3E0D0E03B9C8FD9E6CC4923" xlink:to="loc_ango_DistributorRelationshipsMember_19640D110147879EB1B38FD9E6CDD764" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryLineItems" xlink:label="loc_us-gaap_InventoryLineItems_7B06AE4BAD800E3D9CA88FC083347E55" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_E00279057826009D9D758FC0833460B2" xlink:to="loc_us-gaap_InventoryLineItems_7B06AE4BAD800E3D9CA88FC083347E55" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaap_InventoryWriteDown_2CA7AC091FFB81049CB28F96E2A0F612" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_7B06AE4BAD800E3D9CA88FC083347E55" xlink:to="loc_us-gaap_InventoryWriteDown_2CA7AC091FFB81049CB28F96E2A0F612" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_8F36FF450C3F12C5D4498C8B9A013225" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_3FA4DA4771F2BC426E8A8C8B9A018D76" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8F36FF450C3F12C5D4498C8B9A013225" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_3FA4DA4771F2BC426E8A8C8B9A018D76" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_56179D871BB0120335218C8B9D9CE496" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaap_LongTermDebtTextBlock_703FEF15D2B3AF74B3B48C8B9D9CD468" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_56179D871BB0120335218C8B9D9CE496" xlink:to="loc_us-gaap_LongTermDebtTextBlock_703FEF15D2B3AF74B3B48C8B9D9CD468" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/LongTermDebtDetails1" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_83BA7F62378060E314488F96E17F016A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_22929C02D1BB38F3A7008F96E17F1E6A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_83BA7F62378060E314488F96E17F016A" xlink:to="loc_us-gaap_DebtInstrumentTable_22929C02D1BB38F3A7008F96E17F1E6A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_82C1D6811B10107C96AB8F96E1862829" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_22929C02D1BB38F3A7008F96E17F1E6A" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_82C1D6811B10107C96AB8F96E1862829" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_74EEECDFCDA6DC9521FF8F96E1861BA7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_82C1D6811B10107C96AB8F96E1862829" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_74EEECDFCDA6DC9521FF8F96E1861BA7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_90E54799C00A5DDE2E8B8F96E1869AAB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_74EEECDFCDA6DC9521FF8F96E1861BA7" xlink:to="loc_us-gaap_LineOfCreditMember_90E54799C00A5DDE2E8B8F96E1869AAB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_BD5BFECC86A2C73B00148F96E18438D4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_22929C02D1BB38F3A7008F96E17F1E6A" xlink:to="loc_us-gaap_CreditFacilityAxis_BD5BFECC86A2C73B00148F96E18438D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_D2C2E6DCACB82A2864448F96E1854D70" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_BD5BFECC86A2C73B00148F96E18438D4" xlink:to="loc_us-gaap_CreditFacilityDomain_D2C2E6DCACB82A2864448F96E1854D70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember_B44B9F98D71B28FE58B28F96E1855D83" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_D2C2E6DCACB82A2864448F96E1854D70" xlink:to="loc_us-gaap_SecuredDebtMember_B44B9F98D71B28FE58B28F96E1855D83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_B769567191A05EF7EF488F96E185952F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_D2C2E6DCACB82A2864448F96E1854D70" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_B769567191A05EF7EF488F96E185952F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_A5235589D2A40C2A787F8F96E186ABE8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_22929C02D1BB38F3A7008F96E17F1E6A" xlink:to="loc_us-gaap_DebtInstrumentLineItems_A5235589D2A40C2A787F8F96E186ABE8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_A5235589D2A40C2A787F8F96E186ABE8" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3A1FC55B6C4EC0E6DCDF8F96E1873323" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3A1FC55B6C4EC0E6DCDF8F96E1873323" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_E6D8B0B9B852505653278F96E187583F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_E6D8B0B9B852505653278F96E187583F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7151635934973BF5323B8F96E18718F8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_7151635934973BF5323B8F96E18718F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_FB47855D543D2C0DA3538F96E187A69D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_FB47855D543D2C0DA3538F96E187A69D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_38F30DCE4B0CEFA85E4A8F96E188756F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_38F30DCE4B0CEFA85E4A8F96E188756F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_B91505A4AAAC3189F4E88F96E1886E5B" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_B91505A4AAAC3189F4E88F96E1886E5B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_60850FB2EECA86CCC34E8F96E1883A4F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:to="loc_us-gaap_LongTermDebt_60850FB2EECA86CCC34E8F96E1883A4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_D4F7B9457642FA983E118F96E1880FD7" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:to="loc_us-gaap_LongTermDebtCurrent_D4F7B9457642FA983E118F96E1880FD7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_13AEB222AD6BA25AB05C8F96E1884F20" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_5AEDA301D67D37637E508F96E1869AEC" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_13AEB222AD6BA25AB05C8F96E1884F20" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/LongTermDebtDetailsTextual" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_22AD58914D72B1ADB26A8F96E168B93E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_BEEF0CA0581A5D3AC09D8F96E1696FFD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_22AD58914D72B1ADB26A8F96E168B93E" xlink:to="loc_us-gaap_DebtInstrumentTable_BEEF0CA0581A5D3AC09D8F96E1696FFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_DC4AE858003BAE2A28F18F96E16B2BD5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_BEEF0CA0581A5D3AC09D8F96E1696FFD" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_DC4AE858003BAE2A28F18F96E16B2BD5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_D2B163499C03CB1D9AFC8F96E16B8FF3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_DC4AE858003BAE2A28F18F96E16B2BD5" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_D2B163499C03CB1D9AFC8F96E16B8FF3" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember" xlink:label="loc_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_4B9CD97D8E27889E44888F96E16B09D0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_D2B163499C03CB1D9AFC8F96E16B8FF3" xlink:to="loc_ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember_4B9CD97D8E27889E44888F96E16B09D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2E2D279C2369D911C6348F96E16E6CEF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_BEEF0CA0581A5D3AC09D8F96E1696FFD" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2E2D279C2369D911C6348F96E16E6CEF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_B1918DEE91360C49286B8F96E16EF74A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2E2D279C2369D911C6348F96E16E6CEF" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_B1918DEE91360C49286B8F96E16EF74A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditMember" xlink:label="loc_us-gaap_LineOfCreditMember_8F6543A4F51C08BDA28A8F96E16E1928" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_B1918DEE91360C49286B8F96E16EF74A" xlink:to="loc_us-gaap_LineOfCreditMember_8F6543A4F51C08BDA28A8F96E16E1928" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="loc_us-gaap_CreditFacilityAxis_1C58C744417F8EF1F5168F96E16C4A2D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_BEEF0CA0581A5D3AC09D8F96E1696FFD" xlink:to="loc_us-gaap_CreditFacilityAxis_1C58C744417F8EF1F5168F96E16C4A2D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="loc_us-gaap_CreditFacilityDomain_C13291A081C93F493EF38F96E16CA64C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_1C58C744417F8EF1F5168F96E16C4A2D" xlink:to="loc_us-gaap_CreditFacilityDomain_C13291A081C93F493EF38F96E16CA64C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SecuredDebtMember" xlink:label="loc_us-gaap_SecuredDebtMember_52317591F3C6063109778F96E16CEDEB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_C13291A081C93F493EF38F96E16CA64C" xlink:to="loc_us-gaap_SecuredDebtMember_52317591F3C6063109778F96E16CEDEB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_A01FED7664875D7E071A8F96E16DAFE8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_C13291A081C93F493EF38F96E16CA64C" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_A01FED7664875D7E071A8F96E16DAFE8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LetterOfCreditMember" xlink:label="loc_us-gaap_LetterOfCreditMember_9E1A7A346AAC7924120D8F96E16CC583" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_C13291A081C93F493EF38F96E16CA64C" xlink:to="loc_us-gaap_LetterOfCreditMember_9E1A7A346AAC7924120D8F96E16CC583" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BridgeLoanMember" xlink:label="loc_us-gaap_BridgeLoanMember_872E21A2F4EA3FF0EB148F96E16D251C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_C13291A081C93F493EF38F96E16CA64C" xlink:to="loc_us-gaap_BridgeLoanMember_872E21A2F4EA3FF0EB148F96E16D251C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_B0AF8C2D0A90E80E60DC8F96E16A91D7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_BEEF0CA0581A5D3AC09D8F96E1696FFD" xlink:to="loc_us-gaap_DebtInstrumentAxis_B0AF8C2D0A90E80E60DC8F96E16A91D7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_18A25C72F3F2D148BCE78F96E16A6041" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_B0AF8C2D0A90E80E60DC8F96E16A91D7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_18A25C72F3F2D148BCE78F96E16A6041" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_FormerCreditAgreementMember" xlink:label="loc_ango_FormerCreditAgreementMember_934D4C383FBE30EE655E8F96E16A7614" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18A25C72F3F2D148BCE78F96E16A6041" xlink:to="loc_ango_FormerCreditAgreementMember_934D4C383FBE30EE655E8F96E16A7614" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="loc_us-gaap_VariableRateAxis_14498A48883BB4EBC7838F96E1698BAE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_BEEF0CA0581A5D3AC09D8F96E1696FFD" xlink:to="loc_us-gaap_VariableRateAxis_14498A48883BB4EBC7838F96E1698BAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="loc_us-gaap_VariableRateDomain_6A5EB4D88C9AAA1DE2908F96E1695527" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_14498A48883BB4EBC7838F96E1698BAE" xlink:to="loc_us-gaap_VariableRateDomain_6A5EB4D88C9AAA1DE2908F96E1695527" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BaseRateMember" xlink:label="loc_us-gaap_BaseRateMember_C2E756AB61157FA520638F96E169B04F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_6A5EB4D88C9AAA1DE2908F96E1695527" xlink:to="loc_us-gaap_BaseRateMember_C2E756AB61157FA520638F96E169B04F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EurodollarMember" xlink:label="loc_us-gaap_EurodollarMember_4A63EBC5E9C0B9D382D28F96E16A54CA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_6A5EB4D88C9AAA1DE2908F96E1695527" xlink:to="loc_us-gaap_EurodollarMember_4A63EBC5E9C0B9D382D28F96E16A54CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_17A07E27DF15296249338F96E16D325C" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_BEEF0CA0581A5D3AC09D8F96E1696FFD" xlink:to="loc_srt_RangeAxis_17A07E27DF15296249338F96E16D325C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_D8A44AD7DCF94BBB4BF98F96E16DD2B7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_17A07E27DF15296249338F96E16D325C" xlink:to="loc_srt_RangeMember_D8A44AD7DCF94BBB4BF98F96E16DD2B7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_0A8BCC58DF6AF1182E508F96E16D8FF8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_D8A44AD7DCF94BBB4BF98F96E16DD2B7" xlink:to="loc_srt_MaximumMember_0A8BCC58DF6AF1182E508F96E16D8FF8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_6E02F0C63645CA25D22C8F96E16EA088" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_D8A44AD7DCF94BBB4BF98F96E16DD2B7" xlink:to="loc_srt_MinimumMember_6E02F0C63645CA25D22C8F96E16EA088" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_BEEF0CA0581A5D3AC09D8F96E1696FFD" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2A9D596F2AB55EE7EA578F96E16F1E49" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2A9D596F2AB55EE7EA578F96E16F1E49" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_AB178F7EBA245FE4C6768F96E1704064" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_AB178F7EBA245FE4C6768F96E1704064" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_DB73835573EE4F4BB0C08F96E1708E91" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_DB73835573EE4F4BB0C08F96E1708E91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaap_DebtInstrumentTerm_440FAA6451E7CE4508718F96E170DF35" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_us-gaap_DebtInstrumentTerm_440FAA6451E7CE4508718F96E170DF35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6DE133E7CCD04B9909928F96E170FCCD" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_6DE133E7CCD04B9909928F96E170FCCD" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_DebtInstrumentIncreaseInInterestRateInCaseOfDefault" xlink:label="loc_ango_DebtInstrumentIncreaseInInterestRateInCaseOfDefault_9113A505CA0F1CD410298F96E170CA2D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_ango_DebtInstrumentIncreaseInInterestRateInCaseOfDefault_9113A505CA0F1CD410298F96E170CA2D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_63EB5B79B1AA839D79AC8F96E17189A0" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_63EB5B79B1AA839D79AC8F96E17189A0" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA" xlink:label="loc_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA_50E04B96ADF981FF78A08F96E171093D" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA_50E04B96ADF981FF78A08F96E171093D" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions" xlink:label="loc_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions_FAA8206B57927E05D9C18F96E1712FD2" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions_FAA8206B57927E05D9C18F96E1712FD2" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_DebtServiceCoverageRatio" xlink:label="loc_ango_DebtServiceCoverageRatio_838AE497F488B6480E478F96E1710EFD" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_ango_DebtServiceCoverageRatio_838AE497F488B6480E478F96E1710EFD" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_DebtInstrumentMaximumCashAmountForNetDebtCalculation" xlink:label="loc_ango_DebtInstrumentMaximumCashAmountForNetDebtCalculation_30B54B880A7199BB2F5E900A532642D3" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3D71B3CF7DD5011D23258F96E16F21BE" xlink:to="loc_ango_DebtInstrumentMaximumCashAmountForNetDebtCalculation_30B54B880A7199BB2F5E900A532642D3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_09C1C47616F0C39F2CE58C8B9A9D8277" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_B07C5E224601F17A242C8C8B9A9D19C7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_09C1C47616F0C39F2CE58C8B9A9D8277" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_B07C5E224601F17A242C8C8B9A9D19C7" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/MarketableSecurities" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0676AF030BB2D38847DF8F96E2CE61DD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_8BE40389B54FA84A9A788F96E2CEAB4D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0676AF030BB2D38847DF8F96E2CE61DD" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_8BE40389B54FA84A9A788F96E2CEAB4D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/MarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_D5F5C05B9FA986D8365D8F96E2BF8D47" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_CDEF05A73D6FFF8FE74F8F96E2BF7B58" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_D5F5C05B9FA986D8365D8F96E2BF8D47" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_CDEF05A73D6FFF8FE74F8F96E2BF7B58" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6757D5ADC0FA0F8C698E8F96E2BFC98F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_CDEF05A73D6FFF8FE74F8F96E2BF7B58" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6757D5ADC0FA0F8C698E8F96E2BFC98F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_75351D897C252A1197748F96E2C5D651" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6757D5ADC0FA0F8C698E8F96E2BFC98F" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_75351D897C252A1197748F96E2C5D651" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_FAF39EF2A68392FE2B448F96E2C54D5E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_75351D897C252A1197748F96E2C5D651" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_FAF39EF2A68392FE2B448F96E2C54D5E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5E296C8EB7075B7A70C08F96E2C69ED7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_CDEF05A73D6FFF8FE74F8F96E2BF7B58" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5E296C8EB7075B7A70C08F96E2C69ED7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_E46A7160C2D79FBBAECA8F96E2C6CC76" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5E296C8EB7075B7A70C08F96E2C69ED7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_E46A7160C2D79FBBAECA8F96E2C6CC76" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_A3FF4A9F356AEAE99E518F96E2C706C7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5E296C8EB7075B7A70C08F96E2C69ED7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_A3FF4A9F356AEAE99E518F96E2C706C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_BD922B6520540F41AE768F96E2C74D9F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5E296C8EB7075B7A70C08F96E2C69ED7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_BD922B6520540F41AE768F96E2C74D9F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_5BDF692AA3A87BEAA12E8F96E2C7F94A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5E296C8EB7075B7A70C08F96E2C69ED7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_5BDF692AA3A87BEAA12E8F96E2C7F94A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/MarketableSecuritiesDetails1" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_E1E06416CD00477359DC8E95127A1F17" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_E03350FC0551764398CA8E95127ADB77" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_E1E06416CD00477359DC8E95127A1F17" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_E03350FC0551764398CA8E95127ADB77" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_25100B7E40F6E2B3ABB08E95127A0876" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_E03350FC0551764398CA8E95127ADB77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_25100B7E40F6E2B3ABB08E95127A0876" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_AE2AB907559C96EC497D8E95127A077C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_E03350FC0551764398CA8E95127ADB77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_AE2AB907559C96EC497D8E95127A077C" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost" xlink:label="loc_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost_FC8AD7DBD7AB7F3190038E95127A13DB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_E03350FC0551764398CA8E95127ADB77" xlink:to="loc_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost_FC8AD7DBD7AB7F3190038E95127A13DB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_38E73C2B7766202EB4C18E95127AC07C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_E03350FC0551764398CA8E95127ADB77" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_38E73C2B7766202EB4C18E95127AC07C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_162983AEEF1300BEEF0C8E95127A74DE" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_E03350FC0551764398CA8E95127ADB77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_162983AEEF1300BEEF0C8E95127A74DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0CD0E8DE9DA229507CA18E95127A7329" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_E03350FC0551764398CA8E95127ADB77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0CD0E8DE9DA229507CA18E95127A7329" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue" xlink:label="loc_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue_ED3FBE11693995AD1DDD8E95127AC888" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_E03350FC0551764398CA8E95127ADB77" xlink:to="loc_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue_ED3FBE11693995AD1DDD8E95127AC888" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5C0A2CF04FF85C9F19218E95127AFAEA" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract_E03350FC0551764398CA8E95127ADB77" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5C0A2CF04FF85C9F19218E95127AFAEA" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/MarketableSecuritiesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_B9DB52F02F88DFF914CA8E951289EEC5" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_7D61345A0C16C34A1B878F05E0576DB7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_B9DB52F02F88DFF914CA8E951289EEC5" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_7D61345A0C16C34A1B878F05E0576DB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_519F95500091726D6F388E9512898E30" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_B9DB52F02F88DFF914CA8E951289EEC5" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_519F95500091726D6F388E9512898E30" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/OtherAssets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_C51AD69DDA0CB28552968F96E31B941D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_OtherAssetsDisclosureTextBlock_D4B353FEFB4246169A668F96E31BB75B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_C51AD69DDA0CB28552968F96E31B941D" xlink:to="loc_us-gaap_OtherAssetsDisclosureTextBlock_D4B353FEFB4246169A668F96E31BB75B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/OtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_D87B31F76867A6DCFCC68F22D14B4649" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesTable" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesTable_323D2B4400424380CC038F22D14B70B9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_D87B31F76867A6DCFCC68F22D14B4649" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesTable_323D2B4400424380CC038F22D14B70B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_437AFD6D27EC0F59893D8F22D14B2252" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesTable_323D2B4400424380CC038F22D14B70B9" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_437AFD6D27EC0F59893D8F22D14B2252" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaap_RelatedPartyDomain_8A79C29ABBABB73E830D8F22D14BFBCC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_437AFD6D27EC0F59893D8F22D14B2252" xlink:to="loc_us-gaap_RelatedPartyDomain_8A79C29ABBABB73E830D8F22D14BFBCC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_AffiliatedEntityMember" xlink:label="loc_srt_AffiliatedEntityMember_AB8374953F9EF75D9ED08F22D14BABC5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_8A79C29ABBABB73E830D8F22D14BFBCC" xlink:to="loc_srt_AffiliatedEntityMember_AB8374953F9EF75D9ED08F22D14BABC5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems" xlink:label="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems_2C715C81B34FDED991828F22D14B9427" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesTable_323D2B4400424380CC038F22D14B70B9" xlink:to="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems_2C715C81B34FDED991828F22D14B9427" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_60FF2B88161FC9CCE7AA8F22D14B9B82" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems_2C715C81B34FDED991828F22D14B9427" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_60FF2B88161FC9CCE7AA8F22D14B9B82" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaap_AssetImpairmentCharges_B4E813FC3777C2F941378F22D14B9745" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems_2C715C81B34FDED991828F22D14B9427" xlink:to="loc_us-gaap_AssetImpairmentCharges_B4E813FC3777C2F941378F22D14B9745" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/PrepaidExpensesAndOther" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_45D681FAEC89F17814E58F96E294A3A5" xlink:type="locator" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PrepaidExpensesAndOtherTextBlock" xlink:label="loc_ango_PrepaidExpensesAndOtherTextBlock_AEE2D03E744CF9D7E66C8F96E294291D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_45D681FAEC89F17814E58F96E294A3A5" xlink:to="loc_ango_PrepaidExpensesAndOtherTextBlock_AEE2D03E744CF9D7E66C8F96E294291D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/PrepaidExpensesAndOtherDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_343E80B57FE84A3F93368C8B9D7D2846" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1FB87BF6CF177F558FFD8C8B9D7DA1D0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_343E80B57FE84A3F93368C8B9D7D2846" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1FB87BF6CF177F558FFD8C8B9D7DA1D0" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_SoftwareLicenses" xlink:label="loc_ango_SoftwareLicenses_AE4D5DD181C249D067E88C8B9D7D222D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1FB87BF6CF177F558FFD8C8B9D7DA1D0" xlink:to="loc_ango_SoftwareLicenses_AE4D5DD181C249D067E88C8B9D7D222D" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PrepaidLicenseeFees" xlink:label="loc_ango_PrepaidLicenseeFees_37F969C91A305BB201E18C8B9D7D6BF1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1FB87BF6CF177F558FFD8C8B9D7DA1D0" xlink:to="loc_ango_PrepaidLicenseeFees_37F969C91A305BB201E18C8B9D7D6BF1" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_TradeShows" xlink:label="loc_ango_TradeShows_79D50CF26F6C2849ADF28C8B9D7DD77E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1FB87BF6CF177F558FFD8C8B9D7DA1D0" xlink:to="loc_ango_TradeShows_79D50CF26F6C2849ADF28C8B9D7DD77E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidRent" xlink:label="loc_us-gaap_PrepaidRent_7EAEDE20139E3CEF162B8C8B9D7D2F5D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1FB87BF6CF177F558FFD8C8B9D7DA1D0" xlink:to="loc_us-gaap_PrepaidRent_7EAEDE20139E3CEF162B8C8B9D7D2F5D" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PrepaidIncomeandOtherTaxes" xlink:label="loc_ango_PrepaidIncomeandOtherTaxes_67B16D4E03A9FE2A22A28C8B9D7D9560" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1FB87BF6CF177F558FFD8C8B9D7DA1D0" xlink:to="loc_ango_PrepaidIncomeandOtherTaxes_67B16D4E03A9FE2A22A28C8B9D7D9560" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_MedicalDeviceExciseTaxReceivable" xlink:label="loc_ango_MedicalDeviceExciseTaxReceivable_C1F3E78CD22A016DEB748C8B9D7D6266" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1FB87BF6CF177F558FFD8C8B9D7DA1D0" xlink:to="loc_ango_MedicalDeviceExciseTaxReceivable_C1F3E78CD22A016DEB748C8B9D7D6266" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_62BA991CC76DA8C771598C8B9D7D853C" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1FB87BF6CF177F558FFD8C8B9D7DA1D0" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_62BA991CC76DA8C771598C8B9D7D853C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_EC6A78B0AFF101ACC2788C8B9D7D8863" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_1FB87BF6CF177F558FFD8C8B9D7DA1D0" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_EC6A78B0AFF101ACC2788C8B9D7D8863" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/PrepaidExpensesAndOtherTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_AD3DF84910FB95DAD0B08C8B9BE702C8" xlink:type="locator" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PrepaidExpensesAndOtherTableTextBlock" xlink:label="loc_ango_PrepaidExpensesAndOtherTableTextBlock_9E83015E0C304320B0E98C8B9BE702EB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_AD3DF84910FB95DAD0B08C8B9BE702C8" xlink:to="loc_ango_PrepaidExpensesAndOtherTableTextBlock_9E83015E0C304320B0E98C8B9BE702EB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNet" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_DC9ECFB116603278994A8F96E27A6E69" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_8E227DB0387D54F69AC78F96E27A241C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_DC9ECFB116603278994A8F96E27A6E69" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_8E227DB0387D54F69AC78F96E27A241C" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_4F7AA7DCBCDBF54419AC8C8B9A117897" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_B866B260E45BF143EA478C8B9A113073" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_4F7AA7DCBCDBF54419AC8C8B9A117897" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_B866B260E45BF143EA478C8B9A113073" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_665BA1825D9349AF39DA8C8B9A11161C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_B866B260E45BF143EA478C8B9A113073" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_665BA1825D9349AF39DA8C8B9A11161C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_665BA1825D9349AF39DA8C8B9A11161C" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_2E5B9217F3F63628812C8C8B9A116C9D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_2E5B9217F3F63628812C8C8B9A116C9D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MachineryAndEquipmentMember" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_820B0266DCED69389B798C8B9A119C90" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_820B0266DCED69389B798C8B9A119C90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaap_ComputerEquipmentMember_A2012ACBC0F95E1794DE8C8B9A113F0C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96" xlink:to="loc_us-gaap_ComputerEquipmentMember_A2012ACBC0F95E1794DE8C8B9A113F0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="loc_us-gaap_ConstructionInProgressMember_A72B659315D994CE991A8C8B9A11D131" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_D4E466B46B38560826708C8B9A119E96" xlink:to="loc_us-gaap_ConstructionInProgressMember_A72B659315D994CE991A8C8B9A11D131" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2F92076A3EE4B27C2FF48C8B9A111EFF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_B866B260E45BF143EA478C8B9A113073" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2F92076A3EE4B27C2FF48C8B9A111EFF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2F92076A3EE4B27C2FF48C8B9A111EFF" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_C6E0DE96869D9D1E20698C8B9A11EFAE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_C6E0DE96869D9D1E20698C8B9A11EFAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_B52FD1D61F055E43072F8C8B9A1150BD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_B52FD1D61F055E43072F8C8B9A1150BD" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements" xlink:label="loc_ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements_10AA323DB108213CCDDA8C8B9A113B1F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A" xlink:to="loc_ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements_10AA323DB108213CCDDA8C8B9A113B1F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LandAndLandImprovements" xlink:label="loc_us-gaap_LandAndLandImprovements_3991D85FE99C720BB4188C8B9A11A5C1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A" xlink:to="loc_us-gaap_LandAndLandImprovements_3991D85FE99C720BB4188C8B9A11A5C1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_E77A0F2748ACD3FBE46F8C8B9A11F114" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_09DFCBD25C76B789BE7A8C8B9A11911A" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_E77A0F2748ACD3FBE46F8C8B9A11F114" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_2396232D1B0271DE7A148C8B9A112DDE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2F92076A3EE4B27C2FF48C8B9A111EFF" xlink:to="loc_us-gaap_Depreciation_2396232D1B0271DE7A148C8B9A112DDE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_97828F8CC5683F6603F48C8B9D0049CA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_CA4CABE1D7F9F98DB7CB8C8B9D007CA0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_97828F8CC5683F6603F48C8B9D0049CA" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_CA4CABE1D7F9F98DB7CB8C8B9D007CA0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/QuarterlyInformationUnaudited" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_62131AA77C4EF045F0FB8F96E0335F9C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_4A1D352141892263CEF28F96E0337FCA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_62131AA77C4EF045F0FB8F96E0335F9C" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_4A1D352141892263CEF28F96E0337FCA" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/QuarterlyInformationUnauditedDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_DB9305C5FC0C31AB19EA94C42DAC0E6A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_E86E1DBE8AF2C8D67EF094C42DAC3E87" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_DB9305C5FC0C31AB19EA94C42DAC0E6A" xlink:to="loc_us-gaap_Revenues_E86E1DBE8AF2C8D67EF094C42DAC3E87" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_294B9CBED0314A97730594C42DBB1515" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_DB9305C5FC0C31AB19EA94C42DAC0E6A" xlink:to="loc_us-gaap_GrossProfit_294B9CBED0314A97730594C42DBB1515" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_FC2E4E1C41CC290B4BD094C42DBBE58E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_DB9305C5FC0C31AB19EA94C42DAC0E6A" xlink:to="loc_us-gaap_NetIncomeLoss_FC2E4E1C41CC290B4BD094C42DBBE58E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9F94DDA11E9F191D011B94C42DBB8FDA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_DB9305C5FC0C31AB19EA94C42DAC0E6A" xlink:to="loc_us-gaap_EarningsPerShareAbstract_9F94DDA11E9F191D011B94C42DBB8FDA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_D265DDA55DE945ACDE5094C42DBB82FC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9F94DDA11E9F191D011B94C42DBB8FDA" xlink:to="loc_us-gaap_EarningsPerShareBasic_D265DDA55DE945ACDE5094C42DBB82FC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5E085E672F43C098424C94C42DBB380F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9F94DDA11E9F191D011B94C42DBB8FDA" xlink:to="loc_us-gaap_EarningsPerShareDiluted_5E085E672F43C098424C94C42DBB380F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81FEA8688D316E28C9E294C42DBBF77B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_DB9305C5FC0C31AB19EA94C42DAC0E6A" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81FEA8688D316E28C9E294C42DBBF77B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupClassificationAxis" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_D3C19CA361DF773648B594C42DBB9660" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81FEA8688D316E28C9E294C42DBBF77B" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_D3C19CA361DF773648B594C42DBB9660" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupClassificationDomain" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_7B3F9B6698AA41E5317994C42DBB28DF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_D3C19CA361DF773648B594C42DBB9660" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_7B3F9B6698AA41E5317994C42DBB28DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_72AC917C26F3CAD1BF4694C42DBBCDB7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_7B3F9B6698AA41E5317994C42DBB28DF" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember_72AC917C26F3CAD1BF4694C42DBBCDB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_62D10A9529CF2E2EBCBA94C42DBBD07E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81FEA8688D316E28C9E294C42DBBF77B" xlink:to="loc_srt_ProductOrServiceAxis_62D10A9529CF2E2EBCBA94C42DBBD07E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_19AA8772CD4BF986526394C42DBBF5D4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_62D10A9529CF2E2EBCBA94C42DBBD07E" xlink:to="loc_srt_ProductsAndServicesDomain_19AA8772CD4BF986526394C42DBBF5D4" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AcculisCapitalSystemsMember" xlink:label="loc_ango_AcculisCapitalSystemsMember_BCAB0C555609C18D44A994C42DBBB283" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_19AA8772CD4BF986526394C42DBBF5D4" xlink:to="loc_ango_AcculisCapitalSystemsMember_BCAB0C555609C18D44A994C42DBBB283" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_365B9693C63F13E9C21A94C42DBBADAE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_81FEA8688D316E28C9E294C42DBBF77B" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_365B9693C63F13E9C21A94C42DBBADAE" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit" xlink:label="loc_ango_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_B6BBBE8CC8D04CAB483B94C42DBB6454" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_365B9693C63F13E9C21A94C42DBBADAE" xlink:to="loc_ango_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit_B6BBBE8CC8D04CAB483B94C42DBB6454" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_LitigationReserve" xlink:label="loc_us-gaap_LitigationReserve_3A4C03BEAB27AA40AC3E94C42DBBE65F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_365B9693C63F13E9C21A94C42DBBADAE" xlink:to="loc_us-gaap_LitigationReserve_3A4C03BEAB27AA40AC3E94C42DBBE65F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_8DB58A14C9A5FFF95C4494C42DBB1EFA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_365B9693C63F13E9C21A94C42DBBADAE" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_8DB58A14C9A5FFF95C4494C42DBB1EFA" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/QuarterlyInformationUnauditedTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_QuarterlyFinancialInformationDisclosureAbstract" xlink:label="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_E0EF0E86A822C6FEBD168F96E031D21E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_47632D791F30B3842CA38F96E03112A2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialInformationDisclosureAbstract_E0EF0E86A822C6FEBD168F96E031D21E" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_47632D791F30B3842CA38F96E03112A2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/RetirementPlans" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3BC6AC942064BA8CFEA08C8B9A406F96" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_DF832C26BC613CE0D5248C8B9A40C2E6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3BC6AC942064BA8CFEA08C8B9A406F96" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_DF832C26BC613CE0D5248C8B9A40C2E6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/RetirementPlansDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7ECD2E5BE112D9B7BF618C8B9DAB6374" xlink:type="locator" />
    <link:loc xlink:href="ango-20180531.xsd#ango_RetirementPlansTextualAbstract" xlink:label="loc_ango_RetirementPlansTextualAbstract_3BF6C293673FE9893ED38C8B9DAB7AAC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7ECD2E5BE112D9B7BF618C8B9DAB6374" xlink:to="loc_ango_RetirementPlansTextualAbstract_3BF6C293673FE9893ED38C8B9DAB7AAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_E296A9F6F7D87AA6F64B8C8B9DAB4F26" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_RetirementPlansTextualAbstract_3BF6C293673FE9893ED38C8B9DAB7AAC" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_E296A9F6F7D87AA6F64B8C8B9DAB4F26" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/SegmentsAndGeographicInformation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_662CC68FC600E341690D8C8B9D3EA0E3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_FD1D859451D874F11B458C8B9D3E9895" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_662CC68FC600E341690D8C8B9D3EA0E3" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_FD1D859451D874F11B458C8B9D3E9895" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_AAC096401F6856BFD9C18F96E0700110" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_CDB40E08D39B456414488F96E0702B2F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_AAC096401F6856BFD9C18F96E0700110" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_CDB40E08D39B456414488F96E0702B2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_152E97255C53227510818F96E0717C2F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_CDB40E08D39B456414488F96E0702B2F" xlink:to="loc_srt_ProductOrServiceAxis_152E97255C53227510818F96E0717C2F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_E728D17A31E38082B9598F96E071FBC9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_152E97255C53227510818F96E0717C2F" xlink:to="loc_srt_ProductsAndServicesDomain_E728D17A31E38082B9598F96E071FBC9" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PeripheralVascularMember" xlink:label="loc_ango_PeripheralVascularMember_443593E35AC0D07E08988F96E071CF17" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_E728D17A31E38082B9598F96E071FBC9" xlink:to="loc_ango_PeripheralVascularMember_443593E35AC0D07E08988F96E071CF17" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AccessMember" xlink:label="loc_ango_AccessMember_3C0B3B8550975A3DD6118F96E0720108" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_E728D17A31E38082B9598F96E071FBC9" xlink:to="loc_ango_AccessMember_3C0B3B8550975A3DD6118F96E0720108" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_OncologySurgeryMember" xlink:label="loc_ango_OncologySurgeryMember_3AA53AB95FC9AE8A6BE78F96E072FD90" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_E728D17A31E38082B9598F96E071FBC9" xlink:to="loc_ango_OncologySurgeryMember_3AA53AB95FC9AE8A6BE78F96E072FD90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_D4D9D83D48C6937452778F96E0722F0A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_CDB40E08D39B456414488F96E0702B2F" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_D4D9D83D48C6937452778F96E0722F0A" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_NetSalesByProductCategoryAbstract" xlink:label="loc_ango_NetSalesByProductCategoryAbstract_3BACADA5C08994F3C0B78F96E072C7E3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_D4D9D83D48C6937452778F96E0722F0A" xlink:to="loc_ango_NetSalesByProductCategoryAbstract_3BACADA5C08994F3C0B78F96E072C7E3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_B72B3C9F8464DF4100948F96E07266B0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_NetSalesByProductCategoryAbstract_3BACADA5C08994F3C0B78F96E072C7E3" xlink:to="loc_us-gaap_Revenues_B72B3C9F8464DF4100948F96E07266B0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetails1" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_B3378012989A3CEEA38C8F96E06ABE2E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_C547B032EAD9A5B2C3878F96E06AE338" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_B3378012989A3CEEA38C8F96E06ABE2E" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_C547B032EAD9A5B2C3878F96E06AE338" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="loc_srt_StatementGeographicalAxis_671A26CE649439C2E3C38F96E06B55D4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_C547B032EAD9A5B2C3878F96E06AE338" xlink:to="loc_srt_StatementGeographicalAxis_671A26CE649439C2E3C38F96E06B55D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="loc_srt_SegmentGeographicalDomain_B8AD87DAD7D5C828DE7A8F96E06BF15C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_671A26CE649439C2E3C38F96E06B55D4" xlink:to="loc_srt_SegmentGeographicalDomain_B8AD87DAD7D5C828DE7A8F96E06BF15C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_7302D3358AA36ACD7C298F96E06B5883" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_B8AD87DAD7D5C828DE7A8F96E06BF15C" xlink:to="loc_country_US_7302D3358AA36ACD7C298F96E06B5883" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_InternationalMember" xlink:label="loc_ango_InternationalMember_8135E22137AF41692F328F96E06C411D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_B8AD87DAD7D5C828DE7A8F96E06BF15C" xlink:to="loc_ango_InternationalMember_8135E22137AF41692F328F96E06C411D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_645EB5D2C00278FBD7B78F96E06C8354" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_C547B032EAD9A5B2C3878F96E06AE338" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_645EB5D2C00278FBD7B78F96E06C8354" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_SummaryOfSalesForGeographicAreasAbstract" xlink:label="loc_ango_SummaryOfSalesForGeographicAreasAbstract_01503E946DB7A7DF93E18F96E06C5B75" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_645EB5D2C00278FBD7B78F96E06C8354" xlink:to="loc_ango_SummaryOfSalesForGeographicAreasAbstract_01503E946DB7A7DF93E18F96E06C5B75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentsGeographicalAreasAbstract" xlink:label="loc_us-gaap_SegmentsGeographicalAreasAbstract_C7D36481BB89932273A78F96E06C7032" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ango_SummaryOfSalesForGeographicAreasAbstract_01503E946DB7A7DF93E18F96E06C5B75" xlink:to="loc_us-gaap_SegmentsGeographicalAreasAbstract_C7D36481BB89932273A78F96E06C7032" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_69E904C96033AC3AFE558F96E06D1C56" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentsGeographicalAreasAbstract_C7D36481BB89932273A78F96E06C7032" xlink:to="loc_us-gaap_Revenues_69E904C96033AC3AFE558F96E06D1C56" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetailsTextual" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_62B5B6E941CF6AE6D2BA8F96E0678A2F" xlink:type="locator" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PercentageOfInternationalSalesToNetSales" xlink:label="loc_ango_PercentageOfInternationalSalesToNetSales_E15BB84EE1C7A7A400238F96E06755B2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_62B5B6E941CF6AE6D2BA8F96E0678A2F" xlink:to="loc_ango_PercentageOfInternationalSalesToNetSales_E15BB84EE1C7A7A400238F96E06755B2" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PercentageOfDomesticAssets" xlink:label="loc_ango_PercentageOfDomesticAssets_9535D11162C4AF5289C38F96E067C096" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_62B5B6E941CF6AE6D2BA8F96E0678A2F" xlink:to="loc_ango_PercentageOfDomesticAssets_9535D11162C4AF5289C38F96E067C096" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/SegmentsAndGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_096F4107941BC99F78718C8B9D7D53BD" xlink:type="locator" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ScheduleOfNetRevenueByProductGroupTableTextBlock" xlink:label="loc_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock_472EC5C6699BED0030228C8B9D7DB783" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_096F4107941BC99F78718C8B9D7D53BD" xlink:to="loc_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock_472EC5C6699BED0030228C8B9D7DB783" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_5509339048608B344B748C8B9D7D70FB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_096F4107941BC99F78718C8B9D7D53BD" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_5509339048608B344B748C8B9D7D70FB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_53410B398314D4E939EF8C8B9D6D5860" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_440E38FFCDD37C7EDE088C8B9D6D8913" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_53410B398314D4E939EF8C8B9D6D5860" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_440E38FFCDD37C7EDE088C8B9D6D8913" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/StockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_CEFDA117DE778BE9EBAB949FCC1A3672" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6CEF9A3CABFC25B348AC949FCC232D67" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_CEFDA117DE778BE9EBAB949FCC1A3672" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6CEF9A3CABFC25B348AC949FCC232D67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_59FE7FC6F1B766F6E00B949FCC233077" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6CEF9A3CABFC25B348AC949FCC232D67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_59FE7FC6F1B766F6E00B949FCC233077" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_D7C53F16E85B001504AD949FCC24E3CF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6CEF9A3CABFC25B348AC949FCC232D67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_D7C53F16E85B001504AD949FCC24E3CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3DA4B2DA571ABE22E3D2949FCC241EDB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6CEF9A3CABFC25B348AC949FCC232D67" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3DA4B2DA571ABE22E3D2949FCC241EDB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_D941CDD862DB925CF3CB949FCC2490FA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6CEF9A3CABFC25B348AC949FCC232D67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_D941CDD862DB925CF3CB949FCC2490FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3FDBC8E97D2AF6B8B624949FCC2437D4" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6CEF9A3CABFC25B348AC949FCC232D67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3FDBC8E97D2AF6B8B624949FCC2437D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_512BAF11F31C4CE1E1BF949FCC24C974" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6CEF9A3CABFC25B348AC949FCC232D67" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_512BAF11F31C4CE1E1BF949FCC24C974" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91AB42653C79670ACE0594A4636AA62C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_CEFDA117DE778BE9EBAB949FCC1A3672" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91AB42653C79670ACE0594A4636AA62C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_E9340773F5E15128624594A4637CFBCC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91AB42653C79670ACE0594A4636AA62C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_E9340773F5E15128624594A4637CFBCC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_76F5202471CD22C0A99194A4637C35CC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91AB42653C79670ACE0594A4636AA62C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_76F5202471CD22C0A99194A4637C35CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_93EC7394860274B0AC9A94A4637DEB24" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91AB42653C79670ACE0594A4636AA62C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_93EC7394860274B0AC9A94A4637DEB24" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1AD1B5C268E7A026597F94A4637D8F9B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91AB42653C79670ACE0594A4636AA62C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1AD1B5C268E7A026597F94A4637D8F9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_4104F30312B68A6A89B694A4637DC19E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91AB42653C79670ACE0594A4636AA62C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_4104F30312B68A6A89B694A4637DC19E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_BB1B90C93463EFB97E8B94A4637D1755" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_91AB42653C79670ACE0594A4636AA62C" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_BB1B90C93463EFB97E8B94A4637D1755" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_77C2CA648E588927833D949FCC24F1AA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_CEFDA117DE778BE9EBAB949FCC1A3672" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_77C2CA648E588927833D949FCC24F1AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_069C0CF29368A24B5FA6949FCC24ACFE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_CEFDA117DE778BE9EBAB949FCC1A3672" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_069C0CF29368A24B5FA6949FCC24ACFE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_C0E4B206E026109F2716949FCC263F83" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_CEFDA117DE778BE9EBAB949FCC1A3672" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_C0E4B206E026109F2716949FCC263F83" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_300D396C6AFD520CEBFA949FCC26861D" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_CEFDA117DE778BE9EBAB949FCC1A3672" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_300D396C6AFD520CEBFA949FCC26861D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_51BB6DF4F60EB41257D5949FCC260E56" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_CEFDA117DE778BE9EBAB949FCC1A3672" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_51BB6DF4F60EB41257D5949FCC260E56" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2B7FAE4E4589AD542102949FCC262A80" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_CEFDA117DE778BE9EBAB949FCC1A3672" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2B7FAE4E4589AD542102949FCC262A80" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_6D86B77F36F041489CE8949FCC2693BC" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_CEFDA117DE778BE9EBAB949FCC1A3672" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_6D86B77F36F041489CE8949FCC2693BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F0377F264E1814CB07E2949FCC26B167" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_CEFDA117DE778BE9EBAB949FCC1A3672" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_F0377F264E1814CB07E2949FCC26B167" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_B803A62478A7DDEEBAEF949FCC262331" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_CEFDA117DE778BE9EBAB949FCC1A3672" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_B803A62478A7DDEEBAEF949FCC262331" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_6DB57F1B04395BF5045E949FCC269963" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_CEFDA117DE778BE9EBAB949FCC1A3672" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_6DB57F1B04395BF5045E949FCC269963" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/StockholdersEquityDetails2" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_90E69C80EC6A2C3EB804949FCBF92569" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_501BED2C49B5CF55B653949FCBF939FD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_90E69C80EC6A2C3EB804949FCBF92569" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_501BED2C49B5CF55B653949FCBF939FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_1B62EB16FA99C55B3A14949FCBFAEE23" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_501BED2C49B5CF55B653949FCBF939FD" xlink:to="loc_us-gaap_AwardTypeAxis_1B62EB16FA99C55B3A14949FCBFAEE23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0A1C07C8BED708127DE9949FCBFA0275" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1B62EB16FA99C55B3A14949FCBFAEE23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0A1C07C8BED708127DE9949FCBFA0275" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5ECD8FA9C2754BDE3978949FCBFAD51E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0A1C07C8BED708127DE9949FCBFA0275" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5ECD8FA9C2754BDE3978949FCBFAD51E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_E3FA128646A65FCB6B15949FCBFBAA0B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0A1C07C8BED708127DE9949FCBFA0275" xlink:to="loc_us-gaap_PerformanceSharesMember_E3FA128646A65FCB6B15949FCBFBAA0B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10EE9F6E310D10821935949FCC001953" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_501BED2C49B5CF55B653949FCBF939FD" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10EE9F6E310D10821935949FCC001953" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_D9F8F2579235E153009D949FCC00E6F4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10EE9F6E310D10821935949FCC001953" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_D9F8F2579235E153009D949FCC00E6F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_EC5F4E32D0FC6850477F949FCC0195B0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_D9F8F2579235E153009D949FCC00E6F4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_EC5F4E32D0FC6850477F949FCC0195B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DED16955126613DDA587949FCC018245" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_D9F8F2579235E153009D949FCC00E6F4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_DED16955126613DDA587949FCC018245" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_94C1334E1E0200040163949FCC013A72" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_D9F8F2579235E153009D949FCC00E6F4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_94C1334E1E0200040163949FCC013A72" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_63F7845BEE7D8B287272949FCC017E07" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_D9F8F2579235E153009D949FCC00E6F4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_63F7845BEE7D8B287272949FCC017E07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7D999CFD9F9D4C340060949FCC012991" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_D9F8F2579235E153009D949FCC00E6F4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7D999CFD9F9D4C340060949FCC012991" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7A74E29FA60CC4B8866F94B6D1A664C3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_10EE9F6E310D10821935949FCC001953" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7A74E29FA60CC4B8866F94B6D1A664C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_887B76ACEF842D72C65F949FCC01ED85" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7A74E29FA60CC4B8866F94B6D1A664C3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_887B76ACEF842D72C65F949FCC01ED85" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_56C929926B2D6133F79C949FCC0249DE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7A74E29FA60CC4B8866F94B6D1A664C3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_56C929926B2D6133F79C949FCC0249DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2D6AF38A52523EE6FA53949FCC02A577" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7A74E29FA60CC4B8866F94B6D1A664C3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2D6AF38A52523EE6FA53949FCC02A577" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8A56D90C58660904108A949FCC020491" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7A74E29FA60CC4B8866F94B6D1A664C3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8A56D90C58660904108A949FCC020491" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_C36335188DB86F62A2B9949FCC029B49" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7A74E29FA60CC4B8866F94B6D1A664C3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_C36335188DB86F62A2B9949FCC029B49" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/StockholdersEquityDetails3" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_9DBB08BCACECC21A8011949FCBE7FDB4" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1C6E5FB8805E218B5B25949FCBE751AC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9DBB08BCACECC21A8011949FCBE7FDB4" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1C6E5FB8805E218B5B25949FCBE751AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_423196CE84BE8EB5D404949FCBE8DDE9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1C6E5FB8805E218B5B25949FCBE751AC" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_423196CE84BE8EB5D404949FCBE8DDE9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_423196CE84BE8EB5D404949FCBE8DDE9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_806AAFF216A3809417B7949FCBE8B911" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86" xlink:to="loc_us-gaap_CostOfSalesMember_806AAFF216A3809417B7949FCBE8B911" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ResearchAndDevelopmentMember" xlink:label="loc_ango_ResearchAndDevelopmentMember_AB3C25032D663E11107C949FCBE9BE8B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86" xlink:to="loc_ango_ResearchAndDevelopmentMember_AB3C25032D663E11107C949FCBE9BE8B" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_SalesandMarketingMember" xlink:label="loc_ango_SalesandMarketingMember_15085B2BD1E110381982949FCBE942DE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86" xlink:to="loc_ango_SalesandMarketingMember_15085B2BD1E110381982949FCBE942DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_873AD77C529EFA4E5EFA949FCBE900E7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_873AD77C529EFA4E5EFA949FCBE900E7" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AcquisitionRestructuringAndOtherItemsNetMember" xlink:label="loc_ango_AcquisitionRestructuringAndOtherItemsNetMember_5AE5FE71CB256CFA269F949FCBE91065" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_D23991EF30D329484279949FCBE8CD86" xlink:to="loc_ango_AcquisitionRestructuringAndOtherItemsNetMember_5AE5FE71CB256CFA269F949FCBE91065" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1234E42466412828134E949FCBE9F51F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1C6E5FB8805E218B5B25949FCBE751AC" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1234E42466412828134E949FCBE9F51F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_A8433594669F83DAC9F4949FCBE9A077" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1234E42466412828134E949FCBE9F51F" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_A8433594669F83DAC9F4949FCBE9A077" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/StockholdersEquityDetailsTextual" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_1514427DD37E58B35940A4E39D8E66E8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfOtherOwnershipInterestsTable" xlink:label="loc_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1514427DD37E58B35940A4E39D8E66E8" xlink:to="loc_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaap_PlanNameAxis_D7F776FEE857607A9287A4E39D9EC08F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:to="loc_us-gaap_PlanNameAxis_D7F776FEE857607A9287A4E39D9EC08F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaap_PlanNameDomain_8E06DA3C45AF458EA832A4E39D9E9028" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_D7F776FEE857607A9287A4E39D9EC08F" xlink:to="loc_us-gaap_PlanNameDomain_8E06DA3C45AF458EA832A4E39D9E9028" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember" xlink:label="loc_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember_59F7E69FA3B12DD04499A4E39D9F8711" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8E06DA3C45AF458EA832A4E39D9E9028" xlink:to="loc_ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember_59F7E69FA3B12DD04499A4E39D9F8711" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_StockPurchasePlanMember" xlink:label="loc_ango_StockPurchasePlanMember_A0B236EB0ACFB7C89AF1A4E39D9F7771" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8E06DA3C45AF458EA832A4E39D9E9028" xlink:to="loc_ango_StockPurchasePlanMember_A0B236EB0ACFB7C89AF1A4E39D9F7771" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_0FB21A5ED03CCC2495EAA4E39D9F8F65" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:to="loc_srt_RangeAxis_0FB21A5ED03CCC2495EAA4E39D9F8F65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_103088B1232CA44D8470A4E39D9F0D1C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0FB21A5ED03CCC2495EAA4E39D9F8F65" xlink:to="loc_srt_RangeMember_103088B1232CA44D8470A4E39D9F0D1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_45FC8860ADE1EDB13351A4E39D9F6C2B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_103088B1232CA44D8470A4E39D9F0D1C" xlink:to="loc_srt_MaximumMember_45FC8860ADE1EDB13351A4E39D9F6C2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_67FF31A331536611A805A4E39D9F1351" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_67FF31A331536611A805A4E39D9F1351" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_B5EC80741D20F85DA1D5A4E39D9F59C7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_67FF31A331536611A805A4E39D9F1351" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_B5EC80741D20F85DA1D5A4E39D9F59C7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_AD1B6F7750D1DE7370A8A4E39D9FFEEA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_B5EC80741D20F85DA1D5A4E39D9F59C7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_AD1B6F7750D1DE7370A8A4E39D9FFEEA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_13C7B7981A577540FF69A4E39D9F1E60" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:to="loc_us-gaap_AwardTypeAxis_13C7B7981A577540FF69A4E39D9F1E60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_B7A8DB8F92BBFDE501AFA4E39D9F7D5E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_13C7B7981A577540FF69A4E39D9F1E60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_B7A8DB8F92BBFDE501AFA4E39D9F7D5E" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_B7A8DB8F92BBFDE501AFA4E39D9F7D5E" xlink:to="loc_us-gaap_EmployeeStockOptionMember_AD1B6F7750D1DE7370A8A4E39D9FFEEA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_EEAB13F3E6AD8BF9F0BAA4E39D9F1260" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_B7A8DB8F92BBFDE501AFA4E39D9F7D5E" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_EEAB13F3E6AD8BF9F0BAA4E39D9F1260" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PerformanceShareAndRestrictedStockUnitAwardsMember" xlink:label="loc_ango_PerformanceShareAndRestrictedStockUnitAwardsMember_489C625B1FF74612BB6FA4E39D9F2A58" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_B7A8DB8F92BBFDE501AFA4E39D9F7D5E" xlink:to="loc_ango_PerformanceShareAndRestrictedStockUnitAwardsMember_489C625B1FF74612BB6FA4E39D9F2A58" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_PerformanceSharesIncludingThreeYearMarketConditionMember" xlink:label="loc_ango_PerformanceSharesIncludingThreeYearMarketConditionMember_93653F31E8B97323116CA4E39D9F8795" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_B7A8DB8F92BBFDE501AFA4E39D9F7D5E" xlink:to="loc_ango_PerformanceSharesIncludingThreeYearMarketConditionMember_93653F31E8B97323116CA4E39D9F8795" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaap_StatementClassOfStockAxis_FC613BD4F85BC7D341CFA4E39D9FD784" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:to="loc_us-gaap_StatementClassOfStockAxis_FC613BD4F85BC7D341CFA4E39D9FD784" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaap_ClassOfStockDomain_2628990EA1C8DBC09BCAA4E39D9F053A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_FC613BD4F85BC7D341CFA4E39D9FD784" xlink:to="loc_us-gaap_ClassOfStockDomain_2628990EA1C8DBC09BCAA4E39D9F053A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_E694DF2CE92DFD78F286A4E39D9F0441" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_2628990EA1C8DBC09BCAA4E39D9F053A" xlink:to="loc_us-gaap_CommonStockMember_E694DF2CE92DFD78F286A4E39D9F0441" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_B6AEAA791EC528C520B2A4E39D9FD9D0" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_B6AEAA791EC528C520B2A4E39D9FD9D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_FE5F1D7A24AB62169294A4E39D9F596B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_B6AEAA791EC528C520B2A4E39D9FD9D0" xlink:to="loc_us-gaap_EquityComponentDomain_FE5F1D7A24AB62169294A4E39D9F596B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaap_CommonStockMember_A78FD8A41F0CA24496A7A4E39D9F32D2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_FE5F1D7A24AB62169294A4E39D9F596B" xlink:to="loc_us-gaap_CommonStockMember_A78FD8A41F0CA24496A7A4E39D9F32D2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_23E85E881163BB3472C1A4E39D9F6DAE" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_FE5F1D7A24AB62169294A4E39D9F596B" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_23E85E881163BB3472C1A4E39D9F6DAE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_OtherOwnershipInterestsLineItems" xlink:label="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOtherOwnershipInterestsTable_B6C9EC58944067F29859A4E39D9E4C0A" xlink:to="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_CapitalStockSharesAuthorized" xlink:label="loc_ango_CapitalStockSharesAuthorized_663B4E031396C2158C59A4E39D9F9642" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_CapitalStockSharesAuthorized_663B4E031396C2158C59A4E39D9F9642" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_668EBD43417C82D55B78A4E39D9F444C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_668EBD43417C82D55B78A4E39D9F444C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_3B25A9699109328AA17FA4E39D9FDD29" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_3B25A9699109328AA17FA4E39D9FDD29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_E8F54EC24ED7A4629D56A4E39D9FE6DF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_E8F54EC24ED7A4629D56A4E39D9FE6DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_B9D4A76AB86BD2DED003A4E39D9F9E32" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_B9D4A76AB86BD2DED003A4E39D9F9E32" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_CommonStockVotesPerShare" xlink:label="loc_ango_CommonStockVotesPerShare_D7FB9B216E7B385F5053A4E39D9F68FF" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_CommonStockVotesPerShare_D7FB9B216E7B385F5053A4E39D9F68FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9C9203805EBAE576EAC2A4E39D9F3B5F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_9C9203805EBAE576EAC2A4E39D9F3B5F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_34A6CF663FB8B610DE33A4E39D9F9971" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_34A6CF663FB8B610DE33A4E39D9F9971" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod" xlink:label="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod_A25FF259DBE985943E5AA4E39D9FAE12" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod_A25FF259DBE985943E5AA4E39D9FAE12" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_44BCA0779E314ECEA592A4E39D9F1C98" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee_44BCA0779E314ECEA592A4E39D9F1C98" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage" xlink:label="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage_C8DE3681AE580D796DD2A4E39D9FD86E" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage_C8DE3681AE580D796DD2A4E39D9FD86E" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1" xlink:label="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1_68B6169DEE4C27299677A4E39D9F9E68" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1_68B6169DEE4C27299677A4E39D9F9E68" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage" xlink:label="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage_47839A2B780079CD3851A4E39D9F7365" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage_47839A2B780079CD3851A4E39D9F7365" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod" xlink:label="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod_C7C6007FD83463C16F6EA4E39D9F77FA" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod_C7C6007FD83463C16F6EA4E39D9F77FA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3A970D6F805FEB0A870DA4E39D9FE41E" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3A970D6F805FEB0A870DA4E39D9FE41E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1B2032CF888D83C821E3A4E39D9FC1A3" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1B2032CF888D83C821E3A4E39D9FC1A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8466A082C47ACC4A4E46A4E39D9F2E8C" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8466A082C47ACC4A4E46A4E39D9F2E8C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_44E008FD583EB4FE12D0A4E39D9FE0CB" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_44E008FD583EB4FE12D0A4E39D9FE0CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_Dividends" xlink:label="loc_us-gaap_Dividends_F96A21DCA949BEA26055A4E39D9F3E75" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_Dividends_F96A21DCA949BEA26055A4E39D9F3E75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4B91C4DE519536B56D6AA4E39D9FC661" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_4B91C4DE519536B56D6AA4E39D9FC661" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_C1E6C65FF68F25C3A879A4E39D9F4F4C" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_C1E6C65FF68F25C3A879A4E39D9F4F4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_F7C031E8DA3B51ACF9D2A4E39D9F17F4" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_F7C031E8DA3B51ACF9D2A4E39D9F17F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_6CB4F755E1FC73FDCD32A4E39D9F93DA" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_6CB4F755E1FC73FDCD32A4E39D9F93DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_EA7D60AA45AD4B85DAA7A4E39D9FDE8F" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_EA7D60AA45AD4B85DAA7A4E39D9FDE8F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_38DB2AA9438F1010E590A4EE65282947" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_38DB2AA9438F1010E590A4EE65282947" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D64D7FBD7A00472BDD5FA4E39D9FDEE1" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_D64D7FBD7A00472BDD5FA4E39D9FDEE1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ADE91AE45A52DB048E3BA4E39D9F07C8" xlink:type="locator" />
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ADE91AE45A52DB048E3BA4E39D9F07C8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_22710570C5359CBB6F63A4E39D9F973F" xlink:type="locator" />
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_22710570C5359CBB6F63A4E39D9F973F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BF5F264DD9D80587B334A4E39D9F6EA3" xlink:type="locator" />
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BF5F264DD9D80587B334A4E39D9F6EA3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4FFE6391D0EE6DE7F991A4E39D9F3325" xlink:type="locator" />
    <link:presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4FFE6391D0EE6DE7F991A4E39D9F3325" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod" xlink:label="loc_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod_B168C3FC43B6481C6B4BA4E39D9FB421" xlink:type="locator" />
    <link:presentationArc order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod_B168C3FC43B6481C6B4BA4E39D9FB421" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6FDC888F62A79556059CA4E39D9F0CB7" xlink:type="locator" />
    <link:presentationArc order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6FDC888F62A79556059CA4E39D9F0CB7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_CACA45F88AF35A46F02EA4E39D9FD887" xlink:type="locator" />
    <link:presentationArc order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_CACA45F88AF35A46F02EA4E39D9FD887" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_947D67FFDBBDA5FD72EBA4E39DAEDC49" xlink:type="locator" />
    <link:presentationArc order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_947D67FFDBBDA5FD72EBA4E39DAEDC49" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_NumberOfSharePurchasePeriod" xlink:label="loc_ango_NumberOfSharePurchasePeriod_F6CE2245D82D1D87EAC4A4E39DAE6565" xlink:type="locator" />
    <link:presentationArc order="35" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_NumberOfSharePurchasePeriod_F6CE2245D82D1D87EAC4A4E39DAE6565" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_SharePurchasePeriod" xlink:label="loc_ango_SharePurchasePeriod_D675AED3AB1EE3058007A4E39DAE40EE" xlink:type="locator" />
    <link:presentationArc order="36" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_SharePurchasePeriod_D675AED3AB1EE3058007A4E39DAE40EE" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_EmployeePlanParticipatingEligibilityPeriod" xlink:label="loc_ango_EmployeePlanParticipatingEligibilityPeriod_961151DEBE928C180179A4E39DAEC9E0" xlink:type="locator" />
    <link:presentationArc order="37" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_EmployeePlanParticipatingEligibilityPeriod_961151DEBE928C180179A4E39DAEC9E0" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription" xlink:label="loc_ango_CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription_EFF1E0F4E1D97CE80678A4E39DAE48B0" xlink:type="locator" />
    <link:presentationArc order="38" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription_EFF1E0F4E1D97CE80678A4E39DAE48B0" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible" xlink:label="loc_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible_6872B2C5FF2D76DE3343A4E39DAEC16B" xlink:type="locator" />
    <link:presentationArc order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible_6872B2C5FF2D76DE3343A4E39DAEC16B" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible" xlink:label="loc_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible_F66E7C98DEDF24E35DD7A4E39DAE7DD3" xlink:type="locator" />
    <link:presentationArc order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible_F66E7C98DEDF24E35DD7A4E39DAE7DD3" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_EmployeePlanParticipatingEligibilityThresholdPercentage" xlink:label="loc_ango_EmployeePlanParticipatingEligibilityThresholdPercentage_8DCDF47E716EC334BBD3A4E39DAEC56F" xlink:type="locator" />
    <link:presentationArc order="41" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_EmployeePlanParticipatingEligibilityThresholdPercentage_8DCDF47E716EC334BBD3A4E39DAEC56F" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod" xlink:label="loc_ango_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod_0CD8AC009BBB9AF57F2AA4E39DAE5EC3" xlink:type="locator" />
    <link:presentationArc order="42" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_ango_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod_0CD8AC009BBB9AF57F2AA4E39DAE5EC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_151EE5C1921DA024D100A4E39DAE0280" xlink:type="locator" />
    <link:presentationArc order="43" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_151EE5C1921DA024D100A4E39DAE0280" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_799F1415099F36E9DF20A4E39DAE089A" xlink:type="locator" />
    <link:presentationArc order="44" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_799F1415099F36E9DF20A4E39DAE089A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_C30EAFD61A3FE64FE0F5A4E39DAE1B62" xlink:type="locator" />
    <link:presentationArc order="45" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_C30EAFD61A3FE64FE0F5A4E39DAE1B62" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_6CE507B636E7844C056CA4E39DAE3717" xlink:type="locator" />
    <link:presentationArc order="46" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_6CE507B636E7844C056CA4E39DAE3717" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_49CEA1DC0BF0F8BA2D04A4E39DAE1118" xlink:type="locator" />
    <link:presentationArc order="47" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_49CEA1DC0BF0F8BA2D04A4E39DAE1118" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_7855C19EEE2D4BFB3896A4E39DAE74FB" xlink:type="locator" />
    <link:presentationArc order="48" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_7855C19EEE2D4BFB3896A4E39DAE74FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_A420C5CD383E945ED1A6A4E39DAE31F0" xlink:type="locator" />
    <link:presentationArc order="49" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_A420C5CD383E945ED1A6A4E39DAE31F0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6140CFBB49A4DBE5DF2EA4E39DAE0E2A" xlink:type="locator" />
    <link:presentationArc order="50" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_6140CFBB49A4DBE5DF2EA4E39DAE0E2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_E5200A5B4679D008BC8AA4E39DAE4136" xlink:type="locator" />
    <link:presentationArc order="51" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_E5200A5B4679D008BC8AA4E39DAE4136" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_F6C8054D51D917B157CEA4E39DAE4FAA" xlink:type="locator" />
    <link:presentationArc order="52" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_F6C8054D51D917B157CEA4E39DAE4FAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_EC336066734F814F2C76A4E39DAE2DBF" xlink:type="locator" />
    <link:presentationArc order="53" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_EC336066734F814F2C76A4E39DAE2DBF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockSharesRetired" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_133840925563EFEE02EFA4E39DAE6D84" xlink:type="locator" />
    <link:presentationArc order="54" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_133840925563EFEE02EFA4E39DAE6D84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_TreasuryStockRetiredParValueMethodAmount" xlink:label="loc_us-gaap_TreasuryStockRetiredParValueMethodAmount_DB654D69E3D5CD7CC865A4E39DAED796" xlink:type="locator" />
    <link:presentationArc order="55" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherOwnershipInterestsLineItems_689AB846782FD68871DBA4E39D9F6AF4" xlink:to="loc_us-gaap_TreasuryStockRetiredParValueMethodAmount_DB654D69E3D5CD7CC865A4E39DAED796" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaap_EquityAbstract_EC9F23491A06F2F476C18C8B9B0B8B51" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_874EBAA3718B50BFDE5B8C8B9B0B414B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_EC9F23491A06F2F476C18C8B9B0B8B51" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_874EBAA3718B50BFDE5B8C8B9B0B414B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_137E02101F91AAA4EDB28C8B9B1A56AD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_EC9F23491A06F2F476C18C8B9B0B8B51" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_137E02101F91AAA4EDB28C8B9B1A56AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_D354A4AD0DF16E38C61D8C8B9B1A0BEF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_EC9F23491A06F2F476C18C8B9B0B8B51" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_D354A4AD0DF16E38C61D8C8B9B1A0BEF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/ValuationAndQualifyingAccounts" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_4BA651DC399F0A66D0138C8B9DABCB4D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_1EFEB204B01789226A068C8B9DABE40B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_4BA651DC399F0A66D0138C8B9DABCB4D" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_1EFEB204B01789226A068C8B9DABE40B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.angiodynamics.com/role/ValuationAndQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_640094EE364E48BE017A8C8B9CC147E0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_6B979FEDCCF2D24255268C8B9CC1FDE6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_640094EE364E48BE017A8C8B9CC147E0" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_6B979FEDCCF2D24255268C8B9CC1FDE6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_BEA2D68F3EF981ED27E08C8B9CC1E5F7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_6B979FEDCCF2D24255268C8B9CC1FDE6" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_BEA2D68F3EF981ED27E08C8B9CC1E5F7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_1B8ACAFAA78C642F87A88C8B9CC1D76B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_BEA2D68F3EF981ED27E08C8B9CC1E5F7" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_1B8ACAFAA78C642F87A88C8B9CC1D76B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember" xlink:label="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_A16DB6570D609D3F6CDC8C8B9CC143E0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_1B8ACAFAA78C642F87A88C8B9CC1D76B" xlink:to="loc_us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember_A16DB6570D609D3F6CDC8C8B9CC143E0" xlink:type="arc" />
    <link:loc xlink:href="ango-20180531.xsd#ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember" xlink:label="loc_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember_348F3360238428CA57688C8B9CC1E729" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_1B8ACAFAA78C642F87A88C8B9CC1D76B" xlink:to="loc_ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember_348F3360238428CA57688C8B9CC1E729" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_C57A871DD343D874504B8C8B9CC1784F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_6B979FEDCCF2D24255268C8B9CC1FDE6" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_C57A871DD343D874504B8C8B9CC1784F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_517043EB34B0E527FE0C8C8B9CC1534B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_C57A871DD343D874504B8C8B9CC1784F" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_517043EB34B0E527FE0C8C8B9CC1534B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_E9A5DB517A041695D3FB8C8B9CC1909F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_517043EB34B0E527FE0C8C8B9CC1534B" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_E9A5DB517A041695D3FB8C8B9CC1909F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_6B5DA7F4B9A47FD25F8A8C8B9CC109D0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_517043EB34B0E527FE0C8C8B9CC1534B" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_6B5DA7F4B9A47FD25F8A8C8B9CC109D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_355EC014F6298C2A55CB8C8B9CC1CA26" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_517043EB34B0E527FE0C8C8B9CC1534B" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_355EC014F6298C2A55CB8C8B9CC1CA26" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_F391CC0FB722EB74851F8C8B9CC1BF58" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_517043EB34B0E527FE0C8C8B9CC1534B" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_F391CC0FB722EB74851F8C8B9CC1BF58" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>a5yeargraphfy2018.jpg
<TEXT>
begin 644 a5yeargraphfy2018.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#Z17AI9@  34T *@    @ ! $[  (
M   0   (2H=I  0    !   (6IR=  $    @   0TNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $MR865M97(L
M($%N9V5L80  !9 #  (    4   0J) $  (    4   0O)*1  (    #,38
M )*2  (    #,38  .H<  <   @,   (G      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                         #(P,3@Z,#8Z,3(@,3 Z,#0Z,S@ ,C Q.#HP
M-CHQ,B Q,#HP-#HS.    $L <@!A &4 ;0!E '( +  @ $$ ;@!G &4 ; !A
M    _^$+(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T
M(&)E9VEN/2?ON[\G(&ED/2=7-4TP37!#96AI2'IR95-Z3E1C>FMC.60G/SX-
M"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR9&8Z4D1&
M('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M
M<WEN=&%X+6YS(R(^/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](G5U:60Z
M9F%F-6)D9#4M8F$S9"TQ,61A+6%D,S$M9#,S9#<U,3@R9C%B(B!X;6QN<SID
M8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B+SX\<F1F.D1E
M<V-R:7!T:6]N(')D9CIA8F]U=#TB=75I9#IF868U8F1D-2UB83-D+3$Q9&$M
M860S,2UD,S-D-S4Q.#)F,6(B('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+R(^/'AM<#I#<F5A=&5$871E/C(P,3@M,#8M,3)4,3 Z
M,#0Z,S@N,38P/"]X;7 Z0W)E871E1&%T93X\+W)D9CI$97-C<FEP=&EO;CX\
M<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB=75I9#IF868U8F1D-2UB83-D
M+3$Q9&$M860S,2UD,S-D-S4Q.#)F,6(B('AM;&YS.F1C/2)H='1P.B\O<'5R
M;"YO<F<O9&,O96QE;65N=',O,2XQ+R(^/&1C.F-R96%T;W(^/')D9CI397$@
M>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS
M>6YT87@M;G,C(CX\<F1F.FQI/DMR865M97(L($%N9V5L83PO<F1F.FQI/CPO
M<F1F.E-E<3X-"@D)"3PO9&,Z8W)E871O<CX\+W)D9CI$97-C<FEP=&EO;CX\
M+W)D9CI21$8^/"]X.GAM<&UE=&$^#0H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(#P_>'!A8VME="!E;F0])W<G/S[_VP!#  <%!08%! <&!08(!P<("A$+"@D)
M"A4/$ P1&!4:&1@5&!<;'B<A&QTE'1<8(BXB)2@I*RPK&B O,R\J,B<J*RK_
MVP!# 0<(" H)"A0+"Q0J'!@<*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" 'P I\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#Z1HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KDOB5XO
MN?!?A(7NF6T-SJ5W=165E%.2(VFD.!NQ@X !/4=.HZUUM<A\3/!MSXV\)+9:
M;=1VNI6EU%>V4LV?+$T9. ^.<$$CC..N#C% &-I&D?%;1/$FDMJ7B:P\3Z7<
MY34HY;*.T-F, [XV09<Y! R.XR!G<N99ZOXX^)/B/76\*>)(?"NB:+?/IT;_
M -G1W<MW*F-[,)#A0,@C&.&Y%:>D:O\ %;6_$FDKJ7AFP\,:7;$R:E)+>QW9
MO!MQLC5#F,Y)89/89)P5;,L]'\<_#;Q'KH\*>'(/%6AZU?2:C''_ &BEI-:2
MOC>K&0893C QDX7DCN 8&N_$_P 9P_#;4K7[1;6'B[1=;ATNYN;>-7AG#YVR
M!74@!L>@Z9P,[14\5_%[Q0GP=\+7NA7@M_$5YYYOY3!&Q"VJLLQ*LI5<MM/
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MA@*HP#C)R<=,F+X+7\'PG\/WFDZ9;:7X]T%_M4;)Y0-PXD+>7(X.U\J%P6)
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MXXH ]!\(MXA_L%8_%PC_ +1A81-)$JA9MJJ#("K$$,P9A\L9 (&P8R=RBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ****  D*I+' '))[5R6D_$'3KO0]3U;5XSI
M-KI\JEGE8ONMY K0S\#(#JPX_A(8$\9K9\1Z=<:QH%SIMK(L0O ()I"Y4K"Q
M EVD#[VPL!TP2#FN0U?X:213L?"]RZ0WELEM>QZEJ%Q/N$<J20LC.7(VXE7;
MP/WA/;D WK7X@>';R]CM(;JZ6X><6YCFT^XB,4K %4DWQCRBP(V[]N[/&:>?
M'OAQ?MA>_=4LX)KB25K681O'#_K6C<KMEV]_++8K/O\ PA?W6HZG<1S6P2[U
MRPU% S-D1P" .#\OWCY38'3D9([8M_X U_4/#'_"/R2Z;':Z?IMY:6%P)I&D
MN'E@>&,RJ4_=A5<[MK/DX(QTH ZF#Q]X<N+*YNDO)E2V,6])+*>.1O-.V+9&
MR!Y-Y!"[ =Q&!FM'1/$&F^(K>>?29I)5MIS;S"2"2%HY JL4974," PR,<'C
MJ#7(>+-!OK36)?$D)63[/;Z<D$"03S-))!-.SJRPQNP5EF #!6P>2N!S>\$)
MK3:)KVIW-E%;WVIW\MW:P3"6-!^YCC0-O02 9CY)121SM&0* -"P\80WGBK4
M](DM6ABM(C);W9DW"Z$9"SX7&1Y;LJGKDG\X['XB^%]1LI[NVU"06\-L+LR3
M6<\(DA)P'CWH/,&<#Y-W) ZD5CM\-!IMOI5SH5[=/JMDY$\E[J$[Q7"2J5N/
MW9+(A8MYGRH!N51P*I:OX+O[3PYH\DD\9?1=#AM2((IIS)<Q3VLJ82-"[1EK
M<@D#< <[3S0!T]OX[T>^N[:WL)SYDEZ+.:*[@GMI8G,,DH&QX\[BL><-M&TY
MS]T-6O?B-I T'4[_ $<M?36-K]J2&6*6V6YCS@/'(Z8D3/\ &FX<CU&>;TS0
M=;\8:I)K6I6J:;$VJK,8F69&,*V,UN=GFQHY.Z8?>1.AQD %K%[X'\2:MHOV
M2_;2HI=/T:33+!H9Y"MR7,6Z27,>8AB!,*OF?>;DX&0#H#XNO-'NVC\::=:Z
M7 UM)<17=E>/=Q8CYD5\Q1LI"G<,!@0KDD;>;VK^,=#T.<P:C=2+*)8H1'%:
MRS,TD@=D0!%)+$1MP.>G]Y<YSZ=JNIZ@FI>+K.QMK/3[:8)9Z?/+>M.9%VL6
MS$AX0, BJQ8O[ '*\-^%M3GT/P_?7KE;M-4&HW7VI625HA;/!$"IR5DV>464
MXP=_?J ;TOC_ ,.Q:=!>BZN98IQ*RI!87$LJ")MLA>)$+H%;Y26 P>#S3+GX
MB^%K2Y$,VJ$_+"[2QVTLD2+, 8BTBJ44/GY22-QX&2*Y^^\$^)WAEM+2\MVL
MKF[OKAXDU*XL_+::<O%(6A3?+M1V!BWHI/<\%5T_X?ZO;>%I-.GGLO/==)&4
MD<J/LGE>9R4!Y\L[>.<C.* .D@\:Z3=20&"X$<+F<3&[BFMY(3"H9@8WC!&
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M(9<'GK0!RWB#QEK^DWUII*PVXU)=/^UW+V^E7E_%*^XJL:+"-T08JQWOG;P
M'Y-+;>-M;?Q19PZG9+H^GW;6XBAO-.N-T@EA#8^U*3''(LI,?E.H)*\-\PK?
MN? ^@7-C:6C6DT4=G"8(FMKR:"0QMC<CR(X9PQ )#$[CR<GFI%\&:"FJQ:A%
M9-%)$Z2+#%<2);[T0(CF ,(BRJ% 8J2-JX/RC !SWCGQ%?\ AW6;J^L9-WV/
MPS?WJ6\K,87ECDA*EE!&>I&>N">>:9+XL\26.M3^'KUM+EU.62S6VNH;618(
MA.)R=Z&0E]HMGP0R[BRCY:ZS5O#>DZX9CJEIY_GV4MA)^\==T$I4NGRD==J\
M]1C@BF:CX6T?59[J:]M&>:[2!)94F=''DLSQ%65@496D8AEP>>O H \]A\9^
M(-+O;C1Y[A)=1FU"]D:[33+K4(DBA\E0J00L70,95/+;4Y&6)!._#XSUN6XT
M2VFTZ"SN=<B5XHKA'1K-D_UXE5BK,"/]7@*23A@.IUU\ ^'8[%+6"UN8 EP]
MR)X;^XCG\QQAV\Y7$AW8!;+?,1DY/-68O"&A0VLMO#8".*2.&+"2.NQ83NB"
M$'*;6^8;<?,2W4DT ;5%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4450UW54T+P]J&K
M202W"6-M)<-%",NX12V![\4 7Z*\X\._$C6M;\!3>(?[!T\^7=.@E75XTM%@
M7<6E>4@LFW;M(V$D[6 VD[5G^+#0VUM<GP_-%#'8VM]J:7,YBELTN)?+4*FP
M^800S$$I\H'<XH ]&HKB]'^(7]J^*8M.;31#8WD]Y;6-X+@L\LEJP60/'L&P
M'YMIW-D+R%R*ZNYU&QLI%2\O+>W=_NK+*JEOID\T 6:*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *KW\$]SI]Q!:7;V4\D;+'<QHKM$Q'#!6!!QUP1BK%% 'F_A/X;
M:[X6M=1N;/Q':P:MJ.H?:KAH]-#6LB OA6B+ALG>6+*ZX(4<A<M%%\&X[:PM
M["UUMEM)+2WM-322VW-<K%.9P8VWCRLL[KC#@*0!@C)]-HH XK1OAY_9/BB+
M46U,3V-G/>7-C:"WVO%)=,&DWR;CO ^8*-JX#<EB :Z3Q#_R+.J?]><O_H!K
M1K.\0_\ (LZI_P!><O\ Z : -&BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MJ."XAN8_,MI4F3<R[HV##*DJPR.X((/H0:DH *SO$/\ R+.J?]><O_H!K1K.
M\0_\BSJG_7G+_P"@&@#1HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHJO>WMOI]JUQ=R!(U_,GT'J:F4HPBY2=DAQBY.RW+%%
M1VTZW5K%<1Y"2H'7/7!&:DIQ:DKH&FG9A1113$%%%% !1110 4444 %9'BR*
M.?P=K$,]Y<6,<EE*K75M&SR0@H1O55^8D=<#GBM>B@#YG\-:_P"%]"^%^L1:
MOHMCJD$&M*ED8;ADL=4NF#A"Z.WEH%0*7!RNWRR<D U>G6#1;7P[//?^&?$L
M^FZ-!!8Z;/"UU]ND>ZPZ6DA(3<N%C4KYC#;RJ@\_0T%O#;1^7;1)"FYFVQJ%
M&6)9C@=R22?4DU)0!XMX-.?BE:>7M_MO[=K']M[0/.^S^8OV?S>^S'E>7GC'
MW>,UZCXG2[;0+\V\\*1"TE\Q'A+,PVGH0PQQ[&MBL[Q#_P BSJG_ %YR_P#H
M!H T:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJGJ
M>J6VE6AGNWP/X5'WG/H!45*D*<7.;LD5&,IR48J[8_4-0M],LVN+M]J+T'=C
MZ#WKG+*PNO$UVNHZN#'9*<P6V?O#U/M[]_I2V&G7/B*]75-:79;+S;VW8CU/
MM_/Z5U8&!@<"O(C"68R52JK4ELOYO-^79?-G?*4<(N2#O/J^WDO/NQ%4(H5
M%4#  & !2T45[1YP4444 %%%% !1110 4444 %%%% !1110 5G>(?^19U3_K
MSE_] -:-9WB'_D6=4_Z\Y?\ T T :-%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?X6];^3^3/7:*KV-_:ZG8Q7EA.EQ;S+NCD0Y#"K%=:=]4>!*+BW&2LT%%%%
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M0BYVT779?>S"->567+0@Y/TLOQ/3=0U_1])S_:>J6=H1_#-.JG\B<UCM\1-
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M"S+#89?[!2:E_/)IM?X4DDGYZLN> ?!-GX%\,QZ=;MY]U(?-O+LC#3RD<GV
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ K.\0_\BSJG_7G+_P"@&M&L[Q#_ ,BSJG_7G+_Z : -&BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K@?$OQ&N]&^)6E>$].TF.[DNE268S72PN\;%Q^
MY#<.5V%B"1G&!R:[ZN"\>_#N]\;ZSI;2ZQ'%I5M,DLML]JK2QLI)W0R#!5FX
M4[L@8R/0@%G0_B&-9\30Z>VFB"ROI+R+3[L7&]IFM9 DF^/8-@))*_,V0.=I
MXKH_$/\ R+.J?]><O_H!KF]!^'G]B^)(+]]3^T65C)>26%K]GV/"UU('DWR;
MCO ((7Y5P#SD\UUEUIMC?.K7ME;W#*,*9HE<CZ9% %FBL[_A'M%_Z!%A_P"
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MD-S'/+/''G=;R"-\COM5OY,*EK._X1[1?^@18?\ @,G^%'_"/:+_ - BP_\
M 9/\* -&HIKF."6".3.ZXD,:8'?:S?R4U3_X1[1?^@18?^ R?X4?\(]HO_0(
ML/\ P&3_  H T:*SO^$>T7_H$6'_ (#)_A1_PCVB_P#0(L/_  &3_"@#1J*V
MN8[J(R19*K(\9R,<JQ4_J#5/_A'M%_Z!%A_X#)_A1_PCVB_] BP_\!D_PH T
M:*SO^$>T7_H$6'_@,G^%'_"/:+_T"+#_ ,!D_P * +C7,:WD=L<^9)&\B\<8
M4J#_ .ABI:SO^$>T7_H$6'_@,G^%'_"/:+_T"+#_ ,!D_P * -&HKJYCL[.:
MYFR(X8VD? R< 9/\JI_\(]HO_0(L/_ 9/\*/^$>T7_H$6'_@,G^% &C16=_P
MCVB_] BP_P# 9/\ "C_A'M%_Z!%A_P" R?X4 :-10W,<\L\<>=UO((WR.^U6
M_DPJG_PCVB_] BP_\!D_PH_X1[1?^@18?^ R?X4 :-%9W_"/:+_T"+#_ ,!D
M_P */^$>T7_H$6'_ (#)_A0!<N;F.UB$DN0K2)&,#/+,%'ZD5+6=_P (]HO_
M $"+#_P&3_"C_A'M%_Z!%A_X#)_A0!HT5G?\(]HO_0(L/_ 9/\*/^$>T7_H$
M6'_@,G^% %RVN8[J(R19*K(\9R,<JQ4_J#4M9W_"/:+_ - BP_\  9/\*/\
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MRD*2&BD8B-B.,F/IS7<:!X._LFSFTG4+A-5T:"XCGTJ&[CWRV>T[@A<D[@K
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M@$C ZXXKI"<#- #)I8[>!YIG"1QJ6=CT4 9)KR[Q=XU\0QZ[HE[X5N(YM"U
MVRV4J&'[/?2.[&6.65SNCQ&GR;1DL<'/2JFK_%#3/$%J6M+J2U:.YEABT[SL
M2ZG;$-'*"F/W<N5<QHQ#DQ@8&XBN@T?X>:((XAH[6EYX0U*V26;2KF$30O(
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MUU\*3JEOLU?6Y)I+O6%U757@A:#[447;%#&5DW1(@"8.YFRN<^DW_"J; _\
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M%+#!XZ9NZSX"O[W4O[2TSQ";:_GTDZ3>W%U9).;B+)82!4,:I("S'."O/*G
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSERK2*H)&3T] /2M:\T/2=1FEEU#2[*ZDF@^S2//;HY>'=N\LDCE<\[>F>:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=A*Y*G)S/8>$TT%E_P"$>NIK:.66-[J)RK+,03YDIRI)D?(#-D9P#USGHJ*
M,6^\+65_KZ:O-+<+<(+<!49=G[EI&7C&>3,V>>PZ=Z4/@2RM=774+/4M3MG,
M[S7$<,RJMSNG><(YV[MJO(^ I7(8JVX'%=/10!QUW\-=.N8I8HM5U2UBN(7@
MND@DBQ<(TTDP#%HR1M>5\;2N0<-N%)>?#33KZ.ZMY]5U7[%-'=QQV8EC\NV%
MRC+*4^3=_&2-Q8+T  XKLJ* .8U;P/I^H:9);NDES_I5S>K!+-Y:2R30RQ,C
M,JDJF)FY W X/.,&#P5X=UO2K[4M1\2WOVJ\O$@@4?:1.1'%O()<0PC),K#
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MA!"T*LKSR39<L#)MRH/11@#@>^3ZDU+10 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% $%E8VFFV45GIUK#:6L(VQP01A$0>@4<"IZ** "BB
MB@ HHHH SHO#NBP:U)K$&CV$>IR@B2]2U03/D8.9 -QX []JT:** "H+:QM+
M.2=[2UA@>YD\V=HHPIE? &YB/O'  R>>!4]% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
( !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>angiovacpicturea04.jpg
<TEXT>
begin 644 angiovacpicturea04.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #R >0# 2(  A$! Q$!_\0
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MW@20#]"J*XWX1?$JP^+?P_TGQ-8[8_M4>VXMPVXV\Z\21GZ'H2!E2IQS794
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(R#@C@\UR8S 5\"TJJT>S6S/3RO.L'F\9/#2UCNFK-?UY7+-%%%><>X%%%%
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M=+;R/;C1I4YRJPBE*5KNVKMM?O8****S-@HHHH **** "BBB@ HHHH ****
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M> L43<]0N6(."#(01D58^%7['_@#X6ZE;ZJEO<:]K-NRR0WFJNKB"0?Q1QJ
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M44 %%%% !1110!Y[8ZIXI\>7FIW&D:C:>'="L[V?3X'ELOM-S=R02-%-(29
ML<?F*Z!=I8[-VX;@HZ74/$+>&[&RCOX+W5;YXLR-I>G2NC,H7>V!N$8);(5G
M)(R!N(-<KH__  D?P[NM6TZ/PU=^)M&N+^YU"QNM*N+9)HOM$K32Q3)/+$/E
MED?:R%LJ0"%*Y:MXSLO$.M>(=+N9M&\177A]].#'3=#U>*PN+:\+98W#K<Q;
MP$(4".1U!#D@Y0T =#-\5/#ZP:#);2W>HMKUJ][IL-E92RO/$@C+$@+^[QYJ
M9\S;@G!YI9/BIX>CT72]3$MY)#J=Y)I]K#'83M.URAD#Q&()O5E,,H.X #8<
MD#FN3^%O@77O#;^ _P"U+-8FTO0M3L;QUG$@2:6ZM'C )8LP989#NYZ?-@G%
M6--\%ZS;WOA622SVI8^+M7U.X/FH=EM.FH")_O<[C<1<#D;^0,' (ZNQ^(NB
MWFGRW1DN+7R-0ATJ>"ZMI(Y8;J5HUCC92,\^=$0PRI#@@XYJG\1/&0T?PUXO
MBTVZ,.NZ3HQU(?N]WEAQ,(G^8%3\T$G'/W>1R,\WKG@W7';QK=6^GFX>?Q/I
M>LV<"S1AKJ&VBL/,"DL K$V\JJ'*@D#)"G=576-"\3>+Y/B/=OX:N-)&J^&[
M;2].M[J[MVEFEC:]+!O+D94YG3'S$8(.0=RJQG>^(_'NF^%97_M&*_BM(0K7
M%^ME*UM;JQP&>0+C:.Y&0HY;:.:W;Z[33[.>ZE65XX8VD98(FED(49(5$!9C
MQPJ@D] ":\,^+/@OQ;XMMO'MBFCZYJMS?026^B36NNBRTR. VJC9+"MPI>0R
M^=_K(G5BR LJ9V>J?$BUUV]\%ZC#X<EDBU9O+V&!TCF:,2*9EB9P561HA(J,
MV &*DD#D("!?BAH:6^N2WC7FF'1;5;Z]COK22)X[=M^V4 CYE/E2?=R1M((!
MXJ?1_B%I.L:@;+9?:?<&U:^C74K&6U$MNI4/(OF*.%+H&4X9=RY !!/E=U\.
M];U#3?B$+'0=9LXM6\,C3;.WU[61?7,MR#<Y&]KF8(I$L>/G SN)Q7<?$7P'
M>>-O$$4*$V^G7/AK6=(GO5*DP27+68C^3(+<1R'CCY.2,C(!3D^+EKKWB+P#
M;Z*]_#9ZWJ$I\RZTZ2&.]M%L+F4,C2(,#S%A8?=8@9&5))Z?QWXFO?#]OI=G
MI5O%<:UK-Z-/LOM!/DQOY<DKRR8()5(XI&V@@L0%RN[<.0LX_%>M:O\ #NWO
M/",VE0:%=M-J-Z]Y;-#N&GW-N/(1)&=D+RCEE1@"OR\MLZCXBZ#JNJ6^C:GH
M2V\VL:'?C4(+2[<QQ70,,L$D1< ["8YI-K8(#!<C&: +6A:7XDT^XFEUCQ#:
MZI;-$<Q0Z9]G,<F00R-YK?*!N^5@QY'S<$'*T3XF:-]E\.:=_:=UKVJZAI]G
M=Q20V+"6YAE^473HJ@1ID$N3A4W*#@LH.IHOB35-<FFM[OPCK&@IY+,+C4)K
M)T9L@!!Y-Q(V3DG) '!YS@5S7PG\%ZCX;71Y-3L5MY[7PGI.E,Y='9)HO.\^
M,%2> 6CY'!XP3B@#<T_XHZ)JWFS6:ZA<Z;'YP_M2.PE-HQB#%]LNW#+\C8<?
M(QP Q) K8_X2G3?+T)_M!VZW((K$^6W[UC!).!T^7]W$YYQTQU(%<+X)L=>T
MWP/IW@+4O#=[ +/33I']O0SVKV3I'"8XYMOG"8;PJ_+Y?RLV,D#=5+1;/Q9J
M5S\,K.\\*3Z5;^'I]^I7=Q>VS*6&G7-NI@6.1F="\@R6",-R?*<OL +Z?%B#
M2_\ A"[1);_Q#'K4LB/J::9*-R+'.P(6./;NW1 %>H7+$8YKTZO'M-\+^(?#
M?ACX;R?V%<:C=Z)>W#WMC:3VXE5)+>YC# R2(C8:1,@-G![XKV&@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHIK4 +NHW5B^)O%6G^$]--[J$WE0[M
MJ@8W.>N%'<X!/T!-+H/BC3_$D!EL9Q+M"EXV!5TSG&5/(S@\]#@^E,#9I:C5
MJ>#2 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ J-VIS-M%4[BZ6,$DT <W\1-+L
M]8\/RQ7C^4B'>)@"6CX(9A@@Y"ENA!Z\BOE;0_"^J> _.O-"UFY6:VEW0233
M!F2/J58X^<$Y."..^[J?=_B)XD&K3?8;:59(HP&D54W[SSQGMCCID]1QBN$D
MT]H;ORI8_*8KN^88##J,5K%\J$=OX'_:#L=29+7Q)$FCSNVV.^7_ (])>F 3
MD^6<'N2O&=W(KV*&595#*0P(R".]?(.K1GP_.9(K5;JPF.7A<'Y3GG'MD_F>
M<\"M+PE\1-2^'MJDV@/<ZMHZ!I;C1;D;EMESEFC<$L!U/"[1N.0>M4Z:EK$5
MSZRHKB?A_P#%[P[\1(46PNO(U KN:PN"%E&,Y*]G''52<9&<=*[:L6FM&4%%
M%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *2EIK]* *]Q+M4U\??M@_M.:]\-TN]'\*36MM>1QIY]
MY-%YCQLQR%56^7[N"20W7'!KZC\:>((?#/A[4=4N-QALX'G98QEB%4G '<\<
M"ORB^-%QJOQ.2W\3&.XLS>3R27%M,?W:R;L$JQZKT ]L=.16D(W8T>D?LU?'
MCXD_$;QXPUS68;S1+=3+>>9:01&5CD(@=(P=Q;!QGD(U?6.J7T&M0Q/%<>3<
M\G9*V.G8/]T].GX5\Q? WX>Q^'?AY;6T\16\OI/M=P64*RY($:EL'(V\C..7
M.*]DM9I+*Z??+-)9* -Y7G> ,@$Y##/U^@J^7J@;U-LQF9;F&X#*\#%90W#1
M'W]CZ]*XS5M-FTFX\YU=8V?/VJW7@D]V4'Y3Z[>.>!7;0ZK)#^\1EO+?!XD!
M( .21UW)R<G!*D\G-6"+2^MB(&,190#;3$$?\!?HP^N*49<N^Q#78\YCLK2X
MB6\C1K>97#"ZL_N9'<J.F.Y7TZ5ZKX!^.6MZ':Q1:R/[<T\$*+Q7!D48'&_&
M"PP?E?!RW+*!BN2L_A;K6I7[?V%"YGVEV5)E0D<9!W$!AR.M9UQ8W&AZA<6U
M[:MIVLQ'8TMK/LW\\@[>.G?..,5M>,E8-=SZS\.>,=*\50AK"Z5I=NYK>3Y9
M4'')4]1S]X94]B:VZ^0K'QA?:%(AN[5;Z"*3>K+^[GC/)W?+T.3]Y<$X'->T
M^!OBUIVJHD,>JFXX %KJ"A+E.<8#CY9.!P,;CGDFN>4&MAGJE%97_"36 16:
M20 DC/DN0,=<D#C\:MVNJ6EX^R"YBEDVARBN"P![D=:S&6J*** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *BF; -
M2&JEU)M4F@#DOB%>6]MX:U&2ZW&!8F9]@RVT#)('TKYYTGX6:)KWA>'2TGBD
MM+2\\RVE6,?,KG>493G/WV7/MTKU3X@,_P 09#H>E7<,MO#<>7?-'(K[64;O
M+( )!!VD]",#UIFA?#5O#NFI:V44\KN/,:X9@F&QTZG Y[?G6B:BKWU#4X+4
MO",_AV,9MGU*U08C9E5RO08C90K*?QKF=D%N\HM)I-/N9?E>&3*YYQM+ !3^
M(  [FO>K71]9MA,UP+22'@!878MCN"#G/UK*UKP?9:I\US9W%J /O(AV\^G%
M-5.X6/-K%3"L431F.8C<"I^5AV(&<_B.*G9EA;<T6%XW;3P?Z?IGWK;_ .$)
MDTR&1;"Y2> L7,4O(W8QG!XSCN0*R[BX:WF\FYMS$_.%*EP>..00W_CQ'M0[
M2 ZGX;^)H]#\02.PVPS 0_O'PHR1SGG S@<GO3?&WB&S\16$]G%$IC>Y>X^U
M;%8*N=@&X9Y7]V2<Y_6N/U"U@-OY,1DA9\1^<R">'K\Q9EPR@\XRIZBN6DTW
M4;J9)K%(M5_=O=-]E8/(XZ1@HOS!2N2=R@X./X:SY=;E'0VTFI3S&VAE>]B5
M6D-O=?O%55(!PXY7'X=*]Y\(_#G1-+L8KO4-.@&HEB[^<5D*'..H'/&.OK7@
M'@F]O[?552Z9F+3) \LB8W-C=)]!@8(]5]Z]@7X@V]]$/+<G=)C(.. .>?88
MJWS;$Z'?WVI6MC"%M+<,@.':%0%3CO[^V*Y'4-<L;Q=CE$F5PRR)A,'U(]>!
M^5<I=>(#-&IA8Q\;L(W3G!KGM0N)I@WF8D4G&[&#WXHC%=26>D:5\1KO1Y=E
M^#>V?3<#^\7Z?WOQ_/M7I.GZA;ZI9Q75K*LUO*NY'7N/Z?2OEN+4I[)A'-NE
MMVX#=<>U>D?"CQ.UEJ0TZ1\VUT?ER?NOV/X]/RJI16Z!7/9****Q*"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!&K$\2V,^H
M:3<V]O*T,LB[0ZG! [X/8^];E121[J /$_#_ (7D^']O-;16*16S'*X3,<8P
M!M4(.%^7I5B3XE7<-Q$D5@LZN#\T-T4; SG*N$QTZ5ZS-9J^<BL/4O"%AJ ;
MSK5&+#!(&#573W0' 0_&:WDA1KN&ZM(I6,:^=(RAL=<%L*?P:M6'QUI<JK*T
M\T:]FD7<#^(R*34OA=$P/V69HQA1L;H%'\(_N@CKCGBN-U?P!>63M(;>1&QS
M+9ML[],=#P<Y8'H:=HL#O$U2RU.3=;7T,CXSM3;D?@.E96N:;#(N\QI)M/&U
M0>?PZ<_RKS6XTZ:'Y@D=Y,O.''E28!()ST/;KC-6M'\47$,T2B61R@R;.[;8
MQ_W3_P#7H=/JAW&^*=%= 3ISA9U58$*G;(2Q 8Y&,X7YAWSFO/Y%%U(WVFW\
MN,R//(T2C"PP8 ;'?!.<=PQKU&?Q1::A(8[B-K2Y"LL;..-[<;C[#^IJGK6B
M6MVA3;OMWDCMXY(^2(E4NW/<,04_&DKQW*W,;P_KFLVL()O6NX8(-I@O%%R$
MED(;8$<$J%&, 8X:K]SXQDC2.%]&L,R/Y:O K1G: "Q.U@.Q[5#J-D\5X"?]
M6@:9BIR<GA<'\_RK#U**?+G),BJ(5)!SO8C<WX#GZ9]*TC9D,TIO$D=PRR0V
M2P1E=[;7W80?7G)_IUJY;Z\DL8::/&T!VP>5SP![FN=^SI(5 7 9U0J3G"(3
MD>O)R/RK0M9!M#L RC,[;>I/1>/I@_A5,#:N+BWF;A4551495P!N]_?%6=(N
M#I>H0N&VO&?-1LXP 1@UB>6(PR*Q5HP@SG@NQY_+@_0U77[3-J@8 -:1NNXA
ML_NX_F<_]]?+BH\AGU;I'B+3=<CS97L-PR_>C1P73IPR]1U'7U%:5?(\4SF,
MIM^S7OE!"0H!6YN9!N/'=5Q^!KK[3XDZWI,P:WU-WMS=R$0W&)1Y$49!R6Y
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M5HQ]"3Q]*]!E\8110JJZ<0P2R3&!_$QXZ_PBJ$GCF3R[ATT\ [;]EW$#.P@
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MO5?)%(T I@?.FL?!74+>S\JU<2!+9H%92 <L1N8CUP./?ZUR^H>#;_3YC'+
MUM;EXH]NP!$@BR_&1QN)*X],=,5]7/:ANU59M,CF&&0,/]H9H"Y\C1I?VD9N
M<2KY:RW\R1M@%G.V&,CD<+D8XZ?E9_M#4;96@8I/)&8K0MLV9=\>9M'(X!!)
M]/I7TS>>"M,O#F2RB8Y!!"@'@Y'ZUD3?"_27D$BPO&P=I!M;(W,,%L'OCO5*
MR'S,\(AUL23-&]NWEO<>6C+\Q:.#\1@;@1SUS[U6BUJ*2U>YVF)1:338;.?W
M[[D[#@;2,]Z]ME^#FF-#Y:M)&OE&$;<<*3DCIU)ZGJ:K?\*3L/FQ=7 !=)"
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
F**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>angologoa15.gif
<TEXT>
begin 644 angologoa15.gif
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MZM7:X>'CY_3CYOSBZ>+H\?#Q\_SQ\_#S^
M
M
M
M
M
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M^DJH<JNO.RS)9QW"5[J21+(I)8DH#"" "$!&GAFQQ-[.LP(34$2C5A(%A?+
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MD;P;M>EC2OOZ1\7@42@J#50PT2%9@QH%/21$IPZ%"#<]T>?0N@5ITGHROX5
MA>D#P<604V3LCU+P0M"Q4SWD"-ITBC=MD25E#.TY4XA(0&+,"5Y,T9UZP9Q(
M0"&MESY='5#L#5&MBCTE"7/DPCE<Q[UQ@15(C%/@NY"S*#"I S#=%4FHT!>3
MU(A A8*3 W034X)H4?Y(S)Y9U'3;57VSC6N,G]0@T_C@'1T=B%CSFE:#S#5X
MA$N"U.W9U(P85D*C$.W4'%+=BH);@V]5B&D%3#_0.ZYP-W0CS8:0SBMCMC5
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M6\)/:%O$]1%0$)@Y>+7+/5D-!#N-/"/*95S,Q=P33%F<<<#^E;U<8&%  DO
M@1A$R8T/4%A<@KG<QXU<U[7=X*A<T'7<!4Q8HE#<!]1=M&7"VLV*#MC;(3G0
MMPF"%Y#0DM!2+BTN,)$!2KC=ZK5>@''6Z]7>^-C#T=W>[P7?\#4Y5<4+OL4.
MMSG%PX4(4K X!_4!",T/XQ3?^:7? L+1^L7?B\ RCH#1_/7?_P7@"-K"XP60
M)9@>):@!DMB$]G5?+VW> (;@Z\W>",9?8QP(I*7@#-;@#2:)E,0+!<,..CBA
M'9#8B&"$P87>M;C8%>B"!^;@%][)"8;A[7W(&9WA&\;A%QY0O"  "8","+
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4$1 /#@T,"PH)" <&!00# @$  #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>bioflopicturea04.jpg
<TEXT>
begin 644 bioflopicturea04.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $T F<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA1Q<HP5EHS[KAK$U<5EE.=9W:NK^CT"BBBO(/J HHHH **** "BBB@ HHHH
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M_/LO)'[1Z;J5IK%A!>V-Q'=V<Z"2*>%@R.IZ$$=17Y0_\%2O^3B+'_L"P?\
MH<E?3_\ P3Z^)VL:QI>J>#[NWFN=-TX>?;7F,K"&/,1/N<D?C7S!_P %2O\
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MQA"-/G6YCM8/*>1#E2V22 >]>SDD)/%J26B3/D^+ZD%EDH-ZMJR^9J_LQ_\
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M^B+EOTKYV,ZV'Q+;5Y'VCAAL7@XJ$N6&GRMT/Q4_X9K^*O\ T3WQ%_X+Y/\
M"C_AFOXJ_P#1/?$7_@OD_P *_:;X7_'+P5\8H;I_"NLQ:@]L^V6%@4E7T;:V
M#@^M> ?MP_MF:C^SXUEX;\-Z4[>(KZ/SQJ-Y%_H\4><?)_?;/'H*]*&.KU*G
MLE#4\NIEN&ITO;.H^7R/S8_X9K^*O_1/?$7_ (+Y/\*/^&:_BK_T3WQ%_P""
M^3_"OK?X!_\ !1;Q5XV\;6WA?QS/9V%AJR-:0:K8P;)+6X;B-SR01G^=8GQ
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M(S*ISGK7)B*G)$VIQYF?//[4OA'2_%=C:ZKJ&KII)LI @EFD(B968?*1D<Y
MP1CIZ5\W?VT?LM_I5M<S6EJR>3;6;6ZR&]N!@/%,,$[VXP0>^17M/[3OPO\
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M+8^*=8^+7AW3_!][<6&LW-RJ+<6[$>7'U=F]5"@DY]*^J?V]/CI\(]1NM,\
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M+O[;?,'?_EG%_#$/\:/:)K0.7N)/)<^);H7%X&2W4YBML\?[S>];NEZ2;AL
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M B#L*EKLA!0.>4G(****T("BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MSKIE4*H X I:*TC%1V(;;W"BBBJ$%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 45'-<);H6=@H]ZR+[6MJY#>2GJ?O'Z"I<DMQVN:5Q
M?16[;2=S_P!U>361J/B)RQAM$^?O(W1:YZ_UTD,L1V*>K9Y/XU7T6ZDGOEC
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M]*T;.QAL81'"@11Z58KOI4(T]>IQ2J.04445TF04444 %%%% !1110 4444
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MPL9BO;M1CL@HHHJ#S0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB@"S14:L:DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "HKA0T9!]*** ///%VGP%BVSFN#O+6+KL /K110!26, U(%%%%
M$T*AB :TK>PCD7DM^8HHH NQZ1 1U?\ .K$6C6^>=_YT44 7H=#M?EX;\ZM+
MHMJ/X3^=%% $Z:/;+T0_G5F/2[=>BT44 68]/AZ;:LI9Q#^&BB@"PMN@[5,L
M*^E%% $RQKZ5(J"BB@!^T8I-HQ110 S:/2FL@HHH CVCFCRU]*** &^6OI08
MUR.*** )!&OI3U4>E%% $JJ.E2A1110 ]13Z** "BBB@ HHHH **** "BBB@
7 HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>ex1011amendmentno1001.jpg
<TEXT>
begin 644 ex1011amendmentno1001.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 0  Q<# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSI5U%8:AJNEZQ=ZU;:_=ZZDR7%Y=74!'EF4S*Z,BJH58]NQ !L"D"@#D]/\
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M /6N[H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** (KHS+:S&V2.2X"$QI*Q5&;' 8@$@9ZD
M_0U\\_ W]HGQ-\2/ W@.*31M.OO&FO>$SXKGC-\UO:K"61(TW"%BK.\A7 #!
M%C)+,< _1=>5>'/V;?"/@^R\/0Z%)JFE7&@6D^FZ;?0WK-/!8R[=UIN8$-"/
M+CVA@2I0,"&RQ .I^%'Q%LOBW\.?#_C#3K:>SM-8M%N5MKH 2PD\-&V"02K
MC()!QD5UE9GAKPWIG@[P]INAZ-:)8:5IUNEK:VT>=L<: !1D\G@=223U/-:=
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI5C"WLYCE0I( QVE &.?E10,#K]2:/X+T_1+S6YX3+)'K$JS75M,5:'*PI"
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MJ%R;V]N97,DMS.55/,D<G)(1$0#HJHJ@!5 &S0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGB6WUNTU/6;.2TUY?$MKI\%U'':QWHM&M'P/++;'A<H5W';_  ;,G/F?PJ^
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M\3^&_$+ZQK.HZMH=C>V,=S?W"2M<K=20R3M,=F2Q:V@QMVJHC"J%7BN9T_\
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MQ-;(!Y.&V8*?,#O5COWGFO0_ W@/2?AYI5U8:1&R17=[/J,[,%!DGF<O(^U
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/\
MQ MO$5YX,U>'PG+90^(W@(LGU%W2W\S(X=D5F4$9&Y5)&<X.,5T%% 'FMMXA
M\3_#^Q\;^(_'TNCP^%].LK>]L6TRYGFGC6.VS=1R+(BC_6JWED%F</\ -M(
MKS_]G3X[W6H:7\2-+\?:]I=UK/@^Y;5KN_T^=9;9=,N8S=1E74G<L!^T6^>N
M+8$\FO4OBKX?U/Q)8:1;V%M<7D5MJ$%_-!!=PVZRF"198E<RQ297S%5L+M.4
M'.,BO.?&'PMU?QM\0)/%>H>%;E);GP_<>&+_ $V'7;86FH6$S;FCF!MRY*DL
M5*NI&]^S'(!S7B#]H+6?#'Q1U7Q1J.EZK%X/L/A?=>+5T2.ZB:241SQ.69,A
M4F6/<"-S##?*S'(KJ?%'[4MQX2?QG]N\ ZJL?A6PLM:OY%OK8_\ $MN3.%F
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M.PE1A!\V64'!UOX>:_XE^%_BOP-JOAJYO[#Q*MXM]?RZU:?:_P#2"VXJ1;!
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M/?S,>U='XR\)Q^,M,M[&74+S3HX;VUOA)9>5N9[>=)T4^8CC:7C7. #C."*
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M7E;_ ++&FW-W>W-WXS\2W,UW=:+>RG%C&/.TN=)K5@JVH &Z- R@8('&"2:
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M;1]<T_7D^UVL'B WHFL2PO+K5[N&ZN)AB4>6JR6Z!4Y^4D%B?FJW\,?@%/\
M#G4?A[.?$,>HQ>$/!Q\'I']@,374>ZV(G+>:VUL6D8*X(.YCD<  '0Z]\49-
M)^+FD^!H]"OKO[=H=YK+ZC;M%MB6":WB"A6<,QS/SA3R4P#EMO$>'/VD]"TO
MP'X5D'_"3>-;J^\'_P#"5QWRZ=!%<7EE&(?,F<!HXDDQ,C%!@<X'S%5/=^(?
MAQ>ZE\5=!\;Z=K,5A/I^DWFCSVD]D9UGBGEMY@RL)$V,KVR@Y#95F VG##SW
MPO\ LNW/AG0?#&E+XKBN(M"\"W/@>-VTLJ98I3!_I!_?<,!;1_+T.6Y&0  =
M)9?M,^$+A=1EO(]2T:TM='M=>ANM2MUBCO;.X?RXGB^8MDR83:X1LLN 0<UT
M?PS^+OA_XK+K:Z-(XNM%O!97]M*T;F*0QK(A#Q.\;JR.I#([#J#AE('G.I_L
MLR:Q8VMO<>+9+>2T\+6/AZVNK&P$<T$]G<I<VUZI:1EW++%&WEE2#MQGFO5_
M >B>(]%TIU\5>(X/$NKR-\UU9Z=]@MU4#"JD/F2$'J22[$D]@%4 '#Z+^T-9
MWNL^-K*^T.^LAH7BB+PM8X>%WU.Z>UMIU2-1)PQ^T,V6PH1=S,I#A>V\#?$/
M2?B!'JZZ>9H+W1K^33-2L+I0L]G<(%;8X!(.4='5E)5E=2"<UYIK/[-$U_KG
MB'5++Q3]AGO/%UKXUTW=I_F&ROXK2&TD64^:/.ADBA*[ (V7S7^<G:1WWPY^
M&T?@2[\4ZG-=KJ&M^)M3_M34KJ.$PQ-(((K>-8XRSE%6*",8+,2=QSS@ '!:
MQ\=DU/3O%0G@USPG:Z%XST[PTNJVD5M<M<227%FNTH6?8DCW B9BH(20,"'R
M%T[[]ISPW9:S<6 T?Q#<I;>(AX6GO(+%3%%J#0I+'&07#D.)% 95(!^]M!4F
MCKW[.]]JUKXNL;?Q3#:Z=KOBK3O%:12:69)+>>VFLYS&S^<H=7>QCQA5*J[@
M[CM*H_[.5T;S4[A/$T2F]\<P>-MITTG8\<4,?V?_ %W((A4[^#DGB@"]_P -
M0^$8_#ZW]Q!?V.H&\OK!M$O3;V]XDMFP6X!+S"(A2T>"LAW>:F,DXKT3P1XR
MTKXB>#]&\3Z%<&ZT?5[6.\M9F0HS1NH894\J>>0>0<BO(6_9NUW2=?\ ^$E\
M-^.8-'\3QZQJE_%<W&B_:;5K74&A>XM)8?/4O\]M;NLBR(08QD$$@^@^'-&\
M9Z7X\N#?Z]'JWA'^RXHXXI[-(K@7P;YY1(K'<KC<2I1 GR!<C. #B_C/\:-3
M\-W'COPUHNGWMGJ>C^"KKQ+%KJ?9WBA<"80CRW))^:!@<H>HXQDTWP=^TQH*
M>&63Q,;_ $S5M,T32-2N9=1ACA6^6^+0P20_-@!YXY$PXCVG!("\UJ_$GX&W
M7COQ/X@U6U\1)I4.N^%)O"U[;R6'GGRV,Q25'\U-I4SOE2#NPN"O.>6UW]E*
M779YKO\ X3&73]13P]HFCV%Y9Z>%>SN=+NI;JVN\-(P?,DI#1$8*C&>2: /4
M/AC\5]"^+.G:K=Z')(3I>H2:9>0RE&:*=%5\!HV='4I(C!D9@0W7(('#ZY\3
M/B%X)MK[7O$/@U(_"VE7&M7.HW-MJL#R1Z=;Q>;9W"1[,L)%5U:/(=7"DG:2
MM>D>!]&U_1='9/$VOP^(]8ED,DMU:V/V*W4;54)%"9)"B_+GYI')+,<XP!>\
M46L-]X<U.UN=+DUNVN+:2&738B@:Y1E*M&/,9%Y!(^9@/>@#RWX<R_$'XA?"
M?P]XS?Q0NF:_KMC;:LFC)9P/IUK',JR"VR4,S,(VVF0R'Y\MMVXCJRG[3OA4
MOK#R6.LVECIE[-I;ZE>6J6]K+?1W"P&U221U!<LP8$X3:&)8;&QS?P[TSQ]\
M._#FG>%+?1?$E[X4TN)+2P2:UTO^THK5 !'"UU_:>Q]J@)O\D,5'7=\]8%W\
M,_%$W@[5],M]"\56&LR>*YO%^E:O;P:5_H%T\YEV/$VI$31_,Z,"5W(YY4X(
M /2/#_[17A?Q[IPB\._VEJ&LS/J%O_9EBD#W<+695+A]S.82JM+ %<.R,9H\
M;@37G/PJ_: O9_AOX*\2>(=4UG6M<D^&]SXHO-)@LK:&"_,;6YDF\PJNR92X
M4("$Q*Q(R!BS<^&/B/+XK\,^,X]-UW_A-=-M+K3K^ZFT[3'L+VTN'A=HDMAJ
MRM#L>WB9&\UR/GW;]W'/^$O@IXC\/Z!X>TB\T'Q+?V^E>";[P4SQ6NEPO-%<
MM"?/&=38*R^0@VX(.6Z<8 /I7P!XEG\9^"-"UVYT^32I]1LXKIK25D9H]Z@]
M49@0<Y'.<$9 .0/,-6^-^J:-^T5H?ARYMHX_ 6K"?08-2(PW]NQQ)="/=T\M
MX#*@Y_UL+KC(K6\"ZWXN\)> ](T*[\$>(-2U#3[-+07T2:9!$^Q=J-Y7]I,1
MP%R-YR0>1GCR_P 6?!>Z\3?#*UT6+P#K&F^-8+ZWU<>-8+'2#=_;X[H7+7(7
M^T=P+R!LJ7*X<C&,  'KOC?]H'PUX#O]4M[VWU.[BTFZL+'4;JQMQ+':7%ZZ
MI:Q,-P=B[21#Y%8#S4W$ G&9<_M/^%K*\\01W.FZY:V6B7K:7=:G<6:Q6GVT
M- J6P=G'SN;F+:2 N-Q+*%)KYZ^(TWQ#U'XS:U>:=\/M<CU6X?3IK:RU+PB+
M_3+Z>UC#PS2W5OJL5O&1,S8,QE>+RT8,<*J^BZK\,O$NJ>&_&E@N@>++#4M:
M\3Q^*]-U2SBTE7TN\C\CR@4;4669 ;=0P.W<'<<9! !W<7[5W@6XT22]AN)9
M;N.]N[!],\^U2;S;9(WFP[3"%U"S0$%9"#YR 9)P*>H?M?\ @>U\/WVN6EIK
MNKZ58Z!9^*+JYLK#Y8=,N3,%N#O93\AMY=Z#+C:<*<-CE-:\+_%/5;KPQXC2
M+7[?Q_HINX3J?]E:4VFSV=R(?.M39_VJ'5=UM;R*WGE@Z$Y*G;57QY\+?%/C
MJ+Q_'<Z'XH4^+_!UOX1N9I;?2GEB6-KMFN01J2J68WTWR!54;4QP"" >H2_M
M(>%;*Y\1VNIP:AHE_HEQ:6[VFII%;R7/VK?]F>(M)M"OY<G^L*%?+8N% -9M
MA^U7X4UN/3DT;2]=UW4;YM1BBT[3K6.67S;%U2XCW^8(B1O5E(<JZL"K'(SY
MYXS^%/BSQ5XNU_Q7;Z/XHT?Q'>/H]UI]W;6NE,EC=6 N%5V1M3/FQRK=S(\9
M*G:W# \UTD&B>/;CQ;X1\4:OH?B#4]:T.WU"*1EL]+B@G:Z6(?NXQJA,2)Y"
M84LY.6RV3F@#23X[3_%C4[?PUX#34-._MWP7'XHTWQ2(+>7[.MPVVW/D2N,D
M;6!5AC<5SQDT[7KSXE_"SP;XT\9Z]XF@\16VBZ19ZHFD0Z?#"C-;6S-J4:.O
MSL)MI>-FVE'X(*##<[\#/A%KOPY\3^!F_LS7(+31/"4'A"ZN+^UT\1SP6[,\
M$N8K^1XVR<, D@;(QL&37KOQIT+4?%_PM\3>&=)3_B8Z_83:1%,RY2V\]#$T
MS]L1JS/CJVW:.2* .JT75[7Q!H]AJEC)YUE?01W,$F,;HW4,IQ[@BLCXE>.;
M3X8_#KQ1XPOXI+BRT#3+G5)H8OOR)#$TA5?<A<#ZU'X*\)W_ (0\^P.K1W?A
MVWMK2TTC3A9B.2RCBA$;AY=Y\XN0&!VKMZ<]:V/$6@:?XK\/ZGHFK6R7NEZE
M:RV=W;2?=EAD0HZ''8JQ'XT >8^![?XB>*/A[X6\47'BI(->U1;#4[S1ULX/
M[.A@D:.2>VB.SSLB(NBR-(?G^;&/E$]W^TGX6TZYU.*[M-8MELM'U'75>2SY
MN+.QG6"YDC0-O&UW3 =5W*P9<C)&A\/_ (<^)_ VA:9X;?QE%J?AS2XH[6T:
M32]FI&WCP(XY;D3%'.U0I<0JQ'/#?-7CWQ _9PUWP[X8\4^(H_$K^(]0B\)^
M)-'6SM]#=[[4QJ'E2Q^9(LKM),KV\2;@F"@ "IC- '6^+/VG/#5_X3\;6PN?
M$W@S4-,\/+KT=ZVE1FY:QDW*MY;1R;T<*RX*R $'&1R#74O\=(;7QIXVT6Y\
M.ZJ+7PT^G6WVRW6.;[7<7C((HT17W $RQC<P"KAR[*!D\._[.]Y\3_AQ=MK>
MNK9ZQK7@N'PO#+_8TENUA;MAYM\,DNYI68)G)0#RQ\O)STGBCX"ZQK>N^+=2
ML?&$6F?\)$VE7-Q;G3&E1I[-X\I)^_7S+::-#&\/!(=OWA!Q0!3UKXUR^(];
M^%MQX:N[O3[+4/&]]X8UJPN8(2SFWT_49'C+#?C;-9QD-&^",\D'B_H7QMT[
M1_ >J>(KF77=?TNSU#6S>7][#:6?]G1V=[)%+%)N>)0D1!C0\NZQY.3DUF^'
M/V:K_0+G09#XJMI8](\:7GC"&&+1_*3-Q;W4+VP FX4"\E(;_9C&WABS#^S1
M?SZ3I^CW?BNVO-!A\3ZCXJNM+ETEO(O[BYO)+R*.8"XRT<,TK,%SARD98?*0
MP!JZE^U5X*T2STFXU,7^F&]AL;B>WO$BBN-/2[<)!Y\)D\S))!945S&OS.%'
M-4/&?QINKOXB?"VQ\,2WW]AZGXOO=!U*^$$+6=W]GT^^>6%6;,@9+BV #*%!
M,4HR0*V4^$7BRQ\?W/B/3/'J6$&L1PKK^G'1Q(MR\6526U<S9MG\LK$2PE!6
M-3@,"QYO2?V9]:T'5_#4=AXVMAX6\.>+[KQ9INF7&BF2YC^TQWBSVK7 N &3
M=?S,C>7N4;0=^,T >A_$[XFO\.[WP;:1:)=ZS+XDUI='C^RR1+Y+&":<L?,=
M<_+ X&#]>P/,7O[57@*Q\2R:*;R>>;;J AFM1',L\EBK-<Q*B.9%91'*09$5
M6\MBK,,$]5\4/AU<>/SX4N++5DT?4/#NM1ZS;S2VOVF-V$$\#(R;T/*7#X.[
MA@I(8 @\=HOP'\0:#IOB7P[;>.@W@K4/[0?3])ETD&XL6N_,,B/<"4>="C32
M,B;%8?*"[!<4 /T[]J'1-5FT*WM?"GBU[O7X9;G1[>334C;4(8X(9S)&SR!0
MNV=!EROS!@<8Y9I?[67@K4=*M=6FM]8TO1[SPS/XKM-0U"S$45S90>3]H"_,
M6#QFXB#!@H._*EEYK0T_X'W5AJOPLOQX@B>;P+I-QI: Z>=M[YL$4/F'][\F
M!"IQSG)Y%<UH?[,6H^'=%\"65IXOM6D\)>%[_P ,P2SZ+YB7*7+VK&22,SX.
M/L<8*=&#/R,C ![+X9\2+XGM+B=+&ZL!%-Y0%UY9$H**ZR1M&[JZ%7&&#>HX
M((KC[;X\>'[B\M;8V>I0R3^)9/"A\R*/$=\D1EPV'/R%5)##/3G%6O@[\(K#
MX-Z1K&F:5+''IM]J+:A#IMI$T-GI^Z*-&AMHF=_+C+1M)L#;0TKX !Q7$W/[
M..K-XO;4K7QC;P:.OC)/&4.GR:.7E6<VQ@FA:;SP&1MQ92$4J20=_& #K(/C
M[X6G\(W'BGS)D\/!;8VNI,\/DWK3RM%&D;"3"OO 5EDV%-P+[1DBEX=_:*\+
M>.+,0Z!]OU#6);R]TX:79B![E)K5%>8[C(82JK+ 0^\H3/$,DMBN./[(\:+K
M-_9^)DT+Q-J L;G^T]#TQ;6%M1M9C*E_/;&1HY97^Y)C9O4N#R05Z.^^"_BV
M^\1>$/%[^.[-O&^AK>6T]V^AL=.N[2Z$/FP+:BY#Q@-;0.K><Q#!L[@V  :O
M[-WC#5_B+\!/!GB+6[R2XUC5-.6>XNFA2)RY)YV!0JD<<;<<=*X/X*?M*V[^
M"=$B\>7.H1ZC-INKZM)XBO+2.&SGAL;EEGQY>,-'&T;8\L @$J6(->H_!;X<
MW7PE^%FA>#Y]7CUN728#;IJ M/LXD7<2N8][8(!P<-SCM7FG_#(\%_X7T#P[
MJ_B3[;I.G:5KFDW"V]B8);B+4SF1E?S6\MDP-IPV: -G_AKCP,(;XF/5'N+.
MYTRV>UM8([J1O[0G\BU=?)D=2&ERA7.]2.5&5S9O_P!J?P;HU[86>K1:AI%W
M/<VEE=6MZL*3Z=<7)40QSQ"4OD^9&28U=5$BLQ .17NO@CXU\2>#;#1O%7Q'
M@UZ\L-7TG4[:^301;@BPNXKI1+&LYWRRO"@>0,JX^Y&F3G87X1Z]I7Q2UOQ+
MH/C(Z7H/B*:WO-<T.33A,\US##' )+>X\Q?(WPPP1N"DF1&"I1CF@#*T?X[Z
M/I"I!+<>(_$][J_BC5=%L+?^SHEE2YMDGF:T7;L4(J6\BH\AR<9=L98>A?#C
MQ]IOQ0\%Z;XFTF.Z@LKT2 07L7ESQ.DC1R1NH) 971E."1D<$BO.]*_9YO-+
MUW0]3'B:"1]*\8ZGXN2,Z80)&O;>Z@> GSN HNY"&[E5XZY[;X0_#V3X6^!K
M?PY)J2ZKY-U=W(N5M_(SY]S).5V[V^Z92,YY '% '*W?[3WA*PM]8GNK/6K>
M'3M"O/$8,EEA[FQM9O*GECCW;QM;:=LBH2&! /.+-A^T9X:NKC7;:ZL=8TJ[
MTK^S2MM?VJI)?+J$CQ61@ <[O-DC= &VE2IW!0":X!OV1M5N;2_@O/'D=Y)>
M^%]8\+7%W)HO^D7$5^\3&YFD\_,DZ^4 6X##&%3!SM>*_P!F&Z\4:MJ&KCQ8
MMCJSV>@)87$.FDK:7>DW%Q/!.5,W[Q':ZE5XCC*X <'YJ .@^"7CG7/&'C'X
MNV6KM>1V^A>)H]/T^TOXH4EMH&TRRN"A,7#*9)Y&5B6)5ER:?J_[1_AS1?%M
MWH,VEZZ[V.NV7AV]OTLA]EM;N\$)M=[EP2DAN(E#*&P6&X $$Z?PN^&NL>!_
M$7CG6=8U^SUNZ\5:C;ZG*EEIC6<=O)'8V]H54-/*2I6U1N3D$GDUS7B7]GJZ
MU_5?%5XGB6&V_MSQ1HGB<(VFE_(DTTVA2+/G#<K_ &*/)X(W-@=, '0+\>_#
M1U+38"E\MAJFK7&@Z?J[1(+.[U"%I%>W5MVY6WP3(K.JHS(0K'*YO_!;XER?
M%[X>:?XJ;1KG0H[YY?*M;J2-V,:R,JMF-V'08.<'(;C&">.\/_LV1:*-)TJ?
M7OM_A'1O$\_BK3-+DL\7$-S))-,(GN/,P\23W$DBCRPW"*6(!W=E\&_AU<_"
MCP):^&)M636+:REE^R3+:?9V2!G+JCC>^]P6.7&T'CY5H [BBBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *SO$7B'3?"6@:C
MK>L7D>GZ5IUO)=75U,<)%$BEF8^P -:-<?\ &#X:V7QB^%_B;P5J%U-8VNMV
M,EFUU;_ZR L/ED4'J58 X/7&* .1^('[2OA_P)X<\17<MAJ4FLZ/#:3OHD]L
MT-Q)%=3>1;S#/'EF3(+#)4J00&PIQM,_:&CT'XD^-M)\5R74.DVVLZ1IFFR1
M:8^RS-[;P&-;F100A:>=4RQ')'  )JMXW_9OUOXH:9K-[XCU_3X?%EYHMCH\
M-U86;_94^S7@O&E:-GW'S9$0% WR*O#,234GBS]G37O%D7C;[1XDTZ*;Q-K.
M@:RSQZ?(%@?39+60H 93D2FT '(V!S]_'(!V5[^T1X&T_P 3IH4^IRB[EDO8
M('CMI)4GGM%9KF"/8"S2(J2' '/EN%)*L!1\+?M+^$_&,VAIIMGX@9-=MWNM
M)GN=&G@BU"-+9;DF%Y% ?,;C&.I# 9VG&-X2^!'B3P?J'B"PM?$&BR^%;JZU
M"_T^*31C_:4$EVTLC0R7/FX>%))G9<('(VJ6PIW6;O\ 9YFU#X*?#OP2_B%[
M+6/!HTU;;7K&#8Y%O$+:8HA8[#-;-/'U.TRY^;;@@%C7?V@?#6K?""\\5Z5K
M5]H^FW?AF[U^VUU=*:Z-E;1KC[0]O@DE2P;RV )"MG&U]O;V/Q TNXUI-&BD
MGOKN)TMKJXAAS';S&V^T*LN#F/=%\P8C;R%W;B!7F;?LOV^G_"KXL>"=&U9;
M*U\:07]E8F2VW1:/:W22DPQQJR[D2:ZNY%&1_K0O 48=K?[.4OB;XCZ=XHO[
MO3[2YM_*AGO](BEM+R[LQ:F*2QG*OMGA:1FD!DR8^B\X8 ';^"OC=X2^('B.
M30]'U!IM0^P+JL$<D907-FS[!/&3U7=@'."-R$C#*3R/QL^-<WAE-(M?#%P\
MEY'XST'P_JDZV1F@B6[O;9)8&<\(Y@GSN .TL@)5F7.G\#?A;XH^&>G0:9K^
MO:+K=EIMHNGZ?/IVC?8KJ>%2NV2[?S&#R!45?W:HI.YB#D!>3\0?LY>)KG4]
M?M-'\4:9;>&M6\7Z;XT6&^TZ2:ZM;NVNK:XEA#+*JO%(UJI!(#)O8<C! !WM
MM\?O!U]XKC\.VM[-<ZE<->1V:Q0DK>RVG_'S%"?XG3#<' ;:VTL%;'E_PC^,
MFM^-;KX:^)M9\6WFF6?C.RFNH/!Y\/!UD>.VDF?RKM!N6-4,9"MN=FC.#AMJ
M]=\+/@MXF^&.KW=I#KVB7OA2WN;N[TJ)M'*:DGGN[B">Y\PAXHS(P!5 [ ("
MWRMOH>"OV==7\(Z=\&+9_$-E=M\.K>YMRZV3QC4!+:M;J<>8?*(W;C][.,<4
M ;OAG]J3X?>*DBGMM0O;33Y]"G\20:AJ&G3VUO/80,BSRQNZC=Y9ECW*.1O'
M'7%_2_VB/!.JS7UK'?S1:I:7=G9-IDL#"YDEN@QM@B#.1($D.?X1%(7V;'QY
M?;?L=7,_@7P=X4U'Q3"]EH/@_5?"CW-K9,DTIO'M76Y3,A"F-K.,[#N#;CD@
M#!VM1^ ?CG7]"\/7>I^*_#L/C#PYK5KK&G3Z5H+6MA,T,4\,BW$7G,[&:.YE
M!*LHC.W:O!+@'7? ;Q_K/Q'T'QA=:H_EW-AXEU'2K99;3R6ABA<*BNF>2.<G
M)W=0<$5RWP._:8TSQ-X!\.R>,+Z6RU^X\.W'B&[O9["2VLI(+=T6Y>*0C8PB
M\V+<%)P''7G'<?!_X=ZU\/-,\4+JNJ6&IWNM:Y=ZTOV.T>". SD'RSND<O@C
M[WR\'IQFO+X_V0[J]\'^%?#.J^)H);#1_".L^%)YK2S:.69;][9A.F9&"-&;
M1/E.X-N.<8P0#N)_VIOA_:?;X[B]OXKRRO+"QFL5TZ:6</>MMM#L16^61@RC
M/(92I ;Y:M1_M)>"1>:7:W5Q?Z9/?75I8-'J-C);/:7=RJM;V\Z. T<C[X_E
M(X\Q-V-ZYYN7X'^-=?\ "NEV7B#Q+X<?5+#6])U3S]'T%K2"9+&Y6?YT\YCY
MDK( 2&V(,;4."6T[7X+>(-$^+FN^(-(UW1U\+Z_?V^JW]A?Z/Y]];W,<4<3B
MVN/, 5)5ACR'1BA#%,%OE "P^/WAW1M8U/3KW6M5U^_NO$-[I5A8VN@3K)#+
M;VBW$EHNU/WA5 S!VQNW'&57-=IHOQ8\,ZY\,1\0(K]K;PL+&74);N[A>)H(
MHPQE\Q"-RLFQ@5QD%2*\\TO]GW6-/^(MKXF;7[&6.#Q=?>*!:BS=21<::;'R
M"WF'E0=^_')XVCK72^!?A/J'@SX'W'@5M1T[4KTVU_#%=W6GF2T8W$DKKYMN
MSGS$!EPR;AO /3/ !SWQ.^->H>'/%7PVCT^&\M=/U'Q//HVKV,FGF:XF1=*N
MKN,0["V[+1Q'<FX')&1AA6K+^T_X$B\&6_BC[5?-I+Z==:M.PL9/,L[2VF$-
MS+,A&5\N0[649;AB%(4D<CX8_9:N?"NI^%)],U>WTS2= \42>(K7P^GG7%I:
M1MILEDUK;%WS%&6FEGP!M4MM50/F.!K7['_B35OA3?\ @4^-=.DTN\TS7+)H
M[K27DCAGO[J:X6ZC03@"2,3M%EMW RNW<P(!L?%OXQ>,/"G_  O+^S-0M8?^
M$4TC2K_2]]FK^6T_G^:&R?F)\M<$\#TKT+X]^.]4^'GAOP[J6ESI"+CQ/H^G
M78-L9V>VN+V*&544<[BKG& 3GH,UR?C7]GK7_&MK\3%N/$NFPW'C71].TUY8
M].D"6LEL)-\@4S$LKF5L)N!7 ^9J[SXL?#Z_^(^@:%96VH6VG7&G:YIFM/)+
M TJ2?9+F.X\L ,I&\Q[=V3@'.#TH H67[0?A34=(6\MUU-[@WMYIYTQK"2.[
M2:U1I)U:-L;=L:[N2-P90,E@#8T[X\>$M7N&BL[BZF0^'(_%<,YMF2.?3G&5
MEC9L;CZKU7(W ;ESP]S^SOXC>YU@0^*M..FZKKVH:O=:9=Z6\UO*ES#'&BNH
MF7>\+1[U)^4E^5!56%O0_P!F^:U\+_!VRU#7T;5/ EDFE7=W8VIBCU6P$"QO
M:NC.VU'>"T=LDY\HC #< '5ZC\??!VC^(=.T6_O9K.]O+VVTO]]"0L%[<1K)
M!;2G^&1PZ#'(!=02"P!M^+/B;%H'Q%\,>"8["\EU'Q#:7EU#>Q0[X;=;<Q*Q
M?D9^:>,X],YZBN6T[X+>(/#_ ,5]<US2M=T=?"NN:E#K%W8WNC^?J%O<I'&D
MB6]SY@"QR^4A.Y&*DOMQN!7I/&OP[U37?B7X+\8:5JEI9RZ#;:A936MW:M*M
MQ%=&W9MK*Z[&!M5 )!&')QP 0#@?@-^TSIOBOX;^&)?%U[/:>(YO"8\37]Y-
MI\EO:30Q^6+F6)MNUA&TL88+G&]>M>F> _BQX=^(VHZWIVD7,AU/16A%_97$
M926%9D+PN1T*NH;!!ZJP.&4@>.6/[(MX?"7A3P]?^*(7MM%\$:AX.:YM;$I*
MYN);21+I TC*K1M91G8VX-N.3@8/K7PJ\*>)_#.G7)\5ZEH>H:E*(XP?#^DG
M3X-J;OG96DD8R.6)/S!0 H5>"S &#8?M.>"-3>_^SMK!@L[V;3#=3:/<PP2W
ML5PUO):I(Z*K2B16RN>%5G)"JQ%S2/VA_!OB&P6YTFZN=3D7[6;BSM8"]Q:B
MUG$%R9(^OR2L%.W=D'<,K\U<5<?LT:PO@2;3;3Q+81>(+7QK?>-=+O)]-,MJ
MDMS<W$KVT\)DS)&8[N:$LK*<,'&" *=XY_9TUSXA:/ID6JZKH<&M6D4KVFM:
M/ILFGW6B7CMQ<6$B2%PH4(&BD9EE* L0,H0#K3^TIX&7Q+#HK7.I1RR:T?#I
MO)=)N8[.+4, K;O.T816<D*N3\Q*X^\N7Q_M)_#XZP^G2ZXMNQLKK4+>XEB8
M17<%LRI.T+ '?M9TXQEPP9 RG->7_#KX?WOQ(O\ QWIU_)%;^'(/B7_PD!66
MUD2XG%LUM/;B,MA3&TT"L9!D%5= .=RZ&G_LJZR/AKK/P[O?%6FIX72S>ST*
M^L-%$>J6P#A[8W,ID*S>1M0 *J&38"Q'((!VOB?]HS1O#\UK:0Z1K%YJ;Z_:
M:!/8_9&CD@DGB\Y)#NX93%R-I/S?*<$-M-,^-NAZ1>ZA'J6N7NK+=^+SX:M<
MZ2ULMC=-%$T=HQ(&X98D3-@,7"@GY<U-;^%/CWQEX<\/OX@\6Z+)XGT;6[35
MH);+2)([ B .I4Q&<R%G$C,3Y@ P@ &"S1WW[/4VL^"?B?H%_K,/F^+-9?7;
M"]M[8J^EW02#[.^"QWM%+;12@_+D\8'< Z?Q#\=?"WABTGFO9;K=%+>QK!%
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M6HD@ED>&&<[03_<G7&1ZG&,9Z_P!\+-:T[Q?IOBWQ;JMEJ?B#3O#P\.Q2:;
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M=0\<Z3XLT#7-#M-2.C1:%J]OK.CM?6\T,<C213P 2HT<J-+. "65A+\WW0:
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M"_PGX'\*7>OZ3J>@>'= 31Y!!ITD-Q<20K#%;RAC*P4>7')O7'+.,$ <^GT
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %>1_'+QEX@^'OB/X<ZO:ZF;;PC>Z_#HNOPB"-F1;E7CM9E=E)0?:
MC!&WJLO&",UZY7(?%SX<VGQ;^&GB+PA>3O9QZM:-!'>1#+VLP^:&=1D?-'(J
M..>J"@#QKX<?%[Q+XQMOB#X6D\02MXOT7QD-$LKM;* ;[%W$D4X39M8"!;DL
M3PS6[[< @5:TOXQWUE\2?C;X<USQBMK#X:-FFC":&W25?.L([EF8^7AR'<J,
MC&WJ">:[O0O@#H/AOXH:3XSL)9HY;#P]%H'V,_<E$3-Y%P_]Z5$EN$#$9VSM
M46@?!O4]#\9_%;7SXBM)_P#A.#;-';_V8R_8##:+;#<WGGS050-P$YH \9T#
MXW^,=2\-?LWWNI^+Y--_X6#I$]]K-S!I]NWER+8K<H(5,3;1O;;SN^4#OS73
M?%'XJ:WX,T+X9WMM\0$BTCQ!XQ;0[S7+RSMH=ME]EO)69MZ!$=9+0*&P%*DY
M7)R-'PW^S+K_ (6T_P""<%GXUTUY?AGITVG1R3Z!(RZ@KVHM@Q478\LA5!QE
MLGT'%=#XQ^"GB7QQ>^#+S4?%^FK-X<\5CQ*L<&A,L,B"UFMQ;*OVDE<BXD=I
M"SDNW0#Y: /.;_XZ^.C^RM\3/'J7D$=UH%Y>/X<U^*Q"0ZWIT8C:"[,,FX;7
MWNNY<!_+#IA7 KV'X?:U/J?BR_M(?&=QXFM+2RCEN;>\T^.!XGED80LCQQH"
M"(9@P(/\)XYKAM<_9>U*?X3>//AGH?B^UTGP9KPD72+*XT=KA]#24AY88V%P
M@DBW[VC0A?+#[<LJJ!W6O^"O'NNVNIQ)XUT?39+K39;*.:Q\/R(\<KD 3,QO
M"6V*9-B J TFXEL 4 <_\,OC9J/BOXQ^*?"FK6<-IIL]E'K?A2YC;)OM/61K
M:X<GH<3(DJXSF.ZB]ZYKP;\<]2\3_$Z\\'ZCKJ^%?'%CK4Z2^#]8LTCCO](6
M=Q#=6$Q :8M"(W9@[@$2KY:?*1TOB3]F^P/BSX=^(_!3Z-X(U3PG=2-,]KHH
MD74+.2 Q2VK!)8RJM\K!F+E6C0X.#F3Q'\"]4\=7OAE?%&OZ?JMEX>\1IXBL
M;A=*9-0B,<YFA@$YF8*H^1&8("\:E2!DM0![%2,=JDX)P.@KE/AQ'XMCTK4%
M\87=G?7?]H3FRGL[,VNZS)!B#Q^9)AQ\PSNY 4D*25'64 ?-EI^TOJOBFZ^&
MNKZ?H^J:=I6K^)]>T2\TG[-%/<7B646H+'LVD[6\VS0GY@ 2P)*C=79ZC^U3
MX$TOP'8^+)KFZ%A<:;-JTEL8T2ZMK6%BDSR1,X.48,NQ-S,4;:K;3C)\+_LW
M:KX5U#P>T'BVSFT[PSXGUGQ#:V\FCMYLB:@;PM \@N<;D-])B0* 0BC8.2:/
MA+]FKQ5\.V\/7GACQ_96FKV=G<Z7J4MWH+36U[:27DEU'LA^T@Q31--*%D+L
MI#G<AX  />M,U*UUK3;34+&=+FRNX4G@GC.5DC90RL/8@@UQ'[0GBC5? OP*
M^(/BC0[O['J^@Z!?ZM:2&-)%,L%N\JJZL""I* 'H<$X(ZUWEM";:VBB,CS&-
M GF2G+O@8R3ZFN4^,7@.?XI_"GQ?X,M]2CT=_$.DW6DM?2VQN1 D\31,XC#I
MN(#DCYASB@#R;PA\=+L_%WPSX6A\46?B[2;_ ,.7.M:U<7$<4$^CF+RO+??&
M$1XY"\B[-NY?+W%L<5WUA^T#X6O&3S4U*Q6YT63Q%IQN+-LZEIZ;=\T"+N8E
M1)$3&P60"1"4&:YGQ!^S9-\0];\*7?C?Q#::G9>'-,O].M;71]+:Q:0WEH;2
M=Y)'GF)7RF;"+MPQ#$MM ":!^SKJMKI'A^VUGQ3;:K>>&?#5[X9T:\33&BQ'
M<+!&9[A/./F2".VB7"E%),AXW*$ +&D?M8>%M>O],LK'P_XPGNM4L1JEA&N@
M3?Z7:$V@,\9Z-&OVZ+<P/&U_09V4_:*\+2O8M'#J4EGJMG=7VC7J6ZM#K$=N
MF^46V&W,VP%U5@ID12R;U!-4/!?P)U#PKXA^'>H3^([6_M_"?@^?PE+;KI;1
M&]65K-C.'\]O+Q]AC^3#_?;YNF*OPY_9SD\$Q?#W3KWQ"NL:+\/VN/\ A'H_
ML1AN41X)+:)9Y/,99/+MYI(\JB;LJQ (Y -W3_VA?"FJ)OMC>21MX:B\6PN(
ME(GT^3[KQX;YFSP5'()7/WERFJ_M%>#-%\7V'AV[O)$O+W4#I$<D825!?"$S
M?9BJ,7W[589"E-XV;M_RUR7AW]DC1O#>K^&;ZVUFY_XD6K7EQ!%Y*@?V7+(9
MH=*4CD00SI;2+U_U)'1SCIO#'PF\3^#?&FOSZ3XRMX_!NK:C-K1T6XTLR74%
MY+AI%2Z$P'V=I<R&,Q;LLP$@!H V?A-\9-&^,^DMJOA^QUB+26@@N;>_U'3W
MMH;M)0V#"S??V["&'\)(]17>5POP-^&LWP=^$WAGP7/JL>MOHMH+07\=J;83
M*"<'RS(^TX//S'\.E=U0!X/\*_CZ]UXAN/#?B?\ M&YOKWQAK/A_2]3%@L=H
M3;&>2*W:1<#S/(MY&R 0=AR0>*Z73OVD?!U_;W<TKWNFQQ:?9ZK VH0"$7=I
M=3-!;2H2V$#RKMQ+Y;+D%PH.:YZV_9QU>"ZT>8>+[56T[QOJ/C)3'H[*S&ZM
M[N VX)N" 4^V.PDP<E%^3KGG_"_[*GB+1B\FI>+?#VN377ANT\/ZD+SPN9$U
M7R;GS6GNE>Z;S7G1I$E+'+%PP(Q@@'T%X>UL>(=*2]%E=Z>3)+$UM>H%E1HY
M&C.=I(()4D,"00002#6@[B-&8Y(49.T$G\AUKB_@_P##&V^$/@Q?#EE=23V$
M=U<7%M;EG,5G%)(76WA#LS"),X4%C@=,# ':.&*,%(#8X)&0#]* /)=(_:=\
M(:YIL=_;0:O%:7,@@L)[ZR^QQ:A+NN T<,DS(A9!:RL^YEVC;DY8"IM,_:7\
M&:_X)C\4Z*]]K6FC39M7N4LK?=+9VL4LD4KRJQ&"LD,R;%RS&&38'VFN=L?V
M<M=T'X>^"]-T?QG:VOBWPAJ=UJ.G:Q)I#-:3+<&<2P7%K]HRZ%+AERLJL&16
M!&"#E_%KX.>,;32O%GBK2_%@U#5-3\'3Z'KNG?V%)<G4O+^URV[6:1S;H)%>
M\F15(F&UER&9=Q ._E_:&\)V^FZQ?2F^CM])M]-N[HFWR5AOCBV< 'D$@@@<
MCN*-7_:,\#Z%XNM/#]YJ8BFN;^724NPR-"+R.%YG@;#;P0D<GS%=FY2F[=\M
M>7+^S?KWC;P=/-9>)H_#MOXF\,Z!9WUAJ>B227-K<V#>8C+F:,J&W%7C=,Y7
MAESQWGASX,^+O"/B#Q$FD^/8K;PCJ]_=:R-,;2-]W:WMQEY1'<&;;]G,[--Y
M9B+98KYFV@!?$'[2&GZ=X>T35M.\.ZQJ<&KZEI=E:.B0A)HKV3;'.C^9AEVA
MN,[@Q4,%R2-6Z_:*\$6'C*Q\.76IK;7%[=W&GPW4CQ^1]K@C:26!B&W*RK'+
M\S*$S&ZAMPQ7"6?[)ITC3;U-%US3O#UQ/K&DZ['8Z?I+KI$-Y9S-))*EG]H&
MPW&0'"2*!Y:'DABW0:;\!M<M&\6:!<>,ENOASXAFU"\FT4:<4OHI;TR/<QK=
M^:1Y!EFEE">5O!?;O*C! '>&?B]?^+OCUI>C627MOX4OO"$NN6XO+9$%RWVJ
M!(IT;EP"DC91]K#()49&?9:\5^&'P-\4^"_&7AK6]<\9:?K\6A>&I/#$<<&B
MM:RW,/FPO'-(_P!H=1(! H;:@5MQ("\5[50!XC\9/CI?>%M4\:^%M'TZ[M]6
MTCP3>>*(]9*1/!&Z"00KM8G(W1.#E>ZCU(T/"O[0^C7FD74.IVNKQ:SIFGZ3
M=7$,M@4>\%^[06\D"CJKSQR)EMH4J2VU>:;\4/@/>^/O%?B#6;#Q)!I USPA
M<>$KN"XTTW)5':1DF1A-'@J96RI!W #!7J<'7/V<?$][J%WJ&G>.K*PNY]#T
M'170Z*[0S)IMY-<.)0+H%XKA;B6)X@1\IQN89! -QOVD],O/$/@?2M,T/5+N
M7Q%KFHZ%<!TC1M/GLH9VG5_GPQ#0X!0LI7<P8_*&]BKY]\+?LP:IX8U7P_J$
M/BO34FT3Q9J/B.VAM]#,<'DWL$L4UL$%Q\I7SF*.#A0J@HW)/T%0!POQ"^)X
M\!^*/ >B?V/>ZG)XJU2;38Y;79MMS'9W%T6;<PSD6YX';<>H /GGP6_:&75+
M.PT?Q=+>MJ]YK'B.R@UF6R6"RE33]1NXUC+C"AUMH%8D#:=C?-N# >B?$GX=
M7GC;6? ^KZ=J\.D:AX6UA]5B-S9FZBG5[*YM)(RHDC(.RZ9@VXX91E6&17G6
MG?LMW*V'AO3]4\46NH:?IFL>(=2N88M*>%KJ+5FNVDA#?:&\LQ_;) 'PV0J_
M*.30!W7@+X\^$OB/XJN?#ND7;MJD6G1:Q'')M(N+.1RBS(59L#<N"C[77<N5
M&17HE>>?"#P'XM\!Z/;Z7XE\8P>*K33K9+#36@TO['*84  >Z;S9!--A5&]!
M$O4[,MQZ'0!YKKG[0/A;P]XNUGP_>1:LLNB11W.K7ZZ;*;/3X'@FF6::;&%C
MVV[C<,C<5 R<XJZ)^TGX,U[4=4TNWGN1K=A<6=L=*VI)/.]TKM;^68W9"&$<
MN<L-GE.7V!2:@\0? -?%NL_%235M;W:1X[T>VTAK6SM3#<6(ACF3S5F,C!V/
MGEA\BX*CKS67K'P6^(/B;P[H<FL?$:PN/&/AW5;?5-)U2VT PV>Z**:!A<6W
MVDM(9HKB57*21@94HJ[>0#J-$^//AS7=5TO38H-1M[_4-5O=#C@N+<*4OK6%
MYIX6(8@82-\,"4;;PQR"<9?CMX<U?7/!^I6_B'4-.T>_TW5[YK*3308;F.T9
M%EDDF*EHVA(;"(?FWDD$ 5YY\,_A1XH\0S2ZLVH'0?$?AOXBZMK,<VJ:!<):
M:C#<6\MNYCA:6-MC+.S(ZR. 4 )?FNF\,_LT:WX:M/!D4/C2U:7PU8ZW9QS'
M1<M*VH.'60@S[1Y15>-I#\_=S0!TNO\ QCT^YT_P_/'=:QX<2^UW3;*"9;"*
MZ2_6X93&@D4O&(I0<&0,"O(&&&*K^'?VD-)U.QUBYU+2[O1FMO$%WX?L;:ZE
M@22^EMRXD*LT@1<"*1CN90!M&2QQ7/6'[*@T734M-$UG3_#UJ?$VF^)7TNPT
MN3^S8I+5E=TM[<W \CSF7<VUBHXPI.6,EY^S;XAL;^35O#WC>UTS6K/Q/?>)
M-(FN-'::&-;P2"ZM+J,7"^?&WF?*R&)E**>2#D ]9^'/Q"T3XJ^"M*\5>';E
MKO1]2C+PR.A1@58HZ,IZ,KJRD>JFM^YB:>WEC29[9W4J)H@I9#ZC<",CW!'M
M5'PWI]_I>BVUMJFI?VOJ*@M/>B$0K([,6.V,$[$&<*I9B% !9CDG0G$C0N(7
M5)2IV,ZEE![$@$9'MD4 >4_LK^-]<^)7P*\->*?$=\+_ %?4UGDF=84B1=L\
MD:JJH!@80=<G)//0#.U']K[X;Z6FHR3ZE.\%KHTOB"*:UB%PMY8Q.J22Q"-F
M/!>,X<(=KA@-N2&?"+X(>-/A7\/O#?@H>.M'OM#TJ;,TD/AV6"ZN83.TS1"0
MWKJF[=L+;&^7. "01D#]FGQ5)\%-=^%EQ\0[>?PRVCOH.AR-H9^T6=J0$C^U
M-]H N7CC C4J(01DL&)& #N=._: \-7T_B"UEM]5T[4=&O;2PDT^^LS%<7$E
MWC[*8DSRLN3@MMV[7WA K$<G\/\ X_E(?&DGBJ6:.YMO%UWHNE:9.+>"Y\N*
MU@F,>=ZQG;ND.\O@@J QW+F+QE^S-JGBCQCX@\5P>+[>PUR[OM%U736726:*
MTN=/65?WJF?,T<JSR*R@H5#<-D9JM!^S;XMT_5;KQ+I_CO3;7QA_PD=QKUK<
M'0I'L52XM(K:XM)H/M0:2-O)1U99$964<D9! .@T;]K#P+XE.AG1%UK68M6L
M(-32:RTF9X[>UDG,!EF; "+&ZL)#SLVG/2N^\$>/['Q[;&YL+2\AM6@@NX+B
MX1/*N8)@QCDC=&96!"GC.1QD URME\)->@^(4OBRX\6PW%U+X9.A./[+VN)S
M,\WVA6\XJ%#/@1%3A0 7/4O^#'P2M?@_<:]-8RVEM#K)@FFTG1[5K338;A X
MEG@MS(XB:;<I=5./W:]3EB >G5Y]/\<?#EMXWM/#$L>HI=WEY<Z;:W)M"89[
MNWMOM,T"8^<L(0S;MNP[64,6&*]!KP2X_9R\17?Q7T?QK/XPTZYGTCQ)=:U9
M_:-$9[G[+/9SVILGF^T#*1B<F/:J@;<E6))H W/#7[4W@?Q+Y$^=4TK2[G0K
MKQ);ZIJM@]O;3V5LT:W+J6^;,?G1E@5'# C-+X+^)>L^)/V@?$WAR>"_T_0;
M7PSINJ6UEJ-K'%()9KB[1Y RDL5988_E<[E8,"!TKB)?V-VU7P3X7\+:QXNC
MNM.TCPEJ_A2:2STMK>6=;Y[9_M",9W$;1FTCPI#ALG..E>@^ ?A;XKT3XE77
MC+Q/XJTS7+VZ\/VFAS1:?HSV8<V\]Q*)\M<2 %C<-E0,<#&.X!ZI7SM^T'^T
M+JWA+P]\8--\.V-YIFM>#?#UIJ\.LR10RP,\[3A5",3D 0$<KR=W P"?HFO#
M?B]^SAJ'Q+N?B+]B\5VVC6?C70+/1;N*?26NI(&MY+ADE1Q/&""MRP*%<Y53
MNQD$ Z6+]H3PKYWB"WNQ?:5?:-J%OILEGJ4*V\L\L\?F0&/>P!5TW-EBNT(Y
M;;M-=%\-?B9H7Q7\-MK>@3M-:Q7=Q83QR "2"X@E:*6-L$C*LIY4E2,%2003
MY?XL_9IUC7_%_B+Q99>-(M*\17>IZ5K&E3QZ46BLKFSMY+<K*AG_ '\4T4TR
M,H,9 ?AL@&O8?".FZSI>B1Q^(-7BUO6'9I+B[MK3[+!N/18HB[E$ P &=SU)
M8DT ;5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 445F>)H]7F\/:C'H,MK;ZT\#K9S7JLT,4I&%=U7E@IYVC&<8R,Y !YMX
M2^-ESKGQVU[P1>Z<EGI+6#7?A_40W.HM;3M;ZBI!/!BE:$ 8Y5MW2JWQ'^.!
MTGQ9X%TOP[-]I@U'Q7_8.J3MITTD/RV\[R11SC""17B /WN0Z\,I H^)OV=%
MBE^'&L>#(=,T'Q/X4U%+J6]N"\AN[9H7BNK=W"@OYP?)=APZJ^"1BLRS_9X\
M6Z3>:-IMGXATE_#&C>-;CQ?9?:K65KP+</=2S6KD.%;$MW*5DZ[2H*_+E@#J
M[3]J/P%J%SIL%I-K5V^IF]2P\G0;UA=RVLC1SPQ_NOFD4HY*]<*2< &G0?'C
MPQJ^J>&=4LO$LJ:'J/AR_P!>73SHMPTES;PO;J\WF;<QM"9"K0[2Y,HX&WGF
M?!W[/WB+PU??#FZFO]+N&\*ZQKVJ3)&TBBY&HO<.$4E?E\LW&,G.[9VSQ1\+
M_LX>)O#]AX-MY-3TF<Z!X8U[0&9?-7SGU":WE60#;P(_LJ CG=O)XV@$ ZC5
M/VD_!^L^"/%E]I6O7VA-IOAL>(5U:\T"ZD2*REC<QWL<+(IN(T*$L$/\/) (
M-=H/BCH4.KQZ-]HNK_4%?[-,UG8S2I'/]E-UY;E%(1FA&\ GG<H&690?&]6_
M9B\1:EX*U'0%U72XS=_#'_A7WGGS#MD*,ANL;>5PY/E]<C&[G(ZN?X#7.H?%
M;1?'!DL]$UBPDM_/U'1IIHIKZU2V\M[&ZCXCN(S*=ZR.-R  *!C- #_#_P"U
MAX*UGPKX6UB:'7;67Q)82:EI^GIH=[<3RP1M&'8".(AMOG1$[20 Q.2 35W5
M/VG_  -8^'_$&JVUS>ZC%I&C7FNA+>QE_P!-M;60Q3O Q4!PD@"DYP-RM]TA
MJY[X7? 'Q)X U'X6B[U?2M0L/!&C:AHBM!#)%+<PS_9=CD$L R_903S@^9@8
MVY;F!^ROXTUF34'U_P 6:->7>I^$=<\*7^JI8S-=W(O7C:&X9FDQE/+ \O[J
M@;5P""H!ZCI_Q?TV\\6*9-7N[>W7PO\ VY-X?;0KGSTC\W!N%DV!G[H(E0L<
M;NX!VHOC1X0N=$T75K?4IKFPUJPAU+3I8;&X;[1#*\:0D#9PSM-&%1L,V3@8
M5L<YX.^%?B+2?BGIGB_5[_3)_L_A5?#TL-DDB9<7/G"10V>-H"X)R3D\?='*
M7G[*<EO\.M4\/Z3X@CCOH==36/#\NH62W%M8017+W$%A)%D>; IFN$ZA@LHP
M?D6@#V+P/X_T7XAZ=>W>BW#RBPO9M-O()XFBFM;F(XDBD1@"K#(/H0RL"003
MPE_\;[G3OVAM(\#SZ=&GAK5+6XL[;6=WS-K$,:7+VN.FTVKEPW=HY%_AKK_
M/AW6_#'A2>'4#HCZS,[S^1HUD;*PB<J J*,LY'R@EVR22< #"CRSQE^S-<>(
M?AIHL-A+I6G_ !,TW5K77D\3LCN@U".X\Z:;;@,4EW2H8\@!)2N2%&0#T3Q1
M\<?"'@_5+JPU"]NGFM+RUT^[:RL)[I;:YN0#;0OY2,=\FY-J@$_O(\XWIN9J
MGQX\&:+KD6EWNH7$$L[7D5O/]AG>"XEM%9[J&)U0AY(U20E5R?W<@&2C ?/7
MC*WU^3XV>+9].TC3+VZEU/3=2_X1W4=,U6,7]Y9VT/D7$=Q&I@D D4!9F 53
M#'O'[H$>E>&_V?/$'A:Y\3Z?;:EX=N?#EY/J=YI\LNDE=5C>\,KM#+<[B#&D
MD[D,%WE0JGH2P!?U;]KKP+:>"/$'B2Q_M;48M*\/1>)H[<Z7<0->V4JGRY(3
M(@#KN 5F&0F<M@5Z;KOCK1_#7AJ+7=2FGM+"::WMXA+:RK,\T\R0PQ"(J'WO
M)(B!2 <L,XKP6]_92UO5? L/AJ?6]/MUC^&J^ Q=1QNY\Y0F+G8<?(?+&4SD
M9/S&O6_B)X6\8^+/A];:?IFLV&F>(!=6L]VZ)*EK<PI,KS6^5;S%61 4+ Y.
M3Q@D4 -L?CKX1U/3K"YL[RYN;F^O[S2X--CLY?MC75H9!=1&(KN!C\I\DX7A
M<$[UW9-G^U!\/]3'A\Z=>ZMJ7]O68U'3A9Z#?2&>V\^* S "'(0/-'EC@ '<
M>,$^"^*OAIKOP6?P[:17^DVU[)XFU[7M.U:UT*_^QV<=V,&S+6SL8G87#;5*
ME2(#A@RKGT[X/_"?5TU+P=K-SI6D^'M"T?PO?^%H](L/M,9:"6X@>.9!,HD0
M;+5<K)\^9"2<CY@#O[3X_P#@B\NVMQJLL);33J]L\UG,BWUF)%B\ZV)7]\-\
MD:@)DMYL94$.I.YX.^)&A^.9=<M],FG%_H=T+/4["ZMI(;BUE,22J&C8 D-'
M(CJPR&#<$\X\/T7]E3Q"GPKO? 6I^(?#RV5E9P6FAZQI^@".^8V\\4UK+>Y?
M;+L-O$KHH42?,21D >R_"_POK7AK1IO^$@_L!-3G<,\/AK3C9VB # P&9G=C
MR2Q('0 <$L 8/@S]H?PWXS\,6&KP6VJ02ZA>WUI9Z:^GS&ZN!;32)(ZILY4*
M@8D9"E@A.[ /2P?%/PO=?#:3Q[;ZG]H\*1V4FH/?0P2N5A0$R$Q!?,#+M8,A
M7<I5@0""*\B\,?LY^*/!.L>#M:T[7=*O;_PM=ZU#!;3PRPQ7NGZC<?:)$D8%
MS',DB0E652N$8$'<"O8V7P2DT3]GK7OAS87\4EYJUGJL;WTJ%(EN+^2>:9P@
M)(027+D+DG  SWH @U+]JOX?Z1%K$MW/K4,>DV$.K7;G0;W"V$N_;=@^5S /
M*DW2#Y1L//(STC_&OPF?%R>&H]2=M2DU'^QUF6UD:V%_]D^V"V,H&WS#;D28
MS@CC.[BO-/%G[._B3Q/I'C2S_M'2K=O$?PYB\#;\R,()5%T#<XV\KB[;"<']
MV/F^;B.^^ 7C[5?'6C^(+[Q'H-Y_8_B:'6['[3:3/-!:BP>U>R1MX5$#2.X*
MK\Y.Y@",$ ZGX+?'*W\5^ =*O/$]_!%KTEK>ZA>M;6LB6MM;0W4T0DD?#)"I
M$9QYC@ML<C.UL=GX1^*?A_QKK=_HVGS74.K65K!?R65_9RVLQM9RXAG5)%4E
M&,4@SU!0A@#Q7AO@3]DK6_"OAGQ#X7GUZU/AKQ?I.H:;XELK=I/WDT_F)'>6
MNX?NI5AD\IU.5?RXV^4@Y]6^#/@/Q1X,L9E\57GAJ\O%BCMHY_#FCFP-R$ZS
MSY=LN_!V+A5^;&[(V@&K+\8_"</B.VT634FCGN9[JUAN6MY!:O/;(TEQ$)]O
ME[HU20L,\&.09W(P&#J/[3'@'1DOFU'4;W3S:6]G>-'<Z9<J\EM=3&"WG1?+
MR8VE&S=CY21NV[AG&T+X&>(M,M/%_A"?Q'9R_#?7KK5+Q;:*T==3B&H/+)/;
M^:7*;!-<2R*X7=@A3TR>;_X9V\;WGPLN?"NI:SX2DO8SI\-O?Z9HK6)N8[:Z
MAG,USAG)D<0*NQ-J*6=OF^4* =3IW[5G@Z\\0>);*Z@UG1M/T#1H-9N]0U;1
M[NU"QR3W,.TQO$'!!M6QD#?N 4,0:U=6^,^AZC:V9L->GT.XA\4VOAZ]ANM'
MFED%TYB;[&ZX'E&2.:(K,3M D4C/2L'XC?!7QGK?C/QCXE\(^*[/P[?>(?#F
MGZ.6E@D>2WEM+BYE!21'4A9%NG0L!N7;E>3QS^G_ +-OB>P.L*FH>'HK>_\
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M (MNM4L9T\.QZDES"L31^9]J2-%6(<X">4#EF)8L?NC KSBU_9,U67P3XJ\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4FO/O'G[/WQ+^*&C^/UUR]\+V>I^*/ L'A)GLY[AXUGCFN7-S\T0*HPN2?+
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M026WP'\46WPHL- 6[T@:SIOC>;Q;;YEE-O,CZO+J'DN_EAD($QCW!6Y4''.
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M:;J7B71H= UN82"YL+>X:>)"LC*K([(C%755<;E4X8 @$5TU !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MSX \7P_&[4O'=M::#=VE]X:M=!?3;G4)HV5HKB>9I-XMV!4^>5V[1]W.>=H
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M>"N:AU?X[>"M"TJUU.^U6:WTZ>*VG-T]A<"."*XD\J"2<^7^Y1WX#2;1@$]
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M&!&017DUQ\#/B=XD^$FE^'-<U3PQ;:_X5?2YM%U'3?.,>J3:?<PW$+7@:,-
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M36<WA^YU'0M"UOP]?I/>3K%Y5]/!,EQ$1 2[(;< QL$!#G#C'.1=?LT?$A_
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M1XK_ &;O&VO:EXIU.+Q!I;:O=Z?X4:PO)A(B3:AHUW+=DW$2)A89GE (1B5
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M]TXXWX<_'O3?$?B/6_#VOW^E:7KT/B.\T33;"*8^9=I!$LH.&YWE"[8XR$;
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MKOPA\6Z-<.+"^TVQ\)OI+R0SE7%V]])=LD:%!^Y'FE%)(.$7*^@!Z9HWQO\
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MC^S\5:[H>GZ?X<T75?$M]J-]9ZBMM;+I]U%*8[A8HU+F4I@RNP,AD+;3LQ@
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M=LI8*<&%!R&)4 =\//C+H7CCX1:'\0+NY@\.Z9?VBS7*ZE<+$ME-G9+!([8
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M4:?\9/ &K36D-CXY\-WLUW=M86T=OJ]O(TUR "T* /\ -( RDH.?F''-?/\
MXO\ A1\0?'FK?$;6)O!\6G#Q&?"30V$VI6\LF=-U!KBY#$'9M*$A3G)^7(&3
MMV/%/P=\4ZCK/CZ[M- 5O[8^(OAGQ/:.;B!6:SL%TL3Y^?A\V-QM7OYJ<C+;
M0#WNX\>>&;.^N[*?Q%I,%Y:0O<7%O)?1+)#$A >1U+955++DG@;AGK7.:O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*;]H.=N\%<],@CK5'QK\3O#GP^U/PUI^N:E#8W?B*^.G:>DKA1)*(9)3DD\
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MF;RU1@H(#,=I*;&J?#+]H1O'RW&MW%SX8TWPM:7=[I5Z1JWF7%O>6\YA4JV
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M 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0H&5O-Y*L2" ?1DWC#0;?4[G39=;TZ/4;6%KF>T>[C$T42@%I'3.54!E)8C
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MI- ?[NJK>QFU/S;>)=VW[P*]>HQ53QK\2?#O@'X>:IXWU;48E\-Z=9-J$EY
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MCJ%[I=E>:A8,6M+J>W1Y;<D8)C<C*$C@X(K1HH **** "BBB@ HHHH ****
M"BBB@#"\3^ _#/C8VI\1>'=)UXVK%K<ZG8Q7/DDXR4WJ=IX'3TK;CC6*-410
MB* JJHP !T %.HH **** "BBB@ HHHH **** "BBB@ HHHH **** ,#P]\/_
M  OX1OKN]T+PWI&BWEY_Q\W&G6,4$D_.?G9%!;GGFM^BB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%0:!X?T6S^)>@>(+R\\/7FC2^--;\0O8S:OI['2K6ZL/)2,JT^"9+@-.5CW
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M:CXQTW3/$%GIWBB?Q )+#4_MXDVM#;M<_))*6B:19HD1&0E68A30!]3-X_\
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MCEM;F(K*;AED*-([,"XD8X2-<8 /K:'Q9H=Q97MY%K.GRVEBQ2ZN$ND,=NP
M)$C9PI (/..M7-.U*TUBQAO;"ZAO;.==\5Q;2"2.1?56!((^E?,OBKPCXN\:
M^%=,\36_PEG\-^(-/U/2IM:\.QZO;07.M6]HDZ>7;SV\_EA86N!+"9'C+-"
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M4;8PTH3[K*H)A\.>!M?\ /ID5U\-M0\1> (];\66TGAO3[>#-I%>WZS6%W%
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M%XK_ &#=;\#>#]-O;VY/A"[T.RL]5MTMKN>\BA> F9"=JS-.C,S9P7);/.:
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MUSX(7NFZ;=:1H7@[4XM*/PKU?P_:6]](EU+'<RS1O:VDD@)!8*#C!,:;=H?
M4D ^KH+32KII%AALY6C(#A%1BI(R <=.*;Y6D(WW+)6#;>B AO3ZUX;\#_AQ
M<^"OC/JNHVGAMM T/4?!&AVUR\=NL*3ZI!->F?S /O2B.: &0YW= QVG')?&
MGX!^*IO&'C2]\':39RV5X;/QS8,ZH"/$-@ GV;:1PMTB6P9^WERYSYF0 ?2^
MHZY>6VM:/:V>FB_L+J6:.]OUNHT6QV1EERA.Z0LPVX7D=3P*Y2V^.7A_4O%G
MA72=-<:AIWB'3M0U*VUN&5/LH2T>%)!DG)R9U(.-N!G)K@]6^%U_%\3/@WJ?
M]@I,+:[UF^\07$$2M'!)>VLFY6/5D,L@C'7Y57/ S7F'PL^"FH6?A_X-:)XG
M^'\OV+P]X9UW2]9M[JSBG@-U*;+RF*J6$@?[/+M;!/R G *$@'U9\0?B!HOP
MR\'7WB?7[V*QT:S\OSKJ:0)&GF2+&A9CPJ[G7+'@#GM7 >)?VIO!NCV6K#3;
MF/6]5LK^XTM-.@N8D:2YAM);IE8EOW:F."0@L,M@%58$$[G[/>@:AH_[//PX
MT+Q)8R0:OI_AK3]/U*TO0'9;B*VCCE5N2&^=6Y!(/4$@U@_M2^%=(\4?";6]
M*U3P?<^)+.[@FF\_3H=]Q87<<+&WN5"?O=P<!0\>67(R-I8@ V_$?Q@U/0_#
M$.J6WPZ\3ZS=A;F2\TNS^R">TC@D9'8M).J/NVDQJC,SCG YQGZC^TIX9BT"
M#6=+MK[7+$^%X_&5P;1%5[?2G&Z.4JY!+NJRE8QR?)D'! #<3:ZO\2/#/PNT
M[POK&@^+/%TU]<WUO)K=D+7^T8-)$S+;><6FB7[7) 5&Y>5Y=OG&UJ?B/P#K
MM@/&^H:!X0O+:W\:?#ZT\.Z;HC>7OTR[MOMJ003%&*1(T=\I+!BJF!QN)*!@
M#W+QA\2=&\'>$+;Q%-(]_:7LUK;6$5GM:2]FN9$BMXXLD EWD0 D@ $DD $C
MFX_CWHKW#:4;2X'BE=>/AO\ L+<GF_:_L_VO.[.WROLO[_?_ '.,;_DKS7Q-
MX=O]9T'0?AUIFC:M-J7PIO?"^L"\N4C2WUN"$@2?9F#EBX2*88<)F1  2/FJ
MG:_"77D^-LWQC>PNTM9?%9N_[),9-R-,_L4:>+CRA\WF&9?,\O&_RCC&\;:
M/4M,_: T?Q!;Z/!H^G7NH^(-2?4HQH8:))[=]/E\F]65B^Q=DVR($$AFECP=
MI+#6D^-GA2+X,K\43>R'PDVEKJRS",F4Q,H94"=?,)(39UW';UKQ/X8_"?Q'
M\+?'UK\1;[2;V\_M>3Q0U[H]HJS7-E_:&I0WEF %;!.RW$<A!PKR*20JLPRO
M^%=:]!^SKI?P ?1KYO%\'A>#Q$NH[HAIDUW;W\,\E@LV_=O\PJF2@78P;/4
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M\2>%-$\9::-/U_1[#7+ 2I.+74K5+B+S$8,C['!&Y6 (.,@C(K5HH 0 *
M . !2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 V2-9
M8V1U#HP*LK#((/4$4JJJ*%4!5 P !@ 4M% !1110 V.-(8U2-51%& JC  ]A
M3J** "BBB@ K#\.^"M&\)Q:E'I%G]A74KJ2]N]DKDRSO]^4DDG<W&2.3@5N4
M4 8WA+PAH_@70XM'T&Q33M,A9WCM8V8HA=BS8R3C+$L?<D]S6S110 4444 <
MMXO^%_A+Q]>65WXA\/6&K7ED&6WN;B$&6)6(+(''.TD*2N<' R.!716%A;:7
M906=E;Q6EI @BA@@0)'&@& JJ.  .PJ>B@ HHHH **** "BBB@ HHHH ****
M "BBB@!B0QQO(R(J-(VYRHP6. ,GU. !^ I]%% !3!#&LS2B-1*P"LX'S$#.
M 3Z#)_,T^B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS2;S5/#D:Z#X8B&JPHVHZ)#=QW'E&1CB)[BV6.T?=D9@#$X8@0#P-X=U[7/
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M:^G? -II%MJ?BYM+\,7GAR>750]]-=6XB749_LT ^T1$,0Z; D>[CF)ACC)
M.PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH Q_$?@W0/&,4$>OZ'INMQP$M$FI6D=P(R>I4.#@G':L+_A2/PZ
M_P"A!\+_ /@FMO\ XBNUHH XK_A2/PZ_Z$'PO_X)K;_XBC_A2/PZ_P"A!\+_
M /@FMO\ XBNUHH XK_A2/PZ_Z$'PO_X)K;_XBC_A2/PZ_P"A!\+_ /@FMO\
MXBNUHH XK_A2/PZ_Z$'PO_X)K;_XBC_A2/PZ_P"A!\+_ /@FMO\ XBNUHH X
MK_A2/PZ_Z$'PO_X)K;_XBC_A2/PZ_P"A!\+_ /@FMO\ XBNUHH XK_A2/PZ_
MZ$'PO_X)K;_XBC_A2/PZ_P"A!\+_ /@FMO\ XBNUHH XK_A2/PZ_Z$'PO_X)
MK;_XBC_A2/PZ_P"A!\+_ /@FMO\ XBNUHH XK_A2/PZ_Z$'PO_X)K;_XBC_A
M2/PZ_P"A!\+_ /@FMO\ XBNUHH XK_A2/PZ_Z$'PO_X)K;_XBC_A2/PZ_P"A
M!\+_ /@FMO\ XBNUHH XK_A2/PZ_Z$'PO_X)K;_XBC_A2/PZ_P"A!\+_ /@F
MMO\ XBNUHH XK_A2/PZ_Z$'PO_X)K;_XBC_A2/PZ_P"A!\+_ /@FMO\ XBNU
MHH XK_A2/PZ_Z$'PO_X)K;_XBC_A2/PZ_P"A!\+_ /@FMO\ XBNUHH QO#G@
MOP]X.2=- T+3-#2<@S+IMG';B0C."VP#.,G&?4UHII]LE])>B%/M<B")IL98
MH"2%SZ9)./4FK%% !1110 4444 <[%\/_#\/B^X\4+IRG7)PN^Y>1V&50QAE
M0ML5]A*;U ;:2,X)KHJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "N$\'?!/PIX$FMVTB#4DM[4YL["[UB\NK.
MRX( @MY96CB !(78HV@X7 XKNZ* "BBB@ HHHH **** "BBB@#FO#GP]T;PK
MXG\3:_I\<Z:GXCGBN=2DEN7D662.)8HRJ,2J8C15PH&0HSD\UTM%% !1110
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MC<H]'_91TR]T_P"$DD]WO6'4]?UO5;%'&,6=SJ=S/;D>S1R(X]G% 'L5%%%
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M9U*;PEK$]P/BS:WEM=OIMTTJZ6]E:QW+QOMW"!V657VG:P'.1BH;;PKJWA6
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MB+8?"?P/J'BG5+6[O+"Q,8EBL51I?GD6-2 [*,;G&>>GK7R+X6\#WGA[X<^
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M\[B@=2<HQ /O"N*^*/Q4L?A39Z)<W^EZEJ:ZOJMMHULFFB$M]IG<)"K>9(@
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M>/;CP1HMSX3T.]\-Z==:;87NG/I\?_"0VT\TT4@@=4*X1+>*5E 616"Y;:V
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M\SB.&)"[NW15 R3^58/_  L+PY_T&+;_ +Z- '14444 %%%% !1110 4444
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M&#\HPHVC !]@U!<7UO:36L4TZ1274AA@1VP97",Y5?4[4=L>BD]J^+=3:_\
M" U*ZAT_QK=VFK^"_#CZFUJ;]Y6OCJ!2XDD+*[;DBD!FC0;S"I7 X*KX>TJ]
MNO$G@NXU;1/$%WI/A[XGZFZ%-#U"*.UL+C1KL0&* JSI ;B2, #*H7525'%
M'V)H&N'78;R0Z;?Z;]FO)K0)?Q"-IA&Y7S4P3F-\;E;C((.!5+Q#X T#Q7KV
MA:SJVG+>ZAH;R2Z?))(X6%WV$L4!VN<QH06!VE01@\U\O>$Y?$=OJNFQ^)-/
MU_4?A\WCGQ1'JB7MM<W!"-*QTN296!=[39Y@#8,88PDXV@C%L?!GB'5;S2M*
M\4KXJNM"7PKXP2QAEFOT_<#5+8Z,EQM(_P!(^R*Q4/\ O#L^;++P ?;E07%]
M;VDUK%//'%+=2&&!'8 RN$9RJ^IVH[8]%)[5X-X@U_4[3]C[PS>ZE9^(KW59
MM+T2'4([!)TU!'>2V2X>5%0RE4R[3(%W,BR+P3D>4:!HM[>>)/!5QJ^B:]=:
M3X>^)^J%#'HM_"EI87&C78@,4)#/' ;B2)1C*H6"DJ.* /LZPU&UU2!IK.XC
MN8EED@9XF# 21NT<BY'=75E([%2*LU\-Z?I+^'/ 5OX0_P"$:\2V=[/X@\8L
MY.DW\UD&-_=/9[XT0>8SPSH\,H<(A4ON+*!71>!=;U'Q6F@V'C_3_&_G:GX:
M\/W'A[4K*QO5F2]A4F\1Y G^C3F8#S'FVAXF&6* X /J#P7X[TWQY#J\FF+<
M*NEZG/I-P+B/8?/A(#X&>5R>#WKHJ^/- T.\TWXA:-KEM8:[;WY^+>J">58+
MM8CIDUE=#>R8V&!Y#!^\(V[@GS9 QAZ?_P )Q>_#G6-9T^/QS'\8-+\/3:?X
MDTJ/3I;:UNYS-&9Y8)FC"W$Q59FM6@D)5) .!M6@#ZYT7X@Z7KWCKQ)X2MEN
M!JN@06=Q>&2+;&4N?-\K8V?F_P!0^>...M.\%^/M,\=R>($TY+F-]#U272+L
M7,7EGST2-V*C/*[95P>,UXQ^S[!IC_'WXKZKH&C:IIOA_5-)T![6>\TNZLX9
MI(Q>"8+YR*-Z[XRRCG+$D9+&N'BT"[L_B-/KMMI^N0ZD/B[N6:.&Z6-M.DT^
M.*60J!L,+,,&0C;N1>?E& #[#HKX4>W\0Z[\$O'-W=M\0=/^+FG^"-8T_6K"
MUT^ZM[:ZU1DS#)'.L8%RQG4-;^0[;8I64@)\M=E\1/"D&D:W#H5V/&]KX(\1
MZ"9;#5=!M[W4[RWUN24F9RQ65[:8H;=HG<*B&.897<P(!]7)+92:K-&C0-J,
M4*&11CS5B9FV9[A24?';*GTJW7QC\0-'\1>#_BMXLU"UT3Q!>6]]>>%YM9O+
M:SN)I+K28]R7^UX5V.P<1>9$GS-'Y@"%217N?P'L-1L=7^(IC^U1^"IM<27P
MW!=JZ>7 ;.W-P(5<!E@^TF?8N !AMHV[: .YUCQWINA^,O#WABY6X_M+74N9
M+0I'F/$"!I-S9X.&&!SFI_&_BZP\ >#=<\3:H)CIFC64VH77V>/?((HD+N57
MN0JDXKXZ\-1:SXNUOX8RZOX=\01?$6/3?$6G^)KB;3+M8TOY(1L)G*^7Y1<'
MR7#;51D52H.*K)JGB7Q-\)KNSDTOQ;/=2_ ZXTN]BO=*O5,VLK"L;Q.'3Y[@
MMN4'DMSM+8. #[>TC4X=:TFRU&W#"WNX$N(PXPVUE##(]<&K=?,&J^&_$.E:
M[X-71X;V72?B#H-MX<U56F>-]'GAB,OVJ-&(,1:V%TC;0#YL5KD9R:[_ /:,
MOM4T'0/"5Q9V>H7/A:#6HU\1PZ19/>3KIYMIU5A;HK-+&MP;9G55)V*W! 8$
M ]"N/ VBW7C:R\72VCMXAL[*73H+L7$@"6\KH\D>P-L(9HHV.5)RBGL*WJ^-
M/'/A#4]$\!>&[[P5-X[UJXT*WO;^]M=36:"YU+099F$EFB&,$705O]%4J)HU
MCVLR%QG?\53S>,OB9-I^H#QKH^GWD>D7_@J^T+1YQL2/#RPO(T3+:2>8K"99
M]FZ&15.0N  ?5E5[^_MM*L;F]O)X[6TMHVFFGE8*D:*,LS$]  "2:^5-%L]4
M\7Z#XGT_4],\6VWQ9T^+Q#;W,L<-S!8W:2F8V<@N&4131!?LWD(C[HVSA5VR
M$<'XP77OB5\-O$5G'H?BR_CG^%6F+);W6E7T?G:I#<2&=2KH"]P %[%FVC&[
M;P ?=]<WKWCW3?#GB[PQX<NTN3?^(I+B*R>.+,0:&%IG#MGY?D0XZY-?.CM+
MKOQ>O--U-/&^D(-5TK4?!=WI.D7/D/IZ00^9#),\16V'G"Z$Z3E&:.5?O?(!
MD_#Z74]9^(?P6O?$6@Z]%X^TW5M:A\47,NF7AABDDMKE48S;#$8"2@A8,55'
M"KM!(H ^H8_'NFR_$.;P8$N1K$6F+JQ9HL0F!I3$,-GEMP/&*Z2OF#X^^";#
MQ#\9M0N-=L-??3YO [V^G76B?;(V-^ET[(B/;X_? .K(K'KR!P2*UEX/\?Z#
MK?@W1]8:YU&X\?>&K#3O%%REWG^R]1LXT>\GBPW[L7$33IOCZ31P,.6+4 ?4
M-W?V]@L;7,\<"RR+"AD8#<['"J/4D]JPO OC[3?B%8ZG=:8ES''I^IW6DSK=
M1>6PGMY#')@9/R[@<'O7FO[37AV+4E^&%]+I-]J=CI'BZVN;I=.M9KAX(#;7
M,9?RX06QN:,9 XW=AFO)/#?A[4]-\<^&]<TRPUFVU>7XI^(8YY)8;M;<Z;/:
M:@T;R)C9Y#SFS(DQ@L5P<T ?9-<+K7QBT+1;_6[?R=1OX="=(M7N]/M&GBL)
M'C658Y-OS%O+DC<[%8(KJSE0<UY-^S%#<:IK5IJ^I/XSL/%MOH8T[Q/IFL:?
M);6#7XD1FE,KQA;F7=YNR6%V7RFYP#&!A?&_PY>:9XU\:>,_AK<>(O#/Q+M6
M@MY=).F3W>C>--MM$T4<L93RR</Y!GC=6BV,7.T# !]85S?@SQ[IOCJ3Q!'I
MR7,;Z'JDFD78N8O+/GHD;DKSRNV5<'CO7S9X[U+Q%I'B_P =Z:FG^)3<O\1/
M"FLZ>=/L+N>%-+)TE+YHI(T*["\=]YD:G)S(2I#$U3G\"7P\>^+K_2K7Q!8>
M/8OB1::A82PFZBMY-(867VQR"1!)$]NMTN3G=(L:YW!0 #ZO\2:X?#FD27ZZ
M;?ZL4DBC^RZ;$)9VWR*FX*2/E7=N8YX56/.,5G^-O'NF^ 8]&DU-+EDU75+;
M2(#;Q;PL\[A(R_(VKN(R:^0;F'QM9_"3Q-:-::IJ%XDOA>XL_$>C6E]8W.I1
M_P!I?Z1'>61RR7B1"1KDJ2KK(I8*1BMOQM-J6M>*%A\1:#K]QXLTSXHZ?>V<
M]MIEY/!_8@N(O(DBDC1HQ"(AF1<@"5'9ANP: /K70]:.MQWCG3[[3OLUW+:A
M;Z(1F8(VWS4P3F-NJMQD=A6E7QK=7NIW.F7&B:AIWBJ]6]\7^)A:SW=A?WML
ML0W_ &42Q*N^161\P,76-"F\,2B@V_@[X7E^*WBCP2WC.+Q;/$GPYT.XN%U"
M;4K*/^UXI)!.7Y0>;]TLI^\"&(8$&@#Z_KD]:^).F:7XG_X1JT@O-<\2"V6]
MDTO38U:2&!F95EE=V6.,,R.%#N"VQMH.UL>6_LZ:)XCM]6O=&\2-<7"_#U9?
M#-GJ4TV\ZN)"DZ74G)W2"U-FK,W/FR7/KS)X2TN_^&'[2'Q4U37;6Z.A>-5T
MV^TO6X87FA@-M:BWEM)F52(2&7S$+X5O.8 E@PH ]?\ "7B^Q\9Z=/=V,=U
M+>YELYH;VV>"6*6,[74HP!Z]&&588925()VZ^2M"\1>.#JO@;Q1XL7Q'>Z8O
MQ"U^Q>1=&=9#H[07T.G&:WMX59HG*VQ#R(?F9"2,BO+?&FL^,+SX#26%OI?C
M6'QE9>%M8N].N)]+OYL7:7\K1" (H\NY58XRL[,0(V"HK!VP ?H/17R'XMT\
M:AJOQP\5S67CJ^^P&SGT.*PNM2M)%BGT^**X-O'@@[2\NY5C8H5;:JN!6+ID
M>KZGK$VAR0^)8M&C^*-K+'%8Z;J6EV8TB?1(F<)&3\EO]J\TLI8A';)V[QD
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M!)_(=:K?VG#_ '+C_P !I/\ XF@"W1110 4444 %%%% !1110 4444 %%%%
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &NP1&8Y(
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M-XEU?QK\>M=T;2_$MQXATP6<WA>1I[NWCD5]/$5XEDSD0N[*TR+C<$D*D;2
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MQ=\1/"\NJZ[\2-?T3PQXG26WNO"-UX?DM](OXF"Q3IYS11A!DI$6#C!*J6#
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M(O"6D:[;?#ZVUSPEJ4.GVFEW44T4L=\1JLEO:>6)?+^R_9O,1$PQ67Y2PDH
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MAE"@;U0<-BN-\!-?67[$_A6*&\O_  UJ</@BRMOM?V"5[BPF%G'&7,'RN2C
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M@8W62.'[>41W5AM#RY/RM0!]=ZC?PZ587-[<LRV]O&TLC(C.0JC)(502>!T
M)JGX;\3:=XN\,:7XATF<W>D:G9Q7]I.L;*98)$#HVT@,,JP.",\],U\GOX[;
M3;O2_#OB+Q[J>H^ =5\/:O=:+XHEDFT]=0O3=#R;7SRY>4Q0$B+>Y\]<M^\P
M&KW7]EVYBNOV:OA2\3AU7PKID;8_A=;6-64^A# @CL010!VW@[QAI/C[PW9:
M_H5T;W2;U6:"<Q/&7 8J3M<!ARIZ@5LU\2? 31M2DC^%^E:%XNUXRWT.L6'B
M_18=2;9I=LJ3^3*(NEI.ER(%4@*[^8^[?@D>T?LZZCXLU\O:>*Y+]-2\%0-X
M9OYI99!%JU\K!FO=I;#JT M94;'!NI5ZIP >VW%U%:*&E?;G.U0"6<@%B%4<
ML< G R>*R_!GC'2/B#X6TWQ'H-T;W1]1B$]K<&)XC(A/!VN PZ=" :\F^,#V
M6F_M#_![4=3O[K3].\C5H2_VZ:"W:XQ;&!&56",Q_>X!!W*&SD X^>OAKXF\
M0^"O /@!_!NKZGJ&KZE\-/$,_P#8RWC7,1O[6:R^R&&U9O+68"2Z 554R;6#
M;B"0 ??%97B?Q3I/@O19M7UR_ATS3(7C22ZN&VHC22+&@)[9=U'XUY3^SGK5
MEXEN?$6KZ'X]O/&GAV[2T:&">"X\O3YPKK*BRW$LDA=@$+Q$@1L.@+D4SXVZ
M):_&_5;OX:)#IFLV-MI\ESK>GW>H&V(^T1R06P^6*7)7,LN-H*LMNV1D9 /;
MJP_!WC71_'VD2ZGH=R]U9Q7ES8.\D$D++/;S/!,A2158%9(W7D?P\<5\O>$O
MV@=0O_AY\,K7Q5K L8-,U^Y\+>/-;M+IHDAN+6"XC@E>=<&*"YFCAD$P*CYU
M7< Q%<[\)K^UNM6\&^&H?%^JVF@:AXH\>+>I::S+;R742ZE/)!(\RL)-Q5PX
MD#!CG.>30!]LWMW'86<]U*',4,;2.(HVD<@#)PJ@ECQT )/:H=&U6#7=(L=2
MMEF6VO($N(EN8'@E".H8!XW 9&P1E6 (/! (KXJ^&OCG5H-$^'=]=>.];N[K
M7OAOKUQJDM[J[R#[5:26(M90C'9%,$:Y&Y55GVN6W%211\5^-=>U;X<ZSJ2>
M.]?@U'3?@M9>([1;'6)(2=:2.<B1@C R.SI&&C;(?=AE.10!]NV?B"TOM=U+
M2(ENA=Z?'#+,TEK*D)$N_9LE90DA^1MP0DKQNQD9O&>)9TA,B"9U9UC+#<R@
M@$@=P"RY/N/6OESQ+\0]:O?%'Q3M=*\:VEBT=KX7FT]M2O)%L8VFED\^/?"=
MT"3#9&TJ<IYBMS@5RNC>(Y]1^)O@;Q#KQUWPE(_@GQ58Q1:AK\UPBWT.IV@"
MQ3[@LZE$D='(R\4:.P/E@J ?:-9VMZ_9Z!I>IWUTTCQZ=:M>7$-K"]Q.(E5F
MRL489W)V,%55)8C !/%?%FI>,[K1_@?X"N9_B!XF;Q/XI\"W.N":]UJ6.![^
M"PM$9(FCQ(9U=V9;92%=O/9\E "EUXRF?_A<WBU/$NI6FNZC\(]&U31KR+4)
MHQ-<)!JADDMX]VPA9?)^ZN%:48P9?F /N"UN4O+6&XC#B.5!(HD0HV",C*D
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&I.\')]X_:IMI[K]F3XLI:&Y6\'A35)+<V<CI+YJVDC)M*$,3N X'7H002*
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MX:FO;Z]LSH&JIJ]NMF8MLLRQR1A9-Z-E-LK\#!YZ\5U:J$4*H"J!@ =!2T4
M<G9_#N"#Q_?>*[K6=6U.:956STR]F1K+3/W:I(ULBH"K2! 6+LYRS[=H9@>L
MHHH 1E5U*L RGJ",@TM%% !2,JNI5@&4C!!&012T4 (!@8' I:** ,R\\+Z-
MJ%Q//=:18W,\ZA)9)K9':11C 8D9(&!P?05H1P1PJBQQJBHNQ0J@!5]!Z#@4
M^B@ HHHH R8_".A1:Q+JR:+IR:K*XDDOEM8Q.[!2H8OC<2%) .>A([UK444
M5/[)L?[2_M#[';_;]GE_:O*7S=G]W?C./;-.U'3+/5[5K:_M(+VV8@F&XC$B
M$CIP015FB@"..".$*(XT0*H0;5 PHZ#Z5)110 54CTBQBU*34$LK=+^50CW2
MQ*)77C@OC)' XSV%6Z* $VC!&!@]J%4*H50  , #M2T4 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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=** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>ex1011amendmentno1002.jpg
<TEXT>
begin 644 ex1011amendmentno1002.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 0  Q<# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHK-\1Z9=:UH&H6%EJ4VCW5U \,>H6ZJTML6&/,0-QN&<C((R!D$<4 >&?#_
M ./E[K?[1^J>&K_4=/F\,:_8S2>%XX)%:9)K"9H;U9,$Y,H=)H_6-#Z&NHF_
M:1T=?%5AI%MH>JWUO>^*)O!\-_!Y 3^T(H'GERKR*PB5(IAOP26C("D%2VCX
MM^!NF^([#P-'870\.WGA#4(-0T^[TZV0,#'"\)A^;/[IXY'1USDJ?O C->/:
M!X!\=K\8M0URTTO4=(OY/$LEY*FHZ/ID^G&T:18FFBNT=9@TEH@'"F0,0C95
M2: .SU+]L/PM8:!K>NQ:-K&IZ-8:!<^)(;S3UAE2YM(-N_GS (W9761$D*ED
MS@;E90_QI^TQ=>'K/Q+!;>#=1BUK0]:T+39;2_FMPLL&IWD=O%<(R2,.K.-A
M((8#( R0Z#]EUH_ACXE^'<WCS7+SP9J.E7.B:=IL\4'_ !*K.8%2B2! TIC0
M[(C(2$4 $-C-:WBS]GF'QA>^*;VZ\0W5O>:\VB3O);VZ!;>?2[H7-NZ*V<AI
M!\ZMG(P!MY) +GB+7+WX47WC+X@^*/$%V?!KVE@(M'N#"8M,EW>7+('"+LC)
MD1G9Y' PS?*J@'N/!WB4>+M!BU-;1[2.5W5 9HYDE56(66-XV97C< ,K Y*L
M,@'(">(?#]WK7ADZ9#J\UG='R<WWDQNTFQU9@Z8"E9 I5E  *NP&.,9/PK^%
MVD?"7P_>:3HT,-M;7>H7&I26]I"(+:*69MSK#$"1&F>B@GDD]2: *7Q:^+MM
M\)=.^VW>C:EJ5NMC=ZA+/;*B011VZHS(TTC*BRR;P(XR07*MC 5B./\ $W[5
M>D>'Y-3>'PMKVIV&EV6DZG?7T MECAM+]Y%BE :8.VWRVW(%W<' /&>G^*_P
M8B^*5_97;:_J&BO!I>HZ0Z6B12)+!>+$LC;948+(ODJ%<<A7D7H_'*7'[+5M
M=Z!XATJ?Q3?S)K>B:5H=Q<-;1"18[!I&BD3 "AB9G#9!& N ""6 *7Q9^,]Y
M>WGA^W\)MJ,5G9_$#3/#FJZE"8EAD8S1^?!ACO9!O\MF4#Y\CD!B/H"O"[S]
MEQ'UB_DL/&.I:7HU[XHM_&,FEQ6L$@CU*.1))#%(ZL5BE9-S(=V&8D$ D5[I
M0!X$/C>^A:E!::/IFN:Y+JWQ N/#5PNL7, ^QNMH]PX@VMCRL0G8"<C<Q/.%
M/H/P]^+VE?$S4=0BT6![BRLIKFVFO5FB80W$$QA>":,,7BDR"P5U&4YZY YN
M?]G6"5VGB\27UI>KXN?QC!<PP1$PW+V[V[Q!6# IY<C8R"0QR20,5L>$?@M9
M^&OB%)XTGOOM^O-ILFE/>+;)!+=P-*DBFZ9?]>\?EA(W(!56<<ER: .P\7^)
M!X1\-7^L'3=1UC[*F\6&DVYGNIR2 %C08R<GN0 ,DD $UXAX]_:(N=8\#O-X
M6T^Z%Y!XXTWPCJ+0W,!VB6ZM/-\F4/@B2&Y"JXPR%R3M*Y'K_P 3O <7Q,\#
M:IX:FU"ZTJ.^$8-W9%?,0I(L@&&!#*2@5E(PREE/!KSW_AFM3;:K$_B[4)VU
M'Q58>+I'EM+<;+JU%ML10BJ!&QM(]PZXX!!R2 >2>+/$.MZ#:_%JQUWQ)\0K
M/P_\/=,AU2/4M'U.S_M,P2)<S31LSC;,?+*HC."ZBW0[O,+,_8_%'XCW7@KQ
M)\>WUC6_$;>&=!\$Z-JL<>AR01WEB9)-56>2V9P%#E;>(Y?/*_05W'C#]GR#
MQI;?%&WO-=GA@^(&F1Z5?K#;J#;1)"\(:$DGYBDCYW;AG!  &#%X]_9TMOB)
M'\0DU+7[J(>-O#EIX;U V]NB^5# ;@B2+.<.3>3YSD?<X^4[@#1\2?'G3/"'
MCS2_"VH:1JL;W^K0Z);WTJ)&D]Q);&X5X@S!I80!Y;2H"%D.T]&*\KX6_:EA
MO_"FGWVL:%)9:SJ>H:S!8Z:EW HDM["\DMWE+NX Q^Y0]R\HP-N6&EK?[-D>
MN^,SXBE\7ZM%(WB&Q\2FV2&!D6YM[5;;8K.C.L+(I(CSA6DD8?>XJ#]F!]+C
MTJ?P_P".M9T'6-&U+5+S3+^*WMI?)M]0G,]W:21NA6:-I"K MRIBB(/RG< ;
MGA3]HWP]XVUG2=*TFROSJ=[8V>I2Z;>JEK?6MO<@[9'MY&$C*A4K(4#!6QU&
MXKU?P]\.Z]X<@UV/7M?N/$'VK5[B[L7NO++VUJ^W9!E(T!"D,1P2 P4LV-QY
M;6?@%9^)-9T&]UK5Y]:.B7]GJ=C<WUO&U];W$ 7<8KA0I1)BF94"[6#,JA :
M]5H \N_:2\<ZU\/?A7<ZGH$#R:A-J.G:<)8V0- ES>PV[.-Y W8E(7KABI/
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M##KOA7\*](^$NC:EIVC0P6T&H:C-JDMO9P""VBEEV[UAB!(C3Y0=H)^8L>]
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M%V1ODAAMJOJ7[5VCZ9X&U/Q/-X7U]+/2HM3FOC+#'%$@L60.L<[N(I'F60/
MJM^]57^Z48#2O/V=+2\\':SHJ^(M0LKV[\1R^*['5[-(TGTV_>?SLQA@RL@8
MLNQP=R.RDG.:I^,OV;9_'FDFWUCQ]KES?7.BZEHE_>&"VQ/%>(B2-'$8]D#*
M(U52@'REPVYF+T ;^G_'WP[JWBVYT.SWRO911W&H2/+%&]E;R6?VN.Y>)F#F
M J1'YB@CS#MQPQ&!??M4Z!I&D66IZAH.M6MKJGAVZ\4:.-L#/J-I;Q)-*J#S
M0$F$4B2;)"N5/!R&59[C]FK2]:OM!D\0ZFWB&+12GV.6YM(X[N)!9?99(%GC
MVE8)!ND>,#EF/..*J0_LMZ:_A"P\.W^OWFIVFC>'KWPOHEQ<0IY]E974:0R%
MV&!+,L421K(0N!G<K%B2 7]-_:.MK^YUJTD\'>(K>_T^STK48;58H9WNK34)
MI(8;@>5(PC1'AE,ADVF-$+D8KA]9_:%U+Q)XP^'-_P"$].UC4K:;5->TB^\.
M6<UH/MD]I$RAA,\@C*!E+JQD *D?+NPM=;KO[,UOKU[->/XHO[6Y?2]$TQ6M
MX(]I72[J2Z@9U;(<.\T@D0C:RE0 I&2ND?LVMX=U2QU?3O%]_+K%CKVHZ[!+
MJ-I!+#NOD99XGCC$9(RVX$,""!VR" <CKW[1]GJNL_"+QC:ZIJ'A[P;='Q ^
MOZ=?Q+&\!L+.<S)<*-QW0RPR A6*DID9X->J_#;XS6'Q(US4]*@TG4=-N;*U
MM[W?<B.2&2.8N HEB9D$J&,AX\Y7<A&0P-<SJW[*_AC6-(\,Z1<75U-I6DKJ
MPN8)0K'4VU..9+YYF&,&0W$S_(% 9N!@;:Z_X6?#O6?A_IQM=9\<ZSXV,426
MUI+JT<$;0PIPN[RD7S9#QND?).T8"Y;(!N^,_%2^#=$_M$Z;?ZJ6N(+80:?#
MYCJ995C\QST2)-^^21N$168]*\RT_P#:?TW6X=!CTCPMK6KZEK-]JNF6]I:R
MVFW[3I[R).IE:<)M;RRR."05(S@_+7>?$_X?+\2O#<&EG5;K2'M[^UU&.>U"
MN&>"99521'!62-BH#*>OJ" :XGPK^SC'X4\0Z5J\7BK4-0GTW6=7UN%;ZVA(
M:74"YF5O+5,J#(Q&,'/MQ0!S_BG]I>U\6_![4]0\&V>KIX@N?!,WBI(HQ D^
MF1%72,R&1BAD,D<P55W ^1)R/E+>P_#:_N-5^'7A:]NYFN+NYTJUFFF<Y9W:
M%2S'W))->-VG[']KHNF6UMHGC'4],E/AF3PCJ$OV:&47U@7E>(LI&%EC:>7:
MZ\8<@J>,>W>#?#O_  B'A+1M"^VS:B--LXK,75PJ+)*(T"AF" *"0.P% 'BW
M[4_QCOM ^%GQ0LO![:DOB+PWH\=Y=:EISPK]@:4,8QF0Y+;5+L%&0A!!W%0>
MN\0?M#Z!X<DU.ZN+.^D\/:5KD'AW4=;B"&"UO)3$JAEW;S&))XHV<*=K-TPK
M,,CXG_LSP_$'4/&\UEXKU'P[:>-=+CTS7K.WMX9DG\I62*>,R*3'($;8QY#*
MJ\ J&JW/^S=I=S/KUG-J]U<>&-?UFU\0ZIHT\2$37T#0OO210"D<DEM"\D>"
M"0VTH&8$ N7_ ,?K*WTJYUFR\-ZUJWAZ*UU*Y36+..-K=_L+$2J3O^3?LD\M
MGP'V'D97=F>*?VH] \)Z5K.H76B:Q/!IGAS3_$[BW6$L]M>2R11J 9!\ZM$V
MX>F""W2K'AC]G>+PS9>)=!7Q;K-UX(U;[>;?PVZP+'8&\+M.(YE02,@,LA1'
M)";_ .+:NWF+S]D1=8T/4M-U;QWJU^+_ ,,67A::7[';1G[/:SR2Q2 !/O\
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M6 )!^7-=EXL_:1T;P?K#:9=:/J-U>VDMG#J5M8F*>:R:Y=53]VKEI-BNDC[
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M-U=1KO[/$.NZEX@O9?$5TLNL:YHVO2_Z/&?+GTUX'@"XQ\KFVBW@]<MMV9&
M T;]H[3]6%G8R>']3T_Q+=^)+CPM%HMT\)<7<-LUV[-*CM&(_LZ%]P)/(7!/
M%=C\*OB1:_%CP5:^);+3+_2;6XEFA6WU+RO-#12-$_\ JI'7 =''7G;G&"*\
M3^,'P;U72TC_ +)37-5MM5\6R^*+V\T>RLKF?3I_L@@C589R"T9PIWH=Z,N<
M[6^7UOX(:+KWAWP#;:=KWEJ;>1DLHA8P64D=J NQ9(;=FB1@=^ AQMV9PVX4
M =_1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %8OC7Q7:>!/"&M>)+^*>:PTBSEOKA+5 \IBC0N^U21DA03C/:MJN>^(?A,^
M/? /B/PR+O[ -9TZXTYKKRO,\I98VC+!<C) 8D<]: /-]5_:K\,:#H+:GJFC
MZWIC?9I=0CL;Q;6*YGLD1'^TQHTXWJPD 5 ?-9E=?+RI W8_V@/#4WB30M*C
MM]3:#6]033+#4WMA';3SO8_;E"AV$C*8<?O%0H&.PL&! HZM\%M<74_#&L>&
M_&K^'=;TO25T2^F_LU+FWU"U!5ES"[_)(C!BCAB!YCAE<'%9>J?LY:A?^.-/
MUY?&DS1V'B&WU^!+S3UN+H>79-9O;&<R#,161Y% 0;'D<G?NP #H-._:#\,Z
MKX<CUZUBO9M'NGLH=-NX_)=-2FNIFABAAVR'$@=<.LFPQ[@6P Q%>]_:.\.V
M-\--DTS6CK0UY/#DNE+;QF>"\DMS<P[_ -YL\N2(;ED#%><$J0<<3<?L>6UX
MM_J#^(8+#Q/+<:9J,.J:1I0M(FU&QF:6.^N+<2E)I9-VR0@IN3(X."O57/[/
M9O\ Q+!XDN=<C.O/XDM?$=]-%8E89FM[(V<4$<9E)C0(S,26<EV8YQA0 )+^
MU%X<A\#-XG;1/$*V\$&K7%[:-:Q++8C3;C[/>),QE$0=9?E5%D9GP2@8 D<C
M=_M+#P)\1?B%=:\FN:QX$T^WTB\CO[*RA:WT6WN(69YICE)#&3AC@2LH!) 4
M5:U+]DZ\O],O[ >-F2UO_P#A(Q/ ^EB2-#J]RUP\L2&7"31,\B)(=W[N1UP"
MQ:M.X_9DEO[/Q'I=YXH%QHGBG1[#1]=MO[.VS3QV\;1/Y,@EQ$LL;%2&20@9
M(8'D %;1/CH/"GCKXMV_BK66N]-T[Q38:/H-LWV>)OW^D6MV85<^6A ,D[[I
M&X53EC@5ZI\-?B/I'Q4\+)KVB^<MJ;B>TDBN%4/'-#*T4BG:65@&0X9&96&"
MI((->;^(OV:9]5\0^)?$&G>+9=%UZ_\ $EGXHTR[M[%773[FWT]-/\MD9\31
M26RNCK\A_>O@CC'K/A/2M3T;0X+?6=8;7M5R7N+_ .SK;K(Q.<)$I(1 , +D
MG Y9F)8@'"?M _$#6? NB^&(=$L;NXN-<\06.D27%H8-\$4LH\S9YKJ-[(&5
M3R 3DXP,XWA[X^^%_".HZ=X/UGQ+>:Y?)>76FOK]Y]E4>?"LLKQSK"P9"B1O
M&9?*6,M&1NW, >V^*'P[F^(D'AM(=432VT;6[76@SVOG^:T#%A&1O7 .>3S7
M-:7\#-0TW6O$MHWC">X^'^O75Y?7'A9[) Z2W08W")=!MPA>5Y)=FW=N<_/M
MRI *6G_M;> +Y[Q6NIK58+6SO8YII+?RIXKJY6VA(D64K&?->,,DQC90ZEE
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M3C;Z+XL727TWQ;+XO\.+'I8,&DS3+*L]L8A*/-MY!<7&4!0@RL5884#0\/\
M[.FHZ1K^BZQ<^+(;RYT[Q9?^+3&NE>7')-=VD]J\('G$JBK<R,"2QR%SG!R
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M+E)D"ED(!P0&!'Y@UX]X&_9WU'P=J/P_N)/%-K>Q>%9]9F:-=):)KO[?,TA
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MW9R!Y1J'[)M]JWA.70KKQC;^5)\/8_ IFAT=E;<GW;O!N#QZQ?\ CXKJ-2^
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MZ#/%!J%G,T;-%YL8DB8/$[HRLIX*L<%6!P5(KR&#]CJ>;PSX8T34/&@>'0_
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MHD,6O:K%K.KL2]S=VUJ;: L>T41=RB 8 !=CW+$DF@#8HHHH **** "BBB@
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M:4=4MM,\3:??V&M65]' S6R7UI<)<1;HRVYHB\84C<#@DC!Q7(ZS^S_K&O\
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M;.5+J=4$:VK1GS"JGB4R9!SN0+C:2WJ5 !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5YA^T7XKUSP)\+=<\2:)XET;PQ)I5G-=_:-;M?.AF
ME5<Q0G,D8178;2V21D8KT^N6\::9XFU9H;71KC0TTNX@F@OXM6LI)V.X *R;
M9%5E WAHV'S9'S+@Y -CPY?7.J>'M+O;R."&\N;6*::.VF$L2.R L$<<,H).
M&'4<UHUQ?@'P1?\ P[T_PYX:TZ_MYO!FA:!;Z3;PW$+-?O-"%C21YMVPJ8D
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M<I3%\*^"KO1-,\#Z;<V'B.6V\/1:]#-)%X:NP]P-1=V!4%<*8]^.<[L?P]*
M/:-/_:<\*-X,\/\ B#4H=1TU-2TFTUBXA-G(_P!@M[AUC224@?<,C;0R@Y +
M8V@D4O$7[0&G7&G>/($NM3\)OX6\1V6@RZM)I#WD<DD@LI  @& )!=B+<Q&T
M,'Z$5X7XG^'GBCQ#\/=.\+27.K7-K9^&++0H8[OP3?-#;W%K(66ZA43?*\J>
M6CDY($2[<!F%=-XGT#5=8T?XC6%O;Z\$\7Z_IOB#,GA"\4VTUO%IZ2)PYW*_
M]GC:."OFG);;R >_:G\:O"^D:Y'IUQ<SB)M4CT-]26!FLXK]P"EL\HX5V+(H
M/W=[JF[>=M9.B_M)>"-?UVQTNVN-2B:]N=1L8;N[TNXM[8W-BTHNH#)(B@.@
M@F;![1MZ5XW+X5,R:[H,ECXIE\%ZQXM@\826[^&+K[9!.EW#>R6RR#Y6B>YA
M#;B RJ[)AN&%;3?#^K:;/X=FAL-?BETGQ7XA\2A_^$9NWS_:?V[;$ 5P3$;X
MG<1A_* VKN^4 ^G/"/CK3?&J/)IJW/D_9X+N*:6$K'<03*6BEC;HRL%)X.1T
M8 \5J:YK5EX:T34-7U*X6TT[3[>2[N9V!(CB12SL0 2<*">/2OG?X(VNG?!^
M_P#$$]EX7\3Z;I^KI;$^'])T&]73+6YC,OG7-O"^1!Y_F1[HD^5?)7EB2:[K
MQS\2I?$O@K7](TC3?&OA[5K^PGM;35X/#EP[V4SQLJ3*I R48AL9&<=10!;?
M]I'P5;6=S/>3:G9-;:AIVFR02:7.\JRWQ06;;41ODD,B@-T!RIPWRU<T3X[>
M&/$6FB:R_M!;]]4GT5-)N+"2.]-Y%&97C,3 $8C&_<2%VD'<,BOFY/ FMFZU
M6Y?3]0B?4=3\-:M)%9^$+^)1-I5TEPP+,[E_-\L*7/S98L<XVG6_X1O5]/\
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M#EL >B_!K6+/X3>$)-!BT/QO<60O)KBTM)M(O;A-/A=LI:Q22 NT:=%SCK@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !44=M##(
M[QQ(CN<LRJ 6^I[U+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCD56&'1AR,'&1D$$^<^+OC;-X6^-_A+PD^G*_AO5C)IUWK);BVU1XC/:6W7
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MN;_[18ZG_8TVG3Z7=0WHNS"MP(A;/&)3F%A*"%QLRV< D>;>)_V?_%>OVGQ
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M$$\M^T+\:;GX+>'K#5+33!JRI<)=ZJF<&TTB.6);V['3)B69#M]\]C6E\,/
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MMU;:8\K6P"S.L;1F54DPT81\.H(W8(% '5T444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !5?4-0MM*L;B]O;B.TL[>-I9IYG"
MI&BC+,Q/   )S5BN9^)?AZ3Q;X U_18].LM7.H6<EL;#4)GA@N%<;61Y$!=
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MQ"([G .%5B> 37+ZY^T!\-?#5K#<ZIX[\/V4$UI#J$;RZA'AK:;/E3#G_5N
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M_(P0D$@5@:)\+OB!H5CXM\,QV/A34=*DO];U;0M?U61[BXCDOVN)A!+;&$J
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M",XSD9KPK_A27CNZ\4ZC>3^'B;&Z^(FB^+@]UJL5S-]G@TRWMYP^<#S%D@)
M7Y?F 7Y0* /HJ#XI>$;[PI;>)++Q1HMUH=VSQVNI+J$?V:>1=X9%D!()!C<$
M#)&QN.#69\&/B4/BU\(]"\97EI;::FJ6SSR6\=QY\,:AW7B0A=RX7.[ SZ5X
M]X6^%GC_ ,$^/M/\5V^AIJ%C!K_B:6?1!>PI(UOJ5S%/!=Q$ML\Q#"5968';
M-)M)/#=Q\*OAOK?AC]F&/P7KFBV5QJZ:5>V;Z2MX?L\_F&7;$95 VJP< D=
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MAF[DAC^UQR7RM;PSE-SQI*X3>!AL':"0N<"H]6^)OA#0=*M=4U+Q5HMAIMW
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M=\#G7M"GUK3=?TK7K+7&M[+26MK>WC\F2V\Y)"T;0.8RD;JZR .5^;/#Z_\
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MAE/\-/A18V>K^&[?0/$GGWBW940-+)$U[<30AI(F8,H6;(!;Y=QX% '>ZO\
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MVFM]%TJQTBWFF>XEBL+9($>5SN>1@H +,222>2>M:5% !1110 4444 %%%%
M'.:3\-O".@:_=:[IGA;1=.UNZ9GN-2M-/ABN9F;[Q>15#,3WR>:Z.BB@ HHH
MH S;[PUI&J:K8:I>:597>IZ>6-G>SVZ/-;;AAO+<C*9'!P1FM*BB@#.\0>'-
M)\6Z1/I6N:79:SI=QM\ZQU"W2>"3:P9=R."IPRJ1D<$ ]JOHBQHJ(H5%& JC
M  ]*=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7C>_MM-U_P /M?>*[+6-$UOP_?6*7%EY>BK9O.8I9#'*F]&C:*0?,DP(&1P
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M+[XD:'J^E:K::[IWAN]BMA9WM_>-<S;1/+#NMV63R2X8,/(1MOS': ?0^O\
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MZIH=YKD6A>+/#OPPUCPUI/\ PD6G7?BGP]>HJ3ZA;Q6T\!*6BNR,+>1[63Y
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MDV)FDG^SVD8CC\R1BSM@<99F+$]R23R37S9:^#?$27NFR-H&I!8OB[=:Z_\
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M(U>UUSX:7>J>$]5D;0_$_BZQMKG4-#D<V23WLDFFOM"'RX-GEE9%Q$@  88
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ME655=I)6VE6+-Z9^RYI5]H/P;L=+U"QO=-ELM3U6&&UOX)(GCM?[0N#; +(
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MMG<R"8J6E+';*RLI91OP2 ?7-03WUO:SVT,TR1RW+F.%&;!D8*6(4=R%5C]
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M$#.X8)W'(!]@UYIXN_: \,>"5\;MJ46I >$(+.XU(Q6N[*7)<1&/D;N4;)X
M]:\>_:HU378O$VN?V3:>)HKS3])T>[T^YL[2ZNH)6&I2-<?9!;KB*98T7SF=
MF+QO$@CQDMD?'W3=2UJ#]HT6.CZM=MJ6A>'X[)8M-G8W3H\Y=(ALR[*'7<JY
M*YY H ^PZ*\9_:*M+G6G^&,%I+K2V5SXJ@74/[&FNHLV;6UP'\XP$$1[S%EF
MP 2.0>:\]T;2;FW^*3Z#J-QX\TG6M"U@2:,VFVT]Q8WFCI;B.)7O94>(QB,G
MS(Y9!(TZ;AEV4D ^J*Q_%WA+2O'7AZ[T/6[9KO3+K9YL*320EMKJZX=&5AAE
M4\$=*^+M7U'Q;H?A?2K76KO4%L&\2^$85\6Z1+?:;+JUO+?/'-'=6K$/%=A
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M44 %%%% !1110 4444 1+:0)<O<"&,7#J$:4*-Y4= 3UP,GCWJ6BB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MIQTF?PNRO\G18?MJ@,"W$C$D+YA! /M/4;P:=87-T8I)A!&TACA +O@9PH)
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M _#S_H4]/_[Y/^-'_"@?AY_T*>G_ /?)_P :] HH \__ .% _#S_ *%/3_\
MOD_XT?\ "@?AY_T*>G_]\G_&O0** //_ /A0/P\_Z%/3_P#OD_XT?\*!^'G_
M $*>G_\ ?)_QKT"B@#S_ /X4#\//^A3T_P#[Y/\ C1_PH'X>?]"GI_\ WR?\
M:] HH \__P"% _#S_H4]/_[Y/^-'_"@?AY_T*>G_ /?)_P :] HH \__ .%
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M_P"->@44 >?_ /"@?AY_T*>G_P#?)_QH_P"% _#S_H4]/_[Y/^->@44 >?\
M_"@?AY_T*>G_ /?)_P :/^% _#S_ *%/3_\ OD_XUZ!10!%:VL5C:PVT""*"
M%!'&B]%4#  _"I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ46CRI'KQL9%LY;C#*MSY9$;-Q@C?@GC'M7QS-X03QA^SA\33#X;\?GQ==^
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MZWI7PH^''@_P_J'AC5M!U'Q#K>JP+C09X$C?[7<2PFX8QCRPT31A"W!X Z'
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT;HVXYSNY.<UY_\ M.>+]5TGQCK TN_\2Z=>Z5::!>VWV=KC[+(AU1Q<F".
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M#Q#=:=I\7Q=CM]5O)M5EDMXK"1HHW:;>Y14).#(V.@R>. #ZUUWQGH_AG5M
MTW4KLVUYKMTUCIR>3(PGG6&28Q[E4JI\N*1OF(R$.,TG@_QKHWC[1WU30KPW
MMBEU<632&%XBL\$SPS(5=58%9(W4\=5XR*^7-,\>_P#"6^(OARUUK8U-M/\
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M]S5FB@""*PMH;N:ZCMXH[F<*)9E0!Y O"[FZG';/2JL'AS2;:"2&'2[**&0
M/&ENBJP#%@" .?F)/U)-:-% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM8['4UU=+;7=>A>Z$RRNS#5[L@N5XW,K*W;(8$<$4 >Y4444 %%%% !1110
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M_#/Q)\,Z+!#>0V6)[/41I?VF*8I I('VV?85VE>.3@4 ?7]1M;Q/.DS1(TR
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M,_ ?Q M?$=SXWNM<\%ZQJFJ:#+8VPB@FM8 \-S"((ED'[TK&Z$L&,@"A2%
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ML?,%?0OC;3M8U?P?K5EX>U5M"UZ>SECL-26*.7[-<%3Y<A2165@&P2"IR,T
M:L%I!:PK###'#"IR(XT"J#G/0>_-35\D?#3XZ^.?'GB;1[6:ZU2PLO%VCV]M
MIS-9VY_LW5[*1%UI=WD8^42L$\W<I>TF"CE16AX-^-VIZM\>="TM?&T.I:+J
M^I^)-,ELYA!;R1/:3^7 BV^"Z&,QN@D9\S?,QC *8 /I3PYXDTSQ=I$6J:/>
M1W^GRO)&EQ%G:S1R-&XY]'1A^%:#PQR'+(K'CDC/0Y'Z\U\F>&/C+XZT/PM\
M/_&&IZY>>)=&UFZUOPY=626ENN[4A>3KIDN^.'<@8VYMB!\FZ:(D#!SIZI\2
M?%4'Q%U/P->_$33_  ]XAT%M%-G)JIAB;7HG6-KB5+40 SF:0W%L%B=?+9$(
M4-]X ^H?+0Y^5>3N/'?U_2FI;Q1S23+$BS2 !Y H#,!TR>^,FO&?V=[WQ)XI
ME\4ZYKGC+4-;@LO$&MZ'!IDMO:QP1QV^HR1PR$Q1*YD$:!?O;2#G;GYB_P"(
M/C?4I?C?I_@)]<G\':3>>%[S5K76(1"&N+R.:-"BM*C*?)C/FE/X@^6&U30!
MZ-XS^(/AWX>V!O?$6K0:5:B-YFDFR0D28\R5L [8TW+N<X5=PW$9%;\4J31I
M)&ZR1N RNIR&!Z$&OE+X8:]X@^)/Q=^!WB+Q->3:;K.K?#'5;Z_TN**%869K
MK1RXV/&759,[BN=PV@ C#9]D^/7C)_!?A71WAUW_ (1^74-;LM.6<0HWFAY/
MFA\QR%@#JK S$,4&=JLVT4 >C_9XOM'G^4GG[=GF[1NVYSC/7&>U%Q;Q7<+1
M3Q)-$W5)%#*>_0U\B_#CXF^+_BA)\.M$;XA7-G_:4_B_3]1O-'^QRRO_ &?J
M'DVCB1H"-_DE"6V@.&W;02")/#7QG^(EM\-OA!XRNM6N-;M_'GA"WTU;>*S@
M$=MXDEMTDM;AF6+<L<S>:C[CY:,J< -@ 'UK-:PW#1M+#'*T3;T+J"4;U'H:
MR/&&J:/I^E1V^M7PL;;4[B/3(FW%6DFF;8D:D<AF)P".GJ.M:&G6=Q::5;6M
MQ?S7UU'"L<E]*B+)*X&#(550@)/. H'MBOE7PMX[\<)\-?!?C*\^(.HZC/K?
MC6UT&>TEM;)+86ZZS<6S!=D 8,\>Q6(;J@V[>10!]5:?867A_2+:RM(HK'3K
M&!888E^6.&)% 51Z * /PJOX9\2:3XOT2UUG0KZWU/2KP&2"\M7#QS $KN5A
MU&01GVKYU\*_$[Q1XN^+]MI \;65K)8>+]5L]6TNVN[%HWTJ%9!9QQHP:7SC
M*(%D PXS<C( B(\U^&FN^)?#OPY\%6.G^+]3BT[7O _BFY^Q0K JVD]I/ 89
M;=A'Y@<>=*"69L[N NU< 'W'-;PW:*LL23(&#J'4, 0<@C/<>M2UY/\  #QG
MH(^%OPWT1_%MCJ>NWOA^WN(+::\@-W.B1()"D:;2RQDA20IQ@;B3DF+XY:_K
MFG>,/A/HND^);CPU:^)-?N=*OY[:*W=VC&E7UPFPS1N%<2V\6T@=>"&SB@#U
ME+>*.:298D6:0 /(% 9@.F3WQDT\C(P>17R/\-/B;XXU[Q9I_P /?%GBN[TZ
MQ:U\0C3?&44=O!/K36>H+;P-DQF+>D.^5E10),!L; P-)?BK\8=;\"^#YXM7
MFT_Q)\0/!VW0Q!86WD6NO0D/YA#PN1'<6[F8JY8(MM)MP2* /KXZ?:FT%J;:
M$VH  @\L;  <CY>G6G36D%PRM+#'*R@J"Z D ]1SV.!GZ5\PWG[0NKW?@WP3
MXQEOIO#_ (5\7ZQ;:<T^K-%9KI2"QD9Q)*8&,;27J& NZE>%V;-ZM3O"&M>-
MO$_Q#\#^%Y/BR]_97/AW4M6FU+0+:S*7QM=5M8X<.\+;@896B=T 5R"R!,T
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M9('7;Q'QD(>.X%:EEX)\.Z;J2ZA::#IEKJ"(D:W4-G&DH5$V(H<+G"H2H&>
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M]>/-.U/0M6UN^L=5TBZ\1^+- N-(TW2S%(R:8=1>&6-S(S>8PL0FT\'?ZC)
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M=)TRTM]:DN[:WACDCC3;%+<QL2%!VL1O)&=V#UKP;X,>,_%UGX T?P'X6O\
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M+_3H9YA&K;E3>ZD[0WS 9P#S7@'P:^,7B#X@6G@SPG%<Z?X3U+5M)UW6&O\
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MFVWF;=-$,#[CM\S#HQY.34MK\)_!=F%$/A72$1=,_L4)]C0J+#_GUP1CR?\
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M'DO)N!W,FU=I/*X&,8J]HO@/PYX;OI+S2M$L=.N9'ED+VT"IAI6#RL !@%V
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MVPQDF..7(^=5R<*<@9..IKJZ* *7]BV!O+*[-G UW91/!;3M&#)"C[=ZJQY
M;8F<==H]*YT_"#P,?%&J>)/^$0T0>(=4@-M?:H+",7-S$5VLCR8W,"H .3R
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MP+DJ5\[?M#;\$@L""0>M:OA#PC9>#M/N;>T!>:\NYK^\N' #W%Q*Q:21L>^
M!V55 X K<HH **** "L;Q'X,\/\ C'[#_;^A:;K?V"X6[M/[2LX[C[/,OW98
M]X.QQV88(]:V:* .?UCX?>%O$-_<WVJ^&M(U.]N;-M.GN;RPBEDEM6.6@9F4
MEHR>J'Y3Z54E^$_@B8W!?P=H+-<6T%G,W]F0YD@@8/!$QV\I&P#(O12 1@BN
MKHH S?\ A&M(.BSZ.=+LVTF=72:Q:!3!*KDEPR$8;<22<CG)SUK.U;X;^$M>
M\,6_AO4_"VBZCX=MO+\C2+O3X9;2+8<IMA92B[<#&!QVKHZ* .4G^$W@>Y-V
M9O!OA^4W=W%J%QOTN!O.N8L>5.^4^:1-J[7/*[1@C%0ZQ\&_ /B#2M2TS4_!
M'AW4-.U.\&H7UI<Z5 \5U=  ">52N'DP -[9; ZUV-% '+ZA\*_!>K"Z%]X0
MT&\^U6":7/\ :-,@?SK-<[+9\K\T0R<1GY1D\54UKX+_  _\1Z@+[5?!'A[4
MKP10P">[TN"5_+A8-"F64\(P!4?P]L5V=% '++\*O!2,&7P?H 9=0.K C3(,
MB](P;G[O^NP2/,^][U3U;X)?#S7M%.CZCX$\-7VDF];4C8W&DV[P&Z8DM/L*
M8\PDG+XR<G)YKM:* .7U+X6^"]8;4FO_  CH-\VI0Q6]\;G3(9#=11$F*.7*
MG>J$DJ&R%SQBM#3O!V@Z/KNH:U8:+I]EK&H)''>7]O;(D]PL:A8Q(X&6"J !
MD\  =A6Q10!R[?"SP8T\\_\ PB>B+<3WO]IRS+IT2O)=[#&;AF"Y,NPE-_WM
MI(S@XJYKW@?P[XI\-?\ ".ZQH.FZIH&V-?[+O+1);;$9#1CRV!7"E5(XXVC'
M2MRB@#$\.^"?#WA""]AT+0M-T:&]E,]U'86D<"SR%0NYPH 8[5 R>P K#L/@
M9\-]*NXKJR^'WA:SNH;H7T<\&BVR.EP'WB8,$R) _P VX<YYSFNWHH YZW^'
MGA:TU>\U6#PWI,.I7OF&YNX[*-99RX D+L%RQ8 !B>H !S@5A6GP ^&-A;&W
MM_AWX6BMS:)8&)=&M]AMUD\U8B-F"@D^<+T#<]:[ZB@#*TKPGH>A:CJ&H:;H
MVGZ=?ZBR->W5I:I%+=%5"H9&4 N0H &XG &*PXO@UX AO[B^C\#>&X[VXN1>
M37*Z1;B26<$$2LVS)?(!W'G@<UV-% &%X@\">&_%EW:W6MZ!IFKW5JK1P3WU
MI',\2,06568$A6*KD=#M&>@J*^^'/A34_%UEXJO/#6D77B:RC\FUUF:QC>[@
M3GY4E*[E')X![GU-=%10!QZ?!SP%'JL^IKX*\/C49[F6]ENO[,A\QYY5*RRE
MMN2[J6#-U(9L]34EM\(_ ME'9I;^"_#T"6=C)IELL6E0*(+1\;[= $^6)L#*
M#Y3CD5UE% '(2?!_P)+>>';MO!?A\W7AQ!'HLW]EP;M,0?=6W.W]T!V"8QVJ
MQ%\+O!D%Q!/'X1T*.>"_?5895TV$-'>."'N5.W(E8,P,@^8Y.3S73T4 <QI/
MPO\ !^@W]M>Z;X5T;3[RVN+B[AGM;"*-XIIP%GD4JH(:0 !B.6 &<UT]%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4]6UG3] L
M7O=3OK;3K-" UQ=S+%&I)P,LQ &3Q5RO*/V@OAM=_$W0;&UT[Q38^']2TQY-
M2AM=6TZVO]/NRJ%/]*@E7)B4.?F1E*E@<Y H ]1LKVWU&TANK2>*ZM9D$D4\
M+ATD4C(96'!!'<5-7%?"#Q1_PD?PU\&7-Y86>@:M?:':7TNAVI"K:!HDRB)P
M1&I.T<#& .M=K0 4444 %9VN>)-)\,6J7.L:I9:3;.XC6:^N$A1G/106(!/!
MXK1KP'P7//<?ME_$F+Q)C[3;Z#I?_")I.,#[ ?,^W/!V+&Y,8D(YP( >-M '
MN>EZO8:Y:+=:=>V^H6K?=GM95D0\ \,I(Z$'\:MU\M^$?C->7OC0>&K.PM/"
M":[X_P!9T.[U73U#>;+9VA<R*)5:-)KAHU.TJXQ'*?F=MRR:=\<O&'AS3M \
M0^)[W[1X9T_Q7JO@_6[JVLT'VHQS2P6-\H"_(6FC2"1%.WS)1MV@%2 ?4%%?
M-?BOXE?$"VUK5_"MEXCT'0_$OA_0M.UJ2;Q!.D,%\TTTWG[E6W<M @A\H-$4
M96;)+$K6!XU^*?Q.TCPQ\4_%%GXNL88/#/BA= L],;1HW1HY9=."R,^[=N1;
MB88Y!W GH* /J75]=TW0(K>75-0M=-BN+B*SA>[G6)99Y7"11*6(R[L0JJ.2
M2  35ZOE_5/B9XST+4?$FBWVLVVN?V+\2?#NCQ7EYIT(D>RO1I\CQ[4 171K
MF0+(%W8"]QNIVC_%3QZWCK0I[OQ%#/I,_P 1]1\'S:3'IT4<;VJ6EU+%)YG,
M@D5X$Y#8()!!Z@ ^GJH:QK^E^'H$GU74K33(7;8LEY.L2LWH"Q S7A7P=\>_
M$KQUXI\,75\0FB3VFJR>(H#:1^18W45TL5E!:S#!E5T,S%P9 ?)4Y7?@WOVT
M0&^#%EN (_X2SPUU_P"PS9T >Z1R)-&LD;*Z, RLIR"#T(-.KS?XT^/V\(Z3
MIEEIVLP:=KFHZG8VD4/E+-<RQRW"HR0JWR+*Z[U1I?W8();(4UY!I'QV\567
M@WPSXFU_6#'HB>)]=\)ZS/;6T#RJT5W=VVGW7"[=YDMXHF50%=YT( &5(!]3
MT5X7\ /BKK_C;1//\67L>G7OABVETOQ2)5BC@_M=)V23:P "(J1"4 $@QW<)
MSQD^Z4 4-9U_3/#EF+O5M1M-+M2P03WLZPIN.<#<Q SP>/:L8?%/P6T$\P\7
MZ"88%#RR#4X=L8+!06.[@%F Y[D#O70W%E;W<EN\T*2O;R>;$6&=C[2NX>^&
M8?C7QC::9;S_ /!/!;_R8CJ$%E=6\-RZ;FC1]6#.O;@M%&2,\[!0!]C:UK^F
M>'+1+K5M1M-+M7FBMDFO9UA1I9'"1QAF(!9W955>I) &2:OU\L^,?BEXT\+C
MQMI=SK-KK3:+X[\,:=!<WFFQ!OLE_-8"6+:H"Y0SR%'(+ 8R21NKN? WQ1U^
M^^-]_P"&/$*7ME;3)J;Z2T45O/IFHQ07,<:M%/&/-BGB4LDT,W5V+)\JXH ]
MMJ*UNH;VWCGMYH[B"0;DEB8,K#U!'!KC_BYXEOO#W@^2'2(+JZU[5IETS3H;
M+R_/\Z0'=(GF,J9BC66;#, 1$02*^<?A]XWUKX*?"KXY^!+6UN_#^K> ]-O?
M$WA:#7#%<R_V7/%-/ &V2N)!%<1W$.=YPJQYY.* /L.BOCSQU\6/B=X6T3XF
M7\'C6.5O#OP_TWQU:QOI%N 9Y#J'F6AX_P!0PLER3F0%SAQC!](E^)?B[Q)\
M2M9LM$UO0=(MO#OB>UT>^TC5IL2SVDL$3&01B$R&5S/NB82+&0@4C[S  ][J
MBNN:<^L/I"ZA:MJJ0BY>Q$RF=8B=HD*9W!<\;L8S7R/IO[1'Q \,^&M#\8:O
MJ<?B6WO_  SXIU.30H-.C@7SM-D4P>6RYDRR[D8$D<@@ @DT?B#X]\1>%-1\
M;?$'1O%%OJNL1?!P:_8WCV<30*ZS22_NU7 ,3$#:'+D9.6;L ?:E%?*?Q,^(
M_P 1_!.L_%18/&BS6_A2UT36[6)M*MP)!=SSQRVC'!/DX@)!_P!:"X_>';SU
MGA_XH>+_ !IX\EDT[7- TO3=+\67OA[4M!U"?-R\$:R)$T<:P[_/<K%<+F38
M89&R!C< #Z HKXB\3?&KXEI\*AK,OC%EN-7\.^,6"V6GP0_9+C36E-M/$Q5F
MW$1E&#$@@@@*PW'ZV^&"2I\.?#(FO9M1E_LZ O<W&S>Y,8/.Q5''3IVYR<F@
M#8UO7M,\-:=)?ZOJ-II5A&0'NKV=88E). "S$ 9) J_7Q?\ %SXH^(/$_P -
M?B/X>\1_:]/U$Z4NHV,+PP3Z;?6OV^%8[NRN(<,R /&&BF(D4NO4'-=Y-\4O
M%VB^*O%/A*\\4+=W</B_3]*TZY6PA2\GAN-.%W);0# A#J4E*O*" BL"6;:2
M ?0=YXBTG3M3MM.N]3L[74+F-Y8+2:X1)9409=E0G+!1R2!QWJ72=8L-?TVW
MU#3+VWU&PN%WPW5I*LL4J^JNI((]P:^5_ /CK5/B/\0/V>-=UJ6&?59+?Q9;
M3RP*%60P21P!\+QEEC5CC R3@ 8%>J?L@X'[,_P]QT_LQ>G^\U 'J.E:]IFO
M"[.F:C::B+2=K6X-I.LODS* 6C?:3M<!E)4\C(]:OU\C:/K7C#P5XJ\<^(-
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M?$OP\^)'Q@\1^'_$31WFB:'X5GG-S:02G4%^UWZ/'*0H"@J7!,:JP.T@C!!
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M>%]&\(V#6.A:18:+9/*\[6VG6R01F1SEW*H -S'DGJ3UK4HH **** "BBB@
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M5(O@5\/(+:6WB\&:+'!)J":LT:6: &[1/+6;@?>"$KGN&8'ACGNJ* .3\/\
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ME"LL?'R A5! QP *T:* *>CZ/8^'])L]+TRTAL-.LX4M[:UMT"1PQJ %15'
M    %9UYX'T+4/%=CXFN--BEU^QA>WM=08GS88GP71#GA6*J6 X.T9S@5NT4
M <SKGPT\+>)->BUK5-"LKW58X5MOM4L0+/$K^8L;_P!]%?Y@K9 ;D 'FH;[X
M4>$=3M?$=M=Z#:7%OXCD$NL0R E-08*J S#.'^157G^%57H *ZRB@#C+OX.>
M"M0NKRYNO#EE<W%Y=6M[<R3*7:>XMMGV:5R3\SQ^6@5CR H'2NSHHH ****
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M?B#XFTW6H[[P_;^$I]8U?1K[2+B=EOK=[629(5B01?Z_,!:57D*['+*!M 8
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M)4%ALZ!=IZKXA_M&:YX:TSXJZ]I=E8W%A\/-7L]-NM(GB<W>H1R0VD\TB.'
MC)6[VQ@HP+0MGAQL /8_#OPT\(^$)UGT+PMHVC3K9QZ>)K#3XH7^S1Y\N'<J
M@^6NYL+T&3QS3?!'PQ\(?#2"]A\(^%](\,PWLOGW,>D6,=LLS]BP0#.,G'ID
MUXS:_'#QRWC:QCF.@G0&^(-QX-FM8[&87+PBT>:*=9C.55PZ@,OEL&&<%>E>
MC?$?XD77AOQ_\/O!NG^3;WOBRXO5%]<Q&2.&.VMFF8*H9<R,=N,G& YP<8H
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MK^+%[XO^#]SXLUK31!J.F2ZG:7UO8*QCGEL;F>WD> ,2=DC0,R@DD!@"3C)
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M@D>UO9[7S$1F<J&$(;:6;&[&30!Z'1110 4444 %%%% !1110 4444 %%%%
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M?",H4D6GROS@MRK=@#U_Q/X!T'QDFD+K6GC4?[)NTO[$RRONM[A 0DRD-G>
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MW9DE!=0 -I8DH0&4JP!KT"TM8[*UAMX05AA18T#,6(4# Y/)^IJ6B@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BD9@BECT R:@^W
MP_WF_P"^&_PH L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 4-?U%](T+4;Z/[*9+6VDG7[;<
M&W@RJDCS)0K%$XY8*V!DX.,5XQ_PT)K/]SX9?^%[/_\ *VO7?&6O_P#"*>$-
M<UO_ $8_V;83WO\ ILSPP?NXV?\ >2)'(R)\O+*CD#)"L>#\K?\ #?8_N?#7
M_P +#5O_ )14 ?85%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH SO$6J_V%X?U/4M]G']CM
M9;C?J%S]FMEV(6S++M;RTX^9]K;1DX.,5X9_PU,O_08^$7_AR&_^5]>X^*-7
M/A_PUJVJ*]C&;&TFN0^J7?V2T78A;,T^U_*CX^:3:VT9.TXQ7SS_ ,-<W/\
MT%_@9_X=L_\ RLH ^F:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** (KN?[-:S39C7RT9\ROL08
M&?F;!P/4XXKFO^$U7_GYT#_P<?\ VJNJHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!#TXZTW,G]U
M?^^O_K42OY<3L-N5!/S' _$]A6?_ &K)ZV/_ (%__84 :=%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% #7+!&*@%L< G )^M5O,OO^?>W_ / AO_B*LN6",5 +8X!. 3]:K>9?
M?\^]O_X$-_\ $4 6Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% &?XAN[VPT#4KG3;1]0U&&VED
MMK2/9NGE"$H@WO&N6( ^9T'/+*.1XE_PM3XS?]$CUK_OWH__ ,NZ]L\1W&H6
MGA[5)])M_M>J16LKVEOM5O-F"$HN&DC4Y; P9$'/++U'A'_"P?CY_P!$^;_P
M7:?_ /+V@#Z(HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH H:]>RZ=H>HW<!A6>"VDEC-R2(@R
MJ2-^.=N1SCM7C7_"Y/%7_/UX._[_ %Q_A7NE% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
:4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>ex1011amendmentno1003.jpg
<TEXT>
begin 644 ex1011amendmentno1003.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 0  Q<# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KSGXU:3?2^'9];7Q_KW@31]#L[F^
MOG\/063S7"H@?YC=6\P 54? 5026Y/&*]&KGO'?@Z+QYX?\ ['N;F2VLY+JV
MGN!& 3/'%.DK0G/\,FS8W^RS#O0!5^%%IK]C\-/#$/BJ^GU+Q*-.A;4KFY6-
M9&N"@:0$1HB<,2ORJ!QTKJZQ_P"R-0_X2X:I_;=Q_97V'[-_8ODQ^3YWF;OM
M'F;?,W;?DV[MN.<9YK8H **** "O%-.\7ZM\3_V@O'G@U=0N]$\-^";+31,E
MBPBFU&\O(Y)MS2XW+%'&L8"H5+,S[B0 *]KKQ3Q?X2UZQ^*-]XO\(Z#J^G:S
M=6L6GZA=0O8RV6K0Q%FA:6&2='#QF20*ZLAPQ#;@%  -^'Q;?> ]:A\(W-W?
M^.O$E^EYJUG$JV\$R6$30JWF-^[C!5YDC7 !?()QAV'/0_M8>%[[P_JNMV&F
M:K>:?8>%)?%S.$C1WMHI)(YH-K."LZ/#(I5L+E>&-9VM>$O$][XMT'Q=8>'?
M$MGXMTJWNK-M0N+O3IXKNVN#&TD,L/VA0%#PQ.FPKM9,\[FW<=K?[/U]<:,=
M)T3P_P"*] L+CPM>>%+]([K2IVNX+AGD:4EY?EE\V25R5 !\Q@ O! !Z+XA_
M:ATWP_J>IVY\*:]<VFDW&DPZC?Q_91%;QZ@RI!* 9M[J&==P52PPQQTS'8_M
M*16U[XJBUS1GT];'Q4WAC2E6XBS>2+:)<,69G 3"^;(2> H &Y^#Q^J?"#7=
M5L?$MM-H'B5O[>31UN)FGTO>ATYU>%EQ.%RY0;^,?W0M)KOP?\0:G=ZO?V&E
M>+M$U.?Q$GBK3KNTN=))TZ_^S"VE*AI3YD4D6]&C<D;9&'7! !V>F_M/V^O:
MAX>TW1_ OB?4M5UFSOKU+55M8?)2SO(+6Y+-+.@(#7".K+E70@J3G%0^'_VK
MM*UVXT!G\&^*;#3-?BU#^RK^2W@F%Y<6:RR2VJ10S/)YIC@F9 5 ?RV"D\9J
M:3X=\5Z1XT\/^+M0T+Q1KFJ:/H]]I<LEU/IF;I;J>">5RL<P"D-:PA%08"@C
M#$Y'F_PJ^&_B[6_A?HFD^*O!_B:W72AJZ6<%O)96=S:37OVF(SB5I\ED@NI%
MC*JH'F-NWL 5 /5I_P!JO1;+3M=GN/#FM?:M&O-&L[JQ@^SR3(VIS+!;Y'F@
M!EE?9(A^96!X8<U G[34VD:]XR3Q9X3O/">D>&M)TO4+J:]NK9W@>[GN8OWI
MCE9!&/)0[PQ"C>S$ "N%;X%>(98]26;3O%4WV_\ L$R+NT:-$;2;H7-L45)%
MP"Z*&'(VEAU*E>QUOPGXKO\ QOKWB?3="\2Z1=:U86%E>6T<VE2PR"TFED3(
M>8G:ZSRHZ9^92.1SD ]E\(>)/^$LT.+4A9O9I([J@:6.5945B%EC>-F5HW #
M*0<E6&0#D#:KR/X.?#"Z\%6EHFGQWG@W2H;^_O+KPW'#:?9+I[C:P,:QM)]G
MCC;<51'&2S%LY%>N4 ,F5WAD6-_+<J0KXSM/8XKYXM--\92?'G5_ J_$WQ$;
M.T\&V6JPW,L%BS_;)+JZA:1@+8 J1"AV# ZXQFOHJN)MOAH+;XQ7WQ _M25K
MF[T:'1&T\PJ(EABFEF1PWWM^^9\G.,8& 1F@#ROX3_'#4M/\02>'O$=KK.L+
MJWCC7/#^G:]*;?R8WM_M,\-LRJRN/W-K( PCVY !.2<7_!'[0OAZP\&^'(K>
M37=7U+6YM;DTZSUVZMEU&\-G?/%-!&V]8Y) S@11*<F-.3\ISO6/[/D%C?:1
M=+KUP[Z;XOO/&4:M;KAKFYAN(9(CS_J@MW-C^+.S+'!!Q[G]E/2[_P"&7_"!
M7VLR:EX<<:CYL%[912,)+NY:Y^T1-P8KB%Y)!%(/NAN58@&@#W6O!?VK?C-K
M'PJT*QG\.7-FE]IQ'B'5;>Y=0]QI5M+']I@B!.?.D1VV<<^5(.M>\(NQ%4$G
M QDG)KF+/P+$FN^(]4OYH=6FU;RXT2[M59;:"-"J0#GYH]S2/@\EI9.<%0H!
MB^)/C/8:/J/@^RTO2=0\32>+()KC2IM-> 0RK'!YWS/)(F R$$'!&.^< \5H
MG[7OAR^L=(U/5M!UGPWHNJ>'[[Q!;:AJ'V=E9+(Q_:H2D<KN'3S1C("OM;:3
MQG3\#_LY)X%L?AW:6_B>\OH? JW<6EB\MT):&>,QB*0KC*Q(0J;<'"J"6QSE
M_P##(^@WGA_PUH6IZQ>ZCI6BZ/JVB"(QK&]Q!J!3SBSK]UU\M-C*!CDG)Q@
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MU^GBVWTN;1[W5+BWBD6_MY)!+\T0"JC1N"8RF NXA@X.*XOQ#^QGH%[X;O\
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M S6W\-?A;=>!/$7B_7+[Q)<Z]J'B:YM[NZ62UB@ACDBMHK?,:H,C*PIP6/\
M,G2^)_P]B^)7AVVTY[^73+BSU*RU:TNHD5]EQ:W"3Q;D;AD+1@,N02"<$'!
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M"T[]FN'3[R]L?[=,W@^7Q6OC.#1WL_W]O?B<7147'F8,/VD><$\L,"2N_'%
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M/B!X"UCPKKI:2SUG3I=.O6MCY;%98RCE#SM/S$@]N*\\F^"OC'5_#=A8Z_\
M$@Z_?V-[;7$<ESHR):7,42N/+NK9)1YQ<N'9MZC?'&51=I# %S2/VD?#?B3P
MC9Z[H>FZUKCW-C>ZC_9=A;QO>)#:S&"?*^8%9A*I151F+D'9N )''VW[1,GA
M?XB^.CKD>M:EX4AO]!MK2:.SAB325OXXU1I@YCDVF:9 PQ(Z9^8!1POA/]E3
M5_A_+H-]X:^(EQI^LZ:=2MI[F?28YHKVQO+UKPPO%O $D<CL4E!_B;*%3MK:
M\7_LVR>*U\:QMXG:&/Q+=Z-=NTMEYLD+:<\3IEO,&\N85W' ZG% 'J?C/QAI
M?@'POJ/B#69S;Z;8Q^9*RKN9B2%5%4?>9F*JH'4L!WKR?XP_M$/X3^'_ ,1V
MT?2;ZV\9^&--BNVTZ^6#=''<*P@NA^\*21;TD7Y6)W1,I%>@_%WX96/QA^&^
MM>$-3N9[*#48TVWEH0);>:.19894SD$I(B, >#MP>#7">+OV=;OQYH?C'^V_
M$T#^)_$^C6>@W.K6FF&*&&UMY)I5$<!F8AFDN)F)+D<J,?+R >A^#]/U;P_H
M.H3:A?ZOKLLTTEY;VFHK:B[MD**1:AHML;X8,59F_C +84&N'T;]J+PIK8TI
MHK'5H%U/PQ<>*[8SI I:U@*B:(KYN1.A=04(X.<G@X]=MUE6",3NDDP4;WC0
MHI/<@$G ]LFO$4_9,\-QZS;:@-1O0;7Q1/XBMXN L4,RS&;3QV^SO+<3RLI'
M)?'0# !E6?Q^OO"7Q.\=P>)+37+SP]%J6@V5LJ6UKMT0W\4:*LY#J64SRJ"4
M\UESD_* :[/P]\4]-@UWQC;->ZUJVH1^*AH5OI-S# C)<C3K>Z,-J05#1>26
MG+2MD$R#/"BL[QC^SW-XLOO&MP/$26B^)=2T;467[ 7-N=/EBD1 ?-&[>85!
M.!@$X[8J:]^S??:CJ.N:SIGC%]%\0W/BR/Q?IM_%IRR+97"Z='ISPR1M)^^B
MDMXRK#*'+L01P  <]K_[1&I:9\5M"OHM*\2R^&)?!6N:K>>%VL((;V.YLM0L
MH6D(E9,;$>X_Y:['!4INW*6]^\.^(['Q3X:TS7M/D,FFZC:17UO(RX+12('4
MD=OE(XKS+6/@/J/B#Q%:Z[J'BS[5J2^%M2\-7$CZ> LHO9899)542#8$:WC"
M)SA<@LQ^:N]\">$3X(^'N@>%TO3=?V1ID&FI>"/87$42QJ^W)P<*#C/6@#R#
MQ_\ M -KOPT\.^*_!LFI6>G7?B#PSY=^D-O/'J-C>ZI#!-$FTR'=Y;2*RX21
M25Z$UUUA^T)I5_I-S<CP[X@AOK35+O2+K2Y(8/.MIK> SR&203&!4,>TJQEP
MQ=0.20.0M_V3E@CO9H]>L;'4;[4M$U6];3-'^RVMU=:;>"Z%P]N)ROG3.J+)
M(I7*J.,X(UIOV=+[^W+W4H/%HC^U^(KG7I+2731+ 3-:QVY789<&2,1*\<AS
MM8ME6!Q0!DWWQ@U#Q;XKT^_\,ZY=6WAC6_AG=>*-/0VT(9)3);M!/AT)W>7+
M@HQ*^U>H_!K7;WQ+\'? VLZI<&ZU'4-!L;RZN& 4R2R6Z.[$  #+$G@ 5Y[X
M,_9HNO"&E>&K+_A*UOO[#\#OX(CDDTS9YD)\K9,0)>&584&WO\QSR,>H_#_P
M@/ _P^\/>%I+H:BFD:;!IOV@Q>7YR11K&&*Y."0HR,]<T <>_P"T;X8@TLZQ
M<6>L6WAZ327UJRUQK+?9W]L)$1?*=&8AY#+$8T<(SAP5!P<1Z_\ M(>&_"MU
MJ=CK&G:Q8:MIMQI<-SIC01R3B/4+A;:UG79(RO&9R8R48E65LCIGF=+_ &5[
MB+X3ZC\,]4\=ZCJ7@Z.S%CH,,=JD%UI<:2*]N7F!(N&@,<8CRJC"X8.2"-#Q
M1^SC/XVN+_5]9\1P2^*;PZ'&^HVVFF.%+?2]0_M"&)83,Q!><MO;?]T@ # -
M &OIW[1WAV^62WFT[5--UM=<G\.KHM_]FBN9;V*W%P41O.\IMT3*ZXD^;<.,
MY YKQS^T&B:7\5+:XTWQ%X9TSPOX7M]8GUVQCM7O+83Q3N2D,CL-\:Q @,I&
MY7!QA=US6OV;!KR>+K74-2T?6='\3:U)K%[I.M:%]JMR6M8+=5 \]65D^S(Z
MR*0P+-ZC&?J/[*37/A+Q9X:@\979TWQ+X/L_"=[/?VHN;QOL\$MNMR9?,4,S
M),Y8%<EP&W8RI -'4?VE+;PSXE\>6.I^']6DT7PA8:5<7&J1&W9YFNRXSL\U
M3C 0\#M)P/E!O^.?VB+7PO?WVFV'A_4M5U2P\2:5X>N85,$:[KTQ,LB,TH!'
MER<9P=V 0!DC/\7?LU/XK;Q[GQ.UDGC#1;'3[KRK ,T%U:!Q#<(3)C9\^3$0
M22H^<<@PWO[-^K:I>:]JMYXSAEUW4]:T?Q LR:1LM8;JP6)0/*\[<T;B+[OF
M!ES]YL9(!T<'[1_@^X\?6'A..6>2\O=0GTF*YB:&2);R%':6%U60RI@Q2)O9
M A9"H8DKGL?&'C.#P='IWFV%_J,U_<-;0PV,:G#+#),S22.RQQ($A?YG91G:
MH)+ 'CO OP?UKP'XIU&2T\:W,_A"\U&YUC^P)+&,2)=W#M+/BY!!\EIY))O+
MV [G(W[/E._\1O -YXWN/#<]GK(TMM(U#[:]O/:_:K:[4Q21[)(MZY92XD1B
M2%=%;:V,4 <-/^UCX7/A_3]7T[1/$6M6U]X6;QA$EE:1!_L"%!)GS)4'F)Y@
M)3/.#MW' /K=MXAT^Z\.Q:ZMTB:5):B]%S*=BB$IOWG/0;>>>E>&^%_V4KCP
MWX7T[1F\8?;19>#+OP8D[Z8%)@F=&$N!+C<HC48Z$Y/&0!Z]IO@BVB^'-MX/
MU&3^T;)=+72;AU4Q>=%Y7E,< DKE??O0!P^I?M/>$]&T@:EJ%GJ]E;S^';CQ
M3IXFMT#:CI\"J\SP@.?G2.2)S&^Q]L@^7(8*R#XR66K^-O"PNHO$_A:"ZM-3
MN(K/4+6V2UOX(8X'-Q(0SR*%6160 J3N<.N5P,&[_94;6O!=EX?UKQ6VIMI'
MA34/".C7YT_RY;>VNXHX9)I@)<33"*&-0P$:Y+DJ=PQU/BSX9:BM]X7\36]P
MNL7_ (2T34+.+2(K5$.JO-#&NT/))MC)," ;MR_,<G'0 PKW]ICP]XA\-:G]
MDM?$FDQS^#Y/%MMJL%M;&1=-9&V742M(WSC 8)(N<[=R\XI^I_M/^&_!6AW3
M7MEXDU>+1-$TG6=2U%;6#*6=Z94CNI,2(N0T$AD5!D<E58 X\M^#OPA\1ZCX
M7OO#*W3P:1J7AB3PW?W6K>#9]+N]/A\ETBBA>6Y(=4:1\111B'EF#+\JOZ)X
MA_98;Q#X>\7:1)XI$4/B3PII?A6=TT[+11V1N"DR_O?O-]JDR#P,+Z'(!WEQ
M\:M%MOB!IOA":RU2WO-3U&?2;.]EMU2":YALS=R*NYMY41*_[P(4+(5W9QG,
M_9C\6ZSXX^#MAJ^OZ@^J:H^IZM;O=21HC.D.I7,,8*HJJ,1QH. .E8UU^SOJ
M=U\2=+\6MXP4RZ=XB;7XD?2E>9@]C-9O:M,9"3$J3N8P /+W-G?D$6_A_P#"
M?Q9\+6\%:)H_B>*[\+V5]J]WK5O+IR(UVMU)+<1!7,C,C1SRX 489"=Q!4!@
M"W^T5XSUGP)X?\*:CHUS=QO+XITJRN;6RACEDO+>6X5)( '!P6!P""IS_$!F
MF^#_ -I'0/&7B2W\.P:+KNG^(7DOK>?3-0@ACFM+BT2&22"3$I7<T=S Z,I:
M-ED!#]<=-\5?AX_Q'T+3;2WU(:3?:;JUEK%I<O;^?'YUM,LJK)'N0LC;<$!E
M//!KC)OV>[J'QOIOC33O$Z67BH:E=WVIW3Z<)8+Q;BUM[5HTB\P&(I%9VH1B
MS@&,EE?<: )/ 7[1EI\2O'?A32=$T*_.B:_X23Q9%JER8D,<,KHL*LGF%@>6
M#8!^8ICC<1VGQ#^)5C\.+.*>\T[4=1\R*XG*V$2$1QPQ&21WDD=(T&   S L
M6  /..!^$G[-\WPGO? MQ!XH;4CX<\*IX3G$M@$-Y;QNKPNN)#Y3 KAL[]P_
MNGFNH^*_PHN?B5=Z/-!KQTJ.QBNX)+:6T%U#*)XU3S0A90L\>TF.0[@N]QM.
MZ@#S#Q[\8M;N-0\6ZGX9\07,&B-\+)/%>D*;:']S<$R-'-AXR22JIE7W <\#
MFO;_  !K$VI?#GPWJNI7 >XN-)MKJYN),*"S0JSL>@'))]*\JL?V8;FW\/MI
M<_BT7(;P&/ K3?V8$/E ,!< "7&X!L;?8<]:];\/^$XM)\#:?X9O)%U"WMM/
MCTZ5]AC$R+&(R<;B5R!Z]Z .4T3X\:%X@G\/Q6EAJ>?$FGRZGX?>6.)%U>%%
M5SY),F%8QND@67RR58G'ROMQ/V8?$7B3XC_#?P]\0=>U._!\3:-9WQT:XCMO
ML]M(ZF0R6[1Y<(RR*@61L_N@2 68EW@/]GV7P;%X,@N?$8UFW\#V-Q8>&O/L
M2DL$<D:PHURPE_?M'"HC!41@AF)!8@CL/@Y\/6^$WPM\+^"_[1_M:+0-.@TV
M&\,'DM)%$@1"R[F&["C)!Q["@#LJ*** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ K(\7^)[;P5X6U;7[V&XGLM+M9+RX2TC\R7
MRHU+.53JQ"@G:.3C !.!6O3)8DGB>.1%DC<%61AD,#U!'<4 >?6?QU\-ZAJ&
MHV-LMW/=66F6&K^6B)FXMKUV2V:'Y_WF]XW7 [KCJ5SQ?P\^/DD?BS6?#_B@
MZC=27'C2^\/:7J$=BJVL.RW$T4$CKCYBJRX;!R0 2,C*^ OV3='\!:_X2U2U
MUF\F?0%O+7R64!+JQ9XVL;609^[:"WM]AZEHRW!=A4\?[.VJIJ45V?%=F1'X
M[?QH$&CN.&@:'[+G[3UPQ/F>WW* -CPA\9]+F\)0W<5_JWBZ_N[S6FM[5-/C
MM[UHK*]DAG40_( D#!(@S89\QYR[X/'S?M,0^'/B'XNO-3;5=0\"Q>&_#FMV
M?V;2\/8)>RWZ2S39"NJ8@MR5?++\V%X;#]+_ &:/%'A1O#VJ^'?'>GV?BC1M
M2UZ9;N[T%Y;.YLM5OC>SVLL NE<E)1&4D65?]6,K@FKGC;]FO6/&/_"PM_C2
M%&\7>&],T!YKC2#++ UI+<R?:&*SHKES=R90*@7"X/!R >O>-O%MGX"\(:QX
MDU&*YFT_2;62]N5LXO-E$2*6=E0<MA03@<G' )P*YE/C?X>EUC6]*BCO)=0T
MFWTZZE@C1&,T=\YCM6B._#AG5ER#@%2/2N[DMENK-K>[2.X22,QS*4^1P1AA
MM.>#SP<UX=\/_P!D_2? 6O>#-6CUR]O[GP]9W&GR&9 /[1MLQ"QCF['[*D$8
M0]206)R3D ;\-/CX_P#PDNH>'?%3W]S<WGC+5/#^E:DMBL=HGD1O-%!)(N!O
M,4,I#8.2N"02!5RY_;!^'%I8ZE>O?7<EK::,_B"*2W@$_P!LL$D5'GB6-F8!
M3)&2) C;9%;&,D0+^S;J$EW9/<^*+.>V@\<7?C&2$:2ZF5)[>> VN[[3\N!<
M,?,P>@^0507]FWQA<?!77?A=?_$:VO/#KZ,^@Z-.VA8N;:V("HUTPN +B2.-
M0BE!"#RS!B> #U/P/\3],\=ZUXDTBUL]2T[4M GBAN[;4[;R6994WQ2IR<HZ
MYQG!!!! (Q7/:S\=K/P[\2?%/AG4-&U&*S\/Z%9ZW-J<,0E61;B6YC5$127)
MW6S*/EY8GH!DZ_A#X=7OAOXD>,_%5UJ]O?+XBBL$^QPV30FW:VC="=YE;<&W
MYQM&,=37.?$+X(ZSXK\7>*=?T3Q>/#MQKOAVQT)E%@TK1-:W5S.D@=9D)1Q=
MR1N@ )7&UU.: ,;QE\>Q+<>%I]'NY="BM_&X\->([;5(H1Y*BREN)%9\LH 4
M0OO1\;6.3G..M\3?'OP[X1T"QU/4K?4+=[ZVN+ZWL)4CBNI+:$*99@DDB@ ;
MX_E)WDNH"D\5YAJ'[&\FOZ??Z3K/B#1+OP_J'BN/Q/=:1!X=>"' TY;*6UCV
MW7R*0N]7'S(?[Q&:Z6V^!_Q!TJ'PCJ-G\3;6Z\6^'[:YTIM5U306GAU'3I6C
M8)<PBZ5FG0PQD3K(NXAMR$,10!=N/VL_ 8B-U9?VOJVF)#I=U-J=EITAMH;?
M4#BUG9VV_(>,X!(STX;'9_&;XC+\(?A1XM\:OITVJIH&F3ZBUG;E0THC0MC+
M$ #C)/4 ' )P#YYXP_9MU7Q4OCL?\)E#')XHL]&MC-<Z299(6L)6D\QBLZ"0
MR%N0 @7MGI7H_P 6OA^OQ6^%/BWP5/?'3AX@TBYTM[V.+?Y/G1-'Y@0D;L;L
M[<C.,9'6@#&\3_'GP_X0@U&XU.UU**VT>&"YUR=(4=-&BE)V/<X?IM!=O+WE
M$&]@JD$IK_Q_\*^'M7:RF^W742:Q!X?DO;*V,\,>HS1)+%;D*2Y9DEC.X*4!
M< L#D#EO$?[.>J>(9?B%&_BNWCL/B'I<6G>);==,;)=;<VTDUH?._<E[<JFU
M_-P45LD[@WF<OA/Q)%\:M=FT?38E1/$$6H6FAZSX/U5[=VAMHK:.Y34(KI;
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MTTP>$KV2QUW2O%GAG3=4L[A(9C]CU'48(,AD:1"LD3S %6W*R$':1BM7Q?\
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M=6#B)"%8Y (C;9G(![YH_P"T_P##S6K6[NHM4O+:T@T6'Q$MQ>Z9<P)<6$N
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M/I\^FW236DMY-%'%)+"8UD";9=XX ?;L5MQKD]-^.'C"7QYXG\+7VIZ)8?\
M"+VVGZS>:K>>'[^"WN;"YGNBR-ND_P!'E2WMAAF+!Y6("C8RU;U+X*^,_$WP
MWU#3K_3? VA^(K[4='N9O^$?BEBMY$L;V*Y+/(8@[L_EE50KB/=]YN<R_$#]
MGS7_ !WXB^*5ZNI:?I<?BS1=&LK&4;KAK6ZT^>YN$>6)D"R1.]PH9=PRJ,/X
MN #TNQ^,/A+44O/)U.3[39WB:?-I\ME/'>K</")DC^S,@E):+]X,(<H&;HI(
MP;#]HGPEX@\2:;H^BW<^H+J.@W.OQ:E#9326\<,4J0X;"@[M[."O!4QE3AF
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MYMKN>$CH20<^@!Z1JWQQ\$Z'IJZA?:R;>R\G[3).;.<I;PF4Q":8A/W,1=6
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MQ#XCU'XMV6GZAI[>'?B9I<5A?M>.ZW.E2"U-G++ H1EF#0[&",R;70G)#?*
M;D/Q1U[Q;\9-<\(>'#;V%MX:>P?4&U32;IA>1S&0S"*8%4C945"A(8.=W5>1
MV/C'XK^%/ %T+?7M72PE\@74@\F200P&18A+*44B*/>X7>^%Z\_*<8O@3X=:
MGX3^)_C;797M'TC6K?3H+1$F=IX_LL3QGS 4 ^;=GACTKCOVC/@IXP^+D>M6
M6CZCI*Z5J.A?V?%!J4DL8M;L3&3SB(T/G!UV)AS^Z*;U#%F! /9O$GB+3O".
M@:CK>KW L]+T^![JZN"C,(HD!9G(4$X !)P.U>>7W[47PTTU-3>YU^XB33;>
M"]NW.DWI6.UFW>7=9$.#;G8^9QF-2,,PKI_B/X8U+QQ\)_$OAR-[2#5M8T:X
MT_S&=A!'+-"T9;.TMM!8GID@5X[XZ_9T\5>+]$\<6$=WH]L?$/PYMO!4;M<2
MMY,\9NMTQ'E<I_I7 Z_)VW< 'L,_Q:\)V_B=/#SZP@U5KW^S1&L,C1_:_LWV
MH6YE"^6)3!^]$9;<5(..:Q=(_:,^'NO7:6UCKLD[R6-SJ,3_ -GW2QSP6[A+
M@Q.8@LC1L0&1"67()&.:X#6?@?X]U3Q]HFN/?:#<V^D^*+?7+<SW$X>.V&FO
M9RVRHL6P,KNT@D^]*-JML"+5?PY^S7XCL+?X>VM[?Z6L/AVS\06=S);RR.T@
MU%LHR*8Q]P=02,]C0!ZU-\:?!5O9FZEU^".W&DPZX)&CD >RE(6*5?E^;<Q"
MA5RQ) QDXKFO&'QMC3_A$IO"MS:WMO>^+X?#.JQ7MK,DUNQ5VD4*Q1HY!M0C
M<I!5@0,$&O-M&_9]^*%EI>FC^T_#6GZAI_@NP\*H]I<3R"9K6Z21GW-"#&LT
M2LN5!:(OE2Y4-6GHG[/7B_3[AS++H$=O_P )_!XQ2*"YN&981;+%)"6:/+OE
M<ASC=RQP6P #M/AU\;TU2]U#3?%5S:6>IR^+=1\.:0EG:S*EU]G!=5))<"3R
MU=SE@"$8@8!KTW1=>L?$-O//82M-%!<RVCN8G0>;$Y211N SM=67(R,@\\5\
MX^._ 4GASP)XE\,W^J06GC7Q/XJN_$?@V338Y;B2._61)[<-\BA0K*!)DA3&
MTF2!FOHGPMH$?A?P[I^E12M<"UB"/<2 !YWZO(V/XG8LQ]V- &K1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %0WEY!I]I/=
M74\=M:P(TLL\SA$C11EF9CP  "234U<A\7O \_Q+^%WBGPK:WPTVYU?3IK2*
MZ="Z1NRD*74$;DS@,N1E21D9H KCXV>!PCM)XCM+<I?0::\=R&A=;F< V\95
MP"#*&4QY'SY&W-:\WCW08-)74CJ"O:/<O9QF*-Y'FG0L'CC15+2,#')E5!(V
M-_=./';/X(:KXO\ !&OZ-XD\#^"_"TGB@6UAKC:#=R3RR6T(D/GI*UNA:4,V
M(48?N<F3>S?)69=_!CXD#X?_  [AO+?PKXEUWP1>RPKILUW+;V6LZ>87@C=V
M%O\ Z/<A#&WRQNFX.!@/\H!["/C-X';3]-OT\3Z=+8:@EO);W<4N^'9._EP,
M[C*QB20%$+E=S@J,L,5=M_B;X6NC9B+6[5S=W\^EP#<07O(5=IK?IQ*JQ2DH
M?FQ&_'RG'C7@GX*>,?AUXOU2+2O#_@IO!7B>*TFOM,21XH]!NHBV[[-#Y!2Y
MC(*,-QA)E#.0-^!#9?!/Q[8^-M%=+?0I-"TKXCWWB];MM0E6>:UN[.^B9/*\
M@A9(WO.FXA@O5: /3M"^/G@S7? UKXM74WM=&NC.87N+>59'CA8[Y?+V[P@4
M;V8C"@_-C!K(^-_QYT_X;> Y]8T:]T[5-1'V"2&%B\T+0W5PL44C-'PJOE]A
M8@.5(!)KR_2OV??'OAO0? Z-H?A'Q:WA^WU+1;G1M4U*:.VNK2YGCE2Z27[,
MYBE4Q@-$8W#(3\V0*;XL_9V\?6&D>/?#_A:Q\,7&B^)XM%FM4:[DL(M)FLH[
M:%[>.)89!]G*VRLFT@J7<$'@D ^G-;\0:?X<M4N-1N5MTDD$,2A2\DTASA(T
M4%G<X.%4$G!XXKG+CXS^"+;1+/6&\2V+Z9=6TM['=1.9$6WB.V69RH/EQQL0
MKN^%0\,0>*P?C/X,\7:]<>!_$GA#^S9O$'A;5&OVTC5+IX;2^BEM9K>:+SEC
M=HW"S%D?81E<$88XY6Y^$OC*Q\87?B.QL/#TJ:YX5;0-0T2.=X+>PG^TW%Q'
M)$1%B9#]KD24E8V;RT<+EBH /4[SXH^$]/\ [5^TZ_90C2DMY;XM)Q;1SY\A
MW/9'VMM;H<'FJ#?&[P&OB9/#W_"5Z:VLMJ!TG[(DVYEO!&LGD,1PKE'4A203
MG R017SUJ/[*/C7POX5\0^$_"T^D:SIFJ>#_  ]H":CJ]]);313Z895):-(9
M RRK(I!##:0W#< ]KJ?P,\9WNJ^)+M!H*C4_B-I7C"(-?S96TMK6QADC;_1_
M]:39L5 RI#C+#!H ])\-_''PIXGT"[UBWNKB.UM]4N]'"26DOG37%O-+%*L<
M04N^#!*<*"0JDD#!Q'=_M#?#.QFTR*;QSH:R:G!;W5H%O$;S89R1#+P3A&(.
M&.![UX[<? +Q]I$EE?V>F^&/$+:5XK\0ZI'H^I:C-%!J-CJEY-<Y:06[>1/"
M7B ^612!*,C<*[+PG\)=1\!^-KGQ$^G>&M"\.1>#8]'%CH\KQI:3)<7%PXC0
MQ*OE#S@-^Y22I8HN<  [#1OVA?AIX@%ZVG^.-$N4LM+36[B1;M0D=BP!%P6/
M'E\C+ _*2 <$XJS?_'+P%I6E3ZC?^*+#3K:"^_LN47KF"6.[\L2>0T;@.)/+
M97"D9*LI'!!KYH^&'PF\3_%+]GCX.:YH::%8W^C?#%-(TY[]UN8+R:Z@L<^<
MOE,%1$M6!#*_[R3[I$?S]I:_ 'QX?%6H:C);Z#':7/CO2?%BI/KEU=3+!;Z9
M!:31EWMB6D#P;E).&#<[,#(![-\/OC'X8^*.IZQ:>&[U]073!;M+<B%TBD$\
M$=Q&49@ P,<T39'][V-:<GQ'\-0^(4T.36+=-2>Y^Q)&Q(1KGRS+]G$F-AF\
ML%_*SOV_-C'-<[X$\$:YX7^*WQ)UBY6QDT+Q+>6FH6LT5PYN(WCLK>U:-XR@
M4#,#,&#G[P&!S7G+?L]^)+U+KPU?7%E)X>/Q!'CBUUF.X;[6B?;1??93$4P&
M$V8@X<CRCG@C:0#LOAQ\6M5^*?C#6&T3^RO^$7T;5+K2;Z*XCF2^W1*-D\;_
M '&5I-ZF,J"% ;<3\M9.O?M-Z3%<>#+W298#X?U/Q;?>%]3NM1BDB>![:UOY
M&:,'&3YM@R8(.=W3-=5\&/ ^N^!H_&2:VNGC^UO$E[K%J=/N9)L0SL"JR;XD
MVN,<@;A[UYUH_P #_&NG:IX7C9-"?3M"^)&L>,//-_,)9[2]&J%4">00LB'4
MD&"V#Y3'=R* /2H?BSH^O:IX,FT+Q/H$VC:XEW,$G=_M-W'#&26MQD!?+93Y
MF\< 8X-=3H'BW2?%#7"Z9=BY:W"&0>6R$*XW(PW 95AR&&01R#7@?AS]G_QG
MI,'@>*[A\-W2:'J'B>ZNXFO9W2:/4I+EX$"FW&['GJ) 2N,'!:NX^ OPKUKX
M6/KEI<:A<GPS-':KI.B7FHMJ3Z4R"031174B+*]N=T?EI(25"M]W=M !;^+_
M ,<;;X3>)/!.GW%@]W9ZUJ<=IJ5ZIPFEV\K""&>0]@]U+;1C.!AI#_ :W/&G
MQJ\"_#NYN[;Q'XHT[2KFTM1?7$$TN9(K<L5\UE&2$R#\Q&  3T!-<1X]^ 3_
M !;T/XBP>*U"WNOVYT_3QIVM7<<4-K'&?LWF*JHN]9GEFY1\-)C+!17+WWP7
M^*'BK3]7N/$+^&)-?U/X;R>$;F>VU*X:*34&+[I^;4$1-OW'@L#Q@]: /8]+
M^,'@O6FUH6/B6PN?[&6*2_*2\0K+N$39Z,KE6"E<ABI R1BJ<WQW\ 6]M!--
MXIL(&GN+BT2WF8I<&>!"\T)A(\P2(HR4*[N1Q\PSXQXU_9L\<>)=5O\ 4K6?
MP]!,GA?PWI]I;7%U-+#<7NEZA->-'.HA7_1Y?-";E)88W;. *Z72/@QX@'B3
MP!XBA\*^$?"4NF:]>:UJNF:5>2.&,NF2V2D3"V7SY270LS*@"J%!;:"0#NO%
M7QL\-Z=\-Y/%.D:WI]_'=:3<:KIC@O)'<11(&:4A 6$2ED#O@!=PW$9K%\.?
MM,>"E\"^']4\5>)M'T76+K1--U;4+(3'_1!=Q!D9EY*1E@X#-P .3WKS/PE^
MS]\1_ -O:26Z:!K,EUX:O_#E]9-J<T<5L9+V>YAN(9#;G<"+@I(A13\D9!.*
MIZM^R_\ $#6/AIXO\/EO#=M>ZS\+M(\#P2?VC.R)=VGVSS)7/V;/E'[6N" 6
M^0Y S0!]$:7\7/!VM6^LS6'B&SNX]'FCM[WRF),4DF/*4#&6WD@)MSO) 7)K
M.N_C[\/+"P@N[CQ;IL*3"YV1-(1.3;OLN%,.-X:-OE92N5/! ->8?$?X#>-/
M%/B[Q;XCL4\//)<RZ#?:?IEY>3-#=R6/V@36]SB$;$=;@['7>0RJQ3C%:OAW
MX-Z_IGCGP3XGM?#7A/PS%IZ:Q-J6D:7=R8$]XENJL)!;*)F/V?+R,J'YL -M
MR0#T31OC%X7\1>+M+\/:3?\ ]I7.I:,NO6UQ;1L]O):.0(G$F-IWC<1@]%YQ
MD9[:OFCX+? OQ_\ !RU\$,(O#VK7>B^ H_#%TJZC,B&Z@=I(F0FWRT;DA22%
M*#)PV,'Z,TF2]FTJRDU*"&UU%X4:Y@MY3+%'*5&]4<JI90V0"5&1S@=* +=%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !371949'4.C#!5AD&G44 ,BAC@C"1
M(L:#HJ# 'X4^BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME1K_ 'H2. RY&1U&1FO7: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH :ZED8!BA(P&&,CWYJM]BF_Y
M_P"X_P"^8_\ XBC5K*;4=*O;2WO[C2[B>%XH[ZT6-IK9F4@2()$="RDY =&7
M(&5(R#YK_P *;\7?]%V^('_@#X>_^55 'JM%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !145T
MTB6TS1;?-"$IN!(SCC(')_#FN=_M+7_[ME_X"W/^% '3T444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ANUG>UF6UDCAN2C"*2:,R(K
MXX+*&4L <9 89]1UKFO[-\<?]#%X?_\ !#/_ /)M=710 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 5=5N_L&EWEUO2/R87DWR8VKA2<G<RC''=E
M'N.M><_\+7;_ *"FD_\ ?=I_\GUZ1J%Q+:6%S/!;2WLT43.EM 4$DS $A%WL
MJY)X&YE&3R0.:XC_ (6#XF_Z)IXG_P"_VE?_ "PH [^BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O&?B#XU\8
M^%?B]X$T^S\0>&Y]/U[4VLI?"LT/EWQLQ!*[WD<YERS(8P2HBVD.$SNPS>S5
MY!\1OAYKOQ@U#3--UO0='TK3-#\26.M:?KD.HM<W86UG2=3'&8$\J23887&\
M@)(^&<\4 >OT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!6U*ZELM.NKB"TFU">&)Y([2W9%DG8 D(I=E4,QX!9
ME&3R0.:X3_A9OBC_ *))XM_\#='_ /D^NZU.ZFL=-N[FWLY=1N(87DCLX&19
M)V"DB-2[*H+$8!9@,GD@<UY]_P +/\8?]$>\4?\ @RTC_P"3: /2Z*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** *VI74MEIUU<06DVH3PQ/)':6[(LD[ $A%+LJAF/ +,HR>2!
MS7"?\+-\4?\ 1)/%O_@;H_\ \GUW>HW4MCI]U<PV<VH30Q-(EI;%!+.P!(1"
M[*@9CP-S*N3R0.:X7_A9WB3_ *)'XR_\"]%_^6- 'H=%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% &?X@U1=#T'4M2<J$L[:6X8NZ(,(A;EG=$ XZLZKZL!R/$_P#AJ/3O^>MA
M_P"#31?_ );5[Y10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
*1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>ex1011amendmentno1004.jpg
<TEXT>
begin 644 ex1011amendmentno1004.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 0  Q<# 2(  A$! Q$!_\0
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MO^^C2[!ZG_OHTZB@!I0'N?\ OHT% 1U/YFG44 ,\H>K?]]&@1*.[?]]&GT4
M,$0'=O\ OHT>6!W;_OHT^B@!NP>_YFCRQZM_WT:=10 SRQZM_P!]&CRQZM_W
MT:?10 TH#W/_ 'T:"@/<_P#?1IU% #?+'JW_ 'T:3RQZM_WT:?10 W8/4_\
M?1I!&!W;_OHT^B@!@C [M_WT:4Q@]V_[Z-.HH ;Y8QU;_OHT! /7\S3J* &[
M![_F:-H]_P S3J* .8\2:M+I7B/P]%'*PANGECDCR2&X7!_#^M=#]H_S@UQ_
MCQ\>)O"*8SNNV/3CJ@Z_C79^4G]Q?RI@.!!Z'-+34! .XY.2>E.I %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444@ 4
M8 ["@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M3G/;%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% '$^/+??XB\(S$9"WA0C/'S%3_[+79^3'_SS7\J
MXWQ\@?7O">X C[=@@].2M=?]C@_YX1_]\"@":BFKT/!')Z_6G4 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 <1\0(U?7?">\!T-\%*E0<Y*__ %ZZ[^SK3_GUA_[]BN6\?PI+J/A@
MNH<?VBB;6Z$'&?KTKIO['L/^?&V_[\K_ (4 7**:HP#P!R>!3J "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** ..\?Q"6^\-;@&0ZBBLA&002.O^>]=+_8]A_SXVW_?E?\ "N9^($"S
M7_AD.%>,ZBBLC#(8$CM_GK71_P!@Z9_T#K3_ +\+_A1T%<NHI4')SR>U.I ,
M4M PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HI!TYI: "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH XWX@0+/J/AD.H=/[00,K<A@2!@CO71_V#IG_0
M.M/^_"_X5SOC]5EO?#<;J'1M0C#(PR",@<_G^M=%_8.F?] ZT_[\+_A0!=4
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MW<%NRWEQ'=3>9(1)%$8P(RY,:D%FR0FT%L_,02 H.T %JBBB@ HHHH ****
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M* "BBB@ HHHH **** "BBB@ HHHH **** "FR,51F52Y )"C&3[<TZB@!!G
MSUI:** "BBB@ HHHH **** "BBB@ HHHH **** "BBDSSB@!:*** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ."^*48FN_"2.GFPOK$"
MNA&0<GO[8SD=\UUG_".Z5_T#+/\ \!T_PKD/BNB33^$(W90CZY;*RL@8.,G*
M]#UKL/\ A'M+_P"@;9_]^$_PHU'9I7(?#=C!I]C/' I1&O+J8@_WGGD=C^+,
M36M6=H<JS6DK(Q8"YN%.?43.#^HK1H)M8****!A1110 4444 %(<Y'I2T4 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:?\ #-'BY/%L^K#QYI<D$GC1/&/E2>'',I=;%;$0M(+Q5(,**2P0?/D@!2$
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MV>M7\#:IJ1T/Q/IZ:0?"6G>$]-M;_1WFGMX[)9A#--*MRBS,3=7)95CC!!C
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'$?$Z&.X;PO%*H=&UJW!5NC#)R".XYZ&NE_X1O2/^@79?^ Z?X5S'Q1BBN'\
M*QRP^<K:W;*5(!&#G.<]1[5T_P#PC>D?] NR_P# =/\ "@"KX0M);33+A)@H
M<ZA>R )G&UKJ5EZ]\$9]^E;E9^B/YEI*=^__ $FX&<YZ3.,?AT_"M"C?4226
MB$.<C!'O2T44#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI._M0 M
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 1,DGGJZN/+VD,A'4]B#GCOG\/2I:** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \W^,NF/
MJDG@A%6%XH_$EI)*LRDAD^8$ #OSWXKMO^$;TC_H%V7_ (#I_A7-?$Y(Y#X7
MCE"LDFMVRE6Z,"3D$=\^E=-_PCFD_P#0+LO_  '3_"G=V2$K=M2KX1##3+G<
M%4_VA>\(,#'VF3'XXY/OFMNL#P2R/I%T8R67^TK\9(QR+N8$?GFM^D,****
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M1110 4444 %%%% ' ?%E%E?PBCQI*C:]:JR.N[()(/'IS77?\(YI/_0+LO\
MP'3_  KB_C%'!+)X*CN 623Q%:($V[@Q.[@CTP#7:?\ ".:3_P! NR_\!T_P
MH S? A9M&NBRNA_M741B0\X%Y, ?H1@CVQ71UC>%%":9<  C_3[P\_\ 7S)6
MS0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>*_@1XLU7QK\0]>LVTYT\0:IX3U"P@N+IT,*Z7>1SW"R$(P7>J$+MW9+<XH
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M#)/</C.R-!RQ_0=20!FN?AN_&VL2?:(M,TC0[22%FBCOY'N;E7YV[UCVHO\
M#D!V^O%9?C3PYXDL?'+^*-%TJT\1QR:3_9QL);PV=Q PD9M\4N" '#8;[I&Q
M"#4VEV_CC1-"U:X%C#.\=F1INB?;Q</Y_.T-.Z1X7ID,6_WAC!Z(TX1IQE!Q
M;=MVNO2U]+=6U;]8N^9IG9^&FU.;1+-M<BM(M6$8-PMF2T0?)SMW<X]N<=,G
M&3>!ADE90REU/S -R,^HKS_3?ACKEIH M9?'6N_;'0O-) +5%:4\L03"SA<D
MX&XD# !KR;P'\%]?\&:MI.N_V3XBU'Q='&1>WVKZ]:QV,LC ^9EHD>9D9SD
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MI-W_ !+/#2(]P$)!3?=2*<..A\M0#VI3P$J,OWTXJ/>][^ED[_EY@JE]D>K
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR3&<E<?>-="3B@"IJVK6NAZ=<7U[,(+:!2[N03Q[ <D^@')K#@^(NCRF'?\
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M1Z1H-T6$WV% @MTB#@LKRR'<[;."Z[0"2=IXKFC0E./,MKV7GZ+?U*<DCT8
M 8 Q2UYGXP^*EJEY#I&C:K965\Z">ZU#4DQ;V,!R%+[G3YW(^0<Y&6(V\GD/
M%7C?P!H^E&75_B9JNLW9)C@_LK5PLSR,,*B1VNR,L3TWCJ>3732P-6I:\7KT
M2;?^7XB=1*_D>]T=*\KU7XS0V7PBU'Q5;V6H:7+9*L4%KXALS'-=2Y4(JJK?
M-YF[:&4D9.<?*17IUI))+;1/+'Y4K*"T><[3CD9[XKEJT*E%7FK:M?-6O^8U
M)2=D34445@6%%%% !1110 TQJ3T%+2T4 %%%% !1110 4444 %%%% !1110
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)UI:* "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH XOXEQI.OAJ.1!)&^M6RLC#((
M.X$$=QC/%=#_ ,(SH_\ T";'_P !D_PKF?BG$LW_  B<;JCQOKULCHZY#*0^
M1_*NF_X1G1_^@38_^ R?X4 2Z1Q;2C@_Z1-R.G^M>KU9^B3">TE8'.+FX0\^
MDSC^E:% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !36W
M8^7&<]Z=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% '%?$V-)_P#A&(I$21'UJV5E<9!7
MYLC'O71?\(SH_P#T";'_ ,!D_P *YOXH;&'A:*1!)'+KEM&RL,A@0V00>QKH
M_P#A%]&_Z!%A_P" R?X4 1^%P@TZXV+M'VZ[R/?[1)D_G6Q6/X6F6?39V12H
M%]>*01CD7,@)_2MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH 0L%ZD#ZTM(RJX&X X.>1WI: "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#@OBPJ2G
MP?%)'YT<GB"U5D*[@1M?.1Z5U?\ PC>D?] NR_\  =/\*Y/XM+'(W@Z*9/,C
MD\06R%"NX-D/P1TQC/6NK_X1C1_^@38_^ R?X4 -\-L&L)R!C_3;H?\ DQ)6
MK6;H*;+*8?\ 3U<G_P C/6E0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 -8L"-H!&><G&*=110 4444 %%%% !1110 4444 <#\642<
M^#XY(Q+&_B&V5U;!!!60$$'J/:NK_P"$8T?_ *!-C_X#)_A7*_%>TBNSX0CE
MC26(^(+8LCJ"&&V3L?K75?\ ",:/_P! FQ_\!D_PHT ETC_CUDSG/VB?K_UU
M>KU5K#_5/_UUDZ_[YJS0 4444 %%%% !1110 4444 %%%% !1110 4A.*6D(
M!&#R* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!QOQ)B6=O"\3QK+$^M0*ZL 005D&"#U!Z5O\ _",:/_T";'_P&3_"
ML'XCVZW1\,QO&DD1UF .K\@J5<8QWZUO?\(QH_\ T";'_P !D_PH T(NAYSR
M>V.YI]-4@@X.>33J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** &NQ5"0-Q X'K2CI2T4 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !11378HC,%+D#(48R?;F@!U%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 <C\0XDG_X1N.15>-M8@5D< A@5<$$>E;?_",:/_T";'_P&3_"L/XB(DI\
M-Q2(DD<FL0(R.N005?(YK<_X1C1_^@38_P#@,G^% &A%G!R /F/3ZFGU'#C:
MV/[Q_G4E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 44ASD8Z=Z6@ HI"< G&?8
M4R"83Q[PKJ,E<.I4\$CH>W'![CF@"2BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** .0^(<,=P?#<4J+(C:Q""CC(8;7R"._%;G_",:/_ - FQ_\  9/\*Y_X
MD*DLGA:&15DCDUJ%61AD,-CY!'I70?\ ",:/_P! FQ_\!D_PH T(@ #C^\?Y
MT^HK?[K?[[?S-2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 44A 88(!'O2T %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 <;\2(UF?PO%)&LD;ZU K
MJPR""KY!'H:W_P#A&-'_ .@38_\ @,G^%8'Q(BCG?PO'*H>-]9@5D;E6!5\@
MCN*W_P#A&-'_ .@38_\ @,G^% %VV(*-C^^W_H1J:J&C0I#;3!$" W,[$#ID
MRL2?Q))_&K] !1110 44A&:%4( !G'N<T +1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% '$?$]%E;PG$ZJ\<FNVZ.K@$,"DF00>H-=)
M_P (QH__ $";'_P&3_"N<^)L44[^$XYHUDC?7(%*N,@@I)D$5T?_  C&C_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X3XJQ)/)
MX/BD"O$^OVZO&ZA@P*2 @@UT_P#PBNB_] >P_P# 9/\ "N1^+MN+N7P5$^TQ
MMXBMMZ,,[UV297Z$=0>HXKK_ /A&-'_Z!-C_ . R?X4 -\.2^;83GRWCQ>72
M[9,9XGD&>">#C(]B.G2M6J.D$&VDP0?](FZ'/_+5JO4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !113)8UFC9&SM8$':Q4_@1R* 'T4@   ' %+0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#@_BK MU)X/B= \;:_;AU895EV29!'H:ZC_A%=%_Z ]A_X
M#)_A7/\ Q*@BN7\+1S*KQMK4"E&7(8%7R"/3&:Z#_A%=%_Z ]A_X#)_A0!=M
M#NC?T\QQ_P"/&IZ@M PC<-R?,?\ +<:GH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH XOXE1).WA6
M*55DC?6X%:-P"&!23((/6N@_X171?^@/8?\ @,G^%8'Q(A2X;PM'*BR1-K4*
MNC $,"D@P1W'-;__  BNB_\ 0'L/_ 9/\* +MI&(XW ).9'/)SU8G^M3TR+H
M>,?,?YT^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH 2EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "D!R <8]C2T4 %%%% !1110!QGQ)MTNO\ A&(Y5$D3:U '1AD,
M"KC!'IS6_P#\(KHO_0'L/_ 9/\*Q/B)%'.?#4<J+(CZQ"I1QD,-KY!'TK<_X
M1C1_^@38_P#@,G^% &BB[0>O))YIU(HQGZTM !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ''_ !%B
M2=_#$<JJ\;:S"K(XR&!208QZ8S6[_P (QH__ $";'_P&3_"L/XAVZ71\-QRJ
MLD3:Q"&1QD,"K@@CTP36W_PBNB_] >P_\!D_PH U**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M .0^(<4<[^&HI462-]8A1D89# H^01Z5M_\ "*Z+_P! >P_\!D_PK%^(2+,W
MAJ*1%DBDU>%'1UR&4J^01Z?XUM?\(KHO_0'L/_ 9/\* -,'-+2*, _6EH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH X_XB0I</X9CD021OK$*LC#(8%),@CTK<_X171?^@/8?^ R
M?X5A_$6&.X;PQ%*BR1OK,*E&&0P*29!'<8K<_P"$5T7_ * ]A_X#)_A0!IJ,
M9^M+35;=GZXIU !1110 4444 %%%% !1110 4444 %%%-(;>I# +SD8Y/XT
M.HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:KJXRK!A[&G4Q(DC9V50"
MYRQ'<XQD_@!^5 #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBFH&"X9@QR>0,<=J '4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% ''?$:-)W\+Q2HLD3ZS"K(PR&!CD!!'
M<5N?\(IHG_0'T_\ \!4_PK$^(L4<[>&(Y5#QOK,(9&7(8%) 01^-;O\ PC.C
M_P#0)L?_  &3_"@"_$VY6[?,1^M25%;G*MQCYV_G4M !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !12+GOC\*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** .-^),:3-X6CE59(WUN!61AD,"D@(([BM[_A%]&_Z!%A_P" R?X5@?$B
M&.Y?PO%*BR(VLPAD<95@5<$$=Q@UO_\ "*Z+_P! >P_\!D_PH OV\9C1@23E
MV//N2:EIJC /UIU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1132H+!CU'2@!U%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1136W8&W!Y&<G'% ''?$J!+E
MO"T4BAXVUN ,C $,"D@((/45O_\ "*Z+_P! >P_\!D_PK!^)$$=PWA>.9!)&
M^M0JR,,JP*2 @CN,9XK=_P"$3T3_ * VG_\ @*G^% &H!BEI%[\YYI: "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M* "BBB@ HHHH 1AN&*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#C_B-$EP?#
M,4D:RQ/K,*NCC*LI20$$=QSTK:_X1+0_^@-I_P#X"Q_X5A?$J)9V\+121K+$
M^M0*Z. 592D@((/7K6[_ ,(EH?\ T!M/_P# 6/\ PH T;?[C?[[?S-2U' "%
M;(Q\S?S-24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%(:
M %HHHH **** "BBB@ HHHH **** .*^)D,=P_A2*5%DC?7(59'&58&.7(([@
MUO\ _")Z'_T!M/\ _ 5/\*P?B5#'<-X5BEC66)];A5T< JP,<@((/4&MW_A$
M="_Z NG?^ D?^% &JA5@=ISR1^-.JKIP @?  _?2\#/_ #T:K5 !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!&&E^T."B" *
M"KASN+9.05Q@ #;@Y.<G@8YDHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCN,5O_\ "*Z+_P! >P_\!D_PH TE[_6G4@&*6@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBJ]D93$_FIY;"1\#=
MNRNX[3GW&#CMG':@"Q1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% ''?$:WCNG\,1RHKQ-K,(97&0P*2#!'H036[
M_P (KHO_ $![#_P&3_"L+XCQK,?#,3HLB2:S"C*Z[E(*29!'<5L?\(GI?_0+
MTS_P"6@#87&#@YYI:15"@X&,G-+0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!P/QBL;W5-%TJRTV
M[@L+^XU!8K>ZN;;[3%#(T4BH[Q;E\Q0Q!*;EW $9&<UYO_PH[XQ?]%5\%?\
MAMU_^3Z],^+6GMJ^F:/8)>3:<UUJ*0B\@2-Y("T<@#JLJ/&2N<@.K*<<J1D5
MQW_#/NH?]%?\4_\ @H\.?_*J@#VNBBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI,G=C''K2T %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!PWQ8
MT]]6TS2+!+N73VN]12W6[@CB>2 M'(!(JRH\99>H#HRD]5(R#QW_  SOJ?\
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MBA5@X .TJP."#794 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ><_'&2V
M@\,64E[JZ>'[);LFXU>1H56QC\F4M.3,K1#8!NS(K)\OS C(KP7_ (2+X7_]
M'<Z;_P"!WA#_ .5M>Z?'Y8F\%)]HU&#1[83.9-1NWB2&T7R)<RR-,DD8502Q
M,B.F =RL,@_*6SPC_P!'&> /_!QX4_\ E+31E.55?PTGZMK]&??-%1QY&1@
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MDB+0![%1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ><_':5;?P8DKZG#HL:3,S:C
M<310QVH$,A\UI)8Y(T5/O%I(W4 996 (/S#_ ,);I?\ T<AX0_\ "O\ "_\
M\S]?3_QQEMX?"=N]WJT6A6R7#/+JDTD4:6B"&7=,S3(\2A!\Q,B,@V_,K#(/
MSE_PE/@/_HZ3PY_X4'A+_P"4] 'VE1110 4444 %%%% !1110 4444 %%%%
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M-<&X6X1U+P'84B*F4 ]POO@EX>O_ !A<^(3-JD$]S?P:K/:6]_)';RWL-O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 <C\0XDN%\/12(LJ/JT2LC@$,"D@((/4<U=_X1/2O^@/I
MW_@-%_\ $U5\?113_P#"/PS1K+%)JL2,KC(8%7R".X(S6I_PB.A?] 73O_ 2
M/_"@#7HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D(R
M",X]Q2T4 )2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 <IX^ACN?^$?AEC66-]5B#(XRK
M JX((/7@UJ_\(EH?_0&T_P#\!8_\*RO'MO'<-X?25%DC?5(D9' *L"KY!'<5
MJ_\ "):'_P! ;3__  %C_P * -:BBB@ HHHH **** "BBB@ HHHH :KA\XZ@
MX-.I ,4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !13
M5<.S@ Y4X.5([ \>O7M_2G4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 <IX^ACN6\/P31+-#)J<2NCKE2"K @CN,'&#ZUI?\
M(9X?_P"@%IG_ (!Q_P"%1>*](&L#2XGB6:*.]225'&5*88$$=P<U+_PAGA__
1 * 6F_\ @)'_ (4PNUL?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>ex1011amendmentno1005.jpg
<TEXT>
begin 644 ex1011amendmentno1005.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 0  Q<# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_%GQ5!>>)]<OM%GUC5M0L+GR;VVD;>)8K64X\@09=%12%&T\?.Q.Q^U;X_\
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M;GX7?'GX#:1I+ZSXJLD;Q&3:I>K)/.C1F2*-VGE1)!"25!=\X4=Z /KM94<
MJZL#W!H$R,"0ZD#D\U\I_"+QO#X7^)/[3'B/4K+4-+MM)OK*[?2[LK)+;@:3
M!(ZHL<DB%I'+MB,G<Q[DXJK^R[X^UV/XA>/O _B;5+^YU"^"^*--N[ZPO+1(
MA(1%>6D*W4:,8H+@*5*Y!$ZYYR* /K7SXRQ7S%W#J,T?:(LX\U,_[PKXV^$B
M7?@+X@^!O"OC_3;R/6I;JX&E^/-,N_M%AXO#6L[,MYSNCE*L)%20,,QMY;[0
M15C]FGPHNH>#O!EQ/X)@,%OK6J.?%?\ :"K/!Y6H70A!7_6$$JD1!)&UB.]
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ME6##.,@YKYG^.UKXPT#XV:7XF^'RR76JV.C2W>K>'F<^3K]HLT"F)0?ECN$
M+1R]2<1L=K8KI?V7_&6C?$&[^(_B30+P76CZEK=O+;KM9#!_Q+;020M&QS&Z
MR>9O3C:Y;(SDD ]S$BDD!AD=1FEZU\@?'?XU7WACXV:%XGLM4U"S\)^#-5BT
MK7[3[%<"UNH;M0ES<-*(S&RVQ:S<$,-I2X!Y(#?75M*LD98,"">H(- $U%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)(R<9(!O45X-XZ_:;N/ ?Q-T_P +W7A@SV5WJUCI2ZBEV2VZY5B',:1L(U#
M*/.>-I"LA12%S6[\&_CPOQ7UGQ#I[V%OI%WHT[6\^G37;&^A822(#-"T2% P
M0%64NC?/ASMR0#URBO#;_P#:(U*R^+EEX*/AVV*7^JS:5;W8U!G=&339;T22
MK'$T:!C#(@1I5EX#>65)(E^#7[0>I?%"[\$?;O#=MH]GXM\+/XFLI(=1:YDC
M5&M \4BF% #_ *:F&#'.UN!Q0![;124M !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.9< '.  (NF.=WM756PSC4]E2?-)+7M>]M/P..EBG*FZM2/*F]/3S.Z#J>C
M_C2Y'K7"?#KXC#QEX9N]3O[$Z/=6;M'=VCR;_*8*''.!U1D;_@7M5KX=_$:S
M\?073PVLUC<6[J'M[C&[8Z;XWX[,ISZCD&L)T*L.;FC;E=G^AO#$4Y\O*_BU
M1V5)D'O2U2M]3M)M1ELDN(WO(HUD> ,"ZHQPK$>AP?RK'7H=#=B[1110,3-+
M7'77Q+TRV\<6GAD0W$UW.YC:XC3,$4GELXC9L\,54G'T]:Z]&+9XQC_"KE"<
M+<ZM?5>A$9QG?E>PZBBBH+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?=HOQB<4/XM1_P DHQ_&_P#[<=VS!1SG\!FO%? %T\OQ[\>W,K ;;>&W(/\
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MK]%T:/Q/#X@T;4_#NHZ)/91BUU*2UC^UI=LZVLJ.)2B(YBFR92A01,6"X(H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?7$<UD8OM,3>073<@FC;*NRLK!E9E*D@'O-(RAA@^N:AM9?.3."#Z-P1S_\
M6J>@!D420QJB*%0= .@I]%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(\$^-=7\465SJ.AV^HV]U:V>C&VM[G[6EJO[H&X<PA?LB'!,N2\G(X ]QHH
M8D8C&!TQBGT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1129/I^M "T444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 -<E48JNY@.%SC-5OM5S_SY-_W\6IKJ5[>VFECA>YD1"RPQ%0T
MA X4%B!D].2!ZD5SW_"5ZK_T)FM?]_['_P"2: .FHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M 9*S)&[(GF, 2$!QN/I5#^T+_P#Z!3_]_P!/\:T3P.F?:F^8W_/-OS'^- #Z
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** &N6",4 9\?*&. 3[GG%5/-U'_GUM?_ EO_C=/U2:
MZMM,NYK&U2]OHX7>"VDE\I9I I*H7P=H)P-V#C.<&O._^$S^*?\ T3/2O_"I
M'_R+0!Z=1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!4U6:[MM+O)M/M4OK^.%WM[66;R4FD"D
MJA?#; 3@;L'&<X/2O./^$S^+/_1,=$_\*T__ "'7I\I<1N8U5I #M5FV@GL"
M<''Y&J'GZQ_SXV/_ (&O_P#&J -*BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!KE@C%0&8#@$
MXR?K57S[W_GTB_[_ )_^)JV>GK3=[_W/UH ?1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!6U.
MZEL=.NKF"SFU&>&)Y([.W9%DG8 D1J794#,1@%F49/) YK@?^%H>*_\ HD'B
MW_P/T;_Y/KT9B0I(&X@<#UJOY]Q_SZG_ +[% %FBBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!
M#TXZTW,G]U?^^O\ ZU/I* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1B0I(&3C@>M0>=/_
M ,^__CXJ<D@'')J/S)/[B_F?\* ):*** "BBB@ HHHH **** "BBB@ HHHH
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M"<L'A*G!W<G/% 'LFG_%WPUJ6@Z]JUOJ7F6^@2RPZK%]FE6XLY(TWNLD)7S
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MC-=#KWPGM/%OC9-9UV6WU338+$VMKI=Q:*X@D=@99M[$Y+A8UVA0,(1R&(H
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M)8PQWJ!(QVYH ZCQ!\=(/"-[X^DUZ!++0O"^B6VOC4+>3S7N+>07!;Y"JJK
MVS* '.<@Y%;/PB^)#?$WP^^J?:-/$RS&-]/L+E;AK,'#(D\B\>:49&*@ *6V
M@N &.#XU^ T?Q#D\?VNKZNZ:+XHT.VT..&RA,4]G'$UPV]9-Q#'-R2/E &P=
M:UOA;\))/ ^N^*/$6HZJ-3U[Q'/;RWDEO"8(%$,"0H%0NYR0F22W<  !10!Z
M31110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 1W$IA@DD"[RBE@H!.<#IP"?R!/M6)
M_P ))/\ \^$G_?FY_P#C%;QX%-W^Q_(_X4 /HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@!,48I:* "BBB@!"H)Z"@ #H,4M% !7SM^TWXZ\2:,T&H^%/MS
MVO@Q8O$NNK8R(IN;9)%WV95B"WF6WVN0$<JT4?4.<?1!&1@]*PY_ ^@7*ZPL
MFD6;?VRGEZB?)7-VNW9MDX^8;<K@]C0!XGKO[1>IV?C=[;3[+3K_ ,,KJ6B6
MQN2T@FN(=0W*LJ'&T!#Y9 (PX)P<USTOQB\0_$#P3J-WJ6D_9M&$FE2)):W-
MY8RQW+ZDT30"9=K2",0Q.60A)1)@;D<$^X1_!'P'8VZ1V?A+1K1(W@E18+*)
M%1X/]0X&W ,?.WCY02!P2*X+P%^R+X+\'7=S-=V=IKOFP_9G,^F6L!G3?'(&
MN?*C47$@>)&#ODYW'JQR </XF_:&UCQ9X<UBRL]/CM-)U27Q#X?BG69X[RQG
MLHI@)F88^5_(D.?E,9:'EMU9_@6ZUWPG!\$+CPSKU[?:WXKT5GU32=5U&:[M
MID72VF6]<2.QB(N1"C-%MW"<@[B@-?2TGPN\)3ZCJ%_+X=TV6]U"%[>\G>U0
MO<1NH5TD.,N&554YSD*!VJK!\*/#GA[3=1C\+:58^$M1NK7[*NIZ190QS0C;
MA&&4*G8<,%8%<CIUH \<T;]H;QAXDTKP>^GZ?H\5_K-_'X>O8KPR+]@U6.PO
M+B\0["=ZQRVZ1X4YY;YN*H>#/VI-<\9I\.KP:-:6=GXEL-.N;F(3.\EO)=V]
MU, &.T'!@0*N&+!B3L &[WC1_AKHMIHFDV-_:1:Q-ITTEU'>7T$1E-S)O\V?
MY%55D<RR$E !\[=C5)?@7\/$:R9?!.@H;%(X[7;IT0\A(V9XU3Y?E"L[$ =-
MS8^\<@'S59_ME^+CX8B\17F@:+#I[>&]-\3RPPW$SNL%S>-;M &*X\S WA\8
MX*E6X8=EHGQCU.UU#4O#_AZQL8-9N-0UZ\B?Q+JTTEO,+*6WW)O;)BWK<J<(
M&6(1N=K 8KVA?@KX#2Q%DOA'1Q9BT2Q\@64>S[.DGFK#MQC8)/G"] W( /-+
MJ/P7\!ZQ;K!?^$-%OH%OVU58KFQCD47;'+3@,#\Y]: .3\%_%S4]7^*]YX6U
MJ"TTU%M9KJS!#C[7$DL<8EAG!,<XR_SI\CQ,54HP8.8/BS<W5O\ &+P!+9W5
MZ'&G:O+]C349H+6X>-("GFQ*P23&YL%E;;DG%=;K7P5\&:]EKCPYIIF-ZM\T
MK6<4C&42I*6&Y3@L\:,2.21GKS6WK'@/P_XAO+>\U/2;2_N[:*2"&>>)6DC2
M10LBJQY&Y1@XZB@#YUT']JK7=4N=+LKW2=,TS4M830WL;@W,LMI$-1@ED19@
M$5F=6MW1<%=Q=!D=:^AO ^NW&L>&M-EU)K$:N\"/=Q:9.9X$=B00CE5)7(/4
M \<@5G7WP7\!ZII=YIE[X/T6[TZ\@@M;BTGL(GCEAA_U,;*5P53)V@_=R<8K
M7T/P+X?\,W<MUI.CV>G7,MO;VLDMM"L9>& ,(8S@?=0,P4= #QB@#<Q1@8QV
MI:* $P ,=J-H]!2T4 -V+G.!GZ4I )''2EHH 3 ]*6BB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** $8D*2!D@=*@\^7_GB/\ OH_X5#KNHRZ/HFH7\%E/J4UK
M;R3I96P!EN&52PC3/&YB,#W->/?\-$>)O^B,>-?^_,7_ ,50![?1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110!3UF^DTO2+Z]ALYM1FMX'F2SML>;.RJ2(TR0-S$8&2!DUY9_P
MO/Q'_P!$?\9?E:__ !ZO5]0N7LK"YN(H'NI(HFD6"/[TA )"CW/2N(_X61K7
M_0CZO^8_PH [^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@"MJ5T]CIUU<Q6\EW)#$\BV\7WY2
M 2%7W.,#ZUP?_"T=;_Z)_KOY)_C7;ZYJ$^DZ+J%];6$^JW-M;R316%J4$MRR
FJ2(D+E5#,1M&X@9(R0.:\A_X7[XT_P"B"^.O_ G2_P#Y+H __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>ex1011amendmentno1006.jpg
<TEXT>
begin 644 ex1011amendmentno1006.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 0  Q<# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "OCCXH?&[QSX5UG]HFXL]?\4W)\'36R>'-,T;P_;W]L)GT>&[6.YV6KS"%
MIF8/(SJ%1OOJ<&OL>O+(_@;-IOB[XA>(M%\;:YHE[XTEM9[M;>"RE6TD@MDM
ME> 2P/R8XTR)-XRN0!DY .4^*?Q,\77OP!\,R^#/$OA;0?'_ (PL8'T_6]1O
MDDTNS+6XGEG1VC_?1@#9&WEG+2Q,R[<BL[QO\7_$GQ0_9Q\(?$KX2ZVV@:QJ
MUYID5KI^K6L<ED\UQ?P6LMM?AHC*$C9I8RT#(VX$@L,5ZKX-^#^C>!-3T2?2
MI;E;'0_#D'AG2].G99([.UB8$LCD>9OD$<"N2Q#"WB. 5)/,:/\ LTZ3H^E:
MYIPU_5KRVU'QBWC:W%Z()3IMZUV+MH[8F/Y(C(#P<MAY!N^<T <[X"^/LOQ5
M^+?@W3[*[N?#?EZ?X@A\1^$;M[5[BVU*RN+"%8Y&578@+<2R(8W02(T;GCY:
MX3]E7XT^*OC[8>$M,;QUJMM?:-H>G:YXGN=1TJUMKW6)[RW\Q8;:(VR(EE&6
M_P!>B%GVQJKXW/)]$#X0^'XOC$GQ+@A>V\1G1YM%N#"%6.ZBDEMY \HVY:1/
MLR*K9X5B#G"X\ZT+]D#0?#&@?#F#2_$FL6GB3P(HM-,\6_9[%]4DT\1S1C3Y
MW:W*26X6<@)L!!1&!#@L0#M?C/XQUCP]!X2T+P_-#8:UXNUL:';ZI<1><NGC
M[)<W<LXB.!(XBM)%0$[=[H6#*I5N9U[Q5KWPS^,_P^\,77B?4?$FE^-TU"Q/
M]I16<<FGW%O!]HCGA:&WCW;E$B,D@8$^4RE-CK+V?QA^$&C?&GPK;:-J\UU8
MSV.H6VKZ9JM@4%UIM];N'AN(2ZLH=3D<J059@1@U0T_X27MWXXMO%?B?Q+)X
M@U/2OM$>AQQV,5M#IT<W$C;?F,DS(%1I"0-JX1(]\F\ \A_9&^(OBCXQ>!OA
MKX@U3X@>)[G6)=-_M+7-.U+PO%:Z=J*M"T96"X^QPC*S20R!H97&$*D$/D>J
M_M%^.M6\'?#V6Q\+:KI^D>.O$+2:7X=N=57-LEYY$LQDD)!552*"9\L"N44;
M6+!6Z'X0?#.P^#7PR\.>"-+O+J_T[0K1;*WN+XH9GC7.W>455)QQD =*@O/A
MHNI_%J/QE?W<%_:6^C+IEII=S:[_ +)+]J6XDGCD+X!=H;;(*9!MHF##&" >
M>W/Q:\2?%G]F/3?&?P]N8-"\1:Y:6#:9-=Q-<QPW[W212VUPBPR8B\S,3R*#
MA6D8&/8)!YM\=OVI]9?]EZV\;^ Y8]$\?W7AJ]U1X;TR.NDI;/"E\3;E&BEE
M2XV6Z&7 !=V4L Z/[%!\!+WP]I/BO3O#/BV>PM=:\1KXJ@CU2V-^MA>F\CNY
MXHP94Q;2R1DF(;65IIF5P67;0\1?LG>&];\)?%30(-7U>QM/B)/YNH8F61;)
M&<O-':(R[8A)))<2G(;]Y<.Q!Z4 <I\3/B?=^!?B]X\T_7OB#XUT;POIOA+2
M]<A;P_X:AU%;)GDU*.YDDD33I_+7;912#SCC<9<?*-JX7Q=^-=_\)_'/A33_
M !7\3?$6A>%'^'MSJ6I:QI6AV=W.U_#<V42W;B.TN$BWB>0' \C<R 8R-WL<
MOPK\6Q?%F^\:6'C6RLX]3T^TTO4-/;0_,W6]J)G@\F0S_NW\^[NW9F60,CQ(
M%4QEY.=T[]E_R_'EAJVM^*IO%V@0^'M3\-W.D^(;3[7/?6][<0W$GG7#28.)
M(BH7R]HC*( -FY@#B_BC\4_BOX0^'/[.>J:U-'X1\8>(?&FAZ'XITC2HH;VT
MEBN=_GQL\L>Z$G8.8R=C,4#R#;+7<?#'Q#XO^.NDZ]XLM_$E]X+TV/6M3TK1
M--L[>SN8I8+6;[+]HNO-A:1G:XM[EMD<D8$<BKRRB0\Y:?LDZ]-IG@'PYK7Q
M%76/!_@CQ9%XFTBWDT9CJ:Q6[2M9V4E[)<R!DB\Q4,@B#ND>W*Y)KK+#]G_5
M/ >J:D?AOXKMO"&C:SJEQJNIV=YHXU*:.6<Q&?[%*\RBWW-'(^V1)D#RDA-J
MA* (?BYXV\<^ _@[H.AZ'J'AUOC-KMO'8:>-1FD-C-?K#YMTZ _.4 201[AC
M>\*M][!]$^&'Q+T3XN?#_P .>,- F=M+UZQ2_M8Y]JS*C ;E=02 R$[6 ) 8
M$9-<M-^S_H^O>-;;6/%[V_CG3M,TFST_1M.\062W1L9XGD::]+.65[B;,(,@
M1"H@&"=QKB/!?P$\=_!6Q71_!/C33;?PU<>.AK<6A1>'RD-GI,\DKWFG*[7#
MB- '$L;Q)'B1"NW;*0@!T'[2/Q)\9?#*Z\ 7'@O3O^$FO]6UUK&Y\-&2*)[R
MTCL+V[F,#LN1,!;*%RVTG"G!;<%^&GQI?XK?%E)/#E[)?> ;GPE#J4>^Q,;0
MWIOKB!TD9@&CD'D2(T3\[H6Q@JV>S\=_#F;QCXS^'NO0ZA;V)\)ZK/J312V7
MG270ELKBT,2R;U,0Q<ER<-DHF1Q7+VGP'@^'WBCXD^*OA[-#X>UWQNMBURC6
M9NK:&^CEG\V^,)GC#%UN 9%1D),1;YW<@@%7]I;XK:Q\+-'L[WPMHT^O^(X+
M:XU::R69UB&D6<EO+J+;>5>9HRD,7!</< K\OF5ZUH&NV'BG0=-UK2KJ*^TO
M4;:.\M+J%@R30R*'1U(X(*D$'WKSW5OV??#'CGQIJOB'Q_H?ASQU)+;VMGIL
M.K:'',-/AB5BZKYK2 M)++*Y950[?+0[O+#5C_"#X/\ C[X1>!?#/A&+Q]I>
MMZ5I&HG]]<Z"\4W]E?O66S7_ $IE#(6BC1P $CCQL; H ]IHKC/A#-XPN/ =
ME)X[,#>(S+.)6@LUM T0F<0LT*SSJC&,(2HE;&><'('9T %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5Y1+^T1I=O\5]-\#S>'-?A.I:I<:/::U+##'9S7$%BUY*55I1,T
M6Q)8Q*D;*9894)&T%O5Z\-3]FRTM?C3IWC2+5;\RPZW>^)-JVEH(?.EL18^1
M-)@3N!'+*\6/E4F7>3^Z4 ':?"3XJO\ %;3KC4%\.7VBZ>\<-WIU[/<6]S;Z
MC:3!C%-%+!(Z9^4[H]VY<H3PZDXGAC]I'0?%/Q3@\$1:)K]A->1:C)IVK:A;
M10VM^;&:.&[2-#+]H0I)+M#2PQJ_EN49@ 3H?"SX*V/PP\2^*M=MIX/MGB,6
M[7MOI]FME:/-$TS-=&%6*_:)?/\ WL@P'\N,[002>:\)?LR1>%OB3HWC.3Q7
M?ZQJ.F/JQ5[^UA,MR+]XF<SRHJM(T:P01(3PL<2H!@"@!VM:CKQ_:]\*Z$?$
MEXWAF7PMJ6NG1'M+-H5NH)[2U1EE,'GJ"EY,3B49.!G;N5M'XP_M->$O@MXD
MTO0=66;4-5O;=KU[2RO+&.:WMPVP2F*XN(I)=Q$@1(%ED<Q2!4)&*T]6^&>J
MZM\4M(\?0:I:Z3JVG:=<Z(+-[=KR"6RFO8)I&)W1,LKQVL0'58V=LB4 9YRZ
M^!'BV76%\3VWQ*DT_P <S6MSIM]J\&B0M;W%D]W)-;1K;2,P22UCE=(GW,"S
M,\J2[G1@"R_[4OA)=;ALX[#6Y].DUZQ\.MKD5FILH[F]M+6YLRQW[]DOVV"(
M$(2KD[PB8<\GXB^/]UK7QY^&^DZ0-2TKP8VJ:U:7^JWBP166K/:64XE$>7,P
M2WGC=6:1(T9E!0R* PWK[]F-9=*:QA\5WLWF^,-"\5SW>J0_:KF8Z;!I\(B>
M3>N7E_LY&:4@X,K_ "GBA/V<M0F\0>%VU'Q<FK>&O#VH:I=6UA>:87OI;>]M
MYHC;R7QFWD1FXDPRJ-R+$'#.GFD J6'[:OPYN_#FJ:U,=5L;6VTQ=<LHYK57
MDU;39)E@AN[<1NX"23.B;)C%+&6'FI$#FO8O"7B9?%VC'44TS4])3[5=6HM]
M7M6MIV$-Q)#YOEMR(Y/+\R,G!:-T; S@>#:?^R?XC7X%W'PGU3XD1ZIX9M[.
MVT_2+@>'TAO+>WAN(Y4%Q()ML[*D*1(42$ 99Q(V"/I%<A1N()QR0,4 +111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MAIQN;!VAHUX544=O0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&N74 N "3@9YKMY?C1X ADA1O&N@$ROL4IJ4+ ':6^8AL*,*>3@9P.I ,O\
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M)\16RJCM-I-]%=(%<$H2T;$88 X/?!JK_P +1\&?]#=H7_@RA_\ BJ\4\4?
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2$!7AL;6)O.8*Z&<?+Y@VXGB;X(?$G6_A?\ %K1F\$Z!X8/C#PKH&A:'X?\
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MX.?L^?!?XE:QX7\'Z9H.IWVB7UG;W;>9<W/G7,3Q16MJ9&=T\V2146"' 9G
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MX+_]$B\!_P#A-67_ ,:KU"B@#R__ (9:^"__ $2+P'_X35E_\:H_X9:^"_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** (IK6&XD@DEACD>!_,B9U!,;;
M2NY3V.UF&1V8CO4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45#
M>2316D[V\(N)U1FCA+[ [ <+NP<9/&<<5S']O^+O^A2MO_!NO_QN@#K:***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@7XF>'M2^W>%M(UO2=9N1/J%MJND(5N[B';"'GBFCRSH($0%QD"-0. *T_\
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M_P (W-HGCYK"U?1[J_$$-Y+96US$V^.1KA26241!67#[SC<" 2-C_A//A/\
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MW?P1\"S>/$9/&4FC6K:JLB;)/M!B7?YB]!)_?   ;=@ 8KOJ "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@"*Z:9+:9K:..6X"$QQRN41FQP&8!BH)ZD X]#TKGO[0\8_
M] '0_P#P=S?_ ")70W<SV]K-+'!)=21HS+!$5#R$#(52Q"Y/09('/)%<U_PF
M.K?]"-K_ /W_ -/_ /DJ@#JJ*** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "$X
M!.,^P[U'YS_\\)/S7_&I:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
/ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>ex1011amendmentno1007.jpg
<TEXT>
begin 644 ex1011amendmentno1007.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 0  Q<# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH BN)6AC#)"\Y+JNR,J" 6 +?,0,*"6/? . 3@&6BB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF8G.XDYSFLZ[^&7@;6_"MWX,O-!TK5/#A:/S= NXUN+2/8$9%$#Y5%7;&P4
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MU/5+N63Q#=:[:16VMOJ.XO(FH(BC9*GF?+'C8D;1B,"/97D/BO0M3^#/QO\
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M/"-E:MILUY-IT1+R0Z<;L$72VL3L4MXY,G='$JH<GY:S]!_90^$/A2*=-"\
M:/H?GW%K=2OI<1M7>2VF6> EXR&(25$<+G&Y%)!P, '?^#+;7[3PU91>*;ZQ
MU'7P&-W<Z9;M;VS,7) CC9F95"D !F8\<DGFMJBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-2 AAD$'MQ0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^%:^);3P5K_B+6)=8O\ 1+JYT&[EM)4N9K233X#<M<2QB7=]FL5+@R_,R @
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M86\]KI7AG4VMS::?')*KHJ.D2RR+$J^5&LKNJ(=J@ +CJ+'X:P67Q>U?Q_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *HZWH>G>)=)N]+U:PMM3TV[B>"XM+R)98IHW4JZ,K @J58@
M@]02*O44 > ^+OV4?[5\ ZUX%T+QQJ^F^!]6T]-)?P[JZ_VG;V%LJQI_H4K,
MEQ%(%0[?-FFC4M_JBH"U[W#&8H8T+%BJ@%B2<^_))_,T^B@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHIH4B0MO)!
M&SC Z\^O.?T'O0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@"OJ+W<6GW3V$,-S?+$QMX;F8
MPQ228.U7<*Y12< L%8@<[3TKA?[;^*O_ $)G@[_PKKO_ .5E=AXDOK[3/#NJ
M7FF6*:GJ5O:RS6MC)*T2W$JH2D9=4<J&8 ;@C$9R%;H?!_\ A>'QP_Z(?H__
M (5=[_\ *B@#Z*HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH J:M<W%GI=Y/:0)<W44+O%#(S*
MLCA254E$=@"<#*HQ]%)X/F__  L3Q[_T)>C_ /@SU/\ ^55>D:MJ<.BZ5>ZA
M<)<26]I"]Q(EI;27,S*JEB$BC5GD; X1%+,<  D@5YK_ ,-+>$?^@1\0/_#<
M>(?_ )!H ]5HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH J:MJ<.BZ5>ZA<)<26]I"]Q(EI;27
M,S*JEB$BC5GD; X1%+,<  D@5YK_ ,-+>$?^@1\0/_#<>(?_ )!KTW4;Z/2]
M/N;R99GAMXFF=;>!YY2J@DA(T!=VP.%4%B> "37#?\+R\.?] WQA_P"$3K/_
M ,B4 >@T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK%03C)"G'H>E<S_:7CG_ *%WP]_X/Y__ )"H ZRBBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"
M&\FDM[2>6&!KJ5$9D@1E5I& R%!8@ GIDD#GFN6_X2_Q#_T(NJ?^!ME_\>KK
MZ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BFR%Q&YC56D .U6; )[ G!Q^1JAY^K?\^5E_X&/_ /&J -&B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKY \96LWAKX[Z3K_B"
M&T\9:'KGCBUL])N8YY(=5\/W(C,)LWCE7]]IY>WCN@(VC"3L'V2C#T ?7]%?
M$7PP^/WCT^#_  KIGA/PUI6FQ7$=]=L]MHLD^F2N?$,MG* _VU7MVCB+715]
MPE'F;64QE3IVW[6/CG3];UM=>O/#-OHHF\;6=O<QV%Q;FP.BS*(KB9_,G,B,
MF[>B1!AU&[&T@'V517QP_P"TU\0=>\3Z+-IGV>QL;23Q8FJ:.]G!/(186D36
MWGR07$ZH5G?:QCEPQ.TX/RC2\*?M+?$KXFWR:9X7C\'65Y+I_A?46N-66X>*
M!=3L[R2=%6.3,CI+;1[%)7Y7<$Y - 'UK17SS\#OC/X[\?\ BJSCUFY\'W6F
M-<:UI.I:?I"S1WNF7VGW?V</S))YD4P!?YTA\L/#EF:1%;S_ .&F@^._$'CW
MQ%JNF>)=131?"'Q,U(7SZMXIU"59=+CT\*MB+9O,C=/-FCDW,<KL) )H ^QJ
M*^._"'[8_BSQ!X662>VT";4+[7-/TRQU+2M/O;JW6"XT5M4\_P"QHQN) 1&\
M:;O)8HZ3.L8#)71^!OVB?BIKOB;PQHNL^"-.TJ_B_LO_ (2FTNI%L_LT=]!O
M2>W>:X#N$E;[/L6*7S);:Y0.A5<@'U#17S]XY^,OB[P%\1O&.DRS:7J5G%#X
M6328A821+;2:MJU]8%YV\UO,\ORH9",QB39L7RV<-73?!_XV?\)1X#\7ZGXN
MN]'L-1\&:QJ6DZ]<:9*6LHOLK%O-!+-@&!HG9=S%&+HV'1U4 ];HKY6\'_&S
M6?!.O_$N_P!<TZX-UK7A8?$C3-"U.SFTZ:W:"W6UO--=V$@S"(+#=)@;GNI&
M1"HPK_#O[6OB_4O%FFQ:KX-T+3-!FN]"L[C[/KQGO$;5XU-L55X8@/+;._=C
M?NVQ[F0A@#ZFHKYC\"?M+_$?QG9^&;L> ?#=G9^*GT^XT&\O_%<<,=_!<64E
MU<0QI%'/*TUKLV%BBK+M=P(P,'C_ (L_'GQE/\#YK*WN&L/$NB:%X=U75];M
MKF6VEDN;G5DMAY"B*/=&PL[PR*R(,21IMY<* ?9E%?/MS\?/'TD>NZA8?#[3
M;BVT^#Q&]C9R>)6BDOQI=\EKF0M8E('E(9D'FE0&^;/+(SQ=^U1>Z%#\0=7T
M?P>?$/AOP=;:FE]>+J MFCO++3EOGC97B_U;F1( REWW*S"-HU9P ?0M%?-M
ME^T_XIUKXJ:5X)@\+:'IMV?%D>A7\L^KS7&ZU?1O[566 "W3]YY6Y2K<*RJ
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **9,9%0&)5=MPX=BHQD9
M.<'D#) [GC(ZTR9IUD@$4<;QLY$S/(5*)M;!4!3N.[:,$KP2<\ $ FHJO9/<
MR0L;N&*"7S) JPRF13&'(C8DJN&*;25QA22 6 W&Q0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>ex1011amendmentno1008.jpg
<TEXT>
begin 644 ex1011amendmentno1008.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 0  Q<# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7<V7_#+X71_#6^\8W,6IRZA_PDVMRZ]<)+$J"&>2..-ECQ_!MA3 ;)SGDYP
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXM>"[7Q##9?V1);:WJ$%Q9)9M(LLAC6.1'68LB?,7*XS\O0UM_!O4/@]\$/
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M)?E8%1A>[5_77\SH-!\+:5X8C=--M%MO,5%=]S.[A1A=S,23@$]3WK6KBO\
MA=_PZ_Z'[PO_ .#FV_\ BZ/^%W?#K_H?O"__ (.;;_XNN9MO<VV.UHKBO^%W
M_#K_ *'[PO\ ^#FV_P#BZ#\;OAT/^9^\+_\ @YMO_BZ0':T5Q+?&_P"'*@D^
M/_"X ZDZS;<?^/T'XX?#E1D^/_"X'J=9MO\ XN@#MJ*XD_&_X<CKX_\ "_\
MX.;;_P"+I?\ A=WPZ_Z'[PO_ .#FV_\ BZ .UHKBO^%W?#K&?^$^\+X_[#-M
M_P#%TG_"\/ASG'_"?^%\^G]LVW_Q= ';45Q7_"[OAU_T/WA?_P '-M_\71_P
MN_X=?]#]X7_\'-M_\70!VM%<2?CA\.0NX^/_  N%QG/]LVV/_0ZFL_C%X!U&
M[@M+3QQX<N;J=UBB@AU:W=Y'8X554/DDD@ #K0!V%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 -<L$8J 6QP"
M< GZU6\R^_Y][?\ \"&_^(JQ*7$3F-5>0 [59MH)[ G!P/?!K/\ M&L?\^%C
M_P"!K_\ QF@#3HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **0\#U
MIN\_\\V_3_&@!]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% #78JC$*7(&0HQD^W-5OMLW_/A<
M?]]1_P#Q=6Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*P!7R^?FR".!SS6W0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS:.\NY%D::%DBE7;N-Q^Z*  S$JR<ANMMO@'H=QX?U2QUJ]U'5]0U9K&YO\
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M** "BBB@ HHHH 9,9%AD,2J\H4E%=MJD]@2 <#WP?I65]JU__H&:;_X,9/\
MXQ6I<-*MO*8$22<*3&DCE%9L< L 2!GO@X]#6']M\5?] ;1__!O+_P#(M '0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<I
MIGPRT/2-:FU.W_M$R2W4E[]EFU2YEM4GD8L[K TAC4EF9L!< DD 'FNKHH *
M*** ,?POX4T_P?ISV>G_ &ITDE,TDU]>37D\KD ;GEF=G; 55&6.%50,  5L
M444 %%%% ",H92IS@C'!P:;!#';0I%$BQQ1J%5%& H'0"GT4 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
IHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>ex1011amendmentno1009.jpg
<TEXT>
begin 644 ex1011amendmentno1009.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 0  Q<# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HJ.6XB@>%))4C>9MD:LP!=MI;"^IPK' [ GM4E !
M1110 4444 %%%% !1110 4444 %%1-=P)=1VS31K<R(TB0EAO9%*AF ZD N@
M)[;AZBI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^1OVI;ZXT_\
M;#_9EM[;3+C6K?5(_$Z7VC6KQ*-2$-A&\*RB5TC<1N[.N\_*2Q7D\Y?BR+4/
M#O[3?['FFR:?<^%FUF'Q3?ZSX<743=0PW36"W36[.&*RI!/-((\?(@ \L*H
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MBBB@ HIKNL:EF(50,DDX %*K!U#*0RD9!!X(H 6BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !117F/[17Q3?X4
M?#2XNM/96\5:U=0^'_#5LQ0"XU:[;RK53O(7:KGS')SA(W.&(P0#,\?Z8?C?
MXRD\!S1))X'TDL?%MK?:<[)JC20(UI:12L A3,IFD*$NC00J0JRY;UZ*)((D
MBB18XT4*J(,!0.@ ["N5^&'PXT_X7^%UTFR<W-Q-*UYJ%^T21/?7DF#-<.B
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M+J7A'Q+X+\3PZ6NJ/H'C'3HX)+NP=O*:9-DDB.@8A&!((+8QUP >>?#WQO\
MM-?$3POI_B/0M9^!/B;0KXLUOJ.EOJPBF190K!3EL,-DR'T8C(^0JW26L'[5
M\Z:M]HO?@W9/M+Z<(K/5K@%MW$4Q,L> 00?-7H4QY9WY3LO'GP)T_P 2L^M^
M$=2F\!^.XFF:U\3:?&78L\FZ1+J LJ7D+$']W+D+G,9C8*P?\&OBIJOB:XU'
MPAXZM=/T3XFZ&H?4-.L)";:]MF.(M0L]Y+M;2<K\WS1R(\;9*AF (H_#WQP:
MVB\SQ_\ #]+CK)M\#7S(.!P/^)P#P<\]^.!76^#=.\:V-E<KXK\0:#K5VTJ&
M"71M"GTZ-(QC>K))>7!9CSA@R@=U:NIHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** /E?\ :G^*7B/P/^T5\"O#.G^)
M]?T+PSXM@\0PZO%X>TM=0NV:WLD>VDAC%O/)N223<=J,N!\ZE0:=\$OV@-9M
M_!]G<?$"WO/$UO<_$"Z\+Z%KT5G!%=VEL[B*PFU:$F(VUQ*)"N$A0XEA#1J9
M/F] ^+OP$U;XB?&3X:?$32?%-EH>H>!$U$65G>Z0][%</>PB"4RE;B(X"*NT
M+C#9))!P/*_B5^SW=>'/A#X]\$0Z=K7Q.\:?&&]N!?\ B V\%KIVF7AMP(+F
M=58?9[6 0JXVB61G3;EV=%H ^B;;XEPZAJ^F6ECH6L:A9WNJWND/JMK'%):V
MDELDAD><B3<D9DADA#;3^] 4A=RD]C7EY\%R_"3PEX3;1-;UB#PSX.LYEO?#
MVF:6E_)K<(MRB)C8UQYJR!9%:-]SDN)-^[<N+J7[5FA6+1"'P)\4-1#KN8VW
M@'50$/H?,@7GZ9'O0![57@%]JS_$;]M#3M#CN2-(^&_AUM7N8!,P\W5-1+P0
M$QF/:1%:QW7[P/G_ $L*./,!Z"#]I[PY+<6L;>%/B/"DT(E>5_A_K)6!O^>;
MXM22P]5#+_M5YK\1H/A+\6O%-OXKU;3?C!HNNMIJ:5<R:'X>\5::US9AWD%M
M.+>W"NH>63I_>/) & #L_B+X\\1_%?Q->?#?X87\FF1VTC6WBCQW;!9$T0@*
MS6=MGY9+YE9<]H%<.V6VJ<'XZ? G3/AU^S;?)\--"M;+4_!LL7BS3+=4!ENK
MZTDCF>9Y=CR27,L,4T.]B3)Y[*^0W&]X8^-O@+X?Z-9:'X>\"_$"QTN'RD5+
M;X?:U@;LJTDC-;;G8!0SN=S-O!RYW8Z;_AHWPI_T"?'G_AO=?_\ D*@#%\6_
MM7^"++P#HFM^$=4L/&VN>*((7\+>'K*]CAN]7DFD\J+"2$-'&KY\UV7]TL<I
M9<QLM;'[/?PAN_A7X2NKGQ%>6^L_$#Q%.-4\4:U @"W=ZRA2D9VK^YB4".,;
M5^5<X#,U<=X7\1_!+P1K,NK^'/A;JV@:M*Q>2_TOX2ZO;3NQ# DR)IX8DAVY
MS_$?4UV?_#1OA3_H$^//_#>Z_P#_ "%0!J_&3XS^&?@;X337?$MY)$D]U#96
M=C:0&XO-0N)'"I;V\"_-+(V3A5Z8)/ -?)3Z<?A_^T9\,_C#\<-9M?"NI:Y!
MK%Z1JD\<=GH!CMX+:PTN.=V<*6AN[Z618W432AGP1$*]/TFY^&FG_$S4_B#?
MVWQ,\4^+KJ<FSO/$7@+7KF+1[5FC)M;&!+&..!,1##A3(6)9WD).?4?^&C?"
MG_0)\>?^&]U__P"0J //M*76OVM/$]OJE_::IX<^"ND7$5UIMC=1-:W/B^=&
M)$US$^V6&SB=%*0NH,Y(=_D 0VO!_A;XM_ I[_PKX3\*^%_&G@J?6+R_TFZN
M_$$VE7.F07,[7#P7"?99_-"2S2A9$8L4 W*#U[?_ (:-\*?] GQY_P"&]U__
M .0JH:G^U5X#T5H5O[?QI9F;/EB;P!KR[\8SC-ESC(_.@#%N?!GQ_P#%.@//
MK/Q%\/\ @N_#3M_9O@?01>/Y99O+3[5?R;9) @0[_)A4,S9! !KD_%MG^T1H
MO[%/BH:EJMK??&&TA:ZMKGPYM-Q):)/'(\0/D!&NC;B:,&.+!8IM!;YCZ)<?
MM7^ +66..:'QG%)(0$5_ .O MG;C'^A?[:?]]#UIB_M:_#UY88@GC(R3!#$H
M\!:]EP^-F/\ 0N<Y&/7- 'E/QF_:&^'_ ,8-!\-S_"+5&\??%*TN4OO"\GAB
MR-Z^FS2+L8W[':EI;2QR-%+YY4A69U0O#\MOX/V?Q$^%<NL>,?B-\*M3\8?$
MO7+C[+/JO@N739+:ULC*'AM8EGN8'CB$T\K,2K'Y2\LK!58>BQ?MA?#6==T;
M^+G&TOE? FNGY0&)/_'ET 1C_P !-(O[8?PT?9M?Q<=\;2KCP)KO*+G<P_T+
MH-K?D: )/A;<_$GQ!\9O&/B+Q!X:O_!W@>YTNPL=-TC6M7@N[MKF%IGDN$AM
M9)8+=7$Y1OWCN_D1'Y0-H]6\1'51X?U,Z$EI)K8M9?L"7\C1V[7&P^6)6569
M4W;=Q"L0,X!Z5Y;_ ,-9_#T?:/W?C+_1O,$W_%!:]^[V%0^[_0N-I9<^F15'
M_AM#X6_\_/BO_P (77?_ )"H \N_92^'*>(/CG\5_%NKZE<:RWA7Q7>:?IL1
MN5GL;?4KBPL3JEQ KAI8F,@**F_;$DLD:CER>D^"/PH^,]NGB1?%NL:9X,?5
MM1GO]2UC0S'?ZOJ\[*T<4BM+%]FLXHH$M(UB$,S,86)9<DO5^#?QQ^"/P/\
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MHWQU\$Z[I8O[;5Y(H#'))LO+"YM9L)C</*EC5\G<,+MRW.T'!QN_\+#\,?\
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M*Q8E C%AC(VG.,4 =U1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA;5M8NM+UJ>>*W78@TR\O(IEGG!2+:]F%(92&$I^Z0"?//AE^V/]D\":"_Q
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%,F,BQ.8E5Y0IV*[;5)[ G!P/?!^E9GVG7/^@=I_\ X'R?_&: -:BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@""_>YCL;A[*&*XO%C8P0SRF*-WQ\JLX5BJDX!8*Q YP>E<
M;_;'Q*_Z%+PI_P"%1<__ "NKLK][F.QN'LH8KB\6-C!#/*8HW?'RJSA6*J3@
M%@K$#G!Z5QO]L?$K_H4O"G_A47/_ ,KJ .YHHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH BN96
M@MY9$A>X=$++#&5#2$#A1N(&3TY('J16#_PE&I_]"?K7_?ZR_P#DFNCHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **JZG)>1:;=OIT$%UJ"PNUM!=3M#%)*%.Q
M7D5'**3@%@C$ D[6Q@^?_P!O_&'_ *$7P/\ ^%I>?_*F@#TJBBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBO/_P!H"YO+/X*>-9].\66W@6^CTN9H?$5V
M,Q6+[>';N/3*@L-V5!8 4 >@45\=VOQ%U70/$^DZ#KOA[7_#7BB/QCH=G?Z;
M?>,[^^L9;:<7D<%]93^>K312FV<-;2J!^ZW20[LM74^#_P!HWXC^)_\ A(+F
M#P59RV,*7AM)M1CN=+MK.>#5C9+9SW1699W>(-*9(%VQF)E*G<" #Z;HKY!^
M(?[6/C[X<Z#XHDNK#PUJFN>#9]4&K:=8VUUNU*&UM=/O%DMBT@6WC6#4 )99
MG8JX58XYF=4;OHOB3\1]!\40:9JFH>&]3_MGQ;J/AZQC33+BS%DB:5=7]M)(
M[2L7&+9%<;!GS69'*A<@'T!17Q7H7[;7CO4/">I>*YO"^B3Z-IGAGPWJMQ:6
M32_;9KO6$"Q)&'=8Q'',06+N/D!^;/([GQGXW\>>)_V-_C'JGC&P?P1XST32
M]9>#^P-6$-Q ;>W:XM)B]K<RF"0@1,T7G/U()9'P0#Z;HKYBDU7XA_!O6?%V
MJ7%_';>'_$.M06GAO0_$VIW.L7-L+>WNFNIH_+1G"W"VT4B0O/LA0R2NR-N@
M-?P3^UKXL\:Z[X<N[7P*K^&]3TS2+Z[M86FDNM/BOM,EO_MK3A/*-LC0M: ,
ML;/*&.5 57 /J6BO!OV?/C9XZ^,OA;Q#J&M>%;'PE++I]GJ_AR;[=;7ZW%K=
MV[/$TD,%T[E4ECD42,8?/4 JL3!T3SJS_:M\<^&_@_H7B35]/T?5+C1? ^C>
M,O%3.7BGN[>^>=%6U1<(LRK:R,X;Y"TBA=HYH ^OJ*\O_:'O=6N? 4GACP]J
M]]X?U_Q09-*M=9TZSEN9=-4Q.\UT%B^<%(T<(5Q^]:%=R[MR^1:K^VCK5GX(
M\*ZE9>"K2ZU:_P##_B#5-5M=0U.2R-A=:*T:7UL(_L\C$M(SA-^Q@ -ZJ20
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** *FK27T.E7LFF6]O>:DD+M:V]W<-!#+*%.Q'D5'**6P"P1R 20K8P?-?
M^$C^-_\ T3SX?_\ A>7W_P IJ]*U:2^ATJ]DTRWM[S4DA=K6WN[AH(990IV(
M\BHY12V 6".0"2%;&#YK_P )'\;_ /HGGP__ /"\OO\ Y34 >JT444 %%%%
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M7[)][=Z3!?P^*(X?B"GCA?&LGB5HKHB9UD*QVSPK<KF-;,BR"[MHB+X4%VR
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MS%@#Z%T_XP>#O$EW%I>B>+=(N-9NV\BU@$HE;SFMWN(PT896R84>4+E2R(S
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MRI*\2/)'G8[*"5SC.#VZ#\JDHHH **** "BBB@ HHHH **** "BBB@ HHHH
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BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>ex1011amendmentno1010.jpg
<TEXT>
begin 644 ex1011amendmentno1010.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 0  Q<# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU&_T^ZTK6-/3Q%X3:SD5C]B1_L\T<A!SO)6"Y"D9"W9!^X:S[JS\:+^T18>
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!O(+E(9K62P>22TN('1 8Y4>60YY!W$%2O%.F_9]TV6^\-ZNOB?Q)%XIT,W
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MV#5^]^ ?A#4_"MIH-[:375M!K?\ PD33R2XFGOC.T\LKD  B1I)%9  NR1D
M"X  /(_B?\>;CXC?LM>+O$7AZ.\T"Y_X0O\ MTW5K?20W.G7+F55MR553YB/
M!*K\C!3!&"#7I&K?'6YA\;3Z-HWA+4?$-A8:W;:%J=[9),SVLLL4<C3!1"8V
MBC$\6\F56'SD*=HW7[[]GWPG=> _&WA&".ZT_2?&%W=7NJ_9)%$C27)S-L+*
M0H8YX X))')S3HO@5I%M\0;KQ9:ZSKMG+J$D%SJFE6]XJ6&I74*(D=S-$$R)
M L<8.QD5A&H96Q0!Y;J/QIOO%'Q&^$'BNQCN;3P'JEIK=]&]KJ,CMJ$$5HSQ
M/+:A0OS*/,3YG(S@[3Q6UIG[6,=QI\.HWOA@P:;=>&+#Q/;36E_]I9H[V4PV
MMNZB,;96DPO!9>3AFVFK\/[,MEX-M+"Y\):SK#3^&HM0D\,:%?7L::=927,3
MJ8-ZPF80Y8 9=VC'"8  KC_AC^S?>SZ!?^&M>C\2Z=X/OM/-CJ6C:W>Z9*UQ
M( OE30364*RJZ,NX2O*&R!\A/S* =?JG[33>$K6YD\7>&9/"4,>KQZ7%J^JR
MSP:1*LEL9DF-U);*T:;E,)+QJ ^!N(()]DT._EU71-/O9[=;2>YMXYI+=91*
M(F902H=>&P3C<.#C-<-IWP5@L](@L[KQ9XDUJ8%UN+W5KB"YDO(FC,?D3(T/
ME-& <A0@^;+$DDD]CX2\,:?X(\*Z-X=TF)H=*TBRAT^TC=R[)#%&(T!8\DA5
M')Y- 'F7C+]H.?P=XN\::?-X8:?1/!^EVVMZOJXOT5DLY8KM]T<)7+N&M"NS
M<,[\Y&,%D/[0&I6VM_V-K'@F]TJ_O+ZRL-'GD>9;+4)9TFD9/-E@C9&B2WE9
MP$;C9M+%L#K;_P"#GA_5]>\9ZEJ0N-1B\7:5#HNJZ=<,IMI;6,3!5 "A@<7,
MP)W<[_88Y:;]F+0[[P8OA_4O$_BS5I;>XM[G3=:O-4!U#2WMR3 ;>14 !7<P
M+.K,X8B0N* (]>^/.NZ+;C3_ /A ;N;QBMG?:A)H273RAX+>;RHVBEAADW>>
M<-'O1.,[]A !Y_5?C_%X4U;QSKQ\)ZXUY9Z9X:GETZ\U-D)2_GGBC06S_N[>
M6-RPDQR^%W'Y!78:I^SOI6I3Z%J$?B?Q1I_B/2TEA?Q#9Z@B7U_#*4:6*X)C
M*.C&.,@!%V;!Y>RN7^./P%EU'PCXJG\)0ZE?Z[KB:'9-9K<P(D5O87BS(R-+
MMPRHTW+,Q8L,@X& #.\0_M)^+K?5G\-Q^#['1O%-GXITC2KN"ZU4S6\EE>[G
MBGBE2'J_E2QLI0;"I(W\9^CAG R #W KS35/@1HNOQW-S>ZAJQUJYU2SUEM6
M\R!;J.:U $"#;'Y811N&W81^\<_>;=7I:KM4 9P!CDYH \=C_:-M9IM,U&+1
M_-\(7_BF3PC%JZ7>9EO%G>V#M!LQY+7,;1!@Y;YE;;M)(S/@)_;GCS7_ !1X
MI\27-S;W^D^)-6TFVM['6KB6T>".4Q")[8HD>$$:%7V[B2Y.W)#=/I/[/7AK
M1M9GN8+C43I,FNMXE30'DC-C!J+$LT\8V>8,R$R[#(4#DL%!KIO /P]LOAW;
M:O!8WM[=IJ>I7&JS?;&C)6>>0R2E=B+@%B3@YQVH 3XA^-+CP3IVGW%MIT5^
M]Y>+:%[F[%K;V^8Y'#ROM9L%D6,!$=B\J +@DB/X2?$*+XK_  T\-^+X;*33
M4UBS2Z^QROO:$G[R%L#."",X&?0=*D\<?#VR\=7'AZZGOK_3+[0K\ZC976GR
M(KI(8)8'4AU92K13R*<C(W94J0#1\+_ASIWPF\#Z;X5TBZOKO3=/5DMWU"82
MRJA8D+N &0,X'&<#DDY) ,CQK\4;S1-?U+P_X<\/GQ1XBT_1QKDVFB\6U:2%
MI'CCCC9E*M+(T4P4,57*?,RY!KFO$'[1T6C6^KZQ%H+7/A30]?M_#VKZ@;P)
M<6\\AA1I$@"$21QR7$:.?,5OED*JP52_1^._@GI?CCQEI?BI-:UWPWKEG:OI
M\MUH-Z+<WMFSAS;S JV5# LK+M=2S%67)JD?V=_"JZAJS0O?6VC:MJ%KJU_X
M?AD06%Q>6YB,<Q4H74YMX"RHZJ_EC<K9;< <C9?M0:I-K&D)<^!'M-"U'Q3?
M>#1JG]JH[1:A!+/%&6B6//D2- 5WYW*6&4(Y/8?#?XTM\1$T.)-%&G:G<'4$
MU73Y;O?)I4EI,()$;" .QD90/N@J=REA7*_"KX0ZG8V&JW_B6POOM-GXOUKQ
M)I.ASW%J;=WN+BXDMY2T>Y@P2<C#/A68G:2JD=9\'_ DNDZMXL\::KX>@\->
M(_%MQ;W-[IT-R+@P+#;I$JO(OR,Y99&+(,'<H.2,D [#QSXRTWX=^"]>\5:S
M(\6D:)83ZC=O&NYA%%&7?:.YPIP.YKROQ=\>-<T;3_$6DR^'[?2/%:>#KKQ7
MI.;_ .T6TD4.U9ED;R@5DB>6$E=K*WF##?>QZ]XD\.Z;XO\ #VIZ%K%I'?Z3
MJ=K+9WEI+]R:&12CH<=BI(_&N"L?V?\ 1+?1[JQN]6UG5Y9="?PU#?W\T3W-
MKI[XWPQLL0!+;4W.X9VV*2Q(H 9^SMHEW%\.M%\1:E>ZA<:IK^E6%U=Q7.K3
MWT D$ S+&)0/+:0,"ZJ N0.O).!\7OB+XCMO&OB'P=8VUO:Z2G@?4-;;4X;^
M6&\296\M#&%3Y2I'9QG?G(V@-ZWX2\-V_@[POI.A6DTUQ::9:QV<$ER5,ACC
M4*NXJ "0 !G Z5SGC#X0Z3XS\1OK=Q?:C8WDNCW&A3BRDC5)[68ABK!D8@JP
MR"I'4YW#B@#R?P#^TA>>'/"&FZ?XJT27[9#X7T#4+&\BOVNYM3>_F%E$LR^7
MF.0W&P':9<B3.205KUWX:^.]4\;)KB:OX7O?#5SIE\;5&G64P7L9C1UG@>2*
M)F7YRI!12&1AR,$\OJ'[,7A+5[![*_NM6NK=O#]IX<4?:4C:."UE\ZVE1T16
M6:.7#K(",, <<"NX\"^"QX(TEK236]6\1W<C[YM3UN=);F7  4$HB(J@#A55
M1DDX)9B0#AOVD_$OB#P]X:\+PZ (@=5\3Z5IET[WLEJYAENHPR*Z(Q <91F&
M"%8XR:YZ+XRVOPL\+:R+#3K[7?"7A+78]#UC5=1UF2XO8))GB=S&)$9IXH#=
MQ)EW5]J-@-L7?ZKX^^'MC\1+;2(+^\O+1-+U.VU: V;(I,\#AX]V]&RH8 XX
MS7.:C^S]X;U'6=?NS<:A!IWB"^MM3U;1(I(_L5[=P&,I.RE"ZL?(AWA'57$8
M#JV6R <9X<_:@U/7]+TN_;P.UI;ZSK%[H&EXU)IWGO+2XO8YPZ10,Z1B*PED
MWA6))"[?XJEU#]J&ZTO3(1>^";S2M=30M8\07FG:O<M:)';Z=*D4GE2-%F0R
M>8KQY1/D.Y]AP*Z";]FKPT_@&S\+1:EK=FNGZW<>(=-U:UNDCOM/OIIIII)(
MG$>W!:YG!5U92LK*05P!P_Q7^"VOWVM>&+:SC\4:_I.FV,ZKJUAJNGM?F\EE
M#227,=]&8BNU(]C1#<OSJ$"!10!O7O[3WE^'/$NLV?A>6ZA\*:)::[X@M9+P
M17%K#/"]QY<2&,B65($,C*Q0?,JAB<[:>J?'JT\*ZOXYU>PT'4=7^SZKX<TY
MU?5V,4RZBT,,$L$4@V0X-Q&65<;SDDYYK9M?V<+36(-1O/$FN:I/JWB'2$T;
MQ0MI+ D.M6Z[U07&V!?WBQ2O$985A+!CPORA=?7OV>_#WB"Z\0S2W^J6XUN^
MTK4+B*V>%4CETZ2.2U\L&([5#0QD@YSMQT)R <_I?[2-W/>0:)J'A>&Q\53>
M+YO""VJ:H9++SH[#[?YQN3"K;6@P OE;BY"XQEAWGP?^(DOQ4\!6/B6726T4
M74DR+;-.)N(Y&C+!@!E2R,5..5P>]>5?%[X$7KH6T&VUS7++5O$;>(=8AT_4
M+*&[6Y%FMM&8DN8_(DBVHA9)#D,B,N6R:]3^$'AW7?"W@R&PUW4;O4)4D/V5
M=0-LUQ;V^U0D,C6T443,N&^ZF "%W/MW, =M1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%9GB;1I/$7A[4=+BU2]T62\@
M> :AIK(MS;[AC?&71U##L2IQZ4 >!?#S]H1M<_:5O_#MQXATO4/#GB2QG/AZ
MRM+F.2:SN-/F:.X20*Q/^D1N)TR!\D3#^$UNWW[35S!K"VUKX%U&ZLQXJE\(
MM<-?6Z/]L$6^-E3<<QL1@DL"H(.&Y Z[QK\$=*\9Z/X)L!JNJ:&WA#4+;4M+
MN])^SQRK)#$T2HV^%T\MHW=&554$,1P*S/\ AG32?/,O_"1:]N_X2W_A,<;K
M7 N]FWRO^/?_ %..WWO]N@#&T[]IO^U-/6UMO"E[-XN2;5H;C0X)'G$?]GSK
M!,1+%$^0[R1!,H,[^=NTU0US]K!M+AU6YC\ :XEGH^G:-JVI?VG)%97%M;:@
MTB@&!B7\V(QL&C8*<JPR,+NU'_99TNVU"'5M(\9>*-"\1Q:GJ.HIK=D]GY^R
M_D62ZM61[9HGA9XXV =&9612&R.;OB+]F?1/$L?BY+CQ%XAB3Q+ING:7=[)K
M=VCBLGD>)D:2!F+LTKEV<OG/:@#F?BU\6=0UBX\-GPO]H@TJR^(>F^'K[4H+
M[RC,XN$2YB\H#YX<LT+;F!WJ?D*C=6CJ/[3=U::Q-;0>!-0N;.#Q9_PB$MP;
M^W1_M31(\3JFX@HQD4$E@5!!P>0M^^_9CTJYU:ZN+7Q3X@TS3KGQ#;^*GTFV
M-J;==2CD21IE+P,ZB1T#.@;:2S$!2QJY-^SGI,UQ<S'Q'KZFX\6Q^,64-:X%
MVB(BQ#_1_P#4XC7C[W'WZ ,*S_:@?4-%OA:^#=1O?%.FOJ:WV@V+/=,OV*<P
M,(Y(HFWM*P_=!E0-A@S)CENK?M3FPU&]$7@;6!I>FWVBVFHW5_+%:S6RZDT*
MPM]G8E]R-.@=&VL,-W&#<C_99TW3M;;7-%\:^*M!UZ34;^]EU*RDL_,DBO)5
MFGM61[9HVB\Q0RDJ9$.2KC)S?US]FK0]<7Q,C:_K]K'K]UI-W.L,MNWDMISQ
M/;B-I(6;!,*;]Y<G!Y&: -?X0_$76?B#J'CI-3TJVTVVT3Q!/I%H8+DRM(D2
M1Y9LHN"2V[O]['.W)POVBY/'-@G@N]^'=^L7B,:PR'2[N3%GJL"65U.]I)GA
M#)Y(591RC$$Y (KM/ _PVMO >L^*;ZRU2_N8-?U ZI)8W/E&&VG9%61HRJ*^
M'V*2'9@"/EV@D5H>(O"2>(M8\.:@^I7MFVB7K7T4%MY7ESN8)8"LF^-FV[)W
M^X5.<<\4 >,:-^TGX<U*#7?B!]IU2/0].T2U^T:%.QCN;346NYK=[22!V"I<
M>8L46&(&2#G#;CZ=X0^)AU[QSXA\&:IIATCQ'HUK:Z@T4<_GP7%I<&18IHI-
MJD_/!,C*5!!3N""<+Q7^S/X$\87GCZZO-/E@F\;V5K9ZPUI+Y1D>V9F@N4P/
MEG0LN'[^5'D';S=M_@R8;B]U,^+M</BB]CT^UN/$"K:I<O:VDSRI;[1#Y81V
MEGWX3<?.;!&%"@'I%>6_#_Q!JU]\</BII%YJ<]YIFFII+V-M*$"VWFPRM(%V
MJ."0#ELGWZ5ZE7(^'OAO:>'/'_BKQ;#J>H7-WXB2U2YL[@P_9X?(5EC,06,.
M#ASG<[9]J *'Q[^(%_\ "GX*>./&6F646H7^@Z/<ZC%;SR>6C&*-GY.#TQG&
M.<8R,Y'.>,/VAHO!]IXPN9=":^A\$VD%]XH^R789K**1#*WE+MS,T< \Y@=G
MRE=I=B5'??$7P-IWQ.\ ^(_"&KM.FEZ[I\^FW3VSA95BEC9&*$@@, QP2",]
MC7 :A^S1I.JW?B.>\\1ZY./%>F1:5XHB)ME36XT5HP\H6$>6YB=HB8=@*8&
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M/F*S%0YC$@B+Y8H230!YY9?M>76K>$WUNW\#W%G'>>"+[QKHXOM0B_TF&U,
MFBE$8;RCFYB(/S9!/0C%>X^ ]7O]?\%:'J>J016VH7=G%/-'"^] S*#P<#KG
M.,<9QSC->9Z3^RGX:TK1=!TDZ[K]W8:/X4O_  ;%%/+;#S;"[\GS3(4@4^8/
ML\6UE*@;>0<FO3_!?AI_!_A73-%?5+S638PK +Z_$0FD4<+N$2(G P.%' '4
MY- 'BO[0'Q9U&X\+ZS%X3^T0CP]XKT/1]2U:VOO(>.::]L6EA1%!\U?)NE1\
ME<>80 Q4XWKG]HY8/'-SX8/AR2.^:/5?L<=Q>K'-(]B 29HMI,,4RG?%)\^Y
M!N*KD"I?%O[,^D>*-3\2SP>)=>T*P\1ZA8ZOJ6EZ<UL;>2^M)('CN%\V!V1F
M%K KA2%8("1G)+-)_9BTG2/$.GZFOBGQ%<P6&H:M?P:?<26IB7^T7:2ZC+"
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M//\ B_X%:5XJ\8:IXCAU?5-"O=9T?^PM7CTYHA'J%J"YCWB2-BKQ^;*%="I
MD8'.%V@'"Q>*M2^,?QL32++4=1T[P</"ND^)=-O](U.2TG)N+BX82/&$Q(KK
M;I&8I,J%+'&6X]&^/2:B/@_XLGT?5[K0=8MM/FN++4K,_/;S*I*.5/RN >J-
MD']1)X>^$&D^%O'S^*--O;ZW_P")':>'X](7R?L4-K;/*\(0>7Y@8&9^2Y&,
M<<5O>-_"D?CCPKJ6@SW]WIL%_"T$MQ8^7YJJ>#M\Q'7D>JF@#Q3PA\7=6\4>
M(O"OA#Q8[Z!\0-#UMK/Q#8V<KPVVH6YT^]EAO(.?GMIGMT<9Y1D>-NC;NBTG
M]HR/6[CP=)9^'I9=*\;VES<>%[W[6H-])%";A8I5V_N3+"DDL9W,-J$/L;"U
MV?B#X2^'?$_CGPCXQO[5I/$GAC[0EE?J0KO'/ \,L4@ PR'?OQ@8901@9!P/
M O[/6@> 7\-16NH:G?:7X6>X?P_IM\\3Q:7YR/&5C98Q(P2*22)-[-M1R,G@
M@ SK']I+2[WX>Z3XP&E7)T^\TN.^EMHWWW-M<RW"6T%DT>T9F>=GBQG :*0$
M\ F&Y_:*O;"^L=-NO .N0ZE>^(%\/VID0P6MP[64EVDT4LZQ%X]L3QMA,JZ,
M",;2VU=?L[>#KOP=XT\,-!=QZ7XJOY=2NA%<LDEM</()=]NP_P!5MG!G4#@2
M.S8^8U%'\!A=)X7EUGQSXHU_4_#^L+K4.H7K68DGD6"6!8I$2V6,1B.>3B-4
M8EMQ8GF@#GO"/[1EQXTU'PUI>H^#[W0+?Q#J^K>&/MBZE'(UOJ5B+OSD79R8
MRMC.5E^4Y ^49!K@_@7^U1<:!\'_ (>'XBZ3JT+ZAX&CUZV\137,=V^KO;V\
M+7095;<DK&9&0-G>&.2I!6O6-$_9TTC0[[PY=1>(=>G;0O$VI^*K=)FM=LEW
M?BZ$Z/M@!,?^FW&T @C</F.T50TG]E/PC:^#[#POJMUJ?B/1-,T"?PSIMOJ,
MD:FSL9519%5HD0F0K%"HD;+ 1C!!+E@"OJG[2=]H;7%O??#S7X[I=9TS2+>3
MRVAM;LWIVQO%-<)%N*."DBA3L.WG:P:O7?#=_?ZIH&G7FJ:6VB:E/ DESIKS
MI.;:0C+1F1/E?:>-PX.*\T'[/"WFBZ98ZSX_\7>(+G3]5L=4AU"_ELS-FSD,
MD$+!;8(4W$EFV^8^?F<X&/7: /$?$WA#7+#XS^$#9_$'Q3,VIZC<ZC>:*TT
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MX).:B/[,EG>^ QX3U;QWXNUO3X;K3Y[.>^GM&GM([*YBN8(%86X#KYD$>YY
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MU:W,I *S3Q21)M=EY7<I!#&O5_!'AW4_#6C&WUGQ'>>*=2DD,DVH7D,4.3@
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M0!\P^#?BMXA\47'AWQ5KFN^)?#=AJ/C+4O#<.A6EEI\UI<&'4+BW@5Y,/+&
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MVOG;\K;6Z%\ FL/%5CJFIZU#J=G#X.7P?<6*6+0^?$'#&7?YS%21D;<'KUK
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MSCOBO.O%W[.FK^-1X[DO_%UHEUXMTK3--N)(-'94@:SEFD$B*;@Y#&=QM)X
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M&)E<.A#1J>1D'VO1K";3-*M;6XO9M1N(T EO)P \S_Q.0H &3DX4 #H   *
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ME JC)9E !#*3J^(?AOJOQ \367C&SOU\/7,_AB]\/WFE:E8-+(AG>-\AUD4
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MFQYIV;/L:?+\V=[<C JM\-OV9_$WPL3P]:Z)XRTTZ>F@Z7HFMQWFBF:2=K&
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M)!'F&2/H#M$B%]H92>,MOV;=;M])M++_ (233V:#X>GP*9/[/<!F(4"ZQYO
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MXPG[)NM>'?!7B/PUH.H:=-9RZ/X9TW2VOII(W8Z3(')G*QMM$HXRH;;C.#G
MW=:^!_Q \2?$&S\0:EK6@SPV/BJTUZR65)WDM;5;+[/+9Q]% #M)(' !D+#=
MMV@4 :GPZ^,&J>)(_#<.NZY8Z;JE[XS\0Z EM;Z3,\>IQV$VH1I$C[R+=_+M
M1,6<MN\IU ^;(ZV'X_\ @>75O[,;4[RVO_[,;6?)N](O(#]C#!?-^>$#!9@J
MCJS<*">*X/P]\"/%.C77@RY>ZT>230O'.N^+956:7$L6HKJ $*GR_O)_:+<G
M@^2.F_Y<Z']G3Q=K?A;Q?9:]J>CQ>)O%-PNH:CXF@:2Z9IX'5["".VDC54M8
M2B?NC(Q8!\G=(S4 >JV7QO\ "%^;V&+4)UU"TU!-)FTR6QG2]6Z>#STC^SE!
M(=T.900N-@9LX5B*7[/7Q%U'XJ_#&/Q%J@A%U)J^L62^1;/; Q6VIW5M$3%(
M2R,8X4+!CG=GITKB9O@CXUEN/"/BF*?PAIGC'P_JCWG]G:5826VEW<$EM);2
MQN_S2^85E+K)@A=JKL(+,W>_ OX?ZQ\,_!%SHNM7ME?W,FM:KJB26$;HBI>7
M\]WL.XDDJ9R,^P^I 'VOQP\+W.O^+=),UW'<>&;JWL;TM93$/<3+&T<<6$_>
M,?.B "Y)+< @9K)O/VG?AY96L<KZK?22O->VWV.VT:]GNEFM,?:8C#'"SAT!
M#%2,E2&&5^:N2\9?L_\ B;Q'X@^(=Y9W^C6JZOK>F>(]'FO$>Y47-I:V]NUO
M=6Y50T+B!P660M^]! !09VM'^$'B.#QKX"\0W?\ PC=HVC/J,NH6>C6SVL&;
MF&.("%=I+%?*!+N06)/"@   U9?VFOA_'J-M9?VCJ<DUSJ-SH\1CT*^9&OH%
M=I;7<(<>=B*0K']YMOR@Y&;]A\?O!.I^'K/6;74;J>UNH[J80QZ;<M<Q);3>
M1<F6 1^9'Y4OR-O4;3U[UPVG_ CQ-:W6B2O=:218?$*^\9.%GE^:"XCND$(_
M=_?7[43GH?+_ -KY><N/V4-8U+P7_9-S=:;9ZW%JFNZKIGB73;NXM[_1I[^^
M>ZCDAD15,BIYA22%L)+Y:$D=  ?2NK:I;:)I=WJ-X[1VEI$T\SI&SE4498[5
M!)P > ":X^'XY>!Y[:TN%UU!!=Z-#X@MY'MYD66QE9%BE4E!DLTB*$^_E@-N
M:ZS6-)36M"O=+FE<)=VSVSRC&[#*5)],\YKYR\,?LS^+]/T?1;#7+KPGKMKI
MG@B'P8]A<VDSV]]'%-$0\NX_*'CB(( .QFXW8R0#V34/C-X7TO3?MEQ-J*D?
M:2;-=)NFNPMN%,[F 1^8$3>F7V[3O3!.]<\/\9_VC],\,?"S4M>\&ZG;:QJ*
M6=C?V\L=C/>6H@NI%$+N\>%3>A8J68=B01UY2W_9:\2>&+K0=3\/ZUI>I2Z7
M)J%I#H?C 3ZM9V^FW1MV%O'.Y$Q:%[8,C-U61HS@!2)?&7[-7B^ZT_Q]I.@:
MWH7]F>,[?3GNOM=K)!]@N[6&& M!%'E3#(EO%^[ROED,07SB@#Z1NYQ;6LTS
M;\1HSGRXVD;@9X502Q]AR>U>,Z-^TUX,T7P%H.H:SXHN/$=Q=>'AXA;4=(\-
MWJK=V2E0]VL")(T: LI*EB5!YKV0FX2S)"Q2W8CX4DI&SX]<$@9]CCWKYH\'
M?LN^)_"_@OP_H3ZGI-PVF?#FZ\#O,KRJ'ED:/;< ;.% BY7KENO'(!]*6.I6
MNIZ;;ZA:3K<65Q"L\4T?*O&R[E8>H((->%WG[3UIJFL_#S4-!\^?PKK>IZMI
MUZC:/<R7LAM(9RA@11O.YX<[1&QP>=I#"O7?AWX>N?"'@#PUH5W)%+=:7IMM
M8R20$E':*)4++D X.W/([UX[X&^!7B[PS=?#X74NB/;^$=;UN_!ANIB]W!>&
MY\LX,($;@7(W+\P&SACNX .M@^.7AG6-8\):C9>+H+7P_JV@7^N+:W6E3H;J
MVA,.^?[0VU8/(WX>)U+GS5SMV\]YX;\7:=XK%[]@^U!K.589EN[.:V8,45P0
M)%7<I5U.Y<CJ,Y! \'\-_LV^*-#M_ 2/?:%.WAKPYK^B.)UDFBN)-0D@>-S&
MR ,B?9U#(3\P=NF.?1_@A\)7^$>GZS8P3FVT:[N4N+'08[R6[MM* B59(X))
M0&$;.&<1@!4SA0 : *MY\3-8\3?&O5?AYX8-G8KX?TJVU36M6O;=KC:UR\JV
M]M%&'3YBL,DC2$D !5"DL2NM;>.=0\'BXM/&TUK<:E<7DJZ3%H-C-)+?6R0Q
MNT@MU:5P59G5N<#Y?[RYS-9^&.LZ'\7KSXB>#Y[![O5],@TO6]&U-WAAO!;O
M(UM.DZ*[1R)YTJ'*.&5A]TKDQ^)OAMXHU'Q[X,\>6>HZ=)K^AP7]C<Z7,'BL
M[BSN_(9XTE"LZ.CVL#"0J=V'!50R[ !=4_:?^'.EZ5;ZB=8N[VUN-(DUZ-M.
MTF\NV-E&X264K%$Q'EL<.IPR'(8#%=1;?%7PQ?ZO::;9Z@]]<7+1JLEI;2S0
MHTD/GQB255*1EHL.-[#(*_WESXUIO[+FK^'K6>UT_4]/GBN?"NN:-,\WF1G[
M9J5\;R255"MB)9'<!<YP1SQS-8_LO7SZKX7O9[NST>_TFQLM-NM8T*ZG@N-1
MLHK00RVES%@1SHS99)'^:/(VC*Y(!WFH?M+_  [TJSOKN\UN:WM;335U@S/I
MUSMFL3((Q<PXC_>Q;V4%TR '0DA74F'5/VF/!&EVEY*\VIF:SUVR\/7%I+I%
MU#/'<W3QB$F-XU;RRL@<.!M8 A26P#YO:?LR>,D^#.N> KK4/!\C?V,-"TW6
M++2FM;JYB#1[9KMANPP6)04C&UF);(X W?&_P*\5Z]XA\4:W83:,;C4?$/AS
M7+:TN;J6-,:;+"TL3R"%BN]8SM8*>< CN #W+5M=L-!T*]UG4;I++2[*V>\N
M;J?Y5AA12[NV>@"@D_2N$;]HGP''93W4VJ7=O'#?V.FR)-I=VLB37I06F4\K
M<%E,B!7QMR<$@@BNH\>Z1KGB#X?>(-,T'5(]#\1WNFSV]CJ9C\Q+2Y>)ECEV
MGJ%8@X]J\%'[-/C&6\U>[DOO#T3ZCJGAC5WBA:X)$NEW<=Q(&E<,TAD\H+O8
M9)<D_=PP!Z[HWQR\(^(=(^VV-[>;VU*;1ELI],N8[S[9$AD>$VS1B7(12_*@
M;?FSCFJW[//Q#U'XJ?"JQ\2:KY/VRXO]3M_]'MGME,<%_<01GRG)9#LB3(8Y
M!SFN!'P \6Z3X]D\::3JFD_VM;^*+_6;>PNFE^S7-G=V<%M+!(X3='(IMTD6
M15<=5*X)->C? OX?ZK\,?A\N@ZQ>V>H7@U+4;[SK&-TCVW-[-<A<,2<KYQ7/
MM0!Z!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %8_C#4[K1?">LZC9&$7=G9RW$7GH7C+(A8!@&4D''8BMBL?QCIEUK7A/6
M=.LA";N\LY;>+[0Y2,,Z%06(5B!SV!H \+^#W[1OB7QAXA^%FFZU8Z-?#QYX
M1'BDG1/,CET7]U!(([F-W?=&_G[$ERNYHV&ST]3D^-_@:">^BG\16UK]CLY]
M0DEN4>*)[>%PDTL4C*%F5'*JQC+8+*#]X9\L^#?[..O_  17P#>^'Y=&AO;?
MP]8^'?%]@DLB6NJBU@$<%]$PBRMPK!@=RX=)-K-E%-9?A+]GCQYX4^'%QX4M
M[7P$M_HFE/I/A[Q2+9FU"]ARBHMWN@(@+11JLC1M,7<!\#;M(!Z#\2?VC-%\
M*^ KG7=%$^J746OV/AN6W;3[G?9W=S<6\7[^'8)%VI<I*$.TR H%.74UY_J7
M[07CF#4_'.AOJ7A?0[WPA86VJ7FMZOX>U-=/DMIWNB&9?,5H&CAAC8JS-YCE
MU4J!N#IOV=O&]UH?C*P/_"/VPUOQSHGC" ?VI=3F);0::9H))'@W.Q.G$+(?
MO>;N8+C:>E\9_!#Q/XEU+XXSP2Z3%'X]\+6^@V/F7,N;>6."[B+R@1?=)N@1
MMR?D]^ #LKWX_>!- U :1J_BBRBUF&"&:XACBEPHDBDE5\8.U2L,I&3QMP3D
MC.?-^U)\,(;>ZG;Q.&BMM/BU9VCL+E\V4@)6Y3$1WQ#!W.N50@ARI%9FC_"7
MQ-9>(?'VI3?V3CQ!X6TW1+9$NY6,<]LEVK%R81\A-UP1D_)TYXY#_AF_Q=_8
MWV/[5HN__A5O_"![OM4V/M6W'G?ZG_5_^/>U 'L]S\7_  ?:>([;0GUR$ZE<
M30VR+&CO&)I8S+#$TJJ421XQN5&8,P((!R,\OH?QYTCQS:^&[O1-1CTB'4/$
MEYH9@U[2[F.6^-LUU%+';9V;9-]MOW,&"JCJRAON^>W_ ,!?B/?Z[I<TT_AN
M>STO6=#U2S8WUQ&T<5I;Q13P&)8-KL76619V)8JXC(15!&SHOP*\6:58^#[!
MIM&DM_#WQ U3Q4)A<RAY[2[EU&0+M\K"RK_:(&W)4^43N^;"@'J=O\6_"-UJ
MITY-:B%R1<F(O'(D5Q]G.+@0R%0DQC((<1EBN#G&#57P/\;O!'Q(U2+3_#>O
M1:I=3:='JT 2&5$GM'*@31.RA9%!90=I.TD!L'BO,O O[/GB7P]I7PWT#4[S
M2[O2OAYJUUJ>F:C!<2"[U%3;W=O;Q3H8ML6$O"9&5WW-$"%&XA;7P4^!/B7X
M;7WPL;4KC2KB#PGX%?PG=M:W$K--,9+1A+&&B V8M#D$@C?WQR >K>-OB3X<
M^'=O'-K^H_8@\,URL<<$D\AAA4--+LC5FV(&4L^-J[ADC(K!UO\ :#^'OAZ^
MGL[[Q-;I/;I9RS^5%+,L$=V6%M+(R*52-RC#>Q"CC)&X9P_C[\,_%OQ(^S6>
MA3:4=(GT?5--O8-0N9;5TFN$B6"=7BC=I439*&@8HC^8K$DQJ*X#4_V</&VL
M>$O&VGSSZ!#>^(/!6A^&8_+O)VCAGL7NV=R3 "4878 XS\G(&> #T3XP_&^/
MP)=^'[#1IK6\U*[\4Z3H-]#-:S2QPK=3Q*Z>:F$CF$4HD57.<%3M((SZ!XQ\
M::'\/]!FUKQ%J4.DZ5"R))=3YV*78*H. >I(%>#ZQ\"OB$+S5=/L)?#U]H5W
MXZL/&T5W?:A<17</EW-O//:%%MW5P&A81R;Q\K*I0;<GU7XZ^!-2^)GPPU7P
MYI,EK#?7<ELZ27LC)&HCN(Y3DJK'D1XZ=Z )M+^-G@O6=-U"]M-9\R.PU%=(
MN(6M9DN%O&5'6%8&02.S)(C*%4[E.X9'-9\_Q_\ "/\ :WA&PLKB[U63Q)?W
M6G6[65C/(()K>.1ITGPF8F1H]K(^&!)) "L1Y[XE^ OC.[^(NI^,]*N]%6]C
M\8V/B>PL;FZF6*XBCTG^S)X)G$),;%&DD1U5\':".IJQHW[/FO:#XWTCQ;:S
MZ6^H2^,-1\2ZK9/<2B&)+K3Q9!8'\O+LBQQ.0RH'8ORO% 'N>N:]I_AK3GO]
M3NDM+572/>^3N=W"1HH'+,SLJJH!+,P !)%>7_#;X[P^)D\<3ZPRQ6^C^*I?
M#^G)9Z=<BYN56SM[C:;<AI6E'F2[@JCY8R=H )K:^-_@#6_'F@:&_AR[M+?7
M-!UNSURU@U%W2UNS"QW03,BLR*RLV'"MM8*VUL8KR6Y^ /Q!DUK5/% M?!]U
MK3>+9?$-OH>H7L\^GW%O-IL%G+!+*;8-'(I@#I*L;CD@J,F@#K_%G[08U?7O
M!^A?#^\L;N;Q1H]_K%EKEYIMU>6 2W:WC56\DH0"]RN]BP\H(0X!9:U-"_:%
M\+Z=X0T2\\3>*]*O=3U&TNKZ-]"L;IH[F&";RY7AAQ)*PCW(&Z]"V O2#1_A
M'K.B_$+X?:[9V/AS3=-T#1-8T^YT[2PUK$DM]<6<_P"XC6+;L0VC L=I<R;B
M <@\WX!^ GBSPE/\/I;B719CX;TSQ!8SK%=S?O6O[F*:(H3#T40X;/\ >XSC
MD ]0U#XU>"=+TK3-4N-?@&F:C;6U[!?1QR20+;W#!;>:615*PQR,<*\A520<
M'@XY[XC?&Z'PSXP\%:#H\MO>SZMXECT+4!);3.D(-M+,RK,N(UF 1#L))PQ.
MWBO+_"/[,7BSPCI'A?2IM/\  WBO3SX2TGPSK,?B")Y_LDEC&T0N;4- PF21
M7R8)/+ 90=YR0=6'X%?$+2]8TRPMYO#VH>'-,^(-QXRM[^ZO[B.]>WN6N9);
M9X1 R[T>[<*_FX954%5H ],_: ^)&H?";X<_\)+IRV3R1:OI5E,M^K&/R;K4
M+>UD;*LNTJLY8$Y&5Y'-:&F_&GP=J^DS:C9ZK)<10ZB^D-;I97'VK[8J>8T
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M)'!4R/A!@_-Q70>*/%.G^#_"VI^(=1>7^R].M9+R=[:%YW\I%+,51 6;@$\
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M\0+VYN-+\%:]X<U:^L-7N+O58GFU+2[J"WMX72W!AVS*?LL;QR,\;1,Q.U\
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MX93TY!!KXN^!F@W7C#0;305LO!/CI3X1B\,":T\43WJ6%E'AVM+J!;%#;*Y
M3+2R3*R)]_8S#ZF^#'@'5OAOX:OM(U+6+G5[?[<\VG)>7LE]-9VI1 MNUS(H
MDGVLLA#N-P5E4D[<D N:]\8/!WAC5CINIZY#:72W<5@^Z-VCCN9$\R.!Y I1
M960A@C$,0RD#YAG+T;XP:)'#J$^K>)-,NH&\2-H%G)I]I.JQSDHL=K*27#3;
MFQN&U26  !Z_.VM:IY/QX\70:;%X<U:#_A*[;6CX2N_$4VGZM<WEO:6\*W,=
MD;*5YOFB#*RS1PL(HV.T!G;UY_@)J>M?#OXJ>&]4O+2SN/$^N76M:5?6,K2-
M8S'RGM93NC7$D4T,<G&1E1S0!W_B#XP>$O"YOQJ6J/"]B91<QQV<\KQ+%'')
M+(51"?+1)8BTF-B^8N2-PK,U#]H7X=Z9J0L9O%%JT_GV=NS01R311O=$"V+R
M(I1%D+*%=B%)8#/(K@/$WP)\61:SX7\0:7!X3\6:E'IESIWB#3?%"21V=S)<
M3+/+=6[+%*482^8/*9<,C*NY=@-5O$O[.OB74++QS::<WA^UM]:7PZEE'$TE
MO% NG2(SKY2Q,(U8)A%4D*,#M0![WXD\06?A3P_J6M:BTJV&GV\EU<-!"\SB
M-%+,0B LQP#P 37$:?\ M!^"KGPQI>N7NHRZ3;WEA;:E*E[:3(;*"<E8I+D[
M,0(S*X620JC;&*D@$UV'B_0Y/%'@_6M'61;>74;">T$A!94:2-DSVR!FOG'2
M_P!FKQ[9^%_&>@RWGA^6R\:^#[/PWJ)>\G<Z7-!:/9^=;@P 3QO&_F;&\HAU
M(R0VX 'TIXE\0V?A+P[J6MZ@9A8:=;27=P;>!YI!&BEF*H@+,< \ $UX@G[6
M.E6GBZQGU<C1_!-WX+3Q3]HN=.N?MD!,XC8.J@GRE3+%PF /FW;>3[!KGA(:
MA\/=0\,6LYC6?2Y--BGF^8J#$8U9O7J":\#O/V</&VK:#>6ES/H%O<7/POD\
M!XBO)Y$2X8%1/DP F/!ST!SQCN0#W+5_BKX4T+5+*POM8C@FNYX+6.3RW: 3
M3?ZF)Y@ICC>3(VJ[ MN7 .X9Y]?VD?AQ)=6EM%XE2YFNVNX[86]I/*+B6V=T
MGAC*QD/,K1O^Z7+D#(4@@G@/#GP!\4>'O&ES)/IO@KQ#X=U:;3=0N[C6(7FO
M]+NK:UM[=Q; PE9486D3QLS1F)RQVOP*M>$?@7XK\/S_  ^DGET:3_A'/%OB
M'Q#<".[E/FPZB^H-&B9A'SI]O .< ^6<'YN #VGPCXMTCQWX;L-?T&]34=(O
MH_,M[E%90XR0<JP!4@@@J0"""" 17&VWQJ\/:0=7?7O%.DR1+X@DT6Q6QMIE
M=95@23[*X)<RSC+G*  @J N0<V_@7X$U/X:_#:S\/ZO):2WT-W?7#/92,\96
M>[FG4 LJG($H!XZBO/C\"O%/_"0/?";1_)_X6+_PF*C[5+N-K]A^S>4?W7$F
M?F_NXXS0!['X)\;Z)\1?#EOKWAZ^74=+G>6))A&\9#QR-'(C(X#*RNC*58 @
MJ017DOC/]IJVLQJ8T"$J=!\;Z5X4U>75M/N(XBES):"5XG.P;E6[&,[L[0V"
MK*3V7P.^'NJ_#?P[X@L=6ELY9]1\2ZQK<9LI'=5CO+V6Y1"613N42[3Q@[<]
MZ\^U?X!^*Y=6\7?8[C1I;#5_B#I'C6"2>YECE6.V2P$L#J(F ;-B=K!B#YHS
MMV_, >GZ;\:/!^L>'1K5EJ<MU9F\FT_RHK"X:Z^TQ;O-B^S>7YV] C$C9D 9
MZ<UTOA_Q'I?BKP_8:YH]_!J.CW]NEU:WMNX:*:)EW*ZMZ$'-?/M_^S_XTT_7
M;KQ)I<7A76-1'B74]331M<EE^Q7-E>1P*RM((':&=&MHV5A&XP77^+(]Y\'>
M'T\->%--TD66FV*V\(1K32;806<1/)2*,#A 20/;KR: /+O ?Q4\:_&7X;7'
MC[P7:Z'#I-Y]I;0-+U6*8S:A%$[QQRRSJX$ F*;@HCDVJ5R220O7'X[>!8M>
MO=#F\0VT6L6#21WMH5<FU>.&.9TD8+M4B.5",GYL_+D@@<Q\'OAKXQ^"?A&W
M\!:0FA:CX3TQY8]'U2[O)DO+>U>1GCBEMQ"5E,6_8&$R;U4$A3FLGQ'\ O$/
MB/3/C):_VEIMI-XMUK3]<TFY<-.L<MG:V$<:749104>33P652<I*P[<@'I%E
M\8/"6I6UW);:L3/:W_\ 9<MD]K,MXEWY7G"'[,4$I<Q?O H7)3YA\O->??"C
MX]W7CS0?">HZAJ>CVDVIZGXAM6T^#3KDW%_!87EU!$]LF\M&VR!'=7#$EBJA
M3@5FM\&/&J:QX3\:V&B>!M"\6Z1J<MQ>:%I4TL6GW\$EHULS278MA(9U!#(Q
MA(51Y>,$O2_#KX%^,?#>J^ [K5'T,+H.O^)=5NA9WDTA>+4[BXGC5-T"Y9/M
M&ULX'RY!YP #UKX7_$?2_BUX'TOQ7HL=W'I>I1B:W^V6TD#LAY5MKJ"000<C
M([9.*Y7XQ_'.'X2^(_!MC+I[7>GZIJ,5OJ]\&PFE6TSBW@F?T#W4L"<\;?-/
M\%:7[/\ X$UCX7_"#PSX1UN2QFO-$M$L%GT^1WCFCC 59#O12&;&2N"%SC+8
MR>5\;_L]CXJ:+\28?%.?MWB6%K"S-AK%U'%!:QQ;;9750J[DE:6;E'P\K8)&
M!0!Z3XO^(OAWP&F[7-26S_T::]95BDE9+>+;YT[*BL5B3>FZ0@*NY<D9%8UI
M\=_ .H:]9:+:^);6ZU.\6V>"W@5Y"ZW E,#Y"D!7$$N&)Q\O)&1GYN^+B^)=
M-U/P=I'BC6_"5CXO;P9<:'K%YJ?B"?1[764N)(ED6WN7LY@[DVS.T:()8_-0
MA\,,^L_#7X8ZMJ&K^(-=O],M?#&B^)/!VE>'HM+M+N62YT\VIOL[3)"A*E;T
M;2P5AY8W("2% .]M/C9X*O;B[MX=;4W%O;0WGDM;RJ]Q!-(8H9;=2@-PCR#8
MK1;PS$ $DC-*7]H;X>PPV;'Q'&\UXUVD-G%;3O=-):MMN8_(5#()(VX:,J&!
M[5X[9?LU>-6\&:-;7.F?#JW\4>%?LD>F:E;63LFN1P, 5OLPAH%D0',<9F"R
M$2 G8%KLM(^#'B"V\>^ ?%0TCPGH+:1_:T^I:5H;/'"9KR.%%,;B!?-(\G+2
M.J$[ON\ 4 =KX<^/GP_\62QII?B:UN%DTDZ['.Z210R6(V[YUE=0C*GF('P2
M4+ ,%-$WQ\\!6JS?:O$,=C-#>PZ=):WMO-!<)<3)OA0PN@?YUY4[<-S@G!KQ
M5/V4/%-_X!\!^&+W5-(M!H/@75O"=S>V\DDVZ>Z:R:*98VB4/&IL1N1BNX2$
M=LGI?^%*^+];M-$OK_0/ ?AS7;7Q!I>IWH\.&58[N&S:0Y:4VZNS-YK;8V4B
M/D;VW$T =Q!^T5X,U&[\(0:9=7NJ#Q-J%WIMJUMIMR?*FMED,ZS*8\Q,C1%2
MK@$9SC:K$>FU\^Z'\"O%NB>*M!UI9M%D;3_&>M:^\)N9L&TOXID&#Y7,L9E!
MV<*V#\ZU[9X6?79-%C;Q)#I\&K^;-OCTJ626 1^:WE$,ZJVXQ["PQ@,6 R "
M0#6HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "L[Q%/J-KH.H3:/;PW>JQ0.]K;SL5CFE"DJC,/NAB ,\XSG!QBM&B@#YX\%
M_M3OXKO/@C))9V%KIGQ(L;LEWD=9K'4+>(/)9[#]XY$L>\D8:+&WYP!W=A\2
M[V[FT%KG4- TR+5->O+"V@O)'6?4+6!+CYK9=W,A,(D[KY08]2,>3ZU^R+JP
MTWXA_P!AZY;V&HS>(X?$7@J1XPR:),)DNY_EQC$MRUP&7D&,J/IZ?XU^%U]/
M??!RW\/0V_\ 9/@O6UO;C[7<,L@M5TR[LE5/E.]\W2-R1PC<Y(H YIOVK-$U
M'6_ $^ER6X\*^(+[5[*[O[]9(I8391RD%%('WVB& 03A@,!N*]+F^+O@R#0=
M/UMO$FGMI%_9G4;>\CE#QO:  M<$C.V)0R[I&PJ[ADC->,^"/@?XX\-ZY\,W
MO+71Y+'P?K7B"[DE@U!VDN8+W[0865#" K@S@,I; "DACTK.^%/[/_C_ .%E
MEHTOE:'K<C^$&\+ZEIL]](D44D=U<3P3Q/Y1WQN+ITD4JI 2,KNQB@#WV]^*
M'A/3O[5-SKUE"-*2WEOB\G%O'.2()'/9'*MM;H<'FF>#_B?H/CG7_%>C:5</
M+>^&M0_LR^5XF0"7R(9CM)&",3J,CN#VYKYQU']EGQOX<\'ZUX0\-S:1K.G7
M_@KP]X=CU/5+V2VDCN-,DFW%HUBDRDB2J00V5*D8;C/M_P ,/!?B#PAX]^)M
MWJ$%@='\2:U%K=I<6]TSRJW]G65H\+QF, ;6M&8.&.0Z\ YP 7)_BMHOA_Q#
MXHC\0>+/#%CI6FSV-K&IO!'<6TTXPL=R6;:'=L>6HP2#SU%='X1\<:#X]T^X
MOO#VJVVK6MO</:326S9\J9,;HV'4,,@X/8@]Z\+^(7P,\8>(O$WQ%O;"#2Y+
M7Q!KGA34;3S[QD81:9=P3W D C.&80E4 )!+#)6O2_A+X*UCPAKWQ)N]4CMD
M@\0>)6UBR^SS&1A";.U@Q("HVMNMV.!D88<YR  ;<GQ3\(0ZC=6,OB/3H+BV
MBN)I?.G"(J6[!;@ASA3Y3,HDP3L) ;!-9,?[0'PXFT_4+Y/&>DO9:?;P7EU<
M+< QPP3$B*4MTV,05#=,@C.>*\5U;X$?$G4/%2:A)8^'76-/%-H9[?598(Y8
MM1??;2BU6W$<<@ 592"S.Q9V=C]ZW;_"VS^'^DV-U\49_#^F> [?X<V/@?6+
MB\U 1PM-Y@C89=5 B;S JL2#EONB@#Z/MM>L+O5[C2XK@-J%O!%<S6Q4ATBD
M+B-R". QCD ]T8?PFL.X^*_A&TNKJVFUZU2>UU.+1IHR3F.^D56CMSQ_K'5T
M*KU(=2,AAGF/V;_"^M>'_AK97/B74Y=:UZ_"M)J%Q$8I9K:-1%:%T/*.T$<<
MCJ>DLLIP,XKCOC)^S7JOC[Q3XHU+0]:31K?6]+@N60%@Z:]8L3IMWT(V+O4N
M.I-K!CH: /6=9^*OA+P[!<S:EKMK9);-.LQE)!C$ 5IW88R$C#H7?[JA@21D
M5*WQ+\++)K\9URT+:!;I>:H ^?L<+H7220C[JE%9@>A"D] :\>^+OP5\:^*O
M#5KI.DKHM\MUX:UK3M1GGNY+"9-1O?*D\^*6.)W,!D67=!N16S%NW;!MRXO"
M<7BGXH^"M+L-<TR+Q'I&CV^E?$#0].N!=*+2%8[JT21L*0WG':F]1OBN;G X
M) !]':EK-EH^FM?WMPMK:+M!DER.6(55 ZEF9@H7&22 !DUSB_%_P:VD#5!X
M@M399N%=QNW0^0XCN/-7&Z/RG*JY<#8S -@D5C?'KP#K?C[P=8Q^')+(ZUI.
MJVNK6]GJ;NEI?>2_S6\S(K,BNC, P5MK!6P<8KR_Q;^S]XC\3:/9W.E:)H_P
M]\4&+4;B'4/"VJNIL+RX\G N T"QW\$ODAIQ)'U1 JMC> #U[2OC9X2U;4_%
M-BFIB*?P[JB:/>"6-UW7+Q0R)'&,9D9OM"* N2S< 'BN.\8?M.>'O"?CWP-;
MSZQHZ^"O$>D:M?G6Y)SE);.6U3RUQQ_R\ON&-RF)L@8.,'4/A)\1+#Q!XRDT
MRV\/:E8:QXPL/$HFO+UX)Y84T^TM)HEQ;O\ 9Y0]J9%E0D[6PI4G(Q_AS\"_
M'_@/5/ .K3:=HM])X;;Q7:R62ZO*QFBU._ANK>7S7@R2OE%'!R<,&!8Y6@#T
MK4_C.P^(":5I][H1\-W7@^Y\2VFO37):WRDT*([R [?(*R[BP/09S74:-\1-
M,?0_#SZAK&FS:CJ=I:2":P+FTFDG7]V8V.=J2,&\O<<L!QD@UXGX8_9J\1^!
M[#2=)L)-.O;*Q^'VH>&#.9FAS>7$R3#9'M;; I5E'S9 VC!Q5CP]\ O%^D7'
M@"\MIH=#UG0-,T+3;Z]T_4Y)+74[>T(%U;7-JZ;)/E,I@F4"16DY*A<, =Q\
M&OC_ *3\0=(MK?6=2TG3O%<ESJR-I5O.?]59WTUN7&XY^XD;L#R-^< $5;T?
MX]>$]*\%Z-J/BOQOX6%_=Z:VI--I-T3;3P(P#SP*Q+M$,CYN1U.< UPGP_\
M@IXQ\+WWPWGO+72R/#NL>)-0O1!>LQ:/4)KB6 1YC&YAYRALX P<%N*Y_P
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MO@-XQ\3^(?']]:0Z7]GU[Q1X6UJU6:\8,(--EMGN%<",@,WV=@@!(.X9*\T
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M;M=(FCM[X0RAS#))CRT(')+[E"XSN) &37C7QR^!?C'QQK7Q<?04TJ:S\<>
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M'1[K2O!'AG4/!NI^&K/PK<:!XGU.2X32X;"6XC@GA<0.M[!+%+NV,(]^(VW
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MD:=51@KDH#NPK,H/'!89ZBOGG6?@_P",M2U;Q+>)H"Q2ZC\3M$\61R"[A/\
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M"/%OP,^&UA\-VT:/6+70VFM='UZ&[C6":T,KM";E&(DCD56"L$60$KD,-V
M>BCXL>"CJ\NDGQ;HB:K#YWFV#ZA$)XO*C628/&6W*41U9LCY0P)P#5B'XC^%
M+G2)]4@\2Z1-I\%P;.2Z2^C,23C'[HL#@/R/EZ\CCFO$_$?P2\5>((/C@]G:
M6FGZQXAU[3=8T.]GF")<+:6>GQF&1HB9(DDDLI4)&2$FSR<K4(^&7C&W\2>%
M_B%I_@FUTS4[76I+W6?#7]N&[N]05[!K-;HW4A$;3Q*55$) \H,-X)"J =A\
M,?CZ/B+H/AO69)O#6E6FH7^N6]Q#)K.^5X+&ZN;=)[3Y )T86_F.QVA5;(S7
MH/P]^(>@?%/PE8^)?#.H1:GH]ZN^&>-@<CMD=5)!!VG! (R!7AGPS^$/C+P[
MK'PWFU/0X+6+1?$7BK4;LV]Y'(L4&HW5U-;X^Z20)U! !QMS[5Z5^S;X2UWX
M?_!3PKX5\16,=CJ>A6:::QAN%F2<1@*)5(Z*V"0#R!C(!X !Z;1110 4444
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M25!R%XQ0!R^G?M->$=5\0^&UMM2TW_A$]<\.7GB&+Q)-J"10Q+!<64/ER!@
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MO9[1Y6N8-Z,981-&Y@+E5^65N2*=)\/_ !9!XG\*?$#1OAKJ.F/%XB;4-?\
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M0 4444 %%%% !1110 4444 %%%% !1110 445F>)M7GT'P]J.HVNF7.LW5M
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MB7X)WMQX3ET:[T[POKVF^(KK[.BN)IKJRDM8Y9%_U@(@F*X+!<<[=P! /?\
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M:OXDUC7+CX>7L]HWQ2L_$L5G.+-I9; Z';6DC*IEVY$\?S*2.F><'&>OP?\
M'>M:!XKT@^'-9TSXEZ?!XB32O&_V^WBTVX-\)O)D0QOYS.X: %)$Q$T6[(V1
M[@#Z7T[XGV.J?%74_ ]O;M)<V&E1:I)>I*C1'?-)%Y6 20RF(DYQU%,T;XI6
M.J?$CQ/X/GMSIUSHJ6+)<7,R!;PW*S,HC4'.1Y+<'D^E>8_"+1-0;XY2>(8O
MAS?^"-%F\%V.E.EQ';1I!<PW,[&#$<A+!4D4*P!4A>#C&>8^-OP/N_'OC+XM
M12>$?[1U'Q)H.FVGA;Q \4;IIM]$+@&?S<[[<PR/!,2 "P0!=Q&V@#ZD^W6V
M&/VB+"-M8[QP?0^]4=8\4Z3X?O\ 2+'4+^&TN]7N&M+"&5P&N)5BDF95]2(X
MG;\/I7B#?#*>R_: O-)TV*SE\%>(&M_%VN0A0&BU*T*Q(2H&!]H=;67/'S6$
M_4R''2_'3P?>:YXR^$6NVWAQO$EMX>\23W5_#"D+2Q02Z7?6ZN!*R@@330$@
M'(P&Q\O !U?PO^*.G_$WP^-1AA.F7)OM2LO[.N9D:<?8[Z:SD?"DY4O 3D9
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MQ%#+.Q2))'"M(V,X4'J<>E?,'[,WPGU/X>>(/A?)-X5DT-[3X86NBZ[<+ J
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MX83^&/%WPQUB'PC?:9J,7B?Q=%J-\VFRQRIIMQ=7TMFDKE<B%M]LRJ3M!.<
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M4I\S<[/7K[X?P/\ M#)JGAWPO'I:GP/-;:=JS:(T4%K?&X!B!8Q@(X7)P<$
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MS>#+3QA\9_AP-9\.R^(/#$&FZU%J22:>]W:#S4MO+250K*V[RGPI!Y4<9VT
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ML?QW^(&O:-X,U/PKX>UGPYH*0F]TA]/5[F";4O/0HRJ=ZK/ "<8/4$C!(!]
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M:RN[*?PQK)T6Z%T$Q+)]EM[D/'L9LH4NH\9P<@Y KY9M/".K_P#",#Q%X>\
M^,=(N%GT2'Q;H%_!;V_VZUM[DO<16T,*J+J10SEY?^6T8$8,FXJOI?P.F7X?
MWWQ1NK7P3KUAHNN^.;:XTRVMM'> M!/IVG0&Y\EPK)$LL4Q<D J 21GB@#Z%
MKDOB'\4O#WPNCT"3Q#=FT36]6M]%M&"Y!N)B5CW'^%<X!8\ D>HKK:^?_BO\
M,KS]H.Y\=Z3=W-UH.D6FFMH=G+<Z1,TC2/LGDO+9\IN*RQVZJ5W$-;$CAQN
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M[J[LU:>%H7\RWN9+:4%& 88DA<<@<#-&N>/]'\.^+O#7AJ]EF35O$+7"6")
M[1N88C+)N<#:N%'0G)[#K7F'[&%FVF? BWL6@OK<V_B#7PJZC',DS1OK%Y)&
MY,H#/NC=&W'.<\G.:\'CUKQ3XSUWX4WJ1ZS#\6++_A)K75(+R.Z,&GZ@]E<K
M;[E8&)(3(4\IQ\IC(P2,T ?=5%?%VL^'?B,?#GA[5/A[HWB'3-0M_ LUOXJT
MR\$UI-?WRRV92-'DP)+PJ-1'VA&).Y29/F0UV'B&*SG/A7QKX3\,>,K'2O\
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M%.N^)=(T^29[WP]=QV6H)+ \825X8YU"E@-P,<J'<,CGK3= \>Z1XE\3^)=
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %-DD2&-I)&5$4%F9C@
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M_M"RZT-#\/+H6IVNG7QU(M]FU6*;^S[]?LTV;>YFA(:W4DADEY DCC&UB0"
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K+\3^'+/Q=X?OM&OVNDL
M[V,Q2M8W<MI, ?[DL3*Z'W5@:U** *.B:+9^'=*MM.T^'R+2W7:B%V=CSDLS
M,2S,222S$DDDDDDFKU%% ",NY2#G!&.#BH;*QM].MDM[6%+>!,[8XUP!DY)^
MI))/J34]% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+_%[_L&:!_Z#>U[!0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]NNKJ^GNGE$6_P M1YKML5?,?"K@#=TZ5TE%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!%=2O!;321PO<2(A98D(#
M.0.%&X@9/3D@>XKGO^$FUC_H4]4_[^V?_P D5N:H+LZ9=BP>..^\E_L[S1&5
M%DVG:60.FX9QD;ESTW#K7GOD_%C_ *"_AS_PFI/_ ):4 >F4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 (<X." >Q-1;9_P#GI'_W[/\ \54U% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
4@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>ex1011amendmentno1011.jpg
<TEXT>
begin 644 ex1011amendmentno1011.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 0  Q<# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#G/&6ISZ8VA"%F7[1JD-O)M
M8C*MNR#^5='7(?$2-91X;1U#HVLVX96&01\W!KHO[$T[_GPM?^_*_P"% %VB
MF1YP<G)R?YT^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $SBEI" <
M9&<=*6@ HHHH **** "BBB@ HHHH **** "BBB@#D/B+$LP\-HZAT;6;<,K#
M((PW!KH?[#TW_H'VO_?E?\*YSXD1+./#4;HLD;:S;JZ.,A@0P((_&M__ (1K
M1_\ H%6/_@.G^% &B#FEIJ# /7J>OUIU !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT_\ \!8_\*P_B3&DZ^&HI8EFBDUJW1T8;@00X(([BMS_ (1+0_\ H#:?_P"
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M +5_C_PA96$%UX#USP4MQXPTN#:ML=5FNF2"1PI!2XFMA.6889EBA8G(0U]
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MJO8R"6)B&#XDD&5]G88_#&*L4"6@4444#"BBB@ HHHH **** "BBB@ HHHH
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MY65X;N4N["=T.0+RZCS[K<2*?U!K5H)M8****!A1110 4444 %%%% !1110
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M1110 444G2@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#J[!8D98X2^U458TWE<G.09![?\ #?P4_@KPXMO=W1U'5[F5KS4;YNMQ</\
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M'<5TO_"*:)_T!]/_ / 5/\*Y?XL1"=O!T3*'CD\06R.C*"&4I)D$'L173_\
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MYK<KE?AM)!)X?O3;2/+'_;.J@L_4.+^X#CZ!@0/I754AA1110 4444 %%%%
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M37=,\>:+XBUBY\$0>"?$7B.^\*M;V<):ZTV2QC-M(SPF:&16NITD4R#$D:]
M&#>A:=X:^*<FCZ'KEUXR*>(;J;39-5\-I:VATBUB,T)O8K:00_:"1$)@KR2O
MD]EW#92U']E;PQJ/Q6\0^+WDF&G^)O#M_H6N>'P66UNWNC:B6[7:RF*5XK58
MY"OWPL1RK(2^MX0^'/C_ ,,QZ;HDOCZSNO">F>3#;@:+)_;$L$)78D][)=R1
MR,RH%D<6ZLX9ROEL0R@'JM(<XXZUC^%]/U?3;*ZCUG55U>XDO;F:&9+46_E6
M[S.\,)4,VXQQLD>_C?LW$ DBMF@!*6BB@ HHHH **** "BBB@ HHHH ****
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M6Y'0@]Z\O\=?%JROK[5--AU8:+X=TN=;/5==C),LER03]AM-O+3=-S*&*#(
M#8*\UX%\3QR>*KF73/"^I7EQI<+6]CH%K&@>Q5PA>:]N)G""YD 7Y-[.J<-\
MQ8#UH9;4=*52III?I\KM[;_);M-I/%U-;(^BJ*Y;0-7\4ZD\+ZAX<LM(@8GS
M5?5#+/&.<?*L.PYX_CXS[<]1VKRI1<'9V^33_(UO<6BO$/$%]X?\->+M:;X@
M3WUO'/<^?I.IW-U*EFR>66$$10A(Y4\M^#\[?>!.<#TKX=WUYJ'@;P_=:@7:
M]GL89)3)][<R _-_M>OOFNRMA72I*K>Z=NFCNKZ/K;KM9D*=WRG2T4T/D]"/
MK2DXK@NF:"T5Q/BCXA77@S6E&IZ#>2^'G48U?3@;GR6YW":%5W(HQPZ[@?8D
M5U]I=1W=O'-'(DL4BATDC.592,@@_2M94YPBIR6CV?\ 77RW$G?0GHI-PI!(
M#65T,=1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** .*^)D23MX4BD19(GUR!7
M1QD,I23(([BN@_X131/^@/I__@*G^%<_\38DG?PG%*BR12:Y CHXR&!CER".
MXKH/^$3T3_H#:?\ ^ J?X4 7+'?Y3^80Q\V3&U<<;SCN>V.>_7CH+-5K#/DO
MN;>?-DYQC^-L#\*LT %%%% !1110 4444 %%%% !1110!YS^T=IE[KWP"^(N
MC:997&HZKJ_A^_TRRM+:(R/+<3V[Q1+P,*"[J"S8502S$*"1XE\.?V?;KPWJ
M?P.FATC7)+K2]'DTSQ4?$%\VI6$$+::L<EM"EW)(T+/<"#!LPD3)'(LA8"-:
M^A?BI\1(_A3X'U3Q5<Z)J>N:=I<$MW?1Z28/-@MXXVDDF(FEC#!50_*I+DD8
M4\XYKQ;\7-"UCP%H.I:;X7O_ (E>%?%L:VZC2A9M"\<P"JDT=W/#E7W%2N#C
M#!PO0@'FWPD^'EWX:M_'7AC5=';Q'X$\"?;M$\/Z/;;I'U.TNHHKPV\D$[;)
M&AAEBLXY6D^<&XWXWG/T'X.CL[?PGHZV.COX<LQ:0^5I,T21/9KL 6%D0E5*
M#"X4D#'!(J3PSX9T3P7H=KHWA_2K'0M(M@P@T_3K=+>"+<Q9ML: *,LS$X')
M)/>K.HV%OJ]L89GE"<G,$[Q-RI'WD8'H3W]#U H YGQ7X]M-)OQINEVYUWQ&
MV-NGVC*7B7(^>4_\LTY'+>H^M8<7PMN/&-Y;ZAX[N4U/RCNATB E;2,^K="_
MIM/&"0QD !'<Z;X:TS15D%G;+;>8_F2%&;,CY)+,<Y9B2<D\G/.:NQV\&YRI
M+$XR/,)Q^&>*ZXXCV2M15GU?7Y=EZ:^9#BF]26.-(T4( J@8 '0421)+C>H;
M!R,C.#ZUF^(/$.E^%M.>^U2ZBL[9.-TAY8]E51RS'H%4$D\ $UYQXC^//_"*
MO8WVJ^$M0TGPW=7D-BFJ:I<06TC/))L#+;EC(%49=MX1@BL=O%11P]6M_#7Z
M7\E?=^2U&Y)'K8 %>7_$#X>^+-5\17NO>&O$>GV&H&Q6TLH]0L#*;4Y)D\N3
M<5C\SY=S&)S\B]0 *FD^-&DKJ%@#X>UL:??7L&G6^KS6:PP22S,%C"K(RRL"
M>=RQE0 3G S7H4NGVMP#YEO$^1@Y4<U<?;8.2E:U^Z37FK._S^X32FK'DVC>
M"?B)X>ET][:^T9X=[37\4MU.TUS*1M\R6=HR9<*JX55A';@ 53L_"WQ.^*.G
M%/%FM-X'TF02*^F: BQ7LJ?P;KCS)!'[[.<$CWKM?'D]AIB:9I-EIEE<ZSJT
MXM[6!HE^6,8,\QX.%CCR<D8+%%ZL,Z7AWP/IECH.G6][IEE<7D5K%%/*\"N9
M'" ,22"3DCJ:ZI8NJH>T<8\SV=M;:ZKYZ7WTTV(4%>W0\ST'X5ZG\'/$OB"_
M\#>&-+NM)N;.".*VFUB>*:1X_,=F?=#+O=FD(!+@8 Z'-<]J?Q:^*MSI!N(K
M"UTR]EN4C@L+?P]J,PBC)7<UQ<S)$J8R>$C?/&W->_MX4T5ASI%CC&,?9T_P
MKB6ETJ[^*B^%]/TG3UBL=-&H:BZV2-@R2%((]P^Z3LE;&#D <BMJ.,=63J5J
M:G)*[;[+O>^^FR6HG3LK1=C%\;?%C7I]8MO#V@Z7?Z1++"+B;6[S2YIXPF<%
M;:%4WR29#?ZQ44  \[A5OQCK'Q1U?PK>#PMHMGHUT+&4K/K-PKWKR^6VT10Q
M%H@Q8+AGEP,\J<8/;:]'X6\/V376KPZ99VH(3S+F-%4GLHR.3SP!R:JZ+IOA
MOQ()V3PRD,=NX16OM,\D2# (9 Z@D<8Z#I^?,JT8QC*%%6CU>MW^'W:I=BK7
M>YYA\$OACH7A>RT2>Q\/:WJ>L65L(QJGB>%K461909$AB<?(2>IB0[OXI#U.
MCX)L?B#\.9-2T"V\(:?K=K+J-U?IK[ZPMLMSY\[RYEC\IG5U#A3@$?+QQBNT
M\36GA+1!;VK^&K'4=1N=S6FF6UE$TTY7&X@$ *HR,NQ"C< 3R,XJ^ IO$-Q:
M/J?@3P;;6*/E[:YB%W-C'&#Y(53G']X<GFMYXJKB.:I62:E_,WTOMJGU>VG=
M7)4$K)=.QNFX\=1:<EU(NC278#L^GVL4C@X!(43O(F,XQN\L\L.  :BFE^(F
MH3JL/_"-:+ 5^9W>?4'4^P @'ZU9N_@]X!O)XY[GP3X=GGB552672H&=0OW0
M"4R,<8]*FA^&?@ED7RO">@E#R"FG0XZ ?W?8?D/2O.5;EUY%]WZ;/YIFENES
MR37? WCCQCJ=W;:CIX\21VEQN@G\63QVNDY#_>CL+4.UP% R/M+J<XQW-=#X
M&_9X'AG3$MM1\8Z]?1+.\XL=*O)-+L8MQ)"110N'5!Q\ID89R>YKIIO@U\+X
M+B""3P+X22:4R-%&VDVP9R1ARHV<\'G'8\U./@9\-UQCX?\ A88.1C1K;@^O
MW*Z9YA7E#V<7RKR5O^&Z[6)5./74\FT3X'>*[;XFIXET,6/@;3K!YH(K>XNK
MC49M25L#S;C]\ R\!E7<"#G=GOV]Q\/?BE?7HDE^+45K;%R7MM/\,VZ?*?X5
M:220CZG-=%-\"_AO<RR2R_#_ ,+2RR AY'T:V+-D8.24R<BJP_9Y^%8Z?#3P
M?Z_\@&U_^-U=7,J]5IRY=%;6*?XR3?XA[.)C7GP5U_4QB[^*_B\#TM/LEM_Z
M! ,5F+^S,8V!/Q5^)17^[_;X4<GVBKK#^SQ\*FZ_#/P?_P""&U_^-U-I_P !
M?AGI-]:WME\//"MI>VLBRP7,&BVR21.IRK*P3(8'D$<@UC]=Q"5E)+T45^@>
MSAV.7M/V9M*;?'K'C'QQXFLI!B6RU?Q#,T+CW6/9FNETWX$?#O1K."UMO"&D
MQI'Q$\EN'E7C'RR-EP<=\YKOJ*F6,Q,M'4=O6WY%*$5LB.W@2V@CA3=LC4(N
M]BQP!@9)Y)]SS4E%%<984444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 </\4(%N9/",
M4BJ\3Z[ KHZAE8&.4$$'MBNC_P"$3T3_ * VG_\ @*G^%<W\4H!<GPC$P1HW
MU^W61)$W!U*2Y4CW'%='_P (EH?_ $!M/_\  6/_  HZ 7-/<R0N3VED'7/1
MV%6JHZ. +67!R/M$_08_Y:M5Z@ HHHH **** "BBB@ HHHH **** /,_VFH[
MBZ_9V^)ME965YJ5_>^&M1M+6RT^TDNIYYI;9XXT2.-69B6=1P..2< $CSN?X
M>>(O"_Q(TC5/"1>^^&OBS6(=5U+1KBUEAN-#OLF8WD*LH80W!7;-"ZJ4E990
M0'F%>[^+/%-EX.TA=1OUE>%KJVLT2!-SO+/.D$2@<#F21!DD #)) !-<IX;^
M-F@^*=8OM.TZRU%O[/UF7P_>7#0((;:]CA,K1N=^0-NT!\%"TB*&).* /DW5
MT\1G3_'-_I_@OQ9I&M^(O#/CB&6U@T*],[ZF9;66PBN+F--MPP4W(MYQB(1N
M(8W<JQ>7X@>%+.30/BG#IGAGQB]['\/-%NM"2/0=59CKJ_:L3IF+#7JE]-#2
M']X@#JQ41S!?L#1OB39:EX?TB]FT_4-+U+5-'?7(- O[<0:@D*+$9(Y(RV$E
M0W$*.I;AVQG'-7_AWXRLOB1X!\->+M/@FM['7M-MM5MHKE%65(YXED0.%+ ,
M%< X)&<X)H ^44\"Z_X@_:5N]=U6'Q^^LIKMCJFA7MAI]O:Z4^BO%"DD$EW-
M:F>W5%6436#3)YL@,B1AI2R_1WP_U#P[X8\":I?V6EWOAC1K?4-2N)H-5CDC
MD$AO)WGE"N2WERRM)+'V995*@ J!Z#M&.@JO?6EM=V_EW4,<T *N4E4,N5(9
M3@]P0"#V(IJUUS; <+X)\.WNOZRWC7Q)9^1J4RF/2]/FY.F6I[$9P)I/O.PY
M VIT4YGMOA[_ &IXBB\2^+!;:KJ-F6.FVD<6^WTT'&6BR,M*V!F0@'H%"C.5
ML?C%H=Z]]Y5OJCV5FP4WT>GR20.N,[U9 2%P0<L!E2&&5^:NZ!W"NVM4KTYM
MR7*VK+R79=O/J^N[(44SQ0VWC+QCXDL/$=MH,=J8YWATYM8Q'_9UJ0/,F,1^
M?SI0-HR,J 0=H))N:_H?BFY\2O#J"^*=4L-L9@N-"O[2QM]Q_P!8K*9DD"YZ
M9\Q@.0^3@=3XJ^,'AGP;)<K?W<KK9E1?26=M)<)8@XP9VC!$0Y!^;'!STYKM
M%8,F[J/:NB6*JT^6?LE%6LM'Y;/?3];O5W)Y4]+GSY_9/CNRTCQ9XJU&UO=.
MN4MC9Z3I^GR?VAJ9@3"Q1!V$@7>P#R/\[L3DE=BYB\%_$?X@>/?#-C;1&XTS
M4[>VC@N1;Z<S75Q<JNV1WGG1;:W&\$F/;*^#P >*]DM?B3X9U#Q.OAZVUBWN
MM6;S!]GARX!CP74L,J&7(RI.1GI73 "M)XQI6JT%?1KI9;;.]UZOYDJ*?PL\
M?AU'XJZCKT/VC1Y=,MK5BAB@N+/[+>X;_6/,QDEC5@/N)#D!\;LC-<[\-?%L
M_ACX3^*_BQK5O]JU+7[MKX0(IA5(%<6]K&2Q.$"@.7/02,2.*^@CR#7#77C;
MP7X!:W\/0206CJ&$6DZ39/,R#.YOW,",5^]GH.OO2AB76C[*%!/:ZBG=Q3;:
M;U>KL[]+>@.*B[MG%V/Q#\#^#[&3Q#KGBC3?$_B8P>;<76G.MR+>,C<(XL$B
M"'D ,Y4,2"S9:O5?"FKWVN:7]MOM)DT4R.3#;3R!IO+P-K2 #",>?ERV.,G.
M0(_"%YH>J:'#=Z D*Z=*[@"&#R<.K%'#(0"K*RE2" 05((R*W ,5Q8BI&;:Y
M6I)]7MY))*WXEQBUZ'C7A#5H;K7O$5Q)K%AIWB;^U+BVU"/4!BYMK&*1UM%B
M1B-J,FR4,058R.><\;,OQ56Q\.Z>UO-!KVH:AJ::9IDUNIC@U)B [.C L BH
M) 7R5S&Q'4+7=:MX9TG76A;4=-M+YX3F)KFW20QGU7<#@_2KLEG#,T+/$CM"
MV^(LH)1L%<CT.&8<=B?6KEB*4FG*%_+3[KVO;R[:;ZB4&MF>+?$'PK\0M:GT
MR*_U+5[W1[GS/M^G^#7MK)HS@>7&9KB19"AR^YU8$[5 1<FN?TGX0:_X9U*X
MLO#?AD^%-!ODBGNS8Z])YUP8RX6*6;+O%QMX@0Y!(\P#BOH^BNB&9U80]FHJ
MWI9>MDTKKH[7)=*+=V>*V^I_%:6#1=8O/"NCZQFZ</81L+2]MH#&<2;WF9%)
M8+N0%R0V.#D#(C\3?$/P?X^LI]5T._GL-8FF5+2&_%YOD89B@4!0D&S!/F$A
M3&DF<L 3] 4A4&HCCDK\U&+3375?K;3TN/V7FS@HS\2]2E6;;X;T" JI^S2"
M?4)0<#(+AH5'X!NG7GCL])6^33+5=3>"74!$HN'M49(FDQ\Q16)(7.< DG'>
MKE%<%2ISV7*EZ+]=_O9HE8****R*"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** .(^)\4<[>$HI462*378%9' (8&.7((/4>U=#_P (EH?_ $!M/_\
M 6/_  KFOBI%'<2>#HIE62-_$$"LCKD,#%+D$=ZZ7_A$]#_Z VG_ /@*G^%
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MTF71S()FT^2RC:!I,??9",%O<C-;#:)I[:;'IYL;<V$:JB6IB7RE5<;0%Q@
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MD!!Z'-+28Q0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <
M'\5H4N)/!L<J+)$_B"W5T8 A@8Y000>HYKI_^$3T3_H#:?\ ^ J?X5RWQ:C2
M=_!D,B+)%+XBMD='&0R^7+D$=\UU/_")Z)_T!M/_ / 5/\* )=#(:RE(((^U
M7 X_Z[/6A6;H$BRV4S*"/]+N5Y]1.X_I6E0 R6,R* ':/!!RN.?;D&G#@4M%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%% !1110 4444 %%%% !131N+ XP.>*=0 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $.>/UI:** "BBB@
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M_75JNT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%(,Y.?PH 6BBB@
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M8]A@9[XS5R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **:[%5)"EB.PZFG4 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% '%?$V*.X?PI%*BR1/KD"L
MC#(8%) 01W%=!_PB>B?] ;3_ /P%3_"N>^)MNET?"L<F&1M<@#(RAE<;),J0
M>H(S71?\(KHO_0'L/_ 9/\* +=AM\E]HP/-D_/><U9JGI<BRV\I7H)Y1^(D8
M']15R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0YR, 8[\TM%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!Q?Q*ACN&\+0S(LL<FMP*R.N58;),@
M@]L9K>_X1'0O^@+IW_@+'_A6#\2HDG;PM%*B21/K<".C@$,"D@(P>M;_ /PB
M>B?] ;3_ /P%3_"@"QI1!MI,+M_?S?\ HQJNU4TQE:"3;P!-*.N>?,;-6"'\
MU2&41X.5*\D\8(.>._;N.F.0!]%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *3I2T4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 <A\1(DG;PS%(JO&^LPJR.H(8%),@
M@UN?\(OHW_0)L?\ P&3_  K!^(T*7#^&(Y$62)]9A5T< AE*2 @@]?I6Y_PB
MFB?] ?3_ /P%3_"@"_:C$;?[[_\ H1J:H;8 (V/[[?\ H1J:@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ***1<XYQGVH 6BBB@ HHHH 3;\V>^
M,4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%(#GMBEH **** "BBB@ HH
MHH **** "BBB@ HHHH **** .0^(D,=S_P (W%+&LL3ZQ"K(Z@JP*2 @@]16
MQ_PB&@_] 33O_ 2/_"L;XBPK<-X9C=%DB?685='&0RE),@CTK;_X171/^@/8
M?^ J?X4 7[;[C<Y^=O\ T(U-45L%"-M.1O;MC^(U+0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 (2!U.*6F/$DC(S(K,ARI(R5.,9'IP3^=
M/H **** "BBB@ HHHH **** "BBB@ I,<]?PI:* "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **:K!LX.<'!IU !1110!R'Q$BCG_X1N*5%DCD
MUB%&C< JP*OD$'J,9XK9_P"$3T/_ * VG_\ @*G^%8GQ'CCF;PO%-&LL<FM0
MHR.,@@I)D$'J*W/^$3T3_H#:?_X"I_A0!>M3E'Z???I_O&IZS]%ABAM9!#$D
M2&YN&*H, L97+'ZDDD^Y-:% !12%0Q!/4'(I: "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ I,?,3D\C&.U+10 4444 %(.12T4
M%(K!E!'0C-+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %-1!&N 2>2?F))Y.>].HH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@!*6BB@ HHHH X[XCP17+>&(YD62)M9A#(X!# I(""#U&#
M6Y_PB>B?] ;3_P#P%3_"N;^*-I;WC>$H[F!+B(Z[;YCD4,I^60<@UTG_  B>
MB?\ 0&T__P !4_PH M:8 +=\  >=+T&/^6C5;JIIG_'N_!'[Z7K_ -=&JW0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 )G-+110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 <7\2X$N3X6BD19(GUN!71UW!EV29!%;_\ PB>B?] ;
M3_\ P%3_  K ^)<:3'PM%+&LL<FMP(R,,J04DR"/3%;_ /PB>B?] ;3_ /P%
M3_"@"QI!)MI"6W_Z1-SZ?O6XJ[573V5H7VE2!+(,KTSO;/ZU8WJ'"9&XC(&>
M<4 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M / 5/\*Y_P")B1RMX4BEC26.76X$97&004DSQWSTY[$UT'_")Z)_T!M/_P#
M5/\ "@"71&5[.4KDC[3< Y7'(F<'_P#7WK0K&\*P/;Z;<*\C2DWUXX+L6(#7
M,I R>P!  [ 8[5LT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !3)(4E9&90Q1MRGT.",C\"1^-/HH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** .%^*ENETWA"*5!+$^OVZLC#*D;),@CN.V/>NE_X1
M/1/^@-I__@*G^%<]\38HYW\)Q2HLD3ZY K(XR"#'+D$=P>E=#_PB>B?] ;3_
M /P%3_"@"]:',;?[[_\ H1J>J]F"(WR<_O'[_P"T:L4 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M<5\3(XYG\)Q2HLL<FN0(R. 58&.7((/45T'_  B>B?\ 0&T__P !4_PK ^)4
M$=R_A6.5%EB;6X59&&0P*2 @@]1STK?_ .$3T3_H#:?_ . J?X4 7;--D3#_
M *:.>N>KDU8J.!=JL,8^9C^IJ2@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#C?B1 ERWA:*2-
M98GUJ%71P"K*8Y000>HK<_X1'0O^@+IW_@+'_A6)\1HHKAO#$4R"2-]9A5D8
M JP*2 @@]1BMS_A$]$_Z VG_ /@*G^% &H#FEIJ9YR<\FG4 %%%% !1110 4
M444 %%)THH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***:%(8DMD
M'MV% #J*** "BBB@#D/B)#%<'PU',B21OK$*E'&0P*2 @COQGBMK_A$]$_Z
MVG_^ J?X5A_$:%+A_"\4L:RQ/K,*NKC*D&.3(([@UN?\(GHG_0&T_P#\!4_P
MH TUQ@X]:=34[_6G4 %%%% !1110 4444 )UH"A1@  >U+10 4444 %%(1D@
MYZ=J6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@! <TM%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !13'#E
MH]C*J@_.&7)(P>!SP<XYYZ'UR'T %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** .,^)ENEY%X<MI/N3ZO%$3M5L QR \,"#]""/44__ (5AI?\ ?'_@OLO_
M (Q57XLZ>=5L=!LEN9;)KG54A%S D;O$6BE&]5D5T)&<@.K+QRI&17/_ /"A
M+S_HI7B;_P %6@?_ "LH ]5@)*MGGYV_G4M16WW&_P!]O_0C4M !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%-=0
MZE22 1C@X/YT .HI , #T]:6@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** .&^*]E_:5IX>L_/>U-QJ\</G1*C-'NBE
M&X!U9"1G.&5EXY!'%9G_  I-_P#H==:_\%FC?_(%;/Q)@2Y?PM%+&LL3ZU"K
MHX!# QR @@]16Y_PB.A?] ;3_P#P%C_PI :-JI5'!S]]CS_O&I:1!@'ZDTZF
M BL& (.0:6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBDQSGG\Z %HHHH **** "BBB@ HHHH **** "B
MBB@ IKKO4KDC(QD=13J* $ P*6BB@ HHHH **** "BBB@#C/B5;K=-X6AD4/
M&^M0JZ, 0P,<@(((((Q6Q_PA>B_] RR_\!(?_B*Q_B7;I=_\(Q#( T<FLPHP
M8 @@QR@@@\'KT/%:7_"":/\ \^5K_P" <'_QND!OIT/U-.ID6,'#;OF/\Z?3
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "D.:6B@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH XWXDP)=?\(Q#(@DBDUF%75@""#'(""#P>O>M7_A"=
M$_Z!EE_X!P__ !%9/Q*A2Y_X1B&50\4NLPHZL 0P,<F00>#^-:O_  A&B?\
M0-LO_ .'_P"(I :]HX>-R/\ GHX_)B*GJO9L6B8D%3YCC!_WSS5BF 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 44A&X8-+0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% '%?$R".Y_X1>&5!)')K4*,K $$&.0$$'@_0UK_ /"#Z)_T
M#++_ , X?_B*QOBE:B^A\-6S$JLVLQ1L0JM@&.4$X8%3]""/4&G_ /"K-/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0$D#
M(P: %HHHH **** "BBB@ HHHH *3'-+10!QGQ)1)F\+12JKPRZW CHP!# I)
MP0>H-;O_  B6A_\ 0&T__P !8_\ "L+XE01W+>%HI562)];A5XW&58>7)D$=
MQ6[_ ,(CH7_0%T[_ ,!8_P#"@#4C7:#D <D\?6G4BXP<'/-+0 4444 %%%%
M!1110 4444 %%%% !326WC &W!R??_.:=10 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!QWQ'@CN3X8BE19(GUJ%71QD,"D@(([@]/QK;_P"$
M1T+_ * NG?\ @+'_ (5B_$:".Y;PQ%,BR1/K,*LC %6!23((/48K:_X1'0O^
M@+IW_@+'_A0!IQJ%!QZG^=/I ,4M !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4C-M&>?P&:6B@ HHHH XWXD0Q
MW#^%HI466)]:A5D<95@8Y,@CN*W/^$1T+_H"Z=_X"Q_X5B?$:WCNF\,12HLD
M3:S"&1URK QR @CN.:V_^$1T+_H"Z=_X"Q_X4 :U%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%-+@.%YR1GH<?G3J "BBB@ HHHH **** "BBB@ HHHH
M**** "BD4DYR,<TM !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCW,22%QDC)H EB^!]W:GPQ>VGBZ[LM<T2/4;07T-I$R3VU[,DLJ&*3> RO#
MR/GY3$,AE9D/0>*OAS+XCU[P1J,>J_9E\+WIOHHIH6F:X<V\MLP=RX/^JN)<
M'D[]C$D JWG]E\5O%%E\1O$7A>:\L+NYOO%[Z1I#7-N8XK*W30[?4"F%;,SD
MLPP6!R\C@[$$0B\6_%[5?%OP2^''B'3[2[\-IXRU31K347CE+2:;;W4J>8@E
M4*1YC$6RS+M(-PDBE2 0 =?XQ^#I\1>-[7Q7'J1-W8>2]G:3PAA$4+%XXY.L
M22YC+[1DM#"6+*FP^)_!;X&>.[6.WM;VQ/@UM*AM9K37+VP@-^;R%/+C2-(]
M2NX?L1CFOD:V1+5(A<GR$4NS)Z/K.EWGP4U29_!VIW?B/4=>FTS2TT3Q=XIO
MKJ&R.ZZ)NHVF,\@,BY#*-BM]FR#N!SC6G[3?B6XOM7FF\ W$'AR+6)?#MIJ[
MWML(GOUUJ/28P LS3-&TDC2.[11&,1843;U:@#TWQ+\,'\2^"(-!FUZYFO(=
M5L=7_M*[C$K-/;:A%?(I0%1LWQ! H(VH0!T%9'@GX&CPCXKMM0DUD:CI.EW&
MI76CV+VFR:VEOYVGNFEFWD2@,[+$%2/9&Q#^:VUU\X\,^(-;TF>3[7<W%[JL
M/B'7C;7,NJ7SV\7EVS^7YEL95$L6!N$3NXBX$>2 Z^HQ>/\ 4/#WP*TSQ+?,
M-8UV72[4Q!K>11=WDZHL*NMO'(R!I)$#-&C!06;;@8  ZU^%.I>'M>\07/AG
MQ,=%TWQ'>2ZAJEL]@MQ-%<O;I#YME(6"0MF-)&$L<ZL^3M7<V>4\2_LP0^*=
M$USP_>>(/^*>NWU>>PMTL%%S93ZI]H%[*9M^)#MO+I8AL4()3O$Q52,_X7?%
MW5K3X;7]AJ%W=:IKVA>)1X=GU77+22"3[//(DEG=W$)6-\_9KFVWC:@,H?E$
M!<0WG[27C2TTNZU6?P%IVF6>D^$[;Q3J]GJ.L3PWL)N$O!%;+&]HJI^]M%#R
M3-'Y:EBR @@ &QXK_9SOO%</B!;C7]):77=8AUJXFFT-WDL[E+&"R\^Q<7*O
M;7");(T4P9FC9G/SY7;8D_9XOAX5\:>&(/&=P/#WB%K^2*TFT^-FLWOI))+O
M]XI5I%+2RM&IQL,C9\P"-4YG4?VE?'MG-;Z+!\)]0N?%LT>HW$6E'5-,5GBM
M%L6W38O62W$AOU'$DSH$W>4ZL*VU^/7B6X\6PZ/!X<TO9>>))?#EK+)J3Y4K
MHXU-9I-L94C:LD95">2A#$9- [7.FL_@Y=6?BZ;Q$GB +?3Z_+K,P6Q&UHGL
MX[06XW.<'9;PY?N?,PJ[EV9WBS]GT>)_B"GBLZZJW,-\;RW6ZL1,\"-IEQ8/
M;)('5A ?/,XC[2M*QSO&SD_ 7[47B+XF:KITFA?#Z<Z$\5D-1O[S4K.&*RDN
MM+M[^(;FF$KD-=00%5@P=[.'RGEO<TGXV>*O$_\ PC-@\&G:%J.I/HVH/-:J
M]Y$;6\M[J7R1NV$.'LW5GQC8XQAN5!&S9_LY+8:IHFJ0^(I!J>AG33I\K689
M +6TN;0B52^9/,BO+C.&7:2A'*G=O7_P:2_^!]Q\-)-;N6LKG2WTB;4GA3SV
MA="C$ 84/M/!P1QR#7)_M ^,;_4=%\6^&=)>XTZ[TG1K/6;F]BO9K1]DUQ,L
M2120L&W V<K/D[2NU"&$I*<[XY_:%\2 >*]%T9+2PN!H^NW6FZU!']ICM9--
MO(+61<NP6>1A<*Y^4)#(IB;SV20 'N>AW7P.+IK$=AXDN]"@U6^L]9F@TF%(
MHX-2AF6:2X@#;MB7#QIYT1W*X\P\/+([4-8_9[?7_$6G:[J'C'4M0U6Q:V:*
M>ZM;=_*\J\DN76)=@$2R;XD8*,L+.TWE_*._EO%/[3?B+PEJWB5W\&I>>'-!
MM[^"75IM4L[5)KZUL3=^7Y?VB2XC\P))A# 2L02?<Z,=O5?!;5+_ $[5?B_%
MKVKM=C2_$X/GW,\H@MXVT?3;APGFR2>5&'FD;:&VKN;: . "-32_@_>Z4N@K
M'K\3KI&NWVO1*]@</)=_:?-1L2YVC[9<;2.1^[SNVMOQ-(_9IM-(\":CX537
M9WL[WP99^"'F-LOF"TMH[B..4<X\TK=2[CC:2$(4 $-A6G[1/B:]\#7FLC0(
M(Y+6XMFN9X;6YN4M+2;3$O!*ULH%RX262.W;$8<9,IB5591Z3XM^(%[8^)O#
MWAO0X+*;5=9LK[4(9]0E9+8Q6I@#("H)9Y#<Q[<# 02R?-Y81P#$7X%M_P )
M-+KC:[_I<OB!/$<@2TPOVC^R?[+=1^\)"& !@#DK)DY9?EJAX:_9OB\-SZ!<
MQ^)+J6[TB\BOTD-I$HEG%K=6TTC8Y9Y1>W$S.Q9C/([L64[!A_"CQC??&GXE
M1>();R^L?#EUX+\.>)M.T>.XF@-O)>?VD&$ACE"RY51N5E*DI$=H:,$\YX9U
M;4_"D,GAWQ+K&N7_ (!U[Q)<:=H^LOJ]W]OTN[BU>2!;&>[#B<PS")3%(\A^
M=I(&;#P(0#T";]FRPNK/6K2;6)7MO$6DS:%K\8AV_;[.2>ZG"J=^8G1KVZ56
M7/RS,&#$(R=)X?\ A/\ \(_K5E?IJ[SK;ZCJ.H&-X "YNWWNFX-P%8G'!R,9
MZ9/'V?QI\6:])&NAZ)I]P-4O==TK3!<R./(O-,N)H0MRRY_=7'V:4^8JCR28
MU*S%LCG;+]I[Q'XHTO0Y_"7A9_$$WB. SZ,S+;VL3"*VMGN%G:2\^203W#Q&
M)=TD?V2Z.V7RL. >@W_P*@F\:7?B>TUJ>WU!_$"^)[>*6!9(8KS^R1I3!@"K
M-&;8<*&5@[,=Q!"CK_A_X*TWX=>%++P_I>6MK8R2/(RJ'FFDD:6:9PH"AI)7
MD=L #<QP .*\GT_X_>(=>\4V.GZ?INC"QU7Q$/#UC="Z:Y"%] 75TN6:/Y)4
M"J\>Q& ;>K"0!3OY'P3\:];FU'3/'%CIAFT+Q7:>$[S4M+O=7N+B33SJK&%?
MLH93&BQO+$S !5<!SA&&7 /JFBOG3P5^T/XU\>>$_"VL6/A72[!/%CV+:4VI
M:@H\N*X@N)G9D@:8R+$L4>&)B,K.ZE(-FYNK_:(\)?V_X%:]?6=?TC7!"=,T
MQ=$UN^L8!J%Y)%!;23"UEB:1$F:/ECA5:0X] #V"BLN#3%M- &DVM[=6Y@M1
M;1W3SFYN(L+M5S)-O,CC .Z3<6(RV<G/SEH7]H^'_$^CVNB>)/$=[\/?$WBF
MUMH)=;U2YNYDBM]/NIY+FUN9I&G^RW%S;6<($C%) 96C#1W*,P!]09Q2U\V>
M&_$6M747P7:XU75&4>/->T(N]U,/MVG6UKKB6IGRW^D%DL[67S'W%F&\'YJE
M^&OQ,\3:E\5Y;KQ#I;-HWB+7=8T#1+BVUB:3[$--FGBV2V7E+'&LHLYYOM&^
M1RTR1L0GEA0#Z.HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** .0^(D,=PWAJ*5%EC?6(59'&58%) 01W'
M-;'_  B.A?\ 0%T[_P !(_\ "L?XAP1W+>&HI422)]8A5TD&0RE),@CN#Z5L
M?\(AH/\ T!-._P# 2/\ PH UZ*** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K#D\$Z#/HMOI$NDV<VEV\
MZW45G) IB659/-1PN,;EDPX.,A@&&" :W** .7G^&'A.ZMYH)O#VF3Q317L$
MB2V<3JT=Y()+M"&4@K,X#R*>)&&7#'FH[_X2^"M4U/4M1O/"6AW5_J=HUA?7
M4VFPO+=6S(B-#*Q7+QE8T4HQ*D*H(( QUE% '+:S\+O"/B+S_P"U/#>E:CY]
MT+^;[58Q2^9=" 6XG;<IS((1Y6\\[/ESMXJ/3/A+X+T6Q@LM/\*Z-8V< M5B
MM[:PBCC06TSSVP"A<8BED>1/[CL67#$FNMHH Y&?X1^"KRZTZZN?"FBW5UIU
MY-J%E<3Z="\EK=2S">6>)BN4D>4+(SK@EP&)+<U*OPN\(K:S6P\-:0+:6"ZM
M7A%A"$,-R_F7,1&W&R5P'D7H[#+9-=310!CCP?HJ6^DP1Z79PPZ0 --2*W11
M8D1-"#  /W9$3O&"N,*[+T)%)<>#M"NYFFFT>QEF:\346E:V0N;I$6-)\XSY
MBHB*'ZA44 X K9HH Q]$\'Z'X;E632=)LM,*V<&G*+.W2(+:P;O(@&T#$<?F
M2;%Z+O; &33['PMH^F:OJ.JV6EV=GJFI-$U]?06Z)/=F-=D?FN!NDVI\HW$X
M' Q6K10!S<_PX\+7&KW&JOX=TO\ M2XNXK^:^%E&)Y;B*(Q12M)MW%UC8H&)
MR%)4'!(J]>^$]%U'PR_AVYTBQGT![86;:7);(UJ8 NT1&(C:4 P-N,8'2M:B
M@#G8_AUX6C\K'AS23Y5W'J$6;&+]W<HFQ)U^7B15^4/U X! K%UCP!\.-/U>
M[FU'PQX;CU7Q>_\ 9EU+/IUN)M8/EM(896*YG_=PNY5L_+$3CY:[NOG']H3P
M3XZ^*5QJMWX3N;;39/"T$=YI-IK&CW4QU#489H[J-HG6XCB5?,MH(@[1R.%:
MXX"2@N >PZ-\(O!/AN*%-(\):'I0AEFGC-EIL$1665!'-(-J##.@"LW5@,'(
MJ'4?#O@KX?\ A?3DDTC3]*T/2KN/[!!::>@CLKB>0Q*\*1I^[9FN&!=0.'8D
MX+&O+]8TC7-1\;KXMTRU\86%PU[HQ2PFU*\2UA1W,>HJUJ9#;$+;CKL*[QNC
M.]@QX#P'=^)-2DL+O4->\37^JWUKHM]86=M>:BR7EK!JD,^I:@VW%J'FANX%
M:U@>5$2)DA9XV( ![A\6/A3X4U+3M2UZ[MM#TRX,T5[J=_JNDPW=I>K!#+'$
M+]2%:2&$2LZG>GEE VX*&!N^$_#G@C2+N3P]YFDWVNZAILIEM)(;=9Y=-^T2
M8B$2J#]DC>X9$!!7#<L[,S-XQX_\)^/]?\*>-=.2/7KG7+JT\3VUW;NTK:?>
M65S]HCTF&!2?*$P067S(!L5+@RLK29?O?&'@?4OB-XH\ VL&G7^D:3HUI>MJ
M7B**X>PNPLMF]M]AMV4K,"SR1W!D&$4V<6"S8V ';/\  GX<2Z!9:$_@/PT^
MB6-PUW:Z:VCVQMK>8Y!DCBV;5;#$;@,X)&>36VO@#PTEY]K70-,%W]JDO1<"
MRB\P7$D/D23;MN?,:+]V7ZE?E)QQ7SCI?@_QEX@M/ $_B6Y\6%;36IM!U9M+
MU+4[0W>FV=C?V@OI4BD4[KF^,%PKJ2QB>W;<1&S"QX/TCX@2:Y\-7U=?%C6]
MAH.G6?B!)+RZVSW(M+Z&:0X959A,R!V(=Y&DMI0T:0;G /<Q\&O 0O;.\_X0
MOP\;RSL/[)MKDZ5!YD%EL9/LR-LRL.QW3RQA=K,,8)JKIG@WX>^+[+4(K;PU
MHU[9PSIIMS#+I480O9EDCC*L@W+%E@G55!.W@FO /!WP^\9Z5X*TF:_;QW-X
MCMM$\+WMP9M>U&56U6&XE34AL:8HRE"IDCP8Y00VUR,UTVNZ#XU%Q/9+:^-;
MCP]*WB.%VT741'J4%U)/ ^G2Q2W$RYC$7VH(&8PHSQAU 4;0#VSQE\+O!WQ#
M-NWBKPKHOB0VT;Q1'6-/AN_+1BI=1YBM@$HA('4J/05R&L_#KX06'C.&&_\
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M'_H":=_X"1_X4"LC7HHHH&%%%% !12$ C!Y%+0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% $5M=P7D9DMYHYXP[1EHV# ,
MK%67([A@01V((J6D"A<X &>N*6@ HHHH **** "BBB@ HHHH **** "BBB@
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MHH **** "BBB@ I&SM.T GMFEHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** .2^($27!\.12HLD3ZO$KHXRK I("".XK7_X1+0_^@-I_P#X
M"Q_X5D?$&&.X/AN*5%DB?5XE9'&0P*29!'<5K_\ ")Z'_P! ;3__  %3_"D!
MK4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** .3\?P1W1\.PRQK+$^K1*\;C*LI20$$=QS^M:G_
M  AN@?\ 0#TW_P !(_\ "F>*-"&NC34>-)HH;M998Y!E63:P((/4<]*7_A"?
4#O\ T -+_P# ./\ ^)IA=K8__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>nanoknifepicturea05.jpg
<TEXT>
begin 644 nanoknifepicturea05.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %* I0# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3,M>_5X>8YABI8BK3]HU&[5O+8]+"86C&E"7*KV3N%%%%> >H%%%% !1110
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M'/\ HH>C?]_3_A4D'[67P>N)5C3XAZ)N;@;I]H_,BOQ<YI*Z/]6L/_/+\/\
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M.O@AJ"3>&]9F2QWAI=+N&,EK+SSE"< G^\,'WK]4?V;_ -I7P_\ M%>%VO+
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MRNMCW>.D5U?Z=ST,5C:>%T>K['ZA^(/V@?AMX5E>+5?'&AV<J'#1M>H6!],
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MS7$5*E&2W;U>MFS>6(C@:4(U$]NFUS@/VQOCW<?'#XL7QMKB3_A&M(D>STV
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M!!K]7_V/OVM++X]>'UT?6I8[3QO8Q_OX<;5O$ _UT8_]"7L?:NS.,G^J_O\
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M\,-8\1FV\CQ1H-C+=6MY"HWRHBEC"_\ >4@''H3QWK4_83_Y-:\%_P"[<_\
MI3+7NFI:?!JNGW-E<H)+>XB:&1#T96!!'Y&O$G4>"QLI4=.63^Z^QZ48_6,,
ME4UNE^1^!5?<'PU_X)P6/Q&\ Z!XGMOB$\4.JV<=T(ETL-Y99<E<^;S@Y'X5
M\P_'OX37_P %?BEK?AB]3,4,QDLYNTUNQ)C8>^.#Z$$5]&?L3_MG67PKT]/
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M1_R0_6?^PS)_Z+CK[ KB_A7\(/"_P8T&?1_"=@^GZ?-.;AXWF>7+D $Y8D]
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MI^RPR:3W;W]#OP>6^QG[2KJUL%%%%?('OA1110 4444 %%%% !1110 4444
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MKI]-T&73[Z)M'GN9H'YDM)2=G/8XQG\16[:^"K.VN#<ZAY:R2'/V: 8S[8%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ2TMKK5K*+RFD>ZTV]M;4A"<7+/ 8\'L?E8Y[!37I\-B=J@\G'-*Y5B@MO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,P _W:U--\*V.G$-Y:RR#HSCI6U12L.[$I:**8@HHHH **** "BBB@ HHHH
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E** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>solerowhitea04.jpg
<TEXT>
begin 644 solerowhitea04.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_X0!P17AI9@  34T *@    @ !0,!  4
M   !    2@,"  (    6    4E$0  $    ! 0   %$1  0    !   >PE$2
M  0    !   >P@       8:@  "QCE!H;W1O<VAO<"!)0T,@<')O9FEL90#_
MX@Q824-#7U!23T9)3$4  0$   Q(3&EN;P(0  !M;G1R4D="(%A96B 'S@ "
M  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@               0  ]M8
M 0    #3+4A0("
M                 !%C<')T   !4    #-D97-C   !A    &QW='!T   !
M\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:   "+    !1B6%E:
M   "0    !1D;6YD   "5    '!D;61D   "Q    (AV=65D   #3    (9V
M:65W   #U    "1L=6UI   #^    !1M96%S   $#    "1T96-H   $,
M  QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $/   " QT97AT
M $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA<F0@0V]M<&%N>0
M9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$              !)S4D="
M($E%0S8Q.38V+3(N,0
M                        6%E:(        /-1  $    !%LQ865H@
M                 %A96B        !OH@  ./4   .06%E:(        &*9
M  "WA0  &-I865H@        )*    ^$  "VSV1E<V,         %DE%0R!H
M='1P.B\O=W=W+FEE8RYC:               %DE%0R!H='1P.B\O=W=W+FEE
M8RYC:
M      !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O
M;&]U<B!S<&%C92 M('-21T(              "Y)14,@-C$Y-C8M,BXQ($1E
M9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M        9&5S8P         L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N
M(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R96YC92!6:65W:6YG
M($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M         '9I97<      !.D_@ 47RX $,\4  /MS  $$PL  UR>     5A9
M6B       $P)5@!0    5Q_G;65A<P         !
M     H\    "<VEG(     !#4E0@8W5R=@        0     !0 *  \ %  9
M !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C &@ ;0!R '< ? "! (8
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC\?\2\OPN%Q%".&IQ@G%WY4E?7K9(****_?S\S"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'_TY ^LX%_Y'N']7_P"DR/D\C)HI#TI>HK^ 3^F#H_@]_P E:\+_ /87M/\
MT<E?H]7YP?!\?\7;\+?]A>T_]')7Z/U_6WT;_P#D7XW_ !Q_])9^)^*W^\X?
M_"_S04445_21^3A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !115?5
M=3AT72[B\N'\NWM(FFE8_P *J"2?R%3*2C%RD[)#C%MV6YX'^W3\=&\)Z!'X
M3TV;9?:M'OO74\Q6_0)]7.?^ @^M?(5;OQ,\<W7Q*\>:IKET6\S4)S(JD_ZM
M.B)_P%0!^%87>O\ /'Q"XNJ\19U5QK?[M/EIKM!/3YOXGYOLD?U'POD<,KR^
M&'2]]ZR?>3W^[9>2"C/-%>Q_LA?L^+\8/%<FI:I&6\/Z0X,JGI=R]1%].[>V
M!WR/ X?R'%YSF%/+<$KSJ.WDENV^R2U?^9Z6:9E0P&&GBL0[1BOO[)>;>B$^
M /['^L?%^VBU/4)&T?07Y25DW370_P"F:G^'_:/'H#7T[X%_9;\#^ 8D^SZ'
M;7EPO6XOA]HD8^OS?*/^ @5Z!#"EO"L<:K''& JJHPJ@= !3J_N7A#PJR+(J
M,;4E5K=:DTF[_P!U.ZBNUM;;MG\ZYYQGF68U'[[A3Z1B[*WFUJWZZ=DB&SL+
M?3XA';PPP(. L:!0/P%3'FBBOTB,5%6BM#Y1R;=V9VJ^$=)UZ/;?:7I]XI[3
MVZ2?S%<)XM_9!\ ^+4;=H<>G3-TEL7,!'_ 1\GYK7IE%>3F7#^5YA'EQV'A4
M7]Z,7^+5T=N%S3&89\V'JRCZ-H^4_'G_  3OO+59)O#>MPW2]1;WZ>6_T$BY
M!/U45XCX]^#/BCX9RLNM:+>6<8.//V;X6^DBY7]:_1JFS0I<Q-'(BR1N,,K#
M(8>XK\CX@\ L@QMYY=*6'GY>]#_P&3O]TDO(^XROQ+S+#VCBDJL?/W9?>M/O
M3/S -?H3^S3_ ,D$\*_]@]/ZUA_$?]COP3\0?,E73SHM[)D^?IY$8)]X_N'\
M #[UW'PU\&#X>> ]+T,7'VI=,@$ F*;/, [XR<?G7-X5^&>:\+YSB*N+<9TI
MT[1E%]>9.S3LT[+S7F:\9<6X/.,!2A03C.,KM-=+-736C_!^1N4445^^GYH%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %?-W_  4:_P"18\+_ /7U/_Z M?2-?-O_  4;_P"17\,?]?4W_H"U^:^,
M'_)'XWTC_P"G('UO O\ R/</ZO\ ])D?*&.*,4=Z7O7\ G]+G1?!_P#Y*UX6
M_P"PO:?^CDK]'J_.'X/G_B[7A;_L+VG_ *.2OT>K^MOHW_\ (OQO^./_ *2S
M\3\5O]YP_P#A?YH****_I(_)PHHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ KRS]LOQ6WA;]G_6/+;;)J31V*D>CM\WYH&%>IU\^?\ !1*]:+X::';@
M_+-J>\CUVQ/_ /%5\3XD8Z>$X7QU>&_LVO\ P+W?U/H>$\.J^<8>G+;F3^[7
M]#Y S2BBDZ5_G:?U(+7Z'_ 'P!'\-/A'HNEJ@686ZSW)QRTSC<^?H3CZ 5^>
MEJZI=1LWW58$_3-?IS:RI/;1O'_JW4,N/0CBOZ8^C?@:,\5C<9+XX1A%>2DY
M-_\ I*/R3Q6Q%2-'#T%\,G)OU227YLDHHHK^L#\5"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBL7Q-\2/#_ (,5O[6UK2]/*_PSW*(Q
M^BDY/Y5CB,51H0]I7FHQ75M)?>S2E1J59<E.+;[)79M45Y=K'[9?P[TABO\
M;WVIAVM[660?GMQ^M93?MX> 5;'G:LWN+,\_K7R];Q X:I2Y9X^E?_KY%_DV
M>Q3X9S::O'#3_P# 6OS1[-17D-C^W)\/;MPLFH7UMGO+928'_?(-=5X>_:+\
M#^*'5;/Q/I)D?[J32^0Q_!\&NC!\:9!BY<N&QM*3[*I&_P!U[F.(R',J*O5P
M\TN_*[??8[2BF6]S'=PK)#(DL;C*LC;E8>Q%/KZ5--71Y.VC"BBBF 4444 %
M%%% !1110 5\V_\ !1K_ )%?PQ_U]3_^@+7TE7S;_P %&_\ D5_#'_7U-_Z
MM?FOC!_R1^-](_\ IR!]9P+_ ,CW#^K_ /29'R@1Q2<TO6@U_ )_3)T?P?\
M^2M>%O\ L+VG_HY*_1ZOSA^#_P#R5KPO_P!A>T_]')7Z/5_6WT;_ /D7XW_'
M'_TEGXEXK?[SA_\ "_S04445_21^3A1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ;=:S(O GF/V>'/L""Y_$"OESQ[\1M:^)NMM?ZWJ$]]<,3MW'"1#^ZBCA1[
M5AGK7\K<4_2!S3$S=+)(*C3Z2DE*;\[.\8^EI>I^RY-X8X.C%3S"3J2[*ZBO
MU?K=>A[1XD_;N\=ZT[BTETW28VZ"WM@[ ?63=_*N3O?VG/']^^Z3Q5JJD_\
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M.5*4K><I)_@HGZ_EGAOE>'2>)O5EYNR^27ZMGK>N?MO_ !"UAF\O4K/3U/\
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M?Q_ .38I:4N1]XNWX:K\#]-M$UZQ\2Z='>:?>6U]:RC*302"1&_$<5;K\W?
M'Q1U[X8:J+S0]2N+&3(+HK9BF]G0_*WXBOK7]GS]LG3/BC+#I.N+#I&NOA8S
MNQ;WC>BD_=8_W3U[$]*_HO@?QJRK.YQP>-7U>N]$F[PD^T9:6;Z*279-L_+.
M(O#_ !N7Q=?#OVE-;V7O)>:[>:]6D>VT445^TGP 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MAU?X&W(M65M2T&9]TMF[8,1/5XC_  GU'0^QYK[.^&GQ9T'XM:(M]HE]'<*
M/-A/RS6Y]'3J/KT/8FOSB%:7A3Q=JG@;6H]0TF^N-/O(?NRPMM./0]B#Z'(-
M?L7A_P",&8\/*.#Q2=;#+[+?O07]QOI_=>G9QU/A.)^!<+FC=>C^[K=^DO\
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M'_%VO"__ &%[3_T<E?H]7YP_!_\ Y*UX6_["]I_Z.2OT>K^MOHW_ /(OQO\
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M9>[+_MY;_P!Y2/YKXVR)99F35)6IS]Z/EW7R?X-!1117Z@?'A7S;_P %&_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXX<JJ&94[1?PSCK"7H^C\FD_*Q^BY+Q'@<UAS82>JWB])+U7ZJZ\RB!7U?\
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M-<<&OO[]D_4?[2_9Z\,OG)CMVA^FR1U'Z 5_1GT<<8XYKB\+TE34O_ 9)?\
MMY^6>*N'3P="M_+)K[U?_P!M/1****_KP_#@HHHH \__ &J/^3?/%'_7H/\
MT-:_/[-?H#^U1_R;YXH_Z]!_Z&M?G\*_COZ1G_(\PW_7I?\ I<S]V\*_^1=5
M_P ?_ML0ZT@X%+1UK^>S]//M/]B+X,1>!/AY'X@N55M4\0QK(K=?)MNJ*/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN>,79Q_WYK\Q\9*KI\'8QKM!??4@CZ_@."EGM!/^\_NC)GR^.13J0G HZU_
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P! %'_P7'_(/]9LW_Z"9_\ @3_S/(?^&'?AW_T#;W_P.D_QI?\ AAWX>?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"I]"*3I7\.[:,_H<*?!,]M,LD;,DB$,K*<%2.A%,-'2A-K5!Y'Z!?LT_%O\
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MEE#[;]Y_RQ6LI?);=W9=2<\S:GEN"GBZGV5HN[>R^;_"[/IKX7^!H?AK\/\
M2=#@VE=/MUC=A_RT?J[?BQ)_&MZBBO\ 1O"86EAJ$,-05H02BEV25DODC^5:
MU:=6I*K4=Y2;;?F]6%%%%=!F%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<GNWZMVV75LHHHK[(\$**** "OF[_@HU_P BQX8_Z^I__0%KZ1KYN_X*-?\
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M]]G+?K7V.4?1YSRO)/'UJ=&/6UYR^Y6C_P"3'A8[Q0RZFK8:$IOSM%?>[O\
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M?T5^._C?_@FM^T9\/O!NK:]J6HK'IVBV<M_=,GB0LRQ1(7<@9Y.U3QWKQO\
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MK'_!337OA+XRN/AI\/;O^S=4M8D;6=8CP9K=G4,L$/96V%69^HW #!!- 'Z
MW-]#9 >=-%#NZ;W"Y_.GQ2K-&K(RLK<@J<@U^._PT_X);?'C]I[P_;^+-6OK
M>QCU6/[1!+XCU.9KNX1AE7*A7=0W4;\'!SC!S6%X]^&G[0'_  2_\2Z?JG]J
M7^E6-U+L@N]/O3=:5=L/F,4D;#;D@$[9$!(!(Z$BN4GF/VGHKPK_ ()__MG6
MG[:/P7_MB2WAT_Q%H\HL]9LXR?+CE*Y65,\^7(,D \@AADXR?=:DH**** "B
MBB@ HHHH **_/+]J#_@L-XV^!?[2OB;P3I_A;PK>6.B:@+2*>X,_G2*54Y;:
MX&?F["OT-4Y6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQC/:@1ZG_P $V/\ @H:O[:7AS4=+UJRM=+\9Z!&DMU';9%O?0D[?/C!)*X;
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M\A\G[>7[47[)/BVQ;QO)KC071WK8^)--'D7J@_,$D"JW'JC\<9]*_3/]D/\
M:ET7]KWX+V/BS1T-K(SFVU"Q=PTEA<J 7C)[C!#*V!E6!P#D#X7_ ."@/_!3
M3X1_M9?LU:KX5TW2?%8U[SX+O2Y[VPACBMY4D7<2RS,1F(R+P#G=5[_@@#XC
MNAK7Q*TGS&-EY%C=B,]%DW3(2/J,9_W11T#J?I51114E'GO[6O\ R:S\2/\
ML6-2_P#262ORY_X(F\_MOV__ & [W_V2OU&_:U_Y-9^)'_8L:E_Z2R5^7/\
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M_M5_MY^&8O$J_P!H1Z]K,VKZFLGS"ZV"2Y=6]59DVD>A-?N3'&L,:JJJJJ,
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M$T#]JK]KG]HF.\\1>&+SQIJ&FPR$%M%TI5M(R.2BA8\,1Z99O6N&_P""GOQ
MNOB)^W/XZDO)7,.DWJZ3;KC(AB@4)@#W;>WU8U]J_"C_ (+$? ?X/?#;1/"^
MCZ+XYMM-T.SCM(433+<9VC!8_O\ EF.6)ZDDGO0&YYI^Q-_P6#\7:3\3K/P?
M\8'CO+"\N18?VK);+:WFES%MH\]5"JR!N&)4,O))."*^S?\ @H=\6M?^!_[(
M7BSQ1X7OO[-UO31;&VN?*27R]]S$C?*X*G*L1R.]?DQ_P4)^.O@W]I+]I"\\
M8>";#4M/L-4LX/MBWMND$DMTFY6?:C,.4$?.<D@FOT&_:[\4W'C;_@C3#J]V
MS/=ZAX;T6>9R<EW,EKN/XG)_&@+GS+\"_P#@K_\ %Z7PKK^BR6]QX[\<:U-;
MQ>'PNFQE+%0)?/8Q0(K2L?W>U>@P23@8/'?%+]L+]J_X,ZW:ZEXNUCQIX;:\
M??;K?:5';VLQZE50Q>6<?W<9 KU/_@@3IMO/\6_'UU)!#)=6VDVZ12L@+Q!I
M6W!3U&=JYQUVBOL+_@J5X3L_%G["GCU;N&.1M/M8K^W9ADPRQS(0R^AQN7Z,
M1WHZAT/EO1_^"W>MZQ^SI;6-GX?CU#XP75W_ &?$D-L[V<B%05NA&O+2$G:(
M@<;AN^[\M>)_$W]K;]K7X/WEKKWBO5/&_AV"\DS"U[I"06;MUV;#%Y?3^$C.
M*Z[_ ((2>$]/US]IOQ%J%Y:0W%YH^@M)92.,FV=YHT9U]&*%ESZ,?6OOS_@H
MCX>L_$O[$GQ*AO84GCM]$FNXPPSLEA'F1L/<,H-'4-6<7_P3._;UD_;/^'VH
M6NN6]M9^,?#1C%\L VPWL3Y"3HI^[DJ0R\@'!& P ^G*_)/_ ((2ZG-;_M<Z
MY:H^(;GPO<-(O]XK<VVW\LFOULI,:"BBBD,**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\4_P#@KS_RD&\=
M_P"YIW_IOMJ_4S]ISX$Q_M(_L=ZSX1\M6O+_ $>.6P)'W+J)%DA/MEU /LQK
MXG_X*)?\$WOB]\?_ -K_ ,5^+/"_AVUO]#U1;,6T[:G;0L_EV<$3_([AAAT8
M<CG&:_2SPY:2:?X>L;>5=LL-O'&XSG!"@&J)1^%/PU_:KUKX2?LT?$7X8QQW
M"0^,KFV;>6V_8O+8BX7'7,BK&A]E/K7Z-?\ !%'X ?\ "K_V7YO%=Y!Y>J>/
M+K[4I8?,MI%NCA'XMYK^X=:\"_:T_P""17Q \=_M;:YJ?@_2[+_A#/$>HI>M
M=M>PQ?8?.(:X_=,P8A'+L H.1@#GBOTS\&>$K'P#X0TO0],A%OIVCVD5E:QC
M^"*- BC\@*&P1^*/[>(_XV*^-?\ L8H__:5?LQ\;_P#DB_B__L"7O_HAZ_.#
M]K#_ ()H_&+XI?MD^)_%^B^&[6ZT'4M92[MYVU2VC9XALR=K.&'0\$9K]*OB
MAHMSXE^&GB+3;.,27FH:9<VT"%@H>1XF51D\#)(Y- (_'K_@CK_R?WX3_P"O
M74/_ $CEKWW_ (+\_#VZ-W\/?%4<9:Q"76E3N!_JY,K+&"?]H>;C_<-4_P#@
MG!_P3E^+G[/7[6WA_P 5>*O#MKI^AV-O=I/.FIVTS(9+:1%^5'+'+,!P*^^O
MVB?@#H/[3?PDU3P?XCB=K#4D!2:/ FM)EY2:,GHRG\",@Y!(HOJ'0\%_X(S_
M !;L/'_[&.EZ'#<1MJ?@^ZN+&[@S\Z*\KS1/C^ZRR$ ]RC#M7JO[8_[8?A_]
MC'X;6OB#7+>XU)[Z\6SM;"VE1;B<D%F90Q^ZH')[;E'<5^<OB;_@F+^T1^RS
MX\GOOAW<7^J0Y*1:GX>U,6<\L?4"2)G5@?51O7/<T[PQ_P $ROVBOVJ_'=O?
M?$:ZU#3+=2$DU/Q#J7VN>*/J5BB5V;/HIV+GN*- U/T1_8N_;&TW]M/P!JGB
M+2=#U31+33;\Z>5O61C,XC1R5*G& ' K\FOV&S_QL+\#_P#8S_\ LSU^R'[.
MOP T']F/X1Z7X/\ #L<BV&FJ2\TN#-=S-R\TA'5F/X 8 P !7YU?LL_\$R_C
M)\,OVPO"OB[6?#=K;:'INN?;;F==5MI"D6YCG:KECU' &:$!^IM?B/\ \%&/
M"M]\%_\ @H%XNNYH6_TC5H]>M"P^69)=LP(]@^Y?JIK]N*^</^"A7_!/G3/V
MV/"EG<VMY#HOC+149+"_D0M%/&3DP3 <[-W(89*$D@$$@I#9[C\+OB/I?Q>^
M'FC>)M%N([K2];M4NX)$;=@,,E3Z,IRI'4$$'D5^<W_!>GXQZ;KGBSP7X'L[
MB.XOM#2?4M05&#?9S,$6)&]&*H[8ZX93W%>9:-^QK^UM^SF]SHOA6'Q=9Z=,
MY)_L+7%^R3$_Q@+(-I/J54UVW[,/_!&GQY\2_'T/B'XP7!TG2FG%S>6CWHNM
M3U0YR5=U+! W\3%B_H >0Q:L^K?^"/?P\NO '[#F@R7D30R^(+NYU9488/EN
MP2-O^!)&K#V85\8?\%;?"$WP$_;^TOQM8QM$FL)9:]$Z]/M%NXC<#W_<HQ_W
MZ_6C2=*MM!TJUL;*WBM;.SB6""&)=J0QJ JJH'0   #VKY._X*U_L7^)/VLO
M 'A2X\&Z?;ZAXA\/W\J-%)<1V^ZUF3YSN<@'#QQ\9_B-">HWL?+G_!/&UF_;
M(_X*=Z]\1KZWD^PZ7-=:^$D^;R2Q\FUB)]45E(_ZXUI?\%E_!%Y\#_VO_!?Q
M0TE6ADU6.&Y\Q1C_ $VQD3DGWC,(_P" FOI?_@DU^QCX@_9,^&GB6;QAI]OI
M_B7Q#?H#%'<1W&RUA3]W\Z$C)=Y3C/3%='_P5"_90U7]K+]G)-,\-VD-YXGT
M748K_3XY)DA\T<QRIO8A1E'+<D9*"B^HNA\'_LA.?VT_^"K:^+)()/[/&K7'
MB5DD&XPP0?\ 'NK?1O(6OT;_ ."@WQ4U;X+_ +''CKQ#H<SVVK6MDD%M.GWK
M=II8X?,![,HD)![$"O"/^"1_[!_B_P#97UOQCKOCK2[?3=4U*""PT]([J*X_
M<AF>4DQLP&6$0P?[IKZV^,WPJTSXX_"O7O".L*_]F^(+-[25D^_%N'RNO^TK
M ,/=10]QK8_(O_@E/^R?X9_:X^.^L+XSFEO-.\/V0U!]/$S1OJ4CR!?G8$-L
M4G+8()+*,X)S]N?MI?L@_ ?X(?LM>-M<;P9X5T2_BTBYATNX*E93>O$RP"/Y
MLL_F%2,9Z$G@&OC/Q+_P3%_:&_9I^)+7W@FUU#4OLK,MGK7A_4%@E>,_WD+K
M(A(QE2"ON>M>J?"__@EU\8OVE9;S7?C=XBUA?LMC.NE:?>ZJ;NZEN&C81[B&
M9(8P^TD [FQC ZT"/-?^"'X_XS5D_P"Q>O/_ $.&OU#_ &H?@U#^T%^S[XL\
M'S*I;6M/DBMV;I'<+\\+_P# 9%0_A7PE_P $V?V ?C'^S%^U7I/B3Q)X9M[7
M09+2YLKV>/5+:5HE>,E3L5RQ_>*@X'?-?I50]PB?A3^SC^TKJ7[-OP^^,'A9
MOM%K<>,-#.E+&<JT-TLPB;([$0RW(^H%?8W_  08^!?V#PSXN^(MU#B34)5T
M33V8?\LTQ).P]F8Q#/K&:X3]N+_@D]\2_&W[3WBG7O .@6>H>'-?N!J,;'4+
M>W,4T@#3)M=U/^MWD8&,,*_0;]DOX(1_LY_LY^$O!RK&MQI%@@O"G*O=/F2=
M@>X,C/@^F*&"/F[_ (+H_#Z\\4?LKZ/K5K&TD?AO7(Y;H ?<BEC>+>?I(8Q_
MP*OG?_@D%\%/@[^T9I_B;PWX[\.V.K>++*=;ZP,UW-"\]H4"NJ+'(H;8ZY/&
M?WH[#C]2/'7@C2_B5X.U/P_K=G%J&DZQ;O:W=O(/EEC88(]0>X(Y! (Y%?EG
M\>?^".OQ3^"GC]]:^%=U-X@TR"4S6,MM?+9:K8CG"G<R!B <;HVR>NU>E"#K
M<^WS_P $L/@"HR?AW8 #O]OO./\ R+77_LV_LU?"OX*I?ZM\--(TNSCU@?9K
MFZL;Z2ZCG\EV7;N:1QE7W@XYR"#TK\W9OV8/VR/C; -%UJ;QRVFS#9*-6\0K
M%;%>AWCS<N/P8FOOK_@G9^R9KW['?P/E\-Z]XBAURXO+QKX06\9%MIQ90&CC
M9OF8$C<20HSG Y)(,]\HHHJ1GGO[6O\ R:S\2/\ L6-2_P#262ORY_X(FC_C
M."W_ .P'>_R2OU8_:$\)WWCWX"^--#TN%;C4M8T*]LK2-G""262!T0%C@#+$
M#)X%?"/_  3$_P"">_Q6_9M_:CA\3>+_  _;Z=HZZ7<VQF34;><B1]NT;4<M
MS@\XQ5+8EGZ/5\9_\%S_ /DSC3?^QFM?_1%S7V97S5_P51_9U\6?M.?LW67A
MWP;I\>I:M#KD%Z\3W,=N!$L4RL=TC =77C.>:D;V/&/^"!''P?\ '_\ V&(/
M_1->B?&#_@JG\*="^+>K?#'Q9X8U^Z^SZG_8]\UY96TNGMEPOF,'DR8N0V2O
M3G%'_!)']E7QO^RM\.O%VG^-M+ATNZU74HKBV6.[BN/,18MI.8V8#GL:P?\
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MG(=U 4;4<MSZXHZ 5/\ @O;\6=8@\2^"_!,-S-!H<MD^KW,*,0MU-YC1IO\
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MQF_93\:^%_#MJMYK6L6(AM(6E6(2-YB-C<Q"C@'J: /S_P#^""!_XR'\9_\
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MJ!7R7^WY_P $L=%_:XU23Q3H%]#X;\;>6$FEDC+6FJ!0 OG!?F5P  )%!.
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MI_LX^'GM5U#P5HMBU_.MK;"?5KJ,W$K?=C3,PW,>RC)-9_\ P4S\':;\/?\
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M8X8(XX885"1QQJ%5%'   X 'I4E !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MANM:Q_QZV(_[:L?Z4WH[ G<UZ*Q_M&N'_EWT\?\  V-(9M>QQ'IH_P"^O\:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ#_R#)_\31_PN'P[C_D(#_OS)_\ $T>TCW#EEV.FHKFO^%O>'L?\A#\H7_\
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M;U%?$*_\'''[&+ X^-FE\?\ 4'U'_P"1Z/\ B(Z_8QSC_A=FEY_[!&H__(]
M'V]17P^/^#CS]C G_DMFE_CH^H__ "/3A_P<=?L8M_S6S2__  3ZC_\ (] '
MV]17Q"?^#CG]C$'_ )+9I?\ X)]1_P#D>@_\'&_[&(7/_"[-*Q_V"-0_^,4
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M_G7]3_\ PYQ_99SG_A0OPS_#18_\*3_ASA^RQG_D@OPSX_Z@T='O!H?RP_\
M#9TW_1*_@'T_Z)Y:?XT+^VA,H.?A3\ >NX9^'EKQ].:_J@_X<Y?LL_\ 1!?A
MGZ?\@:/_  I!_P $<OV65_YH+\,__!-'1[P:'\L!_;0F/_-*O@'G/;X=VG^-
M$?[9\JIM_P"%5_ 0YXR?AY:9_G7]3Y_X(X_LL-_S07X9_P#@FC_PI#_P1O\
MV5R!_P 6%^&?R]/^)-'3U#0_EA;]LV9SS\+/@(O/;X=VG^-*?VTIO+_Y)3\
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MWP*^)^EI9>(OA7X,UJTCE$RQ7>GK(JN 1NP>^"?SKE/^'./[+&,?\*%^&?\
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MKX:OB ?AS:D1$1\/P>,>IKZ(_8E_;-AF_9\L6G^!/[/NHR->SYF'PXMOFP_
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M[8FFFT;;^S]^SXK)&5 ;X=6^ WMQ[FO!_P!@7]L:&X\'^*)+KX&_L_:IC5P
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M)'L.&0GN/3/3%3>+?VY-+U#2)+?POIFJZAJ5PI2)I(=J1D\9P"2WT%)^R/\
M [4/!VH7'B;7HVMKZYC:*VMW'[Q%8Y9W]"< 8ZU^%X7!97/CC!XK@/2#YOK3
MIIJCR:6OM'F>ME'[7*[7N?<5:V*ADE:EGV^GLE*W/?KYV6FKZ71<_:$%ZGQ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGM_&$?RKN//\0Z9XZUY;+J%UI<S0W"2VTB#+1S JP],@C-)'XF9HV)$FYAU
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,_AW=N^9[M_FZX-U,17JU<SW.J.P4444#"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;5XG^96!'Z5\6?'/PC_PA7Q/>6-2([R/S.G0BN6I&S-Z<NC.L\'7^1&W W=
M.WM7J'A>7:B]2R\=:\9\%SMY$>6SN.=K<X_&O6O",P=4V^@Y]JSB4STK0GY7
MKZ5UVD\?XUQ>@,<1CD>I]:[#23\PXK:)G(Z"W/ ^E357M#P*L42W-(;!1114
ME!5:\;AJLU5OC@5=/<SJ;',^)FS"W:O"_CHW_$HN <+\C=>YQ7M_B9LQ-_.O
M"OCK,5T6X.5S@]1QG%:R,4>Q?LA0B#]FOPCMSB2R\SG_ &G9OZUZ17!_LOP^
M1^SKX)7^]H]L_P"<8/\ 6N\KG.I;!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^-"FV8?Z/=K_ *N4=/P;VKE/"'CQ9 J^8>H&#VKJ-?\ #^C_ !(T%[/4(8Y
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MPKTAB5!^  J>BBL3J"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MLRVME;VJY]7DD8\_\ 6B6PH;GT511161N%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %##<,'D'@@]Z** /CG]L+]GJW^%
M_B&/Q%H\/DZ-K$^V>%?N6DYYP!T"/@D>A!'0@5R'@6]8>6JY^4Y]<_2OLWXT
M^!HOB/\ "W6M'D16:XMF:'(^[*OSQM^# 5\;?#K3VNM,AF93O9/F4#Y1_GBN
M.<>6>FS--XGM/@:^)1?[I]#7J&@3^9 M>1^"HOL^,CD8&#VKU3PRQ$6:ZJ9S
MR/-OVH=*\F]M+E?E^?:21US7,>%6W1+N7:6..M>F_M(Z2;CPA'<+@^4P;\J\
MN\*/N5/X=P/'^?PJ9?$..QZ)X??IG^72NTT)LQK]WTXKA_#S ,H!SWKM=!;<
MG;Z541'5Z6W[M?YUI1_=K+TD[D%:D7W:UEL%,=1114&@R<X2N>UUL"M^Z;"U
MSFO2?X?2MH;&-3<X/QU<!+9^_P IK+_8<M#/:>-=2VD"YU=;=<CJ(X4/\Y#4
MWQ*N1'I\Q+?=4UK?L26)A^!D=TR[6U+4KRX/RXSB9HP?Q$8J9!3W/7****S-
M@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH ",BOC'P9IQT;4=5T_:JK8W\T. ,?=D9?TP*^SJ^4O$=I_8WQ@\66?'
M_(0>8  ]),2?^SUS8CHRX&[X89EF7/3OS7IGAF7*#'ZUYCH#LLZCTKTCPI*6
M ]QVK6D931H_$O1UU;P7,K+G:"?IQ7S_ .%@T*['ZJVS!'3!KZ;N+07NA2QM
MT9#V]J^;7LFTOQ1>V_4"7<#Z FKJ[W)AV.Z\//\ <^9<9[UV>@-C\:X;09,,
MOU_*NU\/M\R]*40.OTAL@5K0GY*QM'/R?CTK9BX6M9;!'<=1114&A#>'"UR^
MNR8+5TUZ<+7*Z\^TR'O@UM'8YY_$>3_&6^%KH5TS-C;&QY]J]0_9DTC^Q/V?
M_",)C\MY--BN77T:4>:WZN:\3_:'GDF\-W-O;MB>\ MH_7=(0@Q^=?3NC::F
MC:1:V<8VQVL*0J!V"@ ?RK.1I3+-%%%2:!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,GLQV1#])&_*OHJLY;FM/8****DL**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#K%DDL.Q9F Z@ U[+134$@"BBBJ **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** .7^+7'AN!O[MW$?U(_K4/PV;;K6N+_T
MW1OSC6K7Q9CW^#)3C.R:)O\ Q\52^';8\3ZPO'S) _\ XYC^E3U V?%@PUF?
M^FC#_P =-?"^I6_V+]HF6%E_YB5TW'IE3T_.ONKQ9\L-JWI-C/I\IKX?\=PM
M;?M821C&UKJ1FY^8!D'^'ZUIT)ZGVE\,ACPU;>T8%=%_'7/_  U39X<MQSC8
M.M=!_'0"V/&?VP,G2M/X[,?KR*M?LS+M\0>(O>&SQ_WS)57]L)L:/I_R[OO'
M^56OV93C7/$*^D5IG\I*.@OM'KU%%%26%%%% !1110 4444 %%%% !1110 4
..444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>venacureevltpicturea06.jpg
<TEXT>
begin 644 venacureevltpicturea06.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #R >4# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?\:ZN678PYXKJ7Z*@:^MEMA<&XB%N?\ EJ7&STZ]*?!<1742R0R)+&W1XV#
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M +^/_P#%5Y-\5?"]GX6UZ!=/1H;>>'S!'N)"L"0<$\^AKZ"KQ?X\?\A;2_\
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M/@F\U&_M]/T62[2&X@*>:_E7 B7=E2.0<G '-?HY7QK^S;_R>!\4O^NVI_\
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M;K]Z::2,?C$HK8_X4OX;_N77_?[_ .M72>&?"]CX3LY+6P$@BDD\QO,;<<X
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MZ2"\NKVPTB:"YM[N:(Q/-$ ?.C/ W@)GG')/L*BOOM<=AI>K.T]]-<R27/\
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MB HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%\+JH6:Z7W6/_&NF50H  P*+#<NB&0P);QK'&H55X %2444S,**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHJ*>X2W3<QQ0 ^218U+,<"L+4M6+Y5#A/YU'?7S7#'G [+5.&UD
MO)ML8R>[=A1Z%)=65&22YE"@%W/1171:1H:68$LP#S?HOTJYI^FQ6,? RYZL
M>M7*!-W"BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 5BZD3Y_7M110!E2=_I70:.H
M6S0@ $CTHHH6Q4MR_11102%%%% !1110 4444 %%%% !1110 4444 %%%% !
B1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6882229216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>Jul. 20, 2018</div></th>
<th class="th"><div>Nov. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ANGIODYNAMICS INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001275187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 31,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--05-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well Known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 631,826,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,885,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document and Entity Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated), (5) Smaller Reporting Accelerated Filer or (6) Smaller Reporting Company and Large Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6882652720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 344,285<span></span>
</td>
<td class="nump">$ 349,643<span></span>
</td>
<td class="nump">$ 353,890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales (exclusive of intangible amortization)</a></td>
<td class="nump">167,410<span></span>
</td>
<td class="nump">173,474<span></span>
</td>
<td class="nump">179,574<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">176,875<span></span>
</td>
<td class="nump">176,169<span></span>
</td>
<td class="nump">174,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">25,459<span></span>
</td>
<td class="nump">25,269<span></span>
</td>
<td class="nump">25,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">77,276<span></span>
</td>
<td class="nump">78,819<span></span>
</td>
<td class="nump">83,743<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">31,265<span></span>
</td>
<td class="nump">31,406<span></span>
</td>
<td class="nump">30,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="nump">16,635<span></span>
</td>
<td class="nump">17,296<span></span>
</td>
<td class="nump">17,964<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_ChangeInFairValueOfContingentConsideration', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">250<span></span>
</td>
<td class="num">(15,261)<span></span>
</td>
<td class="nump">948<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_AcquisitionRestructuringAndOtherItemsNet', window );">Acquisition, restructuring and other items, net</a></td>
<td class="nump">15,432<span></span>
</td>
<td class="nump">27,510<span></span>
</td>
<td class="nump">12,591<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_MedicalDeviceExciseTax', window );">Medical device excise tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,837)<span></span>
</td>
<td class="nump">2,416<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">166,317<span></span>
</td>
<td class="nump">163,202<span></span>
</td>
<td class="nump">173,298<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">10,558<span></span>
</td>
<td class="nump">12,967<span></span>
</td>
<td class="nump">1,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net</a></td>
<td class="num">(3,062)<span></span>
</td>
<td class="num">(2,839)<span></span>
</td>
<td class="num">(3,385)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Other expense</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(281)<span></span>
</td>
<td class="num">(886)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Total other expenses, net</a></td>
<td class="num">(3,093)<span></span>
</td>
<td class="num">(3,120)<span></span>
</td>
<td class="num">(4,271)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before income tax expense (benefit)</a></td>
<td class="nump">7,465<span></span>
</td>
<td class="nump">9,847<span></span>
</td>
<td class="num">(3,253)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="num">(8,870)<span></span>
</td>
<td class="nump">4,839<span></span>
</td>
<td class="nump">40,337<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 16,335<span></span>
</td>
<td class="nump">$ 5,008<span></span>
</td>
<td class="num">$ (43,590)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings (loss) per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (usd per share)</a></td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="num">$ (1.21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (usd per share)</a></td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="num">$ (1.21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Weighted average shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">37,074,797<span></span>
</td>
<td class="nump">36,616,859<span></span>
</td>
<td class="nump">36,161,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">37,539,400<span></span>
</td>
<td class="nump">36,959,250<span></span>
</td>
<td class="nump">36,161,383<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_AcquisitionRestructuringAndOtherItemsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition Restructuring And Other Items Net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_AcquisitionRestructuringAndOtherItemsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_ChangeInFairValueOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expense charged against earnings in the period resulting from remeasurement to fair value of contingent earn out liabilities related to  acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_ChangeInFairValueOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_MedicalDeviceExciseTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of excise tax imposed on the sale of certain medical devices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_MedicalDeviceExciseTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6882303808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements Comprehensive Income (Loss) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 16,335<span></span>
</td>
<td class="nump">$ 5,008<span></span>
</td>
<td class="num">$ (43,590)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), before tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Unrealized gain on interest rate swap</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax', window );">Foreign currency translation gain (loss)</a></td>
<td class="nump">270<span></span>
</td>
<td class="num">(545)<span></span>
</td>
<td class="num">(112)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent', window );">Other comprehensive income (loss), before tax</a></td>
<td class="nump">372<span></span>
</td>
<td class="num">(533)<span></span>
</td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1', window );">Income tax benefit (expense) related to items of other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(92)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">372<span></span>
</td>
<td class="num">(533)<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total comprehensive income (loss), net of tax</a></td>
<td class="nump">$ 16,707<span></span>
</td>
<td class="nump">$ 4,475<span></span>
</td>
<td class="num">$ (43,548)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82918529&amp;loc=d3e30304-110892<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b,d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109240241&amp;loc=d3e32211-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109228884&amp;loc=d3e1436-108581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109978405&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of unrealized holding gain (loss) on available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27357-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6882456640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 74,096<span></span>
</td>
<td class="nump">$ 47,544<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities, at fair value</a></td>
<td class="nump">1,317<span></span>
</td>
<td class="nump">1,215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowances of $2,466 and $2,945, respectively</a></td>
<td class="nump">39,401<span></span>
</td>
<td class="nump">44,523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">48,916<span></span>
</td>
<td class="nump">54,506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">4,302<span></span>
</td>
<td class="nump">6,126<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">168,032<span></span>
</td>
<td class="nump">153,914<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">42,461<span></span>
</td>
<td class="nump">45,234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">3,417<span></span>
</td>
<td class="nump">1,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">130,310<span></span>
</td>
<td class="nump">145,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">361,252<span></span>
</td>
<td class="nump">361,252<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">705,472<span></span>
</td>
<td class="nump">707,961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">15,775<span></span>
</td>
<td class="nump">18,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">34,426<span></span>
</td>
<td class="nump">38,804<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Current portion of contingent consideration</a></td>
<td class="nump">2,100<span></span>
</td>
<td class="nump">9,625<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">57,301<span></span>
</td>
<td class="nump">71,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLoansPayable', window );">Long-term debt, net of current portion</a></td>
<td class="nump">86,621<span></span>
</td>
<td class="nump">91,320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent', window );">Deferred income taxes</a></td>
<td class="nump">17,173<span></span>
</td>
<td class="nump">26,112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent consideration, net of current portion</a></td>
<td class="nump">1,161<span></span>
</td>
<td class="nump">3,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">621<span></span>
</td>
<td class="nump">850<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">162,877<span></span>
</td>
<td class="nump">192,934<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 15)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $.01 per share, 5,000,000 shares authorized; no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $.01 per share, 75,000,000 shares authorized; 37,594,493 and 37,210,091 shares issued and 37,224,493 and 36,840,091 shares outstanding at May 31, 2018 and 2017, respectively</a></td>
<td class="nump">370<span></span>
</td>
<td class="nump">367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">543,762<span></span>
</td>
<td class="nump">532,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings (accumulated deficit)</a></td>
<td class="nump">5,129<span></span>
</td>
<td class="num">(11,007)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, 370,000 shares, at cost at May 31, 2018 and 2017, respectively</a></td>
<td class="num">(5,714)<span></span>
</td>
<td class="num">(5,714)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(952)<span></span>
</td>
<td class="num">(1,324)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Equity</a></td>
<td class="nump">542,595<span></span>
</td>
<td class="nump">515,027<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity</a></td>
<td class="nump">$ 705,472<span></span>
</td>
<td class="nump">$ 707,961<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109196051&amp;loc=SL49130549-203045<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109979856&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6882683904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowances</a></td>
<td class="nump">$ 2,466<span></span>
</td>
<td class="nump">$ 2,945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (usd per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (shares)</a></td>
<td class="nump">75,000,000<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (shares)</a></td>
<td class="nump">37,594,493<span></span>
</td>
<td class="nump">37,210,091<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (shares)</a></td>
<td class="nump">37,224,493<span></span>
</td>
<td class="nump">36,840,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares (shares)</a></td>
<td class="nump">370,000<span></span>
</td>
<td class="nump">370,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5074-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6890720992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Restricted Stock Units</div></th>
<th class="th"><div>Performance Shares</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>Restricted Stock Units</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Performance Shares</div>
</th>
<th class="th"><div>Additional paid in capital</div></th>
<th class="th">
<div>Additional paid in capital </div>
<div>Restricted Stock Units</div>
</th>
<th class="th">
<div>Additional paid in capital </div>
<div>Performance Shares</div>
</th>
<th class="th"><div>Retained earnings (accumulated deficit)</div></th>
<th class="th"><div>Accumulated other comprehensive loss</div></th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at May. 31, 2015</a></td>
<td class="nump">$ 545,099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 520,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,575<span></span>
</td>
<td class="num">$ (833)<span></span>
</td>
<td class="num">$ (2,104)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning Balance, Shares at May. 31, 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,043,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,305.000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="num">(43,590)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43,590)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">1,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance/cancellation of common stock units</a></td>
<td class="num">(331)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(332)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance/cancellation of common stock units, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Purchase of common stock under Employee Stock Purchase Plan</a></td>
<td class="nump">1,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Purchase of common stock under Employee Stock Purchase Plan, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">3,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at May. 31, 2016</a></td>
<td class="nump">507,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">525,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,015)<span></span>
</td>
<td class="num">(791)<span></span>
</td>
<td class="num">$ (2,104)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance, Shares at May. 31, 2016</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,420,403.000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(142,305.000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">5,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">9,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">751,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance/cancellation of common stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (586)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (587)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance/cancellation of common stock units, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,341<span></span>
</td>
<td class="nump">23,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Purchase of common stock under Employee Stock Purchase Plan</a></td>
<td class="nump">1,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Purchase of common stock under Employee Stock Purchase Plan, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">6,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredParValueMethodAmount', window );">Treasury stock retirement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,942)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,944<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Treasury stock retirement, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(642,305)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">642,305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchased</a></td>
<td class="num">(13,557)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (13,554)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Common stock repurchased, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(370,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(870,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(533)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(533)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at May. 31, 2017</a></td>
<td class="nump">515,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,007)<span></span>
</td>
<td class="num">(1,324)<span></span>
</td>
<td class="num">$ (5,714)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance, Shares at May. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,210,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption', window );">Adjustment for ASU 2016-09</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(199)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">16,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 1,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, Shares</a></td>
<td class="nump">271,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">148,937<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance/cancellation of common stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (231)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (232)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance/cancellation of common stock units, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Purchase of common stock under Employee Stock Purchase Plan</a></td>
<td class="nump">$ 1,263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Purchase of common stock under Employee Stock Purchase Plan, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">7,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at May. 31, 2018</a></td>
<td class="nump">$ 542,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 543,762<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,129<span></span>
</td>
<td class="num">$ (952)<span></span>
</td>
<td class="num">$ (5,714)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending Balance, Shares at May. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,594,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) from recognition of equity-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=109196918&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109196918&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79507207&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109228884&amp;loc=d3e1436-108581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockRetiredParValueMethodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the par value method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockRetiredParValueMethodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6874685504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 16,335<span></span>
</td>
<td class="nump">$ 5,008<span></span>
</td>
<td class="num">$ (43,590)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">23,163<span></span>
</td>
<td class="nump">24,811<span></span>
</td>
<td class="nump">28,115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="nump">7,912<span></span>
</td>
<td class="nump">6,183<span></span>
</td>
<td class="nump">3,240<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_ChangeInFairValueOfContingentConsideration', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">250<span></span>
</td>
<td class="num">(15,261)<span></span>
</td>
<td class="nump">948<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_DeferredIncomeTaxRelatedToOperatingActivity', window );">Deferred income tax provision</a></td>
<td class="num">(8,947)<span></span>
</td>
<td class="nump">4,428<span></span>
</td>
<td class="nump">39,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Changes in accounts receivable allowances</a></td>
<td class="nump">179<span></span>
</td>
<td class="num">(313)<span></span>
</td>
<td class="nump">2,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Fixed and intangible asset impairments and disposals</a></td>
<td class="nump">540<span></span>
</td>
<td class="nump">3,930<span></span>
</td>
<td class="nump">1,190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Write-off of other assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,685<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="num">(605)<span></span>
</td>
<td class="num">(586)<span></span>
</td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">5,044<span></span>
</td>
<td class="nump">8,479<span></span>
</td>
<td class="nump">3,131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">5,740<span></span>
</td>
<td class="nump">687<span></span>
</td>
<td class="nump">11,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other</a></td>
<td class="num">(1,231)<span></span>
</td>
<td class="num">(3,520)<span></span>
</td>
<td class="nump">712<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued and other liabilities</a></td>
<td class="num">(7,093)<span></span>
</td>
<td class="nump">19,214<span></span>
</td>
<td class="num">(2,956)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">41,287<span></span>
</td>
<td class="nump">55,745<span></span>
</td>
<td class="nump">45,216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions to property, plant and equipment</a></td>
<td class="num">(2,391)<span></span>
</td>
<td class="num">(3,001)<span></span>
</td>
<td class="num">(2,326)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_PaymentsToAcquireIntangibleAssetsNetOfCashAcquired', window );">Acquisition of intangibles</a></td>
<td class="num">(1,265)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,268)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Acquisition of warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sale or maturity of marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">450<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(3,656)<span></span>
</td>
<td class="num">(2,551)<span></span>
</td>
<td class="num">(7,569)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of and borrowings on long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">116,471<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="num">(140,381)<span></span>
</td>
<td class="num">(16,250)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Deferred financing costs on long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,364)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Payment of acquisition related contingent consideration</a></td>
<td class="num">(9,500)<span></span>
</td>
<td class="num">(9,850)<span></span>
</td>
<td class="num">(9,850)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(13,557)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from exercise of stock options and employee stock purchase plan</a></td>
<td class="nump">2,949<span></span>
</td>
<td class="nump">10,698<span></span>
</td>
<td class="nump">2,437<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(11,551)<span></span>
</td>
<td class="num">(37,983)<span></span>
</td>
<td class="num">(23,663)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">472<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Increase in cash and cash equivalents</a></td>
<td class="nump">26,552<span></span>
</td>
<td class="nump">15,211<span></span>
</td>
<td class="nump">13,942<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at beginning of year</a></td>
<td class="nump">47,544<span></span>
</td>
<td class="nump">32,333<span></span>
</td>
<td class="nump">18,391<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of year</a></td>
<td class="nump">74,096<span></span>
</td>
<td class="nump">47,544<span></span>
</td>
<td class="nump">32,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1', window );">Contractual obligations for purchase of fixed assets</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_CashPaidDuringPeriodAbstract', window );"><strong>Cash paid (received) during the year for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest</a></td>
<td class="nump">3,190<span></span>
</td>
<td class="nump">2,969<span></span>
</td>
<td class="nump">3,063<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="num">$ (102)<span></span>
</td>
<td class="nump">$ 332<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_CashPaidDuringPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Paid During Period [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_CashPaidDuringPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_ChangeInFairValueOfContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expense charged against earnings in the period resulting from remeasurement to fair value of contingent earn out liabilities related to  acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_ChangeInFairValueOfContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_DeferredIncomeTaxRelatedToOperatingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash flows from operating activities related to components of deferred income tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_DeferredIncomeTaxRelatedToOperatingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_PaymentsToAcquireIntangibleAssetsNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of intangible assets, net of cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_PaymentsToAcquireIntangibleAssetsNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30700-110894<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 220<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114873921&amp;loc=SL114875236-224282<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net book value of a nonmonetary asset transferred or exchanged in connection with the acquisition of a business or asset in a noncash transaction. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Nonmonetary assets and liabilities are assets and liabilities that will not result in cash receipts or cash payments in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based compensation arrangement. Issuance includes, but is not limited to, exercise of stock options and similar instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=82913815&amp;loc=SL49130534-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6878800912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation, Business Description and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">BASIS OF PRESENTATION, BUSINESS DESCRIPTION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">BASIS OF PRESENTATION, BUSINESS DESCRIPTION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation and Description of Business</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of AngioDynamics, Inc. and its wholly owned subsidiaries,  (collectively, the &#8220;Company&#8221;).  The Company designs, manufactures and sells a wide range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and in oncology and surgical settings. The devices are generally used in minimally invasive, image-guided procedures. Most of the Company's products are intended to be used once and then discarded, or they may be temporarily implanted for short- or long-term use. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounting Principles</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements and accompanying notes have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP").</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Principles of Consolidation</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of AngioDynamics and it subsidiaries (all of which are wholly owned).  All intercompany balances and transactions have been eliminated.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements, in conformity with accounting principles generally accepted in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect reported amounts of sales and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cash and Cash Equivalents</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company considers all unrestricted highly liquid investments with an initial maturity of </font><font style="font-family:inherit;font-size:10pt;">less than three months</font><font style="font-family:inherit;font-size:10pt;"> at the date of purchase to be cash equivalents. The Company maintains cash and cash equivalent balances with financial institutions in the United States in excess of amounts insured by the Federal Deposit Insurance Corporation.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Marketable Securities</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable securities, which include auction rate investments, are classified as &#8220;available-for-sale securities&#8221; and are reported at fair value, with unrealized gains and losses excluded from operations and reported as a component of accumulated other comprehensive income (loss), net of the related tax effects, in stockholders&#8217; equity. Cost is determined using the specific identification method. The Company holds an investment in auction rate securities in order to generate higher than typical money market rate investment returns. Auction rate securities typically are high credit quality, generally achieved with municipal bond insurance.  As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, in an auction rate security issued by a local government authority. The authority is current in its interest payments on the security.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fair Value Instruments</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The carrying amount of the Company's cash and cash equivalents, accounts receivable, accounts payable and long-term debt approximates fair value due to the short-term nature or market interest rates of these items. The Company bases the fair value of short-term investments on quoted market prices or other relevant information generated by market transactions involving identical or comparable assets. The Company measures and records derivative financial instruments at fair value. See Note 3 for further discussion of financial instruments that are carried at fair value on a recurring and nonrecurring basis.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounts Receivable</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable, principally trade receivables, are generally due within </font><font style="font-family:inherit;font-size:10pt;">30</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">90</font><font style="font-family:inherit;font-size:10pt;"> days and are stated at amounts due from customers, net of an allowance for estimated sales returns and doubtful accounts. The Company performs ongoing credit evaluations of customers and adjusts credit limits based upon payment history and the customer&#8217;s current creditworthiness, as determined by a review of their current credit information. The Company continuously monitors aging reports, collections and payments from customers, and a provision for estimated credit losses is maintained based upon historical experience and any specific customer collection issues that have been identified. While such credit losses have historically been within expectations and the provisions established, the Company cannot guarantee that the same credit loss rates will be experienced in the future. The Company writes off accounts receivable when they are determined to be uncollectible.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Inventories</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories are stated at the lower of cost (using the first-in, first-out method) or market. Appropriate consideration is given to deterioration, obsolescence, expiring and other factors in evaluating net realizable value.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Property, Plant and Equipment</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets.  Refer below for useful lives by category:</font></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:79%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated useful lives</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and building improvements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Machinery and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 to 8 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer software and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3 to 5 years</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:6px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluates property, plant and equipment for impairment periodically to determine if changes in circumstances or the occurrence of events suggest the carrying value of the asset or asset group may not be recoverable. Expenditures for repairs and maintenance are charged to expense as incurred. Renewals and betterments are capitalized.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill and Intangible Assets</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets other than goodwill and acquired IP R&amp;D are amortized over their estimated useful lives, on either a straight-line basis or proportionately to the benefit being realized.  Useful lives range from </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">eighteen</font><font style="font-family:inherit;font-size:10pt;"> years. The Company periodically reviews the estimated useful lives of intangible assets and reviews such assets for impairment whenever events or changes in circumstances indicate that the carrying value of the asset or asset group is not recoverable.  If an intangible asset or asset group is considered to be impaired, the amount of the impairment will equal the excess of the carrying value over the fair value of the asset.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill is the amount by which the cost of acquired net assets in a business combination exceeded the fair value of net identifiable assets on the date of purchase.  Goodwill and other intangible assets that have indefinite useful lives are not amortized, but rather, are tested for impairment annually or more frequently if impairment indicators arise. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For goodwill, the impairment test requires a comparison of the estimated fair value of the reporting unit to which the goodwill is assigned to carrying value of the assets and liabilities of that reporting unit. The determination of reporting units also requires management judgment. The Company considers whether a reporting unit exists within a reportable segment based on the availability of discrete financial information. If carrying value of the reporting unit exceeds the fair value of the reporting unit, the carrying value of the reporting unit&#8217;s goodwill is reduced to its fair value through an adjustment to the goodwill balance, resulting in an impairment charge. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's annual testing for impairment of goodwill was completed as of December 31, 2017. The Company operates as a single operating segment with </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> reporting unit and consequently evaluates goodwill for impairment based on an evaluation of the fair value of the Company as a whole. The Company determines the fair value of the reporting unit based on the market valuation approach and concluded that it was not more-likely-than-not that the fair value of the Company's reporting unit was less than its carrying value.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contingent Consideration</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of the liability for contingent consideration recorded on the acquisition date for a business combination is based on probability weighted estimated cash flow streams, discounted back to present value using a discount rate determined in accordance with accepted valuation methods and reflective of the risk associated with the estimated cash flow streams. The liability for contingent consideration is remeasured to fair value at each reporting period with changes recorded in earnings until the contingency is resolved.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes revenue when the following four criteria has been met: (i)&#160;persuasive evidence that an arrangement exists; (ii)&#160;the price is fixed or determinable; (iii)&#160;collectability is reasonably assured; and (iv)&#160;product delivery has occurred or services have been rendered. The Company recognizes revenue, net of sales taxes assessed by any governmental authority, as products are shipped, based on shipping terms, and when title and risk of loss passes to customers. The Company negotiates shipping and credit terms on a customer-by-customer basis and products are shipped at an agreed upon price. All product returns must be pre-approved by the Company and customers may be subject to a </font><font style="font-family:inherit;font-size:10pt;">20%</font><font style="font-family:inherit;font-size:10pt;"> restocking charge. To be accepted, a returned product must be unadulterated, undamaged and have at least </font><font style="font-family:inherit;font-size:10pt;">twelve months</font><font style="font-family:inherit;font-size:10pt;"> remaining prior to its expiration date.  Charges for discounts, returns, rebates and other allowances are recognized as a deduction from revenue on an accrual basis in the period in which the revenue is recorded. The accrual for product returns, discounts and other allowances is based on the Company&#8217;s history. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shipping and handling costs, associated with the distribution of finished products to customers, are recorded in costs of goods sold and are recognized when the related finished product is shipped to the customer. Amounts charged to customers for shipping are recorded in net sales.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Research and Development</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development costs, including salaries, consulting fees, building costs, utilities and administrative expenses that are related to developing new products, enhancing existing products, validating new and enhanced products, managing clinical, regulatory and medical affairs are expensed as incurred.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company calculates income tax expense for each jurisdiction in which it operates. This involves estimating actual current taxes due plus assessing temporary differences arising from differing treatment for tax and accounting purposes that are recorded as deferred tax assets and liabilities. The Company periodically evaluates deferred tax assets, capital loss carryforwards and tax credit carryforwards to determine their recoverability based primarily on the Company's ability to generate future taxable income and capital gains.  Where it is more-likely-than-not these will not be recovered, the Company estimates a valuation allowance and records a corresponding additional tax expense in the consolidated statement of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes and measures uncertain tax positions taken or expected to be taken in a tax return utilizing a two-step approach. The Company first determines if the weight of available evidence indicates that it is more likely than not that the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is that the Company measures the tax benefit as the largest amount that is more likely than not to be realized upon ultimate settlement. The Company recognizes interest and penalties related to uncertain tax positions in the provision for income taxes on the consolidated statements of operations.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Warranty Costs</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company makes periodic provisions for expected warranty costs. Historically, warranty costs have been insignificant.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Stock Based Compensation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation expense reflects the fair value of stock-based awards measured at the grant date and recognized over the relevant service period. The Company estimates the fair value of each stock-based award on the measurement date using either the current market price of the stock, the Black-Scholes option valuation model, or the Monte Carlo Simulation valuation model. The Black-Scholes and Monte Carlo Simulation valuation models incorporate assumptions as to stock price volatility, the expected life of options or restricted stock units, a risk-free interest rate and dividend yield. The Company recognizes stock-based compensation expense related to options, restricted stock units and market based performance stock units on a straight-line basis over the service period of the award, which is generally </font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;"> years for options and restricted stock units and </font><font style="font-family:inherit;font-size:10pt;">3</font><font style="font-family:inherit;font-size:10pt;"> years for market based performance stock units.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Foreign Currency Translation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The functional currency of the Company's foreign subsidiaries is the local currency in which the subsidiary operates. For foreign operations where the local currency is considered to be the functional currency, the Company translates assets and liabilities into U.S. dollars at the exchange rate on the balance sheet date. The Company translates income and expense items at average rates of exchange prevailing during each period. The Company accumulates translation adjustments in accumulated other comprehensive loss, a component of stockholders&#8217; equity.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transaction gains or losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in other expense in the statements of operations as incurred.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Derivative Financial Instruments</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is exposed to market risks, including changes in foreign currency and interest rates. The Company periodically enters into certain derivative financial instruments to hedge the underlying economic exposure. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative instruments are presented in the consolidated financial statements at their fair value. Changes in the fair value of derivative financial instruments are either recognized periodically in income or in stockholders&#8217; equity as a component of accumulated other comprehensive income (loss) depending on whether the derivative financial instrument qualifies for hedge accounting and, if so, whether it qualifies as a fair value or cash flow hedge. Generally, the changes in the fair value of derivatives accounted for as fair value hedges are recorded in income along with the portions of the changes in the fair value of hedged items that relate to the hedged risks. Changes in the fair value of derivatives accounted for as cash flow hedges, to the extent they are effective as hedges, are recorded in accumulated other comprehensive income (loss).</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is subject to various legal proceedings that arise in the ordinary course of business, including patent infringement and product liability matters. The Company records accruals for contingencies when it is probable the liability has been incurred and the amount can be reasonably estimated.  Legal fees are expensed as incurred. Insurance recoveries related to potential claims are recognized up to the amount of the recorded liability when coverage is confirmed and the estimated recoveries are probable of payment. These recoveries are not netted against the related liabilities for financial statement presentation.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a description of recent accounting pronouncements that may have a material effect on the Company's consolidated financial statements:  </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:33%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Issued Accounting Pronouncements - Adopted</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Standard</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Date Adopted</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Effect on the Consolidated Financial Statements</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2016-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation - Stock Based Compensation (Topic 718: Improvements to Employee Share-Based Payment Accounting)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This ASU simplifies and improves various aspects of ASC 718 for share-based payments, including income tax items and the classification of these items on the statement of cash flows.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2017</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company now recognizes unrealized excess tax benefits and will classify such benefits as an operating activity in the statement of cash flows on a prospective basis. Due to the full valuation allowance on our federal and state income taxes, the adoption of ASU 2016-09 did not impact our accounting for income taxes.                  </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company elected the accounting policy change to account for forfeitures as they occur.  This was adopted using the modified retrospective transition method by means of a cumulative-effect adjustment to equity as of June 1, 2017.  The adoption of ASU 2016-09 did not materially impact the Company's consolidated statements of income, consolidated balance sheet, equity or cash flows. </font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2017-04, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles - Goodwill and Other (Topic 350)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This ASU simplifies the subsequent measurement of goodwill by eliminating steps from the goodwill impairment test.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2017</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This adoption did not have an impact on the Company's financial statements.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASC Update No. 2015-11, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Inventory (Topic 330): Simplifying the Measurement of Inventory</font><font style="font-family:inherit;font-size:10pt;">. Update No. 2015-11</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This ASU more closely aligns the measurement of inventory in U.S. GAAP with the measurement of inventory in International Financial Reporting Standards by requiring companies using the first-in, first-out and average costs methods to measure inventory using the lower of cost and net realizable value, where net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2017</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This adoption did not have an impact on the Company's financial statements.</font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:33%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Issued Accounting Pronouncements - Not Yet Applicable or Adopted</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Standard</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Effective Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Effect on the Consolidated Financial Statements</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU No. 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers (Topic 606, ASU 2014-09)</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under Topic 606, an entity is required to recognize revenue upon transfer of promised goods or services to customers in an amount that reflects the expected consideration to be received in exchange for those goods or services. Topic 606 defines a five-step process in order to achieve this core principle, which may require the use of judgment and estimates, and also requires expanded qualitative and quantitative disclosures relating to the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers, including significant judgments and estimates used. The new standard also defines accounting for certain costs related to origination and fulfillment of contracts with customers, including whether such costs should be capitalized. </font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2018</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company established an implementation team which included third-party specialists to assist in the evaluation and implementation of the new standard. The Company&#8217;s assessment has included performing analysis for each revenue stream identified, assessing the potential differences in recognition and measurement that may result from adopting this standard and assessing whether the Company meets certain practical expedients. Based on the results of the assessment, the adoption of this standard will not have a material impact on the timing or amount of revenue recognized upon adoption and there is no cumulative prior period adjustment to be recorded to the opening balance of retained earnings upon adoption.  The Company will adopt the standard using the modified retrospective method. The Company is implementing changes to accounting policies, business processes and internal controls to support the new standard as necessary. Upon adoption of Topic 606, as the disclosure requirements under the new guidance have been significantly expanded in comparison to the disclosure requirements under the current guidance, we will provide additional disclosures in the notes to the consolidated financial statements, specifically related to performance obligations, the judgments made in revenue recognition determinations, costs to obtain or fulfill contracts and contract balances.</font></div><div style="padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU No. 2016-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (ASU 2016-15)</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This ASU identifies how certain cash receipts and cash payments are presented and classified in the Statement of Cash Flows under Topic 230.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2018</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This adoption is not expected to have a material impact on the Company's financial statements.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This ASU increases transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet and disclosing key information about leasing arrangements.  For leases with a term of twelve months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and liabilities.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2019</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is currently in the process of evaluating the impact of this ASU on its consolidated financial statements.</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6872704336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsDisclosureTextBlock', window );">OTHER ASSETS</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">OTHER ASSETS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2015, the Company filed an 8-K stating that it executed a non-binding letter of intent to enter into a strategic relationship with privately-held EmboMedics Inc., which develops injectable and resorbable embolic microspheres. </font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company made an initial </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> purchase of non-transferable warrants in a subsidiary of EmboMedics which become exercisable upon a change of control of EmboMedics.  The Company did not have significant influence, or control of the subsidiary.  This initial investment was recorded at cost and the Company reviewed for impairment at each balance sheet date. </font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the second quarter of fiscal year 2017, the Company decided to terminate its agreements with EmboMedics.  The termination of these agreements resulted in a write-off of the initial </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> investment in EmboMedics which is included in acquisition, restructuring and other items, net on the consolidated statements of operations.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6878931376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE OF FINANCIAL INSTRUMENTS</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">FAIR VALUE OF FINANCIAL INSTRUMENTS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On a recurring basis, the Company measures certain financial assets and financial liabilities at fair value based upon quoted market prices, where available. Where quoted market prices or other observable inputs are not available, the Company applies valuation techniques to estimate fair value. FASB ASC Topic 820,&#160;</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements and Disclosures, </font><font style="font-family:inherit;font-size:10pt;">establishes a three-level valuation hierarchy for disclosure of fair value measurements. The categorization of financial assets and financial liabilities within the valuation hierarchy is based upon the lowest level of input that is significant to the measurement of fair value.  The three levels of the hierarchy are defined as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 1 - Inputs to the valuation methodology are quoted market prices for identical assets or liabilities.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 2 - Inputs to the valuation methodology are other observable inputs, including quoted market prices for similar assets or liabilities and market-corroborated inputs.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level 3 - Inputs to the valuation methodology are unobservable inputs based on management&#8217;s best estimate of inputs market participants would use in pricing the asset or liability at the measurement date, including assumptions about risk.</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's financial instruments include cash and cash equivalents, marketable securities, accounts receivable, accounts payable and contingent consideration. The carrying amount of cash and cash equivalents, accounts receivable, and accounts payable approximates fair value due to their immediate or short-term maturities.  The recurring fair value measurements using significant unobservable inputs (Level 3) relate to marketable securities, which are comprised of auction rate securities, and contingent consideration liabilities. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables provide information by level for assets and liabilities that are measured at fair value on a recurring basis:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value Measurements using inputs considered as:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level&#160;1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level&#160;2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value at    May 31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Financial Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term investments*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable securities </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Financial Assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,417</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Financial Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent liability for acquisition earn outs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,261</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,261</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Financial Liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,261</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,261</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">*included in cash and cash equivalents.</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value Measurements using inputs considered as:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value at   May 31, 2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Financial Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable securities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Financial Assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Financial Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent liability for acquisition earn outs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,761</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,761</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Financial Liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,761</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,761</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There were no transfers in and out of Level 1, 2 and 3 measurements for the years ended </font><font style="font-family:inherit;font-size:9pt;">May 31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below presents the changes in fair value components of Level 3 instruments in the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> (in thousands of dollars):    </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Financial&#160;Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Financial&#160;Liabilities</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair&#160;Value&#160;Measurements<br clear="none"/>Using Significant<br clear="none"/>Unobservable Inputs<br clear="none"/>(Level 3)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair&#160;Value&#160;Measurements<br clear="none"/>Using Significant<br clear="none"/>Unobservable Inputs    (Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,761</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of contingent consideration, net </font><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">250</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair market value adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration payments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,750</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,261</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below presents the changes in fair value components of Level 3 instruments in the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> (in thousands of dollars):   </font></div><div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:60%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Financial&#160;Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Financial&#160;Liabilities</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair&#160;Value&#160;Measurements<br clear="none"/>Using Significant<br clear="none"/>Unobservable Inputs<br clear="none"/>(Level 3)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair&#160;Value&#160;Measurements<br clear="none"/>Using Significant<br clear="none"/>Unobservable Inputs    (Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,653</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,275</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of contingent consideration (1)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,261</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency (gain) loss from remeasurement</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(153</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair market value adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sale of securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(450</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration payments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,100</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,761</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1) Change in the fair value of contingent consideration is included in earnings and comprised of changes in estimated earn out payments based on projections of Company performance and amortization of the present value discount. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company made the decision to discontinue its investment in the TiLo product that was acquired in August 2013 as part of the Clinical Devices acquisition.  This decision resulted in the write-off of the acquired in-process research and development (IPR&amp;D) of </font><font style="font-family:inherit;font-size:10pt;">$3.6 million</font><font style="font-family:inherit;font-size:10pt;"> along with a </font><font style="font-family:inherit;font-size:10pt;">$3.1 million</font><font style="font-family:inherit;font-size:10pt;"> gain from the reduction in the fair value of contingent consideration liability associated with future milestones that will no longer be met during the second quarter of fiscal year 2017.  The write-off of the IPR&amp;D is included in acquisition, restructuring and other, net on the consolidated statement of operations. </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company revised the sales projections for the AngioVac product as a result of reviews performed by executive management across all products.  The adjustments to the sales projections resulted in a </font><font style="font-family:inherit;font-size:10pt;">$13.4 million</font><font style="font-family:inherit;font-size:10pt;"> gain in the second quarter of fiscal year 2017 from the reduction in the fair value of the contingent liability that is based on lower projected sales volume over the contractual earn out period. </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Short-term Investments</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term investments consist of highly liquid investments in municipal bonds that reset on a weekly basis and can be called at any point in time. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Marketable Securities</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable securities consist solely of an auction rate security.  Assumptions associated with the auction rate security include the interest rate benchmarks, the probability of full repayment of the principal considering the credit quality and guarantees in place, and the rate of return required by investors to own such securities given the current liquidity risk.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contingent Liability for Acquisition Earn Outs</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Some of our business combinations involve the potential for the payment of future contingent consideration upon the achievement of certain product development milestones or various other performance conditions. Payment of the additional consideration is generally contingent on the acquired company reaching certain performance milestones, including attaining specified revenue levels or product development targets. Contingent consideration is recorded at the estimated fair value of the contingent payments on the acquisition date. The fair value of the contingent consideration is remeasured at the estimated fair value at each reporting period with the change in fair value recognized as income or expense within change in fair value of contingent consideration in the consolidated statements of income. </font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We measure the initial liability and remeasure the liability on a recurring basis using Level 3 inputs as defined under authoritative guidance for fair value measurements and is determined using a discounted cash flow model applied to projected net sales, using probabilities of achieving projected net sales and projected payment dates. Projected net sales are based on our internal projections and extensive analysis of the target market and the sales potential. Increases or decreases in any valuation inputs in isolation may result in a significantly lower or higher fair value measurement in the future. </font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The recurring Level 3 fair value measurements of the contingent consideration liabilities include the following significant unobservable inputs as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair&#160;value&#160;at</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May&#160;31,&#160;2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Valuation</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Technique</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Input</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Range</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue based payments</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,261</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discounted cash flow</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discount rate<br clear="none"/>Probability of payment<br clear="none"/>Projected fiscal year of payment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4%<br clear="none"/>100%<br clear="none"/>2019 - 2020</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, the estimated potential amount of undiscounted future contingent consideration that the Company expects to pay as a result of all completed acquisitions is approximately </font><font style="font-family:inherit;font-size:10pt;">$3.3 million</font><font style="font-family:inherit;font-size:10pt;">, which represents the remaining contractual minimum payments.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6873557408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">MARKETABLE SECURITIES</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">MARKETABLE SECURITIES </font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, marketable securities consisted of the following:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sales securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">New York State government agency obligations</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,350</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,350</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, marketable securities consisted of the following:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sales securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">New York State government agency obligations</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,350</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(135</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,350</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(135</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amortized cost and fair value of marketable securities as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, by contractual maturity, are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of May&#160;31, 2018:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due in one year or less</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due after one through five years</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due after five through twenty years </font><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,350</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,350</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1)  This auction rate security represents investments available for current operations and are classified as current in the consolidated balance sheets.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6878779488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INVENTORIES</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, inventories consisted of the following:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:66%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,678</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,563</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,808</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,602</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,430</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,341</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,916</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54,506</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company periodically reviews its inventory for both obsolescence and loss of value.  The Company makes assumptions about the future demand for and market value of the inventory.  Based on these assumptions, the Company estimates the amount of obsolete, expiring and slow moving inventory.  The total inventory reserve at </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$6.1 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$7.3 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.  Of the </font><font style="font-family:inherit;font-size:10pt;">$6.1 million</font><font style="font-family:inherit;font-size:10pt;"> reserve at </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;"> relates to the inventory reserve for Acculis inventory as a result of the recall announced in the fourth quarter of fiscal year 2017 and </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;"> relates to a specific reserve related to the termination of an agreement with a Japanese distributor in the second quarter of fiscal year 2018.  Of the </font><font style="font-family:inherit;font-size:10pt;">$7.3 million</font><font style="font-family:inherit;font-size:10pt;"> in the prior year, </font><font style="font-family:inherit;font-size:10pt;">$2.4 million</font><font style="font-family:inherit;font-size:10pt;"> relates to the reserve for Acculis inventory.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6878864928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses and Other<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_PrepaidExpensesAndOtherTextBlock', window );">PREPAID EXPENSES AND OTHER</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PREPAID EXPENSES AND OTHER</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, prepaid expenses and other consisted of the following:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Software licenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,043</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">582</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">License fees</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">143</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade shows</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">223</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rent</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other prepaid taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">254</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">544</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical device excise tax receivable </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,837</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,505</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,762</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,302</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,126</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_PrepaidExpensesAndOtherTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid expenses and other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_PrepaidExpensesAndOtherTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6878800112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY, PLANT AND EQUIPMENT, NET</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PROPERTY, PLANT AND EQUIPMENT, NET</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, property, plant and equipment are summarized as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and building improvements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,887</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,597</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Machinery and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,668</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,434</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer software and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,899</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,668</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Construction in progress</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,153</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,464</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,607</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,163</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less accumulated depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(48,794</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49,652</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,813</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,511</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Land and land improvements</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,648</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,723</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,461</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,234</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation expense for fiscal </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$4.6 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$6.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$8.2 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6878867136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND INTANGIBLE ASSETS</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">GOODWILL AND INTANGIBLE ASSETS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's annual testing for impairment of goodwill was completed as of December 31, 2017. The Company operates as a single operating segment with </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> reporting unit and consequently evaluates goodwill for impairment based on an evaluation of the fair value of the Company as a whole. The Company determines the fair value of the reporting unit based on the market valuation approach and concluded that it was not more-likely-than-not that the fair value of the Company's reporting unit was less than its carrying value.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;">Even though the Company determined that there was </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> goodwill impairment as of December 31, 2017, the future occurrence of a potential indicator of impairment, such as a significant adverse change in legal, regulatory, business or economic conditions or a more-likely-than-not expectation that the reporting unit or a significant portion of the reporting unit will be sold or disposed of, would require an interim assessment for the reporting unit prior to the next required annual assessment as of December 31, 2018.  The Company continued to assess for potential impairment through </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and noted no events that would be considered a triggering event.  There were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> adjustments to goodwill for the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">.</font><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, intangible assets consisted of the following:</font></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross&#160;carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net&#160;carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product technologies</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147,175</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(68,880</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,295</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56,428</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23,237</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,191</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,400</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,809</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,591</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Licenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,752</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,357</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,395</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distributor relationships</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,250</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(412</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">838</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">239,005</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(108,695</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130,310</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross&#160;carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net&#160;carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product technologies</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147,172</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(59,696</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87,476</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56,375</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19,194</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,181</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,400</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,069</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,331</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Licenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,487</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,821</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">666</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distributor relationships</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(229</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">237,684</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(92,009</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145,675</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization expense was </font><font style="font-family:inherit;font-size:10pt;">$16.6 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$17.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$18.0 million</font><font style="font-family:inherit;font-size:10pt;"> for fiscal years </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Annual amortization of these intangible assets is expected to approximate the following amounts for each of the next five fiscal years:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:91%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,555</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,001</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,842</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,958</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,507</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2024 and thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,447</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130,310</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6873502000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INCOME TAXES</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of income (loss) before income tax (benefit) expense for the years ended May&#160;31 are as follows:</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:47%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) before tax expense:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,274</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,825</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,444</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-U.S.</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,191</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,022</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,191</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,465</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,847</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,253</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax (benefit) expense is comprised of the following:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:47%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(148</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State and local</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">152</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">141</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non U.S.</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">217</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">411</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">354</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,947</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,428</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,983</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax (benefit) expense </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,870</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,839</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,337</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Temporary differences that give rise to deferred tax assets and liabilities are summarized as follows:</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:normal;">May&#160;31,&#160;2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:normal;">May&#160;31,&#160;2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net operating loss carryforward</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,880</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,975</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,421</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,653</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal and state R&amp;D tax credit carryforward</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,644</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,548</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,550</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,407</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expenses incurred not currently deductible</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,714</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,522</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">277</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,289</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross deferred tax asset</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,486</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,394</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Excess tax over book depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,044</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,158</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,044</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,158</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation Allowance</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,607</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(48,348</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred tax liability </font><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17,165</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,112</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1) Net deferred tax liability is inclusive of a non-U.S. </font><font style="font-family:inherit;font-size:8pt;">$0.08 million</font><font style="font-family:inherit;font-size:8pt;"> deferred tax asset that is included in other assets on the Company's balance sheet for the year ended May 31, 2018.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The net deferred tax liability as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> principally relates to tax amortization of intangibles that have an indefinite reversal period for book purposes, also known as a &#8220;naked credit deferred tax liability&#8221;, that cannot be considered as a source of income to recover the deferred tax asset. </font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's Federal net operating loss carryforwards as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> after considering IRC Section&#160;382 limitations are </font><font style="font-family:inherit;font-size:10pt;">$157.8 million</font><font style="font-family:inherit;font-size:10pt;">. The expiration of the Federal net operating loss carryforwards are as follows: </font><font style="font-family:inherit;font-size:10pt;">$28.8 million</font><font style="font-family:inherit;font-size:10pt;"> between 2018 and 2023 and </font><font style="font-family:inherit;font-size:10pt;">$129.0 million</font><font style="font-family:inherit;font-size:10pt;"> between 2027 and 2037.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's state net operating loss carryforwards as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> after considering remaining IRC Section&#160;382 limitations are </font><font style="font-family:inherit;font-size:10pt;">$19.1 million</font><font style="font-family:inherit;font-size:10pt;"> which expire in various years from 2018 to 2038.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (&#8220;Tax Reform Act&#8221;). The legislation significantly changes U.S. tax law by, among other things, lowering corporate income tax rates, implementing a territorial tax system, expanding the tax base and imposing a tax deemed repatriated earnings of foreign subsidiaries.&#160; The Tax Reform Act permanently reduces the U.S. corporate federal income tax rate from a maximum of 35% to a flat 21% rate, effective January 1, 2018. </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s estimated fiscal 2018 blended U.S. federal statutory corporate income tax rate of </font><font style="font-family:inherit;font-size:10pt;">28.6%</font><font style="font-family:inherit;font-size:10pt;"> was applied in the computation of the income tax provision for the year ended May 31, 2018 and represents the average rate between the pre-enactment U.S. federal statutory corporate tax rate of </font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;"> and the post-enactment U.S. federal statutory corporate tax rate of </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;"> thereafter.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2017, the Securities and Exchange Commission staff issued Staff Accounting Bulletin No. 118 (SAB 118), which addresses how a company recognizes provisional amounts when a company does not have the necessary information available, prepared or analyzed (including computations) in reasonable detail to complete its accounting for the effect of the changes in the Tax Reform Act. The measurement period ends when a company has obtained, prepared and analyzed the information necessary to finalize its accounting, but cannot extend beyond one year that begins on the date of enactment of December 22, 2017. The Company has elected to apply the measurement period guidance provided in SAB 118. The final impact of the Tax Reform Act may differ from the estimates reported due to, among other things, changes in interpretations and assumptions made by us, additional guidance that may be issued by the U.S. Department of the Treasury and actions that we may take as a result.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has estimated the provision for incomes taxes in accordance with the Tax Reform Act and guidance available as of the date of this filing and as a result recorded a provisional amount of one-time income tax benefit of </font><font style="font-family:inherit;font-size:10pt;">$9.3 million</font><font style="font-family:inherit;font-size:10pt;"> in the third quarter of fiscal year 2018, the period in which the legislation was enacted.  This estimate has not changed as of May 31, 2018.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due to various uncertainties as described above, the Company has not completed its accounting for certain tax impacts of the Act.  A discussion of the most significant impacts of tax law changes under the Act for which the accounting is incomplete is as follows:</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is required to record deferred tax assets and liabilities based on the enacted tax rates at which they are expected to reverse in the future.  The Company has remeasured its deferred tax positions as of December 31, 2017 at the new enacted tax rate, resulting in a decrease to it net deferred tax assets and a corresponding decrease to its valuation allowance, with no net impact to tax expense. The Company recorded an income tax benefit of approximately </font><font style="font-family:inherit;font-size:10pt;">$9.3 million</font><font style="font-family:inherit;font-size:10pt;"> due to the revaluation of the naked credit deferred tax liability.</font><font style="font-family:Arial;font-size:10pt;">  </font><font style="font-family:inherit;font-size:10pt;">The Tax Reform Act changed the NOL carryover rules and created a new limitation on their use.  NOLs created in fiscal 2018 and beyond may be carried forwarded indefinitely in any year. As a result, the Company&#8217;s naked credit deferred tax liability can now be considered as a source of income to recover indefinite lived NOLs.  Consequently, the Company has offset certain of its naked credit deferred tax liability against its deferred tax assets resulting in a reduction in the valuation allowance and a </font><font style="font-family:inherit;font-size:10pt;">$3.0 million</font><font style="font-family:inherit;font-size:10pt;"> benefit in the year ended May 31, 2018.  </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Tax Reform Act imposes a one-time transition tax on the deemed repatriation of post-1986 undistributed foreign subsidiaries&#8217; earnings. Based on the information available as of December 31, 2017, the Company estimated undistributed foreign earnings of approximately </font><font style="font-family:inherit;font-size:10pt;">$4.9 million</font><font style="font-family:inherit;font-size:10pt;">. The taxable income arising from this deemed repatriation is expected to result in the utilization of net operating loss carryforwards and other tax credits, offset by changes in the valuation allowance, resulting in no net impact to tax expense.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:52px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Tax Reform Act also creates a new requirement that certain income earned by foreign subsidiaries (&#8220;GILTI&#8221;), must be included in U.S. gross income. The FASB allows an accounting policy election of either recognizing deferred taxes for temporary differences expected to reverse as GILTI in future years or recognizing such taxes as a current period expense when incurred.  The Company has not yet adopted an accounting policy.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The other provisions of the Tax Reform Act are not expected to have a material impact on the Company's financial statements.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company regularly assesses its ability to realize its deferred tax assets. Assessing the realization of deferred tax assets requires significant management judgment. In determining whether its deferred tax assets are more likely than not realizable, the Company evaluated all available positive and negative evidence, and weighted the evidence based on its objectivity. Evidence the Company considered included its history of net operating losses, which resulted in the Company recording a full valuation allowance for its deferred tax assets in fiscal 2016 and each year thereafter. The Company was marginally profitable (pretax and adjusted for permanent items) on a cumulative basis for the three years ended May 31, 2018, but substantially all of that profitability was achieved during 2018. </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on the review of all available evidence, the Company determined that it has not yet attained a sustained level of profitability and the objectively verifiable negative evidence outweighed the positive evidence and therefore the Company has provided a valuation allowance for the full amount, with the exception of the naked credit deferred tax liability, of its net deferred tax asset as of May 31, 2018.  The decrease in the valuation allowance during fiscal 2018 was principally due to the impact of tax reform as discussed above. The Company will continue to assess the level of the valuation allowance required. If sufficient positive evidence exists in future periods to support a release of some or all of the valuation allowance, such a release would likely have a material impact on the Company&#8217;s results of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's consolidated income tax expense has differed from the amount that would be provided by applying the U.S. Federal statutory income tax rate to the Company's income before income taxes for the following reasons:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax (benefit) expense at statutory tax rate of 28.6%, 35.0% and 35.0%, respectively</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,136</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,447</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of graduated tax rates</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(98</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State income taxes, net of Federal tax benefit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(215</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Impact of Non-U.S. operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(288</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">403</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(162</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development tax credit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(951</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(403</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(499</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Impact of tax reform </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,912</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Meals and entertainment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">242</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">266</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">329</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-deductible interest on contingent payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">174</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">262</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-taxable gain on revaluation of contingent consideration liability</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,576</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(170</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in valuation allowance</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,741</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,139</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,685</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of elimination of stock compensation APIC pool</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,380</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">739</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">IPR&amp;D intangible write-off</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,224</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">700</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">474</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax (benefit) expense</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,870</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,839</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,337</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a reconciliation of the beginning and ending amount of unrecognized tax benefits:</font></div><div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrecognized tax benefits balance at June 1 </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">899</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">899</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increase in gross amounts of tax positions related to prior years</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">899</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decrease in gross amounts of tax positions related to prior years due to U.S. tax reform</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(287</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decrease due to lapse in statute of limitations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(148</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrecognized tax benefits balance at May 31</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">464</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">899</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">899</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table above includes unrecognized tax benefits associated with the calculation of limitations placed on the utilization of tax attributes related to an acquired company. If recognized </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;"> would result in adjustments to other tax accounts. &#160; </font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense. There are no accrued interest and penalties recognized in the consolidated balance sheet as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company files income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. In the normal course of business the Company is subject to examination by taxing authorities throughout the world.  Fiscal years 2015 through 2018 remain open to examination by the various tax authorities. </font></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company does not anticipate that the amount of unrecognized tax benefits will significantly change in the next twelve months.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The accumulated undistributed earnings of the Company&#8217;s foreign operations amounted to </font><font style="font-family:inherit;font-size:10pt;">$4.9 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$5.3 million</font><font style="font-family:inherit;font-size:10pt;"> at May 31, 2018 and 2017, respectively. These earnings are considered indefinitely reinvested.  Beginning in 2018, except for GILTI, the Company will no longer record United States federal income tax on its share of the income of its foreign subsidiaries, nor will it record a benefit for foreign tax credits related to that income.&#160; Upon distribution of these earnings in the form of dividends or otherwise, the Company would be subject to withholding taxes payable, where applicable, to foreign countries, but would have no further federal income tax liability.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6878833120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCRUED LIABILITIES</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ACCRUED LIABILITIES</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, accrued liabilities consist of the following:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May&#160;31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payroll and related expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,235</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,383</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalties</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,537</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,885</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued severance</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,940</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,075</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales and franchise taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">683</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">856</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outside services</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,396</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,622</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Litigation matters (Note 15)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acculis recall liability</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,563</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,135</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,920</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,426</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,804</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth quarter of fiscal year 2017, the Company issued a voluntary recall of its Acculis probes that were sold over the past </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> years and recorded a liability of </font><font style="font-family:inherit;font-size:10pt;">$2.6 million</font><font style="font-family:inherit;font-size:10pt;">.  In the third quarter of fiscal year 2018, the Company completed the replacement of Acculis probes that were returned for Solero probes.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6873526912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">LONG-TERM DEBT</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LONG-TERM DEBT</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 7, 2016, the Company entered into a Credit Agreement with the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, Bank of America, N.A. and Keybank National Association as co-syndication agents, and JPMorgan Chase Bank, N.A., Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated and Keybank National Association as joint bookrunners and joint lead arrangers.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Credit Agreement provides for a </font><font style="font-family:inherit;font-size:10pt;">$100.0 million</font><font style="font-family:inherit;font-size:10pt;"> senior secured term loan facility and a </font><font style="font-family:inherit;font-size:10pt;">$150.0 million</font><font style="font-family:inherit;font-size:10pt;"> senior secured revolving credit facility, which includes up to a </font><font style="font-family:inherit;font-size:10pt;">$20.0 million</font><font style="font-family:inherit;font-size:10pt;"> sublimit for letters of credit and a </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;"> sublimit for swingline loans.  </font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 7, 2016, the Company borrowed </font><font style="font-family:inherit;font-size:10pt;">$100.0 million</font><font style="font-family:inherit;font-size:10pt;"> under the Term Loan and approximately </font><font style="font-family:inherit;font-size:10pt;">$16.5 million</font><font style="font-family:inherit;font-size:10pt;"> under the Revolving Facility to repay the balance of </font><font style="font-family:inherit;font-size:10pt;">$116.5 million</font><font style="font-family:inherit;font-size:10pt;"> under the former credit agreement.  As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> the carrying value of long-term debt approximates its fair market value.  </font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The proceeds of the Revolving Facility may be used for general corporate purposes of the Company and its subsidiaries. The Facilities have a </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> year maturity.&#160; Interest on both the Term Loan and Revolving Facility are based on a base rate or Eurodollar rate plus an applicable margin which increases as total leverage ratio increases, with the base rate and Eurodollar rate having ranges of </font><font style="font-family:inherit;font-size:10pt;">0.50%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">1.25%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">1.50%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">2.25%</font><font style="font-family:inherit;font-size:10pt;"> respectively.  In case of default, the interest rate may be increased by </font><font style="font-family:inherit;font-size:10pt;">2.0%</font><font style="font-family:inherit;font-size:10pt;">.&#160;The Revolving Facility carries a commitment fee of </font><font style="font-family:inherit;font-size:10pt;">0.20%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">0.35%</font><font style="font-family:inherit;font-size:10pt;">&#160;per annum on the unused portion.  The interest rate on the Term Loan at </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">3.41%</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's obligations under the Facilities are unconditionally guaranteed, jointly and severally, by the Company's material direct and indirect domestic subsidiaries (the &#8220;Guarantors&#8221;). All obligations of the Company and the Guarantors under the Facilities are secured by first priority security interests in substantially all of the assets of the Company and the Guarantors.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Credit Agreement includes customary representations, warranties and covenants, and acceleration, indemnity and events of default provisions, including, among other things, two quarterly financial covenants as follows:&#160;</font></div><div style="line-height:120%;padding-left:48px;padding-top:16px;text-indent:32px;"><font style="padding-top:16px;font-family:inherit;font-size:10pt;padding-right:16px;">&#8226;</font><font style="font-family:inherit;font-size:10pt;">maximum leverage ratio of consolidated total indebtedness* to consolidated EBITDA* of not greater than </font><font style="font-family:inherit;font-size:10pt;">3.50</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">1.00</font><font style="font-family:inherit;font-size:11pt;"> </font><font style="font-family:inherit;font-size:10pt;">(during certain periods following material acquisitions shall be increased to </font><font style="font-family:inherit;font-size:10pt;">3.75</font><font style="font-family:inherit;font-size:10pt;"> to 1.00). </font></div><div style="line-height:120%;padding-left:48px;padding-top:16px;text-indent:32px;"><font style="padding-top:16px;font-family:inherit;font-size:10pt;padding-right:16px;">&#8226;</font><font style="font-family:inherit;font-size:10pt;"> fixed charge coverage ratio of consolidated EBITDA minus consolidated capital expenditures to&#160;consolidated interest expense paid or payable in cash plus scheduled principal payments in respect of indebtedness under the Credit Agreement of not less than </font><font style="font-family:inherit;font-size:10pt;">1.25</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">1.00</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:16px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">* The definitions of consolidated total indebtedness and consolidated EBITDA are maintained in the credit agreement included as an exhibit to Form 8-k filed on November 10, 2016 and in Amendment One, dated May 24, 2018 and included as an exhibit to the fiscal 2018 Form 10-K. This amendment increased the amount of U.S. cash that can be utilized to calculate net debt from </font><font style="font-family:inherit;font-size:8pt;">$10.0 million</font><font style="font-family:inherit;font-size:8pt;"> to </font><font style="font-family:inherit;font-size:8pt;">$20.0 million</font><font style="font-family:inherit;font-size:8pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company was in compliance with both covenants as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's maturities of principal obligations under the credit agreement are as follows, as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:90%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,750</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total term loan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revolving facility</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Unamortized debt issuance costs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(879</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91,621</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Current portion of long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total long-term debt, net of current portion</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86,621</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6878778656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">RETIREMENT PLANS</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RETIREMENT PLANS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has a 401(k) plan under which eligible employees can defer a portion of their compensation, part of which is matched by the Company. Matching contributions were </font><font style="font-family:inherit;font-size:10pt;">$3.9 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$4.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$3.7 million</font><font style="font-family:inherit;font-size:10pt;"> in </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. There are also various immaterial foreign retirement plans.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6625785728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">STOCKHOLDERS&#8217; EQUITY </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Capitalization</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 29, 2014, the Board of Directors approved the Amended and Restated Certificate of Incorporation (the &#8220;Amended Certificate&#8221;). Under the Amended Certificate, the authorized capital stock is </font><font style="font-family:inherit;font-size:10pt;">80,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares, consisting of </font><font style="font-family:inherit;font-size:10pt;">75,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock, par value </font><font style="font-family:inherit;font-size:10pt;">$.01</font><font style="font-family:inherit;font-size:10pt;"> per share and </font><font style="font-family:inherit;font-size:10pt;">5,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares of preferred stock, par value </font><font style="font-family:inherit;font-size:10pt;">$.01</font><font style="font-family:inherit;font-size:10pt;"> per share. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The holders of common stock are entitled to </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> vote for each share held. Subject to preferences applicable to any outstanding shares of preferred stock, the holders of common stock are entitled to receive ratably dividends, if any, as may be declared by the Board of Directors out of funds legally available for dividend payments. If the Company liquidates, dissolves, or winds up, the holders of common stock are entitled to share ratably in all assets remaining after payment of liabilities and liquidation preferences of any outstanding shares of preferred stock. Holders of common stock have no pre-emptive rights or rights to convert their common stock into any other securities. There are no redemption or sinking fund provisions applicable to the common stock. The rights, preferences and privileges of the holders of common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that the Company may designate in the future.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The board of directors has the authority to (i)&#160;issue the undesignated preferred stock in one or more series, (ii)&#160;determine the powers, preferences and rights and the qualifications, limitations or restrictions granted to or imposed upon any wholly un-issued series of undesignated preferred stock and (iii)&#160;fix the number of shares constituting any series and the designation of the series, without any further vote or action by the Company's stockholders.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Stock Options</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">2004 Stock and Incentive Award Plan</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2004 Stock and Incentive Award Plan (the &#8220;2004 Plan&#8221;) provides for the grant of incentive options to employees and for the grant of non-statutory stock options, restricted stock, stock appreciation rights, performance units, performance shares and other incentive awards to employees, directors and other service providers. A total of </font><font style="font-family:inherit;font-size:10pt;">7,000,000</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock have been reserved for issuance under the 2004 Plan, of which up to </font><font style="font-family:inherit;font-size:10pt;">800,000</font><font style="font-family:inherit;font-size:10pt;"> shares may be issued upon the exercise of incentive stock options. The compensation committee of the Board of Directors administers the 2004 Plan. The committee determines vesting terms and the exercise price of options granted under the 2004 Plan, but for all incentive stock options the exercise price must at least be equal to the fair market value of common stock on the date of grant. The term of an incentive stock option may not exceed </font><font style="font-family:inherit;font-size:10pt;">ten years</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October&#160;25, 2016, the Company amended the 2004 Stock and Incentive Award Plan to increased the shares of common stock reserved for issuance by </font><font style="font-family:inherit;font-size:10pt;">250,000</font><font style="font-family:inherit;font-size:10pt;"> shares.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, there remained approximately </font><font style="font-family:inherit;font-size:10pt;">1.8 million</font><font style="font-family:inherit;font-size:10pt;"> shares available for granting under the 2004 Plan. </font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes information about stock option activity for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted-</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">exercise</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">remaining</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">contractual</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">life</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Aggregate</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">intrinsic</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">value (in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">thousands)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at beginning of year - June 1, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,667,443</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.01</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">518,498</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(271,344</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.83</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(204,184</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.75</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at end of year - May 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,696,413</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.58</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,520</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options exercisable at year-end</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">652,543</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.41</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.48</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,321</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options expected to vest in future periods</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,043,870</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.05</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,199</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock options are granted at exercise prices equal to the quoted market price of common stock at the date of the grant. Options vest </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;">&#160;per year over </font><font style="font-family:inherit;font-size:10pt;">four years</font><font style="font-family:inherit;font-size:10pt;"> for employees.  Grants to directors vest </font><font style="font-family:inherit;font-size:10pt;">33.33%</font><font style="font-family:inherit;font-size:10pt;">&#160;per year over </font><font style="font-family:inherit;font-size:10pt;">three years</font><font style="font-family:inherit;font-size:10pt;">.  Stock options granted prior to May 1, 2007 and after June 1, 2017 expire on the tenth anniversary of the grant date.  Stock options granted between May 1, 2007 through May 31, 2017 expire on the seventh anniversary of the grant date. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company measures the fair value of each stock option grant at the date of grant using a Black-Scholes option pricing model.  The weighted average grant-date fair value of options granted during the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$4.95</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$4.70</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$4.16</font><font style="font-family:inherit;font-size:10pt;">, respectively.  The following assumptions were used in arriving at the fair value of options granted during </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively:  risk-free interest rates of </font><font style="font-family:inherit;font-size:10pt;">2.08%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">1.30%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">1.48%</font><font style="font-family:inherit;font-size:10pt;">; expected volatility of </font><font style="font-family:inherit;font-size:10pt;">30%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">31%</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">31%</font><font style="font-family:inherit;font-size:10pt;">; and expected lives of </font><font style="font-family:inherit;font-size:10pt;">4.72 years</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">4.80 years</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">4.81 years</font><font style="font-family:inherit;font-size:10pt;">.  The Company does not declare dividends therefore a dividend yield of zero was used for the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">.  Risk-free interest rates reflect the yield on zero-coupon U.S. Treasury bonds whose maturity period equals the expected term of the option.  Expected volatilities are based on the historical volatility of the Company's stock.  The expected option lives are based on historical experience of employee exercise behavior. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The total intrinsic value of options exercised during the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$2.8 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.  As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, there was </font><font style="font-family:inherit;font-size:10pt;">$3.9 million</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation cost related to non-vested options, which is expected to be recognized over a weighted average period of </font><font style="font-family:inherit;font-size:10pt;">3 years</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Cash received from option exercises during 2018, 2017 and 2016 was </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$9.9 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.  The tax benefit realized from stock options exercised during the year ended May 31, </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">.  Due to the valuation allowance there was </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> tax benefit realized from stock option exercises during the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Performance Share and Restricted Stock Unit Awards</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company grants restricted stock units to certain employees under the 2004 Plan which give the recipients the right to receive shares of Company stock upon vesting. The restricted stock unit awards vest in four equal annual installments beginning on the first anniversary of the grant date.  Restricted stock unit awards granted to directors vest&#160;over </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> year. Unvested restricted stock unit awards will be forfeited if the recipient ceases to be employed by the Company. </font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;The following table summarizes information about restricted stock unit activity for the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restricted Stock Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted&#160;Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Grant-Date&#160;Fair&#160;Value</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested at beginning of year, June 1, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">439,297</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.55</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">299,392</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.60</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(158,756</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canceled</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(105,431</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.25</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested at end of year, May 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">474,502</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.23</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of each restricted stock unit is the market price of Company stock on the date of grant.  The weighted average grant date fair value of restricted stock units granted during the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$16.60</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$16.54</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$15.21</font><font style="font-family:inherit;font-size:10pt;">, respectively.  The total intrinsic value of restricted stock units (meaning the fair value of the units on the date of vest) vesting during the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$2.7 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$2.9 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;">,&#160;respectively.  As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, there was </font><font style="font-family:inherit;font-size:10pt;">$5.1 million</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation cost related to non-vested restricted stock awards, which is expected to be recognized over a weighted average period of </font><font style="font-family:inherit;font-size:10pt;">3 years</font><font style="font-family:inherit;font-size:10pt;">.   </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company grants performance share awards to certain employees under the 2004 Plan which gives the recipients the right to receive shares of Company stock if certain criteria is met. The performance criteria is established by the compensation committee for vesting of the performance share awards and is determined by the achievement of relative total shareholder return ("TSR"). Performance share awards are subject to additional conditions, including the recipient&#8217;s continued employment with the Company. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;The following table summarizes information about performance unit award activity for the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Performance Unit Awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted&#160;Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Grant-Date&#160;Fair&#160;Value</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested at beginning of year, June 1, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">361,164</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.54</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135,135</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.83</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canceled</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(44,443</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.76</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested at end of year, May 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">451,856</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During fiscal years 2018, 2017 and 2016, we granted performance unit awards that include a three-year market condition.  Vesting of the performance unit awards is based on the Company's level of attainment of specified total shareholder return ("TSR") targets relative to the percentage appreciation of a specified index of companies for the respective three-year periods.  It is also subject to the continued employment of the grantees.  In order to estimate the fair value of such awards, we used a Monte Carlo Simulation valuation model on the date of the grant.  For the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, the weighted average grant date fair market value for new grants was </font><font style="font-family:inherit;font-size:10pt;">$23.83</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$22.61</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$18.07</font><font style="font-family:inherit;font-size:10pt;">, respectively.  Compensation cost is recognized over the performance period which is typically </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> years.  As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">0.5 million</font><font style="font-family:inherit;font-size:10pt;"> performance share units with a weighted average remaining contractual term of </font><font style="font-family:inherit;font-size:10pt;">2</font><font style="font-family:inherit;font-size:10pt;"> years and </font><font style="font-family:inherit;font-size:10pt;">$3.9 million</font><font style="font-family:inherit;font-size:10pt;"> of unrecognized compensation cost were outstanding. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Compensation Expense</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables represents the break out of share-based compensation included in the Company's consolidated statement of operations:</font></div><div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:60%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">119</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">299</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">172</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">554</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">314</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales and marketing</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,778</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,762</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,489</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,461</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,026</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,291</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition, restructuring and other items, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(218</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,061</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,912</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,183</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,240</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The income tax benefit on the compensation expense recognized for all share-based compensation arrangements was </font><font style="font-family:inherit;font-size:10pt;">$1.8 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$2.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> for the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, respectively.  The income tax benefit for 2018, 2017 and 2016 are negated by the full valuation allowance established as of May 31, 2016.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Employee Stock Purchase Plan</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Employee Stock Purchase Plan (the &#8220;Stock Purchase Plan&#8221;) provides a means by which employees (the &#8220;participants&#8221;) are given an opportunity to purchase the Company's common stock through payroll deductions.   A total of  </font><font style="font-family:inherit;font-size:10pt;">2,500,000</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock have been reserved for issuance under the Stock Purchase Plan.  Shares are offered through </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> purchase periods, each with duration of approximately </font><font style="font-family:inherit;font-size:10pt;">6 months</font><font style="font-family:inherit;font-size:10pt;">, commencing on the first business day of the first and third fiscal quarters. An employee is eligible to participate in an offering period if, on the first day of an offering period, he or she has been employed in a full-time capacity for at least </font><font style="font-family:inherit;font-size:10pt;">six months</font><font style="font-family:inherit;font-size:10pt;">, with a customary working schedule of </font><font style="font-family:inherit;font-size:10pt;">20 or more hours per week and more than five months in a calendar year</font><font style="font-family:inherit;font-size:10pt;">. Employees who own stock possessing </font><font style="font-family:inherit;font-size:10pt;">5%</font><font style="font-family:inherit;font-size:10pt;"> or more of the total combined voting power or value of all classes of stock are not eligible to participate in the Stock Purchase Plan. The purchase price of the shares of common stock acquired on each purchase date will be the lower of (i)&#160;</font><font style="font-family:inherit;font-size:10pt;">85%</font><font style="font-family:inherit;font-size:10pt;"> of the fair market value of a share of common stock on the first day of the offering period or (ii)&#160;</font><font style="font-family:inherit;font-size:10pt;">85%</font><font style="font-family:inherit;font-size:10pt;"> of the fair market value of a share of common stock on the last day of the purchase period, subject to adjustments made by the Board of Directors. The Stock Purchase Plan is intended to qualify as an &#8220;employee stock purchase plan&#8221; within the meaning of Section&#160;423 of the Internal Revenue Code.  During the year ended May 31, 2015, an additional </font><font style="font-family:inherit;font-size:10pt;">800,000</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company's common stock have been reserved for issuance under the Stock Purchase Plan.  During the year ended May 31, 2017, an additional </font><font style="font-family:inherit;font-size:10pt;">500,000</font><font style="font-family:inherit;font-size:10pt;"> shares of the Company's common stock were reserved for issuance under the Stock Purchase Plan.  </font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company uses the Black-Scholes option-pricing model to calculate the purchase date fair value of the shares issued under the Stock Purchase Plan and recognize expense related to shares purchased ratably over the offering period.  During the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">89,943</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">129,185</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">137,957</font><font style="font-family:inherit;font-size:10pt;"> shares, respectively, were issued at an average price of </font><font style="font-family:inherit;font-size:10pt;">$14.03</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$11.00</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$10.67</font><font style="font-family:inherit;font-size:10pt;">, respectively, under the Stock Purchase Plan.  As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">1.2</font><font style="font-family:inherit;font-size:10pt;"> million shares remained available for future purchases under the Stock Purchase Plan.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Share Repurchases</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On November 6, 2016, the Board of Directors approved the Repurchase Program under which they authorized the Company the option to repurchase up to&#160;</font><font style="font-family:inherit;font-size:10pt;">$25.0 million</font><font style="font-family:inherit;font-size:10pt;">&#160;of its outstanding common stock during the </font><font style="font-family:inherit;font-size:10pt;">twenty-four</font><font style="font-family:inherit;font-size:10pt;"> month period ending November 6, 2018.  During the second quarter of fiscal year 2017, the Company repurchased </font><font style="font-family:inherit;font-size:10pt;">500,000</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock in the open market at an aggregate cost of </font><font style="font-family:inherit;font-size:10pt;">$7.8 million</font><font style="font-family:inherit;font-size:10pt;"> under the Repurchase Program.  During the fourth quarter of fiscal year 2017, the Company repurchased </font><font style="font-family:inherit;font-size:10pt;">370,000</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock in the open market at an aggregate cost of </font><font style="font-family:inherit;font-size:10pt;">$5.7 million</font><font style="font-family:inherit;font-size:10pt;"> under the Repurchase Program.  As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$11.4 million</font><font style="font-family:inherit;font-size:10pt;"> remained available for repurchase under the Repurchase Program.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2017, the Company retired </font><font style="font-family:inherit;font-size:10pt;">642,305</font><font style="font-family:inherit;font-size:10pt;"> shares of treasury stock.  These retired shares are now included in the Company&#8217;s pool of authorized but unissued shares.  The retired stock had a carrying value of approximately </font><font style="font-family:inherit;font-size:10pt;">$9.9 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$0.01</font><font style="font-family:inherit;font-size:10pt;"> was the par value that was deducted from common stock and the remaining </font><font style="font-family:inherit;font-size:10pt;">$9.9 million</font><font style="font-family:inherit;font-size:10pt;"> was deducted from additional paid-in capital.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6873526912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">EARNINGS PER SHARE</font></div><div style="line-height:120%;padding-top:18px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings per share are based on the weighted average number of common shares outstanding.  In addition, diluted earnings per share include the dilutive effect of potential common stock consisting of stock options, restricted stock units and performance stock units, provided that the inclusion of such securities is not anti-dilutive.  In periods with a net loss, stock options and restricted stock units are not included in the computation of basic loss per share as the impact would be anti-dilutive. </font></div><div style="line-height:120%;padding-top:18px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table reconciles basic to diluted weighted average shares outstanding for the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:18px;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,074,797</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,616,859</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,161,383</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of dilutive securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">464,603</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342,391</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,539,400</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,959,250</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,161,383</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Securities excluded as their inclusion would be anti-dilutive</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,077,256</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,058,790</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,277,037</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6872666064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">COMMITMENTS AND CONTINGENCIES</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Leases</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is committed under non-cancelable operating leases for facilities and equipment. During fiscal </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, aggregate rental costs under all operating leases were approximately </font><font style="font-family:inherit;font-size:10pt;">$2.8 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2.5 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. Future annual payments under non-cancelable operating leases in the aggregate, of which one includes an escalation clause, with initial remaining terms of more than one year at </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, are summarized as follows (in thousands):</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:81%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,234</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,829</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">993</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">884</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023 and thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,668</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,608</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Commitments and Contingencies </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the Company's other future commitments and contingencies as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2023 and thereafter</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase obligations (1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56,201</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,751</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,243</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,485</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,189</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,533</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalties</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">667</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">166</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101,868</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,918</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,910</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,152</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,855</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,033</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The non-cancelable inventory purchase obligations are not reflected on our consolidated balance sheets under accounting principles generally accepted in the United States of America.</font></div></td></tr></table><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Legal Proceedings</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is involved in various legal proceedings, including commercial, intellectual property, product liability, and regulatory matters of a nature considered normal for its business. The Company accrues for amounts related to these matters if it is probable that a liability has been incurred, and an amount can be reasonably estimated. The Company discloses such matters when there is at least a reasonable possibility that a material loss may have been incurred. However, the Company cannot predict the outcome of any litigation or the potential for future litigation.</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">C.R. Bard, Inc. v. AngioDynamics, Inc.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January&#160;11, 2012, C.R. Bard, Inc. (&#8220;Bard&#8221;) filed a suit in the United States District Court of Utah claiming certain of our implantable port products infringe on&#160;</font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> U.S. patents held by Bard (the &#8220;Utah Action&#8221;). Bard&#8217;s Complaint sought unspecified damages and other relief. We filed petitions for reexamination in the U.S. Patent and Trademark Office (&#8220;USPTO&#8221;) seeking to invalidate all </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> patents asserted by Bard in the litigation. Our petitions were granted and </font><font style="font-family:inherit;font-size:10pt;">40 of Bard's 41 patent</font><font style="font-family:inherit;font-size:10pt;"> patent claims were rejected and, following further proceedings, the Patent Office issued a Final Rejection of all </font><font style="font-family:inherit;font-size:10pt;">40</font><font style="font-family:inherit;font-size:10pt;"> claims subject to reexamination. Thereafter, Bard filed appeals to the USPTO Board of Appeals and Interferences for all&#160;three&#160;reexaminations. The Patent Office issued decisions in all </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> appeals. In one (issued on March 11, 2016 for U.S. Patent No. 7,785,302), the rejections of </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> of the </font><font style="font-family:inherit;font-size:10pt;">ten</font><font style="font-family:inherit;font-size:10pt;"> claims under reexamination were affirmed, but were reversed on </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> of the ten claims. &#160;&#160;In the second (issued on March 24, 2016 for U.S. Patent No. 7,959,615), the rejections of&#160;</font><font style="font-family:inherit;font-size:10pt;">eight</font><font style="font-family:inherit;font-size:10pt;"> of the </font><font style="font-family:inherit;font-size:10pt;">ten</font><font style="font-family:inherit;font-size:10pt;"> claims under reexamination were affirmed but the rejections of the other </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> of the ten claims were reversed. In the third (issued on March 29 for U.S. Patent No. 7,947.022) the rejections of all&#160; </font><font style="font-family:inherit;font-size:10pt;">twenty</font><font style="font-family:inherit;font-size:10pt;"> claims under reexamination were affirmed. Thereafter, Bard filed Requests for Rehearing in all&#160;</font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> reexamination appeals and the Company filed Requests for Rehearing in </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> of the reexamination appeals (the &#8216;302 and &#8216;615 patent reexaminations). The PTO denied all three Rehearing Requests - - on February 1, 2017 for the &#8216;302 reexam; on February 17, 2017 for the &#8216;022 reexam; and on February 21, 2017 for the &#8216;615 reexam, but modified its characterization of one prior art reference for the &#8216;302 and &#8216;022 decisions.&#160; Bard filed a Notice of Appeal to the Federal Circuit Court of Appeals in all three reexams and the Company filed Cross-Appeals for the &#8216;302 and the &#8216;615 reexams. The parties have completed the process of filing the various appellate briefs. &#160;MedComp also filed an Amicus Brief in support of the Company on November 22, 2017. A date for the oral hearing has not yet been set. The Utah Action has been stayed pending final resolution of the USPTO process.&#160;We believe these claims are without merit and intend to defend them vigorously. We have not recorded an expense related to the outcome of this litigation because it is not yet possible to determine if a potential loss is probable nor reasonably estimable.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 10, 2015, C.R. Bard, Inc. (&#8220;Bard&#8221;) and Bard Peripheral Vascular, Inc. (&#8220;BPV&#8221;) filed suit in the United States District Court for the District of Delaware claiming certain of our implantable port products infringe on&#160; </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> U.S. patents held by Bard (the &#8220;Delaware Action&#8221;). Bard's complaint seeks unspecified damages and other relief. The patents asserted in the Delaware Action are different than those asserted in the Utah Action. On June 1, 2015, the Company filed </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> motions in response to Bard&#8217;s Complaint - one sought transfer to the District of Utah where the Utah Action is currently pending, and the other sought dismissal of the entire complaint on grounds that none of the claims in the asserted patents is directed to patent eligible subject matter under Section 101 of the Patent Statute and in light of recent authority from the U. S. Supreme Court. On January 12, 2016, the Court issued a decision denying both motions. A Markman hearing was held on March 10, 2017 and the Court issued its Claim Construction Order on May 19, 2017. On May 19, 2017, Bard served its Final Infringement Contentions and on June 2, 2017, the Company served its Final Invalidity Contentions.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 20, 2017, the scheduling order for the case was amended to, among other things, set a trial date commencing July 23, 2018.&#160;The parties completed Expert Discovery in January 2018.  The parties completed briefing on their respective case dispositive motions on April 27, 2018. On June 26, 2018, the Court denied all case dispositive motions, ruling that issues of material fact remained in dispute. On July 9, 2018, the Court continued the trial to a later date to be determined by the Court and the parties.  We believe these claims are without merit and intend to defend them vigorously. We have not recorded an expense related to the outcome of this litigation because it is not yet possible to determine if a potential loss is probable nor reasonably estimable.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">AngioDynamics, Inc. v. C.R. Bard, Inc.  </font></div><div style="line-height:120%;text-align:left;text-indent:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 30, 2017, we commenced an action in the United States District Court for the Northern District of New York entitled AngioDynamics, Inc. v. C.R. Bard, Inc. and Bard Access Systems, Inc. (&#8220;Bard&#8221;). &#160;In this action, we allege that Bard has illegally tied the sales of its tip location systems to the sales of its PICCs.&#160; We allege that this practice violates the federal antitrust laws and has had, and continues to have, an anti-competitive effect in the market for PICCs.&#160; We seek both monetary damages and injunctive relief.  Bard moved to dismiss on September 8, 2017 and the motion has been submitted to the court.&#160; The court has adjourned the initial conference in the case pending its resolution of the motion to dismiss. </font></div><div style="line-height:120%;text-align:left;text-indent:64px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Governmental Investigations</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2014 we received a subpoena from the U.S. Department of Justice (the &#8220;DOJ&#8221;) requesting documents in relation to a criminal and civil investigation the DOJ is conducting regarding BTG International, Inc.&#8217;s LC Bead&#174;&#160;product beginning in 2003.&#160; RITA Medical Systems and AngioDynamics, Inc., after its acquisition of RITA, was the exclusive distributor of LC Beads in the United States from 2006 through December 31, 2011.&#160; We are cooperating fully with this investigation.  </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2015 we received a subpoena from the DOJ requesting documents in relation to a criminal and civil investigation the DOJ is conducting regarding purported promotion of certain of AngioDynamics&#8217; VenaCure EVLT products for un-cleared indications.&#160; We are cooperating fully with this investigation.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of May 31, 2017 the Company accrued </font><font style="font-family:inherit;font-size:10pt;">$12.5 million</font><font style="font-family:inherit;font-size:10pt;"> for these matters and in August 2017, the Company agreed in principle with the government to resolve these matters for approximately </font><font style="font-family:inherit;font-size:10pt;">$12.5 million</font><font style="font-family:inherit;font-size:10pt;">.  This amount was still accrued for at May 31, 2018 and was paid in the first quarter of fiscal year 2019.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6801975200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENTS AND GEOGRAPHIC INFORMATION</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SEGMENTS AND GEOGRAPHIC INFORMATION</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Segment information</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company considers its business to be a single segment entity related to the development, manufacture and sale on a global basis of medical devices for vascular access, surgery, peripheral vascular disease and oncology. The Company's chief operating decision maker (CEO) evaluates the various global product portfolios on a net sales basis. Executives reporting in to the CEO include those responsible for operations and supply chain management, research and development, sales, franchise marketing and certain corporate functions. The CEO evaluates profitability, investment and cash flow metrics on a consolidated worldwide basis due to shared infrastructure and resources. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total sales by product category are summarized below (in thousands):</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales by Product Category</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Peripheral Vascular</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">202,334</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208,602</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">205,620</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vascular Access</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92,760</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96,481</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99,375</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Oncology/Surgery</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,191</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,560</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,895</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">344,285</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349,643</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353,890</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Geographic information</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total sales for geographic areas are summarized below (in thousands):</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales by Geography</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">273,327</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282,168</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">285,824</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70,958</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67,475</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,066</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">344,285</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349,643</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353,890</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For fiscal years </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, International sales as a percentage of total net sales were </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">19%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">19%</font><font style="font-family:inherit;font-size:10pt;">, respectively. Sales to any </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> country outside the U.S., as determined by shipment destination, did not comprise a material portion of net sales in any of the last three fiscal years. In addition, no one customer represents more than 10% of consolidated net sales.  </font><font style="font-family:inherit;font-size:10pt;">99%</font><font style="font-family:inherit;font-size:10pt;"> of long-lived assets are located within the United States.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6801964784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition, Restructuring and Other Items, net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">ACQUISITION, RESTRUCTURING AND OTHER ITEMS, NET</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ACQUISITION, RESTRUCTURING AND OTHER ITEMS, NET</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> acquisition, restructuring and other items, net consisted of:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:47%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Legal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,067</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,480</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,487</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible and other asset impairment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,604</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">352</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,674</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,348</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,462</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">691</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,078</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,290</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,432</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,510</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,591</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Of the </font><font style="font-family:inherit;font-size:10pt;">$19.5</font><font style="font-family:inherit;font-size:10pt;"> million in legal for fiscal year 2017, </font><font style="font-family:inherit;font-size:10pt;">$12.5 million</font><font style="font-family:inherit;font-size:10pt;"> relates to a reserve for DOJ litigation settlement (see Note 15) and the remaining legal expenses relates to DOJ matters.  The remaining legal expenses relate to litigation that is outside of the normal course of business. </font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Restructuring</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluates its performance and looks for opportunities to improve the overall operations of the Company on an ongoing basis.  As a result of this evaluation, certain restructuring initiatives are taken to enhance the Company&#8217;s overall operations.  </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Operational Consolidation </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 1, 2017, the Company announced to employees an operational consolidation plan (the &#8220;plan&#8221;) to consolidate manufacturing facilities in Manchester, GA and Denmead, UK into the Glens Falls and Queensbury, NY facilities.  This plan will streamline and optimize the manufacturing functions into one centralized location increasing the utilization of the Glens Falls and Queensbury facilities, optimizing inventory and reducing cost of goods sold through savings in overhead expenses and direct labor.  The restructuring activities associated with the plan were completed in the fourth quarter of fiscal year 2018 with immaterial validation costs to be incurred in the first quarter of fiscal year 2019.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recorded restructuring charges related to the plan during the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> of </font><font style="font-family:inherit;font-size:10pt;">$4.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.  Total restructuring charges recorded as part of the plan were </font><font style="font-family:inherit;font-size:10pt;">$6.0 million</font><font style="font-family:inherit;font-size:10pt;">.  Termination benefits are only earned if an employee stays until their termination date; therefore, the expenses related to termination benefits are being recorded ratably over the service period.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents a rollforward of the restructuring reserve for the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25" rowspan="1"></td></tr><tr><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Contract</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Termination</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Plant </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Regulatory</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cancellation </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Benefits</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Consolidation</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Filings</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Costs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Costs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Charges</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">851</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">494</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,348</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-cash adjustments </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(108</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(108</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(275</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(278</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">851</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">962</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Charges</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,440</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,892</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,674</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-cash adjustments </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(276</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(276</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,453</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,706</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(56</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(74</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,289</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">838</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,071</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s restructuring liability of </font><font style="font-family:inherit;font-size:10pt;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;"> is mainly comprised of accruals for termination benefits which are expected to be paid in the next twelve months and are included in accrued expenses on the consolidated balance sheet.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6801981104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">ACCUMULATED OTHER COMPREHESIVE INCOME (LOSS)</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ACCUMULATED OTHER COMPREHESIVE INCOME (LOSS)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in each component of accumulated other comprehensive income (loss), net of tax, are as follows for fiscal </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign currency translation gain (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unrealized gain (loss) on marketable securities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(760</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(791</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss) before reclassifications, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(545</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(533</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reclassified from accumulated other comprehensive income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net other comprehensive income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(545</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(533</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,305</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,324</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income before reclassifications, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">372</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reclassified from accumulated other comprehensive income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net other comprehensive income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">372</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,035</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(952</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6608617024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Information (unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">QUARTERLY INFORMATION (unaudited)</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">QUARTERLY INFORMATION (unaudited)</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quarterly results of operations during the fiscal years ended May 31, </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> are as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">First</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Second</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Third</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fourth</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands, except per share data)</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85,411</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86,706</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,851</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,317</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,229</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,731</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,448</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,467</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) </font><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">249</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings (loss) per common share</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.00</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.06</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.00</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.01</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.37</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.06</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">First</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Second</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Third</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fourth</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands, except per share data)</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,098</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,029</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85,602</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86,914</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,032</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,010</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,792</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,335</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) </font><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,734</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,887</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,913</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings (loss) per common share</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.04</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.08</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.04</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.37</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.08</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.35</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1) Included within net income during the third quarter of fiscal 2018 is a </font><font style="font-family:inherit;font-size:10pt;">$9.3 million</font><font style="font-family:inherit;font-size:10pt;"> discrete tax benefit as a result of the Tax Reform Act and the revaluation of the Company's deferred tax assets, liabilities and valuation allowance to reflect the lower U.S. federal statutory rate (see Note 9).</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2) Included within net income (loss) during the fourth quarter of fiscal 2017 is the </font><font style="font-family:inherit;font-size:10pt;">$12.5 million</font><font style="font-family:inherit;font-size:10pt;"> charge for a litigation reserve (see Note 15) and </font><font style="font-family:inherit;font-size:10pt;">$4.5 million</font><font style="font-family:inherit;font-size:10pt;"> impact relating to the Acculis recall (see Note 10).  </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The data in the schedules above has been intentionally rounded to the nearest thousand and therefore the quarterly&#160;&#160;&#160;&#160; amounts may not sum to the full year amounts.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6801981104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Valuation and Qualifying Accounts<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">VALUATION AND QUALIFYING ACCOUNTS</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;"></font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:46%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">SCHEDULE&#160;II&#160;-VALUATION&#160;AND&#160;QUALIFYING&#160; ACCOUNTS</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Column A</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Column&#160;B</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Column&#160;C</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Column&#160;D</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Column&#160;E</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Description</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance&#160;at</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Beginning</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">of&#160;Year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Additions&#160;-</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Charged&#160; to</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">costs and</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deductions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Balance&#160;at</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">End&#160;of&#160;Period</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year Ended May&#160;31, 2016</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for deferred tax asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,791</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,685</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(267</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,209</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for sales returns and doubtful accounts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,043</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,748</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,419</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,372</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year Ended May&#160;31, 2017</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for deferred tax asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,209</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,348</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for sales returns and doubtful accounts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,372</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(291</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,136</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,945</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Year Ended May&#160;31, 2018</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for deferred tax asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,348</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,741</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26,607</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowance for sales returns and doubtful accounts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,945</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">608</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,087</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,466</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6889028464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation, Business Description and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Description of Business</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation and Description of Business</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of AngioDynamics, Inc. and its wholly owned subsidiaries,  (collectively, the &#8220;Company&#8221;).  The Company designs, manufactures and sells a wide range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and in oncology and surgical settings. The devices are generally used in minimally invasive, image-guided procedures. Most of the Company's products are intended to be used once and then discarded, or they may be temporarily implanted for short- or long-term use. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounting Principles</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements and accompanying notes have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP").</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Principles of Consolidation</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of AngioDynamics and it subsidiaries (all of which are wholly owned).  All intercompany balances and transactions have been eliminated.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements, in conformity with accounting principles generally accepted in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect reported amounts of sales and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cash and Cash Equivalents</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company considers all unrestricted highly liquid investments with an initial maturity of </font><font style="font-family:inherit;font-size:10pt;">less than three months</font><font style="font-family:inherit;font-size:10pt;"> at the date of purchase to be cash equivalents. The Company maintains cash and cash equivalent balances with financial institutions in the United States in excess of amounts insured by the Federal Deposit Insurance Corporation.</font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Marketable Securities</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable securities, which include auction rate investments, are classified as &#8220;available-for-sale securities&#8221; and are reported at fair value, with unrealized gains and losses excluded from operations and reported as a component of accumulated other comprehensive income (loss), net of the related tax effects, in stockholders&#8217; equity. Cost is determined using the specific identification method. The Company holds an investment in auction rate securities in order to generate higher than typical money market rate investment returns. Auction rate securities typically are high credit quality, generally achieved with municipal bond insurance. </font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value Instruments</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fair Value Instruments</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The carrying amount of the Company's cash and cash equivalents, accounts receivable, accounts payable and long-term debt approximates fair value due to the short-term nature or market interest rates of these items. The Company bases the fair value of short-term investments on quoted market prices or other relevant information generated by market transactions involving identical or comparable assets. The Company measures and records derivative financial instruments at fair value. See Note 3 for further discussion of financial instruments that are carried at fair value on a recurring and nonrecurring basis.</font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounts Receivable</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable, principally trade receivables, are generally due within </font><font style="font-family:inherit;font-size:10pt;">30</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">90</font><font style="font-family:inherit;font-size:10pt;"> days and are stated at amounts due from customers, net of an allowance for estimated sales returns and doubtful accounts. The Company performs ongoing credit evaluations of customers and adjusts credit limits based upon payment history and the customer&#8217;s current creditworthiness, as determined by a review of their current credit information. The Company continuously monitors aging reports, collections and payments from customers, and a provision for estimated credit losses is maintained based upon historical experience and any specific customer collection issues that have been identified. While such credit losses have historically been within expectations and the provisions established, the Company cannot guarantee that the same credit loss rates will be experienced in the future. The Company writes off accounts receivable when they are determined to be uncollectible.</font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Inventories</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories are stated at the lower of cost (using the first-in, first-out method) or market. Appropriate consideration is given to deterioration, obsolescence, expiring and other factors in evaluating net realizable value.</font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Property, Plant and Equipment</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets.  Refer below for useful lives by category:</font></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:79%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated useful lives</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and building improvements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Machinery and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 to 8 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer software and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3 to 5 years</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:6px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluates property, plant and equipment for impairment periodically to determine if changes in circumstances or the occurrence of events suggest the carrying value of the asset or asset group may not be recoverable. Expenditures for repairs and maintenance are charged to expense as incurred. Renewals and betterments are capitalized.</font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill and Intangible Assets</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets other than goodwill and acquired IP R&amp;D are amortized over their estimated useful lives, on either a straight-line basis or proportionately to the benefit being realized.  Useful lives range from </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">eighteen</font><font style="font-family:inherit;font-size:10pt;"> years. The Company periodically reviews the estimated useful lives of intangible assets and reviews such assets for impairment whenever events or changes in circumstances indicate that the carrying value of the asset or asset group is not recoverable.  If an intangible asset or asset group is considered to be impaired, the amount of the impairment will equal the excess of the carrying value over the fair value of the asset.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill is the amount by which the cost of acquired net assets in a business combination exceeded the fair value of net identifiable assets on the date of purchase.  Goodwill and other intangible assets that have indefinite useful lives are not amortized, but rather, are tested for impairment annually or more frequently if impairment indicators arise. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For goodwill, the impairment test requires a comparison of the estimated fair value of the reporting unit to which the goodwill is assigned to carrying value of the assets and liabilities of that reporting unit. The determination of reporting units also requires management judgment. The Company considers whether a reporting unit exists within a reportable segment based on the availability of discrete financial information. If carrying value of the reporting unit exceeds the fair value of the reporting unit, the carrying value of the reporting unit&#8217;s goodwill is reduced to its fair value through an adjustment to the goodwill balance, resulting in an impairment charge. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's annual testing for impairment of goodwill was completed as of December 31, 2017. The Company operates as a single operating segment with </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> reporting unit and consequently evaluates goodwill for impairment based on an evaluation of the fair value of the Company as a whole. The Company determines the fair value of the reporting unit based on the market valuation approach and concluded that it was not more-likely-than-not that the fair value of the Company's reporting unit was less than its carrying value.</font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Contingent Consideration</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contingent Consideration</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of the liability for contingent consideration recorded on the acquisition date for a business combination is based on probability weighted estimated cash flow streams, discounted back to present value using a discount rate determined in accordance with accepted valuation methods and reflective of the risk associated with the estimated cash flow streams. The liability for contingent consideration is remeasured to fair value at each reporting period with changes recorded in earnings until the contingency is resolved.</font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes revenue when the following four criteria has been met: (i)&#160;persuasive evidence that an arrangement exists; (ii)&#160;the price is fixed or determinable; (iii)&#160;collectability is reasonably assured; and (iv)&#160;product delivery has occurred or services have been rendered. The Company recognizes revenue, net of sales taxes assessed by any governmental authority, as products are shipped, based on shipping terms, and when title and risk of loss passes to customers. The Company negotiates shipping and credit terms on a customer-by-customer basis and products are shipped at an agreed upon price. All product returns must be pre-approved by the Company and customers may be subject to a </font><font style="font-family:inherit;font-size:10pt;">20%</font><font style="font-family:inherit;font-size:10pt;"> restocking charge. To be accepted, a returned product must be unadulterated, undamaged and have at least </font><font style="font-family:inherit;font-size:10pt;">twelve months</font><font style="font-family:inherit;font-size:10pt;"> remaining prior to its expiration date.  Charges for discounts, returns, rebates and other allowances are recognized as a deduction from revenue on an accrual basis in the period in which the revenue is recorded. The accrual for product returns, discounts and other allowances is based on the Company&#8217;s history. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shipping and handling costs, associated with the distribution of finished products to customers, are recorded in costs of goods sold and are recognized when the related finished product is shipped to the customer. Amounts charged to customers for shipping are recorded in net sales.</font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Research and Development</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development costs, including salaries, consulting fees, building costs, utilities and administrative expenses that are related to developing new products, enhancing existing products, validating new and enhanced products, managing clinical, regulatory and medical affairs are expensed as incurred.</font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company calculates income tax expense for each jurisdiction in which it operates. This involves estimating actual current taxes due plus assessing temporary differences arising from differing treatment for tax and accounting purposes that are recorded as deferred tax assets and liabilities. The Company periodically evaluates deferred tax assets, capital loss carryforwards and tax credit carryforwards to determine their recoverability based primarily on the Company's ability to generate future taxable income and capital gains.  Where it is more-likely-than-not these will not be recovered, the Company estimates a valuation allowance and records a corresponding additional tax expense in the consolidated statement of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company recognizes and measures uncertain tax positions taken or expected to be taken in a tax return utilizing a two-step approach. The Company first determines if the weight of available evidence indicates that it is more likely than not that the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is that the Company measures the tax benefit as the largest amount that is more likely than not to be realized upon ultimate settlement. The Company recognizes interest and penalties related to uncertain tax positions in the provision for income taxes on the consolidated statements of operations.</font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Warranty Costs</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Warranty Costs</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company makes periodic provisions for expected warranty costs. Historically, warranty costs have been insignificant.</font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock Based Compensation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Stock Based Compensation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation expense reflects the fair value of stock-based awards measured at the grant date and recognized over the relevant service period. The Company estimates the fair value of each stock-based award on the measurement date using either the current market price of the stock, the Black-Scholes option valuation model, or the Monte Carlo Simulation valuation model. The Black-Scholes and Monte Carlo Simulation valuation models incorporate assumptions as to stock price volatility, the expected life of options or restricted stock units, a risk-free interest rate and dividend yield. The Company recognizes stock-based compensation expense related to options, restricted stock units and market based performance stock units on a straight-line basis over the service period of the award, which is generally </font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;"> years for options and restricted stock units and </font><font style="font-family:inherit;font-size:10pt;">3</font><font style="font-family:inherit;font-size:10pt;"> years for market based performance stock units.</font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Foreign Currency Translation</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The functional currency of the Company's foreign subsidiaries is the local currency in which the subsidiary operates. For foreign operations where the local currency is considered to be the functional currency, the Company translates assets and liabilities into U.S. dollars at the exchange rate on the balance sheet date. The Company translates income and expense items at average rates of exchange prevailing during each period. The Company accumulates translation adjustments in accumulated other comprehensive loss, a component of stockholders&#8217; equity.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transaction gains or losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in other expense in the statements of operations as incurred.</font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Derivative Financial Instruments</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is exposed to market risks, including changes in foreign currency and interest rates. The Company periodically enters into certain derivative financial instruments to hedge the underlying economic exposure. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative instruments are presented in the consolidated financial statements at their fair value. Changes in the fair value of derivative financial instruments are either recognized periodically in income or in stockholders&#8217; equity as a component of accumulated other comprehensive income (loss) depending on whether the derivative financial instrument qualifies for hedge accounting and, if so, whether it qualifies as a fair value or cash flow hedge. Generally, the changes in the fair value of derivatives accounted for as fair value hedges are recorded in income along with the portions of the changes in the fair value of hedged items that relate to the hedged risks. Changes in the fair value of derivatives accounted for as cash flow hedges, to the extent they are effective as hedges, are recorded in accumulated other comprehensive income (loss).</font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Contingencies</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is subject to various legal proceedings that arise in the ordinary course of business, including patent infringement and product liability matters. The Company records accruals for contingencies when it is probable the liability has been incurred and the amount can be reasonably estimated.  Legal fees are expensed as incurred. Insurance recoveries related to potential claims are recognized up to the amount of the recorded liability when coverage is confirmed and the estimated recoveries are probable of payment. These recoveries are not netted against the related liabilities for financial statement presentation.</font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a description of recent accounting pronouncements that may have a material effect on the Company's consolidated financial statements:  </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:33%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Issued Accounting Pronouncements - Adopted</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Standard</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Date Adopted</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Effect on the Consolidated Financial Statements</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2016-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation - Stock Based Compensation (Topic 718: Improvements to Employee Share-Based Payment Accounting)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This ASU simplifies and improves various aspects of ASC 718 for share-based payments, including income tax items and the classification of these items on the statement of cash flows.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2017</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company now recognizes unrealized excess tax benefits and will classify such benefits as an operating activity in the statement of cash flows on a prospective basis. Due to the full valuation allowance on our federal and state income taxes, the adoption of ASU 2016-09 did not impact our accounting for income taxes.                  </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company elected the accounting policy change to account for forfeitures as they occur.  This was adopted using the modified retrospective transition method by means of a cumulative-effect adjustment to equity as of June 1, 2017.  The adoption of ASU 2016-09 did not materially impact the Company's consolidated statements of income, consolidated balance sheet, equity or cash flows. </font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2017-04, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles - Goodwill and Other (Topic 350)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This ASU simplifies the subsequent measurement of goodwill by eliminating steps from the goodwill impairment test.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2017</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This adoption did not have an impact on the Company's financial statements.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASC Update No. 2015-11, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Inventory (Topic 330): Simplifying the Measurement of Inventory</font><font style="font-family:inherit;font-size:10pt;">. Update No. 2015-11</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This ASU more closely aligns the measurement of inventory in U.S. GAAP with the measurement of inventory in International Financial Reporting Standards by requiring companies using the first-in, first-out and average costs methods to measure inventory using the lower of cost and net realizable value, where net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2017</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This adoption did not have an impact on the Company's financial statements.</font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:33%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Issued Accounting Pronouncements - Not Yet Applicable or Adopted</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Standard</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Effective Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Effect on the Consolidated Financial Statements</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU No. 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers (Topic 606, ASU 2014-09)</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under Topic 606, an entity is required to recognize revenue upon transfer of promised goods or services to customers in an amount that reflects the expected consideration to be received in exchange for those goods or services. Topic 606 defines a five-step process in order to achieve this core principle, which may require the use of judgment and estimates, and also requires expanded qualitative and quantitative disclosures relating to the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers, including significant judgments and estimates used. The new standard also defines accounting for certain costs related to origination and fulfillment of contracts with customers, including whether such costs should be capitalized. </font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2018</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company established an implementation team which included third-party specialists to assist in the evaluation and implementation of the new standard. The Company&#8217;s assessment has included performing analysis for each revenue stream identified, assessing the potential differences in recognition and measurement that may result from adopting this standard and assessing whether the Company meets certain practical expedients. Based on the results of the assessment, the adoption of this standard will not have a material impact on the timing or amount of revenue recognized upon adoption and there is no cumulative prior period adjustment to be recorded to the opening balance of retained earnings upon adoption.  The Company will adopt the standard using the modified retrospective method. The Company is implementing changes to accounting policies, business processes and internal controls to support the new standard as necessary. Upon adoption of Topic 606, as the disclosure requirements under the new guidance have been significantly expanded in comparison to the disclosure requirements under the current guidance, we will provide additional disclosures in the notes to the consolidated financial statements, specifically related to performance obligations, the judgments made in revenue recognition determinations, costs to obtain or fulfill contracts and contract balances.</font></div><div style="padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU No. 2016-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (ASU 2016-15)</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This ASU identifies how certain cash receipts and cash payments are presented and classified in the Statement of Cash Flows under Topic 230.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2018</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This adoption is not expected to have a material impact on the Company's financial statements.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This ASU increases transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet and disclosing key information about leasing arrangements.  For leases with a term of twelve months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and liabilities.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2019</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is currently in the process of evaluating the impact of this ASU on its consolidated financial statements.</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6052-115624<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109250915&amp;loc=d3e13279-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32247-109318<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32280-109318<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66092785&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109236672&amp;loc=d3e543-108305<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66092785&amp;loc=d3e4492-108314<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for trade and other accounts receivable, and finance, loan and lease receivables, including those classified as held for investment and held for sale. This disclosure may include (1) the basis at which such receivables are carried in the entity's statements of financial position (2) how the level of the valuation allowance for receivables is determined (3) when impairments, charge-offs or recoveries are recognized for such receivables (4) the treatment of origination fees and costs, including the amortization method for net deferred fees or costs (5) the treatment of any premiums or discounts or unearned income (6) the entity's income recognition policies for such receivables, including those that are impaired, past due or placed on nonaccrual status and (7) the treatment of foreclosures or repossessions (8) the nature and amount of any guarantees to repurchase receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e4975-111524<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6878932064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation, Business Description and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, plant and equipment</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Refer below for useful lives by category:</font></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:79%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated useful lives</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and building improvements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Machinery and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 to 8 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer software and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3 to 5 years</font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, property, plant and equipment are summarized as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and building improvements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,887</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,597</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Machinery and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,668</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,434</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer software and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,899</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,668</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Construction in progress</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,153</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,464</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,607</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,163</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less accumulated depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(48,794</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49,652</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,813</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,511</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Land and land improvements</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,648</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,723</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,461</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,234</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Recent accounting pronouncements</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a description of recent accounting pronouncements that may have a material effect on the Company's consolidated financial statements:  </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:33%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Issued Accounting Pronouncements - Adopted</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Standard</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Date Adopted</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Effect on the Consolidated Financial Statements</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2016-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation - Stock Based Compensation (Topic 718: Improvements to Employee Share-Based Payment Accounting)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This ASU simplifies and improves various aspects of ASC 718 for share-based payments, including income tax items and the classification of these items on the statement of cash flows.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2017</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company now recognizes unrealized excess tax benefits and will classify such benefits as an operating activity in the statement of cash flows on a prospective basis. Due to the full valuation allowance on our federal and state income taxes, the adoption of ASU 2016-09 did not impact our accounting for income taxes.                  </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company elected the accounting policy change to account for forfeitures as they occur.  This was adopted using the modified retrospective transition method by means of a cumulative-effect adjustment to equity as of June 1, 2017.  The adoption of ASU 2016-09 did not materially impact the Company's consolidated statements of income, consolidated balance sheet, equity or cash flows. </font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2017-04, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles - Goodwill and Other (Topic 350)</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This ASU simplifies the subsequent measurement of goodwill by eliminating steps from the goodwill impairment test.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2017</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This adoption did not have an impact on the Company's financial statements.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASC Update No. 2015-11, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Inventory (Topic 330): Simplifying the Measurement of Inventory</font><font style="font-family:inherit;font-size:10pt;">. Update No. 2015-11</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This ASU more closely aligns the measurement of inventory in U.S. GAAP with the measurement of inventory in International Financial Reporting Standards by requiring companies using the first-in, first-out and average costs methods to measure inventory using the lower of cost and net realizable value, where net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2017</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This adoption did not have an impact on the Company's financial statements.</font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:34%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:33%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Recently Issued Accounting Pronouncements - Not Yet Applicable or Adopted</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Standard</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Description</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Effective Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Effect on the Consolidated Financial Statements</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU No. 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers (Topic 606, ASU 2014-09)</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Under Topic 606, an entity is required to recognize revenue upon transfer of promised goods or services to customers in an amount that reflects the expected consideration to be received in exchange for those goods or services. Topic 606 defines a five-step process in order to achieve this core principle, which may require the use of judgment and estimates, and also requires expanded qualitative and quantitative disclosures relating to the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers, including significant judgments and estimates used. The new standard also defines accounting for certain costs related to origination and fulfillment of contracts with customers, including whether such costs should be capitalized. </font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2018</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company established an implementation team which included third-party specialists to assist in the evaluation and implementation of the new standard. The Company&#8217;s assessment has included performing analysis for each revenue stream identified, assessing the potential differences in recognition and measurement that may result from adopting this standard and assessing whether the Company meets certain practical expedients. Based on the results of the assessment, the adoption of this standard will not have a material impact on the timing or amount of revenue recognized upon adoption and there is no cumulative prior period adjustment to be recorded to the opening balance of retained earnings upon adoption.  The Company will adopt the standard using the modified retrospective method. The Company is implementing changes to accounting policies, business processes and internal controls to support the new standard as necessary. Upon adoption of Topic 606, as the disclosure requirements under the new guidance have been significantly expanded in comparison to the disclosure requirements under the current guidance, we will provide additional disclosures in the notes to the consolidated financial statements, specifically related to performance obligations, the judgments made in revenue recognition determinations, costs to obtain or fulfill contracts and contract balances.</font></div><div style="padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU No. 2016-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (ASU 2016-15)</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This ASU identifies how certain cash receipts and cash payments are presented and classified in the Statement of Cash Flows under Topic 230.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2018</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This adoption is not expected to have a material impact on the Company's financial statements.</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This ASU increases transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet and disclosing key information about leasing arrangements.  For leases with a term of twelve months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and liabilities.</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">June 1, 2019</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is currently in the process of evaluating the impact of this ASU on its consolidated financial statements.</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109236672&amp;loc=d3e765-108305<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.10-01.(b)(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=27015980&amp;loc=d3e46468-122699<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22580-107794<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=109236672&amp;loc=d3e725-108305<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6873716144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair value of assets and liabilities measured on recurring basis</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables provide information by level for assets and liabilities that are measured at fair value on a recurring basis:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value Measurements using inputs considered as:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level&#160;1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level&#160;2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value at    May 31, 2018</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Financial Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short-term investments*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,100</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable securities </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Financial Assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,417</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Financial Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent liability for acquisition earn outs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,261</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,261</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Financial Liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,261</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,261</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">*included in cash and cash equivalents.</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value Measurements using inputs considered as:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Level 3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair Value at   May 31, 2017</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Financial Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable securities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Financial Assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Financial Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent liability for acquisition earn outs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,761</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,761</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:84px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Financial Liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,761</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,761</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below presents the changes in fair value components of Level 3 instruments in the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> (in thousands of dollars):    </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Financial&#160;Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Financial&#160;Liabilities</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair&#160;Value&#160;Measurements<br clear="none"/>Using Significant<br clear="none"/>Unobservable Inputs<br clear="none"/>(Level 3)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair&#160;Value&#160;Measurements<br clear="none"/>Using Significant<br clear="none"/>Unobservable Inputs    (Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,761</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of contingent consideration, net </font><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">250</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair market value adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration payments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,750</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,261</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below presents the changes in fair value components of Level 3 instruments in the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;"> (in thousands of dollars):   </font></div><div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:60%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Financial&#160;Assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Financial&#160;Liabilities</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair&#160;Value&#160;Measurements<br clear="none"/>Using Significant<br clear="none"/>Unobservable Inputs<br clear="none"/>(Level 3)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair&#160;Value&#160;Measurements<br clear="none"/>Using Significant<br clear="none"/>Unobservable Inputs    (Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,653</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,275</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value of contingent consideration (1)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15,261</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency (gain) loss from remeasurement</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(153</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair market value adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sale of securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(450</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contingent consideration payments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10,100</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,761</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1) Change in the fair value of contingent consideration is included in earnings and comprised of changes in estimated earn out payments based on projections of Company performance and amortization of the present value discount. </font></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The recurring Level 3 fair value measurements of the contingent consideration liabilities include the following significant unobservable inputs as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair&#160;value&#160;at</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May&#160;31,&#160;2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Valuation</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Technique</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Input</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Range</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue based payments</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,261</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discounted cash flow</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discount rate<br clear="none"/>Probability of payment<br clear="none"/>Projected fiscal year of payment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4%<br clear="none"/>100%<br clear="none"/>2019 - 2020</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).  Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19190-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19190-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6878803888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Marketable securities</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, marketable securities consisted of the following:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sales securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">New York State government agency obligations</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,350</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,350</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(33</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2017</font><font style="font-family:inherit;font-size:10pt;">, marketable securities consisted of the following:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="15" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Available-for-sales securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">New York State government agency obligations</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,350</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(135</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,350</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(135</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,215</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Amortized cost and fair value of marketable securities by contractual maturity</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amortized cost and fair value of marketable securities as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, by contractual maturity, are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of May&#160;31, 2018:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due in one year or less</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due after one through five years</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due after five through twenty years </font><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,350</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,350</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,317</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1)  This auction rate security represents investments available for current operations and are classified as current in the consolidated balance sheets.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6872565120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, inventories consisted of the following:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:66%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18,678</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,563</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,808</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,602</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,430</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,341</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,916</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54,506</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6878745952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses and Other (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_PrepaidExpensesAndOtherTableTextBlock', window );">Prepaid expenses and other</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, prepaid expenses and other consisted of the following:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Software licenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,043</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">582</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">License fees</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">143</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">118</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade shows</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">223</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rent</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other prepaid taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">254</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">544</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical device excise tax receivable </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,837</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,505</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,762</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,302</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,126</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_PrepaidExpensesAndOtherTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_PrepaidExpensesAndOtherTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6878916928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, plant and equipment</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Refer below for useful lives by category:</font></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td style="width:79%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated useful lives</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and building improvements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Machinery and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 to 8 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer software and equipment</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3 to 5 years</font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, property, plant and equipment are summarized as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and building improvements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,887</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,597</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Machinery and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22,668</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,434</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer software and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24,899</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,668</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Construction in progress</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,153</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,464</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,607</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93,163</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less accumulated depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(48,794</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(49,652</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,813</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,511</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Land and land improvements</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,648</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,723</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,461</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,234</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6659389424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_ScheduleOfIntangibleAssetsTableTextBlock', window );">Intangible assets</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, intangible assets consisted of the following:</font></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross&#160;carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net&#160;carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product technologies</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147,175</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(68,880</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,295</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56,428</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23,237</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,191</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,400</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11,809</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,591</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Licenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,752</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,357</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,395</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distributor relationships</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,250</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(412</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">838</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">239,005</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(108,695</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130,310</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:56%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May 31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Gross&#160;carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net&#160;carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product technologies</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">147,172</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(59,696</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87,476</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56,375</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19,194</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,181</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,400</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,069</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,331</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Licenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,487</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,821</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">666</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distributor relationships</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(229</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,021</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">237,684</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(92,009</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">145,675</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Expected amortization expense</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Annual amortization of these intangible assets is expected to approximate the following amounts for each of the next five fiscal years:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:91%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,555</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,001</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,842</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,958</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,507</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2024 and thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,447</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">130,310</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_ScheduleOfIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_ScheduleOfIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6873543776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Components of income (loss) before income tax provision</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The components of income (loss) before income tax (benefit) expense for the years ended May&#160;31 are as follows:</font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:47%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) before tax expense:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,274</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,825</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,444</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-U.S.</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,191</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,022</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,191</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,465</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,847</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,253</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Summary of Income tax (benefit) provision analyzed by category</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax (benefit) expense is comprised of the following:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:47%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(148</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State and local</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">152</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">141</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non U.S.</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">217</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">411</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">354</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,947</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,428</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39,983</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax (benefit) expense </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,870</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,839</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,337</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Summary of deferred tax asset and liabilities</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Temporary differences that give rise to deferred tax assets and liabilities are summarized as follows:</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:normal;">May&#160;31,&#160;2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:normal;">May&#160;31,&#160;2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net operating loss carryforward</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33,880</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,975</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,421</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,653</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal and state R&amp;D tax credit carryforward</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,644</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,548</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,550</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,407</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expenses incurred not currently deductible</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,714</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,522</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">277</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,289</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross deferred tax asset</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,486</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,394</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Excess tax over book depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,044</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,158</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,044</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,158</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation Allowance</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,607</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(48,348</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred tax liability </font><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17,165</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26,112</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1) Net deferred tax liability is inclusive of a non-U.S. </font><font style="font-family:inherit;font-size:8pt;">$0.08 million</font><font style="font-family:inherit;font-size:8pt;"> deferred tax asset that is included in other assets on the Company's balance sheet for the year ended May 31, 2018.</font></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Summary of Income tax rate reconciliation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's consolidated income tax expense has differed from the amount that would be provided by applying the U.S. Federal statutory income tax rate to the Company's income before income taxes for the following reasons:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax (benefit) expense at statutory tax rate of 28.6%, 35.0% and 35.0%, respectively</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,136</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,447</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,139</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of graduated tax rates</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(98</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State income taxes, net of Federal tax benefit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(215</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Impact of Non-U.S. operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(288</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">403</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(162</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development tax credit</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(951</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(403</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(499</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Impact of tax reform </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,912</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Meals and entertainment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">242</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">266</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">329</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-deductible interest on contingent payments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">174</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">262</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-taxable gain on revaluation of contingent consideration liability</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,576</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(170</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in valuation allowance</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21,741</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,139</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,685</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of elimination of stock compensation APIC pool</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,380</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">739</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">IPR&amp;D intangible write-off</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,224</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">700</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">474</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax (benefit) expense</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,870</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,839</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40,337</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Summary of unrecognized tax benefits reconciliation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides a reconciliation of the beginning and ending amount of unrecognized tax benefits:</font></div><div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrecognized tax benefits balance at June 1 </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">899</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">899</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increase in gross amounts of tax positions related to prior years</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">899</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decrease in gross amounts of tax positions related to prior years due to U.S. tax reform</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(287</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Decrease due to lapse in statute of limitations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(148</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unrecognized tax benefits balance at May 31</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">464</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">899</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">899</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=109238393&amp;loc=d3e36027-109320<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6659565216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Accrued liabilities</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, accrued liabilities consist of the following:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May&#160;31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May&#160;31, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payroll and related expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,235</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,383</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalties</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,537</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,885</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued severance</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,940</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,075</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales and franchise taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">683</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">856</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outside services</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,396</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,622</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Litigation matters (Note 15)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acculis recall liability</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,563</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,135</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,920</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34,426</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,804</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6873597568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Future minimum principal payments on long-term debt</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's maturities of principal obligations under the credit agreement are as follows, as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:90%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,750</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total term loan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revolving facility</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Unamortized debt issuance costs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(879</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91,621</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less: Current portion of long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,000</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;Total long-term debt, net of current portion</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86,621</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6804297456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule summarizes stock option activity</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes information about stock option activity for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted-</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">exercise</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">remaining</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">contractual</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">life</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Aggregate</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">intrinsic</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">value (in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">thousands)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at beginning of year - June 1, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,667,443</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.01</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">518,498</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(271,344</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.83</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(204,184</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expired</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14,000</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.75</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding at end of year - May 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,696,413</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.58</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,520</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options exercisable at year-end</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">652,543</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.41</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.48</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,321</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Options expected to vest in future periods</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,043,870</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.05</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6.90</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,199</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Share based compensation arrangement by share based payment award nonvested shares and weighted average grant date fair value</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;The following table summarizes information about performance unit award activity for the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Performance Unit Awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted&#160;Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Grant-Date&#160;Fair&#160;Value</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested at beginning of year, June 1, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">361,164</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.54</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">135,135</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.83</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canceled</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(44,443</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.76</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested at end of year, May 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">451,856</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;The following table summarizes information about restricted stock unit activity for the year ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restricted Stock Units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Weighted&#160;Average</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Grant-Date&#160;Fair&#160;Value</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested at beginning of year, June 1, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">439,297</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.55</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">299,392</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.60</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(158,756</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canceled</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(105,431</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.25</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested at end of year, May 31, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">474,502</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.23</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables represents the break out of share-based compensation included in the Company's consolidated statement of operations:</font></div><div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:60%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">119</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">299</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">172</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">554</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">314</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales and marketing</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,778</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,762</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,489</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,461</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,026</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,291</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition, restructuring and other items, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(218</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,061</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,912</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,183</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,240</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6878755600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Weighted Average Number of Shares</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table reconciles basic to diluted weighted average shares outstanding for the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;padding-top:18px;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,074,797</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,616,859</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,161,383</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effect of dilutive securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">464,603</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">342,391</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,539,400</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,959,250</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36,161,383</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Securities excluded as their inclusion would be anti-dilutive</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,077,256</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,058,790</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,277,037</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6875419568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments And Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationFiscalYearMaturityScheduleTableTextBlock', window );">Aggregate of future annual payments under non cancelable operating leases for facilities and equipment</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Future annual payments under non-cancelable operating leases in the aggregate, of which one includes an escalation clause, with initial remaining terms of more than one year at </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, are summarized as follows (in thousands):</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:81%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,234</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,829</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">993</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">884</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2023 and thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,668</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,608</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsTableTextBlock', window );">Other commitments and contingencies</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the Company's other future commitments and contingencies as of </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2023 and thereafter</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase obligations (1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56,201</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,751</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,243</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,485</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,189</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,533</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Royalties</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,500</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">667</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">167</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">166</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101,868</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,918</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,910</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,152</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,855</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37,033</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The non-cancelable inventory purchase obligations are not reflected on our consolidated balance sheets under accounting principles generally accepted in the United States of America.</font></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationFiscalYearMaturityScheduleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the aggregate amount of payments due on known contractual obligations for the five years following the date of the latest balance sheet and the combined aggregate amount of maturities of known contractual obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 303<br> -Paragraph a<br> -Subparagraph 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationFiscalYearMaturityScheduleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about obligations resulting from other commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6878790064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments and Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock', window );">Summary of total net sales by product category</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total sales by product category are summarized below (in thousands):</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales by Product Category</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Peripheral Vascular</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">202,334</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208,602</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">205,620</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vascular Access</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92,760</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96,481</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99,375</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Oncology/Surgery</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,191</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44,560</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48,895</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">344,285</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349,643</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353,890</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Summary of net sales for geographic areas</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total sales for geographic areas are summarized below (in thousands):</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:50%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales by Geography</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">273,327</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">282,168</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">285,824</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">International</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70,958</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67,475</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68,066</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">344,285</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">349,643</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353,890</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_ScheduleOfNetRevenueByProductGroupTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of net revenue by product group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_ScheduleOfNetRevenueByProductGroupTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6882726416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition, Restructuring and Other Items, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Acquisition, Restructuring and Other Items, net</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> acquisition, restructuring and other items, net consisted of:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:47%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Year ended May 31, </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Legal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,067</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,480</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,487</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible and other asset impairment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,604</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">352</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,674</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,348</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,462</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">691</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,078</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,290</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,432</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27,510</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,591</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents a rollforward of the restructuring reserve for the years ended </font><font style="font-family:inherit;font-size:10pt;">May&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25" rowspan="1"></td></tr><tr><td style="width:25%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Contract</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Termination</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Plant </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Regulatory</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cancellation </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Benefits</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Consolidation</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Filings</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Costs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Costs</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Charges</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">851</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">494</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,348</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-cash adjustments </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(108</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(108</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(275</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(278</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">851</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">962</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Charges</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,440</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,892</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,674</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-cash adjustments </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(276</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(276</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,453</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,706</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(56</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(74</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,289</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">838</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,071</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6878774592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in each component of accumulated other comprehensive income (loss), net of tax, are as follows for fiscal </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:64%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Foreign currency translation gain (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Unrealized gain (loss) on marketable securities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(760</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(791</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss) before reclassifications, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(545</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(533</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reclassified from accumulated other comprehensive income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net other comprehensive income (loss)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(545</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(533</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,305</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,324</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income before reclassifications, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">372</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts reclassified from accumulated other comprehensive income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net other comprehensive income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">270</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">102</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">372</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance at May 31, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,035</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(952</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6878962080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Information (unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>May 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Summary of Quarterly Financial Information</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quarterly results of operations during the fiscal years ended May 31, </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> are as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">First</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Second</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Third</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fourth</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands, except per share data)</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85,411</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86,706</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83,851</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,317</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41,229</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,731</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,448</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47,467</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) </font><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">249</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14,019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,102</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings (loss) per common share</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.00</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.06</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.00</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.01</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.37</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.06</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">First</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Second</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Third</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Fourth</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">quarter</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(in thousands, except per share data)</font></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88,098</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89,029</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85,602</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86,914</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross profit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,032</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,010</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43,792</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42,335</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income (loss) </font><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,734</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,887</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12,913</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings (loss) per common share</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.04</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.37</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.08</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.04</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.37</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.08</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.35</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1) Included within net income during the third quarter of fiscal 2018 is a </font><font style="font-family:inherit;font-size:10pt;">$9.3 million</font><font style="font-family:inherit;font-size:10pt;"> discrete tax benefit as a result of the Tax Reform Act and the revaluation of the Company's deferred tax assets, liabilities and valuation allowance to reflect the lower U.S. federal statutory rate (see Note 9).</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2) Included within net income (loss) during the fourth quarter of fiscal 2017 is the </font><font style="font-family:inherit;font-size:10pt;">$12.5 million</font><font style="font-family:inherit;font-size:10pt;"> charge for a litigation reserve (see Note 15) and </font><font style="font-family:inherit;font-size:10pt;">$4.5 million</font><font style="font-family:inherit;font-size:10pt;"> impact relating to the Acculis recall (see Note 10).  </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The data in the schedules above has been intentionally rounded to the nearest thousand and therefore the quarterly&#160;&#160;&#160;&#160; amounts may not sum to the full year amounts.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109225645&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6889187664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation, Business Description and Summary of Significant Accounting Policies (Details Textual)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 31, 2018 </div>
<div>USD ($) </div>
<div>segment </div>
<div>unit</div>
</th>
<th class="th">
<div>May 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_ShortTermInvestmentsMaturityPeriod', window );">Maturity period</a></td>
<td class="text">less than three months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities, at fair value | $</a></td>
<td class="nump">$ 1,317<span></span>
</td>
<td class="nump">$ 1,215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | unit</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_PercentageOfRestockingCharge', window );">Restocking charge percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Period of recognition for costs not yet recognized</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Period of recognition for costs not yet recognized</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_AccountsReceivableDuePeriod', window );">Accounts receivables period due</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimates useful life of intangible assets other than goodwill</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct', window );">Undamaged product expiration date</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_AccountsReceivableDuePeriod', window );">Accounts receivables period due</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimates useful life of intangible assets other than goodwill</a></td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and building improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">39 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer software and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer software and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_AccountsReceivableDuePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable due period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_AccountsReceivableDuePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of months remaining for product to be accepted prior to expiration date of product</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_NumberOfMonthsRemainingForProductToBeAcceptedPriorToExpirationDateOfProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_PercentageOfRestockingCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of restocking charge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_PercentageOfRestockingCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_ShortTermInvestmentsMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short term investments maturity period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_ShortTermInvestmentsMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109979856&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6890748064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 07, 2015</div></th>
<th class="th"><div>Nov. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems', window );"><strong>Investments in and Advances to Affiliates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of non-transferable warrants</a></td>
<td class="nump">$ 2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems', window );"><strong>Investments in and Advances to Affiliates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Write-off of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAndAdvancesToAffiliatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6890670480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments Fair Value of Financial Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">$ 1,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure', window );">Short-term investments</a></td>
<td class="nump">2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">1,317<span></span>
</td>
<td class="nump">$ 1,215<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total Financial Assets</a></td>
<td class="nump">3,417<span></span>
</td>
<td class="nump">1,215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent liability for acquisition earn outs</a></td>
<td class="nump">3,261<span></span>
</td>
<td class="nump">12,761<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Financial Liabilities</a></td>
<td class="nump">3,261<span></span>
</td>
<td class="nump">12,761<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure', window );">Short-term investments</a></td>
<td class="nump">2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total Financial Assets</a></td>
<td class="nump">2,100<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent liability for acquisition earn outs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Financial Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total Financial Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent liability for acquisition earn outs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Financial Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Financial Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities</a></td>
<td class="nump">1,317<span></span>
</td>
<td class="nump">1,215<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total Financial Assets</a></td>
<td class="nump">1,317<span></span>
</td>
<td class="nump">1,215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Financial Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent liability for acquisition earn outs</a></td>
<td class="nump">3,261<span></span>
</td>
<td class="nump">12,761<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total Financial Liabilities</a></td>
<td class="nump">$ 3,261<span></span>
</td>
<td class="nump">$ 12,761<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments Excluding Marketable Securities, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_InvestmentsExcludingMarketableSecuritiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109979856&amp;loc=d3e26610-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6889178816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments Fair Value of Financial Instruments (Details 2) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">$ 1,215<span></span>
</td>
<td class="nump">$ 1,653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Currency (gain) loss from remeasurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements', window );">Fair market value adjustments</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sale of securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(450)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Contingent consideration payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">1,317<span></span>
</td>
<td class="nump">1,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">12,761<span></span>
</td>
<td class="nump">38,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">250<span></span>
</td>
<td class="num">(15,261)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Currency (gain) loss from remeasurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(153)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements', window );">Fair market value adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales', window );">Sale of securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet', window );">Contingent consideration payments</a></td>
<td class="num">(9,750)<span></span>
</td>
<td class="num">(10,100)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 3,261<span></span>
</td>
<td class="nump">$ 12,761<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Liabilities Measured on Recurring Basis Gain Included in Earnings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_FairValueLiabilitiesMeasuredonRecurringBasisGainIncludedinEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Change In Contingent Consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetChangeInContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in the income statement for financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases, (sales), issuances and (settlements) of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized on the income statement for financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases, (sales), issuances and (settlements) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sales of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6890833680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments Fair Value of Financial Instruments (Details 3)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 07, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of non-transferable warrants</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_UndiscountedContingentConsiderationFairValueFairValueDisclosure', window );">Potential amount of undiscounted future contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract', window );"><strong>Summary showing the recurring fair value measurements of the contingent consideration liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Revenue based payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,261<span></span>
</td>
<td class="nump">$ 12,761<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract', window );"><strong>Summary showing the recurring fair value measurements of the contingent consideration liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Revenue based payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,261<span></span>
</td>
<td class="nump">$ 12,761<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=ango_RevenueBasedPaymentMember', window );">Revenue based payments | Level 3 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract', window );"><strong>Summary showing the recurring fair value measurements of the contingent consideration liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Revenue based payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=ango_RevenueBasedPaymentMember', window );">Revenue based payments | Level 3 | Recurring | Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract', window );"><strong>Summary showing the recurring fair value measurements of the contingent consideration liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Discount rate used in fair value calculation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=ango_RevenueBasedPaymentMember', window );">Revenue based payments | Level 3 | Maximum | Recurring | Contingent Consideration Earn Out Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract', window );"><strong>Summary showing the recurring fair value measurements of the contingent consideration liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_FairValueInputsProbabilityOfPayment', window );">Probability of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=ango_AngioVacProductMember', window );">AngioVac Product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Gain from reduction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ango_DiscontinuedInvestmentinTiLoProductMember', window );">Discontinued Investment in TiLo Product | Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations, Abandonment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss', window );">Gain from reduction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ango_DiscontinuedInvestmentinTiLoProductMember', window );">Discontinued Investment in TiLo Product | Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations, Abandonment | In Process Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown', window );">Write-down</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_FairValueInputsProbabilityOfPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value inputs probability of payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_FairValueInputsProbabilityOfPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Liabilities Measured On Recurring Basis [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_FairValueLiabilitiesMeasuredOnRecurringBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_UndiscountedContingentConsiderationFairValueFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted contingent consideration fair value fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_UndiscountedContingentConsiderationFairValueFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of (gain) loss recognized for the (reversal of write-down) write-down to fair value, less cost to sell, of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2443-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized (holding) gain (loss) which is included in the statement of income (or changes in net assets) related to those liabilities still held at the reporting date for which fair value is measured on a recurring basis using significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99377789&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=ango_RevenueBasedPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=ango_RevenueBasedPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ango_ContingentConsiderationEarnOutLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ango_ContingentConsiderationEarnOutLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=ango_AngioVacProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=ango_AngioVacProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ango_DiscontinuedInvestmentinTiLoProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=ango_DiscontinuedInvestmentinTiLoProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsAbandonmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6875599296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 1,350<span></span>
</td>
<td class="nump">$ 1,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(33)<span></span>
</td>
<td class="num">(135)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair Value</a></td>
<td class="nump">1,317<span></span>
</td>
<td class="nump">1,215<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">New York State government agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,350<span></span>
</td>
<td class="nump">1,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(33)<span></span>
</td>
<td class="num">(135)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair Value</a></td>
<td class="nump">$ 1,317<span></span>
</td>
<td class="nump">$ 1,215<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109979856&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6875564432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract', window );"><strong>Amortized cost and fair value of marketable securities by contractual maturity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Amortized cost, Due in one year or less</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Amortized cost, Due after one through five years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost', window );">Amortized cost, Due after five through twenty years</a></td>
<td class="nump">1,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,350<span></span>
</td>
<td class="nump">$ 1,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Fair Value, Due in one year or less</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Fair Value, Due after one through five years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue', window );">Fair Value, Due after five through twenty years</a></td>
<td class="nump">1,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value, Total</a></td>
<td class="nump">$ 1,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Available for sale securities debt maturities after five through twenty years amortized cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Available for sale securities debt maturities after five through twenty years fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTwentyYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27198-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62586-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27198-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109979856&amp;loc=d3e26610-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6875880736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 18,678<span></span>
</td>
<td class="nump">$ 17,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">10,808<span></span>
</td>
<td class="nump">12,602<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">19,430<span></span>
</td>
<td class="nump">24,341<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">48,916<span></span>
</td>
<td class="nump">54,506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory valuation reserve</a></td>
<td class="nump">6,100<span></span>
</td>
<td class="nump">7,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ango_UndisclosedInventoryDistributorMember', window );">Japanese inventory distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-off</a></td>
<td class="nump">700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_InventoryTypeAxis=ango_AcculisInventoryMember', window );">Acculis inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-off</a></td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=SL66093879-108312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 1C<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=SL66093883-108312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66092785&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ango_UndisclosedInventoryDistributorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ango_UndisclosedInventoryDistributorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_InventoryTypeAxis=ango_AcculisInventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_InventoryTypeAxis=ango_AcculisInventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6874980176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Expenses and Other (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid expenses and other</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_SoftwareLicenses', window );">Software licenses</a></td>
<td class="nump">$ 1,043<span></span>
</td>
<td class="nump">$ 582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_PrepaidLicenseeFees', window );">License fees</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_TradeShows', window );">Trade shows</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidRent', window );">Rent</a></td>
<td class="nump">134<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_PrepaidIncomeandOtherTaxes', window );">Other prepaid taxes</a></td>
<td class="nump">254<span></span>
</td>
<td class="nump">544<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_MedicalDeviceExciseTaxReceivable', window );">Medical device excise tax receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,837<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Other</a></td>
<td class="nump">2,505<span></span>
</td>
<td class="nump">2,762<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total</a></td>
<td class="nump">$ 4,302<span></span>
</td>
<td class="nump">$ 6,126<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_MedicalDeviceExciseTaxReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical Device Excise Tax Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_MedicalDeviceExciseTaxReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_PrepaidIncomeandOtherTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Income and Other Taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_PrepaidIncomeandOtherTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_PrepaidLicenseeFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of prepaid licensee fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_PrepaidLicenseeFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_SoftwareLicenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of payments made for software licenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_SoftwareLicenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_TradeShows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of payments made in advance related to trade shows.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_TradeShows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6787-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for rent that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6787-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5865-108316<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6882366336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant, and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 89,607<span></span>
</td>
<td class="nump">$ 93,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(48,794)<span></span>
</td>
<td class="num">(49,652)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements', window );">Property, plant and equipment excluding land and land improvements</a></td>
<td class="nump">40,813<span></span>
</td>
<td class="nump">43,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LandAndLandImprovements', window );">Land and land improvements</a></td>
<td class="nump">1,648<span></span>
</td>
<td class="nump">1,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, Net</a></td>
<td class="nump">42,461<span></span>
</td>
<td class="nump">45,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">4,600<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">$ 8,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and building improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">39,887<span></span>
</td>
<td class="nump">40,597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">22,668<span></span>
</td>
<td class="nump">25,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer software and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">24,899<span></span>
</td>
<td class="nump">25,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, plant and equipment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment</a></td>
<td class="nump">$ 2,153<span></span>
</td>
<td class="nump">$ 1,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Property plant and equipment excluding land and land improvements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_PropertyPlantAndEquipmentExcludingLandAndLandImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LandAndLandImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated deprecation and depletion of real estate held for productive use and additions or improvements to real estate held for productive use, examples include, but are not limited to, walkways, driveways, fences, and parking lots. Excludes land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LandAndLandImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6656676288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Details Textual)<br></strong></div></th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2018 </div>
<div>USD ($) </div>
<div>Segment</div>
</th>
<th class="th">
<div>May 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_GoodwillAndIntangibleAssetsTextualAbstract', window );"><strong>Goodwill and Intangible Assets (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Goodwill, period increase (decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,635,000<span></span>
</td>
<td class="nump">$ 17,296,000<span></span>
</td>
<td class="nump">$ 17,964,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_GoodwillAndIntangibleAssetsTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_GoodwillAndIntangibleAssetsTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6890092432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying value, finite-lived intangible assets</a></td>
<td class="nump">$ 239,005<span></span>
</td>
<td class="nump">$ 237,684<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(108,695)<span></span>
</td>
<td class="num">(92,009)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying value, finite-lived intangible assets</a></td>
<td class="nump">130,310<span></span>
</td>
<td class="nump">145,675<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ango_ProductTechnologiesMember', window );">Product technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying value, finite-lived intangible assets</a></td>
<td class="nump">147,175<span></span>
</td>
<td class="nump">147,172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(68,880)<span></span>
</td>
<td class="num">(59,696)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying value, finite-lived intangible assets</a></td>
<td class="nump">78,295<span></span>
</td>
<td class="nump">87,476<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying value, finite-lived intangible assets</a></td>
<td class="nump">56,428<span></span>
</td>
<td class="nump">56,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(23,237)<span></span>
</td>
<td class="num">(19,194)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying value, finite-lived intangible assets</a></td>
<td class="nump">33,191<span></span>
</td>
<td class="nump">37,181<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying value, finite-lived intangible assets</a></td>
<td class="nump">28,400<span></span>
</td>
<td class="nump">28,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(11,809)<span></span>
</td>
<td class="num">(9,069)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying value, finite-lived intangible assets</a></td>
<td class="nump">16,591<span></span>
</td>
<td class="nump">19,331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicenseAgreementTermsMember', window );">Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying value, finite-lived intangible assets</a></td>
<td class="nump">5,752<span></span>
</td>
<td class="nump">4,487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(4,357)<span></span>
</td>
<td class="num">(3,821)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying value, finite-lived intangible assets</a></td>
<td class="nump">1,395<span></span>
</td>
<td class="nump">666<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ango_DistributorRelationshipsMember', window );">Distributor relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross carrying value, finite-lived intangible assets</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(412)<span></span>
</td>
<td class="num">(229)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying value, finite-lived intangible assets</a></td>
<td class="nump">$ 838<span></span>
</td>
<td class="nump">$ 1,021<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ango_ProductTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ango_ProductTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicenseAgreementTermsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicenseAgreementTermsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ango_DistributorRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ango_DistributorRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6657402128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Details 2) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Expected amortization expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2019</a></td>
<td class="nump">$ 16,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2020</a></td>
<td class="nump">15,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2021</a></td>
<td class="nump">13,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2022</a></td>
<td class="nump">12,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2023</a></td>
<td class="nump">12,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">2024 and thereafter</a></td>
<td class="nump">59,447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net carrying value, finite-lived intangible assets</a></td>
<td class="nump">$ 130,310<span></span>
</td>
<td class="nump">$ 145,675<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6878795936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract', window );"><strong>Income (loss) before tax expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">U.S.</a></td>
<td class="nump">$ 6,274<span></span>
</td>
<td class="nump">$ 8,825<span></span>
</td>
<td class="num">$ (4,444)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Non-U.S.</a></td>
<td class="nump">1,191<span></span>
</td>
<td class="nump">1,022<span></span>
</td>
<td class="nump">1,191<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income (loss) before tax expense</a></td>
<td class="nump">$ 7,465<span></span>
</td>
<td class="nump">$ 9,847<span></span>
</td>
<td class="num">$ (3,253)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6875574896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details 2) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">$ (148)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State and local</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">141<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Non U.S.</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">270<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Current</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">411<span></span>
</td>
<td class="nump">354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred</a></td>
<td class="num">(8,947)<span></span>
</td>
<td class="nump">4,428<span></span>
</td>
<td class="nump">39,983<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) expense</a></td>
<td class="num">$ (8,870)<span></span>
</td>
<td class="nump">$ 4,839<span></span>
</td>
<td class="nump">$ 40,337<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6882881232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">5 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2018</div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_IncomeTaxesTextualAbstract', window );"><strong>Income Taxes (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit', window );">Tax benefit due to revaluation of indefinite lived deferred tax liability</a></td>
<td class="nump">$ 9,300,000<span></span>
</td>
<td class="nump">$ 9,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Estimated blended corporate income tax rate (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit', window );">Tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries', window );">Foreign subsidiary undistributed earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,900,000<span></span>
</td>
<td class="nump">$ 4,900,000<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Additional unrecognized tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_IncomeTaxesTextualAbstract', window );"><strong>Income Taxes (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse', window );">Net operating loss carryforwards after considering limitations of use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,800,000<span></span>
</td>
<td class="nump">157,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=ango_TaxPeriodOneMember', window );">Tax Year 2018 To 2023 | Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_IncomeTaxesTextualAbstract', window );"><strong>Income Taxes (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Federal and State net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,800,000<span></span>
</td>
<td class="nump">28,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=ango_TaxPeriodTwoMember', window );">Tax Year 2027 To 2037 | Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_IncomeTaxesTextualAbstract', window );"><strong>Income Taxes (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse', window );">Net operating loss carryforwards after considering limitations of use</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,000,000<span></span>
</td>
<td class="nump">129,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=ango_TaxPeriodThreeMember', window );">Tax Year 2018 To 2038 | State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_IncomeTaxesTextualAbstract', window );"><strong>Income Taxes (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Federal and State net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,100,000<span></span>
</td>
<td class="nump">$ 19,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_IncomeTaxesTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Taxes (Textual) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_IncomeTaxesTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Amount After Limitation Of Use</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_OperatingLossCarryforwardsAmountAfterLimitationOfUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Change In Tax Rate, Deferred Tax Liability, Provisional Income Tax Benefit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Change In Tax Rate, Deferred Tax Liability, Provisional Income Tax Expense (Benefit)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6487024&amp;loc=d3e29054-158556<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28200-109314<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6479915&amp;loc=d3e66715-112838<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=ango_TaxPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=ango_TaxPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=ango_TaxPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=ango_TaxPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=ango_TaxPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=ango_TaxPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6874928480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Details 3) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">$ 33,880<span></span>
</td>
<td class="nump">$ 55,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">2,421<span></span>
</td>
<td class="nump">2,653<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Federal and state R&amp;D tax credit carryforward</a></td>
<td class="nump">3,644<span></span>
</td>
<td class="nump">2,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventories</a></td>
<td class="nump">1,550<span></span>
</td>
<td class="nump">2,407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">Expenses incurred not currently deductible</a></td>
<td class="nump">1,714<span></span>
</td>
<td class="nump">6,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred revenue</a></td>
<td class="nump">277<span></span>
</td>
<td class="nump">1,289<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax asset</a></td>
<td class="nump">43,486<span></span>
</td>
<td class="nump">71,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Excess tax over book depreciation and amortization</a></td>
<td class="nump">34,044<span></span>
</td>
<td class="nump">49,158<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Gross deferred tax liability</a></td>
<td class="nump">34,044<span></span>
</td>
<td class="nump">49,158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation Allowance</a></td>
<td class="num">(26,607)<span></span>
</td>
<td class="num">(48,348)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liability</a></td>
<td class="num">(17,165)<span></span>
</td>
<td class="num">$ (26,112)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Non-U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">Expenses incurred not currently deductible</a></td>
<td class="nump">$ 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31931-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=115928272&amp;loc=d3e28680-109314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6889451824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details 4) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Reasons for consolidated income tax provision</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate (as percent)</a></td>
<td class="nump">28.60%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax (benefit) expense at statutory tax rate of 28.6%, 35.0% and 35.0%, respectively</a></td>
<td class="nump">$ 2,136<span></span>
</td>
<td class="nump">$ 3,447<span></span>
</td>
<td class="num">$ (1,139)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Effect of graduated tax rates</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(98)<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of Federal tax benefit</a></td>
<td class="nump">120<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="num">(215)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_IncomeTaxReconciliationEffectOfForeignOperations', window );">Impact of Non US operations</a></td>
<td class="num">(288)<span></span>
</td>
<td class="nump">403<span></span>
</td>
<td class="num">(162)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development tax credit</a></td>
<td class="num">(951)<span></span>
</td>
<td class="num">(403)<span></span>
</td>
<td class="num">(499)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount', window );">Impact of tax reform</a></td>
<td class="nump">10,912<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment', window );">Meals and entertainment</a></td>
<td class="nump">242<span></span>
</td>
<td class="nump">266<span></span>
</td>
<td class="nump">329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_IncomeTaxReconciliationNondeductibleInterestOnContingentPayment', window );">Nondeductible interest on contingent payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">174<span></span>
</td>
<td class="nump">262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability', window );">Nontaxable gain on revaluation of contingent consideration liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,576)<span></span>
</td>
<td class="num">(170)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(21,741)<span></span>
</td>
<td class="nump">6,139<span></span>
</td>
<td class="nump">40,685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_IncomeTaxReconciliationEffectofEliminationofASC718APICPool', window );">Effect of elimination of stock compensation APIC pool</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,380<span></span>
</td>
<td class="nump">739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Nondeductible stock-based compensation</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,224)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">353<span></span>
</td>
<td class="nump">474<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (benefit) expense</a></td>
<td class="num">$ (8,870)<span></span>
</td>
<td class="nump">$ 4,839<span></span>
</td>
<td class="nump">$ 40,337<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Tax Cuts And Jobs Act Of 2017, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_IncomeTaxReconciliationEffectOfForeignOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the difference, between total income tax expense or benefit as reported in the Income Statement for the period and the expected income tax expense or benefit computed by applying the domestic federal statutory income tax rates to pretax income from continuing operations, that is attributable to the impact of non US operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_IncomeTaxReconciliationEffectOfForeignOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_IncomeTaxReconciliationEffectofEliminationofASC718APICPool">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Reconciliation, Effect of Elimination of ASC 718 APIC Pool</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_IncomeTaxReconciliationEffectofEliminationofASC718APICPool</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Reconciliation, Gain on Revaluation of Contingent Consideration Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_IncomeTaxReconciliationGainonRevaluationofContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_IncomeTaxReconciliationNondeductibleInterestOnContingentPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation nondeductible interest on contingent payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_IncomeTaxReconciliationNondeductibleInterestOnContingentPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32123-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e32059-109318<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible meals and entertainment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible equity-based compensation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6874849280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes Income Taxes (Details 5) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits, beginning balance</a></td>
<td class="nump">$ 899<span></span>
</td>
<td class="nump">$ 899<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increase in gross amounts of tax positions related to prior years</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">899<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decrease in gross amounts of tax positions related to prior years due to U.S. tax reform</a></td>
<td class="num">(287)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Decrease due to lapse in statute of limitations</a></td>
<td class="num">(148)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits, ending balance</a></td>
<td class="nump">$ 464<span></span>
</td>
<td class="nump">$ 899<span></span>
</td>
<td class="nump">$ 899<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=SL37586934-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6889304912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and related expenses</a></td>
<td class="nump">$ 10,235<span></span>
</td>
<td class="nump">$ 11,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Royalties</a></td>
<td class="nump">1,537<span></span>
</td>
<td class="nump">2,885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Accrued severance</a></td>
<td class="nump">1,940<span></span>
</td>
<td class="nump">2,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Sales and franchise taxes</a></td>
<td class="nump">683<span></span>
</td>
<td class="nump">856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Outside services</a></td>
<td class="nump">2,396<span></span>
</td>
<td class="nump">1,622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_AccruedLitigation', window );">Litigation matters (Note 15)</a></td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_AccruedRecallLiability', window );">Acculis recall liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">5,135<span></span>
</td>
<td class="nump">4,920<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 34,426<span></span>
</td>
<td class="nump">$ 38,804<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_AccruedLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Litigation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_AccruedLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_AccruedRecallLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Recall Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_AccruedRecallLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6702690224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities Accrued Liabilites (Details) (Textual)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>May 31, 2017 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_RecallPeriod', window );">Recall period</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue', window );">Disposal group, deferral of revenue</a></td>
<td class="nump">$ 2.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_RecallPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recall Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_RecallPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as deferred revenue attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6890416528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Details Textual) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 07, 2016</div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
<th class="th"><div>May 24, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of and borrowings on long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 116,471,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,000,000)<span></span>
</td>
<td class="num">$ (140,381,000)<span></span>
</td>
<td class="num">$ (16,250,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember', window );">JPMorgan Chase Bank, N.A., Bank of America, N.A., Keybank National Association | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">State interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.41%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_DebtInstrumentIncreaseInInterestRateInCaseOfDefault', window );">Percentage of increase in interest</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA', window );">Debt instrument, maximum leverage ratio of total indebtedness to adjusted EBITDA</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions', window );">Debt instrument, maximum leverage ratio of total indebtedness to adjusted EBITDA, following material acquisitions</a></td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_DebtServiceCoverageRatio', window );">Ratio for debt service coverage</a></td>
<td class="nump">1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_DebtInstrumentMaximumCashAmountForNetDebtCalculation', window );">Maximum cash amount that can be utilized to calculate net debt</a></td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember', window );">JPMorgan Chase Bank, N.A., Bank of America, N.A., Keybank National Association | Line of Credit | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember', window );">JPMorgan Chase Bank, N.A., Bank of America, N.A., Keybank National Association | Line of Credit | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember', window );">JPMorgan Chase Bank, N.A., Bank of America, N.A., Keybank National Association | Line of Credit | Base Rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">State interest rate</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember', window );">JPMorgan Chase Bank, N.A., Bank of America, N.A., Keybank National Association | Line of Credit | Base Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">State interest rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember', window );">JPMorgan Chase Bank, N.A., Bank of America, N.A., Keybank National Association | Line of Credit | Eurodollar | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">State interest rate</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember', window );">JPMorgan Chase Bank, N.A., Bank of America, N.A., Keybank National Association | Line of Credit | Eurodollar | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">State interest rate</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember', window );">JPMorgan Chase Bank, N.A., Bank of America, N.A., Keybank National Association | Line of Credit | Former Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="num">$ (116,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember', window );">JPMorgan Chase Bank, N.A., Bank of America, N.A., Keybank National Association | Line of Credit | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility borrowing capacity</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of and borrowings on long-term debt</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember', window );">JPMorgan Chase Bank, N.A., Bank of America, N.A., Keybank National Association | Line of Credit | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility borrowing capacity</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of and borrowings on long-term debt</a></td>
<td class="nump">16,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember', window );">JPMorgan Chase Bank, N.A., Bank of America, N.A., Keybank National Association | Line of Credit | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility borrowing capacity</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember', window );">JPMorgan Chase Bank, N.A., Bank of America, N.A., Keybank National Association | Line of Credit | Bridge Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility borrowing capacity</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_DebtInstrumentIncreaseInInterestRateInCaseOfDefault">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument increase in interest rate in case of default.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_DebtInstrumentIncreaseInInterestRateInCaseOfDefault</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_DebtInstrumentMaximumCashAmountForNetDebtCalculation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maximum Cash Amount For Net Debt Calculation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_DebtInstrumentMaximumCashAmountForNetDebtCalculation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maximum Leverage Ratio of Total Indebtedness to Adjusted EBITDA</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maximum Leverage Ratio of Total Indebtedness to Adjusted EBITDA, Following Material Acquisitions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_DebtInstrumentMaximumLeverageRatioofTotalIndebtednesstoAdjustedEBITDAFollowingMaterialAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_DebtServiceCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt service coverage ratio.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_DebtServiceCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=ango_JPMorganChaseBankN.A.BankofAmericaN.A.KeybankNationalAssociationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ango_FormerCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ango_FormerCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_BridgeLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_BridgeLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6882937488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt (Details1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Future minimum principal payments on long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 92,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Less: Unamortized debt issuance costs</a></td>
<td class="num">(879)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">91,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion of long-term debt</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="num">$ (5,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt, net of current portion</a></td>
<td class="nump">86,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Future minimum principal payments on long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2019</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2020</a></td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2021</a></td>
<td class="nump">11,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2022</a></td>
<td class="nump">68,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">92,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Future minimum principal payments on long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6878775136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_RetirementPlansTextualAbstract', window );"><strong>Retirement Plans (Textual) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Matching contributions</a></td>
<td class="nump">$ 3.9<span></span>
</td>
<td class="nump">$ 4.2<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_RetirementPlansTextualAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Retirement Plans (Textual) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_RetirementPlansTextualAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6895564736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details Textual)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 06, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 25, 2016 </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 29, 2014 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 28, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2016 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2018 </div>
<div>USD ($) </div>
<div>working_hour </div>
<div>Employees </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2017 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2016 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2015 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOwnershipInterestsLineItems', window );"><strong>Other Ownership Interests [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_CapitalStockSharesAuthorized', window );">Authorized capital stock (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Shares of common stock (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_CommonStockVotesPerShare', window );">Common stock, votes per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage', window );">Subsequent grants for directors vesting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.33%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod', window );">Subsequent grants for directors vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Option grants in the period, weighted average grant date fair value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.95<span></span>
</td>
<td class="nump">$ 4.70<span></span>
</td>
<td class="nump">$ 4.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.08%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">1.48%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 8 months 20 days<span></span>
</td>
<td class="text">4 years 9 months 20 days<span></span>
</td>
<td class="text">4 years 9 months 21 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">The total intrinsic value of options exercised | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">2,800,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Compensation not yet recognized | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock options exercised | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">9,900,000<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Tax benefit | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Grants in the period, weighted average grant date fair value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.54<span></span>
</td>
<td class="nump">$ 15.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased', window );">Average price of share issued | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.03<span></span>
</td>
<td class="nump">$ 11.00<span></span>
</td>
<td class="nump">$ 10.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchased | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,557,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">13,557,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredParValueMethodAmount', window );">Treasury stock retirement | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOwnershipInterestsLineItems', window );"><strong>Other Ownership Interests [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Maximum number of shares to be offered under the Stock Purchase Plan | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,943<span></span>
</td>
<td class="nump">129,185<span></span>
</td>
<td class="nump">137,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Common stock repurchased (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchased | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Treasury stock retirement (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">642,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(642,305)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredParValueMethodAmount', window );">Treasury stock retirement | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOwnershipInterestsLineItems', window );"><strong>Other Ownership Interests [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredParValueMethodAmount', window );">Treasury stock retirement | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,942,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOwnershipInterestsLineItems', window );"><strong>Other Ownership Interests [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Share repurchases, authorized amount | $</a></td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Share repurchase program period</a></td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Common stock repurchased (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchased | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Share repurchases | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">370,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Share repurchases, remaining shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOwnershipInterestsLineItems', window );"><strong>Other Ownership Interests [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage', window );">Percentage of grants to employees vesting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1', window );">Option grants to employees vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Period of recognition for costs not yet recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Tax benefit | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOwnershipInterestsLineItems', window );"><strong>Other Ownership Interests [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Period of recognition for costs not yet recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage (as percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Grants in the period, weighted average grant date fair value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Employee service, compensation cost not yet recognized | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested compensation, weighted average grant date fair value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.23<span></span>
</td>
<td class="nump">$ 15.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested compensation (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">439,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">474,502<span></span>
</td>
<td class="nump">439,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ango_PerformanceShareAndRestrictedStockUnitAwardsMember', window );">Performance Share and Restricted Stock Unit Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOwnershipInterestsLineItems', window );"><strong>Other Ownership Interests [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of restricted stock awards vesting | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700,000<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ango_PerformanceSharesIncludingThreeYearMarketConditionMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOwnershipInterestsLineItems', window );"><strong>Other Ownership Interests [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Employee service, compensation cost not yet recognized | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested compensation, weighted average grant date fair value (usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.83<span></span>
</td>
<td class="nump">$ 22.61<span></span>
</td>
<td class="nump">$ 18.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod', window );">Performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested compensation (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted average remaining contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOwnershipInterestsLineItems', window );"><strong>Other Ownership Interests [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Period of recognition for costs not yet recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember', window );">2004 Stock and Incentive Award Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOwnershipInterestsLineItems', window );"><strong>Other Ownership Interests [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total number of common stock reserved for issuance (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Total number of common stock available to be issued (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod', window );">Options exercisable period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee', window );">Incentive award plan to increase the minimum number of shares (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember', window );">2004 Stock and Incentive Award Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOwnershipInterestsLineItems', window );"><strong>Other Ownership Interests [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Total number of common stock available to be issued (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ango_StockPurchasePlanMember', window );">Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOwnershipInterestsLineItems', window );"><strong>Other Ownership Interests [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Total number of common stock available to be issued (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Maximum number of shares to be offered | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_NumberOfSharePurchasePeriod', window );">Share purchase periods | Employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_SharePurchasePeriod', window );">Duration of purchase of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_EmployeePlanParticipatingEligibilityPeriod', window );">Employee eligible in participating in offering period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription', window );">Working schedule of employee to participate in offering period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 or more hours per week and more than five months in a calendar year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible', window );">Number of working hours to be eligible (working hour) | working_hour</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible', window );">Number of working months to be eligible</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_EmployeePlanParticipatingEligibilityThresholdPercentage', window );">Employees ownership threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod', window );">Percentage of fair market value of a share of common stock on the first day of the offering period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Percentage of fair market value of a share of common stock on the last day of the offering period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares reserved for issuance (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Maximum number of shares to be offered under the Stock Purchase Plan | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,943<span></span>
</td>
<td class="nump">129,185<span></span>
</td>
<td class="nump">137,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_CapitalStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Capital stock shares authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_CapitalStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_CommonStockVotesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Votes Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_CommonStockVotesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Customary working schedule to participate in employee offering period description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_CustomaryWorkingScheduleToParticipateInEmployeeOfferingPeriodDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_EmployeePlanParticipatingEligibilityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee plan participating eligibility period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_EmployeePlanParticipatingEligibilityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_EmployeePlanParticipatingEligibilityThresholdPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ownership threshold for participating plan eligibility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_EmployeePlanParticipatingEligibilityThresholdPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_NumberOfSharePurchasePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share purchase period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_NumberOfSharePurchasePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award award granted to employees vesting percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award award granted to employees vesting period1.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardGrantedToEmployeesVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award award subsequent grants to directors vesting percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award award subsequent grants to directors vesting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardSubsequentGrantsToDirectorsVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options maximum exercisable period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsMaximumExercisablePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_SharePurchasePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share purchase period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_SharePurchasePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation arrangement by sharebased payment award purchase price of common stock percent on first day of offering period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercentOnFirstDayOfOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Compensation Cost Probable Recognition Performance Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsCompensationCostProbableRecognitionPerformancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Working Hours Per Week to be Eligible</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingHoursPerWeektobeEligible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Working Months Per Year to be Eligible</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_SharebasedCompensationArrangementbySharebasedPaymentAwardWorkingMonthsPerYeartobeEligible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested options awarded to employees as compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total recognized tax benefit related to compensation cost for equity-based payment arrangements recognized in income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOwnershipInterestsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOwnershipInterestsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of stock options granted under share-based compensation arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest quantity of shares an employee can purchase under the plan per period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under an established share-based compensation plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average of per share prices paid for shares purchased on the open market for issuance to employees under the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramPeriodInForce1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramPeriodInForce1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockRetiredParValueMethodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the par value method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockRetiredParValueMethodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ango_PerformanceShareAndRestrictedStockUnitAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ango_PerformanceShareAndRestrictedStockUnitAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ango_PerformanceSharesIncludingThreeYearMarketConditionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ango_PerformanceSharesIncludingThreeYearMarketConditionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ango_TwoThousandAndFourStockAndIncentiveAwardPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ango_StockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ango_StockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6893159584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>May 31, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Schedule summarizes stock option activity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares Outstanding at beginning of year (shares) | shares</a></td>
<td class="nump">1,667,443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares Granted (shares) | shares</a></td>
<td class="nump">518,498<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares Exercised (shares) | shares</a></td>
<td class="num">(271,344)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Shares Forfeited (shares) | shares</a></td>
<td class="num">(204,184)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Shares Expired (shares) | shares</a></td>
<td class="num">(14,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares Outstanding at end of year (shares) | shares</a></td>
<td class="nump">1,696,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Outstanding at beginning of year (usd per share) | $ / shares</a></td>
<td class="nump">$ 15.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price Granted (usd per share) | $ / shares</a></td>
<td class="nump">16.78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price Exercised (usd per share) | $ / shares</a></td>
<td class="nump">14.83<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price Forfeited (usd per share) | $ / shares</a></td>
<td class="nump">16.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price Expired (usd per share) | $ / shares</a></td>
<td class="nump">15.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Outstanding at end of year (usd per share) | $ / shares</a></td>
<td class="nump">$ 15.42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Shares Options exercisable at year-end (shares) | shares</a></td>
<td class="nump">652,543<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Shares Options expected to vest in future periods (shares) | shares</a></td>
<td class="nump">1,043,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price, Options exercisable at year end (usd per share) | $ / shares</a></td>
<td class="nump">$ 14.41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Options expected to vest in future periods (usd per share) | $ / shares</a></td>
<td class="nump">$ 16.05<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life</a></td>
<td class="text">5 years 6 months 30 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual life, Option exercisable at year end</a></td>
<td class="text">3 years 5 months 23 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual life, Option expected to vest in future periods</a></td>
<td class="text">6 years 10 months 25 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, Outstanding at end of year | $</a></td>
<td class="nump">$ 9,520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value, Options exercisable at year end | $</a></td>
<td class="nump">4,321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value, Option expected to vest in future periods | $</a></td>
<td class="nump">$ 5,199<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6874574032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details 2) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant-Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Granted (usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.54<span></span>
</td>
<td class="nump">$ 15.21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-Vested Stock Award Units Beginning Balance (shares)</a></td>
<td class="nump">439,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Non-Vested Stock Award Units, Granted (shares)</a></td>
<td class="nump">299,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Non-Vested Stock Award Units, Vested (shares)</a></td>
<td class="num">(158,756)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Non-Vested Stock Award Units, Cancelled (shares)</a></td>
<td class="num">(105,431)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-Vested Stock Award Units Ending Balance (shares)</a></td>
<td class="nump">474,502<span></span>
</td>
<td class="nump">439,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant-Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value Beginning Balance (usd per share)</a></td>
<td class="nump">$ 15.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Granted (usd per share)</a></td>
<td class="nump">16.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Vested (usd per share)</a></td>
<td class="nump">16.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Cancelled (usd per share)</a></td>
<td class="nump">18.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value Ending Balance (usd per share)</a></td>
<td class="nump">$ 16.23<span></span>
</td>
<td class="nump">$ 15.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-Vested Stock Award Units Beginning Balance (shares)</a></td>
<td class="nump">361,164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Non-Vested Stock Award Units, Granted (shares)</a></td>
<td class="nump">135,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Non-Vested Stock Award Units, Vested (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Non-Vested Stock Award Units, Cancelled (shares)</a></td>
<td class="num">(44,443)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Non-Vested Stock Award Units Ending Balance (shares)</a></td>
<td class="nump">451,856<span></span>
</td>
<td class="nump">361,164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant-Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value Beginning Balance (usd per share)</a></td>
<td class="nump">$ 18.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Granted (usd per share)</a></td>
<td class="nump">23.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Vested (usd per share)</a></td>
<td class="nump">0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Cancelled (usd per share)</a></td>
<td class="nump">22.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value Ending Balance (usd per share)</a></td>
<td class="nump">$ 19.75<span></span>
</td>
<td class="nump">$ 18.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6873935120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details 3) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation pre tax amount</a></td>
<td class="nump">$ 7,912<span></span>
</td>
<td class="nump">$ 6,183<span></span>
</td>
<td class="nump">$ 3,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation pre tax amount</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="nump">172<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ango_ResearchAndDevelopmentMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation pre tax amount</a></td>
<td class="nump">554<span></span>
</td>
<td class="nump">314<span></span>
</td>
<td class="nump">349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ango_SalesandMarketingMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation pre tax amount</a></td>
<td class="nump">1,778<span></span>
</td>
<td class="nump">1,762<span></span>
</td>
<td class="nump">1,489<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation pre tax amount</a></td>
<td class="nump">5,461<span></span>
</td>
<td class="nump">4,026<span></span>
</td>
<td class="nump">2,291<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ango_AcquisitionRestructuringAndOtherItemsNetMember', window );">Acquisition, restructuring and other items, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation pre tax amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (218)<span></span>
</td>
<td class="num">$ (1,061)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109197908&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ango_ResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ango_ResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ango_SalesandMarketingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ango_SalesandMarketingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ango_AcquisitionRestructuringAndOtherItemsNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ango_AcquisitionRestructuringAndOtherItemsNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6873802048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">37,074,797<span></span>
</td>
<td class="nump">36,616,859<span></span>
</td>
<td class="nump">36,161,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive securities</a></td>
<td class="nump">464,603<span></span>
</td>
<td class="nump">342,391<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">37,539,400<span></span>
</td>
<td class="nump">36,959,250<span></span>
</td>
<td class="nump">36,161,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Securities excluded as their inclusion would be anti-dilutive</a></td>
<td class="nump">1,077,256<span></span>
</td>
<td class="nump">1,058,790<span></span>
</td>
<td class="nump">3,277,037<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6890366480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details Textual)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 29, 2016 </div>
<div>claim</div>
</th>
<th class="th">
<div>Mar. 24, 2016 </div>
<div>claim</div>
</th>
<th class="th">
<div>Mar. 11, 2016 </div>
<div>claim</div>
</th>
<th class="th">
<div>Jun. 01, 2015 </div>
<div>motion</div>
</th>
<th class="th">
<div>Mar. 10, 2015 </div>
<div>patent</div>
</th>
<th class="th">
<div>Jan. 11, 2012 </div>
<div>reexamination_appeal </div>
<div>patent </div>
<div>claim</div>
</th>
<th class="th">
<div>Feb. 28, 2017 </div>
<div>Petition </div>
<div>reexamination_appeal</div>
</th>
<th class="th">
<div>May 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Aggregate rental costs under operating leases | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Reserve | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=ango_C.R.BardInc.Member', window );">C.R. Bard, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_LossContingencyU.S.PatentsNumber', window );">Number of patents | patent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_NumberOfPatentsAssertedForReexamination', window );">Number of petitions filed for reexamination of patents | Petition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=ango_TheUtahActionMember', window );">The Utah Action</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsDismissedNumber', window );">Number of claims rejected (claim)</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_LossContingencyReexaminationsNumber', window );">Number of reexaminations (reexamination appeal) | reexamination_appeal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of pending claims (claim)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_LossContingencyClaimsReversedNumber', window );">Number of claims reversed (claim)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Loss contingency, new claims filed, number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=ango_TheUtahActionMember', window );">The Utah Action | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_LossContingencyReexaminationsNumber', window );">Number of reexaminations (reexamination appeal) | reexamination_appeal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=ango_TheUtahActionMember', window );">The Utah Action | C.R. Bard, Inc. | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_LossContingencyReexaminationsNumber', window );">Number of reexaminations (reexamination appeal) | reexamination_appeal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=ango_TheDelawareActionMember', window );">The Delaware Action</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber', window );">Number of patents allegedly infringed (patent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_LossContingencyClaimsReversedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Reversed, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_LossContingencyClaimsReversedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_LossContingencyReexaminationsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Reexaminations, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_LossContingencyReexaminationsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_LossContingencyU.S.PatentsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, U.S. Patents, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_LossContingencyU.S.PatentsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_NumberOfPatentsAssertedForReexamination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of patents asserted for reexamination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_NumberOfPatentsAssertedForReexamination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyClaimsDismissedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of claims dismissed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyClaimsDismissedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of another entity's patents that the entity has allegedly infringed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPatentsAllegedlyInfringedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=ango_C.R.BardInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=ango_C.R.BardInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=ango_TheUtahActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=ango_TheUtahActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ango_C.R.BardInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ango_C.R.BardInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=ango_TheDelawareActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=ango_TheDelawareActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6874492368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>May 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract', window );"><strong>Aggregate of future annual payments under non cancelable operating leases for facilities and equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2019</a></td>
<td class="nump">$ 2,234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2020</a></td>
<td class="nump">1,829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2021</a></td>
<td class="nump">993<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2022</a></td>
<td class="nump">884<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_OperatingLeasesFutureMinimumPaymentsDueAfterFourYears', window );">2023 and thereafter</a></td>
<td class="nump">1,668<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
<td class="nump">$ 7,608<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_OperatingLeasesFutureMinimumPaymentsDueAfterFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating leases future minimum payments due after four years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_OperatingLeasesFutureMinimumPaymentsDueAfterFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6873790416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details 1)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>May 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Purchase obligation</a></td>
<td class="nump">$ 56,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInSecondYear', window );">Purchase obligation, 2019</a></td>
<td class="nump">11,751<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInThirdYear', window );">Purchase obligation, 2020</a></td>
<td class="nump">14,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInFourthYear', window );">Purchase obligation, 2021</a></td>
<td class="nump">15,485<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInFifthYear', window );">Purchase obligation, 2022</a></td>
<td class="nump">9,189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueAfterFifthYear', window );">Purchase obligation, 2023 and thereafter</a></td>
<td class="nump">5,533<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_Royalties', window );">Royalties</a></td>
<td class="nump">45,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_RoyaltiesDueinSecondYear', window );">Royalties, 2019</a></td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_RoyaltiesDueinThirdYear', window );">Royalties, 2020</a></td>
<td class="nump">3,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_RoyaltiesDueinFourthYear', window );">Royalties, 2021</a></td>
<td class="nump">3,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_RoyaltiesDueinFifthYear', window );">Royalties, 2022</a></td>
<td class="nump">3,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_RoyaltiesDueAfterFifthYear', window );">Royalties, 2023 and thereafter</a></td>
<td class="nump">31,500<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Other</a></td>
<td class="nump">667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInSecondYear', window );">Other, 2019</a></td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInThirdYear', window );">Other, 2020</a></td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInFourthYear', window );">Other, 2021</a></td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInFifthYear', window );">Other, 2022</a></td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueAfterFifthYear', window );">Other, 2023 and thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Total</a></td>
<td class="nump">101,868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInSecondYear', window );">Total, 2019</a></td>
<td class="nump">14,918<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInThirdYear', window );">Total, 2020</a></td>
<td class="nump">17,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInFourthYear', window );">Total, 2021</a></td>
<td class="nump">19,152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInFifthYear', window );">Total, 2022</a></td>
<td class="nump">12,855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueAfterFifthYear', window );">Total, 2023 and thereafter</a></td>
<td class="nump">$ 37,033<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_Royalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_Royalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_RoyaltiesDueAfterFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalties, Due After Fifth Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_RoyaltiesDueAfterFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_RoyaltiesDueinFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalties, Due in Fifth Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_RoyaltiesDueinFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_RoyaltiesDueinFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalties, Due in Fourth Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_RoyaltiesDueinFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_RoyaltiesDueinSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalties, Due in Second Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_RoyaltiesDueinSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_RoyaltiesDueinThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalties, Due in Third Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_RoyaltiesDueinThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationDueAfterFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationDueAfterFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationDueInFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationDueInFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueAfterFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment maturing after the fifth fiscal year following the latest fiscal year for commitments not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in this taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueAfterFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment maturing in the fifth fiscal year following the latest fiscal year for commitments not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in this taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment maturing in the fourth fiscal year following the latest fiscal year for commitments not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in this taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment maturing in the second fiscal year following the latest fiscal year for commitments not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in this taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment maturing in the third fiscal year following the latest fiscal year for commitments not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in this taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueAfterFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement maturing after the fifth fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueAfterFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement maturing in the fifth fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement maturing in the fourth fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement maturing in the second fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement maturing in the third fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6874379328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments and Geographic Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>Feb. 28, 2018</div></th>
<th class="th"><div>Nov. 30, 2017</div></th>
<th class="th"><div>Aug. 31, 2017</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>Feb. 28, 2017</div></th>
<th class="th"><div>Nov. 30, 2016</div></th>
<th class="th"><div>Aug. 31, 2016</div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_NetSalesByProductCategoryAbstract', window );"><strong>Net sales by Product Category</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 88,317<span></span>
</td>
<td class="nump">$ 83,851<span></span>
</td>
<td class="nump">$ 86,706<span></span>
</td>
<td class="nump">$ 85,411<span></span>
</td>
<td class="nump">$ 86,914<span></span>
</td>
<td class="nump">$ 85,602<span></span>
</td>
<td class="nump">$ 89,029<span></span>
</td>
<td class="nump">$ 88,098<span></span>
</td>
<td class="nump">$ 344,285<span></span>
</td>
<td class="nump">$ 349,643<span></span>
</td>
<td class="nump">$ 353,890<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ango_PeripheralVascularMember', window );">Peripheral Vascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_NetSalesByProductCategoryAbstract', window );"><strong>Net sales by Product Category</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202,334<span></span>
</td>
<td class="nump">208,602<span></span>
</td>
<td class="nump">205,620<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ango_AccessMember', window );">Vascular Access</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_NetSalesByProductCategoryAbstract', window );"><strong>Net sales by Product Category</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,760<span></span>
</td>
<td class="nump">96,481<span></span>
</td>
<td class="nump">99,375<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ango_OncologySurgeryMember', window );">Oncology/Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_NetSalesByProductCategoryAbstract', window );"><strong>Net sales by Product Category</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,191<span></span>
</td>
<td class="nump">$ 44,560<span></span>
</td>
<td class="nump">$ 48,895<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_NetSalesByProductCategoryAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Sales by Product Category [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_NetSalesByProductCategoryAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ango_PeripheralVascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ango_PeripheralVascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ango_AccessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ango_AccessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ango_OncologySurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ango_OncologySurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6877443408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments and Geographic Information (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>Feb. 28, 2018</div></th>
<th class="th"><div>Nov. 30, 2017</div></th>
<th class="th"><div>Aug. 31, 2017</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>Feb. 28, 2017</div></th>
<th class="th"><div>Nov. 30, 2016</div></th>
<th class="th"><div>Aug. 31, 2016</div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentsGeographicalAreasAbstract', window );"><strong>Net sales by Geography</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 88,317<span></span>
</td>
<td class="nump">$ 83,851<span></span>
</td>
<td class="nump">$ 86,706<span></span>
</td>
<td class="nump">$ 85,411<span></span>
</td>
<td class="nump">$ 86,914<span></span>
</td>
<td class="nump">$ 85,602<span></span>
</td>
<td class="nump">$ 89,029<span></span>
</td>
<td class="nump">$ 88,098<span></span>
</td>
<td class="nump">$ 344,285<span></span>
</td>
<td class="nump">$ 349,643<span></span>
</td>
<td class="nump">$ 353,890<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentsGeographicalAreasAbstract', window );"><strong>Net sales by Geography</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273,327<span></span>
</td>
<td class="nump">282,168<span></span>
</td>
<td class="nump">285,824<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=ango_InternationalMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentsGeographicalAreasAbstract', window );"><strong>Net sales by Geography</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,958<span></span>
</td>
<td class="nump">$ 67,475<span></span>
</td>
<td class="nump">$ 68,066<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentsGeographicalAreasAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentsGeographicalAreasAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ango_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ango_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6872707168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments and Geographic Information (Details Textual)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_PercentageOfInternationalSalesToNetSales', window );">International sales percentage of total net sales</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_PercentageOfDomesticAssets', window );">Total assets are located within the United States</a></td>
<td class="nump">99.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_PercentageOfDomesticAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_PercentageOfDomesticAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_PercentageOfInternationalSalesToNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of international sales to net sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_PercentageOfInternationalSalesToNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6889225568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition, Restructuring and Other Items, net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_AcquisitionRestructuringAndOtherItemsNet', window );">Total</a></td>
<td class="nump">$ 15,432<span></span>
</td>
<td class="nump">$ 27,510<span></span>
</td>
<td class="nump">$ 12,591<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=ango_LegalCostsMember', window );">Legal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_AcquisitionRestructuringAndOtherItemsNet', window );">Total</a></td>
<td class="nump">10,067<span></span>
</td>
<td class="nump">19,480<span></span>
</td>
<td class="nump">7,487<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=ango_IntangibleImpairmentMember', window );">Intangible and other asset impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_AcquisitionRestructuringAndOtherItemsNet', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,604<span></span>
</td>
<td class="nump">352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember', window );">Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_AcquisitionRestructuringAndOtherItemsNet', window );">Total</a></td>
<td class="nump">4,674<span></span>
</td>
<td class="nump">1,348<span></span>
</td>
<td class="nump">1,462<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_AcquisitionRestructuringAndOtherItemsNet', window );">Total</a></td>
<td class="nump">$ 691<span></span>
</td>
<td class="nump">$ 1,078<span></span>
</td>
<td class="nump">$ 3,290<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_AcquisitionRestructuringAndOtherItemsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition Restructuring And Other Items Net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_AcquisitionRestructuringAndOtherItemsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=ango_LegalCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=ango_LegalCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=ango_IntangibleImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=ango_IntangibleImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_FacilityClosingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6876462288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition, Restructuring and Other Items, net (Details 1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">16 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
<th class="th"><div>May 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_AcquisitionRestructuringAndOtherItemsNet', window );">Acquisition, restructuring and other items, net</a></td>
<td class="nump">$ 15,432<span></span>
</td>
<td class="nump">$ 27,510<span></span>
</td>
<td class="nump">$ 12,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">4,674<span></span>
</td>
<td class="nump">1,348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">1,071<span></span>
</td>
<td class="nump">962<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1,071<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=ango_AccruedExpensesMember', window );">Accrued Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember', window );">Manchester, GA and Denmead, UK into Glens Falls and Queensbury, NY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">4,700<span></span>
</td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=ango_LegalCostsMember', window );">Legal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_AcquisitionRestructuringAndOtherItemsNet', window );">Acquisition, restructuring and other items, net</a></td>
<td class="nump">$ 10,067<span></span>
</td>
<td class="nump">19,480<span></span>
</td>
<td class="nump">$ 7,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=ango_LegalCostsMember', window );">Legal | DOJ Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_AcquisitionRestructuringAndOtherItemsNet', window );">Acquisition, restructuring and other items, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_AcquisitionRestructuringAndOtherItemsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition Restructuring And Other Items Net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_AcquisitionRestructuringAndOtherItemsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=ango_AccruedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=ango_AccruedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=ango_ManchesterGAandDenmeadUKintoGlensFallsandQueensburyNYMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=ango_LegalCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=ango_LegalCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=ango_DOJLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=ango_DOJLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6876063856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisition, Restructuring and Other Items, net (Details 2) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve, beginning of period</a></td>
<td class="nump">$ 962<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">4,674<span></span>
</td>
<td class="nump">1,348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash adjustments</a></td>
<td class="num">(276)<span></span>
</td>
<td class="num">(108)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(4,289)<span></span>
</td>
<td class="num">(278)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve, end of period</a></td>
<td class="nump">1,071<span></span>
</td>
<td class="nump">962<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OneTimeTerminationBenefitsMember', window );">Termination Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve, beginning of period</a></td>
<td class="nump">851<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">1,440<span></span>
</td>
<td class="nump">851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(1,453)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve, end of period</a></td>
<td class="nump">838<span></span>
</td>
<td class="nump">851<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=ango_EquipmentTransferMember', window );">Plant Consolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve, beginning of period</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">2,892<span></span>
</td>
<td class="nump">494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash adjustments</a></td>
<td class="num">(276)<span></span>
</td>
<td class="num">(108)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(2,706)<span></span>
</td>
<td class="num">(275)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve, end of period</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=ango_RegulatoryFilingsMember', window );">Regulatory Filings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve, beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(56)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve, end of period</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_ContractTerminationMember', window );">Contract Cancellation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve, beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve, end of period</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember', window );">Other Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve, beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Charges</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(74)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Reserve, end of period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OneTimeTerminationBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OneTimeTerminationBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=ango_EquipmentTransferMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=ango_EquipmentTransferMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=ango_RegulatoryFilingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=ango_RegulatoryFilingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_ContractTerminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_ContractTerminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6874373328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="nump">$ 515,027<span></span>
</td>
<td class="nump">$ 507,228<span></span>
</td>
<td class="nump">$ 545,099<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total comprehensive income (loss), net of tax</a></td>
<td class="nump">16,707<span></span>
</td>
<td class="nump">4,475<span></span>
</td>
<td class="num">(43,548)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
<td class="nump">542,595<span></span>
</td>
<td class="nump">515,027<span></span>
</td>
<td class="nump">507,228<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign currency translation gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="num">(1,305)<span></span>
</td>
<td class="num">(760)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="nump">270<span></span>
</td>
<td class="num">(545)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total comprehensive income (loss), net of tax</a></td>
<td class="nump">270<span></span>
</td>
<td class="num">(545)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
<td class="num">(1,035)<span></span>
</td>
<td class="num">(1,305)<span></span>
</td>
<td class="num">(760)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Unrealized gain (loss) on marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total comprehensive income (loss), net of tax</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
<td class="nump">83<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance</a></td>
<td class="num">(1,324)<span></span>
</td>
<td class="num">(791)<span></span>
</td>
<td class="num">(833)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications, net of tax</a></td>
<td class="nump">372<span></span>
</td>
<td class="num">(533)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent', window );">Amounts reclassified from accumulated other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total comprehensive income (loss), net of tax</a></td>
<td class="nump">372<span></span>
</td>
<td class="num">(533)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance</a></td>
<td class="num">$ (952)<span></span>
</td>
<td class="num">$ (1,324)<span></span>
</td>
<td class="num">$ (791)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=109228884&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6876222864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Quarterly Information (unaudited) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>Feb. 28, 2018</div></th>
<th class="th"><div>Nov. 30, 2017</div></th>
<th class="th"><div>Aug. 31, 2017</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>Feb. 28, 2017</div></th>
<th class="th"><div>Nov. 30, 2016</div></th>
<th class="th"><div>Aug. 31, 2016</div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract', window );"><strong>Quarterly Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 88,317<span></span>
</td>
<td class="nump">$ 83,851<span></span>
</td>
<td class="nump">$ 86,706<span></span>
</td>
<td class="nump">$ 85,411<span></span>
</td>
<td class="nump">$ 86,914<span></span>
</td>
<td class="nump">$ 85,602<span></span>
</td>
<td class="nump">$ 89,029<span></span>
</td>
<td class="nump">$ 88,098<span></span>
</td>
<td class="nump">$ 344,285<span></span>
</td>
<td class="nump">$ 349,643<span></span>
</td>
<td class="nump">$ 353,890<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">47,467<span></span>
</td>
<td class="nump">45,448<span></span>
</td>
<td class="nump">42,731<span></span>
</td>
<td class="nump">41,229<span></span>
</td>
<td class="nump">42,335<span></span>
</td>
<td class="nump">43,792<span></span>
</td>
<td class="nump">45,010<span></span>
</td>
<td class="nump">45,032<span></span>
</td>
<td class="nump">176,875<span></span>
</td>
<td class="nump">176,169<span></span>
</td>
<td class="nump">174,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 2,102<span></span>
</td>
<td class="nump">$ 14,019<span></span>
</td>
<td class="nump">$ 249<span></span>
</td>
<td class="num">$ (35)<span></span>
</td>
<td class="num">$ (12,913)<span></span>
</td>
<td class="nump">$ 2,887<span></span>
</td>
<td class="nump">$ 13,734<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="nump">$ 16,335<span></span>
</td>
<td class="nump">$ 5,008<span></span>
</td>
<td class="num">$ (43,590)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings (loss) per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (usd per share)</a></td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.38<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="num">$ (0.35)<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.37<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="num">$ (1.21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (usd per share)</a></td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="nump">$ 0.37<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="num">$ (0.35)<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.37<span></span>
</td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="num">$ (1.21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ango_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit', window );">Discrete tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Estimated litigation liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember', window );">Discontinued Operations, Disposed of by Means Other than Sale | Acculis Capital Systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Disposal group, impact to income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ango_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Provisional Income Tax Expense (Benefit)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ango_TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ango_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=109256448&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109260490&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873765&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=114867106&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=114873790&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=109223946&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=115205541&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfByMeansOtherThanSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ango_AcculisCapitalSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ango_AcculisCapitalSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.10.0.1</span><table class="report" border="0" cellspacing="2" id="idp6873966048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Valuation and Qualifying Accounts (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember', window );">Allowance for deferred tax asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>Valuation and Qualifying Accounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="nump">$ 48,348<span></span>
</td>
<td class="nump">$ 42,209<span></span>
</td>
<td class="nump">$ 1,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions - Charged to costs and expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,139<span></span>
</td>
<td class="nump">40,685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="num">(21,741)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(267)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Period</a></td>
<td class="nump">26,607<span></span>
</td>
<td class="nump">48,348<span></span>
</td>
<td class="nump">42,209<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember', window );">Allowance for sales returns and doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>Valuation and Qualifying Accounts</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at Beginning of Year</a></td>
<td class="nump">2,945<span></span>
</td>
<td class="nump">4,372<span></span>
</td>
<td class="nump">3,043<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Additions - Charged to costs and expenses</a></td>
<td class="nump">608<span></span>
</td>
<td class="num">(291)<span></span>
</td>
<td class="nump">3,748<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="num">(1,087)<span></span>
</td>
<td class="num">(1,136)<span></span>
</td>
<td class="num">(2,419)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Period</a></td>
<td class="nump">$ 2,466<span></span>
</td>
<td class="nump">$ 2,945<span></span>
</td>
<td class="nump">$ 4,372<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_ValuationAllowanceOfDeferredTaxAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=ango_AllowanceForSalesReturnsAndDoubtfulAccountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>123
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+""
MWTG] E!+ P04    " "\B/=,ON+P\.\    K @  $0   &1O8U!R;W!S+V-O
M<F4N>&ULS9+;2@,Q$(9?17*_.WM0*V&;&\4K!<&"XEU(IFWHYD RLMNW=S>V
M6T0?P,O,_/GF&YA.!:Y\Q)?H T8RF*Y&V[O$55BS/5'@ $GMT<I43@DW-;<^
M6DG3,^X@2'60.X2FJF[!(DDM2<(,+,)"9*+3BJN(DGP\X;5:\.$S]AFF%6"/
M%ATEJ,L:F)@GAN/8=W !S##":--W ?5"S-4_L;D#[)0<DUE2PS"40YMSTPXU
MO#\_O>9U"^,22:=P^I4,IV/ -3M/?FOO'S:/3#15?5=4JZ)I-_6*5]?\IOF8
M77_X782MUV9K_K'Q65!T\.LNQ!=02P,$%     @ O(CW3)E<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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MO0@RJSTD9JX7W7CNADS*M>?]@B:G\T50Q>F2\ )*YI+B;AP%D^+3U["%)*C
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MOU=OU3[ >R:ACX=ZWPY_%P^O;5<?1BN!RJ'\=O[='8??]]'^]V:X 8T-Z-+
M^*L->&S /QKPU09V;&!%@_79E6%LBK(K[V^;^GW1G*?W5/:KR-S8,/H/_<=A
ML(?_A>%IP]>W>V.SV_5;;VC$;,X8FF(NB'6P?NF"4!<;4LUIWL%6(SB90PH
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MU\O-W<?AXDY\WYB;XGS_]L/,^3KPC[)YWAW;Q9>ZZ^K#<'OT5-==%3@F'\*
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M_H%-CH32!?/>VV98L\%QV(XOB$W/./L 4$L#!!0    ( +R(]TPRR2U=MP$
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M MFF*T#*IJI:J956J9H^>V$ *[Y0VRSIWW=L""4I+[9G/.?,F?$X'XU]=AV
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M3G %)X/L("4S;T<0>BQPBM\=3[SM7'"0,N]9"S_!_>I/QEMD8:FY!&6Y5LA
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M^;.9QFPRG.[G'T26;US^!U!+ P04    " "\B/=,+,+H*[<!  #2 P  &0
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MLYG&;#(<]O,/8LLW+OX!4$L#!!0    ( +R(]TQXXUJ]M0$  -(#   9
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MDRHI#=A2H@?;<&.?BB7@4!FW_6#W:AJ8*3"RG]\"LCQ(^1]02P,$%     @
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MO;-S-;_E>6'DL+0I6?\5Q6]02P,$%     @ O(CW3.:*+ASM 0  9@4  !D
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M_*_5D-#Z>/P4SG:>LMGP9E@^$%E_<?4?4$L#!!0    ( +R(]TQ+P4Q>MP$
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MMA@*:A^.G_!LIS&;#&_Z^0>QY1L7?P%02P,$%     @ O(CW3&S:3YO/ 0
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MXC$-%_\//H_4=ZH[)@TZ*^N>3[CD5BD+SDIRY[ST;HK7@$-K_?;>[?7\EN?
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M@MJ%XR=_-M.838;#?OY!;/G&Q5]02P,$%     @ O(CW3&FO%PLG P  = \
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MR_;DW@ZT.MJW$L'UU<CJ'U!+ P04    " "\B/=,DOVLI]H"   K"P  &0
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MW#6 N(9&#@K<#T!OT(O[ 9 ]9JAW:4$][Q*G7-PU@+B&.OP N!\@O4$N[@=
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MQ^ )!HV(0'L?0V HQ!H[YO@R0.HB2'@)N0<@,R0(F"<Q]F1*@C/8 04=4..
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M33^,]ALEZV'0#L9I?_4?4$L#!!0    ( +R(]TP&UON].0(  +$&   9
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M3@;(,3M'9N4QE=Q$/&:6=^:.O888%()\N$_Z=BDHNA#B0JM%XW<] EO@ \*
MH=ALQ=CR"T5)"LWQ*.A0&-S04  ("RZ$@%L:"K]@#]R$$-!A@M"T)[)JQBGL
MS@CD4!;<MA#0MX)+:P=N2"CY@CEP:T!0;[#6CKWK$<Y\T)TQT*$PN$D@J$O$
M< @,[T[LC[<'P[L3HQ%KIP.=MQ&4(<B=,<A6EG=V5"LIW^J#MG!6;%_I4_[9
M:'^8?\#ZJ'>"MU\"/PG?YI5PWIA4!T9]K-LP)JD2Y-^IB=JICX_^H: ;V=PF
MZIZW)_#V0;*Z^[KP^D^<V7]02P,$%     @ O(CW3 .6BI'. @  CPH  !D
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M<Z'=YGK1S5!C"? 8?7M8%4TU.:"['!!M+K3;''S>YPC)#!A#V7S+TS4OW>L
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M+K>IV--Q+(P'3OIIXH%Y[!9_ %!+ P04    " "\B/=,8R+X^6D"   S"
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ML_<M+N ZN9M DV8W:N!"XR@J7X'269)H@)D"!BF@]:.%GV1A/PKZD?5G[ZI
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M7XS7V#A0O)^NZ&3^G[#]"U!+ P04    " "\B/=,;9LZ0LT!   [!   &0
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M)Q0NNE+*@K,2;9R7QDWR''"HK-]^<'L]ON<QL*J;1I7,_Q?Y7U!+ P04
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M3M*7,'WII"^3!#M0T(&Z_GK'T$$,,K"N]\;5\(7 01(8)'&#+.RKA#04!UG
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MW[Z&@\8<Q^]ZT?GCXOI_4$L#!!0    ( +R(]TS>$#:"= (  /((   9
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M=BIV5J:9Z+;H3^&^HW@[W#""\9J3_P502P,$%     @ O(CW3"'RN&CM 0
MV@0  !D   !X;"]W;W)K<VAE971S+W-H965T-CDN>&UL?53;CILP$/T5Q ?$
MW)+M1H"T252U4BM%6[5]=F"X:&U,;1.V?U_?EB6$[@OVC,\Y<\'C=&3\130
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ML\T[94^K5L^K-(X7P5D+]9AUA\$C#!H0@5(?ML#0%FOLT/'U!O<N@H37D T
MF0B"@'D2PR=7>2:P0 0*1$8@NA)(+:,Z3&(P=8?)D9VL"TI01JQT71#!40C'
M&X/QQD"\&2R0@ +)?,=24""=X5B'B4=Y(I1;AKD8G%N8#:"38CC8# PV<X(E
M*<S/07X^WRT4PC<QG.%7#QHG&L>191@ (L@";2!0E$]$/%$[D&O:Q!%#8&FX
M0_@3ML$7&Y$YMA'@?*29[1N$2K!M'("*LBGGX&*"W&I"IA3@ZXWB3S@'7W"4
MS'$N<0]<E"#;.1<5A3BQG7-1&.<391S!106Y526:N.@(ONDH^X1S\&5'^1SG
M<J>&A[9M+N0+1IEM&X!"86+[%HP^^143!]-.M=Z6GVJIOYRCU:%EN\.Z9;#6
MU[J5,ZW$NTS7!_ZDXE#4K??,I6I(3-NPYUPR%65XH_[6HVH]ATG)]E(/4S46
M7?_5321O^MXR&!K<U7]02P,$%     @ O(CW3&TS"/5; @  #P<  !D   !X
M;"]W;W)K<VAE971S+W-H965T-S0N>&UL?57M;ILP%'T5Q .4#X,=*H)4$DV;
MM$E1IW6_'>($5(.9[83N[6<;2JGQ\B>V+^><>^Z%7.<#XZ^B)D1Z;RWMQ-:O
MI>P?@T!4-6FQ>& ]Z=23,^,MENK(+X'H.<$G0VII$(<A#%K<='Z1F]B!%SF[
M2MITY, ]<6U;S/^6A+)AZT?^>^"YN=12!X(B[_&%_"3R5W_@ZA3,*J>F)9UH
M6.=Q<M[Z3]'C'FF\ ;PT9!"+O:<K.3+VJ@_?3EL_U(8()974"E@M-[(CE&HA
M9>//I.G/*35QN7]7_V)J5[4<L2 [1G\W)UEO_8WOG<@97ZE\9L-7,M63^MY4
M_'=R(U3!M1.5HV)4F%^ON@K)VDE%66GQV[@VG5F'\0F,)YJ;$$^$>"9$\"X!
M3 3P00!W"<E$2"Q",)9B>K/'$A<Y9X/'Q[?;8_T118^)ZGZE@Z;9YIEJCU#1
M6X'2+ ]N6FC"E",F7F"B&1$H]3E%[$I1QBMZ_#G!;HT X6?(W@'YCPG@K!,8
M/EB: - MD#@%$B.0+!L%+9/EB$D-IAM-HA E*$-6P0X@A!'<V*W?NX 1C, &
MN+VG3N^IPWMD>4]7F1*8P!!8SM<PD,0@L]3V:UCH-@R=AJ'#L/71E-#1[!1D
M26B]E9T#"+,TBU/[&W,![S4;.;TCAW>KBR5:98I"A.(46M9=N'2#,MOY&@=B
MA$* +./!8BRTA%_,R!5>Q:Z=U/^N172>ZD]FTEGQ4DW[<3A_R(Q7Q0_,+TTG
MO".3:FB9T7)F3!)E,WQ0#FMU.\T'2LY2;Y':\W%&CP?)^NGZ">8[L/@'4$L#
M!!0    ( +R(]TS>!AUX*@,  (<.   9    >&PO=V]R:W-H965T<R]S:&5E
M=#<U+GAM;)57[7*;,!!\%88'"$A\B8SMF29IXB3M3":=MK^)+=M, %&0[?3M
M*PF%&'%RR1^#8'?O3M*MT>S(FM=V1REWWLJB:N?NCO/ZTO/:U8Z667O!:EJ)
M-QO6E!D7PV;KM75#L[4BE86'?3_VRBROW,5,/7MJ%C.VYT5>T:?&:?=EF35_
MKVC!CG,7N>\/GO/MCLL'WF)69UOZ@_*?]5,C1EZOLLY+6K4YJYR&;N;N%W3Y
MB$-)4(A?.3VV)_>.+.6%L5<YN%_/75]F1 NZXE(B$Y<#O:9%(95$'G^TJ-O'
ME,33^W?U6U6\*.8E:^DU*W[G:[Z;N\1UUG23[0O^S(Y+J@N*7$=7_XT>:"'@
M,A,18\6*5OTZJWW+6:E51"IE]M9=\TI=C]V;!&D:3,":@'L"2L\2 DT(IA)"
M30BG$B)-B'H"]L\28DV(IQ(234AZ0AB=)1!-(!\$?):0:D(Z-27DOZ^</YG2
M+S8R*%ZW2]2VN\EXMI@U[.@T7>?4F6Q0="E80EP^51M9O11;KQ5/#XLD#F?>
M02IIS%6'P0-,-,1<0YAXB+F!,,D0\Q7"D"'F%L*D0\P=@$G\(68)8= 0<S_&
MA-B(]3#&!&;MCX!.^I&/)Q:I7RD,KQ16"L$@6PPK!+!"H!3"@4)@U-MA4H6I
M% 9?&//_ &&,_?!X'C/(-H2S#8%LC9WY$(ZB(&N8" X3 6$L"C&L$$]?F 16
M2( <C UTUV&BDU(#. :!8Q @AM%\2S(U1@K'2($8!%:07@?ZD3]]-I'-TQ"0
M1VJ:&AH5BWW3U,888GK:&&*N'  )+:V/++V/\+@BXIMQ\-3E0Q:#0(!#$&1.
M2C *@WQS5LYBAKE8VA\!_4^PF4LX7D0SE3$DM&1B<0@$6 0)S,F/QF&0)8[%
M1U ,Q+'E:G$2E'RB?2Q.@0"K,#?;$HV]PA;&8A8(< MB<5YL<0O\";? %K?
M@%N,RL7C'K;T%K;]?4,M'%LT+/V)@T^4:^DK#/65^16&_]M7MP#$G!'OY"M4
M'M&^9\TVKUKGA7'Q2:N^.C>,<2KD_ LAM!.GPGY0T V7MXFX;[JC43?@K-;'
M/J\_>R[^ 5!+ P04    " "\B/=,!WSR[?$!  !;!0  &0   'AL+W=O<FMS
M:&5E=',O<VAE970W-BYX;6QUE-&.HR 4AE_%^ "#8JNTL2;;V4QVD]VDF<W.
M7E-[6LV .$#K[-LOH#6NTAOAX'_^[W (Y)V0[ZH"T,$G9XW:A976[18A55;
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M6=MI9N:RO^]]H$4[/&5H?$^+?U!+ P04    " "\B/=,IGPZWPD#  "^#
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MD.=%@$,+ 7PC".;Z#0@E!#FT$<!7@F#N,@+?"6$.[03PI2"8:SCPK1#FT%8
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M_#\2HP\+"!9$V(>CCN"H(Z!RWRC$L$(\O'+R> +/ W2]=AK3-DJ(XL HRAR
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M&_)MJ]_]=_$J<@UOF.@8&YG7[:>U.=5*%KT73:5(W[IK5K;7<^__W8PV@-X
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MWTY*)31)=J>3>A#I]O*0BYUJ;D-]7W4#=/>@Y+'_<\"Y_$.Q_ ]02P,$%
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M;^ZSVW4:)8^XA7^CB368V8<B+\MH6^1W66.!93E@\]-OP%_+Y@BNTA*H>?E
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M:#-#NT;.NLX>,:[U$O2WWW<<L!?$Y\:7C0,0'72(P%V?RG'XWL_LR>CZMNM
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M+"DMH3&S[N@P84Y6=W"^..OY1%M"@>[U7'+!?<Z@)47AXD&04FFSBGWL1J?
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MN9BDC/9<X!7WF[)AA:/-U>;@[),.C]GL7@+=]SIA?W 4#DS9WP!!51&Z4B@
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M+YL>>:\;:^96X?=8^%YAV]N?]_Z5C@)-(!$UP5&X7NQ4Q^7G9.EHC+)0)%Z
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M_^GHZB^G-T?O/IY&UZ?'GZ_.;EIJQ;:^U%9OJ\/_I%)CZL!4'#W_B/"!4CF
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MJN#*L_.?3\]O+JY:>*UY]$)%P\S4:-K',8+ONVWL;^%2?W(QS72(Y_%T1MZ
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M4^[Q%',J:A.FPMFWC/-HYL)^%)D,T[*?O%\2K'.>;2@(JS9P-).ZZYW"8M%
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M:0%\CM^G'?Y+^GR+#\\3B<,Y$@&7KCL\](?E,R>=TB_WC%Y&8:7= _F$D9Q
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M[H5O! OU@IKX&&3B5%38P6=(&.(W'F9)O->&.-SQS=!"".2,%F+CTX.C8RS
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MR:CYZJETDN\5EADM&40=_O$ @K! NG<0IR-XM0O9^@3[VC.+U=Z@8Z"#Z4]
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M?#$QE2C'\9#B04;PWI1"1$:3$;S3MXPI./)F+;GDF7LM0?7CG[&8.K3GFI@
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M?#0>Q,/A(AK#K0H,8@P?CQ&4.QY/9]1L>+PP0^^ 2&0X7F!J'^4KQDA<#F!
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M0VJO:H\S<TOJ95@UYX^.]1BR6_!0?N:B0-A(XE.#QVXTS)7%FB0'G)>0@$
MMZ18F3U'?UD;=A?VC/%\(% ;+WA<WE1_CRFPS%.+JHIQI_E?L 5C&^MFD:'!
MM$UBDSU(0B*SM=R]U?[TZO[4.LG8^"'G7:3CEBB/H(+838D3RB%Y,PW&=?H1
M@8:N*+!^:HD6+7*@J;!=*<>HY%YH/E@X'O]$94"[Y0=7,XCUA 1S([(B)7WG
MP$!FIA_F_7?;<@6G.[OXB;^2L-=6@OCV6^4(*_PB'U>NS>#5HF:0"\F5#9[9
MZBQ* Q-)1Q1F- [XRY6-W$L)O?$]UQ(HM$SJ=*):XFRV(,U&Y?-9BIIDJL3G
M9PBAMTK)-8^MG?SAM6):N&8C5T^:D^DMW=4'AII(JYZ)NQJ).=7J S&XVIBJ
M7?),A]+: I2YH :SJMN5J%=]:@?.R%7.H/0K@ETDU@ZPE78FY-E\#WZB6>\&
M.4_>>F9K2I27Q"U?S@XRG]WHG@/4B$!:.$R@IPX3:.A]R64+J) 9;<=P QV0
MI#4\X43EO:[P#];S)@]1[;;-$BE7F)R%CA+&/#2I&3;&I$IDI0?L1/UDIR^5
MRGW\.YT+O+',15,&+4^1QXTK_5?J+C*4J)>PG#@=3G'OD#]+L*G*ZVOV<>UM
M=U>>)RMT8U-P_!U)>,_V,JS"M0F@4Y1<G&,4NT -X)]W(*F1C$9 *237X&#5
M>:F_%UJBVJ@G4G".&])$8_B4P?#5[>;.'#=\2G!6VKU%I&81LJ:K)"SX MUL
M$_@HI0_34B7+S*0K(>I=8Q9=)7:D"J!I G=XL9S-$:TF$$<A'VJD74NQLX1-
MX%8YL?R+GGOU(&"\XF!B98&E$PCLCYR\Y\LI--T,!Y'*'A N('BMT%_1-'/4
MG#M*.1H8%R*.(Q(2+?8&1K+)QO)=L<V(CTKHBM92Z* QNC[V##G&GG)'4ZJ7
MXCI2;VJ3L/Q"JU:UA[>0!*X1^X*Q.? UC$=,*6>$Q8$+WR^:Y;^3]P$?X#-%
M4"#8$#A\VIW6A^K6VG1^1X22WEF/:U;Q/UDB%,>=:Q5/XZ6LK44HDY/PY+ 9
MYQF#^G-L**T&0<Y11IP(K%C3HM/'.^518Y%G2$ P(]05E C-@=DD0@Y#W[ZN
M74^"9 '3/5730[8@J1@FMIT8;)CX9^Z$S(O3BTA/0UG_D3-<#+)-ZQJP^1FD
M!U9;H:I3(KYM81AMQ(OL.J'94A.MLD;]1=H4T7\CVX(PQ^LP2\:_VDAX^U#5
M5D#IB.RU7L6?3 MT!IXE_Z[BO&GCJD=55KLD^1!]DGAA?R"QA/V!K1J'G&RY
MCWG/3UFN+?4%AW]-)G$T3T8]6[((M8:LK$!BM6)'@9$YHBI9![G-FHF!6(0"
M+>P&'9!!7ZS#AWO$$&GEP;@-)#[#"A@?C#JKQYC_U*PPO&]*>,/;)3JD:D/(
MKMP(.[ 03:9W\A/BUB<7Y7ZS2]ZN*88:N9V_T6\8AVG8TZPQ&,1&G;5;TEG&
MG,'\.;\A1+7@-7+L0E;E9GU=\<:07))]$J<=)BL(K,73:\P3];*L)-671.8J
MN5]7FW;+M^Y?;U80#.%KEDF3@SE.WLPF:300%P=0L;[Y3P17+LJ6SKLN),++
ML%8Z?[*UI[EZ9$BO@[UN, <N#.; .X<Y<,R][! 4T"6K&"[O0]?EM;3B9=!+
MN IAF=2SGG%H[[]7^BE!+4J#*NO4$8DT6XP$Z@[QGOO*CX%B$%]*)+A".%-4
M.KK:;38X*2*NJL_L5.-E+1+$0]40J_Q=_'U*M[-Z$T-M'RPWMLU+M"^[Q8)9
M)FJ2;'02:3$YZ#(R:@]R0L.RL-NS,U>7&<<;";Y=Z;CO7,:B9!13B4JM%'Q$
MF20CP1_$ZPU"K)A,M:V?^P@"8R>%$ZS9N;7HXO,MDQY I/ C#7VU[?COM-:>
MNCQ*C7#0FD+;=W^3/!;ZN*MY49L$8I"L/EVL"YM?-[%&N"9*I[EVV4I;)G+%
M)6_TJMX\4>0DJ%8WO.&('F=#$0K4,V'"EOP%E BFOMW+--U;Q"F7/#:@5.D@
MAI=.4U7H+^'IWY_SBC8ZG_9*_?#&:+TU.Y<TRHZ=\*5Y\9A&)3P':!Q(N)4\
M5-W?P7GAUVOQ!/+L*'.[1/Y/,&CJ76J;7>NGJ.-ZZ/8J<$'-G24_FO--0J?#
MQKTV_9#H?>D%2ZGI.O!8&4F)R=\*_(Y38EQ215</J.65"%@)EAND2[Q;KM/6
M&KR((A_3&"8D4MW):4'T4 >3VLBU#3B#1,C$]S8__*CETAX,Q*+8SHM-F:/\
MWJU\U5J4RSCMD,, #_(0$E2+*V'86FL2*.7H5\$P#[/4!Q2L?4PMGW*=7*L!
M%[4.LP5$U#9)=@@1-:/57E=5AU=/E1*)XZ5ANCI&'\5*I*3.W:U9.WZ2D5T@
M[FOH>]GY=%.),B3TJ^:S7 A2]4:*<'F ,)6'\Z1IO.NJ>2=:]-N*B%Q*.M=-
MF1]_DE::&!PKD-E&RD>KJOYR211I""W$U&->&>N. 5"C1^H[+V1H$ RIMIB#
M&%Z-MF%BT]62NG5>V)8#7(%A"\%.X,CK/:J>)(._+3E-SE>[6RECVZ[0.M5%
MYD]1:)D[GC4ZI+KA=(NW[L0\?_LSH3(0+(9GVI\FK5;_R;O=+9SBLVS^)'FA
MDV%A=3XSH)9O$:#FE)]^(P4#[AL?L\,97U]C#;.<,JB:<(.U8QPEK$XN1WU[
M@6^5: :V+S:09/-KF:+\X6O+5T.G@H?1U2CQ,2/G^2:M" >YHY@39WYT$R2\
MLE15#9UD^BG/&7>&G'O2FWO.BW37-92O@WV]#Q13OW]LJ\( 6A(X 3I^ZLJ?
M"&0EYM;%P;C;*PXJ<7]Y7C))<ESM[.Y12\@"QPL6#3:G=E73X]9PTFS$7_O>
M4TUN$</A7LYRBKOR-98HN_UU)=G#[(V\Y^BZ!#2(O$^VALLMMZ3 ^^J@AHIL
MB[7*ZJ":JZH4>NA$3EZX]53VO9^_Y72\W;6W3B2TV3-F1JAP57^Y/'3)%-\P
MX4%-.^ <4],[K;AAA2%W9'8Z*E*5YXQ"Q\O=9/ [V?CY9!3?O\9ZY_0NSWFF
M\\ZN[FW).T7^#M5M[;B57!:=GVX9[+UU[<;4#"(+: N&% CF> DXRI6?;\F_
MAS3A2 %UBM3N+RR^L_GR?/3X"3K5;@UB$+GK_.]T3YU%6G4#1PYR+'!'#SG(
MBIMM'?@<:7)-<[#WR>V 2 A.Z^VZW2>><"> XPXR1PH51'#2)T=:<<36!-G1
M50E#83O1,MCW;!*BT#KEGJDNN<;\>ANJ\(M4M:3BX(E=,ZXD51Y7;3:2$K%T
MNGJG#DJY=$JEN\7(WI(5!ANUEQS)-5-C(/DE!G<MH /ELG(BZC=;H<=H"Z_@
M+7^' 3N_A56Z9$UNWZU#/+.V!VD3#]$B9(D7I$F85"_:U ;:60KV+VQ2@FRJ
MZ6B:&D&$CR/L*=90JZN8^\DL490Q(NGLA.DF)ZY-*:&0DB4@1A46^D"HNYQ\
MH7.NO!0)3J_502PO>&%]WGX"G@EH"5D<(PSP6<5H-8CP$+SYS'U<0BGOI)9>
MX]%"83C#P:[KR:6..R&2@N6.%'7!]#!.9E119738]\++W>1MLV?1Q$*DUM%+
M]H:/+ F6ANO(V:%0,KPBCC__P>%RU '<'%=4IS*.H"TP&3>V82-SG-1M)LP6
M@+,&XV4,+/VEHU)L5.*(0H$R7UK[GTKX.GP*8P)';;8 ?;P=?U]1<:Q6]<&S
MTG;[]8W)4<6W@#YU#<>55<8&=-FX6+B(DUY0OR=TD"N_4$D+E'DSI&7*-46:
M<.145F55?O01)5"O6N]7IPAB+R6H\ [!]$<5M+8\H2K+6A1RW;38G'H</3W.
MIEMQ:@@7"I>UZX<$+'A5E)M[C*383!6S*#@75M6]ICK5A'P]QE;6Z2;KK9$(
MMOOZ>+1VG !1,N(N26AJ%AT==FTPEHV\4OO:7%P<HP-FG0BAJY3\KM8LMW_0
M"6D*5Y:47#M H5+M]\7F;#3M3_\0D;VVVRO_@!E0SXU +O^=PU0[<.H(YJHK
M+5=2"R6HY>NZ5\KK8+B-P4#DXGS6.^GEDK7@$HOUNQMUP*1KXB5CX?#']^KM
M,=P.3&8RZU8[Q)W]8&V+-:>820:ZS8UP?G(A4H%7;C@R>D=,-,$V0,U_6^'3
M)689_NP-,XR&/L]JDU=H (Y$!+/P8DIYTSXBC-&(NK"^DGGHAS)2F\25+40R
M1(J]+S$A;/,B8D:FZ1"?B<[JT<+?@-#OA%5HD)<^M07P4E/H_%\JE+D#X79C
M4+2Q72?:/R(< ^UT;VFSEJ6+FRB74$3<[HKI4O=&7BM!+;4;S#]AT(7.M%8S
M/<TFJ=-X"'@,CZSG=&2)'C,FX^ B<"]<B(2@)PAXXE9>2G]Y8TD-K%6(^*[6
M3+ RL$[>[SZY<PF?W>O6EAY%@A]"H>L.-4@FKNV#[I3^!5\5'$-:KY5:2IUN
MU2VE^HTQ8QN/T^1E12@K,L+S8JP'AAE]3"P3,>A,?,O G[ S%*0AB<4;L&C^
MKP3PKEQ> 4J"#<,%ME33Q2*Y"J ,&_A0W7O +>45FD<;81Q2A0<2R]YPS[FL
MA'+?2>Q[2=YT&X=:\6=%(OH6U[?ASB;\-4Z\;OA+*@,H@77N./'8O(K%<5&K
MI&0Y+;IK'+QEL&B*6Q$B&^NB,CHLU8Y;[ *\8M:#'',XESLI9NJ%:_N>\*'O
M".TE  _MA$,(7=C_3V,0! S/"MP^[<$B:+!_:AQ\KT$/;+?)SM/_]8_@^PDW
MG?"")XM9ZS",Q^D4J6F0PZ_H'8=QD<X7"[P;'T(CF/A>)(4:.G"SQP4V3K-)
M3MR!!8+$(VCN(D^S:0ZRJP,$@_5+KF<6KWHQ3V<+YJV!=HAL 3YHGN4()#_)
MLN0E(\C IE2.<AZ$+)T2@^%LG#,<<3$E .5).LZ+>%BE/=[1@?$%BR&>HS#D
MGK8-]=R+IK8(89L;R&6%&@EJ0/2GMJJ,%M*P_S98$2"QVNA[;0*Z3DYLQZJB
M#CW1PZ&\@\:;MM["RO,2E,HZ((EY23W+Y.=8?N:ZZ29IAQMV0:YX&\4B^U?"
M8LX:5$?N-[X6Q2D,"$<R(I'@_S/[3-")V,OX 03C+HC1P3SR4HV\*DGUJR%U
M%2E:%D1#V?(M>3JFG< _FSW4KQOR_+_JC*%6^+JS/V3Z9^'(QZ<P_J%9.LXF
M]F?K5/8_^@TG,T.:Z\S]<OQT-EIHEW2I'4,E=R[M-B>U(TU^WNZNT*='0_P"
MIY6J6[?(%AG+K(SCA+ZCO'IL@O4$R[772&)14L?F$-'Y;-:&3EP2+:R-+M%;
M;93$PKF,8,$$LQX?X":G5<N2;_M[.PF374X\5YQZT_A^'P_8<\ER62RRFYAI
M'T]&W U5OE]Y28](66/)^]IJK4.6O44ZFXPZ^>6<G"/Q\]TG>O:_=:*G-#C3
M"3$RS%/D*SQVHKTY/@$#'8?XL4M:/L&4E,=<QR7%JMH9J)Y$KIV>!>+6!]*M
M4\*KDZ@G!2V#!ZR@;$1'8Q<G66,[X$>[D0J3T;J@ O3I95URQEZVU(1J(;K8
MFA'-[ALT.,,_#;8B(;)[V).V8LQ3=L4%ZD,RF/K>+BS:U%N:'<(YIA0Z-<UL
M)#5V'_6B=?#A\<'T\\$=G+Q3.W58XDX?$W+ZEZ%E%?($>F .WKV.PN9=M7R_
M7?]Z5T5/(UHH)ASG9\M8L?34866X;,6G'BY&\:?F>,;!K=M4_*@F$J"SAD.2
MMA =:G)Y?^"?8"&T@*T1##03="DFQ1\I SWX\TO.1U=BK#$;YP' =JV[]*KZ
ME/Q]M__ 7C4%O)"4#)^A7)I\,DQ\G?B$R G=F=%W1S!<L_^_ABL3=D*G?G;?
M$BPW^^$V!\$7I?&QO+JWSN([A8<?DS?EP]X0$0UIVVM3 <'8?=JR4L&8BDL&
MFCZ8)C'HI9D'(DW1MU7+$H/&5[O]'A,T:I?U2 $L*G4E,++-AG$(*Y FWE0Q
M]-.>?N)YX=\JJ)12MWG67'P=JRD8DR>4U$;L+J+]B+\TJOKCO>4U4;%M'087
M1MS%T]4T;-T#=)-YXO"IPO@U/X-G,:^ZYI[E?^-U]I9'@-S1 6T50(T4[NJ(
M*0XMP9D&U'Y( V!NC%5+>*[KT(FJH7';)'BW)W"M6N@2-H,=?Y?E)QM H/T_
M3Z<STJAGZ62:)W]#T;&VM<R@P:?ST1R5)&1G?&Z ,SCS(END13Y"CUY>&*N1
M&+ 6I(=.BG0R"HBIWA 4Z8HA2DU T.3!/62,;J7!2C=HDOB_PI"]-7[,S7K)
M+R#^:B(]F\S'H#@M&18"L]0S^'.&P1P"-T?Y42?C,?QM.D8<U4.2Y06,9B9?
M;/K.E=+C20&#5H#ZQ8 6S)V$F2^8^\_U]1; V7F*YOE,FAO#@$\25&C';CK2
MG'@UIVDVCDQ&!T!Q2MR:;9/2 ^[:]E@ ^GKLAFC"7 Z>8SYJ&\B#FG[;TZ3Q
MTQOW-M;%&ZFB.*"BB#Q8[![)BEF:S8A=;SI/YW,FAIZ!+;:8V"0MR>^!KK]?
MW];)9)H6XWER,@;%,4=2MSQ/LT7&JP@/,U@;\[0 B^8D@_D>(;U>-DTG<,M+
MLR@G8#2/D9L]GV +("GA?4\-PLZN^4HXND&BGA09^L.%KCU?I*,1]3P;@5Q8
MR"&?CT#JCOP]\ET'DSFF%] C)NF;S])B-NT8S!S&_P2D4T9^_QS:F$<'$[YW
M2F.Y2/-<C661%D@8FZ>PQ>#R=#KM'TDD^,5A'Q'K/4QC.IT7Q.\\AE%E0L2L
MF("X#30FJUEX@R;R+-@?C$,9,?NH/JBY/;BPT<:0%8]'P[ R% HV9\AF)'T^
M\%FMZ9D#FXIBEX]H54Y !(W&<'A/X,,S_#U#)MYY,<;?QWB8+"9S_#W'WR>C
M&?Y>N)09U@]@PHMBYA9@)WI/F[BY\/P\4>YU5=%@42)B6N?RJ*9.I.;@L0<;
M9#Q*/KUUG,^:]AFY=!I#_2+V:H4*\X33F5'DCV>X!$$,C6E;P[HN<$>\VFU/
MZ9Z,Q PNVK'\#J(J+:9X]P)FC,C;02BA*R= KW AWQ>Q[W:0()2/ALJH"LRV
MS&9\Z 3+WKI2&F*^>[@N1($S#%0HWHHY[4<5CRC$8*(X%=6\9R!.,]!KLE&.
M \:#.LN)ZGT,[YK-$N0 S^'0?FH CTY ]RE0_!8DT$&@+N9Y?'C,MSW"A^:S
MD3"FSHGGM( 5G\\Z1CS"/=J(L 5+. HD16$XY%%(J+Z0P)9Z0:"^2@CZ:>0]
M>$ZXXIP *0KG*:<C%32O2;H *=^*E#*&"0#90Z[0YT'IC0&1;T&=2O)T6B!O
M^ 06BM;B,Y!N(VP;9)958&UE(Z9]N'P-@?1#69RELZR [3B!;7:.U92-*K[Q
M#&-]X_E"SM7([!8YG$G39(;G>N$/GF[IF2N*(AB-J]WN0T^ /"] F2V2 HY+
MD,K^OYP[S#'6G@B'[6,*K>>TE7#B5K$^W9.QAEL.#N$I*Q380$9Z!U[K>-2X
M5FN!?BV1KH@%UR/B7+?4Z.%X&;BD$(O !U=W:5-^'I*6UI% 3XCY$Y6&9)CN
MNT)7?WGWOK4:*8(]ARF_LG]7KK9'9]=_,@G/$IEGR-+;VXVMJZ$!?![0LZ\;
MW9;$0]<WN2$XZZ0,U5<GN/@#!,+?6R)E?<=;7%K"![H>VZ["H(_G9],_I2"-
MST9_8F07_(U0:FX-4R^'S/,I!\CY<,N(6?JQK<VX1G2DU5UIJ/$8&,2%IN:D
MG<MAX5?P"6RL&5D-Z96-24/$)8].M<=8WRFY6O8L5IZ(D_%\3FDJ.71PBH^U
M CXJ"7:RF&2T*T<Y9[LLO!>Q_8BQ [3J%RKT8G[^5!F6#\QNI'Q(2=D!S0UT
MX!Q47.RNDFP6\6*WU5[]("*3@2(RAB_!QPWFW@UECE+"J<8?[PT.W+OIF*23
MV90$"1V@+H 3*\1T/-Q,)RXTZ&[F;?4<=X1A?[Q3Y?S-BXOD=K?;Z$0-.(]F
MT-R+-^9445HXL3"=(@F3BTVEXW&APEILNL_ 'LGAK"I@H+Z!OH!ULS93W2N9
M[9=.'17?_L-&-;NJ;M;;K4DO$V0-ESO?VI<'"(N?6[_KRD7^.+\2%>'%PO[?
M#/\+27?%57-#IZ^BIO6Q[G1.->7PQUV<V/[3ZDM;%69%$@UJZX)HF*G%8]VJ
MYGWRV*:\Y9>SM"0128QS1L*P"MQL9M!PBM$"JVY:Z$&-L *2IN,%O1_DXBLC
M.I/X?;[$L_>FO-_OQ(-E9L%Z$1^AE!SG% '!39XGE[M[P44$-3"']0BJZ,3J
M<S52[- 096 #H)(X0OW4<AM?X\7WXLB#OTVAQ?EDFKR^.Z",<]5S8]#PIAC$
M'Z-OT:)+"D1'<D+<D)C*3K;SR/Q Y\N&@9\Q-! *RS$Y>%G:3%(,X13I LXE
MXRC,T6:9<M[ ?!1D-[Y$0M!WF/+V% E!6Y,.&5>5B-WO/CK"1W<DH"3WR$6[
M-2(51J&J0].>#HZHF@L^"@FOW&;+.OLD'10?%E\&NB]&[,J8T1"S)X/]/>3)
MF,XI4X5'D+YGLRNWR8)GY+(R'*+7Y=*?"WZ"F%7E9LQJ!<-]ZV);=!5Y"VE1
M<<7%R7R&ASH_OL UDLF3QLH5L!Z&C_<H7$_X>\S3_E6KO2P;[<#.GN)KHMB5
M@L;T+^0S1EV_95&\7;X'E6&CC$;!'#2(C0:'8<CQH]H(*P.BK3KUU'FP8J?,
M$T;7J)._"1?&J2W"KCY7>_+",W*CN<'AQUG@>!T")!S'\QM8C#>L+A[VB!RZ
MC/M 41)@S1.=E@=UBL*T4)=/_4)HF/[I#/18#$1DH.UF8#V6E&XPR>9IL:"P
MSO1L-@>KD'N_@N,#+4AR J$[\@R$T',&>Z"+HR+-YG)Q>@9JRC-$OL=+62&K
MA]X%DJW16P29=/WTAC5#QVU:9-)/4"8G9Y,Y>9@FL+=>"U*C##$38!VHI5-L
M=3I!.SSG_H+ZEI\5<XYK8!C%/NQ\G!CRHW0G%D5<:%=SS(8T)_JXT229GBW(
ME9!FX>%%*R&).!8TV0585K6ZSP1B&>H4;-7?F#VKYE5%X"3-A:.P6%T,>U!Z
M8W+TYM"I0\P;1!T-MDG[_GBC6D .^.2<$6;M?CB7SZ*5>$I5[RKXC-J_C$EL
M@:?^^LZG8)R1B@'V]J2PJQN.+CJ^T,N."_@7;C$,3E]@/S>X>HN"]@FNWO'X
M#$P&OR=J\:;^)Q>3+,53&OJPP%5_])A'L4>/&?)+UP C!_U,X*7?9,2+?)&.
M%S/>IY.)'?'Q8@%*R9@WSG1D1OPDF^ !.#7R N;"#7DVPGJ0C*_-S\:3X6,^
MP\"QO&V<MQXF\+2#11*HV+<*ODB#*Z7DP'+%@Y=.S7W#A;A1@.EHR8/*+R!K
M!Q3O#Y3#AS:C>K\G-K0?:@@ C0^,&;6,0JU%&TH7PE+(&4*HQ*).,R9E'4-J
MK1Z%"6RU/(/_BH527SFE!D<!C.@9U<1,,690H-.2$0ICM!$3JIB!LP,TRS&L
MK0ST5)N8+AC""$7:(.@ET"C62:S=/,[F9.FGHRFOJADY,2BR/<\YZZX(HD3/
M3#XF3#.OCGXM!48MV%ZO[HB^#>O;2)H/T52,=5Q15B<<^^A>7V^(DC<X".20
MV*ECM3UB9-.7:+[%4IHF0PSH'Z@G^0S,DR*=+5#,IM-L"E)N@;]F4S9VG%>$
M>HQSJ5*IP/)+IZ,<U@A:*YDS0^7KH/D)R!(,LD*;B\F"=&;5O,IMK#[+SN#J
M[?7>.'T1B],X,Q$FX]3V!-; ; 9-HIDT0AD$YSC,/OQM%'I!8*>!W2N(*E@=
M["$8MAJD5FN#(1!-0B@ K27#9L<675\D]A@3QL4ON!:5 +78 #!@;*UEC<][
M7G3:]2*1+*7I>8I=9[0*3,X2"40(:!7JP2R8EAM,34LYP0Q)0C%/W:FS0A]U
MS;!*!/UK$\.:R;-I>V"H(:S:3*XQUM5)]#B=CQ=L<BT6.=M;\WG!8>-&J#BC
M6D*4"-/1O#FFKR45R*T"4YC>BMG9<\K[\ELHQ7GF.E\3,SX;X\"V&8T&C0)]
M/WU[[+O?"".L9PQSP&4R3:$5=E[,)O1+ ?*1=7"0VASAS>9LZ$YR[=XHV%+,
MY?^3YO\S^L'C"B8('-/ZOZFN"QK!--+4P-L7F22:+3+2P3'$-.8,_/D$^X-"
M*<\EO:]JKG<'=W4;^VP#G"GH0IR\3J1V[1E[LK&\BDW!_M&X\I:?4'88:F"D
MCAG0\/./%7)&A$&A2L'F_%CM0-F_A?V8O%!J8NMIY)RW!UH4EDX*S0X#X=H6
M3N=UU'I[<Z-RW4QSCQZM<[S2730I/1?FG:AHW;XG3>&7LD:"I3UN^1$<(7E!
MO\TIRQ!_FZ136/WVMO,EA347F-HV2M":G*-8H$2?U]LE)@S=__GMW?X&JY,Q
M=@EG$NC\$[BYF*?SQ41YN6 ;T.K/L1R8-D0^ ;MP$:@.:@;<V*,TOW$S6:+7
MM6OP8_=_C]$WJ^V^L5IA<&<YF,ZHY(_G8SB0*?5K/@%Q6S2 [68C2M1!)P.,
M\W0.FM?T(0/IJ7R7@<K'@N2%4_E:?8O'ZD/ED;JFSB5\P 0P6C$YCD?3&8NX
M@K(59I10IG,?'=,>A:L5**.1GK %1J"%3\:-(0/-:U9@W(DJTPO0PD42<R8/
MZ.:@"BV<7Q?%?4Z["I0REKQC2AV,QW;$LBD3=(V;? B+B*P[(IZ(?C75>O*?
M6-"ZY)TBR^;<TTO'ZL96I"@H_'4_F$"$@\W#B\^)H:$6 B"A :(/;R(>M);+
MQ>I9A_UF6"#G<+X6BR*(IN0R2Z_H(,.J9E7ZIFK58I&8QN4+#X3&V42S2>39
M$XK_CF?SS@*X.6L%6=;[O0M88^9;8<51<&.^0/<WM#5*8#7RFNS^SC%%:EN_
MDR_[WPG&7C'ACTEG(PKT3G0C)S/&=:#4F:YZ44EPY0IE.F":=?.C6>#BUNFL
MO @O/%!XDX?WDO+P6H16W'>G<.\IU_+AW 76<7\H/Z>-:(>@@Y//N[D1FR5Q
M33H+S6-"@7I)-U2E2OK/%*"*%=WP9FS??2=XH%-6D/B*3F8+_.5UWX>;/!0P
MLCUHJ%J/"*R7 G<(3/K)A*J\#)VG>\PDT@P<]K8%3+EKO9U^9'HD"U%ZU;Y+
M80OD(\F;RA;R$\[OHGN,!@T.9C)BB78^&_]AX_*(>O&(^O&(>M*^B]'W(Y5G
MY/ Y61":2W/?_N==N3\@().O9]]MB>&O6K7N5:WQN48TZ(IMKOV="HU09?0(
MA5 C"-5]6D:S@I\37^*O_#ITH^P81I3^^0ZQ*.V_GH/U S:]^:>WXU."3[^E
MF(#$,.!$+1\K)1)/B+2@XV$^)?&+PY[RL3&?4R46IRN"=8%)3@5FMBP0)6<&
M>QF,R*) 9RZH*#-JUM\):.6=T&R.BP6:AV3SIK@.K,].;KT5^WVWE:ZR#VMT
M!E)\A'&OT1G(=_AM:AU0WK497Q,PC^\X?J Q4Q1NODA'XP6/*%LX,**+K&B,
M'YC=H*CA#U#3BCR=P1F+#C88I<CXC:G( Q, X$[TFA!:TPEFUV<H4X:/8F$'
M:9Z<P*\X*6H@8Y=Q]EX8ES:ZCH3O6/JHEOO!&U-TIJD#"6OXDD>+L]RE<L+5
M?74(&#%+ RXJJN@[N'S)*3'GRX-E(6CDDOF>FB@OK9?7#*W$,L<(RXW<"M0B
M@VQ39LYUD$9)"8DGB"I'B1J+QV<T51V#94B(E(CP5YXW:#,#T/TH&Y]-[+@Q
M/35#OVA24J.DNQYAZ@A^Z*-"/2[8<4W8X492B6ID])B107'56_8$<: CX^[N
MMTISOQ"J+!J5*"%W=UL%<+JM2LH@-'O+.;FXL %N^=5*5Y-%A?6SZ.T!*]HC
M8&"_)-_T74'MGB(FZP;TG>HSAO[QC%HCJ9_(B[!PWTG\G]\^34X>/:[9683Q
MP8Z[9W)W\&WF(Y2QG?SC);(JDF7]7V&;7.DL\?'F9:KX%:8WY)9D[,1!^ -I
M \KK]^11\SD737%>[-HXRWXWO[8_M;= ^TSE^'L2&S:TFW?+#P)4B]L#7H88
M;>5-4%8UQA,C0&-P\44*O7*V05!$:>DI-60JDR6A/8KK])Z0]DW,L=F"$%?&
M^J]#O\WK>?RQGSCW*F+.6!5/BD@-02YF#0:-CV!OWP>-/]/@WPRGR%RE8>F9
M8@LTY!/!J,>_X.?MJOQ8(D^8<5Q6F(?"$@T=N<T'0)=N6Z"?8V.QB']<-H_W
MIQ\N,?@"-SC!P"Y:IJT%7O'WI&5")T>W$Q^,EH_N W)L[=> !^,=87O&%!"+
M1'V<G"8B\UBF_L1'5H3O<7F6C&8D)8,2RU>[W\Z2?,1F9ZQ.7_-T0F_/5[^5
M6^$R.+^^I@QG^%>70'7!F&L*71BR!)*.PB0=5CN;ME?),V)B""BN;0*YD)!P
M1[\9EF3;J+>>9$VTJP@J)H,#A1E6,1#%N"^][R51A*U6)KY!6'E]'>EXD8-,
M^MW@#?;?,NZ_)4B%^=JSGHR/F/>OC>F7)A?E9FEHM?]QB9G9S]G_'.RU'VPB
MDP3T@KD>AE86_:@VM+)@ 0>(91TK+HY8%IRNG/C1\E$/@.OZRN/^U1=<WK?,
M/*G>HOMZPKWEGHC"W?%QLJ Q720ZT*_U0.-=KW;;O3_RW6>%I=G093$K!QAF
MTPGB"ZC-<86 (\:(=/WY4C2VX%"* Y\%%0,"!O=[TGH&M""H68'WM9Z%WRWP
MVF5$?_11V9#6IHD7Z;;( _HA^DZC1THZ7'CCCIX;S*^V:R^8@#?$)<HGV,[2
MB0;J["AJU)R#FK[[I5R:"'V [()^?9&5*T98BHX7]AXK7YSZ1#MY_7)G8_\T
M[$3LA:ZNN]M4_LUE_%?WN*.VM3BRR5) H9H2UY;WCM?6E0JGS14(BMTV]L7_
M6_H%+WBQQ;=1VH*7:OG4I5K&=;W5[E,PWBVH@$<K:U2Z\U99ZB&:7*?<\G'%
M@H43Q;CKO8LA[]JE<2#NCX"X.VX@DVSX4/HP=VD;:MJ0Q[H U(8_WXJGUJ5&
M#.QU\Y%C>AQ_]D&])1T\9KU9E+6C=X0'B!9L2!\-+6)U*#BTMG[=*Y>R>&.;
MM_ZUO"VWC-]CGEDYO*'VAKNVJKO+UB#' MR;=>W>&AXS[5AM1X]T@*,6Z L*
M2"VPOAR>6GC^AI(T@JX62((!(&N18U?#I:51O+2C!^8X0HOV/L7(0CBYFI*$
M6UDN@OX,OK/SW30<X0&D/JT%X:K%@76DFREBBT691H+CJ0?7KNGH;SX_2WYB
MFJ%G&.2(FC,]KOR(J?(V[A#7N10MC?7"])EXQ3_.KVI*S0HD2=/M+NY^ZZUO
MZ=R/$<)A-,/;[DN-,]H04"4G*ZEJ#[/S!P"E#9W((\[\%UMBM41QNB%>TK#9
M+I$< \U#UE_58.!%C\GL&,9>J"0U(?>.?5,,DB]TL\0@^*+"FY#W6D1^J*>V
MH>T]=)*/<&Q%L.C"=:"AYXX6^+T ;D$TX>QM$,PTN#''-C[H6XX9+ZD\#Y0C
MCHP'6H"/LA;YJB3V50;PJJ7W4:B485]J!:#]WN9S>:=$GW1>?5Y=G2'<) GS
M[@X-D,3O5$Z$ 'TT$A[65D(EO,WCT%J!W]$2$L#FH>#\<K='N#@/Y$AR&\K:
MQ%&#H4(4IM#AH+H=C(_D'2*]_7JU1A\6^<%X]U>.XC20@XXZLPU/)B(Z":G#
M8A;A*K2@V3$!VH%%5XL=8SQF=),"6$&'7K@$<20HK9P9'W=<U?-[TK)9-' =
M;YQM3Z\Z7CB>\0OS6?L+(_W+YWC$'R).L_A^RH_Q1@3Y.$?.0M> #4+Z"S;"
M8%"_UH\1_M3XX1^F('4.2@>>X_%(?P-ZU"H@(D" L:D:UEA\X11'&.T,+B<Y
M%G'$O%8L5ZYL52FH@R0;PLF%DNW;8=7%>]V"3Q<_9(>BTP4?I;'I8$94'FLX
M$;VP=.VM.U2KT#:/ M%%E(7A4'21A[\8B"Y0A;KPY]IG] C<N>XAJ%O04#LW
M8'PW3H[9C4T0. ]&#,\44[V3(D"I."1,QOD;GF#).GSVN?Q(W.:<X'FXV\,^
M[PY*MH*6I0KPHB6D^L7H;Q$#_YL O[6^9QC@VQ%C5G7&H*.@;D=;0%W(:\'R
M,G7);5VQR&N!&&P#7PO<A0T,MM!,;8=A:W.J-G'8A@QD\V_>V)[XJ:5M:5"R
MG2T'>6H+*MY:@FVE/#]5O/-7]XVP&*P&SEO&!=$2]^KT>%SR(,133.V[;C@$
MQ\H#0KM=MRE131"ZX48<Y0A('D&0 (9^M'$1-]+H12YWH?-S__KF)Z)#QVJY
M&A/LMQ_2Y-79^5E*OZM2<?/G_ZCNK_#**U-S>U[7.Z/ _9[0NY#\+7J44M<<
M9V%*8 UMNH <CON((I^?%5F@VKRQJ;("=V_%FFDK,/YB&E+0QX\2"]]4!CH-
M/]:5N:,%>P7R@)*9D;& $G P/^Z'%^^>GG_K]E-5$FOB0CI!+!) PN91$R64
M/1$A</SRZ\.EQMWC.DF%V[PLD6DJN3NL.2K*=%"4=,!F7PPJ\1LON/9430>J
M@N&:CKQJK!<)%L5WZ'8\-75T-@Z7Z+?OS0_8+N:=M ]H=C;^(\;)ZUG;F$W^
MB#%[=K??,:=J^Z"-_YA!\[L6'[7LCQDUT)'1'2__/C<PJ-^_(Y1=4:WHG Z$
M!]]D45&9%H_*-$HP#B/*TK?OKP-KE3\]E]Y]_ZZ\K Y2]14_]K^#5-BO5W!R
MOMR5@>G8HH$=$41SV+=!VT,P<.,/]<+?QGLQ# 0W- >.6.P/7VE@_:Z%5!G3
M#1Y0$A&V,"#(\%-YP/B[(-FB&S[6=!S_MR\XSEKXM#-B_7IY.$O&$[ZGCH+M
M\2T+NJ5XE/Q9P//B-^L0C FY]ST3*;CK>R26A-S;N(GO?]KML4SMOV'/[$W-
M67U$)Z?'?]>D96@I<^;UIRW,Z_OU+2,"575/9/O\[O!^QV!&(,+7!']$7JP3
M?LMC+.J+OD\0E\G=QK7)PYZ[4'>GR6UI$G5/[NJ5*\K&Y]V8!";.WKBKI1D#
MU.N^IK<?01L/ZXK_.;_M#ER;QW<'8W9W55>_WN&V)OA@=H2O8*LO#[M]30#(
MD83I/#_+\T G&=A8BPW/%9'F2:D#YEO3@6#'1XW3Y;K^D%QC06JG10NFZ#SX
MTNPL#U6R[*P([[2$?""IRP,K*5'#.9I?G6?14E*+4!TQTJ4 -)E+&2-LT&B!
MHKEO<?1]6?2^IVMD\H!#.E:DB^7=QF;V@<NI;M=#[8;OBK2@$7@C9;"Q1RAG
MNEI)L8Z&<^]YEXZ-1R[_^+U6J &,9:!X PE,2@QW?) ,P%0KJ2>,?NUE=:O*
M#3W1&1N;/95]W-NVK5H0N=EX*+8V[4O$XF&'#HJ=D$\YS@6NC;;ECZAI#!+;
MWC?V"MKV;QAVQJBW886Z$_'BA(F,1/,YSADL/[;(PG'14H0<O/^8GCHH5IF&
MV*;Q?'4BC&&Z*J-*M!T)XVA4TQ?JL79:1N 7=]7TIRNF^DMG8QG)L$",FHI\
M<;2E?J",".&'29I7%I]_Z0&%?P.9$'_5 .5"P>WSTD#O?1017I#XXV:.ZC;Y
MUAN0]"4GM)BYC2\PVY'X; UDQ(@=?N/1J) OX2P^7"P8GZ=/(GD2_RPGH9:^
M6*$D^Q4I,M9X[!<P76TZ\GB6@B+.>QN-D5NT+/=1/*#HAH/9&C#3&CMA/?(H
M@@W=3B"S>SLX8/#;_6\1R?_ TZ1;(#H!+%P>OUOD_U"EN=O;.+0^(^/M3UM$
MMA4SU69](^D%J-H?UL@^1-L$<P:P]^T2[&]LU5E<'(KUFX8QZFO;JP:T!JH>
MK&>"X48SD>V#3U7%$^?@N:FR1M0^1#/ , *H>.4^*D]=<K?8H-(X3X_]^A-]
M%5>3MEC[VY3N^(TV'YOTS 58B=8L15":&MT/02.Q \T_'Z^#(F\$710]K;GQ
MA2;TFF##0(4V1;,]DS7_1OW8E$=UP\U$Z4*^L@$?*"8['3^/U2&(BX^X2M+C
ML9#Z_!CB->AE3!KJ?C!$)T/O5X1* Y]0+$N#WR'42P/O[R!D&M9$A#8E.??9
MCO1];X3MB Z*U# QI;H?:<BC848N>4/V4;L;,E H? JN=,#D'Z&A];S-+9"O
MV*9:1%^Q5;70OFI?93%^O3:#&?16[!'O,>N_AT=L\#X:3BG6VV3_$+1WFL;C
MZX[W$5_V)>]M)\,+CWSV4QDU+&E!'3OB%>8SVX8T\-9)%R;6599_Q2[T#72H
MCW)OP!HPW9E$N]/**MBYK2*F75=#/8OS(:T-67PQ5TQGN(FJE08LT$ZNM(<]
ME;8=#7'I$O$,G J;&AM3;'8QQYM#.3(I?$;@'--,&F@WQSUMR-X>]+ @^3_P
M^43PD/H^?R 97F0\N^=LZ!(P0_1U6E-C]C4:# :Q9YUV[K0CJGN^@D[I/4:$
M=EU!2%X^$>Z]6ZF 9$]OZ))61'F![1FACU-1^+B\(6#EH*4N0K4P+D/HR\$7
M?@EK6LP5KZFJ&KQH<4#;MDR#G\J]C<A/EYMR'=9TT!U%WQU9UG''7^^V9\E(
MXM<?=['<#&Z$P_ 3]*Q$DI_*K7W/>%]55'% *^6_R]O;JMSP8]$>>,D$;ZH#
MV=2Q-IH/(LA-8X@[ ^KV',5$%- K&$J6@RX!\ULT0,2XS[&HW-GE&4@#W& O
MMLNPL-CZ#'@<L/GX0*H[923JY'J]$9>"-RI^<V;@8A''GP_E>X3TCM6T.]\L
MS@VZ,/[)NL0)_2$\6Q1R@>H,K&Z_<SQEJ.4.F4K]V2Q:I3N]O;#=!GE=MW>;
MUHICCKO'O*1/YF$:X%3\J3T#2$/-770E#/W/-!;(X%:>5IN2@#CZIL^LA!).
MN9MJM;E'XEQT8^&8\,5@4(:)JU[4IN]"Z]CAUHC0^#U0,&>]138A3=Z 6TBT
M!738+3>. ZZOMAL#!-2V&P,<U+8;^X;1U@W%O\B[''Z'?SG$;_4NA]BMWN6^
MGE+.5;R7]E+80W<IZ)V[%/3,7>KK%<7#XKVRE\)>N4M!K]REH%?N4E^O!E$J
M'EV/=GYWXV!Y.L_\KB>#NJ)./L1(<*!)C]B\I<&'&,QM@PGQ2\;N&%B<./%@
M\RZ/A[!YT2,>_*)^MZ6>^M2&W-U;+Q[3H-D,)'<TK2M;Q/[*L63!P<<3D;C'
M*\O^$;"(-AM81)L]FDCQ>#@\KU$RC23E@+3)+I65V \CH]Y/>=C9B:\U!L<L
MZ&S:">KBOY6I)7I&L@7XSQ1\/FNI??T)RU;1N0 B^\=SP0_=?JQ*4,U^_@_T
ML>V2'S?P*-C[&RF9_\^["OYP=;<'O?'5WZ.SA/BGK__:H<T]>)"/P WRF[4K
MK+/4._I,ZL=^XI'0B_@LQ2@+@T<U)^' 'HG3-=X7S7UI*N.#TX  ]3RRR_#5
MEC!3:#!#35+8-C6A9E0C8.K,R/(\A@'Q^&/W]<6+Y/S 508FN^9-N;=@BC"$
MF-<Y% S^AWC-NN\ BW__ES(-!I_VA7QZS?8&D-I%A__H:'P?;5CHJ@H)NX(V
M+;R48J9JK8QO!5@>@M$,HLU4X%]()<+;^QHE5>0U7OFY4&!Q:E5D!AP$#DO9
M<K.^)G0]2ZSS@ U@*<:X@+@/'$AQ(_Z@9=[?(YD]ILB_AMZP]..B8G(DD;G:
M<N@\-:C?$<>F??TS%G!OH@+._RS6M?:"Y4%(,;N[JP/RXPCSNGK1G^OZ\)?_
M 5!+ P04    " "\B/=,%^PUNDD"  !:"P  #0   'AL+W-T>6QE<RYX;6S5
M5EMKVS 4_BM"':.%4=M)D]+5-FR%PF ;A>9A;T6QCVV!+IXL9TY__23+ER0C
MNV3=2%ZB<[ZC\YU/%^<HK/2:P6,!H%'#F:@B7&A=OO6\*BF D^I2EB!,)).*
M$VU<E7M5J8"DE4WBS)OX_MSCA H<AZ+F]UQ7*)&UT!&^&B#D\N]D"A%^.G_]
MM9;Z]A5RX]F;LS/_Z>)V%S]O Q<8.8X/:82#^17V?I_TTM_/:V([U+,_H_X)
M\P[Q? _Q2+0G\=HF>MVNQF$FQ;BY4^P PTPXH!5A$;XCC"X5M5D9X92M'3RQ
M0"*95$B;4S65 XM4SRX<.,\>>,?#J9"JK>TJN-]E-WTGT'M6(&5L$#C!#HC#
MDF@-2MP;IYW<@C^$4&<OUJ51F"NR#B8S/":T@RFRE"H%-90)< _%(8/,RE$T
M+^RH9>G9H-:2&R.E))>"M!KZC,XPM DP]FB_AB_9%G>3(3?''HF/D571FV;5
MG3F>FM]*WF1SW)NTA_&BDJZD?E^;Y8C6MW<.'A1DM&G])AL$&'92EFS]CM%<
M<'"+^67!X,""<4CZ.JB0BCX;/GM5$@. PF@%2M-D$_FF2+F 1O?7J<D.U3PY
M0<TOO<\Y"%"$;8HV=_^8=_D_*YY>_[WD]E]E5_ +:K2][01$SHY?Y/3F^#7:
M5\$)B/S7WXW7M<:-_KO5?0<4+6O*-!6=W(*F*3@]]OD3X<_V7<6V>N#8A V]
M)DOST-WB-[DI9*1F^L$NL0U&>+0_6N'!?)BU&"@B/-J?(*4UOVD+CJ_I^#M0
M2P,$%     @ O(CW3.NA6<.8!0  [C<   \   !X;"]W;W)K8F]O:RYX;6S%
MFUM/XS@8AO^*U9ME)7;;G ,")(8Y"(G=Z0YH[DWJMA8Y=&V'P[\?)QTT7R#[
M:F^^YHHV=9)'B>W'KVW.GAKS<-\T#^*Y*FM[/MLZMSN=SVVQ596T?S8[5?M?
MUHVII/-?S69N=T;)E=TJY:IR'BX6Z;R2NIY=G+U>:VGF%V?=A^]:/=E?Q[NO
M0A9./ZH[>7\^6\Q\N3DIV%_T]>^>Z-3\'Z9FO=:%^M@4;:5JMX<RJI1.-[7=
MZIV=B5I6ZGSV6D3(>B4^U4Z[%W%=[R_ER\Y$?^OKU?DL\)^==/Z<1VWU?:EF
MPIQJ_X.Y7@4=.!_DE?_>E'KE[[X2MQU$=X(5S5I\W2E#($, &4X#>=54OH)L
M"60$(*,#0GZ0I:P+)6[[6D8 8P 83P8HCI:20"8 ,IFL/MZZIB"0*8!,)X.\
MDI;6QPQ 9KR0'Z35/=+2*.N+]B6.Q8?6ZEI96B=S )GS0GYU6V7$I;7#5G("
MB$YXB3Y+;<1W6;:J>W:?=>V;B9:E[[FM,VU%>^T%ZK87O)A_2?.@G/0W%;>J
M:(UV6M$G&$"G,$OENG[T!1KS!@D9)&!6B&\$.ZF]AY_]1:RRO93[VD<)D3X"
M9G\LC3_;N)=CL?1=\\]1P[^MWG7G'0N*B202,%OD2].LGG19]GS7OENI-QW!
M^S8<((L$S!JYKHNF4N)./@^K())&P&R-RZ(PK1?&C9;WNGS78)$J F97W#3U
MYH\[92KQ4=T[2H7<$##+X9MRVO1J[9O$X&DA0P3,BN@&(@_;IEPI8W_KVZA[
MH0-EY(60V0N?I*EUO;%BZ;UZNY5&43(DA9 ]:525=ON!4M=W^$&4\Z3*ZW70
M$$(8-)@U<:LVOPB_J&9CY&ZKB]?<1C&1*T)F5UP6OM)9O1_1?5/=R*1P?A!0
M;WIPBHE<$3*[PO=X;=66_3!Y/]+[F=B\@GTPIYA(%B&S+/YII7'*E(-X+H[:
M6K8K[0:8R!\ALS^Z0>D>K7O''KK4ZY?NE?O'W+1T/B%$+@FGS!UA3C&17$)F
MN6#,$XJ)7!-.&4>B!9WZ0-J)IH@CXNBN.V)_IY1(0='A<LDH&S)/-%E Z5$I
M)ISDFC*E1#'%1.:))DTI5) 1,D]TP)@R6B.1;Z+#YY511B2;Z*#!910/229B
MELQ84AB%1(J)F!7S/C*,(<9(+S&S7FAVN'R;'<01Q41^B9G] M-#'%),I)J8
M634P/<01Q42JB=E##D@/,55-#%=5F%4#TT.<4$RDFIA9-7"\&Z<4$TDG9I8.
M71 01Q_]F%*7PWX(Z29FU@T<C<<TV\1(.S&S=C FS38Q$D\\9;9):+9)D'R2
M:;+-2-U,D'P29OE@3#KD39!\$F;Y##+8V#-$RDG8T\U_AS#/2C&1<A)FY;P)
M8<=OUHHH)ES*9U8.#&$)54Z"E),P*P=C9A03N2=A=@_&I.Y)D'L29O<,(^U8
M T?*29B5,THG0LJ7(M>DS*X9Y[M3SZZ5Y8 2J29EGT<;HXP&?,@Q*;MCQOCB
M 1_23,JLF0'?>UB*B323\B_?O)\ &FG1*9),RBR9,4ARC&+"'6/,DGD[4?6F
M:5-,))GTP/-I/S&#P>M&>DD/O"=@O$(BQ:03[ X@[YMN#D2FR9A- S'IP\R0
M:3+N&37X,.F,6H:$DW%O&X"8=$8M0][)F+TS-M,[]L:1=#+V7<I@FTA&I],R
MI)V,?9\RPJ39)D/:R=AW*B-,FFTRN%6963MPXCRCV29#\LFXEW,@)IU7RY"!
M,FX#(<R<SJOER$ YLX'@,D0>4$RDH)Q901B3*BA'"LJG7-3)J8)RI*!\RD6=
MG"[JY,A"^92+.CFU4(XLE#-;"&X)RZF%<F2AO+?0O"]L+\Y6:JUKM?K;W\+Z
MXX4LBZ41W9_N2D$8)]WVVW5;EE?^V-?ZII'=\?X:K_]_=_$#4$L#!!0    (
M +R(]TP#![=0H (  $<S   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'/%VD%NVS 0A>&K&#I : [)(5/$6763;=L+"#9M&;$E0531Y/95O:D*)'I=
M&$\;&8*,X;_Z(%!\^I8O]7CNVM*<^[)YNU[:LJN:<>R_&%/V3;[6Y:'K<SL]
M.7;#M1ZGV^%D^GK_6I^RD>U6S3"?43T_S6=N7@Z[:G@YV&KSHQY.>=Q5YNUB
M?G7#:VER'HNY_=B':8'I+^]]_I_EN^/QO,]?N_W/:V['#RK^+E"9CX-D.4CH
M06XYR-&#_'*0IP>%Y:! #]+E(*4'Q>6@2 ]*RT&)'O2X'/1(#[);(..6GX2P
MYFMM =>6[[4%8%N^V!:0;?EF6X"VY:MM =N6[[8%<%N^W!;0;?EV6X"WY>LM
M0&_AZRU ;UGA71N];//U%J"W\/46H+?P]1:@M_#U%J"W\/46H+?P]1:@M_#U
M%J"W\/5V0&_'U]L!O1U?;P?T=BOLE:#-$K[>#NCM^'H[H+?CZ^V WHZOMP-Z
M.[[>#NCM^'H[H+?CZ^V!WIZOMP=Z>[[>'NCM^7I[H+=?8:\;;7;S]?9 ;\_7
MVP.]/5]O#_3V?+T]T-OS]?9 ;\_7.P"] U_O /0.?+T#T#OP]0Y [\#7.P"]
MPPK?*M''2K[> >@=^'H'H'?@ZQV WH&O=P!Z![[>"O16OMX*]%:^W@KT5K[>
M"O16OMX*]%:^W@KTUA7.FJ##)GR]%>BM?+T5Z*U\O17HK7R](] [\O6.0._(
MUSL"O2-?[PCTCGR](] [\O6.0._(USL"O>,*9P7184&^WA'H'?EZ1Z!WY.N=
M@-Z)KW<">B>^W@GHG?AZ)Z!WXNN=@-Z)KW<">B>^W@GHG?AZIYG>I:F'?/@^
M#N?V5.Y=\L_P3VMF<)?Q_9+OGW&;^NGZ,Z7':95L;M>[JW.;^B?"S"O*\V]0
M2P,$%     @ O(CW3%OL=<DV @  S#$  !,   !;0V]N=&5N=%]4>7!E<UTN
M>&ULS=O?;ILP%,?Q5XFXG8*##89-36_:W6Z5MA?PP$E0^"?;[=*WGT/;2:LR
MJ543Z7L3 L><\X-8G[M<_7R<K%\<^F[PZV07PO1%"%_O;&]\.DYVB)7-Z'H3
MXJG;BLG4>[.U0JY66M3C$.P0EN'8([F^NK4;<]^%Q<W3]6/K=6*FJ6MK$]IQ
M$ ]#\ZKI\KEAZFPWK_&[=O*?XH)D\?40N_AX;9W$JD_$&R:\OO%X'N_[_F"=
M:QO[KFCC9M/6MAGK^S[>DOK)6=/XG;6A[U*_,\XV/X)KA^USWCOCPC?3Q\;B
MT(E_%J27RQ$>.WLZP%PYY^00MX4]-6HN/'UF'QKXLAOJT=GEY&+5A?;$X\5(
M=['JQ7'A.1_1'K=.8YLW#8^M+_?#_A[=?OY^ZH7_+7HQ'S[VUL^70T)R*$B.
M')*C@.30D!PE)$<%R?$9DB-;48)01,THI&844S,*JAE%U8S":D9Q-:/ FE%D
ME119)45629%54F25%%DE159)D5529)44625%5D6155%D5119%45619%54615
M%%D5159%D5519,TILN8467.*K#E%UIPB:TZ1-:?(FE-DS2FRYA19"XJL!476
M@B)K09&UH,A:4&0M*+(6%%D+BJP%159-D5539-44635%5DV155-DU119-456
M39%54V0M*;*6%%E+BJPE1=:2(FM)D;6DR%I29"TILI8462N*K!5%UHHB:T61
MM:+(6E%DK2XHZWQ,>],._TOR:QSW+_/%_">.ZS]02P$"% ,4    " "\B/=,
M'R// \     3 @  "P              @ $     7W)E;',O+G)E;'-02P$"
M% ,4    " "\B/=,9O,+8((   "Q    $               @ 'I    9&]C
M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( +R(]TR^XO#P[P   "L"   1
M          "  9D!  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( +R(
M]TR97)PC$ 8  )PG   3              "  ;<"  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ O(CW3'$9HR"> @  H@D  !@
M ( !^ @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( +R(
M]TP3A/(B<@0  -T4   8              "  <P+  !X;"]W;W)K<VAE971S
M+W-H965T,BYX;6Q02P$"% ,4    " "\B/=,ZZT)N[0"  #A"0  &
M        @ %T$   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%
M  @ O(CW3$1ZH.U$!   ?Q0  !@              ( !7A,  'AL+W=O<FMS
M:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( +R(]TS_'<C[;0(  -@(   8
M              "  =@7  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"
M% ,4    " "\B/=,W<O.ZA<&  "5(   &               @ %[&@  >&PO
M=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ O(CW3+J\5>2?!0
M\QP  !@              ( !R"   'AL+W=O<FMS:&5E=',O<VAE970W+GAM
M;%!+ 0(4 Q0    ( +R(]TP%73D\LP$  -(#   8              "  9TF
M  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " "\B/=,,LDM
M7;<!  #2 P  &               @ &&*   >&PO=V]R:W-H965T<R]S:&5E
M=#DN>&UL4$L! A0#%     @ O(CW3"X.VF>W 0  T@,  !D
M ( !<RH  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " "\
MB/=,1HJ*YK@!  #2 P  &0              @ %A+   >&PO=V]R:W-H965T
M<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( +R(]TS/E2^ M0$  -$#   9
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M970Q-BYX;6Q02P$"% ,4    " "\B/=,>.-:O;4!  #2 P  &0
M    @ 'U-P  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (
M +R(]TSZZ:/4M@$  -(#   9              "  >$Y  !X;"]W;W)K<VAE
M971S+W-H965T,3@N>&UL4$L! A0#%     @ O(CW3/[04B&X 0  T@,  !D
M             ( !SCL  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"
M% ,4    " "\B/=,7"#F:K4!  #2 P  &0              @ &]/0  >&PO
M=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( +R(]TR+66*:M@$
M -(#   9              "  :D_  !X;"]W;W)K<VAE971S+W-H965T,C$N
M>&UL4$L! A0#%     @ O(CW3.8]0'*V 0  T@,  !D              ( !
MED$  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " "\B/=,
MK*[U#+8!  #2 P  &0              @ &#0P  >&PO=V]R:W-H965T<R]S
M:&5E=#(S+GAM;%!+ 0(4 Q0    ( +R(]TS%!GKZN $  -(#   9
M      "  7!%  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%
M  @ O(CW3%97E+ZV 0  T@,  !D              ( !7T<  'AL+W=O<FMS
M:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " "\B/=,SN]:#K<!  #2 P
M&0              @ %,20  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+
M 0(4 Q0    ( +R(]TQL^F*RMP$  -(#   9              "  3I+  !X
M;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ O(CW3!_V6RJ>
M @  JPH  !D              ( !*$T  'AL+W=O<FMS:&5E=',O<VAE970R
M."YX;6Q02P$"% ,4    " "\B/=,3!MF@L(!   W!   &0
M@ ']3P  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( +R(
M]TP0ZXG!SP$  )P$   9              "  ?91  !X;"]W;W)K<VAE971S
M+W-H965T,S N>&UL4$L! A0#%     @ O(CW3&(6>@_' 0  -P0  !D
M         ( !_%,  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
M    " "\B/=,2QZ'_+<!  #1 P  &0              @ 'Z50  >&PO=V]R
M:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( +R(]TRS[2<\N0$  -$#
M   9              "  >A7  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL
M4$L! A0#%     @ O(CW3#F=UE&W 0  T@,  !D              ( !V%D
M 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " "\B/=,N7Z1
MM,4!   W!   &0              @ '&6P  >&PO=V]R:W-H965T<R]S:&5E
M=#,U+GAM;%!+ 0(4 Q0    ( +R(]TSFBBX<[0$  &8%   9
M  "  <)=  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @
MO(CW3'&KU"*W 0  T0,  !D              ( !YE\  'AL+W=O<FMS:&5E
M=',O<VAE970S-RYX;6Q02P$"% ,4    " "\B/=,2\%,7K<!  #2 P  &0
M            @ '480  >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4
M Q0    ( +R(]TQLVD^;SP$  )P$   9              "  <)C  !X;"]W
M;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ O(CW3+PE6A>V 0
MT@,  !D              ( !R&4  'AL+W=O<FMS:&5E=',O<VAE970T,"YX
M;6Q02P$"% ,4    " "\B/=,5N2NI<,!   W!   &0              @ &U
M9P  >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( +R(]TST
ME(P%Q $  #<$   9              "  :]I  !X;"]W;W)K<VAE971S+W-H
M965T-#(N>&UL4$L! A0#%     @ O(CW3(9F)ZZW 0  T@,  !D
M     ( !JFL  'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +R(]TSZMH_78 ,  "81   9              "
M =%V  !X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ O(CW
M3)+]K*?: @  *PL  !D              ( !:'H  'AL+W=O<FMS:&5E=',O
M<VAE970T.2YX;6Q02P$"% ,4    " "\B/=,^H((>N4"  ![#   &0
M        @ %Y?0  >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0
M   ( +R(]TQ;(V!31@(  " (   9              "  96   !X;"]W;W)K
M<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ O(CW3*3DZSP7 @  E 8
M !D              ( !$H,  'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q0
M2P$"% ,4    " "\B/=,3-B50(P"  "9"   &0              @ %@A0
M>&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( +R(]TQ@#H)R
M3 (  )<'   9              "  2.(  !X;"]W;W)K<VAE971S+W-H965T
M-30N>&UL4$L! A0#%     @ O(CW3,R1S\L- P  ^0L  !D
M ( !IHH  'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    " "\
MB/=,!M;[O3D"  "Q!@  &0              @ 'JC0  >&PO=V]R:W-H965T
M<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( +R(]TQ0UB4690,   (0   9
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M970V,2YX;6Q02P$"% ,4    " "\B/=, Y:*D<X"  "/"@  &0
M    @ &?G@  >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    (
M +R(]TQ(5(H$9 ,  (H.   9              "  :2A  !X;"]W;W)K<VAE
M971S+W-H965T-C,N>&UL4$L! A0#%     @ O(CW3,$5E_%/ @  @@<  !D
M             ( !/Z4  'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"
M% ,4    " "\B/=,8R+X^6D"   S"   &0              @ '%IP  >&PO
M=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( +R(]TQMFSI"S0$
M #L$   9              "  66J  !X;"]W;W)K<VAE971S+W-H965T-C8N
M>&UL4$L! A0#%     @ O(CW3.+(:9_K P  :!0  !D              ( !
M::P  'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4    " "\B/=,
MWA V@G0"  #R"   &0              @ &+L   >&PO=V]R:W-H965T<R]S
M:&5E=#8X+GAM;%!+ 0(4 Q0    ( +R(]TPA\KAH[0$  -H$   9
M      "  3:S  !X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%
M  @ O(CW3%.VO=>]!P  /C$  !D              ( !6K4  'AL+W=O<FMS
M:&5E=',O<VAE970W,"YX;6Q02P$"% ,4    " "\B/=,EY03OBX#  #!#
M&0              @ %.O0  >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+
M 0(4 Q0    ( +R(]TS83-Z\? ,  "@/   9              "  ;/   !X
M;"]W;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ O(CW3#FU]S/'
M @  [ H  !D              ( !9L0  'AL+W=O<FMS:&5E=',O<VAE970W
M,RYX;6Q02P$"% ,4    " "\B/=,;3,(]5L"   /!P  &0
M@ %DQP  >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( +R(
M]TS>!AUX*@,  (<.   9              "  ?;)  !X;"]W;W)K<VAE971S
M+W-H965T-S4N>&UL4$L! A0#%     @ O(CW3 =\\NWQ 0  6P4  !D
M         ( !5\T  'AL+W=O<FMS:&5E=',O<VAE970W-BYX;6Q02P$"% ,4
M    " "\B/=,IGPZWPD#  "^#   &0              @ %_SP  >&PO=V]R
M:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    ( +R(]TQL!%^-*0,  +(,
M   9              "  ;_2  !X;"]W;W)K<VAE971S+W-H965T-S@N>&UL
M4$L! A0#%     @ O(CW3(I+Z4_\ @  <@L  !D              ( !']8
M 'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6Q02P$"% ,4    " "\B/=,P%4K
MR_8!   _!0  &0              @ %2V0  >&PO=V]R:W-H965T<R]S:&5E
M=#@P+GAM;%!+ 0(4 Q0    ( +R(]TPA$;Y*I (  +T)   9
M  "  7_;  !X;"]W;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#%     @
MO(CW3"\P>*;C @  )@L  !D              ( !6MX  'AL+W=O<FMS:&5E
M=',O<VAE970X,BYX;6Q02P$"% ,4    " "\B/=,L0=?*D8$  "\%@  &0
M            @ %TX0  >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4
M Q0    ( +R(]TQQ966GFP,  *T0   9              "  ?'E  !X;"]W
M;W)K<VAE971S+W-H965T.#0N>&UL4$L! A0#%     @ O(CW3,P,WI@A!
MX1(  !D              ( !P^D  'AL+W=O<FMS:&5E=',O<VAE970X-2YX
M;6Q02P$"% ,4    " "\B/=,,CUIM-P"  "+"@  &0              @ $;
M[@  >&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0    ( +R(]TP"
M!M)"R*D  )&$ @ 4              "  2[Q  !X;"]S:&%R9613=')I;F=S
M+GAM;%!+ 0(4 Q0    ( +R(]TP7[#6Z20(  %H+   -              "
M 2B; 0!X;"]S='EL97,N>&UL4$L! A0#%     @ O(CW3.NA6<.8!0  [C<
M  \              ( !G)T! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M +R(]TP#![=0H (  $<S   :              "  6&C 0!X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( +R(]TQ;['7)-@(  ,PQ   3
M              "  3FF 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !?
- %\ "QH  *"H 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.10.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>274</ContextCount>
  <ElementCount>460</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>88</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>14</UnitCount>
  <MyReports>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001000 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/ConsolidatedStatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002000 - Statement - Consolidated Statements Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/ConsolidatedStatementsComprehensiveIncomeLoss</Role>
      <ShortName>Consolidated Statements Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003000 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003501 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004000 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/ConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1005000 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101100 - Disclosure - Basis of Presentation, Business Description and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation, Business Description and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2102100 - Disclosure - Other Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/OtherAssets</Role>
      <ShortName>Other Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2103100 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/FairValueOfFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2104100 - Disclosure - Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/MarketableSecurities</Role>
      <ShortName>Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2105100 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2106100 - Disclosure - Prepaid Expenses and Other</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/PrepaidExpensesAndOther</Role>
      <ShortName>Prepaid Expenses and Other</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2107100 - Disclosure - Property, Plant and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNet</Role>
      <ShortName>Property, Plant and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2108100 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/GoodwillAndIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2109100 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2110100 - Disclosure - Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AccruedLiabilities</Role>
      <ShortName>Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2112100 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2113100 - Disclosure - Retirement Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/RetirementPlans</Role>
      <ShortName>Retirement Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2114100 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2115100 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2116100 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2117100 - Disclosure - Segments and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/SegmentsAndGeographicInformation</Role>
      <ShortName>Segments and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2118100 - Disclosure - Acquisition, Restructuring and Other Items, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNet</Role>
      <ShortName>Acquisition, Restructuring and Other Items, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2120100 - Disclosure - Accumulated Other Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLoss</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2121100 - Disclosure - Quarterly Information (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/QuarterlyInformationUnaudited</Role>
      <ShortName>Quarterly Information (unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2122100 - Schedule - Valuation and Qualifying Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/ValuationAndQualifyingAccounts</Role>
      <ShortName>Valuation and Qualifying Accounts</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2201201 - Disclosure - Basis of Presentation, Business Description and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation, Business Description and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2301302 - Disclosure - Basis of Presentation, Business Description and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation, Business Description and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Fair Value of Financial Instruments Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsTables</Role>
      <ShortName>Fair Value of Financial Instruments Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/MarketableSecuritiesTables</Role>
      <ShortName>Marketable Securities (Tables)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2306301 - Disclosure - Prepaid Expenses and Other (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/PrepaidExpensesAndOtherTables</Role>
      <ShortName>Prepaid Expenses and Other (Tables)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2307301 - Disclosure - Property, Plant and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNetTables</Role>
      <ShortName>Property, Plant and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2308301 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2309301 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2310301 - Disclosure - Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AccruedLiabilitiesTables</Role>
      <ShortName>Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2312301 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2314301 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2315301 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2316301 - Disclosure - Commitments And Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments And Contingencies (Tables)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2317301 - Disclosure - Segments and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/SegmentsAndGeographicInformationTables</Role>
      <ShortName>Segments and Geographic Information (Tables)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2318301 - Disclosure - Acquisition, Restructuring and Other Items, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetTables</Role>
      <ShortName>Acquisition, Restructuring and Other Items, net (Tables)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2320301 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) (Tables)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2321301 - Disclosure - Quarterly Information (unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/QuarterlyInformationUnauditedTables</Role>
      <ShortName>Quarterly Information (unaudited) (Tables)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2401403 - Disclosure - Basis of Presentation, Business Description and Summary of Significant Accounting Policies (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/BasisOfPresentationBusinessDescriptionAndSummaryOfSignificantAccountingPoliciesDetailsTextual</Role>
      <ShortName>Basis of Presentation, Business Description and Summary of Significant Accounting Policies (Details Textual)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Other Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/OtherAssetsDetails</Role>
      <ShortName>Other Assets (Details)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2403402 - Disclosure - Fair Value of Financial Instruments Fair Value of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails</Role>
      <ShortName>Fair Value of Financial Instruments Fair Value of Financial Instruments (Details)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2403403 - Disclosure - Fair Value of Financial Instruments Fair Value of Financial Instruments (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails2</Role>
      <ShortName>Fair Value of Financial Instruments Fair Value of Financial Instruments (Details 2)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2403404 - Disclosure - Fair Value of Financial Instruments Fair Value of Financial Instruments (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/FairValueOfFinancialInstrumentsFairValueOfFinancialInstrumentsDetails3</Role>
      <ShortName>Fair Value of Financial Instruments Fair Value of Financial Instruments (Details 3)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2404402 - Disclosure - Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/MarketableSecuritiesDetails</Role>
      <ShortName>Marketable Securities (Details)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2404403 - Disclosure - Marketable Securities (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/MarketableSecuritiesDetails1</Role>
      <ShortName>Marketable Securities (Details 1)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Prepaid Expenses and Other (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/PrepaidExpensesAndOtherDetails</Role>
      <ShortName>Prepaid Expenses and Other (Details)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - Property, Plant, and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/PropertyPlantAndEquipmentNetDetails</Role>
      <ShortName>Property, Plant, and Equipment, Net (Details)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2408402 - Disclosure - Goodwill and Intangible Assets (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetailsTextual</Role>
      <ShortName>Goodwill and Intangible Assets (Details Textual)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Goodwill and Intangible Assets (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetails1</Role>
      <ShortName>Goodwill and Intangible Assets (Details 1)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Goodwill and Intangible Assets (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/GoodwillAndIntangibleAssetsDetails2</Role>
      <ShortName>Goodwill and Intangible Assets (Details 2)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2409402 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2409403 - Disclosure - Income Taxes (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/IncomeTaxesDetails2</Role>
      <ShortName>Income Taxes (Details 2)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Income Taxes (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/IncomeTaxesDetailsTextual</Role>
      <ShortName>Income Taxes (Details Textual)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - Income Taxes (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/IncomeTaxesDetails3</Role>
      <ShortName>Income Taxes (Details 3)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2409406 - Disclosure - Income Taxes (Details 4)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/IncomeTaxesDetails4</Role>
      <ShortName>Income Taxes (Details 4)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2409407 - Disclosure - Income Taxes Income Taxes (Details 5)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/IncomeTaxesIncomeTaxesDetails5</Role>
      <ShortName>Income Taxes Income Taxes (Details 5)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2410402 - Disclosure - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AccruedLiabilitiesDetails</Role>
      <ShortName>Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2410403 - Disclosure - Accrued Liabilities Accrued Liabilites (Details) (Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AccruedLiabilitiesAccruedLiabilitesDetailsTextual</Role>
      <ShortName>Accrued Liabilities Accrued Liabilites (Details) (Textual)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2412402 - Disclosure - Long-Term Debt (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/LongTermDebtDetailsTextual</Role>
      <ShortName>Long-Term Debt (Details Textual)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2412403 - Disclosure - Long-Term Debt (Details1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/LongTermDebtDetails1</Role>
      <ShortName>Long-Term Debt (Details1)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2413401 - Disclosure - Retirement Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/RetirementPlansDetails</Role>
      <ShortName>Retirement Plans (Details)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2414402 - Disclosure - Stockholders' Equity (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/StockholdersEquityDetailsTextual</Role>
      <ShortName>Stockholders' Equity (Details Textual)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2414403 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/StockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2414404 - Disclosure - Stockholders' Equity (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/StockholdersEquityDetails2</Role>
      <ShortName>Stockholders' Equity (Details 2)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2414405 - Disclosure - Stockholders' Equity (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/StockholdersEquityDetails3</Role>
      <ShortName>Stockholders' Equity (Details 3)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2415402 - Disclosure - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Details)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2416402 - Disclosure - Commitments and Contingencies (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetailsTextual</Role>
      <ShortName>Commitments and Contingencies (Details Textual)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2416403 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2416404 - Disclosure - Commitments and Contingencies (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/CommitmentsAndContingenciesDetails1</Role>
      <ShortName>Commitments and Contingencies (Details 1)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2417402 - Disclosure - Segments and Geographic Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetails</Role>
      <ShortName>Segments and Geographic Information (Details)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2417403 - Disclosure - Segments and Geographic Information (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetails1</Role>
      <ShortName>Segments and Geographic Information (Details 1)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2417404 - Disclosure - Segments and Geographic Information (Details Textual)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/SegmentsAndGeographicInformationDetailsTextual</Role>
      <ShortName>Segments and Geographic Information (Details Textual)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2418402 - Disclosure - Acquisition, Restructuring and Other Items, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails</Role>
      <ShortName>Acquisition, Restructuring and Other Items, net (Details)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2418403 - Disclosure - Acquisition, Restructuring and Other Items, net (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails1</Role>
      <ShortName>Acquisition, Restructuring and Other Items, net (Details 1)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2418404 - Disclosure - Acquisition, Restructuring and Other Items, net (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AcquisitionRestructuringAndOtherItemsNetDetails2</Role>
      <ShortName>Acquisition, Restructuring and Other Items, net (Details 2)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2420402 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/AccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2421402 - Disclosure - Quarterly Information (unaudited) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/QuarterlyInformationUnauditedDetails</Role>
      <ShortName>Quarterly Information (unaudited) (Details)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="ango-20180531.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>2422401 - Schedule - Valuation and Qualifying Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angiodynamics.com/role/ValuationAndQualifyingAccountsDetails</Role>
      <ShortName>Valuation and Qualifying Accounts (Details)</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ango-20180531.xml</File>
    <File>ango-20180531.xsd</File>
    <File>ango-20180531_cal.xml</File>
    <File>ango-20180531_def.xml</File>
    <File>ango-20180531_lab.xml</File>
    <File>ango-20180531_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2017-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>129
<FILENAME>0001275187-18-000011-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001275187-18-000011-xbrl.zip
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MDPZS$1ZT#;_MB W!@Y;A15?@J6B-/!4==DK19J04'9 4K8"DEYU\*F#*Y<+
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M([DMF5:&'_XDUR=9\8]D,$G-7?WC?P&.2=&[OGN;?DL'2R*V'G,Q!)=O5 [
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MQ$SYR&D4(VLB[#%2%7 :&[4*'.&"-F!;@6!G -=2S\5.1TA1C1%1.!;*DPI
M;W"\"N#6H/UGDHU*F;M4:@G,SO(.PT6X:O$^'3?WR?1 KA->Q&0<$6LI@;55
M7C%MY11>"_Q(;,MJ*[Q(T>W@.A@B!ZNWUD40ZF)JM> @RC"3L#L]FRV@ULXB
MLDH0RLG)D*-17:Q3-GE-@I $IB!&Q<#-P/4S(F L&UPL621/@0KK*S1V44-3
MRA"H-(24Y(X;2BO-813LDN8>8>(D>&)C^?0N@DB"*!5,4F<\LK%WU.N*/6+
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M8UH&^WTZ_G!97@::/F\1'AL,LLA8CR),-:?A5#TBDHJZ $_<K!%)R>(FVAW
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M98_,M#^]Y;"I*#[!UH1[$Q$*,6BL8EHGV2&MFQT@&TJ\%:L&WCM>9V42+#\
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M/&XV(201YULAL0#2EAB -[$/"D@K 4(L%&O&5H&!A%6- IA^S1H1"J\ZGUO
MM!T.GU, O;\[#L#3*@['@]Y*&GGFHWF9<I#9S=QAIO 66V %INUP^'*=%7N@
M8"B.M8LQ%Q$%Z4<PF75\#7>-"&YK((%7Y<Q&D)8Q"-UQ?LOS?O"Y9RV!1Y_S
M07_G:)/4S@AJ8@-&-L41\U6]_-"W0[@F"Y67/5: [X)F7Y@WA)+ M"/&D]"^
M@)E0#@*,O"I\H5CSL!!+RAX<YDT](T(P4C,IK9!61]1069]DV):3#"PD:S#)
M5C!/2_Z$)D&7EVD/9KQ/O\\ZPH#6_UADPUYV.P#6FH:8/ESJ?G[;KKO6WOP)
M)FN$7&P8PX(QCKQ4%.PK+#2C:%V6S/X@/B"B=>CG(3N($RT0<T+$)C*Q<@PL
M)#8C&K=2-CEWI9_A<Z#<IW2<9,.T7[5(V)3=:5RL)(ZX!=>9<(FB4-ZO)!F*
M(MX0KJ\?BF;EZ9A/P]'9X$OR8];\RJ3#]#+;JDW)LCQ@ +[0CBJ!.!%<X*I+
M.!6*-@O*T17YM1Z<>T&^2?HJ!-923 C5#B-JM9GU0 B0"[.N,LE#0KU!_D:.
M$N*= #-/6F,1R.,Z0DE:$DQ>!^%V3XKG19I=#>_/*PR,5,K!@0&@"6?$(Q=5
ML#O;K)=%5FY7;8#G7J!OZO)$(^P%CH'BH+$-YZPZS*("O.SF\<BJ _: H&_@
M&"5]9"+-F0S%=\"<-K,H6.#SEK)#DMX3\FE#P/NSBP\T5$18QR-$N1"AJ]R,
M75!,FJ*%M\J6#G#N _@&9C$Q"TU,0I$-Q'WPB7F]1\'+;.0&L-4#P@<#?)-P
M 18/FHD**Q5!%HFJ#5MH9XL;-Q!DZ_[<'NY2T8(-&'I&'D 7*8.E\YI;3N _
MH'#I[-@#P.<1;EHEJ)75UT-U #0VL(^4#,QJ(#<EX%]AL ]<7*%!D&@Z]*R5
M?1X<C0W,1 PRFFB/83-(JYP&GZQ"0T;-W)*&2[\K&N&*[?QF<)7TT-9J:V,\
M0@F,L?;:8$V9943'4=5=3LJXD5"BR.K-PG6PW OF>6?9(@7+'< M\YY6+--O
M^> ;O&=YS$INW]M\>#5.BYL 0B-'\"U8MA\NI_,W-K2PL+J,JPAKI+7P\$]%
M+!71=57DGY1*Y6WLM%_6DGL8RA 3.63+DAA<8^RU$'5K8V-M0P\<BHTN@"!%
M.BH3.J='A. 1A+/]Y&I#NL B<DM$*U,'_O;Q75Y<)</X.H$-F S_?/]&OPE_
MYI?Z!GR.7A)^\??T[FMXEDS=2CT:Y;VL_,OAR+QR.DE#&R0:@W$C(J6$1(94
M=/9.+5HX"XFEE.$N0J\CX '(/LW*(^_S;[)L;O<IW">N6]V]2WYD-Y.;56(=
M\<HLI L76:A^$"BP-"<D"<_3B]>LI/)(@@7BM&/.Q2SRA-:"%RUI\(65Q(2?
M5_*15M)-BKR?#P9)L6DM1;@40Y'FX2($$\88Q:HS;&F1;5]+<JQKF0V?W5IN
MNRM1#/:GPU09117%VBJFJI7T?JF;YL)*(MZIR,XK^62[TBA#I)'&&QV,7%"9
M\RI'!HS<#@E[Z+7\ M@OK9E=6+-36)-%?\U:%X&O&=O0D!AQ'E4!%@S^/]$_
M_?J1_ZN+?($0W63Z8YA419RK6SH?B_0FF]R\3W?T:4(E6N^((52!@1XS1F1=
MY$&;9L@^-%#N-D77 K:,SV4*?ES_4$$A$"O*@_QQH705$]9A4SO'F,MF\PX%
M/L@*(FLANA?P&SQ[[1G0GQO0?IH1"EJQ"MZ"9P\^?R,PQ$CT:+!OJK:C*$=<
M6QYBY9P*"IY>!3M"S>#MZT@Q>3#@JPL^W4GAG3>OP/D*71HDY5;AV!-6EZO3
MHGE/ARG,-]!\ 9;]85ZW596P1#C$E$ 8*<^\T+Z^">*;158I0ROW6?:&.0U'
MLA_&UVFQ/&G?BV\6@QD8&86)5M80C5%UJ<6J.$8-5 CH)+(>E<T@'AS#M8OE
MG ]+9*D,34ZL=PS-+TXT8T588KE!(.V'(8R=-AI<?M^.ZZ4,I8J ="(6QS(V
M$:VO@3#:$K0CT:J:6 O-O0!?NPQ,,"P-,@SI./81AVU< 4Z=:(A6(MN%TSYP
METV)=J-S$/ZJ+!%/D:3&Q*&[VPQ<3IMW(V6X';4>X!**?>!<FQ+$H] ? &G)
M*'$"3']>)QZ2B#;2/1AED;@OG!?#;\#C>=%>7:@[;D[!I'4610"LE5Y:INMN
M[<JT=-9E: ,/U(#L"^XZTGJB/=@!"%N$:5E5T=2D#?6'F_%QOAH<W O<#[?E
MI=GA56B>5884+_,BW/C9D84Y)=;)T!Z6@1,(!H$5NH+?"-\P*#E7DJ]'H!NT
M@V&TMH$E2&_8B3(R&"'-B0\93C.,)':-@Q=*HVC#DNR)$?PP=3:6IH0K4:'B
MP&[K%'OC"<',<(YCY+!R8GZOU/BF"N:LW0#:$KJ#(K8^>Q=3SJP/MSJ")Q!2
M+FL9*IK],:GHL)(.A%CUNYE9&]*&X,]I^<AA?V;ECLK\];)HPN* ]FY":R\]
M,_""F 4;0W' %LQQ66MJ C94RX7-=K/CD"@\/HG65B=12$91.#(%T0K^%:)5
MK -,,\):% +!QT:BT@S<C3.01HJ!6X8M:.*(<QO36HS%V#5,(<%)N\F]":S#
MH+)VB[/0+9 8D%,Q13'UW-6RRT5-]P&,Z\U;_$%1J4-&M34_NW6U<OHXRZ>)
M0^2DN&LY2&1+ 5CE#0$;1CC0K81$W%,#'BVUL2.R>4]ADU;:APAU*1@]&.3?
MVV\>K^^9B9W6H=,;L@Z#W< ]KLV%"#5C'V!=;M!#39#NC<':6RZ28QE'*I(P
M+G)2,%[;[(XW+^$0(389F%MCL'?\PTANXEB'.DTQ T?#4%=7:%*:-"LT=3K@
MFZ,(]XEY@,FHF2>@HX1R,09M-F_ H(UI6L,2BTYK<B<X/Q8Y&&GCNW#A?0PB
M/"3]WM[L'.E /M0L1HIKRK3D3 ;NGB%@33-HTQUHVA*\@V*V;FD<,YHISP36
MA%A#56SGKC5233NK,QRU'V8AR;J\6))]G82]$L8'3?HI[>57P^:]X(XH\F*O
MAYBX6!+A8P>:44NO&%XH:M_<%=/[=,L8;0;K 'BT!)07\?!<6N>YQ1&R7CLE
M8C^OW^.B9G23/!$>+<'E13RXUR86)HX8]EXZL.FKEMP^BBEIUB%2]\?CMDAG
M)T$[LP^(*<]CS C'RF"L*'!0?5$4K/*&/FZ2??[U[:':P QQ3+A"%B'8@!'C
M1GE.Y]=7=2.F)%8OC.\'U8:EU40IY6,IB'2&:@DJL]::X(HVM"83>T %TF/6
M[73[!5T*'0E%!-( )P 5*V+9O%( ]J;I*408KVJ?3FCV!GI3GBB3D3 N-LX9
MK:CVQLEJO04B37N$17C5OSD\T!N.D3SL<C#_P+BCL+%1H'.MYVW4#'P2BL6J
MW[H=T-GH-A\E@]^*?'(+QOA@$BZ+EX>5X;[,).W/8C/YL%)/LXJ&F_7^(G]C
MRHW7,3B7BD7"@_7B7=V%PM*&Z"(-_MX;T#W1K6-24Q?E;2,H/..]W[_8,F$"
M]'1_TAM_*&97]>9'\+K7FPRR456WYVXT3F]&*^?J2X#%@V0TRBZSWG3U%AVB
M5E!'T]GPF\NR3.9P-#T6N4Z&H;U.B]NTN#2*.*(L<IP9%H0A!K5?Y^%SW33)
M&NF7]R)JY_*\S\>M[PB3?DM"*^-_@K^8VOQ[Y_[:A[SS<>NIV@7>2']-AOU\
M.*_TN=B9"0!^FWT+YR5CX(WLZR"=NCCPA>1_\J($;0FBBR$P5B\=U?$UV,PV
M5$K-;UN^,"5K?3//)(/@+7V^3M-@.LYO,0;(!WFH^0E?7D)ZM'X!1W.V7GP>
M8NJCLBQ8-OR2O<UGFV$#YQF/K9:..Z=1[%%LB>&5:.:(- M%KQ4*._#+,L]]
MR_KI<#4*WJX.5^K/()#'1./(>829IN#<U*W*#5][*;;^ZI:@-)7<,B@*8RF5
M0I'TV."8FTC5R6>VI7+T/4!IJJZ5C$9GP=P6+*2@.&00V*:F!D4TZKQM!*6Z
M.5K5;C+)*.MMLUB+)<L$5M9:'UMF8DVI\4[S^N([6XWVS2M+O<9OR$("="LL
M>P K?\>_=P,;@]*7L >8, @Y$_Q(4DED2E=K52R5P6(/ 2M9 ZLGCA$PH@DQ
MGG$I=33K, RP"D9%-ZQ4/@2L= VLQBGN;+A_X9$1@<AVX<:965<I+7H(6-D:
M6 G!*NADJT. FOM0#KF^+X)LU,FP0%C^(,"NVUW."J6= ^\EQA% 2F)?[2X9
M\S4,BQ^ 8:.UF\M9\$N%E";4@HD%U0C5C29,%'42-N3J/@2LZS:75K$Q6H X
M9])*&I)FZM)^RJ[>I^VJAW<X6-=M+A%1'RL1$XT4#6FS\4+O K-ZG7-)$#S
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MHR@;)9T@HU6PZUO-UKM&['!\/7_3K"+G[_N#NY/=-?BH/.-2EH)[DO17;-+
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M-4179Z**0>CB"$,*@5MGF%P9(L<ZH'\""\R9]=SM_WGH6Y,LS7.4G$25;<+
MT2IH"M424Y6VR=;'B$ZYSJ)*Q[X50H=L2_F#%B?':)-J3B[MYYIWK[6X>AU5
M.G8>%(XC5>I/+">==#:Q>0R445;!JV9[JB2/5F5.NDA>^N?)S>!NHUQW\D;S
M(*W79>+01UJ.D-(*Q9WB<<]JGH!=/IX3!3RK;ITM/(&!%"+2=8$B*-F\]M"J
M^1H.ZE7K8\_3J-:Q$V/D:,J8*&>:PF/.034[T2.K#M4<@_*BJM%OA.GP=E00
MUF?#P?3F\^G-A0H,&)U2<CPX'0(8LU+*L%AWS-FCXMM:LC.IT[7]!%.IE)R
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M$>CDU4#]G+VT17L__#:Y^U9^V/9'_0BKQPVFI*RR*&W,,1:<\=7J966J-F[
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M5:4EQ<[C-AX:&7@.5@<G@5.L;NP: SG6[*'(X2B56H0[ETH=&T^YB H*C(5
M<ML)F&_0W86OV2J0 EA\8I6Z-AX&*Q+$7*8)Z.RXI-:HHRVH%K22.Y!%O55:
M,S/U0$F,$1CM%ZZLS=HSB*R9R5)0 ZG1A;0SW;\EP,F2K6N3!8.TE/@6PQ,%
M?7DRG@>6V\_4!9M\>)L&TS&99-91CD3R5]+R5-"32\N%TZ&9C8L425Q0O0[N
M<NDR,^2KDDO962?G4$.K&F.J^0U@=]ZYOUP'29U+9$%^TXF"19E*(4SK=6H0
M*B0 $'IG'*J_8 >)G7.6WG$=@\E1 $44,34S9,+4I41NZN/54ZZ#W,X4$@A
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MP?1?PR4GVVKTYN3#QYRTI6AO@Z?H392$1#20QKRET(U[+7&4@&?6KO.(*&:
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M=@*<35XVEC=83Z8 :.S:Z ?(^?9\<4]^/F^*Z4OG;7:^$"(:TYQ2X6K:+J#
M_8A=OX>D[_WPYFXPFXT^CF[F7UF*XFYR,UIVBRT@\58HQR^!BR&!*I21P7GF
M:-T]G<(FC(V:'<)C>+0MGKEA>^*1"Z$P><U4,. MA])*N1KT%% W^_V!+-H'
MCIPR"8TZ,.E-DH[B&Z9@M4%%$(?@>)^[.9^6BD!C4)"%RA3Y1IT"]\LPK'"&
M6',(".%'-VS/DY\I_56F]/EB\([SA+;9JB[D0Y@:/[I%^YS\K(W0$JW%)#6
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M0H!,.?>2V;%P;LO=5KJ-DVE_TO\YF6=?O5[>E3L +7E(.2L6"BYU6$^ A5U
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M?OWVY?KS$A?D8?@[KB6H'-"E?F5Q<F! <D-;G_G2^'D.?!<NEJ<F1 ODN<_
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M'R]+ 1N>WMA"R"L.P\LE@(,P9\-5Q3,L\VB:%O-P"P#X+$6\!)A[(1#[CID
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MGEU&_SGA?"Z;LS(*7I2/F/S,9:U.BLRY '2-CWG]\SX G,]$@DG@XLMXT1,
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M<@>FVSM8]BGWH;$27MY+.VTCK:]E;Q%R86[EE:K,&0+=P4CB1Y )T$+CI8M
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M.._@HX*7$P<,3>P]N:*#I''NQE1#;Y_V*RL&.0R^,N&0 ^:8DRIA9YM"^B9
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MMC<26^\=:&UY+=5;R))8>L5[DF:WW:F\X;8A.T-VSY-=99ZZ(3M#=IN3W<:
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MC61B?4@9O0%%-U9?PZ!L]1>:U%.13"+O1RQN9ANZ99UCZ3:P/%83:_@=%H+
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M[0+'PJ5"KFR)\=K"&G.I*T)[*<R_#-^ N4FC-N4E9:4ZX1Q#1";P!3WRXQO
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M9!Y/Z]IH)D)\O<XKHY>K]M0@N_$W67ZW2GS+NN52@A+^II.Y>?;/9N:M G^
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M##J]SA(8KH'L'F#9GRMWV71&)PMEO;6PJ_9N=2X^4E9 6*<R 79"JL(^/\"
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M2IY362('T880%674DHY;RJW(Y2TG+BPV75T\F_"7Z(BST/A>.LY7WR_(=CP
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MLO&8QZJVV6K(,)_B82;SSV009"[3Q5ZCOVA?D%>$T:*F'_ET667(>2D0O14
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M)][W5<K@$Y%MMU9/EQK\8GO?;>ZL-;]=3\J]]49H6J6$9N,QCV4,5D9NAU%
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MG;2F1=VMN@5USA/?@TORFH@:9XT&/!*X^W#W2\$6$M.!+6"K%&PY^OKF %O
M%K!57+=P=G-?4>K*.UF7?I"EXO4*3<>2J*?3FS)E?LM>?+#&U!L0.-T 0  0
M!;\%B=P ! !1AK-1%T!LW-VI\%[/]^8IJQ?/5F_ZVFB7#T&S&!_-8EZA@"IV
MS3#L<KQ\94=?J9<_^AK!:!:SD;B>[6&'^M-H%E.&LJ%93/V]9F@YFL5 S8]
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M]5(H[YWU=T-8U!-N:M,!4^937H>N+. "< &X %P +@ 7@ O !> "< &X %P
M+@ 7@ O !> "< &X0#<7U#<+<W?97N3M2'2IC$%2,XYOE_7_][F-ND&RM'Y2
MZK;T]79^22BF(*ELBP70 K0*U[D]%] "M "M2IC2@!@@!H@!8H 8(+8GB#D
M%H %8.D'EFTY[M,VH0 7TN!?$.&G*#SU>#)B?/ _69*.50-<70H$#EJ?@RI'
M-=C4 2Z BZ?7G=@-;2OPTTFOT%:WMLHI@$N-X8)E!+@ +H +X *X "Z "^ "
M;L=^W ZD7KZ2>BE#@A,^5?% 76IED.RJ2TQOE;&MSUY&&?OPVPK/%%R6;2(
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M=QKY=X"HT1 ]T9B=A[45P 5P]P5<UVIV>\"NN9'Y>@7@GR\]K;U1Z!&3W 8
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M6BP4RDB;)V]*$VT652\#7O4IG6$WT=@-41F#5J[Z0.M$7YN=(X]" '@ WD;
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M5_*?2YGJQ\-[E?7WC:X0I]%P"+>L')O0% U N,*<1:ARN#BQK6936XH?(MX
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M:;%0I!*NWBJ"R['@-*7XOSC#LZ>I7%%C@RG[.QBP2Z91&:(LH;MT6ZNQLK5
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M$NQ_*9_=2(?)&$0M3M<TR_<L3=$+N-8U6H^-US8CO&?P387YYM@]X0NYUQ?
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MMH M8*NX;N'LYKZBU)5WLB[](-NLV6=]$_5T>E.FS&_9BP_6F'H# J<;  @
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M.Y@R/Y_W0Z?3)/[.)S1ELIO&HDM',2T(^VPPZH_S14D$+T.&>$AQR 5PG&K
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MGMO[A=S^W^\?OO[[^<X]M>6M XNK:SJ5?_^O;>RX&[2?(O+)3^-[,**\@4.
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MVGB:LGG>?5T ,0#3A8L43=TEG,W7RY>8FSF"/# 5)<,?%C; ',9YJK_@I,*
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MI/?6MB[?OC9;@=1U?WSYR/O:@_?Y*_7WO+_6M_<.^OC7%=O;5A\K+./58N1
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MR[FOX5S7:>H+#%G>/84PMG%\:_&CC2?73 +9J4:E#F4%^DI1MD5A[4M2>L[
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M@<H,*4Z->P>I 6:'C]/@V;+(6HS^GDN_DOK#O8-M?';GI+TS#[.6 J^AC*O
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MO++VW_[TEY]Q'?X.__W;_P=02P,$%     @ O(CW3/V8*F M%P  KA<! !$
M  !A;F=O+3(P,3@P-3,Q+GAS9.U=6W/;.+)^GU_!XY>=K8HOLN/))#6>+?F6
M]:P3>2UE9O=I"R(A"2<DH0% VSJ__C3 NPB"%\D6O?1+(A- L[L_H+L!-,!?
M_O;DN=8#9IQ0_VQO<'"T9V'?I@[QYV=[W\;[P_'%S<W>WW[]X9?_V=__U_G]
MK75)[<##OK N&$8".]8C$0OK#P?S[]:,4<_Z@[+OY 'M[X>-+/7CB3N?N+W
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M*K\<KK==HQIP[(S\7]7O=65$C:,JAH9KH[=VN_P T3:+'L:Z;H3 VA/,+[%
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M5K[[P,+T52*YB7'N0I],)*E9>0.Q1$SFV22K*U1'Y0DWF5"B^J>,4S#5Z&P
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MX\WTI_>I74SFL[_^3/]"?OXIS<(\3F9O__KS'Z_AZO7CY\]__M=_^8=__E\
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MI'% B.&@;(PX*)1D&T_G7)W8D<OBW.G(7ACC.APV'E51DY5F7&<..F@#QLD
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MB<ZIZ!&C6V<[9[B![PE-Q0.A=VX2GWY\AXYAN@NYZ&J"=BC=A&0)%2X <4$
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M5+_(9>&Z4PB/YXO]4?N[2S7*A1"I8Y ICH(VZ- QBR/#K"',96%]'.;EWA_
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MKQ*<A57.J',W?YCT&Y.L_.+=(OW+/_Q_4$L#!!0    ( +R(]TSL&]-U46D
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MAQQ30V/D1+,A1]ALV3O>JL_Q^716_&LZ7V7OK_UL$:;_63I_LZBVX^L/X=1
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M_7P08%I^MF?;TD]6,#-/RW)=Z6&-_?Z5OV'+Q%),J97<A!4."0" T_7'X(@
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M!+=&,L0XXD B6F.!*7X]IE O"F\R6?4,Y5^;7F.WE<;/J@NSZ<WB;K4LUZ#
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M-B^651$M.RO7M20_%-GM;'7[+FM.CZ.])%K"L(@KHI0R& KIB:NWI((YVO[
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MHIVE:.T>0(KR?+-TS Z>D<MQMSPP?CG>VO6IA/DPA?B<"89(-V8E,#0R'I"
M1)-.U=0#1,*?TK$T<@GND %ZRL':EX3SS"KO,0G'/7R:E=^*8EOH;@_Q9I6
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M#P8G/"7.(.+BV4H8DI8VSA'';'Y-B,Y"3YTQ1ZM(78<O,G:0TP8(6EJB.(O
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M5D5!_OZ79?'QH;K*TL/)N5OX;%9^2>GXRPC!NV)9+#X7RYNX /5U>L@#<-H
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MI0J>Y91*-\%#16L6MQ9QD"8@9D,HGZ>N#;+HC,0-9TL^=_Z8E<FA]AV'26I
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MNLB<-L9HLRK3VP7%LNSFF8JK^^OD*<O+:H'L)GFH>F>Q@#2H-A-8 211]7\
M!>U"F<OJ^4AHA7] ,YHSZ@99M;"<]]B,H@4GED,/X9(O<QZ)1K'8L&-P!\NX
M.<>@E@SY.#\G\F(%I,XC&U9A2*:\P\EM)[Q\?(K3O&KI0U84BR"T(LSD#U)
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MC&P>71_-H3,+ N/9?2QBC,R\<'A!SWO#A.;)7[?)9OE<WPM@^H#8@1TXMHD
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MJ>412H+0"]P@0(%MXM"E/K:$+C26;$(H8Q._P:D&<6##Y$"=XJ1/4I[4,Z=
ME6I0$VM1C4%$@L28G*GR"!IQ3G!D.!FXY7'OWJ=^"U*5A$5N:#G =1S/0RZ*
M:"=TD&*B9-^C3,/C;GZ4WK.MDFH^G9J(8S'M.K$7<O\9T)EMB#S H?BNR"&.
MF(?TZ3",;W_D<.XD4K&]1C_EU8[ \OD3Z\PEW*S(7[?I4W6@:D$<:&&+6@$.
M$&O6QS3L$T(2 ?DS+DI:URZ6Y.NRNE:WDLJ,?8!QEV6_LWSN*4^6Z6Z'1_R8
MY67ZMV%;>-2X0SCG&]T/ Y+!%[=U=FC95Q7>VA$]XLDR11XZ^5)(I8Z9A\!J
ML^YXTJF!15&IW3NLV&-9F#@@$8:^%= H! @[A+0'S*GML)Q8IO:5:FC\"KB_
M)EY.*N7H%--%[4RJ$L$)R^)#''$HVR!JYR5CPTPYHED*^)&>EJMN1&[V^ZW7
MV1\Q(V/APR @'D6>&P6N"[#K!6'7,K8CM-@D#W&9K"1GZ21:Y!IF83/,]L%Q
MC[8>D]&#&CA?)\.KY.2=+D+5S>2)T#O.O-Y;SD0F^08P/B\Y4V+1N>F_P6P-
M*W07=AC8IF?9A$DIAIYC!R#H&G.Q@SL]NY5:>A!I24+';L7SK^JTG\KL2Y3.
M(?6H&@H59UP?3ZS>C%A<"M>0W&3.3I2DC."J" 4YX94>ULBG)$^S57TM*H:(
M6B@,;<MV'&+Z+B0V<CP/ I^I'7%$=JJ)?;+F[6C5T&C02%V!+,@2GY#H(TA,
M/_BYT:(9+V@X(15R=,U#(22Q9RHZC*0>M!>5>FX86*YO$0(LP%H @0.[5FPJ
MMG=5]+-'U 2I:XJ%N1+4!0TTR2O#)%<1OZ*"1QT$29N9/HBB/Z804BQP70W:
M-W&U2=H+2$DUV^-B5@Y9OHMH:+L(M:UX%'H6]X6@$I\]@D;\9Q+G1M5!C=N,
M_1?8 M=7RK!U6B7&($I:)1B<\Q<+JV%)X&I/S6S)7>@IRAK?)9YO33V@F4-)
MF<&%G4/09VJZAHQFWOZ1M:UXD8U!!&@8(ML,3-^SO+!KQ:*N)ZZ9_)\]GF8"
MO]%,VY=1 P&V1#13#U'2FLG@#-), 99D-%,/6X,UDXLU0<WL33VKF>*DS$DS
M)= ?U$Q9%@0UDSFOTV9J^U$81)Y?+2^:GH,BW.6S'J28ZRT+^4\?/]>T RE%
M$&%,2#DUD26OG16@8>HIPI64?FKB;+B"\G$GJJ$[<\^KJ 0UL])1&?R'E52:
M">XEQNPQ*<IT^?+I$!L0Z@8$>('KF@"%/C"#MBT?(B!ZM:A4&R*=?L@M0X)K
MB')\<2XA:B=*< 6QQ3.+)X(.DG-J"7$0F?.8_QMHP^L%1 6,\.K*375M%]RL
M/C &U_]GFZ?%*EU6(:EM%7M.0$P76O7C]*9E1D[4MPH#P<MXAK:F76MJ@&)*
M,YA!/LT9DSHQ]:F1U5OB:VS&/KB)-.@,62?42!7-\] E9=9D>CJC0#W9[U5-
MBMOD:[F-U_WI)3.T?0HA)E: (F3YV E<Y/@04\LB@>WP:=305K1KT^[9J*0P
MWK7P?N YWZ>638Z*<R0:Q71J+OP)5*$C\2A7B\KSR5>3'C?^6&6J@*X9U*<J
MK,C4=B*Q>3^\+0L6'/Y/=E? 97EUSUSKUR">U@D+&\MEE=>FFP?\F?U%<KEA
M?W+-XLF!?7//G_+L2UJP7AFO>S/:JX_:2X(7@-+ Q&[D1\!!-O9#U_0Z&Z"+
MHGZ7+?_4XKP,X!K)KS;ORLU>WC6(C-4V,<JLNNBHWS^?W1OI9L7^=9.R9&^=
M?DE6@_;ZSI-JSMG4>8'6.U-;V6HP8XW*6H.9:US=5S/<_H6Q,]G8V7QA-%:S
M?ZVG(RK#+P[?3O!<'ZSMS-]_%K-EP'C7<O##-]VIQ*:=YP5^G"GMF7<R[CGT
M47UW8GY^GGUH!KG5?+G)O@45$,@#CS\P!!\K[/"^3/(/Z6/:R,75_:]%LD F
M-.V 9:(N""W?=9W0,SL<8>00[O5A+:UK7C\^\UA:8<05:(-U\R)E8Z3^I=Z"
M^@Z@;<$Y=ZG10QP9U.3.$<N"3KVD=F$TD(T:L[$#706P7V?@#H'<8W*WR.4/
M6MS#%_%E&#L6M;6R/X/(J]>^;*Q^++:Z=N*5/3?R:&@!&[JF"^P NBS,=@U2
M!WMB"VL#&AIK_;Y>(6K6BC9G(IW8 MP0DOG6WD9B5UU8&G>U3>H]3P6<SF.-
M384AF?+^)J93Y/X^69;IEZ0O$*IBXCJI*& U1'.)0MD.Y&H,;ZMW.5[\\H(0
MT_8#!,W09P(:AN9>#>$A)'32< P\FK-Y4I3I8S47:]RMD\VJ?GPS?\KR2O_2
M9A*BFC:MOW\7%P9S^9+E/IPS7:,ZCD\DY^8S,37MT>_/$%W73]J]L.#"B$NC
MBVB]%:__Z*+:I+D<_6Y !2XXH=AC.G@>TCZJQ=ETPVE6RWO=G)2/'=<$.$0(
M^A$#:Q(+=."Q:_+/!<T'\@@'$-HEO%FMEW![=!:K;SJ<^8TLNZ%ON?/,:I5-
M1R?ZQI;7SG6FN2RJ3;Z:)MI79C"9-T-2QET_D_,9;SG^ZV:5%F6>WFU9_4CB
M?,. %E?W-,N3]&%SL[TKTE4:5\_&+A#+[S!V/0=YH>]$(:7 [@#X06"+5-T*
MF]6<Z;20C*+#]&QL]\$;28M>K)I6R3M?T3P1Y6+YR N01H>R6G#L_+ /=-R2
MEY_ $Y6M!B_,HX#585BFO0>+B273Y#R)"Z;AOVYR5AX_;-*_U0+>:G1Q65RS
M?V?R?;=^_I051?5H[0+[,+ <"Q W\I%#0!"Y?6F,0L!U?X=>!)HE%*Y6:=DD
M;=L]U/6DI% 1J=D/?#HZO0O$)+7#:Z0;8Q_Q?N9<&&EA[% ;'>QQ!5:*V1-:
MJ]=3\Y!=S39F8_9]T<SU,((N;_Z4,,&IGY[:K"XW3+:2HF3)>+Y-5@O+AA#9
M-(!1@ .,PRC<S58& $=BJ:P^'+J%N8'!E*&!5:^;/W5X11-:C>[@S7#GX0G1
ME/>()E_L3W'TV&L?=>B-%O[8B; TSR<S8_W>FX=FCV+IF]QY+'9Y];O]]+U[
MR_$VSY--V1\9\Z#E> 1BSW,MC.PP#%P_H*%'+ A#)W#%]BT-;T_[]J5.CZ6?
M+U7 *9_4CDNFF*!V++YXWZ"%-]D3I6<).Z&,ZLB>A_XIM"?3U2T%-S4]/JVS
MYR2Y3M;UPTQOVE]X/G0(]BSL Q-$U9LPU:M7=;O(MF$@IF7#V].N99_B9_;'
MS5;,O(%I),U1$$%14T NY[:B45D5W#348GO?<7E(W4;> G2.KE,;?)11/0])
M4VC/Z\TYBID23,^NL^<F+^Q:([Z%/3L@/F;Y8.1!'#E^WQJD4"HI$VY%NWSU
MB*02,''6A-(NK73))5L]I(G$Z @SY[,J:2[G(3R#K3B<00UDA5=DKEF5F6^7
MY;8Z8LB^2?(O2=>B92/?=GU$ &L1V+8/7;=K$6%;4&B&M#1:W5<D[,_%'^8<
MQ"*?\(Q%GYCXO$!EM+ F$J 3#)T0(16\SD.(E%B2J>]U@G=4QNMZ"HQ\7:9%
M/2\6/\=WZ[Y59(+ 0H$'(0Q"Y 4N\DDO@V& !.^H'-B:=F&J =8EW'VE2Y\9
MRFK55C0K&LPJGTB-2:>84.UX;+ U4_H-NHGTZ@Q9)S1+%<WST"UEUKR^MU(I
M2X)5VZ<\NT^*9B,A37:S8)O51\9*E](A:KEVZ)C =#W3=ST7]@I*;2QTBDYE
MNYH7/:^V976IA5%%DW0I6>"I(5BHZ!N=6[E"<!^F4>&<I [D(>M\;:B4\GG(
MG1;+#M>0&MCC.C?6+P*4Z4-S0B,(0]<F $/$I);IKNF!;H8,XP#POSHH_M&:
MQ6R'Q'B,R^H#C'<?LS(Q+%?D(CL)RDYKUPALR2X*=F#TTB-P1$@O37)'>03H
MXCM<\\;( ^H[D(T9'%89 #Y3TB/$9?(Z6<;K=7\"90%-X'@F\ BT$,2F#VV/
M=BV%?L1URF/(Y^O?\K9=IX61U["DKI*5)8Y?,75R)CF]W]#U842ZQ!54)VW#
M9)2;/B$Q?67O&46596<^LBIMP0%M'<8&]Z5<Y><D/[HI96&&%HRP;5+;]P)@
MHBB"O:I3X LN<0QL3/MD8HU/\+ZM@?SQ%=@C$B>FOC4P8Y>+3;WCXS11)^II
M10S/HX169<SKF[A4<C1X$^X"(_;9Q*5V!"CRS,@U">C:\ZB)%F56QFNAV4&)
M5H2RP1X0]P"[K?Y$T1;;\XP)3?=I)DNV>IY:@F349SBC\Q >!7;P[I<59(:K
MX*1QFO][O-XF>\W]DL3%-D]65QN6D+&FT\T#BHNT^'63W543]-6*R>7F:5N^
MNHVJV\YKVR[+V2S<['MS;,_$#4Q <8 \S@QJ,GC:<Z[***.VRFAMJ8J8PM@6
MU8Z)F_1AD]ZGRWA3&OLF&;5-G"LCT_F6HZ">NU/%9'C/FWOV=)Y=&=G&Z$TR
M:IL.N/75+8-RCY)-XF^!&8&Y^UUN.N&<_Z\T^9]O5D(#Y\>F-*9T[PSF0R8U
M/YO),!,K='JDL"B24A8DCM?+[;K^\CI;KVES5?+"#'S7PVZ$,0TLGU++-&$+
M.0HCZHOLI)@4J.;)]YU^71B->:=BU\5Y\6)%R,Y0X[?*5*.UE3.:S8)VSLKP
MF^D:LEG-E+U"2[6JTV,G"MY9=)1YU,SSH"*;X4"6C)][9>1?TO+S&XS%2Y O
M+:KMK3]F05T:VE80^HX9!-!C PC:'4S3\OW%4Y*GV>JFC/-2,'*.!5%$$E];
MPZV.*'E(-]5-9\9=O!8_&S*^WP1CV1R=)1^_]JPQ_F#F')I6>1.MWD2XVJSF
M(R>*5XJ\PA.CQNX ,XM+HYM_+!9-XP>QF>,]C'_(8>PNX<59?2<O^R#</G+8
MS"JAT'>!0P/?PBC EN54^ZMH2+ =8!?[@'O[TXPP:Z[JV@N\TXUQ7RGAEWI^
M*KNO7H]LX?8/28INO)P1B4*SS=/#_>;"W?Y%\#NC#?P=]!R9>>OI88\YG3V?
MGB0XU:W=36=GP.?34>8T,3XC5@[.E\\(WU33 #_'Z:9Z=/!RLUQO5\GJ<M-=
MZ6TM7"^RHL@++=,"),*(>BCJ<LB ^);8QLB9@-:^V-_LW5@^&^\>&,P?FM=.
MJQ%B5#;WID\V@3#(XZ-/*XSEZIED7Y6YQKO*X!^,SN0JIR?GGK>8^T3$"3^.
M,SVAHB-]=Y,62DC1-Y6ASF<31-9/3#L^QT52U'<07!;%MIHW+FZ2LEPW^[\6
MKN,YU((H M0WB>.[IMTMLA./8,&3!_/"/LZFNL<X_STIV]F.>/5?VZ*LX4T6
M755X??0@.[*[9Q)K>ZLOC'>UX3]<&+WMU<]VYA\_Q3WWN'O>M>.$7X5=[+N+
MPBJYT1>,E7MP@IA<0U]8H>EBAQ(; #MT"/0IH!W,D%"XV"0/U2VOMQ+[Q<;"
MR*6W8:.W;\SAUMX*2[6(4%0P)6["']]UH\=.A>Z:5WBL#?MFXUZ-?IS0)M8#
MOKOH)6B^O@ EXX<)8M!M'F^*>Z;%'Y-R 4*?!B9R;-\/(VC[V(-1'S$CU^U"
MT>A12 BE1# 2G%,]LHAM/,7/T]9[8MX</3JI=^.\@E1OWX7!+/QFH]6^F\8)
M6E(=X[N+77(LZ MA [PRV1;B$/F$F"$P0VS;&#J>2TD'TS0=K]U"3#;C!S$^
M@.(;B#M;N/6/_0'/WN&YR]3HNTEY7??="9.@^;IWDXKY05B*AI];/'(*(T ^
M"A#Q("2>7;W/ ]Q^0LI'(98Z$C@9VA'/!7(>;)_F<.!TW44P?_\F>HI\)C]Q
M)]$;+77YCB=\3MYO9A9/I^?C6("='MDHR7_QTJ3.ZN<F.W!-$+!:);(\:'D1
M]3T:NBU62EWDC7>(<!C.[_DDX4 /ZIVX&L]M4T];]:9]2^<*3[I'0SFHICO,
M+(9-PX&BPE"E1P;?4O>Z3JUV"78[!--^A^#"HI9E(F!'8>@#[(7$H]T)2&K1
M"(F?(=2'Y3LX&ZC14:>#SQQ])!MFN"^4J_>)"VT0G\9UBBZ+F\"%>NZ&4^+*
MX1?!\?%Y]M2;?D_-Z33;"-;RWNJFA>5Q5Y#Z'.+X)O^%#:F#7=N&!)FN@\PH
MLG% (?(\"ULLW9AB?[P*W/^=SZ I\?N8^RC&=OAL2M3O\S0:ASNUKW"J[%+?
M=IFKD1<M:Z+J/3=1U.78S8]<:B*?F6#9   +PVI<MMD#=&@P:?15@/^_WPDU
MI=Z?) :/[/89Q>+O_;2:@(O'B\\*N]MW&:=5\J,W7BOWY$1QNSGDX$&35?(6
M\CW?(8Y)@$^:VV5MT_1#+YSL!)L@SO].I]A$73A)?%7HMOF%T&_V1-M+]XP7
M_L1ZPW<9X00IT!O$9/PQ49QZ<9+!<EQ( Q];GN7Z7H@(<4B'V$-XDHO$Y)#J
MG[F=XTDW2:].$L&TN7-&@>S;/_5VT%WC!3:I3O)=QC<Y)O2&N0'>F78CK$<1
M=0,KA) 0#X4^HJ'=8:5A0,8Z"C<,Y?\[#_<-[(+D=>*W+5J*.!AE%Z281[AV
M07Y*V/#9E/%#<G5_N2F3?%/CB-=U(7";?>PNO2"6BU#@$&)A'_K0,4W0M&UZ
MONLB(/  K[(VM:?*+] 9107*>.K15Q,^]5ODQB8IFW\5V!NGCGF.S8N34"Z6
MSGYZP>M+YFMLC.LJ%STSQZ*3:(&MAI,0+K>A\"7QZ8$NSXCO>_B/ _<,\A)S
M;&>@<F)GL/]/O4V9SJXH&5ZB[#$IRG39O(6W"%W;C2S+\@!V('5!$.*^-6R&
MG#OOAK:B/83<U@$B;IZ[C//$J'M:LJK+]'1CE)\35JRGU4]NV,"55C91=@6#
MAD9:AX2)#E;[GNA(W$G& 8T<JE#^5<=ETUE5"OU+RWFD79*KF8FYK!7'Y'L0
M*^<$N\C+155GU'T(;E;_MHW7Z?TSJT7@<IEM-V71/]WML=@0LD!A>PYQ D1,
MRX<!#E"(L>7XQ#RC+@I;TB<T-P0;-\O/R6J[3BX,"[PWPPNC1VW$FY6QPVUT
MP(W?.NC#;A5@%.W--[#O7L\U\'-X8+AI<,"T(T^'09FVSJIJ/$9IL5QGU?S"
M;36AL*CF!$)*JA>!000<X+K Z]JG$?%XSB.J;U5DB$J</)0<ISLKC-]J.SBO
MBM'@E:%BJ=,AHVBF@"]&TLY7E$I)J*Q;YJZDTG9Q"^HPYG@7:'88UNOLCWJO
M'D-SG53SLZPN9I\%OZ;% A$((B^@-J%A8)$(,"'O&B<N]44N^%+4Y+2*NL->
M#^@.O5'!9^D/,T#PUBU5CN#;##"!#Y2*Z!#ZM:QV\1%Z8OE*L4?FL1ZEVJA,
M:R]6J9RL2(W3S<)" <200N@'V', #5@NW#4=^1[7Y1A*&YRG:O[6H%<JF;P>
M4"&8&L@?12[/\CZ!5C:0I)52T!7?@DZ*FB2DDE)\R6ODU7V4W"=YGJQNXZ_-
M#-XOR>-=DB^J.XV0Y_IFY)EA9%,/1[B?-[")*;9Y567+VI='>HS&?98;JQ:F
M4<9?FVGHH;(X@'19=1R';3TB>6%TV T&OEE5,7YKX$\NE4>)%5+,X>Z9JW J
ML.RL?JIBCVOUN&^59GF]1'V=E-M\4VEXE&WOROOMNILR:$'8#LMU;:]:N'9
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MJZRJ?Z^U:TZZ>X1Z:1T>ZLIO09<'VRBDTVH85;0YC@V(9=V_%[;K$FQ:#O5
M&&  71?W80-#X$G<L*FL;2Y=&'QKY@Z0TMUO A2KT%[5M(XJMSWX.4GJCE'Y
MO7#B3OD6A%/&++$]<;*\J2WUJ1U:&)L4^0 0Y#N!:]&N[>H.'-%KKM2T*E[H
M"U];M5?FL[^M"OQ/]0?-:7BJJC1YZ?X6!J:P35*5IAACO$.R>U:$];0;EBHE
M_7E6/Z 6H38U(Y,QYF'DA^VY*]>I\B;.\"G]^?K"90>I&EU&#4K5P6WAL7:,
MG1/#:S"A\QA1P\W(%'<TL7'3Y5M7]W])TH?/+ >&7Y(\?D@^;JL=)%?W-8BB
M/L-XFWPM$3/^]T7D08?:B-4;E$0V]%WL@0Z+BTU;Y%R,'@2Z]W:TH*O@UL$V
M6MQ& [SZIP:Z6&&@R2-\,C>],P1+!A$_M >SC0JX42,?62:EV#VAH7J]-0^!
MU6QC-F;_%Y-FG#U6<SS=?I/KI$R;2SAW^TSZX& C[$$<.L#T' 0#3 ELSDA"
MQ_3HV:NR=#2I;]#O8!DHV23WJ;HK:X2'M !C)P:R#M[G,7RU6);I[[5B0_43
M:[YI_*K\G.2?,M9:CZ+KHWLW0NR4@P8VP,!CJ"P;$S-R@=/!P8 (/MVK#8;V
MU:YK<GMY37XA'V^-3Q_@QQNQE$D?_7RR.0O>Q32TA5S/I-:@C9>H=\KZXF*;
MJ3(G689/:*YVI\U#@/6;F8T\& 0+W.I"TJKIZN+89?:8,&!5P,B3SQ70+TG[
MTRY  "\ MNL[(86A$SE.9 4!<BP_M*HD#T6\A93B9C664!W2JE!Z =%H,$Z6
M6PER>*I0TN2->0QQ;=:]+HZTLL@[H#\F9=-.]:[TPC,#&/DA1#AP"7)Q2!RG
M:\,B)A1+H,0^6WM65-T4GS9C\-VZ>EY>+"T29(I/V/11)"9;%3>M/KVKH/Q@
MP++,T[MM6<_QE)GQB57J8V]O?,'."4&28W$><B.)/5/1C\2DHDY #BA4U21*
M[K/J;KZOS=HD^X<\B8LD2IK_]B+F>-4Z<5C="( B2&T'H+!#%H86$1.8,1!I
MEZ6F7EB^2!5>R-2%<5?;4EV!\@]BFC6*R_B4;FZ^$M/'QDD'\[E&+WLG59>D
M3)7B*>#XA,J.Z<%Y:/.H%F?3C1<U<>#7#6M]G?XM6?TY6U=/K?T<IYL*[M7F
MIG\$&^9IP?XIVE8O6C7P>VL6'K50&/E6X%-@LCHU +1/<5G:R_FBU/0XM<>,
MG0G& P/?!@HCVQB/<?Y[TB1MLB^/3^C?8:%D7HY5'F!V-EP8\$N<KBLOOV?0
MWU?75UP8>YVBM=_XN>X<;4+?&&XTEK>;R/;#UCQBU6 G2D2P\3K.O./:B#QP
M1KNQ/:,N!NZ 1@S1E[ADOW,:*359J+9P  EP*'(MR[?-#FE 10]J38%P]+C'
M E[].EU2E$8>ERSF_1$_J8YV&CRI*LY-ZT+E$6[/O?N1BWEYS[QO+Y )>VE0
M"-/7)[Z5X*61 >&PI=L;*B;O*&LY?=C@;9XGFV7S$GJ\;/=_U-^MF]T@J__:
M%F6S\-BA#2CU?,OV+=]'F+ 2T[-QA]9SD:UN0D\G2NV!JP5O+%OT1KD#O%_"
MJ9O>T^K4X5-^<_&F\AC6>;JSS-@SK=X?LF><L;-N?O%KH)<D)Q+'Z!?SCF.C
ML2 PX3B>5]0N1F5YC6IO*?,V:Q8R%SAP@1W8P+196/7#D-J1W<&"%(6+^AUW
ME>M0 \ (G;_H<>M9@M*Q C7$3RJ7GT9RD<:UIPNC-6(6"_A#61^\&J7 H?./
M%FK-E5J'4L:S"OT_#<A:T,@U$?9)"$+H>\AQ+.CW%9:-:7?-QG#Q'XJ$2U1>
M7KHAIORMCE2/J]PUFTF-=^U52#\8>;*NWZ5GXI%6UZ]66QJS<Z%"77@8[,;A
MD6$4_^D*"M]4-#C#M&0@4.6_^<< 998*R+]:=E4H_\>DO+JOB@[7L4($J(N
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M/F,R)-.N>9S2Z8\&?')\H+&C ;FA9\#EOWL.6TW'7\'O5&TX+Y GR[*>]LT
MGBN]V=1_B2U7K&[R^G"]OSUL>A6\QRBK[V)6K[M!EM?'-/(IS5D415GJYW[
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MD::3RP"1;A*UT:<+6"F=7K6/^V]E(V[>:<IOY797?2^/*[]]_"C.W"@-4S[
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MK_FTQLX:-.>;$@^/PY-.Q"H/L!<G>>@3ER:Q*[Z+R@< 9SA4)B LS%S,4YN
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MINHY!D:N';-TB2NQ5&K0-&7>VC'/%&[AZ\U2M!U;-S;BT>)8JY#"9=2J^J%
MVK,5FR @/J8)CI&?^%$249H/6P+CC$A-.>I%F)2UDBN^FIZ!86O)+EW:RJSG
MFO1-F;>6_#,%7(5U<2GBCJYOF[%I<<Q5R>$R=)4=4:'N,.4:^9F?DH"Y081B
MG+"0MW$?*@L3J<TW6@$F9:[DRK2>8W#D6C%+F[AO+\H8-$V=MU;,,X9;\,J6
M'&U'EJ>,>+0\UL)3&$&MHA]@TCY;WT*!%Y,PH7F2Q5'L^AB?N,YH3)5@"XPQ
M*6_5EL^U;002V**#6A!&LHOC9MU31+%%%XW06-I-.)#?W#)@RJR%85DUBTMD
MUG)%\=#459JSW T1(CA.B9A()J<ICBST4\C'Q="?;7F#0"M'Z^#3M]T99^T4
MQL 8^_QHTUF/,1W97:3JV#)V$BFK'S^9%.B"(A*>?]V7^WD0$AXW%H<=4)PG
M@=\'C2@#?6:G&<IR]=:J4_E$6-=!)8K8-$\/*O-_&3QNE3QW5#U>)(:4DQFG
MDIY'.I Z+=00+W1SSPU9D@9ARKTZ.T^!_Y+H,DH^TE2(@G[YJ^F?.J'L6&<(
M4'-]\#MJ%!!/<(.72R>%7"3@I.J0#IO.UC,H'SJG7IR%;I:$ ?4S/QN^Q8LS
MV*6LFJ$FHQ/P@UY=!]7Q9,D\0WR:[3O><:N A%+P>+F(4DE&@E'*'FE!:IAL
M\E*4)2[AE5LDL!C[.!Y&ECZ5VWUB)M)DB )^IZOIGP:AK%AG"E S?;LV:A04
M3V"#%TPG>"XR<%)T2)U-S^;"$R^B8A](G$4QRFB<^O%PPA3!2:J')V"PR0BE
M]_FMOJFJS++HIPELS?O5[5MV@>"EZ/12^:6:SIL(T_))Z[[:%8E32K'K!6F0
M4)8D/LJ&6#0BH/ONU2)87F;[*OZ*@:M?WW9*CD?V38)!Z/6K6A=P\>H(:?0\
M7 9>-'.0N0 5Z(@62)Y/L\<D\#(6N5%$ N9G-/'<82I+K M"2B(C 2V712UF
M5!;GS+BIP1Z;1II T?S+=3*V06FEZOJ"X:6<D@S+]/S21]MIDCY*@C3$&+'0
MI2Y.\BA.XSZR%^6@JW),Q)L*;- E/2->ZG+-CHU&L3;7(I^$:4I0@UN^=*8I
M9"2--%6W](EV-J4?1E%$TYPD<423),OXF/-T4$I,L1FD 0).QC3@0J 9-W6A
M9LE(HU2;;6E0QC8EKBFXOG2PJ:0D339EOPR@[71&9^HR1E/J1AE-,R]$OC]
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M>FD?#44$N'U!-8KU2:/W%]]&V(A(V4:Y <X4_L'Z)H5.Q\JH0QYIIKQ<QIA
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M-8_=JJYU3 (:$H1YTY&3T#@.W7!H/77\6/J>@L$V+6=7=TCYX@O</*D9O3[
M%5\>\2J\!F22^/."-2?G:@IVI/M8!JT]=3K2C1= M\+S2S/1KO< T_5=#O+N
MB<O^K1B^2+C-BEW=@#RK=AQU+9S3\-_CJ[BBW(@G(/;;=DNB/8RH\KYL>GM>
MV)2O#QOQ>:#<-T]JKK?7@GBC_!^"[/A<4#WVL2=Y+[PP3]GRXP*N#MFPJK3;
M^U6NW>4W>56)/0>Q(W&=??O<=:_K\OD>Q./*":#+'(?YGN>&?IP&+#K$\(@Q
MR8UKX\U.L"G0@1TVGIOL6[?37*O)JU&N)::SN4A6W2[HV>UW>3E.T ,%U^7W
M^[F/<S&N,*/-Q;S>E"9S6GXZ[8C%9KEKM^KY?+5Y871T^7EC9R0%%E^;DFPX
M8@%SDA6S2LL=6&UKY],@L*RL2+G_TMSLMVB]+O>\VZT@HBP.6.!&)(Q=YD?4
MHT.3(56M>SJJ*?NY+&U\T,:460]*G(?F15?[/MOR@9OQ+J.8#CN.7[G=G\F(
M59MQ#K# 35F! 1@8D$V[%72.HS,;0D:H7<:VD!E32@M=3_%J_OT##^&[[,!W
MY>ZVS;[M<F[_,]]N.)#?ZGSE.@G!3L+C]PA1FC(6,/^P/45]I=</S;1H>7N(
M%=_$$GGW?0(_* [XNU>H-D7]4-;95E'*#!$OIVG3<ZXF;D=\(C@3"/N<__Z"
MO0#Y"]>]7_;UQ,\L2C%W1O+,,K\,[3-LT_,[\Q88D[[75%9Y<;O#>QY&[M:/
MUU6VJ[/VH/?7K-B)U(??=E6>;8M_Y9M50L+0%XW!F$6>SZ*(PAX"8R@FBG='
M338M-5+'W!K]1R7NY90W-V*\ENT#[EK7FXSR+:>%TQ.M=_6I@PD&G. $*!!(
M^\PR\:K4 '?BNU *1)Y12"O^6(90VC'M^:TI>_S)RN9'(0 ?."=9?=<MOFEW
MV+!RG)0ES/$08B&+*5]RN\/U$D:=,%#32/UVK MB"TU-_$:P)J=TENG2DK46
M$^A!'7)D>UROOX%B1<!>Y>>,6HWG=!G29,".TG1O4RTJM^:R5N<D[_X\24#%
MV4/19-M#]BF.F!.EB8/BR'=XFQB%_D'U/.2K[;P9;'C*?;B3#?(7W\56O&9@
MDG[)1>P\O"NN9'N0X*<!YL^"_..!4 ]UMNQ^>1;/K6K-NV(9LFC#L.]JPEGB
M3E\XASW&SX<=^E5$4>)[&/JIY_B0$$@3-#0=NTQQ<6ND2>LQ'/K^I&*L)NHP
MJZN&MB@UJ8,'BC^_3?%$\O<];4K"-X+UI4K>&)/>%+O1?.G+W.7N:[[C5/-@
M9T5BAT:8$!;",'!<$D#D#FVF,7;'ZIM*6]:%[03,6$%3XE!7R8R39U+"9,B<
M2+I.H"AIE@Z_2Q4K+5O>5"E]AO3EZ5.5/V3%9LABZ5?/:+=I5];="<@*0IJF
ME,4I#HCCX!AY[G!1@ 6^'XW5+2,@K M:CW+(:>[6LJ7Z%IPM)^@*WW3LFU3$
MP1L]W-89W3X?.G\F-)%,RK"JI)]&W;14835KY)N*:X'3\0OB3]FCB%#%O=#U
MNMISF3KNEZU8Z! WQBST/8\%3+R6<0"34.*K/5!A!8+E+)G#:NZA WDADOT$
MQJ,>G^XPFEI,C_/*V.7U9 XQN^#N87<7VGLOO9/PS<2K\'/L:JW+C;AKJ1IM
MUDCIM;M!3LU7%%R%/D9Q&@1.'#IN2!ECWN&XR7>9JU)]V&"S2EJL6XE8HIR4
MK0J";_,NI[PS4:ZFMAH5 Y=:)O",JEIPQ3*4U(9AVN4 %;D;J9AB9Z-^I4I3
M&"68)AZ$<02Q#_U(/#': PE#GQFIP3H&@/WS\F>WRHH!K/$:K*/\,$I)IW*
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M?D=?^$=FZ^:OEXJKTCOFC2NL].-_F^C##GO3QR@6>\&/%,FLDB1.XPAARI+
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MQ$L]AB$-4R_R<.#1V/<2!B/JA#'!CM0;E&/;L'S+X(BL?>BP;$/EK'TBK#A
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M,7*\$$&5FZ/3(E/:KM I,W(0VI^^=(A_!GEG <@:4 ^HCUI<W@ O^5OTORZ
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M:;(K*6A)?ON\)5+>9\5NE2:(<,E"A,L6%O<H:(R&MI@;8FDMT6[!LI;TP"[
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MML&9]*4+WC4_9/=YFTI(8A;'$:,T">/(B1'TDGAH O/84D7UE#[8LK8)+$"
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M>F6OG2!/FT\71<YTGA^0).<BHI(FI5A+B"CO+TM^+R+Y79J_."L B&T'%,/
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MC.M6>DH>+!MSY3U!]6_MJZR?J_=ABL&H$"_ L1M%(? "ZMB.36!8'?H2!-W
M#8&OI1UHEH2*Z:(;B= /$+)^7A?=/Z>\P*G?AHK;@K293_O)2#,THW.!1K>;
M,3/)S&H&.F<@%7U 4AS"#$9:& -9W3\2+:*\,6 H:S=0%". ?1IC/[)MX+LQ
MQI#VE$KTW! ^13!][#1Z8,\R!E)\6*_:-@M3SX6!3&:=O9^PA8HS]CDF-XA<
MM*LNZ\Q\/O[*J83\M=^6WS_LBC*O!V<5M^53FM\]K7<3QP5$F(1.1-C.#KHX
MMD% O+C3S_:30 L/:==*,8GUDTX4#M0Q*T3*-J&*^+J8FUUY<%X.-UF1?6'+
M+T\+7^J#[H,FL%X9U_4=&_IV CT8)G&,*.+OQH>^1S4U(ZM50GU[<MV:/ CD
MV:-5C1_(M_6K5LW)=3UX4O#F ,.!5;T1,L<MM&^9&M6M@>Y6K3Q+*]:[OLNY
M 6#8XGQUP]-F&7F17$&*U_WHB8$<D+1E 1)MNGB7]"JFD+IL]XI#'-@P\&//
M YV\B(@-5%M.2L4[-7YF7S2:W1P.E'Y@(IO;)'W9Q LW1DNU[E+-T)5B)SJB
M#>S.F&*B)=J>1[N%&?1H  ZZVIL%+;/\OI8K>7G+#B@ER L=;!.",/%I&/([
M9#S/%7I;_RH44DR=?=A\. BG_^XRYWC[+;)K4>!>9@3IZX),VXY&F;W'W[%U
MKKOC_IWNCM-ZE;U>QT3V*<_NU_?/:4MEU<=L$_>8Y2]KYC[M?1>Q@X+$HPGP
M8@0")T$QX$7;&+BC>BZN42_5;^CT DV\D^MZH!Q]=]?UJ/0C5$#?;M@Z:*P!
M-M;04Z?="'8]9A6^.>QZ5!/QV!DWC%VIYPI<1V:,R4_DP@9*.=HQ3;G>[ J1
M>W,-VA7J8%IMY./^Y3[-5XCB) @"BMS(#R%$-@P3WK.0Q.)OQA@A]2)5#NOG
MNFI1_'AEBP;U96L3@I;_UQ0@1''17V689+GE(^7MOBS*]6ZSW7T]JI-\3E_6
MVQW[/,EV9;Y^*/?KYVJX;+%*(J82I$$040]& %';Y9=GXB P))JJT$QQQ/W]
MN'Z<=Y*R$,Q%G3K'_&I07KRM:FG7,;76,,#EQ V6'!MK $X]9UWST"RC'&.1
M?$*E __H.8=2[+3E)>H]0'GNTF14MX_U5XMH7SYE>7U2'P(?(Y]2',<X@A3[
M+FEWHQ'!"0BUY!^3I5.<0_RZ_F?[LG^Q=K5\52=VLU^SRLRZKSJS']-<VXCH
MZ294G )HL9YV&O_(;=[H9?6*70D#OV<7%2PZVP>NG GGZR^+S2198M3!_,&S
M/K&U^,2D:<N<%"7$=0'$@8L='/@D2D#W. 01'/<VT.S'*']?IQ;*>FVE:D^N
M1]YZ,A_$$>?(NM 3B]!'X=7J!!,_4)V%G\#IIBX<IQTU?CQ,48X=\C\SS_G.
M*/_>H9L,O PX 9.B1B;9CT2;IXX>PW@ LJ#O1;%#B&?#P+;][C' )D0@-D_Y
M\<IC,M[G3;K'E@-?"#Q[%VW6$ 5O;&^/0M0F9,LS(O DE$3[2A2B-:.Y0W:<
M%8BO<U Q(*[.$O_-\?XL'$;%T>YEB4_,"3ZM\W+[L'U=5V]?D^?MU^U]??-M
M^_00.0YT,(E)Z 8),['3#72/2!(26R"\2GRJ\JC+WY5*:]F>T^I5XM>AT-4'
M==%$=#27= N,B-$+02\6NCGFE936@9C60$[QF"X3;(%0OQ#HTQB @_]:@7_H
MZ>D ?#G4,!Z:]QA# ;@&$(D*K3*U+BE .\F^*+.7=?[]]RS_DSWTMX>G=+-_
M3N^R7I;TPZX3\K:-KHU ."T>\FU]B+$BE#K$IH X./03$MC(#S@E!K$(*6F3
M23EEM0I81:M!M4E(NU5=9H,UG<[C+GUF',%L1MI/C/>X"E9GPDZ)RFR?#LW&
MXW2G24N'UD 7(VTI0)Q&VG0:K?:V_?MX>;Y=DGRU'JU-:]/K-)=Y96'['B]K
MMYT!K*U?YVS)U:+C;<=6E_^R=55-L?X]3?\LL_N4M+NQ%0I\-W832*F+?82)
MYP&/9R<.BM6_MSA70M5-VKR&W@6>ITK2]K2?[VI_'GYUY$4'"UMV;$G2=*-J
M[P+HLHM:NRIML"K]6H_H5+P*%]#Q'I].5UCLC;QY+J'XM;H+%I#^@IPLBQN0
MD2R/@927UN1:1$O&\FNV*Y\J8?](6?8U%)8B1/PD###!U&5"0HQY'=_'>-3P
MN85%U)ZSO-2B'B4M&BEJAC4UI"EZ#+E8GM*H5[-2I>!RB<H,+]"8J>CQAL53
ME8E>H2=7>=<&JI*5^4;_ ;(5"2#(3%=DV43:4?X=\_GB*7O>?.KO PMP@BGP
MB>\@DK"\*8YQGSI!-'+ O5(1M!WR%U;V]XZE*T_;5ZOL!)5\OCS)!I).]E6#
MK^:8GTL]YBY&C4:1W &@VCC3"/OV[8*P'K/\J#&@[A48= ?H: LX@=><'H$Y
M\!M G<I5%.T>F(^GG&WZ>Y=D\N:Z?/N0WCZR_\WVF+]5%Y&T M_NZ#8O2KS^
M?OMX>%:RLA,<1(EMAW$<AQ&%/G6C3@_(-!-M-39-?N6$V_M$M<FO)]^^K/,_
MT[*_'F;=]ORSOS[4NK6WQ&3-Q6&/E6[69OV]^H;J@^EM#$::0$K9P'3?F5!1
ML$;N':T3>\=!-WBE>.4YC>I6K7N77E0N5JMOX<:]CCHLKMZU9-8B3'>Q&66*
MQH,.1ENM#SVMZ+_MM76T^A*K00-]YV@',>RU=[2#.'84PZ3TW6LVWN3ZQI*.
M9$#^9C8^0E61Y2TI-'E"B2HK!SJ$P,0)70='M@NP8]N=P+8;C.Q,-4#0*\@%
MG]<24D$#H!:9:6&^,V@_+CJ?W=UTZ=T"@RZ4&.L$TQKD(0:-OE@8B%,S,$RP
MC;;Q3-%F4T\-7C^_&=_AAR%U@ -M]J>'2(BIVTL<A)'604TSY-36#['F,G93
MF]BO-/^6-E79;5'LZSGH%V?PFF=J ?*[ BMK9[_>1WH-KW[*T_O&NL1^"[N(
M0?2W-!*R9T!)L\YH JPX]@.+K.D&[_L]:?-T?MU@3<0=1;/%7:P2SR81Q<B)
M/$H0H,2FL)/&B9$K1&Z*9%!,7.-F#5K[W:8>)9MVA5B>R;.?ICED30/Z7#A2
M;#I#0HUJ+8_#B!94E>?(3.KZ"T<C6-L<O]&F4V"S0@F!MA\C%MO\ (#$ABCI
MA/=\QY]05%I>:.4%IF[\-*_%-\6D;>T\FA)DR796G"LO9V#]12-&/,V!X9MQ
MY;R,U&;17.,K2:*%K*@BGU;C1H;PG6&@R,JR5=I,*.'^G+[R@E?V-5^_]'E^
M])+M=Z6S F%"(@<G=DQM&L21BVT^6-!QG$ XP9;P3,4)=1.J<BYG<6.MN8S6
MNA92D-)D@3V2DQ; 69!4ZBU(+Z+5RG@S**-8T7FDU6U-+D-W:2LB$7Q#0K%L
MK4YM-:2C-B\8-KN=#SN:,2=V5GX J[H_(<3%(*:Q%X2(OT\ Z*@I"%(?J#D,
MLMR^EG+:B:\4A.>$/X7@RHI][7"A[<ZJA30A\AVB)ASV)H)N<LR;JM*H@#<+
MK['1[BY/U\4^_UZ+T-9W'_[:;W.6;$; M1.88"_P2 @@P4[$G^@Y5+"E9LZ3
ME)<LDF&72Q_F-@O=K7D&JS/+3@;"9JPV*9ID\OUOQMKZ4O56=0^LKOG]-67Y
M#-O1.<!.:!R#, (X)A#3[HJGB-C$%3J1E_) Q9G$>RMMP07V#E)C5]I<H U<
M<K-5.K?VY. U,9T_<7BQ(I !%L$8(#_$MAW$2<![78'CH1G)_)3'Z:YHS$K>
M)^$Y*757#>6\Q'UC->*U>?M-6\->-&T_@=CXI'T.W&9$-)D*G4_8YV,U-IJU
ME>."[0GZQQ_T)E:WOP0V!!@Z.'3\V(%^PL,HH)%00B'A<8JCV6#K?-2LKG?I
M74;JS-*3"+,92T^F0IDREY11%^1WM_;ER?Y[ND)E]>XULA'R/4 #!U W\?GV
MPL4QG5\ME"*&_J.4_C;UXCQ=:K?(G.JB=F/(JCGV]X4/3EX&WVC.(<P8B(4+
ME%+M9D8@UJ'HJ&*F FQGE#@_IV5=]W$\+P!VZ$*(/$()L5U"NP<B'(#9%<ZQ
M#U)>X.QDXX672JZZ+\>8"F>+E5B!4Q1@,Y:E#$4NES>G8=,OJZ%'_(_][9>?
MND_8;U5SUR\__1]02P,$%     @ O(CW3&%"9O/)MP  )%@) !4   !A;F=O
M+3(P,3@P-3,Q7W!R92YX;6SLO5F;&[>2)GP_O\+?F6O;V)=^IF<>K&<T+5L:
M2>XS?86'8J54;+.8U5QD5?_Z#TDR61N7))$))JGNQ:IB 2#BQ8M !! (_(__
M]?UN_-.W8CH;E9-__AO\!?SMIV(R+&]&DZ___+<_/OZL/IHW;_[VO_[G?_L?
M_]_//_\__>'M3[8<+NZ*R?PG,RT&\^+FI[]&\]N?_G%3S/[\Z<NTO/OI'^7T
MS]&WP<\_KRK]M/QA/)K\^4_5?SX/9L5/WV>C?YH-;XN[P=MR.)@OO_MV/K__
MIU]__>NOOW[Y_GDZ_J6<?OT5 8!_W=3:6:+Z[>>ZV,_51S]#]#.&OWR?W?SM
MIRCA9+;\[@9?4A?__JK\7WA9&DHI?UW^=5-T-MI6,#8+?_U_O[W]N)3SY]%D
M-A],AL7?_N=_^^FG%1S3<EQ\*+[\5/W[QX<WSQH93+Z.RIN'R>!N-)S],BSO
M?JU*_:J&P^FBN'D[&GP>C4?S43&+O5@V=CLMOOSSWV*U,@( !: K\?_[[AKS
MA_OBG_\V&]W=CZ/8O[;<KQ>?%#-;S >C\>Q3\7V^&(R/[W;#!KN5:OV=Q_?^
M1<5N>_EI\'E\"C.>UVNYCXN[Q;C2%^_FM\74E'?WT^*VF,Q&WXHW4>'<%6_+
M69,N']/,&21H3I 36CN#/(VI='QC[4KS'XO1;%2M)!^*V7RZ&,X7T[B&J<FJ
M0V_FQ=WL]V)^6)#CVCF'#(TI=E)S9Y0(MBP2[(%,J&69T#EE:JH,3FFM37GT
M8#::O?OR?EK,HJ&ZM"_U8C::%)5&G0VGH_OJH]B?CXN[N\'TX=V7CZ.OD]&7
MT7 PF4==5BXF\]CA]^5X-&Q@8G7T=3U&Y#A;+LN7]QBM,_'H@OC43+%T^J5M
MHA/-G[O1O'*29[$WIEQ^;72K&W"@0=5,/6UH9C1O(6^_#QH31S21M^<-M>K1
M#662HME<;MQ N[V>S.+DOZG\%#T85]LQ'V^+8MZ@MP<J9NGE^\$TXG5;S*-"
M:T"/8UKIJO\?HYHNEJ-\HL=_4F/=2_/NBQG,;OVX_.M$";8TD*/7[^Z+Z7+A
M/+G;KUO(T>^/\W+XYVTYOBFF,Q?=B_G#J?W?W5*;<M2;Y%&WN:C:Y@]O)E_*
MZ=T2N$,];U*WS;ZZP702E>_L?3']>!N5PZ'^[2K?99\:&B,'JG79PV;+WOY:
M;?;/#T;3?QV,%\6[+WXTB>I_-!B_F53N^'(B'.IHP^H9>WS@SPT9TNJ7]$[Z
M@[M-[7Y+[^3'6>3'_9._F?9I\SO:E/WO97GSUV@\CBO>F^C8QT+QF]1LUL R
M;U U4T^;^IU'-)&WYP>5QQ%-Y.UY0X_YZ(8R2=%L\C9NH,U>KWRK3X/OA_NW
MI6A'/6FXU.^NT6V_#LZC/56Z[=G!Y7%/E6Y[1H[O&<G3LX:ZY6#%CGKY^GOI
M$5W=4[NC_C;3=3LKM-NK;]&L*:<-=N6W%.VH)XUUVZX:'?6KZ;CMJ-!FK]Z6
MDZ^?BNF=+3X?C.?85K:KOC0U /?5Z;AO#979X9I=];,9S7;7:+-?OPVF?T;A
M8_,?B^%BVBC:<E^=KOO64'4TJ)JIIP=G2I.Z7?>U&2,/UVRSG\LPFF;^\9:B
M'?6D(?UVUVBS7^^GQ?U@=..^WQ>363&K0X\.=>Y M0P];(ABL]H9^MML>C2J
MW&YOR_MB.G]X/QZL#E+^8S&ZKW:Q&L2 -JF;JZ^-Z="XB5P];TJ,IBVTV>__
MNQA,Y\5T_/1D[8_)8'$SFA<WA[K<J'*VWC8DR#%M9.M[,XH<T42;/?]0S$?3
MY:%QQ<V#O=Q1O,,>-1SY_;7:[-_'XFL=S_/WHOPZ'=S?CH9'G'LWK9^SSPU!
M/K*9,TAPT-8^MITSR-#0>SVMM9SR-%-\Q[72:O^/CK;)$U7S^EN:SL]#%;/T
M\N#!P.&:6?IY\)C@<,TL_6RJ#QK6[[;/#>?\@7IM]K$ZZA^L(^:CD34>?7FH
M;NFLXN0/]K19[7S];:@)CFKDI-X_O5<N5SV?%%^K,,2W@\_%"[9NJS>>3I]5
MJRZTR^I".V1+$;:UUG)/H_?5;F=?-MAR?]\7T\@8-VD9XNW-=M+WC_/HY731
M^]<-M]S_3U%5%>WV_'63;?>YG _&+??Y59/M]?D$8LQ?=[,A"^Z?7*]Z&S]8
MEZ_:3<M0L?K&N.86DYOB9ID'H_[.<3G<)MQ2L"^#V>>E=(O9SU\'@_M?*WW^
M:S&>S^I/EAK^9P#7&3_^^_KC\'[PL%P\HZI?]FHPGJG/L_ET,-SLXXTK2/[Y
M;_'[0X-:03&N(%?(&XVYYUQIIX016AI*J%'NN:CC*K=).5VCVZVL]0JV[GW=
M^><Y*$:SX;B<+:9%9?GHV)$_]^!P8HO!$J\Y)Y)Y:I@G!@-*:XRTH[X)1D\Y
MJ*;#G\II-(C^^6_1^8Q_^5),I^OE;T]"ER49OQ73S^4+53*8#E]Q^7G5=8E?
M[Y<W97X>WH[&FXV]*L--!WPISX%]E+.>^;]NG?H=*H6CLKE<M,XP1 JLN4"2
M(64@8DA2X25S4')*B#Z?SEA%V6PNQSR])58)<G.SO,,_&#\R;:8?XB_WY6PP
M_ONT7-Q7 43C194LJBJSO,07!_7QBM#2>=F#6Z8>!*]D1-U:;X3DFC&".5N/
M@3 :TIPZ:?[*N,FID1JSL;R$D7K48$?-E-ET_F26Q-]>SI#X47@_+6\6P_F[
MZ<=B^FTT+-3WT6P+E7<5#1A[S@R+:AY@305VVH%:$NJTN2[.]8X?9:O#DX%H
MU71==W!FR[O!:+*?;:_+!PV)=()9H0B%7AM/-%G+9"GGC9::_E,N?4A?<R,9
MS,,$>;T757U2F7J+\6AF!O>CZ$!^?)A5V7%^*^X^/X:=/!G_0U5"%)]"@K0G
M&&% D.-"K'OMH@6:U?K.0H&4D2L[ ?5$77&T^?9,>YKQ8#9;ICI9CMKVM:IA
MS6 IIM1*;J)V10( X'0]D1P1@">0"/6'1'U?NKH9K1ZP<^?JUKAN,);!*"'"
M-&*'2+1C<3W%G7'RR@SZUAC0G%DGX9R16UMFV4J:^,D7_?!;,9C,5C&&MX/)
MQ\&XV+FDIC<:N',2&HLI5YX[2"R*P[!&B=EFVX)7P<9C6?.:CWF&(!=1NU]:
MWHXFQ3*AXEEW63:]") J8+&04$O,D-1<D7J1\Q[K%/L3]V\J]-UTZ._(G^PO
M?2B&@_%X=;:YRT%Z6B98 1WBPCLO@<;>(T-=W2\@T)4IYUZ.>-G.V)S%=-V/
MAEV/_H?B6Q'_T-2F/:K1P("T#D-GK&""2(&$535*3!KP7^Y8+@9G'\QS'M%M
M#8:ZZ*,X!+D0DF+E#:3::F+-6MTH)2UJ9)QT=GS_ GVSF%:SI8'$!^L&IB!A
M3AG&*#0:2RDHW\A-1%9O^?F1_'U<!J:C^<.RH?RG88T)\?I\OE7(<ZUL[NY^
M7#X4Q8=B^5;#Z_[OH=G!NH%%]>D,@X8C@"RC5G"XEEECK,15TZQ%2I3= I^+
M;&M$/I0/@W$SBNVH$1R'AF'AN!'*6J:,)7PCG_(JIP%T1<1J!^Y<='KVED3\
MI9A^*PY3:D^M +'FF'+M4)038<P5I;6<VN 46AV]5W%%M&H/\ES4JO81*_O
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M?< I]UP":!G0FAO9B^B&8T;@Z%C%XUL.#@.G@!'"*B\DHMX#ML0,8BJQRQK
MF#U*HC%A]@4I=@YZ3O40\9DM\]4\NQ1;OW^\W/MY]:IP1LWPLE?K% -J.!]]
M6SW3<%AI-&XC,,0U1= ;IXD0@"EB5Q=C0-3B%#?*#W$F'(Y[.N64Y@*UWD76
M N@\$XIR@CVHT5&(75F>L@Y8L^\:>C>#T#]-<NY RKP*)1*#\RJ/EF":(> ,
M1ZM<6H!2CTFCL\VN#90=TIAR-C\B'/-@*T$IQH$6))K'C'#/&%TG/8]8.,:O
M+)JE X[LM$G:QOXL"5.JWB[[ODS'<2"6\T#-8'5U)QD+IZ665& +58TI \C9
MZ^):)TS8MU@E(YZ+89_BM[U Y6",Y\XZP7)%";56:> X )9P VH9.357%B/<
MVHB7W>![<GZ"M\77P7@Y)?:_8O*R7)":8L-B![DCHGIO0V%3]X^9I"Q?/1S_
M%L:I; _-DT?[300[FJQ1][VYNQ^,IGL#= _4"!9IY(UT5".&3/7."D;K/G-K
MKNW=D989T!JNN58//Q@N$V:8Z(1%V0_&/&XM'R3U@@+!891$$P,)\+J6C1)_
M90GGV^-,FZAF/7%\)OQ!TNRJ$AR5E"%( 6)6.\(%-[B6$#.0LMH<?T9X@;QI
M"=@>.$-O&T3&-JD> (^&F:1$60J9L ISX&O).=$IQX$]7+[.[!:="GM"WJWC
M-O-?9^)J5C](A[#R6"#!N?.:8(A$+8_@[,INR+<[Q&7W@/=VT_<%T:]XUS>N
M4=IR8;PDP&KL%98DFK4V_N":W0>]EEU?9(0BU17T*N,#\]YZ(&LLN"(_\*YO
M0XXD[/H>AWT/#)W475\7%:)'7ELDE?2,*N(WF&)U90D@.F'"L;N^1R%^F;N^
M6KD(FZ 8:>Z8%CQ*6,N(/+_F8^^4$6^\ZWL<OOEW?;&#5!H>=33WQF%.N()U
M_P#$5W;[JX5QVKOK>QR:)VJ,1J_:/R9&-H/9KJ5G>\'@B272>&$0$AH1@"#4
M40K+J38")3TD<^&.]+$K32L YZ-)-3UVKB7[B@<:'34CO10<"V<1B""!E41.
M1]5Y)4?2J<.YDQ4G(WGR@F'?_9_'+NQ?,[84#0)9SJ*)#[GU//Z(&;&QEPXR
M1H3R6=^:RCG>IPQ4V2J69W%DWH\'DV/<E[I\\%0!3!DP7"+K(F1(T,VRBEC6
M-WXN>REI$^>S<>B@H[*C1H >.@XT@B).#X$0T'1CGJF(XW7HFY;&^!!C3L+T
MY)7FM\$D3HM91.WO:C"YL<7DKAC<_/$OH\F\_/NXF,S\8#R>Q;_\WT41?_N\
MF#[\_F_[5Z2$)@/$ FJEC6588R*0\'XS[Z &*0EY+H%)QXY]>1;8<RFHIZ\;
MORU7]X,/K'.[J@2(')%0,Z=P%(A3P2S?0,J;99&_G!/M'$M=2U"?DTP'%[S=
ME0*ET!IDK?,66QJ=#*EU+:7G(.4\NX>:*GVP&[#G)&03CJR7*?_=]_NH#8L#
M.W-;"P?!H')<6V\!8)Q+I>%FS6<"IKP]?R$<.';(MKP0E81I#PZ.WK85(8.0
MA]I+ZX4EQ /HO6&UY 3)E%1R/7R/\,Q'2*?"WO\(&8.HUMQQ"2@B2BA-T&8N
M.NRRGGH_?R7FC#$RC0?YI!B9XR _C\ZZ'4R_%LUUU*IX0(JBZ!/0* O!VGA)
M\>;(33F4\A1B#P\;.J%2B_B>A3EK )HR9UT\*,0HU$)'*]!($854:K..4\Q2
M+BSU<&\Q'W-.P[>W<7DOX@>O-B[/NFBT(,$Q(L1R[Z 1ZULFA'';[$W9:XG+
M\]8R#J.B8\I!+IG4R-98($6N.:JE'8XDQ.4=AWT/W*O$N#P-B8 :<D(-E5%&
MZ_TZN)YP*NR5;=-TPH0CX_*.0_PRX_*@-0P(ZA2!G$?8C"$U=IRXJSZF2!GQ
MQG%YQ^&;[8;=I/@TNBL^%=.[T60Y;KJ8%%]&>\+ZFE8-1G)B@61"&LN@1A**
M^O%#06'2F_,]9%0+(__RQEV[ )^\S5,E?;NO;A<O7_Z)H._?5]Y1/&!F--5$
M<Z:!<1PA4U\\) (@FQ*QU4._NSTZM CJR13X4'RMDO25TP<_BJ6_'CA:V%$\
M" &$L@I[P@V7!E! S8:PDJ?<=.NA ]TR!=H!-=?"8LK)T@-XHKT.KB@[ZP1E
MD- .<T\H!]5#]<35@,7/5<K.2P^/NMM?2MI"]A(O_D,718.>$LV<8<(;!V@M
MH90BZQE4CL.##@R1=J#M@>?=VL$FL,HYZ+14BAD9#3$M:_] "L.N]HVLL_C@
MI\)^SK.%#XV>S3I0,UC-L10(4BVMPXYJ:$ET1P$33%*E?YP4:2=0H,&)P^E0
M7]*QE8V^()(:>Z\MI<I "7F-&!0L:TA/KA>S6AOM)N=6QP%\26?EQC@"B$'0
MQ#'@CE,+=2T9MC3KQ;SL@1==T>8T<,^I<3X6\_FXN/G':'Y;+N9F,+M%1RJA
M+2T$Q.*,<009"1"(5D(T&WPMOP?^.A^@RJF8TD'/1;KW@X=J<VL647@FR!Z6
M[:H2/ %(4^M-G$^(&J.0K_=#)!,\Y8)Y\[V":Z%52RA?DKFD>?1AJ6>F.J"&
MV$H+-P8FLCKE6D5/'WG*:BP=!V__@GS._+93WA ?A+R#&',')(F.O#3>K9-2
M,T0@;70+\JPA/D>] -6HI5 ]( \1)@IJAJE5 *L-)KYA.K(+]<G;X<IIH3XG
MXI]/@>C!;#1[]^7]DU;T8C::%+.9+6;#Z>A^.=J3FX^+N[O!].'=EX^CKY/E
M*Z&3N1H.R\5D7MV9+,>CX>B,&N9U5QJHE-V5@G >.0@E\22J>X\15G(Y7AA;
M[&"C&_D=G3),OPXFH_]<Y5HH)[/8\YO!>I">#N.[+WXT&4R&H\'X8_RD6%I$
MCZ\)54.Z;R2;**'<70D>F^AE.LL9B.."XK"L#X[CJ,2)E9)Z/?%*Q7TT>::C
M^<.RH6Z46AML?7E&TN\!O%@UN(ZIKN1>#,97HQ0EX-Y'QYM2"P"R EGE%+;&
MQ-&DT/3BJ<UZV)Y8QC/]\.2WY@'4S9H*T#E*I1;"&1R] ZNUUS4JSLBSY88[
MKTIJS)6=AE4G\&?;&YJ6T0V>/U3))*H3H4THE'ZHCKH/!%,WJ!T8I\A:YB7R
M !@3-6CU>LI*;D+0E>5ZZ8X6+_>.6H?^[)3;FZ_NB-I!2,L0$E13QW'$EE!O
M:[DY27I)O(>4:Y4)35EV,MK9TG<L(F@K3[?^\<W=_;3\MC(*#T8\-:H?<+0'
MD20(2:RTJ%[JX!M<(>-97]G*<837*A]>9OCH /%<;/MM$(&;%-.'IY@<Y-B>
M6D%Z8P54U;ZPAUY[0="C7<*34G#V\G"X2V:UAW.^ -^[^T5<.IIS:4>-H(E2
M!(.(631GI=-1.%++)Y5+N2=R=%3XI?.H'8Q/Y%"C!, ?!I.O^])#;_X>D+:>
M8VRT-QXY2Q!@JNZSP2#EMD!2C&4&;[!S&ST%Z<[9L5.3O"@1%(8"T^@<2^%0
M]?R'MNS1,T9G>PVE0X:<.' OA_TD +L<^-]&D]'=XF[OT#\K$Q0 7F-II<!2
M$$:0U& CNT59-XNR[6"?/(!E.S!V2H'!]\,4>%HF2,&%$DY@X+A!W%86TD9Z
MK[)&X5\6!1)@S&5@JBKVI,$.W[-RP4?AC?! (0DTM55TTL9P8N;:KAAFV\M+
M 3D783[>1LST8%9%#-Q5"1C7 SBM)LO20=</CV76D6U+P1ZEF]Q45OGO@[O#
MVWQ=?%TPBCJ)"--(8N8L]542XS6RBI(KN_!Q(JM>GG.<?R!R4=S=W8_+AZ+X
M."^'?[Z[;W2K=F>=0!C40 AA %?1>)2(0;J14?HK2_EQ7IJ4W0Q*UL#:T7!>
MW"Q[?)!T6\L'I:VP&%N*J!%"(^?$9B=+(942\=_'6Y-](EP; Y+O8.25+?.V
MP<7=?=6"L(I33:1F-"XO3%DH-[@9G_3$6%(&@6O83.I@ $[.5/+QMIPNTQR\
MF7R+E%^=RPRJD-+YP_ME-/T6!C6L&80@$F*'/7#$6VT$-7AS1HF2KI;T<,%L
M9SC++B'.YHM^&XS&U=SPY?3C8%Q\+(95IY?Q:9_GC[^9Q;1"=I^W>EQ+ 7B$
M0>7&(XHIQ89HNMF>J9*M7MLA6ZNDRP/ZR;IJ'?,U^U ,B]&WJG]V4>Q74GNJ
MQ%X+[[R4V%&NH*$.25CW6@.>LAN>>(Z689%K7UFU!_79PY;^F!5?%N.WHR_[
MHC4;U Y<628A4H)!*R@33$3YUW);G$2Q'N9AZD07M0]S+GKYT60T+]Z.OA4W
M;^+X3;Z.XIQ0LUG1C%]-J@?@I()D^;(E1@@P@>T&5>)D2EQ<TH,AEZ;!.@0]
M%]U^7U0NZKLO[^)T&52!T1^+KTN+<0_'=M8)$E.OO=(T.KH.2^JP=8H(Z124
M486G^'_L!]%<;8&;FT ?BOOH=L3^_A'G0A/V/*\0"$!$"\>M 01B#)&U.$K'
M#87<H"03G/]@U$E"]F0[.QIMPPK\K^L[IN7PSTT:EEV&]KXZP3C+N !88 BE
MHA)*OS'_&,4I&97$#VAIMXCUR1RI&?I;.9G?1IN_VFR-G8@.8S38;A;#^:=2
M%]$E*.[GQ<W["N5/I?M^/YJNWHP;S(OJSMNRY"Y*M?@5@2(-N80D0B&T)A9C
MM+$0&4O*G2-_0 :>;VBRGQP6TV^CZL7#;6<3OY?+?;EB=0 Q^U3.!^.G?Z]N
MXO]>SO^MF$>GN/PZ&?UG1&/I$2_SPRP_JLK!/8MLWHX$[JQF!COBN&381NL6
MF<U>MO(I\2#5PXT_Q.K=ZR&[V)O-5Y?H 2$OHREGJ,!,,2:-(UAXA"SDQ))F
M#^MU=*"X&KD7?7]8_;=)>H9F#02@E#.2<4PEYMQ%$\/Y&@'H1-87+_J45*$Q
M,UZ]J-P![-DNR QFMU$95/]4>WS?!N/*5V[.N4;U@T(*>.$<D,XQS0C6MH:6
MVJ@[KS($MD/*=8%ZOBM^TS^+>752\7BDM>KY'IKMKA0\$(I2Z*# 45S@(>:D
MEK+ZY*H/E#K@5FM09]OQ'XRF_SH8+XHG66O>3*HD77>/LV+?EG^3^@$B3;$G
M!FH'$7:*5WN':]D1%5=VJ-0!K[J .5]@87VZ>L32N+M2D$X30"F"G@*AA?#&
MJ(UF-B9E/4Q\[>,R=59K4.<B5!5:-*E>26I.IUU5@N(*($FJ7*6&,4V,<X]:
M6>JLAT;70*:6@#Y[/$5S:C5M(GCGD*6&*"LDDDA%;'6- "$H)4U'#P^9.N!6
M1TCGXMK?R_+FK]%X''O^XJ#^B'6Q>2/5 Z=:64Q\U-E(8@EI=)Q7*# +38IJ
MZ_\15@?TZPSZW$'WIKS[O'XB[K"!O[M2L,) 283@3$A*&<(,B%I*D78]^^@3
MJHM4:*UAF\^4CZO[HGBREW^,17^@;G4ORFF F66 <"^TTK+>Y&-*I26L/?H@
MYQHT5MN09[R*5L3OJG;I;!1A7"Y7>?>].FDJ#FJL!K4#MDH*9X""U )"#8LV
M:"TWH#SI$NX/N8_?/NCYO,EA>5=\&GP_QIO<7B5 J>+J#JQA7D)9/=)+-M-)
MFK2[W3_D7GU+2&?+3Q#-PIO!]&8=*/*/0743=/YP4&7MK1=M@:BF/1)8<@Z%
M$(1H5,NJD4K)P@=[F/&B QJUB>]Y<UV\JR,0XLR(6(Z^%94W?-B,/Z&U *3W
MW&CH$,2,88:48VM<./5)+^#"'V/;OGO4LYT3E=-B]'6RNCX7%7&</[.(3.6Q
M1$&6OXZ?.C!-EM&3VPR2<>6T9QAC)"706K%Z@X=S;)*B,)(ND5P,,W-AGXN?
MMIB.O@VJN70$ 7=7"E9+@J2A1LLX&:4F#-M:2L1)4D[E'_)@H#6LLP7WE'=W
MH]4%]BI:I%S"$>?*Z!B&-6\D8.0CM+1Z\=IPIRW6N#YKXUZ+I#><?XSS@<[
MSG:=J?CK"2S3<A)_'!9/3OB;$^_8IH)B'&&J)5,61[N71;W.:T2$@$G&W@]Y
M7-#Q"%QL4/297]=L.R0:&H&(H)@[Z0FA6"JZWHA@GF)[QI#HW4G(4TZU'_EJ
MK$;6Q@6;$JX]$=RQVE$!!M,S9N?-KB,:DZ#QRR8GHIQM<V*3<&J/FJL6X=LJ
M$]KLS>1IF5%<DN_'S5Y-;/>+ C:. Z4MBB!RJP46Q@E/ 1?&,Y+$V1ZFI^N
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M6XOVR+II+5CE$&)"<JH I"XZWIS6N" FKSN7:__H>NK ](ZPOEQ,6^/KIK$
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M>++N7UE*SNYYU@+(9R*7&@ZGB\%8S<U@.GV('_[K8+SWR;!&]8.@F B/H*!
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M\>[+7NMP.19-?/.3V@N6*>*Q]A9Y9W'UU!I#-3[4@$:O8%^!W]Z8)B]ONF0
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MD=*8<@_DWH]4Q:AG=<'U*6<S(.= EG]_W!@Q2E]>"G:+VI>C!PZ JC2.E1A
M("UFL.Z\"3"B*2)Y1*>PB\!P(F_2S8)MALS'1?G7;D8?ONYL[I-6P.%7@R1*
M($$ 8<X(XZQD=<%@#Q5G66O>95/Z^0#7$Q\>T33NOC,;]_;R^=POO>N,11Z;
M^(_D&&B!O#-,&*&E=APIT"C5M)_5?K[Y7MRN9Q4KSC1F'Z\BOD3NZ#B]?Q\A
M3Z??"8PJ+ZT41DK+H6&.*U?34SJ3DFH^*D.M6W"5XV')0!>D+9N0-0%XQU\*
M""$.K?00:&B$%UP37M,34I!R;30B*ZY7@ _+DC%>#IT%Y'/&"P!:I0@B7C@.
MI*$64K3GD4PZ.H_9>]X+7'LD?#X;\+>RO/U[.IM%9?*R_NE@IMV1.3TRLH&M
M=]8XP3. N:22VJ@B@8-"<[+AD*)>>3*@\==H'4UDQGD#!>"4L-0RH(V,,X/6
M<%M3Q)"D:JVC--]ZPDN9D0FC$!R[CJ3PC0D0H8C@3CBMC&;41&G/=OX#["V$
MC4S!OD^/[R('OAXN>7VJ,>EY P6,$3*6:4T)AE'-<F1%31$E\M;5R1Q V!-T
M#IX->^!'QIR6S,U #(%8:B&XC4:8Q$H"8H6WBK%('4FR5N3HWPKN"R0)'3_.
M8\ (@-ASQP]GE(HG!.G(IAR.IMBC'3T\A-=6Y[,7I"1V_#B/ ZUO?';5LC<%
M3LM9^6US=CR6G'+PA8!@97 2YQWF\>#*HAWJMC-V)EJ'@[7VSHZ9-'Z6/1 [
ME\ RZ^6JO"L6GXK9MO_7]^G]83PU>"O$U7$K%1=,V7C>$-+9W7;S IND!L%C
M=&?V#*KN*9XQ_?.VN)LL_GT:3B\?#=1)X0 ')))+2H(95F:S(@XHESPE.WV,
M/L9,&$HD<R[@O)_>%/-EH;XMBDT\Q9=B<7<:0T?>"IYP1@ C#DO/'$1>P>T&
MX1 )8E)$TAA[!F6"4W<4;VT+Q7/P:C']:QW9U4R!-7@K$&*)TMI0J($&###K
M=[L" 0Q$"EK&V*(CAU74*<5SR:$31]VGYXSW#3)KVPP7@):&"J2EQ3*J>0JE
MV/75(8AJF'*J2S*F,KB_,OD<,K!E!,Z'WQ8GT@)/O!J \"!N=&X0YCI* !8-
MAMV*L4,P:Z7&[-'__6*DN=NA#2M& #YU<[.^6T>Q7]RJNW*QFO[?!@+MX'A@
ML" <5-YQ"BA!VB@-+28U56P\%V61E'(+T'GQK9K?VP-H-\P9 63_*(Y&@!Y]
M,1J_7CC/).38&5"M&>U7RSS@64^OY6HR>WM /)\-8[KV?G&+=OW7WA(I9IC@
M&BBD(GL@V.7_("DU:V1<9!<1?KVJUO!$S+E_[C<'X@8AY G#!@$M5_%P)'3<
M+"B2A_B=_D<*4CY@,>/Q78HW!59SR=(U?T:@[%Y9S!]1YGSYNYC]*'XOYZOO
M+8\.#08.R%1$8582'4]L''KL<$TMHN" $6(YTHJSX.P,^ZUSAHT3WO]=3!9?
M_BX[0_5NO&"]1$YA'VT.R[RU"CI6TX9ZG5*^X6QWS2\P=\6G$6,X?OY8L%W+
M$8.%5F,DK;, *8F%%F)7(PAIYW!*UM5XTSXO#<<M.#5>)/MR?;3+1ZL!@_%<
M<&DY%IR9N-V1=[ZF#A$LI6E:8CF=7SA.8-2(81R?[1;&\=E @2: :*^P%MA$
MDF@-:NHPK5+$\064WKD0&)_/J''"6'U=%8O.L?QLU&" Q<P"9:0!'A$DI#<U
MG>+NQPF 3FH@_F81G,*>$< XR5V/ ,-(:&Z)-0(2KQ7=KS8N/$6ZGM^4]XF[
M_FV \7P.C,E37R79K2>SYQ.\>G\]=Y@H@KC"2GD+2103]0VT1PPW<G/TG:9V
M!'+-4]1.#1)<!*B.EJLPE %G"97[NWAOJ$XJ<#_R^)R>('.X=$FWO&BIM3IN
M"&^JVH_& 0JU!0XPQ)C:SID""T76\C:#Q7=UQ]E7.[Z?1^/><=&\X[L@4C+@
M?17(!BEFTL%ZWM6ZKQ ;+1EWJ./[603LD_&_1X2?[/C^])D@#$?80D<1BA-6
MS ,A]FMG)&M_ON$ZOC=E8-D-&7N%P--.](<@\*Q;O;'>4:U<%0A-C(>"\9U/
MC$(*2=9$JLN"0 (91W"8?=^D35.#UX-ES$&)>=702F#/(8*V7KG3/"5'_7*"
MQSLW+GID0>L\F".V^.Z$>JHD?/,1 H&$"N"<8-I!@[V!?+\FCOUUJJ9^N%[F
MX$ ND?;'NI*W'[Y^*N[+Q:K:6Y^+;Z>:MAQ^*2@OJL,A%,K9ZA^DQ6YCTJC3
M[6!GZVZ!U1OORYX(G0M.-4W>W=U/IHMJIB=:6[W^0A 26A-)ICQRPA@EJ$?U
MZG2T+8;2@I<)HTZ(G!M"'XNH&"));A;%9%G88OO_!E!Z_<4 C&$J[AI+A8K"
M72(HZU,%HI9<20G,W)#JA-BYH/7TEJ3*4'R][N4KT#K^8I (".\4Q,0ZXYE'
M2NT*O4>#C\NL#: RV>RY<-8IY4=Q"35P_?R!DD7B^1]@S%!U,ZTT4(#X;35+
MIQD@K9)%#ARKGJ8@OT+Y8_52SWH_1*/+*XL$8 Z(>&J0Q/!Z3<+HK)UCQY[2
MT93]9?^,R*5LZNF7Q[P9!V_OS^[<T,5G K=2*TT=X(1I:9&B@.WY)'C6#K%7
M!ND1\"N?^HOV8'D7)_O/@(IN/X>SU-J1MP*GEF.J'8#$>L*UUF9;RUUQ9R1O
ME"*<;:U-9,>QUX+'RA$#H;'*$V4\)@#4J^60#G;+W<_F[X3O/U4IZ8R\@VS=
M7;C4%>U@I)6D6"@"!$%&4FLIUB0>% !&CM-&(:Q]KK5RR_B(S6WCNO5T_NW#
M_:YIW5(77\M%\80]OT_G&Y48E4<1>;[:Z*VGHQSHUMR8AEEG$Z"C1D,E-I>%
M"L73'*<U;XS% W;WS%*"H0/0OBI^QLS$?$7!SJ:$C7]8KJ8WW6Z2>M0@A3%(
M RJB 4><((P 7M,IJI>LUR0#@7VDP$S?1"V9/.+-X../TV_':C^U'S0 (Q"!
M7BG(#>0"QFGOQ9M2*,7.'/^9\\JW0CL>CW@GM"7^.&RMX)E4\=QA& !1) F,
MY2,?K 59.P-G+W)UU3LM$R2&/(<.5V"K^X,HIJQ*T=,<0$XX$,Y!K+ U4 ./
M\)#).*:\NR_G%30JO_MN!3OOHR[FQ=?IZC5 -J!'XLA!>.V\,CC2RA/K'3::
MU32K;A/?@,V<"*:7[0FR,B275C?K1470CK';>M!@O3<4(HN ==!PQ:@A>RHI
M?]U%>+-![*?.&YGXE1G5OHB,G\Q^6M%IZ!YZ,V '%)046" LQAHA&6V5W7JC
M$7#=U]@Y</(Z-#OB1V;\?8X\+JH&]!$&;5!X_/U@""$">$>Q=%1K2+#=TS0:
MSRFE?\;O"Q@.BYUR);=$W+H8VDC$ V\&+2W0U@-KL(F'H*A])-W;4\"D&)KC
M+Z0VH$3LAA_CL#-;VY+!(P25(9@1QBRR4>8K\;C;0$H"V/G!I'E]-,-AKQMF
MY(*>W?'P?.R=>#,0!R35BL5E"^\5Y3:N>+=>$PEQQ=F'0QU5NF5)7M_Y.= [
MM#[ (53:$PQ\W&:F^N_C%D/-7&$7ZI,>"G+=L&)(7_"+2)V+]@53R8#1 !CD
M+'#<2T*Q%LAK[20'S8JIGQD;7S["[5!=I://!ZH)580P'74M\5YB)N5NSD9&
MI?EV@@,;<^^UT/9$NF87]FJ]^KX1B@?J)!U_(7#*@%48(D@AE=H;K<UN==9"
MG=45VG,*7CJ'#\GL%)(.!YAM(\JS(+/K70D= B1N*6Z]1E!21WA-,,L]2/$)
MC0@T7;'Y)&I:435;@96M"\"4Z_EJ\7"R??!KCP=HF,">(< L4X!1I33?K<P9
M"%/.SQ>!EW,9_+)"2CI-6U=$>45HOC]25^?D.P$Q"S2,1BW2W  &(!>DGC>B
M*J6IV]C*"'2F<+JF:FZG2+47ZB*U#2SS8Z\%6MV?0Q_/15(*L>E&!^J5>B!2
MXJ7&>S?6(0 .N#HZH'4V+^^3(_I/TS\SZ.7@^X$)C@'#-)+/*J<I!U4]E\W:
M/20TI6/T>''6+2J.Q+9T1??!)-G.]3/_5@7SF<EB\?"U7/P]6=P>.X.=,4J0
M%$&N&>&>(,V\\5345/:6)[5<&3_^.H;**9G7&1L&@V/E"-G];N= K$@8_[_E
M_?QVYT]<?OX>&: GR^+VZ0.F7)ZED#OX7  "$"TM\801BHTP6,,M93WT)*ED
M\P4$%N0%>'Y^#;D33/QYNGJVCS]%G,0I?3\3Y$=&"L ISJ-I5?5&C0<PR*&G
M-3V03FJ4?@$A"=GQVQTK!H-F%>,_CR!X. >%^Y>"(P(*K1E&#F%A;#RJZ]TJ
M$80R!7#C;\*6&7!MJ3XB ^##ZOM13UW3(8*W3$M*A815^@D'VAE64Z#J,)>
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M-GC,K126\2HC'3"BK:G7RY0W60/6+X[;K>F8_;"?V(U&4*5!5') $N 8-0S
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MH_?3N^F6\1^^_KD\>!'99JQ .(5813N!*\*=L1RZVAP5GC4K?#5^/V0OF,Q
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MMFOP5H"2$6 AC#3A@DNGH<;UW"U/BO@^^VK\ZL#3/0.RWZ*_/](0[?##@6O
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M/5GM)_PCLJ5B532*/T^B1FQ0N/K$V\%8YP%5'%OF?=PBCA-?KYUK>F4UT/H
MQ2N7<-T2/=?-B)_.)_.;:>4$:E@TX, ;@7'*+576 *^ %X9)X>KU&2FN+#^K
M4XZ7?5 X%X*B%IPO(V\JQ;AU"$6=^.'K*XM85A4(EZ__U<E,T2X_$SC%%%HA
MN4$4*0@EYV2GF*EE],K*%B3CJ1P-*W*!^L_/OU5.S?F&5M^*./=B^7S+GTQ3
M;#I$\,ICZ3Q23&")?*0^V5. 6)H2E#Y", X#GC(+;W*A\]%Y\E+Q/"[@?8,T
MB;/&"=0AR8QPF@-.-5>\#FI$47*XI-) (TRS[5/!]TGW7!A\.?,7]*H;!IIR
MN=*3Y5&+\MRA@B-,<<B 099+K[6J.LKM*&(,9UDE9N]-17M"2YF5"2.!Y<W-
M^JZZ3RIN?UN4R^6?\T4QF57K^BVJ$UU\+1=Q:__3'JO-Q@]5P3BBI,>4*:><
ME(["'>TX8$DW"2,4I:, <"^<&3NJW\>?^D3UL_&#MA(AS2@"E !/H'*[A)E(
M.V)EB@=@E.DDX\9U"F^&PO53=_3359YNS'KF2(%JZYE$2F$EN'9*0>1J>GB9
MU#MDA+DLPR"U6QZ,XGKDA3OBBN]'''2 $<B,!8!PCJFT$1*20L15=0$_W/W(
M<9@]AA,TH,>Y0P4',*; &T IY(Q@*:+1NZ.*U<T"8]["56QC])PE0I(9,@Z]
M]KB,_YJNOD_G'^;%?Q>3Q;,S5@>@/3QX0!0"H+F+ID#EK,!*:U!3#8C,!^B\
M=3#Z0UA+*'?&IK&!6WVM2NK/BR_?%^7ZVW<__;%9XK)KG#?Z3JB:A&H9#1HJ
M330Q#-DT4]S1DO.4,G%C;S,X.LCWP;'6@>1G3;J:ZF[67_Z.I']HA.A>OA.\
M$56Q)VVYTMQC*",R]CH6VY360F>W^\ANB_2.Z3'P;"3NI5Y]^7'Y'!L4.< 8
M LAI8F!-$0.2Y/+Y!_$GOOQKP' FIHS-\'AF4?G)=/&OR6Q]+&8N;>  &9("
M*^<\Q-%>VQ15JZG%B<U:TO[Z!/$@3!H;I ]93%VB^^0W HC'>2>LDU8A)&D4
M!&HO%CA&*57MQE]:8W1 [YI?0UK0QW#<^3>"LU4_%0B9Q%)29:&U^Y.%$4G5
M8L=>!O1B[.:VW!J'Y/XY%RSASBI0 Q0R'A#O!3720XGV^]@KEW)9=7XECS=B
M(W?$C&%OK09.1\Y]9Z6EU11Y@+P0UGL)2<U[(9TSC0H4#I;3TR3%\)QA K<,
M8D(5,) 93!34@@L/J .4,YNW)\*8[ZH:H^;\I)^VS,BEQ)Y0R<PFR^7TZ[2X
MU0^FG&](LY[,=A+VP4Y6S6&:,FR@4'I)*0! 0HZ891Z+FAW"X93*:>,MY9\1
MMAF9DT_Y?5A]+Q;;1-S!M)W=(:MRHRW-Y'ZZV@9B?5P4]Y/I;>3EDUF>6:4C
M:>1@*%2626NC^-%(T*I#S";0!D,M"1PP3?_5>3<1,<=?#)9H3+%W7A-$6#PZ
M*+9?L>8TY6YDA#DUV?!1]LB$083%T%GOXY495G"-H>=,,*Z8-=Z8R#Q4M;75
MA#7K8-&[T?)N'M>A;G]4U?N77TKU]>MT-HU::WDJ2[[Q& $C;*NL+P BB+$
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M8 7L_EB33]!\*E;3Q4:\5TE<PPF5JF!@M(<GNZH=C],Z2Z"<,4K VC!E)$&
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M)A(D=H9C687%(4YTA(Q4.VY8IU'*V6Z\13+?X@[M$Q87LTE?\;0.M4W/G$J
MRD)-#6+"<04B@B3W-4>$ERF78<T=_K\V:O\;M5]@7,Q6?<6Y.YQ&/6LJ@4!
M/ 88(LV$8DI(S6J.&"@;E19,OF/XM55SZ-0^@3&:K7HUKB*MH9; 2!PI[KR6
MW E=TQ]RFE(*Y8U=9 R^-0=!Q*7LR-T:JPRHWJ\+?_I6X-P@HQ@1C@HA$1<8
M[X/9/%0IH2EG'RDSU[H:R2U&*D\N!>?_*I;5QI[?1D5<W%3A>67UJYRWY4VG
M$ "3!AA?-8\5"A%-O6(U!Y3Q*4;A^,]O(]D7/3'K4K;+$[$PD*'6< ;! $<T
M LS%\RP$TB,.:_HS[),*!YQ]@GKS*J1#3EW*3CDM* ;:0&D3"Q@ BR4S3'E+
M$3!.>U5S2["D(KAG'X!^*:$,+,RZX?XZ392_SCZO?2JJ6L7Q]Z:<;QBWGLR^
M%(L[=&J7Y9U-H%!K9CWQ##A-(*+<TIHOP"75)^1O:FN-FF^7LI\.J^]#E( ]
M[J<6LPE(<Z\<<80*J2PE"((Z<8@A)5(Z4(DW9 *.FFN7LIO.5ME#;++N)AF8
M%4QS[C'S@$ BI'&BYJ+$.B5L2_[292-GYZ6<T9Y0XEU<\'2^G-[\:S);9[IH
M>O[-X &.%$:,."@@,1IPMQ=\&J:5<@%O2%^-@#F7HI6>Z.?GZ\UDRKWX:- "
M8,40X4)Q:UUDN_-[W8\Q3-D";ZN<T1CX<REJX+2>5-^^+3:9MMG41.LY156M
M*?=0 X(EU9X"0MU>54N65$-P_!'S(U$DN=@W@J*$+XKX74!50@D<DT8 9YA"
M!KLHU;8)WMI+1)ELLD-ZDF3[ZK7M \N:M_!-_$:@ &IGD2%24^,IU8SBFHY8
M^I2K@*26F%DD2V,0'2Q0G)?\N93Q=H+QDP<Z^+[Z7(":(1?M:*^D-'$I6,&:
MFLHYE+7P;?]0&@ #97?4'XU9=Y VCZN;WWZ<3>9_3.Z*@VU_^_Q<  H:P$TT
M/2P' J)HB,B:L@#E[9S7/ZY;HJJSF.K.&)$+XI^B3;B85O;AQKSZ<SY=+3]]
M_O-@:]I&[P7JC!61ZB:NBVCKL.2B7JNE,"5.;(2@&Q8N/_5"ZXXQN4#XL5AL
MNN/,;XH-G98GX7?@C>"P5U6J/&&*T;@JIB'=K4\K!;*VLGACP.N&):-1[8<H
M][Y!A^7TP0,$SDG/'(; 0B 0E'AWHP\ E#3%'!TCD <W1[.S;/1 WYXVW\VC
M.EEO"/]A];U8?/D^F>\\3'^4\Q\;)U//[0=:3218Z85'E$N$J_HI& !I:VXX
MYE-J HS?CY\3S5UMI!QLOJ)-UU]2R+ES",Y03QQ&%GC#! 6$\]V=3(44G1+E
M=.7%JWK&?/ZMV0H1E[\KGU<.&F13/I]"L,Y")BF%B#&(K554\)H# I$4M\_X
MK^#>_'Y, L/E;\?MW>>@V_'Y%((D!F),''0@XAD0 !FN.8!5LS9D'7>!^+4=
MLVW')#!<_G;<%0,:>$?^-(O L.>"4.T<MT(CP1%'-1^X RGACE?<?N):-F4J
M'BY_7X[Q+,FME-+X"!=IB<$$  9J'B I4^(OSTZ:OJ3J-M>R*]/P<$5[\D5B
MQ,:BMU%%^,ETL8G3&XW7]9R9!JXX<4AZQ8 Q1 O!F)=$,PL58Y'!5W:O<=5^
MV!X9_Y8V\LAW;Q"":\Z4<5X09#DRC.Z=><Z*K!%$U^K>[6<KC5 DG(FFRY<#
M1XO*CT08G#G'0)F1T?A"3"/+(([')KGK^@00D38EO.N7<_GRI4&_<+I\D?#<
M'3A.D7#F'$/DG/)8*(HHPBZ>'16M?9I(T9=-T_NME_E+)(Q.)/0+I\L7"4_J
MY8]3'IPSP1#YQJP$AD;@ 0E(/+>JFGN )#GQQE\F])<P&!!+ER\)KL=O8###
MF$(AK!;,,Z20EC7GI":-DEQ_N?*O6 [TAJ41Y*2_\&=>0DZZU1H(;91QQB"H
M!(!P&SGON+>Z4<!TWSGI[NY^5CX4Q>=B\6.ZRS/Y&9JSS>3BGSY\_53<E-_F
MT_^+R-Q( %,N5\OF^>D=?B] PQSU<=\!ZA 4FFI$:_I2J+*V>,V?J]X47 =S
MU8=C12Z;XMT\BI7B<^3N1JR^WZWD1!;[D;<"01A*9IP@V@FGJ25UA0 GK'4I
M&GB$D!L8*V5??!D8?R?3UH^^%RS"4D+G,; 822((XK)>J[$BI:3P"#'8"=>;
M(:D5?7-AJ=I '[Y^GLP:Y/+^]&P0@"GE/8),80$D@5SS>DU:PJ0B;!>#F7/Y
M6W9+U=-(B29QN>$_H#ON5[^I$M"+^/)W-;^UQ8]B5MY7JSJ(@I/O!*6Q011@
M9!G##D((N-G-6U93OZZ0D6[1T#5U6Z-B \3)_/;WR>+?Q6HZ_W8<$ <>#Y "
M$36PMC!.%6 !I4#U; E*NGE,:LMU,5CHAK"YU,AOQ;Q83&81N.KV;CJ?5J>)
MU?1'4=6TFR^+DZJET?M!<*PLYX8BZ;PBCKI=-XJX=@!<GCCP"P55GY1N+6S4
M33Q]+J?5LC;E4-8WJ_6BJG@XO]WXH#:1=7\4)Y32>:,$JN(YP7%HX@&!&:\0
MD[Y>&P0L)4PJJ=W3):"H?WKGDEC='#W?-R@RTO&7 D28.(((8P0B@02,/];T
M]!3ZZS*SQN4L&):7V0HS;A=0W+Z^OIVJ. +Y9@,$)0BN@J19E @"6V6DKP_:
M4H&D6)01'A\'P\[+@HY],&<$-SE?BG^J+A07=Y\#*211[UJ+N:-"5S0'T>3"
MT@K'F!-CN,_9Z/4/?T?3<?E]>O]N'G=+<=8%S;$!@F9&.D.%) 0P[I$45&XI
M(!TQ(*6'<Y(<R%^$O#$6#EZ_=$CH;%4%=W7M3ER@/'TL6.XY9]XY03D#7$DD
M>+T2 T2*$31VR'3-ZY?E =N3.3=@3MYXO*B8*!Q@5F%#J/*$"J<$1O5J)$"-
M).V%@J8=5P] HQ4Y6SL)OOQ=?OE>KBMG6#QA^G*]V)@ \<_Q;!N7/OU1;,)8
MJMD==Q2</U*@_W][U];;1HZEW_?'S/)^ 18#\(H),!EG,T8/^HE0[$HBM"SU
MZ))-]M</*:E*MF/)4K&J1%EY:'<LJUCD.1]Y;CSG2,]=U( 4UA!9"PB1]2[R
M@@\;X1C\AF1;?L^&I'E[3W>:QX?5_.YK5(%?!\^>KP<%-,+,::",U]P(J3RL
M9\LYST%(@>9X%Y#HAI(MA<UBOGPD:.)OSX5,_"A\3%?F]J@C3_X>@-<(*NHL
MP,881"1UJL&JSW(F9G'_<O60'/KVCHF]1\2S;P0(,! BGE\8&46(%82#>M[
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M7>?3'1V76B<_]''6O_;.0(@VJ5ICU/%AM#:=HK(1I]#(K))7X/HV1&D,&_[
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MDQ6(*^-L.!H=LV'H/Y3.O%M#5(7^+Q6F7,35?(QLGD<SX#;.17T?'XH!'S=
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MQ3W14A'N+:)>-.ZSJ&3G6#;E:YSE0+4;]I0!75O=K^[6MV#:>W^:(0*FU!D
MB6=("H,4I:;9O$:A'._W\=%TN0'HM/HR6D8N#>L(*@>EK=E2!C"[$O$>2V@,
M\)HCY#0G@D)?KUU[FI6<WD[$N^G]->*Q'4..B-=N_Y!^I(I5?_VO_P!02P$"
M% ,4    " "\B/=,MJ, KKL5 @"*.2, $0              @ $     86YG
M;RTR,#$X,#4S,2YX;6Q02P$"% ,4    " "\B/=,_9@J8"T7  "N%P$ $0
M            @ 'J%0( 86YG;RTR,#$X,#4S,2YX<V102P$"% ,4    " "\
MB/=,M8*^IQ\R  !>,P( %0              @ %&+0( 86YG;RTR,#$X,#4S
M,5]C86PN>&UL4$L! A0#%     @ O(CW3.P;TW51:0  +BP% !4
M     ( !F%\" &%N9V\M,C Q.# U,S%?9&5F+GAM;%!+ 0(4 Q0    ( +R(
M]TR>(]S>GC(! #50$  5              "  1S) @!A;F=O+3(P,3@P-3,Q
M7VQA8BYX;6Q02P$"% ,4    " "\B/=,84)F\\FW   D6 D %0
M    @ 'M^P, 86YG;RTR,#$X,#4S,5]P<F4N>&UL4$L%!@     &  8 B@$
' .FS!     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
